PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Suharti, S; Wang, MY; de Vries, S; Ferry, JG				Suharti, Suharti; Wang, Mingyu; de Vries, Simon; Ferry, James G.			Characterization of the RnfB and RnfG Subunits of the Rnf Complex from the Archaeon Methanosarcina acetivorans	PLOS ONE			English	Article							MEMBRANE-PROTEIN TOPOLOGY; IRON-SULFUR PROTEIN; ELECTRON-TRANSPORT; ECH HYDROGENASE; RHODOBACTER-CAPSULATUS; ESCHERICHIA-COLI; ACETOBACTERIUM-WOODII; DEPENDENT GROWTH; GENOME SEQUENCE; GENE-PRODUCTS	Rnf complexes are redox-driven ion pumps identified in diverse species from the domains Bacteria and Archaea, biochemical characterizations of which are reported for two species from the domain Bacteria. Here, we present characterizations of the redox-active subunits RnfG and RnfB from the Rnf complex of Methanosarcina acetivorans, an acetate-utilizing methane-producing species from the domain Archaea. The purified RnfG subunit produced in Escherichia coli fluoresced in SDS-PAGE gels under UV illumination and showed a UV-visible spectrum typical of flavoproteins. The Thr166Gly variant of RnfG was colorless and failed to fluoresce under UV illumination confirming a role for Thr166 in binding FMN. Redox titration of holo-RnfG revealed a midpoint potential of -129 mV for FMN with n = 2. The overproduced RnfG was primarily localized to the membrane of E. coli and the sequence contained a transmembrane helix. A topological analysis combining reporter protein fusion and computer predictions indicated that the C-terminal domain containing FMN is located on the outer aspect of the cytoplasmic membrane. The purified RnfB subunit produced in E. coli showed a UV-visible spectrum typical of iron-sulfur proteins. The EPR spectra of reduced RnfB featured a broad spectral shape with g values (2.06, 1.94, 1.90, 1.88) characteristic of magnetically coupled 3Fe-4S and 4Fe-4S clusters in close agreement with the iron and acid-labile sulfur content. The ferredoxin specific to the aceticlastic pathway served as an electron donor to RnfB suggesting this subunit is the entry point of electrons to the Rnf complex. The results advance an understanding of the organization and biochemical properties of the Rnf complex and lay a foundation for further understanding the overall mechanism in the pathway of methane formation from acetate.	[Suharti, Suharti; Wang, Mingyu; Ferry, James G.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [de Vries, Simon] Delft Univ Technol, Dept Biotechnol, Delft, Netherlands	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Delft University of Technology	Ferry, JG (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	jgf3@psu.edu	Suharti, Suharti/ABB-7837-2020	Suharti, Suharti/0000-0002-9849-8083; Wang, Mingyu/0000-0003-1215-9556	NSF [0820734]	NSF(National Science Foundation (NSF))	This work was supported by NSF grant number 0820734 to JGF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG FA, 1988, FEBS LETT, V234, P107, DOI 10.1016/0014-5793(88)81313-9; Backiel J, 2008, BIOCHEMISTRY-US, V47, P11273, DOI 10.1021/bi800920j; Biegel E, 2011, CELL MOL LIFE SCI, V68, P613, DOI 10.1007/s00018-010-0555-8; Biegel E, 2010, P NATL ACAD SCI USA, V107, P18138, DOI 10.1073/pnas.1010318107; Biegel E, 2009, ENVIRON MICROBIOL, V11, P1438, DOI 10.1111/j.1462-2920.2009.01871.x; Buan NR, 2010, MOL MICROBIOL, V75, P843, DOI 10.1111/j.1365-2958.2009.06990.x; Pereira IAC, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00069; CLEMENTS AP, 1994, J BACTERIOL, V176, P2689, DOI 10.1128/JB.176.9.2689-2693.1994; Curatti L, 2005, P NATL ACAD SCI USA, V102, P6291, DOI 10.1073/pnas.0501216102; ESKELINEN S, 1983, SCAND J CLIN LAB INV, V43, P453; Galagan JE, 2002, GENOME RES, V12, P532, DOI 10.1101/gr.223902; Guss AM, 2009, J BACTERIOL, V191, P2826, DOI 10.1128/JB.00563-08; Heidelberg JF, 2004, NAT BIOTECHNOL, V22, P554, DOI 10.1038/nbt959; Hess V, 2013, J BIOL CHEM, V288, P31496, DOI 10.1074/jbc.M113.510255; Jasso-Chavez R, 2013, J BACTERIOL, V195, P3987, DOI 10.1128/JB.00581-13; Jouanneau Y, 1998, EUR J BIOCHEM, V251, P54, DOI 10.1046/j.1432-1327.1998.2510054.x; Juarez O, 2012, BBA-BIOENERGETICS, V1817, P1823, DOI 10.1016/j.bbabio.2012.03.017; Kim J, 2004, FEMS MICROBIOL REV, V28, P455, DOI 10.1016/j.femsre.2004.03.001; Koo MS, 2003, EMBO J, V22, P2614, DOI 10.1093/emboj/cdg252; Kumagai H, 1997, BIOCHEMISTRY-US, V36, P5509, DOI 10.1021/bi970014q; Li LY, 2007, J PROTEOME RES, V6, P759, DOI 10.1021/pr060383l; Li QB, 2006, J BACTERIOL, V188, P702, DOI 10.1128/JB.188.2.702-710.2006; Lu CH, 2004, BIOTECHNOL PROGR, V20, P1634, DOI 10.1021/bp049751l; LU WP, 1993, J BIOL CHEM, V268, P5605; MANOIL C, 1990, J BACTERIOL, V172, P515, DOI 10.1128/jb.172.2.515-518.1990; Masepohl B, 1996, ARCH MICROBIOL, V165, P80, DOI 10.1007/s002030050301; MaupinFurlow J, 1996, J BACTERIOL, V178, P340, DOI 10.1128/jb.178.2.340-346.1996; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; McInerney MJ, 2007, P NATL ACAD SCI USA, V104, P7600, DOI 10.1073/pnas.0610456104; Melchers K, 1999, RES MICROBIOL, V150, P507, DOI 10.1016/S0923-2508(99)00106-0; Melen K, 2003, J MOL BIOL, V327, P735, DOI 10.1016/S0022-2836(03)00182-7; Meuer J, 1999, EUR J BIOCHEM, V265, P325, DOI 10.1046/j.1432-1327.1999.00738.x; Meuer J, 2002, P NATL ACAD SCI USA, V99, P5632, DOI 10.1073/pnas.072615499; Meyer B, 2014, ENV MICROBI IN PRESS; Muller V, 2008, ANN NY ACAD SCI, V1125, P137, DOI 10.1196/annals.1419.011; Nakayama Y, 2000, FEBS LETT, V474, P165, DOI 10.1016/S0014-5793(00)01595-7; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; RAGSDALE SW, 1987, J BIOL CHEM, V262, P14289; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Saaf A, 1999, P NATL ACAD SCI USA, V96, P8540, DOI 10.1073/pnas.96.15.8540; Saeki K, 1998, ARCH MICROBIOL, V169, P464, DOI 10.1007/s002030050598; Schlegel K, 2013, BIOCHEM SOC T, V41, P421, DOI 10.1042/BST20120294; Schlegel K, 2012, FEBS J, V279, P4444, DOI 10.1111/febs.12031; Schlegel K, 2012, P NATL ACAD SCI USA, V109, P947, DOI 10.1073/pnas.1115796109; Schmidt S, 2009, BBA-BIOENERGETICS, V1787, P691, DOI 10.1016/j.bbabio.2008.12.015; Seedorf H, 2008, P NATL ACAD SCI USA, V105, P2128, DOI 10.1073/pnas.0711093105; SIEGEL LM, 1965, ANAL BIOCHEM, V11, P126, DOI 10.1016/0003-2697(65)90051-5; Suharti, 2001, BIOCHEMISTRY-US, V40, P2632, DOI 10.1021/bi0020067; Suharti S, 2008, BIOCHEMISTRY-US, V47, P11528, DOI 10.1021/bi801012p; Tietze M, 2003, CHEMBIOCHEM, V4, P333, DOI 10.1002/cbic.200390053; TREMBLAY P, 2012, MBIO; Verkhovsky MI, 2010, BBA-BIOENERGETICS, V1797, P738, DOI 10.1016/j.bbabio.2009.12.020; VONWACHENFELDT C, 1994, FEBS LETT, V340, P109, DOI 10.1016/0014-5793(94)80182-7; Wang MY, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-165; Welte C, 2013, BIOCH BIOPH IN PRESS; Welte C, 2011, METHOD ENZYMOL, V494, P257, DOI 10.1016/B978-0-12-385112-3.00013-5; Welte C, 2010, FEBS J, V277, P3396, DOI 10.1111/j.1742-4658.2010.07744.x; Welte C, 2010, J BACTERIOL, V192, P674, DOI 10.1128/JB.01307-09; WHITBY LG, 1953, BIOCHEM J, V54, P437, DOI 10.1042/bj0540437; Worm P, 2011, MICROBIOL-SGM, V157, P280, DOI 10.1099/mic.0.043927-0	60	22	25	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97966	10.1371/journal.pone.0097966	http://dx.doi.org/10.1371/journal.pone.0097966			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836163	Green Submitted, Green Published, gold			2022-12-27	WOS:000339614800093
J	Arachiche, A; de la Fuente, M; Nieman, MT				Arachiche, Amal; de la Fuente, Maria; Nieman, Marvin T.			Platelet Specific Promoters Are Insufficient to Express Protease Activated Receptor 1 (PAR1) Transgene in Mouse Platelets	PLOS ONE			English	Article							FACTOR-VIII; THROMBIN; IDENTIFICATION; HEMATOPOIESIS; HEMOSTASIS; MICE	The in vivo study of protease activated receptors (PARs) in platelets is complicated due to species specific expression profiles. Human platelets express PAR1 and PAR4 whereas mouse platelets express PAR3 and PAR4. Further, PAR subtypes interact with one another to influence activation and signaling. The goal of the current study was to generate mice expressing PAR1 on their platelets using transgenic approaches to mimic PAR expression found in human platelets. This system would allow us to examine specific signaling from PAR1 and the PAR1-PAR4 heterodimer in vivo. Our first approach used the mouse GPIb alpha promoter to drive expression of mouse PAR1 in platelets (GPIb alpha-Tg-mPAR1). We obtained the expected frequency of founders carrying the transgene and had the expected Mendelian distribution of the transgene in multiple founders. However, we did not observe expression or a functional response of PAR1. As a second approach, we targeted human PAR1 with the same promoter (GPIb alpha-Tg-hPAR1). Once again we observed the expected frequency and distributing of the transgene. Human PAR1 expression was detected in platelets from the GPIb alpha-Tg-hPAR1 mice by flow cytometry, however, at a lower level than for human platelets. Despite a low level of PAR1 expression, platelets from the GPIb alpha-Tg-hPAR1 mice did not respond to the PAR1 agonist peptide (SFLLRN). In addition, they did not respond to thrombin when crossed to the PAR4(-/-) mice. Finally, we used an alternative platelet specific promoter, human a(IIb), to express human PAR1 (a(IIb)-Tg-hPAR1). Similar to our previous attempts, we obtained the expected number of founders but did not detect PAR1 expression or response in platelets from alpha(IIb)-Tg-hPAR1 mice. Although unsuccessful, the experiments described in this report provide a resource for future efforts in generating mice expressing PAR1 on their platelets. We provide an experimental framework and offer considerations that will save time and research funds.	[Arachiche, Amal; de la Fuente, Maria; Nieman, Marvin T.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA	Case Western Reserve University	Nieman, MT (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA.	nieman@case.edu			American Heart Association [10SDG2600021]; NIH [HL098217]; Cytometry and Light Microscopy Core Facility; Transgenic & Targeting Core Facility of the Comprehensive Cancer Center of Case Western Reserve University; University Hospitals of Cleveland [P30 CA43703]; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098217] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cytometry and Light Microscopy Core Facility; Transgenic & Targeting Core Facility of the Comprehensive Cancer Center of Case Western Reserve University; University Hospitals of Cleveland; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by grants from the American Heart Association (AHA Scientist Development Grant, 10SDG2600021) and the NIH (HL098217) to MTN. This research was also supported by the Cytometry and Light Microscopy Core Facility and the Transgenic & Targeting Core Facility of the Comprehensive Cancer Center of Case Western Reserve University and University Hospitals of Cleveland (P30 CA43703). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arachiche A, 2013, J BIOL CHEM, V288, P32553, DOI 10.1074/jbc.M113.472373; Arachiche A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055740; Aronovich A, 2013, BLOOD, V122, P2562, DOI 10.1182/blood-2012-08-447458; CONNOLLY TM, 1994, THROMB HAEMOSTASIS, V72, P627; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; de la Fuente M, 2012, J BIOL CHEM, V287, P10414, DOI 10.1074/jbc.M112.341438; DERIAN CK, 1995, THROMB RES, V78, P505, DOI 10.1016/0049-3848(95)00084-5; Dowal L, 2011, P NATL ACAD SCI USA, V108, P2951, DOI 10.1073/pnas.1014863108; KOZAK M, 1978, CELL, V13, P201, DOI 10.1016/0092-8674(78)90150-2; Nakanishi-Matsui M, 2000, NATURE, V404, P609, DOI 10.1038/35007085; Pawlinski R, 2007, CIRCULATION, V116, P2298, DOI 10.1161/CIRCULATIONAHA.107.692764; Sambrano GR, 2001, NATURE, V413, P74, DOI 10.1038/35092573; Sun HM, 2003, BLOOD, V102, P2856, DOI 10.1182/blood-2003-04-1225; Wilcox DA, 1999, P NATL ACAD SCI USA, V96, P9654, DOI 10.1073/pnas.96.17.9654; Yang TL, 2000, THROMB HAEMOSTASIS, V83, P70; Yarovoi HV, 2003, BLOOD, V102, P4006, DOI 10.1182/blood-2003-05-1519; Yin YJ, 2006, CANCER RES, V66, P5224, DOI 10.1158/0008-5472.CAN-05-4234; Yue R, 2012, DEV CELL, V22, P1092, DOI 10.1016/j.devcel.2012.01.025; Zhang C, 2012, NATURE, V492, P387, DOI 10.1038/nature11701; Zhang Y, 2012, J THROMB HAEMOST, V10, P2149, DOI 10.1111/j.1538-7836.2012.04894.x	20	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97724	10.1371/journal.pone.0097724	http://dx.doi.org/10.1371/journal.pone.0097724			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830314	Green Published, Green Submitted, gold			2022-12-27	WOS:000336789500106
J	Bregeon, F; Brioude, G; De Dominicis, F; Atieh, T; D'Journo, XB; Flaudrops, C; Rolain, JM; Raoult, D; Thomas, PA				Bregeon, Fabienne; Brioude, Geoffrey; De Dominicis, Florence; Atieh, Therese; D'Journo, Xavier Benoit; Flaudrops, Christophe; Rolain, Jean-Marc; Raoult, Didier; Thomas, Pascal Alexandre			MALDI-ToF Mass Spectrometry for the Rapid Diagnosis of Cancerous Lung Nodules	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; DIRECT IDENTIFICATION; PROTEOMIC ANALYSIS; FROZEN-SECTION; CLASSIFICATION	Recently, tissue-based methods for proteomic analysis have been used in clinical research and appear reliable for digestive, brain, lymphomatous, and lung cancers classification. However simple, tissue-based methods that couple signal analysis to tissue imaging are time consuming. To assess the reliability of a method involving rapid tissue preparation and analysis to discriminate cancerous from non-cancerous tissues, we tested 141 lung cancer/non-tumor pairs and 8 unique lung cancer samples among the stored frozen samples of 138 patients operated on during 2012. Samples were crushed in water, and 1.5 mu l was spotted onto a steel target for analysis with the Microflex LT analyzer (Bruker Daltonics). Spectra were analyzed using ClinProTools software. A set of samples was used to generate a random classification model on the basis of a list of discriminant peaks sorted with the k-nearest neighbor genetic algorithm. The rest of the samples (n = 43 cancerous and n = 41 non-tumoral) was used to verify the classification capability and calculate the diagnostic performance indices relative to the histological diagnosis. The analysis found 53 m/z valid peaks, 40 of which were significantly different between cancerous and non-tumoral samples. The selected genetic algorithm model identified 20 potential peaks from the training set and had 98.81% recognition capability and 89.17% positive predictive value. In the blinded set, this method accurately discriminated the two classes with a sensitivity of 86.7% and a specificity of 95.1% for the cancer tissues and a sensitivity of 87.8% and a specificity of 95.3% for the non-tumor tissues. The second model generated to discriminate primary lung cancer from metastases was of lower quality. The reliability of MALDI-ToF analysis coupled with a very simple lung preparation procedure appears promising and should be tested in the operating room on fresh samples coupled with the pathological examination.	[Bregeon, Fabienne; Brioude, Geoffrey; De Dominicis, Florence; Atieh, Therese; D'Journo, Xavier Benoit; Flaudrops, Christophe; Rolain, Jean-Marc; Raoult, Didier; Thomas, Pascal Alexandre] Aix Marseille Univ, Fac Med & Pharm, IHU Mediterranee Infect, URMITE,UMR 63,CNRS 7278,IRD 3R198,INSERM,U1095, Marseille, France; [Bregeon, Fabienne] Explorat Fonct Resp Ctr Hosp Univ Nord, Assistance Publ Hop Marseille, Pole Thorac & Cardiovasc, Marseille, France; [Brioude, Geoffrey; De Dominicis, Florence; D'Journo, Xavier Benoit; Thomas, Pascal Alexandre] Aix Marseille Univ, Ctr Hosp Univ Nord, Assistance Publ Hop Marseille, Serv Chirurg Thorac & Malad Oesophage,Pole Thorac, Marseille, France; [Rolain, Jean-Marc; Raoult, Didier] CHU Timone, Assistance Publ Hop Marseille, Pole Malad Infect & Trop Clin & Biol, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Bregeon, F (corresponding author), Aix Marseille Univ, Fac Med & Pharm, IHU Mediterranee Infect, URMITE,UMR 63,CNRS 7278,IRD 3R198,INSERM,U1095, Marseille, France.		Rolain, Jean-Marc/Y-3788-2019; D'journo, Xavier Benoit/AAJ-4457-2021; RAOULT, Didier/A-8434-2008; Thomas, Pascal/L-3355-2019; Thomas, Pascal A/E-5036-2010	Rolain, Jean-Marc/0000-0002-2402-4467; D'journo, Xavier Benoit/0000-0001-6747-4583; RAOULT, Didier/0000-0002-0633-5974; Thomas, Pascal/0000-0002-3305-6989; Thomas, Pascal A/0000-0002-3305-6989	URMITE	URMITE	A grant from the URMITE was provided. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balluff B, 2010, J PROTEOME RES, V9, P6317, DOI 10.1021/pr100573s; Chatelain D, 2012, J VISC SURG, V149, pE134, DOI 10.1016/j.jviscsurg.2012.01.005; Eberlin LS, 2013, P NATL ACAD SCI USA, V110, P1611, DOI 10.1073/pnas.1215687110; Ferreira L, 2010, J CLIN MICROBIOL, V48, P2110, DOI 10.1128/JCM.02215-09; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Groseclose MR, 2008, PROTEOMICS, V8, P3715, DOI 10.1002/pmic.200800495; James P, 1997, Q REV BIOPHYS, V30, P279, DOI 10.1017/S0033583597003399; La Scola B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008041; Le Faouder J, 2011, J PROTEOME RES, V10, P3755, DOI 10.1021/pr200372p; Lee GK, 2012, LUNG CANCER, V76, P197, DOI 10.1016/j.lungcan.2011.10.016; Marchevsky AM, 2004, ANN THORAC SURG, V78, P1755, DOI 10.1016/j.athoracsur.2004.05.003; Maygarden SJ, 2004, MODERN PATHOL, V17, P1080, DOI 10.1038/modpathol.3800154; Meding S, 2012, J PROTEOME RES, V11, P1996, DOI 10.1021/pr200784p; Poon TCW, 2001, CLIN CHIM ACTA, V313, P231, DOI 10.1016/S0009-8981(01)00677-5; Rahman SMJ, 2011, CANCER RES, V71, P3009, DOI 10.1158/0008-5472.CAN-10-2510; Remmerbach TW, 2011, ORAL ONCOL, V47, P278, DOI 10.1016/j.oraloncology.2011.02.005; Rivera MP, 2003, CHEST, V123, p129S, DOI 10.1378/chest.123.1_suppl.129S; Scott WJ, 2007, CHEST, V132, p234S, DOI 10.1378/chest.07-1378; Yssouf A, 2013, J CLIN MICROBIOL, V51, P522, DOI 10.1128/JCM.02665-12	19	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97511	10.1371/journal.pone.0097511	http://dx.doi.org/10.1371/journal.pone.0097511			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830707	Green Published, gold, Green Submitted			2022-12-27	WOS:000336789500071
J	Jafari, M; Xu, W; Pan, R; Sweeting, CM; Karunaratne, DN; Chen, P				Jafari, Mousa; Xu, Wen; Pan, Ran; Sweeting, Chad M.; Karunaratne, Desiree Nedra; Chen, Pu			Serum Stability and Physicochemical Characterization of a Novel Amphipathic Peptide C6M1 for SiRNA Delivery	PLOS ONE			English	Article							CELL-PENETRATING PEPTIDES; RNA INTERFERENCE; NUCLEIC-ACIDS; STABILIZATION; SOLUBILITY; CARRIER; POTENT	The efficient delivery of nucleic acids as therapeutic agents is a major challenge in gene therapy. Peptides have recently emerged as a novel carrier for delivery of drugs and genes. C6M1 is a designed amphipathic peptide with the ability to form stable complexes with short interfering RNA (siRNA). The peptide showed a combination of random coil and helical structure in water but mainly adopted a helical conformation in the presence of anions or siRNA. Revealed by dynamic light scattering (DLS) and microscopy techniques, the interaction of C6M1 and siRNA in water and HEPES led to complexes of similar to 70 and similar to 155 nm in size, respectively, but showed aggregates as large as similar to 500 nm in PBS. The time-dependent aggregation of the complex in PBS was studied by DLS and fluorescence spectroscopy. At molar ratio of 15:1, C6M1 was able to completely encapsulate siRNA; however, higher molar ratios were required to obtain stable complexes. Naked siRNA was completely degraded in 4 h in the solution of 50% serum; however C6M1 protected siRNA against serum RNase over the period of 24 h. Western blotting experiment showed similar to 72% decrease in GAPDH protein level of the cells treated with C6M1-siRNA complexes while no significant knockdown was observed for the cells treated with naked siRNA.	[Jafari, Mousa; Xu, Wen; Pan, Ran; Sweeting, Chad M.; Karunaratne, Desiree Nedra; Chen, Pu] Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada; [Jafari, Mousa; Xu, Wen; Pan, Ran; Chen, Pu] Univ Waterloo, Waterloo Inst Nanotechnol, Waterloo, ON N2L 3G1, Canada; [Karunaratne, Desiree Nedra] Univ Peradeniya, Dept Chem, Peradeniya, Sri Lanka	University of Waterloo; University of Waterloo; University of Peradeniya	Chen, P (corresponding author), Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada.	p4chen@uwaterloo.ca			Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Research Chairs (CRC) Program; Waterloo Institute for Nanotechnology fellowship	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs (CRC) Program(Canada Research Chairs); Waterloo Institute for Nanotechnology fellowship	This research was financially supported by the Natural Sciences and Engineering Research Council of Canada (NSERC), the Canada Research Chairs (CRC) Program, and Waterloo Institute for Nanotechnology fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEMAN C, 1995, INT J PEPT PROT RES, V46, P408; Crombez L, 2009, MOL THER, V17, P95, DOI 10.1038/mt.2008.215; Deshayes S, 2004, BIOCHEMISTRY-US, V43, P7698, DOI 10.1021/bi049298m; Deshayes S, 2008, ADV DRUG DELIVER REV, V60, P537, DOI 10.1016/j.addr.2007.09.005; Dykxhoorn DM, 2003, NAT REV MOL CELL BIO, V4, P457, DOI 10.1038/nrm1129; Elshereef R, 2006, BIOTECHNOL BIOENG, V95, P863, DOI 10.1002/bit.21039; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hao JG, 2009, ARCH PHARM RES, V32, P1045, DOI 10.1007/s12272-009-1710-3; Harutyunyan EH, 1996, EUR J BIOCHEM, V239, P220, DOI 10.1111/j.1432-1033.1996.0220u.x; He CB, 2010, BIOMATERIALS, V31, P3657, DOI 10.1016/j.biomaterials.2010.01.065; Jafari M, 2013, BIOCHEMISTRY-US, V52, P3428, DOI 10.1021/bi4001326; Jafari M, 2012, J PHYS CHEM B, V116, P13183, DOI 10.1021/jp3072553; Jarvert P, 2007, BIOCHEM SOC T, V35, P770; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Konate K, 2010, BIOCHEMISTRY-US, V49, P3393, DOI 10.1021/bi901791x; Koren E, 2012, TRENDS MOL MED, V18, P385, DOI 10.1016/j.molmed.2012.04.012; Lee SY, 2010, J CONTROL RELEASE, V141, P339, DOI 10.1016/j.jconrel.2009.10.007; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Lundberg P, 2002, BIOCHEM BIOPH RES CO, V299, P85, DOI 10.1016/S0006-291X(02)02595-0; Madani Fatemeh, 2011, J Biophys, V2011, P414729, DOI 10.1155/2011/414729; Mann RA, 2012, J CONTROL RELEASE, V157, P260, DOI 10.1016/j.jconrel.2011.09.081; Manoharan M, 2004, CURR OPIN CHEM BIOL, V8, P570, DOI 10.1016/j.cbpa.2004.10.007; Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775; Paddison PJ, 2008, RNA INTERFERENCE; Rao NM, 2006, BIOSCIENCE REP, V26, P301, DOI 10.1007/s10540-006-9026-8; Shi ZS, 2001, BIOPOLYMERS, V60, P366, DOI 10.1002/1097-0282(2001)60:5<366::AID-BIP10177>3.0.CO;2-5; Veldhoen S, 2008, INT J MOL SCI, V9, P1276, DOI 10.3390/ijms9071276; Verma S, 2003, CHEM REC, V3, P51, DOI 10.1002/tcr.10047; Wasungu L, 2006, J CONTROL RELEASE, V116, P255, DOI 10.1016/j.jconrel.2006.06.024; Xu PS, 2006, BIOTECHNOL BIOENG, V95, P893, DOI 10.1002/bit.21036; Zhang HY, 2006, CURR TOP MED CHEM, V6, P893, DOI 10.2174/156802606777303676	31	31	32	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97797	10.1371/journal.pone.0097797	http://dx.doi.org/10.1371/journal.pone.0097797			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831131	Green Published, gold, Green Submitted			2022-12-27	WOS:000336789500117
J	Koutsoni, O; Barhoumi, M; Guizani, I; Dotsika, E				Koutsoni, Olga; Barhoumi, Mourad; Guizani, Ikram; Dotsika, Eleni			Leishmania Eukaryotic Initiation Factor (LeIF) Inhibits Parasite Growth in Murine Macrophages	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; NECROSIS-FACTOR-ALPHA; IFN-GAMMA; VISCERAL LEISHMANIASIS; IMMUNE-RESPONSE; CC-CHEMOKINE; INFLAMMATORY PROTEIN-1-ALPHA; ACTIVATED MACROPHAGES; INTERLEUKIN (IL)-12; MAJOR AMASTIGOTES	The leishmaniases constitute neglected global public health problems that require adequate control measures, prophylactic clinical vaccines and effective and non-toxic drug treatments. In this study, we explored the potential of Leishmania infantum eukaryotic initiation factor (LieIF), an exosomal protein, as a novel anti-infective therapeutic molecule. More specifically, we assessed the efficacy of recombinant LieIF, in combination with recombinant IFN-gamma, in eliminating intracellular L. donovani parasites in an in vitro macrophage model. J774A.1 macrophages were initially treated with LieIF/IFN-gamma prior to in vitro infection with L. donovani stationary phase promastigotes (pre-infection treatment), and resistance to infection was observed 72 h after infection. J774A.1 macrophages were also treated with LieIF/IFN-gamma after L. donovani infection (post-infection treatment), and resistance to infection was also observed at both time points tested (19 h and 72 h) after infection. To elucidate the LieIF/IFN-gamma-induced mechanism(s) that mediate the reduction of intracellular parasite growth, we examined the generation of potent microbicidal molecules, such as nitric oxide (NO) and reactive oxygen species (ROS), within infected macrophages. Furthermore, macrophages pre-treated with LieIF/IFN-gamma showed a clear up-regulation in macrophage inflammatory protein 1 alpha (MIP-1 alpha) as well as tumor necrosis factor alpha (TNF-alpha) expression. However, significant different protein levels were not detected. In addition, macrophages pre-treated with LieIF/IFN-gamma combined with anti-TNF-alpha monoclonal antibody produced significantly lower amounts of ROS. These data suggest that during the pre-treatment state, LieIF induces intramacrophage parasite growth inhibition through the production of TNF-alpha, which induces microbicidal activity by stimulating NO and ROS production. The mechanisms of NO and ROS production when macrophages are treated with LieIF after infection are probably different. Overall, these results indicate that LieIF is a good candidate for use as an anti-leishmanial molecule.	[Koutsoni, Olga; Dotsika, Eleni] Hellenic Pasteur Inst, Dept Microbiol, Cellular Immunol Lab, Athens, Greece; [Barhoumi, Mourad; Guizani, Ikram] Univ Tunis El Manar, Inst Pasteur Tunis, Lab Epidemiol Mol & Pathol Expt Appl Malad Infect, Tunis, Tunisia; [Koutsoni, Olga] Natl & Kapodistrian Univ, Med Sch Athens, Dept Microbiol, Athens, Greece	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; National & Kapodistrian University of Athens	Guizani, I (corresponding author), Univ Tunis El Manar, Inst Pasteur Tunis, Lab Epidemiol Mol & Pathol Expt Appl Malad Infect, Tunis, Tunisia.	ikram.guizani@pasteur.rns.tn; e.dotsika@pasteur.gr	Koutsoni, Olga/AAH-5511-2021; Barhoumi, Mourad/AAU-8031-2020; Dotsika, Elissavet/D-7260-2016	Dotsika, Elissavet/0000-0003-1858-2961; Guizani, Ikram/0000-0003-2763-8963	Institut Pasteur fellowship (programme Calmette et Yersin); Greek Ministry of Education, Religious Affairs, Culture and Sport; UNICEF/UNDP/World Bank/WHO; TDR [A30134]; Tunisian ministry of higher education and scientific research [LR00SP04, LR11IPT04]	Institut Pasteur fellowship (programme Calmette et Yersin); Greek Ministry of Education, Religious Affairs, Culture and Sport; UNICEF/UNDP/World Bank/WHO(World Health Organization); TDR; Tunisian ministry of higher education and scientific research	This work was conducted in the frame of an Institut Pasteur fellowship (programme Calmette et Yersin) granted to M. B. as post-doctoral fellow. O.K. received a PhD fellowship from the Greek Ministry of Education, Religious Affairs, Culture and Sport. Work in the HPI was funded by an internal grant. Work in IPT received support from the special program of the UNICEF/UNDP/World Bank/WHO for research and training on tropical diseases, TDR (A30134) and the Tunisian ministry of higher education and scientific research (LR00SP04 and LR11IPT04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASSREUY J, 1994, EUR J IMMUNOL, V24, P672, DOI 10.1002/eji.1830240328; Awasthi A, 2004, INDIAN J MED RES, V119, P238; Badaro R, 2001, Braz J Infect Dis, V5, P223; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Barhoumi M, 2013, PARASITE IMMUNOL, V35, P194, DOI 10.1111/pim.12026; Barhoumi M, 2011, PARASITE IMMUNOL, V33, P583, DOI 10.1111/j.1365-3024.2011.01320.x; Barhoumi M, 2006, FEBS J, V273, P5086, DOI 10.1111/j.1742-4658.2006.05506.x; Basu R, 2005, J IMMUNOL, V174, P7160, DOI 10.4049/jimmunol.174.11.7160; Bhattacharyya S, 2002, J INFECT DIS, V185, P1704, DOI 10.1086/340820; Bisti S, 2006, MICROBES INFECT, V8, P1464, DOI 10.1016/j.micinf.2006.01.014; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Brandonisio O, 2002, CLIN EXP MED, V2, P125, DOI 10.1007/s102380200017; Coler RN, 2007, INFECT IMMUN, V75, P4648, DOI 10.1128/IAI.00394-07; CUNHA FQ, 1993, EUR J IMMUNOL, V23, P1385, DOI 10.1002/eji.1830230631; Das P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000899; Dey R, 2007, SCAND J IMMUNOL, V66, P671, DOI 10.1111/j.1365-3083.2007.02025.x; Dey R, 2005, INFECT IMMUN, V73, P8334, DOI 10.1128/IAI.73.12.8334-8344.2005; DING AH, 1988, J IMMUNOL, V141, P2407; Eruslanov E, 2010, METHODS MOL BIOL, V594, P57, DOI 10.1007/978-1-60761-411-1_4; EVANS TG, 1993, J IMMUNOL, V151, P907; FAHEY TJ, 1992, J IMMUNOL, V148, P2764; Gantt KR, 2001, J IMMUNOL, V167, P893, DOI 10.4049/jimmunol.167.2.893; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gossage SA, 2003, INT J PARASITOL, V33, P1027, DOI 10.1016/S0020-7519(03)00142-5; GREEN SJ, 1990, J IMMUNOL, V145, P4290; GREEN SJ, 1990, J IMMUNOL, V144, P278; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097; Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3; Kar S, 2010, J LEUKOCYTE BIOL, V88, P9, DOI 10.1189/jlb.0909644; Kumar P, 2002, J MED MICROBIOL, V51, P832, DOI 10.1099/0022-1317-51-10-832; Kumar R, 2001, CLIN EXP IMMUNOL, V124, P262, DOI 10.1046/j.1365-2249.2001.01551.x; Kyriazis JD, 2013, PHYTOMEDICINE, V20, P275, DOI 10.1016/j.phymed.2012.11.013; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liew FY, 1999, IMMUNOL LETT, V65, P101, DOI 10.1016/S0165-2478(98)00131-X; LIEW FY, 1990, J IMMUNOL, V145, P4306; LIEW FY, 1990, J IMMUNOL, V144, P4794; LIEW FY, 1991, EUR J IMMUNOL, V21, P3009, DOI 10.1002/eji.1830211216; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locati M, 1999, ANNU REV MED, V50, P425, DOI 10.1146/annurev.med.50.1.425; Matsukawa A, 2000, J IMMUNOL, V164, P5362, DOI 10.4049/jimmunol.164.10.5362; Maurer M, 2004, INT J BIOCHEM CELL B, V36, P1882, DOI 10.1016/j.biocel.2003.10.019; McConville MJ, 2011, ANNU REV MICROBIOL, V65, P543, DOI 10.1146/annurev-micro-090110-102913; Mikus Judith, 2000, Parasitology International, V48, P265, DOI 10.1016/S1383-5769(99)00020-3; Mougneau E, 2011, IMMUNOL REV, V240, P286, DOI 10.1111/j.1600-065X.2010.00983.x; Mukbel RM, 2007, AM J TROP MED HYG, V76, P669, DOI 10.4269/ajtmh.2007.76.669; MURRAY HW, 1981, J EXP MED, V153, P1302, DOI 10.1084/jem.153.5.1302; MURRAY HW, 1982, J IMMUNOL, V129, P344; NACY CA, 1991, PATHOBIOLOGY, V59, P182, DOI 10.1159/000163640; Naderer T, 2008, CELL MICROBIOL, V10, P301, DOI 10.1111/j.1462-5822.2007.01096.x; O'Garra A, 1998, CURR BIOL, V8, pR646, DOI 10.1016/S0960-9822(07)00413-7; Olivier M, 2005, CLIN MICROBIOL REV, V18, P293, DOI 10.1128/CMR.18.2.293-305.2005; Panaro MA, 1999, INT J CLIN LAB RES, V29, P122, DOI 10.1007/s005990050076; Probst P, 1997, EUR J IMMUNOL, V27, P2634, DOI 10.1002/eji.1830271024; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; SADICK MD, 1990, J EXP MED, V171, P115, DOI 10.1084/jem.171.1.115; Sakai S, 2010, VACCINE, V28, P2207, DOI 10.1016/j.vaccine.2009.12.055; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Sato N, 1999, J IMMUNOL, V163, P5519; Sato N, 2000, J EXP MED, V192, P205, DOI 10.1084/jem.192.2.205; Scott P, 2003, IMMUNOL RES, V27, P489, DOI 10.1385/IR:27:2-3:489; Sharma A, 2009, J IMMUNOL, V183, P7719, DOI 10.4049/jimmunol.0900132; Silverman JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r35; Silverman JM, 2012, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00026; Silverman JM, 2010, J CELL SCI, V123, P842, DOI 10.1242/jcs.056465; SKEIKY YAW, 1995, J EXP MED, V181, P1527, DOI 10.1084/jem.181.4.1527; Skeiky YAW, 2002, VACCINE, V20, P3292, DOI 10.1016/S0264-410X(02)00302-X; Stafford JL, 2002, CRIT REV MICROBIOL, V28, P187, DOI 10.1080/1040-840291046731; STENGER S, 1994, J EXP MED, V180, P783, DOI 10.1084/jem.180.3.783; Strieter RM, 1996, J IMMUNOL, V156, P3583; Tsagozis P, 2003, PARASITE IMMUNOL, V25, P569, DOI 10.1111/j.0141-9838.2004.00672.x; Tsikas D, 2007, J CHROMATOGR B, V851, P51, DOI 10.1016/j.jchromb.2006.07.054; Van Assche T, 2011, FREE RADICAL BIO MED, V51, P337, DOI 10.1016/j.freeradbiomed.2011.05.011; von Stebut E, 2004, MICROBES INFECT, V6, P1102, DOI 10.1016/j.micinf.2004.05.024; Zhang SY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000648	76	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97319	10.1371/journal.pone.0097319	http://dx.doi.org/10.1371/journal.pone.0097319			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830439	Green Published, gold, Green Submitted			2022-12-27	WOS:000336789500048
J	Santos, DA; Dawson, JA; Matias, CN; Rocha, PM; Minderico, CS; Allison, DB; Sardinha, LB; Silva, AM				Santos, Diana A.; Dawson, John A.; Matias, Catarina N.; Rocha, Paulo M.; Minderico, Claudia S.; Allison, David B.; Sardinha, Luis B.; Silva, Analiza M.			Reference Values for Body Composition and Anthropometric Measurements in Athletes	PLOS ONE			English	Article							X-RAY ABSORPTIOMETRY; RESEARCH WORKING GROUP; SKELETAL-MUSCLE MASS; POSITION STATEMENT; PERFORMANCE; SPORT; DETERMINANTS; VALIDATION; AUSPICES; BEHALF	Background: Despite the importance of body composition in athletes, reference sex-and sport-specific body composition data are lacking. We aim to develop reference values for body composition and anthropometric measurements in athletes. Methods: Body weight and height were measured in 898 athletes (264 female, 634 male), anthropometric variables were assessed in 798 athletes (240 female and 558 male), and in 481 athletes (142 female and 339 male) with dual-energy X-ray absorptiometry (DXA). A total of 21 different sports were represented. Reference percentiles (5th, 25th, 50th, 75th, and 95th) were calculated for each measured value, stratified by sex and sport. Because sample sizes within a sport were often very low for some outcomes, the percentiles were estimated using a parametric, empirical Bayesian framework that allowed sharing information across sports. Results: We derived sex-and sport-specific reference percentiles for the following DXA outcomes: total (whole body scan) and regional (subtotal, trunk, and appendicular) bone mineral content, bone mineral density, absolute and percentage fat mass, fat-free mass, and lean soft tissue. Additionally, we derived reference percentiles for height-normalized indexes by dividing fat mass, fat-free mass, and appendicular lean soft tissue by height squared. We also derived sex-and sport-specific reference percentiles for the following anthropometry outcomes: weight, height, body mass index, sum of skinfold thicknesses (7 skinfolds, appendicular skinfolds, trunk skinfolds, arm skinfolds, and leg skinfolds), circumferences (hip, arm, midthigh, calf, and abdominal circumferences), and muscle circumferences (arm, thigh, and calf muscle circumferences). Conclusions: These reference percentiles will be a helpful tool for sports professionals, in both clinical and field settings, for body composition assessment in athletes.	[Santos, Diana A.; Matias, Catarina N.; Rocha, Paulo M.; Minderico, Claudia S.; Sardinha, Luis B.; Silva, Analiza M.] Univ Lisbon, Exercise & Hlth Lab, CIPER, Fac Motricidade Humana, Cruz Quebrada, Portugal; [Dawson, John A.; Allison, David B.] Univ Alabama Birmingham, Sch Publ Hlth, Off Energet, Nutr Obes Res Ctr, Birmingham, AL 35294 USA; [Rocha, Paulo M.] Portuguese Inst Sport & Youth, Sport Med & Training Control Unit, Cruz Quebrada, Portugal	Universidade de Lisboa; University of Alabama System; University of Alabama Birmingham	Silva, AM (corresponding author), Univ Lisbon, Exercise & Hlth Lab, CIPER, Fac Motricidade Humana, Cruz Quebrada, Portugal.	analiza@fmh.ulisboa.pt	Santos, Diana A/H-9086-2013; Sardinha, Luís Bettencourt/F-2641-2013; Manuel Rocha, Paulo/AAE-7124-2022; Sardinha, Luís B./ABG-5389-2020; Dawson, John/HDM-6702-2022; Santos, Vanessa/AAP-4130-2020; Matias, Catarina N/I-7957-2014; Silva, Analiza M/C-9858-2010	Santos, Diana A/0000-0003-0429-3093; Sardinha, Luís Bettencourt/0000-0002-6230-6027; Sardinha, Luís B./0000-0002-6230-6027; Silva, Analiza M/0000-0002-8984-8600; Allison, David/0000-0003-3566-9399; Rocha, Paulo/0000-0001-8971-5501; Minderico, Claudia Sofia/0000-0002-3621-9501	Portuguese Foundation for Science and Technology [PTDC/DES/098963/2008, SFRH/BD/46503/2008]; National Institutes of Health (NIH) [T32HL072757]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL072757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056336, P30DK079626] Funding Source: NIH RePORTER	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Portuguese Foundation for Science and Technology (Grant: PTDC/DES/098963/2008). DAS was supported by a scholarship from the Portuguese Foundation for Science and Technology (SFRH/BD/46503/2008). JAD is supported National Institutes of Health (NIH) grant T32HL072757. The opinions expressed are those of the authors and not necessarily those of the NIH or any other organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackland TR, 2012, SPORTS MED, V42, P227, DOI 10.2165/11597140-000000000-00000; [Anonymous], 2007, MED SCI SPORT EXER, V39, P1867, DOI 10.1249/mss.0b013e318149f111; [Anonymous], 2005, CHAPTER 8 ANTHROPOME; Brun JF, 2011, CLIN HEMORHEOL MICRO, V49, P207, DOI 10.3233/CH-2011-1470; Granados C, 2008, MED SCI SPORT EXER, V40, P351, DOI 10.1249/mss.0b013e31815b4905; HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P52, DOI 10.1093/ajcn/52.1.52; HEYMSFIELD SB, 1982, AM J CLIN NUTR, V36, P680, DOI 10.1093/ajcn/36.4.680; Heymsfield SB, 2007, AM J CLIN NUTR, V86, P82, DOI 10.1093/ajcn/86.1.82; Hogstrom GM, 2012, J STRENGTH COND RES, V26, P1799, DOI 10.1519/JSC.0b013e318237e8da; Iannuzzi-Sucich M, 2002, J GERONTOL A-BIOL, V57, pM772, DOI 10.1093/gerona/57.12.M772; Jones MM, 2001, P SEOUL INT SPORT SC, P313; Kelly TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007038; Kim J, 2004, J APPL PHYSIOL, V97, P655, DOI 10.1152/japplphysiol.00260.2004; Lee RC, 2000, AM J CLIN NUTR, V72, P796, DOI 10.1093/ajcn/72.3.796; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Malina R. M., 2005, HUMAN BODY COMPOSITI, P271; Malina RM, 2007, CLIN SPORT MED, V26, P37, DOI 10.1016/j.csm.2006.11.004; Midorikawa T, 2007, INT J SPORTS MED, V28, P100, DOI 10.1055/s-2006-924139; Muller W, 2013, BRIT J SPORT MED, V47, P1028, DOI 10.1136/bjsports-2013-092232; National Institutes of Health, 1998, CLIN GUID ID EV TREA; Pietrobelli A, 1998, AM J PHYSIOL-ENDOC M, V274, pE808, DOI 10.1152/ajpendo.1998.274.5.E808; Prior BM, 1997, J APPL PHYSIOL, V83, P623, DOI 10.1152/jappl.1997.83.2.623; Prior BM, 2001, J APPL PHYSIOL, V90, P1523, DOI 10.1152/jappl.2001.90.4.1523; R Core Team, 2012, R LANG ENV STAT COMP; Rodriguez NR, 2009, MED SCI SPORT EXER, V41, P709, DOI 10.1249/MSS.0b013e31890eb86; Santos DA, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-22; Santos DA, 2013, J SPORT SCI, V31, P405, DOI 10.1080/02640414.2012.734918; Shen W., 2005, HUMAN BODY COMPOSITI, P3; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Silva AM, 2006, EUR J CLIN NUTR, V60, P955, DOI 10.1038/sj.ejcn.1602405; Silva AM, 2010, INT J SPORTS MED, V31, P737, DOI 10.1055/s-0030-1255115; Silva AM, 2011, J STRENGTH COND RES, V25, P2488, DOI 10.1519/JSC.0b013e3181fb3dfb; St-Onge MP, 2004, AM J PHYSIOL-ENDOC M, V287, pE842, DOI 10.1152/ajpendo.00361.2003; Sundgot-Borgen J, 2013, BRIT J SPORT MED, V47, P1012, DOI 10.1136/bjsports-2013-092966; TANNER J. M., 1962, Growth at adolescence. With a general consideration of the effects of hereditary and environmental factors upon growth and maturation from birth to maturity.; Toombs RJ, 2012, OBESITY, V20, P30, DOI 10.1038/oby.2011.211; Vicente-Rodriguez G, 2005, BRIT J SPORT MED, V39, P611, DOI 10.1136/bjsm.2004.014431; WANG ZM, 1992, AM J CLIN NUTR, V56, P19, DOI 10.1093/ajcn/56.1.19; World Medical Association (WMA), 2008, DECL HELS ETH PRINC	39	121	123	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97846	10.1371/journal.pone.0097846	http://dx.doi.org/10.1371/journal.pone.0097846			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830292	gold, Green Submitted, Green Published			2022-12-27	WOS:000336789500125
J	Wang, SP; Wang, L; Shi, Z; Zhong, ZF; Chen, MW; Wang, YT				Wang, Shengpeng; Wang, Lu; Shi, Zhi; Zhong, Zhangfeng; Chen, Meiwan; Wang, Yitao			Evodiamine Synergizes with Doxorubicin in the Treatment of Chemoresistant Human Breast Cancer without Inhibiting P-Glycoprotein	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; KAPPA-B ACTIVATION; MULTIDRUG-RESISTANCE; CELL-LINES; APOPTOSIS RESISTANCE; SIGNALING PATHWAYS; THERAPY RESISTANCE; DOWN-REGULATION; IN-VITRO; DEATH	Drug resistance is one of the main hurdles for the successful treatment of breast cancer. The synchronous targeting of apoptosis resistance and survival signal transduction pathways may be a promising approach to overcome drug resistance. In this study, we determined that evodiamine (EVO), a major constituent of the Chinese herbal medicine Evodiae Fructus, could induce apoptosis of doxorubicin (DOX)-sensitive MCF-7 and DOX-resistant MCF-7/ADR cells in a caspase-dependent manner, as confirmed by significant increases of cleaved poly(ADP-ribose) polymerase (PARP), caspase-7/9, and caspase activities. Notably, the reversed phenomenon of apoptosis resistance by EVO might be attributed to its ability to inhibit the Ras/MEK/ERK pathway and the expression of inhibitors of apoptosis (IAPs). Furthermore, our results indicated that EVO enhanced the apoptotic action of DOX by inhibiting the Ras/MEK/ERK cascade and the expression of IAPs without inhibiting the expression and activity of P-glycoprotein (P-gp). Taken together, our data indicate that EVO, a natural product, may be useful applied alone or in combination with DOX for the treatment of resistant breast cancer.	[Wang, Shengpeng; Wang, Lu; Zhong, Zhangfeng; Chen, Meiwan; Wang, Yitao] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macao, Peoples R China; [Shi, Zhi] Jinan Univ, Coll Life Sci & Technol, Dept Cell Biol, Guangzhou, Guangdong, Peoples R China; [Shi, Zhi] Jinan Univ, Coll Life Sci & Technol, Inst Biomed, Guangzhou, Guangdong, Peoples R China	University of Macau; Jinan University; Jinan University	Chen, MW (corresponding author), Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macao, Peoples R China.	mwchen@umac.mo; yo'wang@umac.mo	Wang, Yitao/O-5184-2016		Macao Science and Technology Development Fund [102/2012/A3, 077/2011/A3]; Research Fund of the University of Macau [MYRG 208 (Y3-L4)-ICMS11-WYT, MRG012/WYT/2013/ICMS, MRG005/CMW/2014/ICMS]	Macao Science and Technology Development Fund; Research Fund of the University of Macau	This study was supported by the Macao Science and Technology Development Fund (102/2012/A3, 077/2011/A3) and the Research Fund of the University of Macau (MYRG 208 (Y3-L4)-ICMS11-WYT, MRG012/WYT/2013/ICMS, MRG005/CMW/2014/ICMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATIST G, 1986, J BIOL CHEM, V261, P5544; Blanc C, 2000, CANCER RES, V60, P4386; Bratton SB, 2001, EMBO J, V20, P998, DOI 10.1093/emboj/20.5.998; Chawla-Sarkar M, 2004, CELL DEATH DIFFER, V11, P915, DOI 10.1038/sj.cdd.4401416; Chen SY, 2013, ASIAN PAC J CANCER P, V14, P6135, DOI 10.7314/APJCP.2013.14.10.6135; CHOU TC, 1977, J BIOL CHEM, V252, P6438; Dai Y, 2009, AM J TRANSL RES, V1, P1; Essmann F, 2004, CANCER RES, V64, P7065, DOI 10.1158/0008-5472.CAN-04-1082; Fei XF, 2003, CANCER SCI, V94, P92, DOI 10.1111/j.1349-7006.2003.tb01358.x; Fulda S, 2012, NAT REV DRUG DISCOV, V11, P109, DOI 10.1038/nrd3627; Hu CMJ, 2012, BIOCHEM PHARMACOL, V83, P1104, DOI 10.1016/j.bcp.2012.01.008; Jia J, 2009, NAT REV DRUG DISCOV, V8, P111, DOI 10.1038/nrd2683; Kan SF, 2004, INT J CANCER, V110, P641, DOI 10.1002/ijc.20138; Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609; Khonkarn R, 2012, COLLOID SURFACE B, V94, P266, DOI 10.1016/j.colsurfb.2012.02.002; Kim TH, 2014, BBA-GEN SUBJECTS, V1840, P615, DOI 10.1016/j.bbagen.2013.10.023; KING CL, 1980, J NAT PROD, V43, P577, DOI 10.1021/np50011a008; Krakstad C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-135; Kruh GD, 2003, ONCOGENE, V22, P7262, DOI 10.1038/sj.onc.1206932; L'Ecuyer T, 2006, AM J PHYSIOL-HEART C, V291, pH1273, DOI 10.1152/ajpheart.00738.2005; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Lee TJ, 2006, MOL CANCER THER, V5, P2398, DOI 10.1158/1535-7163.MCT-06-0167; Lu M, 2007, MOL CELL, V26, P689, DOI 10.1016/j.molcel.2007.05.006; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; McCubrey JA, 2012, ONCOTARGET, V3, P1068, DOI 10.18632/oncotarget.659; McCubrey JA, 2011, J CELL PHYSIOL, V226, P2762, DOI 10.1002/jcp.22647; Molnar J, 2010, CURR TOP MED CHEM, V10, P1757; Ogasawara M, 2002, BIOL PHARM BULL, V25, P1491, DOI 10.1248/bpb.25.1491; Peng XH, 2007, MOL PHARMACOL, V71, P101, DOI 10.1124/mol.106.027367; Plenchette S, 2004, BLOOD, V104, P2035, DOI 10.1182/blood-2004-01-0065; Rangwala F, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-402; Rumjanek VM, 2013, BIOSCIENCE REP, V33, P875, DOI 10.1042/BSR20130067; Saha S, 2012, ANTICANCER RES, V32, P2567; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Shyu KG, 2006, LIFE SCI, V78, P2234, DOI 10.1016/j.lfs.2005.09.027; Silva KL, 2013, LEUKEMIA RES, V37, P1350, DOI 10.1016/j.leukres.2013.06.014; Takada Y, 2005, J BIOL CHEM, V280, P17203, DOI 10.1074/jbc.M500077200; Vaux DL, 2005, CELL DEATH DIFFER, V12, P1205, DOI 10.1038/sj.cdd.4401696; Wang C, 2010, TOXICOL IN VITRO, V24, P898, DOI 10.1016/j.tiv.2009.11.019; Wang H, 2011, BIOMATERIALS, V32, P8281, DOI 10.1016/j.biomaterials.2011.07.032; Wang ZW, 2010, DRUG RESIST UPDATE, V13, P109, DOI 10.1016/j.drup.2010.07.001; Yamaguchi Y, 2005, ONCOL REP, V14, P1311; Yang J, 2008, FREE RADICAL RES, V42, P492, DOI 10.1080/10715760802112791; Yu H, 2013, MOLECULES, V18, P1826, DOI 10.3390/molecules18021826	44	53	54	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97512	10.1371/journal.pone.0097512	http://dx.doi.org/10.1371/journal.pone.0097512			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830744	Green Published, Green Submitted, gold			2022-12-27	WOS:000336789500072
J	Kraal, L; Abubucker, S; Kota, K; Fischbach, MA; Mitreva, M				Kraal, Laurens; Abubucker, Sahar; Kota, Karthik; Fischbach, Michael A.; Mitreva, Makedonka			The Prevalence of Species and Strains in the Human Microbiome: A Resource for Experimental Efforts	PLOS ONE			English	Article							GUT MICROBIOME; BACTEROIDES; DIET; DIVERSITY; GENOMES	Experimental efforts to characterize the human microbiota often use bacterial strains that were chosen for historical rather than biological reasons. Here, we report an analysis of 380 whole-genome shotgun samples from 100 subjects from the NIH Human Microbiome Project. By mapping their reads to 1,751 reference genome sequences and analyzing the resulting relative strain abundance in each sample we present metrics and visualizations that can help identify strains of interest for experimentalists. We also show that approximately 14 strains of 10 species account for 80% of the mapped reads from a typical stool sample, indicating that the function of a community may not be irreducibly complex. Some of these strains account for >20% of the sequence reads in a subset of samples but are absent in others, a dichotomy that could underlie biological differences among subjects. These data should serve as an important strain selection resource for the community of researchers who take experimental approaches to studying the human microbiota.	[Kraal, Laurens; Fischbach, Michael A.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Kraal, Laurens; Fischbach, Michael A.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94143 USA; [Abubucker, Sahar; Kota, Karthik; Mitreva, Makedonka] Washington Univ Sch Med, Genome Inst, St Louis, MO USA; [Mitreva, Makedonka] Washington Univ Sch Med, Dept Med, St Louis, MO USA; [Mitreva, Makedonka] Washington Univ Sch Med, Dept Genet, St Louis, MO USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Fischbach, MA (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.	fischbach@fischbachgroup.org; mmitreva@genome.wustl.edu		Mitreva, Makedonka/0000-0001-9572-3436; Fischbach, Michael/0000-0003-3079-8247	Medical Research award from the W.M. Keck Foundation; David and Lucile Packard Foundation; NIH [DP2 OD007290, U54HG004968]; UCSF Center for Systems and Synthetic Biology; NIGMS (NIGMS Systems Biology Center grant) [P50 GM081879]; ARCS Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079, U54HG004968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067547] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007290] Funding Source: NIH RePORTER	Medical Research award from the W.M. Keck Foundation; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF Center for Systems and Synthetic Biology; NIGMS (NIGMS Systems Biology Center grant); ARCS Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a Medical Research award from the W.M. Keck Foundation (M.A.F.); a Fellowship for Science and Engineering from the David and Lucile Packard Foundation (M.A.F.); NIH DP2 OD007290 (M.A.F.); the UCSF Center for Systems and Synthetic Biology (http://systemsbiology.ucsf.edu/), one of the NIGMS-funded National Centers for Systems Biology (http://www.systemscenters.org) (NIGMS Systems Biology Center grant P50 GM081879); and a fellowship from the ARCS Foundation (https://www.arcsfoundation.org/) (L.K.). Research at Washington University was supported by NIH U54HG004968 (G.M. Weinstock). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, 2012, FASEB J; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Budding AE, 2010, FASEB J, V24, P4556, DOI 10.1096/fj.10-156190; Chatzidaki-Livanis M, 2010, P NATL ACAD SCI USA, V107, P11976, DOI 10.1073/pnas.1005039107; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Eggerth AH, 1933, J BACTERIOL, V25, P389, DOI 10.1128/JB.25.4.389-413.1933; Faith JJ, 2011, SCIENCE, V333, P101, DOI 10.1126/science.1206025; Fischbach MA, 2011, CELL HOST MICROBE, V10, P336, DOI 10.1016/j.chom.2011.10.002; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kembel SW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002743; Legendre P, 2005, J AGR BIOL ENVIR ST, V10, P226, DOI 10.1198/108571105X46642; Lemon KP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004183; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Mahowald MA, 2009, P NATL ACAD SCI USA, V106, P5859, DOI 10.1073/pnas.0901529106; Markowitz VM, 2010, NUCLEIC ACIDS RES, V38, pD382, DOI 10.1093/nar/gkp887; Martin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036427; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; McNulty NP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002701; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Parks DH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-328; Patil KR, 2011, NAT METHODS, V8, P191, DOI 10.1038/nmeth0311-191; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Rey FE, 2010, J BIOL CHEM, V285, P22082, DOI 10.1074/jbc.M110.117713; Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Shade A, 2012, ENVIRON MICROBIOL, V14, P4, DOI 10.1111/j.1462-2920.2011.02585.x; Sonnenburg ED, 2010, CELL, V141, P1241, DOI 10.1016/j.cell.2010.05.005; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; von Mering C, 2007, SCIENCE, V315, P1126, DOI 10.1126/science.1133420; Vos M, 2011, PLOS ONE, V7; Waters JL, 2012, J BACTERIOL, V194, P5228, DOI 10.1128/JB.00941-12; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	45	59	61	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97279	10.1371/journal.pone.0097279	http://dx.doi.org/10.1371/journal.pone.0097279			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827833	Green Submitted, Green Published, gold			2022-12-27	WOS:000336857400072
J	Lee, DH; Lind, L; Jacobs, DR; Salihovic, S; van Bavel, B; Lind, PM				Lee, Duk-Hee; Lind, Lars; Jacobs, David R., Jr.; Salihovic, Samira; van Bavel, Bert; Lind, P. Monica			Does Mortality Risk of Cigarette Smoking Depend on Serum Concentrations of Persistent Organic Pollutants? Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study	PLOS ONE			English	Article							TELOMERE LENGTH; CARDIOVASCULAR-DISEASE; NATIONAL-HEALTH; IN-VITRO; HORMESIS; ASSOCIATION; DICHLORODIPHENYLTRICHLOROETHANE; KERATINOCYTES; TRANSCRIPTION; PESTICIDES	Cigarette smoking is an important cause of preventable death globally, but associations between smoking and mortality vary substantially across country and calendar time. Although methodological biases have been discussed, it is biologically plausible that persistent organic pollutants (POPs) like polychlorinated biphenyls (PCBs) and organochlorine (OC) pesticides can affect this association. This study was performed to evaluate if associations of cigarette smoking with mortality were modified by serum concentrations of PCBs and OC pesticides. We evaluated cigarette smoking in 111 total deaths among 986 men and women aged 70 years in the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) with mean follow-up for 7.7 years. The association between cigarette smoking and total mortality depended on serum concentration of PCBs and OC pesticides (P value for interaction = 0.02). Among participants in the highest tertile of the serum POPs summary score, former and current smokers had 3.7 (95% CI, 1.5-9.3) and 6.4 (95% CI, 2.3-17.7) times higher mortality hazard, respectively, than never smokers. In contrast, the association between cigarette smoking and total mortality among participants in the lowest tertile of the serum POPs summary score was much weaker and statistically nonsignificant. The strong smoking-mortality association observed among elderly people with high POPs was mainly driven by low risk of mortality among never smokers with high POPs. As smoking is increasing in many low-income and middle-income countries and POPs contamination is a continuing problem in these areas, the interactions between these two important health-related issues should be considered in future research.	[Lee, Duk-Hee] Kyungpook Natl Univ, Sch Med, Dept Prevent Med, Taegu, South Korea; [Lee, Duk-Hee] Kyungpook Natl Univ, Dept Biomed Sci, Plus KNU Biomed Convergence Program BK21, Taegu, South Korea; [Lind, Lars] Univ Uppsala Hosp, Dept Med Sci, Uppsala, Sweden; [Jacobs, David R., Jr.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Jacobs, David R., Jr.] Univ Oslo, Dept Nutr, Oslo, Norway; [Salihovic, Samira; van Bavel, Bert] Univ Orebro, Sch Sci & Technol, MTM Res Ctr, SE-70182 Orebro, Sweden; [Lind, P. Monica] Uppsala Univ, Dept Med Sci Occupat & Environm Med, Uppsala, Sweden	Kyungpook National University; Kyungpook National University; Uppsala University; Uppsala University Hospital; University of Minnesota System; University of Minnesota Twin Cities; University of Oslo; Orebro University; Uppsala University	Lind, PM (corresponding author), Uppsala Univ, Dept Med Sci Occupat & Environm Med, Uppsala, Sweden.	monica.lind@medsci.uu.se	van Bavel, Bert/K-1377-2015; Lind, Monica/B-6677-2017	van Bavel, Bert/0000-0001-6217-8857; Lind, Monica/0000-0002-8949-3555; Salihovic, Samira/0000-0001-5752-4196; Jacobs, David/0000-0002-7232-0543	Swedish Research Council (VR); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS); Korea Health technology RD Project; Ministry of Health & Welfare, Republic of Korea [A111716]; BK21 PLUS KNU Biomedical Convergence Program for Creative Talent	Swedish Research Council (VR)(Swedish Research Council); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); Korea Health technology RD Project; Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); BK21 PLUS KNU Biomedical Convergence Program for Creative Talent	This study was supported by the Swedish Research Council (VR) and the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS), Korea Health technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A111716), and BK21 PLUS KNU Biomedical Convergence Program for Creative Talent. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakaysa SL, 2007, AGING CELL, V6, P769, DOI 10.1111/j.1474-9726.2007.00340.x; Blackburn EH, 2005, FEBS LETT, V579, P859, DOI 10.1016/j.febslet.2004.11.036; Carpenter David O., 2011, Reviews on Environmental Health, V26, P61, DOI 10.1515/REVEH.2011.009; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; DIWAN BA, 1994, TOXICOL PATHOL, V22, P430, DOI 10.1177/019262339402200409; DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901; Ha MH, 2007, ENVIRON HEALTH PERSP, V115, P1204, DOI 10.1289/ehp.10184; Hunt D, 2005, INT J EPIDEMIOL, V34, P1020, DOI 10.1093/ije/dyi139; HUTTON JJ, 1979, MUTAT RES, V66, P75, DOI 10.1016/0165-1218(79)90010-7; Jacobs DR, 1999, ARCH INTERN MED, V159, P733, DOI 10.1001/archinte.159.7.733; Lee DH, 2006, DIABETES CARE, V29, P1638, DOI 10.2337/dc06-0543; Lee YM, 2013, J KOREAN MED SCI, V28, P1122, DOI 10.3346/jkms.2013.28.8.1122; Mattson MP, 2008, AGEING RES REV, V7, P1, DOI 10.1016/j.arr.2007.08.007; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; PHILLIPS DL, 1989, ARCH ENVIRON CON TOX, V18, P495, DOI 10.1007/BF01055015; PSATY BM, 1990, J CLIN EPIDEMIOL, V43, P961, DOI 10.1016/0895-4356(90)90079-5; Salihovic S, 2012, ENVIRON INT, V44, P59, DOI 10.1016/j.envint.2012.01.011; Sandau CD, 2003, ANAL CHEM, V75, P71, DOI 10.1021/ac026121u; Shin JY, 2010, MUTAGENESIS, V25, P511, DOI 10.1093/mutage/geq035; Shutoh Y, 2009, J TOXICOL SCI, V34, P469, DOI 10.2131/jts.34.469; Solomon GM, 2002, ENVIRON HEALTH PERSP, V110, pA339, DOI 10.1289/ehp.021100339; Someya M, 2010, ENVIRON INT, V36, P27, DOI 10.1016/j.envint.2009.09.003; Sukata T, 2002, INT J CANCER, V99, P112, DOI 10.1002/ijc.10312; Tanabe S, 2010, ECOTOXICOLOGY, V19, P463, DOI 10.1007/s10646-009-0445-8; Tuomisto Jouko, 2005, Dose-Response, V3, P332, DOI 10.2203/dose-response.003.03.004; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; van de Mheen PJ, 1996, PUBLIC HLTH REP, V111, P427; van de Mheen PJ, 1996, PUBLIC HLTH REP, V111, P420; Viluksela M, 2000, CANCER RES, V60, P6911; Wong MH, 2005, CHEMOSPHERE, V60, P740, DOI 10.1016/j.chemosphere.2005.04.028; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; Yokoo S, 2004, J CELL BIOCHEM, V93, P588, DOI 10.1002/jcb.20208; Zhang TC, 2003, CARCINOGENESIS, V24, P1811, DOI 10.1093/carcin/bgg141	33	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e95937	10.1371/journal.pone.0095937	http://dx.doi.org/10.1371/journal.pone.0095937			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828407	Green Published, Green Submitted, gold			2022-12-27	WOS:000336857400019
J	Weber, ND; Stone, D; Sedlak, RH; Feelixge, HSD; Roychoudhury, P; Schiffer, JT; Aubert, M; Jerome, KR				Weber, Nicholas D.; Stone, Daniel; Sedlak, Ruth Hall; Feelixge, Harshana S. De Silva; Roychoudhury, Pavitra; Schiffer, Joshua T.; Aubert, Martine; Jerome, Keith R.			AAV-Mediated Delivery of Zinc Finger Nucleases Targeting Hepatitis B Virus Inhibits Active Replication	PLOS ONE			English	Article							FACTOR-IX; VIRAL TRANSCRIPTION; RNA INTERFERENCE; GENE-TRANSFER; IN-VIVO; DNA; HEMOPHILIA; LIVER; MUTAGENESIS; CLEAVAGE	Despite an existing effective vaccine, hepatitis B virus (HBV) remains a major public health concern. There are effective suppressive therapies for HBV, but they remain expensive and inaccessible to many, and not all patients respond well. Furthermore, HBV can persist as genomic covalently closed circular DNA (cccDNA) that remains in hepatocytes even during otherwise effective therapy and facilitates rebound in patients after treatment has stopped. Therefore, the need for an effective treatment that targets active and persistent HBV infections remains. As a novel approach to treat HBV, we have targeted the HBV genome for disruption to prevent viral reactivation and replication. We generated 3 zinc finger nucleases (ZFNs) that target sequences within the HBV polymerase, core and X genes. Upon the formation of ZFN-induced DNA double strand breaks (DSB), imprecise repair by non-homologous end joining leads to mutations that inactivate HBV genes. We delivered HBV-specific ZFNs using self-complementary adeno-associated virus (scAAV) vectors and tested their anti-HBV activity in HepAD38 cells. HBV-ZFNs efficiently disrupted HBV target sites by inducing site-specific mutations. Cytotoxicity was seen with one of the ZFNs. scAAV-mediated delivery of a ZFN targeting HBV polymerase resulted in complete inhibition of HBV DNA replication and production of infectious HBV virions in HepAD38 cells. This effect was sustained for at least 2 weeks following only a single treatment. Furthermore, high specificity was observed for all ZFNs, as negligible off-target cleavage was seen via high-throughput sequencing of 7 closely matched potential off-target sites. These results show that HBV-targeted ZFNs can efficiently inhibit active HBV replication and suppress the cellular template for HBV persistence, making them promising candidates for eradication therapy.	[Weber, Nicholas D.; Stone, Daniel; Feelixge, Harshana S. De Silva; Roychoudhury, Pavitra; Schiffer, Joshua T.; Aubert, Martine; Jerome, Keith R.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Weber, Nicholas D.; Sedlak, Ruth Hall; Jerome, Keith R.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Schiffer, Joshua T.] Univ Washington, Dept Med, Div Allergy & Infect Dis, Seattle, WA USA; [Schiffer, Joshua T.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Jerome, Keith R.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Jerome, KR (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.	kjerome@fhcrc.org	Roychoudhury, Pavitra/K-8841-2012	Roychoudhury, Pavitra/0000-0002-4567-8232; Stone, Daniel/0000-0003-1619-7541	NIH [U19 AI 096111]; NIH Interdisciplinary Training Grant postdoctoral fellowship [T32 CA080416]; NATIONAL CANCER INSTITUTE [T32CA080416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI096111] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Interdisciplinary Training Grant postdoctoral fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Portions of this work were funded by NIH supported Martin Delaney Collaboratory grant U19 AI 096111. NDW was supported by NIH Interdisciplinary Training Grant postdoctoral fellowship T32 CA080416. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arad U, 1998, BIOTECHNIQUES, V24, P760, DOI 10.2144/98245bm14; Aubert M, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2013.75; Aubert M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016825; BEASLEY RP, 1981, LANCET, V2, P1129; Bloom K, 2013, MOL THER, V21, P1889, DOI 10.1038/mt.2013.170; Boissel S, 2014, NUCLEIC ACIDS RES, V42, P2591, DOI 10.1093/nar/gkt1224; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Chen CC, 2009, MOL THER, V17, P352, DOI 10.1038/mt.2008.245; Chen JL, 2014, MOL THER, V22, P303, DOI 10.1038/mt.2013.212; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Choi V.W., 2007, CURR PROTOC MOL BIOL; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Cradick TJ, 2010, MOL THER, V18, P947, DOI 10.1038/mt.2010.20; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; Fagone P, 2012, HUM GENE THER METHOD, V23, P1, DOI 10.1089/hgtb.2011.104; Fechner H, 2008, J MOL MED, V86, P987, DOI 10.1007/s00109-008-0363-x; Fine EJ, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1326; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Grosse S, 2011, MOL THER, V19, P694, DOI 10.1038/mt.2010.302; Handel EM, 2011, CURR GENE THER, V11, P28, DOI 10.2174/156652311794520120; Harding TC, 2004, GENE THER, V11, P204, DOI 10.1038/sj.gt.3302142; Ho KJ, 2008, AM J PHYSIOL-GASTR L, V295, pG412, DOI 10.1152/ajpgi.00590.2007; Hoeksema KA, 2010, METHODS MOL BIOL, V649, P97, DOI 10.1007/978-1-60761-753-2_6; Hosel M, 2014, HEPATOLOGY, V59, P2110, DOI 10.1002/hep.26990; Kitsera N, 2007, BIOTECHNIQUES, V43, P222, DOI 10.2144/000112479; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Ladner SK, 1997, ANTIMICROB AGENTS CH, V41, P1715, DOI 10.1128/AAC.41.8.1715; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Levrero M, 2009, J HEPATOL, V51, P581, DOI 10.1016/j.jhep.2009.05.022; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Lisowski L, 2014, NATURE, V506, P382, DOI 10.1038/nature12875; Loeb KR, 2000, HEPATOLOGY, V32, P626, DOI 10.1053/jhep.2000.9878; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Mayrose I, 2004, MOL BIOL EVOL, V21, P1781, DOI 10.1093/molbev/msh194; McCarty DM, 2001, GENE THER, V8, P1248, DOI 10.1038/sj.gt.3301514; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Mino T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056633; Mount JD, 2002, BLOOD, V99, P2670, DOI 10.1182/blood.V99.8.2670; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Niemeyer GP, 2009, BLOOD, V113, P797, DOI 10.1182/blood-2008-10-181479; Otto EA, 2008, HUM MUTAT, V29, P418, DOI 10.1002/humu.20669; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Pollicino T, 2006, GASTROENTEROLOGY, V130, P823, DOI 10.1053/j.gastro.2006.01.001; Qiu P, 2004, BIOTECHNIQUES, V36, P702, DOI 10.2144/04364PF01; Sander JD, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt716; Schiffer JT, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003131; Schiffer JT, 2012, J VIROL, V86, P8920, DOI 10.1128/JVI.00052-12; Sedlak RH, 2013, DIAGN MICR INFEC DIS, V75, P1, DOI 10.1016/j.diagmicrobio.2012.10.009; Shi LP, 2012, J VIROL, V86, P10059, DOI 10.1128/JVI.00535-12; Stone D, 2013, CURR OPIN HIV AIDS, V8, P217, DOI 10.1097/COH.0b013e32835f736c; Tanaka A, 2013, LEUKEMIA, V27, P1621, DOI 10.1038/leu.2013.46; Wang LL, 2012, HUM GENE THER, V23, P533, DOI 10.1089/hum.2011.183; Weber ND, 2014, VIROLOGY, V454, P353, DOI 10.1016/j.virol.2013.12.037; Werle-Lapostolle B, 2004, GASTROENTEROLOGY, V126, P1750, DOI 10.1053/j.gastro.2004.03.018; Zimmerman KA, 2008, J VIROL, V82, P8013, DOI 10.1128/JVI.00366-08; Zychlinski D, 2008, MOL THER, V16, P718, DOI 10.1038/mt.2008.5	59	78	93	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97579	10.1371/journal.pone.0097579	http://dx.doi.org/10.1371/journal.pone.0097579			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827459	gold, Green Published, Green Submitted			2022-12-27	WOS:000336857400109
J	Ye, WL; Du, JB; Zhang, BL; Na, R; Song, YF; Mei, QB; Zhao, MG; Zhou, SY				Ye, Wei-liang; Du, Jiang-bo; Zhang, Bang-le; Na, Ren; Song, Yan-feng; Mei, Qi-bing; Zhao, Ming-gao; Zhou, Si-yuan			Cellular Uptake and Antitumor Activity of DOX-hyd-PEG-FA Nanoparticles	PLOS ONE			English	Article							DRUG-DELIVERY; POLYMERIC MICELLES; CANCER; CONJUGATE; TUMOR; PH; BIODISTRIBUTION; NANOCARRIERS; ENDOCYTOSIS; RESVERATROL	A PEG-based, folate mediated, active tumor targeting drug delivery system using DOX-hyd-PEG-FA nanoparticles (NPs) were prepared. DOX-hyd-PEG-FA NPs showed a significantly faster DOX release in pH 5.0 medium than in pH 7.4 medium. Compared with DOX-hyd-PEG NPs, DOX-hyd-PEG-FA NPs increased the intracellular accumulation of DOX and showed a DOX translocation from lysosomes to nucleus. The cytotoxicity of DOX-hyd-PEG-FA NPs on KB cells was much higher than that of free DOX, DOX-ami-PEG-FA NPs and DOX-hyd-PEG NPs. The cytotoxicity of DOX-hyd-PEG-FA NPs on KB cells was attenuated in the presence of exogenous folic acid. The IC50 of DOX-hyd-PEG-FA NPs and DOX-hyd-PEG NPs on A549 cells showed no significant difference. After DOX-hyd-PEG-FA NPs were intravenously administered, the amount of DOX distributed in tumor tissue was significantly increased, while the amount of DOX distributed in heart was greatly decreased as compared with free DOX. Compared with free DOX, NPs yielded improved survival rate, prolonged life span, delayed tumor growth and reduced the cardiotoxicity in tumor bearing mice model. These results indicated that the acid sensitivity, passive and active tumor targeting abilities were likely to act synergistically to enhance the drug delivery efficiency of DOX-hyd-PEG-FA NPs. Therefore, DOX-hyd-PEG-FA NPs are a promising drug delivery system for targeted cancer therapy.	[Ye, Wei-liang; Du, Jiang-bo; Zhang, Bang-le; Song, Yan-feng; Zhou, Si-yuan] Fourth Mil Med Univ, Sch Pharm, Dept Pharmaceut, Xian 710032, Peoples R China; [Mei, Qi-bing; Zhao, Ming-gao] Fourth Mil Med Univ, Sch Pharm, Dept Pharmacol, Xian 710032, Peoples R China; [Na, Ren] Fourth Mil Med Univ, West Changle Sanat Xian Army Retired Cadres, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Zhou, SY (corresponding author), Fourth Mil Med Univ, Sch Pharm, Dept Pharmaceut, Xian 710032, Peoples R China.	zhousy@fmmu.edu.cn		Zhao, Ming-gao/0000-0002-7539-3887; Zhang, Bang-Le/0000-0001-9008-5391	Shaanxi Science and Technology Innovation Project [2012KTCL03-18]	Shaanxi Science and Technology Innovation Project	This research was supported by the Shaanxi Science and Technology Innovation Project (2012KTCL03-18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal P, 2009, ADV DRUG DELIVER REV, V61, P428, DOI 10.1016/j.addr.2009.03.009; Alexis F, 2008, MOL PHARMACEUT, V5, P505, DOI 10.1021/mp800051m; Andersson L, 2005, BIOMACROMOLECULES, V6, P914, DOI 10.1021/bm049381p; Arote RB, 2010, BIOMATERIALS, V31, P2435, DOI 10.1016/j.biomaterials.2009.11.106; Barenholz Y, 2012, J CONTROL RELEASE, V160, P117, DOI 10.1016/j.jconrel.2012.03.020; Cho KJ, 2008, CLIN CANCER RES, V14, P1310, DOI 10.1158/1078-0432.CCR-07-1441; DEVERDIERE AC, 1994, CANCER CHEMOTH PHARM, V33, P504; Dhawan D, 2013, CANCER RES, V73, P875, DOI 10.1158/0008-5472.CAN-12-2101; Dosio F, 2010, CURR OPIN INVEST DR, V11, P1424; Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088; Fang J, 2011, ADV DRUG DELIVER REV, V63, P136, DOI 10.1016/j.addr.2010.04.009; Fipula D, 2008, ADV DRUG DELIVER REV, V60, P29, DOI 10.1016/j.addr.2007.02.001; Ghaghada KB, 2005, J CONTROL RELEASE, V104, P113, DOI 10.1016/j.jconrel.2005.01.012; Guo X, 2013, BIOMATERIALS, V34, P4544, DOI 10.1016/j.biomaterials.2013.02.071; He CB, 2010, BIOMATERIALS, V31, P3657, DOI 10.1016/j.biomaterials.2010.01.065; Hu QY, 2013, BIOMATERIALS, V34, P5640, DOI 10.1016/j.biomaterials.2013.04.025; Huan ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044116; Huang L, 2011, ANNU REV BIOMED ENG, V13, P507, DOI 10.1146/annurev-bioeng-071910-124709; Jayant S, 2007, PHARM RES, V24, P2120, DOI 10.1007/s11095-007-9406-1; Kim SH, 2005, J CONTROL RELEASE, V103, P625, DOI 10.1016/j.jconrel.2004.01.006; Koyama Junichi, 2011, Gan To Kagaku Ryoho, V38, P461; Lalatsa A, 2012, J CONTROL RELEASE, V161, P523, DOI 10.1016/j.jconrel.2012.04.046; Lancon A, 2004, BIOCHEM BIOPH RES CO, V316, P1132, DOI 10.1016/j.bbrc.2004.02.164; Lancon A, 2007, DRUG METAB DISPOS, V35, P699, DOI 10.1124/dmd.106.013664; LEAMON CP, 1991, P NATL ACAD SCI USA, V88, P5572, DOI 10.1073/pnas.88.13.5572; Lee ES, 2005, J CONTROL RELEASE, V103, P405, DOI 10.1016/j.jconrel.2004.12.018; Liu F, 2010, MOL IMAGING BIOL, V12, P595, DOI 10.1007/s11307-010-0305-1; Low PS, 2004, ADV DRUG DELIVER REV, V56, P1055, DOI 10.1016/j.addr.2004.02.003; Ma RJ, 2012, BIOMACROMOLECULES, V13, P3409, DOI 10.1021/bm3012715; MAEDA H, 1989, CRIT REV THER DRUG, V6, P193; Maeda H, 2012, P JPN ACAD B-PHYS, V88, P53, DOI 10.2183/pjab.88.53; Midoux P, 2009, BRIT J PHARMACOL, V157, P166, DOI 10.1111/j.1476-5381.2009.00288.x; Minko T, 1998, J CONTROL RELEASE, V54, P223, DOI 10.1016/S0168-3659(98)00009-1; Parker N, 2005, ANAL BIOCHEM, V338, P284, DOI 10.1016/j.ab.2004.12.026; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Prabaharan M, 2009, BIOMATERIALS, V30, P6065, DOI 10.1016/j.biomaterials.2009.07.048; Sahoo SK, 2005, MOL PHARMACEUT, V2, P373, DOI 10.1021/mp050032z; Torchilin VP, 2007, PHARM RES-DORDR, V24, P1, DOI 10.1007/s11095-006-9132-0; Torchilin V, 2011, ADV DRUG DELIVER REV, V63, P131, DOI 10.1016/j.addr.2010.03.011; van Steenis JH, 2003, J CONTROL RELEASE, V87, P167, DOI 10.1016/S0168-3659(02)00361-9; Xiong XB, 2010, BIOMATERIALS, V31, P757, DOI 10.1016/j.biomaterials.2009.09.080; Yang C, 2012, BIOMATERIALS, V33, P2971, DOI 10.1016/j.biomaterials.2011.11.035; Ye WL, 2013, J PHARM SCI-US, V102, P530, DOI 10.1002/jps.23381; Yoo HS, 2004, J CONTROL RELEASE, V100, P247, DOI 10.1016/j.jconrel.2004.08.017	44	43	45	4	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97358	10.1371/journal.pone.0097358	http://dx.doi.org/10.1371/journal.pone.0097358			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828815	Green Submitted, Green Published, gold			2022-12-27	WOS:000336857400084
J	Algama, M; Oldmeadow, C; Tasker, E; Mengersen, K; Keith, JM				Algama, Manjula; Oldmeadow, Christopher; Tasker, Edward; Mengersen, Kerrie; Keith, Jonathan M.			Drosophila 3 ' UTRs Are More Complex than Protein-Coding Sequences	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HELIX-LOOP-HELIX; DNA; TRANSCRIPTION; BINDING; ELEMENTS; 1-PERCENT; REGIONS; 3'-UTR; MOTIFS	The 3 ' UTRs of eukaryotic genes participate in a variety of post-transcriptional (and some transcriptional) regulatory interactions. Some of these interactions are well characterised, but an undetermined number remain to be discovered. While some regulatory sequences in 3 ' UTRs may be conserved over long evolutionary time scales, others may have only ephemeral functional significance as regulatory profiles respond to changing selective pressures. Here we propose a sensitive segmentation methodology for investigating patterns of composition and conservation in 3 ' UTRs based on comparison of closely related species. We describe encodings of pairwise and three-way alignments integrating information about conservation, GC content and transition/transversion ratios and apply the method to three closely related Drosophila species: D. melanogaster, D. simulans and D. yakuba. Incorporating multiple data types greatly increased the number of segment classes identified compared to similar methods based on conservation or GC content alone. We propose that the number of segments and number of types of segment identified by the method can be used as proxies for functional complexity. Our main finding is that the number of segments and segment classes identified in 3 ' UTRs is greater than in the same length of protein-coding sequence, suggesting greater functional complexity in 3 ' UTRs. There is thus a need for sustained and extensive efforts by bioinformaticians to delineate functional elements in this important genomic fraction. C code, data and results are available upon request.	[Algama, Manjula; Tasker, Edward; Keith, Jonathan M.] Monash Univ, Sch Math Sci, Clayton, Vic, Australia; [Oldmeadow, Christopher] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW 2300, Australia; [Mengersen, Kerrie] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia	Monash University; University of Newcastle; Queensland University of Technology (QUT)	Keith, JM (corresponding author), Monash Univ, Sch Math Sci, Clayton, Vic, Australia.	jonathan.keith@monash.edu	Mengersen, Kerrie/AHC-4096-2022	Keith, Jonathan/0000-0002-9675-3976; Mengersen, Kerrie/0000-0001-8625-9168; Oldmeadow, Christopher/0000-0001-6104-1322	Australian Research Council [DP0556631, DP0879308, DP1095849]; National Health and Medical Research Council [389892]; Vice Chancellor's Research Fellowship - Queensland University of Technology	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Vice Chancellor's Research Fellowship - Queensland University of Technology	This work was supported by the Australian Research Council ( grants DP0556631, DP0879308 and DP1095849), the National Health and Medical Research Council ( grant ID 389892) and by a Vice Chancellor's Research Fellowship funded by Queensland University of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed F., 2011, J NAT SCI BIOL MED, V2, P2; Andken BB, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-274; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Braun JV, 1998, STAT SCI, V13, P142; Burger A, 2010, P NATL ACAD SCI USA, V107, P4016, DOI 10.1073/pnas.0915138107; Chatterjee S, 2009, BIOL CELL, V101, P251, DOI 10.1042/BC20080104; Doolittle WF, 2013, P NATL ACAD SCI USA, V110, P5294, DOI 10.1073/pnas.1221376110; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Graur D, 2013, GENOME BIOL EVOL, V5, P578, DOI 10.1093/gbe/evt028; Grillo G, 2010, NUCLEIC ACIDS RES, V38, pD75, DOI 10.1093/nar/gkp902; Grun D, 2005, PLOS COMPUT BIOL, V1, P51, DOI 10.1371/journal.pcbi.0010013; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Keich U, 2006, J COMPUT GRAPH STAT, V15, P779, DOI 10.1198/106186006X159377; Keith JM, 2004, METHODOL COMPUT APPL, V6, P29, DOI 10.1023/B:MCAP.0000012414.14405.15; Keith JM, 2008, J COMPUT BIOL, V15, P407, DOI 10.1089/cmb.2007.0173; Keith JM, 2006, J COMPUT BIOL, V13, P1369, DOI 10.1089/cmb.2006.13.1369; Kuersten S, 2003, NAT REV GENET, V4, P626, DOI 10.1038/nrg1125; Ledent V, 2001, GENOME RES, V11, P754, DOI 10.1101/gr.177001; Lee TH, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.7; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Liu JS, 1999, BIOINFORMATICS, V15, P38, DOI 10.1093/bioinformatics/15.1.38; Margulies EH, 2007, GENOME RES, V17, P760, DOI 10.1101/gr.6034307; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Matoulkova E, 2012, RNA BIOL, V9, P563, DOI 10.4161/rna.20231; Mattick JS, 2005, SCIENCE, V309, P1527, DOI 10.1126/science.1117806; Mercer TR, 2012, NAT BIOTECHNOL, V30, P99, DOI 10.1038/nbt.2024; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Molkentin JD, 1996, P NATL ACAD SCI USA, V93, P9366, DOI 10.1073/pnas.93.18.9366; Morrison AA, 2008, BBA-REV CANCER, V1785, P55, DOI 10.1016/j.bbcan.2007.10.002; Moses AM, 2006, PLOS COMPUT BIOL, V2, P1219, DOI 10.1371/journal.pcbi.0020130; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; Oldmeadow C, 2011, BIOINFORMATICS, V27, P604, DOI 10.1093/bioinformatics/btq716; Oldmeadow C, 2010, MOL BIOL EVOL, V27, P942, DOI 10.1093/molbev/msp299; Penalva LOF, 2003, MICROBIOL MOL BIOL R, V67, P343, DOI 10.1128/MMBR.67.3.343-359.2003; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Rousseau J, 2011, J R STAT SOC B, V73, P689, DOI 10.1111/j.1467-9868.2011.00781.x; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Splinter E, 2011, EMBO J, V30, P4345, DOI 10.1038/emboj.2011.344; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	45	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97336	10.1371/journal.pone.0097336	http://dx.doi.org/10.1371/journal.pone.0097336			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824035	Green Submitted, Green Published, gold			2022-12-27	WOS:000336369200097
J	Lemmens, RJM; Timmermans, AAA; Janssen-Potten, YJM; Pulles, SANTD; Geers, RPJ; Bakx, WGM; Smeets, RJEM; Seelen, HAM				Lemmens, Ryanne J. M.; Timmermans, Annick A. A.; Janssen-Potten, Yvonne J. M.; Pulles, Sanne A. N. T. D.; Geers, Richard P. J.; Bakx, Wilbert G. M.; Smeets, Rob J. E. M.; Seelen, Henk A. M.			Accelerometry Measuring the Outcome of Robot-Supported Upper Limb Training in Chronic Stroke: A Randomized Controlled Trial	PLOS ONE			English	Article							ASSISTED THERAPY; ARM ACTIVITY; ACTIVITY LEVEL; RECOVERY; REHABILITATION; INDIVIDUALS; PERFORMANCE; EXERCISE; GRAVITY; IMPACT	Purpose: This study aims to assess the extent to which accelerometers can be used to determine the effect of robot-supported task-oriented arm-hand training, relative to task-oriented arm-hand training alone, on the actual amount of arm-hand use of chronic stroke patients in their home situation. Methods: This single-blind randomized controlled trial included 16 chronic stroke patients, randomly allocated using blocked randomization (n = 2) to receive task-oriented robot-supported arm-hand training or task-oriented (unsupported) arm-hand training. Training lasted 8 weeks, 4 times/ week, 2 Chi 30 min/ day using the (T-) TOAT ((Technology-supported)-Task-Oriented-Arm-Training) method. The actual amount of arm-hand use, was assessed at baseline, after 8 weeks training and 6 months after training cessation. Duration of use and intensity of use of the affected arm-hand during unimanual and bimanual activities were calculated. Results: Duration and intensity of use of the affected arm-hand did not change significantly during and after training, with or without robot-support (i.e. duration of use of unimanual use of the affected arm-hand: median difference of -0.17% in the robot-group and -0.08% in the control group between baseline and after training cessation; intensity of the affected arm-hand: median difference of 3.95% in the robot-group and 3.32% in the control group between baseline and after training cessation). No significant between-group differences were found. Conclusions: Accelerometer data did not show significant changes in actual amount of arm-hand use after task-oriented training, with or without robot-support. Next to the amount of use, discrimination between activities performed and information about quality of use of the affected arm-hand are essential to determine actual arm-hand performance.	[Lemmens, Ryanne J. M.; Timmermans, Annick A. A.; Janssen-Potten, Yvonne J. M.; Smeets, Rob J. E. M.; Seelen, Henk A. M.] Maastricht Univ, Dept Rehabil Med, Res Sch CAPHRI, Maastricht, Netherlands; [Lemmens, Ryanne J. M.; Timmermans, Annick A. A.; Janssen-Potten, Yvonne J. M.; Pulles, Sanne A. N. T. D.; Geers, Richard P. J.; Bakx, Wilbert G. M.; Smeets, Rob J. E. M.; Seelen, Henk A. M.] Adelante, Ctr Expertise Rehabil & Audiol, Hoensbroek, Netherlands; [Timmermans, Annick A. A.] Hasselt Univ, BIOMED Biomed Res Inst, Diepenbeek, Belgium; [Bakx, Wilbert G. M.] Adelante Rehabil Ctr, Hoensbroek, Netherlands; [Seelen, Henk A. M.] Maastricht Univ, Med Ctr, Dept Rehabil Med, Maastricht, Netherlands	Maastricht University; Hasselt University; Maastricht University	Lemmens, RJM (corresponding author), Maastricht Univ, Dept Rehabil Med, Res Sch CAPHRI, Maastricht, Netherlands.	ryanne.lemmens@maastrichtuniversity.nl	Pulles, Alexandra/AAD-9251-2021; Smeets, Rob JEM/D-1522-2011; Pulles, Alexandra/AAB-6275-2019	Smeets, Rob JEM/0000-0002-9503-366X; Pulles, Alexandra/0000-0002-0130-428X; Timmermans, Annick/0000-0002-5461-947X	Philips Research, The Netherlands; Technical University Eindhoven, The Netherlands; Adelante Centre of Expertise in Rehabilitation and Audiology (formerly Rehabilitation Foundation Limburg), The Netherlands	Philips Research, The Netherlands(Netherlands Government); Technical University Eindhoven, The Netherlands; Adelante Centre of Expertise in Rehabilitation and Audiology (formerly Rehabilitation Foundation Limburg), The Netherlands(Netherlands Government)	This study was funded by 3 parties, i.e. Philips Research, The Netherlands; Technical University Eindhoven, The Netherlands; and Adelante Centre of Expertise in Rehabilitation and Audiology (formerly Rehabilitation Foundation Limburg), The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altun K, 2010, PATTERN RECOGN, V43, P3605, DOI 10.1016/j.patcog.2010.04.019; Barman J, 2011, IEEE ENG MED BIO, P5219, DOI 10.1109/IEMBS.2011.6091291; Broeks JG, 1999, DISABIL REHABIL, V21, P357; Cambridge-Neurotechnology-Ltd, 2008, ACT US MAN; Conroy SS, 2011, ARCH PHYS MED REHAB, V92, P1754, DOI 10.1016/j.apmr.2011.06.016; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; De Bleser R., 1991, LOGOPEDIE FONIATRIE, V63, P207; Ferber S, 2001, J CLIN EXP NEUROPSYC, V23, P599, DOI 10.1076/jcen.23.5.599.1243; Fortune E, 2011, IEEE ENG MED BIO, P3059, DOI 10.1109/IEMBS.2011.6090836; GAUTHIER L, 1989, INT J CLIN NEUROPSYC, V11, P49; Hesse S, 2007, WHAT DOES CLIN EXPEC; Housman SJ, 2009, NEUROREHAB NEURAL RE, V23, P505, DOI 10.1177/1545968308331148; Hsieh YW, 2011, NEUROREHAB NEURAL RE, V25, P503, DOI 10.1177/1545968310394871; Hubbard IJ, 2009, OCCUP THER INT, V16, P175, DOI 10.1002/oti.275; Kahn LE, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-12; Kwakkel G, 2013, INT J STROKE, V8, P25, DOI 10.1111/j.1747-4949.2012.00967.x; Kwakkel G, 2008, NEUROREHAB NEURAL RE, V22, P111, DOI 10.1177/1545968307305457; Lang CE, 2013, J HAND THER, V26, P104, DOI 10.1016/j.jht.2012.06.005; Lang CE, 2012, J HAND THER, V26, P115; Lemmens RJM, 2013, RELIABILITY REGISTRA; Lemmens RJM, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-21; Liao WW, 2012, CLIN REHABIL, V26, P111, DOI 10.1177/0269215511416383; Linde Van der RQ, 2002, HAPTICMASTER NEW HIG, P1; Lo AC, 2010, NEW ENGL J MED, V362, P1772, DOI 10.1056/NEJMoa0911341; Magill RA, 2007, MOTOR LEARNING CONTR, P2; Mehrholz J, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006676.pub2; Mehrholz J, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006876.pub4, 10.1002/14651858.CD006876.pub3]; Michielsen ME, 2012, ARCH PHYS MED REHAB, V93, P1975, DOI 10.1016/j.apmr.2012.03.016; Nichols-Larsen DS, 2005, STROKE, V36, P1480, DOI 10.1161/01.STR.0000170706.13595.4f; Page SJ, 2004, ARCH PHYS MED REHAB, V85, P1377, DOI 10.1016/j.apmr.2003.12.031; Peter O, 2011, INT J REHABIL RES, V34, P196, DOI 10.1097/MRR.0b013e328346e8ad; Prange GB, 2006, J REHABIL RES DEV, V43, P171, DOI 10.1682/JRRD.2005.04.0076; Rohrer B, 2002, J NEUROSCI, V22, P8297; Schmidt RA, 1999, CONDITIONS PRACTICE, P321; Schmidt RA, 1999, MOTOR CONTROL LEAR A, P432; Timmermans Annick A. A., 2009, 2009 IEEE International Conference on Rehabilitation Robotics: Reaching Users & the Community (ICORR), P98, DOI 10.1109/ICORR.2009.5209558; Timmermans AAA, 2014, J NEUROENGINEERING R, V11; Timmermans AAA, 2011, IEEE ENG MED BIO, P3507, DOI 10.1109/IEMBS.2011.6090947; Timmermans AAA, 2010, NEUROREHAB NEURAL RE, V24, P858, DOI 10.1177/1545968310368963; Timmermans AAA, 2010, IEEE T NEUR SYS REH, V18, P284, DOI 10.1109/TNSRE.2010.2047608; Uswatte G, 2005, ARCH PHYS MED REHAB, V86, P1498, DOI 10.1016/j.apmr.2005.01.010; Uswatte G, 2005, REHABIL PSYCHOL, V50, P34, DOI 10.1037/0090-5550.50.1.34; Uswatte G, 2006, NEUROREHABILITATION, V21, P147; van der Pas SC, 2011, ARCH PHYS MED REHAB, V92, P1437, DOI 10.1016/j.apmr.2011.02.021; van Heugten C M, 2004, Tijdschr Gerontol Geriatr, V35, P196; Van Peppen RPS, 2004, CLIN REHABIL, V18, P833, DOI 10.1191/0269215504cr843oa; WHO, 2001, WHO INT CLASS FUNCT; WMA-Declaration-of-Helsinki, 2008, WMA DECL HELS ETH PR; Wolfe CDA, 2000, BRIT MED BULL, V56, P275, DOI 10.1258/0007142001903120; Wu CY, 2000, ARCH PHYS MED REHAB, V81, P95, DOI 10.1053/apmr.2000.0810095	50	27	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96414	10.1371/journal.pone.0096414	http://dx.doi.org/10.1371/journal.pone.0096414			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24823925	Green Published, Green Submitted, gold			2022-12-27	WOS:000336369200019
J	Liu, PF; Feng, YT; Dong, C; Yang, DD; Li, B; Chen, X; Zhang, ZJ; Wang, Y; Zhou, YL; Zhao, L				Liu, Pengfei; Feng, Yetong; Dong, Chao; Yang, Dandan; Li, Bo; Chen, Xin; Zhang, Zhongjun; Wang, Yi; Zhou, Yulai; Zhao, Lei			Administration of BMSCs with Muscone in Rats with Gentamicin-Induced AKI Improves Their Therapeutic Efficacy	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; MESENCHYMAL STEM-CELLS; ACUTE-RENAL-FAILURE; FUNCTIONAL CHEMOKINE RECEPTORS; REPERFUSION-INDUCED ACUTE; PROGENITOR CELLS; CXCR4; TRANSPLANTATION; MIGRATION; PROTECT	The therapeutic action of bone marrow-derived mesenchymal stem cells (BMSCs) in acute kidney injury (AKI) has been reported by several groups. However, recent studies indicated that BMSCs homed to kidney tissues at very low levels after transplantation. The lack of specific homing of exogenously infused cells limited the effective implementation of BMSC-based therapies. In this study, we provided evidence that the administration of BMSCs combined with muscone in rats with gentamicin-induced AKI intravenously, was a feasible strategy to drive BMSCs to damaged tissues and improve the BMSC-based therapeutic effect. The effect of muscone on BMSC bioactivity was analyzed in vitro and in vivo. The results indicated that muscone could promote BMSC migration and proliferation. Some secretory capacity of BMSC still could be improved in some degree. The BMSC-based therapeutic action was ameliorated by promoting the recovery of biochemical variables in urine or blood, as well as the inhibition of cell apoptosis and inflammation. In addition, the up-regulation of CXCR4 and CXCR7 expression in BMSCs could be the possible mechanism of muscone amelioration. Thus, our study indicated that enhancement of BMSCs bioactivities with muscone could increase the BMSC therapeutic potential and further developed a new therapeutic strategy for the treatment of AKI.	[Liu, Pengfei; Feng, Yetong; Dong, Chao; Yang, Dandan; Li, Bo; Wang, Yi; Zhou, Yulai] Jilin Univ, Sch Pharmaceut Sci, Dept Regenerat Med, Changchun 130023, Peoples R China; [Liu, Pengfei; Feng, Yetong; Yang, Dandan; Li, Bo] Chinese Acad Sci, Guangzhou Inst Biomed, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Key Lab Regenerat Biol, Guangzhou, Guangdong, Peoples R China; [Liu, Pengfei; Feng, Yetong; Yang, Dandan; Li, Bo] Chinese Acad Sci, Guangzhou Inst Hlth, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Key Lab Regenerat Biol, Guangzhou, Guangdong, Peoples R China; [Chen, Xin] Jinan Univ, Shenzhen Peoples Hosp, Clin Med Coll 2, Dept Lab Med, Shenzhen, Peoples R China; [Zhang, Zhongjun; Zhao, Lei] Jinan Univ, Shenzhen Peoples Hosp, Clin Med Coll 2, Dept Anesthesiol, Shenzhen, Peoples R China	Jilin University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Jinan University; Jinan University	Wang, Y (corresponding author), Jilin Univ, Sch Pharmaceut Sci, Dept Regenerat Med, Changchun 130023, Peoples R China.	wangyi@jlu.ecu.cn; zhouyl@jlu.edu.cn; zhaoleicx@126.com	YANG, Dan/HHD-2733-2022		Basic Research Project of Knowledge Innovation Program of Shenzhen City, Graduate Innovation Fund of Jilin University [201404163000377]; Science and Technology Project of Shenzhen City [200702120, 200602035]; Scientific Research of Health Department of Jilin Province [2009Z043]; Science and Technology Development Project of Jilin Province [20120955]	Basic Research Project of Knowledge Innovation Program of Shenzhen City, Graduate Innovation Fund of Jilin University; Science and Technology Project of Shenzhen City; Scientific Research of Health Department of Jilin Province; Science and Technology Development Project of Jilin Province	This study was supported by the grants from the Basic Research Project of Knowledge Innovation Program of Shenzhen City (No. 201404163000377), Graduate Innovation Fund of Jilin University, the Science and Technology Project of Shenzhen City (No. 200702120, 200602035), the Scientific Research of Health Department of Jilin Province (No. 2009Z043) and Science and Technology Development Project of Jilin Province (No. 20120955). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadbeigi N, 2010, CELL BIOL INT, V34, P687, DOI 10.1042/CBI20090415; Bagshaw SM, 2008, NEPHROL DIAL TRANSPL, V23, P2126, DOI 10.1093/ndt/gfn300; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Bellomo R, 2012, LANCET, V380, P756, DOI 10.1016/S0140-6736(11)61454-2; Bilousova Ganna, 2013, Methods Mol Biol, V961, P337, DOI 10.1007/978-1-62703-227-8_22; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Cai Jinglei, 2013, Cell Regen, V2, P6, DOI 10.1186/2045-9769-2-6; Chamberlain G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002934; Cheng K, 2013, EXP MOL PATHOL, V94, P466, DOI 10.1016/j.yexmp.2013.03.002; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Choi HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087853; Daley GQ, 2012, CELL STEM CELL, V10, P740, DOI 10.1016/j.stem.2012.05.010; Ebenezer PJ, 2009, LIFE SCI, V85, P357, DOI 10.1016/j.lfs.2009.06.019; Eliopoulos N, 2011, MOL THER, V19, P2072, DOI 10.1038/mt.2011.162; FORD RA, 1990, FOOD CHEM TOXICOL, V28, P55, DOI 10.1016/0278-6915(90)90136-B; Fujimoto Y, 2012, STEM CELLS, V30, P1163, DOI 10.1002/stem.1083; Gatti S, 2011, NEPHROL DIAL TRANSPL, V26, P1474, DOI 10.1093/ndt/gfr015; Gheisari Y, 2012, STEM CELLS DEV, V21, P2969, DOI 10.1089/scd.2011.0588; Hanf W, 2010, CLIN NEPHROL, V74, P319; Hasegawa M, 2010, THER APHER DIAL, V14, P451, DOI 10.1111/j.1744-9987.2010.00863.x; Hauser PV, 2010, AM J PATHOL, V177, P2011, DOI 10.2353/ajpath.2010.091245; He B, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-22; Herberg S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058207; Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Hwang NS, 2008, P NATL ACAD SCI USA, V105, P20641, DOI 10.1073/pnas.0809680106; Iwasaki M, 2005, J AM SOC NEPHROL, V16, P658, DOI 10.1681/ASN.2004010067; Jia XH, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-105; Johannes T, 2009, SHOCK, V31, P521, DOI 10.1097/SHK.0b013e318188d198; Kanno Hiroshi, 2013, World J Stem Cells, V5, P163, DOI 10.4252/wjsc.v5.i4.163; Kellum JA, 2008, SCAND J CLIN LAB INV, V68, P6, DOI 10.1080/00365510802144813; Kolambkar YM, 2014, TISSUE ENG PT A, V20, P398, DOI [10.1089/ten.TEA.2012.0426, 10.1089/ten.tea.2012.0426]; Krzysiek-Maczka G, 2013, J PHYSIOL PHARMACOL, V64, P77; Kumar S, 2009, J AM SOC NEPHROL, V20, P2412, DOI 10.1681/ASN.2008080868; Lee AK, 2004, BIOPHARM DRUG DISPOS, V25, P273, DOI 10.1002/bdd.409; Li L, 2012, AM J PHYSIOL-RENAL, V302, pF9, DOI 10.1152/ajprenal.00377.2011; Li TJ, 2013, J SURG RES, V184, P1161, DOI 10.1016/j.jss.2013.04.054; Lin DL, 2004, J FORENSIC SCI, V49, P1187; Lipfert J, 2013, NEUROPATH APPL NEURO, V39, P667, DOI 10.1111/nan.12015; Liu NM, 2013, J CELL BIOCHEM, V114, P2677, DOI 10.1002/jcb.24615; Liu NM, 2013, EXP CELL RES, V319, P2019, DOI 10.1016/j.yexcr.2013.04.008; Liu PF, 2013, LIFE SCI, V92, P829, DOI 10.1016/j.lfs.2013.02.016; Luo Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055860; Mazzinghi B, 2008, J EXP MED, V205, P479, DOI 10.1084/jem.20071903; Nash K, 2002, AM J KIDNEY DIS, V39, P930, DOI 10.1053/ajkd.2002.32766; PALLER MS, 1984, J CLIN INVEST, V74, P1156, DOI 10.1172/JCI111524; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Qi SH, 2013, INT J MOL MED, V32, P1262, DOI 10.3892/ijmm.2013.1517; Raja N, 1998, BONE MARROW TRANSPL, V21, P1283, DOI 10.1038/sj.bmt.1701256; Reis LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044092; Rota C, 2012, STEM CELLS DEV, V21, P1911, DOI 10.1089/scd.2011.0333; Shi SF, 2012, AM J KIDNEY DIS, V60, P1044, DOI 10.1053/j.ajkd.2012.05.023; Smirkin A, 2010, J CEREBR BLOOD F MET, V30, P603, DOI 10.1038/jcbfm.2009.233; Sun Qiao-ling, 2010, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V32, P205, DOI 10.3881/j.issn.1000-503X.2010.02.016; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Wadhwa NK, 2012, CLIN NEPHROL, V78, P501, DOI 10.5414/CN107347; Wang L, 2011, CHINESE MED J-PEKING, V124, P3622, DOI 10.3760/cma.j.issn.0366-6999.2011.22.005; Wu QB, 2011, J ETHNOPHARMACOL, V138, P34, DOI 10.1016/j.jep.2011.08.009; Xie Xing-Wen, 2012, Zhongguo Zhong Xi Yi Jie He Za Zhi, V32, P980; Xinaris C, 2013, CELL TRANSPLANT, V22, P423, DOI 10.3727/096368912X653246; Yamada Y, 2002, NEUROSCIENCE, V114, P165, DOI 10.1016/S0306-4522(02)00210-5; Yu SY, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/652059; Zarjou A, 2011, AM J PHYSIOL-RENAL, V300, pF254, DOI 10.1152/ajprenal.00594.2010; Zhang ZL, 2009, EXP EYE RES, V89, P522, DOI 10.1016/j.exer.2009.05.012; Zhou LY, 2012, INFLAMMATION, V35, P289, DOI 10.1007/s10753-011-9318-4	65	38	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97123	10.1371/journal.pone.0097123	http://dx.doi.org/10.1371/journal.pone.0097123			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824427	Green Submitted, Green Published, gold			2022-12-27	WOS:000336369200061
J	Nawa, NE; Ando, H				Nawa, Norberto Eiji; Ando, Hiroshi			Classification of Self-Driven Mental Tasks from Whole-Brain Activity Patterns	PLOS ONE			English	Article							AUTOBIOGRAPHICAL MEMORY; COGNITIVE STATES; FMRI; REPRESENTATIONS; ACTIVATION; SIGNAL	During wakefulness, a constant and continuous stream of complex stimuli and self-driven thoughts permeate the human mind. Here, eleven participants were asked to count down numbers and remember negative or positive autobiographical episodes of their personal lives, for 32 seconds at a time, during which they could freely engage in the execution of those tasks. We then examined the possibility of determining from a single whole-brain functional magnetic resonance imaging scan which one of the two mental tasks each participant was performing at a given point in time. Linear support-vector machines were used to build within-participant classifiers and across-participants classifiers. The within-participant classifiers could correctly discriminate scans with an average accuracy as high as 82%, when using data from all individual voxels in the brain. These results demonstrate that it is possible to accurately classify self-driven mental tasks from whole-brain activity patterns recorded in a time interval as short as 2 seconds.	[Nawa, Norberto Eiji; Ando, Hiroshi] Natl Inst Informat & Commun Technol NICT, Ctr Informat & Neural Networks CiNet, Suita, Osaka, Japan; [Nawa, Norberto Eiji; Ando, Hiroshi] Osaka Univ, Suita, Osaka, Japan; [Nawa, Norberto Eiji; Ando, Hiroshi] Natl Inst Informat & Commun Technol NICT, Universal Commun Res Inst, Seika, Kyoto, Japan	National Institute of Information & Communications Technology (NICT) - Japan; Osaka University; National Institute of Information & Communications Technology (NICT) - Japan	Nawa, NE (corresponding author), Natl Inst Informat & Commun Technol NICT, Ctr Informat & Neural Networks CiNet, Suita, Osaka, Japan.	eiji.nawa@nict.go.jp			National Institute of Information and Communications Technology	National Institute of Information and Communications Technology	This research was supported by the National Institute of Information and Communications Technology. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsalidou M, 2011, NEUROIMAGE, V54, P2382, DOI 10.1016/j.neuroimage.2010.10.009; Baucom LB, 2012, NEUROIMAGE, V59, P718, DOI 10.1016/j.neuroimage.2011.07.037; Birn RM, 2008, NEUROIMAGE, V40, P644, DOI 10.1016/j.neuroimage.2007.11.059; Bishop C. M, 2006, PATTERN RECOGNITION; Boly M, 2007, NEUROIMAGE, V36, P979, DOI 10.1016/j.neuroimage.2007.02.047; Brett M., 2002, 8 INT C FUNCT MAPP H, V16, P497; Brodersen Kay H., 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P3121, DOI 10.1109/ICPR.2010.764; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Chang C, 2009, NEUROIMAGE, V44, P857, DOI 10.1016/j.neuroimage.2008.09.029; Chang CL, 2011, GENOME RES, V21, P21, DOI 10.1101/gr.110593.110; Chu C, 2012, NEUROIMAGE, V60, P59, DOI 10.1016/j.neuroimage.2011.11.066; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cuingnet R, 2011, NEUROIMAGE, V56, P766, DOI 10.1016/j.neuroimage.2010.06.013; Gilboa A, 2004, NEUROPSYCHOLOGIA, V42, P1336, DOI 10.1016/j.neuropsychologia.2004.02.014; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Greenberg DL, 2005, NEUROPSYCHOLOGIA, V43, P659, DOI 10.1016/j.neuropsychologia.2004.09.002; Guillot A, 2009, HUM BRAIN MAPP, V30, P2157, DOI 10.1002/hbm.20658; Handwerker DA, 2004, NEUROIMAGE, V21, P1639, DOI 10.1016/j.neuroimage.2003.11.029; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2005, CURR BIOL, V15, P1301, DOI 10.1016/j.cub.2005.06.026; Heinzle J, 2012, J NEUROSCI, V32, P9960, DOI 10.1523/JNEUROSCI.1604-12.2012; LaConte SM, 2007, HUM BRAIN MAPP, V28, P1033, DOI 10.1002/hbm.20326; Lindquist KA, 2012, TRENDS COGN SCI, V16, P533, DOI 10.1016/j.tics.2012.09.005; Maguire EA, 2012, NEUROIMAGE, V62, P1170, DOI 10.1016/j.neuroimage.2012.01.009; Mitchell TM, 2004, MACH LEARN, V57, P145, DOI 10.1023/B:MACH.0000035475.85309.1b; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Mourao-Miranda J, 2005, NEUROIMAGE, V28, P980, DOI 10.1016/j.neuroimage.2005.06.070; Naci L, 2013, J NEUROSCI, V33, P9385, DOI 10.1523/JNEUROSCI.5577-12.2013; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Penny WD, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P156, DOI 10.1016/B978-012372560-8/50012-7; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Poline JB, 2012, NEUROIMAGE, V62, P871, DOI 10.1016/j.neuroimage.2012.01.133; Schreiber K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069328; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Sitaram R, 2011, NEUROIMAGE, V56, P753, DOI 10.1016/j.neuroimage.2010.08.007; Smith SM, 2004, BRIT J RADIOL, V77, pS167, DOI 10.1259/bjr/33553595; Sorger B, 2012, CURR BIOL, V22, P1333, DOI 10.1016/j.cub.2012.05.022; St Jacques PL, 2011, J PSYCHIATR RES, V45, P630, DOI 10.1016/j.jpsychires.2010.10.011; Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wang J, 2013, HUM BRAIN MAPP, V34, P1133, DOI 10.1002/hbm.21498	43	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97296	10.1371/journal.pone.0097296	http://dx.doi.org/10.1371/journal.pone.0097296			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824899	Green Submitted, gold, Green Published			2022-12-27	WOS:000336369200088
J	Orban, A; Butykai, A; Molnar, A; Prohle, Z; Fulop, G; Zelles, T; Forsyth, W; Hill, D; Muller, I; Schofield, L; Rebelo, M; Hanscheid, T; Karl, S; Kezsmarki, I				Orban, Agnes; Butykai, Adam; Molnar, Andras; Proehle, Zsofia; Fueloep, Gergoe; Zelles, Tivadar; Forsyth, Wasan; Hill, Danika; Mueller, Ivo; Schofield, Louis; Rebelo, Maria; Haenscheid, Thomas; Karl, Stephan; Kezsmarki, Istvan			Evaluation of a Novel Magneto-Optical Method for the Detection of Malaria Parasites	PLOS ONE			English	Article							RAPID DIAGNOSTIC-TESTS; PLASMODIUM-FALCIPARUM; INFECTED ERYTHROCYTES; MAGNETIC SEPARATION; HEMOZOIN; MICROSCOPY; BLOOD; SENSITIVITY; HAEMOZOIN; IRON	Improving the efficiency of malaria diagnosis is one of the main goals of current malaria research. We have recently developed a magneto-optical (MO) method which allows high-sensitivity detection of malaria pigment (hemozoin crystals) in blood via the magnetically induced rotational motion of the hemozoin crystals. Here, we evaluate this MO technique for the detection of Plasmodium falciparum in infected erythrocytes using in-vitro parasite cultures covering the entire intraerythrocytic life cycle. Our novel method detected parasite densities as low as,40 parasites per microliter of blood (0.0008% parasitemia) at the ring stage and less than 10 parasites/mu L (0.0002% parasitemia) in the case of the later stages. These limits of detection, corresponding to approximately 20 pg/mu L of hemozoin produced by the parasites, exceed that of rapid diagnostic tests and compete with the threshold achievable by light microscopic observation of blood smears. The MO diagnosis requires no special training of the operator or specific reagents for parasite detection, except for an inexpensive lysis solution to release intracellular hemozoin. The devices can be designed to a portable format for clinical and in-field tests. Besides testing its diagnostic performance, we also applied the MO technique to investigate the change in hemozoin concentration during parasite maturation. Our preliminary data indicate that this method may offer an efficient tool to determine the amount of hemozoin produced by the different parasite stages in synchronized cultures. Hence, it could eventually be used for testing the susceptibility of parasites to antimalarial drugs.	[Orban, Agnes; Butykai, Adam; Molnar, Andras; Proehle, Zsofia; Fueloep, Gergoe; Kezsmarki, Istvan] Budapest Univ Technol & Econ, Dept Phys, Budapest, Hungary; [Zelles, Tivadar] Semmelweis Univ, Dept Oral Biol, H-1085 Budapest, Hungary; [Forsyth, Wasan; Hill, Danika; Mueller, Ivo; Schofield, Louis; Karl, Stephan] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Infect & Immun Div, Parkville, Vic 3050, Australia; [Hill, Danika] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Schofield, Louis] James Cook Univ, Australian Inst Trop Hlth & Med, Queensland Trop Hlth Alliance, Douglas, Qld, Australia; [Rebelo, Maria; Haenscheid, Thomas] Fac Med, Inst Mol Med, Lisbon, Portugal; [Kezsmarki, Istvan] Hungarian Acad Sci, Condensed Matter Res Grp, Budapest, Hungary	Budapest University of Technology & Economics; Semmelweis University; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; James Cook University; Universidade de Lisboa; Hungarian Academy of Sciences	Kezsmarki, I (corresponding author), Budapest Univ Technol & Econ, Dept Phys, Budapest, Hungary.	kezsmark@dept.phy.bme.hu	Karl, Stephan/A-2365-2012; Hill, Danika/ADA-4249-2022; Kezsmarki, Istvan/B-1753-2012; Hanscheid, Thomas/AAT-3639-2021; Zelles, Tivadar/O-9621-2017	Hill, Danika/0000-0001-6284-7061; Kezsmarki, Istvan/0000-0003-4706-3247; Hanscheid, Thomas/0000-0001-6353-9132; Rebelo, Maria/0000-0003-2715-7182	Hungarian Research Funds [OTKA K108918, TAMOP-4.2.1.B-09/1/KMR-2010-0001]; NHMRC [GNT1021544, GNT1043345, GNT637406, GNT1058665]; NHMRC early career research fellowship [GNT1052760]	Hungarian Research Funds(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NHMRC early career research fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Hungarian Research Funds OTKA K108918, TAMOP-4.2.1.B-09/1/KMR-2010-0001, by NHMRC grants GNT1021544 and GNT1043345 awarded to Ivo Muller and by NHMRC grants GNT637406 and GNT1058665 awarded to Louis Schofield. Stephan Karl is supported through an NHMRC early career research fellowship (GNT1052760). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Bakar N, 2010, J CELL SCI, V123, P441, DOI 10.1242/jcs.061499; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000396; Baird JK, 2010, LANCET, V376, P1883, DOI 10.1016/S0140-6736(10)61494-8; Becker K, 2004, INT J PARASITOL, V34, P163, DOI 10.1016/j.ijpara.2003.09.011; Butykai A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01431; Carter V, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-35; Carvalho BO, 2010, J INFECT DIS, V202, P638, DOI 10.1086/654815; Chen MM, 2001, MOL BIOCHEM PARASIT, V113, P1, DOI 10.1016/S0166-6851(00)00365-0; Coleman RE, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-121; COOKE BM, 1995, PARASITOL TODAY, V11, P282, DOI 10.1016/0169-4758(95)80040-9; Castilho MD, 2011, ANAL CHEM, V83, P5570, DOI 10.1021/ac200573s; Francis SE, 1997, ANNU REV MICROBIOL, V51, P97, DOI 10.1146/annurev.micro.51.1.97; Frita R, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-74; Hackett S, 2009, BBA-MOL BASIS DIS, V1792, P93, DOI 10.1016/j.bbadis.2008.11.001; Hanscheid T, 1999, CLIN LAB HAEMATOL, V21, P235, DOI 10.1046/j.1365-2257.1999.00220.x; Hobro AJ, 2013, ANALYST, V138, P3927, DOI 10.1039/c3an00255a; Jaramillo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006957; Karl S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002219; Karl S, 2011, AM J TROP MED HYG, V84, P158, DOI 10.4269/ajtmh.2011.10-0416; Karl S, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-66; Khairnar K, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-284; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lukianova-Hleb EY, 2014, P NATL ACAD SCI USA, V111, P900, DOI 10.1073/pnas.1316253111; Maltha J, 2013, CLIN MICROBIOL INFEC, V19, P399, DOI 10.1111/1469-0691.12151; Mens PF, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-207; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Moore LR, 2006, FASEB J, V20, P747, DOI 10.1096/fj.05-5122fje; Nam J, 2013, ANAL CHEM, V85, P7316, DOI 10.1021/ac4012057; Newman DM, 2008, BIOPHYS J, V95, P994, DOI 10.1529/biophysj.107.128140; Newman DM, 2010, IEEE J SEL TOP QUANT, V16, P573, DOI 10.1109/JSTQE.2009.2029068; Noland GS, 2003, MOL BIOCHEM PARASIT, V130, P91, DOI 10.1016/S0166-6851(03)00163-4; O'Meara WP, 2006, PARASITOL RES, V99, P500, DOI 10.1007/s00436-006-0135-x; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Oliveira MF, 2004, J INFECT DIS, V190, P843, DOI 10.1086/422759; Oliveira MF, 2000, MOL BIOCHEM PARASIT, V111, P217, DOI 10.1016/S0166-6851(00)00299-1; ORJIH AU, 1993, BIOCHIM BIOPHYS ACTA, V1157, P270, DOI 10.1016/0304-4165(93)90109-L; Owusu-Ofori AK, 2013, CLIN INFECT DIS, V56, P1735, DOI 10.1093/cid/cit130; PAUL F, 1981, LANCET, V2, P70; PAYNE D, 1988, B WORLD HEALTH ORGAN, V66, P621; Perkins MD, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S5; Rebelo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061606; Schwarzer E, 2001, PARASITOLOGY, V123, P125, DOI 10.1017/S0031182001008216; SLATER AFG, 1991, P NATL ACAD SCI USA, V88, P325, DOI 10.1073/pnas.88.2.325; Snounou G, 1996, Methods Mol Biol, V50, P263; Tangpukdee N, 2009, KOREAN J PARASITOL, V47, P93, DOI 10.3347/kjp.2009.47.2.93; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Weissbuch I, 2008, CHEM REV, V108, P4899, DOI 10.1021/cr078274t; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119; Yuen C, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.1.017005; Zimmerman PA, 2006, AM J TROP MED HYG, V74, P568, DOI 10.4269/ajtmh.2006.74.568	50	35	35	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96981	10.1371/journal.pone.0096981	http://dx.doi.org/10.1371/journal.pone.0096981			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824542	Green Published, Green Accepted, gold			2022-12-27	WOS:000336369200044
J	Orlowska-Baranowska, E; Gora, J; Baranowski, R; Stoklosa, P; Betka, LG; Pedzich-Placha, E; Milkowska, M; Koblowska, MK; Hryniewiecki, T; Gaciong, Z; Placha, G				Orlowska-Baranowska, Ewa; Gora, Jaroslaw; Baranowski, Rafal; Stoklosa, Patrycjusz; Betka, Lucja Gadomskavel; Pedzich-Placha, Ewa; Milkowska, Malogrzata; Koblowska, Marta K.; Hryniewiecki, Tomasz; Gaciong, Zbigniew; Placha, Grzegorz			Association of the Common Genetic Polymorphisms and Haplotypes of the Chymase Gene with Left Ventricular Mass in Male Patients with Symptomatic Aortic Stenosis	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; GENDER-DIFFERENCES; PRESSURE-OVERLOAD; VALVE-REPLACEMENT; CELL CHYMASE; MYOCARDIAL HYPERTROPHY; WALL THICKNESS; HEART-FAILURE; SEX; COHORT	We investigated the association between polymorphisms and haplotypes of the chymase 1 gene (CMA1) and the left ventricular mass index (LVM/BSA) in a large cohort of patients with aortic stenosis (AS). Additionally, the gender differences in cardiac remodeling and hypertrophy were analyzed. The genetic background may affect the myocardial response to pressure overload. In human cardiac tissue, CMA1 is involved in angiotensin II production and TGF-beta activation, which are two major players in the pathogenesis of hypertrophy and fibrosis. Preoperative echocardiographic data from 648 patients with significant symptomatic AS were used. The LVM/BSA was significantly lower (p < 0.0001), but relative wall thickness (RWT) was significantly higher (p = 0.0009) in the women compared with the men. The haplotypes were reconstructed using six genotyped polymorphisms: rs5248, rs4519248, rs1956932, rs17184822, rs1956923, and rs1800875. The haplotype h1.ACAGGA was associated with higher LVM/BSA (p = 9.84 x 10(-5)), and the haplotype h2.ATAGAG was associated with lower LVM/BSA (p = 0.0061) in men, and no significant differences were found in women. Two polymorphisms within the promoter region of the CMA1 gene, namely rs1800875 (p = 0.0067) and rs1956923 (p = 0.0015), influenced the value of the LVM/BSA in males. The polymorphisms and haplotypes of the CMA1 locus are associated with cardiac hypertrophy in male patients with symptomatic AS. Appropriate methods for the indexation of heart dimensions revealed substantial sex- related differences in the myocardial response to pressure overload.	[Orlowska-Baranowska, Ewa; Stoklosa, Patrycjusz; Milkowska, Malogrzata; Hryniewiecki, Tomasz] Inst Cardiol, Dept Valvular Heart Dis, Warsaw, Poland; [Gora, Jaroslaw; Betka, Lucja Gadomskavel; Pedzich-Placha, Ewa; Gaciong, Zbigniew; Placha, Grzegorz] Med Univ Warsaw, Dept Internal Med Hypertens & Vasc Dis, Warsaw, Poland; [Baranowski, Rafal] Inst Cardiol, Clin Arrhythmia, Warsaw, Poland; [Koblowska, Marta K.] Univ Warsaw, Fac Biol, Warsaw, Poland; [Koblowska, Marta K.] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland	Institute of Cardiology - Poland; Medical University of Warsaw; Institute of Cardiology - Poland; University of Warsaw; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Placha, G (corresponding author), Med Univ Warsaw, Dept Internal Med Hypertens & Vasc Dis, Warsaw, Poland.	Grzegorz.Placha@wum.edu.pl	Stokłosa, Patrycjusz/AAO-5055-2020	Stokłosa, Patrycjusz/0000-0001-9191-5959; Pedzich, Ewa/0000-0001-8965-0736; Koblowska, Marta/0000-0003-4497-6200	Polpharma Scientific Foundation [12/VIII/2009]; Ministry of Science and Higher Education [4354/B/P01/2007/33]; Foundation for Polish Science, Programme TEAM [TEAM/2012-9/2]; European Union European Regional Development Fund	Polpharma Scientific Foundation; Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Foundation for Polish Science, Programme TEAM; European Union European Regional Development Fund(European Commission)	The study was supported by an unrestricted grant from the Polpharma Scientific Foundation (12/VIII/2009, http://www.polpharma.pl/en/foundation/), a governmental grant from the Ministry of Science and Higher Education (4354/B/P01/2007/33, http://www.ncn.gov.pl/)and an unrestricted grant from the Foundation for Polish Science, Programme TEAM (TEAM/2012-9/2, http://www.fnp.org.pl/), co-financed by the European Union European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir RE, 2008, GENET MED, V10, P593, DOI [10.1097/GIM.0b013e3181804b9c, 10.1097GIM.0b013e3181804b9c]; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; CARROLL JD, 1992, CIRCULATION, V86, P1099, DOI 10.1161/01.CIR.86.4.1099; Carter KW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-557; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Dellgren G, 1999, AM J CARDIOL, V84, P909, DOI 10.1016/S0002-9149(99)00464-6; DEVEREUX RB, 1977, CIRCULATION, V55, P613, DOI 10.1161/01.CIR.55.4.613; Dobaczewski M, 2011, J MOL CELL CARDIOL, V51, P600, DOI 10.1016/j.yjmcc.2010.10.033; DOUGLAS PS, 1995, BRIT HEART J, V73, P548; Duncan AI, 2008, ANN THORAC SURG, V85, P2030, DOI 10.1016/j.athoracsur.2008.02.075; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; GRIFFITH MJ, 1991, CLIN CARDIOL, V14, P227, DOI 10.1002/clc.4960140310; Gusterson R, 2002, J BIOL CHEM, V277, P2517, DOI 10.1074/jbc.M104626200; HARSHFIELD GA, 1990, AM J HYPERTENS, V3, P538, DOI 10.1093/ajh/3.7.538; Hersberger M, 2010, HUM IMMUNOL, V71, P1154, DOI 10.1016/j.humimm.2010.08.008; Kararigas G, 2011, PHYSIOL GENOMICS, V43, P438, DOI 10.1152/physiolgenomics.00199.2010; Kostkiewicz M, 1999, INT J CARDIOL, V71, P57, DOI 10.1016/S0167-5273(99)00114-X; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Li P, 2002, HYPERTENS RES, V25, P757; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Miyazaki M, 2006, PHARMACOL THERAPEUT, V112, P668, DOI 10.1016/j.pharmthera.2006.05.008; Montalvo C, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035635, DOI 10.1371/J0URNAL.P0NE.0035635.EPUB]; Orlowska-Baranowska E, 2004, J HEART VALVE DIS, V13, P574; ORSINELLI DA, 1993, J AM COLL CARDIOL, V22, P1679, DOI 10.1016/0735-1097(93)90595-R; Ortlepp JR, 2001, AM HEART J, V141, P671, DOI 10.1067/mhj.2001.113394; Petrov G, 2010, CIRCULATION, V122, pS23, DOI 10.1161/CIRCULATIONAHA.109.927764; Piro M, 2010, J AM COLL CARDIOL, V55, P1057, DOI 10.1016/j.jacc.2009.09.065; Re RN, 2004, NAT CLIN PRACT CARD, V1, P42, DOI 10.1038/ncpcardio0012; Regitz-Zagrosek V, 2010, CIRC J, V74, P1265, DOI 10.1253/circj.CJ-10-0196; SADOSHIMA J, 1993, CIRC RES, V73, P413, DOI 10.1161/01.RES.73.3.413; Salton CJ, 2002, J AM COLL CARDIOL, V39, P1055, DOI 10.1016/S0735-1097(02)01712-6; Sharma S, 2005, J HUM GENET, V50, P276, DOI 10.1007/s10038-005-0252-x; Stram DO, 2003, HUM HERED, V55, P27, DOI 10.1159/000071807; URATA H, 1990, J BIOL CHEM, V265, P22348; Villar AV, 2009, J MOL CELL CARDIOL, V46, P526, DOI 10.1016/j.yjmcc.2008.12.024; VILLARI B, 1995, EUR HEART J, V16, P1410, DOI 10.1093/oxfordjournals.eurheartj.a060749; Wang Y, 1992, J Clin Anesth, V4, P4, DOI 10.1016/0952-8180(92)90111-D; Weidinger S, 2005, ALLERGY, V60, P1256, DOI 10.1111/j.1398-9995.2005.00879.x; Wong KK, 1996, CLIN EXP PHARMACOL P, V23, P587, DOI 10.1111/j.1440-1681.1996.tb02788.x	40	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96306	10.1371/journal.pone.0096306	http://dx.doi.org/10.1371/journal.pone.0096306			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24823657	Green Submitted, gold, Green Published			2022-12-27	WOS:000336369200015
J	Rakotoniana, JS; Rakotomanga, JDM; Barennes, H				Rakotoniana, Jerry S.; Rakotomanga, Jean de Dieu M.; Barennes, Hubert			Can Churches Play a Role in Combating the HIV/AIDS Epidemic? A Study of the Attitudes of Christian Religious Leaders in Madagascar	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; SEX WORKERS; CONDOM USE; RURAL MADAGASCAR; HIV; BEHAVIOR; WOMEN; PREVENTION; YOUTH; CARE	Introduction: Churches occupy an important social and cultural position in Madagascar. The sexual transmission of HIV raises controversies about the role that Churches can play in preventing HIV/AIDS. This cross-sectional survey investigated recommendations by religious leaders for condom use and other preventive strategies in the context of international guidelines. Methods: A questionnaire was self-administered to a random sample of religious leaders. The questions related to preventive methods against HIV/AIDS such as: condom use, marital fidelity, sexual abstinence before marriage, and HIV-testing. Associations with recommendations for condom use were evaluated using univariate and multivariate logistic regression analyses. Results: Of 231 religious leaders, 215 (93.1%) were willing to share their knowledge of HIV/AIDS with their congregations. The majority received their information from the media (N = 136, 58.9%), a minority from their church (N = 9, 3.9%), and 38 (16.4%) had received prior training on HIV. Nearly all (N = 212, 91.8%) knew that HIV could be sexually transmitted though only a few (N = 39, 16.9%) were aware of mother-to-child transmission or unsafe injections (N = 56, 24.2%). A total of 91 (39.4%) were willing to, or had recommended (N = 64, 27.7%), condom use, while 50 (21.6%) had undergone HIV testing. Only nine (3.9%) had ever cared for a person living with HIV/AIDS (PLHIV). Multivariable logistic regression shows that condom use recommendations by religious leaders were negatively associated with tertiary level education (OR: 0.3, 95% CI 0.1-0.7), and positively associated with knowing a person at risk (OR: 16.2, 95% CI 3.2-80.2), knowing of an ART center (OR: 2.6, 95% CI 1.4-4.8), and receiving information about HIV at school (OR: 2.6, 95% CI 1.2-5.6). Conclusions: Malagasy church leaders could potentially become key players in HIV/AIDS prevention if they improved their knowledge of the illness, their commitment to international recommendations, and extended their interaction with people most at risk.	[Rakotoniana, Jerry S.; Barennes, Hubert] Inst Francophone Med Trop, Viangchan, Laos; [Rakotoniana, Jerry S.; Rakotomanga, Jean de Dieu M.] Inst Natl Sante Publ & Communautaire INSPC Befela, Antananarivo, Madagascar; [Barennes, Hubert] Agence Natl Rech VIH & Hepatites, Phnom Penh, Cambodia; [Barennes, Hubert] INSERM, ISPED, Ctr INSERM, Epidemiol Biostat U897, Bordeaux, France; [Barennes, Hubert] Inst Pasteur, Epidemiol Unit, Phnom Penh, Cambodia	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia	Barennes, H (corresponding author), Inst Francophone Med Trop, Viangchan, Laos.	barenneshub@yahoo.fr			Agence Universitaire de la Francophonie (AUF); Institut Francophone pour la Medecine Tropicale (IFMT)	Agence Universitaire de la Francophonie (AUF); Institut Francophone pour la Medecine Tropicale (IFMT)	This study was supported by Agence Universitaire de la Francophonie (AUF), Institut Francophone pour la Medecine Tropicale (IFMT). The findings and conclusions in this report are those of the authors, and do not necessarily represent the official position of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANGRE H, 2004, FRANCE TRANSFUSE AFR; Behets F, 2001, TROP MED INT HEALTH, V6, P202, DOI 10.1046/j.1365-3156.2001.00690.x; Benton KW, 2008, J RELIG HEALTH, V47, P314, DOI 10.1007/s10943-007-9158-6; *DEM HLTH SURV, 2008, DEM HLTH SURV; Feldblum PJ, 2007, CONTRACEPTION, V76, P105, DOI 10.1016/j.contraception.2007.04.009; Frickmann H, 2013, TROP MED INT HEALTH, V18, P35, DOI 10.1111/tmi.12007; GREEN EC, 2013, RETHINKING AIDS PREV; Harijaona V, 2009, MED MALADIES INFECT, V39, P909, DOI 10.1016/j.medmal.2009.01.007; Kagimu M, 2012, AFR HEALTH SCI, V12, P119, DOI 10.4314/ahs.v12i2.7; Kanda K, 2013, GLOB PUBLIC HEALTH, V8, P159, DOI 10.1080/17441692.2012.745892; Khan MR, 2008, SEX TRANSM DIS, V35, P738, DOI 10.1097/OLQ.0b013e3181724383; Kruse N, 2003, SEX TRANSM DIS, V30, P664, DOI 10.1097/01.OLQ.0000079523.04451.82; Lanouette NM, 2003, AM J PUBLIC HEALTH, V93, P917, DOI 10.2105/AJPH.93.6.917; Leutscher P, 2005, SEX TRANSM DIS, V32, P150, DOI 10.1097/01.olq.0000152820.17242.17; Leutscher PDC, 2003, SEX TRANSM DIS, V30, P262, DOI 10.1097/00007435-200303000-00017; Liebowitz J, 2006, RES GLOB CHILD ADVOC, P209; Manglos ND, 2011, J HEALTH SOC BEHAV, V52, P107, DOI 10.1177/0022146510395025; Meekers D, 2006, J BIOSOC SCI, V38, P365, DOI 10.1017/S0021932005007200; Rahamefy OH, 2008, SAHARA J-J SOC ASP H, V5, P28, DOI 10.1080/17290376.2008.9724899; Randrianasolo B, 2008, J BIOSOC SCI, V40, P879, DOI 10.1017/S0021932007002672; *SE CNLS, 2007, PLAN ACT MAD LUTT EF; Stoebenau K, 2009, AM J PUBLIC HEALTH, V99, P811, DOI 10.2105/AJPH.2007.118422; Szaflarski M, 2013, AIDS BEHAV, V17, P1839, DOI 10.1007/s10461-013-0455-7; Trinitapoli J, 2011, GLOB PUBLIC HEALTH, V6, P41, DOI 10.1080/17441692.2010.486764; Trinitapoli J, 2009, SOC SCI MED, V69, P199, DOI 10.1016/j.socscimed.2009.04.018; Watt MH, 2009, AIDS PATIENT CARE ST, V23, P389, DOI 10.1089/apc.2008.0195; *WHO, 2009, POS STAT; Xueref S, 2003, TROP MED INT HEALTH, V8, P60, DOI 10.1046/j.1365-3156.2003.00986.x; Zou J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-75	29	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97131	10.1371/journal.pone.0097131	http://dx.doi.org/10.1371/journal.pone.0097131			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AH8EY	24824620	Green Published, gold, Green Submitted			2022-12-27	WOS:000336369200064
J	Ruan, ZL; Liu, GY; Guo, YF; Zhou, YH; Wang, QQ; Chang, YL; Wang, BL; Zheng, JM; Zhang, LM				Ruan, Zengliang; Liu, Guoyan; Guo, Yufeng; Zhou, Yonghong; Wang, Qianqian; Chang, Yinlong; Wang, Beilei; Zheng, Jiemin; Zhang, Liming			First Report of a Thioredoxin Homologue in Jellyfish: Molecular Cloning, Expression and Antioxidant Activity of CcTrx1 from Cyanea capillata	PLOS ONE			English	Article							DNA PROTECTION ACTIVITY; OXIDATIVE STRESS; CRYSTAL-STRUCTURES; REDOX REGULATION; GENE-EXPRESSION; PROTEIN; MECHANISM; PURIFICATION; SYSTEMS; FAMILY	Thioredoxins (Trx proteins) are a family of small, highly-conserved and ubiquitous proteins that play significant roles in the resistance of oxidative damage. In this study, a homologue of Trx was identified from the cDNA library of tentacle of the jellyfish Cyanea capillata and named CcTrx1. The full-length cDNA of CcTrx1 was 479 bp with a 312 bp open reading frame encoding 104 amino acids. Bioinformatics analysis revealed that the putative CcTrx1 protein harbored the evolutionarily-conserved Trx active site (31)CGPC(34) and shared a high similarity with Trx1 proteins from other organisms analyzed, indicating that CcTrx1 is a new member of Trx1 sub-family. CcTrx1 mRNA was found to be constitutively expressed in tentacle, umbrella, oral arm and gonad, indicating a general role of CcTrx1 protein in various physiological processes. The recombinant CcTrx1 (rCcTrx1) protein was expressed in Escherichia coli BL21 (DE3), and then purified by affinity chromatography. The rCcTrx1 protein was demonstrated to possess the expected redox activity in enzymatic analysis and protection against oxidative damage of supercoiled DNA. These results indicate that CcTrx1 may function as an important antioxidant in C. capillata. To our knowledge, this is the first Trx protein characterized from jellyfish species.	[Ruan, Zengliang; Liu, Guoyan; Guo, Yufeng; Zhou, Yonghong; Wang, Qianqian; Chang, Yinlong; Wang, Beilei; Zheng, Jiemin; Zhang, Liming] Second Mil Med Univ, Fac Naval Med, Dept Marine Biotechnol, Shanghai, Peoples R China	Naval Medical University	Zhang, LM (corresponding author), Second Mil Med Univ, Fac Naval Med, Dept Marine Biotechnol, Shanghai, Peoples R China.	lmzhang1969@163.com	Ruan, Zengliang/CAG-5992-2022; Ruan, Zengliang/AAD-3032-2022	Ruan, Zengliang/0000-0002-9468-0232; Ruan, Zengliang/0000-0002-9468-0232; Zhou, Yonghong/0000-0002-1242-1764	Young Scientists Fund of National Natural Science Foundation of China [41306136]; Natural Science Foundation of Shanghai Municipal Government [12ZR1437000]; National High Technology Research and Development Program of China (863 Program) [2013AA092904]	Young Scientists Fund of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai Municipal Government; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by the Young Scientists Fund of National Natural Science Foundation of China (41306136), the Natural Science Foundation of Shanghai Municipal Government (12ZR1437000) and the National High Technology Research and Development Program of China (863 Program) (2013AA092904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aispuro-Hernandez E, 2008, COMP BIOCHEM PHYS C, V148, P94, DOI 10.1016/j.cbpc.2008.03.013; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen JF, 1997, BIOCHEMISTRY-US, V36, P13979, DOI 10.1021/bi971004s; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Berggren M, 1996, ANTICANCER RES, V16, P3459; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bramucci E, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S2; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Collet JF, 2010, ANTIOXID REDOX SIGN, V13, P1205, DOI 10.1089/ars.2010.3114; Das KC, 2000, BIOCHEM BIOPH RES CO, V277, P443, DOI 10.1006/bbrc.2000.3689; De Zoysa M, 2008, COMP BIOCHEM PHYS B, V149, P630, DOI 10.1016/j.cbpb.2007.12.009; EKLUND H, 1991, PROTEINS, V11, P13, DOI 10.1002/prot.340110103; FERNANDO MR, 1992, EUR J BIOCHEM, V209, P917, DOI 10.1111/j.1432-1033.1992.tb17363.x; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; Grant CM, 2001, MOL MICROBIOL, V39, P533, DOI 10.1046/j.1365-2958.2001.02283.x; Gromer S, 2004, MED RES REV, V24, P40, DOI 10.1002/med.10051; Hoflehner E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042026; Holmgren A, 2005, BIOCHEM SOC T, V33, P1375, DOI 10.1042/BST0331375; HOLMGREN A, 1995, STRUCTURE, V3, P239, DOI 10.1016/S0969-2126(01)00153-8; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Huang J, 2014, BIOCHIMIE, V97, P92, DOI 10.1016/j.biochi.2013.09.024; Kondo N, 2006, ANTIOXID REDOX SIGN, V8, P1881, DOI 10.1089/ars.2006.8.1881; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAURENT TC, 1964, J BIOL CHEM, V239, P3436; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Li HL, 2011, MOL BIOL REP, V38, P1989, DOI 10.1007/s11033-010-0321-x; Li J, 2004, GENE, V326, P157, DOI 10.1016/j.gene.2003.10.027; Li RF, 2012, INT J BIOL MACROMOL, V51, P274, DOI 10.1016/j.ijbiomac.2012.05.015; Liu F, 2003, GENE, V315, P71, DOI 10.1016/S0378-1119(03)00732-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; McGonigle S, 1998, PARASITOL TODAY, V14, P139, DOI 10.1016/S0169-4758(97)01211-8; Miranda-Vizuete A, 2001, J BIOL CHEM, V276, P31567, DOI 10.1074/jbc.M101760200; Mu CK, 2009, FISH SHELLFISH IMMUN, V26, P716, DOI 10.1016/j.fsi.2009.02.024; Nakamura H, 2009, ADV DRUG DELIVER REV, V61, P303, DOI 10.1016/j.addr.2009.01.003; Nakamura T, 2005, ANTIOXID REDOX SIGN, V7, P60, DOI 10.1089/ars.2005.7.60; Nappi AJ, 2000, BIOESSAYS, V22, P469, DOI 10.1002/(SICI)1521-1878(200005)22:5<469::AID-BIES9>3.3.CO;2-W; Park CI, 2012, FISH SHELLFISH IMMUN, V32, P808, DOI 10.1016/j.fsi.2012.02.002; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Revathy KS, 2012, DEV COMP IMMUNOL, V36, P85, DOI 10.1016/j.dci.2011.06.006; Ruan ZL, 2014, MAR DRUGS, V12, P214, DOI 10.3390/md12010214; SAARINEN M, 1995, STRUCTURE, V3, P1097, DOI 10.1016/S0969-2126(01)00245-3; Scandalios JG, 2005, BRAZ J MED BIOL RES, V38, P995, DOI 10.1590/S0100-879X2005000700003; Smeets A, 2005, PROTEIN SCI, V14, P2610, DOI 10.1110/ps.051632905; Song CW, 2012, FISH SHELLFISH IMMUN, V32, P855, DOI 10.1016/j.fsi.2012.02.013; Su D, 2007, BIOCHEMISTRY-US, V46, P6903, DOI 10.1021/bi700152b; Tanabe N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079016; Tanaka R, 2004, PROTEIN EXPRES PURIF, V37, P385, DOI 10.1016/j.pep.2004.06.016; Wang QF, 2013, MOL BIOL REP, V40, P6587, DOI 10.1007/s11033-013-2771-4; Watson WH, 2004, TOXICOL SCI, V78, P3, DOI 10.1093/toxsci/kfh050; Wei JG, 2012, DEV COMP IMMUNOL, V38, P108, DOI 10.1016/j.dci.2012.04.011; Weichsel A, 1996, STRUCTURE, V4, P735, DOI 10.1016/S0969-2126(96)00079-2; Yao PB, 2013, GENE, V527, P33, DOI 10.1016/j.gene.2013.05.062; Yao PB, 2013, J INSECT PHYSIOL, V59, P273, DOI 10.1016/j.jinsphys.2012.11.005; Yu HH, 2005, BIOORG MED CHEM LETT, V15, P2659, DOI 10.1016/j.bmcl.2005.03.044; Zhuang YL, 2009, J FOOD SCI, V74, pH183, DOI 10.1111/j.1750-3841.2009.01236.x	60	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97509	10.1371/journal.pone.0097509	http://dx.doi.org/10.1371/journal.pone.0097509			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824597	Green Published, Green Submitted, gold			2022-12-27	WOS:000336369200124
J	Zuloaga, KL; Krasnow, SM; Zhu, XX; Zhang, WR; Jouihan, SA; Shangraw, RE; Alkayed, NJ; Marks, DL				Zuloaga, Kristen L.; Krasnow, Stephanie M.; Zhu, Xinxia; Zhang, Wenri; Jouihan, Sari A.; Shangraw, Robert E.; Alkayed, Nabil J.; Marks, Daniel L.			Mechanism of Protection by Soluble Epoxide Hydrolase Inhibition in Type 2 Diabetic Stroke	PLOS ONE			English	Article							ISCHEMIC BRAIN-DAMAGE; EPOXYEICOSATRIENOIC ACIDS; POSTSTROKE HYPERGLYCEMIA; GLUCOSE CONTROL; INSULIN; OVEREXPRESSION; OBESITY; MODEL; DIET	Inhibition of soluble epoxide hydrolase (sEH) is a potential target of therapy for ischemic injury. sEH metabolizes neuroprotective epoxyeicosatrienoic acids (EETs). We recently demonstrated that sEH inhibition reduces infarct size after middle cerebral artery occlusion (MCAO) in type 1 diabetic mice. We hypothesized that inhibition of sEH would protect against ischemic injury in type 2 diabetic mice. Type 2 diabetes was produced by combined high-fat diet, nicotinamide and streptozotocin in male mice. Diabetic and control mice were treated with vehicle or the sEH inhibitor t-AUCB then subjected to 60-min MCAO. Compared to chow-fed mice, high fat diet-fed mice exhibited an upregulation of sEH mRNA and protein in brain, but no differences in brain EETs levels were observed between groups. Type 2 diabetic mice had increased blood glucose levels at baseline and throughout ischemia, decreased laser-Doppler perfusion of the MCA territory after reperfusion, and sustained larger cortical infarcts compared to control mice. t-AUCB decreased fasting glucose levels at baseline and throughout ischemia, improved cortical perfusion after MCAO and significantly reduced infarct size in diabetic mice. We conclude that sEH inhibition, as a preventative treatment, improves glycemic status, post-ischemic reperfusion in the ischemic territory, and stroke outcome in type 2 diabetic mice.	[Zuloaga, Kristen L.; Zhang, Wenri; Jouihan, Sari A.; Shangraw, Robert E.; Alkayed, Nabil J.] Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Dept Anesthesiol & Perioperat Med, Portland, OR 97201 USA; [Krasnow, Stephanie M.; Zhu, Xinxia; Marks, Daniel L.] Oregon Hlth & Sci Univ, Pape Family Pediat Res Inst, Dept Pediat, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Marks, DL (corresponding author), Oregon Hlth & Sci Univ, Pape Family Pediat Res Inst, Dept Pediat, Portland, OR 97201 USA.	marksd@ohsu.edu	Marks, Daniel/C-3712-2009	Zuloaga, Kristen/0000-0002-5395-7362	National Institute of Neurological Disorders and Stroke [R01NS044313, R01NS070837, F32NS082017-01]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK70333]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070333] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS082017, R01NS044313, R01NS070837] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in part, by the National Institute of Neurological Disorders and Stroke (R01NS044313 and R01NS070837 to Dr. Alkayed and F32NS082017-01 to Dr. Zuloaga) and the National Institute of Diabetes and Digestive and Kidney Diseases (R01DK70333 to Dr. Marks). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Baird TA, 2003, STROKE, V34, P2208, DOI 10.1161/01.STR.0000085087.41330.FF; Bergman M, 2013, ENDOCRINE, V43, P504, DOI 10.1007/s12020-012-9830-9; Cipolla MJ, 2010, TRANSL STROKE RES, V1, P127, DOI 10.1007/s12975-010-0014-8; Cui X, 2011, NEUROBIOL DIS, V43, P285, DOI 10.1016/j.nbd.2011.04.005; Dave KR, 2011, STROKE, V42, P1404, DOI 10.1161/STROKEAHA.110.594937; De Taeye BM, 2010, OBESITY, V18, P489, DOI 10.1038/oby.2009.227; Deutsch C, 2009, MICROVASC RES, V78, P100, DOI 10.1016/j.mvr.2009.04.004; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Fabian RH, 2012, TRANSL STROKE RES, V3, P482, DOI 10.1007/s12975-012-0210-9; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gray CS, 2007, LANCET NEUROL, V6, P397, DOI 10.1016/S1474-4422(07)70080-7; HEIZER ML, 1991, STROKE, V22, P1389, DOI 10.1161/01.STR.22.11.1389; Iliff JJ, 2010, J NEUROCHEM, V115, P1530, DOI 10.1111/j.1471-4159.2010.07059.x; Iliff JJ, 2010, PROSTAG OTH LIPID M, V91, P68, DOI 10.1016/j.prostaglandins.2009.06.004; Jouihan SA, 2013, J CEREB BLOOD FLOW M; Klaidman L, 2003, PHARMACOLOGY, V69, P150, DOI 10.1159/000072668; Liu JY, 2009, BRIT J PHARMACOL, V156, P284, DOI 10.1111/j.1476-5381.2008.00009.x; Luitse MJA, 2013, CEREBROVASC DIS, V35, P163, DOI 10.1159/000346588; Luo PC, 2010, J PHARMACOL EXP THER, V334, P430, DOI 10.1124/jpet.110.167544; Luria A, 2011, P NATL ACAD SCI USA, V108, P9038, DOI 10.1073/pnas.1103482108; Ma B, 2013, ENDOCRINOLOGY, V154, P2843, DOI 10.1210/en.2012-2166; McCrimmon RJ, 2012, LANCET, V379, P2291, DOI 10.1016/S0140-6736(12)60360-2; Megherbi SE, 2003, STROKE, V34, P688, DOI 10.1161/01.STR.0000057975.15221.40; Meng L, 2012, BMJ, V344; Merkel MJ, 2010, AM J PHYSIOL-HEART C, V298, pH679, DOI 10.1152/ajpheart.00533.2009; Naramura T, 2006, BIOL PHARM BULL, V29, P1167, DOI 10.1248/bpb.29.1167; Ning R, 2012, NEUROSCIENCE, V222, P326, DOI 10.1016/j.neuroscience.2012.07.018; Ntaios G, 2013, INT J STROKE; Obrosova IG, 2007, DIABETES, V56, P2598, DOI 10.2337/db06-1176; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Prakash R, 2013, STROKE; PULSINELLI WA, 1983, AM J MED, V74, P540, DOI 10.1016/0002-9343(83)91007-0; PULSINELLI WA, 1982, NEUROLOGY, V32, P1239, DOI 10.1212/WNL.32.11.1239; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Simpkins AN, 2009, AM J PATHOL, V174, P2086, DOI 10.2353/ajpath.2009.080544; Spector AA, 2007, AM J PHYSIOL-CELL PH, V292, pC996, DOI 10.1152/ajpcell.00402.2006; Tureyen K, 2011, J NEUROCHEM, V116, P499, DOI 10.1111/j.1471-4159.2010.07127.x; Wang P, 2011, ANN NEUROL, V69, P360, DOI 10.1002/ana.22236; Wang Z, 2008, J BIOMED OPT, V13, DOI 10.1117/1.3041710; WARNER DS, 1995, STROKE, V26, P655, DOI 10.1161/01.STR.26.4.655; Xu XZ, 2010, DIABETES, V59, P997, DOI 10.2337/db09-1241; Yang BC, 2001, MOL PHARMACOL, V60, P310, DOI 10.1124/mol.60.2.310; Zhang WR, 2007, J CEREBR BLOOD F MET, V27, P1931, DOI 10.1038/sj.jcbfm.9600494; Zhang WR, 2009, J CEREBR BLOOD F MET, V29, P1475, DOI 10.1038/jcbfm.2009.65	46	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97529	10.1371/journal.pone.0097529	http://dx.doi.org/10.1371/journal.pone.0097529			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824753	gold, Green Submitted, Green Published			2022-12-27	WOS:000336369200127
J	Ku, PI; Bendjennat, M; Ballew, J; Landesman, MB; Saffarian, S				Ku, Pei-I; Bendjennat, Mourad; Ballew, Jeff; Landesman, Michael B.; Saffarian, Saveez			ALIX Is Recruited Temporarily into HIV-1 Budding Sites at the End of Gag Assembly	PLOS ONE			English	Article							LATE-DOMAIN; ESCRT-III; HELICAL STRUCTURES; STRUCTURAL BASIS; BINDING PARTNER; BRO1 DOMAIN; IN-VITRO; PROTEIN; UBIQUITIN; RELEASE	Polymerization of Gag on the inner leaflet of the plasma membrane drives the assembly of Human Immunodeficiency Virus 1 (HIV-1). Gag recruits components of the endosomal sorting complexes required for transport (ESCRT) to facilitate membrane fission and virion release. ESCRT assembly is initiated by recruitment of ALIX and TSG101/ESCRT-I, which bind directly to the viral Gag protein and then recruit the downstream ESCRT-III and VPS4 factors to complete the budding process. In contrast to previous models, we show that ALIX is recruited transiently at the end of Gag assembly, and that most ALIX molecules are recycled into the cytosol as the virus buds, although a subset remains within the virion. Our experiments imply that ALIX is recruited to the neck of the assembling virion and is mostly recycled after virion release.	[Ku, Pei-I; Bendjennat, Mourad; Ballew, Jeff; Landesman, Michael B.; Saffarian, Saveez] Univ Utah, Dept Phys & Astron, Salt Lake City, UT 84112 USA; [Saffarian, Saveez] Univ Utah, Ctr Cell & Genome Sci, Salt Lake City, UT USA; [Saffarian, Saveez] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Saffarian, S (corresponding author), Univ Utah, Dept Phys & Astron, Salt Lake City, UT 84112 USA.	saffarian@physics.utah.edu			NSF [1121972]	NSF(National Science Foundation (NSF))	This work was supported by NSF grants 1121972 (SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelrod D, 2008, METHOD CELL BIOL, V89, P169, DOI 10.1016/S0091-679X(08)00607-9; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; Balasubramaniam M, 2011, PHYSIOLOGY, V26, P236, DOI 10.1152/physiol.00051.2010; Baumgartel V, 2011, NAT CELL BIOL, V13, P469, DOI 10.1038/ncb2215; Bieniasz PD, 2009, CELL HOST MICROBE, V5, P550, DOI 10.1016/j.chom.2009.05.015; Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; Bodon G, 2011, J BIOL CHEM, V286, P40276, DOI 10.1074/jbc.M111.283671; Chung HY, 2008, J VIROL, V82, P4884, DOI 10.1128/JVI.02667-07; Demirov DG, 2002, P NATL ACAD SCI USA, V99, P955, DOI 10.1073/pnas.032511899; Demirov DG, 2004, VIRUS RES, V106, P87, DOI 10.1016/j.virusres.2004.08.007; Demirov DG, 2002, J VIROL, V76, P105, DOI 10.1128/JVI.76.1.105-117.2002; Dowlatshahi DP, 2012, DEV CELL, V23, P1247, DOI 10.1016/j.devcel.2012.10.023; Dussupt V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000339; Effantin G, 2013, CELL MICROBIOL, V15, P213, DOI 10.1111/cmi.12041; Fisher RD, 2007, CELL, V128, P841, DOI 10.1016/j.cell.2007.01.035; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; GHEYSEN D, 1989, CELL, V59, P103, DOI 10.1016/0092-8674(89)90873-8; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; HUANG MJ, 1995, J VIROL, V69, P6810, DOI 10.1128/JVI.69.11.6810-6818.1995; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Ivanchenko S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000652; Joshi A, 2008, TRAFFIC, V9, P1972, DOI 10.1111/j.1600-0854.2008.00817.x; Jouvenet N, 2008, NATURE, V454, P236, DOI 10.1038/nature06998; Jouvenet N, 2011, NAT CELL BIOL, V13, P394, DOI 10.1038/ncb2207; Jouvenet N, 2009, P NATL ACAD SCI USA, V106, P19114, DOI 10.1073/pnas.0907364106; Katoh K, 2004, ARCH BIOCHEM BIOPHYS, V421, P159, DOI 10.1016/j.abb.2003.09.038; Keren-Kaplan T, 2013, EMBO J, V32, P538, DOI 10.1038/emboj.2013.4; Kim JW, 2005, DEV CELL, V8, P937, DOI 10.1016/j.devcel.2005.04.001; Ku PI, 2013, BIOPHYS J, V105, P2262, DOI 10.1016/j.bpj.2013.09.047; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; Lee S, 2007, NAT STRUCT MOL BIOL, V14, P194, DOI 10.1038/nsmb1203; Martin-Serrano J, 2003, P NATL ACAD SCI USA, V100, P12414, DOI 10.1073/pnas.2133846100; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; Martin-Serrano J, 2011, NAT REV MICROBIOL, V9, P519, DOI 10.1038/nrmicro2596; McCullough J, 2008, P NATL ACAD SCI USA, V105, P7687, DOI 10.1073/pnas.0801567105; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Morita E, 2011, CELL HOST MICROBE, V9, P235, DOI 10.1016/j.chom.2011.02.004; Pashkova N, 2013, DEV CELL, V25, P520, DOI 10.1016/j.devcel.2013.04.007; Patnaik A, 2000, P NATL ACAD SCI USA, V97, P13069, DOI 10.1073/pnas.97.24.13069; Pires R, 2009, STRUCTURE, V17, P843, DOI 10.1016/j.str.2009.04.007; Popov S, 2008, J VIROL, V82, P1389, DOI 10.1128/JVI.01912-07; Puffer BA, 1997, J VIROL, V71, P6541, DOI 10.1128/JVI.71.9.6541-6546.1997; Saffarian S, 2008, BIOPHYS J, V94, P2333, DOI 10.1529/biophysj.107.117234; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Salmon P, 2000, MOL THER, V2, P404, DOI 10.1006/mthe.2000.0141; Schubert U, 2000, P NATL ACAD SCI USA, V97, P13057, DOI 10.1073/pnas.97.24.13057; Sette P, 2010, J VIROL, P00634; Sette P, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-79; Sette P, 2012, J VIROL, V86, P11608, DOI 10.1128/JVI.01260-12; Strack B, 2000, P NATL ACAD SCI USA, V97, P13063, DOI 10.1073/pnas.97.24.13063; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Sund SE, 1999, BIOPHYS J, V77, P2266, DOI 10.1016/S0006-3495(99)77066-9; Sundquist WI, 2012, COLD SPRING HARBOR P, P2; Usami Y, 2007, J VIROL, V81, P6614, DOI 10.1128/JVI.00314-07; Usami Y, 2009, BIOCHEM SOC T, V37, P181, DOI 10.1042/BST0370181; Van Engelenburg SB, 2014, SCIENCE, V343, P653, DOI 10.1126/science.1247786; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; Vincent O, 2003, MOL CELL BIOL, V23, P1647, DOI 10.1128/MCB.23.5.1647-1655.2003; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Votteler J, 2013, CELL HOST MICROBE, V14, P232, DOI 10.1016/j.chom.2013.08.012; Weiss ER, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001107; Weissleder R, 1999, NAT BIOTECHNOL, V17, P375, DOI 10.1038/7933; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Wriggers W, 2005, BIOPOLYMERS, V80, P736, DOI 10.1002/bip.20291; Yoo L, 2012, BIOMATERIALS, V33, P6194, DOI 10.1016/j.biomaterials.2012.05.028; Zhai Q, 2011, J VIROL; Zhai Q, 2008, NAT STRUCT MOL BIOL, V15, P43, DOI 10.1038/nsmb1319; Zhou X, 2009, BIOCHEM J, V418, P277, DOI 10.1042/BJ20081388	68	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e96950	10.1371/journal.pone.0096950	http://dx.doi.org/10.1371/journal.pone.0096950			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24834918	Green Submitted, Green Published, gold			2022-12-27	WOS:000339614800023
J	Zhang, L; Meng, S; Tu, QS; Yu, LM; Tang, Y; Dard, MM; Kim, SH; Valverde, P; Zhou, XD; Chen, JK				Zhang, Lan; Meng, Shu; Tu, Qisheng; Yu, Liming; Tang, Yin; Dard, Michel M.; Kim, Sung-Hoon; Valverde, Paloma; Zhou, Xuedong; Chen, Jake			Adiponectin Ameliorates Experimental Periodontitis in Diet-Induced Obesity Mice	PLOS ONE			English	Article							MAPK SIGNALING PATHWAY; INSULIN-RESISTANCE; OXIDATIVE STRESS; PLASMA-CONCENTRATIONS; GLOBULAR ADIPONECTIN; METABOLIC SYNDROME; HUMAN OSTEOBLASTS; BONE LOSS; EXPRESSION; PROTEIN	Adiponectin is an adipokine that sensitizes the body to insulin. Low levels of adiponectin have been reported in obesity, diabetes and periodontitis. In this study we established experimental periodontitis in male adiponectin knockout and diet-induced obesity mice, a model of obesity and type 2 diabetes, and aimed at evaluating the therapeutic potential of adiponectin. We found that systemic adiponectin infusion reduced alveolar bone loss, osteoclast activity and infiltration of inflammatory cells in both periodontitis mouse models. Furthermore, adiponectin treatment decreased the levels of pro-inflammatory cytokines in white adipose tissue of diet-induced obesity mice with experimental periodontitis. Our in vitro studies also revealed that forkhead box O1, a key transcriptional regulator of energy metabolism, played an important role in the direct signaling of adiponectin in osteoclasts. Thus, adiponectin increased forkhead box O1 mRNA expression and its nuclear protein level in osteoclast-precursor cells undergoing differentiation. Inhibition of c-Jun N-terminal kinase signaling decreased nuclear protein levels of forkhead box O1. Furthermore, over-expression of forkhead box O1 inhibited osteoclastogenesis and led to decreased nuclear levels of nuclear factor of activated T cells c1. Taken together, this study suggests that systemic adiponectin application may constitute a potential intervention therapy to ameliorate type 2 diabetes-associated periodontitis. It also proposes that adiponectin inhibition of osteoclastogenesis involves forkhead box O1.	[Zhang, Lan; Meng, Shu; Tu, Qisheng; Yu, Liming; Tang, Yin; Chen, Jake] Tufts Univ, Sch Dent Med, Div Oral Biol, Boston, MA 02111 USA; [Zhang, Lan; Meng, Shu; Tang, Yin; Zhou, Xuedong] Sichuan Univ, West China Hosp Stomatol, Key Lab Oral Dis, Chengdu 610064, Sichuan, Peoples R China; [Dard, Michel M.] NYU, Coll Dent, New York, NY USA; [Kim, Sung-Hoon] Kyung Hee Univ, Coll Oriental Med, Canc Prevent Mat Dev Res Ctr, Seoul, South Korea; [Kim, Sung-Hoon] Kyung Hee Univ, Coll Oriental Med, Seoul, South Korea; [Valverde, Paloma] Wentworth Inst Technol, Dept Sci, Boston, MA USA; [Chen, Jake] Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Dept Anat & Cell Biol, Boston, MA 02111 USA	Tufts University; Sichuan University; New York University; Kyung Hee University; Kyung Hee University; Tufts University	Tu, QS (corresponding author), Tufts Univ, Sch Dent Med, Div Oral Biol, Boston, MA 02111 USA.	qisheng.tu@tufts.edu; jk.chen@tufts.edu	ZHOU, XUE/F-6129-2013; tang, yin/GXZ-6989-2022; tang, yin/AAR-2123-2021	Zhang, Lan/0000-0002-9714-999X; Chen, Jake/0000-0001-8829-7504; Tu, Qisheng/0000-0003-0639-8761; kim, sunghoon/0000-0002-1570-3230; Zhou, Xuedong/0000-0002-9319-7302	National Institutes of Health (NIH) [R01DE16710, R01DE21464]; International Association of Dental Research (IADR); Academy of Osseointegration (AO) Innovation in Implant Science Award; Ministry of Education, Science and Technology (MEST) in South Korea [2007-0054931]; NIH [DK080344]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080344] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Association of Dental Research (IADR); Academy of Osseointegration (AO) Innovation in Implant Science Award; Ministry of Education, Science and Technology (MEST) in South Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was supported by National Institutes of Health (NIH) grants R01DE16710 and R01DE21464, and the International Association of Dental Research (IADR) and the Academy of Osseointegration (AO) Innovation in Implant Science Award (to J.C.); Ministry of Education, Science and Technology (MEST) grant 2007-0054931 in South Korea (to S. H. K.); NIH grant DK080344 (to L. Q. D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar S, 2007, P NATL ACAD SCI USA, V104, P20466, DOI 10.1073/pnas.0710335105; Bartell S, 2012, ASBMR 2012 ANN M, P284; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Bobbert P, 2008, J MOL CELL CARDIOL, V44, P388, DOI 10.1016/j.yjmcc.2007.10.018; Bullon P, 2009, J DENT RES, V88, P503, DOI 10.1177/0022034509337479; Combs TP, 2002, ENDOCRINOLOGY, V143, P998, DOI 10.1210/endo.143.3.8662; Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Galli C, 2011, J PERIODONTAL RES, V46, P397, DOI 10.1111/j.1600-0765.2011.01354.x; Hay N, 2011, BBA-MOL CELL RES, V1813, P1965, DOI 10.1016/j.bbamcr.2011.03.013; Hirotani H, 2004, J BIOL CHEM, V279, P13984, DOI 10.1074/jbc.M213067200; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kajimura D, 2013, CELL METAB, V17, P901, DOI 10.1016/j.cmet.2013.04.009; Kang EH, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3218; Kousteni S, 2012, BONE, V50, P437, DOI 10.1016/j.bone.2011.06.034; Li CH, 2007, J PERIODONTOL, V78, P1120, DOI 10.1902/jop.2007.060320; Li H, 2013, STEROIDS, V78, P115, DOI 10.1016/j.steroids.2012.10.015; Luo E, 2012, ACTA BIOMATER, V8, P734, DOI 10.1016/j.actbio.2011.10.029; Luo XH, 2005, EXP CELL RES, V309, P99, DOI 10.1016/j.yexcr.2005.05.021; Luo XH, 2006, J BONE MINER RES, V21, P1648, DOI 10.1359/JBMR.060707; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Manolagas SC, 2007, MOL ENDOCRINOL, V21, P2605, DOI 10.1210/me.2007-0259; Manolagas SC, 2010, ENDOCR REV, V31, P266, DOI 10.1210/er.2009-0024; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Mealey BL, 2006, J AM DENT ASSOC, V137, p26S, DOI 10.14219/jada.archive.2006.0404; Miyazaki T, 2005, BIOCHEM BIOPH RES CO, V333, P79, DOI 10.1016/j.bbrc.2005.05.076; Nakanishi S, 2005, METABOLISM, V54, P194, DOI 10.1016/j.metabol.2004.08.012; Park PH, 2008, J LEUKOCYTE BIOL, V83, P1258, DOI 10.1189/jlb.0907631; Ren WH, 2006, PROG BIOCHEM BIOPHYS, V33, P846; Saito T, 2008, J DENT RES, V87, P319, DOI 10.1177/154405910808700416; Saxena NK, 2010, GASTROENTEROLOGY, V139, P1762, DOI 10.1053/j.gastro.2010.07.001; Shu RZ, 2009, LAB INVEST, V89, P1043, DOI 10.1038/labinvest.2009.63; Subedi A, 2013, FEBS LETT, V587, P1556, DOI 10.1016/j.febslet.2013.03.040; Sun WL, 2011, INTERNAL MED, V50, P1569, DOI 10.2169/internalmedicine.50.5166; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Toker H, 2009, J PERIODONTOL, V80, P672, DOI 10.1902/jop.2009.080509; Tu Q, 2008, J CELL PHYSIOL, V217, P40, DOI 10.1002/jcp.21472; Tu QS, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.152405; Tu QS, 2009, J CELL PHYSIOL, V218, P135, DOI 10.1002/jcp.21576; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Wulster-Radcliffe MC, 2004, BIOCHEM BIOPH RES CO, V316, P924, DOI 10.1016/j.bbrc.2004.02.130; Yamaguchi N, 2008, FEBS LETT, V582, P451, DOI 10.1016/j.febslet.2007.12.037; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zimmermann GS, 2013, J PERIODONTOL, V84, P624, DOI 10.1902/jop.2012.120254	47	27	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97824	10.1371/journal.pone.0097824	http://dx.doi.org/10.1371/journal.pone.0097824			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836538	Green Submitted, gold, Green Published			2022-12-27	WOS:000339614800072
J	Chioccioli, M; Hankamer, B; Ross, IL				Chioccioli, Maurizio; Hankamer, Ben; Ross, Ian L.			Flow Cytometry Pulse Width Data Enables Rapid and Sensitive Estimation of Biomass Dry Weight in the Microalgae Chlamydomonas reinhardtii and Chlorella vulgaris	PLOS ONE			English	Article							REFRACTIVE-INDEX; CELL-DIVISION; LIGHT SCATTER; SINGLE-CELL; ALGAE; SIZE; GROWTH; PHYTOPLANKTON; BACTERIA; ATLANTIC	Dry weight biomass is an important parameter in algaculture. Direct measurement requires weighing milligram quantities of dried biomass, which is problematic for small volume systems containing few cells, such as laboratory studies and high throughput assays in microwell plates. In these cases indirect methods must be used, inducing measurement artefacts which vary in severity with the cell type and conditions employed. Here, we utilise flow cytometry pulse width data for the estimation of cell density and biomass, using Chlorella vulgaris and Chlamydomonas reinhardtii as model algae and compare it to optical density methods. Measurement of cell concentration by flow cytometry was shown to be more sensitive than optical density at 750 nm (OD750) for monitoring culture growth. However, neither cell concentration nor optical density correlates well to biomass when growth conditions vary. Compared to the growth of C. vulgaris in TAP (tris-acetate-phosphate) medium, cells grown in TAP + glucose displayed a slowed cell division rate and a 2-fold increased dry biomass accumulation compared to growth without glucose. This was accompanied by increased cellular volume. Laser scattering characteristics during flow cytometry were used to estimate cell diameters and it was shown that an empirical but nonlinear relationship could be shown between flow cytometric pulse width and dry weight biomass per cell. This relationship could be linearised by the use of hypertonic conditions (1 M NaCl) to dehydrate the cells, as shown by density gradient centrifugation. Flow cytometry for biomass estimation is easy to perform, sensitive and offers more comprehensive information than optical density measurements. In addition, periodic flow cytometry measurements can be used to calibrate OD750 measurements for both convenience and accuracy. This approach is particularly useful for small samples and where cellular characteristics, especially cell size, are expected to vary during growth.	[Chioccioli, Maurizio; Hankamer, Ben; Ross, Ian L.] Univ Queensland, Inst Mol Biosci IMB, Brisbane, Qld, Australia	University of Queensland	Ross, IL (corresponding author), Univ Queensland, Inst Mol Biosci IMB, Brisbane, Qld, Australia.	i.ross@imb.uq.edu.au	Ross, Ian/A-8622-2011; Hankamer, Ben D/C-9688-2015	Ross, Ian/0000-0002-2389-4292; Hankamer, Ben D/0000-0001-9284-4929	Australian Research Council (ARC) [LP0883380]; University of Queensland Research Scholarship (UQRS) Living Allowance Scholarship; University of Queensland International Research Award (UQIRTA)	Australian Research Council (ARC)(Australian Research Council); University of Queensland Research Scholarship (UQRS) Living Allowance Scholarship; University of Queensland International Research Award (UQIRTA)	This work was supported by Australian Research Council (ARC) grant LP0883380 (www.arc.gov.au). MC was supported by a University of Queensland Research Scholarship (UQRS) Living Allowance Scholarship and a University of Queensland International Research Award (UQIRTA) Tuition Fees Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agwa OK, 2013, INT J BIOCH BIOTECH, V2, P289; Alcaraz M, 2003, MAR BIOL, V143, P307, DOI 10.1007/s00227-003-1094-8; Altenburger R, 2008, J ENVIRON QUAL, V37, P16, DOI 10.2134/jeq2006.0556; Alvarez E, 2012, J PLANKTON RES, V34, P454, DOI 10.1093/plankt/fbs017; Collier JL, 2000, J PHYCOL, V36, P628, DOI 10.1046/j.1529-8817.2000.99215.x; Foladori P, 2008, WATER RES, V42, P3757, DOI 10.1016/j.watres.2008.06.026; Gerashchenko BI, 2000, CYTOMETRY, V41, P209, DOI 10.1002/1097-0320(20001101)41:3<209::AID-CYTO8>3.0.CO;2-U; Gerashchenko Bogdan I, 2010, Curr Protoc Cytom, VChapter 11, DOI 10.1002/0471142956.cy1119s52; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Gray AJ, 2002, J APPL PHYCOL, V14, P193, DOI 10.1023/A:1019976310527; Green RE, 2003, APPL OPTICS, V42, P526, DOI 10.1364/AO.42.000526; GRIFFITHS D, 1961, ANN BOT-LONDON, V25, P85, DOI 10.1093/oxfordjournals.aob.a083746; GRIFFITHS DJ, 1963, ANN BOT-LONDON, V27, P493, DOI 10.1093/oxfordjournals.aob.a083865; Hoffman RA, 2009, CURR PROTOC CYTOM; Jahnke J, 2011, J APPL PHYCOL, V23, P655, DOI 10.1007/s10811-010-9557-z; Lorenzen H., 1974, ALGAL PHYSL BIOCH, P894; Madrid RE, 2005, CRIT REV BIOTECHNOL, V25, P97, DOI 10.1080/07388550500248563; Mahlmann DM, 2008, EUR J PHYCOL, V43, P355, DOI 10.1080/09670260802168625; OLSON RJ, 1990, LIMNOL OCEANOGR, V35, P45, DOI 10.4319/lo.1990.35.1.0045; Pearsall WH, 1936, P ROY SOC          B, V121, P451; Popescu G, 2008, AM J PHYSIOL-CELL PH, V295, pC538, DOI 10.1152/ajpcell.00121.2008; Quirantes A, 2004, J QUANT SPECTROSC RA, V89, P311, DOI 10.1016/j.jqsrt.2004.05.031; Reckermann M, 2000, SCI MAR, V64, P235, DOI 10.3989/scimar.2000.64n2235; Rioboo C, 2009, AQUAT TOXICOL, V94, P229, DOI 10.1016/j.aquatox.2009.07.009; Robertson BR, 1998, APPL ENVIRON MICROB, V64, P3900; Robertson BR, 2001, CURR PROTOC CYTOM; SHARPLESS TK, 1977, J HISTOCHEM CYTOCHEM, V25, P845, DOI 10.1177/25.7.330734; SHARPLESS TK, 1976, J HISTOCHEM CYTOCHEM, V24, P257, DOI 10.1177/24.1.1254921; Stephens E, 2010, NAT BIOTECHNOL, V28, P126, DOI 10.1038/nbt0210-126; Stramski D, 1999, DEEP-SEA RES PT I, V46, P335, DOI 10.1016/S0967-0637(98)00065-X; SYRETT PJ, 1963, BIOCHEM J, V89, P308, DOI 10.1042/bj0890308; Tanaka JY, 2001, CRYOBIOLOGY, V42, P286, DOI 10.1006/cryo.2001.2334; Toepel J, 2005, J PHYCOL, V41, P1099, DOI 10.1111/j.1529-8817.2005.00137.x; Tzur A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016053; Umen JG, 2001, GENE DEV, V15, P1652, DOI 10.1101/gad.892101; Umorin M, 2005, BIOTECHNOL LETT, V27, P347, DOI 10.1007/s10529-005-1010-z; Veldhuis MJW, 2004, DEEP-SEA RES PT I, V51, P507, DOI 10.1016/j.dsr.2003.12.002; Wang YY, 2010, TRENDS BIOTECHNOL, V28, P416, DOI 10.1016/j.tibtech.2010.04.006; WITKOWSKI K, 1993, LIMNOL OCEANOGR, V38, P1365, DOI 10.4319/lo.1993.38.7.1365; Wood A., 2005, ALGAL CULTURING TECH, P253; Zhu CJ, 1997, J APPL PHYCOL, V9, P189, DOI 10.1023/A:1007914806640	41	60	61	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97269	10.1371/journal.pone.0097269	http://dx.doi.org/10.1371/journal.pone.0097269			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24832156	Green Published, Green Submitted, gold			2022-12-27	WOS:000336789500044
J	Kurtyka, CA; Chen, L; Cress, WD				Kurtyka, Courtney A.; Chen, Lu; Cress, W. Douglas			E2F Inhibition Synergizes with Paclitaxel in Lung Cancer Cell Lines	PLOS ONE			English	Article							RETINOBLASTOMA PROTEIN; S-PHASE; TRANSCRIPTIONAL REPRESSION; RB/E2F PATHWAY; RB PROTEIN; PD 0332991; CYCLE; PROLIFERATION; INACTIVATION; EXPRESSION	The CDK/Rb/E2F pathway is commonly disrupted in lung cancer, and thus, it is predicted that blocking the E2F pathway would have therapeutic potential. To test this hypothesis, we have examined the activity of HLM006474 (a small molecule pan-E2F inhibitor) in lung cancer cell lines as a single agent and in combination with other compounds. HLM006474 reduces the viability of both SCLC and NSCLC lines with a biological IC50 that varies between 15 and 75 mu M, but with no significant difference between the groups. Combination of HLM006474 with cisplatin and gemcitabine demonstrate little synergy; however, HLM006474 synergizes with paclitaxel. Surprisingly, we discovered that brief treatment of cells with HLM006474 led to an increase of E2F3 protein levels (due to de-repression of these promoter sites). Since paclitaxel sensitivity has been shown to correlate with E2F3 levels, we hypothesized that HLM006474 synergy with paclitaxel may be mediated by transient induction of E2F3. To test this, H1299 cells were depleted of E2F3a and E2F3b with siRNA and treated with paclitaxel. Assays of proliferation showed that both siRNAs significantly reduced paclitaxel sensitivity, as expected. Taken together, these results suggest that HLM006474 may have efficacy in lung cancer and may be useful in combination with taxanes.	[Kurtyka, Courtney A.; Chen, Lu; Cress, W. Douglas] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Biol & Evolut, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Cress, WD (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Biol & Evolut, Tampa, FL 33612 USA.	douglas.cress@moffitt.org			National Cancer Institute [CA119997]; Bankhead Coley Cancer Research Program of the Florida Department of Health [FDH 08BB-05]; Moffitt Cancer Center; NATIONAL CANCER INSTITUTE [P30CA076292, P50CA119997] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Bankhead Coley Cancer Research Program of the Florida Department of Health; Moffitt Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the National Cancer Institute (CA119997), the Bankhead Coley Cancer Research Program of the Florida Department of Health (FDH 08BB-05) and the Moffitt Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACS, 2010, CANC FACTS FIG 2010, P1; Adams MR, 2000, MOL CELL BIOL, V20, P3633, DOI 10.1128/MCB.20.10.3633-3639.2000; Beasley MB, 2003, HUM PATHOL, V34, P136, DOI 10.1053/hupa.2003.8; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Chen L, 2012, J BIOL CHEM, V287, P40106, DOI 10.1074/jbc.M112.380865; Chong JL, 2009, NATURE, V462, P930, DOI 10.1038/nature08677; Chong JL, 2009, MOL CELL BIOL, V29, P414, DOI 10.1128/MCB.01161-08; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Conklin JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2254; Cooper CS, 2006, LUNG CANCER, V54, P155, DOI 10.1016/j.lungcan.2006.07.005; Corsino P, 2009, J BIOL CHEM, V284, P29945, DOI 10.1074/jbc.M109.055251; Danielian PS, 2008, ONCOGENE, V27, P6561, DOI 10.1038/onc.2008.253; Dickson MA, 2013, J CLIN ONCOL, V31, P2024, DOI 10.1200/JCO.2012.46.5476; Flaherty KT, 2012, CLIN CANCER RES, V18, P568, DOI 10.1158/1078-0432.CCR-11-0509; Guha M, 2013, NAT BIOTECHNOL, V31, P187, DOI 10.1038/nbt0313-187a; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; He LL, 2008, J BIOL CHEM, V283, P31012, DOI 10.1074/jbc.M803547200; He S, 2000, MOL CELL BIOL, V20, P363, DOI 10.1128/MCB.20.1.363-371.2000; He YW, 2000, ONCOGENE, V19, P3422, DOI 10.1038/sj.onc.1203682; Hu QH, 2006, NUCLEIC ACIDS RES, V34, P6272, DOI 10.1093/nar/gkl801; Humbert PO, 2000, GENE DEV, V14, P690; Hurst CD, 2008, ONCOGENE, V27, P2716, DOI 10.1038/sj.onc.1210934; KELLEY MJ, 1995, JNCI-J NATL CANCER I, V87, P756, DOI 10.1093/jnci/87.10.756; Kong LJ, 2007, ONCOGENE, V26, P321, DOI 10.1038/sj.onc.1209817; Lang SE, 2001, J BIOL CHEM, V276, P32627, DOI 10.1074/jbc.M102067200; Leonard JP, 2012, BLOOD, V119, P4597, DOI 10.1182/blood-2011-10-388298; Leone G, 1998, GENE DEV, V12, P2120, DOI 10.1101/gad.12.14.2120; Leone G, 2001, MOL CELL, V8, P105, DOI 10.1016/S1097-2765(01)00275-1; Leone G, 2000, MOL CELL BIOL, V20, P3626, DOI 10.1128/MCB.20.10.3626-3632.2000; Ma YH, 2008, CANCER RES, V68, P6292, DOI 10.1158/0008-5472.CAN-08-0121; Ma YH, 2010, J BIOL CHEM, V285, P9813, DOI 10.1074/jbc.M109.091496; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Matsumura N, 2009, MOL CANCER RES, V7, P210, DOI 10.1158/1541-7786.MCR-08-0255; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; OTTERSON GA, 1994, ONCOGENE, V9, P3375; Porlan E, 2013, NAT NEUROSCI, V16, P1567, DOI 10.1038/nn.3545; Sangwan M, 2012, ONCOGENE, V31, P5019, DOI 10.1038/onc.2011.654; Schwartz GK, 2011, BRIT J CANCER, V104, P1862, DOI 10.1038/bjc.2011.177; SHAPIRO GI, 1995, CANCER RES, V55, P6200; SHAPIRO GI, 1995, CANCER RES, V55, P505; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; SHIMIZU E, 1994, ONCOGENE, V9, P2441; Taubert S, 2004, MOL CELL BIOL, V24, P4546, DOI 10.1128/MCB.24.10.4546-4556.2004; Tordai A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2088; WEINTRAUB SJ, 1992, NATURE, V358, P259, DOI 10.1038/358259a0; WEINTRAUB SJ, 1995, NATURE, V375, P812, DOI 10.1038/375812a0; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; XU HJ, 1991, CANCER RES, V51, P2735; Zheng YB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070371; Zhu WC, 2004, EMBO J, V23, P4615, DOI 10.1038/sj.emboj.7600459	52	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e96357	10.1371/journal.pone.0096357	http://dx.doi.org/10.1371/journal.pone.0096357			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831239	Green Submitted, gold, Green Published			2022-12-27	WOS:000336789500017
J	Zhai, H; Lu, SX; Wang, YQ; Chen, X; Ren, HX; Yang, JY; Cheng, W; Zong, CM; Gu, HP; Qiu, HM; Wu, HY; Zhang, XZ; Cui, TT; Xia, ZJ				Zhai, Hong; Lu, Shixiang; Wang, Yueqiang; Chen, Xin; Ren, Haixiang; Yang, Jiayin; Cheng, Wen; Zong, Chunmei; Gu, Heping; Qiu, Hongmei; Wu, Hongyan; Zhang, Xingzheng; Cui, Tingting; Xia, Zhengjun			Allelic Variations at Four Major Maturity E Genes and Transcriptional Abundance of the E1 Gene Are Associated with Flowering Time and Maturity of Soybean Cultivars	PLOS ONE			English	Article							RESIDUAL HETEROZYGOUS LINE; MAP-BASED CLONING; PHOTOPERIOD-SENSITIVITY; GLYCINE-MAX; LOCUS-T; INHERITANCE; LANDRACES; MARKERS; GROWTH; TRAIT	The time to flowering and maturity are ecologically and agronomically important traits for soybean landrace and cultivar adaptation. As a typical short-day crop, long day conditions in the high-latitude regions require soybean cultivars with photoperiod insensitivity that can mature before frost. Although the molecular basis of four major E loci (E1 to E4) have been deciphered, it is not quite clear whether, or to what degree, genetic variation and the expression level of the four E genes are associated with the time to flowering and maturity of soybean cultivars. In this study, we genotyped 180 cultivars at E1 to E4 genes, meanwhile, the time to flowering and maturity of those cultivars were investigated at six geographic locations in China from 2011 to 2012 and further confirmed in 2013. The percentages of recessive alleles at E1, E2, E3 and E4 loci were 38.34%, 84.45%, 36.33%, and 7.20%, respectively. Statistical analysis showed that allelic variations at each of four loci had a significant effect on flowering time as well as maturity. We classified the 180 cultivars into eight genotypic groups based on allelic variations of the four major E loci. The genetic group of e1-nf representing dysfunctional alleles at the E1 locus flowered earliest in all the geographic locations. In contrast, cultivars in the E1E2E3E4 group originated from the southern areas flowered very late or did not flower before frost at high latitude locations. The transcriptional abundance of functional E1 gene was significantly associated with flowering time. However, the ranges of time to flowering and maturity were quite large within some genotypic groups, implying the presence of some other unknown genetic factors that are involved in control of flowering time or maturity. Known genes (e. g. E3 and E4) and other unknown factors may function, at least partially, through regulation of the expression of the E1 gene.	[Zhai, Hong; Lu, Shixiang; Wu, Hongyan; Zhang, Xingzheng; Cui, Tingting; Xia, Zhengjun] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Soybean Mol Design Breeding, Harbin, Peoples R China; [Lu, Shixiang; Zhang, Xingzheng] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Yueqiang; Qiu, Hongmei] Jilin Acad Agr Sci, Soybean Res Inst, Changchun, Peoples R China; [Chen, Xin; Gu, Heping] Jiangsu Acad Agr Sci, Nanjing, Jiangsu, Peoples R China; [Ren, Haixiang; Zong, Chunmei] Heilongjiang Acad Agr Sci, Mudanjiang Branch, Mudanjiang, Peoples R China; [Yang, Jiayin] Huaiyin Inst Agr Sci Xuhuai Reg Jiangsu, Huaian, Peoples R China; [Cheng, Wen] Shandong Normal Univ, Coll Life Sci, Jinan, Peoples R China	Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Jilin Academy of Agricultural Sciences; Jiangsu Academy of Agricultural Sciences; Heilongjiang Academy of Agricultural Sciences; Jiangsu Academy of Agricultural Sciences; Shandong Normal University	Xia, ZJ (corresponding author), Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Soybean Mol Design Breeding, Harbin, Peoples R China.	xiazhj@iga.ac.cn		Chen, Xin/0000-0002-8292-7699	Chinese Academy of Sciences [KZCX2-EW-303, XDA08010105]; National Natural Science Foundation of China [31271742, 31301338]; Natural Science Foundation of Heilongjiang Province of China [ZD201120]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province of China(Natural Science Foundation of Heilongjiang Province)	This work was supported by the Chinese Academy of Sciences (Grant KZCX2-EW-303 and Hundred Talents Program, Grant XDA08010105), and National Natural Science Foundation of China (31271742 and 31301338), and Natural Science Foundation of Heilongjiang Province of China (ZD201120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe J, 2003, CROP SCI, V43, P1300, DOI 10.2135/cropsci2003.1300; BERNARD RL, 1971, CROP SCI, V11, P242, DOI 10.2135/cropsci1971.0011183X001100020022x; Bonato ER, 1999, GENET MOL BIOL, V22, P229, DOI 10.1590/S1415-47571999000200016; Buzzell R. I., 1980, SOYBEAN GENETICS NEW, V7, P26, DOI DOI 10.1093/JHERED/ESP113; BUZZELL RI, 1971, CAN J GENET CYTOL, V13, P703, DOI 10.1139/g71-100; Cober ER, 2010, CROP SCI, V50, P524, DOI 10.2135/cropsci2009.04.0174; Cober ER, 2010, THEOR APPL GENET, V120, P1005, DOI 10.1007/s00122-009-1228-6; Cober ER, 1996, CROP SCI, V36, P606, DOI 10.2135/cropsci1996.0011183X003600030014x; Cober ER, 2001, CROP SCI, V41, P698, DOI 10.2135/cropsci2001.413698x; FEHR WR, 1971, CROP SCI, V11, P929, DOI 10.2135/cropsci1971.0011183X001100060051x; Funatsuki H, 2005, THEOR APPL GENET, V111, P851, DOI 10.1007/s00122-005-0007-2; Gai J., 2001, ACTA AGRONOMICA SINI, V27, P286; Garner WW, 1919, J AGRIC RES, V18, P0553; Hartwig E. E., 1973, AGRONOMY, P187; Kawasaki S, 2000, J PLANT RES, V113, P497, DOI 10.1007/PL00013960; Kong FJ, 2010, PLANT PHYSIOL, V154, P1220, DOI 10.1104/pp.110.160796; Kumudini SV, 2007, CROP SCI, V47, P1510, DOI 10.2135/cropsci2006.10.0662; Liu B, 2008, GENETICS, V180, P995, DOI 10.1534/genetics.108.092742; MCBLAIN BA, 1987, J HERED, V78, P160, DOI 10.1093/oxfordjournals.jhered.a110349; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Norman A.G., 1978, SOYBEAN PHYSL AGRONO; Owen FV, 1927, GENETICS, V12, P519; RAY JD, 1995, CROP SCI, V35, P1001, DOI 10.2135/cropsci1995.0011183X003500040012x; Sawa M, 2007, SCIENCE, V318, P261, DOI 10.1126/science.1146994; Sawa M, 2011, P NATL ACAD SCI USA, V108, P11698, DOI 10.1073/pnas.1106771108; Sayama T, 2010, BREEDING SCI, V60, P380, DOI 10.1270/jsbbs.60.380; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Shin JH, 2012, MOL BREEDING, V30, P1793, DOI 10.1007/s11032-012-9743-6; Stupar RM, 2013, ADV AGRON, V118, P177, DOI 10.1016/B978-0-12-405942-9.00004-9; Tsubokura Y, 2014, ANN BOT-LONDON, V113, P429, DOI 10.1093/aob/mct269; Wang JL, 1961, SCI AGR SIN, V2, P24; Wang YS, 2006, GENET RESOUR CROP EV, V53, P803, DOI 10.1007/s10722-004-5731-y; Watanabe S, 2011, GENETICS, V188, P395, DOI 10.1534/genetics.110.125062; Watanabe S, 2009, GENETICS, V182, P1251, DOI 10.1534/genetics.108.098772; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036; Xia Z, 2007, DNA RES, V14, P257, DOI 10.1093/dnares/dsm027; Xia ZJ, 2013, SCI WORLD J, DOI 10.1155/2013/281367; Xia ZJ, 2012, P NATL ACAD SCI USA, V109, pE2155, DOI 10.1073/pnas.1117982109; Xu ML, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-91; Yamanaka N, 2005, THEOR APPL GENET, V110, P634, DOI 10.1007/s00122-004-1886-3; Zhang, 2007, CROP MANAGE, V6, DOI [10.1094/cm-2007-0927-01-rs, DOI 10.1094/CM-2007-0927-01-RS, 10.1094/CM-2007-0927-01-RS]	41	33	37	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97636	10.1371/journal.pone.0097636	http://dx.doi.org/10.1371/journal.pone.0097636			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830458	Green Published, Green Submitted, gold			2022-12-27	WOS:000336789500090
J	Bjornstrom, K; Turina, D; Strid, T; Sundqvist, T; Eintrei, C				Bjornstrom, Karin; Turina, Dean; Strid, Tobias; Sundqvist, Tommy; Eintrei, Christina			Orexin A Inhibits Propofol-Induced Neurite Retraction by a Phospholipase D/Protein Kinase C-epsilon-Dependent Mechanism in Neurons	PLOS ONE			English	Article							GABA(A) RECEPTOR; PKC-EPSILON; RHO-KINASE; GENERAL-ANESTHESIA; MYOSIN PHOSPHATASE; BETA-SUBUNIT; RAT NEURONS; CELLS; ACTIVATION; MODULATION	Background: The intravenous anaesthetic propofol retracts neurites and reverses the transport of vesicles in rat cortical neurons. Orexin A (OA) is an endogenous neuropeptide regulating wakefulness and may counterbalance anaesthesia. We aim to investigate if OA interacts with anaesthetics by inhibition of the propofol-induced neurite retraction. Methods: In primary cortical cell cultures from newborn rats' brains, live cell light microscopy was used to measure neurite retraction after propofol (2 mu M) treatment with or without OA (10 nM) application. The intracellular signalling involved was tested using a protein kinase C (PKC) activator [phorbol 12-myristate 13-acetate (PMA)] and inhibitors of Rho-kinase (HA-1077), phospholipase D (PLD) [5-fluoro-2-indolyl des-chlorohalopemide (FIPI)], PKC (staurosporine), and a PKC epsilon translocation inhibitor peptide. Changes in PKC epsilon Ser(729) phosphorylation were detected with Western blot. Results: The neurite retraction induced by propofol is blocked by Rho-kinase and PMA. OA blocks neurite retraction induced by propofol, and this inhibitory effect could be prevented by FIPI, staurosporine and PKC epsilon translocation inhibitor peptide. OA increases via PLD and propofol decreases PKC epsilon Ser(729) phosphorylation, a crucial step in the activation of PKC epsilon. Conclusions: Rho-kinase is essential for propofol-induced neurite retraction in cortical neuronal cells. Activation of PKC inhibits neurite retraction caused by propofol. OA blocks propofol-induced neurite retraction by a PLD/PKC epsilon-mediated pathway, and PKC epsilon maybe the key enzyme where the wakefulness and anaesthesia signal pathways converge.	[Bjornstrom, Karin; Turina, Dean; Strid, Tobias; Eintrei, Christina] Linkoping Univ, Fac Hlth Sci, Div Anaesthesiol, Dept Med & Hlth Sci, Linkoping, Sweden; [Sundqvist, Tommy] Linkoping Univ, Fac Hlth Sci, Div Med Microbiol, Dept Clin & Expt Med, Linkoping, Sweden; [Bjornstrom, Karin; Turina, Dean; Eintrei, Christina] Ostergotland Cty Council UHL, Clin Anaesthesiol, Linkoping, Sweden	Linkoping University; Linkoping University; City Council Ostergotland	Bjornstrom, K (corresponding author), Linkoping Univ, Fac Hlth Sci, Div Anaesthesiol, Dept Med & Hlth Sci, Linkoping, Sweden.	karin.bjornstrom-karlsson@liu.se			Ostergotland County Council research foundation; Henry and Ella Stahl Foundation; Linkoping Society of Medicine	Ostergotland County Council research foundation; Henry and Ella Stahl Foundation; Linkoping Society of Medicine	This study was funded by the Ostergotland County Council research foundation, the Henry and Ella Stahl Foundation and Linkoping Society of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita Y, 2002, J BIOCHEM, V132, P847, DOI 10.1093/oxfordjournals.jbchem.a003296; Bjornstrom K, 2008, J PHYSIOL PHARMACOL, V59, P617; Bjorklund U, 2010, NEUROCHEM RES, V35, P1733, DOI 10.1007/s11064-010-0236-x; Bjornstrom K, 2003, ACTA ANAESTH SCAND, V47, P157, DOI 10.1034/j.1399-6576.2003.00007.x; Bjornstrom K, 2002, ACTA PHYSIOL SCAND, V175, P227, DOI 10.1046/j.1365-201X.2002.00991.x; Brandon NJ, 2000, J BIOL CHEM, V275, P38856, DOI 10.1074/jbc.M004910200; Brindley DN, 2009, J LIPID RES, V50, pS225, DOI 10.1194/jlr.R800055-JLR200; Chou WH, 2010, J NEUROSCI, V30, P13955, DOI 10.1523/JNEUROSCI.0270-10.2010; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Friedman EB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011903; Hansson E., 1989, DISSECTION TISSUE CU, P92; Hodge CW, 2002, J CLIN INVEST, V110, P1003, DOI 10.1172/JCI200215903; Hodge CW, 1999, NAT NEUROSCI, V2, P997, DOI 10.1038/14795; Holmqvist T, 2005, J BIOL CHEM, V280, P6570, DOI 10.1074/jbc.M407397200; JENSEN AG, 1994, ANESTHESIOLOGY, V81, P1220, DOI 10.1097/00000542-199411000-00016; Johansson L, 2008, CELL MOL LIFE SCI, V65, P1948, DOI 10.1007/s00018-008-8206-z; Kelz MB, 2008, P NATL ACAD SCI USA, V105, P1309, DOI 10.1073/pnas.0707146105; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Krasowski MD, 1997, NEUROPHARMACOLOGY, V36, P941, DOI 10.1016/S0028-3908(97)00074-9; Kushikata T, 2003, NEUROSCIENCE, V121, P855, DOI 10.1016/S0306-4522(03)00554-2; Kushikata T, 2010, BRIT J ANAESTH, V104, P723, DOI 10.1093/bja/aeq098; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee U, 2010, ANESTHESIOLOGY, V113, P1081, DOI 10.1097/ALN.0b013e3181f229b5; Ling M, 2004, EXP CELL RES, V292, P135, DOI 10.1016/j.yexcr.2003.08.013; Mashour GA, 2004, ANESTHESIOLOGY, V100, P428, DOI 10.1097/00000542-200402000-00035; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Monovich L, 2007, BIOORG MED CHEM LETT, V17, P2310, DOI 10.1016/j.bmcl.2007.01.059; Morgan A, 2005, BIOCHEM SOC T, V33, P1341, DOI 10.1042/BST0331341; Nagumo H, 2000, AM J PHYSIOL-CELL PH, V278, pC57, DOI 10.1152/ajpcell.2000.278.1.C57; NAKADATE T, 1988, BIOCHEM PHARMACOL, V37, P1541, DOI 10.1016/0006-2952(88)90016-0; Newton PM, 2010, BIOCHEM J, V427, P189, DOI 10.1042/BJ20091302; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Satoh SI, 2011, BRAIN RES BULL, V84, P174, DOI 10.1016/j.brainresbull.2010.11.013; Slater SJ, 2001, BIOCHEMISTRY-US, V40, P4437, DOI 10.1021/bi001654n; TAKAI Y, 1979, BIOCHEM BIOPH RES CO, V91, P1218, DOI 10.1016/0006-291X(79)91197-5; Tose R, 2009, ANESTH ANALG, V108, P491, DOI 10.1213/ane.0b013e31819000c8; Turina D, 2008, BRIT J ANAESTH, V101, P374, DOI 10.1093/bja/aen185; Turina D, 2011, J PHYSIOL PHARMACOL, V62, P119; Wickley PJ, 2010, PROPOFOL MODULATES A; Xiang SY, 2013, BBA-MOL CELL BIOL L, V1831, P213, DOI 10.1016/j.bbalip.2012.09.004; Yasuda Y, 2003, ANESTH ANALG, V97, P1663, DOI 10.1213/01.ANE.0000089964.85834.EF; Yedovitzky M, 1997, J BIOL CHEM, V272, P1417, DOI 10.1074/jbc.272.3.1417; Zeidman R, 1999, J CELL BIOL, V145, P713, DOI 10.1083/jcb.145.4.713	44	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97129	10.1371/journal.pone.0097129	http://dx.doi.org/10.1371/journal.pone.0097129			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828410	gold, Green Published, Green Submitted			2022-12-27	WOS:000336857400058
J	Eichner, J; Wrzodek, C; Romer, M; Ellinger-Ziegelbauer, H; Zell, A				Eichner, Johannes; Wrzodek, Clemens; Roemer, Michael; Ellinger-Ziegelbauer, Heidrun; Zell, Andreas			Evaluation of Toxicogenomics Approaches for Assessing the Risk of Nongenotoxic Carcinogenicity in Rat Liver	PLOS ONE			English	Article							DNA-DAMAGE; EXPRESSION PROFILES; CELL-PROLIFERATION; CANCER; PREDICTION; INDUCTION; HEPATOCARCINOGENICITY; CLASSIFICATION; GENOTOXICITY; MICROARRAY	The current gold-standard method for cancer safety assessment of drugs is a rodent two-year bioassay, which is associated with significant costs and requires testing a high number of animals over lifetime. Due to the absence of a comprehensive set of short-term assays predicting carcinogenicity, new approaches are currently being evaluated. One promising approach is toxicogenomics, which by virtue of genome-wide molecular profiling after compound treatment can lead to an increased mechanistic understanding, and potentially allow for the prediction of a carcinogenic potential via mathematical modeling. The latter typically involves the extraction of informative genes from omics datasets, which can be used to construct generalizable models allowing for the early classification of compounds with unknown carcinogenic potential. Here we formally describe and compare two novel methodologies for the reproducible extraction of characteristic mRNA signatures, which were employed to capture specific gene expression changes observed for nongenotoxic carcinogens. While the first method integrates multiple gene rankings, generated by diverse algorithms applied to data from different subsamplings of the training compounds, the second approach employs a statistical ratio for the identification of informative genes. Both methods were evaluated on a dataset obtained from the toxicogenomics database TG-GATEs to predict the outcome of a two-year bioassay based on profiles from 14-day treatments. Additionally, we applied our methods to datasets from previous studies and showed that the derived prediction models are on average more accurate than those built from the original signatures. The selected genes were mostly related to p53 signaling and to specific changes in anabolic processes or energy metabolism, which are typically observed in tumor cells. Among the genes most frequently incorporated into prediction models were Phlda3, Cdkn1a, Akr7a3, Ccng1 and Abcb4.	[Eichner, Johannes; Wrzodek, Clemens; Roemer, Michael; Zell, Andreas] Univ Tubingen, Ctr Bioinformat Tuebingen ZBIT, Tubingen, Germany; [Ellinger-Ziegelbauer, Heidrun] Bayer Pharma AG, Global Early Dev, Wuppertal, Germany	Eberhard Karls University of Tubingen; Bayer AG; Bayer Healthcare Pharmaceuticals	Eichner, J (corresponding author), Univ Tubingen, Ctr Bioinformat Tuebingen ZBIT, Tubingen, Germany.	johannes.eichner@uni-tuebingen.de		Romer, Michael/0000-0003-2821-4425; Wrzodek, Clemens/0000-0003-4995-780X	Innovative Medicine Initiative Joint Undertaking (IMI JU) [115001]; Deutsche Forschungsgemeinschaft; Tuebingen University	Innovative Medicine Initiative Joint Undertaking (IMI JU); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tuebingen University	The research leading to these results has received funding from the Innovative Medicine Initiative Joint Undertaking (IMI JU) under grant agreement nr. 115001 (MARCAR project). The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeel T, 2010, BIOINFORMATICS, V26, P392, DOI 10.1093/bioinformatics/btp630; Afshari CA, 2011, TOXICOL SCI, V120, pS225, DOI 10.1093/toxsci/kfq373; Albrethsen J, 2011, BBA-PROTEINS PROTEOM, V1814, P1367, DOI 10.1016/j.bbapap.2011.05.018; Amundson SA, 2001, COMP BIOCHEM PHYS B, V129, P703, DOI 10.1016/S1096-4959(01)00389-X; Auerbach SS, 2010, TOXICOL APPL PHARM, V243, P300, DOI 10.1016/j.taap.2009.11.021; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; CATTLEY RC, 1989, CANCER RES, V49, P3246; Chen C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017238; Chen MJ, 2012, TOXICOL SCI, V130, P217, DOI 10.1093/toxsci/kfs223; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Deutsch WA, 2001, MUTAGENESIS, V16, P439, DOI 10.1093/mutage/16.5.439; Ellinger-Ziegelbauer H, 2005, MUTAT RES-FUND MOL M, V575, P61, DOI 10.1016/j.mrfmmm.2005.02.004; Ellinger-Ziegelbauer H, 2008, MUTAT RES-FUND MOL M, V637, P23, DOI 10.1016/j.mrfmmm.2007.06.010; ELLIOTT BM, 1987, CARCINOGENESIS, V8, P1213, DOI 10.1093/carcin/8.9.1213; Fielden MR, 2007, TOXICOL SCI, V99, P90, DOI 10.1093/toxsci/kfm156; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GLAUERT HP, 1986, CANCER RES, V46, P4601; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; He ZY, 2010, COMPUT BIOL CHEM, V34, P215, DOI 10.1016/j.compbiolchem.2010.07.002; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kawase T, 2009, CELL, V136, P535, DOI 10.1016/j.cell.2008.12.002; Kirkland D, 2006, MUTAT RES-GEN TOX EN, V608, P29, DOI 10.1016/j.mrgentox.2006.04.017; Kuncheva LI, STABILITY INDEX FEAT, P390; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Lima BS, 2000, REGUL TOXICOL PHARM, V32, P135; Locasale JW, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-88; Mally A, 2002, TOXICOLOGY, V180, P233, DOI 10.1016/S0300-483X(02)00393-1; Manuppello J, 2008, ENVIRON HEALTH PERSP, V116, pA516, DOI 10.1289/ehp.11964; Nakayama K, 2006, TOXICOL APPL PHARM, V217, P299, DOI 10.1016/j.taap.2006.09.008; Nie AY, 2006, MOL CARCINOGEN, V45, P914, DOI 10.1002/mc.20205; Nuwaysir EF, 1999, MOL CARCINOGEN, V24, P153, DOI 10.1002/(SICI)1098-2744(199903)24:3<153::AID-MC1>3.0.CO;2-P; Opgen-Rhein R, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1252; REDDY JK, 1989, MUTAT RES, V214, P63, DOI 10.1016/0027-5107(89)90198-X; Silva-Neto JP, 2010, TOXICON, V55, P105, DOI 10.1016/j.toxicon.2009.07.007; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Sonnenburg S, 2010, J MACH LEARN RES, V11, P1799; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; TURNER NT, 1987, MUTAT RES, V189, P285, DOI 10.1016/0165-1218(87)90060-7; Uehara T, 2008, TOXICOLOGY, V250, P15, DOI 10.1016/j.tox.2008.05.013; Uehara T, 2011, TOXICOL APPL PHARM, V255, P297, DOI 10.1016/j.taap.2011.07.001; Uehara T, 2010, MOL NUTR FOOD RES, V54, P218, DOI 10.1002/mnfr.200900169; van Delft JHM, 2005, MUTAT RES-FUND MOL M, V575, P17, DOI 10.1016/j.mrfmmm.2005.02.006; Venkataramani V, 2010, J BIOL CHEM, V285, P10678, DOI 10.1074/jbc.M109.057836; Wang RX, 2011, CURR PHARM BIOTECHNO, V12, P636, DOI 10.2174/138920111795163986; Warfel NA, 2012, CURR OPIN ONCOL; Waters MD, 2010, MUTAT RES-REV MUTAT, V705, P184, DOI 10.1016/j.mrrev.2010.04.005; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520; Wrzodek C, 2013, BIOINFORMATICS, V29, P506, DOI 10.1093/bioinformatics/bts709; Yang LX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r227; ZHAN QM, 1993, MOL CELL BIOL, V13, P4242, DOI 10.1128/MCB.13.7.4242; Zhao L, 2003, MOL CANCER RES, V1, P195	52	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97678	10.1371/journal.pone.0097678	http://dx.doi.org/10.1371/journal.pone.0097678			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828355	Green Published, Green Submitted, gold			2022-12-27	WOS:000336857400118
J	Huang, HL				Huang, Hui-Ling			Propensity Scores for Prediction and Characterization of Bioluminescent Proteins from Sequences	PLOS ONE			English	Article							PHOTOPROTEIN AEQUORIN; CRYSTAL-STRUCTURE; FLUORESCENT; DATABASE; MACHINE; CELLS	Bioluminescent proteins (BLPs) are a class of proteins with various mechanisms of light emission such as bioluminescence and fluorescence from luminous organisms. While valuable for commercial and medical applications, identification of BLPs, including luciferases and fluorescent proteins (FPs), is rather challenging, owing to their high variety of protein sequences. Moreover, characterization of BLPs facilitates mutagenesis analysis to enhance bioluminescence and fluorescence. Therefore, this study proposes a novel methodological approach to estimating the propensity scores of 400 dipeptides and 20 amino acids in order to design two prediction methods and characterize BLPs based on a scoring card method (SCM). The SCMBLP method for predicting BLPs achieves an accuracy of 90.83% for 10-fold cross-validation higher than existing support vector machine based methods and a test accuracy of 82.85%. A dataset consisting of 269 luciferases and 216 FPs is also established to design the SCMLFP prediction method, which achieves training and test accuracies of 97.10% and 96.28%, respectively. Additionally, four informative physicochemical properties of 20 amino acids are identified using the estimated propensity scores to characterize BLPs as follows: 1) high transfer free energy from inside to the protein surface, 2) high occurrence frequency of residues in the transmembrane regions of the protein, 3) large hydrophobicity scale from the native protein structure, and 4) high correlation coefficient (R = 0.921) between the amino acid compositions of BLPs and integral membrane proteins. Further analyzing BLPs reveals that luciferases have a larger value of R (0.937) than FPs (0.635), suggesting that luciferases tend to locate near the cell membrane location rather than FPs for convenient receipt of extracellular ions. Importantly, the propensity scores of dipeptides and amino acids and the identified properties facilitate efforts to predict, characterize, and apply BLPs, including luciferases, photoproteins, and FPs. The web server is available at http://iclab.life.nctu.edu.tw/SCMBLP/index.html.	[Huang, Hui-Ling] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Huang, Hui-Ling] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Huang, HL (corresponding author), Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan.	hlhuang@mail.nctu.edu.tw			National Science Council of Taiwan [NSC-102-2221-E-009-169]; "Center for Bioinformatics Research of Aiming for the Top University Program" of the National Chiao Tung University; Ministry of Education, Taiwan, R.O.C. [102W962]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); "Center for Bioinformatics Research of Aiming for the Top University Program" of the National Chiao Tung University; Ministry of Education, Taiwan, R.O.C.(Ministry of Education, Taiwan)	This work was funded by National Science Council of Taiwan, under the contract number NSC-102-2221-E-009-169, and "Center for Bioinformatics Research of Aiming for the Top University Program" of the National Chiao Tung University and Ministry of Education, Taiwan, R.O.C., for the project 102W962. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonora M, 2013, NAT PROTOC, V8, P2105, DOI 10.1038/nprot.2013.127; Bovolenta S, 2007, J BIOMOL SCREEN, V12, P694, DOI 10.1177/1087057107301497; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Cainarca S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008882; CAMPBELL AK, 1974, BIOCHEM J, V143, P411, DOI 10.1042/bj1430411; CASARI G, 1992, J MOL BIOL, V224, P725, DOI 10.1016/0022-2836(92)90556-Y; Cedano J, 1997, J MOL BIOL, V266, P594, DOI 10.1006/jmbi.1996.0804; Charoenkwan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072368; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; DEGLIESPOSTI M, 1990, EUR J BIOCHEM, V190, P207, DOI 10.1111/j.1432-1033.1990.tb15566.x; Denis C, 2012, CURR PHARM DESIGN, V18, P128, DOI 10.2174/138161212799040466; Eglen RM, 2008, ASSAY DRUG DEV TECHN, V6, P659, DOI 10.1089/adt.2008.160; Fan GL, 2013, J THEOR BIOL, V334, P45, DOI 10.1016/j.jtbi.2013.06.003; Head JF, 2000, NATURE, V405, P372, DOI 10.1038/35012659; Ho SY, 2004, IEEE T EVOLUT COMPUT, V8, P522, DOI 10.1109/TEVC.2004.835176; Huang HL, 2012, IEEE INT C BIOINF BI, P40; Huang HL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S47; Huang HL, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S17-S3; Huang WL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-80; JANIN J, 1979, NATURE, V277, P491, DOI 10.1038/277491a0; Kandaswamy KK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-345; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Nakashima H, 2013, J BIOMEDICAL SCI ENG, V6, P36, DOI [DOI 10.4236/jbise.2013.61006, 10.4236/jbise.2013.61006]; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; Titushin MS, 2011, PROTEIN CELL, V2, P957, DOI 10.1007/s13238-011-1118-y; Tung CW, 2007, BIOINFORMATICS, V23, P942, DOI 10.1093/bioinformatics/btm061; Vidi PA, 2009, MOL PHARMACOL, V75, P733, DOI 10.1124/mol.108.053819; Weast RC, 1974, EDITOR HDB CHEM PHYS; WHITE E H, 1971, Bioorganic Chemistry, V1, P92, DOI 10.1016/0045-2068(71)90009-5; WILSON T, 1995, PHOTOCHEM PHOTOBIOL, V62, P601, DOI 10.1111/j.1751-1097.1995.tb08706.x; Wunder F, 2008, MOL PHARMACOL, V73, P1235, DOI 10.1124/mol.107.042283; Zhao XW, 2012, INT J MOL SCI, V13, P3650, DOI 10.3390/ijms13033650	34	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97158	10.1371/journal.pone.0097158	http://dx.doi.org/10.1371/journal.pone.0097158			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828431	Green Submitted, Green Published, gold			2022-12-27	WOS:000336857400060
J	Noguchi-Shinohara, M; Yuki, S; Dohmoto, C; Ikeda, Y; Samuraki, M; Iwasa, K; Yokogawa, M; Asai, K; Komai, K; Nakamura, H; Yamada, M				Noguchi-Shinohara, Moeko; Yuki, Sohshi; Dohmoto, Chiaki; Ikeda, Yoshihisa; Samuraki, Miharu; Iwasa, Kazuo; Yokogawa, Masami; Asai, Kimiko; Komai, Kiyonobu; Nakamura, Hiroyuki; Yamada, Masahito			Consumption of Green Tea, but Not Black Tea or Coffee, Is Associated with Reduced Risk of Cognitive Decline	PLOS ONE			English	Article							ALZHEIMER TRANSGENIC MICE; POLYPHENOL (-)-EPIGALLOCATECHIN-3-GALLATE; PRECURSOR PROTEIN; DIETARY-INTAKE; IMPAIRMENT; CAFFEINE; DISEASE; DEMENTIA; CATECHIN; ANTIOXIDANTS	Our objective was to determine whether the consumption of green tea, coffee, or black tea influences the incidence of dementia and mild cognitive impairment (MCI) in older people. We conducted a population-based prospective study with Japanese residents aged >60 years from Nakajima, Japan (the Nakajima Project). Participants received an evaluation of cognitive function and blood tests. The consumption of green tea, coffee, and black tea was also evaluated at baseline. Of 723 participants with normal cognitive function at a baseline survey (2007-2008), 490 completed the follow up survey in 2011-2013. The incidence of dementia during the follow-up period (mean +/- SD: 4.9 +/- 0.9 years) was 5.3%, and that of MCI was 13.1%. The multiple-adjusted odds ratio for the incidence of overall cognitive decline (dementia or MCI) was 0.32 (95% CI: 0.16-0.64) among individuals who consumed green tea every day and 0.47 (95% CI: 0.25-0.86) among those who consumed green tea 1-6 days per week compared with individuals who did not consume green tea at all. The multiple-adjusted odds ratio for the incidence of dementia was 0.26 (95% CI: 0.06-1.06) among individuals who consumed green tea every day compared with those who did not consume green tea at all. No association was found between coffee or black tea consumption and the incidence of dementia or MCI. Our results indicate that green tea consumption is significantly associated with reduced risk of cognitive decline, even after adjustment for possible confounding factors.	[Noguchi-Shinohara, Moeko; Yuki, Sohshi; Dohmoto, Chiaki; Ikeda, Yoshihisa; Samuraki, Miharu; Iwasa, Kazuo; Yamada, Masahito] Kanazawa Univ, Grad Sch Med Sci, Dept Neurol & Neurobiol Aging, Kanazawa, Ishikawa, Japan; [Yokogawa, Masami] Kanazawa Univ, Grad Sch Med Sci, Div Hlth Sci, Dept Phys Therapy, Kanazawa, Ishikawa, Japan; [Asai, Kimiko] Bishoen Geriatr Hlth Serv Facil, Suzu, Japan; [Komai, Kiyonobu] Natl Hosp Org, Ioh Hosp, Dept Neurol, Kanazawa, Ishikawa, Japan; [Nakamura, Hiroyuki] Kanazawa Univ, Grad Sch Med Sci, Dept Environm & Prevent Med, Kanazawa, Ishikawa, Japan	Kanazawa University; Kanazawa University; Kanazawa University	Yamada, M (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Neurol & Neurobiol Aging, Kanazawa, Ishikawa, Japan.	m-yamada@med.kanazawa-u.ac.jp			Grant for the Hokuriku Innovation Cluster for Health Science from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Health, Labour and Welfare, Japan	Grant for the Hokuriku Innovation Cluster for Health Science from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported in part by a Grant for the Hokuriku Innovation Cluster for Health Science (to M.Y.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. In addition, this work was also supported from the Research on Dementia, Health and Labour Sciences Research Grants (to M.Y.) from the Ministry of Health, Labour and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1987, DIAGN STAT MAN MENT; Arendash GW, 2006, NEUROSCIENCE, V142, P941, DOI 10.1016/j.neuroscience.2006.07.021; Barone JJ, 1996, FOOD CHEM TOXICOL, V34, P119, DOI 10.1016/0278-6915(95)00093-3; Bastianetto S, 2006, EUR J NEUROSCI, V23, P55, DOI 10.1111/j.1460-9568.2005.04532.x; Choi YT, 2001, LIFE SCI, V70, P603, DOI 10.1016/S0024-3205(01)01438-2; Dai Q, 2006, AM J MED, V119, P751, DOI 10.1016/j.amjmed.2006.03.045; Dall'Igna OP, 2007, EXP NEUROL, V203, P241, DOI 10.1016/j.expneurol.2006.08.008; de Bruijn RFAG, 2013, EUR J EPIDEMIOL, V28, P277, DOI 10.1007/s10654-013-9773-3; Engelhart MJ, 2002, JAMA-J AM MED ASSOC, V287, P3223, DOI 10.1001/jama.287.24.3223; Eskelinen MH, 2009, J ALZHEIMERS DIS, V16, P85, DOI 10.3233/JAD-2009-0920; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hamaguchi T, 2009, AM J PATHOL, V175, P2557, DOI 10.2353/ajpath.2009.090417; Ho L, 2012, NUTR NEUROSCI, V15, P37, DOI 10.1179/1476830511Y.0000000027; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; KAMBOH MI, 1988, J LIPID RES, V29, P1535; Khokhar S, 2002, J AGR FOOD CHEM, V50, P565, DOI 10.1021/jf010153l; Kim TI, 2009, FREE RADICAL BIO MED, V47, P1601, DOI 10.1016/j.freeradbiomed.2009.09.008; Kuriyama S, 2006, AM J CLIN NUTR, V83, P355; Landau SM, 2012, ARCH NEUROL-CHICAGO, V69, P623, DOI 10.1001/archneurol.2011.2748; Laurin D, 2004, AM J EPIDEMIOL, V159, P959, DOI 10.1093/aje/kwh124; Levites Y, 2003, FASEB J, V17, P952, DOI 10.1096/fj.02-0881fje; Levites Y, 2001, J NEUROCHEM, V78, P1073, DOI 10.1046/j.1471-4159.2001.00490.x; Lindsay J, 2002, AM J EPIDEMIOL, V156, P445, DOI 10.1093/aje/kwf074; LYKKESFELDT J, 1995, ANAL BIOCHEM, V229, P329, DOI 10.1006/abio.1995.1421; Morris J. C., 1993, NEUROLOGY, V43, P2411, DOI [10.1212/WNL.43.11.24118232970, DOI 10.1212/WNL.43.11.24118232970]; Morris JC, 2001, ARCH NEUROL-CHICAGO, V58, P397, DOI 10.1001/archneur.58.3.397; Nakagawa K, 1997, J NUTR SCI VITAMINOL, V43, P679, DOI 10.3177/jnsv.43.679; Noguchi-Shinohara M, 2013, J ALZHEIMERS DIS, V37, P691, DOI 10.3233/JAD-130398; Ogawa Keiko, 2002, J Epidemiol, V12, P1; Ono K, 2003, J NEUROCHEM, V87, P172, DOI 10.1046/j.1471-4159.2003.01976.x; Ono K, 2012, J BIOL CHEM, V287, P14631, DOI 10.1074/jbc.M111.325456; Peterson J, 2005, J FOOD COMPOS ANAL, V18, P487, DOI 10.1016/j.jfca.2004.05.006; Rezai-Zadeh K, 2005, J NEUROSCI, V25, P8807, DOI 10.1523/JNEUROSCI.1521-05.2005; Rezai-Zadeh K, 2008, BRAIN RES, V1214, P177, DOI 10.1016/j.brainres.2008.02.107; Ritchie K, 2007, NEUROLOGY, V69, P536, DOI 10.1212/01.wnl.0000266670.35219.0c; Science and Technology Agency, 2010, STAND TABL FOOD COMP; Sugano K, 2012, DEMENT GER COGN D EX, V2, P69, DOI 10.1159/000337224; van Gelder BM, 2007, EUR J CLIN NUTR, V61, P226, DOI 10.1038/sj.ejcn.1602495; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x	39	90	96	8	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96013	10.1371/journal.pone.0096013	http://dx.doi.org/10.1371/journal.pone.0096013			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828424	Green Published, gold, Green Submitted			2022-12-27	WOS:000336857400020
J	Carl, C; de Nys, R; Lawton, RJ; Paul, NA				Carl, Christina; de Nys, Rocky; Lawton, Rebecca J.; Paul, Nicholas A.			Methods for the Induction Reproduction in a Species of Filamentous Ulva	PLOS ONE			English	Article							ALGA ENTEROMORPHA; GAMETE RELEASE; FLOATING ULVA; GREEN TIDE; CHLOROPHYTA; MUTABILIS; SPORULATION; ZOOSPORES; SETTLEMENT; PROLIFERA	The green seaweed Ulva is a major fouling organism but also an edible aquaculture product in Asia. This study quantified for the first time the effect of key factors on the reproduction of a tropical species of filamentous Ulva (Ulva sp. 3). The controlled timing of release of swarmers (motile reproductive bodies) was achieved when experiments were initiated in the early afternoon by exposing the thalli to a temperature shock (4 degrees C) for 10 min and subsequently placing them into autoclaved filtered seawater under a 12 h light: 12 h dark photoperiod at 25 degrees C. The release of swarmers then peaked two days after initiation. In contrast, segmentation, dehydration, salinity or time of initiation of experiments had no effect of any magnitude on reproduction. The released swarmers were predominantly biflagellate (95%), negatively phototactic and germinated without complementary gametes. This indicates that Ulva sp. 3 has a simple asexual life history dominated by biflagellate zoids.	[Carl, Christina] James Cook Univ, MACRO Ctr Macroalgal Resources & Biotechnol, Townsville, Qld 4811, Australia; James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	James Cook University; James Cook University	Carl, C (corresponding author), James Cook Univ, MACRO Ctr Macroalgal Resources & Biotechnol, Townsville, Qld 4811, Australia.	tine.carl@jcu.edu.au	Paul, Nicholas/B-6496-2009; Lawton, Rebecca/E-5711-2014; de Nys, Rocky/D-6741-2012; Praeger, Christina/A-7224-2013	Lawton, Rebecca/0000-0001-6296-6415; de Nys, Rocky/0000-0003-3869-4928; Praeger, Christina/0000-0002-1947-122X; Paul, Nicholas/0000-0002-9275-1535	Australian Government through the Australian Renewable Energy Agency; Advanced Manufacturing Cooperative Research Centre (AMCRC); Australian Government's Cooperative Research Centre Scheme	Australian Government through the Australian Renewable Energy Agency(Australian Renewable Energy Agency (ARENA)); Advanced Manufacturing Cooperative Research Centre (AMCRC)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Government's Cooperative Research Centre Scheme(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This research is part of the MBD Energy Research and Development program for Biological Carbon Capture and Storage. The project is supported by the Australian Government through the Australian Renewable Energy Agency, and the Advanced Manufacturing Cooperative Research Centre (AMCRC), funded through the Australian Government's Cooperative Research Centre Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRATEN T, 1973, J CELL SCI, V13, P69; Callow JA, 2006, BIOLOGICAL ADHESIVES, P63, DOI 10.1007/978-3-540-31049-5_4; Callow ME, 1997, J PHYCOL, V33, P938, DOI 10.1111/j.0022-3646.1997.00938.x; CALLOW ME, 1986, BOT MAR, V29, P351, DOI 10.1515/botm.1986.29.4.351; CHRISTIE AO, 1962, NATURE, V193, P193, DOI 10.1038/193193a0; Clarke K, 2006, PRIMER V6 USER MANUA, P190; Corradi MG, 2006, AQUAT BOT, V84, P144, DOI 10.1016/j.aquabot.2005.08.007; Dan A, 2002, FISHERIES SCI, V68, P1182, DOI 10.1046/j.1444-2906.2002.00553.x; DENYS R, 1995, BIOFOULING, V8, P259, DOI 10.1080/08927019509378279; Cruz-Suarez LE, 2010, AQUACULTURE, V301, P64, DOI 10.1016/j.aquaculture.2010.01.021; EVANS LV, 1970, ANN BOT-LONDON, V34, P451, DOI 10.1093/oxfordjournals.aob.a084382; FLETCHER RL, 1989, INT BIODETERIOR, V25, P407, DOI 10.1016/0265-3036(89)90067-5; Forbord S, 2012, J APPL PHYCOL, V24, P393, DOI 10.1007/s10811-011-9784-y; Gao S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008571; Godwin LS, 2003, BIOFOULING, V19, P123, DOI 10.1080/0892701031000061750; Graham LE, 2000, ALGAE; Han TJ, 2005, AQUAT TOXICOL, V75, P202, DOI 10.1016/j.aquatox.2005.08.003; Han TJ, 2003, J EXP MAR BIOL ECOL, V290, P115, DOI 10.1016/S0022-0981(03)00068-6; Hayden HS, 2003, EUR J PHYCOL, V38, P277, DOI 10.1080/1364253031000136321; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hiraoka M, 2004, PHYCOL RES, V52, P17, DOI 10.1111/j.1440-1835.2003.00321.x; Hiraoka M, 2004, HYDROBIOLOGIA, V512, P239, DOI 10.1023/B:HYDR.0000020332.12641.a2; Hiraoka M, 2003, PHYCOLOGIA, V42, P275, DOI 10.2216/i0031-8884-42-3-275.1; Hiraoka M, 2008, J APPL PHYCOL, V20, P97, DOI 10.1007/s10811-007-9186-3; Hiraoka Masanori, 2003, Phycological Research, V51, P29; Hiraoka M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019371; Hiraoka M, 2010, J PHYCOL, V46, P882, DOI 10.1111/j.1529-8817.2010.00873.x; Hiraoka Masanori, 1998, Phycological Research, V46, P199, DOI 10.1111/j.1440-1835.1998.tb00114.x; Hodson SL, 2000, AQUACULTURE, V184, P277, DOI 10.1016/S0044-8486(99)00328-2; Imchen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032651; Kalita TL, 2011, RUSS J MAR BIOL+, V37, P52, DOI 10.1134/S106307401101007X; Kawashima Y, 2013, FISHERIES SCI, V79, P521, DOI 10.1007/s12562-013-0610-0; Kuwano K, 2012, J PHYCOL, V48, P394, DOI 10.1111/j.1529-8817.2011.01110.x; Lawton RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077344; LERSTEN NELS R., 1960, BOT GAZ, V122, P33, DOI 10.1086/336083; Long CJ, 2010, BIOFOULING, V26, P411, DOI 10.1080/08927011003628849; Luning K, 2008, J PHYCOL, V44, P866, DOI 10.1111/j.1529-8817.2008.00535.x; LUNING K, 1988, MAR ECOL PROG SER, V45, P137, DOI 10.3354/meps045137; Luo MB, 2011, J EXP MAR BIOL ECOL, V409, P223, DOI 10.1016/j.jembe.2011.08.023; Malta EJ, 1999, EUR J PHYCOL, V34, P443, DOI 10.1080/09541449910001718801; Mantri VA, 2011, J APPL PHYCOL, V23, P243, DOI 10.1007/s10811-010-9544-4; MCARTHUR DM, 1979, BRIT PHYCOL J, V14, P43, DOI 10.1080/00071617900650071; Msuya FE, 2006, AQUACULTURE, V254, P284, DOI 10.1016/j.aquaculture.2005.10.044; Neori A, 2003, J APPL PHYCOL, V15, P543, DOI 10.1023/B:JAPH.0000004382.89142.2d; NIESENBAUM RA, 1988, AQUAT BOT, V32, P155, DOI 10.1016/0304-3770(88)90095-2; NILSEN G, 1975, PLANTA, V125, P127, DOI 10.1007/BF00388699; NORDBY O, 1974, J CELL SCI, V15, P443; NORDBY O, 1977, BOT MAR, V20, P19, DOI 10.1515/botm.1977.20.1.19; NORDBY O, 1972, EXP CELL RES, V75, P321, DOI 10.1016/0014-4827(72)90436-3; Ohno M, 1993, SEAWEED CULTIVATION, P7; Pandey RS, 1985, REP US MAR BIOL I, V7, P21; Pickett-Heaps JD, 1975, GREEN ALGAE, P167; Poole LJ, 1997, PROG PHYCOL RES, V12, P1; Ruangchuay R., 2012, Songklanakarin Journal of Science and Technology, V34, P501; Scardino AJ, 2008, BIOFOULING, V24, P45, DOI 10.1080/08927010701784391; Scardino AJ, 2009, BIOFOULING, V25, P757, DOI 10.1080/08927010903165936; Schumacher JF, 2007, BIOFOULING, V23, P55, DOI 10.1080/08927010601136957; Shimada S, 2008, J APPL PHYCOL, V20, P979, DOI 10.1007/s10811-007-9296-y; Shin HW, 2008, J ENVIRON BIOL, V29, P613; Shokita S, 1991, AQUACULTURE TROPICAL, P31; Silva PHD, 2008, AQUACULTURE, V284, P74, DOI 10.1016/j.aquaculture.2008.07.035; SMITH GM, 1947, AM J BOT, V34, P80, DOI 10.2307/2437232; Stratmann J, 1996, J PHYCOL, V32, P1009, DOI 10.1111/j.0022-3646.1996.01009.x; THIADENS AJ, 1967, PLANTA, V72, P60; Thome I, 2012, BIOFOULING, V28, P501, DOI 10.1080/08927014.2012.689288; Thompson SEM, 2007, PLANT CELL ENVIRON, V30, P733, DOI 10.1111/j.1365-3040.2007.01661.x; Titlyanov EA, 1996, EUR J PHYCOL, V31, P181, DOI 10.1080/09670269600651361; Wichard T, 2010, J PHYCOL, V46, P248, DOI 10.1111/j.1529-8817.2010.00816.x; Yokoyama H, 2010, AQUACULTURE, V310, P74, DOI 10.1016/j.aquaculture.2010.10.018	69	29	30	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97396	10.1371/journal.pone.0097396	http://dx.doi.org/10.1371/journal.pone.0097396			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824896	Green Accepted, gold, Green Published			2022-12-27	WOS:000336369200107
J	Cui, JD; Cui, LL; Zhang, SP; Zhang, YF; Su, ZG; Ma, GH				Cui, Jian dong; Cui, Li li; Zhang, Song ping; Zhang, Yu fei; Su, Zhi guo; Ma, Guang hui			Hybrid Magnetic Cross-Linked Enzyme Aggregates of Phenylalanine Ammonia Lyase from Rhodotorula glutinis	PLOS ONE			English	Article							PENICILLIN-G ACYLASE; SILICA; BIOCATALYSTS; CLEAS; IMMOBILIZATION; COAGGREGATION; ENHANCEMENT; METHODOLOGY; POLYMERS; LIPASE	Novel hybrid magnetic cross-linked enzyme aggregates of phenylalanine ammonia lyase (HM-PAL-CLEAs) were developed by co-aggregation of enzyme aggregates with magnetite nanoparticles and subsequent crosslinking with glutaraldehyde. The HM-PAL-CLEAs can be easily separated from the reaction mixture by using an external magnetic field. Analysis by scanning electron microscopy (SEM) and confocal laser scanning microscopy (CLSM) indicated that PAL-CLEAs were inlayed in nanoparticle aggregates. The HM-PAL-CLEAs revealed a broader limit in optimal pH compared to free enzyme and PAL-CLEAs. Although there is no big difference in K-m of enzyme in CLEAs and HM-PAL-CLEAs, V-max of HM-PAL-CLEAs is about 1.75 times higher than that of CLEAs. Compared with free enzyme and PAL-CLEAs, the HM-PAL-CLEAs also exhibited the highest thermal stability, denaturant stability and storage stability. The HM-PAL-CLEAs retained 30% initial activity even after 11 cycles of reuse, whereas PAL-CLEAs retained 35% of its initial activity only after 7 cycles. These results indicated that hybrid magnetic CLEAs technology might be used as a feasible and efficient solution for improving properties of immobilized enzyme in industrial application.	[Cui, Jian dong; Cui, Li li] Hebei Univ Sci & Technol, Coll Biosci & Bioengn, Res Ctr Fermentat Engn Hebei, Shijiazhuang, Peoples R China; [Cui, Jian dong; Cui, Li li; Zhang, Song ping; Zhang, Yu fei; Su, Zhi guo; Ma, Guang hui] Chinese Acad Sci, Inst Proc Engn, Natl Key Lab Biochem Engn, Beijing, Peoples R China; [Cui, Jian dong] Tianjin Univ Sci & Technol, Key Lab Ind Microbiol, Tai Da Dev Area, Minist Educ, Tianjin, Peoples R China; [Zhang, Song ping] Collaborat Innovat Ctr Chem Sci & Engn Tianjin, Tianjin, Peoples R China	Hebei University of Science & Technology; Chinese Academy of Sciences; Institute of Process Engineering, CAS; Tianjin University Science & Technology	Cui, JD (corresponding author), Hebei Univ Sci & Technol, Coll Biosci & Bioengn, Res Ctr Fermentat Engn Hebei, Shijiazhuang, Peoples R China.	cjd007cn@163.com; spzhang@home.ipe.ac.cn	Zhang, yufei/HHC-7375-2022	cui, jian dong/0000-0002-2809-530X	National Natural Science Foundation of China [21072041, 21106164, 21376249]; Open Funding Project of the National Key Laboratory of Biochemical Engineering [KF2010-12]; Foundation of Key Laboratory of Industry Microbiology [2012IM004]; Ministry of Education (Tianjin Key Laboratory of Industrial Microbiology); Foundation of Hebei University of Science and Technology [SW10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Funding Project of the National Key Laboratory of Biochemical Engineering; Foundation of Key Laboratory of Industry Microbiology; Ministry of Education (Tianjin Key Laboratory of Industrial Microbiology); Foundation of Hebei University of Science and Technology	The project was partially supported by the National Natural Science Foundation of China (project no. 21072041, 21106164, 21376249). Dr. J.D. Cui also thanks supports from Open Funding Project of the National Key Laboratory of Biochemical Engineering (no. KF2010-12) and the Foundation (no. 2012IM004) of Key Laboratory of Industry Microbiology, Ministry of Education (Tianjin Key Laboratory of Industrial Microbiology), (Tianjin University of Science & Technology), People's Republic of China, the Natural Science Foundation of Hebei Province, China (project no. B2014208054), and the Foundation of Hebei University of Science and Technology (project no. SW10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aytar BS, 2008, PROCESS BIOCHEM, V43, P125, DOI 10.1016/j.procbio.2007.11.001; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cabana H, 2009, BIOTECHNOL BIOENG, V102, P1582, DOI 10.1002/bit.22198; Cao LQ, 2000, ORG LETT, V2, P1361, DOI 10.1021/ol005593x; Cui JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080581; Cui JD, 2013, APPL BIOCHEM BIOTECH, V170, P1827, DOI 10.1007/s12010-013-0317-9; Cui JD, 2012, APPL BIOCHEM BIOTECH, V167, P835, DOI 10.1007/s12010-012-9738-0; Dong T, 2010, BIORESOURCE TECHNOL, V101, P6569, DOI 10.1016/j.biortech.2010.03.061; Jung D, 2009, J MATER SCI, V44, P6747, DOI 10.1007/s10853-009-3917-6; Kim MI, 2007, BIOTECHNOL BIOENG, V96, P210, DOI 10.1002/bit.21107; Lee J, 2009, J MATER CHEM, V19, P7864, DOI 10.1039/b909109b; Li Y, 2010, J MOL CATAL B-ENZYM, V66, P182, DOI 10.1016/j.molcatb.2010.05.007; Mateo C, 2004, BIOTECHNOL BIOENG, V86, P273, DOI 10.1002/bit.20033; Matijosyte I, 2010, J MOL CATAL B-ENZYM, V62, P142, DOI 10.1016/j.molcatb.2009.09.019; Montoro-Garcia S, 2010, BIORESOURCE TECHNOL, V101, P331, DOI 10.1016/j.biortech.2009.08.016; Park JM, 2013, INT J BIOL MACROMOL, V54, P37, DOI 10.1016/j.ijbiomac.2012.11.025; Park JM, 2012, BIOMACROMOLECULES, V13, P3780, DOI 10.1021/bm3012264; Park JM, 2010, PROCESS BIOCHEM, V45, P259, DOI 10.1016/j.procbio.2009.09.015; Ranjbakhsh E, 2012, CHEM ENG J, V179, P272, DOI 10.1016/j.cej.2011.10.097; Rees DG, 1996, ENZYME MICROB TECH, V19, P282; Reshmi R, 2013, J MOL CATAL B-ENZYM, V85-86, P111, DOI 10.1016/j.molcatb.2012.08.007; Talekar S, 2013, RSC ADV, V3, P12485, DOI 10.1039/c3ra40818c; Talekar S, 2012, BIORESOURCE TECHNOL, V123, P542, DOI 10.1016/j.biortech.2012.07.044; Wang MF, 2010, BIOCHEM ENG J, V52, P168, DOI 10.1016/j.bej.2010.08.003; Wilson L, 2004, BIOTECHNOL BIOENG, V86, P558, DOI 10.1002/bit.20107; Wilson L, 2004, BIOMACROMOLECULES, V5, P852, DOI 10.1021/bm0343895; Wilson L, 2006, ENZYME MICROB TECH, V39, P750, DOI 10.1016/j.enzmictec.2005.12.011; YAMADA S, 1981, APPL ENVIRON MICROB, V42, P773, DOI 10.1128/AEM.42.5.773-778.1981; Yang XE, 2012, J BIOTECHNOL, V161, P27, DOI 10.1016/j.jbiotec.2012.05.014; Zhang BZ, 2010, J AGR FOOD CHEM, V58, P2795, DOI 10.1021/jf9036744; Zhang S, 2012, BIOTECHNOL BIOTEC EQ, V26, P3418, DOI 10.5504/BBEQ.2012.0106; Zheng MQ, 2013, J BIOTECHNOL, V168, P212, DOI 10.1016/j.jbiotec.2013.05.016; Zheng MQ, 2011, J BIOTECHNOL, V154, P274, DOI 10.1016/j.jbiotec.2011.04.013	33	40	43	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97221	10.1371/journal.pone.0097221	http://dx.doi.org/10.1371/journal.pone.0097221			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24825453	Green Published, Green Submitted, gold			2022-12-27	WOS:000336369200072
J	Grandl, S; Willner, M; Herzen, J; Sztrokay-Gaul, A; Mayr, D; Auweter, SD; Hipp, A; Birnbacher, L; Marschner, M; Chabior, M; Reiser, M; Pfeiffer, F; Bamberg, F; Hellerhoff, K				Grandl, Susanne; Willner, Marian; Herzen, Julia; Sztrokay-Gaul, Aniko; Mayr, Doris; Auweter, Sigrid D.; Hipp, Alexander; Birnbacher, Lorenz; Marschner, Mathias; Chabior, Michael; Reiser, Maximilian; Pfeiffer, Franz; Bamberg, Fabian; Hellerhoff, Karin			Visualizing Typical Features of Breast Fibroadenomas Using Phase-Contrast CT: An Ex-Vivo Study	PLOS ONE			English	Article							PHYLLODES TUMORS; HIGH-RESOLUTION; SYNCHROTRON-RADIATION; MAMMOGRAPHY; DIAGNOSIS; TOMOGRAPHY; BIOPSY; CANCER; TISSUE; CARCINOMA	Background: Fibroadenoma is the most common benign solid breast lesion type and a very common cause for histologic assessment. To justify a conservative therapy, a highly specific discrimination between fibroadenomas and other breast lesions is crucial. Phase-contrast imaging offers improved soft-tissue contrast and differentiability of fine structures combined with the potential of 3-dimensional imaging. In this study we assessed the potential of grating-based phase-contrast CT imaging for visualizing diagnostically relevant features of fibroadenomas. Materials and Methods: Grating-based phase-contrast CT was performed on six ex-vivo formalin-fixed breast specimens containing a fibroadenoma and three samples containing benign changes that resemble fibroadenomas using Talbot Lau interferometry and a polychromatic X-ray source. Phase-contrast and simultaneously acquired absorption-based 3D-datasets were manually matched with corresponding histological slices. The visibility of diagnostically valuable features was assessed in comparison with histology as the gold-standard. Results: In all cases, matching of grating-based phase-contrast CT images and histology was successfully completed. Grating-based phase-contrast CT showed greatly improved differentiation of fine structures and provided accurate depiction of strands of fibrous tissue within the fibroadenomas as well as of the diagnostically valuable dilated, branched ductuli of the fibroadenomas. A clear demarcation of tumor boundaries in all cases was provided by phase- but not absorption-contrast CT. Conclusions: Pending successful translation of the technology to a clinical setting and considerable reduction of the required dose, the data presented here suggest that grating-based phase- contrast CT may be used as a supplementary non-invasive diagnostic tool in breast diagnostics. Phase-contrast CT may thus contribute to the reduction of false positive findings and reduce the recall and core biopsy rate in population-based screening. Phase-contrast CT may further be used to assist during histopathological workup, offering a 3D view of the tumor and helping to identify diagnostically valuable tissue sections within large tumors.	[Grandl, Susanne; Sztrokay-Gaul, Aniko; Auweter, Sigrid D.; Reiser, Maximilian; Bamberg, Fabian; Hellerhoff, Karin] Univ Munich, Inst Clin Radiol, Munich, Germany; [Willner, Marian; Herzen, Julia; Birnbacher, Lorenz; Marschner, Mathias; Chabior, Michael; Pfeiffer, Franz] Tech Univ Munich, Dept Phys, D-80290 Munich, Germany; [Willner, Marian; Herzen, Julia; Birnbacher, Lorenz; Marschner, Mathias; Chabior, Michael; Pfeiffer, Franz] Tech Univ Munich, Inst Med Engn, D-80290 Munich, Germany; [Herzen, Julia; Hipp, Alexander] Helmholtz Zentrum Geesthacht, Inst Mat Res, Geesthacht, Germany; [Mayr, Doris] Ludwig Maximilians Univ Hosp Munich, Inst Pathol, Munich, Germany	University of Munich; Technical University of Munich; University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung; University of Munich	Grandl, S (corresponding author), Univ Munich, Inst Clin Radiol, Munich, Germany.	susanne.grandl@med.uni-muenchen.de	Herzen, Julia/B-2368-2015	Herzen, Julia/0000-0002-9456-1591	DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP) [EXC158]	DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP)(German Research Foundation (DFG))	This study was supported by the DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP, EXC158). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton G, 2013, Z MED PHYS, V23, P228, DOI 10.1016/j.zemedi.2013.01.001; Auweter SD, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20130606; Bode MK, 2007, ACTA RADIOL, V48, P708, DOI 10.1080/02841850701367911; Bravin A, 2007, PHYS MED BIOL, V52, P2197, DOI 10.1088/0031-9155/52/8/011; Dillon MF, 2006, SURGERY, V140, P779, DOI 10.1016/j.surg.2006.03.022; Fiedler S, 2004, PHYS MED BIOL, V49, P175, DOI 10.1088/0031-9155/49/2/001; Foxcroft LM, 2007, BREAST, V16, P27, DOI 10.1016/j.breast.2006.05.004; Grabowski J, 2007, AM SURGEON, V73, P967; Grandl S, 2013, Z MED PHYS; Hofvind S, 2012, J MED SCREEN, V19, P57, DOI 10.1258/jms.2012.012083; Kerlikowske K, 2003, ANN INTERN MED, V139, P274, DOI 10.7326/0003-4819-139-4-200308190-00010; Keyrilainen J, 2010, ACTA RADIOL, V51, P866, DOI 10.3109/02841851.2010.504742; Michel T, 2013, PHYS MED BIOL, V58, P2713, DOI 10.1088/0031-9155/58/8/2713; Pani S, 2004, PHYS MED BIOL, V49, P1739, DOI 10.1088/0031-9155/49/9/011; Pearlman MD, 2010, OBSTET GYNECOL, V116, P747, DOI 10.1097/AOG.0b013e3181ee9fc7; Pfeiffer F, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108105; Pfeiffer F, 2006, NAT PHYS, V2, P258, DOI 10.1038/nphys265; Rosen PP, 2009, ROSENS BREAST PATHOL, P187; ROWELL MD, 1993, AM J SURG, V165, P376, DOI 10.1016/S0002-9610(05)80849-9; Schrading S, 2008, RADIOLOGY, V246, P58, DOI 10.1148/radiol.2461062173; Sztrokay A, 2012, PHYS MED BIOL, V57, P2931, DOI 10.1088/0031-9155/57/10/2931; Sztrokay A, 2013, EUR RADIOL, V23, P381, DOI 10.1007/s00330-012-2592-1; Tilanus-Linthorst M, 2002, INT J CANCER, V102, P91, DOI 10.1002/ijc.10666; Veltman J, 2008, EUR RADIOL, V18, P931, DOI 10.1007/s00330-008-0851-y; Weaver DL, 2006, CANCER, V106, P732, DOI 10.1002/cncr.21652; Weitkamp T, 2005, OPT EXPRESS, V13, P6296, DOI 10.1364/OPEX.13.006296; Willner M, 2014, PHYS MED BIOL, V59, P1557, DOI 10.1088/0031-9155/59/7/1557; Zhao YZ, 2012, P NATL ACAD SCI USA, V109, P18290, DOI 10.1073/pnas.1204460109	28	27	27	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97101	10.1371/journal.pone.0097101	http://dx.doi.org/10.1371/journal.pone.0097101			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824169	gold, Green Published, Green Submitted			2022-12-27	WOS:000336369200059
J	Huang, CY; Ger, TR; Wei, ZH; Lai, MF				Huang, Chen-Yu; Ger, Tzong-Rong; Wei, Zung-Hang; Lai, Mei-Feng			Compare Analysis for the Nanotoxicity Effects of Different Amounts of Endocytic Iron Oxide Nanoparticles at Single Cell Level	PLOS ONE			English	Article							INORGANIC NANOPARTICLES; APOPTOSIS; RESONANCE; MECHANISMS; PROTEIN; GROWTH; ASSAY; LINE; MTT	Developing methods that evaluate the cellular uptake of magnetic nanoparticles (MNPs) and nanotoxicity effects at single-cellular level are needed. In this study, magnetophoresis combining fluorescence based cytotoxicity assay was proposed to assess the viability and the single-cellular MNPs uptake simultaneously. Malignant cells (SKHep-1, HepG2, HeLa) were incubated with 10 nm anionic iron oxide nanoparticles. Prussian blue stain was performed to visualize the distribution of magnetic nanoparticles. MTT and fluorescence based assay analyzed the cytotoxicity effects of the bulk cell population and single cell, respectively. DAPI/PI stained was applied to evaluate death mechanism. The number of intracellular MNPs was found to be strongly correlated with the cell death. Significant differences between cellular MNP uptake in living and dead cells were observed. The method could be useful for future study of the nanotoxicity induced by MNPs.	[Huang, Chen-Yu; Wei, Zung-Hang] Natl Tsing Hua Univ, Dept Power Mech Engn, Hsinchu, Taiwan; [Ger, Tzong-Rong; Lai, Mei-Feng] Natl Tsing Hua Univ, Inst NanoEngn & MicroSyst, Hsinchu, Taiwan	National Tsing Hua University; National Tsing Hua University	Wei, ZH (corresponding author), Natl Tsing Hua Univ, Dept Power Mech Engn, Hsinchu, Taiwan.	wei@pme.nthu.edu.tw; mflai@mx.nthu.edu.tw	HUANG, CHENYU/GVT-7299-2022; HUANG, CHEN-YU/F-7226-2018	HUANG, CHEN-YU/0000-0002-9932-5651	ROC National Science Council [NSC 99-2112-M-007-016-MY3, NSC 99-2112-M-007-015-MY3, NSC 102-2112-M-007-006-MY3, NSC 102-2112-M-007-012 -MY3]	ROC National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported partly by the ROC National Science Council Grant Numbers NSC 99-2112-M-007-016-MY3, NSC 99-2112-M-007-015-MY3, NSC 102-2112-M-007-006-MY3 and NSC 102-2112-M-007-012 -MY3. No additional funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311; Bredesen DE, 1995, ANN NEUROL, V38, P839, DOI 10.1002/ana.410380604; Canton I, 2012, CHEM SOC REV, V41, P2718, DOI 10.1039/c2cs15309b; Cogger VC, 2008, AM J PHYSIOL-GASTR L, V295, pG137, DOI 10.1152/ajpgi.00069.2008; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; De Jong WH, 2008, INT J NANOMED, V3, P133, DOI 10.2147/ijn.s596; Figuerola A, 2010, PHARMACOL RES, V62, P126, DOI 10.1016/j.phrs.2009.12.012; Ger TR, 2014, J APPL PHYS, V115, DOI 10.1063/1.4867600; Ger TR, 2014, J APPL PHYS, V115, DOI 10.1063/1.4867606; Ger TR, 2013, LAB CHIP, V13, P4225, DOI 10.1039/c3lc50721a; Ger TR, 2013, IEEE T MAGN, V49, P3496, DOI 10.1109/TMAG.2013.2245866; Ger TR, 2013, IEEE T MAGN, V49, P3453, DOI 10.1109/TMAG.2013.2245865; Ger TR, 2013, LAB CHIP, V13, P2364, DOI 10.1039/c3lc50287b; Hawkins MJ, 2008, ADV DRUG DELIVER REV, V60, P876, DOI 10.1016/j.addr.2007.08.044; HEFFELFINGER SC, 1992, IN VITRO CELL DEV-AN, V28A, P136; Huang CY, 2014, MAG IEEE T, V50, P1; Jing Y, 2008, FASEB J, V22, P4239, DOI 10.1096/fj.07-105544; Kovochich M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018270; Lamm GM, 1997, NUCLEIC ACIDS RES, V25, P4855, DOI 10.1093/nar/25.23.4855; Lu AH, 2007, ANGEW CHEM INT EDIT, V46, P1222, DOI 10.1002/anie.200602866; Lu SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054963; Na HB, 2009, ADV MATER, V21, P2133, DOI 10.1002/adma.200802366; Orrenius S, 2011, TOXICOL SCI, V119, P3, DOI 10.1093/toxsci/kfq268; Pisanic TR, 2007, BIOMATERIALS, V28, P2572, DOI 10.1016/j.biomaterials.2007.01.043; Pisanic TR, 2009, INCIDENCE MECH NANOT, P298; Rad AM, 2007, BIOTECHNIQUES, V43, P627, DOI 10.2144/000112599; Rahbari R, 2009, BIOTECHNIQUES, V46, P277, DOI 10.2144/000113089; Riemer J, 2004, ANAL BIOCHEM, V331, P370, DOI 10.1016/j.ab.2004.03.049; ROE AL, 1993, BIOCHEM BIOPH RES CO, V190, P15, DOI 10.1006/bbrc.1993.1003; Smirnov P, 2009, METHODS MOL BIOL, V512, P333, DOI 10.1007/978-1-60327-530-9_19; Soenen SJ, 2011, NANO TODAY, V6, P446, DOI 10.1016/j.nantod.2011.08.001; Soenen SJH, 2010, SMALL, V6, P832, DOI 10.1002/smll.200902084; Strebel A, 2001, CYTOMETRY, V43, P126, DOI 10.1002/1097-0320(20010201)43:2<126::AID-CYTO1027>3.0.CO;2-J; Stroh A, 2005, NEUROIMAGE, V24, P635, DOI 10.1016/j.neuroimage.2004.09.014; Stroh A, 2005, FREE RADICAL BIO MED, V36, P969; Sylvester PW, 2011, METHODS MOL BIOL, V716, P157, DOI 10.1007/978-1-61779-012-6_9; Vallejo-Fernandez G, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/31/312001; Wang DJ, 2010, TRENDS BIOTECHNOL, V28, P281, DOI 10.1016/j.tibtech.2010.03.002; Wang YXJ, 2011, QUANT IMAGING MED SU, V1, P35, DOI 10.3978/j.issn.2223-4292.2011.08.03; Wilhelm C, 2002, EUR BIOPHYS J BIOPHY, V31, P118, DOI 10.1007/s00249-001-0200-4; Wilhelm C, 2008, BIOMATERIALS, V29, P3161, DOI 10.1016/j.biomaterials.2008.04.016; Yocum GT, 2005, RADIOLOGY, V235, P547, DOI 10.1148/radiol.2352040383	42	17	18	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96550	10.1371/journal.pone.0096550	http://dx.doi.org/10.1371/journal.pone.0096550			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824523	gold, Green Published, Green Submitted			2022-12-27	WOS:000336369200024
J	Brady, MT; Hilchey, SP; Hyrien, O; Spence, SA; Bernstein, SH				Brady, Michael T.; Hilchey, Shannon P.; Hyrien, Ollivier; Spence, Stephen A.; Bernstein, Steven H.			Mesenchymal Stromal Cells Support the Viability and Differentiation of Follicular Lymphoma-Infiltrating Follicular Helper T-Cells	PLOS ONE			English	Article							HUMAN BONE-MARROW; STEM-CELLS; ACTIVATING FACTOR; GROWTH; EXPRESSION; PROLIFERATION; FIBROBLASTS; CANCER; NICHE; BCL6	The biology of follicular lymphoma (FL) is largely dictated by the immune-effector and stromal cells that comprise its tumor microenvironment. FL-infiltrating T-cell populations that are thought to be fundamental to FL biology are follicular helper T-cells (TFH), follicular regulatory T-cells (TFR), a recently described population that regulates TFH activity, and regulatory T-cells (Treg). These T-cell populations have dynamic interactions with mesenchymal stromal cells (MSCs) in the tumor microenvironment. Whereas MSCs have been shown to support FL B-cell and Treg viability, their effects on FL-infiltrating TFH and TFR cells have not been described. Herein we show that MSCs support the viability of FL-infiltrating TFH and TFR, as well as Tregs, in part through an IL-6-dependent mechanism. We further demonstrate that MSCs mediate TFH to TFR conversion by inducing the expression of FoxP3 in TFH cells, demonstrating for the first time that human TFR can be derived from TFH cells. Given that the balance of TFH and TFR populations likely dictate, in part, the biology of this disease, our data support the potential for targeting MSCs as a therapeutic strategy.	[Brady, Michael T.; Hilchey, Shannon P.; Spence, Stephen A.; Bernstein, Steven H.] Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Rochester, NY 14642 USA; [Hyrien, Ollivier] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Bernstein, SH (corresponding author), Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Rochester, NY 14642 USA.	steven_bernstein@urmc.rochester.edu		Brady, Michael/0000-0002-0711-0435	University of Rochester Human Immunology Center Pilot Project Grant [5-29712]; Leukemia and Lymphoma Society Translational Grant [6344-11]; U.S. Public Health Service Grants [RO1-CA122645]; SPORE in Lymphoma Grant [P50-CA130805]; T32 training grant [5T32HL007152-35]; NATIONAL CANCER INSTITUTE [R01CA122645, P50CA130805] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000042] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007152] Funding Source: NIH RePORTER	University of Rochester Human Immunology Center Pilot Project Grant; Leukemia and Lymphoma Society Translational Grant(Leukemia and Lymphoma Society); U.S. Public Health Service Grants(United States Department of Health & Human ServicesUnited States Public Health Service); SPORE in Lymphoma Grant; T32 training grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by a University of Rochester Human Immunology Center Pilot Project Grant 5-29712, a Leukemia and Lymphoma Society Translational Grant 6344-11, U.S. Public Health Service Grants RO1-CA122645 and a SPORE in Lymphoma Grant P50-CA130805. The authors would also like to acknowledge the generous support of Peter and Kathy Landers and Gary and Laura Haseley. MTB is a recipient of a T32 training grant 5T32HL007152-35. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Akiyama K, 2012, CELL STEM CELL, V10, P544, DOI 10.1016/j.stem.2012.03.007; Ame-Thomas P, 2012, LEUKEMIA, V26, P1053, DOI 10.1038/leu.2011.301; Ame-Thomas P, 2007, BLOOD, V109, P693, DOI 10.1182/blood-2006-05-020800; Augello A, 2005, EUR J IMMUNOL, V35, P1482, DOI 10.1002/eji.200425405; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Chauhan D, 1996, BLOOD, V87, P1104, DOI 10.1182/blood.V87.3.1104.bloodjournal8731104; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; Di Lanni M, 2008, EXP HEMATOL, V36, P309, DOI 10.1016/j.exphem.2007.11.007; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Guilloton F, 2012, BLOOD, V119, P2556, DOI 10.1182/blood-2011-08-370908; Hilchey SP, 2007, J IMMUNOL, V178, P4051, DOI 10.4049/jimmunol.178.7.4051; Hilchey SP, 2011, BLOOD, V118, P3591, DOI 10.1182/blood-2011-03-340646; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Lwin T, 2009, LEUKEMIA, V23, P170, DOI 10.1038/leu.2008.266; Mayer H, 2005, J CELL BIOCHEM, V95, P827, DOI 10.1002/jcb.20462; Medina DJ, 2012, HAEMATOL-HEMATOL J, V97, P1255, DOI 10.3324/haematol.2011.040659; Mosna F, 2010, STEM CELLS DEV, V19, P1449, DOI 10.1089/scd.2010.0140; Mourcin F, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00280; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Pangault C, 2010, LEUKEMIA, V24, P2080, DOI 10.1038/leu.2010.223; Shinagawa K, 2010, INT J CANCER, V127, P2323, DOI 10.1002/ijc.25440; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328; Zhu W, 2006, EXP MOL PATHOL, V80, P267, DOI 10.1016/j.yexmp.2005.07.004	30	21	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97597	10.1371/journal.pone.0097597	http://dx.doi.org/10.1371/journal.pone.0097597			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836297	gold, Green Submitted, Green Published			2022-12-27	WOS:000339614800056
J	Chen, K; Ciannelli, L; Decker, MB; Ladd, C; Cheng, W; Zhou, ZQ; Chan, KS				Chen, Kun; Ciannelli, Lorenzo; Decker, Mary Beth; Ladd, Carol; Cheng, Wei; Zhou, Ziqian; Chan, Kung-Sik			Reconstructing Source-Sink Dynamics in a Population with a Pelagic Dispersal Phase	PLOS ONE			English	Article							EASTERN BERING-SEA; SETTLEMENT PREFERENCES; MARINE POPULATIONS; LARVAL DISPERSAL; LIFE-HISTORY; NORTH-SEA; IN-SITU; CONNECTIVITY; JELLYFISH; MODEL	For many organisms, the reconstruction of source-sink dynamics is hampered by limited knowledge of the spatial assemblage of either the source or sink components or lack of information on the strength of the linkage for any source-sink pair. In the case of marine species with a pelagic dispersal phase, these problems may be mitigated through the use of particle drift simulations based on an ocean circulation model. However, when simulated particle trajectories do not intersect sampling sites, the corroboration of model drift simulations with field data is hampered. Here, we apply a new statistical approach for reconstructing source-sink dynamics that overcomes the aforementioned problems. Our research is motivated by the need for understanding observed changes in jellyfish distributions in the eastern Bering Sea since 1990. By contrasting the source-sink dynamics reconstructed with data from the pre-1990 period with that from the post-1990 period, it appears that changes in jellyfish distribution resulted from the combined effects of higher jellyfish productivity and longer dispersal of jellyfish resulting from a shift in the ocean circulation starting in 1991. A sensitivity analysis suggests that the source-sink reconstruction is robust to typical systematic and random errors in the ocean circulation model driving the particle drift simulations. The jellyfish analysis illustrates that new insights can be gained by studying structural changes in source-sink dynamics. The proposed approach is applicable for the spatial source-sink reconstruction of other species and even abiotic processes, such as sediment transport.	[Chen, Kun] Univ Connecticut, Dept Stat, Storrs, CT 06269 USA; [Ciannelli, Lorenzo] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Decker, Mary Beth] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA; [Ladd, Carol; Cheng, Wei] NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA; [Cheng, Wei] Univ Washington, Joint Inst Study Atmosphere & Ocean, Seattle, WA 98195 USA; [Zhou, Ziqian; Chan, Kung-Sik] Univ Iowa, Dept Stat & Actuarial Sci, Iowa City, IA 52242 USA	University of Connecticut; Oregon State University; Yale University; National Oceanic Atmospheric Admin (NOAA) - USA; University of Washington; University of Washington Seattle; University of Iowa	Chan, KS (corresponding author), Univ Iowa, Dept Stat & Actuarial Sci, Iowa City, IA 52242 USA.	kung-sik-chan@uiowa.edu	Ladd, Carol/M-6159-2014; Chen, Kun/C-2975-2015; Cheng, Wei/J-1030-2017	Ladd, Carol/0000-0003-1065-430X; Chen, Kun/0000-0003-3579-5467; Cheng, Wei/0000-0002-5892-2177	US National Science Foundation [NSF-0934617, 0934727, 0934961, DMS-1021292]	US National Science Foundation(National Science Foundation (NSF))	The authors gratefully acknowledge the US National Science Foundation(NSF-0934617, 0934727, 0934961 and DMS-1021292) for financial support. The funders had no role in study design, data collection and analysis, decision topublish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Arai MN, 1997, FUNCTIONAL BIOL SCYP; Bailey KM, 2008, FISH FISH, V9, P44, DOI 10.1111/j.1467-2979.2007.00268.x; Bode M, 2006, MAR ECOL PROG SER, V308, P17, DOI 10.3354/meps308017; Brodeur RD, 1998, MAR ECOL PROG SER, V163, P11, DOI 10.3354/meps163011; Brodeur RD, 2002, MAR ECOL PROG SER, V233, P89, DOI 10.3354/meps233089; Brodeur RD, 1999, FISH OCEANOGR, V8, P296, DOI 10.1046/j.1365-2419.1999.00115.x; Brodeur RD, 2008, PROG OCEANOGR, V77, P103, DOI 10.1016/j.pocean.2008.03.017; Brown PJ, 2002, J R STAT SOC B, V64, P519, DOI 10.1111/1467-9868.00348; Chatterjee A, 2011, J AM STAT ASSOC, V106, P608, DOI 10.1198/jasa.2011.tm10159; Chen K, 2014, J AM STAT A IN PRESS; Chen K, 2012, J R STAT SOC B, V74, P203, DOI 10.1111/j.1467-9868.2011.01002.x; COACHMAN LK, 1986, CONT SHELF RES, V5, P23, DOI 10.1016/0278-4343(86)90011-7; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; COYLE KO, 1993, CONT SHELF RES, V13, P803, DOI 10.1016/0278-4343(93)90028-V; Crowder LB, 2000, B MAR SCI, V66, P799; Curchitser EN, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2005JC002902; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Decker Mary Beth, 2014, P153; Decker MB, 2013, MAR ECOL PROG SER, V494, P179, DOI 10.3354/meps10545; Duarte CM, 2013, FRONT ECOL ENVIRON, V11, P91, DOI 10.1890/110246; DUNNING JB, 1992, OIKOS, V65, P169, DOI 10.2307/3544901; Haidvogel DB, 2000, DYNAM ATMOS OCEANS, V32, P239, DOI 10.1016/S0377-0265(00)00049-X; HANSKI I, 1991, BIOL J LINN SOC, V42, P17, DOI 10.1111/j.1095-8312.1991.tb00549.x; Harden-Jones FR, 1968, FISH MIGRATION; Hoff GR, 2006, FISH B-NOAA, V104, P226; Holst S, 2007, MAR BIOL, V151, P863, DOI 10.1007/s00227-006-0530-y; Holst S, 2012, HYDROBIOLOGIA, V690, P127, DOI 10.1007/s10750-012-1043-y; Lipcius RN, 2008, REV FISH SCI, V16, P101, DOI 10.1080/10641260701812574; Liu H, 2011, J AGR BIOL ENVIR ST, V16, P185, DOI 10.1007/s13253-010-0044-4; Pitt KA, 2000, MAR BIOL, V136, P269, DOI 10.1007/s002270050685; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Purcell JE, 2009, MAR ECOL PROG SER, V375, P139, DOI 10.3354/meps07785; Roberts CM, 1998, FISHERIES, V23, P16; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; See KE, 2010, BIOL INVASIONS, V12, P1305, DOI 10.1007/s10530-009-9548-7; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; Sohn D, 2010, FISH OCEANOGR, V19, P339, DOI 10.1111/j.1365-2419.2010.00549.x; Stabeno PJ, 2006, SEA, P1177; Thomas GH, 1996, J N AMER BENTHOL SOC, V15, P564; White JW, 2010, MAR ECOL PROG SER, V398, P49, DOI 10.3354/meps08327; Yu HS, 2009, J MARINE SYST, V76, P369, DOI 10.1016/j.jmarsys.2007.07.010; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735	45	8	8	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e95316	10.1371/journal.pone.0095316	http://dx.doi.org/10.1371/journal.pone.0095316			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835251	Green Published, Green Submitted, gold			2022-12-27	WOS:000339614800006
J	Sawa, Y; Takata, S; Hatakeyama, Y; Ishikawa, H; Tsuruga, E				Sawa, Yoshihiko; Takata, Shunsuke; Hatakeyama, Yuji; Ishikawa, Hiroyuki; Tsuruga, Eichi			Expression of Toll-Like Receptor 2 in Glomerular Endothelial Cells and Promotion of Diabetic Nephropathy by Porphyromonas gingivalis Lipopolysaccharide	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; PROINFLAMMATORY STATE; EPITHELIAL-CELLS; INNATE IMMUNITY; PATHWAY; INFLAMMATION; MACROPHAGES; INHIBITION; MECHANISMS; FIBROSIS	The toll-like receptor (TLR) has been suggested as a candidate cause for diabetic nephropathy. Recently, we have reported the TLR4 expression in diabetic mouse glomerular endothelium. The study here investigates the effects of the periodontal pathogen Porphyromonas gingivalis lipopolysaccharide (LPS) which is a ligand for TLR2 and TLR4 in diabetic nephropathy. In laser-scanning microscopy of glomeruli of streptozotocin-and a high fat diet feed-induced type I and type II diabetic mice, TLR2 localized on the glomerular endothelium and proximal tubule epithelium. The TLR2 mRNA was detected in diabetic mouse glomeruli by in situ hybridization and in real-time PCR of the renal cortex, the TLR2 mRNA amounts were larger in diabetic mice than in non-diabetic mice. All diabetic mice subjected to repeated LPS administrations died within the survival period of all of the diabetic mice not administered LPS and of all of the non-diabetic LPS-administered mice. The LPS administration promoted the production of urinary protein, the accumulation of type I collagen in the glomeruli, and the increases in IL-6, TNF-alpha, and TGF-beta in the renal cortex of the glomeruli of the diabetic mice. It is thought that blood TLR ligands like Porphyromonas gingivalis LPS induce the glomerular endothelium to produce cytokines which aid glomerulosclerosis. Periodontitis may promote diabetic nephropathy.	[Sawa, Yoshihiko; Hatakeyama, Yuji; Tsuruga, Eichi] Fukuoka Dent Coll, Dept Morphol Biol, Fukuoka, Japan; [Takata, Shunsuke; Ishikawa, Hiroyuki] Fukuoka Dent Coll, Dept Oral Growth & Dev, Fukuoka, Japan	Fukuoka Dental College (FDC); Fukuoka Dental College (FDC)	Sawa, Y (corresponding author), Fukuoka Dent Coll, Dept Morphol Biol, Fukuoka, Japan.	ysawa@college.fdcnet.ac.jp			Japan Society for the Promotion of Science [25670803]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Exploratory Research 25670803 grants from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Benakanakere MR, 2009, J BIOL CHEM, V284, P23107, DOI 10.1074/jbc.M109.013862; Cheng A, 2013, INT J BIOL SCI, V9, P94, DOI 10.7150/ijbs.5246; Cheng XY, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/463740; Dasu MR, 2010, DIABETES CARE, V33, P861, DOI 10.2337/dc09-1799; Devaraj S, 2008, J CLIN ENDOCR METAB, V93, P578, DOI 10.1210/jc.2007-2185; Devaraj S, 2011, ARTERIOSCL THROM VAS, V31, P1796, DOI 10.1161/ATVBAHA.111.228924; Devaraj S, 2011, METABOLISM, V60, P256, DOI 10.1016/j.metabol.2010.01.005; Eskan MA, 2008, INFECT IMMUN, V76, P2080, DOI 10.1128/IAI.01428-07; Fan MHM, 2010, J PERIODONTAL RES, V45, P100, DOI 10.1111/j.1600-0765.2009.01206.x; Forbes JM, 2003, J AM SOC NEPHROL, V14, pS254, DOI 10.1097/01.ASN.0000077413.41276.17; Haneda M, 2003, J AM SOC NEPHROL, V14, P1374, DOI 10.1097/01.ASN.0000064500.89551.76; Herminajeng E, 2001, J PERIODONTOL, V72, P1527, DOI 10.1902/jop.2001.72.11.1527; Hornigold N, 2013, LAB INVEST, V93, P553, DOI 10.1038/labinvest.2013.42; Huang CL, 2013, DIABETES, V62, P2923, DOI 10.2337/db13-0135; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Kaur H, 2012, AM J PHYSIOL-RENAL, V303, pF1145, DOI 10.1152/ajprenal.00319.2012; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kuwabara T, 2012, DIABETOLOGIA, V55, P2256, DOI 10.1007/s00125-012-2578-1; Lei L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071849; Li CL, 2002, CELL GROWTH DIFFER, V13, P27; Li FL, 2010, AM J NEPHROL, V32, P179, DOI 10.1159/000317023; Lin M, 2012, J AM SOC NEPHROL, V23, P86, DOI 10.1681/ASN.2010111210; MAUER SM, 1984, J CLIN INVEST, V74, P1143, DOI 10.1172/JCI111523; Mudaliar H, 2013, AM J PHYSIOL-RENAL, V305, pF143, DOI 10.1152/ajprenal.00398.2012; Schaeffler A, 2009, IMMUNOLOGY, V126, P233, DOI 10.1111/j.1365-2567.2008.02892.x; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Sherry CL, 2007, J IMMUNOL, V178, P663, DOI 10.4049/jimmunol.178.2.663; Shishido T, 2003, CIRCULATION, V108, P2905, DOI 10.1161/01.CIR.0000101921.93016.1C; STEFFES MW, 1989, DIABETES, V38, P1077, DOI 10.2337/diabetes.38.9.1077; Takata S, 2013, ACTA HISTOCHEM CYTOC, V46, P35, DOI 10.1267/ahc.13002; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; van Beijnum JR, 2008, ANGIOGENESIS, V11, P91, DOI 10.1007/s10456-008-9093-5; Wong FS, 2008, ANN NY ACAD SCI, V1150, P123, DOI 10.1196/annals.1447.063; Yan SF, 2008, NAT CLIN PRACT ENDOC, V4, P285, DOI 10.1038/ncpendmet0786; Zhou Q, 2005, INFECT IMMUN, V73, P935, DOI 10.1128/IAI.73.2.935-943.2005	36	26	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97165	10.1371/journal.pone.0097165	http://dx.doi.org/10.1371/journal.pone.0097165			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835775	gold, Green Published, Green Submitted			2022-12-27	WOS:000339614800029
J	Arab, HH; Al-Shorbagy, MY; Abdallah, DM; Nassar, NN				Arab, Hany H.; Al-Shorbagy, Muhammad Y.; Abdallah, Dalaal M.; Nassar, Noha N.			Telmisartan Attenuates Colon Inflammation, Oxidative Perturbations and Apoptosis in a Rat Model of Experimental Inflammatory Bowel Disease	PLOS ONE			English	Article							TNBS-INDUCED COLITIS; ACTIVATED-RECEPTOR-GAMMA; NF-KAPPA-B; SIGNAL-TRANSDUCTION PATHWAYS; ACID-INDUCED COLITIS; PPAR-GAMMA; SUPEROXIDE-DISMUTASE; ULCERATIVE-COLITIS; GENE-EXPRESSION; INTERLEUKIN-10	Accumulating evidence has indicated the implication of angiotensin II in the pathogenesis of inflammatory bowel diseases (IBD) via its proinflammatory features. Telmisartan (TLM) is an angiotensin II receptor antagonist with marked anti-inflammatory and antioxidant actions that mediated its cardio-, reno- and hepatoprotective actions. However, its impact on IBD has not been previously explored. Thus, we aimed to investigate the potential alleviating effects of TLM in tri-nitrobenezene sulphonic acid (TNBS)-induced colitis in rats. Pretreatment with TLM (10 mg/kg p.o.) attenuated the severity of colitis as evidenced by decrease of disease activity index (DAI), colon weight/length ratio, macroscopic damage, histopathological findings and leukocyte migration. TLM suppressed the inflammatory response via attenuation of tumor necrosis factor-alpha (TNF-alpha), prostaglandin E-2 (PGE(2)) and myeloperoxidase (MPO) activity as a marker of neutrophil infiltration besides restoration of interleukin-10 (IL-10). TLM also suppressed mRNA and protein expression of nuclear factor kappa B (NF-kappa B) p65 and mRNA of cyclo-oxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) proinflammatory genes with concomitant upregulation of PPAR-gamma. The alleviation of TLM to colon injury was also associated with inhibition of oxidative stress as evidenced by suppression of lipid peroxides and nitric oxide (NO) besides boosting glutathione (GSH), total anti-oxidant capacity (TAC) and the activities of superoxide dismutase (SOD) and glutathione peroxidase (GPx). With respect to apoptosis, TLM downregulated the increased mRNA, protein expression and activity of caspase-3. It also suppressed the elevation of cytochrome c and Bax mRNA besides the upregulation of Bcl-2. Together, these findings highlight evidences for the beneficial effects of TLM in IBD which are mediated through modulation of colonic inflammation, oxidative stress and apoptosis.	[Arab, Hany H.] Cairo Univ, Fac Pharm, Dept Biochem, Cairo, Egypt; [Al-Shorbagy, Muhammad Y.; Abdallah, Dalaal M.; Nassar, Noha N.] Cairo Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University	Arab, HH (corresponding author), Cairo Univ, Fac Pharm, Dept Biochem, Cairo, Egypt.	hany.arab@pharma.cu.edu.eg	Arab, Hany/AAF-3652-2020; Abdallah, Dalaal/GVT-0783-2022; Al-Shorbagy, Muhammad/R-3968-2019	Arab, Hany/0000-0002-4195-6901; Al-Shorbagy, Muhammad/0000-0002-5104-6821				Atreya I, 2008, J INTERN MED, V263, P591, DOI 10.1111/j.1365-2796.2008.01953.x; Attia YM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-199; Autschbach F, 1998, AM J PATHOL, V153, P121, DOI 10.1016/S0002-9440(10)65552-6; Barada KA, 2007, CYTOKINE, V37, P236, DOI 10.1016/j.cyto.2007.04.005; Becker C, 2013, GASTROENTEROLOGY, V144, P283, DOI 10.1053/j.gastro.2012.11.035; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; Bobin-Dubigeon C, 2001, EUR J PHARMACOL, V431, P103, DOI 10.1016/S0014-2999(01)01410-8; Bregonzio C, 2003, AM J PHYSIOL-GASTR L, V285, pG414, DOI 10.1152/ajpgi.00058.2003; Buege J A, 1978, Methods Enzymol, V52, P302; Cai H, 2003, TRENDS PHARMACOL SCI, V24, P471, DOI 10.1016/S0165-6147(03)00233-5; Cianchetti S, 2008, ATHEROSCLEROSIS, V198, P22, DOI 10.1016/j.atherosclerosis.2007.09.013; COOPER HS, 1993, LAB INVEST, V69, P238; Crespo I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050407; Destro M, 2011, EXPERT OPIN PHARMACO, V12, P2719, DOI 10.1517/14656566.2011.632367; Dey I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061891; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Fujita H, 2012, HYPERTENS RES, V35, P213, DOI 10.1038/hr.2011.176; Galvez J, 2001, ALIMENT PHARM THERAP, V15, P2027, DOI 10.1046/j.1365-2036.2001.01133.x; Gillberg L, 2013, ACTA PHYSIOL, V207, P326, DOI 10.1111/apha.12017; Goyal SN, 2011, DIABETES OBES METAB, V13, P533, DOI 10.1111/j.1463-1326.2011.01377.x; Goyal S, 2010, CHEM-BIOL INTERACT, V185, P271, DOI 10.1016/j.cbi.2010.03.030; Hassan A, 2010, J NUTR, V140, P1714, DOI 10.3945/jn.109.119768; Hume Georgia E, 2008, Expert Rev Gastroenterol Hepatol, V2, P645, DOI 10.1586/17474124.2.5.645; KRAWISZ JE, 1984, GASTROENTEROLOGY, V87, P1344; Kretzmann NA, 2008, INFLAMM BOWEL DIS, V14, P1504, DOI 10.1002/ibd.20543; Kruidenier L, 2003, J PATHOL, V201, P28, DOI 10.1002/path.1409; KUCHARZIK T, 1995, CLIN EXP IMMUNOL, V100, P452; Kushwaha S, 2013, MUTAT RES-GEN TOX EN, V755, P11, DOI 10.1016/j.mrgentox.2013.04.013; Liu HR, 2004, CARDIOVASC RES, V62, P135, DOI 10.1016/j.cardiores.2003.12.027; Liu X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024740; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Mizushima T, 2010, AM J PHYSIOL-GASTR L, V298, pG255, DOI 10.1152/ajpgi.00264.2009; MORRIS GP, 1989, GASTROENTEROLOGY, V96, P795, DOI 10.1016/0016-5085(89)90904-9; Nagib MM, 2013, TOXICOL APPL PHARM, V271, P106, DOI 10.1016/j.taap.2013.04.026; Neurath M, 2000, Int Rev Immunol, V19, P51, DOI 10.3109/08830180009048389; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Qin HY, 2012, WORLD J GASTROENTERO, V18, P2481, DOI 10.3748/wjg.v18.i20.2481; Remuzzi A, 2006, J RENIN-ANGIO-ALDO S, V7, P185, DOI 10.3317/jraas.2006.036; Sanchez-Hidalgo M, 2007, EUR J PHARMACOL, V562, P247, DOI 10.1016/j.ejphar.2007.01.047; Sanchez-Munoz F, 2008, WORLD J GASTROENTERO, V14, P4280, DOI 10.3748/wjg.14.4280; Santiago OI, 2008, REGUL PEPTIDES, V146, P250, DOI 10.1016/j.regpep.2007.10.004; SCHREIBER S, 1995, GASTROENTEROLOGY, V108, P1434, DOI 10.1016/0016-5085(95)90692-4; Sukumaran V, 2011, INT J BIOL SCI, V7, P1077, DOI 10.7150/ijbs.7.1077; Sukumaran V, 2011, EUR J PHARMACOL, V652, P126, DOI 10.1016/j.ejphar.2010.10.081; Takaya T, 2006, ATHEROSCLEROSIS, V186, P402, DOI 10.1016/j.atherosclerosis.2005.08.009; Talero E, 2011, INFLAMM BOWEL DIS, V17, P696, DOI 10.1002/ibd.21420; Thoene-Reineke C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023646; Toba H, 2012, EUR J PHARMACOL, V685, P91, DOI 10.1016/j.ejphar.2012.01.026; Tomoyose M, 1998, SCAND J GASTROENTERO, V33, P435; Tsune I, 2003, GASTROENTEROLOGY, V125, P775, DOI 10.1016/S0016-5085(03)01067-9; Tuzun A, 2002, CLIN BIOCHEM, V35, P569, DOI 10.1016/S0009-9120(02)00361-2; Wang RQ, 1999, AM J PHYSIOL-LUNG C, V277, pL1245, DOI 10.1152/ajplung.1999.277.6.L1245; Wang YH, 2011, INT IMMUNOPHARMACOL, V11, P1620, DOI 10.1016/j.intimp.2011.05.024; Witaicenis A, 2012, CHEM-BIOL INTERACT, V195, P76, DOI 10.1016/j.cbi.2011.11.004; Yamagishi SI, 2007, CURR MOL MED, V7, P463; Yue G, 2001, J PHARMACOL EXP THER, V297, P915; Zhang M, 2006, INT IMMUNOPHARMACOL, V6, P1233, DOI 10.1016/j.intimp.2006.02.013	61	85	90	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97193	10.1371/journal.pone.0097193	http://dx.doi.org/10.1371/journal.pone.0097193			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831514	Green Submitted, Green Published, gold			2022-12-27	WOS:000336789500039
J	Duelli, A; Kiss, B; Lundholm, I; Bodor, A; Petoukhov, MV; Svergun, DI; Nyitray, L; Katona, G				Duelli, Annette; Kiss, Bence; Lundholm, Ida; Bodor, Andrea; Petoukhov, Maxim V.; Svergun, Dmitri I.; Nyitray, Laszlo; Katona, Gergely			The C-Terminal Random Coil Region Tunes the Ca2+-Binding Affinity of S100A4 through Conformational Activation	PLOS ONE			English	Article							METASTASIS-ASSOCIATED PROTEIN; CALCIUM-BINDING PROTEIN; NONMUSCLE MYOSIN-IIA; CRYSTAL-STRUCTURE; MOLECULAR-DYNAMICS; MTS1 S100A4; SCATTERING; COMPLEX; PLASMIN; TARGET	S100A4 interacts with many binding partners upon Ca2+ activation and is strongly associated with increased metastasis formation. In order to understand the role of the C-terminal random coil for the protein function we examined how small angle X-ray scattering of the wild-type S100A4 and its C-terminal deletion mutant (residues 1-88, Delta 13) changes upon Ca2+ binding. We found that the scattering intensity of wild-type S100A4 changes substantially in the 0.15-0.25 angstrom(-1) q-range whereas a similar change is not visible in the C-terminus deleted mutant. Ensemble optimization SAXS modeling indicates that the entire C-terminus is extended when Ca2+ is bound. Pulsed field gradient NMR measurements provide further support as the hydrodynamic radius in the wild-type protein increases upon Ca2+ binding while the radius of Delta 13 mutant does not change. Molecular dynamics simulations provide a rational explanation of the structural transition: the positively charged C-terminal residues associate with the negatively charged residues of the Ca2+-free EF-hands and these interactions loosen up considerably upon Ca2+-binding. As a consequence the Delta 13 mutant has increased Ca2+ affinity and is constantly loaded at Ca2+ concentration ranges typically present in cells. The activation of the entire C-terminal random coil may play a role in mediating interaction with selected partner proteins of S100A4.	[Duelli, Annette; Lundholm, Ida; Katona, Gergely] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden; [Kiss, Bence; Nyitray, Laszlo] Eotvos Lorand Univ, Dept Biochem, Budapest, Hungary; [Bodor, Andrea] Eotvos Lorand Univ, Lab Struct Chem & Biol, Inst Chem, Budapest, Hungary; [Petoukhov, Maxim V.; Svergun, Dmitri I.] DESY, European Mol Biol Lab, Hamburg Outstn, Hamburg, Germany	University of Gothenburg; Eotvos Lorand University; Eotvos Lorand University; Hungarian Academy of Sciences; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Nyitray, L (corresponding author), Eotvos Lorand Univ, Dept Biochem, Budapest, Hungary.	nyitray@elte.hu; gergely.katona@cmb.gu.se	Nyitray, László/AAE-5910-2020; Bodor, Andrea/AAL-7854-2020; Kiss, Bence/AAF-1808-2020; Bodor, Andrea/G-1797-2018; Katona, Gergely/B-3491-2008; Petoukhov, Maxim V/R-7371-2016	Nyitray, László/0000-0003-4717-5994; Bodor, Andrea/0000-0002-7422-298X; Bodor, Andrea/0000-0002-7422-298X; Katona, Gergely/0000-0002-2031-8716; Petoukhov, Maxim V/0000-0001-6760-4595; Svergun, Dmitri/0000-0003-0830-5696; Lundholm, Ida/0000-0003-4342-990X; Kiss, Bence/0000-0001-5810-5858	Swedish Research Council; Harald and Greta Jeanssons Foundation; Hungarian Scientific Research Fund [OTKA K108437, NK81950, OTKANK101072]; German Ministry of Education andScience (BMBF) project BIOSCAT [05K20912]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Harald and Greta Jeanssons Foundation; Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); German Ministry of Education andScience (BMBF) project BIOSCAT(Federal Ministry of Education & Research (BMBF))	The work was supported by the Swedish Research Council, Harald and Greta Jeanssons Foundation, Hungarian Scientific Research Fund (OTKA K108437, NK81950, OTKANK101072). DIS and MVP acknowledge support from the German Ministry of Education andScience (BMBF) project BIOSCAT, contract 05K20912. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Boye K, 2010, AM J PATHOL, V176, P528, DOI 10.2353/ajpath.2010.090526; Dutta K, 2002, BIOCHEMISTRY-US, V41, P4239, DOI 10.1021/bi012061v; Dutta K, 2008, BIOCHEMISTRY-US, V47, P7637, DOI 10.1021/bi8005048; Elliott PR, 2012, STRUCTURE, V20, P654, DOI 10.1016/j.str.2012.02.002; Ford HL, 1997, BIOCHEMISTRY-US, V36, P16321, DOI 10.1021/bi971182l; Gingras AR, 2008, FEBS LETT, V582, P1651, DOI 10.1016/j.febslet.2008.04.017; Grigorian M, 2001, J BIOL CHEM, V276, P22699, DOI 10.1074/jbc.M010231200; Guinier A, 1938, CR HEBD ACAD SCI, V206, P1374; Ismail TM, 2008, CARCINOGENESIS, V29, P2259, DOI 10.1093/carcin/bgn217; Kiss B, 2012, P NATL ACAD SCI USA, V109, P6048, DOI 10.1073/pnas.1114732109; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Linegar KL, 2010, COLLOID J+, V72, P279, DOI 10.1134/S1061933X10020195; MacLeod TJ, 2003, J BIOL CHEM, V278, P25577, DOI 10.1074/jbc.M301017200; Malashkevich VN, 2008, BIOCHEMISTRY-US, V47, P5111, DOI 10.1021/bi702537s; Mishra SK, 2012, CANCER METAST REV, V31, P163, DOI 10.1007/s10555-011-9338-4; Novitskaya V, 2000, J BIOL CHEM, V275, P41278, DOI 10.1074/jbc.M007058200; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pathuri P, 2008, J MOL BIOL, V383, P62, DOI 10.1016/j.jmb.2008.04.076; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Ramagopal UA, 2013, BMC STRUCT BIOL, V13, DOI 10.1186/1472-6807-13-31; Semov A, 2005, J BIOL CHEM, V280, P20833, DOI 10.1074/jbc.M412653200; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Vallely KM, 2002, BIOCHEMISTRY-US, V41, P12670, DOI 10.1021/bi020365r; VERLET L, 1967, PHYS REV, V159, P98, DOI 10.1103/PhysRev.159.98; Zhang S, 2005, ONCOGENE, V24, P4401, DOI 10.1038/sj.onc.1208663	27	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97654	10.1371/journal.pone.0097654	http://dx.doi.org/10.1371/journal.pone.0097654			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830809	Green Published, gold, Green Submitted			2022-12-27	WOS:000336789500095
J	Himsworth, CG; Parsons, KL; Feng, AYT; Kerr, T; Jardine, CM; Patrick, DM				Himsworth, Chelsea G.; Parsons, Kirbee L.; Feng, Alice Y. T.; Kerr, Thomas; Jardine, Claire M.; Patrick, David M.			A Mixed Methods Approach to Exploring the Relationship between Norway Rat (Rattus norvegicus) Abundance and Features of the Urban Environment in an Inner-City Neighborhood of Vancouver, Canada	PLOS ONE			English	Article								Urban rats (Rattus spp.) are among the most ubiquitous pest species in the world. Previous research has shown that rat abundance is largely determined by features of the environment; however, the specific urban environmental factors that influence rat population density within cities have yet to be clearly identified. Additionally, there are no well described tools or methodologies for conducting an in-depth evaluation of the relationship between urban rat abundance and the environment. In this study, we developed a systematic environmental observation tool using methods borrowed from the field of systematic social observation. This tool, which employed a combination of quantitative and qualitative methodologies, was then used to identify environmental factors associated with the relative abundance of Norway rats (Rattus norvegicus) in an inner-city neighborhood of Vancouver, Canada. Using a multivariate zero-inflated negative binomial model, we found that a variety of factors, including specific land use, building condition, and amount of refuse, were related to rat presence and abundance. Qualitative data largely supported and further clarified observed statistical relationships, but also identified conflicting and unique situations not easily captured through quantitative methods. Overall, the tool helped us to better understand the relationship between features of the urban environment and relative rat abundance within our study area and may useful for studying environmental determinants of zoonotic disease prevalence/distribution among urban rat populations in the future.	[Himsworth, Chelsea G.; Parsons, Kirbee L.; Feng, Alice Y. T.; Patrick, David M.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Himsworth, Chelsea G.] British Columbia Minist Agr, Ctr Anim Hlth, Abbotsford, BC, Canada; [Kerr, Thomas] St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; [Kerr, Thomas] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Jardine, Claire M.] Univ Guelph, Dept Pathobiol, Guelph, ON N1G 2W1, Canada	University of British Columbia; B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan; University of British Columbia; University of Guelph	Himsworth, CG (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada.	Chelsea.Himsworth@gov.bc.ca			Canadian Institutes of Health Research [MOP - 119530, CGV - 104833]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research [MOP - 119530 and CGV - 104833]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bricki N., 2007, MED FRONT; Caughy MO, 2001, HEALTH PLACE, V7, P225, DOI 10.1016/S1353-8292(01)00012-0; Cavia R, 2009, LANDSCAPE URBAN PLAN, V90, P11, DOI 10.1016/j.landurbplan.2008.10.017; DAVIS DE, 1953, Q REV BIOL, V28, P373, DOI 10.1086/399860; Dohoo I, 2007, VET EPIDEMIOLOGIC RE; Easterbrook JD, 2005, VECTOR-BORNE ZOONOT, V5, P296, DOI 10.1089/vbz.2005.5.296; EMLEN JT, 1949, ECOLOGY, V30, P430, DOI 10.2307/1932446; Feng AYT, 2014, URBAN ECOSYST, V17, P149, DOI 10.1007/s11252-013-0305-4; Figgs LW, 2011, INT J PEST MANAGE, V57, P217, DOI 10.1080/09670874.2011.567307; Frantz SC, 1976, P 7 VERT PEST C; Glass GE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005794; Villafane IEG, 2013, MAMMALIA, V77, P187, DOI 10.1515/mammalia-2012-0075; Himsworth CG, 2013, VECTOR-BORNE ZOONOT, V13, P349, DOI 10.1089/vbz.2012.1195; Krebs Charles J., 1999, ACIAR Monograph Series, V59, P33; Leslie PH, 1939, J ANIM ECOL, V8, P94, DOI 10.2307/1255; Nagorsen D.W, 2002, IDENTIFICATION MANUA; NELSON L, 1973, J MAMMAL, V54, P295, DOI 10.2307/1378903; Parsons JA, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-6; Promkerd P, 2008, INTEGR ZOOL, V3, P11, DOI 10.1111/j.1749-4877.2008.00069.x; RAND Corperation, 2011, ANG FAM NEIGHB SURV; Raudenbush SW, 1999, SOCIOL METHODOL, V29, P1, DOI 10.1111/0081-1750.00059; Smith H. A., 2000, WORLDS COLLIDE SOCIA; Traweger D, 2006, J PEST SCI, V79, P113, DOI 10.1007/s10340-006-0123-z; Vadell MV, 2010, INT J PEST MANAGE, V56, P327, DOI 10.1080/09670874.2010.499479; Weich S, 2001, HEALTH PLACE, V7, P283, DOI 10.1016/S1353-8292(01)00019-3; Yin Jia-Xiang, 2008, BMC Ecology, V8, P18, DOI 10.1186/1472-6785-8-18	26	23	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97776	10.1371/journal.pone.0097776	http://dx.doi.org/10.1371/journal.pone.0097776			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830847	Green Submitted, gold, Green Published			2022-12-27	WOS:000336789500115
J	Jackson, AM; Semmens, BX; de Mitcheson, YS; Nemeth, RS; Heppell, SA; Bush, PG; Aguilar-Perera, A; Claydon, JAB; Calosso, MC; Sealey, KS; Scharer, MT; Bernardi, G				Jackson, Alexis M.; Semmens, Brice X.; de Mitcheson, Yvonne Sadovy; Nemeth, Richard S.; Heppell, Scott A.; Bush, Phillippe G.; Aguilar-Perera, Alfonso; Claydon, John A. B.; Calosso, Marta C.; Sealey, Kathleen S.; Schaerer, Michelle T.; Bernardi, Giacomo			Population Structure and Phylogeography in Nassau Grouper (Epinephelus striatus), a Mass-Aggregating Marine Fish	PLOS ONE			English	Article							SNAPPER LUTJANUS-ANALIS; SPAWNING AGGREGATION; BRACHIDONTES-EXUSTUS; GENETIC-STRUCTURE; LARVAL DISPERSAL; SCORCHED MUSSEL; OCEAN CURRENTS; CARIBBEAN SEA; REEF FISHES; CONNECTIVITY	To address patterns of genetic connectivity in a mass-aggregating marine fish, we analyzed genetic variation in mitochondrial DNA (mtDNA), microsatellites, and single nucleotide polymorphisms (SNPs) for Nassau grouper (Epinephelus striatus). We expected Nassau grouper to exhibit genetic differentiation among its subpopulations due to its reproductive behavior and retentive oceanographic conditions experienced across the Caribbean basin. All samples were genotyped for two mitochondrial markers and 9 microsatellite loci, and a subset of samples were genotyped for 4,234 SNPs. We found evidence of genetic differentiation in a Caribbean-wide study of this mass-aggregating marine fish using mtDNA (F-ST = 0.206, p<0.001), microsatellites (F-ST = 0.002, p = 0.004) and SNPs (F-ST = 0.002, p = 0.014), and identified three potential barriers to larval dispersal. Genetically isolated regions identified in our work mirror those seen for other invertebrate and fish species in the Caribbean basin. Oceanographic regimes in the Caribbean may largely explain patterns of genetic differentiation among Nassau grouper subpopulations. Regional patterns observed warrant standardization of fisheries management and conservation initiatives among countries within genetically isolated regions.	[Jackson, Alexis M.; Bernardi, Giacomo] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Semmens, Brice X.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [de Mitcheson, Yvonne Sadovy] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Nemeth, Richard S.] Univ Virgin Isl, Dept Zool Marine Biol, St Thomas, VI USA; [Heppell, Scott A.] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Bush, Phillippe G.] Cayman Isl Dept Environm, Protect & Conservat Unit, Grand Cayman, British West In, Iceland; [Aguilar-Perera, Alfonso] Univ Autonoma Yucatan, Dept Biol Marina, Merida, Yucatan, Mexico; [Claydon, John A. B.; Calosso, Marta C.] Ctr Marine Resource Studies, Sch Field Studies, South Caicos, Turks & Caicos, Iceland; [Sealey, Kathleen S.] Univ Miami, Dept Biol, Coral Gables, FL 33124 USA; [Schaerer, Michelle T.] Univ Puerto Rico, Mayaguez, PR USA	University of California System; University of California Santa Cruz; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Hong Kong; University of the Virgin Islands; Oregon State University; Universidad Autonoma de Yucatan; University of Miami; University of Puerto Rico; University of Puerto Rico Mayaguez	Jackson, AM (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	almjacks@ucsc.edu	Bernardi, Giacomo/F-6346-2011; Schärer-Umpierre, Michelle/R-2318-2019; Sealey, Kathleen Sullivan/A-8112-2019; Aguilar-Perera, Alfonso/D-6327-2012	Bernardi, Giacomo/0000-0002-8249-4678; Schärer-Umpierre, Michelle/0000-0002-0068-4049; Sealey, Kathleen Sullivan/0000-0003-4470-0909; Aguilar-Perera, Alfonso/0000-0002-7579-2183	National Geographic [8928-11]; Reef Environmental Education Foundation (REEF); Lenfest Ocean Program, Puerto Rico Sea Grant [R-31-1-06]; USGS State Partnership Program [07ERAG0078]; Caribbean Coral Reef Institute of the University of Puerto Rico; Friends of Long Marine Lab	National Geographic(National Geographic Society); Reef Environmental Education Foundation (REEF); Lenfest Ocean Program, Puerto Rico Sea Grant; USGS State Partnership Program; Caribbean Coral Reef Institute of the University of Puerto Rico; Friends of Long Marine Lab	Sample collection and lab work was funded by National Geographic (Young Explorers Grant #8928-11), the Reef Environmental Education Foundation (REEF), the Lenfest Ocean Program, Puerto Rico Sea Grant (#R-31-1-06), the USGS State Partnership Program (07ERAG0078), the Caribbean Coral Reef Institute of the University of Puerto Rico and grant from the Friends of Long Marine Lab. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abello P, 2012, MOL ECOL RESOUR, V12, P972, DOI 10.1111/j.1755-0998.2012.03173.x; Aguilar-Perera A, 2006, MAR ECOL PROG SER, V327, P289, DOI 10.3354/meps327289; Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; Almany GR, 2013, CURR BIOL, V23, P626, DOI 10.1016/j.cub.2013.03.006; Avise John C., 2004, P1; Barber PH, 2002, MOL ECOL, V11, P659, DOI 10.1046/j.1365-294X.2002.01468.x; Benzie JAH, 1999, EVOLUTION, V53, P1782, DOI 10.1111/j.1558-5646.1999.tb04562.x; Bolden SK, 2000, FISH B-NOAA, V98, P642; Buston PM, 2012, P ROY SOC B-BIOL SCI, V279, P1883, DOI 10.1098/rspb.2011.2041; Carson EW, 2011, FISH B-NOAA, V109, P416; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Chapman DD, 2005, MAR TECHNOL SOC J, V39, P42, DOI 10.4031/002533205787521640; Cherubin LM, 2011, ECOL MODEL, V222, P3132, DOI 10.1016/j.ecolmodel.2011.05.031; Cheung WWL, 2013, ENDANGER SPECIES RES, V20, P27, DOI 10.3354/esr00472; COLIN PL, 1992, ENVIRON BIOL FISH, V34, P357, DOI 10.1007/BF00004740; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; De Mitcheson YS, 2008, CONSERV BIOL, V22, P1233, DOI 10.1111/j.1523-1739.2008.01020.x; Diaz-Ferguson E, 2012, J MOLLUS STUD, V78, P112, DOI 10.1093/mollus/eyr050; Diaz-Ferguson E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012675; Domeier ML, 2012, FISH FISH SER, V35, P1, DOI 10.1007/978-94-007-1980-4_1; Domeier ML, 1997, B MAR SCI, V60, P698; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Ersts PJ, 2012, GEOGRAPHIC DISTANCE; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Foster NL, 2012, MOL ECOL, V21, P1143, DOI 10.1111/j.1365-294X.2012.05455.x; Froese R., 2012, FISHBASE; Galindo HM, 2006, CURR BIOL, V16, P1622, DOI 10.1016/j.cub.2006.06.052; Gutierrez-Rodriguez C, 2004, MOL ECOL, V13, P2211, DOI 10.1111/j.1365-294X.2004.02247.x; Haney RA, 2007, HEREDITY, V98, P294, DOI 10.1038/sj.hdy.6800940; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Hauser L, 2002, P NATL ACAD SCI USA, V99, P11742, DOI 10.1073/pnas.172242899; Hellberg ME, 2002, B MAR SCI, V70, P273; Heppell SA, 2012, BIOL CONSERV, V155, P119, DOI 10.1016/j.biocon.2012.06.002; Heyman WD, 2008, B MAR SCI, V83, P531; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Jones GP, 2009, CORAL REEFS, V28, P307, DOI 10.1007/s00338-009-0469-9; Jones GP, 2005, CURR BIOL, V15, P1314, DOI 10.1016/j.cub.2005.06.061; Jones KMM, 2005, J FISH BIOL, V66, P150, DOI 10.1111/j.0022-1112.2005.00589.x; KINDER TH, 1985, MAR GEOL, V68, P25, DOI 10.1016/0025-3227(85)90004-0; King TL, 2001, MOL ECOL, V10, P807, DOI 10.1046/j.1365-294X.2001.01231.x; Kingsford MJ, 2002, B MAR SCI, V70, P309; Lavery S, 1996, MOL ECOL, V5, P557; Lee T, 2004, MOL ECOL, V13, P3527, DOI 10.1111/j.1365-294X.2004.02337.x; Lee T, 2005, EVOLUTION, V59, P2139; Lessios HA, 2001, EVOLUTION, V55, P955, DOI 10.1554/0014-3820(2001)055[0955:PSASIT]2.0.CO;2; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; McCartney MA, 2000, MOL ECOL, V9, P1391, DOI 10.1046/j.1365-294x.2000.01022.x; Meirmans PG, 2012, MOL ECOL, V21, P2839, DOI 10.1111/j.1365-294X.2012.05578.x; Miller MR, 2012, MOL ECOL, V21, P237, DOI 10.1111/j.1365-294X.2011.05305.x; MITTON JB, 1989, BIOL BULL-US, V177, P356, DOI 10.2307/1541595; Murphy SJ, 1999, J GEOPHYS RES-OCEANS, V104, P1431, DOI 10.1029/1998JC900010; Nemeth RS, 2012, FISH FISH SER, V35, P21, DOI 10.1007/978-94-007-1980-4_2; Nemeth RS, 2009, P GULF CARIB FISH I, V61, P329; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Palumbi S.R, 1991, SIMPLE FOOLS GUIDE P; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Paris CB, 2008, CORAL REEFS, V27, P773, DOI 10.1007/s00338-008-0396-1; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; POWELL AB, 1992, B MAR SCI, V50, P171; Puebla O, 2012, MOL ECOL, V21, P5675, DOI 10.1111/j.1365-294X.2012.05734.x; Puebla O, 2009, ECOLOGY, V90, P3087, DOI 10.1890/08-0859.1; Quenouille B, 2004, MOL PHYLOGENET EVOL, V31, P66, DOI 10.1016/s1055-7903(03)00278-1; Richardson PL, 2005, DEEP-SEA RES PT II, V52, P429, DOI 10.1016/j.dsr2.2004.11.001; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; Sadovy Y, 1999, SYNOPSIS BIOL DATA N, V146; Salas E, 2010, MAR BIOL, V157, P437, DOI 10.1007/s00227-009-1330-y; Sale PF, 2004, INTEGR COMP BIOL, V44, P390, DOI 10.1093/icb/44.5.390; Scharsack JP, 2012, ECOL EVOL, V2, P1122, DOI 10.1002/ece3.232; Selkoe KA, 2011, MAR ECOL PROG SER, V436, P291, DOI 10.3354/meps09238; Semmens BX, 2006, CARIBBEAN CONNECTIVI, V9, P186; SHULMAN MJ, 1995, EVOLUTION, V49, P897, DOI 10.1111/j.1558-5646.1995.tb02325.x; Shulzitski K, 2009, FISH B-NOAA, V107, P501; SILBERMAN JD, 1994, MAR BIOL, V120, P601, DOI 10.1007/BF00350081; Sluka R, 1998, B MAR SCI, V62, P219; SMITH CL, 1972, T AM FISH SOC, V101, P257, DOI 10.1577/1548-8659(1972)101<257:ASAONG>2.0.CO;2; Stallings CD, 2008, ECOLOGY, V89, P2090, DOI 10.1890/07-1671.1; Starr RM, 2007, MAR ECOL PROG SER, V343, P239, DOI 10.3354/meps06897; Stevenson DE, 1997, STOCK IDENTIFICATION, P727; Swearer SE, 2002, B MAR SCI, V70, P251; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; Taylor MS, 2006, MOL ECOL, V15, P695, DOI 10.1111/j.1365-294X.2006.02820.x; Taylor MS, 2003, SCIENCE, V299, P107, DOI 10.1126/science.1079365; TUCKER JW, 1993, B MAR SCI, V52, P961; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; VERON JEN, 1995, CORALS SPACE TIME BI; Verweij MC, 2007, HYDROBIOLOGIA, V592, P257, DOI 10.1007/s10750-007-0772-9; WARNER RR, 1988, NATURE, V335, P719, DOI 10.1038/335719a0; White C, 2010, P ROY SOC B-BIOL SCI, V277, P1685, DOI 10.1098/rspb.2009.2214	89	36	41	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97508	10.1371/journal.pone.0097508	http://dx.doi.org/10.1371/journal.pone.0097508			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830641	Green Published, gold, Green Submitted			2022-12-27	WOS:000336789500070
J	Sueur, C; Maire, A				Sueur, Cedric; Maire, Anais			Modelling Animal Group Fission Using Social Network Dynamics	PLOS ONE			English	Article							COLLECTIVE DECISION-MAKING; FUSION DYNAMICS; MACACA-SYLVANUS; PRIMATE GROUPS; TROOP FISSION; GROUP-SIZE; MACAQUES; POPULATION; EVOLUTION; BEHAVIOR	Group life involves both advantages and disadvantages, meaning that individuals have to compromise between their nutritional needs and their social links. When a compromise is impossible, the group splits in order to reduce conflict of interests and favour positive social interactions between its members. In this study we built a dynamic model of social networks to represent a succession of temporary fissions involving a change in social relations that could potentially lead to irreversible group fission (i.e. no more group fusion). This is the first study that assesses how a social network changes according to group fission-fusion dynamics. We built a model that was based on different parameters: the group size, the influence of nutritional needs compared to social needs, and the changes in the social network after a temporary fission. The results obtained from this theoretical data indicate how the percentage of social relation transfer, the number of individuals and the relative importance of nutritional requirements and social links influence the average number of days before irreversible fission occurs. The greater the nutritional needs and the higher the transfer of social relations during temporary fission, the fewer days will be observed before an irreversible fission. It is crucial to bridge the gap between the individual and the population level if we hope to understand how simple, local interactions may drive ecological systems.	[Sueur, Cedric; Maire, Anais] CNRS, Dept Ecol Physiol & Ethol, Strasbourg, France; [Sueur, Cedric; Maire, Anais] Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, Strasbourg, France; [Sueur, Cedric] Univ Libre Brussels, Unit Social Ecol, Brussels, Belgium	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite Libre de Bruxelles	Sueur, C (corresponding author), CNRS, Dept Ecol Physiol & Ethol, Strasbourg, France.	cedric.sueur@iphc.cnrs.fr	Sueur, Cédric/A-4020-2011	Sueur, Cédric/0000-0001-8206-2739	Fyssen foundation; USIAS (University of Strasbourg Institute for Advanced Study)	Fyssen foundation; USIAS (University of Strasbourg Institute for Advanced Study)	CS is granted by the Fyssen foundation and the USIAS (University of Strasbourg Institute for Advanced Study). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; Asensio N, 2009, BEHAV ECOL SOCIOBIOL, V63, P649, DOI 10.1007/s00265-008-0699-9; Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; Baigger A, 2013, NATURWISSENSCHAFTEN, V100, P895, DOI 10.1007/s00114-013-1090-x; Bull CM, 2012, MOL ECOL, V21, P4386, DOI 10.1111/j.1365-294X.2012.05653.x; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Conradt L, 2003, NATURE, V421, P155, DOI 10.1038/nature01294; Couzin ID, 2009, CURR BIOL, V19, pR633, DOI 10.1016/j.cub.2009.05.034; CROOK JH, 1966, NATURE, V210, P1200, DOI 10.1038/2101200a0; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; DITTUS WPJ, 1988, ANIM BEHAV, V36, P1626, DOI 10.1016/S0003-3472(88)80104-0; Dunbar RIM, 1998, EVOL ANTHROPOL, V6, P178, DOI 10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.0.CO;2-8; Foster EA, 2012, ANIM BEHAV, V83, P731, DOI 10.1016/j.anbehav.2011.12.021; Freeman HD, 2010, AM J PRIMATOL, V72, P653, DOI 10.1002/ajp.20833; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Hood LC, 1995, INT J PRIMATOL, V16, P997, DOI 10.1007/BF02696113; Jacobs A, 2011, INT J PRIMATOL, V32, P721, DOI 10.1007/s10764-011-9497-8; Jacobs A, 2010, BEHAV PROCESS, V84, P678, DOI 10.1016/j.beproc.2010.03.004; Kanngiesser P, 2011, AM J PRIMATOL, V73, P758, DOI 10.1002/ajp.20914; Kasper C, 2009, PRIMATES, V50, P343, DOI 10.1007/s10329-009-0153-2; Kerth G, 2011, P ROY SOC B-BIOL SCI, V278, P2761, DOI 10.1098/rspb.2010.2718; King AJ, 2011, ANIM BEHAV, V82, P1337, DOI 10.1016/j.anbehav.2011.09.017; King AJ, 2009, BEHAV ECOL, V20, P1039, DOI 10.1093/beheco/arp095; Krause J, 2002, LIVING GROUPS; Lefebvre D, 2003, BEHAV ECOL SOCIOBIOL, V53, P402, DOI 10.1007/s00265-002-0578-8; Lehmann J, 2009, P ROY SOC B-BIOL SCI, V276, P4417, DOI 10.1098/rspb.2009.1409; Lusseau D, 2004, P ROY SOC B-BIOL SCI, V271, pS477, DOI 10.1098/rsbl.2004.0225; Lycett SJ, 2007, P NATL ACAD SCI USA, V104, P17588, DOI 10.1073/pnas.0707930104; Martin-Ordas G, 2013, CURR BIOL, V23, P1438, DOI 10.1016/j.cub.2013.06.017; MELNICK DJ, 1983, BEHAV ECOL SOCIOBIOL, V12, P229, DOI 10.1007/BF00290775; MENARD N, 1993, INT J PRIMATOL, V14, P479, DOI 10.1007/BF02192778; Morrell LJ, 2008, ANIM BEHAV, V76, P855, DOI 10.1016/j.anbehav.2008.02.015; OI T, 1988, PRIMATES, V29, P1, DOI 10.1007/BF02380846; Okamoto K, 2001, INT J PRIMATOL, V22, P481, DOI 10.1023/A:1010711813637; Petit O, 2009, P ROY SOC B-BIOL SCI, V276, P3495, DOI 10.1098/rspb.2009.0983; PRUDHOMME J, 1991, PRIMATES, V32, P9, DOI 10.1007/BF02381597; R Core Team, 2020, R LANG ENV STAT COMP; Ramos-Fernandez G, 2006, BEHAV ECOL SOCIOBIOL, V60, P536, DOI 10.1007/s00265-006-0197-x; Romey WL, 2008, BEHAV ECOL, V19, P338, DOI 10.1093/beheco/arm138; Simpson SJ, 2004, ANIM BEHAV, V68, P1299, DOI 10.1016/j.anbehav.2004.03.003; Smith JE, 2008, ANIM BEHAV, V76, P619, DOI 10.1016/j.anbehav.2008.05.001; Suddendorf T, 2003, TRENDS COGN SCI, V7, P391, DOI 10.1016/S1364-6613(03)00187-6; Sueur C, 2011, ANIM BEHAV, V82, P845, DOI 10.1016/j.anbehav.2011.07.020; Sueur C, 2011, P ROY SOC B-BIOL SCI, V278, P1697, DOI 10.1098/rspb.2010.2084; Sueur C, 2010, J EXP BIOL, V213, P1338, DOI 10.1242/jeb.039016; Sueur C, 2009, ANIM BEHAV, V78, P1087, DOI 10.1016/j.anbehav.2009.07.029; Sueur C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032566; Sueur C, 2011, INT J PRIMATOL, V32, P1413, DOI 10.1007/s10764-011-9520-0; Sueur C, 2011, OIKOS, V120, P1608, DOI 10.1111/j.1600-0706.2011.19685.x; Sueur C, 2011, J THEOR BIOL, V273, P156, DOI 10.1016/j.jtbi.2010.12.035; Sueur C, 2011, AM J PRIMATOL, V73, P703, DOI 10.1002/ajp.20915; Sueur C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000917; Tisue S., 2004, NETLOGO SIMPLE ENV M; Van Horn RC, 2007, BEHAV ECOL SOCIOBIOL, V61, P1823, DOI 10.1007/s00265-007-0415-1; Voelkl B, 2008, J THEOR BIOL, V252, P77, DOI 10.1016/j.jtbi.2008.02.002; Wey T, 2008, ANIM BEHAV, V75, P333, DOI 10.1016/j.anbehav.2007.06.020; Wittemyer G, 2005, ANIM BEHAV, V69, P1357, DOI 10.1016/j.anbehav.2004.08.018; Wolf JBW, 2008, P ROY SOC B-BIOL SCI, V275, P2063, DOI 10.1098/rspb.2008.0356; Wolf M, 2012, TRENDS ECOL EVOL, V27, P452, DOI 10.1016/j.tree.2012.05.001; WRANGHAM RW, 1980, BEHAVIOUR, V75, P262, DOI 10.1163/156853980X00447; YAMAGIWA J, 1985, Primates, V26, P105, DOI 10.1007/BF02382011	63	16	16	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97813	10.1371/journal.pone.0097813	http://dx.doi.org/10.1371/journal.pone.0097813			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831471	gold, Green Published, Green Submitted			2022-12-27	WOS:000336789500119
J	Sundstrom, K; Wahlstrom, H; Ivarsson, S; Lewerin, SS				Sundstrom, Kristian; Wahlstrom, Helene; Ivarsson, Sofie; Lewerin, Susanna Sternberg			Economic Effects of Introducing Alternative Salmonella Control Strategies in Sweden	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; WILLINGNESS-TO-PAY; BACTERIAL GASTROENTERITIS; RISK; CAMPYLOBACTER; REDUCTIONS; OUTBREAK; DISEASE	The objective of the study was to analyse the economic effects of introducing alternative Salmonella control strategies in Sweden. Current control strategies in Denmark and the Netherlands were used as benchmarks. The true number of human Salmonella cases was estimated by reconstructing the reporting pyramids for the various scenarios. Costs were calculated for expected changes in human morbidity (Salmonella and two of its sequelae), for differences in the control programmes and for changes in cattle morbidity. The net effects (benefits minus costs) were negative in all scenarios ((sic) -5 to -105 million), implying that it would not be cost-effective to introduce alternative control strategies in Sweden. This result was mainly due to an expected increase in the incidence of Salmonella in humans (6035-57108 reported and unreported new cases/year), with expected additional costs of (sic) 5-55 million. Other increased costs were due to expected higher incidences of sequelae ((sic) 3-49 million) and a higher cattle morbidity ((sic) 4-8 million). Benefits in terms of lower control costs amounted to (sic) 4-7 million.	[Sundstrom, Kristian] Lund Univ, Inst Food & Agr Econ, Lund, Sweden; [Wahlstrom, Helene] Natl Vet Inst, Zoonosis Ctr, S-75007 Uppsala, Sweden; [Ivarsson, Sofie] Swedish Inst Communicable Dis Control, Dept Preparedness, Solna, Sweden; [Lewerin, Susanna Sternberg] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden	Lund University; National Veterinary Institute SVA; Swedish Institute for Infectious Disease Control; Swedish University of Agricultural Sciences	Sundstrom, K (corresponding author), Lund Univ, Inst Food & Agr Econ, Lund, Sweden.	kristian.sundstrom@agrifood.lu.se	Lewerin, Susanna Sternberg/C-1621-2015	Lewerin, Susanna Sternberg/0000-0001-7907-8377				Adak GK, 2002, GUT, V51, P832, DOI 10.1136/gut.51.6.832; Brouwer R, 2005, J HEALTH ECON, V24, P591, DOI 10.1016/j.jhealeco.2004.09.004; CDC, 1981, JINFECTDIS, V143; Danish Ministry of Food A and Fisheries, SALM CONTR; de Jong B, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-4; Engvall A, 1992, EC SWEDISH SALMONELL; European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2597; Falkenhorst G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-523; Haagsma J, 2012, EPIDEMIOLOGY INFECT, V1, P1; Haagsma JA, 2010, EPIDEMIOL INFECT, V138, P1650, DOI 10.1017/S0950268810000531; Hahn BA, 1997, ALIMENT PHARM THERAP, V11, P553, DOI 10.1046/j.1365-2036.1997.00160.x; Hall G, 2008, EMERG INFECT DIS, V14, P1601, DOI 10.3201/eid1410.071042; Hannu T, 2002, RHEUMATOLOGY, V41, P312, DOI 10.1093/rheumatology/41.3.312; Havelaar A, 2012, EPIDEMIOLOGY INFECT, V1, P1; Henson S, 1996, J AGR ECON, V47, P403, DOI 10.1111/j.1477-9552.1996.tb00701.x; Jung IS, 2009, J CLIN GASTROENTEROL, V43, P534, DOI 10.1097/MCG.0b013e31818c87d7; Kahng LS, 2009, GASTROENTEROLOGY, V137, P415, DOI 10.1053/j.gastro.2009.06.019; KOOPMANSCHAP MA, 1995, J HEALTH ECON, V14, P171, DOI 10.1016/0167-6296(94)00044-5; Mangen MJJ, 2006, EUR J PUBLIC HEALTH, V16, P11; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Mearin F, 2005, GASTROENTEROLOGY, V129, P98, DOI 10.1053/j.gastro.2005.04.012; Nilsson J, 2011, 20114 AGRIFOOD; Osterberg E, 2000, SCAND J GASTROENTERO, V35, P264; Osterberg J, 2006, ACTA VET SCAND, V47, P13, DOI 10.1186/1751-0147-47-13; Parry SD, 2003, AM J GASTROENTEROL, V98, P1970, DOI 10.1016/S0002-9270(03)00627-0; Pettersson L., 2010, 20102 SJV; Rodriguez LAG, 1999, BRIT MED J, V318, P565, DOI 10.1136/bmj.318.7183.565; SANCO, 2010, SANCO2008E2036; SIKA, 2008, 20083 SIKA PM; Thabane M, 2007, ALIMENT PHARM THER, V26, P535, DOI 10.1111/j.1365-2036.2007.03399.x; Tsuchiya A, 2001, EC EVALUATION HLTH C, P22; Wahlstrom H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089833; Wang LH, 2004, GUT, V53, P1390, DOI 10.1136/gut.2003.021154corr1; Wierup M, 2006, SALMONELLA CONTAMINA, P1	34	14	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e96446	10.1371/journal.pone.0096446	http://dx.doi.org/10.1371/journal.pone.0096446			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831797	Green Published, Green Submitted, gold			2022-12-27	WOS:000336789500020
J	Chi, W; Dao, D; Lau, TC; Henriksbo, BD; Cavallari, JF; Foley, KP; Schertzer, JD				Chi, Wendy; Dao, Dyda; Lau, Trevor C.; Henriksbo, Brandyn D.; Cavallari, Joseph F.; Foley, Kevin P.; Schertzer, Jonathan D.			Bacterial Peptidoglycan Stimulates Adipocyte Lipolysis via NOD1	PLOS ONE			English	Article							NF-KAPPA-B; INSULIN-RESISTANCE; ACTIVATION; INFLAMMATION; RECOGNITION; MICROBIOTA; ENDOTOXEMIA; MECHANISM; OBESITY; EXPRESSION	Obesity is associated with inflammation that can drive metabolic defects such as hyperlipidemia and insulin resistance. Specific metabolites can contribute to inflammation, but nutrient intake and obesity are also associated with altered bacterial load in metabolic tissues (i.e. metabolic endotoxemia). These bacterial cues can contribute to obesity-induced inflammation. The specific bacterial components and host receptors that underpin altered metabolic responses are emerging. We previously showed that Nucleotide-binding oligomerization domain-containing protein 1 (NOD1) activation with bacterial peptidoglycan (PGN) caused insulin resistance in mice. We now show that PGN induces cell-autonomous lipolysis in adipocytes via NOD1. Specific bacterial PGN motifs stimulated lipolysis in white adipose tissue (WAT) explants from WT, but not NOD1(-/-) mice. NOD1-activating PGN stimulated mitogen activated protein kinases (MAPK), protein kinase A (PKA), and NF-kappa B in 3T3-L1 adipocytes. The NOD1-mediated lipolysis response was partially reduced by inhibition of ERK1/2 or PKA alone, but not c-Jun N-terminal kinase (JNK). NOD1-stimulated lipolysis was partially dependent on NF-kappa B and was completely suppressed by inhibiting ERK1/2 and PKA simultaneously or hormone sensitive lipase (HSL). Our results demonstrate that bacterial PGN stimulates lipolysis in adipocytes by engaging a stress kinase, PKA, NF-kappa B-dependent lipolytic program. Bacterial NOD1 activation is positioned as a component of metabolic endotoxemia that can contribute to hyperlipidemia, systemic inflammation and insulin resistance by acting directly on adipocytes.	[Schertzer, Jonathan D.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; McMaster Univ, Dept Pediat, Hamilton, ON L8N 3Z5, Canada	McMaster University; McMaster University	Schertzer, JD (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada.	schertze@mcmaster.ca	; Schertzer, Jonathan/P-3395-2017	Dao, Dyda/0000-0003-2941-8374; Dao, Dyda/0000-0002-8261-5361; Chi, Wendy/0000-0003-2973-7084; Schertzer, Jonathan/0000-0002-1547-5856	Canadian Diabetes Association (CDA) [SC-5-12-3891-JS, OG-3-12-3745-JS]; Canadian Institutes of Health Research (CIHR) [MOP 130432]	Canadian Diabetes Association (CDA); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Diabetes Association (CDA) [SC-5-12-3891-JS and OG-3-12-3745-JS] and Canadian Institutes of Health Research (CIHR) [MOP 130432]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar J, 2011, DIABETOLOGIA, V54, P3055, DOI 10.1007/s00125-011-2329-8; Amar J, 2008, AM J CLIN NUTR, V87, P1219, DOI 10.1093/ajcn/87.5.1219; Amar J, 2011, EMBO MOL MED, V3, P559, DOI 10.1002/emmm.201100159; Balwani S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046528; Boden G, 2005, DIABETES, V54, P3458, DOI 10.2337/diabetes.54.12.3458; Burcelin R, 2012, SEMIN IMMUNOL, V24, P67, DOI 10.1016/j.smim.2011.11.011; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Carmen GY, 2006, CELL SIGNAL, V18, P401, DOI 10.1016/j.cellsig.2005.08.009; Carneiro LAM, 2008, J PATHOL, V214, P136, DOI 10.1002/path.2271; Carneiro LAM, 2004, MICROBES INFECT, V6, P609, DOI 10.1016/j.micinf.2004.01.012; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Correa RG, 2011, CHEM BIOL, V18, P825, DOI 10.1016/j.chembiol.2011.06.009; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dziarski R, 2005, J ENDOTOXIN RES, V11, P304, DOI 10.1179/096805105X67256; Girousse A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001485; Grisouard J, 2012, INNATE IMMUN-LONDON, V18, P25, DOI 10.1177/1753425910386632; HARDARDOTTIR I, 1992, BIOCHEM BIOPH RES CO, V186, P237, DOI 10.1016/S0006-291X(05)80798-3; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Inouye K., 2006, J CLIN INVEST; Khan PM, 2011, ACS MED CHEM LETT, V2, P780, DOI 10.1021/ml200158b; Lam TKT, 2003, AM J PHYSIOL-ENDOC M, V284, pE281, DOI 10.1152/ajpendo.00332.2002; Magalhaes JG, 2005, EMBO REP, V6, P1201, DOI 10.1038/sj.embor.7400552; Mottillo EP, 2010, BBA-MOL CELL BIOL L, V1801, P1048, DOI 10.1016/j.bbalip.2010.04.012; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Olefsky JM, 2008, CELL, V134, P914, DOI 10.1016/j.cell.2008.09.001; Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851; Purohit JS, 2013, BIOCHEM CELL BIOL, V91, P428, DOI 10.1139/bcb-2013-0049; Rickard DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069619; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Royet J, 2011, NAT REV IMMUNOL, V11, P837, DOI 10.1038/nri3089; Schertzer JD, 2004, ACTA PHYSIOL SCAND, V180, P195, DOI 10.1046/j.0001-6772.2003.01227.x; Schertzer JD, 2011, AM J PHYSIOL-ENDOC M, V301, pE585, DOI 10.1152/ajpendo.00362.2011; Schertzer JD, 2011, DIABETES, V60, P2206, DOI 10.2337/db11-0004; Souza SC, 2003, J CELL BIOCHEM, V89, P1077, DOI 10.1002/jcb.10565; Steinberg GR, 2010, J BIOL CHEM, V285, P37198, DOI 10.1074/jbc.M110.102434; Tamrakar AK, 2010, ENDOCRINOLOGY, V151, P5624, DOI 10.1210/en.2010-0437; Watanabe T, 2010, J CLIN INVEST, V120, P1645, DOI 10.1172/JCI39481; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Yeretssian G, 2011, NATURE, V474, P96, DOI 10.1038/nature09982; Zhao L, 2011, AM J PHYSIOL-ENDOC M, V301, pE587, DOI 10.1152/ajpendo.00709.2010; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zu LX, 2009, J BIOL CHEM, V284, P5915, DOI 10.1074/jbc.M807852200	46	46	46	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97675	10.1371/journal.pone.0097675	http://dx.doi.org/10.1371/journal.pone.0097675			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828250	Green Published, Green Submitted, gold			2022-12-27	WOS:000336857400117
J	Gholizadeh, H; Abu Osman, NA; Eshraghi, A; Ali, S				Gholizadeh, Hossein; Abu Osman, Noor Azuan; Eshraghi, Arezoo; Ali, Sadeeq			The Effects of Suction and Pin/Lock Suspension Systems on Transtibial Amputees' Gait Performance	PLOS ONE			English	Article							MOTION-ANALYSIS; SEAL-IN(R) X5; SOCKET; LINER; SYMMETRY; WALKING; BIOMECHANICS; PRESSURE	Background: The suction sockets that are commonly prescribed for transtibial amputees are believed to provide a better suspension than the pin/lock systems. Nevertheless, their effect on amputees' gait performance has not yet been fully investigated. The main intention of this study was to understand the potential effects of the Seal-in (suction) and the Dermo (pin/lock) suspension systems on amputees' gait performance. Methodology/Principal Findings: Ten unilateral transtibial amputees participated in this prospective study, and two prostheses were fabricated for each of them. A three-dimensional motion analysis system was used to evaluate the temporal-spatial, kinematics and kinetics variables during normal walking. We also asked the participants to complete some part of Prosthesis Evaluation Questionnaire (PEQ) regarding their satisfaction and problems with both systems. The results revealed that there was more symmetry in temporal-spatial parameters between the prosthetic and sound limbs using the suction system. However, the difference between two systems was not significant (p<0.05). Evaluation of kinetic data and the subjects' feedback showed that the participants had more confidence using the suction socket and the sockets were more fit for walking. Nevertheless, the participants had more complaints with this system due to the difficulty in donning and doffing. Conclusion: It can be concluded that even though the suction socket could create better suspension, fit, and gait performance, overall satisfaction was higher with the pin/lock system due to easy donning and doffing of the prosthesis.	[Gholizadeh, Hossein; Abu Osman, Noor Azuan; Eshraghi, Arezoo; Ali, Sadeeq] Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur, Malaysia	Universiti Malaya	Gholizadeh, H (corresponding author), Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur, Malaysia.	gholizadeh@um.edu.my	Gholizadeh, Hossein/G-4838-2010; ABU OSMAN, NOOR AZUAN/B-9265-2010; ali, sadeeq/S-6441-2016	Gholizadeh, Hossein/0000-0001-5847-7985; ABU OSMAN, NOOR AZUAN/0000-0002-2853-4421; Eshraghi, Arezoo/0000-0002-1525-8093	Malaysia UM/MOHE/HIR [D000014-16001]	Malaysia UM/MOHE/HIR	This study was supported by Malaysia UM/MOHE/HIR (Project Number: D000014-16001). The prosthetic components were donated by Ossur (Reykjavik, Iceland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2012, CLIN BIOMECH, V27, P943, DOI 10.1016/j.clinbiomech.2012.06.004; American Academy of Orthotists & Prosthetists. Medicare, 2010, PSC044 MED GUID FORM; Astrom I, 2004, PROSTHET ORTHOT INT, V28, P28; Baars ECT, 2005, PROSTHET ORTHOT INT, V29, P27, DOI 10.1080/17461550500069612; BAKER PA, 1990, PROSTHET ORTHOT INT, V14, P80; Bateni H., 2002, JPO J PROSTHETICS OR, V14, P2, DOI [10.1097/00008526-200203000-00003, DOI 10.1097/00008526-200203000-00003]; Board WJ, 2001, PROSTHET ORTHOT INT, V25, P202, DOI 10.1080/03093640108726603; Boutwell E, 2012, J REHABIL RES DEV, V49, P227, DOI 10.1682/JRRD.2010.06.0121; Brunelli S, 2013, PROSTHET ORTHOT INT, V37, P436, DOI 10.1177/0309364613476531; Chow DHK, 2006, PROSTHET ORTHOT INT, V30, P114, DOI 10.1080/03093640600568617; Collins SH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009307; CZERNIECKI JM, 1996, GAIT POSTURE, V4, P258; ENGSBERG JR, 1993, PROSTHET ORTHOT INT, V17, P83; Eshraghi A, 2012, PROSTHET ORTHOT INT, V36, P15, DOI 10.1177/0309364611431625; Farahmand F, 2006, SCI IRAN, V13, P261; Gholizadeh H, 2012, CLIN BIOMECH, V27, P34, DOI 10.1016/j.clinbiomech.2011.07.004; Gholizadeh H, 2012, J REHABIL RES DEV, V49, P1321, DOI 10.1682/JRRD.2011.11.0221; Gholizadeh H, 2012, AM J PHYS MED REHAB, V91, P894, DOI 10.1097/PHM.0b013e31823c74d7; Heim M, 1997, J BONE JOINT SURG BR, V79B, P638, DOI 10.1302/0301-620X.79B4.7350; HERZOG W, 1989, MED SCI SPORT EXER, V21, P110, DOI 10.1249/00005768-198902000-00020; Isakov E, 2000, PROSTHET ORTHOT INT, V24, P216, DOI 10.1080/03093640008726550; Kishner S., 2010, GAIT ANAL AMPUTATION; Ku PX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041539; Legro MW, 1999, J REHABIL RES DEV, V36, P155; Marinakis GNS, 2004, J REHABIL RES DEV, V41, P581, DOI 10.1682/JRRD.2003.04.0049; Moosabhoy MA, 2006, GAIT POSTURE, V24, P493, DOI 10.1016/j.gaitpost.2005.12.004; Nolan L, 2003, GAIT POSTURE, V17, P142, DOI 10.1016/S0966-6362(02)00066-8; Ossur, 2008, COMP PERF FIT ISNT T; Perry Jacquelin, 1992, J PEDIATR ORTHOPED, P4, DOI [DOI 10.1097/01241398-199211000-00023, 10.1097/01241398-199211000-00023]; Pitkin MR, 1997, P 23 ANN M SCI S AM, P21; ROBINSON RO, 1987, J MANIP PHYSIOL THER, V10, P172; Rusaw D, 2011, PROSTHET ORTHOT INT, V35, P8, DOI 10.1177/0309364610393060; Sanderson DJ, 1997, GAIT POSTURE, V6, P126, DOI 10.1016/S0966-6362(97)01112-0; Stergiou N, 2002, CLIN BIOMECH, V17, P615, DOI 10.1016/S0268-0033(02)00072-4; Vanicek N, 2009, GAIT POSTURE, V29, P415, DOI 10.1016/j.gaitpost.2008.10.062; WINTER DA, 1988, J BIOMECH, V21, P361, DOI 10.1016/0021-9290(88)90142-X; Winter DA, 1991, KINEMATIC KINETIC PA; Zmitrewicz RJ, 2006, ARCH PHYS MED REHAB, V87, P1334, DOI 10.1016/j.apmr.2006.06.013	38	11	12	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e94520	10.1371/journal.pone.0094520	http://dx.doi.org/10.1371/journal.pone.0094520			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827560	gold, Green Published, Green Submitted			2022-12-27	WOS:000336857400010
J	Junca, P; Carcaud, J; Moulin, S; Garnery, L; Sandoz, JC				Junca, Pierre; Carcaud, Julie; Moulin, Sibyle; Garnery, Lionel; Sandoz, Jean-Christophe			Genotypic Influence on Aversive Conditioning in Honeybees, Using a Novel Thermal Reinforcement Procedure	PLOS ONE			English	Article							DOPAMINE-LIKE IMMUNOREACTIVITY; PROBOSCIS EXTENSION RESPONSE; DIVISION-OF-LABOR; APIS-MELLIFERA; GUSTATORY RESPONSIVENESS; SUCROSE RESPONSIVENESS; LEARNING-PERFORMANCE; MEMORY FORMATION; BEE; TACTILE	In Pavlovian conditioning, animals learn to associate initially neutral stimuli with positive or negative outcomes, leading to appetitive and aversive learning respectively. The honeybee (Apis mellifera) is a prominent invertebrate model for studying both versions of olfactory learning and for unraveling the influence of genotype. As a queen bee mates with about 15 males, her worker offspring belong to as many, genetically-different patrilines. While the genetic dependency of appetitive learning is well established in bees, it is not the case for aversive learning, as a robust protocol was only developed recently. In the original conditioning of the sting extension response (SER), bees learn to associate an odor (conditioned stimulus CS) with an electric shock (unconditioned stimulus - US). This US is however not a natural stimulus for bees, which may represent a potential caveat for dissecting the genetics underlying aversive learning. We thus first tested heat as a potential new US for SER conditioning. We show that thermal stimulation of several sensory structures on the bee's body triggers the SER, in a temperature-dependent manner. Moreover, heat applied to the antennae, mouthparts or legs is an efficient US for SER conditioning. Then, using microsatellite analysis, we analyzed heat sensitivity and aversive learning performances in ten worker patrilines issued from a naturally inseminated queen. We demonstrate a strong influence of genotype on aversive learning, possibly indicating the existence of a genetic determinism of this capacity. Such determinism could be instrumental for efficient task partitioning within the hive.	[Junca, Pierre; Carcaud, Julie; Moulin, Sibyle; Garnery, Lionel; Sandoz, Jean-Christophe] CNRS, UPR 9034, Evolut Genomes & Speciat Lab LEGS, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Sandoz, JC (corresponding author), CNRS, UPR 9034, Evolut Genomes & Speciat Lab LEGS, Gif Sur Yvette, France.	sandoz@legs.cnrs-gif.fr	Sandoz, Jean-Christophe/A-6085-2012; Carcaud, Julie/AAF-3453-2019	Sandoz, Jean-Christophe/0000-0002-5423-9645; Carcaud, Julie/0000-0003-3672-9963				Ardiel EL, 2010, LEARN MEMORY, V17, P191, DOI 10.1101/lm.960510; Benjamin PR, 2000, LEARN MEMORY, V7, P124, DOI 10.1101/lm.7.3.124; Beshers SN, 2001, ANNU REV ENTOMOL, V46, P413, DOI 10.1146/annurev.ento.46.1.413; BHAGAVAN S, 1994, ANIM BEHAV, V48, P1357, DOI 10.1006/anbe.1994.1372; Biergans SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039349; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; BRANDES C, 1988, ANIM BEHAV, V36, P981, DOI 10.1016/S0003-3472(88)80056-3; BRANDES C, 1991, BEHAV GENET, V21, P271, DOI 10.1007/BF01065820; BRANDES C, 1990, COMP BIOCHEM PHYS C, V97, P53, DOI 10.1016/0742-8413(90)90171-5; Chapman NC, 2007, BEHAV ECOL SOCIOBIOL, V61, P1185, DOI 10.1007/s00265-006-0348-0; Cox MD, 2003, J THEOR BIOL, V223, P179, DOI 10.1016/S0022-5193(03)00085-7; Eckholm BJ, 2011, BEHAV ECOL SOCIOBIOL, V65, P1037, DOI 10.1007/s00265-010-1108-8; Erber J, 2006, BEHAV BRAIN RES, V174, P174, DOI 10.1016/j.bbr.2006.07.023; Estoup A, 1996, MOL MAR BIOL BIOTECH, V5, P295; ESTOUP A, 1995, GENETICS, V140, P679; ESTOUP A, 1994, P ROY SOC B-BIOL SCI, V258, P1; Franck P, 1998, EVOLUTION, V52, P1119, DOI [10.2307/2411242, 10.1111/j.1558-5646.1998.tb01839.x]; FRUMHOFF PC, 1988, NATURE, V333, P358, DOI 10.1038/333358a0; Furey TS, 2013, SCIENCE, V342, P705, DOI 10.1126/science.1246755; Gallio M, 2011, CELL, V144, P614, DOI 10.1016/j.cell.2011.01.028; Garnery L, 1998, GENET SEL EVOL, V30, P1, DOI DOI https://doi.org/10.1186/1297-9686-30-S1-S31; Giurfa M, 2007, J COMP PHYSIOL A, V193, P801, DOI 10.1007/s00359-007-0235-9; Giurfa M, 2006, CURR BIOL, V16, pR892, DOI 10.1016/j.cub.2006.09.021; Giurfa M, 2012, LEARN MEMORY, V19, P54, DOI 10.1101/lm.024711.111; Groh C, 2004, P NATL ACAD SCI USA, V101, P4268, DOI 10.1073/pnas.0400773101; Guzman-Novoa E, 2005, J HERED, V96, P376, DOI 10.1093/jhered/esi038; Herb BR, 2012, NAT NEUROSCI, V15, P1371, DOI 10.1038/nn.3218; Jeanson R, 2014, BIOL REV, V89, P671, DOI 10.1111/brv.12074; Jones JC, 2004, SCIENCE, V305, P402, DOI 10.1126/science.1096340; Kohno K, 2010, J NEUROSCI, V30, P12219, DOI 10.1523/JNEUROSCI.2001-10.2010; Kryger P, 2000, ETHOLOGY, V106, P769, DOI 10.1046/j.1439-0310.2000.00571.x; LACHER V, 1964, Z VERGL PHYSIOL, V48, P587, DOI 10.1007/BF00333743; Laloi D, 2010, APIDOLOGIE, V41, P436, DOI 10.1051/apido/2009080; Lenoir JC, 2006, INSECT SOC, V53, P80, DOI 10.1007/s00040-005-0838-5; Lockett GA, 2010, NEUROREPORT, V21, P812, DOI 10.1097/WNR.0b013e32833ce5be; LUNNEY GH, 1970, J EDUC MEAS, V7, P263, DOI 10.1111/j.1745-3984.1970.tb00727.x; Matsumoto Y, 2014, LEARN MEM IN PRESS; Matsumoto Y, 2012, J NEUROSCI METH, V211, P159, DOI 10.1016/j.jneumeth.2012.08.018; Mattila HR, 2007, SCIENCE, V317, P362, DOI 10.1126/science.1143046; Menzel R, 1999, J COMP PHYSIOL A, V185, P323, DOI 10.1007/s003590050392; Miguel I, 2007, APIDOLOGIE, V38, P141, DOI 10.1051/apido:2007007; Mizunami M, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00172; Muller U, 2012, APIDOLOGIE, V43, P322, DOI 10.1007/s13592-011-0115-8; Neely GG, 2010, CELL, V143, P628, DOI 10.1016/j.cell.2010.09.047; Newland PL, 1997, J INSECT PHYSIOL, V43, P107, DOI 10.1016/S0022-1910(96)00081-9; Nishino H, 2009, J COMP NEUROL, V515, P161, DOI 10.1002/cne.22064; Norton W, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-90; Nunez J, 1997, PHYSIOL BEHAV, V63, P75, DOI 10.1016/S0031-9384(97)00391-0; Page RE, 2006, CURR TOP DEV BIOL, V74, P253, DOI 10.1016/S0070-2153(06)74008-X; Paratore S, 2006, GENES BRAIN BEHAV, V5, P209, DOI 10.1111/j.1601-183X.2005.00159.x; Perez M, 2013, LEARN MEMORY, V20, P417, DOI 10.1101/lm.031427.113; ROBINSON GE, 1989, WESTV STUD, P61; Roussel E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004197; Ruchty M, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00174; Sandoz JC, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00098; SCHAFER S, 1989, J COMP NEUROL, V280, P43, DOI 10.1002/cne.902800105; Scheiner R, 1999, J COMP PHYSIOL A, V185, P1, DOI 10.1007/s003590050360; Scheiner R, 2005, LEARN MEMORY, V12, P626, DOI 10.1101/lm.98105; Scheiner R, 2001, NEUROBIOL LEARN MEM, V76, P138, DOI 10.1006/nlme.2000.3996; Scheiner R, 2001, BEHAV BRAIN RES, V120, P67, DOI 10.1016/S0166-4328(00)00359-4; Scheiner R, 2010, APIDOLOGIE, V41, P29, DOI 10.1051/apido/2009040; Scheiner R, 2009, J EXP BIOL, V212, P994, DOI 10.1242/jeb.021188; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; SCHURMANN FW, 1989, CELL TISSUE RES, V256, P399, DOI 10.1007/BF00218898; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; SEELEY TD, 1982, BEHAV ECOL SOCIOBIOL, V11, P287, DOI 10.1007/BF00299306; Solignac M, 2003, MOL ECOL NOTES, V3, P307, DOI 10.1046/j.1471-8286.2003.00436.x; Tautz J, 2003, P NATL ACAD SCI USA, V100, P7343, DOI 10.1073/pnas.1232346100; Tedjakumala SR, 2013, J EXP BIOL, V216, P2985, DOI 10.1242/jeb.086629; Ugajin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032902; Unoki S, 2005, EUR J NEUROSCI, V22, P1409, DOI 10.1111/j.1460-9568.2005.04318.x; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; YOKOHARI F, 1983, CELL TISSUE RES, V233, P355, DOI 10.1007/BF00238302	75	13	13	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97333	10.1371/journal.pone.0097333	http://dx.doi.org/10.1371/journal.pone.0097333			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828422	gold, Green Published, Green Submitted			2022-12-27	WOS:000336857400079
J	Munshi, SU; Panda, H; Holla, P; Rewari, BB; Jameel, S				Munshi, Saif Ullah; Panda, Harekrushna; Holla, Prasida; Rewari, Bharat Bhushan; Jameel, Shahid			MicroRNA-150 Is a Potential Biomarker of HIV/AIDS Disease Progression and Therapy	PLOS ONE			English	Article							T-CELL COUNT; CERAMIDE PRODUCTION; VIRAL LOAD; HIV-1; EXPRESSION; PLASMA; MECHANISMS; SERUM; PCR; MIR-150	Background: The surrogate markers of HIV/AIDS progression include CD4 T cell count and plasma viral load. But, their reliability has been questioned in patients on anti-retroviral therapy (ART). Five microRNAs (miRNAs) - miR-16, miR-146b-5p, miR-150, miR-191 and miR-223 in peripheral blood mononuclear cells (PBMCs) were earlier found to assign HIV/AIDS patients into groups with varying CD4 T cell counts and viral loads. In this pilot study, we profiled the expression of these five miRNAs in PBMCs, and two of these miRNAs (miR-146b-5p and miR-150) in the plasma of HIV/AIDS patients, including those on ART and those who developed ART resistance, to evaluate if these are biomarkers of disease progression and therapy. Results: We quantified miRNA levels by quantitative reverse transcription polymerase chain reaction (qRT-PCR) using RNA isolated from PBMCs and plasma of healthy persons or HIV-infected patients who were (1) asymptomatic; (2) symptomatic and ART naive; (3) on ART; and (4) failing ART. Our results show miR-150 (p<0.01) and to a lesser extent miR-146b-5p (p<0.05) levels in PBMCs to reliably distinguish between ART-naive AIDS patients, those on ART, and those developing drug resistance and failing ART. The plasma levels of these two miRNAs also varied significantly between patients in these groups and between patients and healthy controls (p values <0.05). Conclusions: We report for the first time that PBMC and plasma levels of miR-150 and miR-146b-5p are predictive of HIV/AIDS disease progression and therapy.	[Munshi, Saif Ullah; Holla, Prasida; Jameel, Shahid] Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi, India; [Panda, Harekrushna] Int Ctr Genet Engn & Biotechnol, ICGEB Emory Vaccine Ctr, New Delhi, India; [Rewari, Bharat Bhushan] Natl AIDS Control Org, ART Dept, New Delhi, India; [Rewari, Bharat Bhushan] Dr Ram Manohar Lohia Hosp, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Jameel, S (corresponding author), Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi, India.	shahid@icgeb.res.in			Department of Biotechnology, Government of India; Indian Council of Medical Research; Emory Vaccine Center; ICGEB	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Emory Vaccine Center; ICGEB(Department of Biotechnology (DBT) India)	This work was supported by grants from the Department of Biotechnology, Government of India and the Indian Council of Medical Research. It also received support from the Emory Vaccine Center through a grant to the ICGEB-Emory Vaccine Centre. S.U.M. received a Pre-Doctoral Fellowship from ICGEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2010, CLIN CHEM, V56, P1183, DOI 10.1373/clinchem.2010.144121; BAGASRA O, 1992, NEW ENGL J MED, V326, P1385, DOI 10.1056/NEJM199205213262103; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bihrer V, 2011, AM J GASTROENTEROL, V106, P1663, DOI 10.1038/ajg.2011.161; Brase JC, 2011, INT J CANCER, V128, P608, DOI 10.1002/ijc.25376; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen X, 2012, PROTEIN CELL, V3, P28, DOI 10.1007/s13238-012-2003-z; Corbeau P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000162; Cortez MA, 2009, EXPERT OPIN BIOL TH, V9, P703, DOI [10.1517/14712590902932889, 10.1517/14712590902932889 ]; De Milito A, 2004, BLOOD, V103, P2180, DOI 10.1182/blood-2003-07-2375; Duskova K, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-250; Fayyad-Kazan H, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-31; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Ghisi M, 2011, BLOOD, V117, P7053, DOI 10.1182/blood-2010-12-326629; Gupta V, 2004, Indian J Med Microbiol, V22, P7; Haughey NJ, 2004, ANN NEUROL, V55, P257, DOI 10.1002/ana.10828; Houzet L, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-118; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Kamat A, 2007, J CLIN VIROL, V39, P9, DOI 10.1016/j.jcv.2006.12.026; Kanekar Amar, 2010, J Clin Med Res, V2, P55, DOI 10.4021/jocmr2010.03.255w; Kawado M, 2006, J EPIDEMIOL, V16, P101, DOI 10.2188/jea.16.101; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu AM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000825; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Moore DM, 2008, JAIDS-J ACQ IMM DEF, V49, P477, DOI 10.1097/QAI.0b013e318186eb18; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Schmidt WM, 2009, BIOCHEM BIOPH RES CO, V380, P437, DOI 10.1016/j.bbrc.2008.12.190; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Singh I, 1998, J BIOL CHEM, V273, P20354, DOI 10.1074/jbc.273.32.20354; Swaminathan S, 2012, J IMMUNOL, V188, P6238, DOI 10.4049/jimmunol.1101196; Swaminathan S, 2009, BLOOD, V113, P5029, DOI 10.1182/blood-2009-01-196741; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; TSOUKAS CM, 1994, CLIN MICROBIOL REV, V7, P14, DOI 10.1128/CMR.7.1.14-28.1994; VANVELDHOVEN PP, 1992, BIOCHEM BIOPH RES CO, V187, P209, DOI 10.1016/S0006-291X(05)81480-9; Vasilatou D, 2010, EUR J HAEMATOL, V84, P1, DOI 10.1111/j.1600-0609.2009.01348.x; Visone R, 2011, BLOOD, V118, P3072, DOI 10.1182/blood-2011-01-333484; Waidmann O, 2012, J VIRAL HEPATITIS, V19, pE58, DOI 10.1111/j.1365-2893.2011.01536.x; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Wang X, 2009, BLOOD, V113, P671, DOI 10.1182/blood-2008-09-175000; Witwer KW, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-5; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Wulfken LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025787; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Yu J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-169; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104	49	50	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e95920	10.1371/journal.pone.0095920	http://dx.doi.org/10.1371/journal.pone.0095920			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828336	Green Published, Green Submitted, gold			2022-12-27	WOS:000336857400018
J	Sirvente, RA; Irigoyen, MC; Souza, LE; Mostarda, C; La Fuente, RN; Candido, GO; Souza, PRM; Medeiros, A; Mady, C; Salemi, VMC				Sirvente, Raquel A.; Irigoyen, Maria C.; Souza, Leandro E.; Mostarda, Cristiano; La Fuente, Raquel N.; Candido, Georgia O.; Souza, Pamella R. M.; Medeiros, Alessandra; Mady, Charles; Salemi, Vera M. C.			Cardiac Impairment Evaluated by Transesophageal Echocardiography and Invasive Measurements in Rats Undergoing Sinoaortic Denervation	PLOS ONE			English	Article							BAROREFLEX SENSITIVITY; AMERICAN-SOCIETY; EUROPEAN-ASSOCIATION; EXERCISE; RECOMMENDATIONS; GUIDELINES; VARIABILITY; ADJUSTMENTS; BRANCH; HEART	Background: Sympathetic hyperactivity may be related to left ventricular (LV) dysfunction and baro- and chemoreflex impairment in hypertension. However, cardiac function, regarding the association of hypertension and baroreflex dysfunction, has not been previously evaluated by transesophageal echocardiography (TEE) using intracardiac echocardiographic catheter. Methods and Results: We evaluated exercise tests, baroreflex sensitivity and cardiovascular autonomic control, cardiac function, and biventricular invasive pressures in rats 10 weeks after sinoaortic denervation (SAD). The rats (n = 32) were divided into 4 groups: 16 Wistar (W) with (n = 8) or without SAD (n = 8) and 16 spontaneously hypertensive rats (SHR) with (n = 8) or without SAD (SHRSAD) (n = 8). Blood pressure (BP) and heart rate (HR) did not change between the groups with or without SAD; however, compared to W, SHR groups had higher BP levels and BP variability was increased. Exercise testing showed that SHR had better functional capacity compared to SAD and SHRSAD. Echocardiography showed left ventricular (LV) concentric hypertrophy; segmental systolic and diastolic biventricular dysfunction; indirect signals of pulmonary arterial hypertension, mostly evident in SHRSAD. The end-diastolic right ventricular (RV) pressure increased in all groups compared to W, and the end-diastolic LV pressure increased in SHR and SHRSAD groups compared to W, and in SHRSAD compared to SAD. Conclusions: Our results suggest that baroreflex dysfunction impairs cardiac function, and increases pulmonary artery pressure, supporting a role for baroreflex dysfunction in the pathogenesis of hypertensive cardiac disease. Moreover, TEE is a useful and feasible noninvasive technique that allows the assessment of cardiac function, particularly RV indices in this model of cardiac disease.	[Sirvente, Raquel A.; Mady, Charles; Salemi, Vera M. C.] Univ Sao Paulo, Fac Med, Cardiomyopathy Unit, Heart Inst InCor,Hosp Clin, Sao Paulo, Brazil; [Sirvente, Raquel A.; Irigoyen, Maria C.; Souza, Leandro E.; Mostarda, Cristiano; La Fuente, Raquel N.; Candido, Georgia O.; Souza, Pamella R. M.] Univ Sao Paulo, Fac Med, Hypertens Unit, Heart Inst InCor,Hosp Clin, Sao Paulo, Brazil; [Medeiros, Alessandra] Univ Fed Sao Paulo, Dept Biosci, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Sirvente, RA (corresponding author), Univ Sao Paulo, Fac Med, Cardiomyopathy Unit, Heart Inst InCor,Hosp Clin, Sao Paulo, Brazil.	raquelsirvente@hotmail.com	IRIGOYEN, MARIA CLAUDIA C/N-6880-2014; Medeiros, Alessandra/E-8132-2012; Mostarda, Cristiano/AAG-4087-2019; Salemi, Vera/AAY-5024-2020; Salemi, Vera MC/C-9104-2013; Mady, Charles/C-8870-2012; Medeiros, Alessandra/F-6149-2014	IRIGOYEN, MARIA CLAUDIA C/0000-0003-2097-3662; Medeiros, Alessandra/0000-0002-7962-7185; Salemi, Vera MC/0000-0002-7152-1810; Mady, Charles/0000-0002-8838-199X; Medeiros, Alessandra/0000-0002-7962-7185; Mostarda, Cristiano Teixeira/0000-0002-1305-1697	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(National Council for Scientific and Technological Development	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(National Council for Scientific and Technological Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruce CJ, 1999, J AM SOC ECHOCARDIOG, V12, P596, DOI 10.1016/S0894-7317(99)70008-8; Brum PC, 2000, HYPERTENSION, V36, P1018, DOI 10.1161/01.HYP.36.6.1018; Carabello BA, 2002, J CARD FAIL, V8, pS258, DOI 10.1054/jcaf.2002.129250; Ceroni A, 2009, EXP PHYSIOL, V94, P630, DOI 10.1113/expphysiol.2008.046128; De Angelis K, 2004, J APPL PHYSIOL, V96, P2174, DOI 10.1152/japplphysiol.00870.2003; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Farah VMA, 1999, BRAZ J MED BIOL RES, V32, P361, DOI 10.1590/S0100-879X1999000300018; Gao ZH, 2005, J AM SOC ECHOCARDIOG, V18, P626, DOI 10.1016/j.echo.2004.08.032; IRIGOYEN MC, 1995, HYPERTENSION, V26, P1111, DOI 10.1161/01.HYP.26.6.1111; Jorge L, 2011, EUR HEART J, V32, P904, DOI 10.1093/eurheartj/ehq244; KRIEGER EM, 1963, AM J PHYSIOL, V205, P771, DOI 10.1152/ajplegacy.1963.205.4.771; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Li P, 2002, J AM SOC ECHOCARDIOG, V15, P349, DOI 10.1067/mje.2002.116312; Miao CY, 2006, J HYPERTENS, V24, P1125, DOI 10.1097/01.hjh.0000226203.57818.88; Miao CY, 2003, AM J HYPERTENS, V16, P585, DOI 10.1016/S0895-7061(03)00866-5; Moraes-Silva IC, 2010, CLIN EXP PHARMACOL P, V37, pe114, DOI 10.1111/j.1440-1681.2009.05333.x; Mostarda C, 2011, J CARD FAIL, V17, P519, DOI 10.1016/j.cardfail.2011.02.007; Mostarda C, 2009, AUTON NEUROSCI-BASIC, V145, P11, DOI 10.1016/j.autneu.2008.10.010; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; NORMAN RA, 1981, HYPERTENSION, V3, P119, DOI 10.1161/01.HYP.3.1.119; Ramires FJA, 2006, J RENIN-ANGIO-ALDO S, V7, P162, DOI 10.3317/jraas.2006.026; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Salemi Vera M C, 2005, Eur J Echocardiogr, V6, P41, DOI 10.1016/j.euje.2004.06.001; Sebbag I, 2001, AM J CARDIOL, V88, P1060, DOI 10.1016/S0002-9149(01)01995-6; Shanewise JS, 1999, J AM SOC ECHOCARDIOG, V12, P884, DOI 10.1016/S0894-7317(99)70199-9; Silva GJJ, 1997, HYPERTENSION, V30, P714, DOI 10.1161/01.HYP.30.3.714; Soares PPDA, 2004, AUTON NEUROSCI-BASIC, V113, P24, DOI 10.1016/j.autneu.2004.05.002; Tei C, 1995, J Cardiol, V26, P357; Van Vliet BN, 1999, J PHYSIOL-LONDON, V516, P885, DOI 10.1111/j.1469-7793.1999.0885u.x; Wichi R, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-14	30	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e87935	10.1371/journal.pone.0087935	http://dx.doi.org/10.1371/journal.pone.0087935			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828834	Green Published, Green Submitted, gold			2022-12-27	WOS:000336857400001
J	Sundberg, T; Petzold, M; Kohls, N; Falkenberg, T				Sundberg, Tobias; Petzold, Max; Kohls, Niko; Falkenberg, Torkel			Opposite Drug Prescription and Cost Trajectories following Integrative and Conventional Care for Pain - A Case-Control Study	PLOS ONE			English	Article							MEDICINE; THERAPY; BACK	Objectives: Pharmacotherapy may have a limited role in long-term pain management. Comparative trajectories of drug prescriptions and costs, two quality-of-care indicators for pain conditions, are largely unknown subsequent to conventional or integrative care (IC) management. The objectives of this study were to compare prescribed defined daily doses (DDD) and cost of first line drugs for pain patients referred to conventional or anthroposophic IC in Stockholm County, Sweden. Methods: In this retrospective high quality registry case-control study, IC and conventional care patients were identified through inpatient care registries and matched on pain diagnosis (ICD-10: M79), age, gender and socio-demographics. National drug registry data was used to investigate changes in DDD and costs from 90/180 days before, to 90/180 days after, index visits to IC and conventional care. The primary selected drug category was analgesics, complemented by musculo-skeletal system drugs (e.g. anti-inflammatories, muscle relaxants) and psycholeptics (e.g. hypnotics, sedatives). Results: After index care visits, conventional care pain patients (n = 1050) compared to IC patients (n = 213), were prescribed significantly more analgesics. The average (95% CI) group difference was 15.2 (6.0 to 24.3), p = 0.001, DDD/patient after 90 days; and 21.5 (7.4 to 35.6), p = 0.003, DDD/patient after 180 days. The cost of the prescribed and sold analgesics was significantly higher for conventional care after 90 days: euro/patient 10.7 (1.3 to 20.0), p = 0.025. Changes in drug prescription and costs for the other drug categories were not significantly different between groups. Conclusions: Drug prescriptions and costs of analgesics increased following conventional care and decreased following IC, indicating potentially fewer adverse drug events and beneficial societal cost savings with IC.	[Sundberg, Tobias; Falkenberg, Torkel] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Nursing, Res Grp Integrat Care, Huddinge, Sweden; [Sundberg, Tobias; Falkenberg, Torkel] I C Integrat Care Sci Ctr, Jarna, Sweden; [Petzold, Max] Univ Gothenburg, Ctr Appl Biostat Occupat & Environm Med, Gothenburg, Sweden; [Kohls, Niko] Univ Appl Sci & Arts, Div Integrat Hlth Promot, Coburg, Germany; [Kohls, Niko] Univ Munich, Generat Res Program, Bad Tolz, Germany; [Kohls, Niko] Samueli Inst, Brain Mind & Healing Program, Alexandria, VA USA	Karolinska Institutet; University of Gothenburg; Klinikum Coburg; University of Munich	Sundberg, T (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Nursing, Res Grp Integrat Care, Huddinge, Sweden.	tobias.sundberg@ki.se		Falkenberg, Torkel/0000-0002-8150-9380	Mahle (Germany); Ekhaga (Sweden); Vidar (Sweden); Jochnick (the Netherlands); Gyllenberg (Finland); Samueli Institute (USA)	Mahle (Germany); Ekhaga (Sweden); Vidar (Sweden); Jochnick (the Netherlands); Gyllenberg (Finland); Samueli Institute (USA)	Financial support: The study was partly funded by the Mahle (Germany), Ekhaga (Sweden), Vidar (Sweden), Jochnick (the Netherlands), Gyllenberg (Finland) and Samueli Institute (USA) charitable non-profit foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson S, 2012, ALTERN THER HEALTH M, V18, P25; Arman Maria, 2011, Complement Ther Clin Pract, V17, P170, DOI 10.1016/j.ctcp.2010.11.001; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; CAMbrella, 2013, ROADMAP EUR CAM RES; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; European Commission, 2014, FULL LIST OF HUMAN M; Experian AB, 2013, EXPERIAN MOSAIC LIVS; Gustavsson A, 2012, EUR J PAIN, V16, P289, DOI 10.1016/j.ejpain.2011.07.006; Hamre HJ, 2005, WIEN KLIN WOCHENSCHR, V117, P256, DOI 10.1007/s00508-005-0344-9; Kienle GS, 2006, COSTS ANTHROPOSOPHIC, P319; Kienle GS, 2006, ANTHROPOSOPHIC MED E, P1; Kooreman P, 2012, EUR J HEALTH ECON, V13, P769, DOI 10.1007/s10198-011-0330-2; National Institute for Health and Clinical Excellence (NICE), CG90 DEPR AD NICE GU; NCCAM, 2013, COMPL ALT INT HLTH W; NICE, 2009, CG88 LOW BACK PAIN N; Rosenquist RW, 2010, ANESTHESIOLOGY, V112, P810, DOI 10.1097/ALN.0b013e3181c43103; SBU, 2010, REH LANGV SMART; SBU, 2006, MET BEH LANGV SM; Stockholm County Council, 2013, VISS MED ADM STOD PR; Stockholm County Council, 2013, AVENZA MAPUBLISHER W; Sundberg T, 2013, EUR J INTEGR MED; Sundberg T, 2012, EUR J INTEGR MED S1, V4, P38; Sundberg T, 2013, ACCEPT PUBL FORSCHE; Sundberg T, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-107; Sundberg T, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-33; Sveriges Kommuner och Landsting, 2012, LAG VALFR LOV; Swedish National Board of Health and Welfare, 2013, LAKEMEDELSREGISTRET; Vidarkliniken, 2012, ANTROPOSOFISK MEDICI; Vidarkliniken, 2012, VID ANTR SJUKH JAM; World Health Organization, TRAD MED; World Health Organization (WHO), 2013, ICD 10 VERSION 2010	31	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96717	10.1371/journal.pone.0096717	http://dx.doi.org/10.1371/journal.pone.0096717			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827981	Green Published, Green Submitted, gold			2022-12-27	WOS:000336857400034
J	von Jonquieres, G; Froud, KE; Klugmann, CB; Wong, ACY; Housley, GD; Klugmann, M				von Jonquieres, Georg; Froud, Kristina E.; Klugmann, Claudia B.; Wong, Ann C. Y.; Housley, Gary D.; Klugmann, Matthias			Loss of Central Auditory Processing in a Mouse Model of Canavan Disease	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; A-DEFICIENT MICE; SPONGY DEGENERATION; METACHROMATIC LEUKODYSTROPHY; COCHLEAR FUNCTION; WHITE-MATTER; BRAIN; ASPARTOACYLASE; RESPONSES; HEARING	Canavan Disease (CD) is a leukodystrophy caused by homozygous null mutations in the gene encoding aspartoacylase (ASPA). ASPA-deficiency is characterized by severe psychomotor retardation, and excessive levels of the ASPA substrate N-acetylaspartate (NAA). ASPA is an oligodendrocyte marker and it is believed that CD has a central etiology. However, ASPA is also expressed by Schwann cells and ASPA-deficiency in the periphery might therefore contribute to the complex CD pathology. In this study, we assessed peripheral and central auditory function in the Aspa(lacZ/lacZ) rodent model of CD using auditory brainstem response (ABR). Increased ABR thresholds and the virtual loss of waveform peaks 4 and 5 from Aspa(lacZ/lacZ) mice, indicated altered central auditory processing in mutant mice compared with Aspa(wt/wt) controls and altered central auditory processing. Analysis of ABR latencies recorded from Aspa(lacZ/lacZ) mice revealed that the speed of nerve conduction was unchanged in the peripheral part of the auditory pathway, and impaired in the CNS. Histological analyses confirmed that ASPA was expressed in oligodendrocytes and Schwann cells of the auditory system. In keeping with our physiological results, the cellular organization of the cochlea, including the organ of Corti, was preserved and the spiral ganglion nerve fibres were normal in ASPA-deficientmice. In contrast, we detected substantial hypomyelination in the central auditory systemof Aspa(lacZ/lacZ) mice. In summary, our data suggest that the lack of ASPA in the CNS is responsible for the observed hearing deficits, while ASPA-deficiency in the cochlear nerve fibres is tolerated both morphologically and functionally.	[Klugmann, Matthias] Univ New S Wales, Sch Med Sci, Translat Neurosci Facil, Sydney, NSW, Australia; Univ New S Wales, Sch Med Sci, Dept Physiol, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Klugmann, M (corresponding author), Univ New S Wales, Sch Med Sci, Translat Neurosci Facil, Sydney, NSW, Australia.	m.klugmann@unsw.edu.au	von Jonquieres, Georg/W-1781-2019	von Jonquieres, Georg/0000-0002-7423-3355; Parley, Kristina E/0000-0002-5710-915X; Wong, Ann CY/0000-0001-7011-0369; Housley, Gary/0000-0002-8413-588X	EU FP7 LeukoTreat; Australian Research Council (ARC)	EU FP7 LeukoTreat; Australian Research Council (ARC)(Australian Research Council)	This work was supported by a project grant of the EU FP7 LeukoTreat and an Australian Research Council (ARC) Future Fellowship to MK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SS, 2013, MOL THER, V21, P2136, DOI 10.1038/mt.2013.138; BANKER BQ, 1964, NEUROLOGY, V14, P981, DOI 10.1212/WNL.14.11.981; BROWN FR, 1981, NEUROLOGY, V31, P980, DOI 10.1212/WNL.31.8.980; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cederholm JME, 2012, HEARING RES, V292, P71, DOI 10.1016/j.heares.2012.08.010; D'Hooge R, 1999, BRAIN RES, V847, P352, DOI 10.1016/S0006-8993(99)02085-5; ELKHATEEB I, 1988, BRAIN DEV-JPN, V10, P243; Fishman MA, 2006, OSKIS PEDIAT PRINCIP, P2378; HENRY KR, 1980, AUDIOLOGY, V19, P369; Hess B, 1996, P NATL ACAD SCI USA, V93, P14821, DOI 10.1073/pnas.93.25.14821; Ishiyama G, 2003, NEUROLOGY, V60, P1702, DOI 10.1212/01.WNL.0000065893.60879.D3; KAUL R, 1993, NAT GENET, V5, P118, DOI 10.1038/ng1093-118; Kemp DT, 2002, BRIT MED BULL, V63, P223, DOI 10.1093/bmb/63.1.223; Klugmann M, 2003, NEUROREPORT, V14, P1837, DOI 10.1097/00001756-200310060-00016; Klugmann Matthias, 2006, P303, DOI 10.1016/B978-012397632-1/50024-1; KLUVER H, 1953, J NEUROPATH EXP NEUR, V12, P400; Kuan CC, 2008, ACTA OTO-LARYNGOL, V128, P539, DOI 10.1080/00016480701258713; Leuzzi V, 2000, NEUROLOGY, V54, P2325, DOI 10.1212/WNL.54.12.2325; Madhavarao CN, 2005, P NATL ACAD SCI USA, V102, P5221, DOI 10.1073/pnas.0409184102; Madhavarao CN, 2004, J COMP NEUROL, V472, P318, DOI 10.1002/cne.20080; Matalon R, 2000, J GENE MED, V2, P165; MATALON R, 1995, J PEDIATR-US, V127, P511, DOI 10.1016/S0022-3476(95)70105-2; Mersmann N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020336; MIKAELIAN DO, 1979, LARYNGOSCOPE, V89, P1; OCHS R, 1979, NEUROLOGY, V29, P1089, DOI 10.1212/WNL.29.8.1089; ORYLAVOLLEE L, 1987, J NEUROCHEM, V48, P895, DOI 10.1111/j.1471-4159.1987.tb05601.x; Parham K, 2001, HANDBOOK OF MOUSE AUDITORY RESEARCH: FROM BEHAVIOR TO MOLECULAR BIOLOGY, P37; SACKS O, 1965, NEUROLOGY, V15, P165, DOI 10.1212/WNL.15.2.165; SUZUKI K, 1968, ACTA NEUROPATHOL, V10, P95, DOI 10.1007/BF00690515; Toriello H. V., 2004, HEREDITARY HEARING L; Traka M, 2008, J NEUROSCI, V28, P11537, DOI 10.1523/JNEUROSCI.1490-08.2008; van Bogaert L., 1949, ACTA NEUROL BELG, V49, P572; VANDERKNAAP MS, 1991, DEV MED CHILD NEUROL, V33, P849; von Jonquieres G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065646; Zafeiriou DI, 1999, BRAIN DEV-JPN, V21, P205, DOI 10.1016/S0387-7604(99)00003-0	35	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97374	10.1371/journal.pone.0097374	http://dx.doi.org/10.1371/journal.pone.0097374			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24826990	gold, Green Published, Green Submitted			2022-12-27	WOS:000336857400087
J	Xu, XL; Li, QK; Wang, JY; Zhang, LM; Tian, SN; Zhi, L; Li, QR; Sun, Y				Xu, Xingliang; Li, Qingkang; Wang, Jingyuan; Zhang, Leiming; Tian, Shengni; Zhi, Lin; Li, Qianru; Sun, Yue			Inorganic and Organic Nitrogen Acquisition by a Fern Dicranopteris dichotoma in a Subtropical Forest in South China	PLOS ONE			English	Article							AMINO-ACID-TRANSPORT; N UPTAKE; RAIN-FOREST; MAUNA-LOA; PLANTS; SOIL; ROOTS; NUTRITION; LINEARIS; AVAILABILITY	The fern Dicranopteris dichotoma is an important pioneer species of the understory in Masson pine (Pinus massoniana) forests growing on acidic soils in the subtropical and tropical China. To improve our understanding of the role of D. dichotoma in nitrogen (N) uptake of these forests, a short-term N-15 experiment was conducted at mountain ridge (MR, with low N level) and mountain foot (MF, with high N level). We injected N-15 tracers as 15 NH4, (NO3)-N-15 or N-15-glycine into the soil surrounding each plant at both MR and MF sites. Three hours after tracer injection, the fern D. dichotoma took up (NH4+)-N-15 significantly faster at MF than at MR, but it showed significantly slower uptake of (NO3-)-N-15 at MF than at MR. Consequently, (NO3-)-N-15 made greater contribution to the total N uptake (50% to the total N uptake) at MR than at MF, but N-15-glycine only contributed around 11% at both sites. Twenty-four hours after tracer injection, D. dichotoma preferred (NH4+)-N-15 (63%) at MR, whereas it preferred (NO3-)-N-15 (47%) at MF. We concluded that the D. dichotoma responds distinctly in its uptake pattern for three available N species over temporal and spatial scales, but mainly relies on inorganic N species in the subtropical forest. This suggests that the fern employs different strategies to acquire available N which depends on N levels and time.	[Xu, Xingliang; Li, Qingkang; Wang, Jingyuan; Zhang, Leiming; Li, Qianru; Sun, Yue] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China; [Li, Qianru; Sun, Yue] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Tian, Shengni; Zhi, Lin] Anhui Agr Univ, Coll Life Sci, Hefei, Anhui, Peoples R China; [Zhi, Lin] Xikou Jr Middle Sch, Xikou City, Zhejiang, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Anhui Agricultural University	Li, QK (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China.	liqk@igsnrr.ac.cn	Xu, Xingliang/P-9916-2015; wang, jingyuan/H-8917-2013	Xu, Xingliang/0000-0003-2869-4932; wang, jingyuan/0000-0001-7904-4695; Sun, Yue/0000-0002-2207-6423	National Basic Research Program of China [2012CB416903]; National Natural Science Foundation of China [41071209, 30970484]; National Key Technologies R D Program [2012BAC11B05-3]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technologies R D Program(National Key Technology R&D Program)	This study was supported by National Basic Research Program of China (2012CB416903) and the National Natural Science Foundation of China (41071209 and 30970484) and National Key Technologies R & D Program (2012BAC11B05-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen KM, 2013, J ECOL, V101, P819, DOI 10.1111/1365-2745.12070; BARBER SA, 1963, J AGR FOOD CHEM, V11, P204, DOI 10.1021/jf60127a017; CHAPIN FS, 1993, NATURE, V361, P150, DOI 10.1038/361150a0; CLARKSON DT, 1980, ANNU REV PLANT PHYS, V31, P239, DOI 10.1146/annurev.pp.31.060180.001323; Cohen AL, 1995, RESTOR ECOL, V3, P261, DOI 10.1111/j.1526-100X.1995.tb00093.x; Dahlman L, 2004, PLANTA, V219, P459, DOI 10.1007/s00425-004-1247-0; GRAY JT, 1983, J ECOL, V71, P43, DOI 10.2307/2259962; Hietz P, 1999, PLANT CELL ENVIRON, V22, P1435, DOI 10.1046/j.1365-3040.1999.00502.x; Hou Xue-Yu, 1983, ANN MISSOURI BOT GAR, V70, P509; Inselsbacher E, 2012, NEW PHYTOL, V195, P329, DOI 10.1111/j.1469-8137.2012.04169.x; Jones DL, 2005, SOIL BIOL BIOCHEM, V37, P413, DOI 10.1016/j.soilbio.2004.08.008; Kronzucker HJ, 1996, PLANT PHYSIOL, V110, P773, DOI 10.1104/pp.110.3.773; Kuzyakov Y, 2013, NEW PHYTOL, V198, P656, DOI 10.1111/nph.12235; Leadley PW, 1997, ECOL MONOGR, V67, P1, DOI 10.1890/0012-9615(1997)067[0001:AMONUB]2.0.CO;2; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; LI ZC, 1990, PLANT PHYSIOL, V94, P268, DOI 10.1104/pp.94.1.268; LI ZC, 1991, PLANT PHYSIOL, V96, P1338, DOI 10.1104/pp.96.4.1338; Liu ZF, 2012, PEDOBIOLOGIA, V55, P7, DOI 10.1016/j.pedobi.2011.07.014; McKane RB, 2002, NATURE, V415, P68, DOI 10.1038/415068a; Nacry P, 2013, PLANT SOIL, V370, P1, DOI 10.1007/s11104-013-1645-9; NASHOLM T, 1987, J CHROMATOGR, V396, P225, DOI 10.1016/S0021-9673(01)94060-9; Nasholm T, 1998, NATURE, V392, P914, DOI 10.1038/31921; Nasholm T, 2009, NEW PHYTOL, V182, P31, DOI 10.1111/j.1469-8137.2008.02751.x; NINNEMANN O, 1994, EMBO J, V13, P3464, DOI 10.1002/j.1460-2075.1994.tb06652.x; Russell AE, 1997, J TROP ECOL, V13, P579, DOI 10.1017/S0266467400010737; Russell AE, 1998, J ECOL, V86, P765, DOI 10.1046/j.1365-2745.1998.8650765.x; Schmidt S, 2003, PLANT SOIL, V248, P157, DOI 10.1023/A:1022352415728; Schmidt S, 1997, PLANT CELL ENVIRON, V20, P1231, DOI 10.1046/j.1365-3040.1997.d01-20.x; Schmidt S, 1999, AUST J PLANT PHYSIOL, V26, P253, DOI 10.1071/PP98116; Stoelken G, 2010, TREE PHYSIOL, V30, P1118, DOI 10.1093/treephys/tpq050; Tinker P.B., 2000, SOLUTE MOVEMENT RHIZ, V2nd, DOI [10.1093/oso/9780195124927.001.0001, DOI 10.1093/OSO/9780195124927.001.0001]; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; vonWiren N, 1997, PLANT SOIL, V196, P191, DOI 10.1023/A:1004241722172; Wanek W, 2002, FUNCT PLANT BIOL, V29, P733, DOI 10.1071/PP01238; Wanek W, 2008, FUNCT PLANT BIOL, V35, P51, DOI 10.1071/FP07191; Warren CR, 2006, FUNCT PLANT BIOL, V33, P653, DOI 10.1071/FP06045; Warren CR, 2007, TREE PHYSIOL, V27, P413, DOI 10.1093/treephys/27.3.413; Warren CR, 2009, TREE PHYSIOL, V29, P401, DOI 10.1093/treephys/tpn037; Watkins Jr J.E., 2006, THESIS; Zhao J, 2012, SOIL BIOL BIOCHEM, V49, P78, DOI 10.1016/j.soilbio.2012.02.020; Zheng H, 2008, J HYDROL, V356, P174, DOI 10.1016/j.jhydrol.2008.04.007	41	4	8	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e90075	10.1371/journal.pone.0090075	http://dx.doi.org/10.1371/journal.pone.0090075			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24829044	Green Published, Green Submitted, gold			2022-12-27	WOS:000336857400003
J	Zhang, MX; Zhao, XY; Cheng, H; Wang, L; Xi, B; Shen, Y; Hou, DQ; Mi, J				Zhang, Meixian; Zhao, Xiaoyuan; Cheng, Hong; Wang, Liang; Xi, Bo; Shen, Yue; Hou, Dongqing; Mi, Jie			Age- and Sex-Dependent Association between FTO rs9939609 and Obesity-Related Traits in Chinese Children and Adolescents	PLOS ONE			English	Article							BODY-MASS INDEX; FAT MASS; GENE VARIANT; CHILDHOOD; HERITABILITY; OVERWEIGHT; TIME; RISK; BMI	Background: The associations between common variants in the fat mass- and obesity-associated (FTO) gene and obesity-related traits may be age-dependent and may differ by sex. The present study aimed to assess the association of FTO rs9939609 with body mass index (BMI) and the risk of obesity from childhood to adolescence, and to determine the age at which the association becomes evident. Methods: Totally 757 obese and 2,746 non-obese Chinese children aged 6-18 years were genotyped for FTO rs9939609. Of these, a young sub-cohort (n = 777) aged 6-11 years was reexamined 6 years later. Obesity was defined using the sex- and age-specific BMI cut-offs recommended by the International Obesity Task Force. Results: The associations of FTO rs9939609 with BMI and obesity did not appear until children reached 12-14 years. The variant was associated with an increased BMI in boys (beta = 1.50, P = 0.004) and girls (beta = 0.97, P = 0.018), respectively. Thereafter, the magnitude of association increased in girls at ages 15-18 years (beta = 2.02, P < 0.001), but not boys (beta = 0.10, P > 0.05). Age was found to interact with the variant on BMI (P < 0.001) and obesity (P = 0.042) only in girls. In the sub-cohort, the associations of FTO rs9939609 with BMI (beta = 1.07, P = 0.008) and obesity (OR = 2.09, 95% CI: 1.12, 3.91) were only observed 6 years later (ages 12-18 years) in girls, even after adjusting for baseline BMI. Conclusions: The association between FTO rs9939609 and obesity-related traits may change from childhood to adolescence in Chinese individuals, and the association may start as early as age 12 years, especially in girls.	[Zhang, Meixian; Zhao, Xiaoyuan; Cheng, Hong; Shen, Yue; Hou, Dongqing; Mi, Jie] Capital Inst Pediat, Dept Epidemiol, Beijing, Peoples R China; [Zhang, Meixian; Mi, Jie] Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China; [Wang, Liang] E Tennessee State Univ, Dept Biostat & Epidemiol, Coll Publ Hlth, Johnson City, TN 37614 USA; [Xi, Bo] Shandong Univ, Sch Publ Hlth, Dept Maternal & Child Hlth Care, Jinan 250100, Peoples R China	Capital Institute of Pediatrics (CIP); Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; East Tennessee State University; Shandong University	Mi, J (corresponding author), Capital Inst Pediat, Dept Epidemiol, Beijing, Peoples R China.	jiemi@vip.163.com			National Basic Research Program of China (973 Program) [2013CB530605]; Beijing Municipal Science and Technology Key Project [D111100000611002, H030930030031]; Beijing Training Project for the Leading Talents in S T [2011LJ07]; Beijing Health System Leading Talent Grant [2009-1-08]; Capital Institute of Pediatrics	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Beijing Municipal Science and Technology Key Project; Beijing Training Project for the Leading Talents in S T; Beijing Health System Leading Talent Grant; Capital Institute of Pediatrics	This work was supported by grants from National Basic Research Program of China (973 Program, 2013CB530605), Beijing Municipal Science and Technology Key Project (D111100000611002, H030930030031), Beijing Training Project for the Leading Talents in S & T (2011LJ07), Beijing Health System Leading Talent Grant (2009-1-08) and Capital Institute of Pediatrics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergen SE, 2007, TWIN RES HUM GENET, V10, P423, DOI 10.1375/twin.10.3.423; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Elks Cathy E, 2012, Front Endocrinol (Lausanne), V3, P29, DOI 10.3389/fendo.2012.00029; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Germer Soren, 2003, Methods Mol Biol, V212, P197; Graff M, 2013, HUM MOL GENET, V22, P3597, DOI 10.1093/hmg/ddt205; Hakanen M, 2009, J CLIN ENDOCR METAB, V94, P1281, DOI 10.1210/jc.2008-1199; Hallman DM, 2012, INT J OBESITY, V36, P61, DOI 10.1038/ijo.2011.190; Hardy R, 2010, HUM MOL GENET, V19, P545, DOI 10.1093/hmg/ddp504; Haworth CMA, 2008, OBESITY, V16, P2663, DOI 10.1038/oby.2008.434; Jacobsson JA, 2008, BIOCHEM BIOPH RES CO, V368, P476, DOI 10.1016/j.bbrc.2008.01.087; Lobstein T., 2004, OBESITY REV OFFIC S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Loos RJF, 2008, OBES REV, V9, P246, DOI 10.1111/j.1467-789X.2008.00481.x; Lopez-Bermejo A, 2008, J CLIN ENDOCR METAB, V93, P1501, DOI 10.1210/jc.2007-2343; Marshall WA, 1986, HUMAN GROWTH, P171, DOI DOI 10.1007/978-1-4899-0522-2_8; McMurray F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003166; Qi L, 2008, DIABETES, V57, P3145, DOI 10.2337/db08-0006; Rutters F, 2011, J CLIN ENDOCR METAB, V96, pE939, DOI 10.1210/jc.2010-2413; Shan XY, 2010, INT J PEDIATR OBES, V5, P383, DOI 10.3109/17477160903572001; Wang J, 2012, INT J OBESITY, V36, P542, DOI 10.1038/ijo.2011.218; Wardle J, 2008, AM J CLIN NUTR, V87, P398, DOI 10.1093/ajcn/87.2.398; Xi B, 2011, AM J EPIDEMIOL, V173, P1256, DOI 10.1093/aje/kwr008; Xi B, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-107	24	24	24	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97545	10.1371/journal.pone.0097545	http://dx.doi.org/10.1371/journal.pone.0097545			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827155	Green Published, Green Submitted, gold			2022-12-27	WOS:000336857400108
J	Mattioli, TA; Leduc-Pessah, H; Skelhorne-Gross, G; Nicol, CJB; Milne, B; Trang, T; Cahill, CM				Mattioli, Theresa Alexandra; Leduc-Pessah, Heather; Skelhorne-Gross, Graham; Nicol, Chris J. B.; Milne, Brian; Trang, Tuan; Cahill, Catherine M.			Toll-Like Receptor 4 Mutant and Null Mice Retain Morphine-Induced Tolerance, Hyperalgesia, and Physical Dependence	PLOS ONE			English	Article							PRIMARY ASTROGLIAL CULTURES; PERIPHERAL-NERVE INJURY; ADENYLATE-CYCLASE; INDUCED ANALGESIA; OPIATE RECEPTORS; IMMUNE-RESPONSES; MU; MICROGLIA; LIPOPOLYSACCHARIDE; ACTIVATION	The innate immune system modulates opioid-induced effects within the central nervous system and one target that has received considerable attention is the toll-like receptor 4 (TLR4). Here, we examined the contribution of TLR4 in the development of morphine tolerance, hyperalgesia, and physical dependence in two inbred mouse strains: C3H/HeJ mice which have a dominant negative point mutation in the Tlr4 gene rendering the receptor non-functional, and B10ScNJ mice which are TLR4 null mutants. We found that neither acute antinociceptive response to a single dose of morphine, nor the development of analgesic tolerance to repeated morphine treatment, was affected by TLR4 genotype. Likewise, opioid induced hyperalgesia and opioid physical dependence (assessed by naloxone precipitated withdrawal) were not altered in TLR4 mutant or null mice. We also examined the behavioural consequence of two stereoisomers of naloxone: (-) naloxone, an opioid receptor antagonist, and (+) naloxone, a purported antagonist of TLR4. Both stereoisomers of naloxone suppressed opioid induced hyperalgesia in wild-type control, TLR4 mutant, and TLR4 null mice. Collectively, our data suggest that TLR4 is not required for opioid-induced analgesic tolerance, hyperalgesia, or physical dependence.	[Mattioli, Theresa Alexandra; Nicol, Chris J. B.; Milne, Brian; Cahill, Catherine M.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Leduc-Pessah, Heather; Trang, Tuan] Univ Calgary, Hotchkiss Brain Inst, Dept Comparat Biol & Expt Med, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Skelhorne-Gross, Graham; Nicol, Chris J. B.] Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada; [Skelhorne-Gross, Graham; Nicol, Chris J. B.] Queens Univ, Canc Res Inst, Canc Biol & Genet Div, Kingston, ON, Canada; [Milne, Brian] Queens Univ, Dept Anaesthesiol & Perioperat Med, Kingston, ON, Canada; [Cahill, Catherine M.] Univ Calif Irvine, Dept Anesthesiol & Perioperat Care, Irvine, CA USA	Queens University - Canada; University of Calgary; McMaster University; Queens University - Canada; Queens University - Canada; Queens University - Canada; University of California System; University of California Irvine	Cahill, CM (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	cmcahill@uci.edu	Cahill, Catherine M/J-6524-2019; Leduc-Pessah, Heather/HCH-2964-2022		Canadian Institutes of Health Research (CIHR); Canadian Foundation for Innovation; National Sciences and Engineering Research Council (NSERC); Ontario Graduate Scholarship (OGS)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); National Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship (OGS)(Ontario Graduate Scholarship)	This work was supported by grants from the Canadian Institutes of Health Research (CIHR) and the Canadian Foundation for Innovation awarded to CMC, and from the National Sciences and Engineering Research Council (NSERC) awarded to TAM. TT was supported by grants from NSERC and the Canadian Foundation for Innovation. GSG was supported in part by an Ontario Graduate Scholarship (OGS). CMC was a Canadian Research Chair in chronic pain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELBASSET E, 1995, J NEUROSCI RES, V41, P222, DOI 10.1002/jnr.490410210; Bettoni I, 2008, GLIA, V56, P1312, DOI 10.1002/glia.20699; Bowman CC, 2003, GLIA, V43, P281, DOI 10.1002/glia.10256; Cheng PY, 1997, BRAIN RES, V778, P367, DOI 10.1016/S0006-8993(97)00891-3; Cicero TJ, 1996, J PHARMACOL EXP THER, V279, P767; Cook CD, 2000, PSYCHOPHARMACOLOGY, V150, P430, DOI 10.1007/s002130000453; Crain SM, 2000, BRAIN RES, V856, P227, DOI 10.1016/S0006-8993(99)02446-4; DOBRENIS K, 1995, BRAIN RES, V686, P239, DOI 10.1016/0006-8993(95)00452-V; Elmer GI, 1998, PAIN, V75, P129, DOI 10.1016/S0304-3959(97)00215-7; ERIKSSON PS, 1991, NEUROPHARMACOLOGY, V30, P1233, DOI 10.1016/0028-3908(91)90170-G; ERIKSSON PS, 1990, NEUROCHEM RES, V15, P1123, DOI 10.1007/BF01101714; Ferrini F, 2013, NAT NEUROSCI, V16, P183, DOI 10.1038/nn.3295; Forshammar J, 2011, J BIOL CHEM, V286, P31586, DOI 10.1074/jbc.M111.247767; Fukagawa H, 2013, J ANESTH, V27, P93, DOI 10.1007/s00540-012-1469-4; Hamann SR, 2004, RECEPTOR CHANNEL, V10, P73, DOI 10.1080/10606820490464334; Hameed H, 2010, CURR PAIN HEADACHE R, V14, P96, DOI 10.1007/s11916-010-0093-y; He L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018190; Horvath RJ, 2010, PAIN, V150, P401, DOI 10.1016/j.pain.2010.02.042; Horvath RJ, 2009, J NEUROSCI, V29, P998, DOI 10.1523/JNEUROSCI.4595-08.2009; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hutchinson MR, 2012, J NEUROSCI, V32, P11187, DOI 10.1523/JNEUROSCI.0684-12.2012; Hutchinson Mark R, 2007, ScientificWorldJournal, V7, P98; Hutchinson MR, 2010, BRAIN BEHAV IMMUN, V24, P83, DOI 10.1016/j.bbi.2009.08.004; Jack CS, 2005, J IMMUNOL, V175, P4320, DOI 10.4049/jimmunol.175.7.4320; Kest B, 1999, J PHARMACOL EXP THER, V289, P1370; Kigerl KA, 2007, J NEUROCHEM, V102, P37, DOI 10.1111/j.1471-4159.2007.04524.x; KOSKI G, 1981, P NATL ACAD SCI-BIOL, V78, P4185, DOI 10.1073/pnas.78.7.4185; Le Bars D, 2001, PHARMACOL REV, V53, P597; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Lehnardt S, 2002, J NEUROSCI, V22, P2478, DOI 10.1523/JNEUROSCI.22-07-02478.2002; Liu B, 2000, J PHARMACOL EXP THER, V293, P607; Liu L, 2011, BRAIN BEHAV IMMUN, V25, P1223, DOI 10.1016/j.bbi.2011.03.016; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; Mattioli TAM, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-22; Merighi S, 2013, BIOCHEM PHARMACOL, V86, P487, DOI 10.1016/j.bcp.2013.05.027; Mogil JS, 1996, J PHARMACOL EXP THER, V276, P532; Peckham EM, 2005, BRAIN RES, V1058, P137, DOI 10.1016/j.brainres.2005.07.060; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Raghavendra V, 2004, NEUROPSYCHOPHARMACOL, V29, P327, DOI 10.1038/sj.npp.1300315; Raghavendra V, 2003, PAIN, V104, P655, DOI 10.1016/S0304-3959(03)00138-6; Raghavendra V, 2002, J NEUROSCI, V22, P9980, DOI 10.1523/jneurosci.22-22-09980.2002; Rivat C, 2014, BRAIN BEHAV IMMUN, V38, P38, DOI 10.1016/j.bbi.2013.11.010; Ruzicka BB, 1995, MOL BRAIN RES, V34, P209, DOI 10.1016/0169-328X(95)00165-O; SEMENOVA S, 1995, PHARMACOL BIOCHEM BE, V50, P17, DOI 10.1016/0091-3057(94)00221-4; Song P, 2001, NEUROSCI RES, V39, P281, DOI 10.1016/S0168-0102(00)00226-1; Sorge RE, 2011, J NEUROSCI, V31, P15450, DOI 10.1523/JNEUROSCI.3859-11.2011; Stevens CW, 2013, BRIT J PHARMACOL, V168, P1421, DOI 10.1111/bph.12028; Stiene-Martin A, 1998, GLIA, V22, P249, DOI 10.1002/(SICI)1098-1136(199803)22:3<249::AID-GLIA4>3.0.CO;2-0; Tanga FY, 2005, P NATL ACAD SCI USA, V102, P5856, DOI 10.1073/pnas.0501634102; Terner JM, 2006, PAIN, V122, P90, DOI 10.1016/j.pain.2006.01.019; Trang T, 2006, PAIN, V126, P256, DOI 10.1016/j.pain.2006.07.008; Wang XH, 2012, P NATL ACAD SCI USA, V109, P6325, DOI 10.1073/pnas.1200130109; Wu HE, 2007, EUR J PHARMACOL, V571, P145, DOI 10.1016/j.ejphar.2007.06.012; Yoon SY, 2012, NEUROSCIENCE, V221, P214, DOI 10.1016/j.neuroscience.2012.06.024; Zhang Y, 2011, NEUROSCI LETT, V489, P43, DOI 10.1016/j.neulet.2010.11.063	55	64	66	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97361	10.1371/journal.pone.0097361	http://dx.doi.org/10.1371/journal.pone.0097361			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824631	gold, Green Published			2022-12-27	WOS:000336369200103
J	Sarkar, S; Zhang, L; Subramaniam, P; Lee, KB; Garfunkel, E; Strickland, PAO; Mainelis, G; Lioy, PJ; Tetley, TD; Chung, KF; Zhang, JF; Ryan, M; Porter, A; Schwander, S				Sarkar, Srijata; Zhang, Lin; Subramaniam, Prasad; Lee, Ki-Bum; Garfunkel, Eric; Strickland, Pamela A. Ohman; Mainelis, Gediminas; Lioy, Paul J.; Tetley, Teresa D.; Chung, Kian Fan; Zhang, Junfeng; Ryan, Mary; Porter, Alex; Schwander, Stephan			Variability in Bioreactivity Linked to Changes in Size and Zeta Potential of Diesel Exhaust Particles in Human Immune Cells	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; PARTICULATE MATTER; ALVEOLAR MACROPHAGES; INFLAMMATORY MEDIATORS; ULTRAFINE PARTICLES; AIR-POLLUTION; INFECTION; CYTOKINE; SUPPRESSION; INHALATION	Acting as fuel combustion catalysts to increase fuel economy, cerium dioxide (ceria, CeO2) nanoparticles have been used in Europe as diesel fuel additives (Envirox (TM)). We attempted to examine the effects of particles emitted from a diesel engine burning either diesel (diesel exhaust particles, DEP) or diesel doped with various concentrations of CeO2 (DEP-Env) on innate immune responses in THP-1 and primary human peripheral blood mononuclear cells (PBMC). Batches of DEP and DEP-Env were obtained on three separate occasions using identical collection and extraction protocols with the aim of determining the reproducibility of particles generated at different times. However, we observed significant differences in size and surface charge (zeta potential) of the DEP and DEP-Env across the three batches. We also observed that exposure of THP-1 cells and PBMC to identical concentrations of DEP and DEP-Env from the three batches resulted in statistically significant differences in bioreactivity as determined by IL-1 beta, TNF-alpha, IL-6, IFN-gamma, and IL-12p40 mRNA (by qRT-PCR) and protein expression (by ELISPOT assays). Importantly, bioreactivity was noted in very tight ranges of DEP size (60 to 120 nm) and zeta potential (-37 to -41 mV). Thus, these physical properties of DEP and DEP-Env were found to be the primary determinants of the bioreactivity measured in this study. Our findings also point to the potential risk of over-or under-estimation of expected bioreactivity effects (and by inference of public health risks) from bulk DEP use without taking into account potential batch-to-batch variations in physical (and possibly chemical) properties.	[Sarkar, Srijata; Zhang, Lin; Schwander, Stephan] Rutgers Sch Publ Hlth, Dept Environm & Occupat Hlth, Piscataway, NJ 08854 USA; [Subramaniam, Prasad; Lee, Ki-Bum; Garfunkel, Eric] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ USA; [Strickland, Pamela A. Ohman] Rutgers Sch Publ Hlth, Dept Biostat, Piscataway, NJ USA; [Mainelis, Gediminas] Rutgers State Univ, Dept Environm Sci, New Brunswick, NJ 08903 USA; [Mainelis, Gediminas; Lioy, Paul J.; Schwander, Stephan] Rutgers State Univ, Environm & Occupat Hlth Sci Inst, Piscataway, NJ USA; [Tetley, Teresa D.; Chung, Kian Fan] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Tetley, Teresa D.; Chung, Kian Fan] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Zhang, Junfeng] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Ryan, Mary] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London, England; [Ryan, Mary] Univ London Imperial Coll Sci Technol & Med, London Ctr Nanotechnol, London, England; [Schwander, Stephan] Rutgers Sch Publ Hlth, Ctr Global Publ Hlth, Piscataway, NJ USA; [Lioy, Paul J.] Rutgers State Univ, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Imperial College London; Duke University; Duke University; Imperial College London; Imperial College London; University of London; University College London; Rutgers State University New Brunswick; Rutgers State University Medical Center	Schwander, S (corresponding author), Rutgers Sch Publ Hlth, Dept Environm & Occupat Hlth, Piscataway, NJ 08854 USA.	schwansk@sph.rutgers.edu	Lioy, Paul J/F-6148-2011; Lee, Ki-Bum/G-7503-2015; Tetley, Teresa D/B-3288-2016; Mainelis, Gediminas/A-9340-2013; Zhang, Junfeng/AAJ-9183-2020; Chung, Kian Fan/B-1872-2012; Chung, Kian Fan/I-8456-2019; Subramaniam, Prasad/C-1746-2015	Mainelis, Gediminas/0000-0002-5837-0413; Zhang, Junfeng/0000-0003-3759-6672; Chung, Kian Fan/0000-0001-7101-1426; Chung, Kian Fan/0000-0001-7101-1426; Subramaniam, Prasad/0000-0002-4460-3773; LEE, Ki-Bum/0000-0002-8164-0047	US - UK Research Program: Environmental Behavior, Bioavailability and Effects of Manufactured Nanomaterials [EPA-G2008-STRAT-R1]; NIEHS [R01ES020382-02]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020382] Funding Source: NIH RePORTER	US - UK Research Program: Environmental Behavior, Bioavailability and Effects of Manufactured Nanomaterials; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding Sources: Joint US - UK Research Program: Environmental Behavior, Bioavailability and Effects of Manufactured Nanomaterials (EPA-G2008-STRAT-R1) and NIEHS R01ES020382-02 (S. Schwander). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amakawa K, 2003, EXP LUNG RES, V29, P149, DOI 10.1080/01902140303770; Bayram H, 1998, AM J RESP CELL MOL, V18, P441, DOI 10.1165/ajrcmb.18.3.2882; Becker S, 1999, J TOXICOL ENV HEAL A, V57, P445, DOI 10.1080/009841099157539; BOYUM A, 1976, SCAND J IMMUNOL, P9, DOI 10.1111/j.1365-3083.1976.tb03851.x; Cassee FR, 2012, ENVIRON RES, V115, P1, DOI 10.1016/j.envres.2012.03.004; Cassee FR, 2011, CRIT REV TOXICOL, V41, P213, DOI 10.3109/10408444.2010.529105; Cohen AJ, 2005, J TOXICOL ENV HEAL A, V68, P1301, DOI 10.1080/15287390590936166; Fariss MW, 2013, TOXICOL SCI, V132, P253, DOI 10.1093/toxsci/kft001; Finkelman FD, 2004, J IMMUNOL, V172, P3808, DOI 10.4049/jimmunol.172.6.3808; Furuyama A, 2009, ARCH TOXICOL, V83, P429, DOI 10.1007/s00204-008-0371-1; Gillespie P, 2013, NEUROTOXICOLOGY, V36, P112, DOI 10.1016/j.neuro.2011.10.006; Health Effects Institute (HEI), 2001, EV HUM HLTH RISK CER; Hiramatsu K, 2005, EXP LUNG RES, V31, P405, DOI 10.1080/01902140590918786; Jung HJ, 2005, COMBUST FLAME, V142, P276, DOI 10.1016/j.combustflame.2004.11.015; Katterman ME, 2007, CHEMOSPHERE, V66, P567, DOI 10.1016/j.chemosphere.2006.05.037; Kreyling WG, 2013, ACCOUNTS CHEM RES, V46, P714, DOI 10.1021/ar300043r; Lundborg M, 2006, ENVIRON RES, V100, P197, DOI 10.1016/j.envres.2005.08.007; Manchester-Neesvig JB, 2003, J AIR WASTE MANAGE, V53, P1065, DOI 10.1080/10473289.2003.10466265; Mundandhara SD, 2006, TOXICOL IN VITRO, V20, P614, DOI 10.1016/j.tiv.2005.10.018; Ohtani T, 2005, J IMMUNOL, V174, P2412, DOI 10.4049/jimmunol.174.4.2412; Pacheco KA, 2001, CLIN EXP IMMUNOL, V126, P374, DOI 10.1046/j.1365-2249.2001.01698.x; Park B, 2008, INHAL TOXICOL, V20, P547, DOI [10.1080/08958370801915309, 10.1080/08958370801915309 ]; Park Barry, 2007, Part Fibre Toxicol, V4, P12, DOI 10.1186/1743-8977-4-12; Sarkar S, 2012, J IMMUNOL, V188, P2778, DOI 10.4049/jimmunol.1101380; Sawyer K, 2010, J TOXICOL ENV HEAL A, V73, P41, DOI 10.1080/15287390903248901; Sawyer K, 2008, J BREATH RES, V2, DOI 10.1088/1752-7155/2/3/037019; Saxena RK, 2003, TOXICOL SCI, V73, P66, DOI 10.1093/toxsci/kfg048; Seagrave J, 2004, INHAL TOXICOL, V16, P93, DOI 10.1080/08958370490443178; Totlandsdal AI, 2013, ENVIRON TOXICOL, DOI [10.1002/tox, DOI 10.1002/T0X]; United States Pharmacopia, 2011, BACT END, P78; Veronesi B, 2002, TOXICOL APPL PHARM, V178, P144, DOI 10.1006/taap.2001.9341; Vogel CFA, 2005, ENVIRON HEALTH PERSP, V113, P1536, DOI 10.1289/ehp.8094; Yang HM, 2001, ENVIRON HEALTH PERSP, V109, P515, DOI 10.2307/3454711; Yin F, 2013, ARTERIOSCL THROM VAS, V33, P1153, DOI 10.1161/ATVBAHA.112.300552; Yin XJJ, 2007, J TOXICOL ENV HEAL A, V70, P820, DOI 10.1080/15287390701209766; Zhang JF, 2013, ENVIRON SCI TECHNOL, V47, P13077, DOI 10.1021/es402140u; Zhao JZ, 2013, OCCUP ENVIRON MED, V70, P426, DOI 10.1136/oemed-2012-100864	37	8	8	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97304	10.1371/journal.pone.0097304	http://dx.doi.org/10.1371/journal.pone.0097304			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24825358	Green Published, gold			2022-12-27	WOS:000336369200091
J	Lindskog, M; Winman, A				Lindskog, Marcus; Winman, Anders			Are All Data Created Equal? - Exploring Some Boundary Conditions for a Lazy Intuitive Statistician	PLOS ONE			English	Article							PROBABILISTIC INFERENCE; CONTINGENCY JUDGMENTS; KNOWLEDGE; PRIMACY; EXEMPLAR; MODELS; FREQUENCY; DECISION; ORDER	The study investigated potential effects of the presentation order of numeric information on retrospective subjective judgments of descriptive statistics of this information. The studies were theoretically motivated by the assumption in the naive sampling model of independence between temporal encoding order of data in long-term memory and retrieval probability (i.e. as implied by a "random sampling'' from memory metaphor). In Experiment 1, participants experienced Arabic numbers that varied in distribution shape/variability between the first and the second half of the information sequence. Results showed no effects of order on judgments of mean, variability or distribution shape. To strengthen the interpretation of these results, Experiment 2 used a repeated judgment procedure, with an initial judgment occurring prior to the change in distribution shape of the information half-way through data presentation. The results of Experiment 2 were in line with those from Experiment 1, and in addition showed that the act of making explicit judgments did not impair accuracy of later judgments, as would be suggested by an anchoring and insufficient adjustment strategy. Overall, the results indicated that participants were very responsive to the properties of the data while at the same time being more or less immune to order effects. The results were interpreted as being in line with the naive sampling models in which values are stored as exemplars and sampled randomly from long-term memory.	[Lindskog, Marcus; Winman, Anders] Uppsala Univ, Dept Psychol, Uppsala, Sweden	Uppsala University	Lindskog, M (corresponding author), Uppsala Univ, Dept Psychol, Uppsala, Sweden.	marcus.lindskog@psyk.uu.se	Lindskog, Marcus/M-9803-2019	Lindskog, Marcus/0000-0003-1326-6177; Winman, Anders/0000-0002-5572-5370	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This research was sponsored by the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aha DW, 1997, ARTIF INTELL REV, V11, P7, DOI 10.1023/A:1006538427943; ALLAN LG, 1993, PSYCHOL BULL, V114, P435, DOI 10.1037/0033-2909.114.3.435; ASHBY FG, 1993, J MATH PSYCHOL, V37, P372, DOI 10.1006/jmps.1993.1023; BREHMER B, 1974, ORGAN BEHAV HUM PERF, V11, P1, DOI 10.1016/0030-5073(74)90002-6; Brown NR, 1996, PSYCHON B REV, V3, P385, DOI 10.3758/BF03210766; BROWN NR, 1995, J EXP PSYCHOL LEARN, V21, P1539, DOI 10.1037/0278-7393.21.6.1539; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; DeLosh EL, 1997, J EXP PSYCHOL LEARN, V23, P968, DOI 10.1037/0278-7393.23.4.968; Dennis MJ, 2001, MEM COGNITION, V29, P152, DOI 10.3758/BF03195749; Dougherty MR, 2008, PSYCHOL REV, V115, P199, DOI 10.1037/0033-295X.115.1.199; Fiedler K, 2000, PSYCHOL REV, V107, P659, DOI 10.1037//0033-295X.107.4.659; Fiedler K, 2006, INFORMATION SAMPLING AND ADAPTIVE COGNITION, P3; FLANNAGAN MJ, 1986, J EXP PSYCHOL LEARN, V12, P241, DOI 10.1037/0278-7393.12.2.241; FOX S, 1993, PERCEPT MOTOR SKILL, V76, P259, DOI 10.2466/pms.1993.76.1.259; Galesic M, 2012, PSYCHOL SCI, V23, P1515, DOI 10.1177/0956797612445313; Galesic M, 2011, MED DECIS MAKING, V31, P444, DOI 10.1177/0272989X10373805; Gilovich T., 2002, HEURISTICS BIASES PS, DOI [DOI 10.1017/CBO9780511808098.004, DOI 10.1017/CBO9780511808098]; Glautier S, 2008, MEM COGNITION, V36, P1087, DOI 10.3758/MC.36.6.1087; Griffiths TL, 2006, PSYCHOL SCI, V17, P767, DOI 10.1111/j.1467-9280.2006.01780.x; Griffiths TL, 2011, J EXP PSYCHOL GEN, V140, P725, DOI 10.1037/a0024899; HENDRICK C, 1970, PSYCHON SCI, V19, P121, DOI 10.3758/BF03337452; Hertwig R, 2004, PSYCHOL SCI, V15, P534, DOI 10.1111/j.0956-7976.2004.00715.x; HINTZMAN DL, 1988, PSYCHOL REV, V95, P528, DOI 10.1037/0033-295X.95.4.528; HOGARTH RM, 1992, COGNITIVE PSYCHOL, V24, P1, DOI 10.1016/0010-0285(92)90002-J; Juslin P, 2002, COGNITIVE SCI, V26, P563, DOI 10.1207/s15516709cog2605_2; Juslin P, 2008, COGNITION, V106, P259, DOI 10.1016/j.cognition.2007.02.003; Juslin P, 2007, PSYCHOL REV, V114, P678, DOI 10.1037/0033-295X.114.3.678; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kalish ML, 2007, PSYCHON B REV, V14, P288, DOI 10.3758/BF03194066; Kalish ML, 2004, PSYCHOL REV, V111, P1072, DOI 10.1037/0033-295x.111.4.1072; Kareev Y, 2002, J EXP PSYCHOL GEN, V131, P287, DOI 10.1037//0096-3445.131.2.287; LICHTENSTEIN S, 1978, J EXP PSYCHOL-HUM L, V4, P551, DOI 10.1037/0278-7393.4.6.551; Lindskog M, 2013, J COGN PSYCHOL, V25, P994, DOI 10.1080/20445911.2013.841170; Lindskog M, 2013, J EXP PSYCHOL LEARN, V39, P782, DOI 10.1037/a0029670; Lopez FJ, 1998, J EXP PSYCHOL LEARN, V24, P672, DOI 10.1037/0278-7393.24.3.672; MALMI RA, 1983, J VERB LEARN VERB BE, V22, P547, DOI 10.1016/S0022-5371(83)90337-7; NISBETT RE, 1985, J PERS SOC PSYCHOL, V48, P297, DOI 10.1037/0022-3514.48.2.297; Nosofsky RM, 2000, PSYCHON B REV, V7, P375; Oaksford M, 2009, BEHAV BRAIN SCI, V32, P69, DOI 10.1017/S0140525X09000284; PETERSON CR, 1967, PSYCHOL BULL, V68, P29, DOI 10.1037/h0024722; POLLARD P, 1984, Current Psychological Research and Reviews, V3, P5, DOI 10.1007/BF02686528; Rescorla, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Shi L, 2010, PSYCHON B REV, V17, P443, DOI 10.3758/PBR.17.4.443; Tenenbaum JB, 2011, SCIENCE, V331, P1279, DOI 10.1126/science.1192788; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; von Helversen B, 2008, J EXP PSYCHOL GEN, V137, P73, DOI 10.1037/0096-3445.137.1.73; YATES JF, 1986, ACTA PSYCHOL, V62, P293, DOI 10.1016/0001-6918(86)90092-2	47	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97686	10.1371/journal.pone.0097686	http://dx.doi.org/10.1371/journal.pone.0097686			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1NZ	24834913	Green Published, gold, Green Submitted			2022-12-27	WOS:000339614800063
J	Bidgood, A; Ambridge, B; Pine, JM; Rowland, CF				Bidgood, Amy; Ambridge, Ben; Pine, Julian M.; Rowland, Caroline F.			The Retreat from Locative Overgeneralisation Errors: A Novel Verb Grammaticality Judgment Study	PLOS ONE			English	Article							ARGUMENT-STRUCTURE; NEGATIVE EVIDENCE; SEMANTICS; CHILDRENS; ENTRENCHMENT; ACQUISITION; LANGUAGE; FREQUENCY; SYNTAX	Whilst some locative verbs alternate between the ground-and figure-locative constructions (e. g. Lisa sprayed the flowers with water/Lisa sprayed water onto the flowers), others are restricted to one construction or the other (e. g. *Lisa filled water into the cup/*Lisa poured the cup with water). The present study investigated two proposals for how learners (aged 5-6, 9-10 and adults) acquire this restriction, using a novel-verb-learning grammaticality-judgment paradigm. In support of the semantic verb class hypothesis, participants in all age groups used the semantic properties of novel verbs to determine the locative constructions (ground/figure/both) in which they could and could not appear. In support of the frequency hypothesis, participants' tolerance of overgeneralisation errors decreased with each increasing level of verb frequency (novel/low/high). These results underline the need to develop an integrated account of the roles of semantics and frequency in the retreat from argument structure overgeneralisation.	[Bidgood, Amy; Ambridge, Ben; Pine, Julian M.; Rowland, Caroline F.] Univ Liverpool, Dept Psychol Sci, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Bidgood, A (corresponding author), Univ Liverpool, Dept Psychol Sci, Liverpool L69 3BX, Merseyside, England.	amy.bidgood@liv.ac.uk	; Pine, Julian/B-6622-2015; Rowland, Caroline/U-5257-2018	Bidgood, Amy/0000-0002-9719-4256; Ambridge, Ben/0000-0003-2389-8477; Pine, Julian/0000-0002-7077-9713; Rowland, Caroline/0000-0002-8675-8669	Economic and Social Research Council [RES-062-23-0931]; Leverhulme Trust [RPG-158]	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Leverhulme Trust(Leverhulme Trust)	This study was funded by Grant RES-062-23-0931 from the Economic and Social Research Council (http://www.esrc.ac.uk/) and Grant RPG-158 from the Leverhulme Trust (http://www.leverhulme.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2002, CATEGORICAL DATA ANA, V359; Alishahi A, 2008, COGNITIVE SCI, V32, P789, DOI 10.1080/03640210801929287; Ambridge B, 2011, GUIDE RES METHODS CH, P113; Ambridge B., 2011, CHILD LANGUAGE ACQUI; Ambridge B, 2008, COGNITION, V106, P87, DOI 10.1016/j.cognition.2006.12.015; Ambridge B, 2012, LANGUAGE, V88, P45, DOI 10.1353/lan.2012.0000; Ambridge B, 2012, COGNITION, V123, P260, DOI 10.1016/j.cognition.2012.01.002; Ambridge B, 2011, COGN LINGUIST, V22, P303, DOI 10.1515/COGL.2011.012; Ambridge B, 2009, COGNITIVE SCI, V33, P1301, DOI 10.1111/j.1551-6709.2009.01055.x; ANDERSON SR, 1971, FOUND LANG, V7, P387; [Anonymous], 2006, AN STUD PROV 5 5; Boas HansC., 2008, REV CANARIA ESTUDIOS, V57, P17; BOWERMAN M, 1978, CHILD DEV, V49, P977, DOI 10.1111/j.1467-8624.1978.tb04066.x; BOWERMAN M, 1981, ANN NY ACAD SCI, V379, P172, DOI 10.1111/j.1749-6632.1981.tb42008.x; Bowerman M., 1982, QUADERNI SEMANTICA, V3, P5; Bowerman Melissa., 1988, EXPLAINING LANGUAGE, P73; Bowerman Melissa., 1982, LANG ACQUIS, V2nd ed., P319; Boyd JK, 2012, J IEEE I C DEVELOP L; Boyd JK, 2011, LANGUAGE, V87, P55, DOI 10.1353/lan.2011.0012; Braine MartinD.S., 1995, NAMES THINGS YOUNG C, P352; Brinkmann U, 1997, LOCATIVE ALTERNATION; Brooks PJ, 2002, J CHILD LANG, V29, P759, DOI 10.1017/S0305000902005287; Brooks PJ, 1999, CHILD DEV, V70, P1325, DOI 10.1111/1467-8624.00097; Brooks PJ, 1999, LANGUAGE, V75, P720, DOI 10.2307/417731; Chang F, 2006, PSYCHOL REV, V113, P234, DOI 10.1037/0033-295X.113.2.234; Chouinard MM, 2003, J CHILD LANG, V30, P637, DOI 10.1017/S0305000903005701; CLARK EV, 1988, J CHILD LANG, V15, P317, DOI 10.1017/S0305000900012393; Fellbaum C., 1999, INT J LEXICOGR, V4, P278, DOI DOI 10.1093/IJL/3.4.278; Fillmore CJ., 1967, P TEX S LANG UN APR; Goldberg Adele, 2006, CONSTRUCTIONS WORK N; Goldberg AE, 2011, COGN LINGUIST, V22, P131, DOI 10.1515/COGL.2011.006; Goldberg AdeleE., 1995, CONSTRUCTIONS CONSTR; GROPEN J, 1991, J CHILD LANG, V18, P115, DOI 10.1017/S0305000900013325; GROPEN J, 1991, COGNITION, V41, P153, DOI 10.1016/0010-0277(91)90035-3; GROPEN J, 1989, LANGUAGE, V65, P203, DOI 10.2307/415332; Hall BC, 1965, THESIS MIT; LEVIN B, 1986, LINGUIST INQ, V17, P623; Levin B., 1993, ENGLISH VERB CLASSES; Lord C, 1979, PAPERS REPORTS CHILD, V17; MacWhinney B, 2004, J CHILD LANG, V31, P883, DOI 10.1017/S0305000904006336; MARCUS GF, 1993, COGNITION, V46, P53, DOI 10.1016/0010-0277(93)90022-N; NAIGLES LG, 1992, COGNITIVE DEV, V7, P403, DOI 10.1016/0885-2014(92)80001-V; Naigles LR, 1998, J CHILD LANG, V25, P95, DOI 10.1017/S0305000997003358; Naigles LR, 2002, J CHILD LANG, V29, P545, DOI 10.1017/S0305000902005159; Perfors A, 2010, J CHILD LANG, V37, P607, DOI 10.1017/S0305000910000012; Pinker Steven., 1989, LEARNABILITY COGNITI; Stefanowitsch A, 2008, COGN LINGUIST, V19, P513, DOI 10.1515/COGL.2008.020; The British National Corpus, 2007, BNC XML ED; Theakston AL, 2004, COGNITIVE DEV, V19, P15, DOI 10.1016/j.cogdev.2003.08.001; Tomasello M., 2003, CONSTRUCTING LANGUAG; Wonnacott E, 2011, J MEM LANG, V65, P1, DOI 10.1016/j.jml.2011.03.001	51	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97634	10.1371/journal.pone.0097634	http://dx.doi.org/10.1371/journal.pone.0097634			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3UI	24830412	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000336789500088
J	Comas, M; Arrospide, A; Mar, J; Sala, M; Vilaprinyo, E; Hernandez, C; Cots, F; Martinez, J; Castells, X				Comas, Merce; Arrospide, Arantzazu; Mar, Javier; Sala, Maria; Vilaprinyo, Ester; Hernandez, Cristina; Cots, Francesc; Martinez, Juan; Castells, Xavier			Budget Impact Analysis of Switching to Digital Mammography in a Population-Based Breast Cancer Screening Program: A Discrete Event Simulation Model	PLOS ONE			English	Article							FILM MAMMOGRAPHY; COST-EFFECTIVENESS; IMPLEMENTATION; TRANSITION; REDUCTION; INTERVAL	Objective: To assess the budgetary impact of switching from screen-film mammography to full-field digital mammography in a population-based breast cancer screening program. Methods: A discrete-event simulation model was built to reproduce the breast cancer screening process (biennial mammographic screening of women aged 50 to 69 years) combined with the natural history of breast cancer. The simulation started with 100,000 women and, during a 20-year simulation horizon, new women were dynamically entered according to the aging of the Spanish population. Data on screening were obtained from Spanish breast cancer screening programs. Data on the natural history of breast cancer were based on US data adapted to our population. A budget impact analysis comparing digital with screen-film screening mammography was performed in a sample of 2,000 simulation runs. A sensitivity analysis was performed for crucial screening-related parameters. Distinct scenarios for recall and detection rates were compared. Results: Statistically significant savings were found for overall costs, treatment costs and the costs of additional tests in the long term. The overall cost saving was 1,115,857(sic) (95%CI from 932,147 to 1,299,567) in the 10th year and 2,866,124(sic) (95% CI from 2,492,610 to 3,239,638) in the 20th year, representing 4.5% and 8.1% of the overall cost associated with screen-film mammography. The sensitivity analysis showed net savings in the long term. Conclusions: Switching to digital mammography in a population-based breast cancer screening program saves long-term budget expense, in addition to providing technical advantages. Our results were consistent across distinct scenarios representing the different results obtained in European breast cancer screening programs.	[Comas, Merce; Sala, Maria; Hernandez, Cristina; Castells, Xavier] Hosp del Mar, Epidemiol & Evaluat Dept, Barcelona, Spain; [Comas, Merce; Sala, Maria; Hernandez, Cristina; Cots, Francesc; Castells, Xavier] Hosp del Mar Med Res Inst IMIM, Barcelona, Spain; [Comas, Merce; Arrospide, Arantzazu; Mar, Javier; Sala, Maria; Vilaprinyo, Ester; Cots, Francesc; Castells, Xavier] Red Invest Serv Salud Enfermedades Cron REDISSEC, Valencia, Spain; [Arrospide, Arantzazu; Mar, Javier] Hosp Alto Deba, Gipuzkoa Oeste Res Unit, Arrasate Mondragon, Spain; [Vilaprinyo, Ester] Univ Lleida, Biomed Res Inst Lleida IRBLLEIDA, Basic Med Sci Dept, Lleida, Spain; [Cots, Francesc] Hosp del Mar, Management Control Dept, Barcelona, Spain; [Martinez, Juan] Hosp del Mar, Dept Radiol, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Universitat de Lleida; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Comas, M (corresponding author), Hosp del Mar, Epidemiol & Evaluat Dept, Barcelona, Spain.	mcomas@parcdesalutmar.cat	Castells, Xavier/S-7798-2016; Serrano, Merce Comas/O-3825-2014; Sala, Maria/H-2562-2013; Vilaprinyo, Ester/A-6702-2010; Serra, Maria Sala/O-9420-2019	Castells, Xavier/0000-0002-2528-0382; Serrano, Merce Comas/0000-0003-1926-2740; Sala, Maria/0000-0002-9955-8746; Vilaprinyo, Ester/0000-0002-5787-5890; Serra, Maria Sala/0000-0002-9955-8746; Sala Serra, Maria/0000-0002-5516-5967; Arrospide, Arantzazu/0000-0003-3537-6588; Cots, Francesc/0000-0003-0238-8902	Health Ministry of Spain (Fondo de Investigacion Sanitaria) [PI07/90357]	Health Ministry of Spain (Fondo de Investigacion Sanitaria)	This was supported by grants from the Health Ministry of Spain (Fondo de Investigacion Sanitaria PI07/90357). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascunce N, 2010, ANN ONCOL, V21, piii43; Baltussen R, 1999, PHARMACOECONOMICS, V16, P449, DOI 10.2165/00019053-199916050-00003; Bluekens AMJ, 2012, RADIOLOGY, V265, P707, DOI 10.1148/radiol.12111461; Chou R, 2009, ANN INTERN MED, V151, P44, DOI 10.7326/0003-4819-151-1-200907070-00008; Ciatto S, 2006, EUR J RADIOL, V57, P69, DOI 10.1016/j.ejrad.2005.08.010; Corral J, 2009, GAC SANIT, V23, P189; Cots F, 2012, GEST EVALUACION COST, V13, P369; Domingo L, 2011, EUR RADIOL, V21, P2020, DOI 10.1007/s00330-011-2143-1; Domingo L, 2010, CANCER CAUSE CONTROL, V21, P1155, DOI 10.1007/s10552-010-9541-6; Glynn CG, 2011, RADIOLOGY, V260, P664, DOI 10.1148/radiol.11110159; Hoff SR, 2012, RADIOLOGY, V264, P378, DOI 10.1148/radiol.12112074; Iared W, 2011, SAO PAULO MED J, V129, P250, DOI 10.1590/S1516-31802011000400009; Karnon J, 2012, VALUE HEALTH, V15, P821, DOI 10.1016/j.jval.2012.04.013; Kerlikowske K, 2011, ANN INTERN MED, V155, P493, DOI 10.7326/0003-4819-155-8-201110180-00005; Lee Sandra, 2006, J Natl Cancer Inst Monogr, P79, DOI 10.1093/jncimonographs/lgj011; Lee SJ, 1998, J AM STAT ASSOC, V93, P1271, DOI 10.2307/2670042; Mar J, 2010, VALUE HEALTH, V13, P69, DOI 10.1111/j.1524-4733.2009.00655.x; Martinez-Cantarero JF, 2006, REV ESP EC SALUD, V5, P230; Mauskopf JA, 2007, VALUE HEALTH, V10, P336, DOI 10.1111/j.1524-4733.2007.00187.x; Mauskopf Josephine A, 2005, Expert Rev Pharmacoecon Outcomes Res, V5, P65, DOI 10.1586/14737167.5.1.65; Nederend J, 2012, ANN ONCOL, V23, P3098, DOI 10.1093/annonc/mds146; Perry N, 2008, ANN ONCOL, V19, P614, DOI 10.1093/annonc/mdm481; Roman R, 2007, J EPIDEMIOL COMMUN H, V61, DOI 10.1136/jech.2006.052639; Rue M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-326; Sala M, 2011, RADIOLOGY, V258, P388, DOI 10.1148/radiol.10100874; Sala M, 2009, RADIOLOGY, V252, P31, DOI 10.1148/radiol.2521080696; Sarriugarte G, 2012, ESTUDIO COSTES PROGR; Skaane P, 2009, ACTA RADIOL, V50, P3, DOI 10.1080/02841850802563269; Timmers JM, 2011, EUR J PUBLIC HLTH; Tosteson ANA, 2008, ANN INTERN MED, V148, P1, DOI 10.7326/0003-4819-148-1-200801010-00002; Trueman P, 2001, PHARMACOECONOMICS, V19, P609, DOI 10.2165/00019053-200119060-00001; van de Wetering G, 2013, EUR J HEALTH ECON, V14, P911, DOI 10.1007/s10198-012-0435-2; Vilaprinyo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030157; Vilaprinyo E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-98; Vinnicombe S, 2009, RADIOLOGY, V251, P347, DOI 10.1148/radiol.2512081235; von Karsa L., 2008, CANC SCREENING EUROP; Wang SH, 2009, AUST NZ J PUBL HEAL, V33, P430, DOI 10.1111/j.1753-6405.2009.00424.x; White J, 2000, J NATL CANCER I, V92, P442, DOI 10.1093/jnci/92.6.442	38	19	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97459	10.1371/journal.pone.0097459	http://dx.doi.org/10.1371/journal.pone.0097459			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3UI	24832200	Green Published, Green Submitted, gold			2022-12-27	WOS:000336789500062
J	Fourati, Z; Kolesnikova, O; Back, R; Keller, J; Charenton, C; Taverniti, V; Plesse, CG; Lazar, N; Durand, D; van Tilbeurgh, H; Seraphin, B; Graille, M				Fourati, Zaineb; Kolesnikova, Olga; Back, Regis; Keller, Jenny; Charenton, Clement; Taverniti, Valerio; Plesse, Claudine Gaudon; Lazar, Noureddine; Durand, Dominique; van Tilbeurgh, Herman; Seraphin, Bertrand; Graille, Marc			The C-Terminal Domain from S. cerevisiae Pat1 Displays Two Conserved Regions Involved in Decapping Factor Recruitment	PLOS ONE			English	Article							MESSENGER-RNA DECAY; SM-LIKE PROTEINS; SACCHAROMYCES-CEREVISIAE; LSM1-7-PAT1 COMPLEX; PROCESSING-BODIES; DIFFRACTION DATA; YEAST; DEADENYLATION; DEGRADATION; MULTIPLE	Eukaryotic mRNA decay is a highly regulated process allowing cells to rapidly modulate protein production in response to internal and environmental cues. Mature translatable eukaryotic mRNAs are protected from fast and uncontrolled degradation in the cytoplasm by two cis-acting stability determinants: a methylguanosine (m(7)G) cap and a poly(A) tail at their 5' and 3' extremities, respectively. The hydrolysis of the m(7)G cap structure, known as decapping, is performed by the complex composed of the Dcp2 catalytic subunit and its partner Dcp1. The Dcp1-Dcp2 decapping complex has a low intrinsic activity and requires accessory factors to be fully active. Among these factors, Pat1 is considered to be a central scaffolding protein involved in Dcp2 activation but also in inhibition of translation initiation. Here, we present the structural and functional study of the C-terminal domain from S. cerevisiae Pat1 protein. We have identified two conserved and functionally important regions located at both extremities of the domain. The first region is involved in binding to Lsm1-7 complex. The second patch is specific for fungal proteins and is responsible for Pat1 interaction with Edc3. These observations support the plasticity of the protein interaction network involved in mRNA decay and show that evolution has extended the C-terminal alpha-helical domain from fungal Pat1 proteins to generate a new binding platform for protein partners.	[Fourati, Zaineb; Back, Regis; Charenton, Clement; Graille, Marc] Ecole Polytech, CNRS, UMR 7654, Biochim Lab, F-91128 Palaiseau, France; [Fourati, Zaineb; Keller, Jenny; Lazar, Noureddine; Durand, Dominique; van Tilbeurgh, Herman; Graille, Marc] Univ Paris 11, CNRS, UMR 8619, IBBMC, F-91405 Orsay, France; [Kolesnikova, Olga; Taverniti, Valerio; Plesse, Claudine Gaudon; Seraphin, Bertrand] Univ Strasbourg, INSERM, U964, CNRS,UMR 7104,IGBMC,Equipe Labellisee La Ligue, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Polytechnique de Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Seraphin, B (corresponding author), Univ Strasbourg, INSERM, U964, CNRS,UMR 7104,IGBMC,Equipe Labellisee La Ligue, Illkirch Graffenstaden, France.	seraphin@igbmc.fr; marc.graille@polytechnique.edu	Charenton, Clement/ABF-8608-2021; GRAILLE, Marc/D-3242-2014	Charenton, Clement/0000-0002-8959-7012; GRAILLE, Marc/0000-0002-7853-5852; Seraphin, Bertrand/0000-0002-5168-1921; Fourati, Zaineb/0000-0002-2316-4142; Valerio, Taverniti/0000-0002-6233-8416	Centre National pour la Recherche Scientifique; ATIP-AVENIR program; Agence Nationale pour la Recherche [ANR-11-BSV800902, ANR-10-LABX-0030-INRT, ANR-10-IDEX-0002-02]; European Union [LSHG-CT-2005-512028]; Human Frontiers Science Program [RGP0018]; Ligue Contre le Cancer (Equipe Labellisee); CERBM-IGBMC; INSERM; Fondation pour la Recherche Medicale (FRM); French Ministere de l'Enseignement Superieur et de la Recherche (MESR); ENS Cachan	Centre National pour la Recherche Scientifique; ATIP-AVENIR program; Agence Nationale pour la Recherche(French National Research Agency (ANR)); European Union(European Commission); Human Frontiers Science Program(Human Frontier Science Program); Ligue Contre le Cancer (Equipe Labellisee); CERBM-IGBMC; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); French Ministere de l'Enseignement Superieur et de la Recherche (MESR)(Ministry of Research, France); ENS Cachan	This work was supported by the Centre National pour la Recherche Scientifique [B. S. and M. G.] including a specific support by the ATIP-AVENIR program [to M. G.], the Agence Nationale pour la Recherche [grant ANR-11-BSV800902 to B. S. and M. G., study ANR-10-LABX-0030-INRT performed under the programme Investissements d'Avenir ANR-10-IDEX-0002-02 to B. S.], the European Union Sixth Framework program "3D-Repertoire" [LSHG-CT-2005-512028 to B. S. and M. G.], the Human Frontiers Science Program [grant RGP0018 to M. G.], the Ligue Contre le Cancer (Equipe Labellisee 2014) [to B. S.], and the CERBM-IGBMC and INSERM [to B. S.]. Z.F. was supported by the Fondation pour la Recherche Medicale (FRM). C. C. holds a PhD fellowship from the French Ministere de l'Enseignement Superieur et de la Recherche (MESR) and ENS Cachan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Badis G, 2004, MOL CELL, V15, P5, DOI 10.1016/j.molcel.2004.06.028; Bahadur RP, 2003, PROTEINS, V53, P708, DOI 10.1002/prot.10461; Balagopal V, 2009, GENETICS, V181, P93, DOI 10.1534/genetics.108.092601; Bonnerot C, 2000, MOL CELL BIOL, V20, P5939, DOI 10.1128/MCB.20.16.5939-5946.2000; Bouveret E, 2000, EMBO J, V19, P1661, DOI 10.1093/emboj/19.7.1661; Braun JE, 2010, EMBO J, V29, P2368, DOI 10.1038/emboj.2010.124; Chang CT, 2014, NUCL ACIDS RES; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chowdhury A, 2007, RNA, V13, P998, DOI 10.1261/rna.502507; Chowdhury A, 2009, RNA, V15, P1837, DOI 10.1261/rna.1650109; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Dong SY, 2007, MOL CELL, V25, P559, DOI 10.1016/j.molcel.2007.01.012; Dong SY, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000360; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fenger-Gron M, 2005, MOL CELL, V20, P905, DOI 10.1016/j.molcel.2005.10.031; Fromm SA, 2012, EMBO J, V31, P279, DOI 10.1038/emboj.2011.408; Fromont-Racine M, 2000, YEAST, V17, P95, DOI 10.1002/1097-0061(20000630)17:2<95::AID-YEA16>3.0.CO;2-H; GABORIAUD C, 1987, FEBS LETT, V224, P149, DOI 10.1016/0014-5793(87)80439-8; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Haas G, 2010, J CELL BIOL, V189, P289, DOI 10.1083/jcb.200910141; Harigaya Y, 2010, MOL CELL BIOL, V30, P1446, DOI 10.1128/MCB.01305-09; HSU CL, 1993, MOL CELL BIOL, V13, P4826, DOI 10.1128/MCB.13.8.4826; Hu WQ, 2009, NATURE, V461, P225, DOI 10.1038/nature08265; Jo S, 2008, NUCLEIC ACIDS RES, V36, pW270, DOI 10.1093/nar/gkn314; Jonas S, 2013, GENE DEV, V27, P2628, DOI 10.1101/gad.227843.113; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kolesnikova O, 2013, NUCLEIC ACIDS RES, V41, P9514, DOI 10.1093/nar/gkt607; Lavut A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002527; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Li Y, 2010, WIRES RNA, V1, P253, DOI 10.1002/wrna.15; Ling SH, 2010, WILEY INTERDISCIP RE, V2, P193; Liu HD, 2002, EMBO J, V21, P4699, DOI 10.1093/emboj/cdf448; Lykke-Andersen J, 2002, MOL CELL BIOL, V22, P8114, DOI 10.1128/MCB.22.23.8114-8121.2002; Marnef A, 2012, MOL BIOL CELL, V23, P213, DOI 10.1091/mbc.E11-05-0415; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Nissan T, 2010, MOL CELL, V39, P773, DOI 10.1016/j.molcel.2010.08.025; Ozgur S, 2013, RNA BIOL, V10, P528, DOI 10.4161/rna.24086; Ozgur S, 2010, MOL CELL BIOL, V30, P4308, DOI 10.1128/MCB.00429-10; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pilkington GR, 2008, MOL CELL BIOL, V28, P1298, DOI 10.1128/MCB.00936-07; Rajyaguru P, 2012, MOL CELL, V45, P244, DOI 10.1016/j.molcel.2011.11.026; ROTHER RP, 1992, EUR J BIOCHEM, V206, P673, DOI 10.1111/j.1432-1033.1992.tb16973.x; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Schneider C, 2009, NUCLEIC ACIDS RES, V37, P1127, DOI 10.1093/nar/gkn1020; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schwartz D, 2003, RNA, V9, P239, DOI 10.1261/rna.2171203; Sharif H, 2013, CELL REP, V5, P283, DOI 10.1016/j.celrep.2013.10.004; Sharif H, 2013, NUCLEIC ACIDS RES, V41, P8377, DOI 10.1093/nar/gkt600; SIKORSKI RS, 1989, GENETICS, V122, P19; Teixeira D, 2007, MOL BIOL CELL, V18, P2274, DOI 10.1091/mbc.E07-03-0199; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P1863, DOI 10.1107/S0907444999010033; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tharun S, 2000, NATURE, V404, P515, DOI 10.1038/35006676; Tharun S, 2009, RNA BIOL, V6, P228, DOI 10.4161/rna.6.3.8282; Tritschler F, 2009, MOL CELL, V33, P661, DOI 10.1016/j.molcel.2009.02.014; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Dijk E, 2002, EMBO J, V21, P6915, DOI 10.1093/emboj/cdf678; Wang ZR, 2002, P NATL ACAD SCI USA, V99, P12663, DOI 10.1073/pnas.192445599; Wu D, 2013, J MED RES DEV, V2, P1; Wyers F, 2000, MOL CELL BIOL, V20, P3538, DOI 10.1128/MCB.20.10.3538-3549.2000	70	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e96828	10.1371/journal.pone.0096828	http://dx.doi.org/10.1371/journal.pone.0096828			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830408	Green Published, gold, Green Submitted			2022-12-27	WOS:000336789500027
J	Tan, CL; Lui, PPY; Lee, YW; Wong, YM				Tan, Chunlai; Lui, Pauline Po Yee; Lee, Yuk Wa; Wong, Yin Mei			Scx-Transduced Tendon-Derived Stem Cells (TDSCs) Promoted Better Tendon Repair Compared to Mock-Transduced Cells in a Rat Patellar Tendon Window Injury Model	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SCLERAXIS; MARROW STROMAL CELLS; BONE-MARROW; RABBIT MODEL; EXTRACELLULAR-MATRIX; MOUSE EMBRYOGENESIS; EXPRESSION; DIFFERENTIATION; TENOCYTES; HISTOLOGY	We hypothesized that the transplantation of Scx-transduced tendon-derived stem cells (TDSCs) promoted better tendon repair compared to the transplantation of mock-transduced cells. This study thus aimed to investigate the effect of Scx transduction on the expression of lineage markers in TDSCs and the effect of the resulting cell line in the promotion of tendon repair. Rat non-GFP or GFP-TDSCs were transduced with Scx or empty lentiviral vector (Mock) and selected by blasticidin. The mRNA expressions of Scx and different lineage markers were examined by qRT-PCR. The effect of the transplantation of GFP-TDSC-Scx on tendon repair was then tested in a rat unilateral patellar tendon window injury model. The transplantation of GFP-TDSC-Mock and scaffold-only served as controls. At week 2, 4 and 8 post-transplantation, the repaired patellar tendon was harvested for ex vivo fluorescent imaging, vivaCT imaging, histology, immunohistochemistry and biomechanical test. GFP-TDSC-Scx consistently showed higher expressions of most of tendon-and cartilage-related markers compared to the GFP-TDSC-Mock. However, the effect of Scx transduction on the expressions of bone-related markers was inconclusive. The transplanted GFP-TDSCs could be detected in the window wound at week 2 but not at week 4. Ectopic mineralization was detected in some samples at week 8 but there was no difference among different groups. The GFP-TDSC-Scx group only statistically significantly improved tendon repair histologically and biomechanically compared to the Scaffold-only group and the GFP-TDSC-Mock group at the early stage of tendon repair. There was significant higher expression of collagen type I in the window wound in the GFP-TDSC-Scx group compared to the other two groups at week 2. The transplantation of GFP-TDSC-Scx promoted healing at the early stage of tendon repair in a rat patellar tendon window injury model.	[Tan, Chunlai; Lee, Yuk Wa; Wong, Yin Mei] Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Tan, Chunlai; Lee, Yuk Wa; Wong, Yin Mei] Chinese Univ Hong Kong, Fac Med, Hong Kong Jockey Club Sports Med & Hlth Sci Ctr, Hong Kong, Hong Kong, Peoples R China; [Lui, Pauline Po Yee] Hosp Author, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Lui, PPY (corresponding author), Hosp Author, Hong Kong, Hong Kong, Peoples R China.	paulinelui00@gmail.com	Tan, Chunlai/D-3038-2016; Lee, Wayne YW/H-8298-2013; Lui, Pauline Po Yee/AAU-9823-2020	Tan, Chunlai/0000-0003-0800-1190; Lee, Wayne YW/0000-0002-0486-360X; Lui, Pauline Po Yee/0000-0003-2446-6203	Research Grants Council of the Hong Kong Special Administrative Region, China [460710]	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council)	This work is supported by the General Research Fund (project number: 460710) from the Research Grants Council of the Hong Kong Special Administrative Region, China (http://www.ugc.edu.hk/eng/rgc/grf/grf.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberton P, 2012, STEM CELLS DEV, V21, P846, DOI 10.1089/scd.2011.0150; Awad HA, 2003, J ORTHOP RES, V21, P420, DOI 10.1016/S0736-0266(02)00163-8; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Brown D, 1999, DEVELOPMENT, V126, P4317; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Chan BP, 1998, J ORTHOP RES, V16, P597, DOI 10.1002/jor.1100160512; Chen JM, 2011, TISSUE ENG PT A, V17, P2037, DOI [10.1089/ten.TEA.2010.0492, 10.1089/ten.tea.2010.0492]; Chen X, 2012, SCI REP-UK, V2, DOI 10.1038/srep00977; Crovace A, 2008, VET COMP ORTHOPAED, V21, P329, DOI 10.3415/VCOT-07-05-0050; CSERJESI P, 1995, DEVELOPMENT, V121, P1099; Espira L, 2009, J MOL CELL CARDIOL, V47, P188, DOI 10.1016/j.yjmcc.2009.03.024; Furumatsu T, 2010, INT J BIOCHEM CELL B, V42, P148, DOI 10.1016/j.biocel.2009.10.003; Gulotta LV, 2011, AM J SPORT MED, V39, P1282, DOI 10.1177/0363546510395485; Gulotta LV, 2009, AM J SPORT MED, V37, P2126, DOI 10.1177/0363546509339582; Harris MT, 2004, J ORTHOP RES, V22, P998, DOI 10.1016/j.orthres.2004.02.012; He M, 2013, J PLAST SURG HAND SU, V47, P509, DOI 10.3109/2000656X.2013.789037; Juncosa-Melvin N, 2006, TISSUE ENG, V12, P369, DOI 10.1089/ten.2006.12.369; Juncosa-Melvin N, 2005, TISSUE ENG, V11, P448, DOI 10.1089/ten.2005.11.448; Kawa-uchi T, 1998, J CELL BIOCHEM, V70, P468, DOI 10.1002/(SICI)1097-4644(19980915)70:4<468::AID-JCB4>3.0.CO;2-H; Kryger GS, 2007, J HAND SURG-AM, V32A, P597, DOI 10.1016/j.jhsa.2007.02.018; Lee JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017531; Lejard V, 2007, J BIOL CHEM, V282, P17665, DOI 10.1074/jbc.M610113200; Liu Y, 1997, J BIOL CHEM, V272, P29880, DOI 10.1074/jbc.272.47.29880; Lui PPY, 2011, J TISSUE ENG REGEN M, V5, pE144, DOI 10.1002/term.424; Lui PPY, 2007, WOUND REPAIR REGEN, V15, P702, DOI 10.1111/j.1524-475X.2007.00276.x; Lui PPY, 2012, J ORTHOP RES, V30, P37, DOI 10.1002/jor.21495; Lui PPY, 2009, J HISTOCHEM CYTOCHEM, V57, P91, DOI 10.1369/jhc.2008.952143; Lui PPY, TISSUE EN A IN PRESS; Movin T, 1997, ACTA ORTHOP SCAND, V68, P170, DOI 10.3109/17453679709004002; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; Ni M, 2012, J ORTHOP RES, V30, P613, DOI 10.1002/jor.21559; Oryan A, 2014, J TISSUE ENG REGEN M, V8, P421, DOI 10.1002/term.1534; Ouyang HW, 2004, CELL TRANSPLANT, V13, P649, DOI 10.3727/000000004783983549; Ouyang HW, 2003, TISSUE ENG, V9, P431, DOI 10.1089/107632703322066615; Park KS, 2010, TRANSPLANTATION, V89, P509, DOI 10.1097/TP.0b013e3181c7dc99; Rui YF, 2013, STEM CELLS DEV, V22, P1076, DOI 10.1089/scd.2012.0555; Rui YF, 2011, J ORTHOP RES, V29, P390, DOI 10.1002/jor.21218; Rui YF, 2011, CHINESE MED J-PEKING, V124, P606, DOI 10.3760/cma.j.issn.0366-6999.2011.04.022; Rui YF, 2010, TISSUE ENG PT A, V16, P1549, DOI 10.1089/ten.TEA.2009.0529; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Shukunami C, 2006, DEV BIOL, V298, P234, DOI 10.1016/j.ydbio.2006.06.036; Sugimoto Y, 2013, DEVELOPMENT, V140, P2280, DOI 10.1242/dev.096354; Sugiura F, 2004, BIOCHEM BIOPH RES CO, V316, P233, DOI 10.1016/j.bbrc.2004.02.038; Tan Q, 2013, STEM CELLS DEV, V22, P3128, DOI 10.1089/scd.2013.0073; Tan Q, 2012, TISSUE ENG PT A, V18, P840, DOI [10.1089/ten.tea.2011.0362, 10.1089/ten.TEA.2011.0362]; Tan Q, 2012, STEM CELLS DEV, V21, P790, DOI 10.1089/scd.2011.0160; Tasso R, 2009, CARCINOGENESIS, V30, P150, DOI 10.1093/carcin/bgn234; Terraz C, 2002, J BIOL CHEM, V277, P19019, DOI 10.1074/jbc.M200125200; Zhang JY, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-10; Zhou ZP, 2010, AGING CELL, V9, P911, DOI 10.1111/j.1474-9726.2010.00598.x	51	40	41	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97453	10.1371/journal.pone.0097453	http://dx.doi.org/10.1371/journal.pone.0097453			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831949	gold, Green Published, Green Submitted			2022-12-27	WOS:000336789500060
J	Agha, M; Agha, RA; Sandell, J				Agha, Maliha; Agha, Riaz A.; Sandell, Jane			Interventions to Reduce and Prevent Obesity in Pre-Conceptual and Pregnant Women: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							GESTATIONAL WEIGHT-GAIN; BODY-MASS INDEX; MATERNAL OBESITY; PHYSICAL-ACTIVITY; PREPREGNANCY WEIGHT; CONTROLLED-TRIAL; OVERWEIGHT; EXERCISE; DIET; MANAGEMENT	Background: The increasing prevalence of obesity in pregnant women is associated with adverse maternal and neonatal outcomes, and increased costs to healthcare, the economy and broader society. Objectives: To assess the efficacy of behavioural interventions for managing gestational weight gain (GWG) in the pre-conceptual and pregnancy period in overweight, obese and morbidly obese women. Search Methods: A search was performed for published studies in the English language, from date? 2000-31 December 2012 in five electronic databases; PubMed, Scopus, Cochrane Library, CINAHL and PsycINFO. Selection criteria: Studies were included if they compared the efficacy or effectiveness of a particular behavioural intervention in pregnant or pre-conceptual women with standard maternity care. Studies that included women with comorbid conditions such as diabetes mellitus and polycystic ovarian syndrome were excluded to help isolate the effect of the intervention. Results: Fifteen studies involving 3,426 participants were included. One study (n = 692) focused on the pre-conceptual period and the remaining 14 (n = 2,734) in the pregnancy period. Pooled mean difference for GWG indicated a lower GWG in the intervention groups when compared to standard maternity care groups (n = 1771, mean difference (MD) -1.66 kg, 95% CI -3.12 to -0.21 kg). With respect to the types of participants, considerable heterogeneity between studies was shown in the obese subgroup [Tau(2) = 15.61; Chi(2) = 40.80, df = 3 (P<0.00001); I-2 = 93%]. Conclusions: Behavioural interventions in pregnancy may be effective in reducing GWG in obese women without comorbid conditions, but not overweight or morbidly obese women. Behavioural interventions had no effect on postpartum weight loss or retention, gestation week of delivery and infant birth weight in overweight, obese and morbidly obese women.	[Agha, Maliha] Kings Coll London, London WC2R 2LS, England; [Agha, Riaz A.] Queen Victoria Hosp NHS Fdn Trust, E Grinstead, England; [Sandell, Jane] Kings Coll London, Womens Acad Hlth Ctr, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London	Agha, RA (corresponding author), Queen Victoria Hosp NHS Fdn Trust, E Grinstead, England.	mail@riazagha.com	; Sandall, Jane/D-4146-2009	Agha, Riaz/0000-0002-9348-0095; Sandall, Jane/0000-0003-2000-743X				ABRAMS BF, 1986, AM J OBSTET GYNECOL, V154, P503, DOI 10.1016/0002-9378(86)90591-0; American Pregnancy Association, EAT 2 WEIGHT; Ananth CV, 2005, OBSTET GYNECOL, V105, P1084, DOI 10.1097/01.AOG.0000158124.96300.c7; [Anonymous], 2012, UK PREGNANCIES BETTE; Bechtel-Blackwell Deborah A, 2002, Clin Nurs Res, V11, P450, DOI 10.1177/105477302237456; Bhattacharya S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-168; Bianco AT, 1998, OBSTET GYNECOL, V91, P97, DOI 10.1016/S0029-7844(97)00578-4; Birdsall KM, 2009, INT J CLIN PRACT, V63, P494, DOI 10.1111/j.1742-1241.2008.01910.x; Campbell F, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-491; Cedergren M, 2006, INT J GYNECOL OBSTET, V93, P269, DOI 10.1016/j.ijgo.2006.03.002; Centre for Maternal and Child Enquiries (CMACE), 2010, MAT OB UK FIND NAT P; Chu SY, 2007, AM J OBSTET GYNECOL, V197, P223, DOI 10.1016/j.ajog.2007.03.027; Claesson IM, 2008, BJOG-INT J OBSTET GY, V115, P44, DOI 10.1111/j.1471-0528.2007.01531.x; Cochrane Effective Practice and Organisation of Care Review Group, 2011, DAT COLL CHEKL; Colley RC, 2008, INT J OBESITY, V32, P837, DOI 10.1038/sj.ijo.0803799; Cunningham FG, 2001, WILLIAMS OBSTET, V23rd; Dodd JM, 2010, BJOG-INT J OBSTET GY, V117, P1316, DOI 10.1111/j.1471-0528.2010.02540.x; Dodd JM, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-79; Drife J, 2005, J ROY COLL PHYS EDIN, V35, P332; Eastman N J, 1968, Obstet Gynecol Surv, V23, P1003, DOI 10.1097/00006254-196811000-00001; Edelman LC, 2006, HLTH PROMOTION LIFE; Fitzsimons Kate, CONFIDENTIAL ENQUIRY; Gardner B, 2011, OBES REV, V12, pE602, DOI 10.1111/j.1467-789X.2011.00884.x; Gray-Donald K, 2000, CAN MED ASSOC J, V163, P1247; GRIMSHAW JM, 1993, LANCET, V342, P1317, DOI 10.1016/0140-6736(93)92244-N; Guelinckx I, 2010, AM J CLIN NUTR, V91, P373, DOI 10.3945/ajcn.2009.28166; Haakstad LAH, 2011, EUR J CONTRACEP REPR, V16, P116, DOI 10.3109/13625187.2011.560307; Herring S. J., 2010, Annales Nestle, V68, P17, DOI 10.1159/000298780; Heslehurst N, 2010, INT J OBESITY, V34, P420, DOI 10.1038/ijo.2009.250; Hui HL., 2006, CAN J DIABETES, V30, P169, DOI DOI 10.1016/S1499-2671(06)02010-7; Ilmonen J, 2011, CLIN NUTR, V30, P156, DOI 10.1016/j.clnu.2010.09.009; Jackson RA, 2011, PATIENT EDUC COUNS, V83, P203, DOI 10.1016/j.pec.2010.05.019; Kanagalingam MG, 2005, BJOG-INT J OBSTET GY, V112, P1431, DOI 10.1111/j.1471-0528.2005.00685.x; Kinnunen TI, 2007, EUR J CLIN NUTR, V61, P884, DOI 10.1038/sj.ejcn.1602602; Kristensen J, 2005, BJOG-INT J OBSTET GY, V112, P403, DOI 10.1111/j.1471-0528.2005.00437.x; Kuhlmann AKS, 2008, AM J PREV MED, V34, P523, DOI 10.1016/j.amepre.2008.02.010; Larsen TB, 2007, THROMB RES, V120, P505, DOI 10.1016/j.thromres.2006.12.003; Li J., 2007, MATERNAL CHILD HLTH, P1901; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lindholm ES, 2010, ACTA OBSTET GYN SCAN, V89, P840, DOI 10.3109/00016340903428370; Linne Y, 2003, INT J OBESITY, V27, P1516, DOI 10.1038/sj.ijo.0802441; Linne Y, 2004, OBES RES, V12, P1166, DOI 10.1038/oby.2004.146; Lombard C, 2009, BMC PUBLIC HEALTH, V9, DOI [10.1186/1471-2458-9-2, 10.1186/1471-2458-9-213]; Ludwig DS, 2010, LANCET, V376, P984, DOI 10.1016/S0140-6736(10)60751-9; Luke B, 1996, J Matern Fetal Med, V5, P168; Montgomery S, 2004, SCIENCE, V303, P1333, DOI 10.1126/science.1095204; Mottola MF, 2010, MED SCI SPORT EXER, V42, P265, DOI 10.1249/MSS.0b013e3181b5419a; National Institute for Health and Clinical Excellence, WEIGHT MAN PREGN; National Obesity Observatory, 2011, MAT OB; Office for National Statistics, 2011, OB DAT; Olson CM, 2004, AM J OBSTET GYNECOL, V191, P530, DOI 10.1016/j.ajog.2004.01.027; Paneth N, 1995, BMJ-BRIT MED J, V310, P310, DOI DOI 10.1136/BMJ.310.6977.411; Phelan S, 2011, AM J CLIN NUTR, V93, P772, DOI 10.3945/ajcn.110.005306; Piirainen T, 2006, BRIT J NUTR, V96, P1095, DOI 10.1017/BJN20061952; Polley BA, 2002, INT J OBESITY, V26, P1494, DOI 10.1038/sj.ijo.0802130; Poston L, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2774; Public Health Agency of Canada, HDB PHYS ACT GUID HL; Rhodes ET, 2010, AM J CLIN NUTR, V92, P1306, DOI 10.3945/ajcn.2010.30130; Rohrich RJ, 2011, PLAST RECONSTR SURG, V127, P981, DOI 10.1097/PRS.0b013e3182008b4f; Santos IA, 2005, OBSTET GYNECOL, V106, P243, DOI 10.1097/01.AOG.0000171113.36624.86; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; Shirazian T, 2010, AM J PERINAT, V27, P411, DOI 10.1055/s-0029-1243368; Society of Obstetricians and Gynaecologists of Canada (SOGC), OB PREGN; Streuling I, 2010, AM J CLIN NUTR, V92, P678, DOI 10.3945/ajcn.2010.29363; Thangaratinam S, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16310; The Baker Theory, OVERVIEW; Tjepkema M, ADULT OBESITY CANADA; Vahratian A, 2004, OBSTET GYNECOL, V104, P943, DOI 10.1097/01.AOG.0000142713.53197.91; Viswanathan M, 2008, EDUC ASIA PAC REG-IS, V12, P1, DOI 10.1007/978-1-4020-5769-4; Weisman CS, 2011, WOMEN HEALTH ISS, V21, P265, DOI 10.1016/j.whi.2011.03.007; Wolff S, 2008, INT J OBESITY, V32, P495, DOI 10.1038/sj.ijo.0803710; World Health Organisation, COR HLTH IND; World Health Organisiation, OB OV FACT SHEET	73	57	60	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e95132	10.1371/journal.pone.0095132	http://dx.doi.org/10.1371/journal.pone.0095132			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827704	Green Published, Green Submitted, gold			2022-12-27	WOS:000336857400011
J	Hetzel, MW; Page-Sharp, M; Bala, N; Pulford, J; Betuela, I; Davis, TME; Lavu, EK				Hetzel, Manuel W.; Page-Sharp, Madhu; Bala, Nancy; Pulford, Justin; Betuela, Inoni; Davis, Timothy M. E.; Lavu, Evelyn K.			Quality of Antimalarial Drugs and Antibiotics in Papua New Guinea: A Survey of the Health Facility Supply Chain	PLOS ONE			English	Article							MALARIA CASE-MANAGEMENT; SOUTHEAST-ASIA; ANTI-MALARIALS; HPLC METHOD; PRIMAQUINE; SUBSTANDARD; MEDICINES; COUNTERFEIT; PHARMACOKINETICS; PYRIMETHAMINE	Background: Poor-quality life-saving medicines are a major public health threat, particularly in settings with a weak regulatory environment. Insufficient amounts of active pharmaceutical ingredients (API) endanger patient safety and may contribute to the development of drug resistance. In the case of malaria, concerns relate to implications for the efficacy of artemisinin-based combination therapies (ACT). In Papua New Guinea (PNG), Plasmodium falciparum and P. vivax are both endemic and health facilities are the main source of treatment. ACT has been introduced as first-line treatment but other drugs, such as primaquine for the treatment of P. vivax hypnozoites, are widely available. This study investigated the quality of antimalarial drugs and selected antibiotics at all levels of the health facility supply chain in PNG. Methods and Findings: Medicines were obtained from randomly sampled health facilities and selected warehouses and hospitals across PNG and analysed for API content using validated high performance liquid chromatography (HPLC). Of 360 tablet/capsule samples from 60 providers, 9.7% (95% CI 6.9, 13.3) contained less, and 0.6% more, API than pharmacopoeial reference ranges, including 29/37 (78.4%) primaquine, 3/70 (4.3%) amodiaquine, and one sample each of quinine, artemether, sulphadoxine-pyrimethamine and amoxicillin. According to the package label, 86.5% of poor-quality samples originated from India. Poor-quality medicines were found in 48.3% of providers at all levels of the supply chain. Drug quality was unrelated to storage conditions. Conclusions: This study documents the presence of poor-quality medicines, particularly primaquine, throughout PNG. Primaquine is the only available transmission-blocking antimalarial, likely to become important to prevent the spread of artemisinin-resistant P. falciparum and eliminating P. vivax hypnozoites. The availability of poor-quality medicines reflects the lack of adequate quality control and regulatory mechanisms. Measures to stop the availability of poor-quality medicines should include limiting procurement to WHO prequalified products and implementing routine quality testing.	[Hetzel, Manuel W.; Pulford, Justin] Papua New Guinea Inst Med Res, Goroka, Ehp, Papua N Guinea; [Hetzel, Manuel W.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Hetzel, Manuel W.] Univ Basel, Basel, Switzerland; [Page-Sharp, Madhu] Curtin Univ, Sch Pharm, Perth, WA 6845, Australia; [Bala, Nancy; Lavu, Evelyn K.] Cent Publ Hlth Lab, Boroko, Ncd, Papua N Guinea; [Pulford, Justin] Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia; [Betuela, Inoni] Papua New Guinea Inst Med Res, Madang, Mdg, Papua N Guinea; [Davis, Timothy M. E.] Univ Western Australia, Sch Med & Pharmacol, Fremantle, WA, Australia	PNG Institute Of Medical Research; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Curtin University; University of Queensland; PNG Institute Of Medical Research; University of Western Australia	Hetzel, MW (corresponding author), Papua New Guinea Inst Med Res, POB 60, Goroka, Ehp, Papua N Guinea.	manuel.hetzel@unibas.ch	Davis, Timothy ME/M-5144-2014	Hetzel, Manuel W./0000-0002-5285-3254; Pulford, Justin/0000-0003-4756-8480	Global Fund to Fight AIDS, Tuberculosis and Malaria through the Papua New Guinea National Malaria Control Program; National Health and Medical Research Council (NHMRC) of Australia [634343]; NHMRC; research fund (Forschungsfonds) of the University of Basel	Global Fund to Fight AIDS, Tuberculosis and Malaria through the Papua New Guinea National Malaria Control Program; National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); research fund (Forschungsfonds) of the University of Basel	This study was financially supported by a Global Fund to Fight AIDS, Tuberculosis and Malaria round 8 grant through the Papua New Guinea National Malaria Control Program (http://www.theglobalfund.org/). The chemical assays for this study were conducted in a facility supported by National Health and Medical Research Council (NHMRC) of Australia Project Grant 634343. TMED is supported by a NHMRC Practitioner Fellowship, MWH in 2013 by the research fund (Forschungsfonds) of the University of Basel (http://www.unibas.ch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achan J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-144; Ahmed M, 2011, INT J CHEM TECH RES, V3, P1037; Almuzaini T, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002923; Amin AA, 2005, J CLIN PHARM THER, V30, P559, DOI 10.1111/j.1365-2710.2005.00685.x; Angwin A, 2014, P N G MED J IN PRESS, V56; [Anonymous], 2011, INT J PHARM BIOMED R; [Anonymous], 2012, T3 TEST TREAT TRACK; [Anonymous], QUALITY ANTIMALARIAL; [Anonymous], 2011, GLOB PLAN ART RES CO; [Anonymous], COCHRANE DATABASE SY; [Anonymous], COCHRANE DATABASE SY; Arayne MS, 2010, MED CHEM RES, V19, P1043, DOI 10.1007/s00044-009-9250-4; Attaran A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7381; Bate R, 2013, INT J TUBERC LUNG D, V17, P308, DOI 10.5588/ijtld.12.0355; Bate R, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-157; Carmona-Fonseca J, 2009, AM J TROP MED HYG, V80, P188, DOI 10.4269/ajtmh.2009.80.188; Chaccour CJ, 2012, LANCET, V380, P1120, DOI 10.1016/S0140-6736(12)60649-7; Cruz AP, 2008, LAT AM J PHARM, V27, P415; Davy CP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-268; Department of Health Government of Papua New Guinea, 2012, HLTH SERVICE DELIVER; Dondorp AM, 2004, TROP MED INT HEALTH, V9, P1241, DOI 10.1111/j.1365-3156.2004.01342.x; Evans L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-203; Faucon B, 2013, WALL STREET J; Fernandez FM, 2011, ANALYST, V136, P3073, DOI 10.1039/c0an00627k; Gaudiano MC, 2006, J PHARMACEUT BIOMED, V42, P132, DOI 10.1016/j.jpba.2006.01.059; Gostin LO, 2013, JAMA-J AM MED ASSOC, V309, P1693, DOI 10.1001/jama.2013.3048; Hehonah NT, 2010, PACIFIC J MED SCI, V7, P4; Hetzel MW, 2010, PAPUA NEW GUINEA GLO; Howes RE, 2013, ADV PARASIT, V81, P133, DOI 10.1016/B978-0-12-407826-0.00004-7; Kaur H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003403; Kazura JW, 2012, ACTA TROP, V121, P274, DOI 10.1016/j.actatropica.2011.08.002; Kogawa AC, 2013, J CHROMATOGR SCI, V51, P919, DOI 10.1093/chromsci/bms190; Moore BR, 2011, ANTIMICROB AGENTS CH, V55, P3899, DOI 10.1128/AAC.00067-11; Nair A, 2011, J PHARM SCI-US, V100, P5059, DOI 10.1002/jps.22691; Nayyar GML, 2012, LANCET INFECT DIS, V12, P488, DOI 10.1016/S1473-3099(12)70064-6; Newton PN, 2006, LANCET INFECT DIS, V6, P602, DOI 10.1016/S1473-3099(06)70581-3; Newton PN, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001139; Newton PN, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-352; Newton PN, 2010, TRENDS PHARMACOL SCI, V31, P99, DOI 10.1016/j.tips.2009.11.005; Newton PN, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000052; Onwujekwe O, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-22; Paediatric Society of Papua New Guinea, 2005, STAND TREATM COMM IL; Page-Sharp M, 2012, J CHROMATOGR B, V902, P142, DOI 10.1016/j.jchromb.2012.06.019; Papua New Guinea Department of Health, 2012, PAP NEW GUIN PHARM C; Papua New Guinea Department of Health, 2009, NAT MAL TREATM PROT; Papua New Guinea Department of Health, 2012, NAT MED FORM; Papua New Guinea Department of Health, 2005, STAND TREATM COMM IL; Phanouvong S, 2013, SE ASIAN J TROP MED, V44, P363; Phanouvong S, 2013, SE ASIAN J TROP MED, V44, P349; Pribluda VS, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-202; Pulford J, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-433; Pulford J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-157; Ranher SS, 2010, J ANAL CHEM+, V65, P507, DOI 10.1134/S1061934810050126; Salman S, 2011, ANTIMICROB AGENTS CH, V55, P5306, DOI 10.1128/AAC.05136-11; Shekalaghe S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001023; The Global Fund, 2013, MAL CONTR PAP NEW GU; United States Pharmacopeia Drug Quality and Information Program, 2007, ENS QUAL MED RES LTD; White NJ, 2013, LANCET INFECT DIS, V13, P175, DOI 10.1016/S1473-3099(12)70198-6; White NJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-253; WHO, 2010, GUID TREATM MAL, V2nd; WHO Malaria Policy Advisory Committee and Secretariat, 2012, Malar J, V11, P424, DOI 10.1186/1475-2875-11-424; World Health Organization, 2013, WHO LIST PREQ MED PR; World Health Organization (WHO), 2006, COUNT MED	63	14	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96810	10.1371/journal.pone.0096810	http://dx.doi.org/10.1371/journal.pone.0096810			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828338	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000336857400038
J	Lindblad, AC; Rosenhall, U; Olofsson, A; Hagerman, B				Lindblad, Ann-Cathrine; Rosenhall, Ulf; Olofsson, Ake; Hagerman, Bjorn			Tinnitus and Other Auditory Problems - Occupational Noise Exposure below Risk Limits May Cause Inner Ear Dysfunction	PLOS ONE			English	Article							HAIR CELL LOSS; BLUE MOUNTAINS HEARING; OTOACOUSTIC EMISSIONS; OLDER-ADULTS; CHINCHILLAS; MUSICIANS; AMPLITUDES; DISORDERS; THRESHOLD; SYSTEM	The aim of the investigation was to study if dysfunctions associated to the cochlea or its regulatory system can be found, and possibly explain hearing problems in subjects with normal or near-normal audiograms. The design was a prospective study of subjects recruited from the general population. The included subjects were persons with auditory problems who had normal, or near-normal, pure tone hearing thresholds, who could be included in one of three subgroups: teachers, Education; people working with music, Music; and people with moderate or negligible noise exposure, Other. A fourth group included people with poorer pure tone hearing thresholds and a history of severe occupational noise, Industry. N-total = 193. The following hearing tests were used: 2 pure tone audiometry with Bekesy technique, 2 transient evoked otoacoustic emissions and distortion product otoacoustic emissions, without and with contralateral noise; 2 psychoacoustical modulation transfer function, 2 forward masking, 2 speech recognition in noise, 2 tinnitus matching. A questionnaire about occupations, noise exposure, stress/anxiety, muscular problems, medication, and heredity, was addressed to the participants. Forward masking results were significantly worse for Education and Industry than for the other groups, possibly associated to the inner hair cell area. Forward masking results were significantly correlated to louder matched tinnitus. For many subjects speech recognition in noise, left ear, did not increase in a normal way when the listening level was increased. Subjects hypersensitive to loud sound had significantly better speech recognition in noise at the lower test level than subjects not hypersensitive. Self-reported stress/anxiety was similar for all groups. In conclusion, hearing dysfunctions were found in subjects with tinnitus and other auditory problems, combined with normal or near-normal pure tone thresholds. The teachers, mostly regarded as a group exposed to noise below risk levels, had dysfunctions almost identical to those of the more exposed Industry group.	[Lindblad, Ann-Cathrine; Olofsson, Ake; Hagerman, Bjorn] Karolinska Inst, Unit Tech & Expt Audiol, Div Ear Nose & Throat Dis, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Rosenhall, Ulf] Karolinska Inst, Div Ear Nose & Throat Dis, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Rosenhall, Ulf] Karolinska Univ Hosp, Dept Audiol & Neurotol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Lindblad, AC (corresponding author), Karolinska Inst, Unit Tech & Expt Audiol, Div Ear Nose & Throat Dis, Dept Clin Sci Intervent & Technol, Stockholm, Sweden.		Hagerman, Björn C/H-6720-2014		AFA Insurance [T-50:05]; Swedish Council for Working Life and Social Research [20030154]	AFA Insurance; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	This project was supported by AFA Insurance, T-50:05, www.afaforsakring.se; and by the Swedish Council for Working Life and Social Research (20030154), www.fasarbetsliv.se. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attias J, 1996, ACTA OTO-LARYNGOL, V116, P534, DOI 10.3109/00016489609137885; AXELSSON A, 1989, British Journal of Audiology, V23, P53, DOI 10.3109/03005368909077819; Berninger E, 1999, SCAND AUDIOL, V28, P117, DOI 10.1080/010503999424842; Cacace AT, 2003, HEARING RES, V175, P112, DOI 10.1016/S0378-5955(02)00717-7; Davis RI, 2009, EAR HEARING, V30, P628, DOI 10.1097/AUD.0b013e3181b527a8; Duan M L, 1996, Audiol Neurootol, V1, P309; Duan M L, 1996, Audiol Neurootol, V1, P320; El-Badry MM, 2007, BRAIN RES, V1134, P122, DOI 10.1016/j.brainres.2006.11.078; El-Badry MM, 2009, HEARING RES, V255, P84, DOI 10.1016/j.heares.2009.06.003; Hagerman B, 2002, INT J AUDIOL, V41, P321, DOI 10.3109/14992020209090406; HAGERMAN B, 1982, SCAND AUDIOL, V11, P79, DOI 10.3109/01050398209076203; ISO, 2000, ISO7029; *ISO, 1990, ISO1999; Jacobson M, 2003, LARYNGOSCOPE, V113, P1707, DOI 10.1097/00005537-200310000-00009; Jansen EJM, 2009, INT ARCH OCC ENV HEA, V82, P153, DOI 10.1007/s00420-008-0317-1; Kahari K, 2003, INT J AUDIOL, V42, P279, DOI 10.3109/14992020309078347; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Kumar UA, 2012, NOISE HEALTH, V14, P100, DOI 10.4103/1463-1741.97252; Lin HW, 2011, JARO-J ASSOC RES OTO, V12, P605, DOI 10.1007/s10162-011-0277-0; Lindblad AC, 1999, ACUSTICA, V85, P870; Lindblad AC, 2011, NOISE HEALTH, V13, P423, DOI 10.4103/1463-1741.90310; Lindblad AC, 2011, NOISE HEALTH, V13, P392, DOI 10.4103/1463-1741.90293; Liu LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049550; McAllister AM, 2009, J VOICE, V23, P587, DOI 10.1016/j.jvoice.2007.10.017; McFadden SL, 1998, HEARING RES, V120, P121, DOI 10.1016/S0378-5955(98)00052-5; Qiu CX, 2000, HEARING RES, V139, P153, DOI 10.1016/S0378-5955(99)00171-9; Schmuziger N, 2006, EAR HEARING, V27, P321, DOI 10.1097/01.aud.0000224737.34907.5e; Shi LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081566; Sindhusake D, 2003, INT J AUDIOL, V42, P289, DOI 10.3109/14992020309078348; Sindhusake D, 2003, EAR HEARING, V24, P501, DOI 10.1097/01.AUD.0000100204.08771.3D; Sjodin F, 2012, NOISE HEALTH, V14, P72, DOI 10.4103/1463-1741.95135; Sztuka A, 2010, AURIS NASUS LARYNX, V37, P55, DOI 10.1016/j.anl.2009.05.001; Walton J, 1999, HEARING RES, V127, P86, DOI 10.1016/S0378-5955(98)00175-0; Wang J, 1997, HEARING RES, V107, P67, DOI 10.1016/S0378-5955(97)00020-8; Wang Y, 2012, JARO-J ASSOC RES OTO, V13, P505, DOI 10.1007/s10162-012-0329-0; Zhao F, 2010, INT J AUDIOL, V49, P54, DOI 10.3109/14992020903202520	36	11	11	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97377	10.1371/journal.pone.0097377	http://dx.doi.org/10.1371/journal.pone.0097377			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827149	gold, Green Submitted, Green Published			2022-12-27	WOS:000336857400088
J	Zhang, QS; Lu, GH; Wang, XB; Li, J				Zhang, Qian-Shi; Lu, Guo-Hua; Wang, Xiao-Bin; Li, Jing			The Significance of Removing Ruptured Intervertebral Discs for Interbody Fusion in Treating Thoracic or Lumbar Type B and C Spinal Injuries through a One-Stage Posterior Approach	PLOS ONE			English	Article							THORACOLUMBAR BURST FRACTURES; INSTRUMENTATION; STABILIZATION	Objectives: To identify the negative effect on treatment results of reserving damaged intervertebral discs when treating type B and type C spinal fracture-dislocations through a one-stage posterior approach. Methods: This is a retrospective review of 53 consecutive patients who were treated in our spine surgery center from January 2005 to May 2012 due to severe thoracolumbar spinal fracture-dislocation. The patients in Group A (24 patients) underwent long-segment instrumentation laminectomy with pedicle screw-rod fixators for neural decompression. In Group B (29 patients), the patients underwent long-segment instrumentation laminectomy with pedicle screw-rod fixators for neural decompression evacuating of the ruptured disc and inserting of a bone graft into the evacuated disc space for interbody fusion. The mean time between injury and operation was 4.1 days (range 2-15 days). The clinical, radiologic and complication outcomes were analyzed retrospectively. Results: Periodic follow-ups were carried out until an affirmative union or treatment failure took place. A progressive kyphosis angle larger than 10(u), loss of disc height, pseudoarthrosis, recurrence of dislocation or subluxation, or instrument failure before fusion were considered treatment failures. Treatment failures were detected in 13 cases in Group A (failure rate was 54.2%). In Group B, there were 28 cases in which definitive bone fusion was demonstrated on CT scans, and CT scans of the other cases demonstrated undefined pseudoarthrosis without hardware failure. There were statistically significant differences between the two groups (p<0.001 chi-square test). The neurologic recoveries, assessed by the ASIA scoring system, were not satisfactory for the neural deficit patients in either group, indicating there was no significant difference with regard to neurologic recovery between the two groups (p>0.05 Fisher's exact test). Conclusion: Intervertebral disc damage is a common characteristic in type B and C spinal fracture-dislocation injuries. The damaged intervertebral disc should be removed and substituted with a bone graft because reserving the damaged disc in situ increases the risk of treatment failure.	[Zhang, Qian-Shi; Lu, Guo-Hua; Wang, Xiao-Bin; Li, Jing] Cent S Univ, Xiangya Hosp 2, Dept Spine Surg, Changsha, Hunan, Peoples R China	Central South University	Li, J (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Spine Surg, Changsha, Hunan, Peoples R China.	jingli1969@126.com						Alanay A, 2001, SPINE, V26, P213, DOI 10.1097/00007632-200101150-00017; Ayberk G, 2008, NEUROL MED-CHIR, V48, P8, DOI 10.2176/nmc.48.8; DANIAUX H, 1991, SPINE, V16, pS125, DOI 10.1097/00007632-199103001-00018; Elgafy H, 2007, SPINE, V32, pE785, DOI 10.1097/BRS.0b013e31815b60fd; Inamasu J, 2008, NEUROL MED-CHIR, V48, P15, DOI 10.2176/nmc.48.15; Knop C, 2002, EUR SPINE J, V11, P251, DOI 10.1007/s00586-001-0360-z; Knop C, 2001, SPINE, V26, P88, DOI 10.1097/00007632-200101010-00016; Ma Yi, 2013, Zhonghua Yi Xue Za Zhi, V93, P2112; Magerl F, 1994, Eur Spine J, V3, P184, DOI 10.1007/BF02221591; Mikles MR, 2004, J AM ACAD ORTHOP SUR, V12, P424, DOI 10.5435/00124635-200411000-00007; Moore TA, 2011, J NEUROSURG-SPINE, V15, P675, DOI 10.3171/2011.8.SPINE1129; MUMFORD J, 1993, SPINE, V18, P955, DOI 10.1097/00007632-199306150-00003; Oner FC, 1998, J BONE JOINT SURG BR, V80B, P833, DOI 10.1302/0301-620X.80B5.8830; Oner FC, 1999, EUR SPINE J, V8, P194, DOI 10.1007/s005860050156; P Oprel Pim, 2010, Open Orthop J, V4, P93, DOI 10.2174/1874325001004010093; Przybyla A, 2006, CLIN BIOMECH, V21, P1013, DOI 10.1016/j.clinbiomech.2006.07.003; SPETH MJGM, 1995, ACTA ORTHOP SCAND, V66, P406, DOI 10.3109/17453679508995575; WILLEN JAG, 1989, SPINE, V14, P1316, DOI 10.1097/00007632-198912000-00008; Xia Qun, 2009, Orthop Surg, V1, P28, DOI 10.1111/j.1757-7861.2008.00006.x; Xu Bao-shan, 2009, Orthop Surg, V1, P85, DOI 10.1111/j.1757-7861.2009.00022.x; Yu Shang-Won, 2002, Chang Gung Med J, V25, P253	21	2	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97275	10.1371/journal.pone.0097275	http://dx.doi.org/10.1371/journal.pone.0097275			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827733	Green Published, gold, Green Submitted			2022-12-27	WOS:000336857400071
J	Romero-Geraldo, RDJ; Garcia-Lagunas, N; Hernandez-Saavedra, NY				de Jesus Romero-Geraldo, Reyna; Garcia-Lagunas, Norma; Yolanda Hernandez-Saavedra, Norma			Effects of In Vitro Exposure to Diarrheic Toxin Producer Prorocentrum lima on Gene Expressions Related to Cell Cycle Regulation and Immune Response in Crassostrea gigas	PLOS ONE			English	Article							SHELLFISH POISONING TOXINS; OKADAIC ACID; PACIFIC OYSTER; MOLECULAR-IDENTIFICATION; MYTILUS-EDULIS; ALGAL TOXINS; DNA-DAMAGE; MARINE; PHOSPHORYLATION; ARREST	Background: Crassostrea gigas accumulates diarrheic shellfish toxins (DSP) associated to Prorocentrum lima of which Okadaic acid (OA) causes specific inhibitions of serine and threonine phosphatases 1 and 2A. Its toxic effects have been extensively reported in bivalve mollusks at cellular and physiological levels, but genomic approaches have been scarcely studied. Methodology/Principal Findings: Acute and sub-chronic exposure effects of P. lima were investigated on farmed juvenile C. gigas (3-5 mm). The Pacific oysters were fed with three dinoflagellate concentrations: 0.3, 3, and 30X10(3) cells mL(-1) along with a nontoxic control diet of Isochrysis galbana. The effects of P. lima on C. gigas were followed by analyzing expression levels of a total of four genes, three involved in cell cycle regulation and one in immune response by polymerase chain reaction and real time quantitative PCR, where changes in time and cell concentration were found. The highest expression levels were found in oysters fed 3X10(3) cells mL(-1) at 168 h for the cycle regulator p21 protein (9 fold), chromatin assembly factor 1 p55 subunit (8 fold), elongation factor 2 (2 fold), and lipopolysaccharide/beta-1, 3 glucan binding protein (13 fold above base line). Additionally, the transcript level of all the genes decreased in oysters fed wich the mixed diet 30X10(3) cells mL(-1) of dinoflagellate after 72 h and was lowest in the chromatin assembly factor 1 p55 subunit (0.9 fold below baseline). Conclusions: On C. gigas the whole cell ingestion of P lima caused a clear mRNA modulation expression of the genes involved in cell cycle regulation and immune system. Over- expression could be related to DNA damage, disturbances in cell cycle continuity, probably a genotoxic effect, as well as an activation of its innate immune system as first line of defense.	[de Jesus Romero-Geraldo, Reyna; Garcia-Lagunas, Norma; Yolanda Hernandez-Saavedra, Norma] Ctr Invest Biol Noroeste, Mol Genet Lab, Baja California Sur, Mexico; [de Jesus Romero-Geraldo, Reyna] Inst Tecnol La Paz, Dept Engn, Baja California Sur, Mexico	CIBNOR - Centro de Investigaciones Biologicas del Noroeste	Hernandez-Saavedra, NY (corresponding author), Ctr Invest Biol Noroeste, Mol Genet Lab, Baja California Sur, Mexico.	nhernan04@cibnor.mx	Hernandez Saavedra, Norma Yolanda/ABB-4249-2021	Hernandez Saavedra, Norma Yolanda/0000-0002-7004-299X	CONACyT [CB07 083442]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Funding for this project was by CONACyT CB07 083442. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguda BD, 1999, ONCOGENE, V18, P2846, DOI 10.1038/sj.onc.1202462; Arima Y, 2004, GENES CELLS, V9, P131, DOI 10.1111/j.1356-9597.2004.00710.x; BARDOUIL M, 1993, J SHELLFISH RES, V12, P417; Bauder AG, 2000, J SHELLFISH RES, V19, P321; Bauder AG, 2001, MAR ECOL PROG SER, V213, P39, DOI 10.3354/meps213039; Beninger PG, 1999, MAR ECOL PROG SER, V178, P259, DOI 10.3354/meps178259; Bougrier S, 1997, AQUACULTURE, V150, P123, DOI 10.1016/S0044-8486(96)01457-3; Boutet I, 2004, BBA-GENE STRUCT EXPR, V1679, P29, DOI 10.1016/j.bbaexp.2004.04.001; Bricelj V. Monica, 1998, Reviews in Fisheries Science, V6, P315, DOI 10.1080/10641269891314294; Browne GJ, 2002, EUR J BIOCHEM, V269, P5360, DOI 10.1046/j.1432-1033.2002.03290.x; Cognie B, 2001, ESTUARIES, V24, P126, DOI 10.2307/1352819; David E, 2005, FEBS J, V272, P5635, DOI 10.1111/j.1742-4658.2005.04960.x; Doucet E, 2007, ANAL BIOANAL CHEM, V389, P335, DOI 10.1007/s00216-007-1489-3; Farcy E, 2009, CELL STRESS CHAPERON, V14, P371, DOI 10.1007/s12192-008-0091-8; Fujiki H, 1997, J ENVIRON SCI HEAL C, V15, P1, DOI 10.1080/10590509709373488; Gainey LF., 1988, J SHELLFISH RES, V7, P623; Galimany E, 2008, HARMFUL ALGAE, V7, P630, DOI 10.1016/j.hal.2008.01.001; Garcia-Lagunas N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072323; GERDES D, 1983, AQUACULTURE, V31, P195, DOI 10.1016/0044-8486(83)90313-7; Gifford D.J., 2000, P193, DOI 10.1016/B978-012327645-2/50006-2; Gonzalez-Romero R, 2012, COMP BIOCHEM PHYS C, V155, P175, DOI 10.1016/j.cbpc.2011.09.003; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Haberkorn H, 2010, AQUAT TOXICOL, V97, P96, DOI 10.1016/j.aquatox.2009.12.006; Hamdoun AM, 2003, BIOL BULL-US, V205, P160, DOI 10.2307/1543236; Heredia-Tapia A, 2002, TOXICON, V40, P1121, DOI 10.1016/S0041-0101(02)00111-3; Herzig S, 2000, PHYSIOL REV, V80, P173, DOI 10.1152/physrev.2000.80.1.173; Huan P, 2010, GENET MOL BIOL, V33, P36, DOI 10.1590/S1415-47572010005000015; Keppler CJ, 2005, HARMFUL ALGAE, V4, P275, DOI 10.1016/j.hal.2004.05.002; Li SC, 2001, J EXP MAR BIOL ECOL, V263, P65, DOI 10.1016/S0022-0981(01)00294-5; Manfrin C, 2010, ENVIRON SCI TECHNOL, V44, P8276, DOI 10.1021/es102213f; Mello DF, 2012, MAR DRUGS, V10, P583, DOI 10.3390/md10030583; Mello DF, 2010, TOXINS, V2, P1166, DOI 10.3390/toxins2051166; Milczarek GJ, 1999, CARCINOGENESIS, V20, P1043, DOI 10.1093/carcin/20.6.1043; Mirzayans R, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/170325; Moore SK, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-S2-S4; Mydlarz LD, 2006, ANNU REV ECOL EVOL S, V37, P251, DOI 10.1146/annurev.ecolsys.37.091305.110103; Nunez-Vazquez E., 2003, P HAB TECH 2003 WORK, P64; Ochoa JL, 1997, MORTANDAD MAMIFEROS; Paul VJ, 2007, BIOL BULL-US, V213, P226, DOI 10.2307/25066642; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pistocchi R, 2012, MAR DRUGS, V10, P140, DOI 10.3390/md10010140; Prego-Faraldo MV, 2013, MAR DRUGS, V11, P2829, DOI 10.3390/md11082829; REDPATH NT, 1989, BIOCHEM J, V262, P69, DOI 10.1042/bj2620069; Romero-Geraldo R. J., 2012, AQUAC RES, P1; Sar A, 2002, FLORACIONES ALGALES, P311; SCHONTHAL AH, 1998, FRONT BIOSCI, V3, P1262; SHUMWAY S E, 1990, Journal of the World Aquaculture Society, V21, P65, DOI 10.1111/j.1749-7345.1990.tb00529.x; Souto C, 2001, SCI MAR, V65, P269, DOI 10.3989/scimar.2001.65s1269; Su JJ, 2004, WORLD J GASTROENTERO, V10, P3559, DOI 10.3748/wjg.v10.i24.3559; Suarez-Ulloa V, 2013, MAR DRUGS, V11, P4370, DOI 10.3390/md11114370; SUGANUMA M, 1988, P NATL ACAD SCI USA, V85, P1768, DOI 10.1073/pnas.85.6.1768; Suzuki T, 2011, ANAL SCI, V27, P571, DOI 10.2116/analsci.27.571; Tanguy A, 2005, FEBS J, V272, P390, DOI 10.1111/j.1742-4658.2004.04479.x; Tanguy A, 2003, MAR ECOL PROG SER, V257, P87, DOI 10.3354/meps257087; Valdiglesias V, 2011, J ENVIRON MONITOR, V13, P1831, DOI 10.1039/c0em00771d; Valdiglesias V, 2010, MUTAT RES-FUND MOL M, V689, P74, DOI 10.1016/j.mrfmmm.2010.05.004; Vale C, 2008, FEBS J, V275, P6060, DOI 10.1111/j.1742-4658.2008.06711.x; Van Dolah FM, 2003, N P TOX ENV, P247; Van Dolah FM, 2000, ENVIRON HEALTH PERSP, V108, P133, DOI 10.1289/ehp.00108s1133; Vieites JM, 2000, SEAFOOD FRESHWATER T, P741; Wikfors GH, 2005, HARMFUL ALGAE, V4, P585, DOI 10.1016/j.hal.2004.08.008; Windust AJ, 1996, MAR BIOL, V126, P19, DOI 10.1007/BF00571373; Yasumoto T, 1984, DIARRHETIC SHELLFISH, P207; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413	64	21	22	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97181	10.1371/journal.pone.0097181	http://dx.doi.org/10.1371/journal.pone.0097181			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24825133	Green Published, Green Submitted, gold			2022-12-27	WOS:000336369200070
J	Hou, AH; Lan, WW; Law, KP; Khoo, SCJ; Tin, MQ; Lim, YP; Tong, L				Hou, Aihua; Lan, Wanwen; Law, Kai Pong; Khoo, Ser Chin Jasmine; Tin, Min Qi; Lim, Yoon Pin; Tong, Louis			Evaluation of Global Differential Gene and Protein Expression in Primary Pterygium: S100A8 and S100A9 as Possible Drivers of a Signaling Network	PLOS ONE			English	Article							LYMPHOCYTE SUBPOPULATIONS CD4; GROWTH-FACTOR; EPITHELIAL-CELLS; GASTRIC-CANCER; PATHOGENESIS; RECEPTOR; OVEREXPRESSION; INFLAMMATION; INVOLVEMENT; FIBROBLASTS	Purpose: Pterygium is a wing shaped fibrovascular growth on the ocular surface, characterized by fibrosis, angiogenesis, extracellular matrix remodeling, and inflammatory infiltrates. Epidemiologic studies have linked pterygium formation to various chronic inflammatory conditions, such as ultraviolet radiation, sawdust exposure, and dry eye disease. The purpose of this study is to identify proteins that are differentially expressed in primary pterygium by using a combination of gene microarray and proteomic platforms. Methods: Paired pterygium and uninvolved conjunctiva tissues of four patients were evaluated for differences in global gene transcript levels using a genechip microarray. Proteins extracted from another four pairs of tissues were quantified by iTRAQ approach. Western blot and immunofluorescent staining on additional patients were used to validate dysregulated protein expression obtained from microarray and proteomics data. In addition, primary conjunctival fibroblasts were treated with recombinant S100A8, S100A9 or both. Transcript level changes of a panel of potential target genes were evaluated by real time-PCR. Results: The following were up-regulated at both protein and transcript levels S100 A8 and A9, aldehyde dehydrogenase 3 family, member1 (ALDH3A1) and vimentin (VIM). Conversely, serpin peptidase inhibitor clade A member 1 (SERPINA1) and transferrin (TF) were down-regulated. Upon adding S100A8, S100A9 or both, the inflammatory chemokine CXCL1, matrix proteins vimentin, biglycan, and gelsolin, as well as annexin-A2, thymosin-b4, chymase (CMA1), member of Ras oncogene family RAB10 and SERPINA1 were found to be up-regulated. Conclusions: We identified 3 up-regulated and 2 down-regulated proteins by using a stringent approach comparing microarray and proteomic data. On stimulating cells with S100A8/9, a repertoire of key genes found to be up-regulated in pterygium tissue, were induced in these cells. S100A8/9 may be an upstream trigger for inflammation and other disease pathways in pterygium.	[Hou, Aihua; Lan, Wanwen; Khoo, Ser Chin Jasmine; Tin, Min Qi; Tong, Louis] Singapore Eye Res Inst, Ocular Surface Res Grp, Singapore, Singapore; [Law, Kai Pong; Lim, Yoon Pin; Tong, Louis] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore; [Tong, Louis] Duke NUS Grad Med Sch, Singapore, Singapore; [Tong, Louis] Singapore Natl Eye Ctr, Singapore, Singapore; [Law, Kai Pong; Lim, Yoon Pin; Tong, Louis] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore	National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore; Singapore National Eye Center; National University of Singapore	Hou, AH (corresponding author), Singapore Eye Res Inst, Ocular Surface Res Grp, Singapore, Singapore.	hou.aihua@seri.com.sg; Louis.tong.h.t@snec.com.sg		Tong, Louis/0000-0002-3986-6552	Singapore National Research Foundation [NMRC/CSA/045/2012, NMRC/BNIG/10075/2012]	Singapore National Research Foundation(National Research Foundation, Singapore)	This research is supported by the Singapore National Research Foundation under its NMRC/CSA/045/2012, NMRC/BNIG/10075/2012 and administered by the Singapore Ministry of Health's National Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awdeh RM, 2008, ADV THER, V25, P479, DOI 10.1007/s12325-008-0056-4; Bautista-de Lucio VM, 2013, EXP EYE RES, V110, P70, DOI 10.1016/j.exer.2013.03.001; Beden U, 2003, OCUL IMMUNOL INFLAMM, V11, P115, DOI 10.1076/ocii.11.2.115.15913; BHARDWAJ RS, 1992, EUR J IMMUNOL, V22, P1891, DOI 10.1002/eji.1830220732; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Chaurasia SS, 2009, EXP EYE RES, V89, P133, DOI 10.1016/j.exer.2009.02.022; Chen YH, 2007, MOL CELL PROTEOMICS, V6, P2072, DOI 10.1074/mcp.M700395-MCP200; Chong PK, 2010, J PROTEOME RES, V9, P3671, DOI 10.1021/pr100192h; Chong PK, 2010, PROTEOMICS, V10, P3210, DOI 10.1002/pmic.201000127; Di Girolamo N, 2003, INVEST OPHTH VIS SCI, V44, P4705, DOI 10.1167/iovs.03-0356; Di Girolamo N, 2004, PROG RETIN EYE RES, V23, P195, DOI 10.1016/j.preteyeres.2004.02.002; Di Girolamo N, 2002, INVEST OPHTH VIS SCI, V43, P3430; DUSHKU N, 1994, CURR EYE RES, V13, P473, DOI 10.3109/02713689408999878; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Estey T, 2007, J BIOL CHEM, V282, P4382, DOI 10.1074/jbc.M607546200; Estey T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015218; Gomes LH, 2013, FREE RADICAL BIO MED, V58, P170, DOI 10.1016/j.freeradbiomed.2012.12.012; Harrison CA, 1999, J BIOL CHEM, V274, P8561, DOI 10.1074/jbc.274.13.8561; Ho J, 2009, J PROTEOME RES, V8, P583, DOI 10.1021/pr8007368; Hou AH, 2013, EXP CELL RES, V319, P2781, DOI 10.1016/j.yexcr.2013.08.022; Ioachim-Velogianni E, 1995, Ger J Ophthalmol, V4, P123; John-Aryankalayil M, 2006, MOL VIS, V12, P55; Kato N, 2007, INVEST OPHTH VIS SCI, V48, P1511, DOI 10.1167/iovs.06-1060; Kessel C, 2013, CLIN IMMUNOL, V147, P229, DOI 10.1016/j.clim.2012.11.008; Klebe S, 2013, J HISTOCHEM CYTOCHEM; Kuo CH, 2007, INVEST OPHTH VIS SCI, V48, P3566, DOI 10.1167/iovs.06-1149; Lassen N, 2006, FREE RADICAL BIO MED, V41, P1459, DOI 10.1016/j.freeradbiomed.2006.08.009; Lee YM, 2009, ARCH DERMATOL RES, V301, P523, DOI 10.1007/s00403-009-0960-8; Li CY, 2010, MOL VIS, V16, P2225; Li J, 2011, MOL VIS, V17, P2263; Lim S, 2009, J PROTEOME RES, V8, P4062, DOI 10.1021/pr900430n; Lim SY, 2011, ANTIOXID REDOX SIGN, V15, P2235, DOI 10.1089/ars.2010.3641; Lucas RM, 2008, INT J EPIDEMIOL, V37, P654, DOI 10.1093/ije/dyn017; Muzio G, 2012, FREE RADICAL BIO MED, V52, P735, DOI 10.1016/j.freeradbiomed.2011.11.033; NEALE FC, 1955, J CLIN PATHOL, V8, P334, DOI 10.1136/jcp.8.4.334; Nolan TM, 2003, AM J PATHOL, V162, P567, DOI 10.1016/S0002-9440(10)63850-3; Perra MT, 2006, MOL VIS, V12, P1136; Raftery MJ, 2001, J BIOL CHEM, V276, P33393, DOI 10.1074/jbc.M101566200; Riau AK, 2009, MOL VIS, V15, P335; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Shiotani A, 2013, DIG DIS SCI; Solomon A, 2003, INVEST OPHTH VIS SCI, V44, P573, DOI 10.1167/iovs.01-1185; Srikrishna G, 2012, J INNATE IMMUN, V4, P31, DOI 10.1159/000330095; Sroussi HY, 2010, FREE RADICAL RES, V44, P389, DOI 10.3109/10715760903431434; Sroussi HY, 2009, FEMS IMMUNOL MED MIC, V55, P55, DOI 10.1111/j.1574-695X.2008.00498.x; Sun Y, 2013, MOL IMMUNOL, V53, P443, DOI 10.1016/j.molimm.2012.10.002; Takashi Kanamoto NS, 2011, J PROTEOM BIOINFORM, V4, P58; Tong L, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-14; Tsai YY, 2005, MOL VIS, V11, P71; Tsironi S, 2002, IN VIVO, V16, P299; Vento G, 2013, PEDIAT RES; Winkler IG, 2005, J EXP MED, V201, P1077, DOI 10.1084/jem.20042299; Wong YW, 2006, BRIT J OPHTHALMOL, V90, P769, DOI 10.1136/bjo.2005.087486; Yang YX, 2010, J PROTEOME RES, V9, P4767, DOI 10.1021/pr100492x; Yano A, 2013, BIOSCI BIOTECH BIOCH, V77, P307, DOI 10.1271/bbb.120724; Zhou L, 2009, INVEST OPHTH VIS SCI, V50, P2077, DOI 10.1167/iovs.08-2604	57	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97402	10.1371/journal.pone.0097402	http://dx.doi.org/10.1371/journal.pone.0097402			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24825356	Green Published, gold, Green Submitted			2022-12-27	WOS:000336369200110
J	Kaza, N; Kohli, L; Graham, CD; Klocke, BJ; Carroll, SL; Roth, KA				Kaza, Niroop; Kohli, Latika; Graham, Christopher D.; Klocke, Barbara J.; Carroll, Steven L.; Roth, Kevin A.			BNIP3 Regulates AT101 [(-)-Gossypol] Induced Death in Malignant Peripheral Nerve Sheath Tumor Cells	PLOS ONE			English	Article							HUMAN PROSTATE-CANCER; BCL-XL; SCHWANN-CELLS; GLIOMA-CELLS; PHASE I/II; GOSSYPOL; EXPRESSION; AUTOPHAGY; APOPTOSIS; PROTEIN	Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive Schwann cell-derived sarcomas and are the leading cause of mortality in patients with neurofibromatosis type 1 (NF1). Current treatment modalities have been largely ineffective, resulting in a high rate of MPNST recurrence and poor five-year patient survival. This necessitates the exploration of alternative chemotherapeutic options for MPNST patients. This study sought to assess the cytotoxic effect of the BH3-mimetic AT101 [(-)-gossypol] on MPNST cells in vitro and to identify key regulators of AT101-induced MPNST cell death. We found that AT101 caused caspase-independent, non-apoptotic MPNST cell death, which was accompanied by autophagy and was mediated through HIF-1 alpha induced expression of the atypical BH3-only protein BNIP3. These effects were mediated by intracellular iron chelation, a previously unreported mechanism of AT101 cytotoxicity.	[Kaza, Niroop; Kohli, Latika; Graham, Christopher D.; Klocke, Barbara J.; Carroll, Steven L.; Roth, Kevin A.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Roth, KA (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	karoth@uab.edu		Kaza, Niroop/0000-0002-7584-1379; Roth, Kevin/0000-0002-0643-995X	National Cancer Institute [CA134773, CA122804]; National Institute of Neurological Disorders and Stroke [NS41962]; Department of Defense [X81XWH-09-1-0086, W81XWH-12-1-0164]; NATIONAL CANCER INSTITUTE [R01CA122804, R01CA134773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041962] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Cancer Institute grants CA134773 (KAR, SLC) and CA122804 (SLC), National Institute of Neurological Disorders and Stroke grant NS41962 (KAR), and Department of Defense grants X81XWH-09-1-0086 and W81XWH-12-1-0164 (SLC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; ADAMS R, 1960, CHEM REV, V60, P555, DOI 10.1021/cr60208a002; Baggstrom MQ, 2011, J THORAC ONCOL, V6, P1757, DOI 10.1097/JTO.0b013e31822e2941; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Brossier NM, 2012, BRAIN RES BULL, V88, P58, DOI 10.1016/j.brainresbull.2011.08.005; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Byun YJ, 2009, NEUROSCI LETT, V461, P131, DOI 10.1016/j.neulet.2009.06.011; Daido S, 2004, CANCER RES, V64, P4286, DOI 10.1158/0008-5472.CAN-03-3084; Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010; DeBonis S, 2004, MOL CANCER THER, V3, P1079; Evans DGR, 2002, J MED GENET, V39, P311, DOI 10.1136/jmg.39.5.311; Ferner RE, 2002, CANCER RES, V62, P1573; FLORIDI A, 1983, EXP MOL PATHOL, V38, P322, DOI 10.1016/0014-4800(83)90072-2; Gao P, 2010, J BIOL CHEM, V285, P25570, DOI 10.1074/jbc.M110.118125; Geng Y, 2010, NEURO-ONCOLOGY, V12, P473, DOI 10.1093/neuonc/nop048; Gewirtz DA, 2014, CANCER RES, V74, P647, DOI 10.1158/0008-5472.CAN-13-2966; Guo K, 2001, CELL DEATH DIFFER, V8, P367, DOI 10.1038/sj.cdd.4400810; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heist RS, 2010, J THORAC ONCOL, V5, P1637, DOI 10.1097/JTO.0b013e3181e8f4dc; Hu WB, 2012, J BIOL CHEM, V287, P68, DOI 10.1074/jbc.M111.271205; Jan CR, 2000, BBA-MOL CELL RES, V1496, P270, DOI 10.1016/S0167-4889(00)00033-1; Jiang JH, 2004, ANTICANCER RES, V24, P91; Jiang JH, 2012, CLIN EXP METASTAS, V29, P165, DOI 10.1007/s10585-011-9439-z; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kang MH, 2009, CLIN CANCER RES, V15, P1126, DOI 10.1158/1078-0432.CCR-08-0144; Kazi AA, 2007, ENDOCRINOLOGY, V148, P2363, DOI 10.1210/en.2006-1394; KIM SH, 1985, CANCER RES, V45, P6338; King AA, 2000, MALIGNANT PERIPHERAL; Kitada S, 2003, J MED CHEM, V46, P4259, DOI 10.1021/jm030190z; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Ko CH, 2007, INT J CANCER, V121, P1670, DOI 10.1002/ijc.22910; Lee Ji-Won, 2004, Experimental & Molecular Medicine, V36, P1; Lee SJ, 2012, INT J MOL MED, V30, P443, DOI 10.3892/ijmm.2012.1013; Lei XB, 2006, FASEB J, V20, P2147, DOI 10.1096/fj.05-5665fje; Lian J, 2011, CELL DEATH DIFFER, V18, P60, DOI 10.1038/cdd.2010.74; Lian JQ, 2010, AUTOPHAGY, V6, P1201, DOI [10.1038/cdd.2010.74, 10.4161/auto.6.8.13549]; Liu G, 2009, CLIN CANCER RES, V15, P3172, DOI 10.1158/1078-0432.CCR-08-2985; Mego M, 2002, Bratisl Lek Listy, V103, P378; Meng Y, 2008, MOL CANCER THER, V7, P2192, DOI 10.1158/1535-7163.MCT-08-0333; Moon DO, 2008, CANCER LETT, V264, P192, DOI 10.1016/j.canlet.2008.01.030; NAKADATE T, 1988, BIOCHEM PHARMACOL, V37, P1541, DOI 10.1016/0006-2952(88)90016-0; Oliver CL, 2005, MOL CANCER THER, V4, P23; Park HJ, 2013, INT J ONCOL, V42, P657, DOI 10.3892/ijo.2012.1751; Park SS, 2008, J CELL BIOCHEM, V103, P1989, DOI 10.1002/jcb.21588; Placzek WJ, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.18; Rasmussen SA, 2000, AM J EPIDEMIOL, V151, P33, DOI 10.1093/oxfordjournals.aje.a010118; Ready N, 2011, J THORAC ONCOL, V6, P781, DOI 10.1097/JTO.0b013e31820a0ea6; REYES J, 1988, AM J PHYSIOL, V254, pC564, DOI 10.1152/ajpcell.1988.254.4.C564; Santos JEP, 2005, J DAIRY SCI, V88, P3563, DOI 10.3168/jds.S0022-0302(05)73041-1; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Sikora MJ, 2008, CANCER BIOL THER, V7, P767, DOI 10.4161/cbt.7.5.5767; Stonecypher MS, 2005, ONCOGENE, V24, P5589, DOI 10.1038/sj.onc.1208730; Treins C, 2002, J BIOL CHEM, V277, P27975, DOI 10.1074/jbc.M204152200; Triantafyllou A, 2007, FREE RADICAL RES, V41, P342, DOI 10.1080/10715760601055324; VERMEL E M, 1965, Fed Proc Transl Suppl, V24, P106; VERMEL' E. M., 1963, VOPR ONKOL, V9, P39; Volate SR, 2010, MOL CANCER THER, V9, P461, DOI 10.1158/1535-7163.MCT-09-0507; Voss V, 2010, MOL CANCER RES, V8, P1002, DOI 10.1158/1541-7786.MCR-09-0562; Waites GMH, 1998, INT J ANDROL, V21, P8; Walls KC, 2009, J NEUROPATH EXP NEUR, V68, P1326, DOI 10.1097/NEN.0b013e3181c3b9be; Walls KC, 2010, J BIOL CHEM, V285, P10497, DOI 10.1074/jbc.M110.103747; WANG YC, 1984, CANCER RES, V44, P35; Wang Y, 2011, MOL ENDOCRINOL, V25, P2041, DOI 10.1210/me.2011-1222; Yu ZH, 1998, INT J ANDROL, V21, P2, DOI 10.1046/j.1365-2605.1998.00091.x; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16; Zhang MC, 2003, BIOCHEM PHARMACOL, V66, P93, DOI 10.1016/S0006-2952(03)00248-X; Zhang ZF, 2011, FEBS J, V278, P134, DOI 10.1111/j.1742-4658.2010.07939.x; Zhong H, 2000, CANCER RES, V60, P1541	68	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96733	10.1371/journal.pone.0096733	http://dx.doi.org/10.1371/journal.pone.0096733			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824755	Green Published, Green Submitted, gold			2022-12-27	WOS:000336369200028
J	Okyere, J; Oppon, E; Dzidzienyo, D; Sharma, L; Ball, G				Okyere, John; Oppon, Ekow; Dzidzienyo, Daniel; Sharma, Lav; Ball, Graham			Cross-Species Gene Expression Analysis of Species Specific Differences in the Preclinical Assessment of Pharmaceutical Compounds	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; ARTIFICIAL NEURAL NETWORKS; PPAR-ALPHA; IN-VITRO; HEPATOCYTES; LIVER; ACID; RAT; CLASSIFICATION; IDENTIFICATION	Animals are frequently used as model systems for determination of safety and efficacy in pharmaceutical research and development. However, significant quantitative and qualitative differences exist between humans and the animal models used in research. This is as a result of genetic variation between human and the laboratory animal. Therefore the development of a system that would allow the assessment of all molecular differences between species after drug exposure would have a significant impact on drug evaluation for toxicity and efficacy. Here we describe a cross-species microarray methodology that identifies and selects orthologous probes after cross-species sequence comparison to develop an orthologous cross-species gene expression analysis tool. The assumptions made by the use of this orthologous gene expression strategy for cross-species extrapolation is that; conserved changes in gene expression equate to conserved pharmacodynamic endpoints. This assumption is supported by the fact that evolution and selection have maintained the structure and function of many biochemical pathways over time, resulting in the conservation of many important processes. We demonstrate this cross-species methodology by investigating species specific differences of the peroxisome proliferator-activator receptor (PPAR) a response in rat and human.	[Okyere, John; Oppon, Ekow; Dzidzienyo, Daniel; Sharma, Lav] CrossGen Ltd, BioCity Nottingham, Nottingham, England; [Ball, Graham] Nottingham Trent Univ, John Van Geest Canc Res Ctr, Nottingham, England	Nottingham Trent University	Okyere, J (corresponding author), CrossGen Ltd, BioCity Nottingham, Pennyfoot St, Nottingham, England.	john.okyere@crossgen.co.uk		Sharma, Lav/0000-0001-6615-2478; Ball, Graham/0000-0001-5828-7129				Abbott BD, 2009, REPROD TOXICOL, V27, P246, DOI 10.1016/j.reprotox.2008.10.001; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ammerschlaeger M, 2004, TOXICOL SCI, V78, P229, DOI 10.1093/toxsci/kfh071; Ball G, 2002, BIOINFORMATICS, V18, P395, DOI 10.1093/bioinformatics/18.3.395; Black MB, 2012, TOXICOL SCI, V127, P199, DOI 10.1093/toxsci/kfs069; Boverhof DR, 2006, TOXICOL SCI, V94, P398, DOI 10.1093/toxsci/kfl100; Cattley RC, 1998, REGUL TOXICOL PHARM, V27, P47, DOI 10.1006/rtph.1997.1163; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Davis AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058201; Deehan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035012; Duncan RE, 2008, LIPIDS, V43, P619, DOI 10.1007/s11745-008-3192-3; Elant G, 2006, CURRENT DRUG METABOL, V7, P629; Glaise D, 1998, CELL GROWTH DIFFER, V9, P165; Grigoryev DN, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r34; Hervent AS, 2012, INT J MOL SCI, V13, P12268, DOI 10.3390/ijms131012268; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Kristiansson E, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-70; Kuhn A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-26; Lancashire LJ, 2010, BREAST CANCER RES TR, V120, P83, DOI 10.1007/s10549-009-0378-1; Lawrence JW, 2001, J BIOL CHEM, V276, P31521, DOI 10.1074/jbc.M103306200; LeCluyse EL, 2001, EUR J PHARM SCI, V13, P343, DOI 10.1016/S0928-0987(01)00135-X; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Maher JM, 2008, TOXICOL SCI, V106, P319, DOI 10.1093/toxsci/kfn177; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Mogilenko DA, 2013, J BIOL CHEM, V288, P1726, DOI 10.1074/jbc.M112.437525; Palmer CNA, 1998, MOL PHARMACOL, V53, P14, DOI 10.1124/mol.53.1.14; Qu Y, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-211; Rakhshandehroo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006796; Richert L, 2008, DRUG METAB DISPOS, V36, P702, DOI 10.1124/dmd.107.018358; Rogue A, 2011, TOXICOL APPL PHARM, V254, P18, DOI 10.1016/j.taap.2011.04.005; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; SHER T, 1993, BIOCHEMISTRY-US, V32, P5598, DOI 10.1021/bi00072a015; Stalteri MA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-13; The National Research Council, 2007, APPL TOX TECHN PRED; Tsunoda M, 2008, AM J PHYSIOL-ENDOC M, V294, pE833, DOI 10.1152/ajpendo.00627.2007; Tugwood JD, 1996, ANN NY ACAD SCI, V804, P252, DOI 10.1111/j.1749-6632.1996.tb18620.x	37	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96853	10.1371/journal.pone.0096853	http://dx.doi.org/10.1371/journal.pone.0096853			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24823806	Green Submitted, Green Published, gold			2022-12-27	WOS:000336369200038
J	Salavirta, H; Oksanen, I; Kuuskeri, J; Makela, M; Laine, P; Paulin, L; Lundell, T				Salavirta, Heikki; Oksanen, Ilona; Kuuskeri, Jaana; Makela, Miia; Laine, Pia; Paulin, Lars; Lundell, Taina			Mitochondrial Genome of Phlebia radiata Is the Second Largest (156 kbp) among Fungi and Features Signs of Genome Flexibility and Recent Recombination Events	PLOS ONE			English	Article							LIGNIN-MODIFYING ENZYMES; GROUP-I INTRON; HOMING ENDONUCLEASES; DEGRADING BASIDIOMYCETE; TRANSFER-RNAS; PROTEIN; GENE; MANGANESE; EVOLUTION; SEQUENCE	Mitochondria are eukaryotic organelles supporting individual life-style via generation of proton motive force and cellular energy, and indispensable metabolic pathways. As part of genome sequencing of the white rot Basidiomycota species Phlebia radiata, we first assembled its mitochondrial genome (mtDNA). So far, the 156 348 bp mtDNA is the second largest described for fungi, and of considerable size among eukaryotes. The P. radiata mtDNA assembled as single circular dsDNA molecule containing genes for the large and small ribosomal RNAs, 28 transfer RNAs, and over 100 open reading frames encoding the 14 fungal conserved protein subunits of the mitochondrial complexes I, III, IV, and V. Two genes (atp6 and tRNA-Ile(GAU)) were duplicated within 6.1 kbp inverted region, which is a unique feature of the genome. The large mtDNA size, however, is explained by the dominance of intronic and intergenic regions (sum 80% of mtDNA sequence). The intergenic DNA stretches harness short (<= 200 nt)repetitive, dispersed and overlapping sequence elements in abundance. Long self-splicing introns of types I and II interrupt eleven of the conserved genes (cox1,2,3; cob; nad1,2,4,4L, 5; rnl; rns). The introns embrace a total of 57 homing endonucleases with LAGLIDADGD and GYI-YIG core motifs, which makes P. radiata mtDNA to one of the largest known reservoirs of intron-homing endonucleases. The inverted duplication, intergenic stretches, and intronic features are indications of dynamics and genetic flexibility of the mtDNA, not fully recognized to this extent in fungal mitochondrial genomes previously, thus giving new insights for the evolution of organelle genomes in eukaryotes.	[Salavirta, Heikki; Oksanen, Ilona; Kuuskeri, Jaana; Makela, Miia; Lundell, Taina] Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland; [Laine, Pia; Paulin, Lars] Univ Helsinki, Inst Biotechnol, DNA Sequencing & Genom Lab, Helsinki, Finland	University of Helsinki; University of Helsinki	Lundell, T (corresponding author), Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland.	taina.lundell@helsinki.fi	Lundell, Taina/ABA-8393-2021; Mäkelä, Miia R./F-2181-2011; Lundell, Taina/P-6623-2016	Lundell, Taina/0000-0003-3899-1658; Mäkelä, Miia R./0000-0003-0771-2329; Lundell, Taina/0000-0003-3899-1658; Laine, Pia/0000-0002-3727-8749; Kuuskeri, Jaana/0000-0002-5838-2086	Academy of Finland [AF-138331 (Ox-Red), AF-129869]; Department of Food and Environmental Sciences, University of Helsinki	Academy of Finland(Academy of Finland); Department of Food and Environmental Sciences, University of Helsinki	This study was supported by the Academy of Finland research project grants AF-138331 (Ox-Red) and AF-129869, and a Master's thesis grant from the Department of Food and Environmental Sciences, University of Helsinki. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alverson AJ, 2011, PLANT CELL, V23, P2499, DOI 10.1105/tpc.111.087189; [Anonymous], NCBI ORG GEN RES; Barr CM, 2005, NEW PHYTOL, V168, P39, DOI 10.1111/j.1469-8137.2005.01492.x; Basse CW, 2010, CURR OPIN MICROBIOL, V13, P712, DOI 10.1016/j.mib.2010.09.003; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bendich AJ, 2010, MOL CELL, V39, P831, DOI 10.1016/j.molcel.2010.09.005; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bullerwell CE, 2005, CURR OPIN MICROBIOL, V8, P362, DOI 10.1016/j.mib.2005.06.009; Caprara MG, 2007, RNA, V13, P211, DOI 10.1261/rna.307907; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Contreras L, 2010, BBA-BIOENERGETICS, V1797, P607, DOI 10.1016/j.bbabio.2010.05.005; Costa GGL, 2012, FUNGAL BIOL-UK, V116, P551, DOI 10.1016/j.funbio.2012.01.008; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ferandon C, 2008, FUNGAL GENET BIOL, V45, P292, DOI 10.1016/j.fgb.2007.10.012; Ferandon C, 2013, FUNGAL GENET BIOL, V55, P85, DOI 10.1016/j.fgb.2013.01.009; Ferandon C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014048; Forget L, 2002, MOL BIOL EVOL, V19, P310, DOI 10.1093/oxfordjournals.molbev.a004084; Formighieri EF, 2008, MYCOL RES, V112, P1136, DOI 10.1016/j.mycres.2008.04.014; Foury F, 1998, FEBS LETT, V440, P325, DOI 10.1016/S0014-5793(98)01467-7; Gerhold JM, 2010, MOL CELL, V39, P851, DOI 10.1016/j.molcel.2010.09.002; Gu SQ, 2010, RNA, V16, P732, DOI 10.1261/rna.2007310; Haridas S, 2010, FEMS MICROBIOL LETT, V308, P29, DOI 10.1111/j.1574-6968.2010.01979.x; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Hilden K, 2005, FUNGAL GENET BIOL, V42, P403, DOI 10.1016/j.fgb.2005.01.008; Hilden KS, 2008, MICROBIOL-SGM, V154, P2371, DOI 10.1099/mic.0.2008/018747-0; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; INAGAKI Y, 1995, J MOL BIOL, V251, P486, DOI 10.1006/jmbi.1995.0450; Jones MDM, 2011, NATURE, V474, P200, DOI 10.1038/nature09984; Kim EK, 2000, CURR GENET, V38, P283, DOI 10.1007/s002940000157; Kitazaki K., 2010, Journal of Botany, V2010, P620137, DOI 10.1155/2010/620137; Lang BF, 2007, TRENDS GENET, V23, P119, DOI 10.1016/j.tig.2007.01.006; Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Li JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054839; Litter J, 2005, ANTON LEEUW INT J G, V88, P249, DOI 10.1007/s10482-005-8544-x; Lukes J, 2002, EUKARYOT CELL, V1, P495, DOI 10.1128/EC.1.4.495-502.2002; LUNDELL T, 1990, APPL ENVIRON MICROB, V56, P2623, DOI 10.1128/AEM.56.9.2623-2629.1990; Lundell TK, 2010, J BASIC MICROB, V50, P5, DOI 10.1002/jobm.200900338; Ma HS, 2009, P NATL ACAD SCI USA, V106, P12980, DOI 10.1073/pnas.0902963106; Makela MR, 2013, FUNGAL BIOL-UK, V117, P62, DOI 10.1016/j.funbio.2012.11.006; MARGULIS L, 1970, P349; MICHEL F, 1985, NATURE, V316, P641, DOI 10.1038/316641a0; Miettinen O, 2012, CLADISTICS, V28, P251, DOI 10.1111/j.1096-0031.2011.00380.x; Moilanen AM, 1996, APPL MICROBIOL BIOT, V45, P792, DOI 10.1007/s002530050764; Mouhamadou B, 2007, FEMS MICROBIOL LETT, V272, P276, DOI 10.1111/j.1574-6968.2007.00771.x; NAKASONE KK, 1993, MYCOLOGIA, V85, P996, DOI 10.2307/3760683; PAQUIN B, 1994, P NATL ACAD SCI USA, V91, P11807, DOI 10.1073/pnas.91.25.11807; Petersen RF, 2002, J MOL BIOL, V318, P627, DOI 10.1016/S0022-2836(02)00037-2; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107; Robbertse B, 2011, PLOS CURR-TREE LIFE, DOI 10.1371/currents.RRN1213; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Sethuraman J, 2009, MOL BIOL EVOL, V26, P2299, DOI 10.1093/molbev/msp145; Sloan DB, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001241; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stoddard BL, 2011, STRUCTURE, V19, P7, DOI 10.1016/j.str.2010.12.003; Stone CL, 2010, MYCOLOGIA, V102, P887, DOI 10.3852/09-198; Taylor GK, 2012, NUCLEIC ACIDS RES, V40, P5189, DOI 10.1093/nar/gks226; Thrash JC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00013; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Wang Y, 2008, FEMS MICROBIOL LETT, V280, P34, DOI 10.1111/j.1574-6968.2007.01048.x; Wibberg D, 2013, J BIOTECHNOL, V167, P142, DOI 10.1016/j.jbiotec.2012.12.010; Williamson D, 2002, NAT REV GENET, V3, P475, DOI 10.1038/nrg814; Xia XH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-211; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	70	46	46	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97141	10.1371/journal.pone.0097141	http://dx.doi.org/10.1371/journal.pone.0097141			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824642	Green Published, Green Submitted, gold			2022-12-27	WOS:000336369200065
J	Zeng, F; Chen, HQ; Yang, JR; Wang, L; Cui, Y; Guan, X; Wang, Z; Niu, JP; Zu, XB; Qi, L; Zhang, XY; Tang, ZY; Liu, LF				Zeng, Feng; Chen, Hequn; Yang, Jinrui; Wang, Long; Cui, Yu; Guan, Xiao; Wang, Zhao; Niu, Jiping; Zu, Xiongbing; Qi, Lin; Zhang, Xiangyang; Tang, Zhengyan; Liu, Longfei			Development and Validation of an Animal Model of Prostate Inflammation-Induced Chronic Pelvic Pain: Evaluating from Inflammation of the Prostate to Pain Behavioral Modifications	PLOS ONE			English	Article							SYMPTOM INDEX; INJECTION	Background: Chronic prostatitis/Chronic pelvic pain syndrome (CP/CPPS) is the most common type of prostatitis. Due to the lack of a suitable animal model partly, the pathogenesis for this condition is obscure. In the current study we developed and validated an animal model for nonbacterial prostatitis and prostate inflammation-induced chronic pelvic pain in rats with the use of intraprostatic injection of lambda-carrageenan. Methods: Male Sprague-Dawley rats weighing 250-350 g were used for the experiments. After intraprostatic injection of 3% l-carrageenan, at different time points(after 24 h, 7d, 14d and 30d of injection), radiant heat and von Frey filaments were applied to the scrotum of rats to measure the heat and mechanical thresholds respectively. Then the prostate was removed for histology, and cyclooxygenase (COX) 2 protein expression was determined by Western-blot. Evans blue(50 mg/kg) was also injected intravenously to assess for plasma protein extravasation at different time points after injection of lambda-carrageenan. Results: Compared to control group, inflamed animals showed a significant reduction in mechanical threshold (mechanical allodynia) at 24 h and 7d(p = 0.022,0.046, respectively), and a significant reduction in heat threshold (thermal hyperalgesia) at 24 h, 7d and 14d(p = 0.014, 0.018, 0.002, respectively) in the scrotal skin. Significant increase of inflammatory cell accumulation, COX2 expression and Evans blue extravasation were observed at 24 h, 7d and 14d after injection. Conclusions: Intraprostatic l-carrageenan injection induced neurogenic prostatitis and prostate inflammation pain, which lasted at least 2 weeks. The current model is expected to be a valuable preclinical tool to study the neurobiological mechanisms of male chronic pelvic pain.	[Zeng, Feng; Chen, Hequn; Wang, Long; Cui, Yu; Guan, Xiao; Niu, Jiping; Zu, Xiongbing; Qi, Lin; Zhang, Xiangyang; Tang, Zhengyan; Liu, Longfei] Cent S Univ, Xiangya Hosp, Dept Urol, Changsha, Hunan, Peoples R China; [Yang, Jinrui; Wang, Zhao] Cent S Univ, Xiangya Hosp 2, Dept Urol, Changsha, Hunan, Peoples R China	Central South University; Central South University	Liu, LF (corresponding author), Cent S Univ, Xiangya Hosp, Dept Urol, Changsha, Hunan, Peoples R China.	longfei_liu@163.com			National Natural Science Foundation of China [81200549]; Program of Central South University [2011QNZT136]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Central South University	The authors' study was supported by the National Natural Science Foundation of China (No. 81200549), and the freedom explore Program of Central South University (2011QNZT136). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altuntas CZ, 2013, AM J PHYSIOL-REG I, V304, pR415, DOI 10.1152/ajpregu.00147.2012; Chen CS, 2013, PROSTATE, V73, P391, DOI 10.1002/pros.22580; Chuang YC, 2008, J UROLOGY, V180, P742, DOI 10.1016/j.juro.2007.07.120; Chuang YC, 2007, EUR UROL, V51, P1119, DOI 10.1016/j.eururo.2006.11.037; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; Ishigooka M, 2000, J UROLOGY, V164, P1751, DOI 10.1016/S0022-5347(05)67101-7; Krieger JN, 1999, JAMA-J AM MED ASSOC, V282, P236, DOI 10.1001/jama.282.3.236; Lang MD, 2000, PROSTATE, V45, P201, DOI 10.1002/1097-0045(20001101)45:3<201::AID-PROS1>3.0.CO;2-Q; Litwin MS, 1999, J UROLOGY, V162, P369, DOI 10.1016/S0022-5347(05)68562-X; Liu LF, 2008, ASIAN J ANDROL, V10, P675, DOI 10.1111/j.1745-7262.2008.00416.x; Nickel JC, 2007, J UROLOGY, V178, P896, DOI 10.1016/j.juro.2007.05.041; NICKEL JC, 2007, J UROLOGY, V178, P900; Quick ML, 2013, JOVE-J VIS EXP, DOI 10.3791/50158; Radhakrishnan R, 2003, PAIN, V104, P567, DOI 10.1016/S0304-3959(03)00114-3; Radhakrishnan R., 2009, Inflammopharmacology, V17, P23, DOI 10.1007/s10787-008-8051-6; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Rudick CN, 2008, AM J PHYSIOL-REG I, V294, pR1268, DOI 10.1152/ajpregu.00836.2007; Schneider H, 2005, BJU INT, V95, P238, DOI 10.1111/j.1464-410X.2005.05373.x; Smyth EM, 2009, J LIPID RES, V50, pS423, DOI 10.1194/jlr.R800094-JLR200; Vykhovanets EV, 2007, PROSTATE CANCER P D, V10, P15, DOI 10.1038/sj.pcan.4500930; Wagenlehner FME, 2013, EUR UROL, V63, P953, DOI 10.1016/j.eururo.2012.10.042; Yang CC, 2003, J UROLOGY, V170, P823, DOI 10.1097/01.ju.0000082710.47402.03	22	18	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96824	10.1371/journal.pone.0096824	http://dx.doi.org/10.1371/journal.pone.0096824			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24823660	gold, Green Published, Green Submitted			2022-12-27	WOS:000336369200035
J	Xia, CQ; Zhang, PC; Li, SW; Yuan, LH; Xia, TN; Xie, C; Clare-Salzler, MJ				Xia, Chang-Qing; Zhang, Pengcheng; Li, Shiwu; Yuan, Lihui; Xia, Tina; Xie, Chao; Clare-Salzler, Michael J.			C-Abl Inhibitor Imatinib Enhances Insulin Production by beta Cells: C-Abl Negatively Regulates Insulin Production via Interfering with the Expression of NKx2.2 and GLUT-2	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; GASTROINTESTINAL STROMAL TUMORS; MESYLATE GLEEVEC; PDX-1; SENSITIVITY; NKX6.1; BINDING; GENE; MAFA; AMELIORATION	Chronic myelogenous leukemia patients treated with tyrosine kinase inhibitor, Imatinib, were shown to have increased serum levels of C-peptide. Imatinib specifically inhibits the tyrosine kinase, c-Abl. However, the mechanism of how Imatinib treatment can lead to increased insulin level is unclear. Specifically, there is little investigation into whether Imatinib directly affects beta cells to promote insulin production. In this study, we showed that Imatinib significantly induced insulin expression in both glucose-stimulated and resting beta cells. In line with this finding, c-Abl knockdown by siRNA and overexpression of c-Abl markedly enhanced and inhibited insulin expression in beta cells, respectively. Unexpectedly, high concentrations of glucose significantly induced c-Abl expression, suggesting c-Abl may play a role in balancing insulin production during glucose stimulation. Further studies demonstrated that c-Abl inhibition did not affect the major insulin gene transcription factor, pancreatic and duodenal homeobox-1 (PDX-1) expression. Of interest, inhibition of c-Abl enhanced NKx2.2 and overexpression of c-Abl in beta cells markedly down-regulated NKx2.2, which is a positive regulator for insulin gene expression. Additionally, we found that c-Abl inhibition significantly enhanced the expression of glucose transporter GLUT2 on beta cells. Our study demonstrates a previously unrecognized mechanism that controls insulin expression through c-Abl-regulated NKx2.2 and GLUT2. Therapeutic targeting beta cell c-Abl could be employed in the treatment of diabetes or beta cell tumor, insulinoma.	[Xia, Chang-Qing] Capital Med Univ, Xuanwu Hosp, Dept Hematol, Beijing, Peoples R China; [Xia, Chang-Qing; Zhang, Pengcheng; Li, Shiwu; Yuan, Lihui; Xia, Tina; Xie, Chao; Clare-Salzler, Michael J.] Univ Florida, Diabet Ctr Excellence, Dept Pathol Immunol & Lab Med, Gainesville, FL USA	Capital Medical University; State University System of Florida; University of Florida	Xia, CQ (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Hematol, Beijing, Peoples R China.	cqx65@yahoo.com	Xie, Chao/ABA-7345-2021	Xie, Chao/0000-0001-7645-1922	JDRF academic RD award [17-2008-1036]; National Natural Science Foundation of China [81172854, 81241015]	JDRF academic RD award; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partially supported by JDRF academic R&D award (17-2008-1036 to CQX) and National Natural Science Foundation of China (81172854 and 81241015 to CQX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KR, 2009, J BIOL CHEM, V284, P31236, DOI 10.1074/jbc.M109.048694; Chang LJ, 2010, METHODS MOL BIOL, V614, P161, DOI 10.1007/978-1-60761-533-0_11; Corless CL, 2011, NAT REV CANCER, V11, P865, DOI 10.1038/nrc3143; Fitter S, 2010, J CLIN ENDOCR METAB, V95, P3763, DOI 10.1210/jc.2010-0086; Frasca F, 2007, J BIOL CHEM, V282, P26077, DOI 10.1074/jbc.M705008200; Gefen-Halevi S, 2010, CELL REPROGRAM, V12, P655, DOI 10.1089/cell.2010.0030; Gerrish K, 2001, J BIOL CHEM, V276, P47775, DOI 10.1074/jbc.M109244200; Hagerkvist R, 2008, CLIN SCI, V114, P65, DOI 10.1042/CS20070122; Hagerkvist R, 2007, FASEB J, V21, P618, DOI 10.1096/fj.06-6910com; Hagerkvist R, 2006, CELL BIOL INT, V30, P1013, DOI 10.1016/j.cellbi.2006.08.006; Hang Y, 2011, TRENDS ENDOCRIN MET, V22, P364, DOI 10.1016/j.tem.2011.05.003; Hill JT, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-62; Joensuu H, 2012, JAMA-J AM MED ASSOC, V307, P1265, DOI 10.1001/jama.2012.347; Kaneto H, 2008, ENDOCR J, V55, P235, DOI 10.1507/endocrj.K07E-041; Kaneto H, 2008, FRONT BIOSCI-LANDMRK, V13, P6406, DOI 10.2741/3162; Kaneto H, 2009, CURR MED CHEM, V16, P3144, DOI 10.2174/092986709788802980; Lehuen A, 2010, NAT REV IMMUNOL, V10, P501, DOI 10.1038/nri2787; Louvet C, 2008, P NATL ACAD SCI USA, V105, P18895, DOI 10.1073/pnas.0810246105; Mauro MJ, 2002, J CLIN ONCOL, V20, P325, DOI 10.1200/JCO.20.1.325; Moibi JA, 2007, DIABETES, V56, P88, DOI 10.2337/db06-0948; Mokhtari D, 2013, DIABETOLOGIA; Nielsen K, 2004, DIABETOLOGIA, V47, P2185, DOI 10.1007/s00125-004-1578-1; Ono K, 2012, INTERNAL MED, V51, P2763, DOI 10.2169/internalmedicine.51.8314; Paronen J, 2003, ANN NY ACAD SCI, V1005, P205, DOI 10.1196/annals.1288.027; Saito S, 2013, DIGESTION, V87, P47, DOI 10.1159/000343938; Savage DG, 2002, NEW ENGL J MED, V346, P683, DOI 10.1056/NEJMra013339; Taylor DG, 2005, BIOCHEMISTRY-US, V44, P11269, DOI 10.1021/bi050821m; Tsapas A, 2008, LEUKEMIA RES, V32, P674, DOI 10.1016/j.leukres.2007.08.014; Veneri D, 2005, NEW ENGL J MED, V352, P1049, DOI 10.1056/NEJM200503103521023; Watada H, 1996, BIOCHEM BIOPH RES CO, V229, P746, DOI 10.1006/bbrc.1996.1875; Yang JS, 2011, CHEM BIOL, V18, P177, DOI 10.1016/j.chembiol.2010.12.013; Yeung David T., 2012, Critical Reviews in Oncogenesis, V17, P17	32	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97694	10.1371/journal.pone.0097694	http://dx.doi.org/10.1371/journal.pone.0097694			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835010	Green Published, Green Submitted, gold			2022-12-27	WOS:000339614800064
J	Dutta, S; Warshall, C; Bandyopadhyay, C; Dutta, D; Chandran, B				Dutta, Sujoy; Warshall, Case; Bandyopadhyay, Chirosree; Dutta, Dipanjan; Chandran, Bala			Interactions between Exosomes from Breast Cancer Cells and Primary Mammary Epithelial Cells Leads to Generation of Reactive Oxygen Species Which Induce DNA Damage Response, Stabilization of p53 and Autophagy in Epithelial Cells	PLOS ONE			English	Article							TUMOR-DERIVED EXOSOMES; CARCINOMA IN-SITU; OF-THE-ART; INTERCELLULAR-COMMUNICATION; MEMBRANE-VESICLES; FIBROBLASTS; GROWTH; MICROENVIRONMENT; PROGRESSION; MICROVESICLES	Exosomes are nanovesicles originating from multivesicular bodies and are released by all cell types. They contain proteins, lipids, microRNAs, mRNAs and DNA fragments, which act as mediators of intercellular communications by inducing phenotypic changes in recipient cells. Tumor-derived exosomes have been shown to play critical roles in different stages of tumor development and metastasis of almost all types of cancer. One of the ways by which exosomes affect tumorigenesis is to manipulate the tumor microenvironments to create tumor permissive "niches". Whether breast cancer cell secreted exosomes manipulate epithelial cells of the mammary duct to facilitate tumor development is not known. To address whether and how breast cancer cell secreted exosomes manipulate ductal epithelial cells we studied the interactions between exosomes isolated from conditioned media of 3 different breast cancer cell lines (MDA-MB-231, T47DA18 and MCF7), representing three different types of breast carcinomas, and normal human primary mammary epithelial cells (HMECs). Our studies show that exosomes released by breast cancer cell lines are taken up by HMECs, resulting in the induction of reactive oxygen species (ROS) and autophagy. Inhibition of ROS by N-acetyl-L-cysteine (NAC) led to abrogation of autophagy. HMEC-exosome interactions also induced the phosphorylation of ATM, H2AX and Chk1 indicating the induction of DNA damage repair (DDR) responses. Under these conditions, phosphorylation of p53 at serine 15 was also observed. Both DDR responses and phosphorylation of p53 induced by HMEC-exosome interactions were also inhibited by NAC. Furthermore, exosome induced autophagic HMECs were found to release breast cancer cell growth promoting factors. Taken together, our results suggest novel mechanisms by which breast cancer cell secreted exosomes manipulate HMECs to create a tumor permissive microenvironment.	[Dutta, Sujoy; Warshall, Case; Bandyopadhyay, Chirosree; Dutta, Dipanjan; Chandran, Bala] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Microbiol & Immunol, HM Bligh Canc Res Labs, N Chicago, IL 60064 USA	Chicago Medical School; Rosalind Franklin University Medical & Science	Dutta, S (corresponding author), Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Microbiol & Immunol, HM Bligh Canc Res Labs, N Chicago, IL 60064 USA.	sujoy.dutta@rosalindfranklin.edu			H. M. Bligh Cancer Research; RFUMS (CMS)-ALGH pilot research grant	H. M. Bligh Cancer Research; RFUMS (CMS)-ALGH pilot research grant	This work was supported by H. M. Bligh Cancer Research support to BC and RFUMS (CMS)-ALGH pilot research grant to BC and SD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboussekhra A, 2011, INT J DEV BIOL, V55, P841, DOI 10.1387/ijdb.113362aa; Andre F, 2010, CURR OPIN ONCOL, V22, P547, DOI 10.1097/CCO.0b013e32833fb384; Bang C, 2012, INT J BIOCHEM CELL B, V44, P2060, DOI 10.1016/j.biocel.2012.08.007; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Brady CA, 2010, J CELL SCI, V123, P2527, DOI 10.1242/jcs.064501; Capparelli C, 2012, CELL CYCLE, V11, P2285, DOI 10.4161/cc.20718; CHANDRASEKARAN EV, 1979, CANCER RES, V39, P870; Chazotte B, 2011, COLD SPRING HARB PRO, V2011; Chen BPC, 2012, CANCER LETT, V327, P103, DOI 10.1016/j.canlet.2011.12.004; Cho JA, 2012, INT J ONCOL, V40, P130, DOI 10.3892/ijo.2011.1193; Christianson HC, 2013, P NATL ACAD SCI USA, V110, P17380, DOI 10.1073/pnas.1304266110; Cichon MA, 2010, J MAMMARY GLAND BIOL, V15, P389, DOI 10.1007/s10911-010-9195-8; Cirri P, 2012, CANCER METAST REV, V31, P195, DOI 10.1007/s10555-011-9340-x; Cowell CF, 2013, MOL ONCOL, V7, P859, DOI 10.1016/j.molonc.2013.07.005; De Palma M, 2011, NATURE, V472, P303, DOI 10.1038/472303a; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Dimov I, 2009, THESCIENTIFICWORLDJO, V9, P1107, DOI 10.1100/tsw.2009.128; Egeblad M, 2005, COLD SH Q B, V70, P383, DOI 10.1101/sqb.2005.70.007; FOIDART JM, 1994, B ACAD NAT MED PARIS, V178, P533; Fontana S, 2013, PROTEOMICS, V13, P1581, DOI 10.1002/pmic.201200398; Gangadhara S, 2012, FUTURE ONCOL, V8, P1427, DOI [10.2217/FON.12.134, 10.2217/fon.12.134]; Ge R, 2012, CANCER MICROENVIRON, V5, P323, DOI 10.1007/s12307-012-0110-2; Gusachenko ON, 2013, BIOCHEMISTRY-MOSCOW+, V78, P1, DOI 10.1134/S000629791301001X; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Hannafon BN, 2013, INT J MOL SCI, V14, P14240, DOI 10.3390/ijms140714240; Hoffman RM, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3426; Houghton AM, 2010, CELL CYCLE, V9, P1732, DOI 10.4161/cc.9.9.11297; Howlader N, 2012, SEER CANC STAT REV 1; Inal JM, 2013, BBA-PROTEINS PROTEOM, V1834, P2317, DOI 10.1016/j.bbapap.2013.04.005; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Kaur P, 2008, TOXICOL IN VITRO, V22, P1392, DOI 10.1016/j.tiv.2008.01.017; Kimura S, 2009, METHOD ENZYMOL, V452, P1, DOI 10.1016/S0076-6879(08)03601-X; Klibi J, 2009, BLOOD, V113, P1957, DOI 10.1182/blood-2008-02-142596; Kotzerke K, 2013, EXP DERMATOL, V22, P650, DOI 10.1111/exd.12230; Koumangoye RB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024234; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Leonard GD, 2004, JNCI-J NATL CANCER I, V96, P906, DOI 10.1093/jnci/djh164; Levine B, 2008, NAT CELL BIOL, V10, P637, DOI 10.1038/ncb0608-637; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Luga V, 2013, CANCER RES, V73, P6843, DOI 10.1158/0008-5472.CAN-13-1791; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Marcucci F, 2014, INT J CANCER, V135, P1265, DOI 10.1002/ijc.28572; Marine JC, 2010, CELL DEATH DIFFER, V17, P93, DOI 10.1038/cdd.2009.68; Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P4297, DOI 10.4161/cc.9.21.13817; Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P3515, DOI 10.4161/cc.9.17.12928; Meckes DG, 2010, P NATL ACAD SCI USA, V107, P20370, DOI 10.1073/pnas.1014194107; Meek DW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000950; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; MURPHY CS, 1990, CANCER RES, V50, P7285; O'Brien K, 2013, EUR J CANCER, V49, P1845, DOI 10.1016/j.ejca.2013.01.017; Obeid E, 2013, INT J ONCOL, V43, P5, DOI 10.3892/ijo.2013.1938; Paltridge JL, 2013, BBA-PROTEINS PROTEOM, V1834, P2233, DOI 10.1016/j.bbapap.2013.03.014; Pavlides S, 2012, ANTIOXID REDOX SIGN, V16, P1264, DOI 10.1089/ars.2011.4243; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Principe S, 2013, PROTEOMICS, V13, P1608, DOI 10.1002/pmic.201200533; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; ROSE HN, 1975, SCIENCE, V190, P673, DOI 10.1126/science.1188362; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Smyth LA, 2013, EUR J IMMUNOL, V43, P2430, DOI 10.1002/eji.201242909; Sui XB, 2011, AUTOPHAGY, V7, P565, DOI 10.4161/auto.7.6.14073; Sun SY, 2010, CANCER BIOL THER, V9, P109, DOI 10.4161/cbt.9.2.10583; Svensson KJ, 2013, J BIOL CHEM, V288, P17713, DOI 10.1074/jbc.M112.445403; Svensson KJ, 2013, BIOCHEM SOC T, V41, P273, DOI 10.1042/BST20120248; Tadokoro H, 2013, J BIOL CHEM, V288, P34343, DOI 10.1074/jbc.M113.480822; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Wendler F, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.22390; Whiteside TL, 2013, BIOCHEM SOC T, V41, P245, DOI 10.1042/BST20120265; Yu SH, 2007, J IMMUNOL, V178, P6867, DOI 10.4049/jimmunol.178.11.6867; Zhang HG, 2014, AM J PATHOL, V184, P28, DOI 10.1016/j.ajpath.2013.09.027	74	100	105	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97580	10.1371/journal.pone.0097580	http://dx.doi.org/10.1371/journal.pone.0097580			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831807	Green Submitted, gold, Green Published			2022-12-27	WOS:000336789500081
J	Nakao, R; Kikushima, K; Higuchi, H; Obana, N; Nomura, N; Bai, DY; Ohnishi, M; Senpuku, H				Nakao, Ryoma; Kikushima, Kenji; Higuchi, Hideo; Obana, Nozomu; Nomura, Nobuhiko; Bai, Dongying; Ohnishi, Makoto; Senpuku, Hidenobu			A Novel Approach for Purification and Selective Capture of Membrane Vesicles of the Periodontopathic Bacterium, Porphyromonas gingivalis: Membrane Vesicles Bind to Magnetic Beads Coated with Epoxy Groups in a Noncovalent, Species-Specific Manner	PLOS ONE			English	Article							ESCHERICHIA-COLI; NEISSERIA-MENINGITIDIS; BACTEROIDES-GINGIVALIS; PSEUDOMONAS-AERUGINOSA; PORIN PORB; FIMA GENE; CELLS; LIPOPOLYSACCHARIDE; PERIODONTITIS; W50	Membrane vesicles (MVs) of Porphyromonas gingivalis are regarded as an offensive weapon of the bacterium, leading to tissue deterioration in periodontal disease. Therefore, isolation of highly purified MVs is indispensable to better understand the pathophysiological role of MVs in the progression of periodontitis. MVs are generally isolated by a conventional method based on ultracentrifugation of the bacterial culture supernatant. However, the resulting MVs are often contaminated with co-precipitating bacterial appendages sheared from the live bacteria. Here, we report an intriguing property of P. gingivalis MVs-their ability to bind superparamagnetic beads coated with epoxy groups (SB-Epoxy). Analysis of fractions collected during the purification revealed that all MVs of five tested P. gingivalis stains bound to SB-Epoxy. In contrast, free fimbriae in the crude MV preparation did not bind to the SB-Epoxy. The SB-Epoxy-bound MVs were easily dissociated from the SB-Epoxy using a mild denaturation buffer. These results suggest that the surface chemistry conferred by epoxy on the beads is responsible for the binding, which is mediated by noncovalent bonds. Both the structural integrity and purity of the isolated MVs were confirmed by electron microscopy. The isolated MVs also caused cell detachment from culture dishes at a physiologically relevant concentration. Assays of competitive binding between the SB-Epoxy and mixtures of MVs from five bacterial species demonstrated that only P. gingivalis MVs could be selectively eliminated from the mixtures. We suggest that this novel approach enables efficient purification and selective elimination of P. gingivalis MVs.	[Nakao, Ryoma; Ohnishi, Makoto; Senpuku, Hidenobu] Natl Inst Infect Dis, Dept Bacteriol 1, Tokyo, Japan; [Kikushima, Kenji; Higuchi, Hideo] Univ Tokyo, Dept Sci, Tokyo, Japan; [Obana, Nozomu; Nomura, Nobuhiko] Univ Tsukuba, Fac Life & Environm Sci, Ibaraki, Japan; [Bai, Dongying] Tokyo Med & Dent Univ, Grad Sch, Dept Gerodontol, Tokyo, Japan	National Institute of Infectious Diseases (NIID); University of Tokyo; University of Tsukuba; Tokyo Medical & Dental University (TMDU)	Nakao, R (corresponding author), Natl Inst Infect Dis, Dept Bacteriol 1, Tokyo, Japan.	ryoma73@nih.go.jp	Nomura, Nobuhiko/AAR-1915-2021; SENPUKU, HIDENOBU/ABC-6160-2021	Nomura, Nobuhiko/0000-0003-1103-9157; 	Ministry of Education, Culture, Sports, Science, and Technology of Japan [22791822, 24659821]; Ministry of Health, Labor and Welfare [H22 Iryo-Ippan-026]; Naito Foundation; Grants-in-Aid for Scientific Research [13J00321, 23247022] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Grants-in-Aid from the Scientific Research of the Ministry of Education, Culture, Sports, Science, and Technology of Japan (22791822 and 24659821); the Ministry of Health, Labor and Welfare (H22 Iryo-Ippan-026); and The Naito Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABIKO Y, 1990, ARCH ORAL BIOL, V35, P689, DOI 10.1016/0003-9969(90)90091-N; Aldick T, 2009, MOL MICROBIOL, V71, P1496, DOI 10.1111/j.1365-2958.2009.06618.x; Amano A, 1999, J CLIN MICROBIOL, V37, P1426, DOI 10.1128/JCM.37.5.1426-1430.1999; Amano A, 2010, MICROBES INFECT, V12, P791, DOI 10.1016/j.micinf.2010.05.008; Balsalobre C, 2006, MOL MICROBIOL, V59, P99, DOI 10.1111/j.1365-2958.2005.04938.x; Bauman SJ, 2006, MICROBES INFECT, V8, P2400, DOI 10.1016/j.micinf.2006.05.001; Chen YY, 2011, MOL MICROBIOL, V79, P1380, DOI 10.1111/j.1365-2958.2010.07530.x; Curtis MA, 1999, INFECT IMMUN, V67, P3816, DOI 10.1128/IAI.67.8.3816-3823.1999; Desvarieux M, 2005, CIRCULATION, V111, P576, DOI 10.1161/01.CIR.0000154582.37101.15; DEVOE IW, 1973, J EXP MED, V138, P1156, DOI 10.1084/jem.138.5.1156; Dorn BR, 1999, INFECT IMMUN, V67, P5792, DOI 10.1128/IAI.67.11.5792-5798.1999; Fan Q, 2001, ORAL MICROBIOL IMMUN, V16, P144, DOI 10.1034/j.1399-302X.2001.016003144.x; Fan Q, 2000, ORAL MICROBIOL IMMUN, V15, P158, DOI 10.1034/j.1399-302x.2000.150303.x; Forner L, 2006, J CLIN PERIODONTOL, V33, P401, DOI 10.1111/j.1600-051X.2006.00924.x; GRENIER D, 1987, INFECT IMMUN, V55, P111, DOI 10.1128/IAI.55.1.111-117.1987; Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873; Haurat MF, 2011, J BIOL CHEM, V286, P1269, DOI 10.1074/jbc.M110.185744; Holst J, 2009, VACCINE, V27, pB3, DOI 10.1016/j.vaccine.2009.04.071; HOLTEN E, 1979, J CLIN MICROBIOL, V9, P186; Horstman AL, 2000, J BIOL CHEM, V275, P12489, DOI 10.1074/jbc.275.17.12489; Ishihara K, 2004, J CLIN MICROBIOL, V42, P1313, DOI 10.1128/JCM.42.3.1313-1315.2004; Kesty NC, 2004, EMBO J, V23, P4538, DOI 10.1038/sj.emboj.7600471; Kimura Y, 1978, Kokubyo Gakkai Zasshi, V45, P20; Kouokam JC, 2006, INFECT IMMUN, V74, P2022, DOI 10.1128/IAI.74.4.2022-2030.2006; Lalla E, 2000, J CLIN INVEST, V105, P1117, DOI 10.1172/JCI8942; Li L, 2002, CIRCULATION, V105, P861, DOI 10.1161/hc0702.104178; MacDonald IA, 2012, RES MICROBIOL, V163, P607, DOI 10.1016/j.resmic.2012.10.020; MANDRELL RE, 1988, J EXP MED, V168, P107, DOI 10.1084/jem.168.1.107; Massari P, 2000, P NATL ACAD SCI USA, V97, P9070, DOI 10.1073/pnas.97.16.9070; Nakagawa I, 2000, J CLIN MICROBIOL, V38, P1909, DOI 10.1128/JCM.38.5.1909-1914.2000; Nakagawa I, 2002, J PERIODONTAL RES, V37, P425, DOI 10.1034/j.1600-0765.2002.01637.x; Nakao R, 2006, INFECT IMMUN, V74, P6145, DOI 10.1128/IAI.00261-06; Nakao R, 2014, MICROBES INFECT, V16, P6, DOI 10.1016/j.micinf.2013.10.005; Nakao R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026163; Paramonov N, 2005, MOL MICROBIOL, V58, P847, DOI 10.1111/j.1365-2958.2005.04871.x; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rangarajan M, 2008, J BACTERIOL, V190, P2920, DOI 10.1128/JB.01868-07; RIVERA M, 1988, J BACTERIOL, V170, P512, DOI 10.1128/jb.170.2.512-521.1988; Rudel T, 1996, CELL, V85, P391, DOI 10.1016/S0092-8674(00)81117-4; SCHLEIN RA, 1991, AM J ORTHOD DENTOFAC, V99, P466, DOI 10.1016/S0889-5406(05)81580-X; van de Waterbeemd B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065157; Wai SN, 2003, CELL, V115, P25, DOI 10.1016/S0092-8674(03)00754-2; WEEL JFL, 1991, J EXP MED, V174, P705, DOI 10.1084/jem.174.3.705	43	9	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e95137	10.1371/journal.pone.0095137	http://dx.doi.org/10.1371/journal.pone.0095137			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830438	Green Published, Green Submitted, gold			2022-12-27	WOS:000336789500008
J	O'Farrill, G; Schampaert, KG; Rayfield, B; Bodin, O; Calme, S; Sengupta, R; Gonzalez, A				O'Farrill, Georgina; Schampaert, Kim Gauthier; Rayfield, Bronwyn; Bodin, Orjan; Calme, Sophie; Sengupta, Raja; Gonzalez, Andrew			The Potential Connectivity of Waterhole Networks and the Effectiveness of a Protected Area under Various Drought Scenarios	PLOS ONE			English	Article							LANDSCAPE CONNECTIVITY; HABITAT AVAILABILITY; CRITICAL THRESHOLDS; HOME-RANGE; FRAGMENTATION; POPULATIONS; PERSISTENCE; DYNAMICS; CALAKMUL; RESERVE	Landscape connectivity is considered a priority for ecosystem conservation because it may mitigate the synergistic effects of climate change and habitat loss. Climate change predictions suggest changes in precipitation regimes, which will affect the availability of water resources, with potential consequences for landscape connectivity. The Greater Calakmul Region of the Yucatan Peninsula (Mexico) has experienced a 16% decrease in precipitation over the last 50 years, which we hypothesise has affected water resource connectivity. We used a network model of connectivity, for three large endangered species (Baird's tapir, white-lipped peccary and jaguar), to assess the effect of drought on waterhole availability and connectivity in a forested landscape inside and adjacent to the Calakmul Biosphere Reserve. We used reported travel distances and home ranges for our species to establish movement distances in our model. Specifically, we compared the effects of 10 drought scenarios on the number of waterholes (nodes) and the subsequent changes in network structure and node importance. Our analysis revealed that drought dramatically influenced spatial structure and potential connectivity of the network. Our results show that waterhole connectivity and suitable habitat (area surrounding waterholes) is lost faster inside than outside the reserve for all three study species, an outcome that may drive them outside the reserve boundaries. These results emphasize the need to assess how the variability in the availability of seasonal water resource may affect the viability of animal populations under current climate change inside and outside protected areas.	[O'Farrill, Georgina] Univ Toronto, Ecol & Evolutionary Biol Dept, Toronto, ON, Canada; [Rayfield, Bronwyn; Gonzalez, Andrew] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Schampaert, Kim Gauthier; Calme, Sophie] Univ Sherbrooke, Dept Geomat KGS, Dept Biol SC, Sherbrooke, PQ J1K 2R1, Canada; [Bodin, Orjan] Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden; [Calme, Sophie] Colegio Frontera Sur, Dept Conservac Biodiversidad, Chetmal, Quintana Roo, Mexico; [Sengupta, Raja] McGill Univ, Dept Geog, Montreal, PQ, Canada	University of Toronto; McGill University; University of Sherbrooke; Stockholm University; El Colegio de la Frontera Sur (ECOSUR); McGill University	O'Farrill, G (corresponding author), Univ Toronto, Ecol & Evolutionary Biol Dept, Toronto, ON, Canada.	georgina.ofarrill@gmail.com	Bodin, Örjan/A-5098-2010; Calmé, Sophie/ABC-9684-2021; Gonzalez, Andrew/F-2247-2010; Calmé, Sophie/J-5723-2013; Rayfield, Bronwyn/ABB-8306-2021	Bodin, Örjan/0000-0002-8218-1153; Calmé, Sophie/0000-0003-0818-3932; Gonzalez, Andrew/0000-0001-6075-8081; Calmé, Sophie/0000-0003-0818-3932; Rayfield, Bronwyn/0000-0003-1768-1300; Sengupta, Raja/0000-0003-4914-5844	Consejo Nacional de Ciencia y Tecnologia-Mexico (CONACYT); Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT); National Science and Engineering Research Council from Canada (NSERC); Canada Research Chair Program; Global Environmental and Climate Change Center (GEC3); Swedish Foundation for Strategic Environmental Research (MISTRA); Stockholm University; NASA-LCLUC program [NAG5-6046, NAG5-11134]	Consejo Nacional de Ciencia y Tecnologia-Mexico (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT)(FQRNT); National Science and Engineering Research Council from Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair Program(Canada Research Chairs); Global Environmental and Climate Change Center (GEC3); Swedish Foundation for Strategic Environmental Research (MISTRA)(Swedish Foundation for Strategic Research); Stockholm University; NASA-LCLUC program	This study was carried out with the support of the Consejo Nacional de Ciencia y Tecnologia-Mexico (CONACYT-doctoral fellowship) and Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT-postdoctoral fellowship) to GO, the National Science and Engineering Research Council from Canada (NSERC) Discovery Grants program to AG and RS, the Canada Research Chair Program (to AG), the Global Environmental and Climate Change Center (GEC3), the Swedish Foundation for Strategic Environmental Research (MISTRA), the strategic research program Ekoklim at Stockholm University, and the NASA-LCLUC program(NAG5-6046 and NAG5-11134) to the Southern Yucatan Peninsular Region(SYPR) project. The Walter Hitschfeld Geographic Information Centre in the Geography Department at McGill University provided the authors with the Quick Bird images. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson E, 2009, ECOGRAPHY, V32, P123, DOI 10.1111/j.1600-0587.2008.05435.x; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Bodin O, 2007, LANDSCAPE ECOL, V22, P31, DOI 10.1007/s10980-006-9015-0; Bodin O, 2010, ECOL MODEL, V221, P2393, DOI 10.1016/j.ecolmodel.2010.06.017; Calabrese JM, 2004, FRONT ECOL ENVIRON, V2, P529, DOI 10.1890/1540-9295(2004)002[0529:ACGTCM]2.0.CO;2; Caso A, 2008, IUCN RED LIST THREAT; Castellanos A, 2008, IUCN 2009 IUCN RED L; Chamaille-Jammes S, 2008, J ANIM ECOL, V77, P135, DOI 10.1111/j.1365-2656.2007.01307.x; Chavez Tovar JC, 2010, THESIS U GRANADA; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Colchero F, 2011, ANIM CONSERV, V14, P158, DOI 10.1111/j.1469-1795.2010.00406.x; Cote D, 2009, LANDSCAPE ECOL, V24, P101, DOI 10.1007/s10980-008-9283-y; Crooks K. R., 2006, CONNECTIVITY CONSERV; Dale MRT, 2010, ANNU REV ECOL EVOL S, V41, P21, DOI 10.1146/annurev-ecolsys-102209-144718; Fall A, 2001, ECOL MODEL, V141, P1, DOI 10.1016/S0304-3800(01)00334-9; Foerster CR, 2002, BIOTROPICA, V34, P423, DOI 10.1111/j.1744-7429.2002.tb00556.x; Fortuna MA, 2006, P ROY SOC B-BIOL SCI, V273, P1429, DOI 10.1098/rspb.2005.3448; Galpern P, 2011, BIOL CONSERV, V144, P44, DOI 10.1016/j.biocon.2010.09.002; García Gil Gerardo, 2002, Invest. Geog, P7; Gomez-Rodriguez C, 2009, AQUAT ECOL, V43, P1179, DOI 10.1007/s10452-009-9235-x; Gonzalez A, 2011, AM J BOT, V98, P503, DOI 10.3732/ajb.1000424; Hansen AJ, 2007, ECOL APPL, V17, P974, DOI 10.1890/05-1098; Herbert ME, 2010, CONSERV BIOL, V24, P1002, DOI 10.1111/j.1523-1739.2010.01460.x; Hetherington DA, 2008, MAMMAL REV, V38, P285, DOI 10.1111/j.1365-2907.2008.00117.x; Kadoya T, 2009, POPUL ECOL, V51, P5, DOI 10.1007/s10144-008-0120-6; Larson BD, 2004, ENVIRON MODELL SOFTW, V19, P7, DOI 10.1016/S1364-8152(03)00098-7; Loarie SR, 2009, BIOL CONSERV, V142, P3086, DOI 10.1016/j.biocon.2009.08.008; Márdero Sofía, 2012, Invest. Geog, P19; Martinez E., 2002, B SOC BOT MEXICO, V71, P7, DOI DOI 10.17129/B0TSCI.1660; Metzger JP, 1997, ACTA OECOL, V18, P1, DOI 10.1016/S1146-609X(97)80075-6; Naranjo Eduardo J., 2002, Tapir Conservation, V11, P25; Neeti N, 2012, REMOTE SENS LETT, V3, P433, DOI 10.1080/01431161.2011.616238; Owen-Smith R.N., 1992, MEGAHERBIVORES INFLU; Pascual-Hortal L, 2006, LANDSCAPE ECOL, V21, P959, DOI 10.1007/s10980-006-0013-z; Pereira M, 2011, LANDSCAPE URBAN PLAN, V100, P67, DOI 10.1016/j.landurbplan.2010.11.009; Perez-Cortez S, 2012, REV MEX BIODIVERS, V83, P753, DOI 10.7550/rmb.25095; Pringle CM, 2001, ECOL APPL, V11, P981, DOI 10.1890/1051-0761(2001)011[0981:HCATMO]2.0.CO;2; Reyna-Hurtado R, 2008, IUCN 2012 IUCN RED L; Reyna-Hurtado R, 2012, J MAMMAL, V93, P124, DOI 10.1644/10-MAMM-A-384.1; Reyna-Hurtado R, 2009, J MAMMAL, V90, P1199, DOI 10.1644/08-MAMM-A-246.1; Saura S, 2007, LANDSCAPE URBAN PLAN, V83, P91, DOI 10.1016/j.landurbplan.2007.03.005; Saura S, 2010, ECOGRAPHY, V33, P523, DOI 10.1111/j.1600-0587.2009.05760.x; Sitters J, 2009, BIOL CONSERV, V142, P738, DOI 10.1016/j.biocon.2008.12.001; Solomon S, 2007, CLIMATE CHANGE 2001; Stevens VM, 2008, CONSERV BIOL, V22, P1194, DOI 10.1111/j.1523-1739.2008.00990.x; Swift TL, 2010, BIOL REV, V85, P35, DOI 10.1111/j.1469-185X.2009.00093.x; Telleria JL, 2008, ORYX, V42, P292, DOI 10.1017/S0030605308007850; Tobler M, 2008, THESIS TEXAS A M U; Urban D, 2001, ECOLOGY, V82, P1205, DOI 10.1890/0012-9658(2001)082[1205:LCAGTP]2.0.CO;2; Valeix M, 2008, ANIM CONSERV, V11, P391, DOI 10.1111/j.1469-1795.2008.00194.x; Vester HFM, 2007, ECOL APPL, V17, P989, DOI 10.1890/05-1106; WITH KA, 1995, ECOLOGY, V76, P2446, DOI 10.2307/2265819; Wright CK, 2010, ECOLOGY, V91, P1924, DOI 10.1890/09-0865.1	53	19	26	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e95049	10.1371/journal.pone.0095049	http://dx.doi.org/10.1371/journal.pone.0095049			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830392	Green Published, gold, Green Submitted			2022-12-27	WOS:000336789500007
J	Bouyer, C; Forestier, L; Renand, G; Oulmouden, A				Bouyer, Claire; Forestier, Lionel; Renand, Gilles; Oulmouden, Ahmad			Deep Intronic Mutation and Pseudo Exon Activation as a Novel Muscular Hypertrophy Modifier in Cattle	PLOS ONE			English	Article							SKELETAL-MUSCLE MASS; MYOSTATIN GENE; GROWTH; MICE; EXPRESSION; SERUM; MYOD; LOOP	Myostatin is essential for proper regulation of myogenesis, and inactivation of Myostatin results in muscle hypertrophy. Here, we identified an unexpected mutation in the myostatin gene which is almost fixed in Blonde d'Aquitaine cattle. In skeletal muscle, the mutant allele was highly expressed leading to an abnormal transcript consisting of a 41-bp inclusion and premature termination codons and to residual levels of a correctly spliced transcript. This expression pattern, caused by a leaky intronic mutation with regard to spliceosome activity and its apparent stability with regard to surveillance mechanisms, could contribute to the moderate muscle hypertrophy in this cattle breed. This finding is of importance for genetic counseling for meat quantity and quality in livestock production and possibly to manipulate myostatin pre-mRNA in human muscle diseases.	[Bouyer, Claire; Forestier, Lionel; Oulmouden, Ahmad] Univ Limoges, INRA, UMR 1061, Unite Genet Mol Anim, Limoges, France; [Renand, Gilles] INRA, UMR 1313, Unite Genet Anim & Biol Integrat, Jouy En Josas, France	INRAE; Universite de Limoges; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Oulmouden, A (corresponding author), Univ Limoges, INRA, UMR 1061, Unite Genet Mol Anim, Limoges, France.	ahmad.oulmouden@unilim.fr		Ahmad, oulmouden/0000-0002-2920-2226	Universite de Limoges; Region Limousin; INRA, France	Universite de Limoges; Region Limousin; INRA, France	This work was funded by the Universite de Limoges, Region Limousin and INRA, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass J, 1999, DOMEST ANIM ENDOCRIN, V17, P191, DOI 10.1016/S0739-7240(99)00036-3; Berry C, 2002, AM J PHYSIOL-CELL PH, V283, pC135, DOI 10.1152/ajpcell.00458.2001; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Forbes D, 2006, J CELL PHYSIOL, V206, P264, DOI 10.1002/jcp.20477; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Grobet L, 1998, MAMM GENOME, V9, P210, DOI 10.1007/s003359900727; Haidet AM, 2008, P NATL ACAD SCI USA, V105, P4318, DOI 10.1073/pnas.0709144105; Han HQ, 2013, INT J BIOCHEM CELL B, V45, P2333, DOI 10.1016/j.biocel.2013.05.019; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; Hill JJ, 2003, MOL ENDOCRINOL, V17, P1144, DOI 10.1210/me.2002-0366; Hu SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058521; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910; Kang JK, 2011, MOL THER, V19, P159, DOI 10.1038/mt.2010.212; Karim L, 2000, ANIM GENET, V31, P396, DOI 10.1046/j.1365-2052.2000.00684.x; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Ma K, 2001, AM J PHYSIOL-ENDOC M, V281, pE1128, DOI 10.1152/ajpendo.2001.281.6.E1128; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Oldham JM, 2001, AM J PHYSIOL-REG I, V280, pR1488, DOI 10.1152/ajpregu.2001.280.5.R1488; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Spiller MP, 2002, MOL CELL BIOL, V22, P7066, DOI 10.1128/MCB.22.20.7066-7082.2002; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.2534946100; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	25	10	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97399	10.1371/journal.pone.0097399	http://dx.doi.org/10.1371/journal.pone.0097399			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827585	Green Submitted, gold, Green Published			2022-12-27	WOS:000336857400090
J	Peel, D; Miller, BS; Kelly, N; Dawson, S; Slooten, E; Double, MC				Peel, David; Miller, Brian S.; Kelly, Natalie; Dawson, Steve; Slooten, Elisabeth; Double, Michael C.			A Simulation Study of Acoustic-Assisted Tracking of Whales for Mark-Recapture Surveys	PLOS ONE			English	Article							MALE SPERM-WHALES; PACIFIC; BLUE; KAIKOURA; ABUNDANCE; BEHAVIOR; DESIGN; CALLS	Collecting enough data to obtain reasonable abundance estimates of whales is often difficult, particularly when studying rare species. Passive acoustics can be used to detect whale sounds and are increasingly used to estimate whale abundance. Much of the existing effort centres on the use of acoustics to estimate abundance directly, e. g. analysing detections in a distance sampling framework. Here, we focus on acoustics as a tool incorporated within mark-recapture surveys. In this context, acoustic tools are used to detect and track whales, which are then photographed or biopsied to provide data for mark-recapture analyses. The purpose of incorporating acoustics is to increase the encounter rate beyond using visual searching only. While this general approach is not new, its utility is rarely quantified. This paper predicts the "acoustically-assisted'' encounter rate using a discrete-time individual-based simulation of whales and survey vessel. We validate the simulation framework using existing data from studies of sperm whales. We then use the framework to predict potential encounter rates in a study of Antarctic blue whales. We also investigate the effects of a number of the key parameters on encounter rate. Mean encounter rates from the simulation of sperm whales matched well with empirical data. Variance of encounter rate, however, was underestimated. The simulation of Antarctic blue whales found that passive acoustics should provide a 1.7-3.0 fold increase in encounter rate over visual-only methods. Encounter rate was most sensitive to acoustic detection range, followed by vocalisation rate. During survey planning and design, some indication of the relationship between expected sample size and effort is paramount; this simulation framework can be used to predict encounter rates and establish this relationship. For a case in point, the simulation framework indicates unequivocally that real-time acoustic tracking should be considered for quantifying the abundance of Antarctic blue whales via mark-recapture methods.	[Peel, David; Kelly, Natalie] CSIRO Computat Informat, Wealth Oceans Natl Res Flagship, Hobart, Tas, Australia; [Peel, David; Miller, Brian S.; Kelly, Natalie; Double, Michael C.] Australian Marine Mammal Ctr, Australian Antarctic Div, Dept Environm, Kingston, Tas, Australia; [Dawson, Steve; Slooten, Elisabeth] Univ Otago, Dunedin, New Zealand	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian Antarctic Division; University of Otago	Peel, D (corresponding author), CSIRO Computat Informat, Wealth Oceans Natl Res Flagship, Hobart, Tas, Australia.	David.peel@csiro.au	Peel, David/E-8888-2010; Kelly, Natalie/B-3481-2010	Peel, David/0000-0002-1413-3168; Dawson, Stephen/0000-0003-3182-0186; Kelly, Nat/0000-0002-9664-354X; Miller, Brian/0000-0001-7615-3044	Australian Government; Australian Antarctic Science Project [4102]	Australian Government(Australian GovernmentCGIAR); Australian Antarctic Science Project	This work was supported by the Australian Government, and contributes to Australian Antarctic Science Project 4102. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow J, 2005, MAR MAMMAL SCI, V21, P429, DOI 10.1111/j.1748-7692.2005.tb01242.x; Branch T.A., 2007, Journal of Cetacean Research and Management, V9, P253; Buckland S.T., 2001, pi; CHILDERHOUSE SJ, 1995, CAN J ZOOL, V73, P723, DOI 10.1139/z95-084; Dawson S.M., 1995, REP INT WHAL COMM, V45, P431; Dawson S, 2008, MAMMAL REV, V38, P19, DOI 10.1111/j.1365-2907.2008.00119.x; Double MC, 2013, CRUISE REPORT 2013 A, P1; Douglas LA, 2005, J ACOUST SOC AM, V118, P523, DOI 10.1121/1.1937283; Ensor P, 2006, 2005 2006 INT WHALIN; Helble TA, 2013, J ACOUST SOC AM, V134, P2556, DOI 10.1121/1.4816581; Jaquet N, 2001, J ACOUST SOC AM, V109, P2254, DOI 10.1121/1.1360718; Jaquet N, 2000, CAN J ZOOL, V78, P407, DOI 10.1139/cjz-78-3-407; Langrock R, 2014, METHODS ECOL EVOL, V5, P190, DOI 10.1111/2041-210X.12155; Leaper R., 1992, DEV PRACTICAL TECHNI; Lettevall E, 2002, CAN J ZOOL, V80, P1189, DOI 10.1139/Z02-102; Marques TA, 2013, BIOL REV, V88, P287, DOI 10.1111/brv.12001; McDonald MA, 2001, J ACOUST SOC AM, V109, P1728, DOI 10.1121/1.1353593; McDonald Mark A., 2006, Journal of Cetacean Research and Management, V8, P55; Miller BS, 2012, P AC 2012; Miller BS, 2012, SCI COMM INT WHAL CO; Miller BS, 2013, SCI COMM INT WHAL CO, P17; Mohl B, 2000, J ACOUST SOC AM, V107, P638, DOI 10.1121/1.428329; Oleson EM, 2007, MAR ECOL PROG SER, V330, P269, DOI 10.3354/meps330269; R Development Core Team, 2012, R LANG ENV STAT COMP; Rankin Shannon, 2005, Journal of Cetacean Research and Management, V7, P13; Rone BK, 2012, MAR MAMMAL SCI, V28, pE528, DOI 10.1111/j.1748-7692.2012.00573.x; Samaran F, 2010, APPL ACOUST, V71, P1099, DOI 10.1016/j.apacoust.2010.05.014; Sirovic A, 2007, J ACOUST SOC AM, V122, P1208, DOI 10.1121/1.2749452; Smith TD, 1999, MAR MAMMAL SCI, V15, P1, DOI 10.1111/j.1748-7692.1999.tb00779.x; Thomas L., 2012, ACOUST TODAY, V8, P35, DOI [10.1121/1.4753915, DOI 10.1121/1.4753915]; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Turchin Peter, 1998; Wade P, 2006, BIOL LETTERS, V2, P417, DOI 10.1098/rsbl.2006.0460; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Whitehead H., 1986, REPORTS INT WHALING, V8, P149; Whitehead H, 2008, MAR ECOL PROG SER, V361, P291, DOI 10.3354/meps07412; Yochem P. K., 1985, HDB MARINE MAMMALS, V3, P193	37	8	9	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e95602	10.1371/journal.pone.0095602	http://dx.doi.org/10.1371/journal.pone.0095602			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827919	Green Submitted, Green Published, gold			2022-12-27	WOS:000336857400013
J	Ritz, U; Spies, V; Mehling, I; Gruszka, D; Rommens, PM; Hofmann, A				Ritz, Ulrike; Spies, Volker; Mehling, Isabella; Gruszka, Dominik; Rommens, Pol Maria; Hofmann, Alexander			Mobilization of CD34(+)-Progenitor Cells in Patients with Severe Trauma	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; BONE-MARROW; CD34(+) CELLS; MUSCULOSKELETAL TRAUMA; CD34-POSITIVE CELLS; PERIPHERAL-BLOOD; MULTIPLE TRAUMA; PRECURSOR CELLS; SKIN BURNS; NEOVASCULARIZATION	Circulating CD34+ progenitor cells () gained importance in the field of regenerative medicine due to their potential to home in on injury sites and differentiate into cells of both endothelial and osteogenic lineages. In this study, we analyzed the mobilization kinetics and the numbers of CD34+, CD31+, CD45+, and CD133+ cells in twenty polytrauma patients (n = 13 male, n = 7 female, mean age 46.5 +/- 17.2 years, mean injury severity score (ISS) 35.8 +/- 12.5 points). In addition, the endothelial differentiation capacity of enriched CD34+ cells was assessed by analyzing DiI-ac-LDL/ lectin uptake, the expression of endothelial markers, and the morphological characteristics of these cells in Matrigel and spheroid cultures. We found that on days 1, 3, and 7 after a major trauma, the number of CD34+ cells increased from 6-up to 12-fold (p < 0.0001) over the number of CD34+ cells from a control population of healthy, age-matched volunteers. The numbers of CD31+ cells were consistently higher on days 1 (1.4-fold, p, 0.01) and 7 (1.3-fold, p, 0.01), whereas the numbers of CD133+ cell did not change during the time course of investigation. Expression of endothelial marker molecules in CD34+ cells was significantly induced in the polytrauma patients. In addition, we show that the CD34+ cell levels in severely injured patients were not correlated with clinical parameters, such as the ISS score, the acute physiology and chronic health evaluation II score (APACHE II), as well as the sequential organ failure assessment score (SOFA-2). Our results clearly indicate that proangiogenic cells are systemically mobilized after polytrauma and that their numbers are sufficient for the development of novel therapeutic models in regenerative medicine.	[Ritz, Ulrike; Spies, Volker; Mehling, Isabella; Gruszka, Dominik; Rommens, Pol Maria; Hofmann, Alexander] Johannes Gutenberg Univ Mainz, Ctr Orthopaed & Trauma Surg, Univ Med Ctr, BiomaT Grp, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz	Hofmann, A (corresponding author), Johannes Gutenberg Univ Mainz, Ctr Orthopaed & Trauma Surg, Univ Med Ctr, BiomaT Grp, D-55122 Mainz, Germany.	hofmann.trauma-surgery@gmx.net	Hofmann, Alexander/C-3943-2013; Gruszka, Dominik/AAB-7785-2020; Gruszka, Dominik/ABE-5001-2020; Ritz, Ulrike/N-6871-2016	Gruszka, Dominik/0000-0001-8360-9441; Ritz, Ulrike/0000-0001-8936-3227	German Research Foundation - Excellence Academy "Medical Technology III" (EAMT III) [HO 4309/1-1]; MAIFOR (University Medical Centre Mainz) [111]	German Research Foundation - Excellence Academy "Medical Technology III" (EAMT III); MAIFOR (University Medical Centre Mainz)	Funds were received in total support of the research presented in this article. The funding agencies were the German Research Foundation - Excellence Academy "Medical Technology III" (EAMT III, HO 4309/1-1) and MAIFOR No. 111 (University Medical Centre Mainz). No benefits of any kind have been received or will be received by the authors from a commercial party related directly or indirectly to the subject of this article. No competing financial interests exist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Busuioc CJ, 2013, ROM J MORPHOL EMBRYO, V54, P163; Casamassimi A, 2007, J BIOCHEM, V141, P503, DOI 10.1093/jb/mvm060; Chang HW, 2010, TRANSL RES, V156, P251, DOI 10.1016/j.trsl.2010.07.010; Chen JL, 1997, STEM CELLS, V15, P368, DOI 10.1002/stem.150368; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386; Foresta C, 2011, J TRAUMA, V70, P459, DOI 10.1097/TA.0b013e3181fcf83c; Fuchs S, 2007, TISSUE ENG, V13, P2577, DOI 10.1089/ten.2007.0022; German Trauma Society, 2002, S3 GUID TREATM PAT S; Henrich D, 2004, SHOCK, V21, P13, DOI 10.1097/01.shk.0000101669.49265.50; Hofmann A, 2008, BIOMATERIALS, V29, P4217, DOI 10.1016/j.biomaterials.2008.07.024; Kawamoto A, 2006, CIRCULATION, V114, P2163, DOI 10.1161/CIRCULATIONAHA.106.644518; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341; Kuroda R, 2014, TISSUE ENG B; Kuroda R, 2011, CELL TRANSPLANT, V20, P1491, DOI 10.3727/096368910X550189; Laib AM, 2009, NAT PROTOC, V4, P1202, DOI 10.1038/nprot.2009.96; Laing AJ, 2007, J BONE JOINT SURG BR, V89B, P116, DOI 10.1302/0301-620X.89B1.18222; Laing AJ, 2007, J ORTHOP RES, V25, P44, DOI 10.1002/jor.20228; Li R, 2012, J ORTHOP TRAUMA, V26, P689, DOI 10.1097/BOT.0b013e318266eb7e; Liu L, 2011, CRIT CARE MED, V39, P1760, DOI 10.1097/CCM.0b013e3182186cee; Maruyama S, 2008, KIDNEY INT, V74, P1603, DOI 10.1038/ki.2008.495; Matsumoto T, 2008, J CELL PHYSIOL, V215, P234, DOI 10.1002/jcp.21309; Matsumoto T, 2006, AM J PATHOL, V169, P1440, DOI 10.2353/ajpath.2006.060064; Musialek P, 2011, J NUCL CARDIOL, V18, P104, DOI 10.1007/s12350-010-9326-z; Pasquet S, 2009, CYTOTHERAPY, V11, P1002, DOI 10.3109/14653240903164963; Patschan SA, 2011, CRIT CARE, V15, DOI 10.1186/cc10100; Qi YY, 2010, INFLAMM RES, V59, P889, DOI 10.1007/s00011-010-0201-9; Rafat N, 2007, CRIT CARE MED, V35, P1677, DOI 10.1097/01.CCM.0000269034.86817.59; Schuh A, 2013, CURR PHARM DES; Shantsila E, 2012, J THROMB HAEMOST, V10, P1252, DOI 10.1111/j.1538-7836.2012.04753.x; Smadja DM, 2013, ANGIOGENESIS, V16, P147, DOI 10.1007/s10456-012-9306-9; Sobrino T, 2007, STROKE, V38, P2759, DOI 10.1161/STROKEAHA.107.484386; TSCHERNE H, 1987, CHIRURG, V58, P631; van Ierssel SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069499; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Walter DH, 2005, CIRC RES, V97, P1142, DOI 10.1161/01.RES.0000193596.94936.2c; Wara AK, 2011, BLOOD; Wu YJ, 2010, STEM CELLS, V28, P905, DOI 10.1002/stem.420; Xin-Long M, 2012, J ORTHOP RES	43	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97369	10.1371/journal.pone.0097369	http://dx.doi.org/10.1371/journal.pone.0097369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24826895	Green Published, gold			2022-12-27	WOS:000336857400086
J	Baldwin, CC; Johnson, GD				Baldwin, Carole C.; Johnson, G. David			Connectivity across the Caribbean Sea: DNA Barcoding and Morphology Unite an Enigmatic Fish Larva from the Florida Straits with a New Species of Sea Bass from Deep Reefs off Curacao	PLOS ONE			English	Article							TELEOSTEI; DIVERSITY	Integrative taxonomy, in which multiple disciplines are combined to address questions related to biological species diversity, is a valuable tool for identifying pelagic marine fish larvae and recognizing the existence of new fish species. Here we combine data from DNA barcoding, comparative morphology, and analysis of color patterns to identify an unusual fish larva from the Florida Straits and demonstrate that it is the pelagic larval phase of a previously undescribed species of Liopropoma sea bass from deep reefs off Curacao, southern Caribbean. The larva is unique among larvae of the teleost family Serranidae, Tribe Liopropomini, in having seven elongate dorsal-fin spines. Adults of the new species are similar to the golden bass, Liopropoma aberrans, with which they have been confused, but they are distinct genetically and morphologically. The new species differs from all other western Atlantic liopropomins in having IX, 11 dorsal-fin rays and in having a unique color pattern-most notably the predominance of yellow pigment on the dorsal portion of the trunk, a pale to white body ventrally, and yellow spots scattered across both the dorsal and ventral portions of the trunk. Exploration of deep reefs to 300 m using a manned submersible off Curacao is resulting in the discovery of numerous new fish species, improving our genetic databases, and greatly enhancing our understanding of deep-reef fish diversity in the southern Caribbean. Oh the mother and child reunion is only a moment away. Paul Simon.	[Baldwin, Carole C.; Johnson, G. David] Smithsonian Inst, Dept Vertebrate Zool, Natl Museum Nat Hist, Washington, DC 20560 USA	Smithsonian Institution; Smithsonian National Museum of Natural History	Baldwin, CC (corresponding author), Smithsonian Inst, Dept Vertebrate Zool, Natl Museum Nat Hist, Washington, DC 20560 USA.	baldwinc@si.edu		Johnson, G D/0000-0003-4339-6589	Consortium for Understanding and Sustaining a Biodiverse Planet; National Geographic Society's Committee for Research and Exploration [9102-12]; Evelyn Axelrod Endowment Fund for systematic ichthyology	Consortium for Understanding and Sustaining a Biodiverse Planet; National Geographic Society's Committee for Research and Exploration(National Geographic Society); Evelyn Axelrod Endowment Fund for systematic ichthyology	Funding for the Smithsonian Institution's Deep Reef Observation Project was provided internally by the Consortium for Understanding and Sustaining a Biodiverse Planet and by National Geographic Society's Committee for Research and Exploration to CCB (Grant # 9102-12). Additional funding for this study was provided to both authors through the generous support of the Herbert R. and Evelyn Axelrod Endowment Fund for systematic ichthyology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin CC, 2013, ZOOL J LINN SOC-LOND, V168, P496, DOI 10.1111/zoj.12033; Baldwin CC, 2013, ZOOKEYS, P71, DOI 10.3897/zookeys.306.5198; Baldwin CC, 2012, COPEIA, P23, DOI 10.1643/CG-11-035; Baldwin CC, 2011, ZOOKEYS, P21, DOI 10.3897/zookeys.79.1045; Baldwin CC, 2009, ZOOTAXA, P1; BALDWIN CC, 1993, B MAR SCI, V52, P240; BALDWIN CC, 1991, B MAR SCI, V48, P67; Baldwin CC, ZOOKEYS IN PRESS; Baldwin CC, 2001, ZOOTAXA, V3133, P1; Chakrabarty P, 2014, ZOOKEYS IN PRESS; Cowen RK, 2007, OCEANOGRAPHY, V20, P14, DOI 10.5670/oceanog.2007.26; DINGERKUS G, 1977, STAIN TECHNOL, V52, P229, DOI 10.3109/10520297709116780; Eschmeyer WN, 2010, ZOOTAXA, P19; Eschmeyer WN, GENERA SPECIES REFER; Frable BW, 2013, FISH B-NOAA, V111, P122, DOI 10.7755/FB.111.2.2; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hubert N, 2010, MOL PHYLOGENET EVOL, V55, P1195, DOI 10.1016/j.ympev.2010.02.023; JOHNSON GD, 1983, COPEIA, P777; Kendall A.W. Jr, 1984, American Society of Ichthyologists and Herpetologists Special Publication, P499; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lagler KF, 1958, FISHES GREAT LAKES R; Mora C, 2008, P ROY SOC B-BIOL SCI, V275, P149, DOI 10.1098/rspb.2007.1315; Moser HG, 1981, MARINE FISH LARVAE M, P90; Moser HG, 1984, ONTOGENY SYSTEMATICS, V1; Neira FJ, 1998, LARVAE TEMPERATE AUS; Pegg GG, 2006, SCI MAR, V70, P7, DOI 10.3989/scimar.2006.70s27; Poey F., 1860, MEMORIAS HIST NATURA, V2, P115; Randall JE, 1963, STUD FAUNA CURACAO, V19, P77; Randall John E., 1988, Indo-Pacific Fishes, V16, P1; ROBINS CR, 1967, COPEIA, P591; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHULTZ LEONARD P., 1958, PROC U S NATL MUS, V108, P321; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tornabene Luke, 2010, Aqua, V16, P141; Uiblein F, 2014, MAR BIOL RES, V10, P655, DOI 10.1080/17451000.2013.850515; Valdez-Moreno M, 2010, MAR FRESHWATER RES, V61, P665, DOI 10.1071/MF09222; Victor Benjamin C., 2007, Zootaxa, V1526, P51; Victor BC, 2009, ZOOTAXA, P24; Weigt Lee A, 2012, Methods Mol Biol, V858, P109, DOI 10.1007/978-1-61779-591-6_6; Weigt LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041059; Winterbottom R, 2014, ZOOKEYS, P79, DOI 10.3897/zookeys.381.6445	42	25	26	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97661	10.1371/journal.pone.0097661	http://dx.doi.org/10.1371/journal.pone.0097661			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24825118	Green Published, Green Submitted, gold			2022-12-27	WOS:000336369200131
J	Chao, THH; Chen, JH; Yen, CT				Chao, Tzu-Hao Harry; Chen, Jyh-Horng; Yen, Chen-Tung			Repeated BOLD-fMRI Imaging of Deep Brain Stimulation Responses in Rats	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; SOMATOSENSORY CORTEX; FUNCTIONAL MRI; FOREPAW STIMULATION; ANESTHETIZED RATS; NEURONAL-ACTIVITY; ALPHA-CHLORALOSE; SENSORY STIMULATION; NEURAL ACTIVITY; ACTIVATION	Functional magnetic resonance imaging (fMRI) provides a picture of the global spatial activation pattern of the brain. Interest is growing regarding the application of fMRI to rodent models to investigate adult brain plasticity. To date, most rodent studies used an electrical forepaw stimulation model to acquire fMRI data, with a-chloralose as the anesthetic. However, a-chloralose is harmful to animals, and not suitable for longitudinal studies. Moreover, peripheral stimulation models enable only a limited number of brain regions to be studied. Processing between peripheral regions and the brain is multisynaptic, and renders interpretation difficult and uncertain. In the present study, we combined the medetomidine-based fMRI protocol (a noninvasive rodent fMRI protocol) with chronic implantation of an MRI-compatible stimulation electrode in the ventroposterior (VP) thalamus to repetitively sample thalamocortical responses in the rat brain. Using this model, we scanned the forebrain responses evoked by the VP stimulation repeatedly of individual rats over 1 week. Cortical BOLD responses were compared between the 2 profiles obtained at day1 and day8. We discovered reproducible frequency- and amplitude-dependent BOLD responses in the ipsilateral somatosensory cortex (S1). The S1 BOLD responses during the 2 sessions were conserved in maximal response amplitude, area size (size ratio from 0.88 to 0.91), and location (overlap ratio from 0.61 to 0.67). The present study provides a long-term chronic brain stimulation protocol for studying the plasticity of specific neural circuits in the rodent brain by BOLD-fMRI.	[Chao, Tzu-Hao Harry; Yen, Chen-Tung] Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan; [Chen, Jyh-Horng] Natl Taiwan Univ, Dept Elect Engn, Interdisciplinary MRI MRS Lab, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University	Yen, CT (corresponding author), Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan.	ctyen@ntu.edu.tw		Yen, Chen-Tung/0000-0002-0076-4487	National Science Council, Taiwan [NSC100-2311-B002-002-MY3, NSC102-2311-B002-034-MY3]; National Health Research Institutes, Taiwan [NHRI-EX102-10104NI]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This study was supported by the National Science Council, Taiwan (NSC100-2311-B002-002-MY3 & NSC102-2311-B002-034-MY3), and the National Health Research Institutes, Taiwan (NHRI-EX102-10104NI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso BD, 2011, J NEUROSCI METH, V195, P236, DOI 10.1016/j.jneumeth.2010.12.010; Alvarez-Salvado E, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0152; Antognini JF, 1999, ANESTHESIOLOGY, V91, P1064, DOI 10.1097/00000542-199910000-00027; Austin VC, 2003, MAGNET RESON MED, V49, P838, DOI 10.1002/mrm.10428; BANDETTINI PA, 1992, MAGNET RESON MED, V25, P390, DOI 10.1002/mrm.1910250220; BONVENTO G, 1994, BRAIN RES, V665, P213, DOI 10.1016/0006-8993(94)91340-4; Canals S, 2008, MAGN RESON IMAGING, V26, P978, DOI 10.1016/j.mri.2008.02.018; Canals S, 2009, CURR BIOL, V19, P398, DOI 10.1016/j.cub.2009.01.037; Detre JA, 1998, BRAIN RES, V796, P91, DOI 10.1016/S0006-8993(98)00322-9; Dijkhuizen RM, 2001, P NATL ACAD SCI USA, V98, P12766, DOI 10.1073/pnas.231235598; Dijkhuizen RM, 2003, J NEUROSCI, V23, P510, DOI 10.1523/JNEUROSCI.23-02-00510.2003; Dunn JF, 2009, MAGN RESON MED, V61, P222, DOI 10.1002/mrm.21803; Duong TQ, 2000, MAGN RESON MED, V44, P231, DOI 10.1002/1522-2594(200008)44:2<231::AID-MRM10>3.0.CO;2-T; Duong TQ, 2001, P NATL ACAD SCI USA, V98, P10904, DOI 10.1073/pnas.191101098; Gountouna VE, 2010, NEUROIMAGE, V49, P552, DOI 10.1016/j.neuroimage.2009.07.026; Gyngell ML, 1996, MAGNET RESON MED, V36, P13, DOI 10.1002/mrm.1910360104; Hau J, 2011, HDB LAB ANIMAL SCI; HYDER F, 1994, J CEREBR BLOOD F MET, V14, P649, DOI 10.1038/jcbfm.1994.81; Kim T, 2010, NEUROIMAGE, V52, P224, DOI 10.1016/j.neuroimage.2010.03.064; Krautwald K, 2013, NEUROIMAGE; Kuo CC, 2005, CHINESE J PHYSIOL, V48, P200; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Lai HY, 2014, NEUROIMAGE, V84, P11, DOI 10.1016/j.neuroimage.2013.08.026; Lindauer U, 2001, NEUROIMAGE, V13, P988, DOI 10.1006/nimg.2000.0709; Liu ZHM, 2004, MAGN RESON MED, V52, P277, DOI 10.1002/mrm.20148; Lu HB, 2004, MAGN RESON MED, V52, P1060, DOI 10.1002/mrm.20265; Mandeville JB, 1998, MAGNET RESON MED, V39, P615, DOI 10.1002/mrm.1910390415; Marota JJA, 1999, MAGNET RESON MED, V41, P247, DOI 10.1002/(SICI)1522-2594(199902)41:2<247::AID-MRM6>3.0.CO;2-U; Masamoto K, 2007, CEREB CORTEX, V17, P942, DOI 10.1093/cercor/bhl005; Masamoto K, 2009, EUR J NEUROSCI, V30, P242, DOI 10.1111/j.1460-9568.2009.06812.x; Matsuura T, 2001, NEUROSCI RES, V40, P281, DOI 10.1016/S0168-0102(01)00236-X; Ngai AC, 1999, BRAIN RES, V837, P221, DOI 10.1016/S0006-8993(99)01649-2; Nielsen AN, 2001, J PHYSIOL-LONDON, V533, P773, DOI 10.1111/j.1469-7793.2001.00773.x; Niskanen J-P, 2012, J NEUROTRAUMA; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; PARKER JL, 1978, LAB ANIM SCI, V28, P575; Pawela CP, 2009, NEUROIMAGE, V46, P1137, DOI 10.1016/j.neuroimage.2009.03.004; Paxinos G, 1998, RAT BRAIN IN STEREOT; Pelled G, 2007, NEUROIMAGE, V37, P262, DOI 10.1016/j.neuroimage.2007.03.069; Pelled G, 2009, P NATL ACAD SCI USA, V106, P14114, DOI 10.1073/pnas.0903153106; Perlmutter JS, 2006, ANNU REV NEUROSCI, V29, P229, DOI 10.1146/annurev.neuro.29.051605.112824; Pikkemaat J, 2002, IMPROVED ANESTHESIA; Rombouts SARB, 1998, MAGN RESON IMAGING, V16, P105, DOI 10.1016/S0730-725X(97)00253-1; Schafer JR, 2005, MAGN RESON MED, V54, P443, DOI 10.1002/mrm.20588; Schmidt C, 2011, ANESTHESIOLOGY; Sheth S, 2003, NEUROIMAGE, V19, P884, DOI 10.1016/S1053-8119(03)00086-7; Shih Y-YI, 2013, BRAIN STIMULATION; Shyu BC, 2004, MAGN RESON MED, V52, P47, DOI 10.1002/mrm.20111; Sicard K, 2003, J CEREBR BLOOD F MET, V23, P472, DOI 10.1097/01.WCB.0000054755.93668.20; Silva AC, 1999, J CEREBR BLOOD F MET, V19, P871, DOI 10.1097/00004647-199908000-00006; SILVERMAN J, 1993, LAB ANIM SCI, V43, P210; Sinclair MD, 2003, CAN VET J, V44, P885; UEKI M, 1988, J CEREBR BLOOD F MET, V8, P486, DOI 10.1038/jcbfm.1988.89; Ureshi M, 2004, NEUROSCI RES, V48, P147, DOI 10.1016/j.neures.2003.10.014; Ward B, 2000, ALPHASIM; Weber R, 2006, NEUROIMAGE, V29, P1303, DOI 10.1016/j.neuroimage.2005.08.028; Weber R, 2008, J NEUROSCI, V28, P1022, DOI 10.1523/JNEUROSCI.4147-07.2008; Yang PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066821; Yang XJ, 1996, P NATL ACAD SCI USA, V93, P475, DOI 10.1073/pnas.93.1.475; Yang XJ, 1997, MAGNET RESON MED, V38, P874, DOI 10.1002/mrm.1910380604; Yu X, 2012, NEURON, V74, P731, DOI 10.1016/j.neuron.2012.04.024; Yu X, 2010, NEUROIMAGE, V49, P1667, DOI 10.1016/j.neuroimage.2009.09.021; Zhao FQ, 2008, NEUROIMAGE, V39, P248, DOI 10.1016/j.neuroimage.2007.07.063; Zong X, 2013, EFFECTS OF THE A2 AD	64	20	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97305	10.1371/journal.pone.0097305	http://dx.doi.org/10.1371/journal.pone.0097305			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24825464	Green Submitted, Green Published, gold			2022-12-27	WOS:000336369200092
J	Kishino, Y; Seki, T; Fujita, J; Yuasa, S; Tohyama, S; Kunitomi, A; Tabei, R; Nakajima, K; Okada, M; Hirano, A; Kanazawa, H; Fukuda, K				Kishino, Yoshikazu; Seki, Tomohisa; Fujita, Jun; Yuasa, Shinsuke; Tohyama, Shugo; Kunitomi, Akira; Tabei, Ryota; Nakajima, Kazuaki; Okada, Marina; Hirano, Akinori; Kanazawa, Hideaki; Fukuda, Keiichi			Derivation of Transgene-Free Human Induced Pluripotent Stem Cells from Human Peripheral T Cells in Defined Culture Conditions	PLOS ONE			English	Article							EFFICIENT GENE-TRANSFER; SENDAI-VIRUS; HUMAN FIBROBLASTS; GENERATION; MAINTENANCE; INDUCTION; VECTOR; LINES; SYSTEM; BLOOD	Recently, induced pluripotent stem cells (iPSCs) were established as promising cell sources for revolutionary regenerative therapies. The initial culture system used for iPSC generation needed fetal calf serum in the culture medium and mouse embryonic fibroblast as a feeder layer, both of which could possibly transfer unknown exogenous antigens and pathogens into the iPSC population. Therefore, the development of culture systems designed to minimize such potential risks has become increasingly vital for future applications of iPSCs for clinical use. On another front, although donor cell types for generating iPSCs are wide-ranging, T cells have attracted attention as unique cell sources for iPSCs generation because T cell-derived iPSCs (TiPSCs) have a unique monoclonal T cell receptor genomic rearrangement that enables their differentiation into antigen-specific T cells, which can be applied to novel immunotherapies. In the present study, we generated transgene-free human TiPSCs using a combination of activated human T cells and Sendai virus under defined culture conditions. These TiPSCs expressed pluripotent markers by quantitative PCR and immunostaining, had a normal karyotype, and were capable of differentiating into cells from all three germ layers. This method of TiPSCs generation is more suitable for the therapeutic application of iPSC technology because it lowers the risks associated with the presence of undefined, animal-derived feeder cells and serum. Therefore this work will lead to establishment of safer iPSCs and extended clinical application.	[Kishino, Yoshikazu; Seki, Tomohisa; Fujita, Jun; Yuasa, Shinsuke; Tohyama, Shugo; Kunitomi, Akira; Tabei, Ryota; Nakajima, Kazuaki; Okada, Marina; Kanazawa, Hideaki; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Shinjuku Ku, Tokyo, Japan; [Seki, Tomohisa; Tohyama, Shugo] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan; [Hirano, Akinori] Keio Univ, Sch Med, Dept Cardiovasc Surg, Shinjuku Ku, Tokyo, Japan	Keio University; Japan Society for the Promotion of Science; Keio University	Fukuda, K (corresponding author), Keio Univ, Sch Med, Dept Cardiol, Shinjuku Ku, Tokyo, Japan.	kfukuda@a2.keio.jp	Fukuda, Keiichi/L-3777-2013; Seki, Tomohisa/L-3524-2013	Kishino, Yoshikazu/0000-0003-3291-2795; Seki, Tomohisa/0000-0002-4281-135X; Yuasa, Shinsuke/0000-0001-5593-7552	Support Program to break the bottlenecks at R&D Systems for accelerating the practical use of Health Research Outcome; Highway Program for the Realization of Regenerative Medicine	Support Program to break the bottlenecks at R&D Systems for accelerating the practical use of Health Research Outcome; Highway Program for the Realization of Regenerative Medicine	This work was partly supported by the Support Program to break the bottlenecks at R&D Systems for accelerating the practical use of Health Research Outcome, the Highway Program for the Realization of Regenerative Medicine, and a Grant-in-Aid for JSPS Fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011373; Catalina P, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-76; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; EMONARD H, 1987, J CELL PHYSIOL, V133, P95, DOI 10.1002/jcp.1041330112; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Giudicelli Veronique, 2011, Cold Spring Harb Protoc, V2011, P695, DOI 10.1101/pdb.prot5633; Gonzalez F, 2011, NAT REV GENET, V12, P231, DOI 10.1038/nrg2937; Ikeda Y, 2002, EXP EYE RES, V75, P39, DOI 10.1006/exer.2002.1177; Kim HT, 2013, BIOMATERIALS, V34, P1041, DOI 10.1016/j.biomaterials.2012.10.064; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kunisato A, 2011, STEM CELLS DEV, V20, P159, DOI 10.1089/scd.2010.0063; Li HO, 2000, J VIROL, V74, P6564, DOI 10.1128/JVI.74.14.6564-6569.2000; Loh YH, 2010, CELL STEM CELL, V7, P15, DOI 10.1016/j.stem.2010.06.004; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Mahlstedt MM, 2010, BIOTECHNOL BIOENG, V105, P130, DOI 10.1002/bit.22520; Masaki I, 2001, FASEB J, V15, P1294, DOI 10.1096/fj.00-0460fje; Nishimura T, 2013, CELL STEM CELL, V12, P114, DOI 10.1016/j.stem.2012.11.002; Ohnuki M, 2009, CURR PROTOC STEM CEL, DOI DOI 10.1002/9780470151808.SC04A02S9; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Rodriguez-Piza I, 2010, STEM CELLS, V28, P36, DOI 10.1002/stem.248; Sampsell-Barron Tori, 2013, Methods Mol Biol, V1001, P81, DOI 10.1007/978-1-62703-363-3_8; Sato H, 2007, TISSUE ENG, V13, P1539, DOI 10.1089/ten.2006.0383; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Staerk J, 2010, CELL STEM CELL, V7, P20, DOI 10.1016/j.stem.2010.06.002; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Sugii S, 2010, P NATL ACAD SCI USA, V107, P3558, DOI 10.1073/pnas.0910172106; Swistowski A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006233; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Vizcardo R, 2013, CELL STEM CELL, V12, P31, DOI 10.1016/j.stem.2012.12.006	33	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97397	10.1371/journal.pone.0097397	http://dx.doi.org/10.1371/journal.pone.0097397			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824994	Green Published, Green Submitted, gold			2022-12-27	WOS:000336369200108
J	Qi, YB; Huang, B; Darilek, JL				Qi, Yanbing; Huang, Biao; Darilek, Jeremy Landon			Effect of Drying on Heavy Metal Fraction Distribution in Rice Paddy Soil	PLOS ONE			English	Article							SEQUENTIAL EXTRACTION PROCEDURE; SEDIMENTS; SPECIATION; RHIZOSPHERE; REDOX; RIVER; ZINC; PH; CADMIUM; SLUDGE	An understanding of how redox conditions affect soil heavy metal fractions in rice paddies is important due to its implications for heavy metal mobility and plant uptake. Rice paddy soil samples routinely undergo oxidation prior to heavy metal analysis. Fraction distribution of Cu, Pb, Ni, and Cd from paddy soil with a wide pH range was investigated. Samples were both dried according to standard protocols and also preserved under anaerobic conditions through the sampling and analysis process and heavy metals were then sequentially extracted for the exchangeable and carbonate bound fraction ( acid soluble fraction), iron and manganese oxide bound fraction (reducible fraction), organic bound fraction ( oxidizable fraction), and residual fraction. Fractions were affected by redox conditions across all pH ranges. Drying decreased reducible fraction of all heavy metals. Cu-residual fraction, Pb-oxidizable fraction, Cd-residual fraction, and Ni-residual fraction increased by 25%, 33%, 35%, and >60%, respectively. Pb-residual fraction, Ni-acid soluble (fraction), and Cd-oxidizable fraction decreased 33%, 25%, and 15%, respectively. Drying paddy soil prior to heavy metal analysis overestimated Pb and underestimated Cu, Ni, and Cd. In future studies, samples should be stored after injecting N-2 gas to maintain the redox potential of soil prior to heavy metal analysis, and investigate the correlation between heavy metal fraction distribution under field conditions and air- dried samples.	[Qi, Yanbing] Northwest Agr & Forestry Univ, Coll Resources & Environm, Yangling, Shaanxi, Peoples R China; [Qi, Yanbing] Minist Agr, Key Lab Plant Nutr & Agrienvironm Northwest China, Yangling, Shaanxi, Peoples R China; [Huang, Biao; Darilek, Jeremy Landon] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Institute of Soil Science, CAS	Qi, YB (corresponding author), Northwest Agr & Forestry Univ, Coll Resources & Environm, Yangling, Shaanxi, Peoples R China.	yanbing_qi@sina.com			Natural Science Foundation of China [31100516]; National "863" Plan Project of China [2013AA102401]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National "863" Plan Project of China(National High Technology Research and Development Program of China)	This work was financially supported by the Natural Science Foundation of China (31100516), and the National "863" Plan Project of China (No. 2013AA102401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu V, 1999, ENVIRON POLLUT, V104, P271, DOI 10.1016/S0269-7491(98)00179-1; Argese E., 2001, TOXICOL ENVIRON CHEM, V79, P157, DOI [10.1080/02772240109358985, DOI 10.1080/02772240109358985]; CALMANO W, 1993, WATER SCI TECHNOL, V28, P223, DOI 10.2166/wst.1993.0622; Chen YouJian, 2001, Acta Pedologica Sinica, V38, P54; Collavini F, 2000, TOXICOL ENVIRON CHEM, V77, P171; F÷rstner U., 1983, METAL POLLUTION AQUA; Goh SW, 2006, GEOCHIM COSMOCHIM AC, V70, P2210, DOI 10.1016/j.gca.2006.02.007; Gong ZT, 1998, ADV EARTH SCI, V23, P184; Hinsinger P, 2003, PLANT SOIL, V248, P43, DOI 10.1023/A:1022371130939; Kashem MA, 2001, NUTR CYCL AGROECOSYS, V61, P247, DOI 10.1023/A:1013762204510; Kashem MA, 2007, NUTR CYCL AGROECOSYS, V77, P187, DOI 10.1007/s10705-006-9056-4; Kazi TG, 2005, ANAL BIOANAL CHEM, V383, P297, DOI 10.1007/s00216-005-0004-y; Kelderman P, 2007, WATER RES, V41, P4251, DOI 10.1016/j.watres.2007.05.058; Li JX, 2007, GEODERMA, V141, P174, DOI 10.1016/j.geoderma.2007.05.006; Li RY, 2007, PEDOSPHERE, V17, P265, DOI 10.1016/S1002-0160(07)60033-2; LI YG, 2004, GEOCHINA, V31, P87; Lin Qi, 1998, Acta Pedologica Sinica, V35, P461; Lu RK, 2004, SOIL AGROCHEMICAL AN; Lu YZ, 2006, CHEM J CHINESE U, V27, P449; Luo YM, 2003, GEODERMA, V115, P113, DOI 10.1016/S0016-7061(03)00080-6; Martinez-Alcala I, 2010, ECOTOX ENVIRON SAFE, V73, P595, DOI 10.1016/j.ecoenv.2009.12.009; Moore P, 2000, METHODS PHOSPHORUS A; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Ngoc MN, 2009, AGR ECOSYST ENVIRON, V129, P8, DOI 10.1016/j.agee.2008.06.008; Qi Yan-bing, 2008, Bulletin of Mineralogy, Petrology and Geochemistry, V27, P50; REDDY CN, 1977, J ENVIRON QUAL, V6, P259, DOI 10.2134/jeq1977.00472425000600030005x; SAEKI K, 1993, WATER RES, V27, P1243, DOI 10.1016/0043-1354(93)90017-C; SAJWAN KS, 1986, SOIL SCI SOC AM J, V50, P1264, DOI 10.2136/sssaj1986.03615995005000050036x; [邵学新 SHAO Xuexin], 2008, [环境化学, Environmental Chemistry], V27, P218; Shao XX, 2006, B MINER PETRO GEOCHE, V25, P35; Shrivastava SK, 2004, WATER AIR SOIL POLL, V152, P219, DOI 10.1023/B:WATE.0000015364.19974.36; Shuman LM, 1997, COMMUN SOIL SCI PLAN, V28, P23, DOI 10.1080/00103629709369769; Singh SP, 2000, J ENVIRON QUAL, V29, P1124, DOI 10.2134/jeq2000.00472425002900040013x; SURIJA B, 1995, SCI TOTAL ENVIRON, V170, P101, DOI 10.1016/0048-9697(95)04607-3; Tao S, 2003, ENVIRON POLLUT, V122, P447, DOI 10.1016/S0269-7491(02)00313-5; Teixeira EC, 2001, ENVIRON GEOL, V41, P145, DOI 10.1007/s002540100257; TESSIER A, 1979, ANAL CHEM, V51, P844, DOI 10.1021/ac50043a017; Tsai LJ, 1998, WATER SCI TECHNOL, V37, P217, DOI 10.2166/wst.1998.0755; URE AM, 1993, INT J ENVIRON AN CH, V51, P135, DOI 10.1080/03067319308027619; [王昌全 Wang Changquan], 2007, [生态学报, Acta Ecologica Sinica], V27, P889; Wang C, 2006, J HAZARD MATER, V137, P1277, DOI 10.1016/j.jhazmat.2006.04.026; Wu HS, 2004, J ENVIRON SCI-CHINA, V16, P640; Zhao KL, 2010, J HAZARD MATER, V181, P778, DOI 10.1016/j.jhazmat.2010.05.081; Zheng SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049664; Zheng SA, 2011, J ENVIRON SCI-CHINA, V23, P434, DOI 10.1016/S1001-0742(10)60428-7	46	30	33	8	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97327	10.1371/journal.pone.0097327	http://dx.doi.org/10.1371/journal.pone.0097327			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24823670	Green Published, Green Submitted, gold			2022-12-27	WOS:000336369200095
J	Scherer, K; Birnbacher, L; Chabior, M; Herzen, J; Mayr, D; Grandl, S; Sztrokay-Gaul, A; Hellerhoff, K; Bamberg, F; Pfeiffer, F				Scherer, Kai; Birnbacher, Lorenz; Chabior, Michael; Herzen, Julia; Mayr, Doris; Grandl, Susanne; Sztrokay-Gaul, Aniko; Hellerhoff, Karin; Bamberg, Fabian; Pfeiffer, Franz			Bi-Directional X-Ray Phase-Contrast Mammography	PLOS ONE			English	Article							BREAST; IMAGE	Phase-contrast x-ray imaging is a promising improvement of conventional absorption-based mammography for early tumor detection. This potential has been demonstrated recently, utilizing structured gratings to obtain differential phase and dark-field scattering images. However, the inherently anisotropic imaging sensitivity of the proposed mono-directional approach yields only insufficient diagnostic information, and has low diagnostic sensitivity to highly oriented structures. To overcome these limitations, we present a two-directional x-ray phase-contrast mammography approach and demonstrate its advantages by applying it to a freshly dissected, cancerous mastectomy breast specimen. We illustrate that the two-directional scanning procedure overcomes the insufficient diagnostic value of a single scan, and reliably detects tumor structures, independently from their orientation within the breast. Our results indicate the indispensable diagnostic necessity and benefit of a multi-directional approach for x-ray phase-contrast mammography.	[Scherer, Kai; Birnbacher, Lorenz; Chabior, Michael; Pfeiffer, Franz] Tech Univ Munich, Dept Phys, Lehrstuhl Biomed Phys, Garching, Germany; [Scherer, Kai; Birnbacher, Lorenz; Chabior, Michael; Pfeiffer, Franz] Tech Univ Munich, Inst Med Tech, Garching, Germany; [Herzen, Julia] Helmholtz Zentrum Geesthacht, Ctr Mat & Coastal Res, Geesthacht, Germany; [Mayr, Doris] Univ Munich, Dept Pathol, Munich, Germany; [Grandl, Susanne; Sztrokay-Gaul, Aniko; Hellerhoff, Karin; Bamberg, Fabian] Univ Munich, Dept Clin Radiol, Munich, Germany	Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung; University of Munich; University of Munich	Scherer, K (corresponding author), Tech Univ Munich, Dept Phys, Lehrstuhl Biomed Phys, Garching, Germany.	kai.scherer@tum.de	Herzen, Julia/B-2368-2015	Herzen, Julia/0000-0002-9456-1591	DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP); DFG Gottfried Wilhelm Leibniz program; European Research Council [StG 240142]	DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP)(German Research Foundation (DFG)); DFG Gottfried Wilhelm Leibniz program(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission)	The authors acknowledge financial support through the DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP), the DFG Gottfried Wilhelm Leibniz program and the European Research Council (ERC, FP7, StG 240142). This work was carried out with the support of the Karlsruhe Nano Micro Facility (KNMF, www.kit.edu/knmf), a Helmholtz Research Infrastructure at Karlsruhe Institute of Technology (KIT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arfelli F, 2000, RADIOLOGY, V215, P286, DOI 10.1148/radiology.215.1.r00ap10286; Arnison MR, 2004, J MICROSCOPY, V214, P712; Barreau A, 2005, EUR J RADIOL, V54, P55, DOI 10.1016/j.ejrad.2004.11.019; Cha BK, 2012, J INSTRUM, V7, DOI 10.1088/1748-0221/7/04/C04020; Dance DR, 2000, PHYS MED BIOL, V45, P3225, DOI 10.1088/0031-9155/45/11/308; DANCE DR, 1990, PHYS MED BIOL, V35, P1211, DOI 10.1088/0031-9155/35/9/002; Dinkel HP, 2000, BRIT J RADIOL, V73, P938, DOI 10.1259/bjr.73.873.11064645; Donath T, 2009, J APPL PHYS, V106, DOI 10.1063/1.3208052; Jensen TH, 2010, PHYS MED BIOL, V55, P3317, DOI 10.1088/0031-9155/55/12/004; Jensen TH, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.214103; Keyrilainen J, 2010, ACTA RADIOL, V51, P866, DOI 10.3109/02841851.2010.504742; Kottler C, 2007, OPT EXPRESS, V15, P1175, DOI 10.1364/OE.15.001175; Li CI, 2003, JAMA-J AM MED ASSOC, V289, P1421, DOI 10.1001/jama.289.11.1421; Malecki A, 2012, EPL-EUROPHYS LETT, V99, DOI 10.1209/0295-5075/99/48001; Menell JH, 2005, BREAST J, V11, P382, DOI 10.1111/j.1075-122X.2005.00121.x; Momose A, 2003, JPN J APPL PHYS 2, V42, pL866, DOI 10.1143/JJAP.42.L866; Perry N, 2008, ANN ONCOL, V19, P614, DOI 10.1093/annonc/mdm481; Pfeiffer F, 2008, NAT MATER, V7, P134, DOI 10.1038/nmat2096; Pfeiffer F, 2006, NAT PHYS, V2, P258, DOI 10.1038/nphys265; Polesel A, 2000, IEEE T IMAGE PROCESS, V9, P505, DOI 10.1109/83.826787; Poplack SP, 2000, RADIOLOGY, V217, P832, DOI 10.1148/radiology.217.3.r00dc33832; Roessl E, 2012, PROC SPIE, V8313, DOI 10.1117/12.911255; Siegel R, 2012, CA-CANCER J CLIN, V62, P1029; Stampanoni M, 2011, INVEST RADIOL, V46, P801, DOI 10.1097/RLI.0b013e31822a585f; STOMPER PC, 1992, AM J ROENTGENOL, V159, P483, DOI 10.2214/ajr.159.3.1323923; Sztrokay A, 2012, PHYS MED BIOL, V57, P2931, DOI 10.1088/0031-9155/57/10/2931; Takeda T, 1998, J SYNCHROTRON RADIAT, V5, P1133, DOI 10.1107/S0909049597020116; Thuring T, 2011, OPT EXPRESS, V19, P25545, DOI 10.1364/OE.19.025545; Wen H, 2009, RADIOLOGY, V251, P910, DOI 10.1148/radiol.2521081903; Zanette I, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.248102	30	8	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e93502	10.1371/journal.pone.0093502	http://dx.doi.org/10.1371/journal.pone.0093502			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824594	Green Submitted, Green Published, gold			2022-12-27	WOS:000336369200003
J	Taki, FA; Abdel-Rahman, AA; Zhang, BH				Taki, Faten A.; Abdel-Rahman, Abdel A.; Zhang, Baohong			A Comprehensive Approach to Identify Reliable Reference Gene Candidates to Investigate the Link between Alcoholism and Endocrinology in Sprague-Dawley Rats	PLOS ONE			English	Article							STABLE REFERENCE GENES; LONG-TERM OVARIECTOMY; HOUSEKEEPING GENES; POSTMENOPAUSAL WOMEN; ESTROGEN REPLACEMENT; PCR DATA; EXPRESSION; NORMALIZATION; RECEPTOR; SELECTION	Gender and hormonal differences are often correlated with alcohol dependence and related complications like addiction and breast cancer. Estrogen (E2) is an important sex hormone because it serves as a key protein involved in organism level signaling pathways. Alcoholism has been reported to affect estrogen receptor signaling; however, identifying the players involved in such multi-faceted syndrome is complex and requires an interdisciplinary approach. In many situations, preliminary investigations included a straight forward, yet informative biotechniques such as gene expression analyses using quantitative real time PCR (qRT-PCR). The validity of qRT-PCR-based conclusions is affected by the choice of reliable internal controls. With this in mind, we compiled a list of 15 commonly used housekeeping genes (HKGs) as potential reference gene candidates in rat biological models. A comprehensive comparison among 5 statistical approaches (geNorm, dCt method, NormFinder, BestKeeper, and RefFinder) was performed to identify the minimal number as well the most stable reference genes required for reliable normalization in experimental rat groups that comprised sham operated (SO), ovariectomized rats in the absence (OVX) or presence of E2 (OVXE2). These rat groups were subdivided into subgroups that received alcohol in liquid diet or isocalroic control liquid diet for 12 weeks. Our results showed that U87, 5S rRNA, GAPDH, and U5a were the most reliable gene candidates for reference genes in heart and brain tissue. However, different gene stability ranking was specific for each tissue input combination. The present preliminary findings highlight the variability in reference gene rankings across different experimental conditions and analytic methods and constitute a fundamental step for gene expression assays.	[Taki, Faten A.; Zhang, Baohong] E Carolina Univ, Dept Biol, Greenville, NC 27858 USA; [Abdel-Rahman, Abdel A.] E Carolina Univ, Dept Pharmacol, Greenville, NC USA	University of North Carolina; East Carolina University; University of North Carolina; East Carolina University	Zhang, BH (corresponding author), E Carolina Univ, Dept Biol, Greenville, NC 27858 USA.	zhangb@ecu.edu	Abdel-Rahman, Abdel/AAJ-6753-2020; Zhang, Baohong/O-4948-2016	Abdel-Rahman, Abdel/0000-0002-3461-2190; 	NIH [2R01 AA014441]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA014441] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	These studies were partly supported by NIH grant 2R01 AA014441 (Abdel-Rahman). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bennett B, 2006, TRENDS GENET, V22, P367, DOI 10.1016/j.tig.2006.05.005; Bonefeld BE, 2008, SYNAPSE, V62, P302, DOI 10.1002/syn.20496; Boujedidi H, 2012, ALCOHOL CLIN EXP RES, V36, P258, DOI 10.1111/j.1530-0277.2011.01627.x; Cabiati M, 2012, J MOL ENDOCRINOL, V48, P251, DOI 10.1530/JME-12-0024; CALDANI M, 1988, HISTOCHEMISTRY, V89, P129, DOI 10.1007/BF00489916; Calkins K.G., 2005, APPL STAT CORRELATIO; Cappelli K, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-49; CDC CfDCaP, 2012, FACT SHEETS ALC US H; Cook NL, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-7; Cook NL, 2009, J NEUROSCI RES, V87, P34, DOI 10.1002/jnr.21846; Di Pasquale C, 1986, Odontostomatol Trop, V9, P175; El-Mas MM, 2004, J CARDIOVASC PHARM, V43, P607, DOI 10.1097/00005344-200405000-00001; Fan SJ, 2000, CANCER RES, V60, P5635; Filby AL, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-10; Galal N, 2010, MOL MED REP, V3, P111, DOI 10.3892/mmr_00000226; Gill J, 2000, ALCOHOL ALCOHOLISM, V35, P417, DOI 10.1093/alcalc/35.5.417; Guarnieri Douglas J, 2003, Int Rev Neurobiol, V54, P199, DOI 10.1016/S0074-7742(03)54006-5; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Kim Insook, 2011, BMC Res Notes, V4, P440, DOI 10.1186/1756-0500-4-440; Lardizabal MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036323; Lee J, 2009, GENES BRAIN BEHAV, V8, P578, DOI 10.1111/j.1601-183X.2009.00513.x; Lenz B, 2012, PROG NEUROBIOL, V96, P136, DOI 10.1016/j.pneurobio.2011.11.001; Mello N, 1988, NIDA Res Monogr, V81, P122; Mohamed MK, 2000, EUR J ENDOCRINOL, V142, P307, DOI 10.1530/eje.0.1420307; Nelissen K, 2010, J NEUROSCI METH, V187, P78, DOI 10.1016/j.jneumeth.2009.12.018; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Onland-Moret NC, 2005, J CLIN ENDOCR METAB, V90, P1414, DOI 10.1210/jc.2004-0614; Oscar-Berman M, 2004, ALCOHOLISM BRAIN OVE; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pohjanvirta R, 2006, CHEM-BIOL INTERACT, V160, P134, DOI 10.1016/j.cbi.2006.01.001; Purohit V, 1998, ALCOHOL CLIN EXP RES, V22, P994, DOI 10.1111/j.1530-0277.1998.tb03694.x; Ruusa J, 1996, ALCOHOL, V13, P139, DOI 10.1016/0741-8329(95)02025-X; Schroder AL, 2009, ENDOCRINE, V35, P211, DOI 10.1007/s12020-009-9154-6; Scott HC, 1998, ALCOHOL CLIN EXP RES, V22, P2111, DOI 10.1111/j.1530-0277.1998.tb05924.x; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Tabakoff B, 2000, ANIMAL MODELS ALCOHO, P24; Tea M, 2013, MOL VIS, V19, P501; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verma AS, 2006, J GASTROEN HEPATOL, V21, P1004, DOI 10.1111/j.1440-1746.2005.03948.x; Wang GP, 2010, MOL BIOTECHNOL, V46, P49, DOI 10.1007/s12033-010-9274-5; Wong AW, 2012, ALCOHOL CLIN EXP RES, V36, P577, DOI 10.1111/j.1530-0277.2011.01654.x; Xie F., 2012, PLANT MOL BIOL	45	25	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e94311	10.1371/journal.pone.0094311	http://dx.doi.org/10.1371/journal.pone.0094311			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824616	gold, Green Published			2022-12-27	WOS:000336369200004
J	Bechah, Y; Verneau, J; Ben Amara, A; Barry, AO; Lepolard, C; Achard, V; Panicot-Dubois, L; Textoris, J; Capo, C; Ghigo, E; Mege, JL				Bechah, Yassina; Verneau, Johanna; Ben Amara, Amira; Barry, Abdoulaye O.; Lepolard, Catherine; Achard, Vincent; Panicot-Dubois, Laurence; Textoris, Julien; Capo, Christian; Ghigo, Eric; Mege, Jean-Louis			Persistence of Coxiella burnetii, the Agent of Q Fever, in Murine Adipose Tissue	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; TARGET-CELL; ADIPOCYTE; INFECTION; EXPRESSION	Coxiella burnetii, the agent of Q fever, is known to persist in humans and rodents but its cellular reservoir in hosts remains undetermined. We hypothesized that adipose tissue serves as a C. burnetii reservoir during bacterial latency. BALB/c and C57BL/6 mice were infected with C. burnetii by the intraperitoneal route or the intracheal route. Adipose tissue was tested for the presence of C. burnetii several months after infection. C. burnetii was detected in abdominal, inguinal and dorsal adipose tissue 4 months post-infection, when no bacteria were detected in blood, liver, lungs and spleen, regardless of the inoculation route and independently of mouse strain. The transfer of abdominal adipose tissue from convalescent BALB/c mice to naive immunodeficient mice resulted in the infection of the recipient animals. It is likely that C. burnetii infects adipocytes in vivo because bacteria were found in adipocytes within adipose tissue and replicated within in vitro-differentiated adipocytes. In addition, C. burnetii induced a specific transcriptional program in in-vivo and in vitro-differentiated adipocytes, which was enriched in categories associated with inflammatory response, hormone response and cytoskeleton. These changes may account for bacterial replication in in-vitro and chronic infection in-vivo. Adipose tissue may be the reservoir in which C. burnetii persists for prolonged periods after apparent clinical cure. The mouse model of C. burnetii infection may be used to understand the relapses of Q fever and provide new perspectives to the follow-up of patients.	[Bechah, Yassina; Verneau, Johanna; Ben Amara, Amira; Barry, Abdoulaye O.; Lepolard, Catherine; Textoris, Julien; Capo, Christian; Ghigo, Eric; Mege, Jean-Louis] Aix Marseille Univ, Unite Rech Malad Infect Transmissibles & Emergent, UMR CNRS 7278, IRD 198,INSERM U1095, Marseille, France; [Achard, Vincent] Aix Marseille Univ, UMR S INSERM, Marseille, France; [Panicot-Dubois, Laurence] Aix Marseille Univ UMR S1076, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Bechah, Y (corresponding author), Aix Marseille Univ, Unite Rech Malad Infect Transmissibles & Emergent, UMR CNRS 7278, IRD 198,INSERM U1095, Marseille, France.	yassina.bechah@univ-amu.fr	Textoris, Julien/H-3317-2019; Panicot-Dubois, Laurence/E-3030-2016; MEGE, JEAN-LOUIS/O-6063-2016; catherine, lepolard/P-5653-2016; Eric, Ghigo/N-9427-2016	Textoris, Julien/0000-0002-3821-9337; Panicot-Dubois, Laurence/0000-0003-0848-5009; 				Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; Adamczak M, 2013, SEMIN NEPHROL, V33, P2, DOI 10.1016/j.semnephrol.2012.12.008; Bammler T, 2005, NAT METHODS, V2, P351, DOI 10.1038/nmeth0605-477a; Barry AO, 2012, CELL HOST MICROBE, V12, P751, DOI 10.1016/j.chom.2012.10.015; Batra A, 2010, ENDOCRINOLOGY, V151, P56, DOI 10.1210/en.2009-0565; Bechah Y, 2008, J INFECT DIS, V197, P142, DOI 10.1086/523649; Bechah Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008547; Ben Amara A, 2010, PLOS ONE, V12; Benslimani A, 2005, EMERG INFECT DIS, V11, P216, DOI 10.3201/eid1102.040668; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Combs TP, 2005, J BIOL CHEM, V280, P24085, DOI 10.1074/jbc.M412802200; Darbousset R, 2012, BLOOD, V120, P2133, DOI 10.1182/blood-2012-06-437772; DESLEX S, 1987, INT J OBESITY, V11, P19; Desruisseaux MS, 2007, INFECT IMMUN, V75, P1066, DOI 10.1128/IAI.01455-06; Erol A, 2008, MED HYPOTHESES, V71, P222, DOI 10.1016/j.mehy.2008.03.028; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghigo E, 2009, ANN NY ACAD SCI, V1166, P55, DOI 10.1111/j.1749-6632.2009.04515.x; Hanses F, 2011, ENDOCRINOLOGY, V152, P4148, DOI 10.1210/en.2011-0103; Harris RJ, 2000, EPIDEMIOL INFECT, V124, P543, DOI 10.1017/S0950268899003763; Hazan U, 2002, FASEB J, V16, P1254, DOI 10.1096/fj.01-0947fje; Ikeoka D, 2010, CYTOKINE, V50, P284, DOI 10.1016/j.cyto.2010.02.015; Kanneganti TD, 2012, NAT IMMUNOL, V13, P707, DOI 10.1038/ni.2343; Larkin JE, 2005, NAT METHODS, V2, P337, DOI 10.1038/nmeth757; Marmion BP, 2005, QJM-INT J MED, V98, P7, DOI 10.1093/qjmed/hci009; Maurin T, 2005, EXP CELL RES, V304, P544, DOI 10.1016/j.yexcr.2004.12.003; Meghari S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040023; Million M, 2010, LANCET INFECT DIS, V10, P527, DOI 10.1016/S1473-3099(10)70135-3; Morguet AJ, 2007, CLIN RES CARDIOL, V96, P519, DOI 10.1007/s00392-007-0522-z; Nagajyothi F, 2008, OBESITY, V16, P1992, DOI 10.1038/oby.2008.331; Nagajyothi F, 2009, MEM I OSWALDO CRUZ, V104, P219, DOI 10.1590/S0074-02762009000900028; Neyrolles O, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000043; Omsland A, 2009, P NATL ACAD SCI USA, V106, P4430, DOI 10.1073/pnas.0812074106; ONG JM, 1992, ENDOCRINOLOGY, V130, P2310, DOI 10.1210/en.130.4.2310; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Sashinami H, 2010, CYTOKINE, V50, P170, DOI 10.1016/j.cyto.2009.12.005; SIDWELL RW, 1964, AM J HYG, V79, P320, DOI 10.1093/oxfordjournals.aje.a120386; SIDWELL RW, 1966, AM J EPIDEMIOL, V84, P132, DOI 10.1093/oxfordjournals.aje.a120618; SIDWELL RW, 1964, AM J HYG, V79, P113, DOI 10.1093/oxfordjournals.aje.a120359; Stein A, 2000, J INFECT DIS, V181, P188, DOI 10.1086/315166; Tissot-Dupont H, 2008, INFECT DIS CLIN N AM, V22, P505, DOI 10.1016/j.idc.2008.03.002	41	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97503	10.1371/journal.pone.0097503	http://dx.doi.org/10.1371/journal.pone.0097503			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835240	Green Published, gold, Green Submitted			2022-12-27	WOS:000339614800047
J	Davoodi-Bojd, E; Chopp, M; Soltanian-Zadeh, H; Wang, SY; Ding, GL; Jiang, Q				Davoodi-Bojd, Esmaeil; Chopp, Michael; Soltanian-Zadeh, Hamid; Wang, Shiyang; Ding, Guangliang; Jiang, Quan			An Analytical Model for Estimating Water Exchange Rate in White Matter Using Diffusion MRI	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; AXON DIAMETER DISTRIBUTION; FIELD GRADIENT NMR; IN-VIVO; RESTRICTED DIFFUSION; SPIN-ECHO; STROKE; TENSOR; DIFFRACTION; FIBERS	Substantial effort is being expended on using micro-structural modeling of the white matter, with the goal of relating diffusion weighted magnetic resonance imaging (DWMRI) to the underlying structure of the tissue, such as axonal density. However, one of the important parameters affecting diffusion is the water exchange rate between the intra-and extra-axonal space, which has not been fully investigated and is a crucial marker of brain injury such as multiple sclerosis (MS), stroke, and traumatic brain injury (TBI). To our knowledge, there is no diffusion analytical model which includes the Water eXchange Rate (WXR) without the requirement of short gradient pulse (SGP) approximation. We therefore propose a new analytical model by deriving the diffusion signal for a permeable cylinder, assuming a clinically feasible pulse gradient spin echo (PGSE) sequence. Simulations based on Markov Random Walk confirm that the exchange parameter included in our model has a linear correlation (R-2>0.88) with the actual WXR. Moreover, increasing WXR causes the estimated values of diameter and volume fraction of the cylinders to increase and decrease, respectively, which is consistent with our findings from histology measurements in tissues near TBI regions. This model was also applied to the diffusion signal acquired from ex vivo brains of 14 male (10 TBI and 4 normal) rats using hybrid diffusion imaging. The estimated values of axon diameter and axonal volume fraction are in agreement with their corresponding histological measurements in normal brains, with 0.96 intra-class correlation coefficient value resulting from consistency analysis. Moreover, a significant increase (p = 0.001) in WXR and diameter and decrease in axonal volume fraction in the TBI boundary were detected in the TBI rats compared with the normal rats.	[Davoodi-Bojd, Esmaeil; Soltanian-Zadeh, Hamid] Univ Tehran, Sch Elect & Comp Engn, Tehran, Iran; [Davoodi-Bojd, Esmaeil; Chopp, Michael; Ding, Guangliang; Jiang, Quan] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael; Wang, Shiyang; Jiang, Quan] Oakland Univ, Dept Phys, Rochester, MI USA; [Soltanian-Zadeh, Hamid] Henry Ford Hosp, Dept Radiol, Image Anal Lab, Detroit, MI 48202 USA	University of Tehran; Henry Ford Health System; Henry Ford Hospital; Oakland University; Henry Ford Health System; Henry Ford Hospital	Jiang, Q (corresponding author), Henry Ford Hlth Syst, Dept Neurol, Detroit, MI 48202 USA.	qjiang1@hfhs.org	Soltanian-Zadeh, Hamid/AAD-7027-2022; Soltanian-Zadeh, Hamid/K-2903-2016	Soltanian-Zadeh, Hamid/0000-0002-7302-6856; Soltanian-Zadeh, Hamid/0000-0002-7302-6856; Ding, Guangliang/0000-0003-1286-5901	NIH [RO1 NS64134, RO1 AG037506, RO1 EB013227]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB013227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037506] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by NIH grants RO1 NS64134, RO1 AG037506, and RO1 EB013227. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DC, 2010, NEUROIMAGE, V52, P1374, DOI 10.1016/j.neuroimage.2010.05.043; Alexander DC, 2005, NEUROIMAGE, V27, P357, DOI 10.1016/j.neuroimage.2005.04.008; Alexander DC, 2005, ANN NY ACAD SCI, V1064, P113, DOI 10.1196/annals.1340.018; Alexander DC, 2004, COMP Q BALL PASMRI S, V90; Aslund I, 2009, J MAGN RESON, V200, P291, DOI 10.1016/j.jmr.2009.07.015; Assaf Y, 2004, MAGN RESON MED, V52, P965, DOI 10.1002/mrm.20274; Assaf Y, 2005, MEASUREMENT AXON DIA, V842; Assaf Y, 2008, MAGN RESON MED, V59, P1347, DOI 10.1002/mrm.21577; Avram L, 2004, J MAGN RESON, V169, P30, DOI 10.1016/j.jmr.2004.03.020; Barazany D, 2009, BRAIN, V132, P1210, DOI 10.1093/brain/awp042; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; CALLAGHAN PT, 1995, J MAGN RESON SER A, V113, P53, DOI 10.1006/jmra.1995.1055; CALLAGHAN PT, 1991, NATURE, V351, P467, DOI 10.1038/351467a0; Callaghan PT, 2004, J CHEM PHYS, V120, P4032, DOI 10.1063/1.1642604; Correia MM, 2011, NEUROIMAGE, V57, P1103, DOI 10.1016/j.neuroimage.2011.03.004; Davoodi-Bojd E, 2011, MAGN RESON IMAGING, V29, P1175, DOI 10.1016/j.mri.2011.07.006; Denk C, 2011, NMR BIOMED, V24, P246, DOI 10.1002/nbm.1581; Fieremans E, 2010, NMR BIOMED, V23, P711, DOI 10.1002/nbm.1577; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Hagslatt H, 2003, J MAGN RESON, V161, P138, DOI 10.1016/S1090-7807(02)00039-3; Harkins KD, 2009, MAGN RESON MED, V62, P1414, DOI 10.1002/mrm.22155; Hwang SN, 2003, MAGNET RESON MED, V50, P373, DOI 10.1002/mrm.10536; Jespersen SN, 2010, NEUROIMAGE, V49, P205, DOI 10.1016/j.neuroimage.2009.08.053; Jiang Q, 2006, NEUROIMAGE, V32, P1080, DOI 10.1016/j.neuroimage.2006.05.025; Jiang Q, 2011, NMR BIOMED, V24, P1119, DOI 10.1002/nbm.1667; Jiang Q, 2010, STROKE, V41, pS112, DOI 10.1161/STROKEAHA.110.595629; Jiang Q, 2010, STROKE, V41, P410, DOI 10.1161/STROKEAHA.109.568048; KARGER J, 1988, ADV MAGN RESON, P1; Karimi-Ashtiani S, 2010, I S BIOMED IMAGING, P1149, DOI 10.1109/ISBI.2010.5490197; Komlosh ME, 2011, J MAGN RESON, V208, P128, DOI 10.1016/j.jmr.2010.10.014; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Lasic S, 2011, MAGN RESON MED, V66, P356, DOI 10.1002/mrm.22782; Latt J, 2009, NMR BIOMED, V22, P619, DOI 10.1002/nbm.1376; Lawrenz M, 2010, J MAGN RESON, V202, P43, DOI 10.1016/j.jmr.2009.09.015; LEIBIG M, 1993, J PHYS A-MATH GEN, V26, P3349, DOI 10.1088/0305-4470/26/14/005; Lindenberg R, 2010, NEUROLOGY, V74, P280, DOI 10.1212/WNL.0b013e3181ccc6d9; Meier C, 2003, MAGN RESON MED, V50, P500, DOI 10.1002/mrm.10557; Momot KI, 2011, EUR BIOPHYS J BIOPHY, V40, P81, DOI 10.1007/s00249-010-0629-4; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; NEUMAN CH, 1974, J CHEM PHYS, V60, P4508, DOI 10.1063/1.1680931; Nilsson M, 2009, MAGN RESON IMAGING, V27, P176, DOI 10.1016/j.mri.2008.06.003; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Ozarslan E, 2005, MAGN RESON MED, V53, P866, DOI 10.1002/mrm.20411; Ozarslan E, 2003, MAGN RESON MED, V50, P955, DOI 10.1002/mrm.10596; Panagiotaki E, 2012, NEUROIMAGE, V59, P2241, DOI 10.1016/j.neuroimage.2011.09.081; Price WS, 1998, BIOPHYS J, V74, P2259, DOI 10.1016/S0006-3495(98)77935-4; Sen PN, 2005, MAGN RESON IMAGING, V23, P215, DOI 10.1016/j.mri.2004.11.014; Stanisz GJ, 1997, MAGNET RESON MED, V37, P103, DOI 10.1002/mrm.1910370115; Torres AM, 1998, MAGN RESON IMAGING, V16, P423, DOI 10.1016/S0730-725X(98)00005-8; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Tuch DS, 2003, NEURON, V40, P885, DOI 10.1016/S0896-6273(03)00758-X; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Wang SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063511; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Wu YC, 2007, NEUROIMAGE, V36, P617, DOI 10.1016/j.neuroimage.2007.02.050; Xu JZ, 2007, PHYS MED BIOL, V52, pN111, DOI 10.1088/0031-9155/52/7/N01; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072; Zhang H, 2011, NEUROIMAGE, V56, P1301, DOI 10.1016/j.neuroimage.2011.01.084; Zhou W, 2009, P 17 ANN M ISMRM HON, V17, P263	61	8	8	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e95921	10.1371/journal.pone.0095921	http://dx.doi.org/10.1371/journal.pone.0095921			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836290	gold, Green Submitted, Green Published			2022-12-27	WOS:000339614800012
J	Kline, KA; Schwartz, DJ; Gilbert, NM; Lewis, AL				Kline, Kimberly A.; Schwartz, Drew J.; Gilbert, Nicole M.; Lewis, Amanda L.			Impact of Host Age and Parity on Susceptibility to Severe Urinary Tract Infection in a Murine Model	PLOS ONE			English	Article							UROPATHOGENIC ESCHERICHIA-COLI; GROUP-B STREPTOCOCCUS; SIALIC-ACID; ASYMPTOMATIC BACTERIURIA; O-ACETYLATION; NEUTROPHIL RECRUITMENT; PREMENOPAUSAL WOMEN; RISK-FACTORS; ESTROGEN; MICE	The epidemiology and bacteriology of urinary tract infection (UTI) varies across the human lifespan, but the reasons for these differences are poorly understood. Using established monomicrobial and polymicrobial murine UTI models caused by uropathogenic Escherichia coli (UPEC) and/or Group B Streptococcus (GBS), we demonstrate age and parity as inter-related factors contributing to UTI susceptibility. Young nulliparous animals exhibited 10-100-fold higher bacterial titers compared to older animals. In contrast, multiparity was associated with more severe acute cystitis in older animals compared to age-matched nulliparous controls, particularly in the context of polymicrobial infection where UPEC titers were similar to 1000-fold higher in the multiparous compared to the nulliparous host. Multiparity was also associated with significantly increased risk of chronic high titer UPEC cystitis and ascending pyelonephritis. Further evidence is provided that the increased UPEC load in multiparous animals required TLR4-signaling. Together, these data strongly suggest that the experience of childbearing fundamentally and permanently changes the urinary tract and its response to pathogens in a manner that increases susceptibility to severe UTI. Moreover, this murine model provides a system for dissecting these and other lifespan-associated risk factors contributing to severe UTI in at-risk groups.	[Kline, Kimberly A.] Nanyang Technol Univ, Sch Biol Sci, Singapore Ctr Environm Life Sci Engn, Singapore 639798, Singapore; [Kline, Kimberly A.; Schwartz, Drew J.; Gilbert, Nicole M.; Lewis, Amanda L.] Washington Univ, Sch Med, Dept Mol Microbiol, Ctr Womens Infect Dis Res, St Louis, MO 63110 USA	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Washington University (WUSTL)	Kline, KA (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore Ctr Environm Life Sci Engn, Singapore 639798, Singapore.	kkline@ntu.edu.sg; allewis@wustl.edu	Schwartz, Drew/AAN-7742-2021; Kline, Kimberly/H-1589-2011	Schwartz, Drew/0000-0003-1568-7733; Kline, Kimberly/0000-0002-5472-3074; Gilbert, Nicole/0000-0003-4830-3257	National Research Foundation; Ministry of Education Singapore under its Research Centre of Excellence Programme; National Research Foundation under its Singapore NRF Fellowship programme; American Heart Association postdoctoral fellowship; NIH [R21DK092586, P50 DK064540-11]; NCRR [C06RR012466];  [F30 DK096751]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK096751, R21DK092586, P50DK064540] Funding Source: NIH RePORTER	National Research Foundation; Ministry of Education Singapore under its Research Centre of Excellence Programme(Ministry of Education, Singapore); National Research Foundation under its Singapore NRF Fellowship programme(National Research Foundation, Singapore); American Heart Association postdoctoral fellowship(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the National Research Foundation and Ministry of Education Singapore under its Research Centre of Excellence Programme and the National Research Foundation under its Singapore NRF Fellowship programme (K. A. K.). This work was also supported by a predoctoral fellowship F30 DK096751 (D.J.S.), an American Heart Association postdoctoral fellowship (N.G.), and NIH grants R21DK092586 (to A. L.) and P50 DK064540-11 (A. L. Co-Investigator). Finally, the animal work performed in this manuscript was performed in a facility supported by NCRR grant C06RR012466. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GG, 2003, SCIENCE, V301, P105, DOI 10.1126/science.1084550; BACHMAN JW, 1993, JAMA-J AM MED ASSOC, V270, P1971, DOI 10.1001/jama.270.16.1971; BERNSTEIN L, 1985, J NATL CANCER I, V74, P741; Cai T, 2012, CLIN INFECT DIS, V55, P771, DOI 10.1093/cid/cis534; Curran EM, 2007, J INFECT DIS, V195, P680, DOI 10.1086/511275; Doran KS, 2003, J CLIN INVEST, V112, P736, DOI 10.1172/JCI200317335; DORGAN JF, 1995, CANCER EPIDEM BIOMAR, V4, P381; Dwyer PL, 2002, CURR OPIN OBSTET GYN, V14, P537, DOI 10.1097/00001703-200210000-00016; EDEN CS, 1984, INFECTION, V12, P118, DOI 10.1007/BF01641692; Edwards MS, 2005, CLIN INFECT DIS, V41, P839, DOI 10.1086/432804; Fonti Ylenia, 2009, J Prenat Med, V3, P57; Foxman B, 2003, DM-DIS MON, V49, P53, DOI 10.1067/mda.2003.7; Foxman B, 2001, J CLIN EPIDEMIOL, V54, P710, DOI 10.1016/S0895-4356(00)00352-8; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; Grandadam F, 1999, BJU INT, V84, P861; Griebling T, 2007, URINARY TRACT INFECT; Guiton PS, 2012, ANTIMICROB AGENTS CH, V56, P4738, DOI 10.1128/AAC.00447-12; HAGBERG L, 1984, INFECT IMMUN, V46, P839, DOI 10.1128/IAI.46.3.839-844.1984; Haider G, 2010, J PAK MED ASSOC, V60, P213; Hannan TJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001042; Haraoka M, 1999, J INFECT DIS, V180, P1220, DOI 10.1086/315006; Hextall A, 2000, MATURITAS, V36, P83, DOI 10.1016/S0378-5122(00)00143-2; Hopkins WJ, 1998, INFECT IMMUN, V66, P2798, DOI 10.1128/IAI.66.6.2798-2802.1998; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hull R, 2000, J UROLOGY, V163, P872, DOI 10.1016/S0022-5347(05)67823-8; HULTGREN SJ, 1986, INFECT IMMUN, V54, P613, DOI 10.1128/IAI.54.3.613-620.1986; Hung CS, 2009, NAT PROTOC, V4, P1230, DOI 10.1038/nprot.2009.116; Jackson SL, 2004, AM J MED, V117, P903, DOI 10.1016/j.amjmed.2004.07.045; Justice SS, 2004, P NATL ACAD SCI USA, V101, P1333, DOI 10.1073/pnas.0308125100; Kline KA, 2012, INFECT IMMUN, V80, P4186, DOI 10.1128/IAI.00684-12; Kline KA, 2011, INFECT IMMUN, V79, P3588, DOI 10.1128/IAI.00122-11; Kline KA, 2010, INFECT IMMUN, V78, P1943, DOI 10.1128/IAI.01235-09; Lewis AL, 2006, J BIOL CHEM, V281, P11186, DOI 10.1074/jbc.M513772200; Lewis AL, 2004, P NATL ACAD SCI USA, V101, P11123, DOI 10.1073/pnas.0403010101; Lewis AL, 2007, J BIOL CHEM, V282, P27562, DOI 10.1074/jbc.M700340200; Luthje P, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005574; Matthews SJ, 2011, AM J GERIATR PHARMAC, V9, P286, DOI 10.1016/j.amjopharm.2011.07.002; Mazor-Dray E, 2009, J MATERN-FETAL NEO M, V22, P124, DOI 10.1080/14767050802488246; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Mysorekar IU, 2006, P NATL ACAD SCI USA, V103, P14170, DOI 10.1073/pnas.0602136103; Nicolle LE, 1997, INFECT DIS CLIN N AM, V11, P647, DOI 10.1016/S0891-5520(05)70378-0; OLD DC, 1970, J BACTERIOL, V103, P447, DOI 10.1128/JB.103.2.447-456.1970; ORLANDER JD, 1992, J AM GERIATR SOC, V40, P817, DOI 10.1111/j.1532-5415.1992.tb01855.x; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Raz R, 2011, KOREAN J UROL, V52, P801, DOI 10.4111/kju.2011.52.12.801; Ronald A, 2003, DM-DIS MON, V49, P71, DOI 10.1067/mda.2003.8; Rosen DA, 2008, INFECT IMMUN, V76, P4290, DOI 10.1128/IAI.00255-08; Rozenberg S, 2004, INT J FERTIL WOMEN M, V49, P71; RYHAMMER AM, 1995, DIS COLON RECTUM, V38, P1206, DOI 10.1007/BF02048338; Rymkiewicz PD, 2012, IMMUNOL RES, V53, P235, DOI 10.1007/s12026-012-8289-3; Schilling JD, 2003, P NATL ACAD SCI USA, V100, P4203, DOI 10.1073/pnas.0736473100; Schilling JD, 2001, J IMMUNOL, V166, P1148, DOI 10.4049/jimmunol.166.2.1148; SHAHIN RD, 1987, J IMMUNOL, V138, P3475; Sheiner E, 2009, J MATERN-FETAL NEO M, V22, P423, DOI 10.1080/14767050802360783; Stamm WE, 1999, CLIN INFECT DIS, V28, P723, DOI 10.1086/515209; Sunden F, 2006, INT J ANTIMICROB AG, V28, pS26, DOI 10.1016/j.ijantimicag.2006.05.007; TERPENNING MS, 1991, GERIATRICS, V46, P77; Thumbikat P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000415; Trivalle C, 1998, J MED MICROBIOL, V47, P649, DOI 10.1099/00222615-47-7-649; Wang CH, 2013, INFECT IMMUN, V81, P733, DOI 10.1128/IAI.01234-12; Weiman S, 2010, BIOCHEM J, V428, P163, DOI 10.1042/BJ20100232; WEISSENBACHER ER, 1993, CURR OPIN OBSTET GYN, V5, P513; Wright KJ, 2005, INFECT IMMUN, V73, P7657, DOI 10.1128/IAI.73.11.7657-7668.2005; Wullt B, 2003, INT J ANTIMICROB AG, V21, P604, DOI 10.1016/S0924-8579(02)00327-8	65	22	22	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97798	10.1371/journal.pone.0097798	http://dx.doi.org/10.1371/journal.pone.0097798			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835885	Green Published, gold			2022-12-27	WOS:000339614800069
J	Nofiele, JT; Cheng, HLM				Nofiele, Joris Tchouala; Cheng, Hai-Ling Margaret			Establishment of a Lung Metastatic Breast Tumor Xenograft Model in Nude Rats	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; MRI	Objective: Larger animal models provide relevant tumor burden in the development of advanced clinical imaging methods for non-invasive cancer detection and diagnosis, and are especially valuable for studying metastatic disease. Most available experimental models, however, are based on immune-compromised mice. To lay the foundation for studying spontaneous metastasis using non-invasive magnetic resonance imaging (MRI), this study aims to establish a highly metastatic breast cancer xenograft model in nude rats. Materials and Methods: A highly metastatic variant of human adenocarcinoma MDA-MB-231 known as LM2 was inoculated into nude rats. Orthotopic and subcutaneous (flank) sites were compared, with half of the orthotopic injections guided by ultrasound imaging. MRI with gadolinium contrast administration was performed weekly beginning on Day 6 and ending on Day 104. Excised tumors were assessed on histology using hematoxylin and eosin and CD34. Fisher's exact test was used to compare successful tumor induction amongst different inoculation methods. Results: Primary LM2 tumors were established orthotopically in all cases under ultrasound-guided injection, and none otherwise (p = 0.0028). Contrast-enhanced MRI revealed rapidly progressing tumors that reached critical size (15 mm diameter) in 2 to 3 weeks after inoculation. MRI and histology findings were consistent: LM2 tumors were characterized by low vascularity confined to the tumor rim and large necrotic cores with increasing interstitial fluid pressure. Conclusions: The metastatic LM2 breast tumor model was successfully established in the mammary fat pads of nude rats, using ultrasound needle guidance as a non-invasive alternative to surgery. This platform lays the foundation for future development and application of MRI to study spontaneous metastasis and different stages throughout the metastatic cascade.	[Nofiele, Joris Tchouala; Cheng, Hai-Ling Margaret] Hosp Sick Children, Res Inst & Diagnost Imaging, Toronto, ON M5G 1X8, Canada; [Nofiele, Joris Tchouala; Cheng, Hai-Ling Margaret] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Cheng, Hai-Ling Margaret] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Cheng, Hai-Ling Margaret] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto	Cheng, HLM (corresponding author), Hosp Sick Children, Res Inst & Diagnost Imaging, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	hailing.cheng@utoronto.ca	Cheng, Hai-Ling Margaret/E-5551-2011	Cheng, Hai-Ling Margaret/0000-0002-0733-9512	Natural Sciences and Engineering Research Council of Canada [355795]; Garron Family Cancer Centre Grant through the SickKids Foundation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Garron Family Cancer Centre Grant through the SickKids Foundation	This study was supported by funding from the Natural Sciences and Engineering Research Council of Canada (#355795) and the Garron Family Cancer Centre Grant through the SickKids Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan HH, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-83; Cheng HLM, 2008, J MAGN RESON IMAGING, V28, P736, DOI 10.1002/jmri.21489; Cheng HLM, 2009, J MAGN RESON IMAGING, V30, P864, DOI 10.1002/jmri.21916; Cheng HLM, 2006, MAGN RESON MED, V55, P566, DOI 10.1002/mrm.20791; Daenen LG, 2009, MOL CANCER THER, V8, P2872, DOI 10.1158/1535-7163.MCT-09-0583; Dickinson L, 2013, J MAGN RESON IMAGING, V37, P48, DOI 10.1002/jmri.23689; Guo Y, 2011, AM J TRANSL RES, V3, P114; HUGGINS C, 1961, NATURE, V189, P204, DOI 10.1038/189204a0; Lederle W, 2012, CURR PHARM BIOTECHNO, V13, P595, DOI 10.2174/138920112799436348; Medina-Ramirez CM, 2011, CANCER RES, V71, P7705, DOI 10.1158/0008-5472.CAN-11-2192; MEHTA RR, 1993, BREAST CANCER RES TR, V25, P65, DOI 10.1007/BF00662402; Munoz R, 2006, CANCER RES, V66, P3386, DOI 10.1158/0008-5472.CAN-05-4411; Olsen OE, 2013, ACTA RADIOL, V54, P1030, DOI 10.1177/0284185113494038; Punwani S, 2011, EUR J RADIOL, V78, P2, DOI 10.1016/j.ejrad.2010.03.010; RUSSO J, 1990, LAB INVEST, V62, P244; Russo J, 2000, J MAMMARY GLAND BIOL, V5, P187, DOI 10.1023/A:1026443305758; Thompson SM, 2013, CARDIOVASC INTER RAD, V36, P198, DOI 10.1007/s00270-012-0466-1	17	9	9	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97950	10.1371/journal.pone.0097950	http://dx.doi.org/10.1371/journal.pone.0097950			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835641	Green Submitted, Green Published, gold			2022-12-27	WOS:000339614800091
J	Tang, K; Li, H; Xia, D; Hu, ZQ; Zhuang, QY; Liu, JH; Xu, H; Ye, ZQ				Tang, Kun; Li, Heng; Xia, Ding; Hu, Zhiquan; Zhuang, Qianyuan; Liu, Jihong; Xu, Hua; Ye, Zhangqun			Laparoscopic versus Open Radical Cystectomy in Bladder Cancer: A Systematic Review and Meta-Analysis of Comparative Studies	PLOS ONE			English	Review							CONTEMPORARY SERIES; ILEAL NEOBLADDER; COMPLICATIONS; EXPERIENCE; MANAGEMENT; THERAPY; IMPACT	Background and Objective: More recently laparoscopic radical cystectomy (LRC) has increasingly been an attractive alternative to open radical cystectomy (ORC) and many centers have reported their early experiences in the treatment of bladder cancer. Evaluate the safety and efficacy of LRC compared with ORC in the treatment of bladder cancer. Methods: A systematic search of Medline, Scopus, and the Cochrane Library was performed up to Mar 1, 2013. Outcomes of interest assessing the two techniques included demographic and clinical baseline characteristics, perioperative, pathologic and oncological variables, and post-op neobladder function and complications. Results: Sixteen eligible trials evaluating LRC vs ORC were identified including seven prospective and nine retrospective studies. Although LRC was associated with longer operative time (p<0.001), patients might benefit from significantly fewer overall complications (p<0.001), less blood loss (p<0.001), shorter length of hospital stay (p<0.001), less need of blood transfusion (p<0.001), less narcotic analgesic requirement (p<0.001), shorter time to ambulation (p = 0.03), shorter time to regular diet (p<0.001), fewer positive surgical margins (p = 0.006), fewer positive lymph node (p = 0.05), lower distant metastasis rate (p = 0.05) and fewer death (p = 0.004). There was no significant difference in other demographic parameters except for a lower ASA score (p = 0.01) in LRC while post-op neobladder function were similar between the two groups. Conclusions: Our data suggest that LRC appears to be a safe, feasible and minimally invasive alternative to ORC with reliable perioperative safety, pathologic & oncologic efficacy, comparable post-op neobladder function and fewer complications. Because of the inherent limitations of the included studies, further large sample prospective, multi-centric, long-term follow-up studies and randomized control trials should be undertaken to confirm our findings.	[Tang, Kun; Li, Heng; Xia, Ding; Hu, Zhiquan; Zhuang, Qianyuan; Liu, Jihong; Xu, Hua; Ye, Zhangqun] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Urol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Xu, H (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Urol, Wuhan 430074, Peoples R China.	xuhua@mail.hust.edu.cn	Tang, Kun/GSD-3218-2022	Tang, Kun/0000-0002-8418-143X				Akin Y, 2013, EVALUATION OPEN LAPA; Basillote JB, 2004, J UROLOGY, V172, P489, DOI 10.1097/01.ju.0000129662.83162.2e; Buscarini M, 2007, UROL INT, V79, P191, DOI 10.1159/000107949; Challacombe BJ, 2011, EUR UROL, V60, P767, DOI 10.1016/j.eururo.2011.05.012; Chang SS, 2001, J UROLOGY, V166, P2151, DOI 10.1016/S0022-5347(05)65524-3; Clarke M, 2001, LANCET, V357, P1728, DOI 10.1016/S0140-6736(00)04934-5; Donat SM, 2009, EUR UROL, V55, P177, DOI 10.1016/j.eururo.2008.07.018; Donat SM, 2007, UROLOGY, V69, P221, DOI 10.1016/j.urology.2006.09.056; Fairey AS, 2009, J UROLOGY, V182, P85, DOI 10.1016/j.juro.2008.11.111; Ghazi A, 2010, EUR UROL, V57, P71, DOI 10.1016/j.eururo.2009.06.024; Gore JL, 2010, JNCI-J NATL CANCER I, V102, P802, DOI 10.1093/jnci/djq121; Guillotreau J, 2009, J UROLOGY, V181, P554, DOI 10.1016/j.juro.2008.10.011; Ha US, 2010, INT J UROL, V17, P55, DOI 10.1111/j.1442-2042.2009.02425.x; Haber GP, 2008, EUR UROL, V54, P54, DOI 10.1016/j.eururo.2008.03.076; Hautmann RE, 2006, WORLD J UROL, V24, P305, DOI 10.1007/s00345-006-0105-z; Hautmann RE, 2009, CURR OPIN UROL, V19, P522, DOI 10.1097/MOU.0b013e32832d9564; Hemal AK, 2007, J UROLOGY, V178, P2340, DOI 10.1016/j.juro.2007.08.020; Herr HW, 2002, J UROLOGY, V167, P1295, DOI 10.1016/S0022-5347(05)65284-6; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Huang Jian, 2008, Zhonghua Wai Ke Za Zhi, V46, P1870; Huang Jian HH, 2005, CHIN J UROL, V26, P4; Kauffman EC, 2010, BJU INT, V105, P520, DOI 10.1111/j.1464-410X.2009.08843.x; Kaufman DS, 2009, LANCET, V374, P239, DOI 10.1016/S0140-6736(09)60491-8; Khan MS, 2012, INT J CLIN PRACT, V66, P656, DOI 10.1111/j.1742-1241.2011.02888.x; Konety BR, 2006, UROLOGY, V68, P58, DOI 10.1016/j.urology.2006.01.051; Kulkarni JN, 2003, BJU INT, V91, P485, DOI 10.1046/j.1464-410X.2003.04131.x; Kulovac Benjamin, 2005, Med Arh, V59, P358; Madersbacher S, 2003, J CLIN ONCOL, V21, P690, DOI 10.1200/JCO.2003.05.101; Meyer JP, 2009, BJU INT, V103, P680, DOI 10.1111/j.1464-410X.2008.08204.x; Minhong W, 2010, COMP SHORT TERM CLIN; Murphy DG, 2008, EUR UROL, V54, P570, DOI 10.1016/j.eururo.2008.04.011; Novara G, 2009, J UROLOGY, V182, P914, DOI 10.1016/j.juro.2009.05.032; Novotny V, 2007, EUR UROL, V51, P397, DOI 10.1016/j.eururo.2006.06.014; PARRA RO, 1992, J UROLOGY, V148, P1140, DOI 10.1016/S0022-5347(17)36843-X; Phillips B, 2004, ARCH DIS CHILD, V89, P489, DOI 10.1136/adc.2004.050898; Porpiglia F, 2007, J ENDOUROL, V21, P325, DOI 10.1089/end.2006.0224; Quek ML, 2005, J UROLOGY, V174, P93, DOI 10.1097/01.ju.0000162085.20043.1f; Shariat SF, 2006, J UROLOGY, V176, P2414, DOI 10.1016/j.juro.2006.08.004; Shariat SF, 2013, EUR UROL, V63, P371, DOI 10.1016/j.eururo.2012.06.008; Stein JP, 2009, J UROLOGY, V181, P2052, DOI 10.1016/j.juro.2009.01.020; Stein JP, 2001, J CLIN ONCOL, V19, P666, DOI 10.1200/JCO.2001.19.3.666; Taylor GD, 2004, J UROLOGY, V172, P1291, DOI 10.1097/01.ju.0000139319.41837.0c; Volkmer BG, 2009, J UROLOGY, V181, P93; Volkmer BG, 2009, J UROLOGY, V181, P1587, DOI 10.1016/j.juro.2008.11.112; Wang SZ, 2010, WORLD J UROL, V28, P451, DOI 10.1007/s00345-010-0571-1; Wang SZ, 2010, UROL INT, V84, P28, DOI 10.1159/000273462; Witjes JA, 2014, EUR UROL, V65, P778, DOI 10.1016/j.eururo.2013.11.046; Ws Jin Ting, 2012, ZHEJIANG MEDCINE, V34, P3; Zhang J, 2010, RADICAL CYSTECTOMY B; Zheng Wei, 2012, Beijing Da Xue Xue Bao Yi Xue Ban, V44, P558	50	64	71	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e95667	10.1371/journal.pone.0095667	http://dx.doi.org/10.1371/journal.pone.0095667			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835573	gold, Green Submitted, Green Published			2022-12-27	WOS:000339614800009
J	Velsko, IM; Chukkapalli, SS; Rivera, MF; Lee, JY; Chen, H; Zheng, DH; Bhattacharyya, I; Gangula, PR; Lucas, AR; Kesavalu, L				Velsko, Irina M.; Chukkapalli, Sasanka S.; Rivera, Mercedes F.; Lee, Ju-Youn; Chen, Hao; Zheng, Donghang; Bhattacharyya, Indraneel; Gangula, Pandu R.; Lucas, Alexandra R.; Kesavalu, Lakshmyya			Active Invasion of Oral and Aortic Tissues by Porphyromonas gingivalis in Mice Causally Links Periodontitis and Atherosclerosis	PLOS ONE			English	Article							ALVEOLAR BONE-RESORPTION; SITU HYBRIDIZATION FISH; ATHEROMATOUS PLAQUES; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; DIRECT VISUALIZATION; IMMUNE-RESPONSE; NITRIC-OXIDE; RAT MODEL; PATHOGENS; INFLAMMATION	Atherosclerotic vascular disease is a leading cause of myocardial infarction and cerebrovascular accident, and independent associations with periodontal disease (PD) are reported. PD is caused by polymicrobial infections and aggressive immune responses. Genomic DNA of Porphyromonas gingivalis, the best-studied bacterial pathogen associated with severe PD, is detected within atherosclerotic plaque. We examined causal relationships between chronic P. gingivalis oral infection, PD, and atherosclerosis in hyperlipidemic ApoE(null) mice. ApoE(null) mice (n = 24) were orally infected with P. gingivalis for 12 and 24 weeks. PD was assessed by standard clinical measurements while the aorta was examined for atherosclerotic lesions and inflammatory markers by array. Systemic inflammatory markers serum amyloid A, nitric oxide, and oxidized low-density lipoprotein were analyzed. P. gingivalis infection elicited specific antibodies and alveolar bone loss. Fluorescent in situ hybridization detected viable P. gingivalis within oral epithelium and aorta, and genomic DNA was detected within systemic organs. Aortic plaque area was significantly increased in P. gingivalis-infected mice at 24 weeks (P<0.01). Aortic RNA and protein arrays indicated a strong Th2 response. Chronic oral infection with P. gingivalis results in a specific immune response, significant increases in oral bone resorption, aortic inflammation, viable bacteria in oral epithelium and aorta, and plaque development.	[Velsko, Irina M.; Chukkapalli, Sasanka S.; Rivera, Mercedes F.; Kesavalu, Lakshmyya] Univ Florida, Dept Periodontol, Gainesville, FL 32611 USA; [Kesavalu, Lakshmyya] Univ Florida, Dept Oral Biol, Gainesville, FL 32610 USA; [Lee, Ju-Youn] Pusan Natl Univ, Sch Dent, Dept Periodontol, Yangsan, South Korea; [Chen, Hao; Zheng, Donghang; Lucas, Alexandra R.] Univ Florida, Dept Cardiovasc Med & Mol Genet & Microbiol, Gainesville, FL USA; [Bhattacharyya, Indraneel] Univ Florida, Dept Oral Diagnost Sci, Gainesville, FL USA; [Gangula, Pandu R.] CWHR Meharry Med Coll, Dept Physiol Oral Biol & Res, Nashville, TN USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Pusan National University; Pusan National University Hospital; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Meharry Medical College	Kesavalu, L (corresponding author), Univ Florida, Dept Periodontol, Gainesville, FL 32611 USA.	Kesavalu@dental.ufl.edu	Stefanadis, Christodoulos/ABH-2232-2020; Bhattacharyya, Indraneel/U-7752-2019	Stefanadis, Christodoulos/0000-0001-5974-6454; 	NIH National Institute for Dental and Craniofacial Research [R01DE020820]; NIH National Center for Research Resources [1U54RR026140-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE020820] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007593] Funding Source: NIH RePORTER	NIH National Institute for Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by NIH National Institute for Dental and Craniofacial Research (R01DE020820; Dr. Kesavalu); NIH National Center for Research Resources (1U54RR026140-01; Dr. Gangula). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimetti M, 2007, J PERIODONTOL, V78, P1718, DOI 10.1902/jop.2007.060473; Allen JD, 2012, NITRIC OXIDE-BIOL CH, V26, P217, DOI 10.1016/j.niox.2012.03.003; Bainbridge B, 2010, INFECT IMMUN, V78, P4560, DOI 10.1128/IAI.00703-10; Brodala N, 2005, ARTERIOSCL THROM VAS, V25, P1446, DOI 10.1161/01.ATV.0000167525.69400.9c; Cairo F, 2004, J PERIODONTAL RES, V39, P442, DOI 10.1111/j.1600-0765.2004.00761.x; Carrion J, 2012, J IMMUNOL, V189, P3178, DOI 10.4049/jimmunol.1201053; Cavrini F, 2005, J MED MICROBIOL, V54, P93, DOI 10.1099/jmm.0.45845-0; Fiehn NE, 2005, J PERIODONTOL, V76, P731, DOI 10.1902/jop.2005.76.5.731; Fuchs BM., 2007, METHODS GEN MOL MICR, V5, P886; Fukasawa A, 2012, IMMUNOPHARM IMMUNOT, V34, P470, DOI 10.3109/08923973.2011.627866; Gibson FC, 2004, CIRCULATION, V109, P2801, DOI 10.1161/01.CIR.0000129769.17895.F0; Gibson FC, 2006, J DENT RES, V85, P106, DOI 10.1177/154405910608500202; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Haraszthy VI, 2000, J PERIODONTOL, V71, P1; Hayashi C, 2011, ATHEROSCLEROSIS, V215, P52, DOI 10.1016/j.atherosclerosis.2010.12.009; Hayashi C, 2010, J INNATE IMMUN, V2, P334, DOI 10.1159/000314686; Holt SC, 1999, PERIODONTOL 2000, V20, P168, DOI 10.1111/j.1600-0757.1999.tb00162.x; Kamath S, 2003, QJM-INT J MED, V96, P711, DOI 10.1093/qjmed/hcg129; Kesavalu L, 2007, INFECT IMMUN, V75, P1704, DOI 10.1128/IAI.00733-06; Kozarov EV, 2005, ARTERIOSCL THROM VAS, V25, pE17, DOI 10.1161/01.ATV.0000155018.67835.1a; Lalla E, 2003, ARTERIOSCL THROM VAS, V23, P1405, DOI 10.1161/01.ATV.0000082462.26258.FE; Lockhart PB, 2012, CIRCULATION, V125, P2520, DOI 10.1161/CIR.0b013e31825719f3; Manz W, 1999, METHOD ENZYMOL, V310, P79; Moter A, 2000, J MICROBIOL METH, V41, P85, DOI 10.1016/S0167-7012(00)00152-4; Paquette DW, 2007, PERIODONTOL 2000, V44, P113, DOI 10.1111/j.1600-0757.2006.00196.x; Progulske-Fox A, 2004, J PERIODONTAL RES, P1; Rafferty B, 2011, J INTERN MED, V270, P273, DOI 10.1111/j.1365-2796.2011.02373.x; Rivera MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057178; Rudney JD, 2005, J DENT RES, V84, P59, DOI 10.1177/154405910508400110; Sunde PT, 2003, MICROBIOL-SGM, V149, P1095, DOI 10.1099/mic.0.26077-0; Tousoulis D, 2012, CURR VASC PHARMACOL, V10, P4, DOI 10.2174/157016112798829760; Trevisan M, 2010, MEDITERR J HEMATOL I, V2, DOI 10.4084/MJHID.2010.030; Vasquez EC, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-22; Verma RK, 2010, ORAL DIS, V16, P686, DOI 10.1111/j.1601-0825.2010.01678.x; Verma RK, 2010, INTERDISCIP PERSPECT, V2010, DOI DOI 10.1155/2010/605125; Wada K, 2010, PERIODONTOL 2000, V54, P222, DOI 10.1111/j.1600-0757.2009.00336.x; Yilmaz O, 2006, INFECT IMMUN, V74, P703, DOI 10.1128/IAI.74.1.703-710.2006; Yilmaz O, 2008, CELL MICROBIOL, V10, P863, DOI 10.1111/j.1462-5822.2007.01089.x	38	107	110	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97811	10.1371/journal.pone.0097811	http://dx.doi.org/10.1371/journal.pone.0097811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836175	Green Published, Green Submitted, gold			2022-12-27	WOS:000339614800070
J	Ji, ZH; Wang, TC; Shao, ZJ; Huang, DH; Wang, AH; Guo, ZW; Long, Y; Zhang, L; Su, HX; Zhang, Q; Yan, YP; Fan, DM				Ji, Zhaohua; Wang, Tingcai; Shao, Zhongjun; Huang, Dahong; Wang, Anhui; Guo, Zhiwen; Long, Yong; Zhang, Lei; Su, Haixia; Zhang, Qi; Yan, Yongping; Fan, Daiming			A Population-Based Study Examining Hepatitis B Virus Infection and Immunization Rates in Northwest China	PLOS ONE			English	Article							UNITED-STATES; RISK-FACTORS; VACCINATION; PREVENTION; IMPACT	Background and Aim: Current baseline data regarding the prevalence of hepatitis B virus (HBV) infections and the immune status in hyperendemic areas is necessary in evaluating the effectiveness of ongoing HBV prevention and control programs in northwest China. This study aims to determine the prevalence of chronic HBV infections, past exposure rates, and immune response profiles in Wuwei City, northwest China in 2010. Methods: Cross-sectional household survey representative of the Wuwei City population. 28,579 participants were interviewed in the seroepidemiological survey >= 1 year of age. House to house screening was conducted using a standard questionnaire. All serum samples were screened by enzyme-linked immunoassays for the presence of hepatitis B surface antigen, antibodies against HBV surface antigen, and antibodies to the hepatitis B core antigen. Results: Among individuals >= 1 year of age, 7.2% (95% CI: 6.3-8.1%) had chronic HBV infections, 43.9% (CI: 40.4-47.4%) had been exposed to HBV, and 23.49% (CI: 21.6-25.3%) had vaccine-induced immunity. Multi-factor weighted logistic regression analysis showed that having household contact with HBV carriers (OR = 2.6, 95% CI: 2.3-3.0) and beauty treatments in public places (OR = 1.2, 95% CI: 1.1-1.3) were the risk factors of HBV infection in whole population. Having household contact with HBV carriers (OR = 3.8, 95% CI: 2.2-6.5) and lack of hepatitis vaccination (OR = 2.0, 95% CI: 1.4-3.3) were the risk factors for HBV infection in children aged 1-14 years. Conclusions: Hepatitis B infection remains a serious public health problem in northwest China. Having household contact with HBV carriers and beauty treatments in public places represented HBV infection risk factors. Hepatitis B vaccine immunization strategies need further improvement, particularly by targeting the immunization of rural migrant workers.	[Ji, Zhaohua; Shao, Zhongjun; Wang, Anhui; Long, Yong; Zhang, Lei; Su, Haixia; Zhang, Qi; Yan, Yongping] Fourth Mil Med Univ, Sch Publ Hlth, Dept Epidemiol, Xian 710032, Peoples R China; [Ji, Zhaohua; Shao, Zhongjun; Wang, Anhui; Long, Yong; Zhang, Lei; Su, Haixia; Zhang, Qi; Yan, Yongping] Fourth Mil Med Univ, Sch Publ Hlth, Minist Educ, Key Lab Hazard Assessment & Control Special Opera, Xian 710032, Peoples R China; [Wang, Tingcai; Huang, Dahong; Guo, Zhiwen] Wuwei Municipal Ctr Dis Control & Prevent, Chongzuo, Gansu, Peoples R China; [Fan, Daiming] Fourth Mil Med Univ, Xijing Hosp Digest Dis, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Yan, YP (corresponding author), Fourth Mil Med Univ, Sch Publ Hlth, Dept Epidemiol, Xian 710032, Peoples R China.	yanyping@fmmu.edu.cn; fandaim@fmmu.edu.cn	Yan, Yongping/K-9634-2019	Su, Haixia/0000-0002-1154-8077	China Special Grant for the Prevention and Control of Infectious Diseases [2009ZX10002-027, 2012ZX10004907]	China Special Grant for the Prevention and Control of Infectious Diseases	This study was supported by the China Special Grant for the Prevention and Control of Infectious Diseases (2009ZX10002-027 and 2012ZX10004907): Infectious disease prevention and control in endemic areas and epidemiological studies of viral hepatitis B in Wuwei City. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTER MJ, 1990, MED CLIN N AM, V74, P1529, DOI 10.1016/S0025-7125(16)30493-X; Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P441; [Anonymous], REP INC RAT HEP B CH; [Anonymous], 2009, CHIN HLTH STAT DIG; Cui F, 2008, CHINESE J VACCINES I, P413; Cui FQ, 2007, VACCINE, V25, P664, DOI 10.1016/j.vaccine.2006.08.027; Ding X, 2001, INTERVIROLOGY, V44, P43, DOI 10.1159/000050029; Goldstein ST, 2005, INT J EPIDEMIOL, V34, P1329, DOI 10.1093/ije/dyi206; Hu XUJ, 2008, LANCET, V372, P1717, DOI 10.1016/S0140-6736(08)61360-4; Ioannou GN, 2011, ANN INTERN MED, V154, P319, DOI 10.7326/0003-4819-154-5-201103010-00006; Li C, 2012, J TRANSL MED, V10, P2214; Li F, 2012, VACCINE, V30, P7118, DOI 10.1016/j.vaccine.2012.09.031; Li JH, 2004, SOC SCI MED, V59, P695, DOI 10.1016/j.socscimed.2003.11.041; Li Z, 2012, CHINESE J EPIDEMIOLO, V33, P305; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Liang XF, 2009, J INFECT DIS, V200, P39, DOI 10.1086/599332; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Liu C, 2011, WORLD J GASTROENTERO, V17, P3054, DOI 10.3748/wjg.v17.i25.3054; Liu J, 2007, LANCET, V369, P1582, DOI 10.1016/S0140-6736(07)60723-5; Liu L, 2011, INT J CANCER, V128, P1692, DOI 10.1002/ijc.25488; Lu FM, 2010, J VIRAL HEPATITIS, V17, P4, DOI 10.1111/j.1365-2893.2010.01266.x; Poland GA, 2004, NEW ENGL J MED, V351, P2832, DOI 10.1056/NEJMcp041507; Shang G, 2007, TRANSFUSION, V47, P529, DOI 10.1111/j.1537-2995.2006.01146.x; Shao ZJ, 2011, J MED VIROL, V83, P791, DOI 10.1002/jmv.22043; Sun ZT, 2002, J MED VIROL, V67, P447, DOI 10.1002/jmv.10094; Wang FZ, 2007, CHINESE J VACCINES I, V13, P309; Wasley A, 2010, J INFECT DIS, V202, P192, DOI 10.1086/653622; Xin D, 2003, JPN J INFECT DIS, V56, P19; Yongri T, 2005, CLIN HEPATOLOGY, V21, P28; Zanetti AR, 2008, VACCINE, V26, P6266, DOI 10.1016/j.vaccine.2008.09.056; Zhang HW, 2008, GUT, V57, P1713, DOI 10.1136/gut.2008.157149; Zhang L, 2010, INT J INFECT DIS, V14, pE483, DOI 10.1016/j.ijid.2009.08.005; Zhang Wei, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P767; Zhang Wei, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P918	34	27	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97474	10.1371/journal.pone.0097474	http://dx.doi.org/10.1371/journal.pone.0097474			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24832483	Green Submitted, Green Published, gold			2022-12-27	WOS:000336789500063
J	Zayas-Santiago, A; Agte, S; Rivera, Y; Benedikt, J; Ulbricht, E; Karl, A; Davila, J; Savvinov, A; Kucheryavykh, Y; Inyushin, M; Cubano, LA; Pannicke, T; Veh, RW; Francke, M; Verkhratsky, A; Eaton, MJ; Reichenbach, A; Skatchkov, SN				Zayas-Santiago, Astrid; Agte, Silke; Rivera, Yomarie; Benedikt, Jan; Ulbricht, Elke; Karl, Anett; Davila, Jose; Savvinov, Alexey; Kucheryavykh, Yuriy; Inyushin, Mikhail; Cubano, Luis A.; Pannicke, Thomas; Veh, Ruediger W.; Francke, Mike; Verkhratsky, Alexei; Eaton, Misty J.; Reichenbach, Andreas; Skatchkov, Serguei N.			Unidirectional Photoreceptor-to-Muller Glia Coupling and Unique K+ Channel Expression in Caiman Retina	PLOS ONE			English	Article							RECTIFYING POTASSIUM CHANNEL; SENSORINEURAL DEAFNESS; GLUTAMATE UPTAKE; ELECTRORETINOGRAM COMPONENTS; CONNEXIN43 IMMUNOREACTIVITY; EXTRACELLULAR K; CELL DIFFUSION; GAP-JUNCTIONS; ATP-CHANNELS; KIR4.1	Background: Muller cells, the principal glial cells of the vertebrate retina, are fundamental for the maintenance and function of neuronal cells. In most vertebrates, including humans, Muller cells abundantly express Kir4.1 inwardly rectifying potassium channels responsible for hyperpolarized membrane potential and for various vital functions such as potassium buffering and glutamate clearance; inter-species differences in Kir4.1 expression were, however, observed. Localization and function of potassium channels in Muller cells from the retina of crocodiles remain, hitherto, unknown. Methods: We studied retinae of the Spectacled caiman (Caiman crocodilus fuscus), endowed with both diurnal and nocturnal vision, by (i) immunohistochemistry, (ii) whole-cell voltage-clamp, and (iii) fluorescent dye tracing to investigate K+ channel distribution and glia-to-neuron communications. Results: Immunohistochemistry revealed that caiman Muller cells, similarly to other vertebrates, express vimentin, GFAP, S100 beta, and glutamine synthetase. In contrast, Kir4.1 channel protein was not found in Muller cells but was localized in photoreceptor cells. Instead, 2P-domain TASK-1 channels were expressed in Muller cells. Electrophysiological properties of enzymatically dissociated Muller cells without photoreceptors and isolated Muller cells with adhering photoreceptors were significantly different. This suggests ion coupling between Muller cells and photoreceptors in the caiman retina. Sulforhodamine-B injected into cones permeated to adhering Muller cells thus revealing a uni-directional dye coupling. Conclusion: Our data indicate that caiman Muller glial cells are unique among vertebrates studied so far by predominantly expressing TASK-1 rather than Kir4.1 K+ channels and by bi-directional ion and uni-directional dye coupling to photoreceptor cells. This coupling may play an important role in specific glia-neuron signaling pathways and in a new type of K+ buffering.	[Zayas-Santiago, Astrid; Rivera, Yomarie; Benedikt, Jan; Davila, Jose; Kucheryavykh, Yuriy; Inyushin, Mikhail; Cubano, Luis A.; Eaton, Misty J.; Skatchkov, Serguei N.] Univ Cent Caribe, Dept Pathol, Bayamon, PR 00960 USA; [Zayas-Santiago, Astrid; Rivera, Yomarie; Benedikt, Jan; Davila, Jose; Kucheryavykh, Yuriy; Inyushin, Mikhail; Cubano, Luis A.; Eaton, Misty J.; Skatchkov, Serguei N.] Univ Cent Caribe, Dept Biochem, Bayamon, PR USA; [Zayas-Santiago, Astrid; Rivera, Yomarie; Benedikt, Jan; Davila, Jose; Kucheryavykh, Yuriy; Inyushin, Mikhail; Cubano, Luis A.; Eaton, Misty J.; Skatchkov, Serguei N.] Univ Cent Caribe, Dept Physiol, Bayamon, PR USA; [Agte, Silke; Ulbricht, Elke; Karl, Anett; Pannicke, Thomas; Francke, Mike; Reichenbach, Andreas] Univ Leipzig, Fac Med, Paul Flechsig Inst Brain Res, D-04109 Leipzig, Germany; [Agte, Silke] Univ Leipzig, Dept Phys, Div Soft Matter Phys, D-04109 Leipzig, Germany; [Savvinov, Alexey] Univ Puerto Rico, Dept Phys Sci, Rio Piedras, PR 00931 USA; [Ulbricht, Elke] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Veh, Ruediger W.] Charite, Berlin, Germany; [Francke, Mike] Univ Leipzig, Translat Ctr Regenerat Med TRM, D-04109 Leipzig, Germany; [Verkhratsky, Alexei] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	Leipzig University; Leipzig University; University of Puerto Rico; University of Puerto Rico Rio Piedras; University of Cambridge; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leipzig University; University of Manchester	Skatchkov, SN (corresponding author), Univ Cent Caribe, Dept Pathol, Bayamon, PR 00960 USA.	sergueis50@yahoo.com	Pannicke, Thomas/A-5078-2017; Verkhratsky, Alexei/J-4527-2013; Francke, Mike/A-7505-2017; Inyushin, Mikhail/B-2459-2016; Reichenbach, Andreas/B-2510-2017	Pannicke, Thomas/0000-0001-7435-9540; Verkhratsky, Alexei/0000-0003-2592-9898; Inyushin, Mikhail/0000-0003-3253-7307; Zayas-Santiago, Astrid/0000-0003-4028-0564; Veh, Rudiger/0000-0002-6253-9808	National Institutes of Health from NINDS [R01-NS065201-02 03]; Title-V PPOHA, RCMI-SRDU from NIMHD; NIGMS [SC1-GM 088019-02, SC2 GM095410]; NIMHD [G12-RR03035, 8G12-MD007583-27 G12-RR03035]; FIPI-NSF-UPR; Deutsche Forschungsgemeinschaft [FOR 748, GRK 1097, RE 849/16-1, SPP 1172, PA 615/2-1]; German Federal Ministry of Education and Research: BMBF [1315883]; European Community [FP7-SPP 1172]; EU FP 7 Program EduGlia [237956]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM088019, SC2GM095410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065201] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007583] Funding Source: NIH RePORTER	National Institutes of Health from NINDS; Title-V PPOHA, RCMI-SRDU from NIMHD; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMHD; FIPI-NSF-UPR; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research: BMBF(Federal Ministry of Education & Research (BMBF)); European Community(European Commission); EU FP 7 Program EduGlia; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This publication was made possible by grants from the National Institutes of Health: R01-NS065201-02 03 from NINDS (to SNS); Title-V PPOHA, RCMI-SRDU from NIMHD (to LC and AZ); SC1-GM 088019-02 from NIGMS (to MJE); SC2 GM095410 from NIGMS (to YK); G12-RR03035-Project-A from NIMHD (to MI); 8G12-MD007583-27 G12-RR03035 from NIMHD (for core facilities at UCC); FIPI-NSF-UPR (to AS); From the Deutsche Forschungsgemeinschaft: FOR 748, GRK 1097, RE 849/16-1 and SPP 1172(to AR); PA 615/2-1 (to TP). From the German Federal Ministry of Education and Research: BMBF 1315883 (to MF), From the European Community: FP7-SPP 1172 (to AR); and EU FP 7 Program EduGlia 237956 (to AR and AV). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiry-Moghaddam M, 2003, NAT REV NEUROSCI, V4, P991, DOI 10.1038/nrn1252; [Anonymous], 1851, Z WISS ZOOL; Ball AK, 1998, J COMP NEUROL, V393, P48, DOI 10.1002/(SICI)1096-9861(19980330)393:1<48::AID-CNE5>3.0.CO;2-Q; BANK M, 1992, J NEUROSCI, V12, P2960, DOI 10.1523/JNEUROSCI.12-08-02960.1992; Benedikt J, 2012, NEUROREPORT, V23, P1021, DOI 10.1097/WNR.0b013e32835aa04b; Biedermann B, 1998, GLIA, V23, P209, DOI 10.1002/(SICI)1098-1136(199807)23:3<209::AID-GLIA4>3.0.CO;2-#; Bockenhauer D, 2009, NEW ENGL J MED, V360, P1960, DOI 10.1056/NEJMoa0810276; Bringmann A, 1999, EUR J NEUROSCI, V11, P2883, DOI 10.1046/j.1460-9568.1999.00706.x; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Buono RJ, 2004, EPILEPSY RES, V58, P175, DOI 10.1016/j.eplepsyres.2004.02.003; Butt AM, 2006, J CELL MOL MED, V10, P33, DOI 10.1111/j.1582-4934.2006.tb00289.x; BYKOV K A, 1984, Fiziologicheskii Zhurnal SSSR Imeni I M Sechenova, V70, P1381; Chao TI, 1997, J NEUROCYTOL, V26, P439, DOI 10.1023/A:1018525222826; CONNER JD, 1985, J PHYSIOL-LONDON, V362, P79, DOI 10.1113/jphysiol.1985.sp015664; Connors NC, 2006, GLIA, V53, P124, DOI 10.1002/glia.20271; COOK DL, 1984, NATURE, V311, P271, DOI 10.1038/311271a0; Cui Y, 2001, P NATL ACAD SCI USA, V98, P729, DOI 10.1073/pnas.011370498; DICK E, 1985, J GEN PHYSIOL, V85, P885, DOI 10.1085/jgp.85.6.885; DICK E, 1985, J GEN PHYSIOL, V85, P911, DOI 10.1085/jgp.85.6.911; Djukic B, 2007, J NEUROSCI, V27, P11354, DOI 10.1523/JNEUROSCI.0723-07.2007; Dmitriev AV, 1999, VISUAL NEUROSCI, V16, P1157, DOI 10.1017/S095252389916615X; DREHER Z, 1994, J COMP NEUROL, V350, P96, DOI 10.1002/cne.903500107; Du GZ, 2011, ANESTHESIOLOGY, V115, P1003, DOI 10.1097/ALN.0b013e3182343660; Eaton MJ, 2004, NEUROREPORT, V15, P321, DOI 10.1097/00001756-200402090-00022; Eaton MJ, 2002, NEUROREPORT, V13, P57, DOI 10.1097/00001756-200201210-00016; Eberhardt C, 2011, GLIA, V59, P697, DOI 10.1002/glia.21139; Ettaiche M, 2001, BRAIN RES, V890, P118, DOI 10.1016/S0006-8993(00)03152-8; Francke M, 1997, GLIA, V20, P210, DOI 10.1002/(SICI)1098-1136(199707)20:3<210::AID-GLIA5>3.0.CO;2-B; Franze K, 2007, P NATL ACAD SCI USA, V104, P8287, DOI 10.1073/pnas.0611180104; Giblin LJ, 1997, BRAIN RES, V755, P146, DOI 10.1016/S0006-8993(97)00174-1; Glukhov AV, 2013, J MOL CELL CARDIOL, V62, P90, DOI 10.1016/j.yjmcc.2013.04.016; Govardovski VI, 1987, SENS SYST, V1, P28; Han J, 2002, J PHYSIOL-LONDON, V542, P431, DOI 10.1113/jphysiol.2002.017590; Hibino H, 1997, J NEUROSCI, V17, P4711; Hoomann T, 2013, P NATL ACAD SCI USA, V110, P10842, DOI 10.1073/pnas.1304714110; Iandiev I, 2006, NEUROSCI LETT, V396, P97, DOI 10.1016/j.neulet.2005.11.016; Iandiev I, 2008, INVEST OPHTH VIS SCI, V49, P3559, DOI 10.1167/iovs.08-1723; Iandiev L, 2008, NEUROSCI LETT, V434, P317, DOI 10.1016/j.neulet.2008.02.026; IMANAGA I, 1987, AM J PHYSIOL, V252, pH223, DOI 10.1152/ajpheart.1987.252.1.H223; Inyushin M, 2010, EPILEPSIA, V51, P1707, DOI 10.1111/j.1528-1167.2010.02592.x; Ishii M, 2003, AM J PHYSIOL-CELL PH, V285, pC260, DOI 10.1152/ajpcell.00560.2002; Iwabe N, 2005, MOL BIOL EVOL, V22, P810, DOI 10.1093/molbev/msi075; Janssen-Bienhold U, 1998, J COMP NEUROL, V396, P310, DOI 10.1002/(SICI)1096-9861(19980706)396:3<310::AID-CNE3>3.0.CO;2-5; Jons T, 2006, J CELL SCI, V119, P3087, DOI 10.1242/jcs.03041; Kofuji P, 2002, GLIA, V39, P292, DOI 10.1002/glia.10112; Kofuji P, 2000, J NEUROSCI, V20, P5733, DOI 10.1523/JNEUROSCI.20-15-05733.2000; Krishnamoorthy V, 2008, INVEST OPHTH VIS SCI, V49, P2643, DOI 10.1167/iovs.07-1471; Kucheryavykh YV, 2007, GLIA, V55, P274, DOI 10.1002/glia.20455; Kucheryavykh YV, 2008, GLIA, V56, P775, DOI 10.1002/glia.20652; Laurens H, 1921, J EXP ZOOL, V32, P207, DOI 10.1002/jez.1400320204; LEDAIN AC, 1994, J MEMBRANE BIOL, V141, P239, DOI 10.1007/BF00235133; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Linn DM, 1998, VISUAL NEUROSCI, V15, P449; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; MacGregor GG, 2002, P NATL ACAD SCI USA, V99, P2726, DOI 10.1073/pnas.042688899; MALCHOW RP, 1989, P NATL ACAD SCI USA, V86, P4326, DOI 10.1073/pnas.86.11.4326; Morton MJ, 2005, AM J PHYSIOL-RENAL, V288, pF162, DOI 10.1152/ajprenal.00248.2004; Nagelhus EA, 1998, J NEUROSCI, V18, P2506; Newman E, 1996, TRENDS NEUROSCI, V19, P307, DOI 10.1016/0166-2236(96)10040-0; NEWMAN EA, 1985, J NEUROSCI, V5, P2225; NEWMAN EA, 1984, NATURE, V309, P155, DOI 10.1038/309155a0; NEWMAN EA, 1987, J NEUROSCI, V7, P2423; NEWMAN EA, 1993, J NEUROSCI, V13, P3333; NEWMAN EA, 1988, GLIA, V1, P275, DOI 10.1002/glia.440010406; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Olsen ML, 2008, J NEUROCHEM, V107, P589, DOI 10.1111/j.1471-4159.2008.05615.x; Olsen ML, 2010, BRAIN, V133, P1013, DOI 10.1093/brain/awq049; Pannicke T, 2006, DIABETES, V55, P633, DOI 10.2337/diabetes.55.03.06.db05-1349; Pannicke T, 2005, VISION RES, V45, P1781, DOI 10.1016/j.visres.2005.01.016; Pannicke T, 2004, MOL CELL NEUROSCI, V26, P493, DOI 10.1016/j.mcn.2004.04.005; Pannicke T, 2002, GLIA, V38, P268, DOI 10.1002/glia.10068; Raap M, 2002, NEUROREPORT, V13, P1037, DOI 10.1097/00001756-200206120-00012; REICHELT W, 1993, NEUROSCI LETT, V155, P15, DOI 10.1016/0304-3940(93)90663-6; REICHELT W, 1993, NEUROSCIENCE, V57, P599, DOI 10.1016/0306-4522(93)90009-5; Reichenbach A, 2013, GLIA, V61, P651, DOI 10.1002/glia.22477; Reichold M, 2010, P NATL ACAD SCI USA, V107, P14490, DOI 10.1073/pnas.1003072107; Reyes R, 1998, J BIOL CHEM, V273, P30863, DOI 10.1074/jbc.273.47.30863; ROBINSON SR, 1993, SCIENCE, V262, P1072; SAFRANYOS RGA, 1987, P NATL ACAD SCI USA, V84, P2272, DOI 10.1073/pnas.84.8.2272; Sala-Rabanal M, 2010, J BIOL CHEM, V285, P36040, DOI 10.1074/jbc.M110.163170; Scholl UI, 2009, P NATL ACAD SCI USA, V106, P5842, DOI 10.1073/pnas.0901749106; Schopf S, 2004, NEUROSCI LETT, V365, P167, DOI 10.1016/j.neulet.2004.04.074; SCHWARTZ EA, 1993, NEURON, V10, P1141, DOI 10.1016/0896-6273(93)90062-V; Seifert G, 2009, J NEUROSCI, V29, P7474, DOI 10.1523/JNEUROSCI.3790-08.2009; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Sicca F, 2011, NEUROBIOL DIS, V43, P239, DOI 10.1016/j.nbd.2011.03.016; Skatchkov SN, 2006, GLIA, V53, P266, DOI 10.1002/glia.20280; Skatchkov SN, 2002, GLIA, V38, P256, DOI 10.1002/glia.10073; Skatchkov SN, 2001, NEUROREPORT, V12, P1437, DOI 10.1097/00001756-200105250-00028; SKATCHKOV SN, 1995, GLIA, V15, P54, DOI 10.1002/glia.440150107; Solessio E, 2000, J NEUROPHYSIOL, V83, P418, DOI 10.1152/jn.2000.83.1.418; Srivastava R, 2012, NEW ENGL J MED, V367, P115, DOI 10.1056/NEJMoa1110740; Steinhauser C, 2012, GLIA, V60, P1192, DOI 10.1002/glia.22313; Thompson DA, 2011, J PHYSIOL-LONDON, V589, P1681, DOI 10.1113/jphysiol.2010.198531; Thomzig A, 2001, MOL CELL NEUROSCI, V18, P671, DOI 10.1006/mcne.2001.1048; WAGNER EC, 1991, EXP EYE RES, V53, P583, DOI 10.1016/0014-4835(91)90216-2; WALD G, 1957, J GEN PHYSIOL, V40, P703, DOI 10.1085/jgp.40.5.703; Walls G., 1967, VERTEBRATE EYE ITS A; Walls GL, 1942, CRANBROOK I SCI B; Wurm A, 2006, GLIA, V54, P411, DOI 10.1002/glia.20391; Zahs KR, 2006, VISUAL NEUROSCI, V23, P1, DOI 10.1017/S0952523806231018; Zahs KR, 2003, J COMP NEUROL, V455, P531, DOI 10.1002/cne.10524; Zahs KR, 1998, GLIA, V24, P85, DOI 10.1002/(SICI)1098-1136(199809)24:1<85::AID-GLIA9>3.3.CO;2-C; Zahs KR, 1997, GLIA, V20, P10, DOI 10.1002/(SICI)1098-1136(199705)20:1<10::AID-GLIA2>3.3.CO;2-2; Zayas-Santiago A, 2013, 32008 SOC NEUR; Zayas-Santiago A, 2012, 56612 SOC NEUR; Zhou M, 2006, J NEUROPHYSIOL, V95, P134, DOI 10.1152/jn.00570.2005; ZHU H, 1994, J NEUROSCI, V14, P6886	108	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97155	10.1371/journal.pone.0097155	http://dx.doi.org/10.1371/journal.pone.0097155			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831221	Green Submitted, Green Published, gold			2022-12-27	WOS:000336789500037
J	Fagiolo, G; Mastrorillo, M				Fagiolo, Giorgio; Mastrorillo, Marina			Does Human Migration Affect International Trade? A Complex-Network Perspective	PLOS ONE			English	Article							CENTRALITY; EVOLUTION	This paper explores the relationships between international human migration and merchandise trade, using a complex-network approach. We firstly compare the topological structure of worldwide networks of human migration and bilateral trade over the period 1960-2000. Next, we ask whether the position of any pair of countries in the migration network affects their bilateral trade flows. We show that: (i) both weighted and binary versions of the networks of international migration and trade are strongly correlated; (ii) such correlations can be mostly explained by country economic/demographic size and geographical distance; and (iii) pairs of countries that are more central in the international-migration network trade more. Our findings suggest that bilateral trade between any two countries is not only affected by the presence of migrants from either countries but also by their relative embeddedness in the complex web of corridors making up the network of international human migration.	[Fagiolo, Giorgio] Scuola Super Sant Anna, Inst Econ, Pisa, Italy; [Mastrorillo, Marina] Princeton Univ, Princeton, NJ 08544 USA	Scuola Superiore Sant'Anna; Princeton University	Fagiolo, G (corresponding author), Scuola Super Sant Anna, Inst Econ, Pisa, Italy.	g.fagiolo@sssup.it	Fagiolo, Giorgio/HGB-6892-2022; Fagiolo, Giorgio/AAI-6807-2021	Fagiolo, Giorgio/0000-0001-5355-3352	project "The International Trade Network: Empirical Analyses and Theoretical Models" - Italian Ministry of Education, University and Research (Scientific Research Programs of National Relevance)	project "The International Trade Network: Empirical Analyses and Theoretical Models" - Italian Ministry of Education, University and Research (Scientific Research Programs of National Relevance)	G.F. gratefully acknowledges support received by the research project "The International Trade Network: Empirical Analyses and Theoretical Models," funded by the Italian Ministry of Education, University and Research (Scientific Research Programs of National Relevance 2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barigozzi M, 2011, PHYSICA A, V390, P2051, DOI 10.1016/j.physa.2011.02.004; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Barthelemy M, 2005, PHYSICA A, V346, P34, DOI 10.1016/j.physa.2004.08.047; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Bonacich P, 2001, SOC NETWORKS, V23, P191, DOI 10.1016/S0378-8733(01)00038-7; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Chinazzi M, 2013, J ECON DYN CONTROL, V37, P1692, DOI 10.1016/j.jedc.2013.01.010; Davis KF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053723; Ductor L, 2013, REV EC STAT IN PRESS; Duenas M, 2013, J ECON INTERACT COOR, V8, P155, DOI 10.1007/s11403-013-0108-y; Egger PH, 2012, WORLD ECON, V35, P216, DOI 10.1111/j.1467-9701.2011.01429.x; Fagiolo G., 2006, EC B, V3, P1; Fagiolo G, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026107; Fagiolo G, 2008, PHYSICA A, V387, P3868, DOI 10.1016/j.physa.2008.01.050; Fagiolo G, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.012812; Fagiolo G, 2010, J ECON INTERACT COOR, V5, P1, DOI 10.1007/s11403-010-0061-y; Fagiolo G, 2010, J EVOL ECON, V20, P479, DOI 10.1007/s00191-009-0160-x; Fagiolo G, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036115; Felbermayr GJ, 2012, WORLD DEV, V40, P928, DOI 10.1016/j.worlddev.2011.11.016; Felbermayr GJ, 2010, ANNALES DECONOMIE ET, P41, DOI DOI 10.2307/41219109; Frankel JA, 1999, AM ECON REV, V89, P379, DOI 10.1257/aer.89.3.379; Garlaschelli D, 2005, PHYSICA A, V355, P138, DOI 10.1016/j.physa.2005.02.075; Gaston N, 2011, PALGRAVE HANDBOOK OF INTERNATIONAL TRADE, P660; Gleditsch KS, 2002, J CONFLICT RESOLUT, V46, P712, DOI 10.1177/002200202236171; GOULD DM, 1994, REV ECON STAT, V76, P302, DOI 10.2307/2109884; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Lewer JJ, 2008, ECON LETT, V99, P164, DOI 10.1016/j.econlet.2007.06.019; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; National Research Council, 2010, UND CHANG PLAN STRAT; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Ortega F, 2011, 5604 IZA, V5604; Ozden C, 2011, WORLD BANK ECON REV, V25, P12, DOI 10.1093/wber/lhr024; Parsons Christopher R., 2012, POLICY RES WORKING P, V6034; Piccardi C, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066119; Rauch JE, 1999, NBER WORKING PAPERS, V7189; Saramaki J, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.027105; Schiavo S, 2010, QUANT FINANC, V10, P389, DOI 10.1080/14697680902882420; Schweitzer F, 2009, SCIENCE, V325, P422, DOI 10.1126/science.1173644; Serrano MA, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.015101; Sgrignoli P, 2013, 2013 INTERNATIONAL CONFERENCE ON SIGNAL-IMAGE TECHNOLOGY & INTERNET-BASED SYSTEMS (SITIS), P548, DOI 10.1109/SITIS.2013.92; Silva JMCS, 2006, REV ECON STAT, V88, P641, DOI 10.1162/rest.88.4.641; Squartini T, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.046118; Squartini T, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.046117; The World Bank Group, 2013, WORLD DEV IND WDI ON; van Bergeijk Peter, 2010, GRAVITY MODEL INT TR; Ward M.D., 2013, NETW SCI, V1, P95, DOI [DOI 10.1017/NWS.2013.1, 10.1017/nws.2013.1]	47	33	34	9	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97331	10.1371/journal.pone.0097331	http://dx.doi.org/10.1371/journal.pone.0097331			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4TJ	24828376	Green Published, Green Submitted, gold			2022-12-27	WOS:000336857400078
J	Li, K; Lu, CX; Huang, YF; Yuan, L; Zeng, D; Wu, K				Li, Ke; Lu, Cuixin; Huang, Yufei; Yuan, Li; Zeng, Dong; Wu, Kan			Alteration of Fractional Anisotropy and Mean Diffusivity in Glaucoma: Novel Results of a Meta-Analysis of Diffusion Tensor Imaging Studies	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; WHITE-MATTER ABNORMALITIES; OPTIC-NERVE DEGENERATION; VOXEL-BASED MORPHOMETRY; CLINICAL SEVERITY; VISUAL-CORTEX; HUMAN BRAIN; MR; PATHWAY; DAMAGE	Objectives: We hypothesized that a meta-analysis of existing studies may help to reveal significant changes on diffusion tensor imaging (DTI) in patients with glaucoma. Therefore, a meta-analysis was utilized to investigate the possibility that DTI can detect white matter damage in patients with glaucoma. Methods: The study design and report adhered to the PRISMA Statement guidelines. DTI studies that compared glaucoma patients and controls were surveyed using PubMed, Web of Science and EMBASE (January 2008 to September 2013). Stata was used to analyze the decrease in fractional anisotropy (FA) and increase in mean diffusivity (MD) in the optic nerve and optic radiation in patients with glaucoma. Results: Eleven DTI studies were identified through a comprehensive literature search, and 10 independent DTI studies of glaucoma patients were eligible for the meta-analysis. A random effects model revealed a significant FA reduction in the optic nerve and optic radiation, as well as a significant MD increase in the tracts. A heterogeneity analysis suggested that FA may be related to glaucoma severity. Conclusions: Our findings revealed that the optic nerve and optic radiation were vulnerable regions in patients with glaucoma and that FA may be correlated with glaucoma severity and age. Furthermore, this study suggests that magnetic resonance imaging in patients with glaucoma may help to provide objective evidence to aid in the diagnosis and management of glaucoma.	[Li, Ke; Zeng, Dong] Univ Elect Sci & Technol China, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China; [Li, Ke; Lu, Cuixin; Huang, Yufei; Yuan, Li; Zeng, Dong; Wu, Kan] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu 610054, Peoples R China	University of Electronic Science & Technology of China; University of Electronic Science & Technology of China	Li, K (corresponding author), Univ Elect Sci & Technol China, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China.	like@uestc.edu.cn			National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2012BAH07F01]; Key Science and Technology Program of SiChuan Province, China [12ZC0220]; Fundamental Research Funds for the Central Universities [ZYGX2011J096]	National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); Key Science and Technology Program of SiChuan Province, China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (Grant No. 2012BAH07F01); the Key Science and Technology Program of SiChuan Province, China (Grant No. 12ZC0220); and the Fundamental Research Funds for the Central Universities (Grant No. ZYGX2011J096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2002, NEUROBIOL AGING, V23, P433, DOI 10.1016/S0197-4580(01)00318-9; Anik I, 2011, ACTA NEUROCHIR, V153, P831, DOI 10.1007/s00701-011-0942-4; Anjari M, 2007, NEUROIMAGE, V35, P1021, DOI 10.1016/j.neuroimage.2007.01.035; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bolacchi F, 2012, INVEST OPHTH VIS SCI, V53, P4191, DOI 10.1167/iovs.11-9345; Chan KC, 2009, EXP EYE RES, V88, P61, DOI 10.1016/j.exer.2008.10.002; Chang ST, 2013, J GLAUCOMA; Charlton RA, 2006, NEUROLOGY, V66, P217, DOI 10.1212/01.wnl.0000194256.15247.83; Chen ZQ, 2013, CLIN EXP OPHTHALMOL, V41, P43, DOI 10.1111/j.1442-9071.2012.02832.x; Dai H, 2013, NEURORADIOLOGY, V55, P233, DOI 10.1007/s00234-012-1122-9; El-Rafei A, 1076, MAGN RESON IMAGING, V29, P1076; El-Rafei A, 2011, LECT NOTES COMPUT SC, V6854, P529, DOI 10.1007/978-3-642-23672-3_64; Engelhorn T, 2012, SCI WORLD J, P1, DOI 10.1100/2012/849632; Engelhorn T, 2012, ACAD RADIOL, V19, P485, DOI 10.1016/j.acra.2011.12.005; Engelhorn T, 2010, ACAD RADIOL, V17, P1313, DOI 10.1016/j.acra.2010.04.017; Garaci FG, 2009, RADIOLOGY, V252, P496, DOI 10.1148/radiol.2522081240; Gavaghan DJ, 2000, PAIN, V85, P415, DOI 10.1016/S0304-3959(99)00302-4; Gupta N, 2006, BRIT J OPHTHALMOL, V90, P674, DOI 10.1136/bjo.2005.086769; Gupta N, 2007, SURV OPHTHALMOL, V52, pS122, DOI 10.1016/j.survophthal.2007.08.006; Hartung J KG, 2011, STAT METAANALYSIS AP, P36; Hasan KM, 2006, RADIOLOGY, V239, P611, DOI 10.1148/radiol.2392051172; Hui ES, 2007, P ANN INT IEEE EMBS, P4312, DOI 10.1109/IEMBS.2007.4353290; Job DE, 2005, NEUROIMAGE, V25, P1023, DOI 10.1016/j.neuroimage.2005.01.006; Kashiwagi K, 2004, J GLAUCOMA, V13, P189, DOI 10.1097/00061198-200406000-00003; Kitsos G, 2009, BRIT J RADIOL, V82, P896, DOI 10.1259/bjr/55866125; Klein JC, 2011, HUM BRAIN MAPP, V32, P896, DOI 10.1002/hbm.21077; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Li CY, 2012, CURR EYE RES, V37, P794, DOI 10.3109/02713683.2012.683506; Menzler K, 2011, NEUROIMAGE, V54, P2557, DOI 10.1016/j.neuroimage.2010.11.029; Michelson G, 2013, GRAEF ARCH CLIN EXP, V251, P243, DOI 10.1007/s00417-011-1887-2; Miki A, 1996, AM J OPHTHALMOL, V122, P404, DOI 10.1016/S0002-9394(14)72067-7; Murai H, 2013, JPN J OPHTHALMOL; Nucci C, 2013, CURR OPIN PHARMACOL, V13, P128, DOI 10.1016/j.coph.2012.08.004; Nucci C, 2012, BRIT J OPHTHALMOL, V96, P976, DOI 10.1136/bjophthalmol-2011-301280; Ondo EA, 2009, NEURORADIOLOGY, V51, pS96; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Sullivan EV, 2010, NEUROBIOL AGING, V31, P464, DOI 10.1016/j.neurobiolaging.2008.04.007; van Haren NEM, 2007, NEUROPSYCHOPHARMACOL, V32, P2057, DOI 10.1038/sj.npp.1301347; Wang MY, 2013, NEURORADIOLOGY, V55, P493, DOI 10.1007/s00234-013-1133-1; Wheeler-Kingshott CAM, 2006, MAGN RESON MED, V56, P446, DOI 10.1002/mrm.20964; Williams AL, 2013, INVEST OPHTH VIS SCI, V54, P5880, DOI 10.1167/iovs.13-11776; Wostyn P, 2010, MED HYPOTHESES, V74, P973, DOI 10.1016/j.mehy.2009.12.019; [吴珂 Wu Ke], 2012, [中华放射学杂志, Chinese Journal of Radiology], V46, P19; Wu SH, 2012, J MED SYST, V36, P2325, DOI 10.1007/s10916-011-9700-7; Zhang X, 2011, INVEST OPHTH VIS SCI, V52, P7001, DOI 10.1167/iovs.11-7619; Zhang YQ, 2012, ACTA OPHTHALMOL, V90, pE295, DOI 10.1111/j.1755-3768.2011.02346.x; Zikou AK, 2012, AM J NEURORADIOL, V33, P128, DOI 10.3174/ajnr.A2714	50	21	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97445	10.1371/journal.pone.0097445	http://dx.doi.org/10.1371/journal.pone.0097445			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828063	Green Submitted, Green Published, gold			2022-12-27	WOS:000336857400095
J	Potamitis, I				Potamitis, Ilyas			Automatic Classification of a Taxon-Rich Community Recorded in the Wild	PLOS ONE			English	Article							BIODIVERSITY	There is a rich literature on automatic species identification of a specific target taxon as regards various vocalizing animals. Research usually is restricted to specific species - in most cases a single one. It is only very recently that the number of monitored species has started to increase for certain habitats involving birds. Automatic acoustic monitoring has not yet been proven to be generic enough to scale to other taxa and habitats than the ones described in the original research. Although attracting much attention, the acoustic monitoring procedure is neither well established yet nor universally adopted as a biodiversity monitoring tool. Recently, the multi-instance multi-label framework on bird vocalizations has been introduced to face the obstacle of simultaneously vocalizing birds of different species. We build on this framework to integrate novel, image-based heterogeneous features designed to capture different aspects of the spectrum. We applied our approach to a taxon-rich habitat that included 78 birds, 8 insect species and 1 amphibian. This dataset constituted the Multi-label Bird Species Classification Challenge-NIPS 2013 where the proposed approach achieved an average accuracy of 91.25% on unseen data.	Technol Educ Inst Crete, Dept Mus Technol & Acoust, Iraklion, Greece	Hellenic Mediterranean University	Potamitis, I (corresponding author), Technol Educ Inst Crete, Dept Mus Technol & Acoust, Iraklion, Greece.	potamitis@staff.teicrete.gr		Potamitis, Ilyas/0000-0002-7111-3331	Project AMIBIO	Project AMIBIO	This work was funded by Project AMIBIO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardeli R, 2010, PATTERN RECOGN LETT, V31, P1524, DOI 10.1016/j.patrec.2009.09.014; Bas Y., 2013, P NEUR INF PROC SCAL; Blumstein DT, 2011, J APPL ECOL, V48, P758, DOI 10.1111/j.1365-2664.2011.01993.x; Brandes TS, 2006, J ACOUST SOC AM, V120, P2950, DOI 10.1121/1.2355479; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Briggs F., 2013, IEEE INT WORKSH MACH; Briggs F, 2012, J ACOUST SOC AM, V131, P4640, DOI 10.1121/1.4707424; Fitzpatrick MC, 2009, ECOL APPL, V19, P1673, DOI 10.1890/09-0265.1; Fodor G, 2013, IEEE INT WORKS MACH, DOI 10.1109/MLSP.2013.6661932; Glotin H., 2013, P NIPS INT C; Glotin H, 2013, P 1 INT WORKSH MACH; Grimsley Jasmine M S, 2012, Front Behav Neurosci, V6, P89, DOI 10.3389/fnbeh.2012.00089; Halkias XC, 2013, J ACOUST SOC AM, V134, P3496, DOI 10.1121/1.4821203; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Keen S, 2014, ECOLOGICAL INFORM; Kottege N, 2012, WUWNET 12 P 7 ACM IN; Lasseck M., 2013, P NEUR INF PROC SCAL; Lundy M, 2013, BIOACOUSTICS, V20, P101; Potamitis I, 2014, APPL ACOUST, V80, P1, DOI 10.1016/j.apacoust.2014.01.001; Riede K., 1997, P442; RIEDE K, 1993, AMBIO, V22, P546; Shih F., 2009, IMAGE PROCESSING MAT; Skowronski MD, 2006, J ACOUST SOC AM, V119, P1817, DOI 10.1121/1.2166948; Slimani T, 2010, P 11 C LUS ESP HERP, P148; Sueur J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004065	25	49	50	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96936	10.1371/journal.pone.0096936	http://dx.doi.org/10.1371/journal.pone.0096936			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24826989	gold, Green Published, Green Submitted			2022-12-27	WOS:000336857400047
J	Trott, M; Weiss, S; Antoni, S; Koch, J; von Briesen, H; Hust, M; Dietrich, U				Trott, Maria; Weiss, Svenja; Antoni, Sascha; Koch, Joachim; von Briesen, Hagen; Hust, Michael; Dietrich, Ursula			Functional Characterization of Two scFv-Fc Antibodies from an HIV Controller Selected on Soluble HIV-1 Env Complexes: A Neutralizing V3-and a Trimer-Specific gp41 Antibody	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODIES; PROXIMAL EXTERNAL REGION; ENVELOPE GLYCOPROTEIN TRIMERS; B-CELL RESPONSES; PBL-SCID MICE; V3 LOOP; RECOMBINANT ANTIBODIES; PASSIVE-IMMUNIZATION; PHAGE DISPLAY	HIV neutralizing antibodies (nAbs) represent an important tool in view of prophylactic and therapeutic applications for HIV-1 infection. Patients chronically infected by HIV-1 represent a valuable source for nAbs. HIV controllers, including long-term non-progressors (LTNP) and elite controllers (EC), represent an interesting subgroup in this regard, as here nAbs can develop over time in a rather healthy immune system and in the absence of any therapeutic selection pressure. In this study, we characterized two particular antibodies that were selected as scFv antibody fragments from a phage immune library generated from an LTNP with HIV neutralizing antibodies in his plasma. The phage library was screened on recombinant soluble gp140 envelope (Env) proteins. Sequencing the selected peptide inserts revealed two major classes of antibody sequences. Binding analysis of the corresponding scFv-Fc derivatives to various trimeric and monomeric Env constructs as well as to peptide arrays showed that one class, represented by monoclonal antibody (mAb) A2, specifically recognizes an epitope localized in the pocket binding domain of the C heptad repeat (CHR) in the ectodomain of gp41, but only in the trimeric context. Thus, this antibody represents an interesting tool for trimer identification. MAb A7, representing the second class, binds to structural elements of the third variable loop V3 and neutralizes tier 1 and tier 2 HIV-1 isolates of different subtypes with matching critical amino acids in the linear epitope sequence. In conclusion, HIV controllers are a valuable source for the selection of functionally interesting antibodies that can be selected on soluble gp140 proteins with properties from the native envelope spike.	[Trott, Maria; Weiss, Svenja; Antoni, Sascha; Koch, Joachim; Dietrich, Ursula] Georg Speyer Haus, Inst Tumor Biol & Expt Therapy, Frankfurt, Germany; [von Briesen, Hagen] Fraunhofer Inst Biomed Engn, HIV Specimen Cryorepository HSC, St Ingbert, Germany; [Hust, Michael] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Biotechnol & Bioinformat, D-38106 Braunschweig, Germany	Octapharma; Fraunhofer Gesellschaft; Braunschweig University of Technology	Dietrich, U (corresponding author), Georg Speyer Haus, Inst Tumor Biol & Expt Therapy, Frankfurt, Germany.	ursula.dietrich@gsh.uni-frankfurt.de	Dietrich, Ursula/AAD-5704-2020	Hust, Michael/0000-0003-3418-6045; Dietrich, Ursula/0000-0003-2491-4758	Dr. Bodo Sponholz-Foundation	Dr. Bodo Sponholz-Foundation	This work was supported by the Dr. Bodo Sponholz-Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almond D, 2010, AIDS RES HUM RETROV, V26, P717, DOI 10.1089/aid.2009.0254; Andrabi R, 2013, VIROLOGY, V439, P81, DOI 10.1016/j.virol.2012.12.010; Antoni S, 2007, AIDS RES HUM RETROV, V23, P1377, DOI 10.1089/aid.2007.0113; Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Beddows S, 2007, VIROLOGY, V360, P329, DOI 10.1016/j.virol.2006.10.032; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Burton DR, 2010, SCIENCE, V329, P770, DOI 10.1126/science.1194693; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; CONLEY AJ, 1994, J VIROL, V68, P6994, DOI 10.1128/JVI.68.11.6994-7000.1994; Corti D, 2013, ANNU REV IMMUNOL, V31, P705, DOI 10.1146/annurev-immunol-032712-095916; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Davenport TM, 2011, J VIROL, V85, P7095, DOI 10.1128/JVI.00411-11; Derby NR, 2007, VIROLOGY, V366, P433, DOI 10.1016/j.virol.2007.05.020; EARL PL, 1994, J VIROL, V68, P3015, DOI 10.1128/JVI.68.5.3015-3026.1994; Earl PL, 2001, J VIROL, V75, P645, DOI 10.1128/JVI.75.2.645-653.2001; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Ferrantelli F, 2003, AIDS, V17, P301, DOI 10.1097/00002030-200302140-00003; Gauduin MC, 1997, NAT MED, V3, P1389, DOI 10.1038/nm1297-1389; Gorny MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027780; Gorny MK, 2000, J VIROL, V74, P6186, DOI 10.1128/JVI.74.13.6186-6192.2000; Gorny MK, 2004, J VIROL, V78, P2394, DOI 10.1128/JVI.78.5.2394-2404.2004; GORNY MK, 1993, J IMMUNOL, V150, P635; Gorny MK, 2002, J VIROL, V76, P9035, DOI 10.1128/JVI.76.18.9035-9045.2002; Harris A, 2011, P NATL ACAD SCI USA, V108, P11440, DOI 10.1073/pnas.1101414108; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hoorelbeke B, 2013, FEBS LETT, V587, P860, DOI 10.1016/j.febslet.2013.02.037; Huang KHG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1100; Humbert M, 2007, EUR J IMMUNOL, V37, P501, DOI 10.1002/eji.200636560; Hust Michael, 2007, V408, P243, DOI 10.1007/978-1-59745-547-3_14; Hust M, 2011, J BIOTECHNOL, V152, P159, DOI 10.1016/j.jbiotec.2010.09.945; Izumi Kazuki, 2011, Antiviral Chemistry & Chemotherapy, V22, P51, DOI 10.3851/IMP1836; Jager V, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-52; Jaworski JP, 2013, J VIROL, V87, P10447, DOI 10.1128/JVI.00049-13; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Kim M, 2005, AIDS RES HUM RETROV, V21, P58, DOI 10.1089/aid.2005.21.58; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Miethe S, 2014, MABS-AUSTIN, V6, P446, DOI 10.4161/mabs.27773; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; Moore PL, 2011, J VIROL, V85, P3128, DOI 10.1128/JVI.02658-10; Morris L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023532; Nkolola JP, 2010, J VIROL, V84, P3270, DOI 10.1128/JVI.02252-09; PARREN PWHI, 1995, AIDS, V9, pF1, DOI 10.1097/00002030-199506000-00001; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Pietzsch J, 2012, P NATL ACAD SCI USA, V109, P15859, DOI 10.1073/pnas.1213409109; Plewnia G, 2007, J MOL BIOL, V369, P95, DOI 10.1016/j.jmb.2007.02.102; Retter I, 2005, NUCLEIC ACIDS RES, V33, pD671, DOI 10.1093/nar/gki088; Ringe RP, 2013, P NATL ACAD SCI USA, V110, P18256, DOI 10.1073/pnas.1314351110; Rondot S, 2001, NAT BIOTECHNOL, V19, P75, DOI 10.1038/83567; Ruprecht Ruth M., 2009, V525, P559, DOI 10.1007/978-1-59745-554-1_31; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Schmitz JE, 2003, J VIROL, V77, P2165, DOI 10.1128/JVI.77.3.2165-2173.2003; Schreiber A, 2005, J COMPUT CHEM, V26, P879, DOI 10.1002/jcc.20229; Schultz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051715; Sharon M, 2003, STRUCTURE, V11, P225, DOI 10.1016/S0969-2126(03)00011-X; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Soltes G, 2007, J BIOTECHNOL, V127, P626, DOI 10.1016/j.jbiotec.2006.08.015; Stanfield RL, 2004, STRUCTURE, V12, P193, DOI 10.1016/j.str.2004.01.003; Sundling C, 2010, J EXP MED, V207, P2003, DOI 10.1084/jem.20100025; TILLEY SA, 1992, AIDS RES HUM RETROV, V8, P461, DOI 10.1089/aid.1992.8.461; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Veselinovic M, 2012, VIROLOGY, V432, P505, DOI 10.1016/j.virol.2012.06.025; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yang XZ, 2001, J VIROL, V75, P1165, DOI 10.1128/JVI.75.3.1165-1171.2001; Yu XW, 2012, J VIROL, V86, P589, DOI 10.1128/JVI.05066-11; Yuan W, 2009, AIDS RES HUM RETROV, V25, P319, DOI 10.1089/aid.2008.0213; Zahn RC, 2008, GENE THER, V15, P1210, DOI 10.1038/gt.2008.73; Zhang CWH, 2001, J BIOL CHEM, V276, P39577, DOI 10.1074/jbc.M107147200; Zhou MK, 2013, EUR J IMMUNOL, V43, P499, DOI 10.1002/eji.201242974; Zhou MK, 2012, VACCINE, V30, P1911, DOI 10.1016/j.vaccine.2012.01.026; Zolla-Pazner Susan, 2005, Human Antibodies, V14, P69; Zolla-Pazner S, 2010, NAT REV IMMUNOL, V10, P527, DOI 10.1038/nri2801; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	87	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97478	10.1371/journal.pone.0097478	http://dx.doi.org/10.1371/journal.pone.0097478			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828352	Green Published, gold, Green Submitted			2022-12-27	WOS:000336857400098
J	Warren, CJ; Griffin, LM; Little, AS; Huang, IC; Farzan, M; Pyeon, D				Warren, Cody J.; Griffin, Laura M.; Little, Alexander S.; Huang, I-Chueh; Farzan, Michael; Pyeon, Dohun			The Antiviral Restriction Factors IFITM1, 2 and 3 Do Not Inhibit Infection of Human Papillomavirus, Cytomegalovirus and Adenovirus	PLOS ONE			English	Article							INTERFERON-ALPHA; IMMUNE-RESPONSES; NATURAL-HISTORY; CERVICAL-CANCER; E7 ONCOPROTEIN; PROTEIN; CELLS; ENTRY; REPLICATION; PREVALENCE	Type I interferons (IFN-alpha and beta) induce dynamic host defense mechanisms to inhibit viral infections. It has been recently recognized that the interferon-inducible transmembrane proteins (IFITM) 1, 2 and 3 can block entry of a broad spectrum of RNA viruses. However, no study to date has focused on the role of IFITM proteins in DNA virus restriction. Here, we demonstrate that IFN-alpha or -beta treatment of keratinocytes substantially decreases human papillomavirus 16 (HPV16) infection while robustly inducing IFITM1, 2 and 3 expression. However, IFITM1, 2 and 3 overexpression did not inhibit HPV16 infection; rather, IFITM1 and IFITM3 modestly enhanced HPV16 infection in various cell types including primary keratinocytes. Moreover, IFITM1, 2 and 3 did not inhibit infection by two other DNA viruses, human cytomegalovirus (HCMV) and adenovirus type 5 (Ad5). Taken together, we reveal that the entry of several DNA viruses, including HPV, HCMV, and Ad5 is not affected by IFITM1, 2 and 3 expression. These results imply that HPV, and other DNA viruses, may bypass IFITM restriction during intracellular trafficking.	[Warren, Cody J.; Griffin, Laura M.; Little, Alexander S.; Pyeon, Dohun] Univ Colorado, Sch Med, Dept Microbiol, Aurora, CO USA; [Pyeon, Dohun] Univ Colorado, Sch Med, Dept Med, Aurora, CO USA; [Huang, I-Chueh] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; [Farzan, Michael] Scripps Res Inst, Dept Infect Dis, Jupiter, FL USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Riverside; Scripps Research Institute	Pyeon, D (corresponding author), Univ Colorado, Sch Med, Dept Microbiol, Aurora, CO USA.	Dohun.Pyeon@ucdenver.edu		Warren, Cody/0000-0003-4101-2705; Pyeon, Dohun/0000-0003-1970-844X; Farzan, Michael/0000-0002-2990-5319	NIH [R01 AI091968, T32 AI052066]; University of Colorado Health Sciences Library Open Access Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R00AI093679, R01AI091968, R01AI100953, T32AI052066] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Colorado Health Sciences Library Open Access Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants, R01 AI091968 (D. P.) and T32 AI052066 (L. G.). Publication of this article was funded in part by the University of Colorado Health Sciences Library Open Access Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amini-Bavil-Olyaee S, 2013, CELL HOST MICROBE, V13, P452, DOI 10.1016/j.chom.2013.03.006; Anafu AA, 2013, J BIOL CHEM, V288, P17261, DOI 10.1074/jbc.M112.438515; Barnard P, 1999, VIROLOGY, V259, P305, DOI 10.1006/viro.1999.9771; Beglin M, 2009, J INTERF CYTOK RES, V29, P629, DOI 10.1089/jir.2009.0075; Bodily J, 2011, TRENDS MICROBIOL, V19, P33, DOI 10.1016/j.tim.2010.10.002; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; BRANCA AA, 1981, NATURE, V294, P768, DOI 10.1038/294768a0; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Clifford G, 2006, VACCINE, V24, P26, DOI 10.1016/j.vaccine.2006.05.026; COMPTON T, 1992, VIROLOGY, V191, P387, DOI 10.1016/0042-6822(92)90200-9; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; Everitt AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080723; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; GARBE C, 1990, J INVEST DERMATOL, V95, pS231, DOI 10.1111/1523-1747.ep12875837; Gastaldelli M, 2008, TRAFFIC, V9, P2265, DOI 10.1111/j.1600-0854.2008.00835.x; Gillison ML, 2004, LANCET, V363, P1488, DOI 10.1016/S0140-6736(04)16194-1; Gillison ML, 2001, CURR OPIN ONCOL, V13, P183, DOI 10.1097/00001622-200105000-00009; GREBER UF, 1993, CELL, V75, P477, DOI 10.1016/0092-8674(93)90382-Z; Griffin LM, 2013, VIROLOGY, V437, P12, DOI 10.1016/j.virol.2012.12.004; HAUSEN HZ, 1991, VIROLOGY, V184, P9, DOI 10.1016/0042-6822(91)90816-T; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Kamper N, 2006, J VIROL, V80, P759, DOI 10.1128/JVI.80.2.759-768.2006; Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10; Meier O, 2004, J GENE MED, V6, pS152, DOI 10.1002/jgm.553; Modis Y, 2002, EMBO J, V21, P4754, DOI 10.1093/emboj/cdf494; Mudhasani R, 2013, J VIROL, V87, P8451, DOI 10.1128/JVI.03382-12; Park JS, 2000, J BIOL CHEM, V275, P6764, DOI 10.1074/jbc.275.10.6764; Perreira JM, 2013, J MOL BIOL, V425, P4937, DOI 10.1016/j.jmb.2013.09.024; Perry AK, 2005, CELL RES, V15, P407, DOI 10.1038/sj.cr.7290309; Pyeon D, 2005, P NATL ACAD SCI USA, V102, P9311, DOI 10.1073/pnas.0504020102; Pyeon D, 2007, CANCER RES, V67, P4605, DOI 10.1158/0008-5472.CAN-06-3619; Pyeon D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000318; Qian ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076469; Raychoudhuri A, 2011, J VIROL, V85, P12881, DOI 10.1128/JVI.05633-11; Richardson H, 2003, CANCER EPIDEM BIOMAR, V12, P485; Rincon-Orozco B, 2009, CANCER RES, V69, P8718, DOI 10.1158/0008-5472.CAN-09-0550; Ronco LV, 1998, GENE DEV, V12, P2061, DOI 10.1101/gad.12.13.2061; Ryckman BJ, 2006, J VIROL, V80, P710, DOI 10.1128/JVI.80.2.710-722.2006; Saslow D, 2007, CA-CANCER J CLIN, V57, P7, DOI 10.3322/canjclin.57.1.7; Schelhaas M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002657; Schiffman Mark, 2009, Infect Agent Cancer, V4, P8, DOI 10.1186/1750-9378-4-8; Schiller John T, 2010, Gynecol Oncol, V118, pS12, DOI 10.1016/j.ygyno.2010.04.004; Sherman ME, 2003, JNCI-J NATL CANCER I, V95, P46, DOI 10.1093/jnci/95.1.46; Sinzger C, 2008, J CLIN VIROL, V41, P174, DOI 10.1016/j.jcv.2007.12.002; Spoden G, 2013, J VIROL, V87, P7765, DOI 10.1128/JVI.00370-13; Stanley M, 2006, VACCINE, V24, P16, DOI 10.1016/j.vaccine.2005.09.002; Stanley MA, 2009, INDIAN J MED RES, V130, P266; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Weinstock H, 2004, PERSPECT SEX REPRO H, V36, P6, DOI 10.1111/j.1931-2393.2004.tb00002.x; Wiethoff CM, 2005, J VIROL, V79, P1992, DOI 10.1128/JVI.79.4.1992-2000.2005; Woodman CBJ, 2001, LANCET, V357, P1831, DOI 10.1016/S0140-6736(00)04956-4	55	56	58	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96579	10.1371/journal.pone.0096579	http://dx.doi.org/10.1371/journal.pone.0096579			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827144	Green Published, Green Submitted, gold			2022-12-27	WOS:000336857400028
J	Boltjes, A; Groothuismink, ZM; van Oord, GW; Janssen, HLA; Woltman, AM; Boonstra, A				Boltjes, Arjan; Groothuismink, Zwier M.; van Oord, Gertine W.; Janssen, Harry L. A.; Woltman, Andrea M.; Boonstra, Andre			Monocytes from Chronic HBV Patients React In Vitro to HBsAg and TLR by Producing Cytokines Irrespective of Stage of Disease	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; RECOMBINANT HBSAG; BLOOD MONOCYTES; SURFACE-ANTIGEN; SERUM-LEVELS; EXPRESSION; INTERLEUKIN-10; ACTIVATION; INFECTION; MACROPHAGES	Individuals who are chronically infected with the hepatitis B virus (HBV) are highly heterogenous with respect to serum levels of HBV DNA, HBV particles and viral proteins. Since circulating leukocytes, such as monocytes, are constantly exposed to these viral components, it is likely that the functionality of these cells is affected. However, at present, little information is available on the consequences of the interaction between monocytes and viral components. Therefore, we examined the in vitro effects of HBV surface antigen (HBsAg) on monocytes and evaluated whether these effects were reflected in vivo. We observed that in vitro HBsAg exposure of monocytes induced robust production of IL-6 and TNF. However, between chronic HBV patients with distinct levels of serum HBsAg, HBV early antigen (HBeAg), and HBV DNA, TLR-induced monocyte cytokine production did not differ. Importantly, HBsAg-induced cytokine production by monocytes was similar between patients and healthy controls showing that earlier in vivo exposure to HBsAg does not affect the in vitro response. Additionally, we show that IL-10 is able to inhibit cytokine production by HBsAg-induced monocytes. In conclusion, we demonstrate that monocytes can recognize and respond to HBsAg, resulting in vigorous pro-inflammatory cytokine production in vitro. However, phenotype and function of the monocyte compartment in chronic HBV patients are not influenced by differences in levels of serum viral components, suggesting that regulatory mechanisms are active to avoid excessive in vivo monocyte activation.	[Boltjes, Arjan; Groothuismink, Zwier M.; van Oord, Gertine W.; Janssen, Harry L. A.; Woltman, Andrea M.; Boonstra, Andre] Erasmus MC Univ, Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Janssen, Harry L. A.] Univ Toronto, Div Gastroenterol, Univ Hlth Network, Liver Clin, Toronto, ON, Canada	Erasmus University Rotterdam; Erasmus MC; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Boonstra, A (corresponding author), Erasmus MC Univ, Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands.	p.a.boonstra@erasmusmc.nl	Woltman, Andrea/GYV-2656-2022	Woltman, Andrea/0000-0001-9904-6751; Boltjes, Arjan/0000-0002-6338-051X; Boonstra, Andre/0000-0001-8607-1616	Dutch government [FES0908]; Netherlands Genomics Initiative [050-060-452]; Netherlands Organization for Scientific Research (NWO VIDI) [91712329]	Dutch government; Netherlands Genomics Initiative; Netherlands Organization for Scientific Research (NWO VIDI)(Netherlands Organization for Scientific Research (NWO))	This study was supported by the Virgo consortium, funded by the Dutch government project number FES0908, by the Netherlands Genomics Initiative (NGI; http://www.genomics.nl/) project number 050-060-452, and by The Netherlands Organization for Scientific Research (NWO VIDI Grant 91712329 to A. M. W.; http://www.nwo.nl/en/funding/our-funding-instruments/nwo/innovational-research-incentives-scheme/vidi/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony DD, 2011, VACCINE, V29, P3558, DOI 10.1016/j.vaccine.2011.02.092; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Boonstra A, 2008, BEST PRACT RES CL GA, V22, P1049, DOI 10.1016/j.bpg.2008.11.015; Bozkaya H, 2000, HEPATO-GASTROENTEROL, V47, P1675; Cheng JD, 2005, J HEPATOL, V43, P465, DOI 10.1016/j.jhep.2005.02.033; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; den Brouw MLO, 2009, IMMUNOLOGY, V126, P280, DOI 10.1111/j.1365-2567.2008.02896.x; Dunn C, 2009, GASTROENTEROLOGY, V137, P1289, DOI 10.1053/j.gastro.2009.06.054; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Gehring AJ, 2013, J CLIN INVEST, V123, P3766, DOI 10.1172/JCI66043; JOCHUM C, 1990, J VIROL, V64, P1956, DOI 10.1128/JVI.64.5.1956-1963.1990; Liu BS, 2012, EUR J IMMUNOL, V42, P2431, DOI 10.1002/eji.201142360; Liu BS, 2011, J LEUKOCYTE BIOL, V89, P981, DOI 10.1189/jlb.1210680; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; NOCKHER WA, 1994, CLIN EXP IMMUNOL, V98, P369, DOI 10.1111/j.1365-2249.1994.tb05499.x; Nockher WA, 1998, INFECT IMMUN, V66, P2782, DOI 10.1128/IAI.66.6.2782-2790.1998; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Peng C, 2011, MOL IMMUNOL, V48, P1505, DOI 10.1016/j.molimm.2011.04.008; Peppa D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001227; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Riordan SM, 2006, CLIN VACCINE IMMUNOL, V13, P972, DOI 10.1128/CVI.00396-05; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Shi BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044900; Shi M, 2007, CLIN EXP IMMUNOL, V147, P277, DOI 10.1111/j.1365-2249.2006.03281.x; Tulek N, 2000, HEPATO-GASTROENTEROL, V47, P828; Vanlandschoot P, 2002, BIOCHEM BIOPH RES CO, V297, P486, DOI 10.1016/S0006-291X(02)02243-X; Vanlandschoot P, 2002, J GEN VIROL, V83, P1281, DOI 10.1099/0022-1317-83-6-1281; Vanlandschoot P, 2002, J GEN VIROL, V83, P2279, DOI 10.1099/0022-1317-83-9-2279; Visvanathan K, 2007, HEPATOLOGY, V45, P102, DOI 10.1002/hep.21482; Woltman AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015324; Wu JF, 2010, GASTROENTEROLOGY, V138, P165, DOI 10.1053/j.gastro.2009.09.018; Xu Y, 2009, MOL IMMUNOL, V46, P2640, DOI 10.1016/j.molimm.2009.04.031; Zhang JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017484	34	24	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97006	10.1371/journal.pone.0097006	http://dx.doi.org/10.1371/journal.pone.0097006			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824830	Green Published, Green Submitted, gold			2022-12-27	WOS:000336369200049
J	Murhekar, MV; Ahmad, M; Shukla, H; Abhishek, K; Perry, RT; Bose, AS; Shimpi, R; Kumar, A; Kaliaperumal, K; Sethi, R; Selvaraj, V; Kamaraj, P; Routray, S; Das, VN; Menabde, N; Bahl, S				Murhekar, Manoj V.; Ahmad, Mohammad; Shukla, Hemant; Abhishek, Kunwar; Perry, Robert T.; Bose, Anindya S.; Shimpi, Rahul; Kumar, Arun; Kaliaperumal, Kanagasabai; Sethi, Raman; Selvaraj, Vadivoo; Kamaraj, Pattabi; Routray, Satyabrata; Das, Vidya Nand; Menabde, Nata; Bahl, Sunil			Measles Case Fatality Rate in Bihar, India, 2011-12	PLOS ONE			English	Article							MORTALITY REDUCTION GOAL; COMMUNITY; SURVEILLANCE; INFECTION; MODEL	Background: Updated estimates of measles case fatality rates (CFR) are critical for monitoring progress towards measles elimination goals. India accounted for 36% of total measles deaths occurred globally in 2011. We conducted a retrospective cohort study to estimate measles CFR and identify the risk factors for measles death in Bihar-one of the north Indian states historically known for its low vaccination coverage. Methods: We systematically selected 16 of the 31 laboratory-confirmed measles outbreaks occurring in Bihar during 1 October 2011 to 30 April 2012. All households of the villages/urban localities affected by these outbreaks were visited to identify measles cases and deaths. We calculated CFR and used multivariate analysis to identify risk factors for measles death. Results: The survey found 3670 measles cases and 28 deaths (CFR: 0.78, 95% confidence interval: 0.47-1.30). CFR was higher among under-five children (1.22%) and children belonging to scheduled castes/tribes (SC/ST, 1.72%). On multivariate analysis, independent risk factors associated with measles death were age,5 years, SC/ST status and non-administration of vitamin A during illness. Outbreaks with longer interval between the occurrence of first case and notification of the outbreak also had a higher rate of deaths. Conclusions: Measles CFR in Bihar was low. To further reduce case fatality, health authorities need to ensure that SC/ST are targeted by the immunization programme and that outbreak investigations target for vitamin A treatment of cases in high risk groups such as SC/ST and young children and ensure regular visits by health-workers in affected villages to administer vitamin A to new cases.	[Murhekar, Manoj V.; Kaliaperumal, Kanagasabai; Selvaraj, Vadivoo; Kamaraj, Pattabi] ICMR, Natl Inst Epidemiol, Madras, Tamil Nadu, India; [Ahmad, Mohammad; Shukla, Hemant; Abhishek, Kunwar; Bose, Anindya S.; Shimpi, Rahul; Kumar, Arun; Sethi, Raman; Routray, Satyabrata; Menabde, Nata; Bahl, Sunil] WHO, Country Off India, Natl Polio Surveillance Project, New Delhi, India; [Shukla, Hemant; Perry, Robert T.] WHO, CH-1211 Geneva, Switzerland; [Bose, Anindya S.] Bill & Melinda Gates Fdn, New Delhi, India; [Das, Vidya Nand] Rajendra Mem Res Inst Med Sci, Patna, Bihar, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Epidemiology (NIE); World Health Organization; World Health Organization; Indian Council of Medical Research (ICMR); ICMR - Rajendra Memorial Research Institute of Medical Sciences (RMRI)	Murhekar, MV (corresponding author), ICMR, Natl Inst Epidemiol, Madras, Tamil Nadu, India.	mmurhekar@gmail.com	Murhekar, Manoj/ABG-2389-2020	Murhekar, Manoj/0000-0002-1720-7628; Bose, Anindya Sekhar/0000-0002-7657-8648	WHO (World Health Organization) [2013-297450-0]	WHO (World Health Organization)	The authors received funding from WHO (World Health Organization). The Reference Number associated with this funding is 2013-297450-0. The authors (MA, HS, KA, RTP, ASB, RS, AK, RS, SR, NM, SB) received salary from WHO during this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AABY P, 1986, J INFECT DIS, V154, P858, DOI 10.1093/infdis/154.5.858; Cairns KL, 2010, EMERG THEMES EPIDEMI, V7, DOI 10.1186/1742-7622-7-4; Chen S, 2012, J R STAT SOC C-APPL, V61, P117, DOI 10.1111/j.1467-9876.2011.01001.x; Coronado F, 2006, J TROP PEDIATRICS, V52, P329, DOI 10.1093/tropej/fml026; D'Souza R. M., 2002, COCHRANE DB SYST REV, V1; Govt of India, ANN HLTH SURV 2010 2; International Institute for Population Sciences (IIPS) and Macro International, 2007, NAT FAM HLTH SURV NF, V1, P227; Joshi AB, 2009, B WORLD HEALTH ORGAN, V87, P456, DOI 10.2471/BLT.07.050427; MANCHANDA KS, 1980, TROP GEOGR MED, V32, P70; Ministry of Health and Family Welfare Government of India, 2005, MEASL SURV OUTBR INV; Ministry of Health and Family Welfare Govt of India, 2010, MEASL CATCH UP IMM C; Ministry of Social Justice and Empowerment Govt of India, 1965, REP ADV COMM REV LIS; Murhekar MV, 2011, J INFECT DIS, V204, pS427, DOI 10.1093/infdis/jir062; ORENSTEIN WA, 1988, EPIDEMIOL REV, V10, P212, DOI 10.1093/oxfordjournals.epirev.a036023; Perry RT, 2013, MMWR-MORBID MORTAL W, V62, P27; Samb B, 1997, AM J EPIDEMIOL, V145, P51, DOI 10.1093/oxfordjournals.aje.a009031; Simons Emily, 2012, Lancet, V379, P2173, DOI 10.1016/S0140-6736(12)60522-4; Singh M B, 1994, Indian Pediatr, V31, P340; Stein CE, 2003, J INFECT DIS, V187, pS8, DOI 10.1086/368114; Sudfeld CR, 2009, INDIAN PEDIATR, V46, P983; UNICEF, COV EV SURV 2009; WHO, 1993, WHOEPIGEN9303; Wolfson LJ, 2007, LANCET, V369, P191, DOI 10.1016/S0140-6736(07)60107-X; Wolfson LJ, 2009, INT J EPIDEMIOL, V38, P192, DOI 10.1093/ije/dyn224	24	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96668	10.1371/journal.pone.0096668	http://dx.doi.org/10.1371/journal.pone.0096668			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824641	Green Published, gold, Green Submitted			2022-12-27	WOS:000336369200027
J	Suarez, SC; Toffton, SM; McCulloch, SD				Suarez, Samuel C.; Toffton, Shannon M.; McCulloch, Scott D.			Biochemical Analysis of DNA Polymerase eta Fidelity in the Presence of Replication Protein A	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; THYMINE-THYMINE DIMER; ACCESSORY PROTEINS; SACCHAROMYCES-CEREVISIAE; BINDING-PROTEIN; HUMAN-CELLS; 8-OXO-GUANINE BYPASS; SITE; PROCESSIVITY; ALPHA	DNA polymerase g (pol eta) synthesizes across from damaged DNA templates in order to prevent deleterious consequences like replication fork collapse and double-strand breaks. This process, termed translesion synthesis (TLS), is an overall positive for the cell, as cells deficient in pol g display higher mutation rates. This outcome occurs despite the fact that the in vitro fidelity of bypass by pol eta alone is moderate to low, depending on the lesion being copied. One possible means of increasing the fidelity of pol eta is interaction with replication accessory proteins present at the replication fork. We have previously utilized a bacteriophage based screening system to measure the fidelity of bypass using purified proteins. Here we report on the fidelity effects of a single stranded binding protein, replication protein A (RPA), when copying the oxidative lesion 7,8-dihydro-8-oxo-guanine(8-oxoG) and the UV-induced cis-syn thymine-thymine cyclobutane pyrimidine dimer (T-T CPD). We observed no change in fidelity dependent on RPA when copying these damaged templates. This result is consistent in multiple position contexts. We previously identified single amino acid substitution mutants of pol eta that have specific effects on fidelity when copying both damaged and undamaged templates. In order to confirm our results, we examined the Q38A and Y52E mutants in the same full-length construct. We again observed no difference when RPA was added to the bypass reaction, with the mutant forms of pol eta displaying similar fidelity regardless of RPA status. We do, however, observe some slight effects when copying undamaged DNA, similar to those we have described previously. Our results indicate that RPA by itself does not affect pol g dependent lesion bypass fidelity when copying either 8-oxoG or T-T CPD lesions.	[Suarez, Samuel C.; Toffton, Shannon M.; McCulloch, Scott D.] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [McCulloch, Scott D.] N Carolina State Univ, Ctr Human Hlth & Environm, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	McCulloch, SD (corresponding author), N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA.	scott_mcculloch@ncsu.edu			National Institute of Environmental Health Sciences [R01 ES016942];  [T32 ES007046]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016942, T32ES007046] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	National Institute of Environmental Health Sciences (http://www.niehs.nih.gov/). R01 ES016942 to SM, supporting SM and SS. T32 ES007046 supporting SM and SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beardslee RA, 2013, ENVIRON MOL MUTAGEN, V54, P638, DOI 10.1002/em.21807; Bebenek A, 2005, GENETICS, V169, P1815, DOI 10.1534/genetics.104.037630; Bebenek A, 2002, GENETICS, V162, P1003; Betous R, 2009, MOL CARCINOGEN, V48, P369, DOI 10.1002/mc.20509; Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; BLACKWELL LJ, 1994, MOL CELL BIOL, V14, P3993, DOI 10.1128/MCB.14.6.3993; Bloom LB, 1997, J BIOL CHEM, V272, P27919, DOI 10.1074/jbc.272.44.27919; CARTY MP, 1992, MUTAT RES, V274, P29, DOI 10.1016/0921-8777(92)90041-Z; Fortune JM, 2006, NUCLEIC ACIDS RES, V34, P4335, DOI 10.1093/nar/gkl403; Frank EG, 2012, ANAL BIOCHEM, V429, P132, DOI 10.1016/j.ab.2012.07.016; Guo CX, 2009, CELL MOL LIFE SCI, V66, P2363, DOI 10.1007/s00018-009-0024-4; Haracska L, 2000, NAT GENET, V25, P458, DOI 10.1038/78169; Hashimoto K, 2003, BIOCHEMISTRY-US, V42, P14207, DOI 10.1021/bi0348359; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Kamath-Loeb AS, 2007, P NATL ACAD SCI USA, V104, P10394, DOI 10.1073/pnas.0702513104; Kawamoto T, 2005, MOL CELL, V20, P793, DOI 10.1016/j.molcel.2005.10.016; Kobayashi S, 2002, J BIOL CHEM, V277, P34198, DOI 10.1074/jbc.M204826200; Kokoska RJ, 2003, J BIOL CHEM, V278, P50537, DOI 10.1074/jbc.M308515200; Kroutil LC, 1998, J MOL BIOL, V278, P135, DOI 10.1006/jmbi.1998.1676; KUNKEL TA, 1994, P NATL ACAD SCI USA, V91, P6830, DOI 10.1073/pnas.91.15.6830; KUNKEL TA, 1991, MUTAT RES, V250, P175, DOI 10.1016/0027-5107(91)90174-M; Lee DH, 2008, MUTAT RES-FUND MOL M, V641, P19, DOI 10.1016/j.mrfmmm.2008.02.006; Maga G, 2001, J BIOL CHEM, V276, P18235, DOI 10.1074/jbc.M009599200; Maga G, 2007, NATURE, V447, P606, DOI 10.1038/nature05843; MAHER VM, 1976, NATURE, V261, P593, DOI 10.1038/261593a0; MAHER VM, 1976, BIOCHEM BIOPH RES CO, V71, P228, DOI 10.1016/0006-291X(76)90272-2; Matsuda T, 2001, J MOL BIOL, V312, P335, DOI 10.1006/jmbi.2001.4937; Matsuda T, 2000, NATURE, V404, P1011, DOI 10.1038/35010014; McCulloch SD, 2007, BIOCHEMISTRY-US, V46, P8888, DOI 10.1021/bi700234t; McCulloch SD, 2009, NUCLEIC ACIDS RES, V37, P2830, DOI 10.1093/nar/gkp103; McCulloch SRD, 2006, METHOD ENZYMOL, V408, P341, DOI 10.1016/S0076-6879(06)08021-9; McCulloch SD, 2004, NATURE, V428, P97, DOI 10.1038/nature02352; Mozzherin DJ, 1996, J BIOL CHEM, V271, P31711, DOI 10.1074/jbc.271.49.31711; Park H, 2002, P NATL ACAD SCI USA, V99, P15965, DOI 10.1073/pnas.242422699; Perales C, 2003, NUCLEIC ACIDS RES, V31, P6473, DOI 10.1093/nar/gkg865; Rey L, 2009, MOL CELL BIOL, V29, P3344, DOI 10.1128/MCB.00115-09; ROBERTS JD, 1990, PROG CLIN BIOL RES, V340, P91; Rogozin IB, 2001, NAT IMMUNOL, V2, P530, DOI 10.1038/88732; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Suarez SC, 2013, MUTAT RES-FUND MOL M, V745, P46, DOI 10.1016/j.mrfmmm.2013.03.001; SUZUKI M, 1994, J BIOL CHEM, V269, P10225; Washington MT, 1999, J BIOL CHEM, V274, P36835, DOI 10.1074/jbc.274.52.36835; Yang ZG, 2002, BIOCHEMISTRY-US, V41, P13012, DOI 10.1021/bi026064z; Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4717, DOI 10.1093/nar/28.23.4717; Zhong XJ, 2006, NUCLEIC ACIDS RES, V34, P4731, DOI 10.1093/nar/gkl465	46	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97382	10.1371/journal.pone.0097382	http://dx.doi.org/10.1371/journal.pone.0097382			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824831	Green Published, gold, Green Submitted			2022-12-27	WOS:000336369200106
J	Wohl, DA; Bhatti, L; Small, CB; Edelstein, H; Zhao, HH; Margolis, DA; DeJesus, E; Weinberg, WG; Ross, LL; Shaefer, MS				Wohl, David A.; Bhatti, Laveeza; Small, Catherine B.; Edelstein, Howard; Zhao, Henry H.; Margolis, David A.; DeJesus, Edwin; Weinberg, Winkler G.; Ross, Lisa L.; Shaefer, Mark S.			Simplification to Abacavir/Lamivudine plus Atazanavir Maintains Viral Suppression and Improves Bone and Renal Biomarkers in ASSURE, a Randomized, Open Label, Non-Inferiority Trial	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; UNBOOSTED ATAZANAVIR; VIROLOGICAL SUPPRESSION; HIV-1-INFECTED PATIENTS; ABACAVIR-LAMIVUDINE; PROTEASE INHIBITOR; POSITIVE PATIENTS; MINERAL DENSITY; EFFICACY	Objective: Simplification of antiretroviral therapy in patients with suppressed viremia may minimize long-term adverse effects. The study's primary objective was to determine whether abacavir/lamivudine + atazanavir (ABC/3TC+ATV) was virologically non-inferior to tenofovir/emtricitabine + atazanavir/ritonavir (TDF/FTC+ATV/r) over 24 weeks in a population of virologically suppressed, HIV-1 infected patients. Design: This open-label, multicenter, non-inferiority study enrolled antiretroviral experienced, HIV-infected adults currently receiving a regimen of TDF/FTC+ATV/r for >= 6 months with no history of virologic failure and whose HIV-1 RNA had been <= 75 copies/mL on 2 consecutive measurements including screening. Patients were randomized 1: 2 to continue current treatment or simplify to ABC/3TC+ ATV. Methods: The primary endpoint was the proportion of patients with HIV-RNA, 50 copies/mL at Week 24 by the Time to Loss of Virologic Response (TLOVR) algorithm. Secondary endpoints included alternative measures of efficacy, adverse events (AEs), and fasting lipids. Exploratory endpoints included inflammatory, coagulation, bone, and renal biomarkers. Results: After 24 weeks, ABC/3TC+ ATV (n = 199) was non-inferior to TDF/FTC+ATV/r (n = 97) by both the primary analysis (87% in both groups) and all secondary efficacy analyses. Rates of grade 2-4 AEs were similar between the two groups (40% vs 37%, respectively), but an excess of hyperbilirubinemia made the rate of grade 3-4 laboratory abnormalities higher in the TDF/FTC+ATV/r group (30%) compared with the ABC/3TC+ATV group (13%). Lipid levels were stable except for HDL cholesterol, which increased significantly in the ABC/3TC+ATV group. Bone and renal biomarkers improved significantly between baseline and Week 24 in patients taking ABC/3TC+ATV, and the difference between groups was significant at Week 24. No significant changes occurred in any inflammatory or coagulation biomarker within or between treatment groups. Conclusions: After 24 weeks, simplification to ABC/3TC+ATV from TDF/FTC+ATV/r maintained viral suppression was well-tolerated, and led to improvements in bone and renal biomarkers and HDL cholesterol.	[Wohl, David A.] Univ N Carolina, AIDS Clin Trials Unit, Chapel Hill, NC 27514 USA; [Bhatti, Laveeza] AIDS Healthcare Fdn, Beverly Hills, CA USA; [Small, Catherine B.] New York Med Coll, Valhalla, NY 10595 USA; [Edelstein, Howard] Alameda Cty Med Ctr, Oakland, CA USA; [Zhao, Henry H.; Margolis, David A.] GlaxoSmithKline, Res Triangle Pk, NC USA; [DeJesus, Edwin] Orlando Immunol Ctr, Orlando, FL USA; [Weinberg, Winkler G.] Kaiser Fdn Hlth Plan Georgia Inc, Atlanta, GA USA; [Ross, Lisa L.; Shaefer, Mark S.] ViiV Healthcare, Res Triangle Pk, NC USA	University of North Carolina; University of North Carolina Chapel Hill; New York Medical College; GlaxoSmithKline; Orlando Immunology Center; GlaxoSmithKline	Wohl, DA (corresponding author), Univ N Carolina, AIDS Clin Trials Unit, Chapel Hill, NC 27514 USA.	david_wohl@med.unc.edu		Shaefer, Mark/0000-0002-0545-7304	ViiV Healthcare [EPZ113734]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER	ViiV Healthcare; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The EPZ113734 study was sponsored by ViiV Healthcare (www.viivhealthcare.com) which along with Dr. Wohl developed the study design with input from study investigators who were contracted by ViiV Healthcare to collect and assist in the analyses of the clinical data, and contracted with GlaxoSmithKline to collect and analyze the clinical data. ViiV employees are named authors and assisted in data analysis and manuscript preparation. In addition to the named authors, the following individuals who were employed or contracted by ViiV Healthcare were instrumental in the initial study design: Parul Patel, the clinical data collection and management: Ilisse Minto, Daphne Percival and Melinda Bomar, the clinical data analysis: Brian Wine, Evit Blackmon, and Shannon Labelle, the study safety evaluation: Teodora Perger and manuscript preparation: Katharine DeBruin. The manuscript was written and approved by all of the authors, who each contributed to the drafts and revisions. All authors had full data access and vouch for the data analysis accuracy and completeness.	[Anonymous], 2013, PRESCR INF NORV; [Anonymous], 2013, PRESCR INF REYAT; Bertz RJ, 2013, PHARMACOTHERAPY, V33, P284, DOI 10.1002/phar.1205; Brown TT, 2011, ANTIVIR THER, V16, P1063, DOI 10.3851/IMP1874; Brown TT, 2009, JAIDS-J ACQ IMM DEF, V51, P554, DOI 10.1097/QAI.0b013e3181adce44; Campo R, 2013, CLIN INFECT DIS, V56, P1637, DOI 10.1093/cid/cis1203; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Elion R, 2010, HIV CLIN TRIALS, V11, P170, DOI 10.1310/hct1103-170; Foca E, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-38; Fux CA, 2007, ANTIVIR THER, V12, P1165; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Gatell J, 2007, CLIN INFECT DIS, V44, P1484, DOI 10.1086/517497; Ghosn J, 2010, ANTIVIR THER, V15, P993, DOI 10.3851/IMP1666; Haskelberg H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038377; Hocqueloux L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049289; Johnson VA, 2013, TOP ANTIVIR MED; Jong E, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-9; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Martin A, 2010, AIDS, V24, P2657, DOI 10.1097/QAD.0b013e32833f147f; Martinez E, 2010, AIDS, V24, pF1, DOI 10.1097/QAD.0b013e32833562c5; McComsey GA, 2011, J INFECT DIS, V203, P1791, DOI 10.1093/infdis/jir188; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2013, GUIDELINES USE ANTIR; Patel P, 2012, ANTIVIR THER, V17, P755, DOI 10.3851/IMP2020; Pavie J, 2011, J ANTIMICROB CHEMOTH, V66, P2372, DOI 10.1093/jac/dkr316; Piso RJ, 2011, JAIDS-J ACQ IMM DEF, V56, P320, DOI 10.1097/QAI.0b013e31820cf010; Post FA, 2010, JAIDS-J ACQ IMM DEF, V55, P49, DOI 10.1097/QAI.0b013e3181dd911e; Santos JR, 2009, HIV CLIN TRIALS, V10, P129, DOI 10.1310/hct1003-129; Rasmussen TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032445; Ryom L, 2012, 19 C RETR OPP INF MA; Sension M, 2009, JAIDS-J ACQ IMM DEF, V51, P153, DOI 10.1097/QAI.0b013e3181a5701c; Smith KY, 2009, AIDS, V23, P1547, DOI 10.1097/QAD.0b013e32832cbcc2; Soriano V, 2008, J ANTIMICROB CHEMOTH, V61, P200, DOI 10.1093/jac/dkm413; Squires KE, 2010, AIDS, V24, P2019, DOI 10.1097/QAD.0b013e32833bee1b; Stellbrink HJ, 2010, CLIN INFECT DIS, V51, P963, DOI 10.1086/656417; Young B, 2013, AIDS RES HUM RETROV, V29, P350, DOI [10.1089/aid.2012.0278, 10.1089/AID.2012.0278]	36	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96187	10.1371/journal.pone.0096187	http://dx.doi.org/10.1371/journal.pone.0096187			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24825167	Green Published, Green Submitted, gold			2022-12-27	WOS:000336369200011
J	Ito, G; Fujimoto, T; Kamikawaji, S; Kuwahara, T; Iwatsubo, T				Ito, Genta; Fujimoto, Tetta; Kamikawaji, Shogo; Kuwahara, Tomoki; Iwatsubo, Takeshi			Lack of Correlation between the Kinase Activity of LRRK2 Harboring Kinase-Modifying Mutations and Its Phosphorylation at Ser910, 935, and Ser955	PLOS ONE			English	Article							DISEASE-ASSOCIATED MUTATIONS; PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; 14-3-3 BINDING; GTP-BINDING; INHIBITION; POTENT; DOMAIN; GENE	Leucine-rich repeat kinase 2 (LRRK2) is extensively phosphorylated in cells within a region amino-terminal to the leucine-rich repeat domain. Since phosphorylation in this region of LRRK2, including Ser910, Ser935, Ser955, and Ser973, is significantly downregulated upon treatment with inhibitors of LRRK2, it has been hypothesized that signaling pathways downstream of the kinase activity of LRRK2 are involved in regulating the phosphorylation of LRRK2, although the precise mechanism has remained unknown. Here we examined the effects of LRRK2 inhibitors on the phosphorylation state at Ser910, Ser935, and Ser955 in a series of kinase-inactive mutants of LRRK2. We found that the responses of LRRK2 to the inhibitors varied among mutants, in a manner not consistent with the above-mentioned hypothesis. Notably, one of the kinase-inactive mutants, T2035A LRRK2, underwent phosphorylation, as well as the inhibitor-induced dephosphorylation, at Ser910, Ser935, and Ser955, to a similar extent to those observed with wild-type LRRK2. These results suggest that the kinase activity of LRRK2 is not involved in the common mechanism of inhibitor-induced dephosphorylation of LRRK2.	[Ito, Genta; Fujimoto, Tetta; Kuwahara, Tomoki; Iwatsubo, Takeshi] Univ Tokyo, Dept Neuropathol, Grad Sch Med, Tokyo, Japan; [Kamikawaji, Shogo; Iwatsubo, Takeshi] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Neuropathol & Neurosci, Tokyo, Japan	University of Tokyo; University of Tokyo	Iwatsubo, T (corresponding author), Univ Tokyo, Dept Neuropathol, Grad Sch Med, Tokyo, Japan.	iwatsubo@m.u-tokyo.ac.jp	Ito, Genta/L-2581-2015; Kuwahara, Tomoki/AAT-7119-2021; Kuwahara, Tomoki/AAX-2459-2020	Ito, Genta/0000-0001-6370-1099; Kuwahara, Tomoki/0000-0003-1788-7018; 	Japan Society for the Promotion of Science [22790058, 24790068]; Ministry of Education, Culture, Sports, Science and Technology [17025009]; Japan Science and Technology Agency [Core Research for Evolutional Science and Technology (CREST) for TI]; Elan Pharmaceuticals (Innovation Program)	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency [Core Research for Evolutional Science and Technology (CREST) for TI]; Elan Pharmaceuticals (Innovation Program)	This work was supported by the Japan Society for the Promotion of Science [grant number 22790058 and 24790068 for GI] [Grant-in-Aid for Young Scientists (B)], by the Ministry of Education, Culture, Sports, Science and Technology [grant number 17025009 for TI] (Grant-in-Aid for Scientific Research on Priority Areas-Research on Pathomechanism of Brain Disorders, and Global Center of Excellence Program), by the Japan Science and Technology Agency [Core Research for Evolutional Science and Technology (CREST) for TI] and by Elan Pharmaceuticals (Innovation Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba M, 1998, AM J PATHOL, V152, P879; Choi HG, 2012, ACS MED CHEM LETT, V3, P658, DOI 10.1021/ml300123a; Delbroek L, 2013, J PHARMACEUT BIOMED, V76, P49, DOI 10.1016/j.jpba.2012.12.002; Deng XM, 2011, NAT CHEM BIOL, V7, P203, DOI 10.1038/NCHEMBIO.538; Doggett EA, 2012, J NEUROCHEM, V120, P37, DOI 10.1111/j.1471-4159.2011.07537.x; Dzamko N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039132; Dzamko N, 2010, BIOCHEM J, V430, P405, DOI 10.1042/BJ20100784; Fahn S, 2003, ANN NY ACAD SCI, V991, P1, DOI 10.1111/j.1749-6632.2003.tb07458.x; Franzini M, 2013, BIOORG MED CHEM LETT, V23, P1967, DOI 10.1016/j.bmcl.2013.02.043; Gloeckner CJ, 2010, J PROTEOME RES, V9, P1738, DOI 10.1021/pr9008578; Haebig K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013762; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Hermanson SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043580; Ikenoya M, 2002, J NEUROCHEM, V81, P9, DOI 10.1046/j.1471-4159.2002.00801.x; Ito G, 2007, BIOCHEMISTRY-US, V46, P1380, DOI 10.1021/bi061960m; Ito G, 2012, BIOCHEM J, V441, P987, DOI 10.1042/BJ20111215; Kamikawaji S, 2013, BIOCHEMISTRY-US, V52, P6052, DOI 10.1021/bi400596m; Kamikawaji S, 2009, BIOCHEMISTRY-US, V48, P10963, DOI 10.1021/bi9011379; Li XT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017153; Lobbestael E, 2013, BIOCH J; Lobbestael E, 2012, BIOCHEM SOC T, V40, P1102, DOI 10.1042/BST20120128; Luerman GC, 2013, J NEUROCHEM, P1; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Nichols RJ, 2010, BIOCHEM J, V430, P393, DOI 10.1042/BJ20100483; O'Farrell AM, 2003, BLOOD, V101, P3597, DOI 10.1182/blood-2002-07-2307; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Reith AD, 2012, BIOORG MED CHEM LETT, V22, P5625, DOI 10.1016/j.bmcl.2012.06.104; Rudenko IN, 2012, BIOCHEM J, V446, P99, DOI 10.1042/BJ20120637; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Sheng ZJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004485; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Taylor SS, 2004, BBA-PROTEINS PROTEOM, V1697, P259, DOI 10.1016/j.bbapap.2003.11.029; Vancraenenbroeck R, 2012, BBA-PROTEINS PROTEOM, V1824, P450, DOI 10.1016/j.bbapap.2011.12.009; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Zhang JW, 2012, BIOORG MED CHEM LETT, V22, P1864, DOI 10.1016/j.bmcl.2012.01.084; Zhao J, 2012, BIOCHEM SOC T, V40, P1158, DOI 10.1042/BST20120137; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	40	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97988	10.1371/journal.pone.0097988	http://dx.doi.org/10.1371/journal.pone.0097988			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836358	Green Submitted, Green Published, gold			2022-12-27	WOS:000339614800094
J	Roda, MA; Sadik, M; Gaggar, A; Hardison, MT; Jablonsky, MJ; Braber, S; Blalock, JE; Redegeld, FA; Folkerts, G; Jackson, PL				Roda, Mojtaba Abdul; Sadik, Mariam; Gaggar, Amit; Hardison, Matthew T.; Jablonsky, Michael J.; Braber, Saskia; Blalock, James Edwin; Redegeld, Frank A.; Folkerts, Gert; Jackson, Patricia L.			Targeting Prolyl Endopeptidase with Valproic Acid as a Potential Modulator of Neutrophilic Inflammation	PLOS ONE			English	Article							CHEMOATTRACTANT; INHIBITION; MECHANISM; MANIA	A novel neutrophil chemoattractant derived from collagen, proline-glycine-proline (PGP), has been recently characterized in chronic obstructive pulmonary disease (COPD). This peptide is derived via the proteolytic activity of matrix metalloproteases (MMP's)-8/9 and PE, enzymes produced by neutrophils and present in COPD serum and sputum. Valproic acid (VPA) is an inhibitor of PE and could possibly have an effect on the severity of chronic inflammation. Here the interaction site of VPA to PE and the resulting effect on the secondary structure of PE is investigated. Also, the potential inhibition of PGP-generation by VPA was examined in vitro and in vivo to improve our understanding of the biological role of VPA. UV-visible, fluorescence spectroscopy, CD and NMR were used to determine kinetic information and structural interactions between VPA and PE. In vitro, PGP generation was significantly inhibited by VPA. In vivo, VPA significantly reduced cigarette-smoke induced neutrophil influx. Investigating the molecular interaction between VPA and PE showed that VPA modified the secondary structure of PE, making substrate binding at the catalytic side of PE impossible. Revealing the molecular interaction VPA to PE may lead to a better understanding of the involvement of PE and PGP in inflammatory conditions. In addition, the model of VPA interaction with PE suggests that PE inhibitors have a great potential to serve as therapeutics in inflammatory disorders.	[Roda, Mojtaba Abdul; Sadik, Mariam; Braber, Saskia; Folkerts, Gert] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacol, Fac Sci, Utrecht, Netherlands; [Roda, Mojtaba Abdul; Sadik, Mariam; Gaggar, Amit; Hardison, Matthew T.; Blalock, James Edwin; Redegeld, Frank A.; Jackson, Patricia L.] Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA; [Roda, Mojtaba Abdul; Sadik, Mariam; Gaggar, Amit; Hardison, Matthew T.; Blalock, James Edwin; Redegeld, Frank A.; Jackson, Patricia L.] Univ Alabama Birmingham, UAB Lung Hlth Ctr, Birmingham, AL 35294 USA; [Jablonsky, Michael J.] Univ Alabama Birmingham, Dept Chem, Birmingham, AL 35294 USA	Utrecht University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Roda, MA (corresponding author), Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacol, Fac Sci, Utrecht, Netherlands.	m.abdulroda@uu.nl	Redegeld, Frank A/O-6534-2016	Redegeld, Frank A/0000-0001-8830-7960; Blalock, J. Edwin/0000-0001-5303-8123	Netherlands Organization for Scientific Research (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, the Hague, the Netherlands) [017.008.029]; University of Alabama Clinical Investigator Fellowship Award; Cystic Fibrosis Foundation [GAGGAR07A0, R464-CR11]; NIH/NHLBI [HL07783, HL090999, HL087824, HL102371-01A1]; NIH/NIDDK [P30 DKO72482]; NIH [RR19231, P30CA13148, P50 AT00477, U54CA100949, P30AR050948, P30 DK079337]; NATIONAL CANCER INSTITUTE [P30CA013148, U54CA100949] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [P50AT000477] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019231] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114439, R01HL110950, R01HL090999, R01HL077783, R01HL087824, R01HL102371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079337] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, the Hague, the Netherlands)(Netherlands Organization for Scientific Research (NWO)Netherlands Government); University of Alabama Clinical Investigator Fellowship Award; Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	M.A.R. recieved a Mosaic grant from the Netherlands Organization for Scientific Research (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, the Hague, the Netherlands; grant (017.008.029). A. G was supported by the University of Alabama Clinical Investigator Fellowship Award, the Cystic Fibrosis Foundation (Grant GAGGAR07A0 to AG) and NIH/NHLBI (HL07783, HL090999, and HL087824 (to JEB) and HL102371-01A1 (to AG). PLJ is supported by Cystic Fibrosis Foundation R464-CR11 "Research Development Program-Component II'', and NIH/NIDDK P30 DKO72482. The Univ. of Alabama Birmingham (UAB) Lung Health Center Pulmonary Proteomics Laboratory is funded through the NIH (by grants RR19231, P30CA13148, P50 AT00477, U54CA100949, P30AR050948, and P30 DK079337). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	BAKKER AV, 1990, BIOCHEM J, V271, P559, DOI 10.1042/bj2710559; Bellemere G, 2003, J NEUROCHEM, V84, P919, DOI 10.1046/j.1471-4159.2003.01536.x; Braber S, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-99; Brodie SA, 2014, CANCER PREV RES, V7, P351, DOI 10.1158/1940-6207.CAPR-13-0254; Chateauvieux S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/479364; Cheng LL, 2005, MOL CELL NEUROSCI, V29, P155, DOI 10.1016/j.mcn.2004.12.003; Gaggar A, 2008, J IMMUNOL, V180, P5662, DOI 10.4049/jimmunol.180.8.5662; Hardison MT, 2009, J IMMUNOL, V182, P4423, DOI 10.4049/jimmunol.0802457; Hsieh CL, 2014, CLIN EXP PHARMACOL P, V41, P210, DOI 10.1111/1440-1681.12205; Hsieh CL, 2013, ROM J MORPHOL EMBRYO, V54, P993; Kaszuba K, 2012, BIOCHIMIE, V94, P1398, DOI 10.1016/j.biochi.2012.03.012; Kosacz Nicole M., 2012, Morbidity and Mortality Weekly Report, V61, P938; MAES M, 1995, PSYCHIAT RES, V58, P217, DOI 10.1016/0165-1781(95)02698-V; O'Reilly P, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-38; O'Reilly PJ, 2009, J NEUROIMMUNOL, V217, P51, DOI 10.1016/j.jneuroim.2009.09.020; Papi A, 2010, ANTICANCER RES, V30, P535; Polgar L, 2002, CELL MOL LIFE SCI, V59, P349, DOI 10.1007/s00018-002-8427-5; Rosenberg G, 2007, CELL MOL LIFE SCI, V64, P2090, DOI 10.1007/s00018-007-7079-x; Shen YF, 2014, COPD, V11, P351, DOI 10.3109/15412555.2013.858315; Shinoda M, 1999, BEHAV BRAIN RES, V99, P17, DOI 10.1016/S0166-4328(98)00005-9; Thanacoody RHK, 2009, CLIN TOXICOL, V47, P609, DOI 10.1080/15563650903167772; Weathington NM, 2006, NAT MED, V12, P317, DOI 10.1038/nm1361; WHO, 2008, WORLD HLTH STAT 2013; WILK S, 1983, J NEUROCHEM, V41, P69, DOI 10.1111/j.1471-4159.1983.tb11815.x; Williams RSB, 2002, NATURE, V417, P292, DOI 10.1038/417292a	25	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97594	10.1371/journal.pone.0097594	http://dx.doi.org/10.1371/journal.pone.0097594			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835793	Green Published, gold, Green Submitted			2022-12-27	WOS:000339614800054
J	Schaller-Schonitz, M; Barzan, D; Williamson, AJK; Griffiths, JR; Dallmann, I; Battmer, K; Ganser, A; Whetton, AD; Scherr, M; Eder, M				Schaller-Schoenitz, Michael; Barzan, David; Williamson, Andrew J. K.; Griffiths, John R.; Dallmann, Iris; Battmer, Karin; Ganser, Arnold; Whetton, Anthony D.; Scherr, Michaela; Eder, Matthias			BCR-ABL Affects STAT5A and STAT5B Differentially	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; GENE-EXPRESSION; REQUIRES PHOSPHORYLATION; CONSTITUTIVE ACTIVATION; LYMPHOID DEVELOPMENT; SEXUAL-DIMORPHISM; BCR/ABL; ROLES; MAINTENANCE; MECHANISMS	Signal transducers and activators of transcription (STATs) are latent cytoplasmic transcription factors linking extracellular signals to target gene transcription. Hematopoietic cells express two highly conserved STAT5-isoforms (STAT5A/STAT5B), and STAT5 is directly activated by JAK2 downstream of several cytokine receptors and the oncogenic BCR-ABL tyrosine kinase. Using an IL-3-dependent cell line with inducible BCR-ABL-expression we compared STAT5-activation by IL-3 and BCR-ABL in a STAT5-isoform specific manner. RNAi targeting of STAT5B strongly inhibits BCR-ABL-dependent cell proliferation, and STAT5B but not STAT5A is essential for BCL-X-L-expression in the presence of BCR-ABL. Although BCR-ABL induces STAT5-tyrosine phosphorylation independent of JAK2-kinase activity, BCR-ABL is less efficient in inducing active STAT5A: STAT5B-heterodimerization than IL-3, leaving constitutive STAT5A and STAT5B-homodimerization unaffected. In comparison to IL-3, nuclear accumulation of a STAT5A-eGFP fusion protein is reduced by BCR-ABL, and BCR-ABL tyrosine kinase activity induces STAT5A-eGFP translocation to the cell membrane and co-localization with the IL-3 receptor. Furthermore, BCR-ABL-dependent phosphorylation of Y682 in STAT5A was detected by mass-spectrometry. Finally, RNAi targeting STAT5B but not STAT5A sensitizes human BCR-ABL-positive cell lines to imatinib-treatment. These data demonstrate differences between IL-3 and BCR-ABL-mediated STAT5-activation and isoform-specific effects, indicating therapeutic options for isoform-specific STAT5-inhibition in BCR-ABL-positive leukemia.	[Schaller-Schoenitz, Michael; Barzan, David; Dallmann, Iris; Battmer, Karin; Ganser, Arnold; Scherr, Michaela; Eder, Matthias] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany; [Williamson, Andrew J. K.; Griffiths, John R.; Whetton, Anthony D.] Univ Manchester, Wolfson Mol Imaging Ctr, Manchester Acad Hlth Sci Ctr, Fac Med & Human Sci, Manchester, Lancs, England	Hannover Medical School; University of Manchester	Eder, M (corresponding author), Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany.	Eder.Matthias@MH-Hannover.de		WHETTON, ANTHONY D/0000-0002-1098-3878	Deutsche Forschungsgemeinschaft [SFB 566]; H. W. & J. Hector-Stiftung; Cancer Research UK; Leukaemia Lymphoma Research UK	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); H. W. & J. Hector-Stiftung; Cancer Research UK(Cancer Research UK); Leukaemia Lymphoma Research UK	This work was supported in part by grants of the Deutsche Forschungsgemeinschaft (SFB 566), the H. W. & J. Hector-Stiftung (MS and ME), Cancer Research UK (ADW), and Leukaemia Lymphoma Research UK (AJKW, ADW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braunstein J, 2003, J BIOL CHEM, V278, P34133, DOI 10.1074/jbc.M304531200; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Casetti L, 2013, CANCER RES, V73, P2052, DOI 10.1158/0008-5472.CAN-12-3955; Chatain N, 2013, ONCOGENE, V32, P3587, DOI 10.1038/onc.2012.369; Deininger MWN, 2000, BLOOD, V96, P3343, DOI 10.1182/blood.V96.10.3343; Dumon S, 1999, ONCOGENE, V18, P4191, DOI 10.1038/sj.onc.1202796; Faderl S, 1999, NEW ENGL J MED, V341, P164, DOI 10.1056/NEJM199907153410306; Feng J, 1997, MOL CELL BIOL, V17, P2497, DOI 10.1128/MCB.17.5.2497; Furqan M, 2013, J HEMATOL ONCOL, V6; Furqan M, 2013, BIOMARK RES, V1, DOI 10.1186/2050-7771-1-5; Gauzzi MC, 1996, J BIOL CHEM, V271, P20494, DOI 10.1074/jbc.271.34.20494; Gesbert F, 2000, BLOOD, V96, P2269, DOI 10.1182/blood.V96.6.2269.h8002269_2269_2276; GOUILLEUX F, 1994, EMBO J, V13, P4361, DOI 10.1002/j.1460-2075.1994.tb06756.x; Hantschel O, 2012, NAT CHEM BIOL, V8, P285, DOI [10.1038/NCHEMBIO.775, 10.1038/nchembio.775]; Harir N, 2007, BLOOD, V109, P1678, DOI 10.1182/blood-2006-01-029918; Hoelbl A, 2006, BLOOD, V107, P4898, DOI 10.1182/blood-2005-09-3596; Hoelbl A, 2010, EMBO MOL MED, V2, P98, DOI 10.1002/emmm.201000062; John S, 1999, MOL CELL BIOL, V19, P1910; Kazansky AV, 1999, J BIOL CHEM, V274, P22484, DOI 10.1074/jbc.274.32.22484; Klejman A, 2002, EMBO J, V21, P5766, DOI 10.1093/emboj/cdf562; Klucher KM, 1998, BLOOD, V91, P3927, DOI 10.1182/blood.V91.10.3927.3927_3927_3934; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; Mertens C, 2007, CELL, V131, DOI 10.1016/j.cell.2007.10.033; MUI ALF, 1995, EMBO J, V14, P1166, DOI 10.1002/j.1460-2075.1995.tb07100.x; Park SH, 1999, J BIOL CHEM, V274, P7421, DOI 10.1074/jbc.274.11.7421; QUELLE FW, 1994, MOL CELL BIOL, V14, P4335, DOI 10.1128/MCB.14.7.4335; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Samanta AK, 2006, CANCER RES, V66, P6468, DOI 10.1158/0008-5472.CAN-06-0025; Scherr M, 2006, BLOOD, V107, P3279, DOI 10.1182/blood-2005-08-3087; Scherr M, 2002, BLOOD, V99, P709, DOI 10.1182/blood.V99.2.709; Scherr M, 2003, CELL CYCLE, V2, P251, DOI 10.4161/cc.2.3.376; Scherr Michaela, 2009, V506, P207, DOI 10.1007/978-1-59745-409-4_15; Shuai K, 1996, ONCOGENE, V13, P247; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; vanderGeer P, 1996, CURR BIOL, V6, P1435, DOI 10.1016/S0960-9822(96)00748-8; Venturini L, 2007, BLOOD, V109, P4399, DOI 10.1182/blood-2006-09-045104; Warsch W, 2012, ONCOTARGET, V3, P1669; Warsch W, 2011, BLOOD, V117, P3409, DOI 10.1182/blood-2009-10-248211; Wenta N, 2008, P NATL ACAD SCI USA, V105, P9238, DOI 10.1073/pnas.0802130105; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103; Ye D, 2006, BLOOD, V107, P4917, DOI 10.1182/blood-2005-10-4110; Zeidan Q, 2010, J CELL SCI, V123, P13, DOI 10.1242/jcs.053678; Zhong MH, 2005, P NATL ACAD SCI USA, V102, P3966, DOI 10.1073/pnas.0501063102; Zhou YJ, 1997, P NATL ACAD SCI USA, V94, P13850, DOI 10.1073/pnas.94.25.13850	48	23	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97243	10.1371/journal.pone.0097243	http://dx.doi.org/10.1371/journal.pone.0097243			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836440	Green Published, Green Submitted, gold			2022-12-27	WOS:000339614800032
J	Altermann, S; Leavitt, SD; Goward, T; Nelsen, MP; Lumbsch, HT				Altermann, Susanne; Leavitt, Steven D.; Goward, Trevor; Nelsen, Matthew P.; Lumbsch, H. Thorsten			How Do You Solve a Problem like Letharia? A New Look at Cryptic Species in Lichen-Forming Fungi Using Bayesian Clustering and SNPs from Multilocus Sequence Data	PLOS ONE			English	Article							POPULATION-STRUCTURE; PHYLOGENETIC ANALYSIS; REPRODUCTIVE MODE; DELIMITATION; COALESCENT; INFERENCE; ACCURACY; PARMELIACEAE; BOUNDARIES; SOFTWARE	The inclusion of molecular data is increasingly an integral part of studies assessing species boundaries. Analyses based on predefined groups may obscure patterns of differentiation, and population assignment tests provide an alternative for identifying population structure and barriers to gene flow. In this study, we apply population assignment tests implemented in the programs STRUCTURE and BAPS to single nucleotide polymorphisms from DNA sequence data generated for three previous studies of the lichenized fungal genus Letharia. Previous molecular work employing a gene genealogical approach circumscribed six species-level lineages within the genus, four putative lineages within the nominal taxon L. columbiana (Nutt.) J.W. Thomson and two sorediate lineages. We show that Bayesian clustering implemented in the program STRUCTURE was generally able to recover the same six putative Letharia lineages. Population assignments were largely consistent across a range of scenarios, including: extensive amounts of missing data, the exclusion of SNPs from variable markers, and inferences based on SNPs from as few as three gene regions. While our study provided additional evidence corroborating the six candidate Letharia species, the equivalence of these genetic clusters with species-level lineages is uncertain due, in part, to limited phylogenetic signal. Furthermore, both the BAPS analysis and the ad hoc Delta K statistic from results of the STRUCTURE analysis suggest that population structure can possibly be captured with fewer genetic groups. Our findings also suggest that uneven sampling across taxa may be responsible for the contrasting inferences of population substructure. Our results consistently supported two distinct sorediate groups, 'L. lupina' and L. vulpina, and subtle morphological differences support this distinction. Similarly, the putative apotheciate species 'L. lucida' was also consistently supported as a distinct genetic cluster. However, additional studies will be required to elucidate the relationships of other L. columbiana s.l. populations with the two sorediate genetic clusters.	[Altermann, Susanne] Whitman Coll, Dept Biol, Walla Walla, WA 99362 USA; [Leavitt, Steven D.; Nelsen, Matthew P.] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA; [Leavitt, Steven D.; Nelsen, Matthew P.; Lumbsch, H. Thorsten] Field Museum, Chicago, IL USA; [Goward, Trevor] Univ British Columbia, Beaty Biodivers Museum, Vancouver, BC V5Z 1M9, Canada	Whitman College; University of Chicago; Field Museum of Natural History (Chicago); University of British Columbia	Leavitt, SD (corresponding author), Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA.	sleavitt@fieldmuseum.org	Leavitt, Steven D./AAC-6462-2021	Leavitt, Steven D./0000-0002-5034-9724; Nelsen, Matthew/0000-0002-6866-815X; Lumbsch, Thorsten/0000-0003-1512-835X	National Science Foundation [DEB-0949147]; California Lichen Society; Northwest Scientific Association; Jean H. Langenheim Graduate Fellowship in Plant Ecology and Evolution; STEPS Institute; University of California, Santa Cruz	National Science Foundation(National Science Foundation (NSF)); California Lichen Society; Northwest Scientific Association; Jean H. Langenheim Graduate Fellowship in Plant Ecology and Evolution; STEPS Institute; University of California, Santa Cruz(University of California System)	This research is based upon work supported by the National Science Foundation under Grant No. DEB-0949147. Molecular work by the first author was supported by the California Lichen Society, the Northwest Scientific Association, the Jean H. Langenheim Graduate Fellowship in Plant Ecology and Evolution, and the STEPS Institute. Additional funding, workspace and equipment were provided by Dr. Lynda Goff at University of California, Santa Cruz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altermann S, 2009, GEOGRAPHIC STRUCTURE; Arnerup J, 2004, MYCOL RES, V108, P311, DOI 10.1017/S0953756204009360; Camargo A, 2013, SPECIES PROBLEM ONGO, P225; Camargo A, 2012, EVOLUTION, V66, P2834, DOI 10.1111/j.1558-5646.2012.01640.x; Camargo A, 2012, SYST BIOL, V61, P272, DOI 10.1093/sysbio/syr105; Carstens BC, 2007, SYST BIOL, V56, P400, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Carstens BC, 2010, SYST BIOL, V59, P400, DOI 10.1093/sysbio/syq024; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; Corander J, 2004, BIOINFORMATICS, V20, P2363, DOI 10.1093/bioinformatics/bth250; Corander J, 2007, MATH BIOSCI, V205, P19, DOI 10.1016/j.mbs.2006.09.015; Corander J, 2006, MOL ECOL, V15, P2833, DOI 10.1111/j.1365-294X.2006.02994.x; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Crespo A, 2010, IMA FUNGUS, V1, P167, DOI 10.5598/imafungus.2010.01.02.09; Crespo A, 2009, AN JARDIN BOT MADRID, V66, P71, DOI 10.3989/ajbm.2225; de Queiroz K, 1999, SPECIES, P49; de Queiroz K, 1998, ENDLESS FORMS, P57; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Del-Prado R, 2010, MOL PHYLOGENET EVOL, V56, P125, DOI 10.1016/j.ympev.2010.04.014; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Ence DD, 2011, MOL ECOL RESOUR, V11, P473, DOI 10.1111/j.1755-0998.2010.02947.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Fu YX, 1997, GENETICS, V147, P915; Fujita MK, 2012, TRENDS ECOL EVOL, V27, P480, DOI 10.1016/j.tree.2012.04.012; GAMS HELMUT, 1955, SVENSK BOT TIDSKR, V49, P29; Geml J, 2012, FUNGAL BIOL-UK, V116, P388, DOI 10.1016/j.funbio.2011.12.009; Geml J, 2010, J BIOGEOGR, V37, P1529, DOI 10.1111/j.1365-2699.2010.02287.x; Gourbiere S, 2010, EVOLUTION, V64, P1, DOI 10.1111/j.1558-5646.2009.00844.x; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hogberg N, 2002, MOL ECOL, V11, P1191, DOI 10.1046/j.1365-294X.2002.01513.x; Huelsenbeck JP, 2011, EVOL BIOINFORM, V7, P55, DOI 10.4137/EBO.S6761; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Johannesson HS, 2000, MOL ECOL, V9, P375, DOI 10.1046/j.1365-294x.2000.00874-6.x; Jovan S, 2007, ENVIRON MONIT ASSESS, V129, P243, DOI 10.1007/s10661-006-9357-8; Kalinowski ST, 2011, HEREDITY, V106, P625, DOI 10.1038/hdy.2010.95; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; KLUGE AG, 1989, SYST ZOOL, V38, P7, DOI 10.2307/2992432; Kroken S, 2000, BRYOLOGIST, V103, P645, DOI 10.1639/0007-2745(2000)103[0645:PSRMAS]2.0.CO;2; Kroken S, 2001, MYCOLOGIA, V93, P38, DOI 10.2307/3761604; Kroken S, 2001, FUNGAL GENET BIOL, V34, P83, DOI 10.1006/fgbi.2001.1291; Lanier HC, 2012, SYST BIOL, V61, P691, DOI 10.1093/sysbio/syr128; Latch EK, 2006, CONSERV GENET, V7, P295, DOI 10.1007/s10592-005-9098-1; Leache AD, 2010, P ROY SOC B-BIOL SCI, V277, P3071, DOI 10.1098/rspb.2010.0662; Leavitt SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085240; Leavitt SD, 2013, BRYOLOGIST, V116, P337, DOI 10.1639/0007-2745-116.4.337; Leavitt SD, 2011, MOL PHYLOGENET EVOL, V60, P317, DOI 10.1016/j.ympev.2011.05.012; Leavitt SD, 2011, MOL PHYLOGENET EVOL, V59, P587, DOI 10.1016/j.ympev.2011.03.020; Liu L, 2008, BIOINFORMATICS, V24, P2542, DOI 10.1093/bioinformatics/btn484; Lumbsch HT, 2011, FUNGAL DIVERS, V50, P59, DOI 10.1007/s13225-011-0123-z; MAYR E, 1970, P453; McCune B, 2009, BRYOLOGIST, V112, P375, DOI 10.1639/0007-2745-112.2.375; McMurray JA, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1487-3; Miralles A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068242; Nelson MF, 2013, ECOL EVOL, V3, P3455, DOI 10.1002/ece3.725; O'Meara BC, 2010, SYST BIOL, V59, P59, DOI 10.1093/sysbio/syp077; O'Neill EM, 2013, MOL ECOL, V22, P111, DOI 10.1111/mec.12049; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Poelt J, 1970, VORTRAGE GESAMTGEBIE, V4, P187; POELT VJ, 1972, BOT NOTISER, V125, P77; Price TD, 2002, EVOLUTION, V56, P2083; Printzen C, 2002, LICHENOLOGIST, V34, P101, DOI 10.1006/lich.2002.0381; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A., 2008, FIGTREE VERSION 1 4; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Rannala B, 2003, GENETICS, V164, P1645; Reid NM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-196; Rowe G, 2007, MOL ECOL, V16, P785, DOI 10.1111/j.1365-294X.2006.03188.x; Rowe KC, 2011, SYST BIOL, V60, P188, DOI 10.1093/sysbio/syq092; Saisho D, 2007, GENETICS, V177, P1765, DOI 10.1534/genetics.107.079491; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schwartz MK, 2009, CONSERV GENET, V10, P441, DOI 10.1007/s10592-008-9622-1; Shaffer HB, 2007, SYST BIOL, V56, P896, DOI 10.1080/10635150701772563; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; TAJIMA F, 1989, GENETICS, V123, P585; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; TONSBERG T, 1996, SOMMERFELTIA, V23, P1; Vitikainen O, 1997, NORRLINIA, V6, P1; Wagner CE, 2013, MOL ECOL, V22, P787, DOI 10.1111/mec.12023; Weisrock DW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009883; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Yeates DK, 2011, SYST ENTOMOL, V36, P209, DOI 10.1111/j.1365-3113.2010.00558.x	87	39	40	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97556	10.1371/journal.pone.0097556	http://dx.doi.org/10.1371/journal.pone.0097556			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831224	Green Published, Green Submitted, gold			2022-12-27	WOS:000336789500077
J	Chen, HW; Liu, GD; Wu, LJ				Chen, Hong-wei; Liu, Guo-dong; Wu, Li-jun			Complications of Treating Terrible Triad Injury of the Elbow: A Systematic Review	PLOS ONE			English	Review							RADIAL HEAD; FRACTURE-DISLOCATIONS; CORONOID FRACTURES; MANAGEMENT; REPAIR	Objective: Terrible triad injury of the elbow (TTIE), comprising elbow dislocation with radial head and coronoid process fracture, is notoriously challenging to treat and has typically been associated with complications and poor outcomes. The objective of this systematic review was to summarize the most recent available evidence regarding functional outcomes and complications following surgical management of TTIE. Methods: Medline, EMBASE, Cochrane Library, and Google Scholar were searched to identify relevant studies, which were included if they were retrospective or prospective in design, involved participants who had TTIE, and were published in English. Outcomes of interest were functional outcomes and complications. Results: Sixteen studies, involving 312 patients, were included in the systematic review. Mean follow up after surgery was typically 25 to 30 months. Mean Mayo elbow performance scores ranged from 78 to 95. Mean Broberg-Morrey scores ranged from 76 to 90. Mean DASH scores ranged from 9 to 31. The proportion of patients who required reoperation due to complications ranged from 0 to 54.5% (overall = 70/312 [22.4%]). Most of these complications were related to hardware fixation problems, joint stiffness, joint instability, and ulnar neuropathy. The most common complications that did not require reoperation were heterotopic ossification (39/312 [12.5%] patients) and arthrosis (35/312 [11.2%] patients). Conclusions: The results of this systematic review indicate that functional outcomes after surgery for TTIE are generally satisfactory and that complications are common. Further research is warranted to determine which surgical techniques optimize functional outcomes and reduce the risk of complications.	[Chen, Hong-wei] Wenzhou Med Coll, Affiliated Yiwu Cent Hosp, Dept Orthoped, Yiwu, Zhejiang, Peoples R China; [Liu, Guo-dong] Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept 8, Chongqing, Peoples R China; [Wu, Li-jun] Wenzhou Med Coll, Affiliated Hosp 2, Dept Orthoped, Wenzhou, Zhejiang, Peoples R China; [Wu, Li-jun] Wenzhou Med Coll, Inst Digital Med, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Army Medical University; Wenzhou Medical University; Wenzhou Medical University	Chen, HW (corresponding author), Wenzhou Med Coll, Affiliated Yiwu Cent Hosp, Dept Orthoped, Yiwu, Zhejiang, Peoples R China.	chw6988@aliyun.com; aryastark@126.com			National Natural Science Foundation of China [81271663]; General Program of Science and Technology Department of Zhejiang Province [2013C33216]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); General Program of Science and Technology Department of Zhejiang Province	This study was supported by National Natural Science Foundation of China (81271663) and General Program of Science and Technology Department of Zhejiang Province (2013C33216). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROBERG MA, 1986, J BONE JOINT SURG AM, V68A, P669, DOI 10.2106/00004623-198668050-00005; Chemama B, 2010, ORTHOP TRAUMATOL-SUR, V96, P147, DOI [10.1016/j.otsr.2009.11.009, 10.1016/j.rcot.2010.02.008]; Dodds SD, 2013, ORTHOP CLIN N AM, V44, P47, DOI 10.1016/j.ocl.2012.08.006; Egol KA, 2007, BULL HOSP JT DIS, V65, P263; Forthman C, 2007, J HAND SURG-AM, V32A, P1200, DOI 10.1016/j.jhsa.2007.06.019; Garrigues GE, 2011, J BONE JOINT SURG AM, V93A, P1873, DOI 10.2106/JBJS.I.01673; Heckman JD, 1996, ROCKWOOD GREENS FRAC, V2, P2377; Hudak PL, 1996, AM J IND MED, V29, P602, DOI 10.1002/(SICI)1097-0274(199606)29:6<602::AID-AJIM4>3.0.CO;2-L; Jeong WK, 2010, J ORTHOP SCI, V15, P612, DOI 10.1007/s00776-010-1515-8; Leigh WB, 2012, J SHOULDER ELB SURG, V21, P1336, DOI 10.1016/j.jse.2012.03.005; Lindenhovius ALC, 2008, J HAND SURG-AM, V33A, P920, DOI 10.1016/j.jhsa.2008.02.007; MASON ML, 1954, BRIT J SURG, V42, P123, DOI 10.1002/bjs.18004217203; Mathew PK, 2009, J AM ACAD ORTHOP SUR, V17, P137, DOI 10.5435/00124635-200903000-00003; Morrey BF., 2009, ELBOW ITS DISORDERS; Pai V, 2009, J Orthop Surg (Hong Kong), V17, P31; Pipicelli Joey G, 2011, Tech Hand Up Extrem Surg, V15, P198, DOI 10.1097/BTH.0b013e31822911fd; Pugh DMW, 2004, J BONE JOINT SURG AM, V86A, P1122, DOI 10.2106/00004623-200406000-00002; REGAN W, 1989, J BONE JOINT SURG AM, V71A, P1348, DOI 10.2106/00004623-198971090-00011; Ring D, 2002, J BONE JOINT SURG AM, V84A, P547, DOI 10.2106/00004623-200204000-00006; Rodriguez-Martin J, 2011, INT ORTHOP, V35, P851, DOI 10.1007/s00264-010-1024-6; Seijas Roberto, 2009, J Orthop Surg (Hong Kong), V17, P335; Toros T, 2012, ACTA ORTHOP TRAUMATO, V46, P96, DOI 10.3944/AOTT.2012.2632; van Riet RP, 2005, J SHOULDER ELB SURG, V14, P519, DOI 10.1016/j.jse.2004.11.007; Wang Yu-xing, 2010, Orthop Surg, V2, P141, DOI 10.1111/j.1757-7861.2010.00081.x; Winter M, 2009, CHIR MAIN, V28, P158, DOI 10.1016/j.main.2009.02.003; Zeiders GJ, 2008, J BONE JOINT SURG AM, V90A, P75, DOI 10.2106/JBJS.H.00893	26	36	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97476	10.1371/journal.pone.0097476	http://dx.doi.org/10.1371/journal.pone.0097476			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24832627	gold, Green Submitted, Green Published			2022-12-27	WOS:000336789500064
J	Chong, HK; Wang, T; Lu, HM; Seidler, S; Lu, H; Keiles, S; Chao, EC; Stuenkel, AJ; Li, X; Elliott, AM				Chong, Hansook Kim; Wang, Tao; Lu, Hsiao-Mei; Seidler, Sara; Lu, Hong; Keiles, Steven; Chao, Elizabeth C.; Stuenkel, A. J.; Li, Xiang; Elliott, Aaron M.			The Validation and Clinical Implementation of BRCAplus: A Comprehensive High-Risk Breast Cancer Diagnostic Assay	PLOS ONE			English	Article							MUTATIONS; BRCA1; RECOMMENDATIONS	Breast cancer is the most commonly diagnosed cancer in women, with 10% of disease attributed to hereditary factors. Although BRCA1 and BRCA2 account for a high percentage of hereditary cases, there are more than 25 susceptibility genes that differentially impact the risk for breast cancer. Traditionally, germline testing for breast cancer was performed by Sanger dideoxy terminator sequencing in a reflexive manner, beginning with BRCA1 and BRCA2. The introduction of next-generation sequencing (NGS) has enabled the simultaneous testing of all genes implicated in breast cancer resulting in diagnostic labs offering large, comprehensive gene panels. However, some physicians prefer to only test for those genes in which established surveillance and treatment protocol exists. The NGS based BRCAplus test utilizes a custom tiled PCR based target enrichment design and bioinformatics pipeline coupled with array comparative genomic hybridization (aCGH) to identify mutations in the six high-risk genes: BRCA1, BRCA2, PTEN, TP53, CDH1, and STK11. Validation of the assay with 250 previously characterized samples resulted in 100% detection of 3,025 known variants and analytical specificity of 99.99%. Analysis of the clinical performance of the first 3,000 BRCAplus samples referred for testing revealed an average coverage greater than 9,000X per target base pair resulting in excellent specificity and the sensitivity to detect low level mosaicism and allele-drop out. The unique design of the assay enabled the detection of pathogenic mutations missed by previous testing. With the abundance of NGS diagnostic tests being released, it is essential that clinicians understand the advantages and limitations of different test designs.	[Chong, Hansook Kim; Seidler, Sara; Elliott, Aaron M.] Ambry Genet, Dept Res & Dev, Aliso Viejo, CA 92656 USA; [Wang, Tao; Lu, Hsiao-Mei; Lu, Hong; Li, Xiang] Ambry Genet, Dept Bioinformat, Aliso Viejo, CA USA; [Keiles, Steven; Chao, Elizabeth C.; Stuenkel, A. J.] Ambry Genet, Dept Clin Genet, Aliso Viejo, CA USA		Elliott, AM (corresponding author), Ambry Genet, Dept Res & Dev, Aliso Viejo, CA 92656 USA.	aelliott@ambrygen.com	Hong, LU/HDM-0673-2022; Wang, Tao/E-5900-2015; Lu, Hong/F-2744-2015	Wang, Tao/0000-0002-1646-6863; Lu, Hong/0000-0002-4026-4292	Ambry Genetics	Ambry Genetics	Work was funded by Ambry Genetics. The funder provided support in the form of salaries for authors HC, TW, HML, SS, HL, SK, EC, AS, XL, AE but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Bogdanova N, 2013, HERED CANCER CLIN PR, V11, DOI 10.1186/1897-4287-11-12; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Campeau PM, 2008, HUM GENET, V124, P31, DOI 10.1007/s00439-008-0529-1; Comino-Mendez I, 2011, NAT GENET, V43, P663, DOI 10.1038/ng.861; Elliott Aaron M, 2012, J Biomol Tech, V23, P24, DOI 10.7171/jbt.12-2301-003; Eng C, 2000, J MED GENET, V37, P828, DOI 10.1136/jmg.37.11.828; Fackenthal JD, 2007, NAT REV CANCER, V7, P937, DOI 10.1038/nrc2054; Fajardo KVF, 2012, HUM MUTAT, V33, P609, DOI 10.1002/humu.22033; Guo Y, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/915636; Hearle N, 2006, CLIN CANCER RES, V12, P3209, DOI 10.1158/1078-0432.CCR-06-0083; Howlader N, 2013, SEER CANC STAT REV 1; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Ku CS, 2013, CLIN GENET, V83, P2, DOI 10.1111/cge.12028; Lalloo F, 2003, LANCET, V361, P1101, DOI 10.1016/S0140-6736(03)12856-5; Lam CW, 2006, CLIN CHEM, V52, P517, DOI 10.1373/clinchem.2005.060491; Landsverk ML, 2012, GENET MED, V14, P877, DOI 10.1038/gim.2012.58; Learning about the BRCAX study. Genome.gov. National Research Genome Institute (NIH), LEARN BRCAX STUD; Mendes-Pereira AM, 2009, EMBO MOL MED, V1, P315, DOI 10.1002/emmm.200900041; Olivier M, 2003, CANCER RES, V63, P6643; Paradiso A, 2011, ANN ONCOL, V22, pi31, DOI 10.1093/annonc/mdq663; Pharoah PDP, 2001, GASTROENTEROLOGY, V121, P1348, DOI 10.1053/gast.2001.29611; Phillips KA, 2013, J CLIN ONCOL, V31, P3091, DOI 10.1200/JCO.2012.47.8313; Plon SE, 2008, HUM MUTAT, V29, P1282, DOI 10.1002/humu.20880; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Rosen EM, 2014, CURR DRUG TARGETS, V15, P17, DOI 10.2174/1389450114666140106095432; Valencia CA, 2012, J MOL DIAGN, V14, P233, DOI 10.1016/j.jmoldx.2012.01.009	27	53	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97408	10.1371/journal.pone.0097408	http://dx.doi.org/10.1371/journal.pone.0097408			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830819	Green Published, gold			2022-12-27	WOS:000336789500052
J	Enyedi, P; Veres, I; Braun, G; Czirjak, G				Enyedi, Peter; Veres, Iren; Braun, Gabriella; Czirjak, Gabor			Tubulin Binds to the Cytoplasmic Loop of TRESK Background K+ Channel In Vitro	PLOS ONE			English	Article							POTASSIUM CHANNEL; C-TERMINUS; DEPENDENT ACTIVATION; FUNCTIONAL-ANALYSIS; GLYCINE RECEPTOR; MESSENGER-RNAS; ALPHA-TUBULIN; BETA-TUBULIN; TASK-1 KCNK3; MIGRAINE	The cytoplasmic loop between the second and third transmembrane segments is pivotal in the regulation of TRESK (TWIK-related spinal cord K+ channel, K2P18.1, KCNK18). Calcineurin binds to this region and activates the channel by dephosphorylation in response to the calcium signal. Phosphorylation-dependent anchorage of 14-3-3 adaptor protein also modulates TRESK at this location. In the present study, we identified molecular interacting partners of the intracellular loop. By an affinity chromatography approach using the cytoplasmic loop as bait, we have verified the specific association of calcineurin and 14-3-3 to the channel. In addition to these known interacting proteins, we observed substantial binding of tubulin to the intracellular loop. Successive truncation of the polypeptide and pull-down experiments from mouse brain cytosol narrowed down the region sufficient for the binding of tubulin to a 16 amino acid sequence: LVLGRLSYSIISNLDE. The first six residues of this sequence are similar to the previously reported tubulin-binding region of P2X2 purinergic receptor. The tubulin-binding site of TRESK is located close to the protein kinase A (PKA)-dependent 14-3-3-docking motif of the channel. We provide experimental evidence suggesting that 14-3-3 competes with tubulin for the binding to the cytoplasmic loop of TRESK. It is intriguing that the 16 amino acid tubulin-binding sequence includes the serines, which were previously shown to be phosphorylated by microtubule-affinity regulating kinases (MARK kinases) and contribute to channel inhibition. Although tubulin binds to TRESK in vitro, it remains to be established whether the two proteins also interact in the living cell.	[Enyedi, Peter; Veres, Iren; Braun, Gabriella; Czirjak, Gabor] Semmelweis Univ, Dept Physiol, H-1085 Budapest, Hungary	Semmelweis University	Czirjak, G (corresponding author), Semmelweis Univ, Dept Physiol, H-1085 Budapest, Hungary.	czirjak.gabor@med.semmelweis-univ.hu	Braun, Gabriella/D-7494-2015	Braun, Gabriella/0000-0002-1762-7622; Czirjak, Gabor/0000-0002-5485-2327	Hungarian National Research Fund [OTKA K108496]	Hungarian National Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by the Hungarian National Research Fund OTKA K108496. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres-Enguix I, 2012, SCI REP-UK, V2, DOI 10.1038/srep00237; BEST D, 1981, ANAL BIOCHEM, V114, P281, DOI 10.1016/0003-2697(81)90481-4; Bista P, 2012, PFLUG ARCH EUR J PHY, V463, P89, DOI 10.1007/s00424-011-1056-9; Braun G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028119; Cadaveira-Mosquera A, 2012, J MOL NEUROSCI, V48, P86, DOI 10.1007/s12031-012-9780-y; Callejo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064471; Canman JC, 1997, J CELL SCI, V110, P1907; Caplow M, 2002, MOL BIOL CELL, V13, P2120, DOI 10.1091/mbc.E01-10-0089; Chen ZW, 2007, J NEUROCHEM, V100, P279, DOI 10.1111/j.1471-4159.2006.04206.x; Cid LP, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00198; Cotten JF, 2013, ANESTH ANALG, V116, P810, DOI 10.1213/ANE.0b013e318284469d; Czirjak B, 2004, J BIOL CHEM, V279, P18550, DOI 10.1074/jbc.M312229200; Czirjak G, 2008, J BIOL CHEM, V283, P15672, DOI 10.1074/jbc.M800712200; Czirjak G, 2006, J BIOL CHEM, V281, P14677, DOI 10.1074/jbc.M602495200; Czirjak G, 2010, J BIOL CHEM, V285, P14549, DOI 10.1074/jbc.M110.102020; Davies LA, 2008, P NATL ACAD SCI USA, V105, P2203, DOI 10.1073/pnas.0712000105; Dobler T, 2007, J PHYSIOL-LONDON, V585, P867, DOI 10.1113/jphysiol.2007.145649; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Gendreau S, 2003, J CHROMATOGR B, V786, P311, DOI 10.1016/S1570-0232(02)00743-2; Goswami C, 2007, J NEUROCHEM, V101, P250, DOI 10.1111/j.1471-4159.2006.04338.x; Goswami C, 2004, J NEUROCHEM, V91, P1092, DOI 10.1111/j.1471-4159.2004.02795.x; Goswami C, 2012, J NEUROCHEM, V123, P1, DOI 10.1111/j.1471-4159.2012.07892.x; Guimaraes MZP, 2008, NEUROCHEM INT, V52, P314, DOI 10.1016/j.neuint.2007.06.032; Guo ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087029; Hanus C, 2004, J NEUROSCI, V24, P1119, DOI 10.1523/JNEUROSCI.4380-03.2004; Honore E, 2002, EMBO J, V21, P2968, DOI 10.1093/emboj/cdf288; JESSUS C, 1987, J CELL SCI, V87, P705; Kang D, 2004, J BIOL CHEM, V279, P28063, DOI 10.1074/jbc.M402940200; Kang D, 2006, AM J PHYSIOL-CELL PH, V291, pC138, DOI 10.1152/ajpcell.00629.2005; Kim Y, 2001, PFLUG ARCH EUR J PHY, V442, P64, DOI 10.1007/s004240000496; Kreneisz O, 2009, J PHYSIOL-LONDON, V587, P5819, DOI 10.1113/jphysiol.2009.180372; Lafreniere RG, 2011, INT J BIOCHEM CELL B, V43, P1533, DOI 10.1016/j.biocel.2011.08.002; Lafreniere RG, 2010, NAT MED, V16, P1157, DOI 10.1038/nm.2216; Li HM, 2011, TRENDS CELL BIOL, V21, P91, DOI 10.1016/j.tcb.2010.09.011; Liu P, 2013, J NEUROSCI, V33, P12810, DOI 10.1523/JNEUROSCI.1237-13.2013; Maas C, 2006, J CELL BIOL, V172, P441, DOI 10.1083/jcb.200506066; Maher BH, 2013, GENE, V528, P343, DOI 10.1016/j.gene.2013.07.030; Maingret F, 1999, J BIOL CHEM, V274, P26691, DOI 10.1074/jbc.274.38.26691; Marc J, 1998, PLANT CELL, V10, P1927, DOI 10.1105/tpc.10.11.1927; Matenia D, 2009, TRENDS BIOCHEM SCI, V34, P332, DOI 10.1016/j.tibs.2009.03.008; Mathie A, 2010, CURR NEUROPHARMACOL, V8, P276, DOI 10.2174/157015910792246146; Murbartian J, 2005, J BIOL CHEM, V280, P30175, DOI 10.1074/jbc.M503862200; O'Kelly I, 2008, TRAFFIC, V9, P72, DOI 10.1111/j.1600-0854.2007.00663.x; Patel AJ, 1998, EMBO J, V17, P4283, DOI 10.1093/emboj/17.15.4283; Penton D, 2012, ENDOCRINOLOGY, V153, P4740, DOI 10.1210/en.2012-1527; Piechotta PL, 2011, EMBO J, V30, P3607, DOI 10.1038/emboj.2011.268; Plant LD, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003431; Pottosin II, 2008, PFLUG ARCH EUR J PHY, V456, P1037, DOI 10.1007/s00424-008-0481-x; Rahm AK, 2013, ARCH PHARM, V387, P291; Rahm AK, 2012, BRIT J PHARMACOL, V166, P764, DOI 10.1111/j.1476-5381.2011.01813.x; Renigunta V, 2006, TRAFFIC, V7, P168, DOI 10.1111/j.1600-0854.2005.00375.x; Samsonov A, 2004, J CELL SCI, V117, P6129, DOI 10.1242/jcs.01531; Sandoz G, 2006, EMBO J, V25, P5864, DOI 10.1038/sj.emboj.7601437; Sano Y, 2003, J BIOL CHEM, V278, P27406, DOI 10.1074/jbc.M206810200; Sanchez-Miguel DS, 2013, BIOCHEM BIOPH RES CO, V434, P273, DOI 10.1016/j.bbrc.2013.02.115; Talley EM, 2002, J BIOL CHEM, V277, P17733, DOI 10.1074/jbc.M200502200; Tulleuda A, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-30; Turner PJ, 2013, J PHYSIOL-LONDON, V591, P5977, DOI 10.1113/jphysiol.2013.262022; VILLASANTE A, 1986, MOL CELL BIOL, V6, P2409, DOI 10.1128/MCB.6.7.2409; Wang S, 2013, J NEUROSCI, V33, P16033, DOI 10.1523/JNEUROSCI.2451-13.2013; Wright PD, 2013, BIOCHEM BIOPH RES CO, V441, P463, DOI 10.1016/j.bbrc.2013.10.090; YEN TJ, 1988, NATURE, V334, P580, DOI 10.1038/334580a0; Yoo S, 2009, NEUROSCI LETT, V465, P79, DOI 10.1016/j.neulet.2009.08.062; Zhou J, 2012, MOL MED REP, V5, P1049, DOI 10.3892/mmr.2012.778; Zuzarte M, 2009, J PHYSIOL-LONDON, V587, P929, DOI 10.1113/jphysiol.2008.164756	65	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97854	10.1371/journal.pone.0097854	http://dx.doi.org/10.1371/journal.pone.0097854			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830385	Green Published, gold, Green Submitted			2022-12-27	WOS:000336789500127
J	Martinson, NA; Gupte, N; Msandiwa, R; Moulton, LH; Barnes, GL; Ram, M; Gray, G; Hoffmann, C; Chaisson, RE				Martinson, Neil A.; Gupte, Nikhil; Msandiwa, Reginah; Moulton, Lawrence H.; Barnes, Grace L.; Ram, Malathi; Gray, Glenda; Hoffmann, Chris; Chaisson, Richard E.			CD4 and Viral Load Dynamics in Antiretroviral-Naive HIV-Infected Adults from Soweto, South Africa: A Prospective Cohort	PLOS ONE			English	Article							T-CELL DECLINE; VIRUS; LYMPHOCYTES; SUBTYPE	Background: CD4 count is a proxy for the extent of immune deficiency and declines in CD4 count are a measure of disease progression. Decline in CD4 count is an important component: for estimating benefits of ARV treatment; for individual level counselling on the rapidity of untreated disease progression and prognosis; and can be used in planning demand for health services. Our objective is to report CD4 decline and changes in viral load (VL) in a group of HIV-infected adults enrolled in a randomized trial of preventive treatment for TB in South Africa where clade C infection predominates. Methods: HIV-infected, tuberculin skin test positive adults who were not eligible for antiretroviral (ARV) treatment were randomized to a trial of preventive treatment from 2003-2005. VL and CD4 count were assessed at enrollment and CD4 counts repeated at least annually. During follow-up, individuals whose CD4 counts decreased to <200 cells/mm(3) were referred for antiretroviral therapy (ART) and were analytically censored. Results: 1106 ARV nave adults were enrolled. Their median age was 30 years and male to female ratio was 1:5. Median baseline CD4 count was 490 cells/mm(3) (IQR 351-675). The overall mean decline in CD4 count was 61 cells/mm(3) per annum. Adjusting for age, gender, baseline hemoglobin, smoking and alcohol use had little impact on the estimate of CD4 decline. However, VL at baseline had a major impact on CD4 decline. The percent decline in CD4 count was 13.3% (95% CI 12.0%, 14.7%), 10.6% (95% CI 8.8%, 12.4%), and 13.8% (95% CI 12.1%, 15.5%) per annum for baseline VLs of <10,000 (N = 314), 10,001-100,000 (N = 338), >100,000 (N = 122) copies/ml. Conclusions: Our data suggests that six and a half years will elapse for an individual's CD4 count to decline from 750 to 350 cells/mm(3) in the absence of ART.	[Martinson, Neil A.; Msandiwa, Reginah; Gray, Glenda] Univ Witwatersrand, Fac Hlth Sci, Perinatal HIV Res Unit, Johannesburg, South Africa; [Martinson, Neil A.; Gupte, Nikhil; Barnes, Grace L.; Ram, Malathi; Hoffmann, Chris; Chaisson, Richard E.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Moulton, Lawrence H.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Martinson, Neil A.] Natl Res Fdn Ctr Excellence Biomed TB Res, Dept Sci & Technol, Johannesburg, South Africa	University of Witwatersrand; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Research Foundation - South Africa	Martinson, NA (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Perinatal HIV Res Unit, Johannesburg, South Africa.	martinson@phru.co.za		Hoffmann, Christopher/0000-0002-9422-0519; Moulton, Lawrence/0000-0001-7041-7387	National Institute of Allergy and Infectious Diseases [AI048526, AI01637]; National Institutes of Health Fogarty International Center [D43 TW000010- 21S1, 5U2RTW007370/3]; U.S. Agency for International Development [GHS-A-00-03-00019-00]; FOGARTY INTERNATIONAL CENTER [U2RTW007370, D43TW000010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048526, K24AI001637, P30AI094189] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); U.S. Agency for International Development(United States Agency for International Development (USAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grants from the National Institute of Allergy and Infectious Diseases (AI048526 and AI01637) (http://www.niaid.nih.gov/Pages/default.aspx), the National Institutes of Health Fogarty International Center (D43 TW000010- 21S1 and 5U2RTW007370/3) (http://www.fic.nih.gov/Pages/Default.aspx), and the U.S. Agency for International Development (GHS-A-00-03-00019-00)(http://www.usaid.gov/). The opinions expressed herein are those of the authors and not necessarily those of US Government or its agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, GUID INT TUB CAS FIN; Diggle P, 2002, OXFORD STAT SCI; Gottlieb GS, 2002, J INFECT DIS, V185, P905, DOI 10.1086/339295; Govender S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090754; Holmes CB, 2006, JAIDS-J ACQ IMM DEF, V42, P464, DOI 10.1097/01.qai.0000225729.79610.b7; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Katubulushi M, 2005, AIDS, V19, P102, DOI 10.1097/00002030-200501030-00016; Keller M, 2009, AIDS, V23, P731, DOI 10.1097/QAD.0b013e328326f77f; Kiwanuka N, 2010, JAIDS-J ACQ IMM DEF, V54, P180, DOI 10.1097/QAI.0b013e3181c98fc0; Martinson NA, 2011, NEW ENGL J MED, V365, P11, DOI 10.1056/NEJMoa1005136; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Urassa W, 2004, AIDS, V18, P433, DOI 10.1097/00002030-200402200-00009	14	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e96369	10.1371/journal.pone.0096369	http://dx.doi.org/10.1371/journal.pone.0096369			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831447	Green Published, gold, Green Submitted			2022-12-27	WOS:000336789500018
J	Moreno, M; Puig, J; Serrano, M; Moreno-Navarrete, JM; Ortega, F; Ricart, W; Fernandez-Real, JM				Moreno, Maria; Puig, Josep; Serrano, Marta; Maria Moreno-Navarrete, Jose; Ortega, Francisco; Ricart, Wifredo; Manuel Fernandez-Real, Jose			Circulating Tryptase as a Marker for Subclinical Atherosclerosis in Obese Subjects	PLOS ONE			English	Article							MAST-CELL TRYPTASE; INTIMA-MEDIA THICKNESS; MYOCARDIAL-INFARCTION; SERUM TRYPTASE; ARTERY-DISEASE; CHOLESTEROL; PROTEASES; PLAQUES; STROKE	Introduction: Mast cells participate in atherogenesis by releasing cytokines to induce vascular cell protease expression. Tryptase is expressed highly in human atherosclerotic lesions and the inhibition of tryptase activity hampers its capacity to maintain cholesterol inside macrophague foam cells. We aimed to investigate the association between circulating tryptase levels and subclinical atherosclerosis through estimation of carotid intima-media thickness (c-IMT) as surrogate marker for increased cardiovascular risk in obese and non-obese subjects. Methods: Circulating tryptase levels (ELISA) and metabolic parameters were analyzed in 228 subjects. Atherosclerosis (c-IMT>0.9 mm) was evaluated ultrasonographically. Results: Significant positive associations were evident between circulating tryptase levels and BMI, fat mass, glycated haemoglobin, fasting insulin, HOMAIR, fasting triglycerides and ultrasensitive PCR (p<0.05 from linear-trend ANOVA). The positive association between tryptase levels and insulin resistance parameters, suggested a glucose homeostasis impairment in individuals with higher tryptase levels. The negative asociation between tryptase levels and HDL-cholesterol supports the proatherogenic role of this protease (p<0.0001). Circulating tryptase levels were strongly associated with c-IMT measurements (p<0.0001 from linear-trend ANOVA), and were higher in subjects with presence of carotid plaque (p<0.0001). Tryptase levels (beta = 0.015, p = 0.001) contributed independently to subclinical atherosclerosis variance after controlling for cardiovascular risk factors (BMI, blood pressure, LDL-cholesterol). Conclusions: Circulating tryptase level is associated to obesity related parameters and has a close relation with various metabolic risk factors. Moreover, serum tryptase level was independently associated with c-IMT, suggesting its potential use as a surrogate marker for subclinical atherosclerosis in obese subjects.	[Moreno, Maria; Serrano, Marta; Maria Moreno-Navarrete, Jose; Ortega, Francisco; Ricart, Wifredo; Manuel Fernandez-Real, Jose] CIBEROBN CB06 03 010, Inst Invest Biomed Girona IdIBGi, Dept Diabet Endocrinol & Nutr, Girona, Spain; [Moreno, Maria; Puig, Josep; Serrano, Marta; Maria Moreno-Navarrete, Jose; Ortega, Francisco; Ricart, Wifredo; Manuel Fernandez-Real, Jose] Inst Salud Carlos III ISCIII, Girona, Spain; [Puig, Josep] CIBEROBN CB06 03 010, Inst Invest Biomed Girona IdIBGi, Dept Radiol, Girona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI)	Fernandez-Real, JM (corresponding author), CIBEROBN CB06 03 010, Inst Invest Biomed Girona IdIBGi, Dept Diabet Endocrinol & Nutr, Girona, Spain.	jmfreal@idibgi.org	Fernandez-Real, Jose Manuel/L-5897-2014; Moreno-Navarrete, José María/ABG-5548-2021; Moreno-Navarrete, José María/H-9772-2015; Ortega, Francisco José J/F-3883-2016	Moreno-Navarrete, José María/0000-0002-2883-511X; Moreno-Navarrete, José María/0000-0002-2883-511X; Ortega, Francisco José J/0000-0003-2111-769X; Fernandez-Real, Jose Manuel/0000-0002-7442-9323; Ricart, Wifredo/0000-0002-3452-9098	Spanish Ministry of Health [FIS 2011-00214]; CIBERobn Fisiopatologia de la Obesidad y la Nutricion (CIBERobn)	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); CIBERobn Fisiopatologia de la Obesidad y la Nutricion (CIBERobn)	This study was supported by the Spanish Ministry of Health (FIS 2011-00214), and CIBERobn Fisiopatologia de la Obesidad y la Nutricion (CIBERobn). The CIBER de la Fisiopatologia de la Obesidad y Nutricion (CIBERobn) is an initiative from the Instituto de Salud Carlos III (ISCIII). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bot I, 2011, THROMB HAEMOSTASIS, V106, P820, DOI 10.1160/TH11-05-0291; Bots ML, 2007, EUR HEART J, V28, P398, DOI 10.1093/eurheartj/ehl482; De Filippis D, 2008, J NEUROENDOCRINOL, V20, P20, DOI 10.1111/j.1365-2826.2008.01674.x; Deliargyris EN, 2005, ATHEROSCLEROSIS, V178, P381, DOI 10.1016/j.atherosclerosis.2004.09.008; Divoux A, 2012, J CLIN ENDOCR METAB, V97, pE1677, DOI 10.1210/jc.2012-1532; Fenger RV, 2012, INT ARCH ALLERGY IMM, V157, P151, DOI 10.1159/000327535; Fukuoka Y, 2007, INT IMMUNOPHARMACOL, V7, P1900, DOI 10.1016/j.intimp.2007.07.007; Fuster V, 2005, J AM COLL CARDIOL, V46, P937, DOI 10.1016/j.jacc.2005.03.074; Hakala JK, 2003, ARTERIOSCL THROM VAS, V23, P1430, DOI 10.1161/01.ATV.0000077207.49221.06; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Johnson JL, 1998, ARTERIOSCL THROM VAS, V18, P1707, DOI 10.1161/01.ATV.18.11.1707; KAARTINEN M, 1994, ARTERIOSCLER THROMB, V14, P966, DOI 10.1161/01.ATV.14.6.966; Kelley JL, 2000, MOL MED TODAY, V6, P304, DOI 10.1016/S1357-4310(00)01747-0; Kervinen H, 2005, INT J CARDIOL, V104, P138, DOI 10.1016/j.ijcard.2004.10.023; KOVANEN PT, 1990, EUR HEART J, V11, P238, DOI 10.1093/eurheartj/11.suppl_E.238; KOVANEN PT, 1995, CIRCULATION, V92, P1084, DOI 10.1161/01.CIR.92.5.1084; Lee M, 2002, ARTERIOSCL THROM VAS, V22, P2086, DOI 10.1161/01.ATV.0000041405.07367.B5; Lehtonen-Smeds EMP, 2005, CEREBROVASC DIS, V19, P291, DOI 10.1159/000084497; Lindstedt KA, 1998, BBA-GEN SUBJECTS, V1425, P617, DOI 10.1016/S0304-4165(98)00115-9; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Metcalfe DD, 2008, BLOOD, V112, P946, DOI 10.1182/blood-2007-11-078097; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Ramalho LS, 2013, ANN DIAGN PATHOL, V17, P28, DOI 10.1016/j.anndiagpath.2012.04.007; SCHWARTZ LB, 1985, J IMMUNOL, V135, P2762; SCHWARTZ LB, 1990, J ALLERGY CLIN IMMUN, V86, P594, DOI 10.1016/S0091-6749(05)80222-2; Thomas VA, 1998, BIOCHEMISTRY-US, V37, P2291, DOI 10.1021/bi972119z; Touboul PJ, 2012, CEREBROVASC DIS, V34, P290, DOI 10.1159/000343145; Wang Z, 2013, ANN MED, V45, P220, DOI 10.3109/07853890.2012.732234; Wang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028962; Willems S, 2013, EUR HEART J, V34, P3699, DOI 10.1093/eurheartj/eht186; Xiang MX, 2011, ATHEROSCLEROSIS, V215, P494, DOI 10.1016/j.atherosclerosis.2011.01.006; Zhi XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060960	32	18	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97014	10.1371/journal.pone.0097014	http://dx.doi.org/10.1371/journal.pone.0097014			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830464	Green Published, Green Submitted, gold			2022-12-27	WOS:000336789500029
J	Sudarshan, S; Kodathala, SB; Mahadik, AC; Mehta, I; Beck, BW				Sudarshan, Sanjana; Kodathala, Sasi B.; Mahadik, Amruta C.; Mehta, Isha; Beck, Brian W.			Protein-Protein Interface Detection Using the Energy Centrality Relationship (ECR) Characteristic of Proteins	PLOS ONE			English	Article							HOT-SPOTS; PREDICTION; BINDING; CLASSIFICATION; CONSERVATION; DIVERSITY; COMPLEXES; CONTACTS; DATABASE	Specific protein interactions are responsible for most biological functions. Distinguishing Functionally Linked Interfaces of Proteins (FLIPs), from Functionally uncorrelated Contacts (FunCs), is therefore important to characterizing these interactions. To achieve this goal, we have created a database of protein structures called FLIPdb, containing proteins belonging to various functional sub-categories. Here, we use geometric features coupled with Kortemme and Baker's computational alanine scanning method to calculate the energetic sensitivity of each amino acid at the interface to substitution, identify hotspots, and identify other factors that may contribute towards an interface being FLIP or FunC. Using Principal Component Analysis and K-means clustering on a training set of 160 interfaces, we could distinguish FLIPs from FunCs with an accuracy of 76%. When these methods were applied to two test sets of 18 and 170 interfaces, we achieved similar accuracies of 78% and 80%. We have identified that FLIP interfaces have a stronger central organizing tendency than FunCs, due, we suggest, to greater specificity. We also observe that certain functional sub-categories, such as enzymes, antibody-heavy-light, antibody-antigen, and enzyme-inhibitors form distinct sub-clusters. The antibody-antigen and enzyme-inhibitors interfaces have patterns of physical characteristics similar to those of FunCs, which is in agreement with the fact that the selection pressures of these interfaces is differently evolutionarily driven. As such, our ECR model also successfully describes the impact of evolution and natural selection on protein-protein interfaces. Finally, we indicate how our ECR method may be of use in reducing the false positive rate of docking calculations.	[Sudarshan, Sanjana; Kodathala, Sasi B.; Mahadik, Amruta C.; Mehta, Isha; Beck, Brian W.] Texas Womans Univ, Dept Biol, Denton, TX 76204 USA; [Beck, Brian W.] Texas Womans Univ, Dept Math & Comp Sci, Denton, TX 76204 USA; [Beck, Brian W.] Texas Womans Univ, Dept Chem & Biochem, Denton, TX 76204 USA	Texas Womans University; Texas Womans University; Texas Womans University	Beck, BW (corresponding author), Texas Womans Univ, Dept Biol, Denton, TX 76204 USA.	bbeck@twu.edu	Mehta, Isha/AFA-1627-2022; Beck, Brian/H-5530-2018	Beck, Brian/0000-0002-7731-3457	TWU (Research Enhancement Program); TWU (Multidisciplinary Research Program); TWU (Art & Sciences Research Development Fund)	TWU (Research Enhancement Program); TWU (Multidisciplinary Research Program); TWU (Art & Sciences Research Development Fund)	The work of SS, ACM, SBK and IM for specific portions of this project were supported by internal funding from TWU (Research Enhancement Program, Multidisciplinary Research Program, and Art & Sciences Research Development Fund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aytuna AS, 2005, BIOINFORMATICS, V21, P2850, DOI 10.1093/bioinformatics/bti443; Bader GD, 2001, NUCLEIC ACIDS RES, V29, P242, DOI 10.1093/nar/29.1.242; Bahadur RP, 2008, CELL MOL LIFE SCI, V65, P1059, DOI 10.1007/s00018-007-7451-x; Bahadur RP, 2003, PROTEINS, V53, P708, DOI 10.1002/prot.10461; Bahadur RP, 2004, J MOL BIOL, V336, P943, DOI 10.1016/j.jmb.2003.12.073; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; De Las Rivas J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000807; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Dey S, 2010, J MOL BIOL, V398, P146, DOI 10.1016/j.jmb.2010.02.020; Duarte JM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-334; Fleishman SJ, 2011, J MOL BIOL, V414, P289, DOI 10.1016/j.jmb.2011.09.031; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; HARTIGAN JA, 1973, ANNU REV BIOPHYS BIO, V2, P81, DOI 10.1146/annurev.bb.02.060173.000501; Havranek JJ, 2010, J BIOL CHEM, V285, P31095, DOI 10.1074/jbc.R110.157685; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hubbard TJP, 1999, NUCLEIC ACIDS RES, V27, P254, DOI 10.1093/nar/27.1.254; Janin J, 2005, PROTEIN SCI, V14, P278, DOI 10.1110/ps.041081905; Janin J, 2010, MOL BIOSYST, V6, P2351, DOI 10.1039/c005060c; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Kortemme T., 2004, SCI STKE, V2004, ppl2, DOI [10.1126/stke.2192004pl2, DOI 10.1126/STKE.2192004PL2]; Krissinel E, 2005, LECT NOTES COMPUT SC, V3695, P163; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krissinel E, 2010, J COMPUT CHEM, V31, P133, DOI 10.1002/jcc.21303; Levy ED, 2007, STRUCTURE, V15, P1364, DOI 10.1016/j.str.2007.09.019; Liu SY, 2006, PROTEINS, V64, P68, DOI 10.1002/prot.20954; Massova I, 1999, J AM CHEM SOC, V121, P8133, DOI 10.1021/ja990935j; Meenan NAG, 2010, P NATL ACAD SCI USA, V107, P10080, DOI 10.1073/pnas.0910756107; Mihalek I, 2004, J MOL BIOL, V336, P1265, DOI 10.1016/j.jmb.2003.12.078; Mintseris J, 2005, PROTEINS, V60, P214, DOI 10.1002/prot.20560; Moretti R, 2013, PROTEINS; Nooren IMA, 2003, EMBO J, V22, P3486, DOI 10.1093/emboj/cdg359; Ofran Y, 2003, J MOL BIOL, V325, P377, DOI 10.1016/S0022-2836(02)01223-8; Ofran Y, 2007, PLOS COMPUT BIOL, V3, P1169, DOI 10.1371/journal.pcbi.0030119; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; PHIZICKY EM, 1995, MICROBIOL REV, V59, P94, DOI 10.1128/MMBR.59.1.94-123.1995; Ponstingl H, 2000, PROTEINS, V41, P47; Ritchie DW, 2000, PROTEINS, V39, P178, DOI 10.1002/(SICI)1097-0134(20000501)39:2<178::AID-PROT8>3.3.CO;2-Y; Schatz DG, 2011, ANNU REV GENET, V45, P167, DOI 10.1146/annurev-genet-110410-132552; Schrodinger L., PYMOL MOL GRAPHICS S; Schwartz GW, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00357; Shoichet BK, 2002, CURR OPIN CHEM BIOL, V6, P439, DOI 10.1016/S1367-5931(02)00339-3; Thorn KS, 2001, BIOINFORMATICS, V17, P284, DOI 10.1093/bioinformatics/17.3.284; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Valdar WSJ, 2001, PROTEINS, V42, P108; Valencia A, 2002, CURR OPIN STRUC BIOL, V12, P368, DOI 10.1016/S0959-440X(02)00333-0; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303; Young KH, 1998, BIOL REPROD, V58, P302, DOI 10.1095/biolreprod58.2.302; Zanzoni A, 2002, FEBS LETT, V513, P135, DOI 10.1016/S0014-5793(01)03293-8; Zhu HB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-27	57	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97115	10.1371/journal.pone.0097115	http://dx.doi.org/10.1371/journal.pone.0097115			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830938	gold, Green Published, Green Submitted			2022-12-27	WOS:000336789500035
J	Xu, ZF; Zhu, WY; Liu, YC; Liu, X; Chen, QS; Peng, M; Wang, XZ; Shen, GM; He, L				Xu, Zhifeng; Zhu, Wenyi; Liu, Yanchao; Liu, Xing; Chen, Qiushuang; Peng, Miao; Wang, Xiangzun; Shen, Guangmao; He, Lin			Analysis of Insecticide Resistance-Related Genes of the Carmine Spider Mite Tetranychus cinnabarinus Based on a De Novo Assembled Transcriptome	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; SODIUM-CHANNEL GENE; DROSOPHILA-MELANOGASTER; URTICAE KOCH; ACARI; EVOLUTION; IDENTIFICATION; ANNOTATION; TOXICOLOGY; MUTATIONS	The carmine spider mite (CSM), Tetranychus cinnabarinus, is an important pest mite in agriculture, because it can develop insecticide resistance easily. To gain valuable gene information and molecular basis for the future insecticide resistance study of CSM, the first transcriptome analysis of CSM was conducted. A total of 45,016 contigs and 25,519 unigenes were generated from the de novo transcriptome assembly, and 15,167 unigenes were annotated via BLAST querying against current databases, including nr, SwissProt, the Clusters of Orthologous Groups (COGs), Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO). Aligning the transcript to Tetranychus urticae genome, the 19255 (75.45%) of the transcripts had significant (e-value <10(-5)) matches to T. urticae DNA genome, 19111 sequences matched to T. urticae proteome with an average protein length coverage of 42.55%. Core Eukaryotic Genes Mapping Approach (CEGMA) analysis identified 435 core eukaryotic genes (CEGs) in the CSM dataset corresponding to 95% coverage. Ten gene categories that relate to insecticide resistance in arthropod were generated from CSM transcriptome, including 53 P450-, 22 GSTs-, 23 CarEs-, 1 AChE-, 7 GluCls-, 9 nAChRs-, 8 GABA receptor-, 1 sodium channel-, 6 ATPase-and 12 Cyt b genes. We developed significant molecular resources for T. cinnabarinus putatively involved in insecticide resistance. The transcriptome assembly analysis will significantly facilitate our study on the mechanism of adapting environmental stress (including insecticide) in CSM at the molecular level, and will be very important for developing new control strategies against this pest mite.	[Xu, Zhifeng; Zhu, Wenyi; Liu, Yanchao; Liu, Xing; Chen, Qiushuang; Peng, Miao; Wang, Xiangzun; Shen, Guangmao; He, Lin] Southwest Univ, Key Lab Entomol & Pest Control Engn Chongqing, Coll Plant Protect, Chongqing, Peoples R China	Southwest University - China	He, L (corresponding author), Southwest Univ, Key Lab Entomol & Pest Control Engn Chongqing, Coll Plant Protect, Chongqing, Peoples R China.	helinok@vip.tom.com			Ministry of Education Program for New Century Excellent Talents [NCET-10-0700]; Fundamental Research Funds for the Central Universities [XDJK2013A007]; National Nature Sciences Foundation [31071984, 31272059]; Special Fund for Agro-scientific Research in the Public Interest [201103020]	Ministry of Education Program for New Century Excellent Talents; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Nature Sciences Foundation(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest	This research was funded in part by the Ministry of Education Program for New Century Excellent Talents (NCET-10-0700), the Fundamental Research Funds for the Central Universities (XDJK2013A007), the National Nature Sciences Foundation (31071984, 31272059) and the Special Fund for Agro-scientific Research in the Public Interest (201103020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass C, 2011, PEST MANAG SCI, V67, P886, DOI 10.1002/ps.2189; Bolland HR., 1998, WORLD CATALOGUE SPID; BOUDREAUX H. BRUCE, 1956, ANN ENT SOC AMER, V49, P43, DOI 10.1093/aesa/49.1.43; BRANDENBURG R L, 1981, International Journal of Acarology, V7, P231; Calvo E, 2004, INSECT MOL BIOL, V13, P73, DOI 10.1111/j.1365-2583.2004.00463.x; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Daborn PJ, 2007, INSECT BIOCHEM MOLEC, V37, P512, DOI 10.1016/j.ibmb.2007.02.008; de Mendonca RS, 2011, EXP APPL ACAROL, V55, P1, DOI 10.1007/s10493-011-9453-5; Dermauw W, 2012, INSECT BIOCHEM MOLEC, V42, P455, DOI 10.1016/j.ibmb.2012.03.002; Dong Ke, 2007, Invertebrate Neuroscience, V7, P17, DOI 10.1007/s10158-006-0036-9; DUPONT LM, 1979, ENTOMOL EXP APPL, V25, P297, DOI 10.1007/BF00302791; Eddy S, 2010, HMMER3 NEW GENERATIO; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ehara S, 1989, SHOKUBUTU BOEKI, V43, P358; Feng YN, 2011, PEST MANAG SCI, V67, P904, DOI 10.1002/ps.2129; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; Feyereisen R, 2011, BBA-PROTEINS PROTEOM, V1814, P19, DOI 10.1016/j.bbapap.2010.06.012; Goka K, 1996, EXP APPL ACAROL, V20, P683, DOI 10.1007/BF00051553; Gotoh Tetsuo, 1996, Japanese Journal of Entomology, V64, P215; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grbic M, 2011, NATURE, V479, P487, DOI 10.1038/nature10640; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; He L, 2009, PESTIC BIOCHEM PHYS, V93, P47, DOI 10.1016/j.pestbp.2008.11.001; Hotelier T, 2010, J PESTIC SCI, V35, P315, DOI 10.1584/jpestics.R10-10; Hsu JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040950; [贾福丽 Jia Fuli], 2011, [中国农学通报, Chinese Agricultural Science Bulletin], V27, P286; JORDAAN LC, 1977, J ENTOMOL SOC S AFR, V40, P147; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Konanz S, 2004, PESTIC BIOCHEM PHYS, V79, P49, DOI 10.1016/J.PESTBP.2004.03.004; KUANG H-Y, 1990, Acta Entomologica Sinica, V33, P109; Li T, 2009, ANN ENTOMOL SOC AM, V102, P674, DOI 10.1603/008.102.0412; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; [梁为 LIANG Wei], 2011, [广东农业科学, Guangdong Agricultural Sciences], V38, P68; Low WY, 2007, GENETICS, V177, P1363, DOI 10.1534/genetics.107.075838; Lu WC, 2009, EFFECTS ABAMECTIN HE; Ma Y, 2004, CHIN J PUBLIC HLTH, V20, P1440; Ma Y, 2006, CHIN J PUBLIC HLTH, V22, P1080; Millar Neil S., 2007, Invertebrate Neuroscience, V7, P53, DOI 10.1007/s10158-006-0040-0; Morin S, 2002, INSECT BIOCHEM MOLEC, V32, P1781, DOI 10.1016/S0965-1748(02)00137-6; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; Qiu Xing-Hui, 2005, Acta Entomologica Sinica, V48, P960; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Ranson H, 2001, BIOCHEM J, V359, P295, DOI 10.1042/0264-6021:3590295; ROBINSON DM, 1961, NATURE, V189, P857, DOI 10.1038/189857a0; Ros VID, 2007, EXP APPL ACAROL, V42, P239, DOI 10.1007/s10493-007-9092-z; Smith F. F., 1969, P155; Sugasawa J, 2002, APPL ENTOMOL ZOOL, V37, P127, DOI 10.1303/aez.2002.127; Sun Qing-tian, 2001, Journal of Jilin Agricultural University, V23, P24; Sun W, 2010, INSECT SCI, V17, P91, DOI 10.1111/j.1744-7917.2009.01302.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tijet N, 2001, GENE, V262, P189, DOI 10.1016/S0378-1119(00)00533-3; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; Van Leeuwen T, 2011, INSECT MOL BIOL, V20, P135, DOI 10.1111/j.1365-2583.2010.01040.x; Van Nieuwenhuyse P, 2009, PEST MANAG SCI, V65, P404, DOI 10.1002/ps.1705; Werck-Reichhart D, 2000, GENOME BIOL, V6, P1, DOI [10.1186/GB-2000-1-6-REVIEWS3003, DOI 10.1186/GB-2000-1-6-REVIEWS3003]; Wolstenholme AJ, 2005, PARASITOLOGY, V131, pS85, DOI 10.1017/S0031182005008218; Yamamoto K, 2009, PESTIC BIOCHEM PHYS, V94, P30, DOI 10.1016/j.pestbp.2009.02.008; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Zhai Qihui, 1995, Acta Entomologica Sinica, V38, P493; Zhang Jian-Ping, 2003, Acta Arachnologica Sinica, V12, P95; Zhang Zhi-Qiang, 2000, Systematic and Applied Acarology, V5, P69; Zhu JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032291	65	34	38	4	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e94779	10.1371/journal.pone.0094779	http://dx.doi.org/10.1371/journal.pone.0094779			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830288	Green Submitted, Green Published, gold			2022-12-27	WOS:000336789500005
J	Pelletreau, KN; Weber, APM; Weber, KL; Rumpho, ME				Pelletreau, Karen N.; Weber, Andreas P. M.; Weber, Katrin L.; Rumpho, Mary E.			Lipid Accumulation during the Establishment of Kleptoplasty in Elysia chlorotica	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; DIETARY FISH-OIL; GENE-EXPRESSION; CODIUM-FRAGILE; SEA SLUGS; SYMBIOTIC ZOOXANTHELLAE; EICOSAPENTAENOIC ACID; DIGESTIVE GLAND; CHLOROPLASTS; DROPLETS	The establishment of kleptoplasty (retention of "stolen plastids") in the digestive tissue of the sacoglossan Elysia chlorotica Gould was investigated using transmission electron microscopy. Cellular processes occurring during the initial exposure to plastids were observed in laboratory raised animals ranging from 1 - 14 days post metamorphosis (dpm). These observations revealed an abundance of lipid droplets (LDs) correlating to plastid abundance. Starvation of animals resulted in LD and plastid decay in animals,5 dpm that had not yet achieved permanent kleptoplasty. Animals allowed to feed on algal prey (Vaucheria litorea C. Agardh) for 7 d or greater retained stable plastids resistant to cellular breakdown. Lipid analysis of algal and animal samples supports that these accumulating LDs may be of plastid origin, as the often algal- derived 20:5 eicosapentaenoic acid was found in high abundance in the animal tissue. Subsequent culturing of animals in dark conditions revealed a reduced ability to establish permanent kleptoplasty in the absence of photosynthetic processes, coupled with increased mortality. Together, these data support an important role of photosynthetic lipid production in establishing and stabilizing this unique animal kleptoplasty.	[Pelletreau, Karen N.; Rumpho, Mary E.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; [Weber, Andreas P. M.; Weber, Katrin L.] Univ Dusseldorf, Cluster Excellence Plant Sci CEPLAS, Inst Plant Biochem, Dusseldorf, Germany	University of Connecticut; Heinrich Heine University Dusseldorf; University of Cologne	Pelletreau, KN (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA.	karen.pelletreau@uconn.edu	Weber, Andreas Paul Michael/O-3043-2019; Weber, Andreas PM/A-6250-2011	Weber, Andreas Paul Michael/0000-0003-0970-4672; Weber, Andreas PM/0000-0003-0970-4672	National Science Foundation [IOS-0726178]; University of Maine - High End Instrumentation Research Grant; University of Connecticut; Deutsche Forschungsgemeinschaft [IRTG 1525-2, EXC 1028]; Direct For Biological Sciences [1265171] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); University of Maine - High End Instrumentation Research Grant; University of Connecticut; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation grant IOS-0726178 (www.nsf.gov); by a University of Maine - High End Instrumentation Research Grant (www.umaine.edu); by the University of Connecticut (www.uconn.edu); and by the Deutsche Forschungsgemeinschaft grants IRTG 1525-2 and EXC 1028 (http://www.dfg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M, 2002, J NUTR, V132, P3566, DOI 10.1093/jn/132.12.3566; Bachok Z, 2006, CORAL REEFS, V25, P545, DOI 10.1007/s00338-006-0130-9; BAJPAI P, 1993, J BIOTECHNOL, V30, P161, DOI 10.1016/0168-1656(93)90111-Y; BATTEY JF, 1984, MAR BIOL, V79, P27, DOI 10.1007/BF00404982; Bhattacharya D, 2013, MOL BIOL EVOL, V30, P1843, DOI 10.1093/molbev/mst084; BISHOP DG, 1980, LIPIDS, V15, P799, DOI 10.1007/BF02534368; Calder PC, 2001, LIPIDS, V36, P1007, DOI 10.1007/s11745-001-0812-7; CHANG HR, 1992, METABOLISM, V41, P1, DOI 10.1016/0026-0495(92)90181-9; CHEN LY, 1994, THROMB RES, V76, P317, DOI 10.1016/0049-3848(94)90160-0; Chen WNU, 2012, CORAL REEFS, V31, P521, DOI 10.1007/s00338-011-0868-6; Christa G, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2493; Christensen SA, 2011, FUNGAL GENET BIOL, V48, P4, DOI 10.1016/j.fgb.2010.05.005; Cirulis JT, 2012, CYTOM PART A, V81A, P618, DOI 10.1002/cyto.a.22066; CLARK KB, 1990, VELIGER, V33, P339; D'Avila H, 2012, MEDIAT INFLAMM, V2012, P1, DOI [10.1017/S1431927611012098., DOI 10.1017/S1431927611012098]; Dall'Armi C, 2013, CURR BIOL, V23, pR33, DOI 10.1016/j.cub.2012.10.041; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; Davidi L, 2012, PLANTA, V236, P19, DOI 10.1007/s00425-011-1585-7; de Pablo MA, 2000, FEMS IMMUNOL MED MIC, V29, P323, DOI 10.1016/S0928-8244(00)00224-8; Deretic V, 2006, CELL MICROBIOL, V8, P719, DOI 10.1111/j.1462-5822.2006.00705.x; Ehrt S, 2007, NAT MED, V13, P284, DOI 10.1038/nm0307-284; Fan CN, 2013, CURR OPIN CLIN NUTR, V16, P124, DOI 10.1097/MCO.0b013e32835c02c8; Fan JL, 2011, FEBS LETT, V585, P1985, DOI 10.1016/j.febslet.2011.05.018; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Fritsche K, 2006, ANNU REV NUTR, V26, P45, DOI 10.1146/annurev.nutr.25.050304.092610; Garrett TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057975; GILES KL, 1980, IN VITRO CELL DEV B, V16, P581; Gong YM, 2013, J BASIC MICROB, V53, P29, DOI 10.1002/jobm.201100487; Gordon BR, 2010, MAR DRUGS, V8, P2546, DOI 10.3390/md8102546; Govender T, 2012, BIORESOURCE TECHNOL, V114, P507, DOI 10.1016/j.biortech.2012.03.024; Green BJ, 2005, SYMBIOSIS, V40, P31; Green BJ, 2000, PLANT PHYSIOL, V124, P331, DOI 10.1104/pp.124.1.331; Guschina IA, 2006, PROG LIPID RES, V45, P160, DOI 10.1016/j.plipres.2006.01.001; HARLAND AD, 1991, MAR BIOL, V110, P13, DOI 10.1007/BF01313087; Harwood JL, 2009, BIOCHIMIE, V91, P679, DOI 10.1016/j.biochi.2008.11.004; Herker E, 2012, J BIOL CHEM, V287, P2280, DOI 10.1074/jbc.R111.300202; Hirose E, 2005, ZOOL SCI, V22, P905, DOI 10.2108/zsj.22.905; HUBBARD NE, 1991, J LEUKOCYTE BIOL, V49, P592, DOI 10.1002/jlb.49.6.592; Imbs AB, 2014, PHYTOCHEMISTRY, V101, P76, DOI 10.1016/j.phytochem.2014.02.012; Irons R, 2003, J NUTR, V133, P1163, DOI 10.1093/jn/133.4.1163; KELLOGG RB, 1983, MAR BIOL, V75, P137, DOI 10.1007/BF00405996; Khozin-Goldberg I, 2011, BIOCHIMIE, V93, P91, DOI 10.1016/j.biochi.2010.07.020; Koga H, 2010, FASEB J, V24, P3052, DOI 10.1096/fj.09-144519; Lee R., 2008, PHYCOLOGY, VFourth, DOI DOI 10.1016/j.energy.2014.06.023; Li X, 2010, BIORESOURCE TECHNOL, V101, P5494, DOI 10.1016/j.biortech.2010.02.016; Liu BS, 2013, CURR OPIN BIOTECH, V24, P300, DOI 10.1016/j.copbio.2012.08.008; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Melo RCN, 2006, INFLAMM RES, V55, P342, DOI 10.1007/s00011-006-5205-0; Melo RCN, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002729; Merchant SS, 2012, CURR OPIN BIOTECH, V23, P352, DOI 10.1016/j.copbio.2011.12.001; Mondy WL, 2003, INVERTEBR BIOL, V122, P126; Msanne J, 2012, PHYTOCHEMISTRY, V75, P50, DOI 10.1016/j.phytochem.2011.12.007; Mujer CV, 1996, P NATL ACAD SCI USA, V93, P12333, DOI 10.1073/pnas.93.22.12333; Muniain C, 2001, MAR BIOL, V139, P687; Murphy DJ, 2012, PROTOPLASMA, V249, P541, DOI 10.1007/s00709-011-0329-7; Papina M, 2003, COMP BIOCHEM PHYS B, V135, P533, DOI 10.1016/S1096-4959(03)00118-0; PATTON JS, 1977, MAR BIOL, V44, P235, DOI 10.1007/BF00387705; PATTON JS, 1983, MAR BIOL, V75, P131, DOI 10.1007/BF00405995; Pelletreau KN, 2012, SYMBIOSIS, V58, P221, DOI 10.1007/s13199-012-0192-0; Peng SE, 2011, PROTEOMICS, V11, P3540, DOI 10.1002/pmic.201000552; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Pierce SK, 2006, MOLLUSCAN RES, V26, P23; Puertollano MA, 2002, CLIN DIAGN LAB IMMUN, V9, P352, DOI 10.1128/CDLI.9.2.352-357.2002; Reue K, 2011, J LIPID RES, V52, P1865, DOI 10.1194/jlr.E020602; Richard D, 2008, PHARMACOL RES, V57, P451, DOI 10.1016/j.phrs.2008.05.002; Rumpho ME, 2011, J EXP BIOL, V214, P303, DOI 10.1242/jeb.046540; Rumpho Mary E., 2006, V23, P451; Rumpho ME, 2000, PLANT PHYSIOL, V123, P29, DOI 10.1104/pp.123.1.29; Rumpho ME, 2001, ZOOL-ANAL COMPLEX SY, V104, P303, DOI 10.1078/0944-2006-00036; Saka HA, 2012, ANNU REV CELL DEV BI, V28, P411, DOI 10.1146/annurev-cellbio-092910-153958; Schmidt S, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-45; Schwerbrock NMJ, 2009, J NUTR, V139, P1588, DOI 10.3945/jn.109.108027; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Sipka S, 1996, CLIN IMMUNOL IMMUNOP, V79, P224, DOI 10.1006/clin.1996.0072; Stehr M, 2012, MICROBES INFECT, V14, P1227, DOI 10.1016/j.micinf.2012.08.001; TAYLOR DL, 1968, J MAR BIOL ASSOC UK, V48, P1, DOI 10.1017/S0025315400032380; Trench R.K., 1975, Symposia Soc exp Biol, VNo. 29, P229; TRENCH RK, 1973, PROC R SOC SER B-BIO, V184, P63, DOI 10.1098/rspb.1973.0031; TRENCH RK, 1969, NATURE, V222, P1071, DOI 10.1038/2221071a0; TRENCH RK, 1973, PROC R SOC SER B-BIO, V184, P51, DOI 10.1098/rspb.1973.0030; TRENCH RK, 1976, NEW PHYTOL, V76, P99, DOI 10.1111/j.1469-8137.1976.tb01442.x; TRENCH RK, 1974, PROC R SOC SER B-BIO, V185, P453, DOI 10.1098/rspb.1974.0029; TRENCH RK, 1969, J CELL BIOL, V42, P404, DOI 10.1083/jcb.42.2.404; Wang ZT, 2009, EUKARYOT CELL, V8, P1856, DOI 10.1128/EC.00272-09; Wu DY, 1998, P NUTR SOC, V57, P503, DOI 10.1079/PNS19980074; Yaqoob P, 2003, TRENDS IMMUNOL, V24, P639, DOI 10.1016/j.it.2003.10.002	86	25	25	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97477	10.1371/journal.pone.0097477	http://dx.doi.org/10.1371/journal.pone.0097477			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828251	Green Submitted, Green Published, gold			2022-12-27	WOS:000336857400097
J	Hamalainen, S; Solovieva, S; Vehmas, T; Luoma, K; Leino-Arjas, P; Hirvonen, A				Hamalainen, Satu; Solovieva, Svetlana; Vehmas, Tapio; Luoma, Katariina; Leino-Arjas, Paivi; Hirvonen, Ari			Genetic Influences on Hand Osteoarthritis in Finnish Women - A Replication Study of Candidate Genes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RADIOGRAPHIC HIP OSTEOARTHRITIS; KNEE OSTEOARTHRITIS; SUSCEPTIBILITY LOCUS; JOINT OSTEOARTHRITIS; POSTMENOPAUSAL WOMEN; CHROMOSOME 7Q22; FEMALE DENTISTS; SCAN; DISEASE	Objectives: Our aims were to replicate some previously reported associations of single nucleotide polymorphisms (SNPs) in five genes (A2BP1, COG5, GDF5, HFE, ESR1) with hand osteoarthritis (OA), and to examine whether genes (BCAP29, DIO2, DUS4L, DVWA, HLA, PTGS2, PARD3B, TGFB1 and TRIB1) associated with OA at other joint sites were associated with hand OA among Finnish women. Design: We examined the bilateral hand radiographs of 542 occupationally active Finnish female dentists and teachers aged 45 to 63 and classified them according to the presence of OA by using reference images. Data regarding finger joint pain and other risk factors were collected using a questionnaire. We defined two hand OA phenotypes: radiographic OA in at least three joints (ROA) and symptomatic DIP OA. The genotypes were determined by PCR-based methods. In statistical analysis, we used SNPStats software, the chi-square test and logistic regression. Results: Of the SNPs, rs716508 in A2BP1 was associated with ROA (OR = 0.7, 95% CI 0.5-0.9) and rs1800470 in TGFB1 with symptomatic DIP OA (1.8, 1.2-2.9). We found an interaction between ESR1 (rs9340799) and occupation: teachers with the minor allele were at an increased risk of symptomatic DIP OA (2.8, 1.3-6.5). We saw no association among the dentists. We also found that the carriage of the COG5 rs3757713 C allele increased the risk of ROA only among women with the BCAP29 rs10953541 CC genotype (2.6; 1.1-6.1). There was also a suggestive interaction between the HFE rs179945 and the ESR1 rs9340799, and the carriage of the minor allele of either of these SNPs was associated with an increased risk of symptomatic DIP OA (2.1, 1.3-2.5). Conclusions: Our results support the earlier findings of A2BP1 and TBGF1 being OA susceptibility genes and provide evidence of a possible gene-gene interaction in the genetic influence on hand OA predisposition.	[Hamalainen, Satu; Solovieva, Svetlana; Vehmas, Tapio; Leino-Arjas, Paivi; Hirvonen, Ari] Ctr Expertise Hlth & Work Abil, Finnish Inst Occupat Hlth, Helsinki, Finland; [Luoma, Katariina] Univ Helsinki, Cent Hosp, Dept Radiol, Helsinki, Finland	Finnish Institute of Occupational Health; University of Helsinki; Helsinki University Central Hospital	Hamalainen, S (corresponding author), Ctr Expertise Hlth & Work Abil, Finnish Inst Occupat Hlth, Helsinki, Finland.	satu.hamalainen@ttl.fi		Leino-Arjas, Paivi/0000-0001-9534-7071; Vehmas, Tapio/0000-0002-4761-9826	Finnish Work Environment Fund [101334]	Finnish Work Environment Fund	The study was financially supported by a grant (101334) from the Finnish Work Environment Fund (http:// www. tsr. fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh BZ, 2007, ANN RHEUM DIS, V66, P1436, DOI 10.1136/ard.2006.063099; Andreassen CN, 2005, RADIOTHER ONCOL, V75, P18, DOI 10.1016/j.radonc.2004.12.012; Bergink AP, 2003, ARTHRITIS RHEUM, V48, P1913, DOI 10.1002/art.11046; Carroll GJ, 2006, J RHEUMATOL, V33, P741; Cicuttini FM, 1996, ANN RHEUM DIS, V55, P665, DOI 10.1136/ard.55.9.665; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Demissie S, 2002, ARTHRITIS RHEUM, V46, P946, DOI 10.1002/art.10149; Ding H, 2010, SCAND J RHEUMATOL, V39, P84, DOI 10.3109/03009740903201834; Driban JB, 2010, CLIN RHEUMATOL, V29, P123, DOI 10.1007/s10067-009-1301-1; Evangelou E, 2011, ANN RHEUM DIS, V70, P349, DOI 10.1136/ard.2010.132787; Evangelou E, 2009, ARTHRITIS RHEUM-US, V60, P1710, DOI 10.1002/art.24524; Fahlgren A, 2001, OSTEOARTHR CARTILAGE, V9, P195, DOI 10.1053/joca.2000.0376; Gonzalez A, 2013, OSTEOARTHR CARTILAGE, V21, P1443, DOI 10.1016/j.joca.2013.07.001; Greig C, 2006, ANN RHEUM DIS, V65, P1131, DOI 10.1136/ard.2005.048165; Gu X, 2012, DIGEST DIS SCI, V57, P2901, DOI 10.1007/s10620-012-2238-9; Guggenbuhl P, 2011, BEST PRACT RES CL RH, V25, P649, DOI 10.1016/j.berh.2011.10.014; Hirsch R, 2000, OSTEOARTHR CARTILAGE, V8, pS16; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Huang X, 2008, BLOOD CELL MOL DIS, V41, P265, DOI 10.1016/j.bcmd.2008.06.009; Huang YT, 2009, J CLIN ONCOL, V27, P2660, DOI 10.1200/JCO.2008.18.7906; Hunter DJ, 2004, ARTHRITIS RHEUM, V50, P2489, DOI 10.1002/art.20445; Husar-Memmer E, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-013-0393-4; Ikegawa S, 2013, ANNU REV GENOM HUM G, V14, P245, DOI 10.1146/annurev-genom-091212-153427; Jian JL, 2009, ANTIOXID REDOX SIGN, V11, P2939, DOI [10.1089/ars.2009.2576, 10.1089/ARS.2009.2576]; Jin SY, 2004, ARTHRITIS RES THER, V6, pR415, DOI 10.1186/ar1207; Kalichman L, 2010, SEMIN ARTHRITIS RHEU, V39, P465, DOI 10.1016/j.semarthrit.2009.03.001; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kerkhof HJM, 2010, ARTHRITIS RHEUM-US, V62, P499, DOI 10.1002/art.27184; Kloppenburg M, 2012, NAT REV RHEUMATOL, V8, P22, DOI 10.1038/nrrheum.2011.170; Lee PH, 2008, NUCLEIC ACIDS RES, V36, pD820, DOI 10.1093/nar/gkm904; Leppavuori J, 1999, AM J HUM GENET, V65, P1060, DOI 10.1086/302569; Lian K, 2007, OSTEOARTHR CARTILAGE, V15, P972, DOI 10.1016/j.joca.2007.02.020; Livshits G, 2007, ANN RHEUM DIS, V66, P623, DOI 10.1136/ard.2006.060236; Loughlin John, 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009257; Ma LJ, 2010, DIABETES, V59, P2837, DOI 10.2337/db09-1604; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P2410, DOI 10.1002/1529-0131(200011)43:11<2410::AID-ANR6>3.0.CO;2-E; Meulenbelt I, 2008, HUM MOL GENET, V17, P1867, DOI 10.1093/hmg/ddn082; Miyamoto Y, 2008, NAT GENET, V40, P994, DOI 10.1038/ng.176; Miyamoto Y, 2007, NAT GENET, V39, P529, DOI 10.1038/2005; Nakahata S, 2005, NUCLEIC ACIDS RES, V33, P2078, DOI 10.1093/nar/gki338; Nakajima M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009723; Panoutsopoulou K, 2011, ANN RHEUM DIS, V70, P864, DOI 10.1136/ard.2010.141473; Peltonen L, 1999, HUM MOL GENET, V8, P1913, DOI 10.1093/hmg/8.10.1913; Raine EVA, 2012, ANN RHEUM DIS, V71, P2020, DOI 10.1136/annrheumdis-2012-201304; Riancho JA, 2010, OSTEOARTHR CARTILAGE, V18, P927, DOI 10.1016/j.joca.2010.04.002; Ross JM, 2003, J RHEUMATOL, V30, P121; Ryder JJ, 2008, ANN RHEUM DIS, V67, P584, DOI 10.1136/ard.2007.073874; Sarachana T, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-14; Schlaak JF, 1996, CLIN EXP RHEUMATOL, V14, P155; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Solovieva S, 2005, RHEUMATOLOGY, V44, P521, DOI 10.1093/rheumatology/keh534; Spector TD, 1996, BRIT MED J, V312, P940; Stefansson SE, 2003, AM J HUM GENET, V72, P1448, DOI 10.1086/375556; Ushiyama T, 1998, J RHEUMATOL, V25, P134; Vaes RBA, 2009, ANN RHEUM DIS, V68, P1754, DOI 10.1136/ard.2008.099655; Valdes AM, 2006, ARTHRITIS RHEUM-US, V54, P533, DOI 10.1002/art.21621; Valdes AM, 2008, AM J HUM GENET, V82, P1231, DOI 10.1016/j.ajhg.2008.04.006; VANSAASE JLCM, 1989, ANN RHEUM DIS, V48, P271, DOI 10.1136/ard.48.4.271; Wise BL, 2009, J RHEUMATOL, V36, P2772, DOI 10.3899/jrheum.081208; Yamada Y, 2000, MECH AGEING DEV, V116, P113, DOI 10.1016/S0047-6374(00)00131-7; Zhai G, 2009, J MED GENET, V46, P614, DOI 10.1136/jmg.2009.067314	62	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97417	10.1371/journal.pone.0097417	http://dx.doi.org/10.1371/journal.pone.0097417			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24825461	Green Submitted, Green Published, gold			2022-12-27	WOS:000336369200111
J	Mousavizadeh, R; Khosravi, S; Behzad, H; McCormack, RG; Duronio, V; Scott, A				Mousavizadeh, Rouhollah; Khosravi, Shahram; Behzad, Hayedeh; McCormack, Robert G.; Duronio, Vincent; Scott, Alex			Cyclic Strain Alters the Expression and Release of Angiogenic Factors by Human Tendon Cells	PLOS ONE			English	Article							ROTATOR CUFF TENDINOPATHY; FIBROBLASTS; INCREASES; PATHOLOGY; PROTEINS; PAIN	Angiogenesis is associated with the tissue changes underlying chronic overuse tendinopathy. We hypothesized that repetitive, cyclic loading of human tendon cells would lead to increased expression and activity of angiogenic factors. We subjected isolated human tendon cells to overuse tensile loading using an in vitro model (1 Hz, 10% equibiaxial strain). We found that mechanically stimulated human tendon cells released factors that promoted in vitro proliferation and tube formation by human umbilical vein endothelial cells (HUVEC). In response to cyclic strain, there was a transient increase in the expression of several angiogenic genes including ANGPTL4, FGF-2, COX-2, SPHK1, TGF-alpha, VEGF-A and VEGF-C, with no change in anti-angiogenic genes (BAI1, SERPINF1, THBS1 and 2, TIMP1-3). Cyclic strain also resulted in the extracellular release of ANGPTL4 protein by tendon cells. Our study is the first report demonstrating the induction of ANGPTL4 mRNA and release of ANGPTL4 protein in response to cyclic strain. Tenocytes may contribute to the upregulation of angiogenesis during the development of overuse tendinopathy.	[Mousavizadeh, Rouhollah; Duronio, Vincent] Univ British Columbia, Dept Med, Vancouver, BC V5Z 1M9, Canada; [Mousavizadeh, Rouhollah; Behzad, Hayedeh; Scott, Alex] Univ British Columbia, Ctr Hip Hlth & Mobil, Vancouver Coastal Hlth Res Inst, Dept Phys Therapy, Vancouver, BC V5Z 1M9, Canada; [Khosravi, Shahram] Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 1M9, Canada; [McCormack, Robert G.] Univ British Columbia, Dept Orthoped Surg, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia; Vancouver Coastal Health Research Institute; University of British Columbia; University of British Columbia	Scott, A (corresponding author), Univ British Columbia, Ctr Hip Hlth & Mobil, Vancouver Coastal Hlth Res Inst, Dept Phys Therapy, Vancouver, BC V5Z 1M9, Canada.	ascott@mail.ubc.ca		Scott, Alex/0000-0003-0366-8404	Canadian Institute of Health Research [CIHR MOP-102476]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by an operating grant from the Canadian Institute of Health Research (CIHR MOP-102476, http://www.cihr.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sadi Onays, 2011, Muscles Ligaments Tendons J, V1, P68; ALMEKINDERS LC, 1993, MED SCI SPORT EXER, V25, P603; Arnaoutova I, 2010, NAT PROTOC, V5, P628, DOI 10.1038/nprot.2010.6; Arnoczky SP, 2007, INT J EXP PATHOL, V88, P217, DOI 10.1111/j.1365-2613.2007.00548.x; Backman LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027209; Blevins FT, 1997, SPORTS MED, V24, P205, DOI 10.2165/00007256-199724030-00009; Divani K, 2010, MANUAL THER, V15, P463, DOI 10.1016/j.math.2010.03.011; Gealekman O, 2008, AM J PHYSIOL-ENDOC M, V295, pE1056, DOI 10.1152/ajpendo.90345.2008; Gotoh M, 1998, J ORTHOP RES, V16, P618, DOI 10.1002/jor.1100160515; Hato T, 2008, TRENDS CARDIOVAS MED, V18, P6, DOI 10.1016/j.tcm.2007.10.003; Hojabrpour P, 2012, BIOCHEM J, V442, P139, DOI 10.1042/BJ20111256; Huang RL, 2011, BLOOD, V118, P3990, DOI 10.1182/blood-2011-01-328716; Jones ER, 2013, BBA-MOL CELL RES, V1833, P2596, DOI 10.1016/j.bbamcr.2013.06.019; Karsan A, 1998, J CLIN INVEST, V101, P2438, DOI 10.1172/JCI905; Lakemeier S, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-230; Le Jan S, 2003, AM J PATHOL, V162, P1521, DOI 10.1016/S0002-9440(10)64285-X; Lewis JS, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-163; Matthews TJW, 2006, J BONE JOINT SURG BR, V88B, P489, DOI 10.1302/0301-620X.88B4.16845; Mehta S, 2003, CLIN SPORT MED, V22, P791, DOI 10.1016/S0278-5919(03)00012-7; Mendias CL, 2012, J ORTHOP RES, V30, P606, DOI 10.1002/jor.21550; Morisada T, 2006, ENDOTHELIUM-J ENDOTH, V13, P71, DOI 10.1080/10623320600697989; Savitskaya YA, 2011, CLIN MED INSIGHTS-AR, V4, P43, DOI 10.4137/CMAMD.S7071; Scott A, 2005, J ORTHOP RES, V23, P1219, DOI 10.1016/j.orthres.2004.12.011; Seitz AL, 2011, CLIN BIOMECH, V26, P1, DOI 10.1016/j.clinbiomech.2010.08.001; Wang JHC, 2003, CONNECT TISSUE RES, V44, P128, DOI 10.1080/03008200390223909; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385	26	28	28	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97356	10.1371/journal.pone.0097356	http://dx.doi.org/10.1371/journal.pone.0097356			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824595	Green Published, Green Submitted, gold			2022-12-27	WOS:000336369200102
J	Danion, F; Bongers, RM; Bootsma, RJ				Danion, Frederic; Bongers, Raoul M.; Bootsma, Reinoud J.			The Trade-Off between Spatial and Temporal Variabilities in Reciprocal Upper-Limb Aiming Movements of Different Durations	PLOS ONE			English	Article							GRIP FORCE ADJUSTMENTS; INFORMATION CAPACITY; DIRECTED MOVEMENTS; REACHING MOVEMENTS; TIMING VARIABILITY; TASK CONSTRAINTS; HAND MOVEMENTS; MOVING TARGET; DRAWING TASKS; MOTOR CONTROL	The spatial and temporal aspects of movement variability have typically been studied separately. As a result the relationship between spatial and temporal variabilities remains largely unknown. In two experiments we examined the evolution and covariation of spatial and temporal variabilities over variations in the duration of reciprocal aiming movements. Experiments differed in settings: In Experiment 1 participants moved unperturbed whereas in Experiment 2 they were confronted with an elastic force field. Different movement durations-for a constant inter-target distance-were either evoked by imposing spatial accuracy constraints while requiring participants to move as fast as possible, or prescribed by means of an auditory metronome while requiring participants to maximize spatial accuracy. Analyses focused on absolute and relative variabilities, respectively captured by the standard deviation (SD) and the coefficient of variation (CV = SD/mean). Spatial variability (both SDspace and CVspace) decreased with movement duration, while temporal variability (both SDtime and CVtime) increased with movement duration. We found strong negative correlations between spatial and temporal variabilities over variations in movement duration, whether the variability examined was absolute or relative. These findings observed at the level of the full movement contrasted with the findings observed at the level of the separate acceleration and deceleration phases of movement. During the separate acceleration and deceleration phases both spatial and temporal variabilities (SD and CV) were found to increase with their respective durations, leading to positive correlations between them. Moreover, variability was generally larger at the level of the constituent movement phases than at the level of the full movement. The general pattern of results was robust, as it emerged in both tasks in each of the two experiments. We conclude that feedback mechanisms operating to maximize task performance are subjected to a form of competition between spatial and temporal variabilities.	[Danion, Frederic] Aix Marseille Univ, CNRS, Inst Neurosci Timone UMR 7289, Marseille, France; [Bongers, Raoul M.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Sci, Groningen, Netherlands; [Bootsma, Reinoud J.] Aix Marseille Univ, CNRS, Inst Sci Mouvement UMR 7287, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; University of Groningen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Danion, F (corresponding author), Aix Marseille Univ, CNRS, Inst Neurosci Timone UMR 7289, Marseille, France.	frederic.danion@univ-amu.fr	Bootsma, Reinoud/B-1254-2008; Danion, Frederic/ABS-1799-2022; Bongers, Raoul/C-1094-2012	Bootsma, Reinoud/0000-0002-3719-7586; Danion, Frederic/0000-0003-4296-7300; Bongers, Raoul/0000-0002-3518-7464				BARTLETT NR, 1959, PSYCHOL REV, V66, P203, DOI 10.1037/h0046490; BEEK PJ, 1995, BIOL CYBERN, V73, P499, DOI 10.1007/BF00199542; Bella SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020518; Billon M, 2000, NEUROSCI LETT, V286, P49, DOI 10.1016/S0304-3940(00)01089-2; Bongers RM, 2009, J EXP PSYCHOL HUMAN, V35, P1443, DOI 10.1037/a0015783; BONNARD M, 1997, MOTOR CONTROL, V1, P247; Bootsma RJ, 2004, INT J HUM-COMPUT ST, V61, P811, DOI 10.1016/j.ijhcs.2004.09.004; Bootsma RJ, 2004, ECOL PSYCHOL, V16, P55, DOI 10.1207/s15326969eco1601_7; Bootsma RJ, 2002, NEUROSCI LETT, V333, P141, DOI 10.1016/S0304-3940(02)01003-0; Brouwer AM, 2005, EXP BRAIN RES, V165, P28, DOI 10.1007/s00221-005-2277-y; Casiez G, 2008, CHI 2008: 26TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS VOLS 1 AND 2, CONFERENCE PROCEEDINGS, P1709; Churchland MM, 2006, NEURON, V52, P1085, DOI 10.1016/j.neuron.2006.10.034; Ciofani G, 2010, MICROGRAVITY SCI TEC, V22, P123, DOI 10.1007/s12217-009-9163-3; Danion F, 2006, GAIT POSTURE, V23, P173, DOI 10.1016/j.gaitpost.2005.01.005; Danion F, 2003, GAIT POSTURE, V18, P69, DOI 10.1016/S0966-6362(03)00030-4; Danion F, 2007, J NEUROSCI, V27, P12839, DOI 10.1523/JNEUROSCI.3110-07.2007; Danion F, 2010, J EXP PSYCHOL HUMAN, V36, P1684, DOI 10.1037/a0020672; Doumas M, 2007, J EXP PSYCHOL HUMAN, V33, P442, DOI 10.1037/0096-1523.33.2.442; Elliott D, 2001, PSYCHOL BULL, V127, P342, DOI 10.1037//0033-2909.127.3.342; Elliott D, 2010, PSYCHOL BULL, V136, P1023, DOI 10.1037/a0020958; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Fernandez L, 2004, EXP BRAIN RES, V159, P458, DOI 10.1007/s00221-004-1964-4; Fernandez L, 2008, ACTA PSYCHOL, V129, P217, DOI 10.1016/j.actpsy.2008.06.001; Fernandez L, 2006, HUM MOVEMENT SCI, V25, P695, DOI 10.1016/j.humov.2006.05.001; FITTS PM, 1964, J EXP PSYCHOL, V67, P103, DOI 10.1037/h0045689; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Flanagan JR, 1997, J NEUROSCI, V17, P1519; GORDON J, 1994, EXP BRAIN RES, V99, P97, DOI 10.1007/BF00241415; Guigon E, 2008, EUR J NEUROSCI, V27, P1003, DOI 10.1111/j.1460-9568.2008.06028.x; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Hancock P.A., 1985, MOTOR BEHAV PROGRAMM, P153, DOI [10.1007/978-3-642-69749-4_5, DOI 10.1007/978-3-642-69749-4_5]; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Huys R, 2010, P ROY SOC B-BIOL SCI, V277, P1179, DOI 10.1098/rspb.2009.1954; IVRY RB, 1995, J EXP PSYCHOL HUMAN, V21, P3, DOI 10.1037/0096-1523.21.1.3; Kim SJ, 1999, J MOTOR BEHAV, V31, P341, DOI 10.1080/00222899909600999; Loras H, 2012, EXP BRAIN RES, V220, P335, DOI 10.1007/s00221-012-3142-4; MacKenzie KM, 1987, AM J OPTOMETRY PHYSL, V64, P186; Mackey DC, 2002, EXP BRAIN RES, V142, P409, DOI 10.1007/s00221-001-0946-z; MEYER DE, 1988, PSYCHOL REV, V95, P340, DOI 10.1037/0033-295X.95.3.340; Mottet D, 1999, BIOL CYBERN, V80, P235, DOI 10.1007/s004220050521; Mottet D, 2001, J EXP PSYCHOL HUMAN, V27, P1275, DOI 10.1037//0096-1523.27.6.1275; Mottet D, 2001, HUM MOVEMENT SCI, V20, P213, DOI 10.1016/S0167-9457(01)00038-0; Newell K.M, 1993, VARIABILITY MOTOR CO; NEWELL KM, 1980, J MOTOR BEHAV, V12, P47; NEWELL KM, 1979, J MOTOR BEHAV, V11, P49; NEWELL KM, 1982, J MOTOR BEHAV, V14, P24; Plamondon R, 1997, BEHAV BRAIN SCI, V20, P279, DOI 10.1017/S0140525X97001441; Robertson SD, 1999, J EXP PSYCHOL HUMAN, V25, P1316, DOI 10.1037/0096-1523.25.5.1316; Sarlegna FR, 2010, J NEUROPHYSIOL, V104, P641, DOI 10.1152/jn.00174.2010; SCHMIDT RA, 1979, PSYCHOL REV, V86, P415, DOI 10.1037//0033-295X.86.5.415; Semjen A, 2000, PSYCHOL RES-PSYCH FO, V63, P137, DOI 10.1007/PL00008172; Shafir T, 2010, J MOTOR BEHAV, V42, P71, DOI 10.1080/00222890903397137; Spencer RMC, 2003, J MOTOR BEHAV, V35, P371, DOI 10.1080/00222890309603157; Spiegel J, 2007, ZBL NEUROCHIR, V68, P67, DOI 10.1055/s-2007-977739; Sternad D, 2000, J MOTOR BEHAV, V32, P249, DOI 10.1080/00222890009601376; Thoroughman KA, 1999, J NEUROSCI, V19, P8573; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Tresilian JR, 2006, EXP BRAIN RES, V171, P421, DOI 10.1007/s00221-005-0286-5; Tresilian JR, 2004, EXP BRAIN RES, V155, P509, DOI 10.1007/s00221-003-1793-x; Tresilian JR, 2002, EXP BRAIN RES, V142, P193, DOI 10.1007/s00221-001-0920-9; van Beers RJ, 2004, J NEUROPHYSIOL, V91, P1050, DOI 10.1152/jn.00652.2003; van Beers RJ, 2002, PHILOS T R SOC B, V357, P1137, DOI 10.1098/rstb.2002.1101; van Beers RJ, 2007, J NEUROSCI, V27, P8757, DOI 10.1523/JNEUROSCI.2311-07.2007; WING AM, 1973, PERCEPT PSYCHOPHYS, V13, P455, DOI 10.3758/BF03205802; Woodworth R. S., 1899, PSYCHOL REV MONOGR S, V3, pi, DOI DOI 10.1037/H0092992; Wu HG, 2014, NAT NEUROSCI, V17, P312, DOI 10.1038/nn.3616; ZELAZNIK HN, 1988, J EXP PSYCHOL HUMAN, V14, P221, DOI 10.1037/0096-1523.14.2.221	67	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97447	10.1371/journal.pone.0097447	http://dx.doi.org/10.1371/journal.pone.0097447			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1NZ	24835236	Green Published, gold, Green Submitted			2022-12-27	WOS:000339614800046
J	Gonzalez-Ruiz, V; Pascua, I; Fernandez-Marcelo, T; Ribelles, P; Bianchini, G; Sridharan, V; Iniesta, P; Ramos, MT; Olives, AI; Martin, MA; Menendez, JC				Gonzalez-Ruiz, Victor; Pascua, Irene; Fernandez-Marcelo, Tamara; Ribelles, Pascual; Bianchini, Giulia; Sridharan, Vellaisamy; Iniesta, Pilar; Teresa Ramos, M.; Olives, Ana I.; Antonia Martin, M.; Carlos Menendez, J.			B-Ring-Aryl Substituted Luotonin A Analogues with a New Binding Mode to the Topoisomerase 1-DNA Complex Show Enhanced Cytotoxic Activity	PLOS ONE			English	Article							CERIUM(IV) AMMONIUM-NITRATE; ALKALOID LUOTONIN; CAMPTOTHECINS; FRIEDLANDER; DERIVATIVES; CATALYST	Topoisomerase 1 inhibition is an important strategy in targeted cancer chemotherapy. The drugs currently in use acting on this enzyme belong to the family of the camptothecins, and suffer severe limitations because of their low stability, which is associated with the hydrolysis of the delta-lactone moiety in their E ring. Luotonin A is a natural camptothecin analogue that lacks this functional group and therefore shows a much-improved stability, but at the cost of a lower activity. Therefore, the development of luotonin A analogues with an increased potency is important for progress in this area. In the present paper, a small library of luotonin A analogues modified at their A and B rings was generated by cerium(IV) ammonium nitrate-catalyzed Friedlander reactions. All analogues showed an activity similar or higher than the natural luotonin A in terms of topoisomerase 1 inhibition and some compounds had an activity comparable to that of camptothecin. Furthermore, most compounds showed a better activity than luotonin A in cell cytotoxicity assays. In order to rationalize these results, the first docking studies of luotonin-topoisomerase 1-DNA ternary complexes were undertaken. Most compounds bound in a manner similar to luotonin A and to standard topoisomerase poisons such as topotecan but, interestingly, the two most promising analogues, bearing a 3,5-dimethylphenyl substituent at ring B, docked in a different orientation. This binding mode allows the hydrophobic moiety to be shielded from the aqueous environment by being buried between the deoxyribose belonging to the G(+1) guanine and Arg364 in the scissile strand and the surface of the protein and a hydrogen bond between the D-ring carbonyl and the basic amino acid. The discovery of this new binding mode and its associated higher inhibitory potency is a significant advance in the design of new topoisomerase 1 inhibitors.	[Gonzalez-Ruiz, Victor; Olives, Ana I.; Antonia Martin, M.] Univ Complutense, Fac Farm, Secc Dept Quim Analit, E-28040 Madrid, Spain; [Gonzalez-Ruiz, Victor; Ribelles, Pascual; Bianchini, Giulia; Teresa Ramos, M.; Olives, Ana I.; Antonia Martin, M.; Carlos Menendez, J.] Univ Complutense, Fac Farm, BIOHET Biol Relevant Heterocycles Grp, E-28040 Madrid, Spain; [Pascua, Irene; Fernandez-Marcelo, Tamara; Iniesta, Pilar] Univ Complutense, Fac Farm, Dept Bioquim & Biol Mol 2, E-28040 Madrid, Spain; [Pascua, Irene; Fernandez-Marcelo, Tamara; Iniesta, Pilar] Hosp Clin San Carlos, Inst Invest Sanitaria, Madrid, Spain; [Ribelles, Pascual; Bianchini, Giulia; Sridharan, Vellaisamy; Teresa Ramos, M.; Carlos Menendez, J.] Univ Complutense, Fac Farm, Dept Quim Organ & Farmaceut, E-28040 Madrid, Spain; [Sridharan, Vellaisamy] SASTRA Univ, Dept Chem & Biotechnol, Thanjavur, India	Complutense University of Madrid; Complutense University of Madrid; Complutense University of Madrid; Hospital Clinico San Carlos; Complutense University of Madrid; Shanmugha Arts, Science, Technology & Research Academy (SASTRA)	Menendez, JC (corresponding author), Univ Complutense, Fac Farm, BIOHET Biol Relevant Heterocycles Grp, E-28040 Madrid, Spain.	josecm@farm.ucm.es	Fernández-Marcelo, Tamara/N-9196-2018; González-Ruiz, Víctor/C-4990-2009; Menéndez, J. Carlos/B-7529-2014; González-Ruiz, Víctor/M-3500-2019; Ramos, M Teresa/H-8552-2015; Fernández-Marcelo, Tamara/Y-9067-2019; Martin, M. Antonia/H-4794-2015	Fernández-Marcelo, Tamara/0000-0001-6550-3838; González-Ruiz, Víctor/0000-0001-7204-2363; Menéndez, J. Carlos/0000-0002-0560-8416; González-Ruiz, Víctor/0000-0001-7204-2363; Fernández-Marcelo, Tamara/0000-0001-6550-3838; Olives, Ana Isabel/0000-0002-5535-1700; Martin, M. Antonia/0000-0001-5525-8621; Ramos, M Teresa/0000-0001-9225-9316; Sridharan, Vellaisamy/0000-0002-3099-4734	MICINN [CTQ 2009-11312]; Santander-UCM [PR6/13-18859]; Fundacion de Investigacion Medica Mutua Madrilena; MINECO [CTQ 2012-33272-BQU]	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Santander-UCM; Fundacion de Investigacion Medica Mutua Madrilena; MINECO(Spanish Government)	MICINN (grant CTQ 2009-11312), www.micinn.es; Santander-UCM PR6/13-18859, www.ucm.es; Fundacion de Investigacion Medica Mutua Madrilena, www.fundacionmutua.es; MINECO (CTQ 2012-33272-BQU), www.mineco.gob.es. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atechian S, 2007, TETRAHEDRON, V63, P2811, DOI 10.1016/j.tet.2007.01.050; Avendano C, 2008, MED CHEM ANTICANCER; Boisse T, 2011, TETRAHEDRON LETT, V52, P1592, DOI 10.1016/j.tetlet.2011.01.105; Cagir A, 2003, J AM CHEM SOC, V125, P13628, DOI 10.1021/ja0368857; Castelli S, 2012, BIOL CHEM, V393, P1327, DOI 10.1515/hsz-2012-0240; Chen SH, 2013, ANNU REV BIOCHEM, V82, P139, DOI 10.1146/annurev-biochem-061809-100002; Dallavalle S, 2004, BIOORG MED CHEM LETT, V14, P5757, DOI 10.1016/j.bmcl.2004.09.039; Dunbrack RL, 2002, CURR OPIN STRUC BIOL, V12, P431, DOI 10.1016/S0959-440X(02)00344-5; Ferlay J, 2013, IARC CANCERBASE; Golubev AS, 2011, RUSS CHEM B INT EDIT, V59, P209; Gonzalez-Ruiz V, 2010, J SEP SCI, V33, P2086, DOI 10.1002/jssc.201000175; Howard EI, 2004, PROTEINS, V55, P792, DOI 10.1002/prot.20015; Kacprzak K., 2013, NATURAL PRODUCTS, P643, DOI [10.1007/978-3-642-22144-6_26, DOI 10.1007/978-3-642-22144-6_26]; Levin B, 2008, WORLD CANC REPORT; Liang JL, 2011, MOLECULES, V16, P4861, DOI 10.3390/molecules16064861; Ma ZZ, 1997, HETEROCYCLES, V46, P541; Marco-Contelles J, 2009, CHEM REV, V109, P2652, DOI 10.1021/cr800482c; Marszall MP, 2011, J PHARM SCI-US, V100, P1142, DOI 10.1002/jps.22318; Molina P, 2000, SYNTHESIS-STUTTGART, P1523; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pizzolato JF, 2003, LANCET, V361, P2235, DOI 10.1016/S0140-6736(03)13780-4; Politzer P, 2013, PHYS CHEM CHEM PHYS, V15, P11178, DOI 10.1039/c3cp00054k; Pommier Y., 2011, DNA TOPOISOMERASES C; Pommier Y, 2013, ACS CHEM BIOL, V8, P82, DOI 10.1021/cb300648v; Pommier Y, 2009, CHEM REV, V109, P2894, DOI 10.1021/cr900097c; Rahman AFMM, 2008, B KOREAN CHEM SOC, V29, P1988; Sridharan V, 2010, CHEM REV, V110, P3805, DOI 10.1021/cr100004p; Sridharan V, 2009, J ORG CHEM, V74, P5715, DOI 10.1021/jo900965f; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tseng MC, 2011, ORG LETT, V13, P920, DOI 10.1021/ol1029707; Venditto VJ, 2010, MOL PHARMACEUT, V7, P307, DOI 10.1021/mp900243b; Verma RP, 2009, CHEM REV, V109, P213, DOI 10.1021/cr0780210; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wadkins Randy M., 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P327, DOI 10.2174/1568011043352894; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005	37	18	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e95998	10.1371/journal.pone.0095998	http://dx.doi.org/10.1371/journal.pone.0095998			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830682	Green Published, gold, Green Submitted			2022-12-27	WOS:000336789500011
J	Hiremath, P; Bauer, M; Aguirre, AD; Cheng, HW; Unno, K; Patel, RB; Harvey, BW; Chang, WT; Groarke, JD; Liao, R; Cheng, S				Hiremath, Pranoti; Bauer, Michael; Aguirre, Aaron D.; Cheng, Hui-Wen; Unno, Kazumasa; Patel, Ravi B.; Harvey, Bethany W.; Chang, Wei-Ting; Groarke, John D.; Liao, Ronglih; Cheng, Susan			Identifying Early Changes in Myocardial Microstructure in Hypertensive Heart Disease	PLOS ONE			English	Article							B-MODE ULTRASOUND; INTEGRATED BACKSCATTER; BLOOD-PRESSURE; GRAY-LEVEL; CYCLIC VARIATION; TIME-DELAY; FIBROSIS; PATTERNS; RECOMMENDATIONS; HYPOTHYROIDISM	The transition from healthy myocardium to hypertensive heart disease is characterized by a series of poorly understood changes in myocardial tissue microstructure. Incremental alterations in the orientation and integrity of myocardial fibers can be assessed using advanced ultrasonic image analysis. We used a modified algorithm to investigate left ventricular myocardial microstructure based on analysis of the reflection intensity at the myocardial-pericardial interface on B-mode echocardiographic images. We evaluated the extent to which the novel algorithm can differentiate between normal myocardium and hypertensive heart disease in humans as well as in a mouse model of afterload resistance. The algorithm significantly differentiated between individuals with uncomplicated essential hypertension (N = 30) and healthy controls (N = 28), even after adjusting for age and sex (P = 0.025). There was a trend in higher relative wall thickness in hypertensive individuals compared to controls (P = 0.08), but no difference between groups in left ventricular mass (P = 0.98) or total wall thickness (P = 0.37). In mice, algorithm measurements (P = 0.026) compared with left ventricular mass (P = 0.053) more clearly differentiated between animal groups that underwent fixed aortic banding, temporary aortic banding, or sham procedure, on echocardiography at 7 weeks after surgery. Based on sonographic signal intensity analysis, a novel imaging algorithm provides an accessible, non-invasive measure that appears to differentiate normal left ventricular microstructure from myocardium exposed to chronic afterload stress. The algorithm may represent a particularly sensitive measure of the myocardial changes that occur early in the course of disease progression.	[Hiremath, Pranoti] Harvard Univ, Sch Med, Boston, MA USA; [Patel, Ravi B.; Harvey, Bethany W.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Bauer, Michael; Aguirre, Aaron D.; Cheng, Hui-Wen; Unno, Kazumasa; Chang, Wei-Ting; Groarke, John D.; Liao, Ronglih; Cheng, Susan] Harvard Univ, Brigham & Womens Hosp, Sch Med, Cardiovasc Div, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Cheng, S (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Cardiovasc Div, Boston, MA 02115 USA.	scheng@rics.bwh.harvard.edu	Unno, Kazumasa/M-5065-2014	Patel, Ravi/0000-0001-5037-5554; Liao, Ronglih/0000-0002-9598-9020; Cheng, Susan/0000-0002-4977-036X	National Institutes of Health (NIH) [HL088533, HL071775, HL093148, HL099073]; American Heart Association; Ellison Foundation; American Medical Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093148, R01HL099073, R01HL088533, R01HL071775] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Ellison Foundation(Lawrence Ellison Foundation); American Medical Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by funding from the National Institutes of Health (NIH) - HL088533, HL071775, HL093148, and HL099073 (R. L.). M. B. was a recipient of an American Heart Association founder affiliate postdoctoral fellowship award. S. C. was supported by an award from the Ellison Foundation. K. U. is a recipient of an American Heart Association founders affiliate postdoctoral fellowship award. P. H. is a recipient of the American Medical Association Medical Student Seed Grant and the American Heart Association Student Scholarship in Cardiovascular Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghini-Lombardi F, 2006, EUR J ENDOCRINOL, V155, P3, DOI 10.1530/eje.1.02174; Baroldi Giorgio, 2007, Cardiovasc Ultrasound, V5, P5, DOI 10.1186/1476-7120-5-5; Bauer M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053956, 10.1371/journal.pone.0059915]; Bauer M, 2011, CIRC RES, V108, P908, DOI 10.1161/CIRCRESAHA.110.239574; Cheng S, 2012, HYPERTENSION, V60, P1393, DOI 10.1161/HYPERTENSIONAHA.112.201780; Ciulla M, 1997, J AM SOC ECHOCARDIOG, V10, P657, DOI 10.1016/S0894-7317(97)70028-2; Di Bello V, 2000, J AM SOC ECHOCARDIOG, V13, P832, DOI 10.1067/mje.2000.106397; Dorn GW, 2003, CIRC RES, V92, P1171, DOI 10.1161/01.RES.0000077012.11088.BC; Drazner MH, 2011, CIRCULATION, V123, P327, DOI 10.1161/CIRCULATIONAHA.108.845792; Finch-Johnston AE, 2000, J AM SOC ECHOCARDIOG, V13, P9, DOI 10.1067/mje.2000.102695; Franklin SS, 1997, CIRCULATION, V96, P308; Hadi AM, 2011, CELL ONCOL, V34, P343, DOI 10.1007/s13402-011-0035-7; Hiremath P BM, 2013, J EXP VIS IN PRESS; Hunt KJ, 2001, ULTRASOUND MED BIOL, V27, P357, DOI 10.1016/S0301-5629(00)00353-7; Hunt KJ, 2001, STROKE, V32, P1120, DOI 10.1161/01.STR.32.5.1120; Kurtz TW, 2005, HYPERTENSION, V45, P299, DOI 10.1161/01.HYP.0000150857.39919.cb; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Maceira AM, 2002, HYPERTENSION, V39, P923, DOI 10.1161/01.HYP.0000014616.48920.8F; Marini C, 1996, EUR HEART J, V17, P472; MEUNIER J, 1995, IEEE T BIO-MED ENG, V42, P403, DOI 10.1109/10.376133; Mizuno R, 2007, CARDIOLOGY, V108, P11, DOI 10.1159/000095595; MOHR GA, 1989, ULTRASONIC IMAGING, V11, P245, DOI 10.1016/0161-7346(89)90078-3; OBRIEN PD, 1995, CIRCULATION, V91, P171, DOI 10.1161/01.CIR.91.1.171; OLSHANSKY B, 1984, CIRCULATION, V70, P972, DOI 10.1161/01.CIR.70.6.972; TEICHHOLZ LE, 1976, AM J CARDIOL, V37, P7, DOI 10.1016/0002-9149(76)90491-4; Yamada S, 2006, CURR OPIN CARDIOL, V21, P433, DOI 10.1097/01.hco.0000240578.05053.f9	26	11	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97424	10.1371/journal.pone.0097424	http://dx.doi.org/10.1371/journal.pone.0097424			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831515	Green Published, gold, Green Submitted			2022-12-27	WOS:000336789500057
J	Manyando, C; Njunju, EM; Mwakazanga, D; Chongwe, G; Mkandawire, R; Champo, D; Mulenga, M; De Crop, M; Claeys, Y; Ravinetto, RM; van Overmeir, C; D' Alessandro, U; Van Geertruyden, JP				Manyando, Christine; Njunju, Eric M.; Mwakazanga, David; Chongwe, Gershom; Mkandawire, Rhoda; Champo, Davies; Mulenga, Modest; De Crop, Maaike; Claeys, Yves; Ravinetto, Raffaella M.; van Overmeir, Chantal; D' Alessandro, Umberto; Van Geertruyden, Jean-Pierre			Safety of Daily Co-Trimoxazole in Pregnancy in an Area of Changing Malaria Epidemiology: A Phase 3b Randomized Controlled Clinical Trial	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-INFECTION; TRIMETHOPRIM-SULFAMETHOXAZOLE; SULFADOXINE-PYRIMETHAMINE; PLACENTAL MALARIA; PRETERM DELIVERY; BIRTH-WEIGHT; MATERNAL HIV; WOMEN; PREVENTION	Introduction: Antibiotic therapy during pregnancy may be beneficial and impacts positively on the reduction of adverse pregnancy outcomes. No studies have been done so far on the effects of daily Co-trimoxazole (CTX) prophylaxis on birth outcomes. A phase 3b randomized trial was conducted to establish that daily (TX in pregnancy is not inferior to SP intermittent preventive treatment (PT) in reducing placental malaria; preventing peripheral parasitaemia; preventing perinatal mortality and also improving birth weight. To establish its safety on the offspring by measuring the gestational age and birth weight at delivery, and compare the safety and efficacy profile of CTX to that of SP Methods: Pregnant women (HIV infected and uninfected) attending antenatal clinic were randomized to receive either daily CTX or sulfadoxine-pyrimethamine as per routine IPT. Safety was assessed using standard and pregnancy specific measurements. Women were followed up monthly until delivery and then with their offspring up to six weeks after delivery. Results: Data from 346 pregnant women (CTX = 190; SP = 156) and 311 newborns (CTX = 166 and SP = 145) showed that preterm deliveries (CTX 3.6%; SP 3.0%); still births (CTX 3.0%; SP 2.1%), neonatal deaths (CTX 0%; SP 1.4%), and spontaneous abortions (CTX 0.6%; SP 0%) were similar between study arms. The low birth weight rates were 9% for CTX and 13% for SP. There were no birth defects reported. Both drug exposure groups had full term deliveries with similar birth weights (mean of 3.1 Kg). The incidence and severity of AEs in the two groups were comparable. Conclusion: Exposure to daily CTX in pregnancy may not be associated with particular safety risks in terms of birth outcomes such as preterm deliveries, still births, neonatal deaths and spontaneous abortions compared to SP. However, more data are required on CTX use in pregnant women both among HIV infected and un-infected individuals.	[Manyando, Christine; Njunju, Eric M.; Mwakazanga, David; Chongwe, Gershom; Champo, Davies; Mulenga, Modest] Trop Dis Res Ctr, Ndola, Zambia; [Mkandawire, Rhoda] Choma Dist Hlth Management Team, Choma, Zambia; [De Crop, Maaike; Claeys, Yves; Ravinetto, Raffaella M.; van Overmeir, Chantal; D' Alessandro, Umberto] Inst Trop Med, B-2000 Antwerp, Belgium; [D' Alessandro, Umberto] MRC, Fajara, Gambia; [Manyando, Christine; Njunju, Eric M.; Van Geertruyden, Jean-Pierre] Univ Antwerp, Int Hlth Unit, B-2020 Antwerp, Belgium; [Ravinetto, Raffaella M.] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Leuven, Belgium	Institute of Tropical Medicine (ITM); University of London; London School of Hygiene & Tropical Medicine; University of Antwerp; KU Leuven	Manyando, C (corresponding author), Trop Dis Res Ctr, Ndola, Zambia.	cmanyando@yahoo.com	Van geertruyden, Jean-Pierre/S-3254-2019; Van geertruyden, Jean-Pierre/K-6425-2014; D'Alessandro, Umberto/D-3457-2015; Chongwe, Gershom/V-8783-2017	Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Van geertruyden, Jean-Pierre/0000-0001-5006-6364; D'Alessandro, Umberto/0000-0001-6341-5009; Chongwe, Gershom/0000-0003-3303-308X	Belgian Development Cooperation	Belgian Development Cooperation	The study was funded under a program for institutional capacity strengthening, funded by the Belgian Development Cooperation and coordinated by the Institute of Tropical Medicine in Antwerp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN S, 1991, J INFECT DIS, V164, P67, DOI 10.1093/infdis/164.1.67; ALTMAN DG, 1995, BRIT MED J, V311, P485, DOI 10.1136/bmj.311.7003.485; Anglaret X, 1999, LANCET, V353, P1463, DOI 10.1016/S0140-6736(98)07399-1; [Anonymous], 2007, ASS SAF ART COMP PRE; [Anonymous], ROLL BACK MAL PARTN; [Anonymous], 2012, INT PREV TREATM MAL; [Anonymous], ASS SAF ART COMP PRE; Ayisi JG, 2003, AIDS, V17, P585, DOI 10.1097/00002030-200303070-00014; BLOLAND PB, 1995, AIDS, V9, P721, DOI 10.1097/00002030-199507000-00009; Brentlinger PE, 2006, LANCET INFECT DIS, V6, P100, DOI 10.1016/S1473-3099(06)70383-8; Chizema-Kawesha E, 2010, AM J TROP MED HYG, V83, P480, DOI 10.4269/ajtmh.2010.10-0035; Cot M, 2003, BRIT MED BULL, V67, P137, DOI 10.1093/bmb/ldg003; Czeizel AE, 2001, REPROD TOXICOL, V15, P637, DOI 10.1016/S0890-6238(01)00178-2; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; DUBOWITZ LM, 1970, J PEDIATR-US, V77, P1, DOI 10.1016/S0022-3476(70)80038-5; Hauth JC, 1995, NEW ENGL J MED, V333, P1732, DOI 10.1056/NEJM199512283332603; Hernandez-Diaz S, 2000, NEW ENGL J MED, V343, P1608, DOI 10.1056/NEJM200011303432204; Juarez-Vazquez J, 2002, BJOG-INT J OBSTET GY, V109, P1009, DOI 10.1016/S1470-0328(02)01378-2; Manyando C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056916; Manyando C, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-249; Marti-Carvajal A, 2004, ARCH LATINOAM NUTR, V54, P45; Masaninga F, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-341; Mermin J, 2004, LANCET, V364, P1428, DOI 10.1016/S0140-6736(04)17225-5; Meshnick SR, 2006, J INFECT DIS, V194, P273, DOI 10.1086/505087; Nosten F, 1999, LANCET, V354, P546, DOI 10.1016/S0140-6736(98)09247-2; Omar SA, 2001, T ROY SOC TROP MED H, V95, P657, DOI 10.1016/S0035-9203(01)90107-5; Parise ME, 1998, AM J TROP MED HYG, V59, P813, DOI 10.4269/ajtmh.1998.59.813; Peters PJ, 2007, DRUG SAFETY, V30, P481, DOI 10.2165/00002018-200730060-00003; Shulman CE, 2003, T ROY SOC TROP MED H, V97, P30, DOI 10.1016/S0035-9203(03)90012-5; Siega-Riz AM, 2004, AM J OBSTET GYNECOL, V191, P1851, DOI 10.1016/j.ajog.2004.07.076; Steketee RW, 1996, AM J TROP MED HYG, V55, P33, DOI 10.4269/ajtmh.1996.55.33; Steketee RW, 1996, AM J TROP MED HYG, V55, P42, DOI 10.4269/ajtmh.1996.55.42; Ter Kuile FO, 2004, AM J TROP MED HYG, V71, P41, DOI 10.4269/ajtmh.2004.71.41; Thera MA, 2005, J INFECT DIS, V192, P1823, DOI 10.1086/498249; Ticconi C, 2003, JAIDS-J ACQ IMM DEF, V34, P289, DOI 10.1097/00126334-200311010-00005; van Eijk AM, 2002, T ROY SOC TROP MED H, V96, P586, DOI 10.1016/S0035-9203(02)90319-6; Van Geertruyden JP, 2004, AM J TROP MED HYG, V71, P35, DOI 10.4269/ajtmh.2004.71.35; Verhoeff FH, 1999, TROP MED INT HEALTH, V4, P5, DOI 10.1046/j.1365-3156.1999.00349.x; Verhoeff FH, 1998, ANN TROP MED PARASIT, V92, P141, DOI 10.1080/00034989859979; Walter J, 2006, J INFECT DIS, V194, P1510, DOI 10.1086/508996; Whitty CJM, 2005, BJOG-INT J OBSTET GY, V112, P1189, DOI 10.1111/j.1471-0528.2005.00714.x; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2010, WORLD MALARIA REPORT 2010, P1; World Health Organization (WHO), 2006, GUID COTR PROPH HIV	44	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e96017	10.1371/journal.pone.0096017	http://dx.doi.org/10.1371/journal.pone.0096017			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830749	gold, Green Published, Green Submitted			2022-12-27	WOS:000336789500012
J	Masala, S; Cossu, D; Palermo, M; Sechi, LA				Masala, Speranza; Cossu, Davide; Palermo, Mario; Sechi, Leonardo Antonio			Recognition of Zinc Transporter 8 and MAP3865c Homologous Epitopes by Hashimoto's Thyroiditis Subjects from Sardinia: A Common Target with Type 1 Diabetes?	PLOS ONE			English	Article							AVIUM-SUBSPECIES-PARATUBERCULOSIS; MULTIPLE-SCLEROSIS; INFECTION	Mycobacterium avium subspecies paratuberculosis (MAP) asymptomatic infection has been previously linked to Type 1 diabetes (T1D) and Multiple Sclerosis. An association between MAP infection and Hashimoto's thyroiditis (HT) was also proposed only in a case report. This study aimed to investigate the robustness of the latter association, testing a large cohort of HT and healthy control (HCs) subjects, all from Sardinia. Prevalence of anti-MAP3865c Abs was assessed by indirect enzyme-linked immunosorbent assay (ELISA). Moreover, given that human ZnT8 is specifically expressed in the pancreatic beta-cells, in the follicle epithelial cells and in the parafollicular cells of the thyroid gland, we also tested ZnT8 epitopes homologues to the MAP3865c immunodominant peptides previously identified. Indeed, Abs targeting MAP3865c and ZnT8 homologous regions display similar frequencies in patients and controls, thus suggesting that Abs recognizing these epitopes could be cross-reactive. A statistically significant difference was found between HT patients and HCs when analyzing the humoral response mounted against MAP3865c/ZnT8 homologues epitopes. To our knowledge, this is the first report, which provides statistically significant evidence sustaining the existence of an association between MAP sero-reactivity and HT. Further studies are required to investigate the relevance of MAP to HT, aimed at deciphering if this pathogen can be at play in triggering this autoimmune disease. Likewise, genetic polymorphism of the host, and other environmental factors need to be investigated.	[Masala, Speranza; Cossu, Davide; Sechi, Leonardo Antonio] Univ Sassari, Dipartimento Sci Biomed, Sez Microbiol & Virol, I-07100 Sassari, Italy; [Palermo, Mario] Azienda Sanit Locale ASL 1, Dept Endocrinol, Sassari, Italy	University of Sassari	Sechi, LA (corresponding author), Univ Sassari, Dipartimento Sci Biomed, Sez Microbiol & Virol, I-07100 Sassari, Italy.	sechila@uniss.it	Cossu, Davide/C-4452-2013; Cossu, Davide/AAD-7958-2019; Sechi, Leonardo Antonio/Y-3109-2018	Cossu, Davide/0000-0002-0557-9467; sechi, leonardo antonio/0000-0003-0566-2049	Sardinian Region [L.R.7]; Progetti di ricerca di base-; PRIN MIUR Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale; P.O.R. Sardinia F.S.E.; Axis IV human capitals, Line of Business I.3.1;  [RF-2009-1545765]	Sardinian Region(Regione Sardegna); Progetti di ricerca di base-; PRIN MIUR Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale(Ministry of Education, Universities and Research (MIUR)); P.O.R. Sardinia F.S.E.; Axis IV human capitals, Line of Business I.3.1; 	This research was supported by the Sardinian Region L.R.7 2009 and 2010 Progetti di ricerca di base-, PRIN MIUR Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale, <Bando PRIN 2009>. Protocollo: 2009ZYECWZ and Italian Minister of Health, "Finalized Research" Protocollo: RF-2009-1545765, to LAS. The present publication was produced as part of the RAS research project selection code 06/A3-10, developed at Sassari University by Speranza Masala and supported by P.O.R. Sardinia F.S.E. 2007-2013; Axis IV human capitals, Line of Business I.3.1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 2012, ADV ANAT PATHOL, V19, P181, DOI 10.1097/PAP.0b013e3182534868; Bitti MLM, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/785262; Burek CL, 2009, J AUTOIMMUN, V33, P183, DOI 10.1016/j.jaut.2009.09.001; Caturegli P, 2007, CURR OPIN RHEUMATOL, V19, P44, DOI 10.1097/BOR.0b013e3280113d1a; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Chujo D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055595; Cossu D, 2013, FUTURE MICROBIOL, V8, P223, DOI [10.2217/fmb.12.135, 10.2217/FMB.12.135]; Cossu D, 2012, MULT SCLER J, V18, P1181, DOI 10.1177/1352458511433430; D'Amore M, 2010, J MED MICROBIOL, V59, P137, DOI 10.1099/jmm.0.013474-0; Derbinski J, 2005, PROMISCUOUS GENE EXP, V202, P33; Masala S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063371; Masala S, 2012, GUT PATHOG, V4, DOI 10.1186/1757-4749-4-24; Masala S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026931; Naser SA, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-14; Pozzato N, 2011, PREV VET MED, V102, P83, DOI 10.1016/j.prevetmed.2011.07.001; Sardu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032487; Sechi LA, 2005, AM J GASTROENTEROL, V100, P1529, DOI 10.1111/j.1572-0241.2005.41415.x; Sisto M, 2010, SCAND J INFECT DIS, V42, P787, DOI 10.3109/00365541003762306	18	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97621	10.1371/journal.pone.0097621	http://dx.doi.org/10.1371/journal.pone.0097621			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830306	Green Submitted, gold, Green Published			2022-12-27	WOS:000336789500086
J	Moussu, L; Saint-Pierre, P; Panayotopoulos, V; Couderc, R; Amat, F; Just, J				Moussu, Lise; Saint-Pierre, Philippe; Panayotopoulos, Virginie; Couderc, Remy; Amat, Flore; Just, Jocelyne			Determinants of Allergic Rhinitis in Young Children with Asthma	PLOS ONE			English	Article							ATOPIC-DERMATITIS; RISK; SENSITIZATION; IMPACT; ASSOCIATION; POPULATION; HEALTH; PREVALENCE; PHENOTYPES; DISEASES	Background: In the preschool period, allergic rhinitis (AR) is infrequent and thus under-diagnosed. However, recent works have highlighted the occurrence of AR in toddlers although the causes of AR in this young population remain unknown. The objective of this study was to identify determinants of AR in young children with asthma. Methods: We carried out a case-control study of 227 children with active asthma and enrolled in the Trousseau Asthma Program. AR and other allergic diseases (asthma, food allergy and eczema) were diagnosed by medical doctors using standardized questionnaires. Parental history of AR and asthma, biological markers of atopy (total IgE, blood eosinophilia, allergic sensitization towards food and aeroallergens) and environmental parameters were also collected. Results: Forty one of the children (18.1%) had AR. By univariate logistic regression analysis, AR was mainly associated with peanut sensitization (OR = 6.75; p = 0.002); food allergy (OR = 4.31; p = 0.026); mold exposure (OR = 3.81 p<0.01) and parental history of AR (OR = 1.42; p = 0.046). Due to the strong link between food allergy and peanut sensitization three models of multivariate logistic regression were performed and confirmed that AR is associated with peanut sensitization but also food allergy and mold exposure. A random forest analysis was also performed to explain AR. The results reinforced the logistic analysis that peanut sensitization and mold exposure were the principal determinants of AR. Conclusions & Clinical Relevance: These results stress the importance of investigating AR in young children with asthma to potentially diagnose a particularly severe allergic asthmatic phenotype. Moreover, these data evoke the hypothesis that peanut could be an aeroallergen.	[Moussu, Lise; Panayotopoulos, Virginie; Amat, Flore; Just, Jocelyne] Univ Paris 06, Hop Enfants Armand Trousseau, AP HP, Allergol Dept,Ctr Asthme & Allergies, Paris, France; [Saint-Pierre, Philippe] Univ Paris 06, Lab Stat Theor & Appl, Paris, France; [Couderc, Remy] Hop Enfants Armand Trousseau, AP HP, Serv Biochim & Biol Mol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite	Just, J (corresponding author), Univ Paris 06, Hop Enfants Armand Trousseau, AP HP, Allergol Dept,Ctr Asthme & Allergies, Paris, France.	jocelyne.just@trs.aphp.fr	Amat, Flore/GPF-4655-2022					Annesi-Maesano I, 2002, ALLERGY, V57, P107, DOI 10.1034/j.1398-9995.2002.1o3170.x; Arshad SH, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.2.e33; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Ballardini N, 2006, ALLERGY, V61, P337, DOI 10.1111/j.1398-9995.2005.00936.x; Biagini JM, 2006, PEDIAT ALLERG IMM-UK, V17, P278, DOI 10.1111/j.1399-3038.2006.00386.x; Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891; BraunFahrlander C, 1997, PEDIATR ALLERGY IMMU, V8, P75, DOI 10.1111/j.1399-3038.1997.tb00147.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Brough HA, 2013, J ALLERGY CLIN IMMUN, V132, P630, DOI 10.1016/j.jaci.2013.02.034; Clarisse B, 2009, PEDIAT ALLERG IMM-UK, V20, P126, DOI 10.1111/j.1399-3038.2008.00743.x; de Groot EP, 2012, THORAX, V67, P582, DOI 10.1136/thoraxjnl-2011-201168; Du Toit G, 2013, J ALLERGY CLIN IMMUN, V131, P135, DOI 10.1016/j.jaci.2012.09.015; Hellings PW, 2006, ALLERGY, V61, P656, DOI 10.1111/j.1398-9995.2006.01109.x; Herr M, 2011, ALLERGY, V66, P214, DOI 10.1111/j.1398-9995.2010.02467.x; HOSMER DW, 1989, APPL LOGISTIC REGRES; Husman T, 1996, SCAND J WORK ENV HEA, V22, P5, DOI 10.5271/sjweh.103; Jaakkola JJK, 2010, AM J EPIDEMIOL, V172, P451, DOI 10.1093/aje/kwq110; Just J, 2008, CLIN EXP ALLERGY, V38, P767, DOI 10.1111/j.1365-2222.2008.02966.x; Just J, 2012, J ALLERGY CLIN IMMUN, V130, P103, DOI 10.1016/j.jaci.2012.02.041; Kim SW, 2013, AM J RHINOL ALLERGY, V27, pE63, DOI 10.2500/ajra.2013.27.3877; Kjaer HF, 2008, PEDIAT ALLERG IMM-UK, V19, P737, DOI 10.1111/j.1399-3038.2008.00733.x; Kulig M, 1998, PEDIAT ALLERG IMM-UK, V9, P61, DOI 10.1111/j.1399-3038.1998.tb00305.x; Kulig M, 2000, J ALLERGY CLIN IMMUN, V106, P832, DOI 10.1067/mai.2000.110098; Lee JT, 2004, ANN ACAD MED SINGAP, V33, P71; Lohia S, 2013, ALLERGY, V68, P569, DOI 10.1111/all.12124; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Mudarri D, 2007, INDOOR AIR, V17, P226, DOI 10.1111/j.1600-0668.2007.00474.x; O'Sullivan MM, 2012, J ASTHMA, V49, P911, DOI 10.3109/02770903.2012.724131; Peroni DG, 2003, CLIN EXP ALLERGY, V33, P1349, DOI 10.1046/j.1365-2222.2003.01766.x; Rochat MK, 2010, J ALLERGY CLIN IMMUN, V126, P1170, DOI 10.1016/j.jaci.2010.09.008; Schroeder A, 2009, CLIN EXP ALLERGY, V39, P261, DOI 10.1111/j.1365-2222.2008.03160.x; Silva CHM da, BRAZ J OTORHINOLARYN, V75, P642; Simpson A, 2010, AM J RESP CRIT CARE, V181, P1200, DOI 10.1164/rccm.200907-1101OC; Strachan D, 1997, PEDIAT ALLERGY IMMUN, V8, P161; TABACHNIK E, 1981, J ALLERGY CLIN IMMUN, V67, P339, DOI 10.1016/0091-6749(81)90077-4; Togias A, 2003, J ALLERGY CLIN IMMUN, V111, P1171, DOI 10.1067/mai.2003.1592; Tolosi L, 2011, BIOINFORMATICS, V27, P1986, DOI 10.1093/bioinformatics/btr300; Wadonda-Kabondo N, 2004, ARCH DIS CHILD, V89, P917, DOI 10.1136/adc.2003.034033; Wang WC, ZHONGHUA MIN GUO XIA, V39, P314; Westman M, 2012, J ALLERGY CLIN IMMUN, V129, P403, DOI 10.1016/j.jaci.2011.09.036; WRIGHT AL, 1994, PEDIATRICS, V94, P895; Zacharasiewicz A, 2000, ALLERGY, V55, P945, DOI 10.1034/j.1398-9995.2000.00575.x	43	6	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97236	10.1371/journal.pone.0097236	http://dx.doi.org/10.1371/journal.pone.0097236			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831804	Green Published, gold, Green Submitted			2022-12-27	WOS:000336789500041
J	Wang, YG; Wang, P; Wang, B; Fu, ZJ; Zhao, WJ; Yan, SL				Wang, Yan-Gang; Wang, Peng; Wang, Bin; Fu, Zheng-Ju; Zhao, Wen-Juan; Yan, Sheng-Li			Diabetes Mellitus and Poorer Prognosis in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							INDEPENDENT RISK-FACTOR; LONG-TERM PROGNOSIS; INSULIN-RESISTANCE; CANCER-PATIENTS; LIVER-CANCER; HEPATITIS-B; IMPACT; RESECTION; RECURRENCE; THERAPY	Background: Previous studies suggested that diabetes mellitus was associated with cancer risk and prognosis, but studies investigating the relationship between diabetes mellitus and survival in patients with hepatocellular carcinoma (HCC) reported inconsistent findings. To derive a more precise estimate of the prognostic role of diabetes mellitus in HCC, we systematically reviewed published studies and carried out a meta-analysis. Methods: Eligible articles were identified in electronic databases from their inception through September 16, 2013. To evaluate the correlation between diabetes mellitus and prognosis in HCC, the pooled hazard ratios (HR) and their 95% confidence intervals (95% CI) for poorer overall and disease-free survivals were calculated by standard meta-analysis techniques with fixed-effects or random-effects models. Results: 21 studies with a total of 9,767 HCC patients stratifying overall survival and/or disease-free survival in HCC patients by diabetes mellitus status were eligible for meta-analysis. 20 studies with a total of 9,727 HCC cases investigated the overall survival, and 10 studies with a total of 2,412 HCC patients investigated the disease-free survival. The pooled HRs for overall survival and disease-free survival were 1.46 (95% CI, 1.29 to 1.66; P<0.001) and 1.57 (95% CI, 1.21 to 2.05; P = 0.001), respectively. The adjusted HRs for overall survival and disease-free survival were 1.55 (95% CI, 1.27 to 1.91; P<0.001) and 2.15 (95% CI, 1.75 to 2.63; P<0.001), respectively. In addition, for patients receiving hepatic resection, diabetes mellitus was associated with both poorer overall survival and poorer disease-free survival, and for patients receiving non-surgical treatment or patients receiving radiofrequency ablation, diabetes mellitus was associated with poorer overall survival. There was no evidence for publication bias. Conclusion: Diabetes mellitus is independently associated with both poorer overall survival and poorer disease-free survival in HCC patients.	[Wang, Yan-Gang; Wang, Peng; Wang, Bin; Fu, Zheng-Ju; Zhao, Wen-Juan; Yan, Sheng-Li] Qingdao Univ, Coll Med, Affiliated Hosp, Dept Endocrinol, Qingdao 266071, Peoples R China	Qingdao University	Wang, YG (corresponding author), Qingdao Univ, Coll Med, Affiliated Hosp, Dept Endocrinol, Qingdao 266071, Peoples R China.	nlwang@126.com; robin.wangqy@gmail.com						Amarapurkar DN, 2008, ANN HEPATOL, V7, P148, DOI 10.1016/S1665-2681(19)31871-X; Baffy G, 2012, AM J GASTROENTEROL, V107, P53, DOI 10.1038/ajg.2011.390; Barone BB, 2008, JAMA-J AM MED ASSOC, V300, P2754, DOI 10.1001/jama.2008.824; Birnbaum MJ, 2011, NATURE, V470, P338, DOI 10.1038/470338a; Bruix J, 2009, LANCET, V373, P614, DOI 10.1016/S0140-6736(09)60381-0; Chang CH, 2012, HEPATOLOGY, V55, P1462, DOI 10.1002/hep.25509; Chen TM, 2011, J GASTROEN HEPATOL, V26, P858, DOI 10.1111/j.1440-1746.2011.06664.x; Chen WT, 2011, HEPATO-GASTROENTEROL, V58, P551; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Evert M, 2012, HEPATOLOGY, V55, P1473, DOI 10.1002/hep.25600; Feng YH, 2011, MED ONCOL, V28, P1080, DOI 10.1007/s12032-010-9650-9; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Gao C, 2010, WORLD J GASTROENTERO, V16, P4467, DOI 10.3748/wjg.v16.i35.4467; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Howell J, 2011, GASTROENTEROL CLIN B; Huo TI, 2010, LIVER INT, V30, P198, DOI 10.1111/j.1478-3231.2009.02143.x; Huo TI, 2004, AM J GASTROENTEROL, V99, P1479, DOI 10.1111/j.1572-0241.2004.30024.x; Huo TI, 2004, ALIMENT PHARM THER, V19, P999, DOI 10.1111/j.1365-2036.2004.01936.x; Huo TI, 2003, EUR J GASTROEN HEPAT, V15, P1203, DOI 10.1097/00042737-200311000-00009; Ikeda Y, 1998, HEPATOLOGY, V27, P1567, DOI 10.1002/hep.510270615; Janghorbani M, 2012, HORM CANCER-US, V3, P137, DOI 10.1007/s12672-012-0112-z; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kaibori M, 2011, J GASTROEN HEPATOL, V26, P536, DOI 10.1111/j.1440-1746.2010.06439.x; Kawamura Y, 2008, J GASTROEN HEPATOL, V23, P1739, DOI 10.1111/j.1440-1746.2008.05436.x; Kim Wan Wook, 2004, Korean J Hepatol, V10, P51; Komura T, 2007, AM J GASTROENTEROL, V102, P1939, DOI 10.1111/j.1572-0241.2007.01354.x; Lai SW, 2012, AM J GASTROENTEROL, V107, P46, DOI 10.1038/ajg.2011.384; Larsson SC, 2011, DIABETOLOGIA, V54, P1013, DOI 10.1007/s00125-011-2051-6; Li DH, 2011, CANCER CAUSE CONTROL, V22, P189, DOI 10.1007/s10552-010-9686-3; Li XP, 2003, WORLD J GASTROENTERO, V9, P1848, DOI 10.3748/wjg.v9.i8.1848; Liu XY, 2010, LINCHUANG GANDANBING, V26, P641; MANTEL N, 1959, J NATL CANCER I, V22, P719; Minguez B, 2011, DIS MARKERS, V31, P181, DOI [10.1155/2011/310675, 10.3233/DMA-2011-0841]; Nagasue N, 1999, ANN SURG, V229, P84, DOI 10.1097/00000658-199901000-00011; NAGASUE N, 1993, ANN SURG, V217, P375, DOI 10.1097/00000658-199304000-00009; Ohgaki Kippei, 1999, Fukuoka Acta Medica, V90, P324; Ou DP, 2007, ZHONG HUA GAN DAN WA, V13, P317; Park SM, 2006, J CLIN ONCOL, V24, P5017, DOI 10.1200/JCO.2006.07.0243; Peairs KS, 2011, J CLIN ONCOL, V29, P40, DOI 10.1200/JCO.2009.27.3011; Poon RTP, 2002, AM J GASTROENTEROL, V97, P1480, DOI 10.1016/S0002-9270(02)04148-5; de Lope CR, 2012, J HEPATOL, V56, pS75, DOI 10.1016/S0168-8278(12)60009-9; Salmon D, 2012, J HEPATOL, V56, P862, DOI 10.1016/j.jhep.2011.11.009; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Snyder CF, 2010, PROSTATE CANCER P D, V13, P58, DOI 10.1038/pcan.2009.39; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sumie S, 2007, ONCOL REP, V18, P545; Takamatsu S, 2008, HEPATO-GASTROENTEROL, V55, P609; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Ting CT, 2012, TOHOKU J EXP MED, V227, P73, DOI 10.1620/tjem.227.73; Tobias A., 1999, STATA TECHNICAL B, V8, P15; Toyoda H, 2001, CANCER-AM CANCER SOC, V91, P957; Wang CG, 2012, INT J CANCER, V130, P1639, DOI 10.1002/ijc.26165; Wang P, 2012, DIABETES-METAB RES, V28, P109, DOI 10.1002/dmrr.1291; Wang WM, 2011, HEPATOB PANCREAT DIS, V10, P346, DOI 10.1016/S1499-3872(11)60059-3; Wells GA, 2012, NEWCASTLE OTTAWA SCA, DOI [10.2307/632432, DOI 10.2307/632432]; Wong LL, 2005, WORLD J GASTROENTERO, V11, P3491, DOI 10.3748/wjg.v11.i23.3491; YANAGA K, 1993, ARCH SURG-CHICAGO, V128, P445; Yang WS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027326; Yuhara H, 2011, AM J GASTROENTEROL, V106, P1911, DOI 10.1038/ajg.2011.301; Zhang ZJ, 2012, J CLIN ENDOCR METAB, V97, P2347, DOI 10.1210/jc.2012-1267	63	41	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e95485	10.1371/journal.pone.0095485	http://dx.doi.org/10.1371/journal.pone.0095485			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830459	gold, Green Published, Green Submitted			2022-12-27	WOS:000336789500009
J	Machado, MN; Nakazone, MA; Maia, LN				Machado, Mauricio N.; Nakazone, Marcelo A.; Maia, Lilia N.			Prognostic Value of Acute Kidney Injury after Cardiac Surgery according to Kidney Disease: Improving Global Outcomes Definition and Staging (KDIGO) Criteria	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; REPLACEMENT THERAPY; SERUM CREATININE; RIFLE CRITERIA; RISK-FACTORS; BYPASS; MORTALITY; DYSFUNCTION; PREDICTION; NETWORK	Objectives: The definition of acute renal failure has been recently reviewed, and the term acute kidney injury (AKI) was proposed to cover the entire spectrum of the syndrome, ranging from small changes in renal function markers to dialysis needs. This study was aimed to evaluate the incidence, morbidity and mortality associated with AKI (based on KDIGO criteria) in patients after cardiac surgery (coronary artery bypass grafting or cardiac valve surgery) and to determine the value of this feature as a predictor of hospital mortality (30 days). Methods: From January 2003 to June 2013, a total of 2,804 patients underwent cardiac surgery in our service. Cox proportional hazard models were used to determine the association between the development of AKI and 30-day mortality. Results: A total of 1,175 (42%) patients met the diagnostic criteria for AKI based on KDIGO classification during the first 7 postoperative days: 978 (35%) patients met the diagnostic criteria for stage 1 while 100 (4%) patients met the diagnostic criteria for stage 2 and 97 (3%) patients met the diagnostic criteria for stage 3. A total of 63 (2%) patients required dialysis treatment. Overall, the 30-day mortality was 7.1% (2.2%) for patients without AKI and 8.2%, 31% and 55% for patients with AKI at stages 1, 2 and 3, respectively. The KDIGO stage 3 patients who did not require dialysis had a mortality rate of 41%, while the mortality of dialysis patients was 62%. The adjusted Cox regression analysis revealed that AKI based on KDIGO criteria (stages 1-3) was an independent predictor of 30-day mortality (P<0.001 for all. Hazard ratio = 3.35, 11.94 and 24.85). Conclusion: In the population evaluated in the present study, even slight changes in the renal function based on KDIGO criteria were considered as independent predictors of 30-day mortality after cardiac surgery.	[Machado, Mauricio N.; Nakazone, Marcelo A.] Hosp Base, Div Cardiac Surg, Intens Care Unit, Sao Jose do Rio Preto Med Sch, Sao Paulo, Brazil; [Machado, Mauricio N.; Nakazone, Marcelo A.] Hosp Base, Coronary Care Unit, Sao Jose do Rio Preto Med Sch, Sao Paulo, Brazil; [Nakazone, Marcelo A.; Maia, Lilia N.] Hosp Base, Div Ctr Integrado Pesquisa CIP, Sao Jose do Rio Preto Med Sch, Sao Paulo, Brazil		Nakazone, MA (corresponding author), Hosp Base, Div Cardiac Surg, Intens Care Unit, Sao Jose do Rio Preto Med Sch, Sao Paulo, Brazil.	naka_med@yahoo.com	Nakazone, Marcelo Arruda/H-2719-2012; Maia, Lilia Nigro/AAV-6938-2021; Machado, Mauricio/B-7012-2008	Nakazone, Marcelo Arruda/0000-0002-0449-7056; Machado, Mauricio/0000-0002-9581-5215				Abramov D, 2000, ANN THORAC SURG, V70, P800, DOI 10.1016/S0003-4975(00)01563-0; Arnaoutakis GJ, 2007, J THORAC CARDIOV SUR, V134, P1554, DOI 10.1016/j.jtcvs.2007.08.039; Bastin AJ, 2013, J CRIT CARE, V28, P389, DOI 10.1016/j.jcrc.2012.12.008; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bellomo R, 2011, SEMIN RESP CRIT CARE, V32, P639, DOI 10.1055/s-0031-1287872; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Cooper WA, 2006, CIRCULATION, V113, P1063, DOI 10.1161/CIRCULATIONAHA.105.580084; Dardashti A, 2013, J THORAC CA IN PRESS; Dasta JF, 2008, NEPHROL DIAL TRANSPL, V23, P1970, DOI 10.1093/ndt/gfm908; De Santo LS, 2010, J HEART VALVE DIS, V19, P139; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Englberger L, 2011, CRIT CARE, V15, DOI 10.1186/cc9960; Ghavidel AA, 2014, J THORACIC IN PRESS; Haase M, 2009, J THORAC CARDIOV SUR, V138, P1370, DOI 10.1016/j.jtcvs.2009.07.007; Han SS, 2012, NEPHROL DIAL TRANSPL, V27, P161, DOI 10.1093/ndt/gfr312; Ho J, 2012, AM J KIDNEY DIS, V59, P196, DOI 10.1053/j.ajkd.2011.08.023; Kumar AB, 2012, J CARDIOTHOR VASC AN, V26, P64, DOI 10.1053/j.jvca.2011.07.007; Levin A, 2007, AM J KIDNEY DIS, V50, P1, DOI 10.1053/j.ajkd.2007.05.008; Liotta M, 2014, AM J CARDIOL, V113, P70, DOI 10.1016/j.amjcard.2013.09.012; Mangano CM, 1998, ANN INTERN MED, V128, P194, DOI 10.7326/0003-4819-128-3-199802010-00005; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Metnitz PGH, 2002, CRIT CARE MED, V30, P2051, DOI 10.1097/00003246-200209000-00016; Mickleborough LL, 2003, J THORAC CARDIOV SUR, V126, P950, DOI 10.1016/S0022-5223(02)73596-4; Molitoris BA, 2007, J AM SOC NEPHROL, V18, P1992, DOI 10.1681/ASN.2007050567; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Nashef SAM, 2012, EUR J CARDIO-THORAC, V41, P734, DOI 10.1093/ejcts/ezs043; Olivero Juan Jose, 2012, Methodist Debakey Cardiovasc J, V8, P31; Robert AM, 2010, ANN THORAC SURG, V90, P1939, DOI 10.1016/j.athoracsur.2010.08.018; Roques F, 1999, EUR J CARDIO-THORAC, V15, P816, DOI 10.1016/S1010-7940(99)00106-2; Rosner MH, 2006, CLIN J AM SOC NEPHRO, V1, P19, DOI 10.2215/CJN.00240605; Sampaio MC, 2013, ARQ BRAS CARDIOL, V101, P18, DOI 10.5935/abc.20130115; Schneider AG, 2012, J CRIT CARE, V27, P488, DOI 10.1016/j.jcrc.2012.02.008; Shahian DM, 2009, ANN THORAC SURG, V88, pS2, DOI 10.1016/j.athoracsur.2009.05.053; Thakar CV, 2009, CRIT CARE MED, V37, P2552, DOI 10.1097/CCM.0b013e3181a5906f; Tolpin DA, 2012, J THORAC CARDIOV SUR, V143, P682, DOI 10.1016/j.jtcvs.2011.09.044; Toumpoulis IK, 2006, J THORAC CARDIOV SUR, V131, P343, DOI 10.1016/j.jtcvs.2005.08.056; Trienekens MP, 2014, J CARDIOVAS IN PRESS; Uchino S, 2006, CURR OPIN CRIT CARE, V12, P538, DOI 10.1097/01.ccx.0000247448.94252.5a; Wang TKM, 2013, NEW ZEAL MED J, V126, P25; Xu Jia-rui, 2012, Zhonghua Nei Ke Za Zhi, V51, P943; Yehia M, 2005, NEPHROLOGY, V10, P541, DOI 10.1111/j.1440-1797.2005.00496.x	41	93	102	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e98028	10.1371/journal.pone.0098028	http://dx.doi.org/10.1371/journal.pone.0098028			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24826910	Green Published, Green Submitted, gold			2022-12-27	WOS:000336857400126
J	Smith, D; Leary, P; Bendall, M; Flach, E; Jones, R; Sweet, M				Smith, David; Leary, Peter; Bendall, Mark; Flach, Edmund; Jones, Rachel; Sweet, Michael			A Novel Investigation of a Blister-Like Syndrome in Aquarium Echinopora lamellosa	PLOS ONE			English	Article							BLACK BAND DISEASE; GEL-ELECTROPHORESIS DGGE; GROWTH ANOMALIES; BACTERIAL COMMUNITIES; MICROBIAL COMMUNITIES; METAGENOMIC ANALYSIS; ASPERGILLUS-SYDOWII; TURTLE HERPESVIRUS; CHELONIA-MYDAS; CORAL	This study investigates potential causes of a novel blister-like syndrome in the plating coral Echinopora lamellosa. Visual inspections of this novel coral syndrome showed no obvious signs of macroparasites and the blisters themselves manifested as fluid-filled sacs on the surface of the coral, which rose from the coenosarc between the coral polyps. Histological analysis of the blisters showed that there was no associated necrosis with the epidermal or gastrodermal tissues. The only difference between blistered areas and apparently healthy tissues was the presence of proliferated growth (possible mucosal cell hyperplasia) directly at the blister interface (area between where the edge of the blister joined apparently healthy tissue). No bacterial aggregates were identified in any histological samples, nor any sign of tissue necrosis identified. We conclude, that the blister formations are not apparently caused by a specific microbial infection, but instead may be the result of irritation following growth anomalies of the epidermis. However, future work should be conducted to search for other potential casual agents, including viruses.	[Smith, David; Leary, Peter; Bendall, Mark; Sweet, Michael] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Smith, David] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [Flach, Edmund; Jones, Rachel] Zool Soc London, London, Greater London, England; [Sweet, Michael] Univ Derby, Biol Sci Res Grp, Derby DE22 1GB, England	Newcastle University - UK; Queens University Belfast; Zoological Society of London; University of Derby	Smith, D (corresponding author), Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	dsmith37@qub.ac.uk	Smith, David/AAH-4738-2020; Sweet, Michael/E-9661-2012	Smith, David/0000-0002-5158-0522; Sweet, Michael/0000-0003-4983-8333	Natural Environment Research Council [NE/H020616/1]; NERC [NE/H020616/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was supported by funding from a Natural Environment Research Council grant (NE/H020616/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeby GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016887; Alker AP, 2001, HYDROBIOLOGIA, V460, P105, DOI 10.1023/A:1013145524136; ANDERS K, 1994, DIS AQUAT ORGAN, V19, P215, DOI 10.3354/dao019215; BAK RPM, 1983, MAR BIOL, V77, P221, DOI 10.1007/BF00395810; Bettarel Y, 2013, J MAR BIOL ASSOC UK, V93, P909, DOI 10.1017/S0025315411002062; Bjorndahl L, 2003, HUM REPROD, V18, P813, DOI 10.1093/humrep/deg199; Bourne D, 2008, ISME J, V2, P350, DOI 10.1038/ismej.2007.112; Bourne DG, 2008, APPL ENVIRON MICROB, V74, P883, DOI 10.1128/AEM.01124-07; Bourne DG, 2011, ISME J, V5, P559, DOI 10.1038/ismej.2010.143; Bruno JF, 2011, ECOL MONOGR, V81, P123, DOI 10.1890/09-1178.1; Burns JHR, 2011, CORAL REEFS, V30, P819, DOI 10.1007/s00338-011-0761-3; Cardenas A, 2012, ISME J, V6, P502, DOI 10.1038/ismej.2011.123; CARLTON RG, 1995, FEMS MICROBIOL ECOL, V18, P155, DOI 10.1016/0168-6496(95)00052-C; Cervino JM, 2008, J APPL MICROBIOL, V105, P1658, DOI 10.1111/j.1365-2672.2008.03871.x; Cheney D P, 1975, Adv Exp Med Biol, V64, P77; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Coffee LL, 2013, VET PATHOL, V50, P390, DOI 10.1177/0300985813480529; Cooney RP, 2002, ENVIRON MICROBIOL, V4, P401, DOI 10.1046/j.1462-2920.2002.00308.x; Croquer A, 2006, DIS AQUATIC ORAGNISM, V69; Croquer A, 2012, ENV MICROBIOLOGY REP; Diez B, 2001, APPL ENVIRON MICROB, V67, P2942, DOI 10.1128/AEM.67.7.2942-2951.2001; Domart-Coulon IJ, 2006, CORAL REEFS, V25, P531, DOI 10.1007/s00338-006-0133-6; Ein-Gil N, 2009, ISME J, V3, P752, DOI 10.1038/ismej.2009.18; Green SJ, 2010, HDB HYDROCARBON LIPI, P4137, DOI DOI 10.1007/978-3-540-77587-4_323; Irikawa A, 2011, MAR POLLUT BULL, V62, P1702, DOI 10.1016/j.marpolbul.2011.05.033; Kang KI, 2008, J COMP PATHOL, V139, P218, DOI 10.1016/j.jcpa.2008.07.003; Klaus JS, 2011, B MAR SCI, V87, P795, DOI 10.5343/bms.2010.1050; Krediet CJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2328; Lackovich JK, 1999, DIS AQUAT ORGAN, V37, P89, DOI 10.3354/dao037089; Lema KA, 2012, APPL ENVIRON MICROB, V78, P3136, DOI 10.1128/AEM.07800-11; Lenz DH, 2000, INFECT IMMUN, V68, P956, DOI 10.1128/IAI.68.2.956-959.2000; Littman RA, 2010, MOL ECOL, V19, P1978, DOI 10.1111/j.1365-294X.2010.04620.x; Marschang RE, 2011, VIRUSES-BASEL, V3, P2087, DOI 10.3390/v3112087; McClanahan TR, 2009, GLOBAL CHANGE BIOL, V15, P1804, DOI 10.1111/j.1365-2486.2008.01799.x; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; Palmer CV, 2010, CORAL REEFS, V29, P469, DOI 10.1007/s00338-010-0597-2; PETERS EC, 1986, JNCI-J NATL CANCER I, V76, P895; Richardson LL, 2004, CORAL HEALTH AND DISEASE, P325; Robert J, 2010, DEV COMP IMMUNOL, V34, P915, DOI 10.1016/j.dci.2010.05.011; Rosenberg E, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P451, DOI 10.1007/978-94-007-0114-4_26; Shen WY, 2011, EUR J CELL BIOL, V90, P323, DOI 10.1016/j.ejcb.2010.10.013; Soffer N, 2014, ISME J, V8, P271, DOI 10.1038/ismej.2013.137; Sweet M, 2012, ENV MICROBIOLOGY; Sweet M, 2011, J MAR BIOL ASSOC UK, P1, DOI DOI 10.1017/S0025315411001688; Sweet M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062580; Sweet M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041989; Sweet M, 2012, ENVIRON MICROBIOL, V14, P2184, DOI 10.1111/j.1462-2920.2012.02746.x; Sweet MJ, 2010, AQUAT MICROB ECOL, V61, P1, DOI 10.3354/ame01433; SZMANT AM, 1990, CORAL REEFS, V8, P217, DOI 10.1007/BF00265014; Thurber RLV, 2011, J EXP MAR BIOL ECOL, V408, P102, DOI 10.1016/j.jembe.2011.07.030; Thurber RLV, 2008, P NATL ACAD SCI USA, V105, P18413, DOI 10.1073/pnas.0808985105; Thurber RV, 2009, ENVIRON MICROBIOL, V11, P2148, DOI 10.1111/j.1462-2920.2009.01935.x; Viehman S, 2006, DIS AQUAT ORGAN, V69, P119, DOI 10.3354/dao069119; Weir-Brush J. R., 2004, Aerobiologia, V20, P119, DOI 10.1023/B:AERO.0000032949.14023.3a; Williams GJ, 2013, DIS AQUAT ORGAN, V106, P181, DOI 10.3354/dao02652; Williams GJ, 2011, J INVERTEBR PATHOL, V106, P165, DOI 10.1016/j.jip.2010.08.002; Work TM, 2008, DIS AQUAT ORGAN, V78, P255, DOI 10.3354/dao01881; Work TM, 2006, DIS AQUAT ORGAN, V70, P155, DOI 10.3354/dao070155; Work TM, 2009, J GEN VIROL, V90, P1943, DOI 10.1099/vir.0.011650-0; Work TM, 2005, CORAL REEFS, V24, P384, DOI 10.1007/s00338-005-0018-0; Yamashiro H, 2000, DIS AQUAT ORGAN, V41, P211, DOI 10.3354/dao041211; Yokouchi H, 2006, ENVIRON MICROBIOL, V8, P1155, DOI 10.1111/j.1462-2920.2006.01005.x; Zhao BY, 2011, CAN J MICROBIOL, V57, P115, DOI 10.1139/w10-107	63	6	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97018	10.1371/journal.pone.0097018	http://dx.doi.org/10.1371/journal.pone.0097018			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827734	gold, Green Published, Green Submitted			2022-12-27	WOS:000336857400051
J	Conway, KW; Baldwin, C; White, MD				Conway, Kevin W.; Baldwin, Carole; White, Macaulay D.			Cryptic Diversity and Venom Glands in Western Atlantic Clingfishes of the Genus Acyrtus (Teleostei: Gobiesocidae)	PLOS ONE			English	Article							CRYPTOBENTHIC FISH ASSEMBLAGES; ENNEANECTES; EVOLUTION; PACIFIC	Examination of genetic data (mitochondrial cytochrome c oxidase I) for western Atlantic clingfishes revealed two distinct lineages within a group of individuals originally identified as Acyrtus artius. Subsequent investigation of preserved voucher specimens was conducted to reconcile the genetic data and the existing classification, which is based on morphology. In addition to discovering that one of the genetic lineages is an undescribed species, which we describe as Acyrtus lanthanum, new species, we found that the nominal species Acyrtus artius has a putative venom gland associated with the subopercle that has been overlooked since the species was described nearly 60 years ago. The new species lacks the subopercular gland as does Acyrtus rubiginosus, but one is present in the related Arcos nudus. Venom glands have not been reported previously for the Gobiesocidae, and the venom gland described herein for Acyrtus and Arcos represents the first example in teleost fishes of a venom gland associated with the subopercle.	[Conway, Kevin W.] Texas A&M Univ, Dept Wildlife & Fisheries Sci & Biodivers Res & T, College Stn, TX 77843 USA; [Baldwin, Carole] Smithsonian Inst, Dept Vertebrate Zool, Natl Museum Nat Hist, Washington, DC 20560 USA; [White, Macaulay D.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, Undergrad Degree Program, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Smithsonian Institution; Smithsonian National Museum of Natural History; Texas A&M University System; Texas A&M University College Station	Conway, KW (corresponding author), Texas A&M Univ, Dept Wildlife & Fisheries Sci & Biodivers Res & T, College Stn, TX 77843 USA.	kevin.conway@tamu.edu			National Science Foundation [IOS 1256793]; Texas A&M Agrilife Research [TEX09452]; Smithsonian Institution Caribbean Coral Reef Ecosystems (CCRE) Program; Direct For Biological Sciences [1256793] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Texas A&M Agrilife Research; Smithsonian Institution Caribbean Coral Reef Ecosystems (CCRE) Program; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was funded by National Science Foundation (IOS 1256793 to KWC), Texas A&M Agrilife Research (TEX09452 to KWC), and several Smithsonian Institution Caribbean Coral Reef Ecosystems (CCRE) Program grants (to CCB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JL, 2003, OECOLOGIA, V136, P137, DOI 10.1007/s00442-003-1244-1; Ackerman JL, 2000, MAR ECOL PROG SER, V206, P227, DOI 10.3354/meps206227; Ahmadia GN, 2012, AQUAT BIOL, V16, P125, DOI 10.3354/ab00440; Baldwin CC, 2012, COPEIA, P23, DOI 10.1643/CG-11-035; Baldwin CC, 2011, ZOOKEYS, P21, DOI 10.3897/zookeys.79.1045; BALDWIN CC, 1993, B MAR SCI, V52, P240; Bohlke JE, 1968, FISHES BAHAMAS ADJAC; Briggs J. C., 1969, Copeia, V1969, P774, DOI 10.2307/1441801; BRIGGS JOHN C., 1955, STANFORD ICHTHYOL BULL, V6, P1; CAMERON AM, 1973, TOXICON, V11, P401, DOI 10.1016/0041-0101(73)90115-3; Chakrabarty P, 2013, ZOOKEYS, P29, DOI 10.3897/zookeys.346.5753; Conway KW, 2012, J MORPHOL, V273, P1127, DOI 10.1002/jmor.20049; Craig MT, 2008, COPEIA, P68, DOI 10.1643/CI-07-025; Craig MT, 2009, ZOOTAXA, P64, DOI 10.11646/zootaxa.2271.1.6; Depczynski M, 2004, MAR BIOL, V145, P455, DOI 10.1007/s002270004-1342-6; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FERNHOLM B, 1983, ZOOL J LINN SOC-LOND, V78, P199, DOI 10.1111/j.1096-3642.1983.tb00867.x; FISHELSON L, 1974, COPEIA, P386; Frable BW, 2013, FISH B-NOAA, V111, P122, DOI 10.7755/FB.111.2.2; Gemballa Sven, 1998, American Museum Novitates, V3241, P1; Greenfield DW, 2012, ZOOTAXA, P33, DOI 10.11646/zootaxa.3572.1.5; Halstead BW, 1970, POISONOUS VENOMOUS M, V3; Halstead BW., 1967, POISONOUS VENOMOUS M, VII; Harborne AR, 2012, CORAL REEFS, V31, P977, DOI 10.1007/s00338-012-0938-4; HORI K, 1979, TOXICON, V17, P418, DOI 10.1016/0041-0101(79)90271-X; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; JOHNSON R K, 1983, Northeast Gulf Science, V6, P33; Konstantinidis P, 2010, J MORPHOL, V271, P215, DOI 10.1002/jmor.10792; Lavett C., 2003, ATOLL RES B, V497, P1, DOI [10.5479/si.00775630.497.1, DOI 10.5479/SI.00775630.497.1]; Linnaeus C, 1767, SYSTEMA NATURAE REGN, VI, DOI 10.5962/bhl.title.542; Maddison WP., 2000, MACCLADE ANAL PHYLOG; McEachran JD, 2002, LIVING MARINE RESOUR, P1773; Perez M. H.Sabaj, 2010, STANDARD SYMBOLIC CO; Rosenblatt RH, 2013, ZOOTAXA, V3636, P361, DOI 10.11646/zootaxa.3636.2.7; Sampaio Claudio L. S., 2004, Neotropical Ichthyology, V2, P205; Schultz Leonard P., 1944, PROC U S NATION MUS, V96, P47; SHIOGAKI M, 1983, JPN J ICHTHYOL, V30, P111; Smith WL, 2006, J HERED, V97, P206, DOI 10.1093/jhered/esj034; Smith-Vaniz W.F., 1971, Copeia, V1971, P291, DOI 10.2307/1442829; Smith-Vaniz WF., 1976, MONOGR ACAD NAT SCI, V19, P1; Smith-Vaniz WF, 2006, B MAR SCI, V79, P17; Springer V. G., 1968, Bulletin United States National Museum, VNo. 284, P1; Suzuki Toshiyuki, 2014, Aqua, V20, P11; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TAYLOR W R, 1985, Cybium, V9, P107; TEYTAUD A R, 1971, Caribbean Journal of Science, V11, P41; Tornabene Luke, 2010, Aqua, V16, P141; Victor Benjamin C., 2013, Journal of the Ocean Science Foundation, V7, P44; Victor Benjamin C., 2007, Zootaxa, V1526, P51; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Williams Jeffrey T., 2003, Smithsonian Contributions to Zoology, V621, P1; Williams JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010676; Wright JJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-282	54	17	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97664	10.1371/journal.pone.0097664	http://dx.doi.org/10.1371/journal.pone.0097664			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24825326	Green Published, Green Submitted, gold			2022-12-27	WOS:000336369200132
J	Gu, JM; Yang, JS; Chang, Q; Lu, XQ; Wang, JY; Chen, MJ; Ghayur, T; Gu, JJ				Gu, Jinming; Yang, Jinsong; Chang, Qing; Lu, Xiaoqing; Wang, Jieyi; Chen, Mingjiu; Ghayur, Tariq; Gu, Jijie			Identification of Anti-ErbB2 Dual Variable Domain Immunoglobulin (DVD-Ig (TM)) Proteins with Unique Activities	PLOS ONE			English	Article							HER2-POSITIVE BREAST-CANCER; BISPECIFIC ANTIBODY; MONOCLONAL-ANTIBODY; TARGETED THERAPY; PI3K INHIBITOR; ERBB FAMILY; TRASTUZUMAB; GROWTH; MOLECULES; COMPLEX	Inhibiting ErbB2 signaling with monoclonal antibodies (mAbs) or small molecules is an established therapeutic strategy in oncology. We have developed anti-ErbB2 Dual Variable Domain Immunoglobulin (DVD-Ig) proteins that capture the function of a combination of two anti-ErbB2 antibodies. In addition, some of the anti-ErbB2 DVD-Ig proteins gain the new functions of enhancing ErbB2 signaling and cell proliferation in N87 cells. We further found that two DVD-Ig proteins, DVD687 and DVD688, have two distinct mechanisms of actions in Calu-3 and N87 cells. DVD687 enhances cell cycle progression while DVD688 induces apoptosis in N87 cells. Using a half DVD687, we found that avidity may play a key role in the agonist activity of DVD687 in N87 cells.	[Gu, Jinming; Yang, Jinsong; Chang, Qing; Lu, Xiaoqing; Chen, Mingjiu; Ghayur, Tariq; Gu, Jijie] AbbVie Biores Ctr, R&D, Worcester, MA 01609 USA; [Wang, Jieyi] AbbVie Inc, Canc Res, R&D, N Chicago, IL USA	AbbVie; AbbVie	Gu, JJ (corresponding author), AbbVie Biores Ctr, R&D, Worcester, MA 01609 USA.	jijie.gu@abbvie.com			AbbVie, Inc	AbbVie, Inc(AbbVie)	This study was supported by fundings from AbbVie, Inc. The funder provided support in the form of salaries for all authors and contributed to the study design, participated in the collection, analysis and interpretation of the data, and in the writing, reviewing, and approval of this publication. The specific roles of these authors are articulated in the 'author contributions' section (JG, JY, and JG designed the study, QC did assays in Fig. 5, other authors analyzed the data).	Adams CW, 2006, CANCER IMMUNOL IMMUN, V55, P717, DOI 10.1007/s00262-005-0058-x; Arteaga CL, 2012, NAT REV CLIN ONCOL, V9, P16, DOI 10.1038/nrclinonc.2011.177; Baselga J., 2010, ANN ONCOL; Cai Z, 2010, SEMIN CELL DEV BIOL, V21, P961, DOI 10.1016/j.semcdb.2010.09.005; Campbell CI, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-235; Chen WW, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.74; Chien AJ, 2009, CANCER TREAT RES, P197, DOI 10.1007/978-0-387-75115-3_13; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Correia I, 2013, MABS-AUSTIN, V5, P364, DOI 10.4161/mabs.24258; Craig RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046778; DiGiammarino Enrico, 2012, Methods Mol Biol, V899, P145, DOI 10.1007/978-1-61779-921-1_9; Eccles SA, 2011, INT J DEV BIOL, V55, P685, DOI 10.1387/ijdb.113396se; English DP, 2013, MOL DIAGN THER, V17, P85, DOI 10.1007/s40291-013-0024-9; Frampton JE, 2009, DRUGS, V69, P2125, DOI 10.2165/11203240-000000000-00000; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Garner AP, 2013, CANCER RES, V73, P6024, DOI 10.1158/0008-5472.CAN-13-1198; Gu JJ, 2012, METHOD ENZYMOL, V502, P25, DOI 10.1016/B978-0-12-416039-2.00002-1; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Ioannou N, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-41; Jakob CG, 2013, MABS-AUSTIN, V5, P358, DOI 10.4161/mabs.23977; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Khurana A, 2013, CURR PHARM DES; Konecny GE, 2013, CURR OPIN OBSTET GYN, V25, P55, DOI 10.1097/GCO.0b013e32835c5e90; Kontermann RE, 2012, MABS-AUSTIN, V4, P182, DOI 10.4161/mabs.4.2.19000; Korkaya H, 2013, CANCER RES, V73, P3489, DOI 10.1158/0008-5472.CAN-13-0260; Kulig Jan, 2013, J Oncol Pharm Pract, V19, P75, DOI 10.1177/1078155212449030; Lee-Hoeflich ST, 2008, CANCER RES, V68, P5878, DOI 10.1158/0008-5472.CAN-08-0380; Liu J, 2012, Patent No. [US20120201746, 20120201746]; McDonagh CF, 2012, MOL CANCER THER, V11, P582, DOI 10.1158/1535-7163.MCT-11-0820; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nielsen DL, 2013, BREAST, V22, P1, DOI 10.1016/j.breast.2012.09.008; Schaefer G, 2011, CANCER CELL, V20, P472, DOI 10.1016/j.ccr.2011.09.003; Scheer JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051817; Sendur MAN, 2012, CURR MED RES OPIN, V28, P1709, DOI 10.1185/03007995.2012.728132; Shak S, 1999, SEMIN ONCOL, V26, P71; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Stern HM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3001539; Tebbutt N, 2013, NAT REV CANCER, V13, P663, DOI 10.1038/nrc3559; Tomas A, 2014, TRENDS CELL BIOL, V24, P26, DOI 10.1016/j.tcb.2013.11.002; Wang SH, 2012, CANCER LETT, V325, P214, DOI 10.1016/j.canlet.2012.07.007; Wheeler DL, 2008, ONCOGENE, V27, P3944, DOI 10.1038/onc.2008.19; Wilson KJ, 2012, GROWTH FACTORS, V30, P107, DOI 10.3109/08977194.2011.649918; Wu CB, 2009, MABS, V1, P339, DOI 10.4161/mabs.1.4.8755; Yamaguchi H, 2014, ONCOGENE, V33, P1073, DOI 10.1038/onc.2013.74; Yao E, 2009, CLIN CANCER RES, V15, P4147, DOI 10.1158/1078-0432.CCR-08-2814; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309	47	7	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97292	10.1371/journal.pone.0097292	http://dx.doi.org/10.1371/journal.pone.0097292			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824849	Green Published, gold, Green Submitted			2022-12-27	WOS:000336369200087
J	Kitzes, J; Merenlender, A				Kitzes, Justin; Merenlender, Adina			Large Roads Reduce Bat Activity across Multiple Species	PLOS ONE			English	Article							FORAGING BATS; CLASSIFICATION; IMPACTS	Although the negative impacts of roads on many terrestrial vertebrate and bird populations are well documented, there have been few studies of the road ecology of bats. To examine the effects of large roads on bat populations, we used acoustic recorders to survey bat activity along ten 300 m transects bordering three large highways in northern California, applying a newly developed statistical classifier to identify recorded calls to the species level. Nightly counts of bat passes were analyzed with generalized linear mixed models to determine the relationship between bat activity and distance from a road. Total bat activity recorded at points adjacent to roads was found to be approximately one-half the level observed at 300 m. Statistically significant road effects were also found for the Brazilian free-tailed bat (Tadarida brasiliensis), big brown bat (Eptesicus fuscus), hoary bat (Lasiurus cinereus), and silver-haired bat ( Lasionycteris noctivagans). The road effect was found to be temperature dependent, with hot days both increasing total activity at night and reducing the difference between activity levels near and far from roads. These results suggest that the environmental impacts of road construction may include degradation of bat habitat and that mitigation activities for this habitat loss may be necessary to protect bat populations.	[Kitzes, Justin; Merenlender, Adina] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Kitzes, J (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	jkitzes@berkeley.edu		MERENLENDER, Adina/0000-0002-0681-8642; Kitzes, Justin/0000-0001-7839-3594	National Science Foundation Graduate Research Fellowship [DGE 0946797]	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF))	This manuscript is based upon work supported by the National Science Foundation Graduate Research Fellowship under Grant No. DGE 0946797. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott IM, 2012, LANDSCAPE URBAN PLAN, V106, P293, DOI 10.1016/j.landurbplan.2012.03.015; Adams AM, 2012, METHODS ECOL EVOL, V3, P992, DOI 10.1111/j.2041-210X.2012.00244.x; ANTHONY ELP, 1981, OECOLOGIA, V51, P151, DOI 10.1007/BF00540593; Armitage DW, 2010, ECOL INFORM, V5, P465, DOI 10.1016/j.ecoinf.2010.08.001; Barclay RMR, 1999, J MAMMAL, V80, P290, DOI 10.2307/1383229; Benitez-Lopez A, 2010, BIOL CONSERV, V143, P1307, DOI 10.1016/j.biocon.2010.02.009; Bennett VJ, 2013, J WILDLIFE MANAGE, V77, P93, DOI 10.1002/jwmg.467; Berthinussen A, 2012, J APPL ECOL, V49, P82, DOI 10.1111/j.1365-2664.2011.02068.x; BLAKE D, 1994, J ZOOL, V234, P453, DOI 10.1111/j.1469-7998.1994.tb04859.x; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brigham R., 2004, BAT ECHOLOCATION RES; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; DEJONG J, 1991, HOLARCTIC ECOL, V14, P92; Fahrig L, 2009, ECOL SOC, V14; Foley J, 2011, CONSERV BIOL, V25, P223, DOI 10.1111/j.1523-1739.2010.01638.x; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Hickey MBC, 1996, J MAMMAL, V77, P325, DOI 10.2307/1382804; Kerth G, 2009, BIOL CONSERV, V142, P270, DOI 10.1016/j.biocon.2008.10.022; Kunz TH, 2007, FRONT ECOL ENVIRON, V5, P315, DOI 10.1890/1540-9295(2007)5[315:EIOWED]2.0.CO;2; Lesinski G, 2011, EUR J WILDLIFE RES, V57, P217, DOI 10.1007/s10344-010-0414-9; Lode T, 2000, AMBIO, V29, P163, DOI 10.1579/0044-7447-29.3.163; Maechler M., 2011, LME4 LINEAR MIXED EF; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pierson Elizabeth D., 1998, P309; R Core Team, 2021, R LANGUAGE ENV STAT; Rainey WE, 2009, D91 SECURESCM; RICHARDS GC, 1989, AUST WILDLIFE RES, V16, P151; RYDELL J, 1989, OECOLOGIA, V80, P562, DOI 10.1007/BF00380082; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Schaub A, 2008, J EXP BIOL, V211, P3174, DOI 10.1242/jeb.022863; Siemers BM, 2011, P ROY SOC B-BIOL SCI, V278, P1646, DOI 10.1098/rspb.2010.2262; Skaug H, 2012, GLMMADMB GEN LINEAR; Stone EL, 2009, CURR BIOL, V19, P1123, DOI 10.1016/j.cub.2009.05.058; van der Ree R, 2011, ECOL SOC, V16; Watts RD, 2007, SCIENCE, V316, P736, DOI 10.1126/science.1138141; Zurcher AA, 2010, ACTA CHIROPTEROL, V12, P337, DOI 10.3161/150811010X537918; Zuur Alain F., 2009, P1	40	29	32	7	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96341	10.1371/journal.pone.0096341	http://dx.doi.org/10.1371/journal.pone.0096341			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24823689	Green Submitted, Green Published, gold			2022-12-27	WOS:000336369200016
J	Kjellberg, MA; Backman, APE; Ohvo-Rekila, H; Mattjus, P				Kjellberg, Matti A.; Backman, Anders P. E.; Ohvo-Rekila, Henna; Mattjus, Peter			Alternation in the Glycolipid Transfer Protein Expression Causes Changes in the Cellular Lipidome	PLOS ONE			English	Article							OXYSTEROL-BINDING PROTEIN; HIGH-THROUGHPUT; GLYCOSPHINGOLIPID SYNTHESIS; ENDOPLASMIC-RETICULUM; QUANTITATIVE-ANALYSIS; CERAMIDE SYNTHASES; PRE-GOLGI; RAT-LIVER; GLUCOSYLCERAMIDE; IDENTIFICATION	The glycolipid transfer protein (GLTP) catalyzes the binding and transport of glycolipids, but not phospholipids or neutral lipids. With its all-alpha helical fold, it is the founding member for a new superfamily, however its biological role still remains unclear. We have analyzed changes in the HeLa cell lipidome in response to down-and up-regulation of GLTP expression. We used metabolic labeling and thin layer chromatography analysis, complemented with a lipidomics mass spectroscopic approach. HeLa cells were treated with GLTP siRNA or were transiently overexpressing the GLTP gene. We identified eight different lipid classes that changed as a result of the GLTP down-or up-regulation treatments; glucosylceramide, lactosylceramide, globotriaosylceramide, ceramide, sphingomyelin, cholesterol-esters, diacylglycerol and phosphatidylserine. We discovered that the amount of globotriaosylceramide (Gb(3)) was extensively lowered after down-regulation of GLTP. Further, an up-regulation of GLTP caused a substantial increase in both the Gb(3) and glucosylceramide levels compared to the controls. Total galactosylceramide levels remained unchanged. Both lactosylceramide and ceramide showed small changes, an increase with increasing GLTP and a decrease in the HeLa cell GLTP knockdowns. The cholesterol-esters and diacylglycerol masses increased in cells that had upregulated GLTP protein levels, wheras down-regulation did not affect their amounts. For the glycerophospholipids, phosphatidylserine was the only species that was lower in GLTP overexpressing cells. Phosphatidylethanolamine, phosphatidylglyerol and phosphatidylinositol remained unaltered. A total of 142 lipid species were profiled and quantified using shotgun lipidomics analyses. This work provides for the first time insights into how alternations in the levels of a protein that binds and transfers glycolipids affects the cellular lipid metabolism. We discuss the observed changes in the lipidome and how these relate to GLTP. We suggest, that GLTP not only could be a significant player in cellular sphingolipid metabolism, but also could have a much broader role in the overall lipid metabolism.	[Kjellberg, Matti A.; Backman, Anders P. E.; Ohvo-Rekila, Henna; Mattjus, Peter] Abo Akad Univ, Dept Biosci, Turku, Finland	Abo Akademi University	Mattjus, P (corresponding author), Abo Akad Univ, Dept Biosci, Turku, Finland.	pmattjus@abo.fi	Mattjus, Peter/AAQ-7531-2021; Mattjus, Peter/ABE-3596-2021	Mattjus, Peter/0000-0001-8991-5933; Backman, Anders/0000-0001-8144-4030	Academy of Finland; Sigrid Juselius Foundation; Abo Akademi University; Magnus Ehrnrooths stiftelse; Medicinska Understodsforeningen Liv och Halsa	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Abo Akademi University; Magnus Ehrnrooths stiftelse; Medicinska Understodsforeningen Liv och Halsa	This work was supported by the Academy of Finland, Sigrid Juselius Foundation, Abo Akademi University, Magnus Ehrnrooths stiftelse and Medicinska Understodsforeningen Liv och Halsa r.f. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlercreutz D, 2010, CARBOHYD RES, V345, P1384, DOI 10.1016/j.carres.2010.02.006; ALLAN D, 1982, J LIPID RES, V23, P1373; Ardail D, 2003, BIOCHEM J, V371, P1013, DOI 10.1042/BJ20021834; Bergan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075904; Brodersen P, 2002, GENE DEV, V16, P490, DOI 10.1101/gad.218202; BROWN RE, 1985, CHEM PHYS LIPIDS, V38, P79, DOI 10.1016/0009-3084(85)90059-3; Chigorno V, 2005, J BIOL CHEM, V280, P2668, DOI 10.1074/jbc.M407749200; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; D'Angelo G, 2013, NATURE, V501, DOI 10.1038/nature12423; De Rosa MF, 2004, J BIOL CHEM, V279, P7867, DOI 10.1074/jbc.M305645200; Ejsing CS, 2006, ANAL CHEM, V78, P6202, DOI 10.1021/ac060545x; Ekroos K, 2003, J LIPID RES, V44, P2181, DOI 10.1194/jlr.D300020-JLR200; Ekroos K, 2002, ANAL CHEM, V74, P941, DOI 10.1021/ac015655c; Ekroos Kim, 2008, P369, DOI 10.1007/978-1-59745-463-6_17; Fugmann T, 2007, J CELL BIOL, V178, P15, DOI 10.1083/jcb.200612017; FUTERMAN AH, 1991, BIOCHEM J, V280, P295, DOI 10.1042/bj2800295; Gao Y, 2011, PLOS ONE, V6; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hanada K, 2013, BIOCH BIOPHYS ACTA; Heiskanen LA, 2013, ANAL CHEM, V85, P8757, DOI 10.1021/ac401857a; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; JECKEL D, 1992, J CELL BIOL, V117, P259, DOI 10.1083/jcb.117.2.259; Jung HR, 2011, BBA-MOL CELL BIOL L, V1811, P925, DOI 10.1016/j.bbalip.2011.06.025; Kjellberg MA, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0070283, 10.1371/annotation/712bb339-6073-4e62-9f68-b285caedd913]; Kojima Y, 2000, J BIOL CHEM, V275, P15152, DOI 10.1074/jbc.M909620199; Kudo N, 2010, J MOL BIOL, V396, P245, DOI 10.1016/j.jmb.2009.12.029; Kumagai K, 2005, J BIOL CHEM, V280, P6488, DOI 10.1074/jbc.M409290200; Lagace TA, 2013, BIOCH BIOPHYS ACTA; Lahiri S, 2005, J BIOL CHEM, V280, P33735, DOI 10.1074/jbc.M506485200; Lev S, 2008, TRENDS CELL BIOL, V18, P282, DOI 10.1016/j.tcb.2008.03.006; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; Litvak V, 2005, NAT CELL BIOL, V7, P225, DOI 10.1038/ncb1221; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Malinina L, 2004, NATURE, V430, P1048, DOI 10.1038/nature02856; Mattjus P, 2009, BBA-BIOMEMBRANES, V1788, P267, DOI 10.1016/j.bbamem.2008.10.003; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Meyer SGE, 2003, ARCH BIOCHEM BIOPHYS, V410, P107, DOI 10.1016/S0003-9861(02)00666-5; Mikitova V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030455; Nhek S, 2010, MOL BIOL CELL, V21, P2327, DOI 10.1091/mbc.E10-02-0090; PELLIZZARI A, 1992, BIOCHEMISTRY-US, V31, P1363, DOI 10.1021/bi00120a011; Peretti D, 2008, MOL BIOL CELL, V19, P3871, DOI 10.1091/mbc.E08-05-0498; Perry RJ, 2005, BBA-MOL CELL BIOL L, V1734, P220, DOI 10.1016/j.bbalip.2005.04.001; Perry RJ, 2006, MOL BIOL CELL, V17, P2604, DOI 10.1091/mbc.E06-01-0060; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; RUSINOL AE, 1994, J BIOL CHEM, V269, P27494; SAUPE S, 1994, P NATL ACAD SCI USA, V91, P5927, DOI 10.1073/pnas.91.13.5927; SKIPSKI VP, 1964, BIOCHEM J, V90, P374, DOI 10.1042/bj0900374; Stahlman M, 2009, J CHROMATOGR B, V877, P2664, DOI 10.1016/j.jchromb.2009.02.037; Stiban J, 2010, ADV EXP MED BIOL, V688, P60; Tidhar R, 2013, BBA-MOL CELL RES, V1833, P2511, DOI 10.1016/j.bbamcr.2013.04.010; Tomishige N, 2009, MOL BIOL CELL, V20, P348, DOI 10.1091/mbc.E08-07-0669; Tuuf J, 2013, CHEM PHYS LIPIDS; Tuuf J, 2010, BIOCH BIOPHYS ACTA; Tuuf J, 2007, BBA-MOL CELL BIOL L, V1771, P1353, DOI 10.1016/j.bbalip.2007.09.001; Tuuf J, 2009, BIOCHEM BIOPH RES CO, V388, P395, DOI 10.1016/j.bbrc.2009.08.023; Vance JE, 2013, BBA-MOL CELL BIOL L, V1831, P543, DOI 10.1016/j.bbalip.2012.08.016; West G, 2008, FEBS J, V275, P3421, DOI 10.1111/j.1742-4658.2008.06498.x; YAMADA K, 1986, BIOCHIM BIOPHYS ACTA, V879, P345; Yokoyama K, 1997, EUR J BIOCHEM, V249, P450, DOI 10.1111/j.1432-1033.1997.00450.x; Zou XQ, 2011, J BIOL CHEM, V286, P1301, DOI 10.1074/jbc.M110.127837	62	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97263	10.1371/journal.pone.0097263	http://dx.doi.org/10.1371/journal.pone.0097263			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824606	Green Submitted, Green Published, gold			2022-12-27	WOS:000336369200083
J	Mariette, J; Noirot, C; Nabihoudine, I; Bardou, P; Hoede, C; Djari, A; Cabau, C; Klopp, C				Mariette, Jerome; Noirot, Celine; Nabihoudine, Ibounyamine; Bardou, Philippe; Hoede, Claire; Djari, Anis; Cabau, Cedric; Klopp, Christophe			RNAbrowse: RNA-Seq De Novo Assembly Results Browser	PLOS ONE			English	Article								Transcriptome analysis based on a de novo assembly of next generation RNA sequences is now performed routinely in many laboratories. The generated results, including contig sequences, quantification figures, functional annotations and variation discovery outputs are usually bulky and quite diverse. This article presents a user oriented storage and visualisation environment permitting to explore the data in a top-down manner, going from general graphical views to all possible details. The software package is based on biomart, easy to install and populate with local data. The software package is available under the GNU General Public License (GPL) at http://bioinfo.genotoul.fr/RNAbrowse.	[Mariette, Jerome; Noirot, Celine; Nabihoudine, Ibounyamine; Hoede, Claire; Klopp, Christophe] INRA, Plate Forme Bioinfo Genotoul, Biometrie & Intelligence Artificielle, F-31326 Castanet Tolosan, France; [Bardou, Philippe; Djari, Anis; Cabau, Cedric; Klopp, Christophe] INRA, Plate Forme SIGENAE Genet Cellulaire, F-31326 Castanet Tolosan, France	INRAE; INRAE	Mariette, J (corresponding author), INRA, Plate Forme Bioinfo Genotoul, Biometrie & Intelligence Artificielle, F-31326 Castanet Tolosan, France.	support.genopole@toulouse.inra.fr	Klopp, Christophe/J-3164-2019	Klopp, Christophe/0000-0001-7126-5477; Hoede, Claire/0000-0001-5054-7731; Bardou, Philippe/0000-0002-0004-0251				Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Grabherr MG, 2011, NAT BIOTECH, V29; Li P, 2012, BIOINFORMATICS, V28, P2382, DOI 10.1093/bioinformatics/bts443; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Westesson O, 2013, BRIEF BIOINFORM, V14, P172, DOI 10.1093/bib/bbr078; Zhang J, 2011, DATABASE         APR, V2011	6	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96821	10.1371/journal.pone.0096821	http://dx.doi.org/10.1371/journal.pone.0096821			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24823498	Green Submitted, Green Published, gold			2022-12-27	WOS:000336369200034
J	Weis, MC; Avva, J; Jacobberger, JW; Sreenath, SN				Weis, Michael C.; Avva, Jayant; Jacobberger, James W.; Sreenath, Sree N.			A Data-Driven, Mathematical Model of Mammalian Cell Cycle Regulation	PLOS ONE			English	Article							DNA-BINDING ACTIVITY; SYSTEMS BIOLOGY; QUANTITATIVE-ANALYSIS; RESTRICTION POINT; POSITIVE FEEDBACK; MOLECULAR-MODEL; DIVISION CYCLE; NUCLEIC-ACID; B-MYB; ACTIVATION	Few of >150 published cell cycle modeling efforts use significant levels of data for tuning and validation. This reflects the difficultly to generate correlated quantitative data, and it points out a critical uncertainty in modeling efforts. To develop a data-driven model of cell cycle regulation, we used contiguous, dynamic measurements over two time scales (minutes and hours) calculated from static multiparametric cytometry data. The approach provided expression profiles of cyclin A2, cyclin B1, and phospho-S10-histone H3. The model was built by integrating and modifying two previously published models such that the model outputs for cyclins A and B fit cyclin expression measurements and the activation of B cyclin/Cdk1 coincided with phosphorylation of histone H3. The model depends on Cdh1-regulated cyclin degradation during G1, regulation of B cyclin/Cdk1 activity by cyclin A/Cdk via Wee1, and transcriptional control of the mitotic cyclins that reflects some of the current literature. We introduced autocatalytic transcription of E2F, E2F regulated transcription of cyclin B, Cdc20/Cdh1 mediated E2F degradation, enhanced transcription of mitotic cyclins during late S/early G2 phase, and the sustained synthesis of cyclin B during mitosis. These features produced a model with good correlation between state variable output and real measurements. Since the method of data generation is extensible, this model can be continually modified based on new correlated, quantitative data.	[Weis, Michael C.; Avva, Jayant; Sreenath, Sree N.] Case Western Reserve Univ, Dept Elect Engn & Comp Sci, Cleveland, OH 44106 USA; [Jacobberger, James W.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Jacobberger, JW (corresponding author), Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.	jwj@case.edu	Jacobberger, James/P-9183-2014	Jacobberger, James/0000-0002-3092-5157	NCI [R01CA73413]; NCI (Case Comprehensive Cancer Center Cytometry and Imaging Microscopy Core Facility) [P30CA43703]; NATIONAL CANCER INSTITUTE [P30CA043703, R01CA073413] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI (Case Comprehensive Cancer Center Cytometry and Imaging Microscopy Core Facility); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI grant R01CA73413 (JWJ) and by NCI P30CA43703 (Case Comprehensive Cancer Center Cytometry and Imaging Microscopy Core Facility). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguda BD, 1999, CELL PROLIFERAT, V32, P321, DOI 10.1046/j.1365-2184.1999.3250321.x; Aguda BD, 1999, P NATL ACAD SCI USA, V96, P11352, DOI 10.1073/pnas.96.20.11352; Akopyan K, 2014, MOL CELL, V53, P843, DOI 10.1016/j.molcel.2014.01.031; Alfieri R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S12-S16; Arooz T, 2000, BIOCHEMISTRY-US, V39, P9494, DOI 10.1021/bi0009643; Avva J, 2012, PLOS ONE IN PRESS; Avva J, 2011, METHODS MOL BIOL, V717, P171, DOI 10.1007/978-1-61779-024-9_10; Barberis M, 2007, PLOS COMPUT BIOL, V3, P649, DOI 10.1371/journal.pcbi.0030064; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Birtwistle MR, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100188; Calzone L, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100171; Charvin G, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000284; Chen KC, 2000, MOL BIOL CELL, V11, P369, DOI 10.1091/mbc.11.1.369; Chen KC, 2004, MOL BIOL CELL, V15, P3841, DOI 10.1091/mbc.E03-11-0794; Chen WW, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.74; Cheung E, 1999, BIOCHEM J, V344, P145, DOI 10.1042/0264-6021:3440145; Chow JPH, 2003, J BIOL CHEM, V278, P40815, DOI 10.1074/jbc.M306683200; Ciliberto A, 2003, J CELL BIOL, V163, P1243, DOI 10.1083/jcb.200306139; Ciliberto A, 2000, B MATH BIOL, V62, P37, DOI 10.1006/bulm.1999.0129; Ciliberto A, 2009, EMBO J, V28, P2162, DOI 10.1038/emboj.2009.186; CLARKE PR, 1992, EMBO J, V11, P1751, DOI 10.1002/j.1460-2075.1992.tb05227.x; COHEN LS, 1967, J CELL PHYSIOL, V69, P331, DOI 10.1002/jcp.1040690309; Conradie R, 2010, FEBS J, V277, P357, DOI 10.1111/j.1742-4658.2009.07473.x; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Cross FR, 2002, MOL BIOL CELL, V13, P52, DOI 10.1091/mbc.01-05-0265; Csikasz-Nagy A, 2006, BIOPHYS J, V90, P4361, DOI 10.1529/biophysj.106.081240; Csikasz-Nagy A, 2009, BRIEF BIOINFORM, V10, P424, DOI 10.1093/bib/bbp005; Darzynkiewicz Z, 1996, CYTOMETRY, V25, P1; DARZYNKIEWICZ Z, 1979, P NATL ACAD SCI USA, V76, P358, DOI 10.1073/pnas.76.1.358; DEVAULT A, 1992, J CELL BIOL, V118, P1109, DOI 10.1083/jcb.118.5.1109; Di Fiore B, 2010, J CELL BIOL, V190, P501, DOI 10.1083/jcb.201001083; Drexler HG, 2000, LEUKEMIA LYMPHOMA CE; Dynlacht BD, 1997, MOL CELL BIOL, V17, P3867, DOI 10.1128/MCB.17.7.3867; Enders GH, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-12; Faure A, 2009, MOL BIOSYST, V5, P1569, DOI [10.1039/b907562n, 10.1039/B907562n]; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; FRANKFURT OS, 1981, J CELL PHYSIOL, V107, P115, DOI 10.1002/jcp.1041070113; Frisa PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007064; Fung TK, 2007, MOL BIOL CELL, V18, P1861, DOI 10.1091/mbc.E06-12-1092; Gardner TS, 1998, P NATL ACAD SCI USA, V95, P14190, DOI 10.1073/pnas.95.24.14190; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; GOLDBETER A, 1991, P NATL ACAD SCI USA, V88, P9107, DOI 10.1073/pnas.88.20.9107; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; GONG JP, 1995, CELL GROWTH DIFFER, V6, P1485; Gonze D, 2001, J THEOR BIOL, V210, P167, DOI 10.1006/jtbi.2000.2294; Haberichter T, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100126; HARTWELL LH, 1991, GENETICS, V129, P975; Hatzimanikatis V, 1999, BIOTECHNOL BIOENG, V65, P631; Hengl S, 2007, BIOINFORMATICS, V23, P2612, DOI 10.1093/bioinformatics/btm382; Hwang A, 1998, J BIOL CHEM, V273, P31505, DOI 10.1074/jbc.273.47.31505; Ibrahim B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001555; Ingolia NT, 2004, CURR BIOL, V14, pR771, DOI 10.1016/j.cub.2004.09.018; Jacobberger JW, 2008, CYTOM PART A, V73A, P5, DOI 10.1002/cyto.a.20501; Jacobberger JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030870; Jaqaman K, 2006, NAT REV MOL CELL BIO, V7, P813, DOI 10.1038/nrm2030; Kafri R, 2013, NATURE, V494, P480, DOI 10.1038/nature11897; Kaizu K, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.73; Kar S, 2009, P NATL ACAD SCI USA, V106, P6471, DOI 10.1073/pnas.0810034106; Kim SY, 2007, CELL, V128, P1133, DOI 10.1016/j.cell.2007.01.039; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kohn KW, 1998, ONCOGENE, V16, P1065, DOI 10.1038/sj.onc.1201608; Laoukili J, 2008, MOL CELL BIOL, V28, P3076, DOI 10.1128/MCB.01710-07; Lavia P, 1999, BIOESSAYS, V21, P221; Li CQ, 2010, MOL CELL BIOL, V30, P116, DOI 10.1128/MCB.01876-08; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; LOZZIO CB, 1973, J NATL CANCER I, V50, P535, DOI 10.1093/jnci/50.2.535; Mena AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013037; Merrick KA, 2008, MOL CELL, V32, P662, DOI 10.1016/j.molcel.2008.10.022; Millat T, 2008, BIOSYSTEMS, V92, P270, DOI 10.1016/j.biosystems.2008.03.007; Moles CG, 2003, GENOME RES, V13, P2467, DOI 10.1101/gr.1262503; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; NOVAK B, 1993, J CELL SCI, V106, P1153; Novak B, 1998, BIOPHYS CHEM, V72, P185, DOI 10.1016/S0301-4622(98)00133-1; NOVAK B, 1995, J THEOR BIOL, V173, P283, DOI 10.1006/jtbi.1995.0063; Novak B, 2001, CHAOS, V11, P277, DOI 10.1063/1.1345725; Novak B, 1997, P NATL ACAD SCI USA, V94, P9147, DOI 10.1073/pnas.94.17.9147; Novak M, 2004, J THEOR BIOL, V230, P563, DOI 10.1016/j.jtbi.2004.04.039; OBEYESEKERE MN, 1995, ONCOGENE, V11, P1199; Peart MJ, 2010, CELL CYCLE, V9, P3956, DOI 10.4161/cc.9.19.13162; Pines J, 2011, NAT REV MOL CELL BIO, V12, P427, DOI 10.1038/nrm3132; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Qu ZL, 2003, AM J PHYSIOL-CELL PH, V284, pC349, DOI 10.1152/ajpcell.00066.2002; Roussel MF, 1999, ONCOGENE, V18, P5311, DOI 10.1038/sj.onc.1202998; Runarsson TP, 2005, IEEE T SYST MAN CY C, V35, P233, DOI 10.1109/TSMCC.2004.841906; Saville MK, 1998, ONCOGENE, V17, P2679, DOI 10.1038/sj.onc.1202503; Schmidt H, 2006, BIOINFORMATICS, V22, P514, DOI 10.1093/bioinformatics/bti799; Singhania R, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001077; Sreenath SN, 2008, ESSAYS BIOCHEM, V45, P1, DOI 10.1042/BSE0450001; Srividhya J, 2006, J THEOR BIOL, V241, P617, DOI 10.1016/j.jtbi.2005.12.020; Stefan T, 2011, METHOD CELL BIOL, V102, P341, DOI 10.1016/B978-0-12-374912-3.00014-6; Streichert F., 2005, WSI200506 EB KARLS U; Sveiczer A, 2000, P NATL ACAD SCI USA, V97, P7865, DOI 10.1073/pnas.97.14.7865; Sveiczer Akos, 2004, Briefings in Functional Genomics & Proteomics, V2, P298, DOI 10.1093/bfgp/2.4.298; Swat M, 2004, BIOINFORMATICS, V20, P1506, DOI 10.1093/bioinformatics/bth110; Thron CD, 1997, ONCOGENE, V15, P317, DOI 10.1038/sj.onc.1201190; THRON CD, 1991, SCIENCE, V254, P122, DOI 10.1126/science.1833817; TRAGANOS F, 1982, CYTOMETRY, V2, P212; TYSON JJ, 1991, P NATL ACAD SCI USA, V88, P7328, DOI 10.1073/pnas.88.16.7328; Tyson JJ, 2008, CURR BIOL, V18, pR759, DOI 10.1016/j.cub.2008.07.001; Vader G, 2008, BBA-REV CANCER, V1786, P60, DOI 10.1016/j.bbcan.2008.07.003; Viallard JF, 1999, EXP CELL RES, V247, P208, DOI 10.1006/excr.1998.4352; XU M, 1994, MOL CELL BIOL, V14, P8420, DOI 10.1128/MCB.14.12.8420; Yam CH, 1999, MOL CELL BIOL, V19, P635; Yang L, 2006, J THEOR BIOL, V241, P120, DOI 10.1016/j.jtbi.2005.11.020; Zhu WC, 2004, EMBO J, V23, P4615, DOI 10.1038/sj.emboj.7600459; Ziebold U, 1997, CURR BIOL, V7, P253, DOI 10.1016/S0960-9822(06)00121-7; Zwolak J, 2009, J THEOR BIOL, V260, P110, DOI 10.1016/j.jtbi.2009.05.018	108	18	18	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97130	10.1371/journal.pone.0097130	http://dx.doi.org/10.1371/journal.pone.0097130			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824602	Green Published, Green Submitted, gold			2022-12-27	WOS:000336369200063
J	Krogh-Jespersen, S; Woodward, AL				Krogh-Jespersen, Sheila; Woodward, Amanda L.			Making Smart Social Judgments Takes Time: Infants' Recruitment of Goal Information When Generating Action Predictions	PLOS ONE			English	Article							DIRECTED ACTIONS; GAZE; ATTRIBUTION; PERCEPTION; ABILITY; OTHERS; OBJECT	Previous research has shown that young infants perceive others' actions as structured by goals. One open question is whether the recruitment of this understanding when predicting others' actions imposes a cognitive challenge for young infants. The current study explored infants' ability to utilize their knowledge of others' goals to rapidly predict future behavior in complex social environments and distinguish goal-directed actions from other kinds of movements. Fifteen-month-olds (N = 40) viewed videos of an actor engaged in either a goal-directed (grasping) or an ambiguous (brushing the back of her hand) action on a Tobii eye-tracker. At test, critical elements of the scene were changed and infants' predictive fixations were examined to determine whether they relied on goal information to anticipate the actor's future behavior. Results revealed that infants reliably generated goal-based visual predictions for the grasping action, but not for the back-of-hand behavior. Moreover, response latencies were longer for goal-based predictions than for location-based predictions, suggesting that goal-based predictions are cognitively taxing. Analyses of areas of interest indicated that heightened attention to the overall scene, as opposed to specific patterns of attention, was the critical indicator of successful judgments regarding an actor's future goal-directed behavior. These findings shed light on the processes that support "smart'' social behavior in infants, as it may be a challenge for young infants to use information about others' intentions to inform rapid predictions.	[Krogh-Jespersen, Sheila; Woodward, Amanda L.] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA	University of Chicago	Krogh-Jespersen, S (corresponding author), Univ Chicago, Dept Psychol, Chicago, IL 60637 USA.			Woodward, Amanda/0000-0002-9383-9969	Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health [P01HD064653]; National Science Foundation [DLS 0951489]; Direct For Social, Behav & Economic Scie [0951489] Funding Source: National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD064653] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health; National Science Foundation(National Science Foundation (NSF)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Research reported in this publication was supported by grants to the second author from the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health under Award Number P01HD064653 ( http://www.nichd.nih.gov) and the National Science Foundation under award number DLS 0951489 (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosini E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067916; Biro S, 2007, DEVELOPMENTAL SCI, V10, P379, DOI 10.1111/j.1467-7687.2006.00544.x; Brandone AC, 2014, DEVELOPMENTAL SCI, V17, P23, DOI 10.1111/desc.12095; Brandone AC, 2009, PSYCHOL SCI, V20, P85, DOI 10.1111/j.1467-9280.2008.02246.x; Cannon EN, 2012, DEVELOPMENTAL SCI, V15, P292, DOI 10.1111/j.1467-7687.2011.01127.x; Daum MM, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00370; Gerson SA, 2012, COGNITION, V122, P181, DOI 10.1016/j.cognition.2011.10.014; Gredeback G, 2010, COGNITION, V114, P197, DOI 10.1016/j.cognition.2009.09.004; Gredeback G, 2009, DEV PSYCHOL, V45, P1190, DOI 10.1037/a0015667; Guajardo JJ, 2004, INFANCY, V6, P361, DOI 10.1207/s15327078in0603_3; Hamlin JK, 2008, DEVELOPMENTAL SCI, V11, P487, DOI 10.1111/j.1467-7687.2008.00694.x; Henrichs I, 2014, DEV PSYCHOL, V50, P100, DOI 10.1037/a0032664; Kanakogi Y, 2010, JPN PSYCHOL RES, V52, P121, DOI 10.1111/j.1468-5884.2010.00429.x; Kiraly I, 2003, CONSCIOUS COGN, V12, P752, DOI 10.1016/S1053-8100(03)00084-9; Luo Y, 2007, COGNITION, V105, P489, DOI 10.1016/j.cognition.2006.10.007; Paulus M, 2011, DEVELOPMENTAL SCI, V14, P1301, DOI 10.1111/j.1467-7687.2011.01076.x; Paulus M, 2011, DEV PSYCHOL, V47, P976, DOI 10.1037/a0023785; Phillips AT, 2002, COGNITION, V85, P53, DOI 10.1016/S0010-0277(02)00073-2; von Hofsten C, 2007, DEVELOPMENTAL SCI, V10, P625, DOI 10.1111/j.1467-7687.2007.00604.x; Wentworth N, 1998, DEV PSYCHOL, V34, P247, DOI 10.1037/0012-1649.34.2.247; Woodward AL, 1998, COGNITION, V69, P1, DOI 10.1016/S0010-0277(98)00058-4; Woodward AL, 1999, INFANT BEHAV DEV, V22, P145, DOI 10.1016/S0163-6383(99)00007-7; Woodward AL, 2009, PSYCHOL LEARN MOTIV, V51, P187, DOI 10.1016/S0079-7421(09)51006-7	23	17	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e98085	10.1371/journal.pone.0098085	http://dx.doi.org/10.1371/journal.pone.0098085			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1NZ	24835053	Green Published, gold, Green Submitted			2022-12-27	WOS:000339614800104
J	Kinlock, BL; Wang, YD; Turner, TM; Wang, CL; Liu, BD				Kinlock, Ballington L.; Wang, Yudi; Turner, Tiffany M.; Wang, Chenliang; Liu, Bindong			Transcytosis of HIV-1 through Vaginal Epithelial Cells Is Dependent on Trafficking to the Endocytic Recycling Pathway	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELLS; INTRAVAGINAL INOCULATION; TYPE-1 TRANSCYTOSIS; INFECTION; TRANSMISSION; MUCOSAL; TISSUE; MODEL; MECHANISMS	Background: While it is accepted that viruses can enter epithelial cells by endocytosis, the lack of an established biological mechanism for the trafficking of infectious virions through vaginal epithelial cells and their release from the plasma membrane has contributed to ongoing controversy about whether endocytosis is a mere artifact of some cell culture systems and whether squamous vaginal epithelial cells are even relevant as it pertains to HIV-1 transmission. Methodology/Principal Findings: In this study, we investigated the intracellular trafficking pathway that HIV-1 exploits to transcytose vaginal epithelial cells. The reduction of endosome tubulation by recycling endosome inhibitors blocked transcytosis of HIV-1 in a cell culture and transwell system. In addition, we demonstrate that although heat-inactivated virus was endocytosed as efficiently as native virus, heat-inactivated virus was trafficked exclusively to the lysosomal pathway for degradation following endocytosis. Lysosomal protease-specific inhibitors blocked the degradation of inactivated virions. Immunofluorescence analysis not only demonstrated that HIV-1 was inside the cells but the different colocalization pattern of native vs. heat inactivated virus with transferrin provided conclusive evidence that HIV-1 uses the recycling pathway to get across vaginal epithelial cells. Conclusions/Significance:Altogether, our findings demonstrate the precise intracellular trafficking pathway utilized by HIV-1 in epithelial cells, confirms that HIV-1 transcytosis through vaginal epithelial cells is a biological phenomenon and brings to light the differential intracellular trafficking of native vs heat-inactivated HIV-1 which with further exploration could prove to provide valuable insights that could be used in the prevention of transcytosis/transmission of HIV-1 across the mucosal epithelia.	[Kinlock, Ballington L.; Wang, Yudi; Turner, Tiffany M.; Wang, Chenliang; Liu, Bindong] Meharry Med Coll, Ctr AIDS Hlth Dispar Res, Nashville, TN 37208 USA; [Kinlock, Ballington L.; Turner, Tiffany M.; Liu, Bindong] Meharry Med Coll, Dept Microbiol & Immunol, Nashville, TN 37208 USA; [Wang, Chenliang] Sun Yat Sen Univ, Inst Gastroenterol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Chenliang] Sun Yat Sen Univ, Inst Human Virol, Guangzhou 510275, Guangdong, Peoples R China	Meharry Medical College; Meharry Medical College; Sun Yat Sen University; Sun Yat Sen University	Liu, BD (corresponding author), Meharry Med Coll, Ctr AIDS Hlth Dispar Res, Nashville, TN 37208 USA.	bliu@mmc.edu		wang, chenliang/0000-0003-4388-681X	National Institutes of Health (NIH) [5C1GM089269, G12MD007586, U54MD007593, P30A1054999, UL1TR000445]; NIH [T32HL007737, T32A1007281]; NATIONAL CANCER INSTITUTE [U54CA163069, U54CA163072, U54CA163066] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026140] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007281, P30AI054999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM059994, SC1GM089269] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007586, U54MD007593] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was partially supported by National Institutes of Health (NIH) grants 5C1GM089269, G12MD007586, U54MD007593, P30A1054999 and UL1TR000445 to BL. BLK and TMT are supported by NIH training grant T32HL007737 and T32A1007281 respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Africander D, 2011, CONTRACEPTION, V84, P423, DOI 10.1016/j.contraception.2011.06.006; Agrawal N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021339; ALOIA RC, 1988, P NATL ACAD SCI USA, V85, P900, DOI 10.1073/pnas.85.3.900; Anderson DJ, 2010, J INFECT DIS, V202, P333, DOI 10.1086/653620; Anderson DJ, 2010, AIDS, V24, P163, DOI 10.1097/QAD.0b013e32833424c8; Anukam KC, 2009, SEX HEALTH, V6, P67, DOI 10.1071/SH08037; APODACA G, 1994, J CELL BIOL, V125, P67, DOI 10.1083/jcb.125.1.67; Ballweber L, 2011, J VIROL, V85, P13443, DOI 10.1128/JVI.05615-11; Bobardt MD, 2003, IMMUNITY, V18, P27, DOI 10.1016/S1074-7613(02)00504-6; Bobardt MD, 2007, J VIROL, V81, P395, DOI 10.1128/JVI.01303-06; Bomsel M, 1997, NAT MED, V3, P42, DOI 10.1038/nm0197-42; BOURINBAIAR AS, 1991, J ACQ IMMUN DEF SYND, V4, P56; Bouschbacher M, 2008, AIDS, V22, P1257, DOI 10.1097/QAD.0b013e3282f736f4; CAMERON PU, 1992, SCIENCE, V257, P383, DOI 10.1126/science.1352913; Carias AM, 2013, J VIROL, V87, P11388, DOI 10.1128/JVI.01377-13; CDC, 2007, HIV AIDS SURVEILLANC; Chertova E, 2002, J VIROL, V76, P5315, DOI 10.1128/JVI.76.11.5315-5325.2002; CHESEBRO B, 1992, J VIROL, V66, P6547, DOI 10.1128/JVI.66.11.6547-6554.1992; Chomont N, 2008, VIROLOGY, V370, P246, DOI 10.1016/j.virol.2007.09.006; Collins KB, 2000, NAT MED, V6, P475, DOI 10.1038/74743; de Figueiredo P, 2001, J BIOL CHEM, V276, P47361, DOI 10.1074/jbc.M108508200; Devito C, 2000, J IMMUNOL, V165, P5170, DOI 10.4049/jimmunol.165.9.5170; Dickerson MC, 1996, SEX TRANSM DIS, V23, P429, DOI 10.1097/00007435-199609000-00015; Dong XH, 2005, CELL, V120, P663, DOI 10.1016/j.cell.2004.12.023; Drosten C, 2005, J MOL DIAGN, V7, P219, DOI 10.1016/S1525-1578(10)60548-X; Fanibunda SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028014; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; Fischer W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012303; FURUTA Y, 1994, P NATL ACAD SCI USA, V91, P12559, DOI 10.1073/pnas.91.26.12559; Ganor Y, 2013, MUCOSAL IMMUNOL, V6, P776, DOI 10.1038/mi.2012.116; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Greenhead P, 2000, J VIROL, V74, P5577, DOI 10.1128/JVI.74.12.5577-5586.2000; Gummuluru S, 2002, J VIROL, V76, P10692, DOI 10.1128/JVI.76.21.10692-10701.2002; Gupta P, 2002, J VIROL, V76, P9868, DOI 10.1128/JVI.76.19.9868-9876.2002; Gupta S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003776; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Hladik F, 2007, IMMUNITY, V26, P257, DOI 10.1016/j.immuni.2007.01.007; Hocini H, 1999, J INFECT DIS, V179, pS448, DOI 10.1086/314802; Jain S, 2010, VACCINE, V28, P7070, DOI 10.1016/j.vaccine.2010.08.009; Jovic M, 2010, HISTOL HISTOPATHOL, V25, P99, DOI 10.14670/HH-25.99; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Khatua AK, 2010, VIROLOGY, V408, P119, DOI 10.1016/j.virol.2010.09.005; LI YX, 1991, J VIROL, V65, P3973, DOI 10.1128/JVI.65.8.3973-3985.1991; Maher D, 2005, P NATL ACAD SCI USA, V102, P11504, DOI 10.1073/pnas.0500848102; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mikulak J, 2009, VIROLOGY, V385, P105, DOI 10.1016/j.virol.2008.11.029; MILLER CJ, 1994, J VIROL, V68, P6391, DOI 10.1128/JVI.68.10.6391-6400.1994; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; Modi M, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-158; Mossop H, 2011, OBSTET GYNECOL, V118, P840, DOI 10.1097/AOG.0b013e31822da9e9; Padian NS, 1997, AM J EPIDEMIOL, V146, P350, DOI 10.1093/oxfordjournals.aje.a009276; POPOVIC M, 1984, SCIENCE, V224, P497, DOI 10.1126/science.6200935; Saidi H, 2007, VIROLOGY, V358, P55, DOI 10.1016/j.virol.2006.07.029; Salle B, 2010, J INFECT DIS, V202, P337, DOI 10.1086/653619; Shen RZ, 2010, J IMMUNOL, V184, P3648, DOI 10.4049/jimmunol.0903346; Sodora DL, 1998, AIDS RES HUM RETROV, V14, pS119; Spira AI, 1996, J EXP MED, V183, P215, DOI 10.1084/jem.183.1.215; Stoddard E, 2007, J IMMUNOL, V179, P3126, DOI 10.4049/jimmunol.179.5.3126; Takahashi S, 2012, J CELL SCI, V125, P4049, DOI 10.1242/jcs.102913; Timmons CL, 2013, J INFECT DIS, V207, P1171, DOI 10.1093/infdis/jit001; Tugizov SM, 2011, VIROLOGY, V409, P211, DOI 10.1016/j.virol.2010.10.004; Tuma PL, 2003, PHYSIOL REV, V83, P871, DOI 10.1152/physrev.00001.2003; Vacharaksa A, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-66; Wang YD, 2011, J VIROL, V85, P4510, DOI 10.1128/JVI.01925-10; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Wu ZW, 2003, J INFECT DIS, V188, P1473, DOI 10.1086/379248; Zheng JY, 2006, JAIDS-J ACQ IMM DEF, V43, P127, DOI 10.1097/01.qai.0000228149.17669.08	70	35	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e96760	10.1371/journal.pone.0096760	http://dx.doi.org/10.1371/journal.pone.0096760			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830293	Green Submitted, Green Published, gold			2022-12-27	WOS:000336789500025
J	Llop, S; Engstrom, K; Ballester, F; Franforte, E; Alhamdow, A; Pisa, F; Tratnik, JS; Mazej, D; Murcia, M; Rebagliato, M; Bustamante, M; Sunyer, J; Sofianou-Katsoulis, A; Prasouli, A; Antonopoulou, E; Antoniadou, I; Nakou, S; Barbone, F; Horvat, M; Broberg, K				Llop, Sabrina; Engstrom, Karin; Ballester, Ferran; Franforte, Elisa; Alhamdow, Ayman; Pisa, Federica; Tratnik, Janja Snoj; Mazej, Datja; Murcia, Mario; Rebagliato, Marisa; Bustamante, Mariona; Sunyer, Jordi; Sofianou-Katsoulis, Aikaterini; Prasouli, Alexia; Antonopoulou, Eleni; Antoniadou, Ioanna; Nakou, Sheena; Barbone, Fabio; Horvat, Milena; Broberg, Karin			Polymorphisms in ABC Transporter Genes and Concentrations of Mercury in Newborns - Evidence from Two Mediterranean Birth Cohorts	PLOS ONE			English	Article							FISH CONSUMPTION; ELEMENTAL MERCURY; EXPOSURE; BLOOD; WOMEN; VAPOR; MRP2	Background: The genetic background may influence methylmercury (MeHg) metabolism and neurotoxicity. ATP binding cassette (ABC) transporters actively transport various xenobiotics across biological membranes. Objective: To investigate the role of ABC polymorphisms as modifiers of prenatal exposure to MeHg. Methods: The study population consisted of participants (n = 1651) in two birth cohorts, one in Italy and Greece (PHIME) and the other in Spain (INMA). Women were recruited during pregnancy in Italy and Spain, and during the perinatal period in Greece. Total mercury concentrations were measured in cord blood samples by atomic absorption spectrometry. Maternal fish intake during pregnancy was determined from questionnaires. Polymorphisms (n = 5) in the ABC genes ABCA1, ABCB1, ABCC1 and ABCC2 were analysed in both cohorts. Results: ABCB1 rs2032582, ABCC1 rs11075290, and ABCC2 rs2273697 modified the associations between maternal fish intake and cord blood mercury concentrations. The overall interaction coefficient between rs2032582 and log2-transformed fish intake was negative for carriers of GT (beta = -0.29, 95%CI -0.47, -0.12) and TT (beta = -0.49, 95%CI -0.71, -0.26) versus GG, meaning that for a doubling in fish intake of the mothers, children with the rs2032582 GG genotype accumulated 35% more mercury than children with TT. For rs11075290, the interaction coefficient was negative for carriers of TC (beta = -0.12, 95%CI -0.33, 0.09), and TT (beta = -0.28, 95%CI -0.51, -0.06) versus CC. For rs2273697, the interaction coefficient was positive when combining GA+AA (beta = 0.16, 95%CI 0.01, 0.32) versus GG. Conclusion: The ABC transporters appear to play a role in accumulation of MeHg during early development.	[Llop, Sabrina; Ballester, Ferran; Murcia, Mario] FISABIO, Fdn Promot Hlth & Biomed Res Valencian Reg, Valencia, Spain; [Llop, Sabrina; Ballester, Ferran; Murcia, Mario; Rebagliato, Marisa; Bustamante, Mariona; Sunyer, Jordi] Spanish Consortium Res Epidemiol & Publ Hlth CIBE, Madrid, Spain; [Engstrom, Karin; Franforte, Elisa; Alhamdow, Ayman; Broberg, Karin] Lund Univ, Div Occupat & Environm Med, Lund, Sweden; [Ballester, Ferran] Univ Valencia, Sch Nursing, Valencia, Spain; [Pisa, Federica; Barbone, Fabio] Univ Udine, Unit Hyg & Epidemiol, I-33100 Udine, Italy; [Tratnik, Janja Snoj; Mazej, Datja; Horvat, Milena] Jozef Stefan Inst, Dept Environm Sci, Ljubljana, Slovenia; [Rebagliato, Marisa] Jaume I Univ, Dept Med, Castellon de La Plana, Spain; [Bustamante, Mariona; Sunyer, Jordi] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Bustamante, Mariona; Sunyer, Jordi] Hosp del Mar Res Inst IMIM, Barcelona, Spain; [Bustamante, Mariona] Ctr Genom Regulat CRG, Barcelona, Spain; [Sunyer, Jordi] Pompeu Fabra Univ UPF, Barcelona, Spain; [Sofianou-Katsoulis, Aikaterini; Prasouli, Alexia; Antonopoulou, Eleni; Antoniadou, Ioanna; Nakou, Sheena] Inst Child Hlth, Dept Social & Dev Paediat, Athens, Greece; [Broberg, Karin] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden	CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Lund University; University of Valencia; University of Udine; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Universitat Jaume I; Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Karolinska Institutet	Broberg, K (corresponding author), Lund Univ, Div Occupat & Environm Med, Lund, Sweden.	karin.broberg@ki.se	Sunyer, Jordi/G-6909-2014; Murcia, Mario/B-5477-2019; Bustamante, Mariona/M-7277-2015; Barbone, Fabio/K-1755-2014; Llop, Sabrina/L-2122-2015; Bustamante, Mariona/ABB-9142-2021; Rebagliato, Marisa/L-6116-2018	Sunyer, Jordi/0000-0002-2602-4110; Murcia, Mario/0000-0001-6996-1158; Bustamante, Mariona/0000-0003-0127-2860; Barbone, Fabio/0000-0001-8795-9959; Llop, Sabrina/0000-0002-6784-4211; Bustamante, Mariona/0000-0003-0127-2860; Rebagliato, Marisa/0000-0001-5825-0190; Pisa, Federica Edith/0000-0003-0459-2616; Barbone, Fabio/0000-0003-1337-5111; Broberg, Karin/0000-0002-5862-468X	European Union; Swedish Research Council for Health, Working Life and Welfare; Swedish Research Council FORMAS; Instituto de Salud Carlos III (Red INMA) [G03/176, CB06/02/0031]; UE [282957, HEALTH.2010.2.4.5-1]; Spanish Ministry of Health (FIS-FEDER) [03/1615, 04/1509, 04/1112, 04/1931, 05/1079, 05/1052, 06/1213, 07/0314, 09/02647, 11/02591, 04/1436, 04/2018, 09/02311, 06/0867, 08/1151, 11/02038, CP11/00178]; Conselleria de Sanitat Generalitat Valenciana, Generalitat de Catalunya (CIRIT) [1999SGR 00241]; Fundacio La marato de TV3 [090430]; European Union [NEWGENERIS FP6-2003-Food-3-A-016320]; ARRS [P1-0143]	European Union(European Commission); Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas); Instituto de Salud Carlos III (Red INMA)(Instituto de Salud Carlos III); UE; Spanish Ministry of Health (FIS-FEDER)(Instituto de Salud Carlos IIISpanish GovernmentEuropean Commission); Conselleria de Sanitat Generalitat Valenciana, Generalitat de Catalunya (CIRIT); Fundacio La marato de TV3; European Union(European Commission); ARRS(Slovenian Research Agency - Slovenia)	This study was funded by The European Union 6th and 7th framework projects PHIME NEWGENERIS, the Swedish Research Council for Health, Working Life and Welfare, the Swedish Research Council FORMAS. The INMA study was funded by grants from the Instituto de Salud Carlos III (Red INMA G03/176 and CB06/02/0031), UE (FP7-ENV-2011 DENAMIC cod 282957 and HEALTH.2010.2.4.5-1), Spanish Ministry of Health (FIS-FEDER 03/1615, 04/1509, 04/1112, 04/1931, 05/1079, 05/1052, 06/1213, 07/0314, 09/02647, 11/02591, 04/1436, 04/2018, 09/02311, 06/0867, 08/1151, 11/02038, CP11/00178), Conselleria de Sanitat Generalitat Valenciana, Generalitat de Catalunya (CIRIT 1999SGR 00241), Fundacio La marato de TV3 (090430) and European Union Sixth Framework Project (NEWGENERIS FP6-2003-Food-3-A-016320). National funding for the PHIME project in Slovenia was provided by the programme ARRS P1-0143. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballatori N, 2002, ENVIRON HEALTH PERSP, V110, P689, DOI 10.1289/ehp.02110s5689; Bjornberg KA, 2003, ENVIRON HEALTH PERSP, V111, P637, DOI [10.1289/ehp.5618, 10.1289/ehp.111-1241457]; Bridges CC, 2005, TOXICOL APPL PHARM, V204, P274, DOI 10.1016/j.taap.2004.09.007; Bridges CC, 2011, TOXICOL APPL PHARM, V251, P50, DOI 10.1016/j.taap.2010.11.015; Custodio HM, 2005, ARCH ENVIRON HEALTH, V60, P17, DOI 10.3200/AEOH.60.1.17-23; Engstrom K, 2013, ENVIRON HEALTH PERSP, V121, P85, DOI 10.1289/ehp.1204951; Engstrom K, 2011, ENVIRON HEALTH PERSP, V119, P182, DOI 10.1289/ehp.1002471; Engstrom KS, 2008, ENVIRON HEALTH PERSP, V116, P734, DOI 10.1289/ehp.10804; Gundacker C, 2010, MUTAT RES-REV MUTAT, V705, P130, DOI 10.1016/j.mrrev.2010.06.003; Guxens M, 2012, INT J EPIDEMIOL, V41, P930, DOI 10.1093/ije/dyr054; Harari R, 2012, TOXICOL LETT, V213, P75, DOI 10.1016/j.toxlet.2011.09.006; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hirrlinger J, 2005, METHOD ENZYMOL, V400, P395, DOI 10.1016/S0076-6879(05)00023-6; Lee BE, 2010, ENVIRON HEALTH PERSP, V118, P437, DOI 10.1289/ehp.0900731; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Liu J, 2003, TOXICOL SCI, V74, P174, DOI 10.1093/toxsci/kfg091; Liu J, 2002, TOXICOLOGY, V170, P55, DOI 10.1016/S0300-483X(01)00532-7; Miklavcic A, 2013, ENVIRON RES, V120, P7, DOI 10.1016/j.envres.2012.08.010; Ni ZL, 2011, CURR PHARM BIOTECHNO, V12, P674, DOI 10.2174/138920111795164057; Parks JM, 2013, SCIENCE, V339, P1332, DOI 10.1126/science.1230667; Ramon R, 2011, ENVIRON INT, V37, P597, DOI 10.1016/j.envint.2010.12.004; Rentschler G, 2013, ENVIRON HEALTH PERSP, V121, P467, DOI 10.1289/ehp.1205672; Scinicariello F, 2007, ENVIRON HEALTH PERSP, V115, P35, DOI 10.1289/ehp.9448; Steuerwald U, 2000, J PEDIATR-US, V136, P599, DOI 10.1067/mpd.2000.102774; Thorisson GA, 2005, GENOME RES, V15, P1592, DOI 10.1101/gr.4413105; Toyama T, 2011, ENVIRON HEALTH PERSP, V119, P1117, DOI 10.1289/ehp.1003123; Vahakangas K, 2009, BRIT J PHARMACOL, V158, P665, DOI 10.1111/j.1476-5381.2009.00336.x; Valent F, 2013, J EPIDEMIOL, V23, P146, DOI 10.2188/jea.JE20120030; Welch AA, 2002, PUBLIC HEALTH NUTR, V5, P1273, DOI 10.1079/PHN2002404; WHO (World Health Organization), 2007, HLTH RISKS HEAV MET; World Health Organization (WHO), 2010, CHILDR EXP MERC COMP	31	33	33	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97172	10.1371/journal.pone.0097172	http://dx.doi.org/10.1371/journal.pone.0097172			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831289	Green Published, Green Submitted, gold			2022-12-27	WOS:000336789500038
J	Zhu, LJ; Liu, MY; Li, H; Liu, X; Chen, C; Han, Z; Wu, HY; Jing, X; Zhou, HH; Suh, H; Zhu, DY; Zhou, QG				Zhu, Li-Juan; Liu, Meng-Ying; Li, Huan; Liu, Xiao; Chen, Chen; Han, Zhou; Wu, Hai-Yin; Jing, Xing; Zhou, Hai-Hui; Suh, Hoonkyo; Zhu, Dong-Ya; Zhou, Qi-Gang			The Different Roles of Glucocorticoids in the Hippocampus and Hypothalamus in Chronic Stress-Induced HPA Axis Hyperactivity	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; MAJOR DEPRESSION; NEUROGENESIS; PHYSIOLOGY; NEUROBIOLOGY; MODULATION; HEALTH	Hypothalamus-pituitary-adrenal (HPA) hyperactivity is observed in many patients suffering from depression and the mechanism underling the dysfunction of HPA axis is not well understood. Chronic stress has a causal relationship with the hyperactivity of HPA axis. Stress induces the over-synthesis of glucocorticoids, which will arrive at all the body containing the brain. It is still complicated whether glucocorticoids account for chronic stress-induced HPA axis hyperactivity and in which part of the brain the glucocorticoids account for chronic stress-induced HPA axis hyperactivity. Here, we demonstrated that glucocorticoids were indispensable and sufficient for chronic stress-induced hyperactivity of HPA axis. Although acute glucocorticoids elevation in the hippocampus and hypothalamus exerted a negative regulation of HPA axis, we found that chronic glucocorticoids elevation in the hippocampus but not in the hypothalamus accounted for chronic stress-induced hyperactivity of HPA axis. Chronic glucocorticoids exposure in the hypothalamus still exerted a negative regulation of HPA axis activity. More importantly, we found mineralocorticoid receptor (MR) - neuronal nitric oxide synthesis enzyme (nNOS) - nitric oxide (NO) pathway mediated the different roles of glucocorticoids in the hippocampus and hypothalamus in regulating HPA axis activity. This study suggests that the glucocorticoids in the hippocampus play an important role in the development of HPA axis hyperactivity and the glucocorticoids in the hypothalamus can't induce hyperactivity of HPA axis, revealing new insights into understanding the mechanism of depression.	[Zhu, Li-Juan; Liu, Meng-Ying; Chen, Chen; Han, Zhou; Wu, Hai-Yin; Zhou, Hai-Hui; Zhu, Dong-Ya; Zhou, Qi-Gang] Nanjing Med Univ, Dept Pharmacol, Coll Pharm, Nanjing, Jiangsu, Peoples R China; [Li, Huan; Liu, Xiao] Nanjing Univ Chinese Med, Coll Pharm, Nanjing, Jiangsu, Peoples R China; [Suh, Hoonkyo; Zhou, Qi-Gang] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44106 USA; [Zhu, Li-Juan] Coochow Univ, Inst Neurosci, Suzhou, Peoples R China; [Jing, Xing] Nanjing Med Univ, Suzhou Hosp, Suzhou, Peoples R China; [Li, Huan] Temasek Polytech, Sch Appl Sci, Singapore, Singapore	Nanjing Medical University; Nanjing University of Chinese Medicine; Cleveland Clinic Foundation; Nanjing Medical University	Zhu, DY (corresponding author), Nanjing Med Univ, Dept Pharmacol, Coll Pharm, Nanjing, Jiangsu, Peoples R China.	dyzhu@njmu.edu.cn; qigangzhou@gmail.com		Suh, Hoonkyo/0000-0002-4227-2982	National Natural Science Foundation of China [81000586, 81370033]; Natural Science Foundation of Jiangsu Province [10KJB31008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by grants from National Natural Science Foundation of China (81000586 and 81370033 to QG Zhou) and Natural Science Foundation of Jiangsu Province (10KJB31008 to QG Zhou). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolomucci A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004265; Belmaker RH, 2009, NEW ENGL J MED, V358, P1855; Brown ES, 1999, NEUROPSYCHOPHARMACOL, V21, P474, DOI 10.1016/S0893-133X(99)00054-8; Chen JJ, 2004, DEV BIOL, V269, P165, DOI 10.1016/j.ydbio.2004.01.024; Conrad C D, 2001, Stress, V4, P305; Coryell W, 2006, PSYCHIAT RES, V142, P99, DOI 10.1016/j.psychres.2005.08.009; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; Grippo AJ, 2005, PSYCHOPHARMACOLOGY, V179, P769, DOI 10.1007/s00213-004-2103-4; Guix FX, 2005, PROG NEUROBIOL, V76, P126, DOI 10.1016/j.pneurobio.2005.06.001; Herman JP, 2008, PROG BRAIN RES, V170, P353, DOI 10.1016/S0079-6123(08)00429-9; Jankord R, 2008, ANN NY ACAD SCI, V1148, P64, DOI 10.1196/annals.1410.012; Joels M, 2011, PSYCHONEUROENDOCRINO, V36, P406, DOI 10.1016/j.psyneuen.2010.03.004; Johnson SA, 2006, BEHAV BRAIN RES, V168, P280, DOI 10.1016/j.bbr.2005.11.019; KATHOL RG, 1989, AM J PSYCHIAT, V146, P311; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Packer MA, 2003, P NATL ACAD SCI USA, V100, P9566, DOI 10.1073/pnas.1633579100; Pariante CM, 2008, TRENDS NEUROSCI, V31, P464, DOI 10.1016/j.tins.2008.06.006; RIVIER C, 1983, NATURE, V305, P325, DOI 10.1038/305325a0; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sapolsky RM, 1996, SCIENCE, V273, P749, DOI 10.1126/science.273.5276.749; Schimmer B, 1996, GOODMAN GILMANS PHAR, P1459; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Yang C, 2006, J NEUROSCI, V26, P7116, DOI 10.1523/JNEUROSCI.0672-06.2006; Zhou QG, 2007, J NEUROCHEM, V103, P1843, DOI 10.1111/j.1471-4159.2007.04914.x; Zhou QG, 2011, J NEUROSCI, V31, P7579, DOI 10.1523/JNEUROSCI.0004-11.2011; Zhu XJ, 2006, NEUROSCIENCE, V141, P827, DOI 10.1016/j.neuroscience.2006.04.032	30	53	56	8	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97689	10.1371/journal.pone.0097689	http://dx.doi.org/10.1371/journal.pone.0097689			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831808	gold, Green Published, Green Submitted			2022-12-27	WOS:000336789500102
J	Chang, CW; Lai, YS; Lamb, LS; Townes, TM				Chang, Chia-Wei; Lai, Yi-Shin; Lamb, Lawrence S., Jr.; Townes, Tim M.			Broad T-Cell Receptor Repertoire in T-Lymphocytes Derived from Human Induced Pluripotent Stem Cells	PLOS ONE			English	Article							HEMATOPOIETIC DIFFERENTIATION; STROMAL CELLS; FETAL THYMUS; HUMAN ES; GENERATION; FIBROBLASTS; COMMITMENT; ACTIVATION; PRECURSORS; EXPRESSION	Human induced pluripotent stem cells (hiPSCs) have enormous potential for the treatment of inherited and acquired disorders. Recently, antigen-specific T lymphocytes derived from hiPSCs have been reported. However, T lymphocyte populations with broad T cell receptor (TCR) diversity have not been generated. We report that hiPSCs derived from skin biopsy are capable of producing T lymphocyte populations with a broad TCR repertoire. In vitro T cell differentiation follows a similar developmental program as observed in vivo, indicated by sequential expression of CD7, intracellular CD3 and surface CD3. The gamma delta TCR locus is rearranged first and is followed by rearrangement of the alpha beta locus. Both gamma delta and alpha beta T cells display a diverse TCR repertoire. Upon activation, the cells express CD25, CD69, cytokines (TNF-alpha, IFN-gamma, IL-2) and cytolytic proteins (Perforin and Granzyme-B). These results suggest that most, if not all, mechanisms required to generate functional T cells with a broad TCR repertoire are intact in our in vitro differentiation protocol. These data provide a foundation for production of patient-specific T cells for the treatment of acquired or inherited immune disorders and for cancer immunotherapy.	[Chang, Chia-Wei; Lai, Yi-Shin; Townes, Tim M.] Univ Alabama Birmingham, Sch Med, Dept Biochem & Mol Genet, Birmingham, AL 35205 USA; [Chang, Chia-Wei; Lai, Yi-Shin; Townes, Tim M.] Univ Alabama Birmingham, Sch Dent, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Lamb, Lawrence S., Jr.] Univ Alabama Birmingham, Sch Med, Dept Med, Birmingham, AL USA; [Lamb, Lawrence S., Jr.] Univ Alabama Birmingham, Sch Dent, Dept Med, Birmingham, AL 35294 USA; [Lamb, Lawrence S., Jr.] Univ Alabama Birmingham, Sch Med, Cell Therapy Lab, Birmingham, AL USA; [Lamb, Lawrence S., Jr.] Univ Alabama Birmingham, Sch Dent, Cell Therapy Lab, Birmingham, AL 35294 USA; [Chang, Chia-Wei; Lai, Yi-Shin; Townes, Tim M.] Univ Alabama Birmingham, Sch Med, UAB Stem Cell Inst, Birmingham, AL USA; [Chang, Chia-Wei; Lai, Yi-Shin; Townes, Tim M.] Univ Alabama Birmingham, Sch Dent, UAB Stem Cell Inst, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Townes, TM (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Biochem & Mol Genet, Birmingham, AL 35205 USA.	ttownes@uab.edu		Lamb, Lawrence/0000-0001-7180-0994	NIH [R01HL057619]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057619] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH R01HL057619. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliahmad P, 2008, J EXP MED, V205, P245, DOI 10.1084/jem.20071944; BARCENA A, 1993, BLOOD, V82, P3401; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Beck RC, 2003, AM J CLIN PATHOL, V120, P785, DOI 10.1309/835B04QXGNNFNRJU; Blom B, 2006, ANNU REV IMMUNOL, V24, P287, DOI 10.1146/annurev.immunol.24.021605.090612; Boria I, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-50; Brentjens RJ, 2003, NAT MED, V9, P279, DOI 10.1038/nm827; Carpenter AC, 2010, NAT IMMUNOL, V11, P666, DOI 10.1038/ni.1887; Chang CW, 2009, STEM CELLS, V27, P1042, DOI 10.1002/stem.39; Grigoriadis AE, 2010, BLOOD, V115, P2769, DOI 10.1182/blood-2009-07-234690; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; HAYNES BF, 1995, J EXP MED, V181, P1445, DOI 10.1084/jem.181.4.1445; Joachims ML, 2006, J IMMUNOL, V176, P1543, DOI 10.4049/jimmunol.176.3.1543; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Kennedy M, 2012, CELL REP, V2, P1722, DOI 10.1016/j.celrep.2012.11.003; KRANGEL MS, 1990, J EXP MED, V172, P847, DOI 10.1084/jem.172.3.847; Ledran MH, 2008, CELL STEM CELL, V3, P85, DOI 10.1016/j.stem.2008.06.001; Lei FY, 2009, CELL IMMUNOL, V260, P1, DOI 10.1016/j.cellimm.2009.09.005; Madsen L, 1999, P NATL ACAD SCI USA, V96, P10338, DOI 10.1073/pnas.96.18.10338; Mohtashami M, 2010, J IMMUNOL, V185, P867, DOI 10.4049/jimmunol.1000782; Nishimura T, 2013, CELL STEM CELL, V12, P114, DOI 10.1016/j.stem.2012.11.002; Ohnuki M., 2009, CURR PROTOC STEM CEL, DOI DOI 10.1002/9780470151808.SC04A02S9]; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Ramsdell F., 2006, CURRENT PROTOCOLS IM; Rothenberg EV, 2005, ANNU REV IMMUNOL, V23, P601, DOI 10.1146/annurev.immunol.23.021704.115737; Rothenberg EV, 2002, SEMIN IMMUNOL, V14, P431, DOI 10.1016/S1044532302000787; Schmitt TM, 2004, NAT IMMUNOL, V5, P410, DOI 10.1038/ni1055; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takayama N, 2008, BLOOD, V111, P5298, DOI 10.1182/blood-2007-10-117622; Timmermans F, 2009, J IMMUNOL, V182, P6879, DOI 10.4049/jimmunol.0803670; Vizcardo R, 2013, CELL STEM CELL, V12, P31, DOI 10.1016/j.stem.2012.12.006; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Wu LC, 2006, BLOOD, V108, P1183, DOI 10.1182/blood-2006-02-004812; YEOMAN H, 1993, P NATL ACAD SCI USA, V90, P10778, DOI 10.1073/pnas.90.22.10778; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zambidis ET, 2005, BLOOD, V106, P860, DOI 10.1182/blood-2004-11-4522	40	19	23	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97335	10.1371/journal.pone.0097335	http://dx.doi.org/10.1371/journal.pone.0097335			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828440	gold, Green Published, Green Submitted			2022-12-27	WOS:000336857400080
J	Heng, YJJ; Pennell, CE; Chua, HN; Perkins, JE; Lye, SJ				Heng, Yujing Jan; Pennell, Craig Edward; Chua, Hon Nian; Perkins, Jonathan Edward; Lye, Stephen James			Whole Blood Gene Expression Profile Associated with Spontaneous Preterm Birth in Women with Threatened Preterm Labor	PLOS ONE			English	Article							PROTEIN-COUPLED-RECEPTOR; CERVICOVAGINAL FETAL FIBRONECTIN; 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE; ANTENATAL CORTICOSTEROIDS; LATE PREGNANCY; IMMUNOHISTOCHEMICAL LOCALIZATION; MULTIPLE COURSES; HUMAN TERM; ACTIVATION; INFLAMMATION	Threatened preterm labor (TPTL) is defined as persistent premature uterine contractions between 20 and 37 weeks of gestation and is the most common condition that requires hospitalization during pregnancy. Most of these TPTL women continue their pregnancies to term while only an estimated 5% will deliver a premature baby within ten days. The aim of this work was to study differential whole blood gene expression associated with spontaneous preterm birth (sPTB) within 48 hours of hospital admission. Peripheral blood was collected at point of hospital admission from 154 women with TPTL before any medical treatment. Microarrays were utilized to investigate differential whole blood gene expression between TPTL women who did (n = 48) or did not have a sPTB (n = 106) within 48 hours of admission. Total leukocyte and neutrophil counts were significantly higher (35% and 41% respectively) in women who had sPTB than women who did not deliver within 48 hours (p<0.001). Fetal fibronectin (fFN) test was performed on 62 women. There was no difference in the urine, vaginal and placental microbiology and histopathology reports between the two groups of women. There were 469 significant differentially expressed genes (FDR<0.05); 28 differentially expressed genes were chosen for microarray validation using qRT-PCR and 20 out of 28 genes were successfully validated (p<0.05). An optimal random forest classifier model to predict sPTB was achieved using the top nine differentially expressed genes coupled with peripheral clinical blood data (sensitivity 70.8%, specificity 75.5%). These differentially expressed genes may further elucidate the underlying mechanisms of sPTB and pave the way for future systems biology studies to predict sPTB.	[Heng, Yujing Jan; Perkins, Jonathan Edward; Lye, Stephen James] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Pennell, Craig Edward] Univ Western Australia, Sch Womens & Infants Hlth, Crawley, WA, Australia; [Chua, Hon Nian] Agcy Sci Technol & Res, Inst Infocomm Res, Singapore, Singapore	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Western Australia; Agency for Science Technology & Research (A*STAR); A*STAR - Institute for Infocomm Research (I2R)	Heng, YJJ (corresponding author), Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada.	heng@lunenfeld.ca	Lye, Stephen J/E-7269-2013; Pennell, Craig/ABD-6902-2020	Lye, Stephen J/0000-0002-3305-4406; Pennell, Craig/0000-0002-0937-6165; Heng, Yu Jing Jan/0000-0002-8930-817X	Canadian Institutes of Health Research fellowship; March of Dimes [21-Fy04-171, 21-Fy10-204]	Canadian Institutes of Health Research fellowship(Canadian Institutes of Health Research (CIHR)); March of Dimes(March of Dimes)	Dr Heng is a Canadian Institutes of Health Research fellowship recipient. This study was funded by March of Dimes (#21-Fy04-171 and #21-Fy10-204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asztalos EV, 2010, PEDIATRICS, V126, pE1045, DOI 10.1542/peds.2010-0857; Baumgart F, 2010, BBA-BIOMEMBRANES, V1798, P592, DOI 10.1016/j.bbamem.2010.01.002; Berriz GF, 2009, BIOINFORMATICS, V25, P3043, DOI 10.1093/bioinformatics/btp498; BERRY SM, 1995, AM J OBSTET GYNECOL, V173, P1315, DOI 10.1016/0002-9378(95)91378-5; Bouchard C, 2007, GLIA, V55, P790, DOI 10.1002/glia.20506; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; BRUMMER HC, 1972, PROSTAGL, V2, P185, DOI 10.1016/S0090-6980(72)80022-4; Campbell MK, 2005, J CLIN EPIDEMIOL, V58, P304, DOI 10.1016/j.jclinepi.2004.06.015; Canadian Institute for Health Information, 2009, TOO EARL TOO SMALL P; Chaiworapongsa T, 2013, J PERINAT MED, V41, P485, DOI 10.1515/jpm-2013-0082; Challis JR, 2009, REPROD SCI, V16, P206, DOI 10.1177/1933719108329095; Charych EI, 2010, J NEUROSCI, V30, P9027, DOI 10.1523/JNEUROSCI.1635-10.2010; Chim SSC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034328; COPPER RL, 1990, AM J OBSTET GYNECOL, V162, P748, DOI 10.1016/0002-9378(90)91000-3; Crowley P, 2003, BJOG-INT J OBSTET GY, V110, P77, DOI 10.1016/S1470-0328(03)00041-7; Crudo A, 2012, ENDOCRINOLOGY, V153, P3269, DOI 10.1210/en.2011-2160; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dallas PB, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-59; DeFranco EA, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.12.015; DELGADO I, 1994, GYNECOL OBSTET INVES, V38, P227, DOI 10.1159/000292487; EFRATI P, 1964, OBSTET GYNECOL, V23, P429; Gervasi MT, 2001, AM J OBSTET GYNECOL, V185, P1124, DOI 10.1067/mob.2001.117681; Giannoulias D, 2002, J CLIN ENDOCR METAB, V87, P1345, DOI 10.1210/jc.87.3.1345; Gillaux C, 2011, J IMMUNOL, V187, P2766, DOI 10.4049/jimmunol.1100217; Goffinet F, 2005, BJOG-INT J OBSTET GY, V112, P38, DOI 10.1111/j.1471-0528.2005.00583.x; Goldenberg RL, 2002, OBSTET GYNECOL, V100, P1020, DOI 10.1016/S0029-7844(02)02212-3; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gomez-Lopez N, 2013, AM J REPROD IMMUNOL, V69, P212, DOI 10.1111/aji.12074; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Hamilton S, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095505; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Heng YJJ, 2012, REPROD SCI, V19, P55, DOI 10.1177/1933719111413299; Honest H, 2002, BMJ-BRIT MED J, V325, P301, DOI 10.1136/bmj.325.7359.301; Hua RY, 2013, AM J REPROD IMMUNOL, V69, P21, DOI 10.1111/aji.12025; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iams J. D., 2004, MATERNAL FETAL MED P; Institute of Medicine (US), 2007, PRETERM BIRTH CAUSES; Johnson RF, 2004, J CLIN ENDOCR METAB, V89, P5639, DOI 10.1210/jc.2004-0540; Kallapur SG, 2013, J IMMUNOL, V191, P1102, DOI 10.4049/jimmunol.1300270; KARIM SMMM, 1968, BRIT MED J, V4, P618, DOI 10.1136/bmj.4.5631.618; KATZ M, 1990, AM J OBSTET GYNECOL, V162, P1150, DOI 10.1016/0002-9378(90)90004-Q; Kaukola T, 2011, CYTOKINE, V54, P85, DOI 10.1016/j.cyto.2011.01.002; Kawakami Y, 2013, J NUTRIGENET NUTRIGE, V6, P154, DOI 10.1159/000354247; Keelan JA, 1999, AM J OBSTET GYNECOL, V181, P1530, DOI 10.1016/S0002-9378(99)70400-X; Korycka J, 2012, EUR J CELL BIOL, V91, P107, DOI 10.1016/j.ejcb.2011.09.013; Kramer BW, 2009, INNATE IMMUN-LONDON, V15, P101, DOI 10.1177/1753425908100455; Krupa FG, 2006, INT J GYNECOL OBSTET, V94, P5, DOI 10.1016/j.ijgo.2006.03.022; Larma JD, 2012, CLIN OBSTET GYNECOL, V55, P324, DOI 10.1097/GRF.0b013e3182487e96; Lartey J, 2009, REPRODUCTION, V138, P407, DOI 10.1530/REP-09-0160; Leitich H, 1999, AM J OBSTET GYNECOL, V180, P1169, DOI 10.1016/S0002-9378(99)70612-5; Lim Gillian, 2009, Healthc Q, V12, P20; Lim R, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105163; LOCKWOOD CJ, 1991, NEW ENGL J MED, V325, P669, DOI 10.1056/NEJM199109053251001; Lucovnik M, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.06.046; Luppi P, 2002, J LEUKOCYTE BIOL, V72, P874; Lyndon A, 2006, J PERINAT NEONAT NUR, V20, P82, DOI 10.1097/00005237-200601000-00024; Mangham LJ, 2009, PEDIATRICS, V123, pE312, DOI 10.1542/peds.2008-1827; Markovic D, 2013, J CLIN ENDOCR METAB, V98, P2864, DOI 10.1210/jc.2013-1094; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; McPheeters ML, 2005, AM J OBSTET GYNECOL, V192, P1325, DOI 10.1016/j.ajog.2004.12.055; Mitchell JA, 2004, AM J PHYSIOL-ENDOC M, V287, pE439, DOI 10.1152/ajpendo.00275.2003; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Murphy KE, 2012, OBSTET GYNECOL, V119, P917, DOI 10.1097/AOG.0b013e31825189dc; Murphy KE, 2011, J OBSTET GYNAECOL CA, V33, P909, DOI 10.1016/S1701-2163(16)35016-2; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Nicholson WK, 2000, OBSTET GYNECOL, V96, P95, DOI 10.1016/S0029-7844(00)00863-2; Orsi NM, 2008, J NEUROENDOCRINOL, V20, P462, DOI 10.1111/j.1365-2826.2008.01668.x; Osman I, 2003, MOL HUM REPROD, V9, P41, DOI 10.1093/molehr/gag001; Patni S, 2009, BIOL REPROD, V80, P243, DOI 10.1095/biolreprod.108.069252; Petrou S, 2005, BJOG-INT J OBSTET GY, V112, P10, DOI 10.1111/j.1471-0528.2005.00577.x; ROMERO R, 1989, AM J OBSTET GYNECOL, V160, P1117, DOI 10.1016/0002-9378(89)90172-5; Sabra S, 2011, REPROD SCI, V18; Sabra S, 2012, REPROD SCI, V19, p119A; SANGHA RK, 1994, J CLIN ENDOCR METAB, V78, P982, DOI 10.1210/jc.78.4.982; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Shynlova O, 2009, REPROD SCI, V16, p222A; SIEGEL I, 1981, DIAGN GYNECOL OBSTET, V3, P123; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Tamiya T, 2011, ARTERIOSCL THROM VAS, V31, P980, DOI 10.1161/ATVBAHA.110.207464; Thomson AJ, 1999, HUM REPROD, V14, P229, DOI 10.1093/humrep/14.1.229; Torbe A, 2007, EUR CYTOKINE NETW, V18, P102, DOI 10.1684/ecn.2007.0092; Tornblom SA, 2004, J CLIN ENDOCR METAB, V89, P2909, DOI 10.1210/jc.2003-031149; Unal ER, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.01.002; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; vanMeir CA, 1997, J CLIN ENDOCR METAB, V82, P969, DOI 10.1210/jc.82.3.969; Vartanian K, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-2; Venkataraman C, 2005, IMMUNOL LETT, V101, P144, DOI 10.1016/j.imlet.2005.05.010; Versleijen MWJ, 2009, CLIN NUTR, V28, P59, DOI 10.1016/j.clnu.2008.09.001; Wang JH, 2006, J BIOL CHEM, V281, P34457, DOI 10.1074/jbc.M608019200; Ward RM, 2003, BJOG-INT J OBSTET GY, V110, P8, DOI 10.1016/S1470-0328(03)00012-0; Welsh T, 2012, REPROD SCI, V19, P1099, DOI 10.1177/1933719112442247; Yellon SM, 2003, J SOC GYNECOL INVEST, V10, P323, DOI 10.1016/S1071-5576(03)00116-3; Yousefi S, 2001, J LEUKOCYTE BIOL, V69, P1045; Yuan M, 2009, MOL HUM REPROD, V15, P713, DOI 10.1093/molehr/gap054	94	49	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96901	10.1371/journal.pone.0096901	http://dx.doi.org/10.1371/journal.pone.0096901			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828675	Green Published, gold			2022-12-27	WOS:000336857400044
J	Huang, Y; Liao, HW; Zhang, Y; Yuan, RF; Wang, FM; Gao, YT; Wang, P; Du, Z				Huang, Yong; Liao, Huaiwei; Zhang, Yong; Yuan, Rongfa; Wang, Fengmei; Gao, Yingtang; Wang, Peng; Du, Zhi			Prognostic Value of Tumor-Infiltrating FoxP3(+) T Cells in Gastrointestinal Cancers: A Meta Analysis	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; GASTRIC-CANCER; COLORECTAL-CANCER; POOR-PROGNOSIS; ADVERSE PROGNOSIS; CLINICAL IMPACT; SURVIVAL; RECURRENCE; EXPRESSION; INFLAMMATION	Purpose: Tumor-infiltrating FoxP3(+) T cells have been reported in various human tumors, which impaired cell-mediated immunity and promoted disease progression. However, its prognostic value for survival in patients with different gastrointestinal cancers [hepatocellular carcinoma (HCC), colorectal cancer (CRC), gastric cancer (GC)] remains controversial. Methods: Relevant literature was searched using PubMed, Embase, Cochrane, Ovid Medline and Chinese wanfang databases. A meta-analysis was conducted to estimate pooled survival and recurrence ratios. The odds ratio (OR) and 95% confidence intervals (CI) were calculated employing fixed-or random-effects models depending on the heterogeneity of the included trials. Results: For HCC and GC, the overall survival at 1, 3 and 5-year of high FoxP3+ T cells infiltration patients were lower than low FoxP3(+) T cells infiltration patients (P<0.05). The recurrences at 1, 3 and 5-year of high FoxP3+ T cells infiltration patients were higher than low FoxP3(+) T cells infiltration patients (P<0.001). But for CRC, the overall survival at 1, 3 and 5-year of high FoxP3(+) T cells infiltration patients were higher than low FoxP3(+) T cells infiltration patients (P<0.001). There were no differences in 1, 3 and 5-year recurrences between high and low FoxP3(+) T cells infiltration patients (P>0.05). Conclusions: Our findings suggested that tumor-infiltrating FoxP3(+) T cells were a factor for a poor prognosis for HCC and GC, but a good prognosis for CRC.	[Huang, Yong; Zhang, Yong] Tianjin Med Univ, Tianjin, Peoples R China; [Huang, Yong; Yuan, Rongfa] Nanchang Univ, Affiliated Hosp 2, Dept Hepatobiliary Surg, Nanchang, Peoples R China; [Liao, Huaiwei] Nanchang Univ, Affiliated Hosp 1, Dept Plast Surg, Nanchang, Peoples R China; [Wang, Fengmei] Third Cent Hosp Tianjin, Dept Gastroenterol & Hepatol, Tianjin, Peoples R China; [Gao, Yingtang; Wang, Peng; Du, Zhi] Third Cent Hosp Tianjin, Inst Hepatobiliary Dis, Key Lab Artificial Cell, Tianjin, Peoples R China	Tianjin Medical University; Nanchang University; Nanchang University	Wang, FM (corresponding author), Third Cent Hosp Tianjin, Dept Gastroenterol & Hepatol, Tianjin, Peoples R China.	wangfengmeitj@gmail.com; zhi-du@163.com	Gao, Yingtang/AGK-4112-2022		Tianjin Science and Technology commission [12ZCZDSY02700, 13JCYBJC22500]	Tianjin Science and Technology commission	This work was supported by Tianjin Science and Technology commission funded key project (No. 12ZCZDSY02700, No. 13JCYBJC22500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang KM, 2005, HEPATOLOGY, V41, P700, DOI 10.1002/hep.20678; Chen KJ, 2012, MED ONCOL, V29, P1817, DOI 10.1007/s12032-011-0006-x; Chen KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024671; deLeeuw RJ, 2012, CLIN CANCER RES, V18, P3022, DOI 10.1158/1078-0432.CCR-11-3216; Deng B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063777; Du LT, 2011, CANCER SCI, V102, P1272, DOI 10.1111/j.1349-7006.2011.01951.x; Frey DM, 2010, INT J CANCER, V126, P2635, DOI 10.1002/ijc.24989; Gao Q, 2007, J CLIN ONCOL, V25, P2586, DOI 10.1200/JCO.2006.09.4565; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Haas M, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-65; Han K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068527; Huang Y, 2014, J GASTROEN HEPATOL, V29, P851, DOI 10.1111/jgh.12418; Huang Y, 2012, DIGESTION, V86, P329, DOI 10.1159/000342801; Ishigami S, 2012, CANCER IMMUNOL IMMUN, V61, P1663, DOI 10.1007/s00262-012-1225-5; Kashimura S, 2012, GASTRIC CANCER, V15, P144, DOI 10.1007/s10120-011-0090-9; Kim HI, 2011, J SURG ONCOL, V104, P728, DOI 10.1002/jso.22038; Kim KJ, 2014, HUM PATHOL, V45, P285, DOI 10.1016/j.humpath.2013.09.004; Kim M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053630; Kobayashi N, 2007, CLIN CANCER RES, V13, P902, DOI 10.1158/1078-0432.CCR-06-2363; Kosmaczewska A, 2008, ARCH IMMUNOL THER EX, V56, P181, DOI 10.1007/s00005-008-0018-1; Kryczek I, 2011, J IMMUNOL, V186, P4388, DOI 10.4049/jimmunol.1003251; Ladoire S, 2011, CANCER IMMUNOL IMMUN, V60, P909, DOI 10.1007/s00262-011-1046-y; Lee WS, 2010, CANCER-AM CANCER SOC, V116, P5188, DOI 10.1002/cncr.25293; LI Sheng-ping, 2008, Zhonghua Zhongliu Zazhi, V30, P523; Lin Guo-He, 2010, Chin J Cancer, V29, P403; Lin SZ, 2013, CANCER PREV RES, V6, P594, DOI 10.1158/1940-6207.CAPR-12-0379; Liu JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071930; Lu XM, 2011, J SURG ONCOL, V104, P571, DOI 10.1002/jso.22005; Ma GF, 2014, BRIT J CANCER, V110, P1552, DOI 10.1038/bjc.2014.47; Mei Z, 2014, BRIT J CANCER, V110, P1595, DOI 10.1038/bjc.2014.46; Mizukami Y, 2008, BRIT J CANCER, V98, P148, DOI 10.1038/sj.bjc.6604149; Morse MA, 2008, BLOOD, V112, P610, DOI 10.1182/blood-2008-01-135319; Nosho K, 2010, J PATHOL, V222, P350, DOI 10.1002/path.2774; Perrone G, 2008, EUR J CANCER, V44, P1875, DOI 10.1016/j.ejca.2008.05.017; Powell DJ, 2008, J IMMUNOTHER, V31, P189, DOI 10.1097/CJI.0b013e31815dc0e8; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sasaki A, 2008, EJSO-EUR J SURG ONC, V34, P173, DOI 10.1016/j.ejso.2007.08.008; Shen SL, 2011, CAN J SURG, V54, P89, DOI 10.1503/cjs.028009; Shen ZB, 2010, J CANCER RES CLIN, V136, P1585, DOI 10.1007/s00432-010-0816-9; Shu Ping, 2011, Zhonghua Wei Chang Wai Ke Za Zhi, V14, P368; Sinicrope FA, 2009, GASTROENTEROLOGY, V137, P1270, DOI 10.1053/j.gastro.2009.06.053; Suzuki H, 2013, CLIN IMMUNOL, V146, P26, DOI 10.1016/j.clim.2012.10.007; Suzuki H, 2010, CANCER IMMUNOL IMMUN, V59, P653, DOI 10.1007/s00262-009-0781-9; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Wang B, 2011, ANN SURG ONCOL, V18, P2585, DOI 10.1245/s10434-011-1609-3; Wang FM, 2012, LIVER INT, V32, P644, DOI 10.1111/j.1478-3231.2011.02675.x; Wu H, 2012, J GASTROEN HEPATOL, V27, P1312, DOI 10.1111/j.1440-1746.2012.07130.x; Yoon HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042274; Yoshii M, 2012, BRIT J CANCER, V106, P1668, DOI 10.1038/bjc.2012.141; Zeestraten ECM, 2013, CANCER MICROENVIRON, V6, P31, DOI 10.1007/s12307-011-0071-x; Zhou J, 2009, INT J CANCER, V125, P1640, DOI 10.1002/ijc.24556; Zhou S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074430; Zhou S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073952	55	52	56	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e94376	10.1371/journal.pone.0094376	http://dx.doi.org/10.1371/journal.pone.0094376			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827118	Green Published, Green Submitted, gold			2022-12-27	WOS:000336857400008
J	Kour, A; Boone, AM; Vodkin, LO				Kour, Anupreet; Boone, Anne M.; Vodkin, Lila O.			RNA-Seq Profiling of a Defective Seed Coat Mutation in Glycine max Reveals Differential Expression of Proline-Rich and Other Cell Wall Protein Transcripts	PLOS ONE			English	Article							GENE FAMILY; ARABIDOPSIS; BIOSYNTHESIS; LIGNIN; POLLEN; ACCUMULATE; EXPANSION; THALIANA; CLONING; AUXIN	The plant cell wall performs a number of essential functions including providing shape to many different cell types and serving as a defense against potential pathogens. The net pattern mutation creates breaks in the seed coat of soybean (Glycine max) because of ruptured cell walls. Using RNA-Seq, we examined the seed coat transcriptome from three stages of immature seed development in two pairs of isolines with normal or defective seed coat phenotypes due to the net pattern. The genome-wide comparative study of the transcript profiles of these isolines revealed 364 differentially expressed genes in common between the two varieties that were further divided into different broad functional categories. Genes related to cell wall processes accounted for 19% of the differentially expressed genes in the middle developmental stage of 100200 mg seed weight. Within this class, the cell wall proline-rich and glycine-rich protein genes were highly differentially expressed in both genetic backgrounds. Other genes that showed significant expression changes in each of the isoline pairs at the 100-200 mg seed weight stage were xylem serine proteinase, fasciclin-related genes, auxin and stress response related genes, TRANSPARENT TESTA 1 (TT1) and other transcription factors. The mutant appears to shift the timing of either the increase or decrease in the levels of some of the transcripts. The analysis of these data sets reveals the physiological changes that the seed coat undergoes during the formation of the breaks in the cell wall.	[Kour, Anupreet; Boone, Anne M.; Vodkin, Lila O.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Vodkin, LO (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.	l-vodkin@illinois.edu			United Soybean Board; United States Department of Agriculture (USDA)	United Soybean Board; United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA))	The research was funded by support from the United Soybean Board and the United States Department of Agriculture (USDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERS S, 2010, GENOME BIOL, V11; BAILEY RW, 1978, AM J CLIN NUTR, V31, pS77, DOI 10.1093/ajcn/31.10.S77; Baskin TI, 2005, ANNU REV CELL DEV BI, V21, P203, DOI 10.1146/annurev.cellbio.20.082503.103053; Bewley JD, 2000, BIOCH MOL BIOL PLANT, P988; Chou YH, 2012, PLANT PHYSIOL, V159, P1355, DOI 10.1104/pp.112.199356; CORNER E. J. H., 1951, PHYTOMORPHOLOGY [DELHI], V1, P117; Cosgrove DJ, 1997, P NATL ACAD SCI USA, V94, P6559, DOI 10.1073/pnas.94.12.6559; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; CREELMAN RA, 1992, P NATL ACAD SCI USA, V89, P4938, DOI 10.1073/pnas.89.11.4938; Dafoe NJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-191; DATTA K, 1989, PLANT CELL, V1, P945, DOI 10.1105/tpc.1.9.945; Denness L, 2011, PLANT PHYSIOL, V156, P1364, DOI 10.1104/pp.111.175737; EVANS ML, 1985, CRC CR REV PLANT SCI, V2, P317, DOI 10.1080/07352688509382200; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Gibalova A, 2009, PLANT MOL BIOL, V70, P581, DOI 10.1007/s11103-009-9493-y; Gillman JD, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-155; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Gou JQ, 2010, PLANT CELL, V22, P623, DOI 10.1105/tpc.109.073239; Grant D, 2010, NUCLEIC ACIDS RES, V38, pD843, DOI 10.1093/nar/gkp798; Han YY, 2012, PLANT PHYSIOL BIOCH, V54, P49, DOI 10.1016/j.plaphy.2012.02.007; HONG JC, 1989, PLANT CELL, V1, P937, DOI 10.1105/tpc.1.9.937; HONG JC, 1987, J BIOL CHEM, V262, P8367; HONG JC, 1990, J BIOL CHEM, V265, P2470; Hunt M, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-145; Hussey SG, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-173; Lamport DTA, 2011, METHODS MOL BIOL, V715, P209, DOI 10.1007/978-1-61779-008-9_15; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lasserre E, 2008, PLANT PHYSIOL BIOCH, V46, P1051, DOI 10.1016/j.plaphy.2008.07.003; LINDSTROM JT, 1991, PLANT CELL, V3, P561, DOI 10.1105/tpc.3.6.561; Lois LM, 2000, PLANT J, V22, P503, DOI 10.1046/j.1365-313x.2000.00764.x; MacMillan CP, 2010, PLANT J, V62, P689, DOI 10.1111/j.1365-313X.2010.04181.x; Mangeon A, 2010, PLANT SIGNAL BEHAV, V5, P99, DOI 10.4161/psb.5.2.10336; MARCUS A, 1991, PHYSIOL PLANTARUM, V81, P273; Martel C, 2011, PLANT PHYSIOL, V157, P1568, DOI 10.1104/pp.111.181107; McCarty DR, 1986, MAIZE GEN COOP NEWSL, V60, P61; Miller SS, 1999, ANN BOT-LONDON, V84, P297, DOI 10.1006/anbo.1999.0915; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NICHOLAS CD, 1993, PLANT MOL BIOL, V21, P145, DOI 10.1007/BF00039625; Overvoorde PJ, 2005, PLANT CELL, V17, P3282, DOI 10.1105/tpc.105.036723; Penfield S, 2001, PLANT CELL, V13, P2777, DOI 10.1105/tpc.13.12.2777; Percy JD, 1999, PLANT MOL BIOL, V40, P603, DOI 10.1023/A:1006221115522; Pestana-Calsa MC, 2012, GENET MOL BIOL, V35, P322, DOI 10.1590/S1415-47572012000200013; Preston J, 2004, PLANT J, V40, P979, DOI 10.1111/j.1365-313X.2004.02280.x; Ringli C, 2001, CELL MOL LIFE SCI, V58, P1430, DOI 10.1007/PL00000786; Ritchie SW, 1996, SOYBEAN PLANT DEV; RYSER U, 1992, PLANT CELL, V4, P773, DOI 10.1105/tpc.4.7.773; Sagasser M, 2002, GENE DEV, V16, P138, DOI 10.1101/gad.212702; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHMIDT JS, 1994, PLANT J, V6, P177, DOI 10.1046/j.1365-313X.1994.6020177.x; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; SHOWALTER AM, 1993, PLANT CELL, V5, P9, DOI 10.1105/tpc.5.1.9; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; TODD JJ, 1993, PLANT PHYSIOL, V102, P663, DOI 10.1104/pp.102.2.663; Todd JJ, 1996, PLANT CELL, V8, P687, DOI 10.1105/tpc.8.4.687; Tsukaya H, 2006, J PLANT RES, V119, P1, DOI 10.1007/s10265-005-0254-y; Tuteja JH, 2009, PLANT CELL, V21, P3063, DOI 10.1105/tpc.109.069856; Vorwerk S, 2004, TRENDS PLANT SCI, V9, P203, DOI 10.1016/j.tplants.2004.02.005; WANG CS, 1994, PLANT PHYSIOL, V105, P739, DOI 10.1104/pp.105.2.739; Wang HZ, 2012, MOL PLANT, V5, P297, DOI 10.1093/mp/ssr098; Wang HZ, 2010, P NATL ACAD SCI USA, V107, P22338, DOI 10.1073/pnas.1016436107; Western TL, 2004, PLANT PHYSIOL, V134, P296, DOI 10.1104/pp.103.035519; WILLIAMS LF, 1950, SOYBEANS SOYBEAN PRO, P111; WU HM, 1993, P NATL ACAD SCI USA, V90, P6829, DOI 10.1073/pnas.90.14.6829; Xu J, 2010, PLANT CELL, V22, P91, DOI 10.1105/tpc.109.071803; Yang XY, 2008, J EXP BOT, V59, P3661, DOI 10.1093/jxb/ern214; Zabala G, 2003, GENETICS, V163, P295; Zhao CS, 2000, PLANT PHYSIOL, V123, P1185, DOI 10.1104/pp.123.3.1185; Zhong RQ, 2012, PLANT CELL PHYSIOL, V53, P368, DOI 10.1093/pcp/pcr185; Zhong RQ, 2011, PLANT CELL PHYSIOL, V52, P1856, DOI 10.1093/pcp/pcr123; Zhong RQ, 2008, PLANT CELL, V20, P2763, DOI 10.1105/tpc.108.061325; Zhou JL, 2009, PLANT CELL, V21, P248, DOI 10.1105/tpc.108.063321	71	10	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96342	10.1371/journal.pone.0096342	http://dx.doi.org/10.1371/journal.pone.0096342			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828743	Green Published, gold, Green Submitted			2022-12-27	WOS:000336857400025
J	Sorber, R; Winston, S; Koech, J; Ayuku, D; Hu, LY; Hogan, J; Braitstein, P				Sorber, Rebecca; Winston, Susanna; Koech, Julius; Ayuku, David; Hu, Liangyuan; Hogan, Joseph; Braitstein, Paula			Social and Economic Characteristics of Street Youth by Gender and Level of Street Involvement in Eldoret, Kenya	PLOS ONE			English	Article							SUBSTANCE USE; CHILDREN; INTERVENTIONS; HEALTH	Background: Street-connected youth are a neglected and vulnerable population, particularly in resource-constrained settings. The development of interventions and supports for this population requires insight into how they live. This study describes the social and economic characteristics of a convenience sample of street youth (SY) in Eldoret, Kenya. Methods: Participants were eligible if they were aged 12-21, living in Eldoret, spending days only (part-time), or nights and days on the street (full-time) and able and willing to consent or assent. Data were collected using a standardized interview conducted in English or Kiswahili. Binary dependent variables were having been arrested and/or jailed, and first priority for spending money (food vs. other). Nominal categorical dependent variables included major source of support, and major reason for being street-involved. Multivariable analysis used logistic regression models to examine the association of gender and level of street-involvement with social and economic factors of interest adjusting for age and length of time on the street. Data were analyzed using SAS 9.3. Results: Of the 200 SY enrolled, 41% were female, mean age of 16.3 years; 71% were on the street full-time, and 29% part-time. Compared with part-time SY, full-time SY were more likely to have been arrested (Adjusted Odds Ratio [AOR]: 2.33, 95% Confidence Interval [95%CI]:1.01-5.35), name food as their first spending priority (AOR: 2.57, 95% CI:1.03-6.45), have left home due to violence (AOR: 5.54, 95%CI: 1.67-18.34), and more likely to report friends on the street as a major source of support (AOR: 3.59, 95% CI: 1.01-12.82). Compared with females, males were more likely to have ever been arrested (AOR: 2.66, 95%CI:1.14-6.18), and to have ever been jailed (AOR: 3.22, 95%CI:1.47-7.02). Conclusions: These results suggest a high degree of heterogeneity and vulnerability among SY in this setting. There is an urgent need for interventions taking into consideration these characteristics.	[Sorber, Rebecca; Braitstein, Paula] Indiana Univ, Sch Med, Indianapolis, IN 46204 USA; [Winston, Susanna] Brown Univ, Dept Pediat, Warren Alpert Sch Med, Providence, RI 02912 USA; [Winston, Susanna] Hasbro Youths Hosp, Rhode Isl Hosp, Providence, RI USA; [Koech, Julius; Hogan, Joseph; Braitstein, Paula] AMPATH Consortium, Eldoret, Kenya; [Ayuku, David] Moi Univ, Coll Hlth Sci, Sch Med, Dept Behav Sci, Eldoret, Kenya; [Hu, Liangyuan; Hogan, Joseph] Brown Univ, Dept Biostat, Providence, RI 02912 USA; [Braitstein, Paula] Moi Univ, Sch Med, Dept Med, Coll Hlth Sci, Eldoret, Kenya; [Braitstein, Paula] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Braitstein, Paula] Regenstrief Inst Inc, Indianapolis, IN USA	Indiana University System; Indiana University-Purdue University Indianapolis; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Moi University; Brown University; Moi University; University of Toronto; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc	Braitstein, P (corresponding author), Indiana Univ, Sch Med, Indianapolis, IN 46204 USA.	pbraitst@iu.edu	Hu, Liangyuan/AAS-8690-2020; Hogan, Joseph/J-4579-2014; Ayuku, David/AAB-8485-2019	Hu, Liangyuan/0000-0002-4067-892X; Hogan, Joseph/0000-0001-7959-7361	Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01HD060478]; Lifespan/Tufts/Brown Center for AIDS Research; National Institute of Allergy and Infectious Diseases [P30AI042853]; Framework in Global Health, Brown University Global Health Initiative; National Institute on Drug Abuse [5T32DA013911]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD041020, R01HD060478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA013911] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Lifespan/Tufts/Brown Center for AIDS Research; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Framework in Global Health, Brown University Global Health Initiative; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by Award Number R01HD060478 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. Additional funding came from a 2011 international developmental grant from the Lifespan/Tufts/Brown Center for AIDS Research. This project was specifically supported by Grant Number P30AI042853 from the National Institute of Allergy and Infectious Diseases. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institute of Allergy and Infectious Diseases, or the National Institute of Health. Further funding was provided by Framework in Global Health, Brown University Global Health Initiative. Dr. Winston received support from the National Institute on Drug Abuse [grant 5T32DA013911]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalsma MC, 2012, SOC SCI MED, V74, P1444, DOI 10.1016/j.socscimed.2012.01.014; Albee A., 1994, SUPPORT WOMENS PRODU; [Anonymous], 2002, STOR CHILDR LIV WORK; Aptekar L, 1999, New Dir Child Adolesc Dev, P35; Aptekar L., 1994, CROSS-CULT RES, V28, P195, DOI [10.1177/106939719402800301, DOI 10.1177/106939719402800301]; Atwoli L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089937; Ayaya S O, 2001, East Afr Med J, V78, P624; Ayuku D., 2005, East African Journal of Public Health, V2, P6; Ayuku D, 2003, HEALTH POLICY PLANN, V18, P109, DOI 10.1093/heapol/18.1.109; Ayuku D, 2004, AFRICAN J FOOD AGR N, V4, P1; Ayuku David O, 2004, Afr Health Sci, V4, P24; Ayuku DO, 2004, INT SOC WORK, V47, P293, DOI 10.1177/0020872804041428; Braitstein P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070054; Cottrell-Boyce J, 2010, AFR J DRUG ALCOHOL S, V9, P93; CSC, 2009, WHO IS STREET CHILD; DCI, 2008, PROT RIGHTS CHILDR C; Dekel R, 2003, J ADOLESCENCE, V26, P201, DOI 10.1016/S0140-1971(02)00130-6; Einterz RM, 2007, ACAD MED, V82, P812, DOI 10.1097/ACM.0b013e3180cc29f1; Embleton L, 2013, INT ASS AD HLTH IAAH; Embleton L, 2013, ADDICTION; Embleton L, 2013, ADDICTION, V108, P1722, DOI 10.1111/add.12252; Embleton L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053435; Embleton L, 2012, SUBST USE MISUSE, V47, P1234, DOI 10.3109/10826084.2012.700678; EMDH, 2009, SURV CHILDR STREET S; Ensing A, 2010, STREET WORKING STREE; Holman B., 2006, DANGERS DETENTION IM; HRW, 2001, RIGHTS RISK ISS KEN; Jacob W. J., 2004, J CHILDREN POVERTY, V10, P3, DOI [DOI 10.1080/1079612042000199207, 10.1080/1079612042000199207]; Johnson H, 2005, RESPONSES CHILD VULN; Kinyanjui DWC, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-53; KNYP, 2002, KEN NAT YOU IN PRESS; KODP, 2011, KEN COUNT FACT SHEET; Lalani S, 2009, LIFE STREET CHOKORA; Ling Minhua, 2019, INCONVENIENT GENERAT; Lugalla JLP, 1999, INT J URBAN REGIONAL, V23, P329, DOI 10.1111/1468-2427.00198; Muchini B, 1994, MORALITY STREET CHIL; Ray P, 2011, STILL STREET STILL S; Slesnick N, 2009, CHILD YOUTH SERV REV, V31, P732, DOI 10.1016/j.childyouth.2009.01.006; Steffan B, 2012, GENERATION OUT PLACE; Steffen B., 2012, CHRONIC URBAN EMERGE; UMP, 2000, STREETCH GANGS AFR C; UN, 1989, CONV RIGHTS CHILD; UNICEF, 2012, STAT WORLDS CHILDR U; UNICEF, 2001, 2001 ZIM STUD STREET; UNICEF, 1986, CHILDR ESP DIFF CIRC; United Nations Human Rights Office of the High Commissioner, 2012, PROT PROM RIGHTS CHI; Winston S, 2012, IDWEEK ADV SCI IMPRO	47	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97587	10.1371/journal.pone.0097587	http://dx.doi.org/10.1371/journal.pone.0097587			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4TJ	24827584	Green Submitted, Green Published, gold			2022-12-27	WOS:000336857400110
J	Valletta, JJ; Chipperfield, AJ; Clough, GF; Byrne, CD				Valletta, John Joseph; Chipperfield, Andrew J.; Clough, Geraldine F.; Byrne, Christopher D.			Daily Energy Expenditure, Cardiorespiratory Fitness and Glycaemic Control in People with Type 1 Diabetes	PLOS ONE			English	Article							BODY-MASS INDEX; PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; DAILY-LIFE; EXERCISE; MEN; ADOLESCENTS; PREDICTORS; MORTALITY; CAPACITY	Objective: Encouraging daily physical activity improves cardiorespiratory fitness and many cardiovascular risk factors. However, increasing physical activity often creates a challenge for people with type 1 diabetes, because of difficulties maintaining euglycemia in the face of altered food intake and adjustments to insulin doses. Our aim was to examine the triangular relationship between glucose control measured by continuous glucose monitoring system (CGMS), objective measures of total daily energy expenditure (TEE) recorded by a multi-sensory monitoring device, and cardiorespiratory fitness (CRF), in free-living subjects with type 1 diabetes. Research Design and Methods: Twenty-three individuals (12 women) with type 1 diabetes who were free from micro- and macrovascular complications were recruited. TEE and glucose control were monitored simultaneously for up to 12 days, using a multi-sensory device and CGMS respectively. CRF was recorded as V02 max from a maximal treadmill test with the Bruce protocol. Results: Subjects (mean +/- SD) were aged 37 +/- 11 years, with BMI = 26.5 +/- 5.1 kg.m(-2), HbA(1c) = 7.7 +/- 1.3% (61 +/- 14 mmol/mol) and V02 max (ml.min(-1).kg(-1)) = 39.9 +/- 8.4 (range 22.4 - 58.6). TEE (36.3 +/- 5.5 kcal.kg(-1).day(-1)) was strongly associated with CRF(39.9 +/- 8.4 ml.min(-1).kg(-1)) independently of sex (r = 0.63, p < 0.01). However, neither TEE (r = -0.20, p = 0.36) nor CRF (r = -0.20, p = 0.39; adjusted for sex), were significantly associated with mean glycaemia measured by CGMS. Conclusion: Higher levels of energy expenditure (due to a more active lifestyle) are associated with increased cardiorespiratory fitness, but not necessarily better glycaemic control. Since increased levels of energy expenditure and good glycaemic control are both needed to protect against diabetes-related complications our data suggest they need to be achieved independently.	[Valletta, John Joseph; Clough, Geraldine F.; Byrne, Christopher D.] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Valletta, John Joseph; Chipperfield, Andrew J.] Univ Southampton, Fac Engn & Environm, Southampton SO9 5NH, Hants, England	University of Southampton; University of Southampton	Chipperfield, AJ (corresponding author), Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England.	A.J.Chipperfield@soton.ac.uk	Chipperfield, Andrew J/B-7001-2009	Byrne, Christopher D/0000-0001-6322-7753; Chipperfield, Andrew/0000-0002-3026-9890	Diabetes UK [BDA: RD06/0003306]; UK EPSRC PhD plus programme	Diabetes UK(Diabetes UK); UK EPSRC PhD plus programme(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Diabetes UK funded this work under grant BDA: RD06/0003306. JJV also gratefully acknowledges the support of the UK EPSRC PhD plus programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer E, 2011, PROG CARDIOVASC DIS, V53, P387, DOI 10.1016/j.pcad.2011.02.006; Benevento D, 2010, Diabetes Res Clin Pract, V88, pe32, DOI 10.1016/j.diabres.2010.03.016; Blair SN, 2001, MED SCI SPORT EXER, V33, pS379, DOI 10.1097/00005768-200106001-00007; Bonnefoy M, 2001, J AM GERIATR SOC, V49, P28, DOI 10.1046/j.1532-5415.2001.49006.x; Brazeau AS, 2008, DIABETES CARE, V31, P2108, DOI 10.2337/dc08-0720; Church TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019657; Church TS, 2005, ARCH INTERN MED, V165, P2114, DOI 10.1001/archinte.165.18.2114; Church TS, 2004, DIABETES CARE, V27, P83, DOI 10.2337/diacare.27.1.83; den Hoed M, 2008, INT J OBESITY, V32, P1264, DOI 10.1038/ijo.2008.72; den Hoed M, 2008, J APPL PHYSIOL, V105, P561, DOI 10.1152/japplphysiol.00091.2008; Ekelund U, 2005, AM J CLIN NUTR, V81, P964; FOSTER C, 1984, AM HEART J, V107, P1229, DOI 10.1016/0002-8703(84)90282-5; Fuchsjager-Mayrl G, 2002, DIABETES CARE, V25, P1795, DOI 10.2337/diacare.25.10.1795; Gross T M, 2000, Diabetes Technol Ther, V2, P49, DOI 10.1089/152091500316737; Harmer AR, 2007, DIABETES CARE, V30, P1269, DOI 10.2337/dc06-1790; Herbst A, 2006, ARCH PEDIAT ADOL MED, V160, P573, DOI 10.1001/archpedi.160.6.573; Kavookjian J, 2007, DIABETES EDUCATOR, V33, P962, DOI 10.1177/0145721707308411; Laaksonen DE, 2000, MED SCI SPORT EXER, V32, P1541, DOI 10.1097/00005768-200009000-00003; Lakoski SG, 2011, AM J CARDIOL, V108, P34, DOI 10.1016/j.amjcard.2011.02.338; Lehmann R, 1997, DIABETES CARE, V20, P1603, DOI 10.2337/diacare.20.10.1603; Ligtenberg PC, 1999, NETH J MED, V55, P59, DOI 10.1016/S0300-2977(99)00039-X; McAuley P, 2009, DIABETES RES CLIN PR, V85, pE30, DOI 10.1016/j.diabres.2009.05.012; Michaliszyn SF, 2010, RES NURS HEALTH, V33, P441, DOI 10.1002/nur.20393; Mittermayer F, 2005, WIEN KLIN WOCHENSCHR, V117, P816, DOI 10.1007/s00508-005-0476-y; Mosher PE, 1998, ARCH PHYS MED REHAB, V79, P652, DOI 10.1016/S0003-9993(98)90039-9; POLLOCK ML, 1982, AM HEART J, V103, P363, DOI 10.1016/0002-8703(82)90275-7; Ramalho AC, 2006, DIABETES RES CLIN PR, V72, P271, DOI 10.1016/j.diabres.2005.11.011; Riazi A, 2004, DIABETES RES CLIN PR, V66, P237, DOI 10.1016/j.diabres.2004.04.001; Rigla M, 2000, METABOLISM, V49, P640, DOI 10.1016/S0026-0495(00)80041-4; Roberts L, 2002, J PEDIATR ENDOCR MET, V15, P621; Ross R, 2011, MED SCI SPORT EXER, V43, P2189, DOI 10.1249/MSS.0b013e31821e4ff2; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; St-Onge M, 2007, AM J CLIN NUTR, V85, P742, DOI 10.1093/ajcn/85.3.742; Sui XM, 2007, JAMA-J AM MED ASSOC, V298, P2507, DOI 10.1001/jama.298.21.2507; Trout KK, 2007, DIABETES TECHNOL THE, V9, P176, DOI 10.1089/dia.2006.0004; Waden J, 2005, DIABETES CARE, V28, P777, DOI 10.2337/diacare.28.4.777; Wallymahmed M, 2007, PRACTICAL DIABETES I, V24, P418; Wallymahmed ME, 2007, DIABETIC MED, V24, P1296, DOI 10.1111/j.1464-5491.2007.02257.x; Wiesinger GF, 2001, WIEN KLIN WOCHENSCHR, V113, P670; Wiesli P, 2005, DIABETES CARE, V28, P1910, DOI 10.2337/diacare.28.8.1910; Wild D, 2007, PATIENT EDUC COUNS, V68, P10, DOI 10.1016/j.pec.2007.05.003	41	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97534	10.1371/journal.pone.0097534	http://dx.doi.org/10.1371/journal.pone.0097534			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24826899	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000336857400106
J	Elliott, VA; Rychahou, P; Zaytseva, YY; Evers, BM				Elliott, Victoria A.; Rychahou, Piotr; Zaytseva, Yekaterina Y.; Evers, B. Mark			Activation of c-Met and Upregulation of CD44 Expression Are Associated with the Metastatic Phenotype in the Colorectal Cancer Liver Metastasis Model	PLOS ONE			English	Article							TUMOR PROGRESSION; COLON-CANCER; INVASION; PATHWAY	Background: Liver metastasis is the most common cause of death in patients with colorectal cancer. Despite extensive research into the biology of cancer progression, the molecular mechanisms that drive colorectal cancer metastasis are not well characterized. Methods: HT29 LM1, HT29 LM2, HT29 LM3 cell lines were derived from the human colorectal cancer cell line HT29 following multiple rounds of in vivo selection in immunodeficient mice. Results: CD44 expression, a transmembrane glycoprotein involved in cell-cell and cell-matrix adhesions, and cancer cells adhesion to endothelial cells was increased in all in vivo selected cell lines, with maximum CD44 expression and cancer cells adhesion to endothelial cells in the highly metastatic HT29 LM3 cell line. Activation of c-Met upon hepatocyte growth factor (HGF) stimulation in the in vivo selected cell lines is CD44 independent. In vitro separation of CD44 high and low expression cells from HT29 LM3 cell line with FACS sorting confirmed that c-Met activation is CD44 independent upon hepatocyte growth factor stimulation. Furthermore, in vivo evaluation of CD44 low and high expressing HT29 LM3 cells demonstrated no difference in liver metastasis penetrance. Conclusions: Taken together, our findings indicate that the aggressive metastatic phenotype of in vivo selected cell lines is associated with overexpression of CD44 and activation of c-MET. We demonstrate that c-Met activation is CD44 independent upon hepatocyte growth factor stimulation and confirm that CD44 expression in HT29 LM3 cell line is not responsible for the increase in metastatic penetrance in HT29 LM3 cell line.	[Elliott, Victoria A.; Rychahou, Piotr; Zaytseva, Yekaterina Y.; Evers, B. Mark] Univ Kentucky, Markey Canc Ctr, Lexington, KY 40506 USA; [Rychahou, Piotr; Evers, B. Mark] Univ Kentucky, Dept Surg, Lexington, KY USA	University of Kentucky; University of Kentucky	Evers, BM (corresponding author), Univ Kentucky, Markey Canc Ctr, Lexington, KY 40506 USA.	mark.evers@uky.edu		Rychahou, Piotr/0000-0001-7352-9122	NIDDK [R01DK048498]; NCl [T32CA165990]; NATIONAL CANCER INSTITUTE [P30CA177558, T32CA165990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048498] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCl; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants R01DK048498 from NIDDK and T32CA165990 from NCl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banky B, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-83; Bruns Christiane J., 1999, Neoplasia (New York), V1, P50, DOI 10.1038/sj.neo.7900005; Comoglio PM, 2008, NAT REV DRUG DISCOV, V7, P504, DOI 10.1038/nrd2530; Ding JA, 2008, HEPATO-GASTROENTEROL, V55, P2072; Dortet L, 2010, MICROBES INFECT, V12, P919, DOI 10.1016/j.micinf.2010.07.009; Garouniatis A, 2013, INT J COLORECTAL DIS, V28, P9, DOI 10.1007/s00384-012-1520-9; Hasenauer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062357; Hunter Kent W, 2008, Breast Cancer Res, V10 Suppl 1, pS2, DOI 10.1186/bcr1988; Ikeguchi M, 2001, J SURG ONCOL, V77, P201, DOI 10.1002/jso.1095; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Li CW, 2011, GASTROENTEROLOGY, V141, P2218, DOI 10.1053/j.gastro.2011.08.009; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; Orian-Rousseau W, 2007, MOL BIOL CELL, V18, P76, DOI 10.1091/mbc.E06-08-0674; Orian-Rousseau V, 2010, EUR J CANCER, V46, P1271, DOI 10.1016/j.ejca.2010.02.024; Rychahou PG, 2006, ANN SURG, V243, P833, DOI 10.1097/01.sla.0000220040.66012.a9; Salgia R, 2009, SEMIN ONCOL, V36, pS52, DOI 10.1053/j.seminoncol.2009.02.008; Su WP, 2004, GLIA, V45, P297, DOI 10.1002/glia.10340; Takeuchi H, 2003, CLIN CANCER RES, V9, P1480; van der Voort R, 1999, J BIOL CHEM, V274, P6499, DOI 10.1074/jbc.274.10.6499; Wielenga VJM, 2000, AM J PATHOL, V157, P1563, DOI 10.1016/S0002-9440(10)64793-1; Yokota J, 2000, CARCINOGENESIS, V21, P497, DOI 10.1093/carcin/21.3.497; Zaytseva YY, 2012, CANCER RES, V72, P1504, DOI 10.1158/0008-5472.CAN-11-4057	22	27	28	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97432	10.1371/journal.pone.0097432	http://dx.doi.org/10.1371/journal.pone.0097432			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24823486	gold, Green Published, Green Submitted			2022-12-27	WOS:000336369200114
J	Laurieri, N; Dairou, J; Egleton, JE; Stanley, LA; Russell, AJ; Dupret, JM; Sim, E; Rodrigues-Lima, F				Laurieri, Nicola; Dairou, Julien; Egleton, James E.; Stanley, Lesley A.; Russell, Angela J.; Dupret, Jean-Marie; Sim, Edith; Rodrigues-Lima, Fernando			From Arylamine N-Acetyltransferase to Folate-Dependent Acetyl CoA Hydrolase: Impact of Folic Acid on the Activity of (HUMAN)NAT1 and Its Homologue (MOUSE)NAT2	PLOS ONE			English	Article							ANTI-TUBERCULAR DRUG; BREAST-CANCER; COENZYME-A; MYCOBACTERIUM-SMEGMATIS; P-AMINOBENZOYLGLUTAMATE; CONFORMATIONAL-ANALYSIS; STEADY-STATE; AMINO-ACIDS; GENE; EXPRESSION	Acetyl Coenzyme A- dependent N-, O- and N, O-acetylation of aromatic amines and hydrazines by arylamine N-acetyltransferases is well characterised. Here, we describe experiments demonstrating that human arylamine N-acetyltransferase Type 1 and its murine homologue (Type 2) can also catalyse the direct hydrolysis of acetyl Coenzyme A in the presence of folate. This folate- dependent activity is exclusive to these two isoforms; no acetyl Coenzyme A hydrolysis was found when murine arylamine N-acetyltransferase Type 1 or recombinant bacterial arylamine N-acetyltransferases were incubated with folate. Proton nuclear magnetic resonance spectroscopy allowed chemical modifications occurring during the catalytic reaction to be analysed in real time, revealing that the disappearance of acetyl CH3 from acetyl Coenzyme A occurred concomitantly with the appearance of a CH3 peak corresponding to that of free acetate and suggesting that folate is not acetylated during the reaction. We propose that folate is a cofactor for this reaction and suggest it as an endogenous function of this widespread enzyme. Furthermore, in silico docking of folate within the active site of human arylamine N-acetyltransferase Type 1 suggests that folate may bind at the enzyme's active site, and facilitate acetyl Coenzyme A hydrolysis. The evidence presented in this paper adds to our growing understanding of the endogenous roles of human arylamine N-acetyltransferase Type 1 and its mouse homologue and expands the catalytic repertoire of these enzymes, demonstrating that they are by no means just xenobiotic metabolising enzymes but probably also play an important role in cellular metabolism. These data, together with the characterisation of a naphthoquinone inhibitor of folate-dependent acetyl Coenzyme A hydrolysis by human arylamine N-acetyltransferase Type 1/murine arylamine N-acetyltransferase Type 2, open up a range of future avenues of exploration, both for elucidating the developmental role of these enzymes and for improving chemotherapeutic approaches to pathological conditions including estrogen receptor-positive breast cancer.	[Laurieri, Nicola; Egleton, James E.; Russell, Angela J.; Sim, Edith] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Laurieri, Nicola; Egleton, James E.; Russell, Angela J.] Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England; [Dairou, Julien; Dupret, Jean-Marie; Rodrigues-Lima, Fernando] Univ Paris Diderot, Sorbonne Paris Cite, Unit Funct & Adapt Biol, Paris, France; [Stanley, Lesley A.] Consultant Investigat Toxicol, Linlithgow, West Lothian, Scotland; [Sim, Edith] Univ Kingston, Fac Sci Engn & Comp, Kingston Upon Thames, England	University of Oxford; University of Oxford; UDICE-French Research Universities; Universite Paris Cite; Kingston University	Sim, E (corresponding author), Univ Oxford, Dept Pharmacol, S Parks Rd, Oxford OX1 3QT, England.	E.Sim@kingston.ac.uk; fernando.rodrigues-lima@univ-paris-diderot.fr		Russell, Angela/0000-0003-3610-9369	Cancer Research United Kingdom through a Cancer Medicinal Chemistry Studentship; Oxford Cancer Research Centre Prize D. Phil. Studentship [C38302/A12450]; Research Councils United Kingdom fellowship	Cancer Research United Kingdom through a Cancer Medicinal Chemistry Studentship; Oxford Cancer Research Centre Prize D. Phil. Studentship; Research Councils United Kingdom fellowship	This work was supported by Cancer Research United Kingdom through a Cancer Medicinal Chemistry Studentship (NL) and an Oxford Cancer Research Centre Prize D. Phil. Studentship (C38302/A12450, JEE). ARR was supported by a Research Councils United Kingdom fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No other external funding was received.	Abuhammad A, 2011, PROTEIN EXPR PURIF; Abuhammad AM, 2010, PROTEIN CELL, V1, P384, DOI 10.1007/s13238-010-0037-7; Adam PJ, 2003, MOL CANCER RES, V1, P826; ANDRES HH, 1985, ANAL BIOCHEM, V145, P367, DOI 10.1016/0003-2697(85)90376-8; Ballester PJ, 2010, J R SOC INTERFACE, V7, P335, DOI 10.1098/rsif.2009.0170; Boukouvala S, 2002, PHARMACOGENETICS, V12, P385, DOI 10.1097/00008571-200207000-00006; Brooke EW, 2003, BIOORGAN MED CHEM, V11, P1227, DOI 10.1016/S0968-0896(02)00642-9; Butcher NJ, 2012, PHARMACOL REV, V64, P147, DOI 10.1124/pr.110.004275; Cao W, 2005, PHARMACOGENOMICS J, V5, P255, DOI 10.1038/sj.tpj.6500319; Claridge TDW, 2008, ORG LETT, V10, P5433, DOI 10.1021/ol802211p; Cornish VA, 2003, PHARMACOGENOMICS J, V3, P169, DOI 10.1038/sj.tpj.6500170; Czeizel AE, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.6.e66; Dairou J, 2003, BIOCHEM BIOPH RES CO, V307, P1059, DOI 10.1016/S0006-291X(03)01311-1; DeLano W.L., 2002, PYMOL OPEN SOURCE MO; DEREWLANY LO, 1994, J PHARMACOL EXP THER, V269, P761; DEREWLANY LO, 1994, J PHARMACOL EXP THER, V269, P756; Egleton JE, 2014, BIOORG MED IN PRESS; Erickson RP, 2008, MOL REPROD DEV, V75, P1071, DOI 10.1002/mrd.20852; Erickson RP, 2010, J CRANIOFAC SURG, V21, P1384, DOI 10.1097/SCS.0b013e3181ec6992; Fullam E, 2008, J MOL BIOL, V375, P178, DOI 10.1016/j.jmb.2007.10.019; Fullam E, 2009, PROTEIN J, V28, P281, DOI 10.1007/s10930-009-9193-0; Goodfellow GH, 2000, BIOCHEM J, V348, P159, DOI 10.1042/0264-6021:3480159; GRANT DM, 1991, MOL PHARMACOL, V39, P184; Hein DW, 2008, PHARMACOGENET GENOM, V18, P367, DOI 10.1097/FPC.0b013e3282f60db0; Hein DW, 2009, EXPERT OPIN DRUG MET, V5, P353, DOI [10.1517/17425250902877698, 10.1517/17425250902877698 ]; JENCKS WP, 1972, J BIOL CHEM, V247, P3756; Jensen LE, 2006, HUM GENET, V120, P52, DOI 10.1007/s00439-006-0181-6; Johansson I, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3116; Kawamura A, 2008, BIOCHEM PHARMACOL, V75, P1550, DOI 10.1016/j.bcp.2007.12.012; Kim SJ, 2008, ONCOL REP, V19, P663; LAM YF, 1972, CAN J CHEMISTRY, V50, P2357, DOI 10.1139/v72-374; Laurieri N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070600; Laurieri N, 2010, J AM CHEM SOC, V132, P3238, DOI 10.1021/ja909165u; MARTELL KJ, 1992, MOL PHARMACOL, V42, P265; Matte C, 2009, NEUROCHEM INT, V54, P7, DOI 10.1016/j.neuint.2008.08.011; MINCHIN RF, 1995, BIOCHEM J, V307, P1; Minchin RF, 2007, INT J BIOCHEM CELL B, V39, P1999, DOI 10.1016/j.biocel.2006.12.006; Mitchell MK, 1999, DRUG METAB DISPOS, V27, P261; Moat SJ, 2000, FREE RADICAL RES, V32, P171, DOI 10.1080/10715760000300171; Murphy M, 1996, ARCH DIS CHILD-FETAL, V75, pF133, DOI 10.1136/fn.75.2.F133; Mushtaq A, 2002, J BIOL CHEM, V277, P12175, DOI 10.1074/jbc.M104365200; PACIFICI GM, 1986, PHARMACOLOGY, V32, P283; PATEL SS, 1987, J BIOL CHEM, V262, P7132; Payton M, 1999, BIOCHEM PHARMACOL, V58, P779, DOI 10.1016/S0006-2952(99)00171-9; ROSSI C, 1993, SPECTROSC LETT, V26, P1603, DOI 10.1080/00387019308010760; Russell AJ, 2009, BIOORGAN MED CHEM, V17, P905, DOI 10.1016/j.bmc.2008.11.032; Sandy J, 2005, PROTEIN SCI, V14, P775, DOI 10.1110/ps.041163505; Sandy J, 2002, J MOL BIOL, V318, P1071, DOI 10.1016/S0022-2836(02)00141-9; Sim E, 2003, BIOCHEM SOC T, V31, P615, DOI 10.1042/bst0310615; Sim E, 2008, DRUG METAB REV, V40, P479, DOI [10.1080/03602530802186603, 10.1080/03602530802186603 ]; Sim E, 2007, EXPERT OPIN DRUG MET, V3, P169, DOI 10.1517/17425255.3.2.169; Sim E, 2012, ADV PHARMACOL, V63, P169, DOI 10.1016/B978-0-12-398339-8.00005-7; Sinclair J, 1997, BIOCHEM PHARMACOL, V53, P11, DOI 10.1016/S0006-2952(96)00592-8; Sinclair JC, 2000, NAT STRUCT BIOL, V7, P560; Smelt VA, 2000, HUM MOL GENET, V9, P1101, DOI 10.1093/hmg/9.7.1101; Stanley LA, 1998, TERATOLOGY, V58, P174, DOI 10.1002/(SICI)1096-9926(199811)58:5<174::AID-TERA3>3.3.CO;2-H; Tiang JM, 2010, BIOCHEM BIOPH RES CO, V393, P95, DOI 10.1016/j.bbrc.2010.01.087; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wakefield L, 2008, GENE CHROMOSOME CANC, V47, P118, DOI 10.1002/gcc.20512; Wakefield L, 2007, BIOCHEM BIOPH RES CO, V364, P556, DOI 10.1016/j.bbrc.2007.10.026; Wakefield L, 2007, MAMM GENOME, V18, P270, DOI 10.1007/s00335-007-9010-z; Wakefield L, 2010, GENE, V452, P16, DOI 10.1016/j.gene.2009.12.002; Wang HQ, 2005, BIOCHEMISTRY-US, V44, P11295, DOI 10.1021/bi047564q; Wang HQ, 2005, PROTEIN J, V24, P65, DOI 10.1007/s10930-004-1513-9; Wang HQ, 2004, BIOCHEMISTRY-US, V43, P8234, DOI 10.1021/bi0497244; WARD A, 1992, BIOCHEM PHARMACOL, V44, P1099, DOI 10.1016/0006-2952(92)90373-Q; WARD A, 1995, BIOCHEM PHARMACOL, V49, P1759, DOI 10.1016/0006-2952(95)00087-G; Westwood IM, 2006, CURR TOP MED CHEM, V6, P1641, DOI 10.2174/156802606778108979; Westwood IM, 2005, BIOCHEM J, V385, P605, DOI 10.1042/BJ20041330; Witham KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077923; Wu H, 2007, J BIOL CHEM, V282, P30189, DOI 10.1074/jbc.M704138200; Wu WJ, 1998, J AM CHEM SOC, V120, P9988, DOI 10.1021/ja982243l	72	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96370	10.1371/journal.pone.0096370	http://dx.doi.org/10.1371/journal.pone.0096370			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24823794	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000336369200018
J	Boualem, A; Fleurier, S; Troadec, C; Audigier, P; Kumar, APK; Chatterjee, M; Alsadon, AA; Sadder, MT; Wahb-Allah, MA; Al-Doss, AA; Bendahmane, A				Boualem, Adnane; Fleurier, Sebastien; Troadec, Christelle; Audigier, Pascal; Kumar, Anish P. K.; Chatterjee, Manash; Alsadon, Abdullah A.; Sadder, Monther T.; Wahb-Allah, Mahmoud A.; Al-Doss, Abdullah A.; Bendahmane, Abdelhafid			Development of a Cucumis sativus TILLinG Platform for Forward and Reverse Genetics	PLOS ONE			English	Article							CHEMICALLY-INDUCED MUTATIONS; BIOSYNTHESIS ENZYME LEADS; SEX DETERMINATION; MELO L; ARABIDOPSIS-THALIANA; MUTANT POPULATION; ETHYLENE; EXPRESSION; PLANTS; IDENTIFICATION	Background: Cucumber (Cucumis sativus) belongs to the Cucurbitaceae family that includes more than 800 species. The cucumber genome has been recently sequenced and annotated. Transcriptomics and genome sequencing of many plant genomes are providing information on candidate genes potentially related to agronomically important traits. To accelerate functional characterization of these genes in cucumber we have generated an EMS mutant population that can be used as a TILLinG platform for reverse genetics. Principal Findings: A population of 3,331 M2 mutant seed families was generated using two EMS concentrations (0.5% and 0.75%). Genomic DNA was extracted from M2 families and eight-fold pooled for mutation detection by ENDO1 nuclease. To assess the quality of the mutant collection, we screened for induced mutations in five genes and identified 26 mutations. The average mutation rate was calculated as 1/1147 Kb giving rise to approximately 320 mutations per genome. We focused our characterization on three missense mutations, G33C, S238F and S249F identified in the CsACS2 sex determination gene. Protein modeling and crystallography studies predicted that mutation at G(33) may affect the protein function, whereas mutations at S-238 and S-249 may not impair the protein function. As predicted, detailed phenotypic evaluation showed that the S238F and the S249F mutant lines had no sexual phenotype. In contrast, plants homozygous for the G33C mutation showed a complete sexual transition from monoecy to andromonoecy. This result demonstrates that TILLinG is a valuable tool for functional validation of gene function in crops recalcitrant to transgenic transformation. Conclusions: We have developed a cucumber mutant population that can be used as an efficient reverse genetics tool. The cucumber TILLinG collection as well as the previously described melon TILLinG collection will prove to be a valuable resource for both fundamental research and the identification of agronomically-important genes for crop improvement in cucurbits in general.	[Boualem, Adnane; Fleurier, Sebastien; Troadec, Christelle; Audigier, Pascal; Bendahmane, Abdelhafid] Saclay Plant Sci, INRA URGV, UMR1165, Unite Rech Genom Vegetale, Evry, France; [Kumar, Anish P. K.; Chatterjee, Manash] Jai Res Fdn, Bench Bio Pvt Ltd, Vapi, Gujarat, India; [Chatterjee, Manash] Natl Univ Ireland Univ Coll Galway, Plant & AgriBiosci Res Ctr PABC, Galway, Ireland; [Alsadon, Abdullah A.; Sadder, Monther T.; Wahb-Allah, Mahmoud A.; Al-Doss, Abdullah A.] King Saud Univ, Coll Food & Agr Sci, Dept Plant Prod, Riyadh, Saudi Arabia	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Ollscoil na Gaillimhe-University of Galway; King Saud University	Bendahmane, A (corresponding author), Saclay Plant Sci, INRA URGV, UMR1165, Unite Rech Genom Vegetale, Evry, France.	bendahm@evry.inra.fr	Sadder, Monther T./AAH-4484-2021; Boualem, Adnane/ABC-5019-2021; Sadder, Monther/B-9081-2015; Al-Doss, Abdullah/AAL-7883-2021; Al-Doss, Abdullah A/F-8539-2016	Sadder, Monther T./0000-0001-6651-0423; Boualem, Adnane/0000-0003-4428-6496; Sadder, Monther/0000-0001-6651-0423; Al-Doss, Abdullah/0000-0003-3828-2384; Abady, Mahmoud/0000-0002-7169-3751; TROADEC, Christelle/0000-0003-1927-7352; fleurier, sebastien/0000-0003-2334-7835	INRA-KSU Plant biotechnology network; Program LABEX Saclay Plant Sciences (SPS) [ANR-10-LABX-40]; ANR MELODY [ANR-11-BSV7-0024]; European Research Council (ERCSEXYPARTH)	INRA-KSU Plant biotechnology network; Program LABEX Saclay Plant Sciences (SPS); ANR MELODY(French National Research Agency (ANR)); European Research Council (ERCSEXYPARTH)(European Research Council (ERC))	This work was supported by INRA-KSU Plant biotechnology network, the Program LABEX Saclay Plant Sciences (SPS, ANR-10-LABX-40), the ANR MELODY (ANR-11-BSV7-0024), and the European Research Council (ERCSEXYPARTH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Belouchi A, 1996, P NATL ACAD SCI USA, V93, P121, DOI 10.1073/pnas.93.1.121; Bentley A, 2000, GENETICS, V156, P1169; Boualem A, 2008, SCIENCE, V321, P836, DOI 10.1126/science.1159023; Boualem A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006144; BYERS RE, 1972, P NATL ACAD SCI USA, V69, P717, DOI 10.1073/pnas.69.3.717; Caldwell DG, 2004, PLANT J, V40, P143, DOI 10.1111/j.1365-313X.2004.02190.x; Chawade A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-86; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; Dahmani-Mardas F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015776; Dalmais M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r43; de Saint Germain A, 2013, CURR OPIN PLANT BIOL, V16, P583, DOI 10.1016/j.pbi.2013.06.007; Ezura H, 2008, PLANT SCI, V175, P121, DOI 10.1016/j.plantsci.2008.02.004; Gomez G, 2005, PLANT J, V41, P107, DOI 10.1111/j.1365-313X.2004.02278.x; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Gottwald Sven, 2009, BMC Res Notes, V2, P258, DOI 10.1186/1756-0500-2-258; Greene EA, 2003, GENETICS, V164, P731; Haritatos E, 1996, PLANTA, V198, P614, DOI 10.1007/BF00262649; Huai Q, 2001, J BIOL CHEM, V276, P38210; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Jeffrey C., 1990, BIOL UTILIZATION CUC, P3; KUBICKI B, 1969, GENET POL, V10, P101; KUBICKI B, 1969, GENET POL, V10, P69; Kumar APK, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-38; Li Z, 2009, GENETICS, V182, P1381, DOI 10.1534/genetics.109.104737; Martin A, 2009, NATURE, V461, P1135, DOI 10.1038/nature08498; Minoia Silvia, 2010, BMC Res Notes, V3, P69, DOI 10.1186/1756-0500-3-69; Pech JC, 2008, PLANT SCI, V175, P114, DOI 10.1016/j.plantsci.2008.01.003; Piron F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011313; Poole CF, 1939, J HERED, V30, P21, DOI 10.1093/oxfordjournals.jhered.a104626; Rashid M, 2011, AUST J CROP SCI, V5, P411; Saito S, 2007, J EXP BOT, V58, P2897, DOI 10.1093/jxb/erm141; Staub Jack E., 2008, V1, P241; Till BJ, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-19; Trebitsh T, 1997, PLANT PHYSIOL, V113, P987, DOI 10.1104/pp.113.3.987; Triques K, 2007, PLANT J, V51, P1116, DOI 10.1111/j.1365-313X.2007.03201.x; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; Wang N, 2008, NEW PHYTOL, V180, P751, DOI 10.1111/j.1469-8137.2008.02619.x; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959; Wu JL, 2005, PLANT MOL BIOL, V59, P85, DOI 10.1007/s11103-004-5112-0; Yamasaki S, 2001, PLANT CELL PHYSIOL, V42, P608, DOI 10.1093/pcp/pce076; Yin TJ, 1995, AM J BOT, V82, P1537, DOI 10.2307/2446182	42	29	30	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97963	10.1371/journal.pone.0097963	http://dx.doi.org/10.1371/journal.pone.0097963			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835852	gold, Green Published, Green Submitted			2022-12-27	WOS:000339614800092
J	Crotty, FV; Fychan, R; Theobald, VJ; Sanderson, R; Chadwick, DR; Marley, CL				Crotty, Felicity V.; Fychan, Rhun; Theobald, Vince J.; Sanderson, Ruth; Chadwick, David R.; Marley, Christina L.			The Impact of Using Alternative Forages on the Nutrient Value within Slurry and Its Implications for Forage Productivity in Agricultural Systems	PLOS ONE			English	Article							NITROGEN MINERALIZATION; METHANE EMISSIONS; MILK-PRODUCTION; LEGUME SILAGES; PIG MANURE; GRASSLAND; SOIL; PHOSPHORUS; LOSSES; CATTLE	Alternative forages can be used to provide valuable home-grown feed for ruminant livestock. Utilising these different forages could affect the manure value and the implications of incorporating these forages into farming systems, needs to be better understood. An experiment tested the hypothesis that applying slurries from ruminants, fed ensiled red clover (Trifolium pratense), lucerne (Medicago sativa) or kale (Brassica oleracea) would improve the yield of hybrid ryegrass (Lolium hybridicum), compared with applying slurries from ruminants fed ensiled hybrid ryegrass, or applying inorganic N alone. Slurries from sheep offered one of four silages were applied to ryegrass plots (at 35 t ha(-1)) with 100 kg N ha(-1) inorganic fertiliser; dry matter (DM) yield was compared to plots only receiving ammonium nitrate at rates of 0, 100 and 250 kg N ha(-1) year(-1). The DM yield of plots treated with 250 kg N, lucerne or red clover slurry was significantly higher than other treatments (P<0.001). The estimated relative fertiliser N equivalence (FNE) (fertiliser-N needed to produce same yield as slurry N), was greatest for lucerne (114 kg) >red clover (81 kg) >kale (44 kg) >ryegrass (26 kg ha(-1) yr(-1)). These FNE values represent relative efficiencies of 22% (ryegrass), 52% (kale), 47% (red clover) and 60% for lucerne slurry, with the ryegrass slurry efficiency being lowest (P = 0.005). Soil magnesium levels in plots treated with legume slurry were higher than other treatments (P<0.001). Overall, slurries from ruminants fed alternative ensiled forages increased soil nutrient status, forage productivity and better N efficiency than slurries from ruminants fed ryegrass silage. The efficiency of fertiliser use is one of the major factors influencing the sustainability of farming systems, these findings highlight the cascade in benefits from feeding ruminants alternative forages, and the need to ensure their value is effectively captured to reduce environmental risks.	[Crotty, Felicity V.; Fychan, Rhun; Theobald, Vince J.; Sanderson, Ruth; Marley, Christina L.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales; [Chadwick, David R.] Bangor Univ, Sch Environm Nat Resources & Geog, Environm Ctr Wales, Bangor, Gwynedd, Wales	Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); Bangor University	Marley, CL (corresponding author), Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales.	cvm@aber.ac.uk	Crotty, Felicity/D-4931-2013	Crotty, Felicity/0000-0002-7363-224X; Sanderson, Ruth/0000-0001-5569-5493	Department for the Environment, Food and Rural Affairs, (DEFRA) United Kingdom [LS3642]	Department for the Environment, Food and Rural Affairs, (DEFRA) United Kingdom(Department for Environment, Food & Rural Affairs (DEFRA))	The authors acknowledge the Department for the Environment, Food and Rural Affairs, (DEFRA) United Kingdom, (LS3642) for the financial support of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashfield A, 2013, AGR SYST, V115, P41, DOI 10.1016/j.agsy.2012.10.001; Begum F, 2013, INT J BIODIV SCI ECO, V9, P1; Berry PM, 2003, SOIL USE MANAGE, V19, P112, DOI 10.1079/SUM2003176; Butler TJ, 2012, CROP SCI, V52, P1931, DOI 10.2135/cropsci2011.11.0611; Cardenas LM, 2007, ATMOS ENVIRON, V41, P7096, DOI 10.1016/j.atmosenv.2007.04.055; Chadwick D, 2011, ANIM FEED SCI TECH, V166-67, P514, DOI 10.1016/j.anifeedsci.2011.04.036; Chadwick DR, 2000, J AGR SCI, V134, P159, DOI 10.1017/S0021859699007510; Chambers BJ, 1999, SOIL USE MANAGE, V15, P137, DOI 10.1111/j.1475-2743.1999.tb00079.x; CUSHNAHAN A, 1994, ANIM PROD, V59, P415, DOI 10.1017/S0003356100007935; DEFRA, 2018, NITRATE VULNERABLE Z; DEFRA, 2013, GOOD AGR PRACT NUTR; Defra, 2010, FERT MAN RB209, P252; DEFRA, 2020, AGR UK; Dewhurst RJ, 2003, J DAIRY SCI, V86, P2598, DOI 10.3168/jds.S0022-0302(03)73855-7; Dewhurst RJ, 2003, J DAIRY SCI, V86, P2612, DOI 10.3168/jds.S0022-0302(03)73856-9; DuPont ST, 2010, AGR ECOSYST ENVIRON, V137, P25, DOI 10.1016/j.agee.2009.12.021; FAO, 2010, CURR WORLD FERT TREN; FAO, 2004, AN PROD HLTH P; Fortune S, 2005, SOIL USE MANAGE, V21, P370, DOI 10.1079/SUM2005338; Fortune S, 2000, SUSTAINABLE MANAGEME, P286; Fraser MD, 2001, GRASS FORAGE SCI, V56, P218, DOI 10.1046/j.1365-2494.2001.00268.x; Groot JCJ, 2007, NJAS-WAGEN J LIFE SC, V54, P235, DOI 10.1016/S1573-5214(07)80017-0; Jarvis SC, 1996, ADV AGRON, V57, P187, DOI 10.1016/S0065-2113(08)60925-6; Kanneganti VR, 1996, 1996 RES SUMMARIES, P26; Kirkham FW, 2001, J ECOL, V89, P1041, DOI 10.1111/j.1365-2745.2001.00626.x; Komiyama T, 2013, J MATER CYCLES WASTE, V15, P106, DOI 10.1007/s10163-012-0089-2; Kyvsgaard P, 2000, NUTR CYCL AGROECOSYS, V57, P207, DOI 10.1023/A:1009874500769; MacLeod M, 2010, AGR SYST, V103, P198, DOI 10.1016/j.agsy.2010.01.002; Mader P, 2002, SCIENCE, V296, P1694, DOI 10.1126/science.1071148; Marley CL, 2007, GRASS FORAGE SCI, V62, P1, DOI 10.1111/j.1365-2494.2007.00556.x; Marley CL, 2009, ADV ANIMAL BIOSCIENC, P162; Misselbrook TH, 1998, J AGR SCI, V130, P183, DOI 10.1017/S0021859697005194; Murray P. J., 2012, SOIL ECOLOGY ECOSYST, P424; Nicholson FA, 2003, J AGR SCI, V140, P53, DOI 10.1017/S0021859602002848; O'Brien D, 2012, AGR SYST, V107, P33, DOI 10.1016/j.agsy.2011.11.004; Payne RW, 2011, INTRO GENSTAT WINDOW, P150; Powell JM, 2009, AGRON J, V101, P747, DOI 10.2134/agronj2008.0193x; Powell JM, 2009, J DAIRY SCI, V92, P1765, DOI 10.3168/jds.2008-1738; Powell JM, 2006, SOIL SCI SOC AM J, V70, P786, DOI 10.2136/sssaj2005.0286; Powell JM, 1999, NUTR CYCL AGROECOSYS, V54, P215, DOI 10.1023/A:1009762900258; Rochon JJ, 2004, GRASS FORAGE SCI, V59, P197, DOI 10.1111/j.1365-2494.2004.00423.x; Shrestha RK, 2013, GEODERMA, V197, P177, DOI 10.1016/j.geoderma.2013.01.005; Sokal RR, 1995, BIOMETRY PRINCIPLES, P240; Sorensen P, 1998, BIOL FERT SOILS, V28, P56, DOI 10.1007/s003740050463; Thomsen IK, 2001, EUR J AGRON, V15, P31, DOI 10.1016/S1161-0301(01)00096-X; UNWIN RJ, 1986, AGR WASTES, V15, P253, DOI 10.1016/0141-4607(86)90023-5; van Eekeren N, 2009, BIOL FERT SOILS, V45, P595, DOI 10.1007/s00374-009-0370-2; Velthof GL, 2005, J ENVIRON QUAL, V34, P698, DOI 10.2134/jeq2005.0698; Velthof GL, 2000, GREEN WORLD RES, P42; Vos J, 2000, NUTR CYCL AGROECOSYS, V56, P87, DOI 10.1023/A:1009807504178; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wiens MJ, 2008, AGR SYST, V98, P74, DOI 10.1016/j.agsy.2008.03.008; Zhang W, 2007, ECOL ECON, V64, P253, DOI 10.1016/j.ecolecon.2007.02.024	53	9	9	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97516	10.1371/journal.pone.0097516	http://dx.doi.org/10.1371/journal.pone.0097516			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830777	Green Published, Green Submitted, gold			2022-12-27	WOS:000336789500073
J	Tsuchiya, M; Hashimoto, M; Takenaka, Y; Motoike, IN; Yoshikawa, K				Tsuchiya, Masa; Hashimoto, Midori; Takenaka, Yoshiko; Motoike, Ikuko N.; Yoshikawa, Kenichi			Global Genetic Response in a Cancer Cell: Self-Organized Coherent Expression Dynamics	PLOS ONE			English	Article							HIGHER-ORDER STRUCTURE; MOLECULAR-INTERACTIONS; CHROMATIN; DNA; NOISE; TRANSITION; DIFFERENTIATION; NORMALIZATION; CHROMOSOMES; SWITCHES	Understanding the basic mechanism of the spatio-temporal self-control of genome-wide gene expression engaged with the complex epigenetic molecular assembly is one of major challenges in current biological science. In this study, the genome-wide dynamical profile of gene expression was analyzed for MCF-7 breast cancer cells induced by two distinct ErbB receptor ligands: epidermal growth factor (EGF) and heregulin (HRG), which drive cell proliferation and differentiation, respectively. We focused our attention to elucidate how global genetic responses emerge and to decipher what is an underlying principle for dynamic self-control of genome-wide gene expression. The whole mRNA expression was classified into about a hundred groups according to the root mean square fluctuation (rmsf). These expression groups showed characteristic time-dependent correlations, indicating the existence of collective behaviors on the ensemble of genes with respect to mRNA expression and also to temporal changes in expression. All-or-none responses were observed for HRG and EGF (biphasic statistics) at around 10-20 min. The emergence of time-dependent collective behaviors of expression occurred through bifurcation of a coherent expression state (CES). In the ensemble of mRNA expression, the self-organized CESs reveals distinct characteristic expression domains for biphasic statistics, which exhibits notably the presence of criticality in the expression profile as a route for genomic transition. In time-dependent changes in the expression domains, the dynamics of CES reveals that the temporal development of the characteristic domains is characterized as autonomous bistable switch, which exhibits dynamic criticality (the temporal development of criticality) in the genome-wide coherent expression dynamics. It is expected that elucidation of the biophysical origin for such critical behavior sheds light on the underlying mechanism of the control of whole genome.	[Tsuchiya, Masa] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan; [Tsuchiya, Masa] Keio Univ, Sch Media & Governance, Syst Biol Program, Fujisawa, Kanagawa, Japan; [Hashimoto, Midori] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan; [Takenaka, Yoshiko] Natl Inst Adv Ind Sci & Technol, Nanosyst Res Inst, Tsukuba, Ibaraki, Japan; [Motoike, Ikuko N.] Tohoku Univ, Tohoku Med Megabank Org, Sendai, Miyagi 980, Japan; [Yoshikawa, Kenichi] Doshisha Univ, Fac Life & Med Sci, Kyotanabe, Japan	Keio University; Keio University; University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); Tohoku University; Doshisha University	Tsuchiya, M (corresponding author), Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan.	tsuchiya@ttck.keio.ac.jp; keyoshik@mail.doshisha.ac.jp	Yoshikawa, Kenichi/N-1867-2019	Yoshikawa, Kenichi/0000-0002-2751-7136	Tsuruoka City; Yamagata prefectural government; GCOE program of Keio University; KAKENHI [23240044, 25103012]	Tsuruoka City(Tsuruoka City Government); Yamagata prefectural government; GCOE program of Keio University; KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded by Tsuruoka City, the Yamagata prefectural government, and the GCOE program of Keio University, and was supported in part by Grants-in-Aid, KAKENHI (Nos. 23240044 and 25103012). The funders had no role in study design, data collection and analysis, decision to publish.	Akitaya T, 2007, BIOMACROMOLECULES, V8, P273, DOI 10.1021/bm060634j; Assaf M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.058102; Barbieri M, 2012, P NATL ACAD SCI USA, V109, P16173, DOI 10.1073/pnas.1204799109; Birtwistle MR, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100188; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chialvo DR, 2010, NAT PHYS, V6, P744, DOI 10.1038/NPHYS1803; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Erenpreisa J, 1992, P LATV ACAD SCI B, V3, P64; Felli N, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-85; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Hilfinger A, 2011, P NATL ACAD SCI USA, V108, P12167, DOI 10.1073/pnas.1018832108; Huang S, 2009, DEVELOPMENT, V136, P3853, DOI 10.1242/dev.035139; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Joti Y, 2012, NUCLEUS-PHILA, V3, P404, DOI 10.4161/nucl.21222; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Klevecz RR, 2004, P NATL ACAD SCI USA, V101, P1200, DOI 10.1073/pnas.0306490101; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Ld L, 1937, ZH EXPER THEOR FIZ, V7, P19, DOI DOI 10.1038/138840A0; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Makita N, 1999, FEBS LETT, V460, P333, DOI 10.1016/S0014-5793(99)01368-X; McClintick JN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-49; Mirny LA, 2011, CHROMOSOME RES, V19, P37, DOI 10.1007/s10577-010-9177-0; Nagahara H, 2010, CHEM PHYS LETT, V494, P88, DOI 10.1016/j.cplett.2010.05.083; Nagashima T, 2007, J BIOL CHEM, V282, P4045, DOI 10.1074/jbc.M608653200; Nakakuki T, 2010, CELL, V141, P884, DOI 10.1016/j.cell.2010.03.054; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Nishino Y, 2012, EMBO J, V31, P1644, DOI 10.1038/emboj.2012.35; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Radonjic M, 2005, MOL CELL, V18, P171, DOI 10.1016/j.molcel.2005.03.010; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Ryabov Y, 2008, NUCLEIC ACIDS RES, V36, P2756, DOI 10.1093/nar/gkn086; Saeki Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-545; Shu GP, 2003, COMP FUNCT GENOM, V4, P287, DOI 10.1002/cfg.290; Sims RJ, 2009, NATURE, V460, P802, DOI 10.1038/460802a; Snijder B, 2011, NAT REV MOL CELL BIO, V12, P119, DOI 10.1038/nrm3044; Southern E, 1999, NAT GENET, V21, P5, DOI 10.1038/4429; Takagi S, 1999, LANGMUIR, V15, P4143, DOI 10.1021/la981158o; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takenaka Y, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.031905; Tsuchiya M., 2012, Proceedings of the 2012 ICME International Conference on Complex Medical Engineering (CME), P744, DOI 10.1109/ICCME.2012.6275649; Tsuchiya M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012116; Tsuchiya M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004905; Tsumoto K, 1999, BIOPHYS CHEM, V82, P1, DOI 10.1016/S0301-4622(99)00098-8; Tu Y, 2002, P NATL ACAD SCI USA, V99, P14031, DOI 10.1073/pnas.222164199; Ueda M, 1996, PHYS REV LETT, V77, P2133, DOI 10.1103/PhysRevLett.77.2133; YANAGIDA M, 1982, COLD SPRING HARB SYM, V47, P177; Yoshikawa K, 2002, J BIOL PHYS, V28, P701, DOI 10.1023/A:1021251125101; Yoshikawa K, 2001, ADV DRUG DELIVER REV, V52, P235, DOI 10.1016/S0169-409X(01)00210-1; Yoshikawa K, 1996, PHYS REV LETT, V76, P3029, DOI 10.1103/PhysRevLett.76.3029; Yoshikawa K., 2002, PHARM PROPERTIES NUC, P137; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhang L, 2003, NAT BIOTECHNOL, V21, P818, DOI 10.1038/nbt836; Zinchenko A.A., 2008, DNA INTERACTIONS POL, P59, DOI DOI 10.1002/9780470286364.CH3	56	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97411	10.1371/journal.pone.0097411	http://dx.doi.org/10.1371/journal.pone.0097411			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831017	Green Submitted, gold, Green Published			2022-12-27	WOS:000336789500053
J	Grzymski, JJ; Marsh, AG				Grzymski, Joseph J.; Marsh, Adam G.			Protein Languages Differ Depending on Microorganism Lifestyle	PLOS ONE			English	Article							MYCOPLASMA-GENITALIUM; STAPHYLOCOCCUS-AUREUS; NUCLEOTIDE-SEQUENCES; BIOLOGICAL-SYSTEMS; COST-MINIMIZATION; GENOME; INFORMATION; COMPLEXITY; EVOLUTION; BACTERIUM	Few quantitative measures of genome architecture or organization exist to support assumptions of differences between microorganisms that are broadly defined as being free-living or pathogenic. General principles about complete proteomes exist for codon usage, amino acid biases and essential or core genes. Genome-wide shifts in amino acid usage between free-living and pathogenic microorganisms result in fundamental differences in the complexity of their respective proteomes that are size and gene content independent. These differences are evident across broad phylogenetic groups-a result of environmental factors and population genetic forces rather than phylogenetic distance. A novel comparative analysis of amino acid usage-utilizing linguistic analyses of word frequency in language and text-identified a global pattern of higher peptide word repetition in 376 free-living versus 421 pathogen genomes across broad ranges of genome size, G+C content and phylogenetic ancestry. This imprint of repetitive word usage indicates free-living microorganisms have a bias for repetitive sequence usage compared to pathogens. These findings quantify fundamental differences in microbial genomes relative to life-history function.	[Grzymski, Joseph J.] Univ Nevada, Desert Res Inst, Div Earth & Ecosyst Sci, Reno, NV 89506 USA; [Marsh, Adam G.] Univ Delaware, Ctr Bioinformat & Computat Biol, Lewes, DE 19958 USA	Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; University of Nevada Reno; University of Delaware	Grzymski, JJ (corresponding author), Univ Nevada, Desert Res Inst, Div Earth & Ecosyst Sci, Reno, NV 89506 USA.	joeg@dri.edu; amarsh@udel.edu		Grzymski, Joseph/0000-0003-2646-8958	U.S. National Science Foundation, Office of Polar Programs [02-38281, 06-32278]	U.S. National Science Foundation, Office of Polar Programs(National Science Foundation (NSF))	This work was supported by the U.S. National Science Foundation, Office of Polar Programs (#02-38281 to AGM and #06-32278 to JJG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami C, 2012, ANN NY ACAD SCI, V1256, P49, DOI 10.1111/j.1749-6632.2011.06422.x; Andersson SGE, 1998, TRENDS MICROBIOL, V6, P263, DOI 10.1016/S0966-842X(98)01312-2; BARRAI I, 1995, INT J PEPT PROT RES, V45, P326; Boneca IG, 1997, J BIOL CHEM, V272, P29053, DOI 10.1074/jbc.272.46.29053; Csuros M, 2007, TRENDS GENET, V23, P543, DOI 10.1016/j.tig.2007.07.008; D'Hondt S, 2004, SCIENCE, V306, P2216, DOI 10.1126/science.1101155; DEJONGE BLM, 1993, ANTIMICROB AGENTS CH, V37, P342, DOI 10.1128/AAC.37.2.342; Denton M, 2001, NATURE, V410, P417, DOI 10.1038/35068645; Drubin DA, 2007, GENE DEV, V21, P242, DOI 10.1101/gad.1507207; Dufton MJ, 1997, J THEOR BIOL, V187, P165, DOI 10.1006/jtbi.1997.0443; Edelman GM, 2001, P NATL ACAD SCI USA, V98, P13763, DOI 10.1073/pnas.231499798; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Forster AC, 2007, GENOME RES, V17, P1, DOI 10.1101/gr.5776007; Frank SA, 2009, J EVOLUTION BIOL, V22, P231, DOI 10.1111/j.1420-9101.2008.01647.x; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; FRIEDMAN JH, 1989, J AM STAT ASSOC, V84, P165, DOI 10.2307/2289860; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Grzymski JJ, 2012, ISME J, V6, P71, DOI 10.1038/ismej.2011.72; Haney PJ, 1999, P NATL ACAD SCI USA, V96, P3578, DOI 10.1073/pnas.96.7.3578; Jaroszewski L, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000205; Lauro FM, 2009, P NATL ACAD SCI USA, V106, P15527, DOI 10.1073/pnas.0903507106; Li WZ, 2002, BIOINFORMATICS, V18, P77, DOI 10.1093/bioinformatics/18.1.77; Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282; Lin LH, 2006, SCIENCE, V314, P479, DOI 10.1126/science.1127376; Liu ZD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-509; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; Mora T, 2010, P NATL ACAD SCI USA, V107, P5405, DOI 10.1073/pnas.1001705107; Moran MA, 2004, NATURE, V432, P910, DOI 10.1038/nature03170; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Ochman H, 2001, SCIENCE, V292, P1096, DOI 10.1126/science.1058543; PEVZNER PA, 1989, J BIOMOL STRUCT DYN, V6, P1013, DOI 10.1080/07391102.1989.10506528; PEVZNER PA, 1989, J BIOMOL STRUCT DYN, V6, P1027, DOI 10.1080/07391102.1989.10506529; Pietrokovski S, 1996, NUCLEIC ACIDS RES, V24, P197, DOI 10.1093/nar/24.1.197; Rabus R, 2004, ENVIRON MICROBIOL, V6, P887, DOI 10.1111/j.1462-2920.2004.00665.x; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Sadovsky MG, 2008, THEOR BIOSCI, V127, P69, DOI 10.1007/s12064-008-0032-1; Seligmann H, 2003, J MOL EVOL, V56, P151, DOI 10.1007/s00239-002-2388-z; Swan BK, 2013, P NATL ACAD SCI USA, V110, P11463, DOI 10.1073/pnas.1304246110; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176; Tononi G, 1999, P NATL ACAD SCI USA, V96, P3257, DOI 10.1073/pnas.96.6.3257; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340	44	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96910	10.1371/journal.pone.0096910	http://dx.doi.org/10.1371/journal.pone.0096910			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828817	gold, Green Published, Green Submitted			2022-12-27	WOS:000336857400045
J	Li, ZJ; Xu, XB; Meng, LX; Zhang, Q; Cao, LY; Li, WX; Wu, YL; Cao, ZJ				Li, Zhongjie; Xu, Xiaobo; Meng, Lanxia; Zhang, Qian; Cao, Luyang; Li, Wenxin; Wu, Yingliang; Cao, Zhijian			Hp1404, a New Antimicrobial Peptide from the Scorpion Heterometrus petersii	PLOS ONE			English	Article							OPISTHACANTHUS-MADAGASCARIENSIS; FUNCTIONAL-CHARACTERIZATION; STAPHYLOCOCCUS-AUREUS; PANDINUS-IMPERATOR; VENOM PEPTIDES; LYTIC PEPTIDES; CDNA SEQUENCES; LIPID-BILAYER; MODEL; MICROORGANISMS	Antimicrobial peptides have attracted much interest as a novel class of antibiotics against a variety of microbes including antibiotics resistant strains. In this study, a new cationic antimicrobial peptide Hp1404 was identified from the scorpion Heterometrus petersii, which is an amphipathic alpha-helical peptide and has a specific inhibitory activity against gram-positive bacteria including methicillin-resistant Staphylococcus aureus. Hp1404 can penetrate the membrane of S. aureus at low concentration, and disrupts the cellular membrane directly at super high concentration. S. aureus does not develop drug resistance after multiple treatments with Hp1404 at sub MIC concentration, which is possibly associated with the antibacterial mechanism of the peptide. In addition, Hp1404 has low toxicity to both mammalian cells (HC50 = 226.6 mu g/mL and CC50 > 100 mu g/mL) and balb-c mice (Non-toxicity at 80 mg/Kg by intraperitoneal injection and LD50 = 89.8 mg/Kg by intravenous injection). Interestingly, Hp1404 can improve the survival rate of the MRSA infected balb-c mice in the peritonitis model. Taken together, Hp1404 may have potential applications as an antibacterial agent.	[Li, Zhongjie; Xu, Xiaobo; Meng, Lanxia; Zhang, Qian; Cao, Luyang; Li, Wenxin; Wu, Yingliang; Cao, Zhijian] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China	Wuhan University	Cao, ZJ (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	zjcao@whu.edu.cn		FCCN, Bogus/0000-0001-6282-8004	National Key Basic Research Program in China [2010CB529800, 2010CB530100]	National Key Basic Research Program in China(National Basic Research Program of China)	This work is supported by the grants from National Key Basic Research Program in China (http://www.973.gov.cn/English/AreaList.aspx): Nos. 2010CB529800, and 2010CB530100. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanis AJ, 2005, ARCH MED RES, V36, P697, DOI 10.1016/j.arcmed.2005.06.009; Azad MA, 2011, ANTIMICROB AGENTS CH, V55, P2137, DOI 10.1128/AAC.01148-10; Banerjee Tarun K., 1993, Biomedical and Environmental Sciences, V6, P31; BOMAN HG, 1981, TRENDS BIOCHEM SCI, V6, P306, DOI 10.1146/annurev.mi.41.100187.000535; BRADBURY AF, 1991, TRENDS BIOCHEM SCI, V16, P112, DOI 10.1016/0968-0004(91)90044-V; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Cao LY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040135; Cao LY, 2012, PEPTIDES, V36, P213, DOI 10.1016/j.peptides.2012.04.010; Cassone M, 2010, EXPERT REV ANTI-INFE, V8, P703, DOI [10.1586/eri.10.38, 10.1586/ERI.10.38]; Conde R, 2000, FEBS LETT, V471, P165, DOI 10.1016/S0014-5793(00)01384-3; Corzo G, 2001, BIOCHEM J, V359, P35, DOI 10.1042/0264-6021:3590035; Dai L, 2002, BIOCHEM BIOPH RES CO, V293, P1514, DOI 10.1016/S0006-291X(02)00423-0; Dai L, 2001, BIOCHEM BIOPH RES CO, V286, P820, DOI 10.1006/bbrc.2001.5472; Deslouches B, 2005, ANTIMICROB AGENTS CH, V49, P3208, DOI 10.1128/AAC.49.8.3208-3216.2005; Domenech A, 2004, MICROB DRUG RESIST, V10, P346, DOI 10.1089/mdr.2004.10.346; FITTON JE, 1980, FEBS LETT, V115, P209, DOI 10.1016/0014-5793(80)81170-7; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Hallock KJ, 2003, BIOPHYS J, V84, P3052, DOI 10.1016/S0006-3495(03)70031-9; Hartmann M, 2010, ANTIMICROB AGENTS CH, V54, P3132, DOI 10.1128/AAC.00124-10; Hernandez-Aponte CA, 2011, TOXICON, V57, P84, DOI 10.1016/j.toxicon.2010.10.008; Huang YB, 2010, PROTEIN CELL, V1, P143, DOI 10.1007/s13238-010-0004-3; Isaac RE, 1998, BIOCHEM J, V330, P61, DOI 10.1042/bj3300061; JACOB L, 1994, CIBA F SYMP, V186, P197; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Lee K, 2004, BIOCHEM BIOPH RES CO, V323, P712, DOI 10.1016/j.bbrc.2004.08.144; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Luna-Ramirez K, 2013, TOXICON, V63, P44, DOI 10.1016/j.toxicon.2012.11.017; Meroueh SO, 2006, P NATL ACAD SCI USA, V103, P4404, DOI 10.1073/pnas.0510182103; Morassutti C, 2002, FEBS LETT, V519, P141, DOI 10.1016/S0014-5793(02)02741-2; Park CB, 1998, BIOCHEM BIOPH RES CO, V244, P253, DOI 10.1006/bbrc.1998.8159; Park S, 2001, FEBS LETT, V507, P95, DOI 10.1016/S0014-5793(01)02956-8; Phadke SM, 2003, PEPTIDES, V24, P1099, DOI 10.1016/j.peptides.2003.07.001; Ranjbar B, 2009, CHEM BIOL DRUG DES, V74, P101, DOI 10.1111/j.1747-0285.2009.00847.x; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Silva ECN, 2009, TOXICON, V54, P252, DOI 10.1016/j.toxicon.2009.04.010; Soman NR, 2009, J CLIN INVEST, V119, P2830, DOI 10.1172/JCI38842; Spellberg B, 2004, CLIN INFECT DIS, V38, P1279, DOI 10.1086/420937; Steffen H, 2006, ANTIMICROB AGENTS CH, V50, P2608, DOI 10.1128/AAC.00181-06; Touhami A, 2004, J BACTERIOL, V186, P3286, DOI 10.1128/JB.186.11.3286-3295.2004; Wiesner J, 2010, VIRULENCE, V1, P440, DOI 10.4161/viru.1.5.12983; Yamaguchi S, 2001, BIOPHYS J, V81, P2203, DOI 10.1016/S0006-3495(01)75868-7; Yang L, 2001, BIOPHYS J, V81, P1475, DOI 10.1016/S0006-3495(01)75802-X; Yuan WY, 2010, PEPTIDES, V31, P22, DOI 10.1016/j.peptides.2009.10.008; Zeh DW, 1990, BIOL SCORPIONS, pxxvi; Zeng XC, 2004, PEPTIDES, V25, P143, DOI 10.1016/j.peptides.2003.12.003; Zeng XC, 2013, PEPTIDES, V45, P28, DOI 10.1016/j.peptides.2013.03.026	48	24	30	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97539	10.1371/journal.pone.0097539	http://dx.doi.org/10.1371/journal.pone.0097539			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24826994	Green Published, gold, Green Submitted			2022-12-27	WOS:000336857400107
J	Alto, LT; Chen, X; Ruhn, KA; Trevino, I; Tansey, MG				Alto, Laura Taylor; Chen, Xi; Ruhn, Kelly A.; Trevino, Isaac; Tansey, Malu G.			AAV-Dominant Negative Tumor Necrosis Factor (DN-TNF) Gene Transfer to the Striatum Does Not Rescue Medium Spiny Neurons in the YAC128 Mouse Model of Huntington's Disease	PLOS ONE			English	Article							MICROGLIAL ACTIVATION; MUTANT HUNTINGTIN; DOPAMINERGIC-NEURONS; IMMUNE ACTIVATION; MINOCYCLINE; NEUROINFLAMMATION; NEURODEGENERATION; ABNORMALITIES; EXPRESSION; NEUROTOXICITY	CNS inflammation is a hallmark of neurodegenerative disease, and recent studies suggest that the inflammatory response may contribute to neuronal demise. In particular, increased tumor necrosis factor (TNF) signaling is implicated in the pathology of both Parkinson's disease (PD) and Alzheimer's disease (AD). We have previously shown that localized gene delivery of dominant negative TNF to the degenerating brain region can limit pathology in animal models of PD and AD. TNF is upregulated in Huntington's disease (HD), like in PD and AD, but it is unknown whether TNF signaling contributes to neuronal degeneration in HD. We used in vivo gene delivery to test whether selective reduction of soluble TNF signaling could attenuate medium spiny neuron (MSN) degeneration in the YAC128 transgenic (TG) mouse model of Huntington's disease (HD). AAV vectors encoding cDNA for dominant-negative tumor necrosis factor (DN-TNF) or GFP (control) were injected into the striatum of young adult wild type WT and YAC128 TG mice and achieved 30-50% target coverage. Expression of dominant negative TNF protein was confirmed immunohistologically and biochemically and was maintained as mice aged to one year, but declined significantly over time. However, the extent of striatal DN-TNF gene transfer achieved in our studies was not sufficient to achieve robust effects on neuroinflammation, rescue degenerating MSNs or improve motor function in treated mice. Our findings suggest that alternative drug delivery strategies should be explored to determine whether greater target coverage by DN-TNF protein might afford some level of neuroprotection against HD-like pathology and/or that soluble TNF signaling may not be the primary driver of striatal neuroinflammation and MSN loss in YAC128 TG mice.	[Alto, Laura Taylor; Ruhn, Kelly A.; Trevino, Isaac; Tansey, Malu G.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Chen, Xi; Tansey, Malu G.] Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30322 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Emory University	Tansey, MG (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	malu.tansey@emory.edu			CHDI Foundation; NIH-NINDS [5R01NS049433]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049433] Funding Source: NIH RePORTER	CHDI Foundation; NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Financial support for the authors of this review includes grants from the CHDI Foundation (MGT) and grant 5R01NS049433 from NIH-NINDS (MGT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; Brambilla R, 2011, BRAIN, V134, P2736, DOI 10.1093/brain/awr199; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Chou SY, 2008, J NEUROSCI, V28, P3277, DOI 10.1523/JNEUROSCI.0116-08.2008; Crocker SF, 2006, BRAIN RES, V1088, P176, DOI 10.1016/j.brainres.2006.02.102; Dalrymple A, 2007, J PROTEOME RES, V6, P2833, DOI 10.1021/pr0700753; Ehrlich ME, 2001, EXP NEUROL, V167, P215, DOI 10.1006/exnr.2000.7551; Ehrlich ME, 2012, NEUROTHERAPEUTICS, V9, P270, DOI 10.1007/s13311-012-0112-2; Franciosi S, 2012, NEUROBIOL DIS, V45, P438, DOI 10.1016/j.nbd.2011.09.003; Frank-Cannon TC, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-47; Gao HM, 2008, TRENDS IMMUNOL, V29, P357, DOI 10.1016/j.it.2008.05.002; Godavarthi SK, 2009, J NEUROCHEM, V108, P787, DOI 10.1111/j.1471-4159.2008.05823.x; Harms AS, 2011, MOL THER, V19, P46, DOI 10.1038/mt.2010.217; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Kim HS, 2009, BEHAV BRAIN RES, V196, P168, DOI 10.1016/j.bbr.2008.09.040; Kuno R, 2005, J NEUROIMMUNOL, V162, P89, DOI 10.1016/j.jneuroim.2005.01.015; Kurihara T, 1997, J EXP MED, V186, P1757, DOI 10.1084/jem.186.10.1757; Kwan W, 2012, J CLIN INVEST, V122, P4737, DOI 10.1172/JCI64484; Kwan W, 2012, J NEUROSCI, V32, P133, DOI 10.1523/JNEUROSCI.4846-11.2012; Lawhorn C, 2008, NEUROBIOL DIS, V32, P471, DOI 10.1016/j.nbd.2008.08.006; Leblhuber F, 1998, CLIN CHEM LAB MED, V36, P747, DOI 10.1515/CCLM.1998.132; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Ma L, 2003, GLIA, V43, P274, DOI 10.1002/glia.10261; McAlpine FE, 2009, NEUROBIOL DIS, V34, P163, DOI 10.1016/j.nbd.2009.01.006; McCoy MK, 2008, MOL THER, V16, P1572, DOI 10.1038/mt.2008.146; Mccoy MK, 2006, J NEUROSCI, V26, P9365, DOI 10.1523/JNEUROSCI.1504-06.2006; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; Moller T, 2010, J NEURAL TRANSM, V117, P1001, DOI 10.1007/s00702-010-0430-7; Palazuelos J, 2009, BRAIN, V132, P3152, DOI 10.1093/brain/awp239; Pavese N, 2006, NEUROLOGY, V66, P1638, DOI 10.1212/01.wnl.0000222734.56412.17; Perry VH, 2010, ACTA NEUROPATHOL, V120, P277, DOI 10.1007/s00401-010-0722-x; Politis M, 2011, HUM BRAIN MAPP, V32, P258, DOI 10.1002/hbm.21008; Rampersad RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025833; Rogers JT, 2011, J NEUROSCI, V31, P16241, DOI 10.1523/JNEUROSCI.3667-11.2011; Sapp E, 2001, J NEUROPATH EXP NEUR, V60, P161, DOI 10.1093/jnen/60.2.161; Schwab C, 2010, BBA-MOL BASIS DIS, V1802, P889, DOI 10.1016/j.bbadis.2009.10.013; Silvestroni A, 2009, NEUROREPORT, V20, P1098, DOI 10.1097/WNR.0b013e32832e34ee; Singhrao SK, 1999, EXP NEUROL, V159, P362, DOI 10.1006/exnr.1999.7170; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Sriram K, 2006, FASEB J, V20, P670, DOI 10.1096/fj.05-5106com; Stack EC, 2006, BBA-MOL BASIS DIS, V1762, P373, DOI 10.1016/j.bbadis.2005.11.002; Steed PM, 2003, SCIENCE, V301, P1895, DOI 10.1126/science.1081297; Tai YF, 2007, BRAIN, V130, P1759, DOI 10.1093/brain/awm044; Tang TS, 2007, J NEUROSCI, V27, P7899, DOI 10.1523/JNEUROSCI.1396-07.2007; Tang TS, 2009, J NEUROSCI, V29, P1257, DOI 10.1523/JNEUROSCI.4411-08.2009; Tang TS, 2005, P NATL ACAD SCI USA, V102, P2602, DOI 10.1073/pnas.0409402102; Thompson LM, 2009, J CELL BIOL, V187, P1083, DOI 10.1083/jcb.200909067; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Van Raamsdonk JM, 2007, NEUROBIOL DIS, V26, P189, DOI 10.1016/j.nbd.2006.12.010; Van Raamsdonk JM, 2005, J NEUROSCI, V25, P4169, DOI 10.1523/JNEUROSCI.0590-05.2005; Vasileva A, 2005, NAT REV MICROBIOL, V3, P837, DOI 10.1038/nrmicro1266; Wang X, 2003, P NATL ACAD SCI USA, V100, P10483, DOI 10.1073/pnas.1832501100; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Wild E., 2011, PLOS CURR, V3, DOI DOI 10.1371/CURRENTS.RRN1231; Zalevsky J, 2007, J IMMUNOL, V179, P1872, DOI 10.4049/jimmunol.179.3.1872; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	58	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96544	10.1371/journal.pone.0096544	http://dx.doi.org/10.1371/journal.pone.0096544			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824433	gold, Green Submitted, Green Published			2022-12-27	WOS:000336369200023
J	Bruning, O; Rodenburg, W; van Oostrom, CT; Jonker, MJ; de Jong, M; Dekker, RJ; Rauwerda, H; Ensink, WA; de Vries, A; Breit, TM				Bruning, Oskar; Rodenburg, Wendy; van Oostrom, Conny T.; Jonker, Martijs J.; de Jong, Mark; Dekker, Rob J.; Rauwerda, Han; Ensink, Wim A.; de Vries, Annemieke; Breit, Timo M.			A Range Finding Protocol to Support Design for Transcriptomics Experimentation: Examples of In-Vitro and In-Vivo Murine UV Exposure	PLOS ONE			English	Article							HAIRLESS MICE; FIBROBLASTS; MUTATIONS; RADIATION; STRESS; SER389; GENES; LEVEL; CELLS	In transcriptomics research, design for experimentation by carefully considering biological, technological, practical and statistical aspects is very important, because the experimental design space is essentially limitless. Usually, the ranges of variable biological parameters of the design space are based on common practices and in turn on phenotypic endpoints. However, specific sub-cellular processes might only be partially reflected by phenotypic endpoints or outside the associated parameter range. Here, we provide a generic protocol for range finding in design for transcriptomics experimentation based on small-scale gene-expression experiments to help in the search for the right location in the design space by analyzing the activity of already known genes of relevant molecular mechanisms. Two examples illustrate the applicability: in-vitro UV-C exposure of mouse embryonic fibroblasts and in-vivo UV-B exposure of mouse skin. Our pragmatic approach is based on: framing a specific biological question and associated gene-set, performing a wide-ranged experiment without replication, eliminating potentially non-relevant genes, and determining the experimental 'sweet spot' by gene-set enrichment plus dose-response correlation analysis. Examination of many cellular processes that are related to UV response, such as DNA repair and cell-cycle arrest, revealed that basically each cellular (sub-) process is active at its own specific spot(s) in the experimental design space. Hence, the use of range finding, based on an affordable protocol like this, enables researchers to conveniently identify the 'sweet spot' for their cellular process of interest in an experimental design space and might have far-reaching implications for experimental standardization.	[Bruning, Oskar; Jonker, Martijs J.; de Jong, Mark; Dekker, Rob J.; Rauwerda, Han; Ensink, Wim A.; Breit, Timo M.] Univ Amsterdam, Fac Sci, Swammerdam Inst Life Sci, RNA Biol & Appl Bioinformat Res Grp, Amsterdam, Netherlands; [Bruning, Oskar; Jonker, Martijs J.; de Jong, Mark; Dekker, Rob J.; Rauwerda, Han; Ensink, Wim A.; Breit, Timo M.] Univ Amsterdam, Fac Sci, Swammerdam Inst Life Sci, MAD,Dutch Genom Serv & Support Provider, Amsterdam, Netherlands; [Bruning, Oskar; Jonker, Martijs J.; de Jong, Mark; Dekker, Rob J.; Rauwerda, Han; Breit, Timo M.] Netherlands Bioinformat Ctr NBIC, Nijmegen, Netherlands; [Rodenburg, Wendy; van Oostrom, Conny T.; de Vries, Annemieke] Natl Inst Publ Hlth & Environm RIVM, Ctr Hlth Protect GZB, Bilthoven, Netherlands	University of Amsterdam; University of Amsterdam; Netherlands National Institute for Public Health & the Environment	Breit, TM (corresponding author), Univ Amsterdam, Fac Sci, Swammerdam Inst Life Sci, RNA Biol & Appl Bioinformat Res Grp, Amsterdam, Netherlands.	t.m.breit@uva.nl		Rauwerda, Han/0000-0003-4360-0797	National Institute of Environmental Health Sciences; NIEHS 72-SNP [1R01 ES015587-01A2]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015587] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS 72-SNP; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was partly supported by the National Institute of Environmental Health Sciences (www.niehs.nih.gov), NIEHS 72-SNP grant 1R01 ES015587-01A2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attardi LD, 2004, ONCOGENE, V23, P973, DOI 10.1038/sj.onc.1207026; Baliga NS, 2004, GENOME RES, V14, P1025, DOI 10.1101/gr.1993504; Boerma M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-6; Bonneau R, 2008, NAT CHEM BIOL, V4, P658, DOI 10.1038/nchembio.122; Bruins W, 2004, MOL CELL BIOL, V24, P8884, DOI 10.1128/mcb.24.20.8884-8894.2004; Bruins W, 2008, MOL CELL BIOL, V28, P1974, DOI 10.1128/MCB.01610-07; Bruning O, 2010, TRANSCR-AUSTIN, V1, P159, DOI 10.4161/trns.1.3.13487; Bruning Oskar, 2011, BMC Res Notes, V4, P438, DOI 10.1186/1756-0500-4-438; Busuttil RA, 2003, AGING CELL, V2, P287, DOI 10.1046/j.1474-9728.2003.00066.x; Choi W, 2010, J INVEST DERMATOL, V130, P1685, DOI 10.1038/jid.2010.5; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; de Vries A, 1998, ONCOGENE, V16, P2205, DOI 10.1038/sj.onc.1201744; Dumaz N, 1997, CARCINOGENESIS, V18, P897, DOI 10.1093/carcin/18.5.897; Fisher RA, 1932, STAT METHODS EXPT DE; Flaherty P, 2005, ROBUST DESIGN BIOL E, V18; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; McFeat GD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075800; Meier-Davis SR, 2012, INT J TOXICOL, V31, P337, DOI 10.1177/1091581812447957; Plottner S, 2013, MUTAT RES-GEN TOX EN, V755, P108, DOI 10.1016/j.mrgentox.2013.04.021; Rosa BA, 2012, OPTIMAL TIMEPOINT SA, P1; Singh R., 2005, P 22 INT C MACH LEAR, P832, DOI DOI 10.1145/1102351.1102456; Subramanian A., 2005, GENE SET ENRICHMENT; Tegner J, 2003, P NATL ACAD SCI USA, V100, P5944, DOI 10.1073/pnas.0933416100; VANKRANEN HJ, 1995, CARCINOGENESIS, V16, P1141; Wu D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks461; Zhu F, 2010, CANCER RES, V70, P5851, DOI 10.1158/0008-5472.CAN-09-4646	26	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97089	10.1371/journal.pone.0097089	http://dx.doi.org/10.1371/journal.pone.0097089			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24823911	Green Submitted, gold, Green Published			2022-12-27	WOS:000336369200057
J	Lees, K; Musgaard, M; Suwanmanee, S; Buckingham, SD; Biggin, P; Sattelle, D				Lees, Kristin; Musgaard, Maria; Suwanmanee, Siros; Buckingham, Steven David; Biggin, Philip; Sattelle, David			Actions of Agonists, Fipronil and Ivermectin on the Predominant In Vivo Splice and Edit Variant (RDLbd, I/V) of the Drosophila GABA Receptor Expressed in Xenopus laevis Oocytes	PLOS ONE			English	Article							GATED CHLORIDE CHANNELS; INSECTICIDE RESISTANCE; TRIBOLIUM-CASTANEUM; NODULISPORIC ACID; SUBUNIT GENE; MUTATION; BINDING; ANTIPARASITICS; PHARMACOLOGY; SENSITIVITY	Ionotropic GABA receptors are the targets for several classes of insecticides. One of the most widely-studied insect GABA receptors is RDL (resistance to dieldrin), originally isolated from Drosophila melanogaster. RDL undergoes alternative splicing and RNA editing, which influence the potency of GABA. Most work has focussed on minority isoforms. Here, we report the first characterisation of the predominant native splice variant and RNA edit, combining functional characterisation with molecular modelling of the agonist-binding region. The relative order of agonist potency is GABA> muscimol> TACA> beta-alanine. The I/V edit does not alter the potency of GABA compared to RDLbd. Docking calculations suggest that these agonists bind and activate RDLbdI/V through a similar binding mode. TACA and beta-alanine are predicted to bind with lower affinity than GABA, potentially explaining their lower potency, whereas the lower potency of muscimol and isoguvacine cannot be explained structurally from the docking calculations. The A(301)S ( resistance to dieldrin) mutation reduced the potency of antagonists picrotoxin, fipronil and pyrafluprole but the I/V edit had no measurable effect. Ivermectin suppressed responses to GABA of RDLbdI/V, RDLbd and RDLbdI/VA301S. The dieldrin resistant variant also showed reduced sensitivity to Ivermectin. This study of a highly abundant insect GABA receptor isoform will help the design of new insecticides.	[Lees, Kristin] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Musgaard, Maria; Suwanmanee, Siros; Biggin, Philip] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Buckingham, Steven David; Sattelle, David] UCL, Dept Med, Wolfson Inst Biomed Res, London, England	University of Manchester; University of Oxford; University of London; University College London	Sattelle, D (corresponding author), UCL, Dept Med, Wolfson Inst Biomed Res, London, England.	d.sattelle@ucl.ac.uk		Lees, Kristin/0000-0002-9783-1227; Musgaard, Maria/0000-0001-6096-9014; Biggin, Philip/0000-0001-5100-8836	Merial Ltd, 3239 Satellite Blvd, Duluth, GA USA; Leverhulme Trust [RPG-059]	Merial Ltd, 3239 Satellite Blvd, Duluth, GA USA; Leverhulme Trust(Leverhulme Trust)	This work was supported by Merial Ltd, 3239 Satellite Blvd, Duluth, GA USA 30096 via a post-doctoral grant to KL with DBS. PCB and MM acknowledge support from the Leverhulme Trust (RPG-059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accardi MV, 2012, INVERTEBR NEUROSCI, V12, P3, DOI 10.1007/s10158-012-0129-6; Adelsberger H, 2000, EUR J PHARMACOL, V394, P163, DOI 10.1016/S0014-2999(00)00164-3; Andreev D, 1999, J MOL EVOL, V48, P615, DOI 10.1007/PL00006504; Anthony N, 1998, MOL GEN GENET, V260, P165, DOI 10.1007/s004380050882; Bass C, 2004, PEST MANAG SCI, V60, P1157, DOI 10.1002/ps.937; Bergmann R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052323; BOULANGER T, 1987, J THEOR BIOL, V127, P479, DOI 10.1016/S0022-5193(87)80144-3; BREHM L, 1972, ACTA CHEM SCAND, V26, P1298, DOI 10.3891/acta.chem.scand.26-1298; Buckingham SD, 2005, MOL PHARMACOL, V68, P942, DOI 10.1124/mol.105.015313; Eguchi Y, 2006, INSECT MOL BIOL, V15, P773, DOI 10.1111/j.1365-2583.2006.00680.x; Es-Salah Z, 2008, NEUROREPORT, V19, P939, DOI 10.1097/WNR.0b013e32830216c7; FFRENCHCONSTANT RH, 1993, NATURE, V363, P449, DOI 10.1038/363449a0; FFRENCHCONSTANT RH, 1990, J ECON ENTOMOL, V83, P1733, DOI 10.1093/jee/83.5.1733; FFRENCHCONSTANT RH, 1991, P NATL ACAD SCI USA, V88, P7209, DOI 10.1073/pnas.88.16.7209; Filippova N, 2004, J BIOL CHEM, V279, P20906, DOI 10.1074/jbc.M401012200; Fisher JL, 2004, J PHYSIOL-LONDON, V561, P433, DOI 10.1113/jphysiol.2003.051839; Gielen MC, 2012, J NEUROSCI, V32, P5707, DOI 10.1523/JNEUROSCI.5663-11.2012; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hoopengardner B, 2003, SCIENCE, V301, P832, DOI 10.1126/science.1086763; Hosie Alastair M., 2006, Invertebrate Neuroscience, V6, P75, DOI 10.1007/s10158-006-0020-4; Hosie AM, 2001, NEUROSCIENCE, V102, P709, DOI 10.1016/S0306-4522(00)00483-8; Hosie AM, 1997, TRENDS NEUROSCI, V20, P578, DOI 10.1016/S0166-2236(97)01127-2; Hosie AM, 1996, BRIT J PHARMACOL, V119, P1577, DOI 10.1111/j.1476-5381.1996.tb16075.x; Jones AK, 2009, J NEUROSCI, V29, P4287, DOI 10.1523/JNEUROSCI.5251-08.2009; Kane NS, 2000, P NATL ACAD SCI USA, V97, P13949, DOI 10.1073/pnas.240464697; King MT, 2003, ARCH BIOCHEM BIOPHYS, V410, P280, DOI 10.1016/S0003-9861(02)00692-6; Krause RM, 1998, MOL PHARMACOL, V53, P283, DOI 10.1124/mol.53.2.283; KROGSGAARDLARSEN P, 1981, MOL CELL BIOCHEM, V38, P129, DOI 10.1007/BF00235692; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le Goff G, 2005, J NEUROCHEM, V92, P1295, DOI 10.1111/j.1471-4159.2004.02922.x; Ludmerer SW, 2002, BIOCHEMISTRY-US, V41, P6548, DOI 10.1021/bi015920o; Lummis SCR, 2011, J NEUROSCI, V31, P12371, DOI 10.1523/JNEUROSCI.1610-11.2011; Lynagh T, 2010, J BIOL CHEM, V285, P14890, DOI 10.1074/jbc.M110.107789; MARTIN RJ, 1982, BRIT J PHARMACOL, V77, P255, DOI 10.1111/j.1476-5381.1982.tb09294.x; McGonigle I, 2010, BIOCHEMISTRY-US, V49, P2897, DOI 10.1021/bi901698c; Melis C, 2008, BIOPHYS J, V95, P4115, DOI 10.1529/biophysj.107.127589; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; MIYAZAKI M, 1995, COMP BIOCHEM PHYS B, V111, P399, DOI 10.1016/0305-0491(95)00007-U; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Osolodkin DI, 2009, J MOL GRAPH MODEL, V27, P813, DOI 10.1016/j.jmgm.2008.12.004; Sali A, 1994, MODELLER PROGRAM PRO; Sattelle D.B., 1990, Advances in Insect Physiology, V22, P1, DOI 10.1016/S0065-2806(08)60005-3; Sattelle DB, 2009, BIOCHEM PHARMACOL, V78, P836, DOI 10.1016/j.bcp.2009.06.020; Shan Q, 2001, J BIOL CHEM, V276, P12556, DOI 10.1074/jbc.M011264200; SMART TG, 1980, BRIT J PHARMACOL, V71, P279, DOI 10.1111/j.1476-5381.1980.tb10937.x; Trapani G, 1998, J MED CHEM, V41, P1846, DOI 10.1021/jm970681h; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wolstenholme AJ, 2012, J BIOL CHEM, V287, P40232, DOI 10.1074/jbc.R112.406280; Wolstenholme AJ, 2010, INVERTEBR NEUROSCI, V10, P5, DOI 10.1007/s10158-010-0105-y; Zhao XL, 2010, PESTIC BIOCHEM PHYS, V97, P153, DOI 10.1016/j.pestbp.2009.10.002	51	20	21	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97468	10.1371/journal.pone.0097468	http://dx.doi.org/10.1371/journal.pone.0097468			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24823815	Green Published, gold, Green Submitted			2022-12-27	WOS:000336369200117
J	Mischler, JA; Taylor, PG; Townsend, AR				Mischler, John A.; Taylor, Philip G.; Townsend, Alan R.			Nitrogen Limitation of Pond Ecosystems on the Plains of Eastern Colorado	PLOS ONE			English	Article							FRESH-WATER; NUTRIENT LIMITATION; PHYTOPLANKTON GROWTH; CONTROLLING EUTROPHICATION; PHOSPHORUS LIMITATION; NITRATE UPTAKE; N-2 FIXATION; ARCTIC LAKES; RIVER-BASIN; DENITRIFICATION	Primary production in freshwater ecosystems is often limited by the availability of phosphorus (P), nitrogen (N), or a combination of both (NP co-limitation). While N fixation via heterocystous cyanobacteria can supply additional N, no comparable mechanism for P exists; hence P is commonly considered to be the predominant and ultimate limiting nutrient in freshwater ecosystems. However, N limitation can be maintained if P is supplied in stoichiometric excess of N (including N fixation). The main objective of this study was to examine patterns in nutrient limitation across a series of 21 vernal ponds in Eastern Colorado where high P fluxes are common. Across all ponds, water column dissolved inorganic N steadily decreased throughout the growth season due to biological demand while total dissolved P remained stable. The water column dissolved inorganic N to total dissolved P ratios suggested a transition from NP co-limitation to N limitation across the growth season. Periphyton and phytoplankton %C was strongly correlated with %N while %P was assimilated in excess of %N and %C in many ponds. Similarly, in nutrient addition bottle assays algae responded more strongly to N additions (11 out of 18 water bodies) than P additions (2 out of 18 water bodies) and responded most strongly when N and P were added in concert (12 out of 18 water bodies). Of the ponds that responded to nutrient addition, 92% exhibited some sort of N limitation while less than 8% were limited by P alone. Despite multiple lines of evidence for N limitation or NP co-limitation, N fixation rates were uniformly low across most ponds, most likely due to inhibition by water column nitrate. Within this set of 18 water bodies, N limitation or NP co-limitation is widespread due to the combination high anthropogenic P inputs and constrained N fixation rates.	[Mischler, John A.] Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA; Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Mischler, JA (corresponding author), Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA.	john.mischler@colorado.edu	Townsend, Alan/AAE-9602-2019		National Science Foundation [DGE-0802270]; U.S. Environmental Protection Agency's Science; University of Colorado Boulder	National Science Foundation(National Science Foundation (NSF)); U.S. Environmental Protection Agency's Science(United States Environmental Protection Agency); University of Colorado Boulder	This work was funded by the National Science Foundation Graduate Research Fellowship under Grant No. DGE-0802270, a grant from the U.S. Environmental Protection Agency's Science to Achieve Results (STAR) program, and grants from the University of Colorado Boulder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleinikoff JN, 1999, GEOL SOC AM BULL, V111, P1876, DOI 10.1130/0016-7606(1999)111<1876:LQLINC>2.3.CO;2; ANDERSEN FO, 1992, HYDROBIOLOGIA, V228, P71; Anderson DM, 2002, ESTUARIES, V25, P704, DOI 10.1007/BF02804901; Association APH, 1999, STANDARD METHODS EXA; Axler RP, 1996, LIMNOL OCEANOGR, V41, P659, DOI 10.4319/lo.1996.41.4.0659; Bennett EM, 2001, BIOSCIENCE, V51, P227, DOI 10.1641/0006-3568(2001)051[0227:HIOEPA]2.0.CO;2; BERGMANN MA, 1990, CAN J FISH AQUAT SCI, V47, P1545, DOI 10.1139/f90-174; Bergstrom AK, 2010, AQUAT SCI, V72, P277, DOI 10.1007/s00027-010-0132-0; Bradburn MJ, 2012, FRESHWATER BIOL, V57, P1042, DOI 10.1111/j.1365-2427.2012.02765.x; Bunting L, 2005, INT VER THEOR ANGEW, V29, P1005; Capone D.G., 1993, HDB METHODS AQUATIC, P621, DOI 10.1201/9780203752746-74; Carpenter SR, 2005, P NATL ACAD SCI USA, V102, P10002, DOI 10.1073/pnas.0503959102; Conley DJ, 2009, SCIENCE, V323, P1014, DOI 10.1126/science.1167755; Council NR, 1992, REST AQ EC SCI TECHN; Cronin G, 2007, FRESHWATER BIOL, V52, P1587, DOI 10.1111/j.1365-2427.2007.01790.x; Pinto PD, 2010, OIKOS, V119, P567, DOI 10.1111/j.1600-0706.2009.17924.x; Dennehy KF, 2007, USGS CIRCULAR, V1167, P37; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; DILLON PJ, 1974, LIMNOL OCEANOGR, V19, P767, DOI 10.4319/lo.1974.19.5.0767; Dodds WK, 2009, ENVIRON SCI TECHNOL, V43, P12, DOI 10.1021/es801217q; Dodds WK, 1998, WATER RES, V32, P1455, DOI 10.1016/S0043-1354(97)00370-9; DOWNING JA, 1992, LIMNOL OCEANOGR, V37, P936, DOI 10.4319/lo.1992.37.5.0936; DOYLE RD, 1994, BIOGEOCHEMISTRY, V26, P41, DOI 10.1007/BF02180403; EINSELE WILHELM, 1941, ZEITSCHR FISCH U HILFSW, V39, P407; Elser JJ, 2009, SCIENCE, V326, P835, DOI 10.1126/science.1176199; ELSER JJ, 1990, CAN J FISH AQUAT SCI, V47, P1468, DOI 10.1139/f90-165; Filippelli GM, 2008, ELEMENTS, V4, P89, DOI 10.2113/GSELEMENTS.4.2.89; Finlay JC, 2013, SCIENCE, V342, P247, DOI 10.1126/science.1242575; FLETT RJ, 1976, CAN J MICROBIOL, V22, P43, DOI 10.1139/m76-006; Forshay KJ, 2005, BIOGEOCHEMISTRY, V75, P43, DOI 10.1007/s10533-004-6016-4; Galloway JN, 1998, ENVIRON POLLUT, V102, P15, DOI 10.1016/S0269-7491(98)80010-9; Golterman HL, 1975, PHYSL LIMNOLOGY APPR; Hauer FR, 2006, METHODS STREAM ECOLO, V2; HECKY RE, 1988, LIMNOL OCEANOGR, V33, P796, DOI 10.4319/lo.1988.33.4_part_2.0796; HENRIKSEN A, 1970, ANALYST, V95, P514, DOI 10.1039/an9709500514; Hillebrand H, 1999, LIMNOL OCEANOGR, V44, P440, DOI 10.4319/lo.1999.44.2.0440; Holl CM, 2005, J PHYCOL, V41, P1178, DOI 10.1111/j.1529-8817.2005.00146.x; Howarth R, 2012, FRONT ECOL ENVIRON, V10, P37, DOI 10.1890/100178; HOWARTH RW, 1988, LIMNOL OCEANOGR, V33, P688, DOI 10.4319/lo.1988.33.4_part_2.0688; Hutchinson GE, 1957, TREATISE LIMNOLOGY, P1015; James C, 2003, ARCH HYDROBIOL, V158, P249, DOI 10.1127/0003-9136/2003/0158-0249; Jones John R., 1993, Lake and Reservoir Management, V8, P17; Keck F, 2012, FRESHWATER BIOL, V57, P1410, DOI 10.1111/j.1365-2427.2012.02802.x; Kemp MJ, 2002, ECOL APPL, V12, P998, DOI 10.1890/1051-0761(2002)012[0998:CONADI]2.0.CO;2; Kemp PF, 1993, HDB METHODS AQUATIC, P5; Kirk J. T. O., 1983, LIGHT PHOTOSYNTHESIS; Knopf Fritz L., 1990, P47; Kuo S., 1996, Methods of soil analysis. Part 3 - chemical methods., P869; LARSEN DP, 1979, WATER RES, V13, P1259, DOI 10.1016/0043-1354(79)90170-2; Leavitt PR, 2006, LIMNOL OCEANOGR, V51, P2262, DOI 10.4319/lo.2006.51.5.2262; LEVINE SN, 1992, LIMNOL OCEANOGR, V37, P917, DOI 10.4319/lo.1992.37.5.0917; Lewis WM, 2008, LAKE RESERV MANAGE, V24, P41, DOI 10.1080/07438140809354049; Lewis WM, 2008, INT REV HYDROBIOL, V93, P446, DOI 10.1002/iroh.200811065; Lewis WM, 2011, ENVIRON SCI TECHNOL, V45, P10300, DOI 10.1021/es202401p; Lewis WM, 2002, INT VER THEOR ANGEW, V28, P210; Liu Y, 2008, J IND ECOL, V12, P229, DOI 10.1111/j.1530-9290.2008.00025.x; Marcarelli AM, 2008, J N AM BENTHOL SOC, V27, P186, DOI 10.1899/07-027.1; McCormick PV, 2006, ECOL ENG, V27, P279, DOI 10.1016/j.ecoleng.2006.05.018; McCutchan JH, 2008, INT VER THEOR ANGEW, V30, P323; MIYACHI S, 1964, BIOCHIM BIOPHYS ACTA, V93, P625, DOI 10.1016/0304-4165(64)90345-9; MORRIS DP, 1988, FRESHWATER BIOL, V20, P315, DOI 10.1111/j.1365-2427.1988.tb00457.x; Mugidde R, 2003, J GREAT LAKES RES, V29, P76, DOI 10.1016/S0380-1330(03)70540-1; MULHOLLAND PJ, 1992, J N AM BENTHOL SOC, V11, P405, DOI 10.2307/1467561; Nichols S.A., 2005, RESTORATION MANAGEME, VThird edition; NRC (National Research Council), 2004, END THREAT FISH KLAM; Ogbebo FE, 2009, CAN J FISH AQUAT SCI, V66, P247, DOI 10.1139/F08-202; Paerl HW, 2011, WATER RES, V45, P1973, DOI 10.1016/j.watres.2010.09.018; Paerl HW, 2010, ENVIRON SCI TECHNOL, V44, P7756, DOI 10.1021/es102665e; Paerl HW, 2009, ESTUAR COAST, V32, P593, DOI 10.1007/s12237-009-9158-8; PAERL HW, 1982, ADV MICROB ECOL, V6, P75; Paterson MJ, 2011, LIMNOL OCEANOGR, V56, P1545, DOI 10.4319/lo.2011.56.4.1545; Pina-Ochoa E, 2006, BIOGEOCHEMISTRY, V81, P111, DOI 10.1007/s10533-006-9033-7; Pocernich M, 1997, 33 USGS; PRAIRIE YT, 1989, CAN J FISH AQUAT SCI, V46, P1176, DOI 10.1139/f89-153; Pribyl AL, 2005, BIOGEOCHEMISTRY, V73, P439, DOI 10.1007/s10533-004-0565-4; REDFIELD AC, 1958, AM SCI, V46, P205; Ryding SO, 1989, MAN BIOSPHERE, V1; Sakamoto M., 1966, ARCH HYDROBIOL, V62, P1, DOI 10.1371/journal.pone.0095757; Saunders DL, 2001, WATER RES, V35, P1897, DOI 10.1016/S0043-1354(00)00479-6; Saunders JF, 2003, J AM WATER RESOUR AS, V39, P33, DOI 10.1111/j.1752-1688.2003.tb01559.x; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Schindler DW, 2008, P NATL ACAD SCI USA, V105, P11254, DOI 10.1073/pnas.0805108105; Schindler DW, 2012, P ROY SOC B-BIOL SCI, V279, P4322, DOI 10.1098/rspb.2012.1032; SCHINDLER DW, 1987, CAN J FISH AQUAT SCI, V44, P26; Schindler DW, 1998, ECOSYSTEMS, V1, P323, DOI 10.1007/s100219900026; SCHINDLER DW, 1977, SCIENCE, V195, P260, DOI 10.1126/science.195.4275.260; Scott JT, 2007, BIOGEOCHEMISTRY, V84, P207, DOI 10.1007/s10533-007-9119-x; Scott JT, 2010, LIMNOL OCEANOGR, V55, P1265, DOI 10.4319/lo.2010.55.3.1265; Scott JT, 2005, WETLANDS, V25, P439, DOI 10.1672/18; Sharpley AN, 2003, J SOIL WATER CONSERV, V58, P137; Sjodin AL, 1997, BIOGEOCHEMISTRY, V39, P327, DOI 10.1023/A:1005884117467; Smith VH, 2006, LIMNOL OCEANOGR, V51, P351, DOI 10.4319/lo.2006.51.1_part_2.0351; Smith VH, 2009, TRENDS ECOL EVOL, V24, P201, DOI 10.1016/j.tree.2008.11.009; Smith VH, 1998, SUCCESSES, LIMITATIONS, AND FRONTIERS IN ECOSYSTEM SCIENCE, P7; SMITH VH, 1982, LIMNOL OCEANOGR, V27, P1101, DOI 10.4319/lo.1982.27.6.1101; SOLORZANO L, 1980, LIMNOL OCEANOGR, V25, P754, DOI 10.4319/lo.1980.25.4.0754; Sondergaard M, 2003, HYDROBIOLOGIA, V506, P135, DOI 10.1023/B:HYDR.0000008611.12704.dd; Sprague Lisa, 2002, NHPF Issue Brief, P1; Sterner RW, 2008, INT REV HYDROBIOL, V93, P433, DOI 10.1002/iroh.200811068; Talling Jack F., 1992, Revue d'Hydrobiologie Tropicale, V25, P87; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Vollenweider RA, 1968, D91 SECURESCM; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER; Wurtsbaugh W.A., 1988, VERHANDLUNGEN INT VE, V23, P121, DOI [10.1080/03680770.1987.11897913, DOI 10.1080/03680770.1987.11897913]; Xu H, 2010, LIMNOL OCEANOGR, V55, P420, DOI 10.4319/lo.2010.55.1.0420; YENTSCH CS, 1963, DEEP-SEA RES, V10, P221, DOI 10.1016/0011-7471(63)90358-9	106	21	22	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e95757	10.1371/journal.pone.0095757	http://dx.doi.org/10.1371/journal.pone.0095757			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824838	gold, Green Submitted, Green Published			2022-12-27	WOS:000336369200008
J	Canning, KL; Brown, RE; Jamnik, VK; Salmon, A; Ardern, CI; Kuk, JL				Canning, Karissa L.; Brown, Ruth E.; Jamnik, Veronica K.; Salmon, Art; Ardern, Chris I.; Kuk, Jennifer L.			Individuals Underestimate Moderate and Vigorous Intensity Physical Activity	PLOS ONE			English	Article							MAXIMAL HEART-RATE; HEALTH; INACTIVITY; AGE	Background: It is unclear whether the common physical activity (PA) intensity descriptors used in PA guidelines worldwide align with the associated percent heart rate maximum method used for prescribing relative PA intensities consistently between sexes, ethnicities, age categories and across body mass index (BMI) classifications. Objectives: The objectives of this study were to determine whether individuals properly select light, moderate and vigorous intensity PA using the intensity descriptions in PA guidelines and determine if there are differences in estimation across sex, ethnicity, age and BMI classifications. Methods: 129 adults were instructed to walk/jog at a "light,'' "moderate'' and "vigorous effort'' in a randomized order. The PA intensities were categorized as being below, at or above the following %HRmax ranges of: 50-63% for light, 64-76% for moderate and 77-93% for vigorous effort. Results: On average, people correctly estimated light effort as 51.5 +/- 8.3%HRmax but underestimated moderate effort as 58.7 +/- 10.7%HRmax and vigorous effort as 69.9 +/- 11.9%HRmax. Participants walked at a light intensity (57.4 +/- 10.5%HRmax) when asked to walk at a pace that provided health benefits, wherein 52% of participants walked at a light effort pace, 19% walked at a moderate effort and 5% walked at a vigorous effort pace. These results did not differ by sex, ethnicity or BMI class. However, younger adults underestimated moderate and vigorous intensity more so than middle-aged adults (P<0.05). Conclusion: When the common PA guideline descriptors were aligned with the associated %HRmax ranges, the majority of participants underestimated the intensity of PA that is needed to obtain health benefits. Thus, new subjective descriptions for moderate and vigorous intensity may be warranted to aid individuals in correctly interpreting PA intensities.	[Canning, Karissa L.; Brown, Ruth E.; Jamnik, Veronica K.; Ardern, Chris I.; Kuk, Jennifer L.] York Univ, Sch Kinesiol, Toronto, ON M3J 2R7, Canada; [Salmon, Art] Ontario Minist Tourism Culture & Sport, Toronto, ON, Canada	York University - Canada	Kuk, JL (corresponding author), York Univ, Sch Kinesiol, Toronto, ON M3J 2R7, Canada.	jennkuk@yorku.ca			Heart and Stroke Foundation; Faculty of Health, York University, Canada	Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); Faculty of Health, York University, Canada	This study was supported in part by a research grant to JL Kuk from the Heart and Stroke Foundation and from the Faculty of Health, York University, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Sports Medicine, 2000, GUID EX TEST PRESCR; Australian Government Department of Health, 2013, AUSTR PHYS ACT SED B; BLAIR SN, 1992, ANNU REV PUBL HEALTH, V13, P99, DOI 10.1146/annurev.pu.13.050192.000531; Braham R, 2012, J SCI MED SPORT, V15, P322, DOI 10.1016/j.jsams.2011.11.252; Canadian Society for Exercise Physiology, 2011, CAN PHYS ACT GUID; Colley Rachel C, 2011, Health Rep, V22, P7; Engels HJ, 1998, RES Q EXERCISE SPORT, V69, P94, DOI 10.1080/02701367.1998.10607673; Gellish RL, 2007, MED SCI SPORT EXER, V39, P822, DOI 10.1097/mss.0b013e31803349c6; Health Canada, 1998, CAN PHYS ACT HLTH AC; Jamnik VK, 2011, APPL PHYSIOL NUTR ME, V36, pS3, DOI [10.1139/h11-044, 10.1139/H11-044]; Kesaniemi A, 2001, MED SCI SPORTS EXERC, pS351; Kohl HW, 2012, LANCET, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Macfarlane D, 2010, PUBLIC HEALTH NUTR, V14, P1; National Center for Disease Control and Prevention, 2011, MUCH PHYS ACT AD NEE; NOBLE BJ, 1983, MED SCI SPORT EXER, V15, P523; Public Health Agency of Canada, 2007, BEN PHYS ACT; Public Health Agency of Canada, 2011, PHYS ACT GUID; Ready AE, 2009, APPL PHYSIOL NUTR ME, V34, P172, DOI 10.1139/H08-143; Spackman M. B., 2001, Measurement in Physical Education and Exercise Science, V5, P1, DOI 10.1207/S15327841MPEE0501_1; SPELMAN CC, 1993, MED SCI SPORT EXER, V25, P1174; US Department of Human and Health Services, 2008, PHYS ACT GUID AM; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; WHALEY MH, 1992, MED SCI SPORT EXER, V24, P1173; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; WILMORE J, 2004, PHYSL SPORT EXERCISE; World Health Organization, 2012, PHYS IN GLOB PUBL HL	27	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97927	10.1371/journal.pone.0097927	http://dx.doi.org/10.1371/journal.pone.0097927			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835105	Green Submitted, gold, Green Published			2022-12-27	WOS:000339614800084
J	Wang, X; Fu, YF; Wang, RY; Li, L; Cao, YH; Chen, YQ; Zhao, HZ; Zhang, QQ; Wu, JQ; Weng, XH; Cheng, XJ; Zhu, LP				Wang, Xuan; Fu, Yong-Feng; Wang, Rui-Ying; Li, Li; Cao, Ya-Hui; Chen, Yan-Qiong; Zhao, Hua-Zhen; Zhang, Qiang-Qiang; Wu, Ji-Qin; Weng, Xin-Hua; Cheng, Xun-Jia; Zhu, Li-Ping			Identification of Clinically Relevant Fungi and Prototheca Species by rRNA Gene Sequencing and Multilocus PCR Coupled with Electrospray Ionization Mass Spectrometry	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; MEDICALLY IMPORTANT YEASTS; BLOOD-STREAM INFECTIONS; RAPID IDENTIFICATION; BASIDIOMYCETOUS YEASTS; ASCOMYCETOUS YEASTS; DNA; ASPERGILLUS; REGION; MOLDS	Background: Multilocus PCR coupled with electrospray ionization mass spectrometry (PCR/ESI-MS) is a new strategy for pathogen identification, but information about its application in fungal identification remains sparse. Methods: One-hundred and twelve strains and isolates of clinically important fungi and Prototheca species were subjected to both rRNA gene sequencing and PCR/ESI-MS. Three regions of the rRNA gene were used as targets for sequencing: the 5' end of the large subunit rRNA gene (D1/D2 region), and the internal transcribed spacers 1 and 2 (ITS1 and ITS2 regions). Microbial identification (Micro ID), acquired by combining results of phenotypic methods and rRNA gene sequencing, was used to evaluate the results of PCR/ESI-MS. Results: For identification of yeasts and filamentous fungi, combined sequencing of the three regions had the best performance (species-level identification rate of 93.8% and 81.8% respectively). The highest species-level identification rate was achieved by sequencing of D1/D2 for yeasts (92.2%) and ITS2 for filamentous fungi (75.8%). The two Prototheca species could be identified to species level by D1/D2 sequencing but not by ITS1 or ITS2. For the 102 strains and isolates within the coverage of PCR/ESI-MS identification, 87.3% (89/102) achieved species-level identification, 100% (89/89) of which were concordant to Micro ID on species/complex level. The species-level identification rates for yeasts and filamentous fungi were 93.9% (62/66) and 75% (27/36) respectively. Conclusions: rRNA gene sequencing provides accurate identification information, with the best results obtained by a combination of ITS1, ITS2 and D1/D2 sequencing. Our preliminary data indicated that PCR/ESI-MS method also provides a rapid and accurate identification for many clinical relevant fungi.	[Wang, Xuan; Wang, Rui-Ying; Cao, Ya-Hui; Chen, Yan-Qiong; Zhao, Hua-Zhen; Wu, Ji-Qin; Weng, Xin-Hua; Zhu, Li-Ping] Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai, Peoples R China; [Fu, Yong-Feng; Cheng, Xun-Jia] Fudan Univ, Shanghai Med Coll, Dept Med Microbiol & Parasitol, Shanghai, Peoples R China; [Li, Li; Zhang, Qiang-Qiang] Fudan Univ, Huashan Hosp, Dept Dermatol, Mycol Lab, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University	Cheng, XJ (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Med Microbiol & Parasitol, Shanghai, Peoples R China.	xjcheng@shmu.edu.cn; zhulp@fudan.edu.cn	付, 永鋒/Q-2449-2019	付, 永鋒/0000-0002-9867-9722; Wang, Ruiying/0000-0002-3638-4582	Chinese Major Infectious Disease Fund [2013ZX10004612]	Chinese Major Infectious Disease Fund	This work was supported by the Chinese Major Infectious Disease Fund (grant number: 2013ZX10004612). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balajee SA, 2007, STUD MYCOL, P39, DOI 10.3114/sim.2007.59.05; Balajee SA, 2009, J CLIN MICROBIOL, V47, P877, DOI 10.1128/JCM.01685-08; Balajee SA, 2007, MED MYCOL, V45, P475, DOI 10.1080/13693780701449425; Begerow D, 2010, APPL MICROBIOL BIOT, V87, P99, DOI 10.1007/s00253-010-2585-4; Borman AM, 2007, J ANTIMICROB CHEMOTH, V61, pI7, DOI 10.1093/jac/dkm425; Boyanton BL, 2008, ARCH PATHOL LAB MED, V132, P667, DOI 10.1043/1543-2165(2008)132[667:DPIOPC]2.0.CO;2; Caston-Osorio JJ, 2008, INT J ANTIMICROB AG, V32, pS103, DOI 10.1016/S0924-8579(08)70009-8; Chang PK, 2010, INT J FOOD MICROBIOL, V138, P189, DOI 10.1016/j.ijfoodmicro.2010.01.033; Chen YC, 2000, J CLIN MICROBIOL, V38, P2302; Chen YC, 2001, J CLIN MICROBIOL, V39, P4042, DOI 10.1128/JCM.39.11.4042-4051.2001; Ciardo DE, 2007, DIAGN MICR INFEC DIS, V59, P49, DOI 10.1016/j.diagmicrobio.2007.04.020; Ciardo DE, 2010, J CLIN MICROBIOL, V48, P2809, DOI 10.1128/JCM.00289-10; Cuenca-Estrella M, 2008, INT J ANTIMICROB AG, V32, pS143, DOI 10.1016/S0924-8579(08)70016-5; Daniel HM, 2003, INT J FOOD MICROBIOL, V86, P61, DOI 10.1016/S0168-1605(03)00248-4; De Carolis E, 2012, CLIN MICROBIOL INFEC, V18, P475, DOI 10.1111/j.1469-0691.2011.03599.x; Desnos-Ollivier M, 2008, J CLIN MICROBIOL, V46, P3237, DOI 10.1128/JCM.01451-08; Eberhardt Ursula, 2012, Methods Mol Biol, V858, P183, DOI 10.1007/978-1-61779-591-6_9; Ecker DJ, 2008, NAT REV MICROBIOL, V6, P553, DOI 10.1038/nrmicro1918; Eckert DJ, 2010, EXPERT REV MOL DIAGN, V10, P399, DOI [10.1586/erm.10.24, 10.1586/ERM.10.24]; Fell JW, 2000, INT J SYST EVOL MICR, V50, P1351, DOI 10.1099/00207713-50-3-1351; Garey KW, 2006, CLIN INFECT DIS, V43, P25, DOI 10.1086/504810; Gu ZM, 2012, MED MYCOL, V50, P259, DOI 10.3109/13693786.2011.600341; Juhasz A, 2007, ANTON LEEUW INT J G, V91, P209, DOI 10.1007/s10482-006-9110-x; Kaleta EJ, 2011, J CLIN MICROBIOL, V49, P345, DOI 10.1128/JCM.00936-10; Klein KR, 2009, J CLIN MICROBIOL, V47, P3669, DOI 10.1128/JCM.01072-09; Kriengkauykiat Jane, 2011, Clin Epidemiol, V3, P175, DOI 10.2147/CLEP.S12502; Kurtzman CP, 1997, J CLIN MICROBIOL, V35, P1216, DOI 10.1128/JCM.35.5.1216-1223.1997; KWONCHUNG KJ, 1982, J CLIN MICROBIOL, V15, P535, DOI 10.1128/JCM.15.3.535-537.1982; Leaw SN, 2006, J CLIN MICROBIOL, V44, P693, DOI 10.1128/JCM.44.3.693-699.2006; Massire C, 2013, J CLIN MICROBIOL, V51, P959, DOI 10.1128/JCM.02621-12; McTaggart L, 2011, J CLIN MICROBIOL, V49, P2522, DOI 10.1128/JCM.00502-11; Perea S, 2002, CLIN INFECT DIS, V35, P1073, DOI 10.1086/344058; Rakeman JL, 2005, J CLIN MICROBIOL, V43, P3324, DOI 10.1128/JCM.43.7.3324-3333.2005; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Scorzetti G, 2002, FEMS YEAST RES, V2, P495, DOI 10.1111/j.1567-1364.2002.tb00117.x; Seifert KA, 2009, MOL ECOL RESOUR, V9, P83, DOI 10.1111/j.1755-0998.2009.02635.x; Shendure JA, 2011, CURR PROTOC MOL BIOL, V81, P711; Shin JH, 2013, J CLIN MICROBIOL, V51, P136, DOI 10.1128/JCM.01907-12; Simner PJ, 2013, J CLIN MICROBIOL, V51, P1699, DOI 10.1128/JCM.03282-12; Spanu T, 2012, J CLIN MICROBIOL, V50, P176, DOI 10.1128/JCM.05742-11; Verweij PE, 1999, J CLIN PATHOL, V52, P271, DOI 10.1136/jcp.52.4.271; Wolk DM, 2009, J CLIN MICROBIOL, V47, P3129, DOI 10.1128/JCM.00709-09	42	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e98110	10.1371/journal.pone.0098110	http://dx.doi.org/10.1371/journal.pone.0098110			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835205	Green Published, Green Submitted, gold			2022-12-27	WOS:000339614800105
J	Obermayer, A; Stoiber, W; Krautgartner, WD; Klappacher, M; Kofler, B; Steinbacher, P; Vitkov, L; Grabcanovic-Musija, F; Studnicka, M				Obermayer, Astrid; Stoiber, Walter; Krautgartner, Wolf-Dietrich; Klappacher, Michaela; Kofler, Barbara; Steinbacher, Peter; Vitkov, Ljubomir; Grabcanovic-Musija, Fikreta; Studnicka, Michael			New Aspects on the Structure of Neutrophil Extracellular Traps from Chronic Obstructive Pulmonary Disease and In Vitro Generation	PLOS ONE			English	Article							ELASTASE; IMMUNITY; INFILTRATION; INFLAMMATION; CHROMATIN; BACTERIA; NETOSIS; SMOKE; DNA	Polymorphonuclear neutrophils have in recent years attracted new attention due to their ability to release neutrophil extracellular traps (NETs). These web-like extracellular structures deriving from nuclear chromatin have been depicted in ambiguous roles between antimicrobial defence and host tissue damage. NETs consist of DNA strands of varying thickness and are decorated with microbicidal and cytotoxic proteins. Their principal structure has in recent years been characterised at molecular and ultrastructural levels but many features that are of direct relevance to cytotoxicity are still incompletely understood. These include the extent of chromatin decondensation during NET formation and the relative amounts and spatial distribution of the microbicidal components within the NET. In the present work, we analyse the structure of NETs found in induced sputum of patients with acutely exacerbated chronic obstructive pulmonary disease (COPD) using confocal laser microscopy and electron microscopy. In vitro induced NETs from human neutrophils serve for purposes of comparison and extended analysis of NET structure. Results demonstrate that COPD sputa are characterised by the pronounced presence of NETs and NETotic neutrophils. We provide new evidence that chromatin decondensation during NETosis is most extensive and generates substantial amounts of double-helix DNA in 'beads-on-a-string' conformation. New information is also presented on the abundance and location of neutrophil elastase (NE) and citrullinated histone H3 (citH3). NE occurs in high densities in nearly all non-fibrous constituents of the NETs while citH3 is much less abundant. We conclude from the results that (i) NETosis is an integral part of COPD pathology; this is relevant to all future research on the etiology and therapy of the disease; and that (ii) release of 'beads-on-a-string' DNA studded with non-citrullinated histones is a common feature of in vivo NETosis; this is of relevance to both the antimicrobial and the cytotoxic effects of NETs.	[Obermayer, Astrid; Stoiber, Walter; Krautgartner, Wolf-Dietrich; Klappacher, Michaela; Steinbacher, Peter; Vitkov, Ljubomir] Salzburg Univ, Dept Cell Biol, A-5020 Salzburg, Austria; [Kofler, Barbara] Paracelsus Med Univ, Dept Pediat, Salzburg, Austria; [Vitkov, Ljubomir] Univ Saarland, Clin Operat Dent Periodontol & Prevent Dent, Homburg, Germany; [Grabcanovic-Musija, Fikreta; Studnicka, Michael] Paracelsus Med Univ, Univ Clin Pneumol, Salzburg, Austria	Salzburg University; Paracelsus Private Medical University; Saarland University; Paracelsus Private Medical University	Obermayer, A (corresponding author), Salzburg Univ, Dept Cell Biol, A-5020 Salzburg, Austria.	astrid.obermayer@sbg.ac.at	Vitkov, Ljubomir/H-5873-2019	Vitkov, Ljubomir/0000-0002-1249-0161; Steinbacher, Peter/0000-0001-8033-5190; Kofler, Barbara/0000-0002-1198-4776	Austrian Research Promotion Agency (FFG) [822782/THERAPEP]	Austrian Research Promotion Agency (FFG)	Parts of the study were supported by the Austrian Research Promotion Agency (FFG, 822782/THERAPEP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Anzilotti C, 2010, AUTOIMMUN REV, V9, P158, DOI 10.1016/j.autrev.2009.06.002; Arazna M, 2013, RESP PHYSIOL NEUROBI, V187, P74, DOI 10.1016/j.resp.2013.03.002; Baraldo S, 2004, THORAX, V59, P308, DOI 10.1136/thx.2003.012146; Belaaouaj A, 2002, MICROBES INFECT, V4, P1259, DOI 10.1016/S1286-4579(02)01654-4; Bock CT, 2007, PROTEINS, P105; Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P7; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2012, J CELL BIOL, V198, P773, DOI 10.1083/jcb.201203170; Daban JR, 2011, MICRON, V42, P733, DOI 10.1016/j.micron.2011.05.002; Douda DN, 2011, J IMMUNOL, V187, P1856, DOI 10.4049/jimmunol.1004201; Dubois AV, 2012, AM J RESP CELL MOL, V47, P80, DOI 10.1165/rcmb.2011-0380OC; Dworski R, 2011, J ALLERGY CLIN IMMUN, V127, P1260, DOI 10.1016/j.jaci.2010.12.1103; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Gaschler GJ, 2009, AM J RESP CRIT CARE, V179, P666, DOI 10.1164/rccm.200808-1306OC; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Kaplan MJ, 2012, J IMMUNOL, V189, P2689, DOI 10.4049/jimmunol.1201719; Khandpur R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005580; Leshner M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00307; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Manzenreiter R, 2012, J CYST FIBROS, V11, P84, DOI 10.1016/j.jcf.2011.09.008; Marcos V, 2010, NAT MED, V16, P1018, DOI 10.1038/nm.2209; Marcos V, 2009, BLOOD, V114, P4908, DOI 10.1182/blood-2009-09-242388; McDonough JE, 2011, NEW ENGL J MED, V365, P1567, DOI 10.1056/NEJMoa1106955; Mehrzad J., 2012, RECENT ADV IMMUNOLOG, P383; Neeli I, 2008, J IMMUNOL, V180, P1895, DOI 10.4049/jimmunol.180.3.1895; Neeli I, 2009, J INNATE IMMUN, V1, P194, DOI 10.1159/000206974; Ohbayashi Ohji, 2011, Nihon Rinsho, V69, P1741; Papayannopoulos V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028526; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Pilsczek FH, 2010, J IMMUNOL, V185, P7413, DOI 10.4049/jimmunol.1000675; Pratesi F., 2013, ANN RHEUM DIS, DOI 10.1136/annrheumdis-2012-202765; Profita M, 2010, AM J PHYSIOL-LUNG C, V298, pL261, DOI 10.1152/ajplung.90593.2008; Radic M, 2013, SEMIN IMMUNOPATHOL, V35, P465, DOI 10.1007/s00281-013-0376-6; Rattner JB, 1981, ELECT MICROSCOPY BIO, P31; Remijsen Q, 2011, CELL DEATH DIFFER, V18, P581, DOI 10.1038/cdd.2011.1; Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366; Sandhaus RA, 2013, COPD, V10, P60, DOI 10.3109/15412555.2013.764403; Singh D, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-77; Ungurs MJ, 2014, AM J PHYSIOL-LUNG C, V306, pL80, DOI 10.1152/ajplung.00221.2013; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Vitkov L, 2009, J PERIODONTAL RES, V44, P664, DOI 10.1111/j.1600-0765.2008.01175.x; von Kockritz-Blickwede M, 2009, J MOL MED, V87, P775, DOI 10.1007/s00109-009-0481-0; Weier HUG, 2001, J HISTOCHEM CYTOCHEM, V49, P939, DOI 10.1177/002215540104900802; Yipp BG, 2012, NAT MED, V18, P1386, DOI 10.1038/nm.2847; Young RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023637; Zhang XJ, 2011, CYTOKINE, V56, P717, DOI 10.1016/j.cyto.2011.09.010	48	58	64	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97784	10.1371/journal.pone.0097784	http://dx.doi.org/10.1371/journal.pone.0097784			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831032	gold, Green Published, Green Submitted			2022-12-27	WOS:000336789500116
J	Ren, T; Wang, JG; Chen, Q; Zhang, FS; Lu, SC				Ren, Tao; Wang, Jingguo; Chen, Qing; Zhang, Fusuo; Lu, Shuchang			The Effects of Manure and Nitrogen Fertilizer Applications on Soil Organic Carbon and Nitrogen in a High-Input Cropping System	PLOS ONE			English	Article							VEGETABLE PRODUCTION; MATTER FRACTIONS; WATER-USE; MANAGEMENT; MINERALIZATION; DYNAMICS; EMISSIONS; GRASSLAND; QUALITY; YIELD	With the goal of improving N fertilizer management to maximize soil organic carbon (SOC) storage and minimize N losses in high-intensity cropping system, a 6-years greenhouse vegetable experiment was conducted from 2004 to 2010 in Shouguang, northern China. Treatment tested the effects of organic manure and N fertilizer on SOC, total N (TN) pool and annual apparent N losses. The results demonstrated that SOC and TN concentrations in the 0-10cm soil layer decreased significantly without organic manure and mineral N applications, primarily because of the decomposition of stable C. Increasing C inputs through wheat straw and chicken manure incorporation couldn't increase SOC pools over the 4 year duration of the experiment. In contrast to the organic manure treatment, the SOC and TN pools were not increased with the combination of organic manure and N fertilizer. However, the soil labile carbon fractions increased significantly when both chicken manure and N fertilizer were applied together. Additionally, lower optimized N fertilizer inputs did not decrease SOC and TN accumulation compared with conventional N applications. Despite the annual apparent N losses for the optimized N treatment were significantly lower than that for the conventional N treatment, the unchanged SOC over the past 6 years might limit N storage in the soil and more surplus N were lost to the environment. Consequently, optimized N fertilizer inputs according to root-zone N management did not influence the accumulation of SOC and TN in soil; but beneficial in reducing apparent N losses. N fertilizer management in a greenhouse cropping system should not only identify how to reduce N fertilizer input but should also be more attentive to improving soil fertility with better management of organic manure.	[Ren, Tao; Wang, Jingguo; Chen, Qing; Zhang, Fusuo] China Agr Univ, Coll Resources & Environm Sci, Beijing 100094, Peoples R China; [Ren, Tao] Huazhong Agr Univ, Coll Resources & Environm, Wuhan, Peoples R China; [Lu, Shuchang] Tianjin Agr Univ, Dept Agron, Tianjin, Peoples R China	China Agricultural University; Huazhong Agricultural University; Tianjin Agricultural University	Chen, Q (corresponding author), China Agr Univ, Coll Resources & Environm Sci, Beijing 100094, Peoples R China.	qchen@cau.edu.cn	Zhang, Fusuo/AAV-4517-2021; Ren, Tao/P-1434-2014	Ren, Tao/0000-0003-1986-7985; Ren, Tao/0000-0002-7147-3775	National Natural Science Foundation of China [31071858]; Innovative Research Team of Beijing Fruit Vegetable Industry; NSFC [30821003]; Basic Application and Cutting-edge Technology Research Projects of Tianjin City [09JCYBJC08600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovative Research Team of Beijing Fruit Vegetable Industry; NSFC(National Natural Science Foundation of China (NSFC)); Basic Application and Cutting-edge Technology Research Projects of Tianjin City	The authors are grateful to the National Natural Science Foundation of China (No. 31071858), Innovative Research Team of Beijing Fruit Vegetable Industry, the innovative group grant of NSFC (No. 30821003) and Basic Application and Cutting-edge Technology Research Projects of Tianjin City (09JCYBJC08600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accoe F, 2004, SOIL BIOL BIOCHEM, V36, P2075, DOI 10.1016/j.soilbio.2004.06.006; Adani F, 2007, WASTE MANAGE, V27, P319, DOI 10.1016/j.wasman.2006.04.004; AJWA HA, 1994, BIOL FERT SOILS, V18, P175, DOI 10.1007/BF00647664; [Anonymous], AGR WATER MANAGE, V96, P23; Antil RS, 2005, J PLANT NUTR SOIL SC, V168, P108, DOI 10.1002/jpln.200421461; Bird JA, 2002, SOIL SCI SOC AM J, V66, P478, DOI 10.2136/sssaj2002.0478; Blagodatskaya E, 2008, BIOL FERT SOILS, V45, P115, DOI 10.1007/s00374-008-0334-y; BLAIR GJ, 1995, AUST J AGR RES, V46, P1459, DOI 10.1071/AR9951459; Blair N, 2006, SOIL TILL RES, V91, P30, DOI 10.1016/j.still.2005.11.002; Cayuela ML, 2010, GEODERMA, V157, P235, DOI 10.1016/j.geoderma.2010.04.026; Chen Q, 2004, NUTR CYCL AGROECOSYS, V69, P51, DOI 10.1023/B:FRES.0000025293.99199.ff; Christopher SF, 2007, CRIT REV PLANT SCI, V26, P45, DOI 10.1080/07352680601174830; Compton JE, 2002, SOIL BIOL BIOCHEM, V34, P933, DOI 10.1016/S0038-0717(02)00025-1; Constantin J, 2010, AGR ECOSYST ENVIRON, V135, P268, DOI 10.1016/j.agee.2009.10.005; Cookson WR, 2005, SOIL BIOL BIOCHEM, V37, P1726, DOI 10.1016/j.soilbio.2005.02.007; Degens BP, 2000, SOIL BIOL BIOCHEM, V32, P189, DOI 10.1016/S0038-0717(99)00141-8; Dolan MS, 2006, SOIL TILL RES, V89, P221, DOI 10.1016/j.still.2005.07.015; Edmeades DC, 2003, NUTR CYCL AGROECOSYS, V66, P165, DOI 10.1023/A:1023999816690; Feller C, 2002, ACTA HORTIC, P195, DOI 10.17660/ActaHortic.2002.571.23; Fonte SJ, 2009, SOIL SCI SOC AM J, V73, P961, DOI 10.2136/sssaj2008.0204; Ge XiaoGuang, 2004, Acta Horticulturae Sinica, V31, P34; Gundersen P, 1998, ENVIRON POLLUT, V102, P403, DOI 10.1016/S0269-7491(98)80060-2; Guo RY, 2008, PLANT SOIL, V313, P55, DOI 10.1007/s11104-008-9679-0; Hagedorn F, 2003, SOIL BIOL BIOCHEM, V35, P1683, DOI 10.1016/j.soilbio.2003.08.015; Hassink J, 1997, PLANT SOIL, V191, P77, DOI 10.1023/A:1004213929699; He FF, 2007, NUTR CYCL AGROECOSYS, V77, P1, DOI 10.1007/s10705-006-6275-7; He FF, 2009, ENVIRON POLLUT, V157, P1666, DOI 10.1016/j.envpol.2008.12.017; Jagadamma S, 2007, SOIL TILL RES, V95, P348, DOI 10.1016/j.still.2007.02.006; Ju XT, 2006, ENVIRON POLLUT, V143, P117, DOI 10.1016/j.envpol.2005.11.005; Lei BK, 2010, SOIL SCI SOC AM J, V74, P1320, DOI 10.2136/sssaj2009.0222; [雷宝坤 LEI Baokun], 2008, [植物营养与肥料学报, Plant Nutrition and Fertitizer Science], V14, P914; Lemke RL, 2010, AGR ECOSYST ENVIRON, V135, P42, DOI 10.1016/j.agee.2009.08.010; Li ZP, 2010, SOIL TILL RES, V106, P268, DOI 10.1016/j.still.2009.12.008; Lin Y, 2010, THESIS CHINA AGR U B; Liu J, 2012, J PLANT NUTR SOIL SC, V175, P698, DOI 10.1002/jpln.201100172; Liu LL, 2010, ECOL LETT, V13, P819, DOI 10.1111/j.1461-0248.2010.01482.x; Lu M, 2011, AGR ECOSYST ENVIRON, V140, P234, DOI 10.1016/j.agee.2010.12.010; Mack MC, 2004, NATURE, V431, P440, DOI 10.1038/nature02887; Malhi SS, 2003, NUTR CYCL AGROECOSYS, V66, P33, DOI 10.1023/A:1023376905096; Mao XS, 2003, AGR WATER MANAGE, V61, P219, DOI 10.1016/S0378-3774(03)00022-2; McLauchlan KK, 2004, SOIL SCI SOC AM J, V68, P1616, DOI 10.2136/sssaj2004.1616; Neff JC, 2002, NATURE, V419, P915, DOI 10.1038/nature01136; Oborn I, 2003, EUR J AGRON, V20, P211, DOI 10.1016/S1161-0301(03)00080-7; Pare MC, 2013, GLOBAL CHANGE BIOL, V19, P1126, DOI 10.1111/gcb.12125; Piccolo A, 2004, CLIMATIC CHANGE, V67, P329, DOI 10.1007/s10584-004-1822-1; Plaza C, 2005, AGROCHIMICA, V49, P87; Ren T, 2010, SCI HORTIC-AMSTERDAM, V125, P25, DOI 10.1016/j.scienta.2010.02.014; RYDEN JC, 1980, SOIL SCI SOC AM J, V44, P505, DOI 10.2136/sssaj1980.03615995004400030013x; SCHIMEL DS, 1986, BIOGEOCHEMISTRY, V2, P345, DOI 10.1007/BF02180325; Sieling K, 2006, AGR ECOSYST ENVIRON, V115, P261, DOI 10.1016/j.agee.2006.01.011; Six J, 2000, SOIL SCI SOC AM J, V64, P681, DOI 10.2136/sssaj2000.642681x; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Song XZ, 2009, CR BIOL, V332, P385, DOI 10.1016/j.crvi.2008.11.005; Swanston C, 2004, BIOGEOCHEMISTRY, V70, P227, DOI 10.1023/B:BIOG.0000049341.37579.86; Wang Xiao-juan, 2012, Yingyong Shengtai Xuebao, V23, P159; Yang YH, 2011, NEW PHYTOL, V190, P977, DOI 10.1111/j.1469-8137.2011.03645.x; [曾希柏 ZENG Xi-Bai], 2009, [生态学报, Acta Ecologica Sinica], V29, P3737; Zhao XC, 2011, THESIS CHINA AGR U B; Zotarelli L, 2009, AGR WATER MANAGE, V96, P23, DOI 10.1016/j.agwat.2008.06.007	59	50	51	3	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97732	10.1371/journal.pone.0097732	http://dx.doi.org/10.1371/journal.pone.0097732			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830463	Green Submitted, Green Published, gold			2022-12-27	WOS:000336789500109
J	Asaoka, Y; Hata, S; Namae, M; Furutani-Seiki, M; Nishina, H				Asaoka, Yoichi; Hata, Shoji; Namae, Misako; Furutani-Seiki, Makoto; Nishina, Hiroshi			The Hippo Pathway Controls a Switch between Retinal Progenitor Cell Proliferation and Photoreceptor Cell Differentiation in Zebrafish	PLOS ONE			English	Article							YES-ASSOCIATED PROTEIN; WW DOMAIN; SIGNALING PATHWAY; TRANSCRIPTIONAL ACTIVATOR; NEURONAL DIFFERENTIATION; EMBRYONIC-DEVELOPMENT; NEGATIVE REGULATION; FATE DETERMINATION; MAMMALIAN RETINA; SELF-RENEWAL	The precise regulation of numbers and types of neurons through control of cell cycle exit and terminal differentiation is an essential aspect of neurogenesis. The Hippo signaling pathway has recently been identified as playing a crucial role in promoting cell cycle exit and terminal differentiation in multiple types of stem cells, including in retinal progenitor cells. When Hippo signaling is activated, the core Mst1/2 kinases activate the Lats1/2 kinases, which in turn phosphorylate and inhibit the transcriptional cofactor Yap. During mouse retinogenesis, overexpression of Yap prolongs progenitor cell proliferation, whereas inhibition of Yap decreases this proliferation and promotes retinal cell differentiation. However, to date, it remains unknown how the Hippo pathway affects the differentiation of distinct neuronal cell types such as photoreceptor cells. In this study, we investigated whether Hippo signaling regulates retinogenesis during early zebrafish development. Knockdown of zebrafish mst2 induced early embryonic defects, including altered retinal pigmentation and morphogenesis. Similar abnormal retinal phenotypes were observed in zebrafish embryos injected with a constitutively active form of yap [(yap (5SA)]. Loss of Yap's TEAD-binding domain, two WW domains, or transcription activation domain attenuated the retinal abnormalities induced by yap (5SA), indicating that all of these domains contribute to normal retinal development. Remarkably, yap (5SA)-expressing zebrafish embryos displayed decreased expression of transcription factors such as otx5 and crx, which orchestrate photoreceptor cell differentiation by activating the expression of rhodopsin and other photoreceptor cell genes. Co-immunoprecipitation experiments revealed that Rx1 is a novel interacting partner of Yap that regulates photoreceptor cell differentiation. Our results suggest that Yap suppresses the differentiation of photoreceptor cells from retinal progenitor cells by repressing Rx1-mediated transactivation of photoreceptor cell genes during zebrafish retinogenesis.	[Asaoka, Yoichi; Hata, Shoji; Namae, Misako; Nishina, Hiroshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Dev & Regenerat Biol, Tokyo, Japan; [Furutani-Seiki, Makoto] Univ Bath, Dept Biol & Biochem, Ctr Regenerat Med, Bath BA2 7AY, Avon, England	Tokyo Medical & Dental University (TMDU); University of Bath	Asaoka, Y (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Dev & Regenerat Biol, Tokyo, Japan.	y-asaoka.dbio@mri.tmd.ac.jp; nishina.dbio@mri.tmd.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science; Ministry of Health, Labor and Welfare of Japan; Grants-in-Aid for Scientific Research [25460358, 26114005] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science, and a Grant-in-Aid from the Ministry of Health, Labor and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agathocleous M, 2009, ANNU REV CELL DEV BI, V25, P45, DOI 10.1146/annurev.cellbio.042308.113259; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; BORK P, 1994, TRENDS BIOCHEM SCI, V19, P531, DOI 10.1016/0968-0004(94)90053-1; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Cheng H, 2004, HUM MOL GENET, V13, P1563, DOI 10.1093/hmg/ddh173; Dowling JE, 2012, RETINA APPROACHABLE, Vxvi; Fadool JM, 2008, PROG RETIN EYE RES, V27, P89, DOI 10.1016/j.preteyeres.2007.08.002; Fujieda H, 2009, J NEUROCHEM, V108, P91, DOI 10.1111/j.1471-4159.2008.05739.x; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Gaffney CJ, 2012, GENE, V509, P215, DOI 10.1016/j.gene.2012.08.025; Gee ST, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020309; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hata S, 2012, J BIOL CHEM, V287, P22089, DOI 10.1074/jbc.M111.334714; Hiemer SE, 2013, BBA-GEN SUBJECTS, V1830, P2323, DOI 10.1016/j.bbagen.2012.07.005; Hilman D, 2011, MOL BIOL EVOL, V28, P2403, DOI 10.1093/molbev/msr065; Hu JY, 2013, INT J BIOL SCI, V9, P267, DOI 10.7150/ijbs.4887; Jadhav AR, 2006, DEVELOPMENT, V133, P913, DOI 10.1242/dev.02245; Jia L, 2009, P NATL ACAD SCI USA, V106, P17534, DOI 10.1073/pnas.0902425106; Jiang Q, 2009, BIOCHEM BIOPH RES CO, V384, P114, DOI 10.1016/j.bbrc.2009.04.070; Jukam D, 2011, DEV CELL, V21, P874, DOI 10.1016/j.devcel.2011.10.004; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Lee JH, 2008, EMBO J, V27, P1231, DOI 10.1038/emboj.2008.63; Lin YT, 2012, EXP CELL RES, V318, P1877, DOI 10.1016/j.yexcr.2012.05.005; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Muranishi Y, 2011, J NEUROSCI, V31, P16792, DOI 10.1523/JNEUROSCI.3109-11.2011; Nejigane S, 2013, INT J DEV BIOL, V57, P407, DOI 10.1387/ijdb.130010st; Nelson SM, 2009, DEV BIOL, V328, P24, DOI 10.1016/j.ydbio.2008.12.040; Oh S, 2009, MOL CELL BIOL, V29, P6309, DOI 10.1128/MCB.00551-09; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pan Y, 2010, DEV BIOL, V339, P494, DOI 10.1016/j.ydbio.2009.12.032; Pellissier LP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003976; Pobbati AV, 2013, CANCER BIOL THER, V14, P390, DOI 10.4161/cbt.23788; Praskova M, 2004, BIOCHEM J, V381, P453, DOI 10.1042/BJ20040025; Rembold M, 2006, SCIENCE, V313, P1130, DOI 10.1126/science.1127144; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Seo J, 2010, J CELL BIOCHEM, V110, P1022, DOI 10.1002/jcb.22616; Shimomura T, 2014, BIOCHEM BIOPH RES CO, V443, P917, DOI 10.1016/j.bbrc.2013.12.100; Shoji W, 2008, DEV GROWTH DIFFER, V50, P401, DOI [10.1111/j.1440-169x.2008.01038.x, 10.1111/j.1440-169X.2008.01038.x]; Srinivas M, 2006, MOL ENDOCRINOL, V20, P1728, DOI 10.1210/me.2005-0505; Stenkamp DL, 2011, PROG RETIN EYE RES, V30, P395, DOI 10.1016/j.preteyeres.2011.06.004; Sudol M, 2010, TRENDS BIOCHEM SCI, V35, P627, DOI 10.1016/j.tibs.2010.05.010; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; Webb C, 2011, BIOCHEMISTRY-US, V50, P3300, DOI 10.1021/bi2001888; Westerfield M, 1994, ZEBRAFISH BOOK GUIDE; Whitaker SL, 2004, J BIOL CHEM, V279, P49010, DOI 10.1074/jbc.M406080200; Xiang MQ, 2013, CELL MOL LIFE SCI, V70, P2519, DOI 10.1007/s00018-012-1183-2; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Yaron O, 2006, DEVELOPMENT, V133, P1367, DOI 10.1242/dev.02311; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zaidi SK, 2004, EMBO J, V23, P790, DOI 10.1038/sj.emboj.7600073; Zhang HQ, 2012, DEV BIOL, V361, P103, DOI 10.1016/j.ydbio.2011.10.017; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303	55	37	37	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97365	10.1371/journal.pone.0097365	http://dx.doi.org/10.1371/journal.pone.0097365			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828882	Green Published, Green Submitted, gold			2022-12-27	WOS:000336857400085
J	Fehrholz, M; Speer, CP; Kunzmann, S				Fehrholz, Markus; Speer, Christian P.; Kunzmann, Steffen			Caffeine and Rolipram Affect Smad Signalling and TGF-beta 1 Stimulated CTGF and Transgelin Expression in Lung Epithelial Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; PHOSPHODIESTERASE-4 INHIBITION; ANTENATAL INFLAMMATION; PULMONARY INFLAMMATION; GENE-EXPRESSION; HYPEROXIA; PROTEIN; INJURY; MICE; ALVEOLARIZATION	Caffeine administration is an important part of the therapeutic treatment of bronchopulmonary dysplasia (BPD) in preterm infants. However, caffeine mediated effects on airway remodelling are still undefined. The TGF-beta/Smad signalling pathway is one of the key pathways involved in airway remodelling. Connective tissue growth factor (CTGF), a downstream mediator of TGF-beta, and transgelin, a binding and stabilising protein of the cytoskeleton, are both regulated by TGF-beta 1 and play an important role in airway remodelling. Both have also been implicated in the pathogenesis of BPD. The aim of the present study was to clarify whether caffeine, an unspecific phosphodiesterase (PDE) inhibitor, and rolipram, a prototypical PDE-4 selective inhibitor, were both able to affect TGF-beta 1-induced Smad signalling and CTGF/transgelin expression in lung epithelial cells. Furthermore, the effect of transgelin knock-down on Smad signalling was studied. The pharmacological effect of caffeine and rolipram on Smad signalling was investigated by means of a luciferase assay via transfection of a TGF-beta 1-inducible reporter plasmid in A549 cells. The regulation of CTGF and transgelin expression by caffeine and rolipram were studied by promoter analysis, real-time PCR and Western blot. Endogenous transgelin expression was down-regulated by lentiviral transduction mediating transgelin-specific shRNA expression. The addition of caffeine and rolipram inhibited TGF-beta 1 induced reporter gene activity in a concentration-related manner. They also antagonized the TGF-beta 1 induced up-regulation of CTGF and transgelin on the promoter-, the mRNA-, and the protein-level. Functional analysis showed that transgelin silencing reduced TGF-beta 1 induced Smad-signalling and CTGF induction in lung epithelial cells. The present study highlights possible new molecular mechanisms of caffeine and rolipram including an inhibition of Smad signalling and of TGF-beta 1 regulated genes involved in airway remodelling. An understanding of these mechanisms might help to explain the protective effects of caffeine in prevention of BPD and suggests rolipram to be a potent replacement for caffeine.	[Fehrholz, Markus; Speer, Christian P.; Kunzmann, Steffen] Univ Wurzburg, Univ Childrens Hosp, D-97070 Wurzburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Wurzburg	Kunzmann, S (corresponding author), Univ Wurzburg, Univ Childrens Hosp, D-97070 Wurzburg, Germany.	kunzmann_s@ukw.de						Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Ahlfeld SK, 2012, BIRTH DEFECTS RES A, V94, P3, DOI 10.1002/bdra.22869; Alapati D, 2011, AM J RESP CELL MOL, V45, P1169, DOI 10.1165/rcmb.2011-0023OC; Alejandre-Alcazar MA, 2008, DEV DYNAM, V237, P259, DOI 10.1002/dvdy.21403; Alejandre-Alcazar MA, 2007, AM J PHYSIOL-LUNG C, V292, pL537, DOI 10.1152/ajplung.00050.2006; Assinder S, 2011, MED HYPOTHESES, V76, P802, DOI 10.1016/j.mehy.2011.02.021; Assinder SJ, 2009, INT J BIOCHEM CELL B, V41, P482, DOI 10.1016/j.biocel.2008.02.011; Barnes Peter J, 2005, Proc Am Thorac Soc, V2, P334, DOI 10.1513/pats.200504-024SR; Barnes Peter J, 2004, Discov Med, V4, P421; Barnes PJ, 2004, NAT REV DRUG DISCOV, V3, P831, DOI 10.1038/nrd1524; Barnes PJ, 2004, LANCET, V364, P985, DOI 10.1016/S0140-6736(04)17025-6; Bartram U, 2004, CHEST, V125, P754, DOI 10.1378/chest.125.2.754; Burgess JK, 2006, J ALLERGY CLIN IMMUN, V118, P649, DOI 10.1016/j.jaci.2006.05.019; Chen SY, 2011, AM J PHYSIOL-LUNG C, V300, pL330, DOI 10.1152/ajplung.00270.2010; Chen SY, 2003, NUCLEIC ACIDS RES, V31, P1302, DOI 10.1093/nar/gkg224; Collins JJP, 2013, AM J PHYSIOL-LUNG C, V304, pL438, DOI 10.1152/ajplung.00251.2012; Leon AEC, 2007, AM J PERINAT, V24, P39, DOI 10.1055/s-2006-958163; de Visser YP, 2008, EUR RESPIR J, V31, P633, DOI 10.1183/09031936.00071307; de Visser YP, 2012, AM J PHYSIOL-LUNG C, V302, pL56, DOI 10.1152/ajplung.00041.2011; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dent G, 1998, PULM PHARMACOL THER, V11, P47, DOI 10.1006/pupt.1998.0115; Fehrholz M, 2014, AM J PHYSIOL-LUNG C, V306, pL101, DOI 10.1152/ajplung.00257.2013; Fehrholz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051575; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Gressner OA, 2008, J HEPATOL, V49, P758, DOI 10.1016/j.jhep.2008.03.029; Homer L, 2012, J PHARMACOL EXP THER, V340, P620, DOI 10.1124/jpet.111.179085; Horrigan LA, 2006, PHARMACOL THERAPEUT, V111, P877, DOI 10.1016/j.pharmthera.2006.02.002; HOWELL RE, 1995, J PHARMACOL EXP THER, V275, P703; Kolosionek E, 2009, MOL BIOL CELL, V20, P4751, DOI 10.1091/mbc.E09-01-0019; Kunzmann S, 2007, AM J PHYSIOL-LUNG C, V292, pL223, DOI 10.1152/ajplung.00159.2006; Kunzmann S, 2013, AM J OBSTET GYNECOL, V208, P429, DOI 10.1016/j.ajog.2013.01.008; Kunzmann S, 2011, AM J RESP CELL MOL, V45, P969, DOI 10.1165/rcmb.2010-0519OC; Kuss H, 2003, J PHARMACOL EXP THER, V307, P373, DOI 10.1124/jpet.103.053942; Leask A, 2001, J CLIN PATHOL-MOL PA, V54, P180, DOI 10.1136/mp.54.3.180; Leask Andrew, 2002, Curr Rheumatol Rep, V4, P136, DOI 10.1007/s11926-002-0009-x; Lecart C, 2000, BIOL NEONATE, V77, P217, DOI 10.1159/000014219; LEESMILLER JP, 1987, BIOCHEM J, V244, P705, DOI 10.1042/bj2440705; Li J, 2011, EUR J PHARMACOL, V654, P295, DOI 10.1016/j.ejphar.2010.12.040; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin-Chouly CAE, 2004, LIFE SCI, V75, P823, DOI 10.1016/j.lfs.2004.01.021; Mata M, 2005, THORAX, V60, P144, DOI 10.1136/thx.2004.025692; Mehats C, 2009, EUR RESPIR J, V33, P1236, DOI 10.1183/09031936.00002809; Mehats C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003445; Miotla JM, 1998, AM J RESP CELL MOL, V18, P411, DOI 10.1165/ajrcmb.18.3.2913; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Nawshad A, 2005, CELLS TISSUES ORGANS, V179, P11, DOI 10.1159/000084505; Ohta A, 2007, J IMMUNOL, V179, P7431, DOI 10.4049/jimmunol.179.11.7431; Philip AGS, 2012, NEONATOLOGY, V102, P1, DOI 10.1159/000336030; Schiller M, 2003, ONCOGENE, V22, P8881, DOI 10.1038/sj.onc.1206871; Schiller M, 2010, J BIOL CHEM, V285, P409, DOI 10.1074/jbc.M109.038620; Schmidt B, 2006, NEW ENGL J MED, V354, P2112, DOI 10.1056/NEJMoa054065; SHAPLAND C, 1993, J CELL BIOL, V121, P1065, DOI 10.1083/jcb.121.5.1065; Soto FJ, 2005, CURR OPIN PULM MED, V11, P129; Speer Christian P, 2009, Neonatology, V95, P353, DOI 10.1159/000209301; Valdez RC, 2011, J PEDIATR-US, V158, P38, DOI 10.1016/j.jpeds.2010.06.051; Weichelt U, 2013, EUR RESPIR J, V41, P966, DOI 10.1183/09031936.00012412; Woyda K, 2009, EUR RESPIR J, V33, P861, DOI 10.1183/09031936.00109008; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Wu S, 2010, AM J RESP CELL MOL, V42, P552, DOI 10.1165/rcmb.2009-0068OC; Yano Y, 2006, BIOCHEM BIOPH RES CO, V341, P684, DOI 10.1016/j.bbrc.2006.01.018; Yu HY, 2008, FASEB J, V22, P1778, DOI 10.1096/fj.07-083857; Zhang RF, 2014, AM J PHYSIOL-LUNG C, V306, pL574, DOI 10.1152/ajplung.00327.2013; Zhang RF, 2009, AM J RESP CELL MOL, V41, P467, DOI 10.1165/rcmb.2008-0333OC; Zinke M, 2009, J VIROL, V83, P9423, DOI 10.1128/JVI.00846-09	64	27	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97357	10.1371/journal.pone.0097357	http://dx.doi.org/10.1371/journal.pone.0097357			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828686	Green Published, Green Submitted, gold			2022-12-27	WOS:000336857400083
J	Simonetto, C; Azizova, TV; Grigoryeva, ES; Kaiser, JC; Schollnberger, H; Eidemuller, M				Simonetto, Cristoforo; Azizova, Tamara V.; Grigoryeva, Evgenia S.; Kaiser, Jan C.; Schoellnberger, Helmut; Eidemueller, Markus			Ischemic Heart Disease in Workers at Mayak PA: Latency of Incidence Risk after Radiation Exposure	PLOS ONE			English	Article							ATOMIC-BOMB SURVIVORS; LEVEL IONIZING-RADIATION; CIRCULATORY DISEASE; CARDIOVASCULAR-DISEASES; APOE(-/-) MICE; CEREBROVASCULAR DISEASES; PRODUCTION-ASSOCIATION; MULTIMODEL INFERENCE; DOSE-RESPONSES; BREAST-CANCER	We present an updated analysis of incidence and mortality from atherosclerotic induced ischemic heart diseases in the cohort of workers at the Mayak Production Association (PA). This cohort constitutes one of the most important sources for the assessment of radiation risk. It is exceptional because it comprises information on several other risk factors. While most of the workers have been exposed to external gamma radiation, a large proportion has additionally been exposed to internal radiation from inhaled plutonium. Compared to a previous study by Azizova et al. 2012, the updated dosimetry system MWDS-2008 has been applied and methods of analysis have been revised. We extend the analysis of the significant incidence risk and observe that main detrimental effects of external radiation exposure occur after more than about 30 years. For mortality, significant risk was found in males with an excess relative risk per dose of 0.09 (95% CI: 0.02; 0.16) Gy(-1) while risk was insignificant for females. With respect to internal radiation exposure no association to risk could be established.	[Simonetto, Cristoforo; Kaiser, Jan C.; Schoellnberger, Helmut; Eidemueller, Markus] Helmholtz Zentrum Munchen, Dept Radiat Sci, Neuherberg, Germany; [Azizova, Tamara V.; Grigoryeva, Evgenia S.] SUBI, Ozyorsk, Chelyabinsk Reg, Russia	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Southern Urals Biophysics Institute	Simonetto, C (corresponding author), Helmholtz Zentrum Munchen, Dept Radiat Sci, Neuherberg, Germany.	cristoforo.simonetto@helmholtz-muenchen.de	Grigoryeva, Evgeniya S./B-9142-2016; Azizova, Tamara V./R-5295-2019; Kaiser, Jan Christian/M-9852-2014; Simonetto, Cristoforo/AAE-7124-2020; Schöllnberger, Helmut/K-1446-2016	Grigoryeva, Evgeniya S./0000-0003-1806-9922; Azizova, Tamara V./0000-0001-6954-2674; Simonetto, Cristoforo/0000-0003-4816-3514; Schöllnberger, Helmut/0000-0002-4398-6565; Kaiser, Jan Christian/0000-0003-0359-2251	Federal Office of Radiation Protection [3611S30022]; EU project ProCardio [295823]	Federal Office of Radiation Protection; EU project ProCardio	This work was supported by a project of the Federal Office of Radiation Protection (contract 3611S30022) and by the EU project ProCardio (contract number 295823). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advisory Group on Ionising Radiation, 2010, RCE16 HPA ADV GROUP, P1; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Anspaugh LR, 2002, RADIAT ENVIRON BIOPH, V41, P19, DOI 10.1007/s00411-002-0148-5; Azizova T. V., 2012, Radiatsionnaya Biologiya Radioekologiya, V52, P158; Azizova TV, 2010, RADIAT RES, V174, P851, DOI 10.1667/RR1928.1; Azizova TV, 2010, RADIAT RES, V174, P155, DOI 10.1667/RR1789.1; Azizova TV, 2008, HEALTH PHYS, V94, P449, DOI 10.1097/01.HP.0000300757.00912.a2; Azizova TV, 2012, HEALTH PHYS, V103, P3, DOI 10.1097/HP.0b013e3182243a62; Azizova TV, 2011, RADIAT ENVIRON BIOPH, V50, P539, DOI 10.1007/s00411-011-0377-6; Bess JD, 2007, HEALTH PHYS, V93, P207, DOI 10.1097/01.HP.0000266741.42070.e8; BOLOTNIKOVA MG, 1994, SCI TOTAL ENVIRON, V142, P29, DOI 10.1016/0048-9697(94)90070-1; Borghini A, 2013, ATHEROSCLEROSIS, V230, P40, DOI 10.1016/j.atherosclerosis.2013.06.010; Committee on Health Risks of Exposure to Radon (BEIR VI) National Research Council, 1999, HLTH EFF EXP RAD BEI; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; Darby SC, 2005, LANCET ONCOL, V6, P557, DOI 10.1016/S1470-2045(05)70251-5; Khokhryakov VV, 2013, HEALTH PHYS, V104, P366, DOI 10.1097/HP.0b013e31827dbf60; Koshurnikova NA, 1999, RADIAT RES, V152, P352, DOI 10.2307/3580220; Krestinina LY, 2013, RADIAT ENVIRON BIOPH, V52, P47, DOI 10.1007/s00411-012-0438-5; Kreuzer M, 2013, RADIAT ENVIRON BIOPH, V52, P37, DOI 10.1007/s00411-012-0446-5; Kumarathasan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065486; Little MP, 2013, RADIAT ENVIRON BIOPH, V52, P435, DOI 10.1007/s00411-013-0484-7; Little MP, 2012, ENVIRON HEALTH PERSP, V120, pA453, DOI 10.1289/ehp.1206046R; Little MP, 2012, INT J RADIAT ONCOL, V84, P1101, DOI 10.1016/j.ijrobp.2012.01.053; Little MP, 2012, ENVIRON HEALTH PERSP, V120, P1503, DOI 10.1289/ehp.1204982; Little MP, 2013, RADIAT ENVIRON BIOPH, V51, P165; Maas AHEM, 2010, NETH HEART J, V18, P598, DOI 10.1007/s12471-010-0841-y; Mitchel REJ, 2013, RADIAT RES, V179, P190, DOI 10.1667/RR3140.1; Mitchel REJ, 2011, RADIAT RES, V175, P665, DOI 10.1667/RR2176.1; Monceau V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057052; Mothersill C, 2013, J ENVIRON RADIOACTIV, DOI [10.1016/j.jenvrad.2013.04.002, DOI 10.1016/J.JENVRAD.2013.04.002.]; Preston DL, 2003, RADIAT RES, V160, P381, DOI 10.1667/RR3049; Roedel F, 2012, CURR MED CHEM, V19, P1741, DOI 10.2174/092986712800099866; Rodel F, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00120; Schollnberger H, 2013, RADIAT ENVIRON BIOPH, V52, P161, DOI 10.1007/s00411-012-0454-5; Schollnberger H, 2012, RADIAT ENVIRON BIOPH, V51, P165, DOI 10.1007/s00411-012-0410-4; Schollnberger H, 2012, ENVIRON HEALTH PERSP, V120, pA452, DOI 10.1289/ehp.1206046; Schollnberger, RAD ENV BIOPHYS, V52, P157; Shimizu Y, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5349; Stewart FA, 2006, AM J PATHOL, V168, P649, DOI 10.2353/ajpath.2006.050409; Tretyakov FD, 2012, RADIOACTIVE SOURCE 4, P4; Tunstall-Pedoe H., 2003, MONICA MONOGRAPH MUL; Vasilenko EK, 2007, HEALTH PHYS, V93, P190, DOI 10.1097/01.HP.0000266071.43137.0e; Vrijheid M, 2007, INT J EPIDEMIOL, V36, P1126, DOI 10.1093/ije/dym138; WHO Regional Office for Europe, 2006, HIGHL HLTH RUSS FED; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yamada M, 2004, RADIAT RES, V161, P622, DOI 10.1667/RR3183	48	32	35	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96309	10.1371/journal.pone.0096309	http://dx.doi.org/10.1371/journal.pone.0096309			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828606	gold, Green Submitted, Green Published			2022-12-27	WOS:000336857400024
J	Lee, S; Griep, AE				Lee, SungKyoung; Griep, Anne E.			Loss of Dlg-1 in the Mouse Lens Impairs Fibroblast Growth Factor Receptor Signaling	PLOS ONE			English	Article							PLANAR CELL POLARITY; FIBER DIFFERENTIATION; CONTAINING PROTEINS; FGF; EXPRESSION; SURVIVAL; MORPHOGENESIS; LOCALIZATION; INTEGRIN; PHOSPHORYLATION	Coordination of cell proliferation, differentiation and survival is essential for normal development and maintenance of tissues in the adult organism. Growth factor receptor tyrosine kinase signaling pathways and planar cell polarity pathways are two regulators of many developmental processes. We have previously shown through analysis of mice conditionally null in the lens for the planar cell polarity gene (PCP), Dlg-1, that Dlg-1 is required for fiber differentiation. Herein, we asked if Dlg-1 is a regulator of the Fibroblast growth factor receptor (Fgfr) signaling pathway, which is known to be required for fiber cell differentiation. Western blot analysis of whole fiber cell extracts from control and Dlg-1 deficient lenses showed that levels of the Fgfr signaling intermediates pErk, pAkt, and pFrs2 alpha, the Fgfr target, Erm, and the fiber cell specific protein, Mip26, were reduced in the Dlg-1 deficient fiber cells. The levels of Fgfr2 were decreased in Dlg-1 deficient lenses compared to controls. Conversely, levels of Fgfr1 in Dlg-1 deficient lenses were increased compared to controls. The changes in Fgfr levels were found to be specifically in the triton insoluble, cytoskeletal associated fraction of Dlg-1 deficient lenses. Immunofluorescent staining of lenses from E13.5 embryos showed that expression levels of pErk were reduced in the transition zone, a region of the lens that exhibits PCP, in the Dlg-1 deficient lenses as compared to controls. In control lenses, immunofluorescent staining for Fgfr2 was observed in the epithelium, transition zone and fibers. By E13.5, the intensity of staining for Fgfr2 was reduced in these regions of the Dlg-1 deficient lenses. Thus, loss of Dlg-1 in the lens impairs Fgfr signaling and leads to altered levels of Fgfrs, suggesting that Dlg-1 is a modulator of Fgfr signaling pathway at the level of the receptors and that Dlg-1 regulates fiber cell differentiation through its role in PCP.	[Lee, SungKyoung; Griep, Anne E.] Univ Wisconsin, Dept Cell & Regenerat Biol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Griep, AE (corresponding author), Univ Wisconsin, Dept Cell & Regenerat Biol, Madison, WI 53706 USA.	aegriep@wisc.edu	Griep, Anne/ABA-9636-2020		National Institutes of Health [EY09091, EY016665, CA14520]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY009091, P30EY016665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding provided by National Institutes of Health: EY09091, EY016665 (www.nei.nih.gov/) and CA14520 (www.cancer.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SY, 2013, J AM SOC NEPHROL, V24, P1127, DOI 10.1681/ASN.2012111074; Beebe D, 2004, INT J DEV BIOL, V48, P845, DOI 10.1387/ijdb.041869db; Behrens C, 2008, CLIN CANCER RES, V14, P6014, DOI 10.1158/1078-0432.CCR-08-0167; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Boswell BA, 2008, DEV BIOL, V324, P202, DOI 10.1016/j.ydbio.2008.09.003; Cain S, 2008, DEV BIOL, V321, P420, DOI 10.1016/j.ydbio.2008.07.002; Chen YJ, 2008, DEV BIOL, V324, P161, DOI 10.1016/j.ydbio.2008.09.002; Cheng C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028147; Chow RL, 1995, DEVELOPMENT, V121, P4383; Dawes LJ, 2013, INVEST OPHTH VIS SCI, V54, P1582, DOI 10.1167/iovs.12-11357; De Iongh RU, 2001, EXP EYE RES, V72, P649, DOI 10.1006/exer.2001.1001; deIongh RU, 1996, DEV DYNAM, V206, P412, DOI 10.1002/(SICI)1097-0177(199608)206:4<412::AID-AJA7>3.0.CO;2-L; Faber SC, 2002, DEVELOPMENT, V129, P3727; Gao B, 2011, DEV CELL, V20, P163, DOI 10.1016/j.devcel.2011.01.001; Garcia CM, 2005, DEV DYNAM, V233, P516, DOI 10.1002/dvdy.20356; Gotoh N, 2008, CANCER SCI, V99, P1319, DOI 10.1111/j.1349-7006.2008.00840.x; Harris BZ, 2001, J CELL SCI, V114, P3219; Hayes JM, 2012, MOL BIOL CELL, V23, P4725, DOI 10.1091/mbc.E12-09-0672; Hoffmann M, 2010, DEV BIOL, V339, P268, DOI 10.1016/j.ydbio.2009.12.002; Iyengar L, 2007, DIFFERENTIATION, V75, P662, DOI 10.1111/j.1432-0436.2007.00167.x; Lee S, 2002, MOL CELL BIOL, V22, P1778, DOI 10.1128/MCB.22.6.1778-1791.2002; Liu H, 2006, INVEST OPHTH VIS SCI, V47, P5088, DOI 10.1167/iovs.06-0403; Liu J, 1996, EXP EYE RES, V63, P621, DOI 10.1006/exer.1996.0156; Lovicu FJ, 2011, PHILOS T R SOC B, V366, P1204, DOI 10.1098/rstb.2010.0339; Lu PF, 2008, DEV BIOL, V321, P77, DOI 10.1016/j.ydbio.2008.06.005; Madakashira BP, 2012, DEVELOPMENT, V139, P4601, DOI 10.1242/dev.081737; Martin Amy J, 2011, BMC Res Notes, V4, P72, DOI 10.1186/1756-0500-4-72; MATSUO T, 1993, JPN J OPHTHALMOL, V37, P215; Nguyen MM, 2005, MOL VIS, V11, P1183; Nguyen MM, 2003, MOL CELL BIOL, V23, P8970, DOI 10.1128/MCB.23.24.8970-8981.2003; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; PIATIGORSKY J, 1981, DIFFERENTIATION, V19, P134, DOI 10.1111/j.1432-0436.1981.tb01141.x; Pontoriero GF, 2009, DEV BIOL, V326, P403, DOI 10.1016/j.ydbio.2008.10.011; RICHARDSON NA, 1993, INVEST OPHTH VIS SCI, V34, P3303; Rivera C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054410; Rivera C, 2009, DEV DYNAM, V238, P2292, DOI 10.1002/dvdy.22036; Robinson ML, 2006, SEMIN CELL DEV BIOL, V17, P726, DOI 10.1016/j.semcdb.2006.10.002; Robinson ML, 1995, DEVELOPMENT, V121, P3959; Rowan S, 2008, DEV BIOL, V321, P111, DOI 10.1016/j.ydbio.2008.06.002; Saravanamuthu SS, 2009, DEV BIOL, V332, P166, DOI 10.1016/j.ydbio.2009.05.566; Schmahl J, 2004, DEVELOPMENT, V131, P3627, DOI 10.1242/dev.01239; Simirskii VN, 2007, DEV BIOL, V306, P658, DOI 10.1016/j.ydbio.2007.04.004; Singh J, 2012, WIRES DEV BIOL, V1, P479, DOI 10.1002/wdev.32; Stolen CM, 2000, DEV BIOL, V217, P205, DOI 10.1006/dbio.1999.9557; Sugiyama Y, 2011, ORGANOGENESIS, V7, P191, DOI 10.4161/org.7.3.18421; Sugiyama Y, 2010, DEV BIOL, V338, P193, DOI 10.1016/j.ydbio.2009.11.033; Tarkkonen KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049970; van der Noll R, 2013, CANCER TREAT REV, V39, P664, DOI 10.1016/j.ctrv.2013.01.003; Walker JL, 2002, DEV DYNAM, V223, P273, DOI 10.1002/dvdy.10050; Wallingford JB, 2012, ANNU REV CELL DEV BI, V28, P627, DOI 10.1146/annurev-cellbio-092910-154208; Wang QA, 2010, INVEST OPHTH VIS SCI, V51, P3599, DOI 10.1167/iovs.09-4797; Wederell ED, 2006, SEMIN CELL DEV BIOL, V17, P759, DOI 10.1016/j.semcdb.2006.10.006; Zhao HT, 2008, DEV BIOL, V318, P276, DOI 10.1016/j.ydbio.2008.03.028; Zhao HT, 2004, INVEST OPHTH VIS SCI, V45, P1930, DOI 10.1167/iovs.03-0856	55	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97470	10.1371/journal.pone.0097470	http://dx.doi.org/10.1371/journal.pone.0097470			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824078	Green Submitted, Green Published, gold			2022-12-27	WOS:000336369200119
J	Wong, VL; Ellison, CE; Eisen, MB; Pachter, L; Brem, RB				Wong, Valerie L.; Ellison, Christopher E.; Eisen, Michael B.; Pachter, Lior; Brem, Rachel B.			Structural Variation among Wild and Industrial Strains of Penicillium chrysogenum	PLOS ONE			English	Article							TANDEM REPEATS; GENE-CLUSTER	Strain selection and strain improvement are the first, and arguably most important, steps in the industrial production of biological compounds by microorganisms. While traditional methods of mutagenesis and selection have been effective in improving production of compounds at a commercial scale, the genetic changes underpinning the altered phenotypes have remained largely unclear. We utilized high-throughput Illumina short read sequencing of a wild Penicillium chrysogenum strain in order to make whole genome comparisons to a sequenced improved strain (WIS 54-1255). We developed an assembly-free method of identifying chromosomal rearrangements and validated the in silico predictions with a PCR-based assay and Sanger sequencing. Despite many rounds of mutagen treatment and artificial selection, WIS 54-1255 differs from its wild progenitor at only one of the identified rearrangements. We suggest that natural variants predisposed for high penicillin production were instrumental in the success of WIS 54-1255 as an industrial strain. In addition to finding a previously published inversion in the penicillin biosynthesis cluster, we located several genes related to penicillin production associated with these rearrangements. By comparing the configuration of rearrangement events among several historically important strains known to be high penicillin producers to a collection of recently isolated wild strains, we suggest that wild strains with rearrangements similar to those in known high penicillin producers may be viable candidates for further improvement efforts.	[Wong, Valerie L.; Ellison, Christopher E.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Eisen, Michael B.; Brem, Rachel B.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Pachter, Lior] Univ Calif Berkeley, Dept Math, Berkeley, CA 94720 USA; [Pachter, Lior] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Pachter, Lior] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Wong, VL (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	vwong@umn.edu		Pachter, Lior/0000-0002-9164-6231; Eisen, Michael/0000-0002-7528-738X				Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Chain E, 1940, LANCET, V2, P226; Demain AL, 1999, ANTON LEEUW INT J G, V75, P5, DOI 10.1023/A:1001738823146; DIEZ B, 1990, J BIOL CHEM, V265, P16358; Eland RP, 1976, IND MICROBIOLOGY, P192; Elander RP, 1967, INDUCED MUTATIONS TH, P403; FIERRO F, 1995, P NATL ACAD SCI USA, V92, P6200, DOI 10.1073/pnas.92.13.6200; Fierro F, 2006, FUNGAL GENET BIOL, V43, P618, DOI 10.1016/j.fgb.2006.03.001; Fleming A, 1929, BR J EXP PATHOL, V10, P185; GORDON M, 1953, SCIENCE, V118, P43, DOI 10.1126/science.118.3054.43; Harris DM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-75; Henk DA, 2011, MOL ECOL, V20, P4288, DOI 10.1111/j.1365-294X.2011.05244.x; Jami MS, 2010, MOL CELL PROTEOMICS, V9, P1182, DOI 10.1074/mcp.M900327-MCP200; Kiel JAKW, 2009, FUNCT INTEGR GENOMIC, V9, P167, DOI 10.1007/s10142-009-0110-6; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le Crom S, 2009, P NATL ACAD SCI USA, V106, P16151, DOI 10.1073/pnas.0905848106; Lein J., 1986, OVERPRODUCTION MICRO, P105; Martin JF, 2010, MICROB BIOTECHNOL, V3, P285, DOI 10.1111/j.1751-7915.2009.00123.x; MOYER AJ, 1946, J BACTERIOL, V51, P79, DOI 10.1128/JB.51.1.79-93.1946; MULLER WH, 1991, EMBO J, V10, P489, DOI 10.1002/j.1460-2075.1991.tb07971.x; Muniz C. C., 2007, REV LATINOAM MICROBI, V49, P88; Raper KB, 1944, J BACTERIOL, V48, P639, DOI 10.1128/JB.48.6.639-659.1944; Raper Kenneth B., 1945, JOUR ELISHA MITCHELL SCI SOC, V61, P74; van den Berg MA, 2008, NAT BIOTECHNOL, V26, P1161, DOI 10.1038/nbt.1498	24	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96784	10.1371/journal.pone.0096784	http://dx.doi.org/10.1371/journal.pone.0096784			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824901	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000336369200031
J	Carrera, S; Senra, J; Acosta, MI; Althubiti, M; Hammond, EM; de Verdier, PJ; Macip, S				Carrera, Samantha; Senra, Joana; Acosta, Maria Isabel; Althubiti, Mohammad; Hammond, Ester M.; de Verdier, Petra J.; Macip, Salvador			The Role of the HIF-1 alpha Transcription Factor in Increased Cell Division at Physiological Oxygen Tensions	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTORS; FACTOR 1-ALPHA; CANCER CELLS; DNA-DAMAGE; HIF-1; P53; ACTIVATION; PATHWAYS; GROWTH	HIF-1 is a transcription factor that mediates the cellular responses to low oxygen environments, mainly as a result of having an oxygen-labile subunit, HIF-1 alpha. HIF-1 alpha has been carefully studied in the context of severe hypoxic stresses (<1% O-2), but it is also known to be present at oxygen tensions commonly found in normal tissues in vivo (similar to 1-13% O-2), albeit at much lower levels. Its role under these physiological conditions is not fully understood. Here, we show that a transcriptionally active HIF-1 alpha was up-regulated at 5% O-2, both in normal and cancer cells, but only some of its target genes were elevated as a result. HIF-1 alpha induction was in part dependent on the activation of the ERK1/2 MAPK signalling pathway, which we have previously shown is active at 5% O-2. We also found that HIF-1 alpha does not contribute to the protection against DNA damage that can be observed in low oxygen environments, and that there are certain DNA damaging agents, such as doxorubicin and actinomycin D, that prevent HIF-1 alpha induction independently of p53. Moreover, absence of HIF-1 alpha significantly reduced the growth advantage of cells cultured at 5% O-2. In view of these data, we conclude that HIF-1 alpha can be induced and activated at physiological oxygen tensions in a MAPK-dependent manner and that, although this does not lead to pro-survival responses to stress, it determines the increased cell proliferation rates that are common under these conditions.	[Carrera, Samantha; Acosta, Maria Isabel; Althubiti, Mohammad; Macip, Salvador] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; [Senra, Joana; Hammond, Ester M.] Univ Oxford, MRC, Gray Inst Radiat Oncol & Biol, Dept Oncol,Canc Res UK, Oxford, England; [de Verdier, Petra J.] Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med & Surg, Urol Lab, Stockholm, Sweden; [de Verdier, Petra J.] Karolinska Univ Hosp, Dept Urol, Stockholm, Sweden	University of Leicester; Cancer Research UK; University of Oxford; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Macip, S (corresponding author), Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England.	sm460@le.ac.uk	Macip, Salvador/P-4233-2019; Macip, Salvador/S-6358-2019; Macip, Salvador/K-5985-2014	Macip, Salvador/0000-0003-1963-8840; Althubiti, Mohammad/0000-0002-9738-3188; Hammond, Ester/0000-0002-2335-3146	MRC; CONACYT [200721]; Stockholm County Council; Karolinska Institutet; CRUK; Cancer Research UK [19276] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); CRUK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This work was funded by the MRC (www.mrc.ac.uk, New Blood Lectureship Research Support Funding). SC held a pre-doctoral fellowship from CONACYT (www.conacyt.mx, fellow #200721). PJDV held financial support through the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet. EMH and JMS are supported by a CRUK grant awarded to EMH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameri K, 2002, BRIT J CANCER, V87, P1173, DOI 10.1038/sj.bjc.6600576; Blagosklonny MV, 1998, J BIOL CHEM, V273, P11995, DOI 10.1074/jbc.273.20.11995; Cao Y, 2013, CANC RES; Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x; Carrera S, 2010, J BIOL CHEM, V285, P13658, DOI 10.1074/jbc.M109.062562; CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337; Dang DT, 2006, CANCER RES, V66, P1684, DOI 10.1158/0008-5472.CAN-05-2887; DOROSHOW JH, 1981, J CLIN INVEST, V68, P1053, DOI 10.1172/JCI110328; Ehrismann D, 2007, BIOCHEM J, V401, P227, DOI 10.1042/BJ20061151; Estrada JC, 2012, CELL DEATH DIFFER, V19, P743, DOI 10.1038/cdd.2011.172; Hall E.J, 2006, RADIOBIOLOGY RADIOLO, V6, P576; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Koivunen P, 2004, J BIOL CHEM, V279, P9899, DOI 10.1074/jbc.M312254200; Lee K, 2009, P NATL ACAD SCI USA, V106, P2353, DOI 10.1073/pnas.0812801106; Lofstedt T, 2007, CELL CYCLE, V6, P919, DOI 10.4161/cc.6.8.4133; Maxwell PH, 2001, CURR OPIN GENET DEV, V11, P293, DOI 10.1016/S0959-437X(00)00193-3; Minet E, 2000, FEBS LETT, V468, P53, DOI 10.1016/S0014-5793(00)01181-9; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Ravi R, 2000, GENE DEV, V14, P34; Ren HX, 2010, P NATL ACAD SCI USA, V107, P5857, DOI 10.1073/pnas.0909570107; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Sang NL, 2003, J BIOL CHEM, V278, P14013, DOI 10.1074/jbc.M209702200; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Sermeus A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.48; Sutton KM, 2007, ONCOGENE, V26, P3920, DOI 10.1038/sj.onc.1210168; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Weinberg RL, 2005, J MOL BIOL, V348, P589, DOI 10.1016/j.jmb.2005.03.014; Xia Y, 2012, EUR J MED CHEM, V49, P24, DOI 10.1016/j.ejmech.2012.01.033; Zhong H, 1999, CANCER RES, V59, P5830	32	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97938	10.1371/journal.pone.0097938	http://dx.doi.org/10.1371/journal.pone.0097938			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835245	Green Published, gold, Green Submitted			2022-12-27	WOS:000339614800087
J	Dermitzaki, E; Liapakis, G; Androulidaki, A; Venihaki, M; Melissas, J; Tsatsanis, C; Margioris, AN				Dermitzaki, Eirini; Liapakis, George; Androulidaki, Ariadne; Venihaki, Maria; Melissas, John; Tsatsanis, Christos; Margioris, Andrew N.			Corticotrophin-Releasing Factor (CRF) and the Urocortins Are Potent Regulators of the Inflammatory Phenotype of Human and Mouse White Adipocytes and the Differentiation of Mouse 3T3L1 Pre-Adipocytes	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; ADIPOSE-TISSUE; DEHYDROGENASE TYPE-1; MESSENGER-RNA; INTERLEUKIN-6; OBESITY; EXPRESSION; MACROPHAGE; SECRETION; INSULIN	Chronic activation of innate immunity takes place in obesity and initiated by the hypertrophic adipocytes which obtain a pro-inflammatory phenotype. The corticotrophin-releasing factor (CRF) family of neuropeptides and their receptors (CRF1 and CRF2) affect stress response and innate immunity. Adipose tissue expresses a complete CRF system. The aim of this study was to examine the role of CRF neuropeptides in the immune phenotype of adipocytes assessed by their expression of the toll-like receptor-4 (TLR4), the production of inflammatory cytokines IL-6, TNF-alpha and IL-1 beta, chemokines IL-8, monocyte attractant protein-1 (MCP-1) and of the adipokines adiponectin, resistin and leptin. Our data are as follows: (a) CRF, UCN2 and UCN3 are expressed in human white adipocytes as well as CRFR1a, CRFR2a and CRFR2b but not CRFR2c. 3T3L1 pre-adipocytes and differentiated adipocytes expressed both CRF1 and CRF2 receptors and UCN3, while UCN2 was detected only in differentiated adipocytes. CRF2 was up-regulated in mouse mature adipocytes. (b) CRF1 agonists suppressed media- and LPS-induced pre-adipocyte differentiation while CRF2 receptor agonists had no effect. (c) In mouse pre-adipocytes, CRF2 agonists suppressed TLR4 expression and the production of IL-6, CXCL1 and adiponectin while CRF1 agonists had no effect. (d) In mature mouse adipocytes LPS induced IL-6 and CXCL1 production and suppressed leptin. (e) In human visceral adipocytes LPS induced IL-6, TNF-alpha, IL-8, MCP-1 and leptin production and suppressed adiponectin and resistin. (f) In mouse mature adipocytes CRF1 and CRF2 agonists suppressed basal and LPS-induced production of inflammatory cytokines, TLR4 expression and adiponectin production, while in human visceral adipocytes CRF and UCN1 suppressed basal and LPS-induced IL-6, TNF-alpha, IL-8 and MCP-1 production. In conclusion, the effects of the activation of CRF1 and CRF2 may be significant in ameliorating the pro-inflammatory activity of adipocytes in obesity.	[Dermitzaki, Eirini; Androulidaki, Ariadne; Venihaki, Maria; Tsatsanis, Christos; Margioris, Andrew N.] Univ Crete, Sch Med, Dept Lab Med, Lab Clin Chem Biochem, Iraklion, Crete, Greece; [Liapakis, George] Univ Crete, Sch Med, Dept Basic Sci, Pharmacol Lab, Iraklion, Crete, Greece; [Melissas, John] Univ Crete, Sch Med, Dept Surg Oncol, Bariatr Unit, Iraklion, Crete, Greece	University of Crete; University of Crete; University of Crete	Margioris, AN (corresponding author), Univ Crete, Sch Med, Dept Lab Med, Lab Clin Chem Biochem, Iraklion, Crete, Greece.	andym@med.uoc.gr	Tsatsanis, Christos/AAM-9362-2020; Tsatsanis, Christos/C-2516-2018	Tsatsanis, Christos/0000-0003-1214-4151; Tsatsanis, Christos/0000-0003-1214-4151	Hellenic Secretariat for Research and Technology [KA296/KA3330]; EU; program THALIS-FAT-VESSEL [379527]	Hellenic Secretariat for Research and Technology; EU(European Commission); program THALIS-FAT-VESSEL	This work was partly funded by Hellenic Secretariat for Research and Technology (Contract grant number: KA296/KA3330) and by the EU and national funds under the action "Education and lifelong learning'', program THALIS-FAT-VESSEL (No 379527). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adapala VJ, 2011, J INFLAMM-LOND, V8, DOI [10.1186/1476-9255-8-5, 10.1186/1476-9255-9-15]; Ahima RS, 2008, J CLIN INVEST, V118, P2380, DOI 10.1172/JCI36284; Cani PD, 2008, PATHOL BIOL, V56, P305, DOI 10.1016/j.patbio.2007.09.008; Charalampopoulos I, 2006, NEUROENDOCRINOLOGY, V84, P49, DOI 10.1159/000096827; Charriere G, 2003, J BIOL CHEM, V278, P9850, DOI 10.1074/jbc.M210811200; Chavey C, 2003, J BIOL CHEM, V278, P11888, DOI 10.1074/jbc.M209196200; Ciardi C, 2012, BRIT J NUTR, V107, P826, DOI 10.1017/S0007114511003680; Cousin B, 1999, FASEB J, V13, P305, DOI 10.1096/fasebj.13.2.305; Dermitzaki E, 2001, ENDOCRINOLOGY, V142, P2022, DOI 10.1210/en.142.5.2022; Fasshauer M, 2003, BIOCHEM BIOPH RES CO, V301, P1045, DOI 10.1016/S0006-291X(03)00090-1; Fried SK, 1998, J CLIN ENDOCR METAB, V83, P847, DOI 10.1210/jc.83.3.847; Friedberg M, 2003, J CLIN ENDOCR METAB, V88, P385, DOI 10.1210/jc.2002-020510; Fruhbeck G, 1998, CLIN PHYSIOL, V18, P399, DOI 10.1046/j.1365-2281.1998.00129.x; Gkountelias K, 2009, MOL PHARMACOL, V75, P793, DOI 10.1124/mol.108.052423; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Hiroi N, 2001, MOL PSYCHIATR, V6, P540, DOI 10.1038/sj.mp.4000908; Lafontan M, 2003, TRENDS PHARMACOL SCI, V24, P276, DOI 10.1016/S0165-6147(03)00132-9; Lin Y, 2000, J BIOL CHEM, V275, P24255, DOI 10.1074/jbc.M002137200; Lira FS, 2012, CYTOKINE, V57, P98, DOI 10.1016/j.cyto.2011.10.001; PEKALA PH, 1981, J BIOL CHEM, V256, P4871; Rentsch J, 1996, FEBS LETT, V379, P55, DOI 10.1016/0014-5793(95)01485-3; Seres J, 2004, J CLIN ENDOCR METAB, V89, P965, DOI 10.1210/jc.2003-031299; Shi HF, 2005, AM J PHYSIOL-REG I, V288, pR1028, DOI 10.1152/ajpregu.00648.2004; Sonti G, 1996, AM J PHYSIOL-REG I, V270, pR1394, DOI 10.1152/ajpregu.1996.270.6.R1394; STOUTHARD JML, 1995, AM J PHYSIOL-ENDOC M, V268, pE813, DOI 10.1152/ajpendo.1995.268.5.E813; Tomlinson JW, 2003, J CLIN ENDOCR METAB, V88, P2113, DOI 10.1210/jc.2002-021894; Trayhurn P, 2005, BIOCHEM SOC T, V33, P1078, DOI [10.1042/BST0331078, 10.1042/BST20051078]; Tsatsanis C, 2006, J IMMUNOL, V176, P1869, DOI 10.4049/jimmunol.176.3.1869; Tsatsanis C, 2005, FEBS LETT, V579, P4259, DOI 10.1016/j.febslet.2005.06.057; Tsatsanis C, 2007, J CELL PHYSIOL, V210, P774, DOI 10.1002/jcp.20900; Tsigos C, 1997, NEUROENDOCRINOLOGY, V66, P54, DOI 10.1159/000127219; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Turner JJ, CLIN EXP IMMUNOL, V162, P487; Vicennati V, 2002, INT J OBESITY, V26, P905, DOI 10.1038/sj.ijo.0802035; Vitseva OI, 2008, OBESITY, V16, P932, DOI 10.1038/oby.2008.25; Wabitsch M, 1996, DIABETES, V45, P1435, DOI 10.2337/diabetes.45.10.1435	36	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97060	10.1371/journal.pone.0097060	http://dx.doi.org/10.1371/journal.pone.0097060			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835211	gold, Green Published, Green Submitted			2022-12-27	WOS:000339614800025
J	Eraly, SA				Eraly, Satish A.			Striking Differences between Knockout and Wild-Type Mice in Global Gene Expression Variability	PLOS ONE			English	Article							MOUSE; IDENTIFICATION; DEFICIENCY; INDUCTION; PROFILES; PATHWAY; TISSUES; ALPHA	Microarray analyses of gene knockouts have traditionally focused on the identification of genes whose mean expression is different in knockout and wild-type mice. However, recent work suggests that changes in the variability of gene expression can have important phenotypic consequences as well. Here, in an unbiased sample of publicly available microarray data on gene expression in various knockouts, highly significant differences from wild-type (either increases or decreases) are noted in the gene expression coefficients of variation (CVs) of virtually every knockout considered. Examination of the distribution of gene-by-gene CV differences indicates that these findings are not attributable to a few outlier genes, but rather to broadly increased or decreased CV in the various knockouts over all the (tens of thousands of) transcripts assayed. These global differences in variability may reflect either authentic biological effects of the knockouts or merely experimental inconsistencies. However, regardless of the underlying explanation, the variability differences are of importance as they will influence both the statistical detection of gene expression changes and, potentially, the knockout phenotype itself.	Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Eraly, SA (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA.	seraly@ucsd.edu			NIH [HL094728]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094728] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grant HL094728. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artinger EL, 2013, P NATL ACAD SCI USA, V110, P12000, DOI 10.1073/pnas.1301278110; Bravo HC, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-272; Destici E, 2011, CELL CYCLE, V10, P3788, DOI 10.4161/cc.10.21.17974; Diwan A, 2007, P NATL ACAD SCI USA, V104, P6794, DOI 10.1073/pnas.0610666104; Doki T, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-5; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Feinberg AP, 2010, P NATL ACAD SCI USA, V107, P1757, DOI 10.1073/pnas.0906183107; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Fulp CT, 2008, HUM MOL GENET, V17, P3740, DOI 10.1093/hmg/ddn271; Furuya S, 2008, FUNCT INTEGR GENOMIC, V8, P235, DOI 10.1007/s10142-007-0072-5; Hand NJ, 2009, HEPATOLOGY, V49, P618, DOI 10.1002/hep.22656; HASTIE ND, 1976, CELL, V9, P761, DOI 10.1016/0092-8674(76)90139-2; Hill R, 2012, MOL CANCER THER, V11, P2127, DOI 10.1158/1535-7163.MCT-12-0342; Ho JWK, 2008, BIOINFORMATICS, V24, pI390, DOI 10.1093/bioinformatics/btn142; Hsiao A, 2004, BIOINFORMATICS, V20, P3108, DOI 10.1093/bioinformatics/bth371; Iwata J, 2012, J BIOL CHEM, V287, P2353, DOI 10.1074/jbc.M111.280974; Johansson PA, 2013, DEVELOPMENT, V140, P1055, DOI 10.1242/dev.090860; Jongeneel CV, 2003, P NATL ACAD SCI USA, V100, P4702, DOI 10.1073/pnas.0831040100; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Khetchoumian K, 2007, NAT GENET, V39, P1500, DOI 10.1038/ng.2007.15; Ma J, 2010, CURR BIOL, V20, P265, DOI 10.1016/j.cub.2009.12.042; MacLennan NK, 2006, HUM MOL GENET, V15, P405, DOI 10.1093/hmg/ddi457; Mar JC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002207; Martens K, 2008, BBA-MOL CELL BIOL L, V1781, P694, DOI 10.1016/j.bbalip.2008.07.010; McClintick JN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-49; Mori MA, 2012, CELL METAB, V16, P336, DOI 10.1016/j.cmet.2012.07.017; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Rampon C, 2008, PHYSIOL GENOMICS, V34, P193, DOI 10.1152/physiolgenomics.00220.2007; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Reineke EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053395; Renault VM, 2009, CELL STEM CELL, V5, P527, DOI 10.1016/j.stem.2009.09.014; Shmueli O, 2003, CR BIOL, V326, P1067, DOI 10.1016/j.crvi.2003.09.012; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suvorova ES, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006158; Van Dyck F, 2007, CELL METAB, V6, P406, DOI 10.1016/j.cmet.2007.09.010; Welle S, 2009, PHYSIOL GENOMICS, V38, P342, DOI 10.1152/physiolgenomics.00054.2009; Zhao B, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-28	37	7	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97734	10.1371/journal.pone.0097734	http://dx.doi.org/10.1371/journal.pone.0097734			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830645	Green Published, gold, Green Submitted			2022-12-27	WOS:000336789500110
J	Lindh, JD; Andersson, ML; Mannheimer, B				Lindh, Jonatan D.; Andersson, Marine L.; Mannheimer, Buster			Adherence to Guidelines for Avoiding Drug Interactions Associated with Warfarin - A Nationwide Swedish Register Study	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; SEROTONIN REUPTAKE INHIBITORS; PHARMACOEPIDEMIOLOGIC RESEARCH; POTENTIAL INTERACTION; HIGH-RISK; TRAMADOL; HEMORRHAGE; DATABASE; PHARMACOKINETICS; PHARMACODYNAMICS	Purpose: To investigate the extent to which clinicians avoid well-established drug-drug interactions associated with warfarin. We hypothesised that clinicians would avoid combining non-steroidal anti-inflammatory drugs (NSAIDs), tramadol and sulfamethoxazole with warfarin. Methods: A cross-sectional analysis of nationwide dispensing data was performed in Swedish individuals 18 years or older (n = 7 563 649). Odds ratios of interacting NSAIDs, tramadol and sulfamethoxazole versus respective prevalence of comparator drugs codeine, and ciprofloxacin in patients co-dispensed interacting warfarin versus patients unexposed was calculated. Results: The odds of receiving an interacting NSAID versus the comparator codeine was markedly lower in patients with warfarin than in the remaining population (adjusted OR 0.21; 95% CI 0.20 - 0.22). Also, the interacting drugs tramadol and sulfamethoxazole were less common among patients dispensed warfarin as compared to the remaining population, although the decrease was much more modest (adjusted OR 0.83; CI 0.80-0.87 and 0.81; CI 0.73 - 0.90). Conclusions: In conclusion, Swedish doctors in the vast majority of cases refrain from prescribing NSAIDs to patients already on warfarin. Tramadol and sulfamethoxazole are however rarely avoided.	[Lindh, Jonatan D.; Andersson, Marine L.] Karolinska Inst, Karolinska Univ Hosp, Div Clin Pharmacol, Dept Lab Med, Stockholm, Sweden; [Mannheimer, Buster] Karolinska Inst, Dept Clin Sci & Educ, Sodersjukhuset, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Sodersjukhuset Hospital	Mannheimer, B (corresponding author), Karolinska Inst, Dept Clin Sci & Educ, Sodersjukhuset, Stockholm, Sweden.	buster.mannheimer@sodersjukhuset.se			Swedish Society for Medical Research	Swedish Society for Medical Research	The work was supported financially by the Swedish Society for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahearn MD, 2003, MED J AUSTRALIA, V179, P34, DOI 10.5694/j.1326-5377.2003.tb05415.x; Battistella M, 2005, ARCH INTERN MED, V165, P189, DOI 10.1001/archinte.165.2.189; Bjerrum L, 1997, EUR J CLIN PHARMACOL, V53, P7, DOI 10.1007/s002280050329; Bottiger Y, 2009, EUR J CLIN PHARMACOL, V65, P627, DOI 10.1007/s00228-008-0612-5; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; Chan FKL, 2007, LANCET, V369, P1621, DOI 10.1016/S0140-6736(07)60749-1; Dalton SO, 2003, ARCH INTERN MED, V163, P59, DOI 10.1001/archinte.163.1.59; de Abajo FJ, 1999, BRIT MED J, V319, P1106, DOI 10.1136/bmj.319.7217.1106; Delaney JA, 2007, CAN MED ASSOC J, V177, P347, DOI 10.1503/cmaj.070186; DIANA FJ, 1989, J PHARM SCI-US, V78, P195, DOI 10.1002/jps.2600780304; Fischer HD, 2010, ARCH INTERN MED, V170, P617, DOI 10.1001/archinternmed.2010.37; Fitzmaurice DA, 2002, BMJ-BRIT MED J, V325, P828, DOI 10.1136/bmj.325.7368.828; Furu K, 2010, BASIC CLIN PHARMACOL, V106, P86, DOI 10.1111/j.1742-7843.2009.00494.x; Gagne JJ, 2008, J CLIN PHARM THER, V33, P141, DOI 10.1111/j.1365-2710.2007.00891.x; Gasse C, 2005, THROMB HAEMOSTASIS, V94, P537, DOI 10.1160/TH05-03-0166; Ghaswalla PK, 2012, AM J GERIATR PHARMAC, V10, P352, DOI 10.1016/j.amjopharm.2012.09.006; Glassman PA, 2006, MED CARE, V44, P250, DOI 10.1097/01.mlr.0000199849.08389.91; Glassman PA, 2002, MED CARE, V40, P1161, DOI 10.1097/00005650-200212000-00004; HASSALL C, 1975, LANCET, V2, P1155; Israel DS, 1996, CLIN INFECT DIS, V22, P251, DOI 10.1093/clinids/22.2.251; Johnell K, 2007, DRUG SAFETY, V30, P911, DOI 10.2165/00002018-200730100-00009; Jonsson AK, 2007, PHARMACOEPIDEM DR S, V16, P309, DOI 10.1002/pds.1291; Juel J, 2013, EUR J CLIN PHARMACOL, V69, P291, DOI 10.1007/s00228-012-1325-3; Klotz U, 2003, ARZNEIMITTELFORSCH, V53, P681; Lane MA, 2012, J CLIN PHARM THER, V37, P157, DOI 10.1111/j.1365-2710.2011.01270.x; LANGMAN MJS, 1994, LANCET, V343, P1075, DOI 10.1016/S0140-6736(94)90185-6; Lau HS, 1997, J CLIN EPIDEMIOL, V50, P619, DOI 10.1016/S0895-4356(97)00040-1; Malone DC, 2005, AM J HEALTH-SYST PH, V62, P1983, DOI 10.2146/ajhp040567; Mannheimer B, 2010, BRIT J CLIN PHARMACO, V69, P411, DOI 10.1111/j.1365-2125.2009.03598.x; Mannheimer B, 2008, EUR J CLIN PHARMACOL, V64, P1209, DOI 10.1007/s00228-008-0547-x; PIPPc Marie Eliasson, 2011, COMMUNICATION; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Rane A, 2010, HUM GENOMICS PROTEOM, V2010, DOI DOI 10.4061/2010/754919; Sabbe JR, 1998, PHARMACOTHERAPY, V18, P871; SCHAFER AI, 1995, J CLIN PHARMACOL, V35, P209, DOI 10.1002/j.1552-4604.1995.tb04050.x; Schelleman H, 2008, CLIN PHARMACOL THER, V84, P581, DOI 10.1038/clpt.2008.150; Scher ML, 1997, ANN PHARMACOTHER, V31, P646, DOI 10.1177/106002809703100523; Settergren J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069545; van Dijk KN, 2004, THROMB HAEMOSTASIS, V91, P95, DOI 10.1160/TH03-05-0325; Washington C, 2007, J CLIN PHARMACOL, V47, P1320, DOI 10.1177/0091270007305504; Wen X, 2002, DRUG METAB DISPOS, V30, P631, DOI 10.1124/dmd.30.6.631; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; Williams D, 2000, BRIT J CLIN PHARMACO, V49, P369, DOI 10.1046/j.1365-2125.2000.00177.x	43	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97388	10.1371/journal.pone.0097388	http://dx.doi.org/10.1371/journal.pone.0097388			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830709	Green Submitted, Green Published, gold			2022-12-27	WOS:000336789500051
J	Pang, S; Pokomo, L; Chen, K; Kamata, M; Mao, SH; Zhang, H; Razi, E; An, DS; Chen, ISY				Pang, Shen; Pokomo, Lauren; Chen, Kevin; Kamata, Masakazu; Mao, Si-Hua; Zhang, Hong; Razi, Elliot; An, Dong Sung; Chen, Irvin S. Y.			High-Throughput Screening of Effective siRNAs Using Luciferase-Linked Chimeric mRNA	PLOS ONE			English	Article							SMALL INTERFERING RNAS; SECONDARY STRUCTURE; MAMMALIAN-CELLS; TARGET SITES; HAIRPIN RNAS; EXPRESSION; HIV-1; VECTOR; CCR5; TRANSFECTION	The use of siRNAs to knock down gene expression can potentially be an approach to treat various diseases. To avoid siRNA toxicity the less transcriptionally active H1 pol III promoter, rather than the U6 promoter, was proposed for siRNA expression. To identify highly efficacious siRNA sequences, extensive screening is required, since current computer programs may not render ideal results. Here, we used CCR5 gene silencing as a model to investigate a rapid and efficient screening approach. We constructed a chimeric luciferase-CCR5 gene for high-throughput screening of siRNA libraries. After screening approximately 900 shRNA clones, 12 siRNA sequences were identified. Sequence analysis demonstrated that most (11 of the 12 sequences) of these siRNAs did not match those identified by available siRNA prediction algorithms. Significant inhibition of CCR5 in a T-lymphocyte cell line and primary T cells by these identified siRNAs was confirmed using the siRNA lentiviral vectors to infect these cells. The inhibition of CCR5 expression significantly protected cells from R5 HIV-1(JRCSF) infection. These results indicated that the high-throughput screening method allows efficient identification of siRNA sequences to inhibit the target genes at low levels of expression.	[Pang, Shen; Razi, Elliot] Univ Calif Los Angeles, David Geffen Sch Med, Dept Orthopaed Surg, Los Angeles, CA 90095 USA; [Pokomo, Lauren; An, Dong Sung] Univ Calif Los Angeles, David Geffen Sch Med, Sch Nursing, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Pokomo, Lauren; An, Dong Sung] Univ Calif Los Angeles, AIDS Inst, Los Angeles, CA USA; [Chen, Kevin; Kamata, Masakazu; Mao, Si-Hua; Chen, Irvin S. Y.] Univ Calif Los Angeles, David Geffen Sch Med, AIDS Inst, Los Angeles, CA 90095 USA; [Zhang, Hong] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA; [Zhang, Hong] Sun Yat Sen Univ, Guanghua Sch Stomatol, Dept Orthodont, Guangzhou 510275, Guangdong, Peoples R China	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Sun Yat Sen University	Chen, ISY (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol Genet & Med, Los Angeles, CA 90095 USA.	syuchen@mednet.ucla.edu	KAMATA, MASAKAZU/E-7550-2017	Kamata, Masakazu/0000-0003-0323-3742; Chen, Irvin/0000-0003-1199-2415	UCLA AIDS Institute (UCLA Center for AIDS Research (CFAR) NIH/NIAID) [AI028697]; National Institutes of Health [AI39975, AI28697, R01 HL086409, 3R01HL086409-03S1]; CIRM [RS1-00172-01]; Intramural Research Program of the National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100652, R01AI039975, P30AI028697] Funding Source: NIH RePORTER	UCLA AIDS Institute (UCLA Center for AIDS Research (CFAR) NIH/NIAID); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the UCLA AIDS Institute (UCLA Center for AIDS Research (CFAR) NIH/NIAID AI028697), the National Institutes of Health (AI39975 and AI28697 (to ISYC) and R01 HL086409 and 3R01HL086409-03S1 (to DSA)), CIRM (RS1-00172-01 (to ISYC)), and partially by the Intramural Research Program of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An DS, 2007, P NATL ACAD SCI USA, V104, P13110, DOI 10.1073/pnas.0705474104; An DS, 2006, MOL THER, V14, P494, DOI 10.1016/j.ymthe.2006.05.015; Barry SC, 2001, HUM GENE THER, V12, P1103, DOI 10.1089/104303401750214311; Chung NJ, 2008, J BIOMOL SCREEN, V13, P142, DOI 10.1177/1087057107312032; Ding Y, 2004, NUCLEIC ACIDS RES, V32, pW135, DOI 10.1093/nar/gkh449; Gu S, 2005, RNA, V11, P38, DOI 10.1261/rna.7158605; Gu S, 2009, NAT STRUCT MOL BIOL, V16, P144, DOI 10.1038/nsmb.1552; Heale BSE, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni026; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; KIEFER J, 1953, P AM MATH SOC, V4, P502, DOI 10.2307/2032161; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Lee NS, 2002, NAT BIOTECHNOL, V20, P500, DOI 10.1038/nbt0502-500; Luo Q, 2007, GENE, V395, P160, DOI 10.1016/j.gene.2007.02.030; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; Morizono K, 2005, NAT MED, V11, P346, DOI 10.1038/nm1192; Orita M, 2009, DRUG DISCOV TODAY, V14, P321, DOI 10.1016/j.drudis.2008.10.006; Pang S, 2001, CLIN CANCER RES, V7, P3567; Pei Y, 2006, NAT METHODS, V3, P670, DOI 10.1038/NMETH911; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Scherer L, 2007, GENE THER, V14, P1057, DOI 10.1038/sj.gt.3302977; Scherer L, 2004, CURR PHARM BIOTECHNO, V5, P355, DOI 10.2174/1389201043376724; Scherer LJ, 2004, MOL THER, V10, P597, DOI 10.1016/j.ymthe.2004.05.003; Shao Y, 2007, RNA, V13, P1631, DOI 10.1261/rna.546207; Shimizu Saki, 2009, Genet Vaccines Ther, V7, P8, DOI 10.1186/1479-0556-7-8; Snove O, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-231; Stevenson M, 2003, NAT REV IMMUNOL, V3, P851, DOI 10.1038/nri1227; Trkola A, 1999, J VIROL, V73, P8966, DOI 10.1128/JVI.73.11.8966-8974.1999; Ui-Tei Kumiko, 2007, Methods Mol Biol, V361, P201; van den Berg A, 2008, BBA-GENE REGUL MECH, V1779, P668, DOI 10.1016/j.bbagrm.2008.07.005; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499; Zhao HF, 2005, NAT METHODS, V2, P967, DOI 10.1038/NMETH812; Zheng XJ, 2011, J BIOTECHNOL, V155, P135, DOI 10.1016/j.jbiotec.2011.05.004	34	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e96445	10.1371/journal.pone.0096445	http://dx.doi.org/10.1371/journal.pone.0096445			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831610	Green Published, gold, Green Submitted			2022-12-27	WOS:000336789500019
J	Abreu, CM; Price, SL; Shirk, EN; Cunha, RD; Pianowski, LF; Clements, JE; Tanuri, A; Gama, L				Abreu, Celina M.; Price, Sarah L.; Shirk, Erin N.; Cunha, Rodrigo D.; Pianowski, Luiz F.; Clements, Janice E.; Tanuri, Amilcar; Gama, Lucio			Dual Role of Novel Ingenol Derivatives from Euphorbia tirucalli in HIV Replication: Inhibition of De Novo Infection and Activation of Viral LTR	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELLS; P-TEFB; DEACETYLASE INHIBITORS; BIOLOGICAL-ACTIVITY; LATENT RESERVOIR; EXPRESSION; PROSTRATIN; KINASE; TYPE-1	HIV infection is not cleared by antiretroviral drugs due to the presence of latently infected cells that are not eliminated with current therapies and persist in the blood and organs of infected patients. New compounds to activate these latent reservoirs have been evaluated so that, along with HAART, they can be used to activate latent virus and eliminate the latently infected cells resulting in eradication of viral infection. Here we describe three novel diterpenes isolated from the sap of Euphorbia tirucalli, a tropical shrub. These molecules, identified as ingenols, were modified at carbon 3 and termed ingenol synthetic derivatives (ISD). They activated the HIV-LTR in reporter cell lines and human PBMCs with latent virus in concentrations as low as 10 nM. ISDs were also able to inhibit the replication of HIV-1 subtype B and C in MT-4 cells and human PBMCs at concentrations of EC50 0.02 and 0.09 mu M respectively, which are comparable to the EC50 of some antiretroviral currently used in AIDS treatment. Control of viral replication may be caused by downregulation of surface CD4, CCR5 and CXCR4 observed after ISD treatment in vitro. These compounds appear to be less cytotoxic than other diterpenes such as PMA and prostratin, with effective dose versus toxic dose TI> 400. Although the mechanisms of action of the three ISDs are primarily attributed to the PKC pathway, downregulation of surface receptors and stimulation of the viral LTR might be differentially modulated by different PKC isoforms.	[Abreu, Celina M.; Cunha, Rodrigo D.; Clements, Janice E.; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, Brazil; [Abreu, Celina M.; Price, Sarah L.; Shirk, Erin N.; Gama, Lucio] Johns Hopkins Univ Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21218 USA; [Pianowski, Luiz F.] Kyolab, Campinas, SP, Brazil	Universidade Federal do Rio de Janeiro; Johns Hopkins University	Gama, L (corresponding author), Johns Hopkins Univ Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21218 USA.	lucio@jhmi.edu	Tanuri, Amilcar/AAM-8601-2021; Abreu, Celina Monteiro/AAT-7447-2020	Gama, Lucio/0000-0001-9511-012X; Price, Sarah/0000-0002-4392-7506	NIH [R01 NS077869, P01 MH070306, U19 AI096113]; Brazilian agency CNPq; Brazilian agency FAPERJ; Brazilian agency CAPES; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI096113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH070306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077869] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brazilian agency CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian agency FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Brazilian agency CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH (www.nih.gov) grants R01 NS077869, P01 MH070306 and U19 AI096113 (JEC). It also received financial assistance from the Brazilian agencies CNPq, FAPERJ and CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali FR, 2012, DERMATOLOGY THER, V2, DOI 10.1007/s13555-012-0008-4; Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; Barrero RA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-600; Biancotto A, 2004, J VIROL, V78, P10507, DOI 10.1128/JVI.78.19.10507-10515.2004; Blanco-Molina M, 2001, CHEM BIOL, V8, P767, DOI 10.1016/S1074-5521(01)00048-5; Bocklandt S, 2003, ANTIVIR RES, V59, P89, DOI 10.1016/S0166-3542(03)00034-2; BOTO WMO, 1991, CELL REGUL, V2, P95, DOI 10.1091/mbc.2.2.95; Bouchat S, 2012, AIDS, V26, P1473, DOI 10.1097/QAD.0b013e32835535f5; Bullen CK, 2014, NAT MED, V20, P425, DOI 10.1038/nm.3489; Buss N, 2001, ANTIVIR THER, V6, P1; Capo C, 2000, IMPACT HIGHLY ACTIVE; Cherrier T, 2013, P NATL ACAD SCI USA, V110, P12655, DOI 10.1073/pnas.1220136110; Chiang Peter K., 1996, Journal of Biomedical Science, V3, P78, DOI 10.1007/BF02255534; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Cimo AM, 2013, BIOCHEM J, V454, P109, DOI 10.1042/BJ20130485; CLOUSE KA, 1989, J IMMUNOL, V142, P431; Colin L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-111; Contreras X, 2007, PLOS PATHOG, V3, P1459, DOI 10.1371/journal.ppat.0030146; Devadas K, 2004, J IMMUNOL, V173, P6735, DOI 10.4049/jimmunol.173.11.6735; Eisele E, 2012, IMMUNITY, V37, P377, DOI 10.1016/j.immuni.2012.08.010; Ersvaer E, 2010, TOXINS, V2, P174, DOI 10.3390/toxins2010174; Fernandez G, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-266; FOLKS TM, 1987, SCIENCE, V238, P800, DOI 10.1126/science.3313729; Friedman J, 2011, J VIROL, V85, P9078, DOI 10.1128/JVI.00836-11; Fujiwara M, 1996, ANTIMICROB AGENTS CH, V40, P271, DOI 10.1128/AAC.40.1.271; Fujiwara M, 1998, ARCH VIROL, V143, P2003, DOI 10.1007/s007050050436; Goel G, 2007, INT J TOXICOL, V26, P279, DOI 10.1080/10915810701464641; Gupta A, 2004, J PHARMACOL EXP THER, V310, P334, DOI 10.1124/jpet.104.065342; Hamer DH, 2004, CURR HIV RES, V2, P99, DOI 10.2174/1570162043484915; Hampson P, 2005, DRUG FUTURE, V30, P1003, DOI 10.1358/dof.2005.030.10.942816; HARADA S, 1985, SCIENCE, V229, P563, DOI 10.1126/science.2992081; Hashemi BB, 1999, FASEB J, V13, P2071, DOI 10.1096/fasebj.13.14.2071; Hezareh Marjan, 2004, Antiviral Chemistry & Chemotherapy, V15, P207; Hong Kee-Jong, 2011, Osong Public Health Res Perspect, V2, P109, DOI 10.1016/j.phrp.2011.07.001; Huang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026677; Huet T, 2010, ANTIMICROB AGENTS CH, V54, P134, DOI 10.1128/AAC.00827-09; Jassbi AR, 2006, PHYTOCHEMISTRY, V67, P1977, DOI 10.1016/j.phytochem.2006.06.030; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Jorgensen L, 2013, SCIENCE, V341, P878, DOI 10.1126/science.1241606; Kauder SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000495; Kedei N, 2004, CANCER RES, V64, P3243, DOI 10.1158/0008-5472.CAN-03-3403; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Kulkosky J, 2004, AIDS RES HUM RETROV, V20, P497, DOI 10.1089/088922204323087741; Kulkosky J, 2001, BLOOD, V98, P3006, DOI 10.1182/blood.V98.10.3006; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Marquez N, 2008, BIOCHEM PHARMACOL, V75, P1370, DOI 10.1016/j.bcp.2007.12.004; McKernan LN, 2012, ADV VIROL, V2012, DOI 10.1155/2012/805347; McNamara LA, 2012, J VIROL, V86, P9337, DOI 10.1128/JVI.00895-12; Mehla R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011160; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Nirmala M. J., 2011, Research in Plant Biology, V1, P1; Norman R, 2013, JAMA DERMATOL, V149, P666, DOI [10.1001/jamadermatol.2013.2766, DOI 10.1001/JAMADERMATOL.2013.2766]; Pedersen OS, 1999, ANTIVIR CHEM CHEMOTH, V10, P285, DOI 10.1177/095632029901000601; PEREZ VL, 1991, J IMMUNOL, V147, P3145; Prins JM, 1999, AIDS, V13, P2405, DOI 10.1097/00002030-199912030-00012; Reuse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006093; Rohr O, 2003, J LEUKOCYTE BIOL, V74, P736, DOI 10.1189/jlb.0403180; Rullas J, 2004, ANTIVIR THER, V9, P545; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Sanchez-Duffhues G, 2011, CURR DRUG TARGETS, V12, P348, DOI 10.2174/138945011794815266; Savarino A, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-52; SCHINAZI RF, 1990, ANTIMICROB AGENTS CH, V34, P1061, DOI 10.1128/AAC.34.6.1061; Scripture-Adams DD, 2002, J VIROL, V76, P13077, DOI 10.1128/JVI.76.24.13077-13082.2002; Shimamura T, 2008, CANCER RES, V68, P5827, DOI 10.1158/0008-5472.CAN-07-5428; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Siliciano RF, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a007096; Spina CA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003834; Vandergeeten C, 2012, CYTOKINE GROWTH F R, V23, P143, DOI 10.1016/j.cytogfr.2012.05.001; Visseaux B, 2012, ANTIMICROB AGENTS CH, V56, P137, DOI 10.1128/AAC.05313-11; Warrilow D, 2006, AIDS RES HUM RETROV, V22, P854, DOI 10.1089/aid.2006.22.854; Wender PA, 2008, SCIENCE, V320, P649, DOI 10.1126/science.1154690; Wender PA, 2011, P NATL ACAD SCI USA, V108, P6721, DOI 10.1073/pnas.1015270108; Williams SA, 2004, J BIOL CHEM, V279, P42008, DOI 10.1074/jbc.M402124200; Xing SF, 2013, DRUG DISCOV TODAY, V18, P541, DOI 10.1016/j.drudis.2012.12.008; Yang HC, 2009, J CLIN INVEST, V119, P3473, DOI 10.1172/JCI39199; Yoshida M, 2003, INT J CANCER, V105, P601, DOI 10.1002/ijc.11157; ZAYED S, 1977, EXPERIENTIA, V33, P1554, DOI 10.1007/BF01933991; Zhou MS, 2004, J VIROL, V78, P13522, DOI 10.1128/JVI.78.24.13522-13533.2004; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	79	62	66	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97257	10.1371/journal.pone.0097257	http://dx.doi.org/10.1371/journal.pone.0097257			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827152	Green Published, gold, Green Submitted			2022-12-27	WOS:000336857400068
J	Bala, S; Marcos, M; Gattu, A; Catalano, D; Szabo, G				Bala, Shashi; Marcos, Miguel; Gattu, Arijeet; Catalano, Donna; Szabo, Gyongyi			Acute Binge Drinking Increases Serum Endotoxin and Bacterial DNA Levels in Healthy Individuals	PLOS ONE			English	Article							LIVER-DISEASE; ALCOHOL; ACTIVATION; ETHANOL; PROTEIN	Binge drinking, the most common form of alcohol consumption, is associated with increased mortality and morbidity; yet, its biological consequences are poorly defined. Previous studies demonstrated that chronic alcohol use results in increased gut permeability and increased serum endotoxin levels that contribute to many of the biological effects of chronic alcohol, including alcoholic liver disease. In this study, we evaluated the effects of acute binge drinking in healthy adults on serum endotoxin levels. We found that acute alcohol binge resulted in a rapid increase in serum endotoxin and 16S rDNA, a marker of bacterial translocation from the gut. Compared to men, women had higher blood alcohol and circulating endotoxin levels. In addition, alcohol binge caused a prolonged increase in acute phase protein levels in the systemic circulation. The biological significance of the in vivo endotoxin elevation was underscored by increased levels of inflammatory cytokines, TNF alpha and IL-6, and chemokine, MCP-1, measured in total blood after in vitro lipopolysaccharide stimulation. Our findings indicate that even a single alcohol binge results in increased serum endotoxin levels likely due to translocation of gut bacterial products and disturbs innate immune responses that can contribute to the deleterious effects of binge drinking.	[Bala, Shashi; Marcos, Miguel; Gattu, Arijeet; Catalano, Donna; Szabo, Gyongyi] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Szabo, G (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA.	gyongyi.szabo@umassmed.edu	Marcos, Miguel/B-3550-2008	Marcos, Miguel/0000-0003-1269-4487	NIH [AA 011576]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011576] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by NIH grant AA 011576. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bala S, 2012, J LEUKOCYTE BIOL, V92, P611, DOI 10.1189/jlb.0112050; Blednov YA, 2011, BRAIN BEHAV IMMUN, V25, pS92, DOI 10.1016/j.bbi.2011.01.008; Blednov YA, 2012, ADDICT BIOL, V17, P108, DOI 10.1111/j.1369-1600.2010.00284.x; Caradonna L, 2000, J ENDOTOXIN RES, V6, P205, DOI 10.1177/09680519000060030101; Hamann L, 2005, INFECT IMMUN, V73, P193, DOI 10.1128/IAI.73.1.193-200.2005; Hartmann P, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00402; Horz HP, 2005, J CLIN MICROBIOL, V43, P5332, DOI 10.1128/JCM.43.10.5332-5337.2005; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Keshavarzian A, 2009, J HEPATOL, V50, P538, DOI 10.1016/j.jhep.2008.10.028; Levy O, 2003, PEDIATR INFECT DIS J, V22, P978, DOI 10.1097/01.inf.0000095196.19606.d2; Massey VL, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00193; Mathurin P, 2009, GUT, V58, P613, DOI 10.1136/gut.2007.145573; Mutlu EA, 2012, AM J PHYSIOL-GASTR L, V302, pG966, DOI 10.1152/ajpgi.00380.2011; Norkina O, 2008, ALCOHOL CLIN EXP RES, V32, P1565, DOI 10.1111/j.1530-0277.2008.00726.x; Rivera CA, 1998, AM J PHYSIOL-GASTR L, V275, pG1252, DOI 10.1152/ajpgi.1998.275.6.G1252; Schnabl B, 2013, CURR OPIN GASTROEN, V29, P264, DOI 10.1097/MOG.0b013e32835ff948; Shukla SD, 2013, ALCOHOL CLIN EXP RES, V37, P550, DOI 10.1111/acer.12011; Szabo G, 2010, DIGEST DIS, V28, P737, DOI 10.1159/000324281; Szabo G, 2010, ALCOHOL CLIN EXP RES, V34, P1675, DOI 10.1111/j.1530-0277.2010.01255.x; Tang YM, 2008, ALCOHOL CLIN EXP RES, V32, P355, DOI 10.1111/j.1530-0277.2007.00584.x; Yan AW, 2011, HEPATOLOGY, V53, P96, DOI 10.1002/hep.24018	21	189	192	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96864	10.1371/journal.pone.0096864	http://dx.doi.org/10.1371/journal.pone.0096864			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828436	Green Published, gold, Green Submitted			2022-12-27	WOS:000336857400041
J	Sjovall, F; Morota, S; Frostner, EA; Hansson, MJ; Elmer, E				Sjovall, Fredrik; Morota, Saori; Frostner, Eleonor Asander; Hansson, Magnus J.; Elmer, Eskil			Cytokine and Nitric Oxide Levels in Patients with Sepsis - Temporal Evolvement and Relation to Platelet Mitochondrial Respiratory Function	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; OXIDATIVE-PHOSPHORYLATION; INFLAMMATORY RESPONSE; BIOGENESIS; DYSFUNCTION; METABOLISM; ACTIVATION; MORTALITY; SURVIVAL; MARKERS	Background: The levels of nitric oxide (NO) and various cytokines are known to be increased during sepsis. These signaling molecules could potentially act as regulators and underlie the enhancement of mitochondrial function described in the later phase of sepsis. Therefore, we investigated the correlation between observed changes in platelet mitochondrial respiration and a set of pro- and anti-inflammatory cytokines as well as NO plasma levels in patients with sepsis. Methods and Results: Platelet mitochondrial respiration and levels of TNF alpha, MCP-1 (monocyte chemotactic protein-1), INF gamma (interferon-gamma), IL-1 beta, IL-4, IL-5, IL-6, IL-8, IL-10 and IL-17 and NO were analyzed in 38 patients with severe sepsis or septic shock at three time points during one week following admission to the ICU. Citrate synthase, mitochondrial DNA and cytochrome c were measured as markers of cellular mitochondrial content. All mitochondrial respiratory states increased over the week analyzed (p < 0.001). IL-8 levels correlated with maximal mitochondrial respiration on day 6-7 (p = 0.02, r(2) = 0.22) and was also higher in non-survivors compared to survivors on day 3-4 and day 6-7 (p = 0.03 respectively). Neither NO nor any of the other cytokines measured correlated with respiration or mortality. Cytochrome c levels were decreased at day 1-2 by 24 +/- 5% (p = 0.03) and returned towards values of the controls at the last two time points. Citrate synthase activity and mitochondrial DNA levels were similar to controls and remained constant throughout the week. Conclusions: Out of ten analyzed cytokines and nitric oxide, IL-8 correlated with the observed increase in mitochondrial respiration. This suggests that cytokines as well as NO do not play a prominent role in the regulation of platelet mitochondrial respiration in sepsis. Further, the respiratory increase was not accompanied by an increase in markers of mitochondrial content, suggesting a possible role for post-translational enhancement of mitochondrial respiration rather than augmented mitochondrial mass.	[Sjovall, Fredrik; Morota, Saori; Frostner, Eleonor Asander; Hansson, Magnus J.; Elmer, Eskil] Lund Univ, Dept Clin Sci, Lund, Sweden; [Sjovall, Fredrik] Univ Copenhagen Hosp, Rigshosp, Intens Care Unit 4131, DK-2100 Copenhagen, Denmark; [Hansson, Magnus J.] Lund Univ, Dept Clin Physiol, Skane Univ Hosp, Lund, Sweden; [Elmer, Eskil] Lund Univ, Dept Clin Neurophysiol, Skane Univ Hosp, Lund, Sweden	Lund University; Rigshospitalet; University of Copenhagen; Lund University; Skane University Hospital; Lund University; Skane University Hospital	Sjovall, F (corresponding author), Lund Univ, Dept Clin Sci, Lund, Sweden.	fredrik.sjovall@med.lu.se	Elmér, Eskil/F-9341-2014; Hansson, Magnus/G-4486-2014	Elmér, Eskil/0000-0001-7901-1826; Hansson, Magnus/0000-0002-0201-0638; Asander Frostner, Eleonor/0000-0001-8426-4836; Sjovall, Fredrik/0000-0001-5612-0325	Swedish Research Council [2011-3470]; Royal Physiographic Society; Swedish Society of Medicine; Carl og Ellen Hertz' legat til Dansk laege- og naturvidenskab; Lippman foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Physiographic Society; Swedish Society of Medicine; Carl og Ellen Hertz' legat til Dansk laege- og naturvidenskab; Lippman foundation	This work was supported by the Swedish Research Council (Reference number 2011-3470), the Royal Physiographic Society, the Swedish Society of Medicine, Carl og Ellen Hertz' legat til Dansk laege- og naturvidenskab, and the Lippman foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Andaluz-Ojeda D, 2012, CYTOKINE, V57, P332, DOI 10.1016/j.cyto.2011.12.002; Andrades ME, 2011, CRIT CARE, V15, DOI 10.1186/cc10334; Belikova I, 2007, CRIT CARE MED, V35, P2702, DOI 10.1097/01.CCM.0000295593.25106.C4; Boczkowski J, 2001, BIOL SIGNAL RECEPT, V10, P66; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; Brealey David, 2003, Curr Infect Dis Rep, V5, P365, DOI 10.1007/s11908-003-0015-9; Brown GC, 2002, FREE RADICAL BIO MED, V33, P1440, DOI 10.1016/S0891-5849(02)01112-7; Carre JE, 2010, AM J RESP CRIT CARE, V182, P745, DOI 10.1164/rccm.201003-0326OC; Cavaillon JM, 2003, SCAND J INFECT DIS, V35, P535, DOI 10.1080/00365540310015935; Damas P, 1997, CRIT CARE MED, V25, P405, DOI 10.1097/00003246-199703000-00006; de Jong HK, 2010, J INNATE IMMUN, V2, P422, DOI 10.1159/000316286; Drabarek B, 2012, INT J BIOCHEM CELL B, V44, P1390, DOI 10.1016/j.biocel.2012.05.022; Fry DE, 2012, AM SURGEON, V78, P1; Garrabou G, 2012, J INFECT DIS, V205, P392, DOI 10.1093/infdis/jir764; Gnaiger E, 2000, LIFE IN THE COLD, P431; HACK CE, 1992, INFECT IMMUN, V60, P2835, DOI 10.1128/IAI.60.7.2835-2842.1992; Haden DW, 2007, AM J RESP CRIT CARE, V176, P768, DOI 10.1164/rccm.200701-161OC; Hoogerwerf JJ, 2010, INTENS CARE MED, V36, P630, DOI 10.1007/s00134-010-1773-0; Hopper RK, 2006, BIOCHEMISTRY-US, V45, P2524, DOI 10.1021/bi052475e; Huttemann M, 2007, BBA-MOL CELL RES, V1773, P1701, DOI 10.1016/j.bbamcr.2007.10.001; Japiassu AM, 2011, CRIT CARE MED, V39, P1056, DOI 10.1097/CCM.0b013e31820eda5c; Kellum JA, 2007, ARCH INTERN MED, V167, P1655, DOI 10.1001/archinte.167.15.1655; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; KILBOURN RG, 1992, J NATL CANCER I, V84, P827, DOI 10.1093/jnci/84.11.827; Leonidou L, 2007, J INFECTION, V55, P340, DOI 10.1016/j.jinf.2007.05.177; Lopez A, 2004, CRIT CARE MED, V32, P21, DOI 10.1097/01.CCM.0000105581.01815.C6; Mauro C, 2011, NAT CELL BIOL, V13, P1272, DOI 10.1038/ncb2324; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Piantadosi CA, 2012, BBA-GEN SUBJECTS, V1820, P532, DOI 10.1016/j.bbagen.2012.01.003; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Reynolds CM, 2009, FREE RADICAL BIO MED, V46, P564, DOI 10.1016/j.freeradbiomed.2008.11.007; Ricart-Jane D, 2002, NITRIC OXIDE-BIOL CH, V6, P178, DOI 10.1006/niox.2001.0392; Ruggieri AJ, 2010, CRIT CARE CLIN, V26, P567, DOI 10.1016/j.ccc.2010.04.007; Samavati L, 2008, J BIOL CHEM, V283, P21134, DOI 10.1074/jbc.M801954200; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; Sjovall F, 2013, CRIT CARE, V17, DOI 10.1186/cc12831; Sjovall F, 2010, CRIT CARE, V14, DOI 10.1186/cc9337; Suliman HB, 2004, CARDIOVASC RES, V64, P279, DOI 10.1016/j.cardiores.2004.07.005; Vincent JL, 2011, CRIT CARE MED, V39, P1050, DOI 10.1097/CCM.0b013e31820eda29; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482	44	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97673	10.1371/journal.pone.0097673	http://dx.doi.org/10.1371/journal.pone.0097673			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828117	Green Published, gold			2022-12-27	WOS:000336857400116
J	Sun, JH; Peng, Y; Duan, XM; Yu, T; Zhang, QF; Liu, Y; Hu, D				Sun, Jihang; Peng, Yun; Duan, Xiaomin; Yu, Tong; Zhang, Qifeng; Liu, Yong; Hu, Di			Image Quality in Children with Low-Radiation Chest CT Using Adaptive Statistical Iterative Reconstruction and Model-Based Iterative Reconstruction	PLOS ONE			English	Article							FILTERED BACK-PROJECTION; LOW-DOSE CT; HELICAL CT; REDUCTION; OPTIMIZATION; FEASIBILITY; ABDOMEN	Objective: To evaluate noise reduction and image quality improvement in low-radiation dose chest CT images in children using adaptive statistical iterative reconstruction (ASIR) and a full model-based iterative reconstruction (MBIR) algorithm. Methods: Forty-five children (age ranging from 28 days to 6 years, median of 1.8 years) who received low-dose chest CT scans were included. Age-dependent noise index (NI) was used for acquisition. Images were retrospectively reconstructed using three methods: MBIR, 60% of ASIR and 40% of conventional filtered back-projection (FBP), and FBP. The subjective quality of the images was independently evaluated by two radiologists. Objective noises in the left ventricle (LV), muscle, fat, descending aorta and lung field at the layer with the largest cross-section area of LV were measured, with the region of interest about one fourth to half of the area of descending aorta. Optimized signal-to-noise ratio (SNR) was calculated. Result: In terms of subjective quality, MBIR images were significantly better than ASIR and FBP in image noise and visibility of tiny structures, but blurred edges were observed. In terms of objective noise, MBIR and ASIR reconstruction decreased the image noise by 55.2% and 31.8%, respectively, for LV compared with FBP. Similarly, MBIR and ASIR reconstruction increased the SNR by 124.0% and 46.2%, respectively, compared with FBP. Conclusion: Compared with FBP and ASIR, overall image quality and noise reduction were significantly improved by MBIR. MBIR image could reconstruct eligible chest CT images in children with lower radiation dose.	[Sun, Jihang; Peng, Yun; Duan, Xiaomin; Yu, Tong; Zhang, Qifeng; Liu, Yong; Hu, Di] Capital Med Univ, Beijing Childrens Hosp, Imaging Ctr, Beijing, Peoples R China	Capital Medical University	Peng, Y (corresponding author), Capital Med Univ, Beijing Childrens Hosp, Imaging Ctr, Beijing, Peoples R China.	ppengyun@yahoo.com	Sun, Jihang/AAG-2811-2020		National Science and Technology Major Project of the Ministry of Science and Technology of China; Application Research of Clinical Characteristics of Beijing [Z141107002514005]	National Science and Technology Major Project of the Ministry of Science and Technology of China; Application Research of Clinical Characteristics of Beijing	This study was supported by the National Science and Technology Major Project of the Ministry of Science and Technology of China and The Application Research of Clinical Characteristics of Beijing (Z141107002514005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, GE BLUEPR GUID CT RA; Bongartz G, 2000, 16262 EUR EN; Cornfeld D, 2011, AM J ROENTGENOL, V196, pW336, DOI 10.2214/AJR.10.4573; Diel J, 2000, J COMPUT ASSIST TOMO, V24, P795, DOI 10.1097/00004728-200009000-00023; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; Funama Y, 2005, RADIOLOGY, V237, P905, DOI 10.1148/radiol.2373041643; Hara AK, 2009, AM J ROENTGENOL, V193, P764, DOI 10.2214/AJR.09.2397; Heyer CM, 2007, RADIOLOGY, V245, P577, DOI 10.1148/radiol.2452061919; Kalra MK, 2004, RADIOLOGY, V230, P619, DOI 10.1148/radiol.2303021726; Kalra MK, 2003, RADIOLOGY, V228, P251, DOI 10.1148/radiol.2281020693; Katsura M, 2012, EUR RADIOL, V22, P1613, DOI 10.1007/s00330-012-2452-z; Leipsic J, 2010, AM J ROENTGENOL, V195, P1095, DOI 10.2214/AJR.09.4050; Peng Y, 2009, ACTA RADIOL, V50, P1175, DOI 10.3109/02841850903241914; Prakash P, 2010, INVEST RADIOL, V45, P202, DOI 10.1097/RLI.ob013e3181dzfeec; Sagara Y, 2010, AM J ROENTGENOL, V195, P713, DOI 10.2214/AJR.09.2989; Singh S, 2012, J COMPUT ASSIST TOMO, V36, P347, DOI 10.1097/RCT.0b013e31824e639e; Singh S, 2011, RADIOLOGY, V259, P565, DOI 10.1148/radiol.11101450; Singh S, 2010, RADIOLOGY, V257, P373, DOI 10.1148/radiol.10092212; Thibault JB, 2007, MED PHYS, V34, P4526, DOI 10.1118/1.2789499; Vorona GA, 2011, PEDIATR RADIOL, V41, P1174, DOI 10.1007/s00247-011-2063-x; Xu X, 2011, ZHONG GUO YI XUE YIN, V27, P1633; Yoon MA, 2012, J COMPUT ASSIST TOMO, V36, P596, DOI 10.1097/RCT.0b013e31826092be; Yu Z, 2011, IEEE T IMAGE PROCESS, V20, P161, DOI 10.1109/TIP.2010.2058811	23	7	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96045	10.1371/journal.pone.0096045	http://dx.doi.org/10.1371/journal.pone.0096045			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828429	Green Published, Green Submitted, gold			2022-12-27	WOS:000336857400021
J	Hasan, RC; Ierodiaconou, D; Laurenson, L; Schimel, A				Hasan, Rozaimi Che; Ierodiaconou, Daniel; Laurenson, Laurie; Schimel, Alexandre			Integrating Multibeam Backscatter Angular Response, Mosaic and Bathymetry Data for Benthic Habitat Mapping	PLOS ONE			English	Article							ECHO-SOUNDER MEASUREMENTS; SEA-FLOOR BACKSCATTER; SPECIES RICHNESS; ECHOSOUNDER DATA; CLASSIFICATION; SONAR; SEGMENTATION; ACCURACY; FEATURES; GEOLOGY	Multibeam echosounders (MBES) are increasingly becoming the tool of choice for marine habitat mapping applications. In turn, the rapid expansion of habitat mapping studies has resulted in a need for automated classification techniques to efficiently map benthic habitats, assess confidence in model outputs, and evaluate the importance of variables driving the patterns observed. The benthic habitat characterisation process often involves the analysis of MBES bathymetry, backscatter mosaic or angular response with observation data providing ground truth. However, studies that make use of the full range of MBES outputs within a single classification process are limited. We present an approach that integrates backscatter angular response with MBES bathymetry, backscatter mosaic and their derivatives in a classification process using a Random Forests (RF) machine-learning algorithm to predict the distribution of benthic biological habitats. This approach includes a method of deriving statistical features from backscatter angular response curves created from MBES data collated within homogeneous regions of a backscatter mosaic. Using the RF algorithm we assess the relative importance of each variable in order to optimise the classification process and simplify models applied. The results showed that the inclusion of the angular response features in the classification process improved the accuracy of the final habitat maps from 88.5% to 93.6%. The RF algorithm identified bathymetry and the angular response mean as the two most important predictors. However, the highest classification rates were only obtained after incorporating additional features derived from bathymetry and the backscatter mosaic. The angular response features were found to be more important to the classification process compared to the backscatter mosaic features. This analysis indicates that integrating angular response information with bathymetry and the backscatter mosaic, along with their derivatives, constitutes an important improvement for studying the distribution of benthic habitats, which is necessary for effective marine spatial planning and resource management.	[Hasan, Rozaimi Che; Ierodiaconou, Daniel; Laurenson, Laurie; Schimel, Alexandre] Deakin Univ, Ctr Integrat Ecol, Sch Life & Environm Sci, Fac Sci & Built Environm, Warrnambool, Vic, Australia; [Hasan, Rozaimi Che] Univ Teknol Malaysia, UTM Razak Sch Engn & Adv Technol, Kuala Lumpur, Malaysia	Deakin University; Universiti Teknologi Malaysia	Ierodiaconou, D (corresponding author), Deakin Univ, Ctr Integrat Ecol, Sch Life & Environm Sci, Fac Sci & Built Environm, Warrnambool, Vic, Australia.	iero@deakin.edu.au	Che Hasan, Rozaimi/L-9086-2013; Schimel, Alexandre CG/C-9273-2013; Laurenson, Laurie J/C-8903-2009; Hasan, Rozaimi Che/V-9202-2019	Schimel, Alexandre CG/0000-0001-9301-0803; Ierodiaconou, Daniel/0000-0002-7832-4801; Che Hasan, Rozaimi/0000-0003-1341-1266	National Heritage Trust; Victorian Marine Habitat Mapping Project; Glenelg Hopkins Catchment Management Authority, Department of Sustainability and Environment, Parks Victoria, University of Western Australia	National Heritage Trust; Victorian Marine Habitat Mapping Project; Glenelg Hopkins Catchment Management Authority, Department of Sustainability and Environment, Parks Victoria, University of Western Australia	This work was supported by the National Heritage Trust and Caring as part of the Victorian Marine Habitat Mapping Project with project partners Glenelg Hopkins Catchment Management Authority, Department of Sustainability and Environment, Parks Victoria, University of Western Australia and Fugro Survey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaman RJ, 2005, MAR FRESHWATER RES, V56, P943, DOI 10.1071/MF04306; Bins L. S., 1996, COGNITIVE RELIABILIT, P677, DOI [10.1016/b978-008042848-2/50002-6, DOI 10.1016/B978-008042848-2/50002-6]; Blondel P, 2009, APPL ACOUST, V70, P1288, DOI 10.1016/j.apacoust.2008.07.015; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown CJ, 2008, ESTUAR COAST SHELF S, V78, P203, DOI 10.1016/j.ecss.2007.11.026; Brown CJ, 2011, ESTUAR COAST SHELF S, V92, P502, DOI 10.1016/j.ecss.2011.02.007; Cheng L, 2011, LIMNOLOGICA ECOLOGY; Coleman N, 1997, MAR ECOL PROG SER, V154, P17, DOI 10.3354/meps154017; Collin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021265; Congalton R. G., 2009, MATER CHARACT, DOI DOI 10.1016/J.MATCHAR.2009.07.002; CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B; Cutter GR, 2003, J EXP MAR BIOL ECOL, V285, P355, DOI 10.1016/S0022-0981(02)00537-3; DAILY M, 1983, PHOTOGRAMM ENG REM S, V49, P349; Dartnell P, 2004, PHOTOGRAMM ENG REM S, V70, P1081, DOI 10.14358/PERS.70.9.1081; De Falco G, 2010, CONT SHELF RES, V30, P1941, DOI 10.1016/j.csr.2010.09.006; Edwards BD, 2003, MAR ENVIRON RES, V56, P47, DOI 10.1016/S0141-1136(02)00324-0; Fonseca L, 2007, MAR GEOPHYS RES, V28, P119, DOI 10.1007/s11001-007-9019-4; Fonseca L, 2009, APPL ACOUST, V70, P1298, DOI 10.1016/j.apacoust.2008.09.008; Freitas R, 2003, J EXP MAR BIOL ECOL, V285, P339, DOI 10.1016/S0022-0981(02)00536-1; Galparsoro I, 2009, ECOL MODEL, V220, P556, DOI 10.1016/j.ecolmodel.2008.11.003; Gratwicke B, 2005, J FISH BIOL, V66, P650, DOI 10.1111/j.0022-1112.2005.00629.x; Gray JS, 1997, BIODIVERS CONSERV, V6, P153, DOI 10.1023/A:1018335901847; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hamilton LJ, 2011, CONT SHELF RES, V31, P138, DOI 10.1016/j.csr.2010.12.002; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hasan RC, 2012, ESTUAR COAST SHELF S, V97, P1, DOI 10.1016/j.ecss.2011.10.004; Hellequin L, 1997, OCEANS '97 MTS/IEEE CONFERENCE PROCEEDINGS, VOLS 1 AND 2, P23, DOI 10.1109/OCEANS.1997.634329; Holmes KW, 2008, CONT SHELF RES, V28, P1800, DOI 10.1016/j.csr.2008.04.016; Huang Z, 2013, CONT SHELF RES, V61-62, P12, DOI 10.1016/j.csr.2013.04.024; Hughes Clarke J, 1997, NATO SACLANTCEN C P, P243; Iampietro PJ, 2005, MAR TECHNOL SOC J, V39, P83, DOI 10.4031/002533205787442495; Ierodiaconou D, 2007, J SPAT SCI, V52, P93, DOI 10.1080/14498596.2007.9635105; Ierodiaconou D, 2011, CONT SHELF RES, V31, pS28, DOI 10.1016/j.csr.2010.01.012; Ierodiaconou D., 2007, VICTORIAN MARINE HAB; IMCRA (Interim Marine and Coastal Regionalisation for Australia), 1998, INT MAR COAST REG AU; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jaiantilal A., 2009, RANDOM FOREST REGRES; Kaiser MJ, 2002, FISH FISH, V3, P114, DOI 10.1046/j.1467-2979.2002.00079.x; Kendall MS, 2005, J COASTAL RES, V21, P1154, DOI 10.2112/03-0101R.1; Kobryn HT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070105; Kostylev VE, 2001, MAR ECOL PROG SER, V219, P121, DOI 10.3354/meps219121; Lamarche G, 2011, CONT SHELF RES, V31, pS93, DOI 10.1016/j.csr.2010.06.001; Le Bas TP, 2009, APPL ACOUST, V70, P1248, DOI 10.1016/j.apacoust.2008.07.010; Le Gonidec Y, 2003, MAR GEOPHYS RES, V24, P311, DOI 10.1007/s11001-004-1945-9; Li J, 2011, CONT SHELF RES, V31, P1365, DOI 10.1016/j.csr.2011.05.015; Lockhart D, 2005, AM FISH S S, V41, P179; Lucieer V, 2013, ESTUAR COAST SHELF S, V117, P94, DOI 10.1016/j.ecss.2012.11.001; Lucieer V, 2011, CONT SHELF RES, V31, P1236, DOI 10.1016/j.csr.2011.04.016; Lundblad E., 2006, GEOD, V29, P89, DOI [10.1080/01490410600738021, DOI 10.1080/01490410600738021]; Lurton X, 1994, P IEEE OCEANS 94, P213; Marsh I, 2009, APPL ACOUST, V70, P1269, DOI 10.1016/j.apacoust.2008.07.012; Masetti G, 2012, J ENVIRON MANAGE, V111, P44, DOI 10.1016/j.jenvman.2012.06.037; McGonigle C, 2011, ESTUAR COAST SHELF S, V91, P87, DOI 10.1016/j.ecss.2010.10.016; Meyer JD, 2007, MAR GEOPHYS RES, V28, P81, DOI 10.1007/s11001-007-9015-8; Micallef A, 2012, CONT SHELF RES, V39-40, P14, DOI 10.1016/j.csr.2012.03.008; Parnum IM, 2011, UNDERWATER TECHNOL, V30, P3, DOI 10.3723/ut.30.003; Parnum IM, 2011, UNDERWATER TECHNOL, V30, P13, DOI 10.3723/ut.30.013; Parnum IM, 2007, THESIS CURTIN U PERT; Preston J.M., 2004, P 7 EUR C UND AC DEL, P813; Rattray A, 2009, ESTUAR COAST SHELF S, V84, P237, DOI 10.1016/j.ecss.2009.06.023; Rzhanov Y, 2012, COMPUT GEOSCI-UK, V41, P181, DOI 10.1016/j.cageo.2011.09.001; Schmidt J, 2003, INT J GEOGR INF SCI, V17, P797, DOI 10.1080/13658810310001596058; Seiler J, 2012, CONT SHELF RES, V45, P87, DOI 10.1016/j.csr.2012.06.003; Simons DG, 2009, APPL ACOUST, V70, P1258, DOI 10.1016/j.apacoust.2008.07.013; van der Meer FD, 2012, INT J APPL EARTH OBS, V14, P112, DOI 10.1016/j.jag.2011.08.002; Weiss AD, 2000, TOPOGRAPHIC POSITION; Wilson MFJ, 2007, MAR GEOD, V30, P3, DOI 10.1080/01490410701295962	67	61	64	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97339	10.1371/journal.pone.0097339	http://dx.doi.org/10.1371/journal.pone.0097339			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824155	gold, Green Published, Green Submitted			2022-12-27	WOS:000336369200098
J	Tachibana, R; Namba, Y; Noguchi, Y				Tachibana, Ryosuke; Namba, Yuri; Noguchi, Yasuki			Two Speed Factors of Visual Recognition Independently Correlated with Fluid Intelligence	PLOS ONE			English	Article							MENTAL ROTATION; GENERAL INTELLIGENCE; ATTENTIONAL BLINK; PROCESSING SPEED; INSPECTION TIME; SEX-DIFFERENCES; BRAIN; NETWORKS; OBJECTS; TASKS	Growing evidence indicates a moderate but significant relationship between processing speed in visuo-cognitive tasks and general intelligence. On the other hand, findings from neuroscience proposed that the primate visual system consists of two major pathways, the ventral pathway for objects recognition and the dorsal pathway for spatial processing and attentive analysis. Previous studies seeking for visuo-cognitive factors of human intelligence indicated a significant correlation between fluid intelligence and the inspection time (IT), an index for a speed of object recognition performed in the ventral pathway. We thus presently examined a possibility that neural processing speed in the dorsal pathway also represented a factor of intelligence. Specifically, we used the mental rotation (MR) task, a popular psychometric measure for mental speed of spatial processing in the dorsal pathway. We found that the speed of MR was significantly correlated with intelligence scores, while it had no correlation with one's IT (recognition speed of visual objects). Our results support the new possibility that intelligence could be explained by two types of mental speed, one related to object recognition (IT) and another for manipulation of mental images (MR).	[Tachibana, Ryosuke; Namba, Yuri; Noguchi, Yasuki] Kobe Univ, Dept Psychol, Grad Sch Humanities, Nada Ku, Kobe, Hyogo 657, Japan	Kobe University	Noguchi, Y (corresponding author), Kobe Univ, Dept Psychol, Grad Sch Humanities, Nada Ku, Kobe, Hyogo 657, Japan.	ynoguchi@lit.kobe-u.ac.jp			KAKENHI from the Japan Society for the Promotion of Science (JSPS) [22680022]	KAKENHI from the Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI Grants Number 22680022 from the Japan Society for the Promotion of Science (JSPS). URL:http://kaken.nii.ac.jp/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar M, 2001, NEURON, V29, P529, DOI 10.1016/S0896-6273(01)00224-0; Blazhenkova O, 2010, COGNITION, V117, P276, DOI 10.1016/j.cognition.2010.08.021; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Carling K, 2000, COMPUT STAT DATA AN, V33, P249, DOI 10.1016/S0167-9473(99)00057-2; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Coyle TR, 2011, PSYCHOL SCI, V22, P1265, DOI 10.1177/0956797611418243; Deary IJ, 1997, TRENDS NEUROSCI, V20, P365, DOI 10.1016/S0166-2236(97)01070-9; Deary IJ, 2001, TRENDS COGN SCI, V5, P164, DOI 10.1016/S1364-6613(00)01623-5; Deary IJ, 2001, TRENDS COGN SCI, V5, P127, DOI 10.1016/S1364-6613(00)01621-1; Duncan J, 2000, SCIENCE, V289, P457, DOI 10.1126/science.289.5478.457; FRIGGE M, 1989, AM STAT, V43, P50, DOI 10.2307/2685173; FUJITA I, 1992, NATURE, V360, P343, DOI 10.1038/360343a0; Garaas TW, 2008, VISION RES, V48, P523, DOI 10.1016/j.visres.2007.11.011; Hamel R, 2006, EDUC PSYCHOL MEAS, V66, P1039, DOI 10.1177/0013164406288169; Hooven CK, 2004, NEUROPSYCHOLOGIA, V42, P782, DOI 10.1016/j.neuropsychologia.2003.11.012; Hugdahl K, 2006, NEUROPSYCHOLOGIA, V44, P1575, DOI 10.1016/j.neuropsychologia.2006.01.026; Jolij J, 2007, NEUROREPORT, V18, P39, DOI 10.1097/01.wnr.0000236863.46952.a6; Jordan K, 2002, NEUROPSYCHOLOGIA, V40, P2397, DOI 10.1016/S0028-3932(02)00076-3; Karadi K, 2001, PERCEPT MOTOR SKILL, V93, P333, DOI 10.2466/PMS.93.5.333-337; Kranczioch C, 2005, NEUROIMAGE, V24, P704, DOI 10.1016/j.neuroimage.2004.09.024; KRANZLER JH, 1989, INTELLIGENCE, V13, P329, DOI 10.1016/S0160-2896(89)80006-6; Lipp I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051316; Marois R, 2000, NEURON, V28, P299, DOI 10.1016/S0896-6273(00)00104-5; Martens S, 2009, EXP BRAIN RES, V192, P43, DOI 10.1007/s00221-008-1551-1; MENG XL, 1992, PSYCHOL BULL, V111, P172, DOI 10.1037/0033-2909.111.1.172; Ng VWK, 2001, J COGNITIVE NEUROSCI, V13, P537, DOI 10.1162/08989290152001943; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pernet CR, 2013, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00606; Raven J.C., 1998, ADV PROGR MATRICES; Riecansky I, 2008, NEUROPSYCHOLOGIA, V46, P3069, DOI 10.1016/j.neuropsychologia.2008.06.016; Rousseeuw PJ, 1999, TECHNOMETRICS, V41, P212, DOI 10.2307/1270566; ROUSSEEUW PJ, 1984, J AM STAT ASSOC, V79, P871, DOI 10.2307/2288718; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; Sheppard LD, 2008, PERS INDIV DIFFER, V44, P535, DOI 10.1016/j.paid.2007.09.015; Soulieres I, 2011, NEUROPSYCHOLOGIA, V49, P848, DOI 10.1016/j.neuropsychologia.2011.01.027; TETEWSKY S, 1992, J EXP PSYCHOL LEARN, V18, P577, DOI 10.1037/0278-7393.18.3.577; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; van Ravenzwaaij D, 2011, COGNITION, V119, P381, DOI 10.1016/j.cognition.2011.02.002; Verboven S, 2005, CHEMOMETR INTELL LAB, V75, P127, DOI 10.1016/j.chemolab.2004.06.003; Vickers D, 1972, Perception, V1, P263, DOI 10.1068/p010263; Wechsler D., 1997, WECHSLER ADULT INTEL; Weiss E, 2003, NEUROSCI LETT, V344, P169, DOI 10.1016/S0304-3940(03)00406-3	42	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97429	10.1371/journal.pone.0097429	http://dx.doi.org/10.1371/journal.pone.0097429			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AH8EY	24825574	Green Submitted, Green Published, gold			2022-12-27	WOS:000336369200112
J	Tsai, WL; Lai, KH; Liang, HL; Hsu, PI; Chan, HH; Chen, WC; Yu, HC; Tsay, FW; Wang, HM; Tsai, HC; Cheng, JS				Tsai, Wei-Lun; Lai, Kwok-Hung; Liang, Huei-Lung; Hsu, Ping-I; Chan, Hoi-Hung; Chen, Wen-Chi; Yu, Hsien-Chung; Tsay, Feng-Woei; Wang, Huay-Min; Tsai, Hung-Chih; Cheng, Jin-Shiung			Hepatic Arterial Infusion Chemotherapy for Patients with Huge Unresectable Hepatocellular Carcinoma	PLOS ONE			English	Article							VEIN TUMOR THROMBOSIS; 10 CM; TRANSARTERIAL CHEMOEMBOLIZATION; RESECTION; LARGER; EMBOLIZATION; MANAGEMENT; NATIONWIDE; CISPLATIN; CANCER	Background and Aim: The optimal treatment for huge unresectable hepatocellular carcinoma (HCC) remains controversial. The outcome of transcatheter arterial chemoembolization (TACE) for patients huge unresectable HCC is generally poor and the survival benefit of TACE in these patients is unclear. The aim of the study is to compare the effect of hepatic arterial infusion chemotherapy (HAIC) versus symptomatic treatment in patients with huge unresectable HCC. Methods: Since 2000 to 2005, patients with huge (size >8cm) unresectable HCC were enrolled. Fifty-eight patients received HAIC and 44 patients received symptomatic treatment. In the HAIC group, each patient received 2.4+1.4 (range: 1-6) courses of HAIC. Baseline characteristics and survival were compared between the HAIC and symptomatic treatment groups. Results: The HAIC group and the symptomatic treatment group were similar in baseline characteristics and tumor stages. The overall survival rates at one and two years were 29% and 14% in the HAIC group and 7% and 5% in the symptomatic treatment group, respectively. The patients in the HAIC group had significantly better overall survival than the symptomatic treatment group (P<0.001). Multivariate analysis revealed that HAIC was the significant factor associated with the overall survival (relative risk: 0.321, 95% confidence interval: 0.200-0.515, P<0.001). None of the patients died due to immediate complications of HAIC. Conclusions: HAIC is a safe procedure and provides better survival than symptomatic treatment in patients with huge unresectable HCC.	[Tsai, Wei-Lun; Lai, Kwok-Hung; Hsu, Ping-I; Chan, Hoi-Hung; Chen, Wen-Chi; Yu, Hsien-Chung; Tsay, Feng-Woei; Wang, Huay-Min; Cheng, Jin-Shiung] Kaohsiung Vet Gen Hosp, Div Gastroenterol, Dept Internal Med, Kaohsiung, Taiwan; [Tsai, Wei-Lun; Lai, Kwok-Hung; Liang, Huei-Lung; Hsu, Ping-I; Chan, Hoi-Hung; Chen, Wen-Chi; Yu, Hsien-Chung; Tsay, Feng-Woei; Wang, Huay-Min; Cheng, Jin-Shiung] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Liang, Huei-Lung] Kaohsiung Vet Gen Hosp, Dept Radiol, Kaohsiung, Taiwan; [Tsai, Hung-Chih] Kun Shan Univ, Dept Finance & Banking, Coll Business & Management, Tainan, Taiwan	Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; Kaohsiung Veterans General Hospital; Kun Shan University	Cheng, JS (corresponding author), Kaohsiung Vet Gen Hosp, Div Gastroenterol, Dept Internal Med, Kaohsiung, Taiwan.	rcheng@ms2.hinet.net						Adachi E, 1996, CANCER, V77, P2022, DOI 10.1002/(SICI)1097-0142(19960515)77:10<2022::AID-CNCR9>3.0.CO;2-S; Ando E, 2002, CANCER-AM CANCER SOC, V95, P588, DOI 10.1002/cncr.10694; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Bruix J, 2001, HEPATOLOGY, V53, P1020; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Chung YH, 2000, CANCER, V88, P1986, DOI 10.1002/(SICI)1097-0142(20000501)88:9<1986::AID-CNCR2>3.0.CO;2-I; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; FURUTA T, 1992, J SURG ONCOL, V51, P114, DOI 10.1002/jso.2930510210; HSU HC, 1985, CANCER-AM CANCER SOC, V56, P672, DOI 10.1002/1097-0142(19850801)56:3<672::AID-CNCR2820560340>3.0.CO;2-V; Huang YH, 2006, ALIMENT PHARM THER, V23, P129, DOI 10.1111/j.1365-2036.2006.02704.x; Huang YH, 2005, ALIMENT PHARM THER, V21, P687, DOI 10.1111/j.1365-2036.2005.02404.x; JWO SC, 1992, HEPATOLOGY, V16, P1367, DOI 10.1002/hep.1840160611; Kao JH, 2005, LIVER INT, V25, P696, DOI 10.1111/j.1478-3231.2005.01139.x; Lau WY, 2013, ONCOLOGY-BASEL, V84, P311, DOI 10.1159/000348325; Lee NH, 1998, BRIT J SURG, V85, P1654; Liang HL, 2007, ACTA RADIOL, V48, P734, DOI 10.1080/02841850701408210; Lin Chi-Pin, 2004, J Chin Med Assoc, V67, P602; Llovet JM, 2005, SEMIN LIVER DIS, V25, P181, DOI 10.1055/s-2005-871198; Manghisi G, 1998, HEPATOLOGY, V28, P751; Mok KT, 2003, J AM COLL SURGEONS, V197, P730, DOI 10.1016/j.jamcollsurg.2003.07.013; Noguchi T, 1997, SEMIN ONCOL, V24, P7; Nouso K, 2013, BRIT J CANCER, V109, P1904, DOI 10.1038/bjc.2013.542; Poon RTP, 2002, J AM COLL SURGEONS, V194, P592, DOI 10.1016/S1072-7515(02)01163-8; Poon RTP, 2000, J SURG ONCOL, V73, P109, DOI 10.1002/(SICI)1096-9098(200002)73:2<109::AID-JSO10>3.3.CO;2-A; SHELL JC, 1985, CANCER, V56, P660, DOI 10.1002/1097-0142(19850801)56:3<660::AID-CNCR2820560338>3.0.CO;2-F; Song DS, 2013, WORLD J GASTROENTERO, V19, P4679, DOI 10.3748/wjg.v19.i29.4679; Takayasu K, 2006, GASTROENTEROLOGY, V131, P461, DOI 10.1053/j.gastro.2006.05.021; Tsai WL, 2008, ALIMENT PHARM THER, V28, P304, DOI 10.1111/j.1365-2036.2008.03702.x; Urbe T, 1998, ONCOLOGY, V55, P39; Yamasaki T, 2005, J GASTROENTEROL, V40, P70, DOI 10.1007/s00535-004-1494-7; Yoshioka H, 1997, SEMIN ONCOL, V24, P29	32	22	26	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e92784	10.1371/journal.pone.0092784	http://dx.doi.org/10.1371/journal.pone.0092784			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824520	gold, Green Published, Green Submitted			2022-12-27	WOS:000336369200002
J	Han, GZ; Worobey, M				Han, Guan-Zhu; Worobey, Michael			Endogenous Viral Sequences from the Cape Golden Mole (Chrysochloris asiatica) Reveal the Presence of Foamy Viruses in All Major Placental Mammal Clades	PLOS ONE			English	Article							PHYLOGENIES	Endogenous retroviruses provide important insights into the deep history of this viral lineage. Endogenous foamy viruses are thought to be very rare and only a few cases have been identified to date. Here we report a novel endogenous foamy virus (CaEFV) within the genome of the Cape golden mole (Chrysochloris asiatica). The identification of CaEFV reveals the presence of foamy virus in the placental mammal superorder Afrotheria. Phylogenetic analyses place CaEFV basal to other foamy viruses of Eutherian origin, suggesting an ancient codivergence between foamy virus and placental mammals. These findings have implications for understanding the long-term evolution, diversity, and biology of retroviruses.	[Han, Guan-Zhu; Worobey, Michael] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA	University of Arizona	Han, GZ (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	guanzhu@email.arizona.edu; worobey@email.arizona.edu	Han, Guan-Zhu/A-6818-2011; Han, Guan-Zhu/P-4188-2019	Han, Guan-Zhu/0000-0002-8352-7726; Han, Guan-Zhu/0000-0002-8352-7726	NIAID [R01 AI084691]; David and Lucile Packard Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084691] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID grant R01 AI084691 and the David and Lucile Packard Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Griffiths DJ, 2001, GENOME BIOL, V2; Han GZ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002790; Han GZ, 2012, J VIROL, V86, P7696, DOI 10.1128/JVI.00650-12; Johnson WE, 1999, P NATL ACAD SCI USA, V96, P10254, DOI 10.1073/pnas.96.18.10254; Katzourakis A, 2009, SCIENCE, V325, P1512, DOI 10.1126/science.1174149; Llorens C, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-41; Meiering CD, 2001, CLIN MICROBIOL REV, V14, P165, DOI 10.1128/CMR.14.1.165-176.2001; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Nishihara H, 2009, P NATL ACAD SCI USA, V106, P5235, DOI 10.1073/pnas.0809297106; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schartl M, 2013, NAT GENET, V45, P567, DOI 10.1038/ng.2604; Springer MS, 2004, TRENDS ECOL EVOL, V19, P430, DOI 10.1016/j.tree.2004.05.006; Switzer WM, 2005, NATURE, V434, P376, DOI 10.1038/nature03341; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wu ZQ, 2012, J VIROL, V86, P10999, DOI 10.1128/JVI.01394-12	19	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97931	10.1371/journal.pone.0097931	http://dx.doi.org/10.1371/journal.pone.0097931			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835242	Green Published, Green Submitted, gold			2022-12-27	WOS:000339614800086
J	Blome, MA; Bjorkman, P; Molnegren, V; Hoglund, P; Widell, A				Blome, Marianne Alanko; Bjorkman, Per; Molnegren, Vilma; Hoglund, Peter; Widell, Anders			Hepatitis C Viremia Patterns in Incident Hepatitis C Infection and One Year Later in 150 Prospectively Tested Persons Who Inject Drugs	PLOS ONE			English	Article							SPONTANEOUS VIRAL CLEARANCE; VIRUS-INFECTION; NATURAL-HISTORY; HCV; USERS; TRANSMISSION; REINFECTION; PREVALENCE; PRISONERS; DIAGNOSIS	Objectives: To assess HCV viremia levels just before, during and one year after anti-HCV seroconversion in people who inject drugs (PWID). Methods: PWID enrolling into a needle exchange program in Malmo, Sweden, 1997-2005 constituted the source population. Sera were obtained at enrolment and at approximately 3-4 monthly intervals afterwards, and were initially tested for anti-HIV, HBsAg/anti-HBc and anti-HCV and thereafter for markers previously negative. Seroconversion to anti-HCV had occurred during the study period in 186 out of 332 seronegative subjects. In these anti-HCV seroconverters, quantitative HCV RNA PCR was retrospectively performed on frozen sera to determine viremia levels in the last anti-HCV negative, the first anti-HCV positive and in one year follow-up samples. Results: Among 150 subjects seroconverting to anti-HCV with samples available from all three defined time-points, eight different patterns of viremia were observed. Spontaneous clearance at one year was noted in 48 cases (32%) and was associated with female gender (p = 0.03, CI 0.17-1.00). In 13 cases HCV-RNA was not detected in any study sample. Among 61 subjects with pre-seroconversion viremia, viral load was significantly higher in the pre-seroconversion samples compared to subsequent samples. For the whole group, viral load declined to undetectable levels at seroconversion in 28% of cases (but with recurrent viremia in 15%). Conclusions: Different patterns of HCV RNA kinetics were observed among PWID with documented seroconversion to anti-HCV. The frequently observed absence of detectable HCV RNA in the first anti-HCV positive sample (irrespective of subsequent viremia) demonstrates the importance of repeated sampling and RNA testing for determination of the outcome of acute infection.	[Blome, Marianne Alanko; Bjorkman, Per] Lund Univ, Div Clin Sci, Infect Dis Unit, Malmo, Sweden; [Molnegren, Vilma; Widell, Anders] Lund Univ, Div Sci Lab, Dept Clin Microbiol, Malmo, Sweden; [Hoglund, Peter] Res & Dev Ctr Skane, Med Stat & Epidemiol Unit, Lund, Sweden	Lund University; Lund University	Widell, A (corresponding author), Lund Univ, Div Sci Lab, Dept Clin Microbiol, Malmo, Sweden.	anders.widell@med.lu.se	Höglund, Peter/H-4774-2014	Höglund, Peter/0000-0002-8395-922X	Region Skane, Lund University; Malmo City Donation funds; Osterlund Foundation	Region Skane, Lund University; Malmo City Donation funds; Osterlund Foundation	This study was funded in part by Region Skane, Lund University (ALF grant), Malmo City Donation funds and the Osterlund Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hamid M, 2007, J GEN VIROL, V88, P1526, DOI 10.1099/vir.0.82626-0; Aberle JH, 2006, J CLIN VIROL, V36, P24, DOI 10.1016/j.jcv.2005.12.010; Alberti A, 1999, J HEPATOL, V31, P17, DOI 10.1016/S0168-8278(99)80369-9; Amini M, 2012, VIRAL IMMUNOL, V25, P241, DOI 10.1089/vim.2011.0052; Blome MA, 2011, J VIRAL HEPATITIS, V18, P831, DOI 10.1111/j.1365-2893.2010.01400.x; Chemaitelly H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069803; Cochrane A, 2002, J INFECT DIS, V186, P1212, DOI 10.1086/344314; Dale CH, 2009, CAN J GASTROENTEROL, V23, P265, DOI 10.1155/2009/912848; Dalgard O, 2002, EUR ADDICT RES, V8, P45, DOI 10.1159/000049487; de Almeida BS, 2011, J VIRAL HEPATITIS, V18, P692, DOI 10.1111/j.1365-2893.2010.01429.x; Doyle JS, 2012, BEST PRACT RES CL GA, V26, P413, DOI 10.1016/j.bpg.2012.09.004; Duberg A, 2008, Euro Surveill, V13; Fabris P, 2008, CURR PHARM DESIGN, V14, P1661, DOI 10.2174/138161208784746789; Gutierrez-Moreno M, 2012, TRANSPL P, V44, P2100, DOI 10.1016/j.transproceed.2012.07.074; Hajarizadeh B, 2012, J HEPATOL, V57, P1349, DOI 10.1016/j.jhep.2012.07.007; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hatzakis A, 2011, J VIRAL HEPATITIS, V18, P1, DOI 10.1111/j.1365-2893.2011.01499.x; Jarlais DCD, 2005, AIDS, V19, pS20, DOI 10.1097/01.aids.0000192066.86410.8c; Jauncey M, 2004, J INFECT DIS, V190, P1270, DOI 10.1086/423943; Lee KCK, 2008, J CLIN VIROL, V41, P297, DOI 10.1016/j.jcv.2007.09.013; Liu L, 2012, HEPATOLOGY, V55, P1684, DOI 10.1002/hep.25575; Maheshwari A, 2008, LANCET, V372, P321, DOI 10.1016/S0140-6736(08)61116-2; Mansson AS, 2000, SCAND J INFECT DIS, V32, P253, DOI 10.1080/00365540050165875; Marco A, 2013, J HEPATOL, V59, P45, DOI 10.1016/j.jhep.2013.03.008; Mathei C, 2001, J INFECT DIS, V184, P659, DOI 10.1086/322795; McGovern BH, 2009, CLIN INFECT DIS, V49, P1051, DOI 10.1086/605561; Micallef JM, 2007, J VIRAL HEPATITIS, V14, P413, DOI 10.1111/j.1365-2893.2006.00812.x; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Miller ER, 2009, INT J INFECT DIS, V13, P201, DOI 10.1016/j.ijid.2008.06.011; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Olsson B, 2001, MAX PROJECT CENTRLAF, V3, P61; Page K, 2013, CLIN INFECT DIS, V56, P405, DOI 10.1093/cid/cis921; Page K, 2009, J INFECT DIS, V200, P1216, DOI 10.1086/605947; Soriano V, 2008, J INFECT DIS, V198, P1337, DOI 10.1086/592171; Turner KME, 2011, ADDICTION, V106, P1978, DOI 10.1111/j.1360-0443.2011.03515.x; van de Laar TJW, 2009, J HEPATOL, V51, P667, DOI 10.1016/j.jhep.2009.05.027; Wawrzynowicz-Syczewska M, 2004, INFECTION, V32, P138, DOI 10.1007/s15010-004-3062-8; Widell A, 2002, TRANSFUSION MED, V12, P107, DOI 10.1046/j.1365-3148.2002.00359.x	38	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97022	10.1371/journal.pone.0097022	http://dx.doi.org/10.1371/journal.pone.0097022			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830647	Green Published, Green Submitted, gold			2022-12-27	WOS:000336789500030
J	Briones, A; Coats, E; Brinkman, C				Briones, Aurelio; Coats, Erik; Brinkman, Cynthia			Should We Build "Obese'' or "Lean'' Anaerobic Digesters?	PLOS ONE			English	Article							COMMUNITY STRUCTURE; CORE	Conventional anaerobic digesters (ADs) treating dairy manure are fed with raw or fermented manure rich in volatile fatty acids (VFAs). In contrast, pre-fermented AD (PF-AD) is fed with the more recalcitrant, fiber-rich fraction of manure that has been pre-fermented and depleted of VFAs. Thus, the substrate of PF-AD may be likened to a lean diet rich in fibers while the pre-fermentation stage fermenter is fed a relatively rich diet containing labile organic substances. Previous results have shown that conventional and pre-fermented ADs fed with raw or pre-fermented manure, respectively, produced comparable methane yields. The primary objective of this study was to characterize, using next-generation DNA sequencing, the bacterial communities in various bioreactors (pre-fermentation stage fermenter; various operational arrangements PF-AD; conventional single-stage AD; and a full scale AD) and compare the Firmicutes to Bacteroidetes (F/B) ratios in these different systems. Firmicutes and Bacteroidetes constituted the two most abundant phyla in all AD samples analyzed, as well as most of the samples analyzed in the fermenters and manure samples. Higher relative abundance of Bacteroidetes, ranging from 26% to 51% of bacteria, tended to be associated with PF-AD samples, while the highest relative abundance of Firmicutes occurred in the fermenter (maximum of 76% of bacteria) and manure (maximum of 66% of bacteria) samples. On average, primary stage fermenters exhibited microbiological traits linked to obesity: higher F/B ratios and a 'diet' that is less fibrous and more labile compared to that fed to PF-AD. On the other hand, microbial characteristics associated with leanness (lower F/B ratios combined with fibrous substrate) were associated with PF-AD. We propose that bacterial communities in AD shift depending on the quality of substrate, which ultimately results in maintaining VFA yields in PF-AD, similar to the role of bacterial communities and a high fiber diet in lean mice.	[Briones, Aurelio] Univ Idaho, Dept Plant Soil & Entomol Sci, Moscow, ID 83843 USA; [Coats, Erik; Brinkman, Cynthia] Univ Idaho, Dept Civil Engn, Moscow, ID 83843 USA	Idaho; University of Idaho; Idaho; University of Idaho	Briones, A (corresponding author), Univ Idaho, Dept Plant Soil & Entomol Sci, Moscow, ID 83843 USA.	abriones@uidaho.edu	Coats, Erik/C-2887-2008	Coats, Erik/0000-0003-2796-9949	Idaho Center for Advanced Energy Studies (CAES) [00042246-00074]	Idaho Center for Advanced Energy Studies (CAES)	The authors gratefully acknowledge the Idaho Center for Advanced Energy Studies (CAES) for funding the project (Contract No. 00042246-00074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agler MT, 2011, TRENDS BIOTECHNOL, V29, P70, DOI 10.1016/j.tibtech.2010.11.006; Angenent LT, 2004, TRENDS BIOTECHNOL, V22, P477, DOI 10.1016/j.tibtech.2004.07.001; Coats ER, 2013, BIOFUEL BIOPROD BIOR, V7, P459, DOI 10.1002/bbb.1408; Coats ER, 2012, BIORESOURCE TECHNOL, V107, P205, DOI 10.1016/j.biortech.2011.12.077; Durso LM, 2010, APPL ENVIRON MICROB, V76, P4858, DOI 10.1128/AEM.00207-10; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Godon JJ, 2005, ENVIRON MICROBIOL, V7, P213, DOI 10.1111/j.1462-2920.2004.00693.x; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Ito T, 2011, ISME J, V5, P1844, DOI 10.1038/ismej.2011.59; Kampmann K, 2012, APPL ENVIRON MICROB, V78, P2106, DOI 10.1128/AEM.06394-11; Keenan MJ, 2006, OBESITY, V14, P1523, DOI 10.1038/oby.2006.176; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; Lee SH, 2012, J ENVIRON MONITOR, V14, P1893, DOI 10.1039/c2em10958a; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Riviere D, 2009, ISME J, V3, P700, DOI 10.1038/ismej.2009.2; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shade A, 2012, ENVIRON MICROBIOL, V14, P4, DOI 10.1111/j.1462-2920.2011.02585.x; Thomas F, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00093; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156; Ziganshin AM, 2013, APPL MICROBIOL BIOT, V97, P5161, DOI 10.1007/s00253-013-4867-0	28	21	21	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97252	10.1371/journal.pone.0097252	http://dx.doi.org/10.1371/journal.pone.0097252			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831948	Green Published, Green Submitted, gold			2022-12-27	WOS:000336789500042
J	Ciarleglio, CM; Resuehr, HES; Axley, JC; Deneris, ES; McMahon, DG				Ciarleglio, Christopher M.; Resuehr, Holly E. S.; Axley, John C.; Deneris, Evan S.; McMahon, Douglas G.			Pet-1 Deficiency Alters the Circadian Clock and Its Temporal Organization of Behavior	PLOS ONE			English	Article							RAT SUPRACHIASMATIC NUCLEUS; BIOLOGICAL CLOCK; IN-VITRO; INTERGENICULATE LEAFLET; SEROTONERGIC AGONISTS; PERIPHERAL-TISSUES; 5-HT7 RECEPTORS; BINDING-SITES; RETINAL INPUT; PHASE-SHIFTS	The serotonin and circadian systems are two important interactive regulatory networks in the mammalian brain that regulate behavior and physiology in ways that are known to impact human mental health. Previous work on the interaction between these two systems suggests that serotonin modulates photic input to the central circadian clock (the suprachiasmatic nuclei; SCN) from the retina and serves as a signal for locomotor activity, novelty, and arousal to shift the SCN clock, but effects of disruption of serotonergic signaling from the raphe nuclei on circadian behavior and on SCN function are not fully characterized. In this study, we examined the effects on diurnal and circadian behavior, and on ex vivo molecular rhythms of the SCN, of genetic deficiency in Pet-1, an ETS transcription factor that is necessary to establish and maintain the serotonergic phenotype of raphe neurons. Pet-1(-/-) mice exhibit loss of rhythmic behavioral coherence and an extended daily activity duration, as well as changes in the molecular rhythms expressed by the clock, such that ex vivo SCN from Pet-1(-/-) mice exhibit period lengthening and sex-dependent changes in rhythmic amplitude. Together, our results indicate that Pet-1 regulation of raphe neuron serotonin phenotype contributes to the period, precision and light/dark partitioning of locomotor behavioral rhythms by the circadian clock through direct actions on the SCN clock itself, as well as through non-clock effects.	[Ciarleglio, Christopher M.; Resuehr, Holly E. S.; McMahon, Douglas G.] Vanderbilt Univ, Silvio O Conte Ctr Neurosci Res, Nashville, TN 37235 USA; [Ciarleglio, Christopher M.; Resuehr, Holly E. S.; McMahon, Douglas G.] Vanderbilt Univ, Vanderbilt Brain Inst, Nashville, TN 37235 USA; [Resuehr, Holly E. S.; Axley, John C.; McMahon, Douglas G.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Deneris, Evan S.] Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44106 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Case Western Reserve University	McMahon, DG (corresponding author), Vanderbilt Univ, Silvio O Conte Ctr Neurosci Res, 221 Kirkland Hall, Nashville, TN 37235 USA.	douglas.g.mcmahon@vanderbilt.edu	Ciarleglio, Christopher M/D-8463-2013	Ciarleglio, Christopher M/0000-0002-8490-8715; Axley, John/0000-0002-4207-7984	NIMH [P50 MH096972, R01 MH062723]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062723, P50MH096972] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIMH P50 MH096972 (R. Blakely, ESD and DGM), and by NIMH R01 MH062723 (ESD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizaid A, 2005, EUR J NEUROSCI, V21, P1536, DOI 10.1111/j.1460-9568.2005.03964.x; Amir S, 1998, NEUROSCIENCE, V84, P1059, DOI 10.1016/S0306-4522(97)00575-7; Antle MC, 2000, J NEUROSCI, V20, P9326; Aton SJ, 2004, J BIOL RHYTHM, V19, P198, DOI 10.1177/0748730404264156; Belenky MA, 2001, J COMP NEUROL, V432, P371, DOI 10.1002/cne.1109; BOSLER O, 1985, J NEUROCYTOL, V14, P749, DOI 10.1007/BF01170826; BOSLER O, 1989, J NEUROCYTOL, V18, P105, DOI 10.1007/BF01188429; Ciarleglio CM, 2011, NEUROSCIENCE, V197, P8, DOI 10.1016/j.neuroscience.2011.09.036; Ciarleglio CM, 2011, NAT NEUROSCI, V14, P25, DOI 10.1038/nn.2699; Colwell CS, 2003, AM J PHYSIOL-REG I, V285, pR939, DOI 10.1152/ajpregu.00200.2003; Deneris ES, 2012, NAT NEUROSCI, V15, P519, DOI 10.1038/nn.3039; Deurveilher S, 2005, NEUROSCIENCE, V130, P165, DOI 10.1016/j.neuroscience.2004.08.030; EDGAR DM, 1991, J BIOL RHYTHM, V6, P185, DOI 10.1177/074873049100600301; EDGAR DM, 1993, J BIOL RHYTHM, V8, P17, DOI 10.1177/074873049300800102; EDGAR DM, 1991, AM J PHYSIOL, V261, pR928, DOI 10.1152/ajpregu.1991.261.4.R928; Edgar DM, 1997, AM J PHYSIOL-REG I, V273, pR265, DOI 10.1152/ajpregu.1997.273.1.R265; EDGAR DM, 1991, PHYSIOL BEHAV, V50, P373, DOI 10.1016/0031-9384(91)90080-8; Gamble KL, 2007, J NEUROSCI, V27, P12078, DOI 10.1523/JNEUROSCI.1109-07.2007; Glass JD, 2003, J NEUROSCI, V23, P7451; Glickman G, 2010, NEUROSCI BIOBEHAV R, V34, P755, DOI 10.1016/j.neubiorev.2009.11.017; Hendricks TJ, 2003, NEURON, V37, P233, DOI 10.1016/S0896-6273(02)01167-4; Herzog ED, 2004, J BIOL RHYTHM, V19, P35, DOI 10.1177/0748730403260776; Karatsoreos IN, 2007, ENDOCRINOLOGY, V148, P5640, DOI 10.1210/en.2007-1083; Karatsoreos IN, 2007, ENDOCRINOLOGY, V148, P5487, DOI 10.1210/en.2007-0775; Kawakami F, 1995, NEUROSCI LETT, V200, P171, DOI 10.1016/0304-3940(95)12130-V; KISS J, 1984, NEUROSCI LETT, V44, P119, DOI 10.1016/0304-3940(84)90068-5; Kiyasova V, 2011, J NEUROSCI, V31, P2756, DOI 10.1523/JNEUROSCI.4080-10.2011; Kriegsfeld LJ, 2006, HORM BEHAV, V49, P557, DOI 10.1016/j.yhbeh.2005.12.011; Kuhlman SJ, 2000, NEUROREPORT, V11, P1479, DOI 10.1097/00001756-200005150-00023; Lerch-Haner JK, 2008, NAT NEUROSCI, V11, P1001, DOI 10.1038/nn.2176; LEVITT P, 1982, DEV BRAIN RES, V4, P35, DOI 10.1016/0165-3806(82)90095-5; LOVENBERG TW, 1993, NEURON, V11, P449, DOI 10.1016/0896-6273(93)90149-L; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Malhi GS, 2013, ACTA PSYCHIAT SCAND, V128, P2, DOI 10.1111/acps.12173; MANRIQUE C, 1994, BRAIN RES, V663, P93, DOI 10.1016/0006-8993(94)90466-9; MANRIQUE C, 1993, BRAIN RES, V623, P345, DOI 10.1016/0006-8993(93)91452-X; Marchant EG, 1997, J NEUROSCI, V17, P7974; Maywood ES, 2006, CURR BIOL, V16, P599, DOI 10.1016/j.cub.2006.02.023; MeyerBernstein EL, 1996, J NEUROSCI, V16, P2097; Mintz EM, 1997, NEUROSCIENCE, V79, P563, DOI 10.1016/S0306-4522(96)00696-3; Mistlberger RE, 1998, BEHAV BRAIN RES, V96, P93, DOI 10.1016/S0166-4328(98)00007-2; Mistlberger RE, 1998, BRAIN RES, V786, P31, DOI 10.1016/S0006-8993(97)01269-9; Molyneux PC, 2008, BRAIN RES, V1228, P127, DOI 10.1016/j.brainres.2008.05.091; Mong JA, 2011, J NEUROSCI, V31, P16107, DOI 10.1523/JNEUROSCI.4175-11.2011; Morin LP, 2006, BRAIN RES REV, V51, P1, DOI 10.1016/j.brainresrev.2005.08.003; MORIN LP, 1977, PSYCHONEUROENDOCRINO, V2, P73, DOI 10.1016/0306-4530(77)90035-X; MORIN LP, 1977, SCIENCE, V196, P305, DOI 10.1126/science.557840; Morin LP, 1999, ANN MED, V31, P12, DOI 10.3109/07853899909019259; Mrosovsky N, 1996, BIOL REV, V71, P343, DOI 10.1111/j.1469-185X.1996.tb01278.x; Ohta H, 2006, PEDIATR RES, V60, P304, DOI 10.1203/01.pdr.0000233114.18403.66; Paulus EV, 2013, CHRONOBIOL INT, V30, P1251, DOI 10.3109/07420528.2013.815198; Paulus EV, 2012, PHYSIOL BEHAV, V105, P257, DOI 10.1016/j.physbeh.2011.08.032; Pendergast JS, 2009, J NEUROSCI, V29, P14681, DOI 10.1523/JNEUROSCI.3261-09.2009; Pickard GE, 1999, J NEUROSCI, V19, P4034; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P333, DOI 10.1007/BF01417860; Prosser RA, 2003, BRAIN RES, V966, P110, DOI 10.1016/S0006-8993(02)04206-3; PROSSER RA, 1993, J BIOL RHYTHM, V8, P1, DOI 10.1177/074873049300800101; Quintero JE, 1999, J NEUROPHYSIOL, V82, P533, DOI 10.1152/jn.1999.82.2.533; Quintero JE, 2003, J NEUROSCI, V23, P8070; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Smith BN, 2001, J BIOL RHYTHM, V16, P25, DOI 10.1177/074873040101600104; Sokal RR, 1995, BIOMETRY PRINCIPLES, Vxix; WALLACE JA, 1983, BRAIN RES BULL, V10, P459, DOI 10.1016/0361-9230(83)90144-2; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Yamazaki S, 2002, J BIOL RHYTHM, V17, P315, DOI 10.1177/074873040201700405; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	66	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97412	10.1371/journal.pone.0097412	http://dx.doi.org/10.1371/journal.pone.0097412			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831114	gold, Green Submitted, Green Published			2022-12-27	WOS:000336789500054
J	Goode, D; Aravantinou, M; Jarl, S; Truong, R; Derby, N; Guerra-Perez, N; Kenney, J; Blanchard, J; Gettie, A; Robbiani, M; Martinelli, E				Goode, Diana; Aravantinou, Meropi; Jarl, Sebastian; Truong, Rosaline; Derby, Nina; Guerra-Perez, Natalia; Kenney, Jessica; Blanchard, James; Gettie, Agegnehu; Robbiani, Melissa; Martinelli, Elena			Sex Hormones Selectively Impact the Endocervical Mucosal Microenvironment: Implications for HIV Transmission	PLOS ONE			English	Article							CELL-ADHESION MOLECULE-1; FEMALE REPRODUCTIVE-TRACT; SIV VAGINAL TRANSMISSION; T-CELLS; CONTRACEPTIVE USE; INTEGRIN ALPHA(4)BETA(7); RECEPTOR EXPRESSION; ADAPTIVE IMMUNITY; ESTROGEN PROTECTS; GENITAL-TRACT	Several studies suggest that progesterone and estrogens may affect HIV transmission in different, possibly opposing ways. Nonetheless, a direct comparison of their effects on the mucosal immune system has never been done. We hypothesize that sex hormones might impact the availability of cells and immune factors important in early stages of mucosal transmission, and, in doing so influence the risk of HIV acquisition. To test this hypothesis, we employed 15 ovarectomized rhesus macaques: 5 were treated with Depot Medroxy Progesterone Acetate (DMPA), 6 with 17-beta estradiol (E2) and 4 were left untreated. All animals were euthanized 5 weeks after the initiation of hormone treatment, a time post-DMPA injection associated with high susceptibility to SIV infection. We found that DMPA-treated macaques exhibited higher expression of integrin alpha(4)beta(7) (alpha(4)beta(7)) on CD4(+) T cells, the gut homing receptor and a marker of cells highly susceptible to HIV, in the endocervix than did the E2-treated animals. In contrast, the frequency of CCR5(+) CD4(+) T cells in DMPA-treated macaques was higher than in the E2-treated group in vaginal tissue, but lower in endocervix. alpha(4)beta(7) expression on dendritic cells (DCs) was higher in the DMPA-treated group in the endocervical tissue, but lower in vaginal tissue and on blood DCs compared with the E2-treated animals. Soluble MAdCAM-1, the alpha(4)beta(7) ligand, was present in the vaginal fluids of the control and E2-treated groups, but absent in the fluids from DMPA-treated animals. Both hormones modulated the expression and release of inflammatory factors and modified the distribution of sialomucins in the endocervix. In summary, we found that sex hormones profoundly impact mucosal immune factors that are directly implicated in HIV transmission. The effect is particularly significant in the endocervix. This may increase our understanding of the potential hormone-driven modulation of HIV susceptibility and potentially guide contraceptive policies in high-risk settings.	[Goode, Diana; Aravantinou, Meropi; Jarl, Sebastian; Truong, Rosaline; Derby, Nina; Guerra-Perez, Natalia; Kenney, Jessica; Robbiani, Melissa; Martinelli, Elena] Populat Council, Ctr Biomed Res, New York, NY 10021 USA; [Blanchard, James] Tulane Univ, Ctr Sci, Tulane Natl Primate Res Ctr, Covington, LA USA; [Gettie, Agegnehu] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA	Population Council; Tulane University; Rockefeller University	Martinelli, E (corresponding author), Populat Council, Ctr Biomed Res, 1230 York Ave, New York, NY 10021 USA.	emartinelli@popcouncil.org	Guerra-Pérez, Natalia/I-1879-2017	Guerra-Pérez, Natalia/0000-0002-4851-3361; Martinelli, Elena/0000-0002-3416-9627; Jarl, Sebastian/0000-0003-3584-7079	United States Agency for International Development (USAID) [GPO-A-00-04-00019-00]; National Institutes of Health (NIH) [R01 AI098456-01]; National Cancer Institute, NIH [HHSN261200800001E]; USAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI098546] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); USAID(United States Agency for International Development (USAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded with the support of the United States Agency for International Development (USAID) Cooperative Agreement GPO-A-00-04-00019-00, the National Institutes of Health (NIH) base grant R01 AI098456-01 and with federal funds from the National Cancer Institute, NIH, under contract HHSN261200800001E. This research is made possible by the generous support of the American people through the USAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agace WW, 2000, CURR OPIN CELL BIOL, V12, P563, DOI 10.1016/S0955-0674(00)00132-0; Aisemberg J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056161; Alvarez Y, 2013, J VIROL, V87, P10843, DOI 10.1128/JVI.01838-13; Arihiro S, 2002, PATHOL INT, V52, P367, DOI 10.1046/j.1440-1827.2002.01365.x; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Baeten JM, 2007, AIDS, V21, P1771, DOI 10.1097/QAD.0b013e328270388a; Baxter MG, 2013, NEUROBIOL AGING, V34, P1882, DOI 10.1016/j.neurobiolaging.2012.12.017; Brahmbhatt H, 2013, J FAM PLANN REPROD H; Campbell DE, 2010, CLIN VACCINE IMMUNOL, V17, P1148, DOI 10.1128/CVI.00533-09; Chandra N, 2013, AIDS RES HUM RETROV, V29, P592, DOI 10.1089/aid.2012.0271; Cicala C, 2009, P NATL ACAD SCI USA, V106, P20877, DOI 10.1073/pnas.0911796106; Clendenen TV, 2011, CYTOKINE, V56, P769, DOI 10.1016/j.cyto.2011.09.013; DCRUZ OJ, 1993, FERTIL STERIL, V60, P1011; Deplancke B, 2001, AM J CLIN NUTR, V73, p1131S; Foulk RA, 2007, J ASSIST REPROD GEN, V24, P316, DOI 10.1007/s10815-007-9151-8; Genbacev OD, 2003, SCIENCE, V299, P405, DOI 10.1126/science.1079546; Gipson IK, 2005, E SCHERING RES FDN W, V52, P219; Gipson IK, 2001, FRONT BIOSCI-LANDMRK, V6, pD1245, DOI 10.2741/Gipson; Gorfu G, 2009, CURR MOL MED, V9, P836, DOI 10.2174/156652409789105525; Heffron R, 2012, LANCET INFECT DIS, V12, P19, DOI 10.1016/S1473-3099(11)70247-X; Hickey DK, 2011, J REPROD IMMUNOL, V88, P185, DOI 10.1016/j.jri.2011.01.005; Hillan KJ, 1999, LIVER, V19, P509, DOI 10.1111/j.1478-3231.1999.tb00084.x; Iqbal SM, 2008, AM J REPROD IMMUNOL, V59, P44; Jelicic K, 2013, NAT IMMUNOL, V14, P1256, DOI 10.1038/ni.2746; Kader M, 2009, J MED PRIMATOL, V38, P24, DOI 10.1111/j.1600-0684.2009.00372.x; Kader M, 2009, MUCOSAL IMMUNOL, V2, P439, DOI 10.1038/mi.2009.90; Kawashima H, 2012, ANN NY ACAD SCI, V1253, P112, DOI 10.1111/j.1749-6632.2011.06356.x; Kelly KA, 2001, J INFECT DIS, V184, P885, DOI 10.1086/323341; Kelly KA, 1997, INFECT IMMUN, V65, P5198, DOI 10.1128/IAI.65.12.5198-5208.1997; Kiddugavu M, 2003, AIDS, V17, P233, DOI 10.1097/00002030-200301240-00014; Kim KC, 2012, PULM PHARMACOL THER, V25, P415, DOI 10.1016/j.pupt.2011.12.003; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; Kobayashi M, 2012, SEMIN IMMUNOPATHOL, V34, P401, DOI 10.1007/s00281-012-0302-3; Lagow E, 1999, HUM REPROD UPDATE, V5, P280, DOI 10.1093/humupd/5.4.280; Leung E, 2004, IMMUNOL CELL BIOL, V82, P400, DOI 10.1111/j.0818-9641.2004.01247.x; Leung E, 2003, IMMUNOL CELL BIOL, V81, P320, DOI 10.1046/j.1440-1711.2003.t01-1-01175.x; Lutalo T, 2013, AIDS, V27, pS27, DOI 10.1097/QAD.0000000000000045; Margarit L, 2009, HUM REPROD, V24, P2767, DOI 10.1093/humrep/dep247; Martinelli E, 2013, J ACQUIR IMMUNE DEFI; Martinelli E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002109; Marx PA, 1996, NAT MED, V2, P1084, DOI 10.1038/nm1096-1084; Mishell DR, 1996, J REPROD MED, V41, P381; Monteiro P, 2011, J IMMUNOL, V186, P4618, DOI 10.4049/jimmunol.1004151; Morrison CS, 2010, AIDS, V24, P1778, DOI 10.1097/QAD.0b013e32833a2537; Nejatbakhsh R, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-46; Prakash M, 2004, BJOG-INT J OBSTET GY, V111, P1468, DOI 10.1111/j.1471-0528.2004.00283.x; Sanchez MG, 2013, J NEUROENDOCRINOL, V25, P560, DOI 10.1111/jne.12034; Shacklett BL, 2011, AM J REPROD IMMUNOL, V65, P230, DOI 10.1111/j.1600-0897.2010.00948.x; Shukair SA, 2013, MUCOSAL IMMUNOL, V6, P427, DOI 10.1038/mi.2012.87; Smith SA, 2004, AIDS, V18, P1637, DOI 10.1097/01.aids.0000131393.76221.cc; Smith SM, 2000, J INFECT DIS, V182, P708, DOI 10.1086/315776; Szabo MC, 1997, J IMMUNOL, V158, P5584; Tal O, 2011, J EXP MED, V208, P2141, DOI 10.1084/jem.20102392; Teleshova N, 2013, ADV EXP MED BIOL, V762, P155, DOI 10.1007/978-1-4614-4433-6_6; Villablanca EJ, 2011, GASTROENTEROLOGY, V140, P1776, DOI 10.1053/j.gastro.2011.02.015; Vishwanathan SA, 2011, JAIDS-J ACQ IMM DEF, V57, P261, DOI 10.1097/QAI.0b013e318220ebd3; Williams IR, 2004, IMMUNOL RES, V29, P283, DOI 10.1385/IR:29:1-3:283; Wira CR, 2008, AIDS, V22, P1909, DOI 10.1097/QAD.0b013e3283060ea4; Wira CR, 2005, IMMUNOL REV, V206, P306, DOI 10.1111/j.0105-2896.2005.00287.x; Wira CR, 2000, ENDOCRINOLOGY, V141, P2877, DOI 10.1210/en.141.8.2877; Zhang ZQ, 2004, P NATL ACAD SCI USA, V101, P5640, DOI 10.1073/pnas.0308425101	61	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97767	10.1371/journal.pone.0097767	http://dx.doi.org/10.1371/journal.pone.0097767			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830732	Green Submitted, gold, Green Published			2022-12-27	WOS:000336789500112
J	Shao, ZR; Zhang, PY; Li, QY; Wang, XL; Duan, DL				Shao, Zhanru; Zhang, Pengyan; Li, Qiuying; Wang, Xiuliang; Duan, Delin			Characterization of Mannitol-2-Dehydrogenase in Saccharina japonica: Evidence for a New Polyol-Specific Long-Chain Dehydrogenases/Reductase	PLOS ONE			English	Article							FLUORESCENS MANNITOL 2-DEHYDROGENASE; SWISS-MODEL; MANNITOL-1-PHOSPHATE DEHYDROGENASE; CARBON METABOLISM; LACTIC-ACID; BROWN; PURIFICATION; EVOLUTION; INSIGHTS; PHOTOSYNTHESIS	Mannitol plays a crucial role in brown algae, acting as carbon storage, organic osmolytes and antioxidant. Transcriptomic analysis of Saccharina japonica revealed that the relative genes involved in the mannitol cycle are existent. Full-length sequence of mannitol-2-dehydrogenase (M2DH) gene was obtained, with one open reading frame of 2,007 bp which encodes 668 amino acids. Cis-regulatory elements for response to methyl jasmonic acid, light and drought existed in the 5'-upstream region. Phylogenetic analysis indicated that SjM2DH has an ancient prokaryotic origin, and is probably acquired by horizontal gene transfer event. Multiple alignment and spatial structure prediction displayed a series of conserved functional residues, motifs and domains, which favored that SjM2DH belongs to the polyol-specific long-chain dehydrogenases/reductase (PSLDR) family. Expressional profiles of SjM2DH in the juvenile sporophytes showed that it was influenced by saline, oxidative and desiccative factors. SjM2DH was over-expressed in Escherichia coli, and the cell-free extracts with recombinant SjM2DH displayed high activity on D-fructose reduction reaction. The analysis on SjM2DH gene structure and biochemical parameters reached a consensus that activity of SjM2DH is NADH-dependent and metal ion-independent. The characterization of SjM2DH showed that M2DH is a new member of PSLDR family and play an important role in mannitol metabolism in S. japonica.	[Shao, Zhanru; Zhang, Pengyan; Li, Qiuying; Wang, Xiuliang; Duan, Delin] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China; [Shao, Zhanru; Zhang, Pengyan; Li, Qiuying] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Duan, DL (corresponding author), Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China.	dlduan@qdio.ac.cn	Duan, Delin/G-9002-2011	Wang, Xiuliang/0000-0003-4262-0083	National High Tech 863 Project [2012AA10A406]; National Key Technology Research & Development Program [2013BAB01B01]; Ocean Public Welfare Scientific Research Project [201405040]; Shandong Agriculture Breeding Engineering Biological Resources Innovation of Research Project	National High Tech 863 Project(National High Technology Research and Development Program of China); National Key Technology Research & Development Program; Ocean Public Welfare Scientific Research Project; Shandong Agriculture Breeding Engineering Biological Resources Innovation of Research Project	This research was supported by the National High Tech 863 Project (2012AA10A406), Shandong Agriculture Breeding Engineering Biological Resources Innovation of Research Project, National Key Technology Research & Development Program (2013BAB01B01), and Ocean Public Welfare Scientific Research Project (201405040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BIDWELL R. G. S., 1958, CANADIAN JOUR BOT, V36, P581; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; Collen J, 2007, NEW PHYTOL, V176, P45, DOI 10.1111/j.1469-8137.2007.02152.x; Delavault P, 2002, PHYSIOL PLANTARUM, V115, P48, DOI 10.1034/j.1399-3054.2002.1150105.x; Deng YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039704; Dittami SM, 2011, PLANT SIGNAL BEHAV, V6, P1237, DOI 10.4161/psb.6.8.16404; Dittami SM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r66; EKLUND H, 1985, BIOCHEMISTRY-US, V24, P8005, DOI 10.1021/bi00348a025; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Gravot A, 2010, NEW PHYTOL, V188, P98, DOI 10.1111/j.1469-8137.2010.03400.x; Groisillier A, 2014, J EXP BOT, V65, P559, DOI 10.1093/jxb/ert405; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Horer S, 2001, J BIOL CHEM, V276, P27555, DOI 10.1074/jbc.M102850200; Iwamoto K, 2005, MAR BIOTECHNOL, V7, P407, DOI 10.1007/s10126-005-0029-4; Iwamoto K, 2003, PLANT PHYSIOL, V133, P893, DOI 10.1104/pp.103.026906; Ji MH, 1980, OCEANOL LIMNOL SINIC, V11, P229; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Karsten U, 1997, PLANTA, V201, P173, DOI 10.1007/BF01007701; Kavanagh KL, 2002, J BIOL CHEM, V277, P43433, DOI 10.1074/jbc.M206914200; Klimacek M, 2003, CHEM-BIOL INTERACT, V143, P559, DOI 10.1016/S0009-2797(02)00219-3; Klimacek M, 2003, BIOCHEM J, V375, P141, DOI 10.1042/BJ20030733; Klimacek M, 2002, BIOCHEM J, V367, P13, DOI 10.1042/BJ20020932; Korakli M, 2003, FEMS MICROBIOL LETT, V220, P281, DOI 10.1016/S0378-1097(03)00129-0; Krahulec S, 2011, FEBS J, V278, P1264, DOI 10.1111/j.1742-4658.2011.08047.x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kroth PG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001426; Kupper FC, 2006, J EXP BOT, V57, P1991, DOI 10.1093/jxb/erj146; KULKARNI RK, 1990, APPL ENVIRON MICROB, V56, P250, DOI 10.1128/AEM.56.1.250-253.1990; Lee JK, 2003, APPL ENVIRON MICROB, V69, P4438, DOI 10.1128/AEM.69.8.4438-4447.2003; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Liu SQ, 2005, APPL BIOCHEM BIOTECH, V121, P391, DOI 10.1385/ABAB:121:1-3:0391; Michel G, 2010, NEW PHYTOL, V188, P82, DOI 10.1111/j.1469-8137.2010.03374.x; Michel G, 2010, NEW PHYTOL, V188, P67, DOI 10.1111/j.1469-8137.2010.03345.x; Moulin P, 1999, J PHYCOL, V35, P1237, DOI 10.1046/j.1529-8817.1999.3561237.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Roberts K, 2007, PHOTOSYNTH RES, V93, P79, DOI 10.1007/s11120-007-9172-2; Rousvoal S, 2011, PLANTA, V233, P261, DOI 10.1007/s00425-010-1295-6; RUMPHO ME, 1983, PLANT PHYSIOL, V73, P869, DOI 10.1104/pp.73.4.869; Saha BC, 2011, APPL MICROBIOL BIOT, V89, P879, DOI 10.1007/s00253-010-2979-3; Saha BC, 2004, BIOTECHNOL PROGR, V20, P537, DOI 10.1021/bp034277p; Salamov AA, 1997, COMPUT APPL BIOSCI, V13, P23; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753; Schwarz E, 1994, ULLMANS ENCY IND CHE, P423; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shao ZR, 2014, CHIN J OCEANOL LIMN, V32, P377, DOI 10.1007/s00343-014-3130-6; Slatner M, 1999, BIOCHEMISTRY-US, V38, P10489, DOI 10.1021/bi990327g; Soetaert W., 1995, Agro Food Industry hi-tech, V6, P41; Stoop JMH, 1998, PLANT SCI, V131, P43, DOI 10.1016/S0168-9452(97)00243-4; Stoop JMH, 1996, TRENDS PLANT SCI, V1, P139, DOI 10.1016/S1360-1385(96)80048-3; Suvarna K, 2000, MICROBIOL-SGM, V146, P2705, DOI 10.1099/00221287-146-10-2705; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tenhaken R, 2011, J BIOL CHEM, V286, P16707, DOI 10.1074/jbc.M111.230979; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van Den Daele K, 2006, EUROPEAN JOURNAL OF, V41, P1; WILLIAMSON JD, 1995, P NATL ACAD SCI USA, V92, P7148, DOI 10.1073/pnas.92.16.7148; Wisselink HW, 2002, INT DAIRY J, V12, P151, DOI 10.1016/S0958-6946(01)00153-4; YAMAGUCH.T, 1969, PLANT CELL PHYSIOL, V10, P425; YAMAGUCHI T, 1966, PLANT CELL PHYSIOL, V7, P217	63	15	15	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97935	10.1371/journal.pone.0097935	http://dx.doi.org/10.1371/journal.pone.0097935			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830763	Green Published, Green Submitted, gold			2022-12-27	WOS:000336789500133
J	Jiang, H; Clise-Dwyer, K; Ruisaard, KE; Fan, XJ; Tian, WH; Gumin, J; Lamfers, ML; Kleijn, A; Lang, FF; Yung, WKA; Vence, LM; Gomez-Manzano, C; Fueyo, J				Jiang, Hong; Clise-Dwyer, Karen; Ruisaard, Kathryn E.; Fan, Xuejun; Tian, Weihua; Gumin, Joy; Lamfers, Martine L.; Kleijn, Anne; Lang, Frederick F.; Yung, Wai-Kwan Alfred; Vence, Luis M.; Gomez-Manzano, Candelaria; Fueyo, Juan			Delta-24-RGD Oncolytic Adenovirus Elicits Anti-Glioma Immunity in an Immunocompetent Mouse Model	PLOS ONE			English	Article							MHC CLASS-I; SYRIAN-HAMSTER; ANTIGEN; CELLS; AUTOPHAGY; INNATE; REPLICATION; EFFICACY; VIRUSES; GAMMA	Background: Emerging evidence suggests anti-cancer immunity is involved in the therapeutic effect induced by oncolytic viruses. Here we investigate the effect of Delta-24-RGD oncolytic adenovirus on innate and adaptive anti-glioma immunity. Design: Mouse GL261-glioma model was set up in immunocompetent C57BL/6 mouse for Delta-24-RGD treatment. The changes of the immune cell populations were analyzed by immunohistochemistry and flow cytometry. The antiglioma immunity was evaluated with functional study of the splenocytes isolated from the mice. The efficacy of the virotherapy was assessed with animal survival analysis. The direct effect of the virus on the tumor-associated antigen presentation to CD8+ T cells was analyzed with an in vitro ovalbumin (OVA) modeling system. Results: Delta-24-RGD induced cytotoxic effect in mouse glioma cells. Viral treatment in GL261-glioma bearing mice caused infiltration of innate and adaptive immune cells, instigating a Th1 immunity at the tumor site which resulted in specific anti-glioma immunity, shrunken tumor and prolonged animal survival. Importantly, viral infection and IFN gamma increased the presentation of OVA antigen in OVA-expressing cells to CD8+ T-cell hybridoma B3Z cells, which is blocked by brefeldin A and proteasome inhibitors, indicating the activity is through the biosynthesis and proteasome pathway. Conclusions: Our results demonstrate that Delta-24-RGD induces anti-glioma immunity and offers the first evidence that viral infection directly enhances presentation of tumor-associated antigens to immune cells.	[Jiang, Hong; Fan, Xuejun; Tian, Weihua; Gumin, Joy; Lang, Frederick F.; Yung, Wai-Kwan Alfred; Gomez-Manzano, Candelaria; Fueyo, Juan] Univ Texas MD Anderson Canc Ctr, Brain Tumor Ctr, Houston, TX 77030 USA; [Clise-Dwyer, Karen; Ruisaard, Kathryn E.] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat, Houston, TX 77030 USA; [Vence, Luis M.] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Lamfers, Martine L.; Kleijn, Anne] Erasmus MC, Dept Neurosurg, Rotterdam, Netherlands	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Erasmus University Rotterdam; Erasmus MC	Jiang, H (corresponding author), Univ Texas MD Anderson Canc Ctr, Brain Tumor Ctr, Houston, TX 77030 USA.	hjiang@mdanderson.org	Lamfers, Martine/C-6246-2016; Yung, W.K. Alfred/W-5016-2019	Lamfers, Martine/0000-0001-7745-9029; Fueyo, Juan/0000-0001-6941-2335; Gomez-Manzano, Candelaria/0000-0002-1259-2133	National Institutes of Health [P50CA127001]; Institutional U.T. M.D. Anderson's Cancer Center Support Grant [CA016672]; Marnie Rose Foundation; Will Power Foundation; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA127001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional U.T. M.D. Anderson's Cancer Center Support Grant; Marnie Rose Foundation; Will Power Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by the National Institutes of Health (P50CA127001), the Institutional U.T. M.D. Anderson's Cancer Center Support Grant (CA016672; Flow Cytometry and Cellular Imaging Facility; Research Animal Support Facility Sequencing, and Microarray Facility), the Marnie Rose Foundation, and the Will Power Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JF, CGM, and WKAY are shareholders of DNAtrix, Inc. The authors confirm here that the Financial Disclosure in the first submission does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Baniyash M, 2004, NAT REV IMMUNOL, V4, P675, DOI 10.1038/nri1434; Cerullo V, 2012, MOL THER, V20, P2076, DOI 10.1038/mt.2012.137; Croft M, 2010, ANNU REV IMMUNOL, V28, P57, DOI 10.1146/annurev-immunol-030409-101243; Falkeholm L, 2001, LAB INVEST, V81, P1213, DOI 10.1038/labinvest.3780335; FALO LD, 1995, NAT MED, V1, P649, DOI 10.1038/nm0795-649; Fruh K, 1999, CURR OPIN IMMUNOL, V11, P76, DOI 10.1016/S0952-7915(99)80014-4; Fueyo J, 2003, J NATL CANCER I, V95, P652, DOI 10.1093/jnci/95.9.652; Griffin TA, 1998, J EXP MED, V187, P97, DOI 10.1084/jem.187.1.97; Hallden G, 2003, MOL THER, V8, P412, DOI 10.1016/S1525-0016(03)00199-0; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jiang H, 2006, REPLICATING VIRUSES, P293; Jiang H, 2011, J VIROL; Jiang H, 2007, J NATL CANCER I, V99, P1410, DOI 10.1093/jnci/djm102; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kelly E, 2007, MOL THER, V15, P651, DOI 10.1038/sj.mt.6300108; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Lazarevic V, 2013, NAT REV IMMUNOL, V13, P777, DOI 10.1038/nri3536; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Li YH, 2008, CANCER RES, V68, P6889, DOI 10.1158/0008-5472.CAN-08-0161; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Melcher A, 2011, MOL THER, V19, P1008, DOI 10.1038/mt.2011.65; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Park HJ, 2011, VACCINE, V29, P3476, DOI 10.1016/j.vaccine.2011.02.061; Russell SJ, 2012, NAT BIOTECHNOL, V30, P658, DOI 10.1038/nbt.2287; Shin EC, 2006, J CLIN INVEST, V116, P3006, DOI 10.1172/JCI29832; Thomas MA, 2008, MOL THER, V16, P1665, DOI 10.1038/mt.2008.162; Uhl M, 2009, CELL DEATH DIFFER, V16, P991, DOI 10.1038/cdd.2009.8; Weinberg AD, 2011, IMMUNOL REV, V244, P218, DOI 10.1111/j.1600-065X.2011.01069.x; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wold WSM, 2012, ADV CANCER RES, V115, P69, DOI 10.1016/B978-0-12-398342-8.00003-3; YEWDELL JW, 1989, SCIENCE, V244, P1072, DOI 10.1126/science.2471266; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250; Young AM, 2012, MOL THER, V20, P1676, DOI 10.1038/mt.2012.116; Zhou F, 2009, INT REV IMMUNOL, V28, P239, DOI 10.1080/08830180902978120	38	74	75	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97407	10.1371/journal.pone.0097407	http://dx.doi.org/10.1371/journal.pone.0097407			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827739	Green Published, gold, Green Submitted			2022-12-27	WOS:000336857400091
J	Karusisi, N; Thomas, F; Meline, J; Brondeel, R; Chaix, B				Karusisi, Noella; Thomas, Frederique; Meline, Julie; Brondeel, Ruben; Chaix, Basile			Environmental Conditions around Itineraries to Destinations as Correlates of Walking for Transportation among Adults: The RECORD Cohort Study	PLOS ONE			English	Article							GEOGRAPHIC LIFE ENVIRONMENTS; PHYSICAL-ACTIVITY; BUILT ENVIRONMENT; RESEARCH AGENDA; BLOOD-PRESSURE; RISK-FACTORS; BODY-WEIGHT; NEIGHBORHOOD; HEALTH; URBAN	Introduction: Assessing the contextual factors that influence walking for transportation is important to develop more walkable environments and promote physical activity. To advance previous research focused on residential environments and overall walking for transportation, the present study investigates objective environmental factors assessed around the residence, the workplace, the home - work itinerary, and the home - supermarket itinerary, and considered overall walking for transportation but also walking to work and to shops. Methods: Data from the RECORD Study involving 7290 participants recruited in 2007-2008, aged 30-79 years, and residing in the Paris metropolitan area were analyzed. Multilevel ordinal regression analyses were conducted to investigate environmental characteristics associated with self-reported overall walking for transportation, walking to work, and walking to shops. Results: High individual education was associated with overall walking for transportation, with walking to work, and walking to shops. Among workers, a high residential neighborhood education was associated with increased overall walking for transportation, while a high workplace neighborhood education was related to an increased time spent walking to work. The residential density of destinations was positively associated with overall walking for transportation, with walking to work, and with walking to shops, while the workplace density of destinations was positively associated with overall walking for transportation among workers. Environmental factors assessed around the itineraries were not associated with walking to work or to the shops. Conclusion: This research improves our understanding of the role of the environments on walking for transportation by accounting for some of the environments visited beyond the residential neighborhood. It shows that workers' walking habits are more influenced by the density of destinations around the workplace than around the residence. These results provide insight for the development of policies and programs to encourage population level active commuting.	[Karusisi, Noella; Meline, Julie; Brondeel, Ruben; Chaix, Basile] INSERM, U707, Paris, France; [Karusisi, Noella; Meline, Julie; Brondeel, Ruben; Chaix, Basile] Univ Paris 06, UMR S 707, Paris, France; [Thomas, Frederique] Ctr Invest Prevent & Clin, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Karusisi, N (corresponding author), INSERM, U707, Paris, France.	karusisi@u707.jussieu.fr	Chaix, Basile/B-8625-2014; Brondeel, Ruben/F-1086-2018; Brondeel, Ruben/L-3419-2019	Brondeel, Ruben/0000-0002-9876-4150; Brondeel, Ruben/0000-0002-9876-4150	Institute for Public Health Research (IReSP, Institut de Recherche en Sante Publique); National Institute for Prevention and Health Education (INPES, Institut National de Prevention et d'Education pour la Sante); National Institute of Public Health Surveillance (InVS, Institut de Veille Sanitaire) (Territory and Health Program); French Ministry of Research; French Ministry of Health; National Health Insurance Office for Salaried Workers (CNAM-TS, Caisse Nationale d'Assurance Maladie des Travailleurs Salaries); Ile-de-France Regional Council (Conseil Regional d'Ile-de-France, DIM SEnT); Ile-de-France Regional Council (Conseil Regional d'Ile-de-France, CODDIM); National Research Agency (ANR, Agence Nationale de la Recherche) (Health-Environment Program); Ile-de-France Regional Health Agency (ARS, Agence Regionale de Sante); City of Paris (Ville de Paris); Ile-de-France Youth, Sports, and Social Cohesion Regional Direction (DRJSCS, Direction Regionale de la Jeunesse, des Sports et de la Cohesion Sociale)	Institute for Public Health Research (IReSP, Institut de Recherche en Sante Publique); National Institute for Prevention and Health Education (INPES, Institut National de Prevention et d'Education pour la Sante); National Institute of Public Health Surveillance (InVS, Institut de Veille Sanitaire) (Territory and Health Program); French Ministry of Research(Ministry of Research, FranceEuropean Commission); French Ministry of Health; National Health Insurance Office for Salaried Workers (CNAM-TS, Caisse Nationale d'Assurance Maladie des Travailleurs Salaries); Ile-de-France Regional Council (Conseil Regional d'Ile-de-France, DIM SEnT)(Region Ile-de-France); Ile-de-France Regional Council (Conseil Regional d'Ile-de-France, CODDIM)(Region Ile-de-France); National Research Agency (ANR, Agence Nationale de la Recherche) (Health-Environment Program)(French National Research Agency (ANR)); Ile-de-France Regional Health Agency (ARS, Agence Regionale de Sante)(Region Ile-de-France); City of Paris (Ville de Paris)(Region Ile-de-France); Ile-de-France Youth, Sports, and Social Cohesion Regional Direction (DRJSCS, Direction Regionale de la Jeunesse, des Sports et de la Cohesion Sociale)(Region Ile-de-France)	The RECORD project received support from the Institute for Public Health Research (IReSP, Institut de Recherche en Sante Publique); the National Institute for Prevention and Health Education (INPES, Institut National de Prevention et d'Education pour la Sante) (Prevention Program 2007; 2010-2011 financial support; and 2011-2013 financial support); the National Institute of Public Health Surveillance (InVS, Institut de Veille Sanitaire) (Territory and Health Program); the French Ministries of Research and Health (Epidemiologic Cohorts Grant 2008); the National Health Insurance Office for Salaried Workers (CNAM-TS, Caisse Nationale d'Assurance Maladie des Travailleurs Salaries); the Ile-de-France Regional Council (Conseil Regional d'Ile-de-France, DIM SEnT and CODDIM); the National Research Agency (ANR, Agence Nationale de la Recherche) (Health-Environment Program 2005); the Ile-de-France Regional Health Agency (ARS, Agence Regionale de Sante); the City of Paris (Ville de Paris); and the Ile-de-France Youth, Sports, and Social Cohesion Regional Direction (DRJSCS, Direction Regionale de la Jeunesse, des Sports et de la Cohesion Sociale). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badland HM, 2012, SOC SCI MED, V75, P1469, DOI 10.1016/j.socscimed.2012.05.029; Beckman A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-71; BIDDLE SJH, 2001, PSYCHOL PHYS ACTIVIT; Brownson RC, 2009, AM J PREV MED, V36, pS99, DOI 10.1016/j.amepre.2009.01.005; Cerin E, 2009, SOC SCI MED, V68, P1013, DOI 10.1016/j.socscimed.2009.01.008; Chaix B, 2002, REV EPIDEMIOL SANTE, V50, P489; Chaix B, 2011, INT J EPIDEMIOL; Chaix B, 2013, HEALTH PLACE, V21, P46, DOI 10.1016/j.healthplace.2013.01.003; Chaix B, 2012, AM J PREV MED, V43, P440, DOI 10.1016/j.amepre.2012.06.026; Chaix B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032908; Chaix B, 2011, SOC SCI MED, V73, P1543, DOI 10.1016/j.socscimed.2011.09.009; Chaix B, 2011, EPIDEMIOLOGY, V22, P18, DOI 10.1097/EDE.0b013e3181fd2961; Chaix B, 2010, HYPERTENSION, V55, P769, DOI 10.1161/HYPERTENSIONAHA.109.143206; Chaix B, 2010, EPIDEMIOLOGY, V21, P124, DOI 10.1097/EDE.0b013e3181c04e70; Chaix B, 2009, ANNU REV PUBL HEALTH, V30, P81, DOI 10.1146/annurev.publhealth.031308.100158; Dalton AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067575; Drewnowski A, 2013, INT J OBES LOND; Durstine JL, 2013, J SPORT HEALTH SCI, V2, P3, DOI 10.1016/j.jshs.2012.07.009; Evans G., 2009, BUILD ENVIRON, V35, P366, DOI DOI 10.2148/BENV.35.3.366; Ewing R, 2003, AM J HEALTH PROMOT, V18, P47, DOI 10.4278/0890-1171-18.1.47; Forsyth A, 2009, TRANSPORT RES D-TR E, V14, P42, DOI 10.1016/j.trd.2008.10.003; Handy SL, 2002, AM J PREV MED, V23, P64, DOI 10.1016/S0749-3797(02)00475-0; Haskell WL, 2009, PREV MED, V49, P280, DOI 10.1016/j.ypmed.2009.05.002; Johansson K, 2012, EUR J PUBLIC HEALTH, V22, P209, DOI 10.1093/eurpub/ckr042; Karusisi N, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-48; Karusisi N, 2012, PREV MED, V55, P50, DOI 10.1016/j.ypmed.2012.04.018; Kerr J, 2013, J PHYS ACT HEALTH, V10, P581, DOI 10.1123/jpah.10.4.581; Larsen J, 2010, QUARTER MILE REEXAMI; Larsen K, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-16; Leal C, 2011, OBES REV, V12, P217, DOI 10.1111/j.1467-789X.2010.00726.x; Leal C, 2012, AM J EPIDEMIOL, V175, P1152, DOI 10.1093/aje/kwr434; Leal C, 2011, EPIDEMIOLOGY, V22, P694, DOI 10.1097/EDE.0b013e3182257784; Lee IM, 2008, MED SCI SPORT EXER, V40, pS512, DOI 10.1249/MSS.0b013e31817c65d0; McCormack GR, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-125; Morris JN, 1997, SPORTS MED, V23, P306, DOI 10.2165/00007256-199723050-00004; Owen N, 2004, AM J PREV MED, V27, P67, DOI 10.1016/j.amepre.2004.03.006; Oyeyemi AL, 2013, INT J HLTH GEOGRAAPH; Panter J, 2013, PREV MED, V56, P211, DOI 10.1016/j.ypmed.2013.01.014; Popham F, 2007, PREV MED, V45, P182, DOI 10.1016/j.ypmed.2007.06.012; Saelens BE, 2003, ANN BEHAV MED, V25, P80, DOI 10.1207/S15324796ABM2502_03; Saelens BE, 2008, MED SCI SPORT EXER, V40, pS550, DOI 10.1249/MSS.0b013e31817c67a4; Sallis JF, 1996, J CLIN EPIDEMIOL, V49, P125, DOI 10.1016/0895-4356(95)00514-5; Stigell E, 2011, ASSESSMENT ACTIVE CO; Sugiyama T, 2012, MED SCI SPORT EXER, V44, P1275, DOI 10.1249/MSS.0b013e318247d286; Tessier S, 2007, PREV MED, V44, P202, DOI 10.1016/j.ypmed.2006.11.012; Turrell G, 2013, HEALTH PLACE, V19, P89, DOI 10.1016/j.healthplace.2012.10.008; Van Hulst A, 2012, J HYPERTENS, V30, P1336, DOI 10.1097/HJH.0b013e3283544863; van Lenthe FJ, 2005, SOC SCI MED, V60, P763, DOI 10.1016/j.socscimed.2004.06.013; Wanner M, 2012, AM J PREV MED, V42, P493, DOI 10.1016/j.amepre.2012.01.030	49	17	17	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e88929	10.1371/journal.pone.0088929	http://dx.doi.org/10.1371/journal.pone.0088929			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828890	Green Published, Green Submitted, gold			2022-12-27	WOS:000336857400002
J	Wagner, AL; Sun, XD; Montgomery, JP; Huang, ZY; Boulton, ML				Wagner, Abram L.; Sun, Xiaodong; Montgomery, JoLynn P.; Huang, Zhuoying; Boulton, Matthew L.			The Impact of Residency and Urbanicity on Haemophilus influenzae Type b and Pneumococcal Immunization in Shanghai Children: A Retrospective Cohort Study	PLOS ONE			English	Article							CHINA; VACCINATION; TIMELINESS; VACCINES; YOUNGER; DISEASE	Background: Haemophilus influenzae type b (Hib) vaccine and pneumococcal conjugate vaccine (PCV) are relatively expensive, newly introduced vaccines in China. This study evaluates the impact of residency and urbanicity on Hib vaccine and PCV coverage for children aged 2 to 7 years living in Shanghai, China, in August 2012. Methods: In this exploratory cohort study, a sample of children aged 2 to 7 years, all of whom were eligible to have received the complete series of Hib vaccine and PCV, was obtained from the Shanghai Immunization Program Information System. Three measures of vaccination coverage for Hib vaccine and PCV were examined: dose 1 coverage, series completion, and timeliness of dose 1 vaccination. Multivariable binomial regression was used to estimate the difference in vaccination coverage between locals and the floating population. Results: Dose 1 coverage was 50.9% for Hib vaccine and 11.4% for PCV for the 28,141 abstracted pediatric records. For both vaccines, dose 1 coverage was higher in locals than in the floating population. The disparity in coverage between locals and the floating population was greater in suburban areas than urban areas. Of all children who received dose 1, 79.7% completed the Hib vaccine series, and 91.3% completed the PCV series. Timely dose 1 coverage was 8.2% for Hib vaccine and 0.5% for PCV. Conclusion: Low vaccination coverage and extremely low levels of timely dose 1 vaccination indicate that current vaccination efforts are inadequate to reduce the burden of Hib and pneumococcal disease among Chinese children, especially infants. Government funding of the Hib vaccine and PCV through the Expanded Program on Immunization would increase uptake and could also ensure that improvement in the timeliness of administration and series completion is targeted for all demographic groups.	[Wagner, Abram L.; Montgomery, JoLynn P.; Boulton, Matthew L.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Sun, Xiaodong; Huang, Zhuoying] Shanghai Municipal Ctr Dis Control & Prevent, Dept Immunizat Program, Shanghai, Peoples R China; [Boulton, Matthew L.] Univ Michigan, Div Infect Dis, Sch Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Shanghai Center for Disease Control & Prevention; University of Michigan System; University of Michigan	Wagner, AL (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.	awag@umich.edu	Wagner, Abram/X-6379-2019	Wagner, Abram/0000-0003-4691-7802; Boulton, Matthew/0000-0002-0565-9010				Akmatov MK, 2008, VACCINE, V26, P3805, DOI 10.1016/j.vaccine.2008.05.031; [Anonymous], 2012, WKLY EPIDEMIOL REC; Barnighausen T, 2011, VACCINE, V29, P2371, DOI 10.1016/j.vaccine.2010.11.090; BART KJ, 1991, JAMA-J AM MED ASSOC, V266, P1547; Bian H, 2012, MED LAB SCI, V4, P82; Bolton P, 1998, PUBLIC HEALTH REP, V113, P527; Centers for Disease Control and Prevention, 2012, HAEM INFL EP PREV VA, P87; Centers for Disease Control and Prevention, 2012, PNEUM DIS EP PREV VA, P233; Centers for Disease Control and Prevention, 2012, GEN REC IMM EP PREV, P9; Chen Peng, 2010, Modern Preventive Medicine, V37, P2041; Chen Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027333; Cui Q, 2012, ZHEJIANG PREVENTIVE, V24, P32; Freeman III C. W., 2009, CHINAS CAPACITY MANA; Gates Foundation, 2013, PNEUM STRAT OV; GAVI Alliance, 2013, HAEM INFL TYP B VACC; Guan XH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011721; Han C, 2012, ZHEJIANG PREVENTIVE, V24, P24; Irigoyen M, 2004, AMBUL PEDIATR, V4, P199, DOI 10.1367/A03-138R1.1; Kalies H, 2006, PEDIATR INFECT DIS J, V25, P507, DOI 10.1097/01.inf.0000222413.47344.23; Lin N, 2006, MED IND INFORM, V3, P142; Qi H, 2012, CHINESE FOREIGN MED, V10, P144; Rudan I, 2010, LANCET, V375, P1083, DOI 10.1016/S0140-6736(10)60060-8; Shanghai Municipal Statistics Bureau, 2011, SHANGH STAT YB; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Sun J, 2012, MED LAB SCI, V3, P117; Sun MP, 2010, VACCINE, V28, P1264, DOI 10.1016/j.vaccine.2009.11.015; Tanaka M, 2003, JAMA-J AM MED ASSOC, V290, P2968, DOI 10.1001/jama.290.22.2968; The Government of the People's Republic of China, 2013, GLOB ALL VACC UNPUB; Wang LD, 2008, LANCET, V372, P1598, DOI 10.1016/S0140-6736(08)61365-3; Wang LX, 2003, J INFECT DIS, V187, pS252, DOI 10.1086/368045; Watt JP, 2009, LANCET, V374, P903, DOI 10.1016/S0140-6736(09)61203-4; WHO, 2012, EST HIB PNEUM DEATHS; World Health Organization, 2006, Wkly Epidemiol Rec, V81, P445; Xiao H, 2012, HEILONGJIANG MED PHA, V35, P55; Xue L, 2010, CLIN INFECT DIS, V50, P741, DOI 10.1086/650534; Yu HJ, 2012, HEALTH AFFAIR, V31, P2545, DOI 10.1377/hlthaff.2011.1272; Zheng JS, 2010, VACCINE, V28, pA84, DOI 10.1016/j.vaccine.2010.02.039; Zheng JS., 2012, CHIN J VACCINES IMMU, V18, P233, DOI 10.13683/j.wph.2017.06.014	38	33	34	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97800	10.1371/journal.pone.0097800	http://dx.doi.org/10.1371/journal.pone.0097800			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828814	Green Submitted, Green Published, gold			2022-12-27	WOS:000336857400124
J	Castillo-Rodriguez, RA; Arango-Rodriguez, ML; Escobedo, L; Hernandez-Baltazar, D; Gompel, A; Forgez, P; Martinez-Fong, D				Castillo-Rodriguez, Rosa A.; Arango-Rodriguez, Martha L.; Escobedo, Lourdes; Hernandez-Baltazar, Daniel; Gompel, Anne; Forgez, Patricia; Martinez-Fong, Daniel			Suicide HSVtk Gene Delivery by Neurotensin-Polyplex Nanoparticles via the Bloodstream and GCV Treatment Specifically Inhibit the Growth of Human MDA-MB-231 Triple Negative Breast Cancer Tumors Xenografted in Athymic Mice	PLOS ONE			English	Article							CELL-LINES; NONVIRAL VECTOR; RECEPTOR 1; BYSTANDER; THERAPY; APOPTOSIS; PATHWAY; MODELS; DNA; PROLIFERATION	The human breast adenocarcinoma cell line MDA-MB-231 has the triple-negative breast cancer (TNBC) phenotype, which is an aggressive subtype with no specific treatment. MDA-MB-231 cells express neurotensin receptor type 1 (NTSR1), which makes these cells an attractive target of therapeutic genes that are delivered by the neurotensin (NTS)-polyplex nanocarrier via the bloodstream. We addressed the relevance of this strategy for TNBC treatment using NTS-polyplex nanoparticles harboring the herpes simplex virus thymidine kinase (HSVtk) suicide gene and its complementary prodrug ganciclovir (GCV). The reporter gene encoding green fluorescent protein (GFP) was used as a control. NTS-polyplex successfully transfected both genes in cultured MDA-MB-231 cells. The transfection was demonstrated pharmacologically to be dependent on activation of NTSR1. The expression of HSVtk gene decreased cell viability by 49% (P<0.0001) and induced apoptosis in cultured MDA-MB-231 cells after complementary GCV treatment. In the MDA-MB-231 xenograft model, NTS-polyplex nanoparticles carrying either the HSVtk gene or GFP gene were injected into the tumors or via the bloodstream. Both routes of administration allowed the NTS-polyplex nanoparticles to reach and transfect tumorous cells. HSVtk expression and GCV led to apoptosis, as shown by the presence of cleaved caspase-3 and Apostain immunoreactivity, and significantly inhibited the tumor growth (55-60%) (P<0.001). At the end of the experiment, the weight of tumors transfected with the HSVtk gene was 55% less than that of control tumors (P<0.05). The intravenous transfection did not induce apoptosis in peripheral organs. Our results offer a promising gene therapy for TNBC using the NTS-polyplex nanocarrier.	[Castillo-Rodriguez, Rosa A.; Escobedo, Lourdes; Hernandez-Baltazar, Daniel; Martinez-Fong, Daniel] Inst Politecn Nacl CINVESTAV, Ctr Invest & Estudios Avanzados, Dept Fisiol Biofis & Neurociencias, Mexico City, DF, Mexico; [Martinez-Fong, Daniel] Inst Politecn Nacl CINVESTAV, Ctr Invest & Estudios Avanzados, Programa Nanociencias & Nanotecnol, Mexico City, DF, Mexico; [Arango-Rodriguez, Martha L.] Univ Desarrollo, Fac Med Clin Alemana, Inst Ciencias, Santiago, Chile; [Gompel, Anne] Univ Paris 05, Port Royal Cochin, AP HP, Unite Gynecol, Paris, France; [Forgez, Patricia] Univ Paris 05, INSERM, Dept Cellular Homeostasis & Canc, UMR S 1007, Paris, France	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Universidad del Desarrollo; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Martinez-Fong, D (corresponding author), Inst Politecn Nacl CINVESTAV, Ctr Invest & Estudios Avanzados, Dept Fisiol Biofis & Neurociencias, Mexico City, DF, Mexico.	dmartine@fisio.cinvestav.mx	FORGEZ, Patricia/N-2960-2018; Gompel, Anne/AAV-3132-2020; BALTAZAR, DANIEL HERNANDEZ/S-9655-2019	BALTAZAR, DANIEL HERNANDEZ/0000-0002-3658-4808; Castillo-Rodriguez, Rosa Angelica/0000-0003-4117-6689	Instituto de Ciencia y Tecnologia del Distrito Federal (ICyT-DF); Agence Internationale de la Recherche Blanc International [ANR-10-INTB-1503]; Consejo Nacional de Ciencia y Tecnologia (CONACYT) [142947]; Evaluation-orientation de la Cooperation Scientifique (ECOS Nord) [M07-S01]	Instituto de Ciencia y Tecnologia del Distrito Federal (ICyT-DF); Agence Internationale de la Recherche Blanc International; Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Evaluation-orientation de la Cooperation Scientifique (ECOS Nord)	This work was supported by Instituto de Ciencia y Tecnologia del Distrito Federal (ICyT-DF), and Agence Internationale de la Recherche Blanc International (ANR-10-INTB-1503) NTS-Polyplex. Consejo Nacional de Ciencia y Tecnologia (CONACYT) # 142947, supported the fellowships of RC-R and DH-B. Evaluation-orientation de la Cooperation Scientifique (ECOS Nord) # M07-S01 supported travel missions and RC-R travel fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexis F, 2008, MOL PHARMACEUT, V5, P505, DOI 10.1021/mp800051m; Alvarez-Maya I, 2001, MOL MED, V7, P186, DOI 10.1007/BF03401952; Arango-Rodriguez ML, 2006, BBA-GEN SUBJECTS, V1760, P1009, DOI 10.1016/j.bbagen.2006.02.021; Asklund T, 2003, EXP CELL RES, V284, P185, DOI 10.1016/S0014-4827(02)00052-6; Bayraktar S, 2013, BREAST CANCER RES TR, V138, P21, DOI 10.1007/s10549-013-2421-5; Bosch A, 2010, CANCER TREAT REV, V36, P206, DOI 10.1016/j.ctrv.2009.12.002; Boyle P, 2012, ANN ONCOL S6, V23, pvi7; Carroll JL, 2001, MOL CANCER THER, V1, P49; Chiu SH, 2004, J CONTROL RELEASE, V97, P357, DOI 10.1016/j.jconrel.2004.03.019; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Dachs GU, 2009, MOLECULES, V14, P4517, DOI 10.3390/molecules14114517; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Dilber MS, 1996, BLOOD, V88, P2192, DOI 10.1182/blood.V88.6.2192.bloodjournal8862192; Drake RR, 2000, MOL THER, V2, P515, DOI 10.1006/mthe.2000.0192; Duarte S, 2012, CANCER LETT, V324, P160, DOI 10.1016/j.canlet.2012.05.023; Dupouy S, 2011, BIOCHIMIE, V93, P1369, DOI 10.1016/j.biochi.2011.04.024; Dupouy S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004223; Eastman A, 2013, ANN SURG ONCOL, V20, P1880, DOI 10.1245/s10434-012-2835-z; Orozco-Barrios CE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008268; Ferraro DA, 2013, P NATL ACAD SCI USA, V110, P1815, DOI 10.1073/pnas.1220763110; Fillat C., 2003, Current Gene Therapy, V3, P13, DOI 10.2174/1566523033347426; FREEMAN SM, 1993, CANCER RES, V53, P5274; GULLY D, 1993, P NATL ACAD SCI USA, V90, P65, DOI 10.1073/pnas.90.1.65; Hamel W, 1996, CANCER RES, V56, P2697; Heakal Y, 2009, MOL CANCER RES, V7, P724, DOI 10.1158/1541-7786.MCR-08-0322; Hernandez-Baltazar D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070951; Hernandez-Baltazar D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051341; Hernandez-Gutierrez M, 2013, NANOMEDICINE NANOTEC; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Huang HL, 2010, BIOMATERIALS, V31, P1830, DOI 10.1016/j.biomaterials.2009.11.012; Huyn ST, 2009, CLIN CANCER RES, V15, P3126, DOI 10.1158/1078-0432.CCR-08-2666; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Li XG, 2001, CANCER GENE THER, V8, P555, DOI 10.1038/sj.cgt.7700337; Lim KI, 2012, BMB REP, V45, P207, DOI 10.5483/BMBRep.2012.45.4.207; LOOKINGBILL DP, 1993, J AM ACAD DERMATOL, V29, P228, DOI 10.1016/0190-9622(93)70173-Q; Martinez-Fong D, 2000, BRAIN RES PROTOC, V6, P13, DOI 10.1016/S1385-299X(00)00032-5; Martinez-Fong D, 1999, MOL BRAIN RES, V69, P249, DOI 10.1016/S0169-328X(99)00114-X; Martinez-Fong D, 2012, NANOMED-NANOTECHNOL, V8, P1052, DOI 10.1016/j.nano.2012.02.009; McLachlan E, 2007, J MEMBRANE BIOL, V218, P107, DOI 10.1007/s00232-007-9052-x; McLachlan E, 2006, CANCER RES, V66, P9886, DOI 10.1158/0008-5472.CAN-05-4302; Mendez M, 1997, J MOL NEUROSCI, V9, P93, DOI 10.1007/BF02736853; Merkel OM, 2009, J CONTROL RELEASE, V138, P148, DOI 10.1016/j.jconrel.2009.05.016; Mesnil M, 2000, CANCER RES, V60, P3989; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Navarro-Quiroga I, 2002, MOL BRAIN RES, V105, P86, DOI 10.1016/S0169-328X(02)00396-0; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Pan JG, 2012, MED ONCOL, V29, P1938, DOI 10.1007/s12032-011-0091-x; Perou CM, 2011, ONCOLOGIST, V16, P61, DOI 10.1634/theoncologist.2011-S1-61; Princen F, 1999, CLIN CANCER RES, V5, P3639; Reis JS, 2006, J PATHOL, V209, P445, DOI 10.1002/path.2004; Rubio-Zapata HA, 2009, CANCER GENE THER, V16, P573, DOI 10.1038/cgt.2009.1; Sakurai H, 2008, INT J PHARMACEUT, V354, P9, DOI 10.1016/j.ijpharm.2007.06.012; Schade B, 2013, CANCER RES, V73, P4474, DOI 10.1158/0008-5472.CAN-12-3925; Shy BR, 2013, CELL REP, V4, P1, DOI 10.1016/j.celrep.2013.06.001; Somai S, 2002, BIOCHEM BIOPH RES CO, V295, P482, DOI 10.1016/S0006-291X(02)00703-9; Souaze F, 2006, CARCINOGENESIS, V27, P708, DOI 10.1093/carcin/bgi269; Souaze F, 2006, CANCER RES, V66, P6243, DOI 10.1158/0008-5472.CAN-06-0450; SPENCER PS, 1987, CUTIS, V39, P119; Stover TC, 2005, CLIN CANCER RES, V11, P3465, DOI 10.1158/1078-0432.CCR-04-1770; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Tomicic MT, 2002, MUTAT RES-FUND MOL M, V505, P1, DOI 10.1016/S0027-5107(02)00105-7; Vyas VK, 2013, ANTI-CANCER AGENT ME, V13, P433; Ward CM, 2001, BLOOD, V97, P2221, DOI 10.1182/blood.V97.8.2221; Wend P, 2013, EMBO MOL MED, V5, P264, DOI 10.1002/emmm.201201320; Wu Zherui, 2012, Front Endocrinol (Lausanne), V3, P184, DOI 10.3389/fendo.2012.00184; Zhu JG, 2009, J CLIN INVEST, V119, P2388, DOI 10.1172/JCI37607	68	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97151	10.1371/journal.pone.0097151	http://dx.doi.org/10.1371/journal.pone.0097151			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824754	gold, Green Published, Green Submitted			2022-12-27	WOS:000336369200066
J	Chen, JP; Wu, MS; Kuo, SH; Liao, F				Chen, Jia-Perng; Wu, Ming-Shiang; Kuo, Sung-Hsin; Liao, Fang			IL-22 Negatively Regulates Helicobacter pylori-Induced CCL20 Expression in Gastric Epithelial Cells	PLOS ONE			English	Article							CC-CHEMOKINE RECEPTOR; INTERLEUKIN (IL)-22; INDUCIBLE FACTOR; HOST-DEFENSE; T-CELLS; GENE; IMMUNITY; STAT3; INFLAMMATION; ACTIVATION	Helicobacter pylori is a Gram-negative bacterium that infects the human gastric mucosa and causes various gastric diseases. H. pylori infection induces the production of inflammatory chemokine CCL20 in gastric mucosa and leads to gastric inflammation. Given that the IL-22/IL-22R axis plays a critical role in the regulation of homeostasis and inflammation of epithelial cells at barrier surfaces, we investigated the effect of IL-22 on CCL20 expression induced by H. pylori. We demonstrated that H. pylori infection of the gastric epithelia-derived AGS cells significantly induced CCL20 expression and the induction was inhibited by IL-22. Functional analysis of the CCL20 promoter revealed that the H. pylori-induced CCL20 expression required the activation of NF-kappa B, and that IL-22 inhibited the induction by attenuating NF-kappa B activation. Knockdown of endogenous STAT3 by either short interfering RNAs or a short hairpin RNA significantly reduced the inhibitory effect of IL-22. Furthermore, STAT3 phosphorylation elicited by IL-22 was crucial for the inhibition of H. pylori-induced CCL20 expression. Consistent with the in vitro data showing that IL-22 negatively regulated H. pylori-induced CCL20 expression in gastric epithelial cells, studies on the tissue sections from patients with H. pylori infection also revealed an inverse association of IL-22 expression and CCL20 expression in vivo. Together, our findings suggest that IL-22 plays a role in the control of overproduction of the inflammatory chemokine and thus may protect the gastric mucosa from inflammationmediated damage.	[Chen, Jia-Perng; Liao, Fang] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Wu, Ming-Shiang] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Wu, Ming-Shiang] Natl Taiwan Univ, Coll Med, Taipei 100, Taiwan; [Kuo, Sung-Hsin] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan; [Kuo, Sung-Hsin] Natl Taiwan Univ, Coll Med, Canc Res Ctr, Taipei, Taiwan; [Kuo, Sung-Hsin] Natl Taiwan Univ, Coll Med, Grad Inst Oncol, Taipei, Taiwan; [Liao, Fang] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan	National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan	Liao, F (corresponding author), Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan.	fl9z@ibms.sinica.edu.tw	Liao, Fang/S-7021-2018	Wu, Ming-Shiang/0000-0002-1940-6428; Kuo, Sung-Hsin/0000-0003-0054-887X	Institution of Biomedical Sciences, Acdemia Sinica	Institution of Biomedical Sciences, Acdemia Sinica	This study was supported by an intramural fund from the Institution of Biomedical Sciences, Acdemia Sinica. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Atreya R, 2008, CURR DRUG TARGETS, V9, P369, DOI 10.2174/138945008784221116; Aujla SJ, 2009, J MOL MED, V87, P451, DOI 10.1007/s00109-009-0448-1; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Baba M, 1997, J BIOL CHEM, V272, P14893, DOI 10.1074/jbc.272.23.14893; Bamford KB, 1998, GASTROENTEROLOGY, V114, P482, DOI 10.1016/S0016-5085(98)70531-1; Bodger K, 1998, BRIT MED BULL, V54, P139; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Bronte-Tinkew DM, 2009, CANCER RES, V69, P632, DOI 10.1158/0008-5472.CAN-08-1191; Caruso R, 2008, EUR J IMMUNOL, V38, P470, DOI 10.1002/eji.200737635; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Cheng GZ, 2008, J BIOL CHEM, V283, P14665, DOI 10.1074/jbc.M707429200; Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008; Cook DN, 2000, IMMUNITY, V12, P495, DOI 10.1016/S1074-7613(00)80201-0; Dumoutier L, 2000, P NATL ACAD SCI USA, V97, P10144, DOI 10.1073/pnas.170291697; Eaton KA, 2001, J IMMUNOL, V166, P7456, DOI 10.4049/jimmunol.166.12.7456; El Kasmi KC, 2006, J IMMUNOL, V177, P7880, DOI 10.4049/jimmunol.177.11.7880; Fujiie S, 2001, INT IMMUNOL, V13, P1255, DOI 10.1093/intimm/13.10.1255; Greaves DR, 1997, J EXP MED, V186, P837, DOI 10.1084/jem.186.6.837; Hedrick MN, 2010, EXPERT OPIN THER TAR, V14, P911, DOI 10.1517/14728222.2010.504716; Hsieh PF, 1998, J FORMOS MED ASSOC, V97, P445; Ito T, 2011, EXP CELL RES, V317, P613, DOI 10.1016/j.yexcr.2010.12.018; Kanda N, 2009, EUR J IMMUNOL, V39, P996, DOI 10.1002/eji.200838852; Khamri W, 2010, INFECT IMMUN, V78, P845, DOI 10.1128/IAI.00524-09; Kirchberger S, 2013, J EXP MED, V210, P917, DOI 10.1084/jem.20122308; Kotenko SV, 2001, J BIOL CHEM, V276, P2725, DOI 10.1074/jbc.M007837200; Kunkel EJ, 2003, MICROCIRCULATION, V10, P313, DOI 10.1038/sj.mn.7800196; Kwon JH, 2003, J BIOL CHEM, V278, P875, DOI 10.1074/jbc.M208241200; Lejeune D, 2002, J BIOL CHEM, V277, P33676, DOI 10.1074/jbc.M204204200; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Liao F, 2002, J IMMUNOL, V168, P4871, DOI 10.4049/jimmunol.168.10.4871; Liao F, 1999, J IMMUNOL, V162, P186; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; Maae E, 2011, J HISTOCHEM CYTOCHEM, V59, P750, DOI 10.1369/0022155411412599; Mabuchi T, 2012, J DERMATOL SCI, V65, P4, DOI 10.1016/j.jdermsci.2011.11.007; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Mizuno T, 2005, WORLD J GASTROENTERO, V11, P6305, DOI 10.3748/wjg.v11.i40.6305; Nishi T, 2003, INFECT IMMUN, V71, P2153, DOI 10.1128/IAI.71.4.2153-2162.2003; Nishimoto N, 2004, CURR OPIN PHARMACOL, V4, P386, DOI 10.1016/j.coph.2004.03.005; Obonyo M, 2011, HELICOBACTER, V16, P398, DOI 10.1111/j.1523-5378.2011.00861.x; PARSONNET J, 1994, NEW ENGL J MED, V330, P1267, DOI 10.1056/NEJM199405053301803; Peek RM, 2006, J PATHOL, V208, P233, DOI 10.1002/path.1868; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Rincon M, 2012, TRENDS IMMUNOL, V33, P571, DOI 10.1016/j.it.2012.07.003; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Singh SP, 2008, J IMMUNOL, V180, P214, DOI 10.4049/jimmunol.180.1.214; Smythies LE, 2000, J IMMUNOL, V165, P1022, DOI 10.4049/jimmunol.165.2.1022; Sommer F, 1998, INFECT IMMUN, V66, P5543, DOI 10.1128/IAI.66.11.5543-5546.1998; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Sonnenberg GF, 2010, ADV IMMUNOL, V107, P1, DOI [10.1016/S0065-2776(10)07008-2, 10.1016/B978-0-12-381300-8.00001-0]; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Watanabe T, 2010, J CLIN INVEST, V120, P1645, DOI 10.1172/JCI39481; Welte T, 2003, P NATL ACAD SCI USA, V100, P1879, DOI 10.1073/PNAS.0237137100; Wen SC, 2004, J IMMUNOL, V172, P2595, DOI 10.4049/jimmunol.172.4.2595; Williams IR, 2006, ANN NY ACAD SCI, V1072, P52, DOI 10.1196/annals.1326.036; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Wolk K, 2010, SEMIN IMMUNOPATHOL, V32, P17, DOI 10.1007/s00281-009-0188-x; Wu YY, 2007, INFECT IMMUN, V75, P4357, DOI 10.1128/IAI.01660-06; Xie MH, 2000, J BIOL CHEM, V275, P31335, DOI 10.1074/jbc.M005304200; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yoshida A, 2009, CLIN IMMUNOL, V130, P290, DOI 10.1016/j.clim.2008.09.016; Yu ZY, 2002, BIOCHEM J, V367, P97, DOI 10.1042/BJ20020588; Zhang DX, 1996, J BIOL CHEM, V271, P9503, DOI 10.1074/jbc.271.16.9503; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	70	14	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97350	10.1371/journal.pone.0097350	http://dx.doi.org/10.1371/journal.pone.0097350			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824519	gold, Green Published, Green Submitted			2022-12-27	WOS:000336369200101
J	Gupta, J; Falb, KL; Carliner, H; Hossain, M; Kpebo, D; Annan, J				Gupta, Jhumka; Falb, Kathryn L.; Carliner, Hannah; Hossain, Mazeda; Kpebo, Denise; Annan, Jeannie			Associations between Exposure to Intimate Partner Violence, Armed Conflict, and Probable PTSD among Women in Rural Cote d'Ivoire	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; POTENTIALLY TRAUMATIC EVENTS; GENDER-BASED VIOLENCE; MENTAL-HEALTH; WAR; INTERVENTION; DISPLACEMENT; PREVALENCE; SURVIVORS; REFUGEES	Background: Objectives were to assess associations between intimate partner violence (IPV), violence during armed conflict (i.e. crisis violence), and probable post-traumatic stress disorder (PTSD). Methods: Using a sample of 950 women in rural Cote d'Ivoire, logistic generalized estimating equations assessed associations between IPV and crisis violence exposures with past-week probable PTSD. Results: Over one in 5 (23.4%) women reported past-year IPV, and over one in 4 women (26.5%) reported experiencing IPV prior to the past year (i.e. remote IPV). Crisis violence was experienced by 72.6% of women. In adjusted models including demographics, crisis violence (overall and specific forms), and IPV (remote and past-year), women who reported past-year IPV had 3.1 times the odds of reporting probable past-week PTSD (95% CI: 1.8-5.3) and those who reported remote IPV had 1.6 times the odds (95% CI: 0.9-2.7). Violent exposures during the crisis were not significantly associated with probable PTSD (any crisis violence: aOR: 1.04 (0.7-1.5); displacement: aOR: 0.9 (95% CI: 0.5-1.7); family victimization during crisis: aOR: 1.1 (95% CI: 0.8-1.7); personal victimization during crisis: aOR: 1.7 (95% CI: 0.7-3.7)). Conclusion: Past-year IPV was more strongly associated with past-week probable PTSD than remote IPV and violence directly related to the crisis. IPV must be considered within humanitarian mental health and psychosocial programming.	[Gupta, Jhumka] Yale Univ, Sch Med, Div Social & Behav Sci, New Haven, CT 06520 USA; [Gupta, Jhumka; Falb, Kathryn L.] Yale Univ, Sch Med, Dept Chron Dis Epidemiol, New Haven, CT USA; [Gupta, Jhumka; Falb, Kathryn L.] Yale Univ, Ctr Interdisciplinary Res AIDS, New Haven, CT USA; [Carliner, Hannah] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Hossain, Mazeda] Univ London London Sch Hyg & Trop Med, Gender Violence & Hlth Ctr, London WC1E 7HT, England; [Kpebo, Denise] Innovat Poverty Act, Abidjan, Cote Ivoire; [Annan, Jeannie] Int Rescue Comm, New York, NY USA	Yale University; Yale University; Yale University; Harvard University; Harvard T.H. Chan School of Public Health; University of London; London School of Hygiene & Tropical Medicine; Innovations for Poverty Action (IPA)	Gupta, J (corresponding author), Yale Univ, Sch Med, Div Social & Behav Sci, New Haven, CT 06520 USA.	Jhumka.gupta@yale.edu	Hossain, Mazeda/AAL-3202-2020	Hossain, Mazeda/0000-0002-1878-8145	World Bank's State; Peace-building Fund [1007007040]; Yale University's Center for Interdisciplinary Research on AIDS (CIRA); National Institute of Mental Health, Paul Cleary, Ph.D., Principal Investigator [P30MH062294]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062294] Funding Source: NIH RePORTER	World Bank's State; Peace-building Fund; Yale University's Center for Interdisciplinary Research on AIDS (CIRA); National Institute of Mental Health, Paul Cleary, Ph.D., Principal Investigator; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by the World Bank's State and Peace-building Fund, Contract #1007007040 (PI J. Gupta). This work was supported, in part, by Yale University's Center for Interdisciplinary Research on AIDS (CIRA), through grants from the National Institute of Mental Health, Paul Cleary, Ph.D., Principal Investigator (P30MH062294). The views presented are those of the authors and do not necessarily represent the views of the World Bank, NIMH, NIH, or IRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Krenawi Alean, 2007, Child Adolesc Ment Health, V12, P27, DOI 10.1111/j.1475-3588.2006.00416.x; Bass JK, 2013, NEW ENGL J MED, V368, P2182, DOI 10.1056/NEJMoa1211853; Chung H, 2008, PSYCHOL MED, V38, P563, DOI 10.1017/S0033291707002589; Crumlish N, 2010, J NERV MENT DIS, V198, P237, DOI 10.1097/NMD.0b013e3181d61258; de Fouchier C, 2012, EUR J PSYCHOTRAUMATO, V3, DOI 10.3402/ejpt.v3i0.19225; de Jong JTVM, 2003, LANCET, V361, P2128, DOI 10.1016/S0140-6736(03)13692-6; de Jong JTVM, 2001, JAMA-J AM MED ASSOC, V286, P555, DOI 10.1001/jama.286.5.555; Devries KM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001439; Falb KL, 2013, INT J GYNAECOL OBSTE; Falb KL, 2013, J TRAUMA STRESS, V26, P1; Fox SH, 2000, J NERV MENT DIS, V188, P490, DOI 10.1097/00005053-200008000-00003; Garcia-Moreno C, 2005, WHO MULTICOUNTRY STU; Gupta J, 2011, VILLAGE SAVINGS LOAN; Gupta J, 2013, BMC INT HEALTH HUM R, V13, DOI 10.1186/1472-698X-13-46; HERMAN JL, 1992, J TRAUMA STRESS, V5, P377, DOI 10.1007/BF00977235; Hossain M, 2010, LIFE EXPERIENCES COT; Hynes M, 2004, DISASTERS, V28, P294, DOI 10.1111/j.0361-3666.2004.00260.x; Institut National de la Statistique (INS) and ICF International, 2012, ENQ DEM SANT IND MUL; International Rescue Committee, 2012, LET ME NOT DIE MY TI; Johnson K, 2010, JAMA-J AM MED ASSOC, V304, P553, DOI 10.1001/jama.2010.1086; Kira I., 2012, PSYCHOLOGY, V3, P643, DOI [https://doi.org/10.4236/psych.2012.39099, DOI 10.4236/PSYCH.2012.39099]; Layne CM, 2010, CHILD DEV, V81, P1053, DOI 10.1111/j.1467-8624.2010.01454.x; Miller KE, 2010, SOC SCI MED, V70, P7, DOI 10.1016/j.socscimed.2009.09.029; MOLLICA RF, 1992, J NERV MENT DIS, V180, P111, DOI 10.1097/00005053-199202000-00008; Molnar BE, 2001, AM J PUBLIC HEALTH, V91, P753, DOI 10.2105/AJPH.91.5.753; Netland M, 2001, J TRAUMA STRESS, V14, P311, DOI 10.1023/A:1011164901867; Neuner F, 2002, BEHAV COGN PSYCHOTH, V30, P205, DOI 10.1017/S1352465802002072; NORRIS FH, 1992, J CONSULT CLIN PSYCH, V60, P409, DOI 10.1037/0022-006X.60.3.409; Panter-Brick C, 2011, J AM ACAD CHILD PSY, V50, P349, DOI 10.1016/j.jaac.2010.12.001; Porter M, 2005, JAMA-J AM MED ASSOC, V294, P602, DOI 10.1001/jama.294.5.602; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; Rees S, 2011, JAMA-J AM MED ASSOC, V306, P513, DOI 10.1001/jama.2011.1098; Stark L, 2010, J EPIDEMIOL COMMUN H, V64, P1056, DOI 10.1136/jech.2009.093799; Stark L, 2011, TRAUMA VIOLENCE ABUS, V12, P127, DOI 10.1177/1524838011404252; Steel Z, 2009, JAMA-J AM MED ASSOC, V302, P537, DOI 10.1001/jama.2009.1132; Tang SS, 2001, J NERV MENT DIS, V189, P507, DOI 10.1097/00005053-200108000-00003; Trevillion K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051740; Usta J, 2008, J WOMENS HEALTH, V17, P793, DOI 10.1089/jwh.2007.0602; Van Dijk Janie A., 2003, American Journal of Psychotherapy, V57, P361; Vinck P, 2012, SOC SCI MED; Vinck P, 2007, JAMA-J AM MED ASSOC, V298, P543, DOI 10.1001/jama.298.5.543; Vinck P, 2013, SOC SCI MED, V77, P41, DOI 10.1016/j.socscimed.2012.10.026; Woods SJ, 2005, J INTERPERS VIOLENCE, V20, P394, DOI 10.1177/0886260504267882; World Health Organization, 2001, WHOFCHGWH011	44	25	25	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96300	10.1371/journal.pone.0096300	http://dx.doi.org/10.1371/journal.pone.0096300			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AH8EY	24823492	gold, Green Published, Green Accepted			2022-12-27	WOS:000336369200014
J	Zhou, C; Ren, Y; Li, J; Wang, K; He, JJ; Chen, WK; Liu, PJ				Zhou, Can; Ren, Yu; Li, Juan; Wang, Ke; He, Jianjun; Chen, Wuke; Liu, Peijun			Association between Irrigation Fluids, Washout Volumes and Risk of Local Recurrence of Anterior Resection for Rectal Cancer: A Meta-Analysis of 427 Cases and 492 Controls	PLOS ONE			English	Article							IMPLANTATION METASTASIS; MESORECTAL EXCISION; SYSTEMATIC REVIEWS; CELLS; SURVIVAL; SURGERY; PERFORATION; VALIDATION; MANAGEMENT; CARCINOMA	Background: Rectal washout can prevent local recurrence after anterior resection of rectal cancer. Few studies have focused particularly on the association between irrigation fluids volume or agents and the risk of local recurrence after anterior resection of rectal cancer. Objective: To estimate the association between irrigation fluids types, volumes of rectal washout and risk of local recurrence after anterior resection for cancer. Data Sources: Relevant studies were identified by a search of Medline, Embase, Wiley Online Library, China National Knowledge Infrastructure, Cochrane Oral Health Group Specialized Register, Wanfang databases and Google Website from their inception until October 18,2013. Study Selection: Studies reporting the association between rectal washout types and volumes and risk of local recurrence after anterior resection for cancer were included. Interventions: Eligible studies used rectal washout. Control groups were defined as no washout. Study Appraisal and Synthesis Methods: Random-effects model were used to obtain summary estimates of RR and 95% CI, with Stata version 11 and RevMan 5.2.5 softwares used. The quality of report was appraised in reference to the MINORS item. Results: Of the 919 rectal cancer patients in 8 included studies, a total of 61(6.64%) cases of local recurrence were reported, with a pooled RR 0.51 (95% CI = 0.28-0.92, P = 0.03). The RRs 0.37 and 0.39 in normal saline and washout volume (>= 1500 ml normal saline) subgroup, respectively, indicated that rectal washout with normal saline, or >= 1500 ml in volume could significantly reduce local recurrence (LR) rate (95% CI = 0.17-0.79, P = 0.01; 95% CI = 0.18-0.87, P = 0.02) after anterior resection for cancer. Limitation: The included studies were non-randomized observational studies, with diversity of study designs. Conclusion: Rectal washout with normal saline alone can reduce the risk of local recurrence in patients with resectable rectal cancer, and 1.5 liters rectal washout in volume is recommended.	[Zhou, Can; Ren, Yu; Wang, Ke; He, Jianjun; Chen, Wuke] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Surg Oncol, Xian 710049, Shaanxi Provinc, Peoples R China; [Zhou, Can; Li, Juan; Liu, Peijun] Xi An Jiao Tong Univ, Dept Translat Med Ctr, Affiliated Hosp 1, Xian 710049, Shaanxi Provinc, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Liu, PJ (corresponding author), Xi An Jiao Tong Univ, Dept Translat Med Ctr, Affiliated Hosp 1, Xian 710049, Shaanxi Provinc, Peoples R China.	peijun1020@163.com						Agaba EA, 2004, DIS COLON RECTUM, V47, P291, DOI 10.1007/s10350-003-0046-1; Basha G, 1999, BRIT J SURG, V86, P219, DOI 10.1046/j.1365-2168.1999.01011.x; Burton S, 2006, BRIT J CANCER, V94, P351, DOI 10.1038/sj.bjc.6602947; Byrne CM, 2005, DIS COLON RECTUM, V48, P172, DOI 10.1007/s10350-004-0755-0; Constantinides VA, 2008, DIS COLON RECTUM, V51, P1339, DOI 10.1007/s10350-008-9308-2; CULLEN PT, 1989, GUT, V30, pA1470; Das P, 2006, AM J CLIN ONCOL-CANC, V29, P219, DOI 10.1097/01.coc.0000214930.78200.4a; Edwards D P, 2007, Tech Coloproctol, V11, P17, DOI 10.1007/s10151-007-0326-1; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eriksen MT, 2004, BRIT J SURG, V91, P210, DOI 10.1002/bjs.4390; Fukuda I, 1991, Gan To Kagaku Ryoho, V18, P1965; GOLIGHER JC, 1951, BRIT J SURG, V39, P199, DOI 10.1002/bjs.18003915504; HALE JE, 1969, P ROY SOC MED, V62, P713, DOI 10.1177/003591576906200738; Han FH, 2010, INT J COLORECTAL DIS, V25, P873, DOI 10.1007/s00384-010-0908-7; Harrold K, 2013, EUR J CANCER CARE, V22, P169, DOI 10.1111/ecc.12023; Heald RJ, 1998, ARCH SURG-CHICAGO, V133, P894, DOI 10.1001/archsurg.133.8.894; HUBENS G, 1990, EUR SURG RES, V22, P356, DOI 10.1159/000129122; HUBENS G, 1994, ACTA CHIR BELG, P258; Jenner DC, 1998, DIS COLON RECTUM, V41, P1432, DOI 10.1007/BF02237063; Johnson JA, 2010, DIABETES, V59, P1129, DOI 10.2337/db10-0334; Jorgren F, 2010, COLORECTAL DIS, V12, P977, DOI 10.1111/j.1463-1318.2009.01930.x; JUHL G, 1990, WORLD J SURG, V14, P255, DOI 10.1007/BF01664886; Kaiser AM, 2006, COLORECTAL DIS, V8, P696, DOI 10.1111/j.1463-1318.2006.01017.x; Kapiteijn E, 1998, EUR J SURG ONCOL, V24, P528, DOI 10.1016/S0748-7983(98)93500-4; Kawahara H, 1998, NIPPON RINSHO GEKA G, V31, P56; Kodeda K, 2010, BRIT J SURG, V97, P1589, DOI 10.1002/bjs.7182; Krivokapic Z, 2004, Acta Chir Iugosl, V51, P133; Liu SYW, 2007, ASIAN J SURG, V30, P72, DOI 10.1016/S1015-9584(09)60132-9; LONG RTL, 1989, AM J SURG, V157, P194, DOI 10.1016/0002-9610(89)90527-8; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Maeda K, 2004, DIS COLON RECTUM, V47, P1706, DOI 10.1007/s10350-004-0659-z; Makano N, 2004, JUNTENDO IGAKU, V50, P373; Manchikanti L, 2009, PAIN PHYSICIAN, V12, P819; Matsuda A, 2013, ANN SURG ONCOL, V20, P856, DOI 10.1245/s10434-012-2660-4; MCCALL JL, 1995, INT J COLORECTAL DIS, V10, P126, DOI 10.1007/BF00298532; MCGREGOR JR, 1989, BRIT J SURG, V76, P331, DOI 10.1002/bjs.1800760405; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Noto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033411; Pahlman L, 2007, BRIT J SURG, V94, P1285, DOI 10.1002/bjs.5679; Peeters KCMJ, 2007, ANN SURG, V246, P693, DOI 10.1097/01.sla.0000257358.56863.ce; Peng JY, 2013, WORLD J GASTROENTERO, V19, P5227, DOI 10.3748/wjg.v19.i32.5227; Radice E, 2001, DIGEST SURG, V18, P355, DOI 10.1159/000050173; Rondelli F, 2012, COLORECTAL DIS, V14, P1313, DOI 10.1111/j.1463-1318.2011.02903.x; SAEED WR, 1991, ANN ROY COLL SURG, V73, P26; Sayfan J, 2000, DIS COLON RECTUM, V43, P1710, DOI 10.1007/BF02236855; Shinto E, 1996, NIPPON DAICHO KOMONB, V49, P399; SKIPPER D, 1987, BRIT J SURG, V74, P1049, DOI 10.1002/bjs.1800741130; SLANETZ CA, 1984, DIS COLON RECTUM, V27, P792, DOI 10.1007/BF02553942; Slim K, 2003, ANZ J SURG, V73, P712, DOI 10.1046/j.1445-2197.2003.02748.x; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Terzi C, 2006, WORLD J SURG, V30, P233, DOI 10.1007/s00268-005-0300-x; Tsunoda A, 1997, SURG TODAY, V27, P457, DOI 10.1007/BF02385713; Tsunoda A, 1999, ANTICANCER RES, V19, P1149; TURNER GG, 1948, P ROY SOC MED, V41, P813; UMPLEBY HC, 1984, BRIT J SURG, V71, P659, DOI 10.1002/bjs.1800710902; Wibe A, 2006, COLORECTAL DIS, V8, P224, DOI 10.1111/j.1463-1318.2005.00924.x; Zhang XM, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0386-6; ZIRNGIBL H, 1990, DIS COLON RECTUM, V33, P610, DOI 10.1007/BF02052218	58	13	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e95699	10.1371/journal.pone.0095699	http://dx.doi.org/10.1371/journal.pone.0095699			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824812	Green Submitted, gold, Green Published			2022-12-27	WOS:000336369200007
J	Wang, BY; Pfeiffer, MJ; Schwarzer, C; Arauzo-Bravo, MJ; Boiani, M				Wang, Bingyuan; Pfeiffer, Martin J.; Schwarzer, Caroline; Arauzo-Bravo, Marcos J.; Boiani, Michele			DNA Replication Is an Integral Part of the Mouse Oocyte's Reprogramming Machinery	PLOS ONE			English	Article							CELL NUCLEAR TRANSFER; GENE-EXPRESSION; POLYMERASE-ALPHA; SOMATIC-CELLS; EMBRYOS; PLURIPOTENCY; APHIDICOLIN; OCT4; CHROMATIN; FUSION	Many of the structural and mechanistic requirements of oocyte-mediated nuclear reprogramming remain elusive. Previous accounts that transcriptional reprogramming of somatic nuclei in mouse zygotes may be complete in 24-36 hours, far more rapidly than in other reprogramming systems, raise the question of whether the mere exposure to the activated mouse ooplasm is sufficient to enact reprogramming in a nucleus. We therefore prevented DNA replication and cytokinesis, which ensue after nuclear transfer, in order to assess their requirement for transcriptional reprogramming of the key pluripotency genes Oct4 (Pou5f1) and Nanog in cloned mouse embryos. Using transcriptome and allele-specific analysis, we observed that hundreds of mRNAs, but not Oct4 and Nanog, became elevated in nucleus-transplanted oocytes without DNA replication. Progression through the first round of DNA replication was essential but not sufficient for transcriptional reprogramming of Oct4 and Nanog, whereas cytokinesis and thereby cell-cell interactions were dispensable for transcriptional reprogramming. Responses similar to clones also were observed in embryos produced by fertilization in vitro. Our results link the occurrence of reprogramming to a previously unappreciated requirement of oocyte-mediated nuclear reprogramming, namely DNA replication. Nuclear transfer alone affords no immediate transition from a somatic to a pluripotent gene expression pattern unless DNA replication is also in place. This study is therefore a resource to appreciate that the quest for always faster reprogramming methods may collide with a limit that is dictated by the cell cycle.	[Wang, Bingyuan; Pfeiffer, Martin J.; Schwarzer, Caroline; Boiani, Michele] Max Planck Inst Mol Biomed, D-48149 Munster, Germany; [Arauzo-Bravo, Marcos J.] Biodonostia Hlth Res Inst, Grp Computat Biol & Syst Biomed, San Sebastian, Spain; [Arauzo-Bravo, Marcos J.] Ikerbasque, Basque Fdn Sci, Bilbao, Spain	Max Planck Society; Instituto de Investigacion Sanitaria Biodonostia; Basque Foundation for Science	Boiani, M (corresponding author), Max Planck Inst Mol Biomed, D-48149 Munster, Germany.	mboiani@mpi-muenster.mpg.de	Schwarzer, Caroline/I-2435-2013; Pfeiffer, Martin Johannes/A-9332-2011; Marcos, Arauzo-Bravo/A-1706-2011; Boiani, Michele/M-3519-2015	Pfeiffer, Martin Johannes/0000-0001-9264-9218; Marcos, Arauzo-Bravo/0000-0002-3264-464X; Boiani, Michele/0000-0003-2765-2781	Deutsche Forschungsgemeinschaft (DFG) [1356, BO2540/3-2]; Max Planck Society	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Max Planck Society(Max Planck Society)	This study was financially supported by the special priority program (Schwerpunktprogramm) no. 1356 of the Deutsche Forschungsgemeinschaft, http://www.dfg.de (DFG grant BO2540/3-2) and by the Max Planck Society (https://www.mpg.de/). The funder (DFG) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balbach ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035322; BERGER NA, 1979, BIOCHEM BIOPH RES CO, V89, P218, DOI 10.1016/0006-291X(79)90966-5; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002; Bortvin A, 2003, DEVELOPMENT, V130, P1673, DOI 10.1242/dev.00366; Bui HT, 2010, BIOL REPROD, V83, P454, DOI 10.1095/biolreprod.109.083337; Byrne JA, 2003, CURR BIOL, V13, P1206, DOI 10.1016/S0960-9822(03)00462-7; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Choi I, 2010, MOL REPROD DEV, V77, P876, DOI 10.1002/mrd.21230; Choi I, 2010, REPROD FERT DEVELOP, V22, P1000, DOI 10.1071/RD09144; de Vries WN, 2008, COLD SH Q B, V73, P33, DOI 10.1101/sqb.2008.73.016; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Egli D, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1503; Esteves TC, 2011, AGING CELL, V10, P80, DOI 10.1111/j.1474-9726.2010.00644.x; Foshay KM, 2012, MOL CELL, V46, P159, DOI 10.1016/j.molcel.2012.02.013; Frum T, 2013, DEV CELL, V25, P610, DOI 10.1016/j.devcel.2013.05.004; Gurdon JB, 2013, DEVELOPMENT, V140, P2449, DOI 10.1242/dev.097170; Han DW, 2008, STEM CELLS, V26, P445, DOI 10.1634/stemcells.2007-0553; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; IKEGAMI S, 1978, NATURE, V275, P458, DOI 10.1038/275458a0; Iqbal K, 2007, BIOCHEM BIOPH RES CO, V358, P727, DOI 10.1016/j.bbrc.2007.04.155; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; KROKAN H, 1981, NUCLEIC ACIDS RES, V9, P4709, DOI 10.1093/nar/9.18.4709; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; Lorthongpanich C, 2012, DEVELOPMENT, V139, P3722, DOI 10.1242/dev.086454; Miyamoto K, 2011, GENE DEV, V25, P946, DOI 10.1101/gad.615211; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; PETZOLDT U, 1984, CELL DIFFER DEV, V15, P163, DOI 10.1016/0045-6039(84)90069-1; Pfeiffer MJ, 2011, J PROTEOME RES, V10, P2140, DOI 10.1021/pr100706k; Pfeiffer MJ, 2010, INT J DEV BIOL, V54, P1649, DOI 10.1387/ijdb.103197mp; Samake S, 1996, J EXP ZOOL, V274, P111, DOI 10.1002/(SICI)1097-010X(19960201)274:2&lt;111::AID-JEZ4&gt;3.0.CO;2-S; Schwarzer C, 2012, HUM REPROD, V27, P2627, DOI 10.1093/humrep/des223; Sebastiano V, 2005, MOL REPROD DEV, V70, P146, DOI 10.1002/mrd.20144; Solter D, 2002, GENE DEV, V16, P1163, DOI 10.1101/gad.998302; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tsubouchi T, 2013, CELL, V152, P873, DOI 10.1016/j.cell.2013.01.012; Vassena R, 2007, MOL REPROD DEV, V74, P1548, DOI 10.1002/mrd.20723; Wang QT, 2004, DEV CELL, V6, P133, DOI 10.1016/S1534-5807(03)00404-0; Wu GM, 2013, NAT CELL BIOL, V15, P1089, DOI 10.1038/ncb2816; Xu YY, 2013, J BIOL CHEM, V288, P9767, DOI 10.1074/jbc.M112.403881; Yurttas P, 2010, REPRODUCTION, V139, P809, DOI 10.1530/REP-09-0538	41	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97199	10.1371/journal.pone.0097199	http://dx.doi.org/10.1371/journal.pone.0097199			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836291	Green Published, Green Submitted, gold			2022-12-27	WOS:000339614800031
J	Aceto, S; Sica, M; De Paolo, S; D'Argenio, V; Cantiello, P; Salvatore, F; Gaudio, L				Aceto, Serena; Sica, Maria; De Paolo, Sofia; D'Argenio, Valeria; Cantiello, Piergiuseppe; Salvatore, Francesco; Gaudio, Luciano			The Analysis of the Inflorescence miRNome of the Orchid Orchis italica Reveals a DEF-Like MADS-Box Gene as a New miRNA Target	PLOS ONE			English	Article							PI/GLO-LIKE LOCUS; TRANSCRIPTOME ANALYSIS; ARABIDOPSIS; EXPRESSION; MICRORNA; FLOWER; IDENTIFICATION; HOMEOSTASIS; EVOLUTION; MIR168A	Plant microRNAs (miRNAs) are small, regulatory non-coding RNAs involved in a wide range of biological processes, from organ development to response to stimuli. In recent years, an increasing number of studies on model plant species have highlighted the evolutionary conservation of a high number of miRNA families and the existence of taxon-specific ones. However, few studies have examined miRNAs in non-model species such as orchids, which are characterized by highly diversified floral structures and pollination strategies. Therefore, we analysed a small RNA library of inflorescence tissue of the Mediterranean orchid Orchis italica to increase the knowledge on miRNAs in a non-model plant species. The high-throughput sequencing and analysis of a small RNA library of inflorescence of O. italica revealed 23 conserved and 161 putative novel miRNA families. Among the putative miRNA targets, experimental validation demonstrated that a DEF-like MADS-box transcript is cleaved by the homolog of miR5179 of O. italica. The presence of conserved miRNA families in the inflorescence of O. italica indicates that the basic developmental flower regulatory mechanisms mediated by miRNAs are maintained through evolution. Because, according to the "orchid code" theory, DEF-like genes exert a key function in the diversification of tepals and lip, the cleavage-mediated inhibitory activity of miR5179 on a OitaDEF-like transcript suggests that, in orchids, miRNAs play an important role in the diversification of the perianth organs.	[Aceto, Serena; Sica, Maria; De Paolo, Sofia; Gaudio, Luciano] Univ Naples Federico II, Dept Biol, Naples, Italy; [D'Argenio, Valeria; Cantiello, Piergiuseppe; Salvatore, Francesco] CEINGE Biotecnol Avanzate, Naples, Italy; [D'Argenio, Valeria; Salvatore, Francesco] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy	University of Naples Federico II; CEINGE Biotecnologie Avanzate; University of Naples Federico II	Aceto, S (corresponding author), Univ Naples Federico II, Dept Biol, Naples, Italy.	serena.aceto@unina.it	D'Argenio, Valeria/K-9345-2016; Aceto, Serena/E-5350-2010; Gaudio, Luciano/AAF-4322-2020; Salvatore, Francesco/A-1966-2011	D'Argenio, Valeria/0000-0001-9273-3698; Gaudio, Luciano/0000-0002-0172-2190; Aceto, Serena/0000-0003-3906-4872; Salvatore, Francesco/0000-0002-2346-3564	Regione Campania Grant [L.R. N5/2002]	Regione Campania Grant(Regione Campania)	This work was supported by the 2009 Regione Campania Grant L.R. N5/2002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceto S, 2011, CURR GENOMICS, V12, P342, DOI 10.2174/138920211796429754; An FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018937; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Cantone C, 2009, GENE, V434, P9, DOI 10.1016/j.gene.2008.12.015; Cantone C, 2011, GENE, V481, P48, DOI 10.1016/j.gene.2011.04.004; Causier B, 2010, SEMIN CELL DEV BIOL, V21, P73, DOI 10.1016/j.semcdb.2009.10.005; Chen TW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S9; Chen XM, 2005, FEBS LETT, V579, P5923, DOI 10.1016/j.febslet.2005.07.071; Chou ML, 2013, PLANTA, V237, P1425, DOI 10.1007/s00425-013-1850-z; Chuck G, 2009, CURR OPIN PLANT BIOL, V12, P81, DOI 10.1016/j.pbi.2008.09.008; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Debernardi JM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002419; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hirsch J, 2006, PLANT PHYSIOL, V140, P1192, DOI 10.1104/pp.105.073817; Hong RL, 2003, PLANT CELL, V15, P1296, DOI 10.1105/tpc.009548; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Husbands AY, 2009, GENE DEV, V23, P1986, DOI 10.1101/gad.1819909; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jouannet V, 2012, EMBO J, V31, P1704, DOI 10.1038/emboj.2012.20; Kanno A, 2007, THESCIENTIFICWORLDJO, V7, P268, DOI 10.1100/tsw.2007.86; Kaufmann K, 2005, GENE, V347, P183, DOI 10.1016/j.gene.2004.12.014; Khraiwesh B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060774; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krizek BA, 2005, NAT REV GENET, V6, P688, DOI 10.1038/nrg1675; Li W, 2012, PLANT PHYSIOL, V158, P1279, DOI 10.1104/pp.111.188789; Lin CS, 2013, PLANT MOL BIOL, V82, P193, DOI 10.1007/s11103-013-0055-y; Lin YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060337; Liu PP, 2007, PLANT J, V52, P133, DOI 10.1111/j.1365-313X.2007.03218.x; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Luo Y, 2013, DEV BIOL, V380, P133, DOI 10.1016/j.ydbio.2013.05.009; Mallory AC, 2005, PLANT CELL, V17, P1360, DOI 10.1105/tpc.105.031716; Manavella PA, 2013, PLANT PHYSIOL, V161, P805, DOI 10.1104/pp.112.207068; Miyashima S, 2013, PLANT CELL PHYSIOL, V54, P375, DOI 10.1093/pcp/pcs188; Mondragon-Palomino M, 2011, PLANT J, V66, P1008, DOI 10.1111/j.1365-313X.2011.04560.x; Mondragon-Palomino M, 2009, ANN BOT-LONDON, V104, P583, DOI 10.1093/aob/mcn258; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Moxon S, 2008, BIOINFORMATICS, V24, P2252, DOI 10.1093/bioinformatics/btn428; Nag A, 2010, CURR TOP DEV BIOL, V91, P349, DOI 10.1016/S0070-2153(10)91012-0; Pan ZJ, 2011, PLANT CELL PHYSIOL, V52, P1515, DOI 10.1093/pcp/pcr092; Salemme M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077454; Salemme M, 2013, MOL BIOL REP, V40, P3523, DOI 10.1007/s11033-012-2426-x; Salemme M, 2011, DEV GENES EVOL, V221, P241, DOI 10.1007/s00427-011-0372-6; Sedeek KEM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064621; Shi Rui, 2012, Methods Mol Biol, V822, P53, DOI 10.1007/978-1-61779-427-8_4; Stocks MB, 2012, BIOINFORMATICS, V28, P2059, DOI 10.1093/bioinformatics/bts311; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thiebaut F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-290; Vaucheret H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006442; Wu G, 2013, J GENET GENOMICS, V40, P217, DOI 10.1016/j.jgg.2013.04.002; Yang XZ, 2011, BIOINFORMATICS, V27, P2614, DOI 10.1093/bioinformatics/btr430; Zhang JX, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-279; Zhang RX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057233; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047; Zhu J, 2013, PLANT CELL REP	57	21	23	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97839	10.1371/journal.pone.0097839	http://dx.doi.org/10.1371/journal.pone.0097839			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24832004	Green Published, gold, Green Submitted			2022-12-27	WOS:000336789500123
J	Carr, RM; Peralta, G; Yin, XY; Ahima, RS				Carr, Rotonya M.; Peralta, Giselle; Yin, Xiaoyan; Ahima, Rexford S.			Absence of Perilipin 2 Prevents Hepatic Steatosis, Glucose Intolerance and Ceramide Accumulation in Alcohol-Fed Mice	PLOS ONE			English	Article							DIFFERENTIATION-RELATED PROTEIN; CHRONIC ETHANOL-CONSUMPTION; FATTY LIVER; INSULIN-RESISTANCE; LIPID-METABOLISM; TRIGLYCERIDE; TIP47; HOMEOSTASIS; HEPATOSTEATOSIS; PATHOGENESIS	Background: Perilipin 2 (Plin2) is a lipid droplet protein that has roles in both lipid and glucose homeostasis. An increase in Plin2 in liver is associated with the development of steatosis, glucose intolerance, and ceramide accumulation in alcoholic liver disease. We investigated the role of Plin2 on energy balance and glucose and lipid homeostasis in wildtype and Plin2 knockout (Plin2KO) mice chronically fed a Lieber-DeCarli liquid ethanol or control diet for six weeks. Methods: We performed in vivo measurements of energy intake and expenditure; body composition; and glucose tolerance. After sacrifice, liver was dissected for histology and lipid analysis. Results: We found that neither genotype nor diet had a significant effect on final weight, body composition, or energy intake between WT and Plin2KO mice fed alcohol or control diets. Additionally, alcohol feeding did not affect oxygen consumption or carbon dioxide production in Plin2KO mice. We performed glucose tolerance testing and observed that alcohol feeding failed to impair glucose tolerance in Plin2KO mice. Most notably, absence of Plin2 prevented hepatic steatosis and ceramide accumulation in alcohol-fed mice. These changes were related to downregulation of genes involved in lipogenesis and triglyceride synthesis. Conclusions: Plin2KO mice chronically fed alcohol are protected from hepatic steatosis, glucose intolerance, and hepatic ceramide accumulation, suggesting a critical pathogenic role of Plin2 in experimental alcoholic liver disease.	[Carr, Rotonya M.] Univ Penn, Dept Med, Perelman Sch Med, Div Gastroenterol, Philadelphia, PA 19104 USA; [Peralta, Giselle; Yin, Xiaoyan; Ahima, Rexford S.] Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Carr, RM (corresponding author), Univ Penn, Dept Med, Perelman Sch Med, Div Gastroenterol, Philadelphia, PA 19104 USA.	Rotonya.Carr@uphs.upenn.edu	Ahima, Rexford/W-1394-2019		National Institutes of Health Grant (NIH) [K08-AA021424]; NIH/National Institute of Diabetes and Digestive and Kidney Diseases Center for Molecular Studies in Digestive and Liver Diseases [P30-DK050306]; Molecular Pathology and Imaging, Molecular Biology/Gene Expression and Cell Culture Cores; NIH [P01-DK-049210]; Diabetes Research Center Mouse Metabolic Phenotyping Core [P30-DK-19525]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK049210, P30DK019525, P30DK050306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K08AA021424] Funding Source: NIH RePORTER	National Institutes of Health Grant (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Institute of Diabetes and Digestive and Kidney Diseases Center for Molecular Studies in Digestive and Liver Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Molecular Pathology and Imaging, Molecular Biology/Gene Expression and Cell Culture Cores; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Research Center Mouse Metabolic Phenotyping Core; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This project was supported by National Institutes of Health Grant (NIH) grant K08-AA021424; and in part by the NIH/National Institute of Diabetes and Digestive and Kidney Diseases P30 Center for Molecular Studies in Digestive and Liver Diseases (P30-DK050306) and its pilot and feasibility grant award, as well as the Molecular Pathology and Imaging, Molecular Biology/Gene Expression and Cell Culture Cores (to RMC); NIH grant P01-DK-049210 (to RSA), Diabetes Research Center Mouse Metabolic Phenotyping Core (grant P30-DK-19525). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamirano J, 2011, NAT REV GASTRO HEPAT, V8, P491, DOI 10.1038/nrgastro.2011.134; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Brasaemle DL, 2012, J BIOL CHEM, V287, P2273, DOI 10.1074/jbc.R111.309088; Buers I, 2009, ARTERIOSCL THROM VAS, V29, P767, DOI 10.1161/ATVBAHA.108.182675; Bulankina AV, 2009, J CELL BIOL, V185, P641, DOI 10.1083/jcb.200812042; Cahill A, 1999, HEPATOLOGY, V30, P881, DOI 10.1002/hep.510300434; Carr RM, 2013, ALCOHOL CLIN EXP RES, V37, P1091, DOI 10.1111/acer.12075; Carr RM, 2012, AM J PHYSIOL-REG I, V302, pR996, DOI 10.1152/ajpregu.00177.2011; Chang BHJ, 2010, J LIPID RES, V51, P2132, DOI 10.1194/jlr.M004515; Chang BHJ, 2006, MOL CELL BIOL, V26, P1063, DOI 10.1128/MCB.26.3.1063-1076.2006; Chen J, 2012, J CHROMATOGR B, V883, P136, DOI 10.1016/j.jchromb.2011.11.017; Clugston RD, 2011, J LIPID RES, V52, P2021, DOI 10.1194/jlr.M017368; Crunk AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067631; Dalen KT, 2006, J LIPID RES, V47, P931, DOI 10.1194/jlr.M500459-JLR200; de la Monte SM, 2008, J GASTROEN HEPATOL, V23, pE477, DOI 10.1111/j.1440-1746.2008.05339.x; de la Monte SM, 2011, HEPATOL RES, V41, P386, DOI 10.1111/j.1872-034X.2011.00775.x; Deaciuc IV, 2000, ALCOHOL CLIN EXP RES, V24, P1557, DOI 10.1111/j.1530-0277.2000.tb04575.x; Denucci SM, 2010, GASTROENTEROLOGY RES, V2010; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; Grosch S, 2012, PROG LIPID RES, V51, P50, DOI 10.1016/j.plipres.2011.11.001; Gross DA, 2011, P NATL ACAD SCI USA, V108, P19581, DOI 10.1073/pnas.1110817108; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; HOLLEY DC, 1981, METABOLISM, V30, P894, DOI 10.1016/0026-0495(81)90068-8; Imai Y, 2007, GASTROENTEROLOGY, V132, P1947, DOI 10.1053/j.gastro.2007.02.046; Imai Y, 2012, PHYSIOL GENOMICS, V44, P1125, DOI 10.1152/physiolgenomics.00045.2012; Imanishi Y, 2008, J BIOL CHEM, V283, P25091, DOI 10.1074/jbc.M802981200; Ji C, 2006, J HEPATOL, V45, P717, DOI 10.1016/j.jhep.2006.05.009; Karahatay S, 2007, CANCER LETT, V256, P101, DOI 10.1016/j.canlet.2007.06.003; Liangpunsakul S, 2012, AM J PHYSIOL-GASTR L, V302, pG515, DOI 10.1152/ajpgi.00455.2011; Liangpunsakul S, 2010, AM J PHYSIOL-GASTR L, V298, pG1004, DOI 10.1152/ajpgi.00482.2009; LIEBER CS, 1982, ALCOHOL CLIN EXP RES, V6, P523, DOI 10.1111/j.1530-0277.1982.tb05017.x; Listenberger LL, 2007, J LIPID RES, V48, P2751, DOI 10.1194/jlr.M700359-JLR200; Lizarazo D, 2013, J GASTROEN HEPATOL, V28, P1660, DOI 10.1111/jgh.12291; Longato L, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/479348; Magne J, 2013, FASEB J, V27, P3090, DOI 10.1096/fj.13-228759; Mak KM, 2008, ALCOHOL CLIN EXP RES, V32, P683, DOI 10.1111/j.1530-0277.2008.00624.x; Mandrekar P, 2011, HEPATOLOGY, V54, P2185, DOI 10.1002/hep.24599; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; McIntosh AL, 2010, LIPIDS, V45, P465, DOI 10.1007/s11745-010-3424-1; McManaman JL, 2013, J LIPID RES, V54, P1346, DOI 10.1194/jlr.M035063; McVicker BL, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/978136; Miller AM, 2011, ALCOHOL CLIN EXP RES, V35, P787, DOI 10.1111/j.1530-0277.2010.01399.x; Nakajima T, 2004, HEPATOLOGY, V40, P972, DOI 10.1002/hep.20399; National Institute on Alcohol Abuse and Alcoholism (U.S.), 2005, ALCOHOL ALERT; O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258; Orlicky DJ, 2011, ALCOHOL CLIN EXP RES, V35, P1020, DOI 10.1111/j.1530-0277.2011.01434.x; Pastorino JG, 2000, HEPATOLOGY, V31, P1141, DOI 10.1053/he.2000.7013; Ramirez T, 2013, J GASTROEN HEPATOL, V28, P179, DOI 10.1111/j.1440-1746.2012.07256.x; Raynard B, 2002, HEPATOLOGY, V35, P635, DOI 10.1053/jhep.2002.31782; Siskind LJ, 2000, J BIOL CHEM, V275, P38640, DOI 10.1074/jbc.C000587200; Straub BK, 2008, HEPATOLOGY, V47, P1936, DOI 10.1002/hep.22268; Straub BK, 2013, HISTOPATHOLOGY, V62, P617, DOI 10.1111/his.12038; Sztalryd C, 2006, J BIOL CHEM, V281, P34341, DOI 10.1074/jbc.M602497200; TIENGO A, 1981, DIABETES, V30, P705, DOI 10.2337/diabetes.30.9.705; Varela GM, 2008, AM J PHYSIOL-GASTR L, V295, pG621, DOI 10.1152/ajpgi.90204.2008; WANLESS IR, 1990, HEPATOLOGY, V12, P1106, DOI 10.1002/hep.1840120505; WATSON CG, 1987, J CLIN PSYCHOL, V43, P404, DOI 10.1002/1097-4679(198705)43:3<404::AID-JCLP2270430315>3.0.CO;2-4; You M, 2004, GASTROENTEROLOGY, V127, P1798, DOI 10.1053/j.gastro.2004.09.049; Zhao ZW, 2011, ALCOHOL CLIN EXP RES, V35, P229, DOI 10.1111/j.1530-0277.2010.01338.x	60	70	73	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97118	10.1371/journal.pone.0097118	http://dx.doi.org/10.1371/journal.pone.0097118			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831094	gold, Green Published, Green Submitted			2022-12-27	WOS:000336789500036
J	Li, S; Zhang, JM; Lu, SY; Huang, WK; Geng, L; Shen, QC; Zhang, J				Li, Shuai; Zhang, Jingmiao; Lu, Shaoyong; Huang, Wenkang; Geng, Lv; Shen, Qiancheng; Zhang, Jian			The Mechanism of Allosteric Inhibition of Protein Tyrosine Phosphatase 1B	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; PTP1B INHIBITORS; STRUCTURAL BASIS; LOOP DYNAMICS; BINDING; PHOSPHORYLATION; RECOGNITION; RESIDUES; INSIGHTS; KINASE	As the prototypical member of the PTP family, protein tyrosine phosphatase 1B (PTP1B) is an attractive target for therapeutic interventions in type 2 diabetes. The extremely conserved catalytic site of PTP1B renders the design of selective PTP1B inhibitors intractable. Although discovered allosteric inhibitors containing a benzofuran sulfonamide scaffold offer fascinating opportunities to overcome selectivity issues, the allosteric inhibitory mechanism of PTP1B has remained elusive. Here, molecular dynamics (MD) simulations, coupled with a dynamic weighted community analysis, were performed to unveil the potential allosteric signal propagation pathway from the allosteric site to the catalytic site in PTP1B. This result revealed that the allosteric inhibitor compound-3 induces a conformational rearrangement in helix alpha 7, disrupting the triangular interaction among helix alpha 7, helix alpha 3, and loop11. Helix alpha 7 then produces a force, pulling helix alpha 3 outward, and promotes Ser190 to interact with Tyr176. As a result, the deviation of Tyr176 abrogates the hydrophobic interactions with Trp179 and leads to the downward movement of the WPD loop, which forms an H-bond between Asp181 and Glu115. The formation of this H-bond constrains the WPD loop to its open conformation and thus inactivates PTP1B. The discovery of this allosteric mechanism provides an overall view of the regulation of PTP1B, which is an important insight for the design of potent allosteric PTP1B inhibitors.	[Li, Shuai; Zhang, Jingmiao; Lu, Shaoyong; Huang, Wenkang; Geng, Lv; Shen, Qiancheng; Zhang, Jian] Shanghai Jiao Tong Univ, Sch Med SJTU SM, Chinese Minist Educ, Dept Pathophysiol,Key Lab Cell Differentiat & Apo, Shanghai 200030, Peoples R China; [Zhang, Jian] Shanghai Jiao Tong Univ, Sch Med, Med Bioinformat Ctr, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhang, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med SJTU SM, Chinese Minist Educ, Dept Pathophysiol,Key Lab Cell Differentiat & Apo, Shanghai 200030, Peoples R China.	jian.zhang@sjtu.edu.cn	Zhang, Jian/GXA-1303-2022	Zhang, Jian/0000-0002-6558-791X	National Basic Research Program of China (973 Program) [2011CB504001]; National Natural Science Foundation of China [81322046, 21002062, 21102090]; Shanghai Rising-Star Program [13QA1402300]; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Program for New Century Excellent Talents in University [NCET-12-0355]; Ph.D. Programs Foundation of Ministry of Education of China [20120073110070]; National Cancer Institute, National Institutes of Health [HHSN261200800001E]; Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Basic Research Program of China (973 Program) (2011CB504001); National Natural Science Foundation of China (81322046, 21002062, 21102090); Shanghai Rising-Star Program (13QA1402300); Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, the Program for New Century Excellent Talents in University (NCET-12-0355); the Ph.D. Programs Foundation of Ministry of Education of China (20120073110070). This work has also been funded in whole or in part with Federal funds from the National Cancer Institute, National Institutes of Health, under contract number HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. This research was supported (in part) by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala PJ, 2006, J BIOL CHEM, V281, P38013, DOI 10.1074/jbc.M607913200; [Anonymous], 2001, VERS S 6 8; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; BARFORD D, 1995, NAT STRUCT BIOL, V2, P1043, DOI 10.1038/nsb1295-1043; Barr AJ, 2010, FUTURE MED CHEM, V2, P1563, DOI [10.4155/fmc.10.241, 10.4155/FMC.10.241]; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; Baskaran SK, 2012, J CHEM INF MODEL, V52, P2004, DOI 10.1021/ci200581g; Case D.A., 2022, AMBER 2020; Cheng A, 2002, DEV CELL, V2, P497, DOI 10.1016/S1534-5807(02)00149-1; Cui W, 2013, J CHEM INF MODEL, V53, P1157, DOI 10.1021/ci300526u; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Fauman EB, 1996, TRENDS BIOCHEM SCI, V21, P413, DOI 10.1016/S0968-0004(96)10059-1; FLOYD RW, 1962, COMMUN ACM, V5, P345, DOI 10.1145/367766.368168; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Hoff RH, 2000, BIOCHEMISTRY-US, V39, P46, DOI 10.1021/bi991570i; Huang WK, 2013, BIOINFORMATICS, V29, P2357, DOI 10.1093/bioinformatics/btt399; Huang ZM, 2014, NUCLEIC ACIDS RES, V42, pD510, DOI 10.1093/nar/gkt1247; Huang ZM, 2011, NUCLEIC ACIDS RES, V39, pD663, DOI 10.1093/nar/gkq1022; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Ivan R, 2012, P NATL ACAD SCI USA, V22, pE1428; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Juszczak LJ, 1997, BIOCHEMISTRY-US, V36, P2227, DOI 10.1021/bi9622130; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kamerlin SCL, 2006, BIOCHEM BIOPH RES CO, V345, P1161, DOI 10.1016/j.bbrc.2006.04.181; Khajehpour M, 2007, BIOCHEMISTRY-US, V46, P4370, DOI 10.1021/bi602335x; Kumar R, 2010, J CHEM INF MODEL, V50, P1147, DOI 10.1021/ci900484g; Li XB, 2013, J MOL GRAPH MODEL, V40, P30, DOI 10.1016/j.jmgm.2012.12.011; Lohse DL, 1997, BIOCHEMISTRY-US, V36, P4568, DOI 10.1021/bi963094r; Lu SY, 2011, J CHEM INF MODEL, V51, P1025, DOI 10.1021/ci100493j; Lu SY, 2014, MED RES REV, V34, P1242, DOI 10.1002/med.21317; Lu SY, 2012, J CHEM INF MODEL, V52, P2398, DOI 10.1021/ci300172r; Kamerlin SCL, 2007, BIOCHEM BIOPH RES CO, V356, P1011, DOI 10.1016/j.bbrc.2007.03.093; Masterson LR, 2011, P NATL ACAD SCI USA, V108, P6969, DOI 10.1073/pnas.1102701108; Montalibet J, 2006, J BIOL CHEM, V281, P5258, DOI 10.1074/jbc.M511546200; Olmez EO, 2011, J BIOMOL STRUCT DYN, V28, P675, DOI 10.1080/07391102.2011.10508599; Pedersen AK, 2004, BIOCHEM J, V378, P421, DOI 10.1042/BJ20030565; Peters GH, 2000, BIOPHYS J, V78, P2191, DOI 10.1016/S0006-3495(00)76768-3; Peters GH, 1999, BIOPHYS J, V77, P505, DOI 10.1016/S0006-3495(99)76907-9; Picha KM, 2007, J BIOL CHEM, V282, P2911, DOI 10.1074/jbc.M610096200; Puius YA, 1997, P NATL ACAD SCI USA, V94, P13420, DOI 10.1073/pnas.94.25.13420; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salmeen A, 2000, MOL CELL, V6, P1401, DOI 10.1016/S1097-2765(00)00137-4; Sarmiento M, 1998, J BIOL CHEM, V273, P26368, DOI 10.1074/jbc.273.41.26368; Schneider R, 2013, J AM CHEM SOC, V135, P6838, DOI 10.1021/ja4030484; Sethi A, 2009, P NATL ACAD SCI USA, V106, P6620, DOI 10.1073/pnas.0810961106; Stuible M, 2008, CANCER METAST REV, V27, P215, DOI 10.1007/s10555-008-9115-1; Tiganis T, 2013, FEBS J, V280, P445, DOI 10.1111/j.1742-4658.2012.08563.x; Wang F, 2011, J CHEM INF MODEL, V51, P2821, DOI 10.1021/ci200264h; Wang Q, 2012, J MOL GRAPH MODEL, V38, P324, DOI 10.1016/j.jmgm.2012.07.006; Wiesmann C, 2004, NAT STRUCT MOL BIOL, V11, P730, DOI 10.1038/nsmb803; Wu XW, 2003, CHEM PHYS LETT, V381, P512, DOI 10.1016/j.cplett.2003.10.013; Zhang J, 2005, J AM CHEM SOC, V127, P11709, DOI 10.1021/ja051199o; Zhang J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006304; Zhang S, 2007, DRUG DISCOV TODAY, V12, P373, DOI 10.1016/j.drudis.2007.03.011; Zhang ZY, 2003, EXPERT OPIN INV DRUG, V12, P223, DOI 10.1517/eoid.12.2.223.21411; Zhang ZY, 2001, CURR OPIN CHEM BIOL, V5, P416, DOI 10.1016/S1367-5931(00)00223-4	59	12	13	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97668	10.1371/journal.pone.0097668	http://dx.doi.org/10.1371/journal.pone.0097668			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831294	gold, Green Submitted, Green Published			2022-12-27	WOS:000336789500099
J	Omae, Y; Sekimizu, K; Kaito, C				Omae, Yosuke; Sekimizu, Kazuhisa; Kaito, Chikara			Identification of Staphylococcus aureus Colony-Spreading Stimulatory Factors from Mammalian Serum	PLOS ONE			English	Article							APOLIPOPROTEIN-A-I; PULMONARY SURFACTANT; VIRULENCE; LIPOPROTEINS; ACTIVATION; EXPRESSION; ALBUMIN; GENE	Staphylococcus aureus forms giant colonies on soft-agar surfaces, which is called colony-spreading. In the present study, we searched for host factors that influence S. aureus colony-spreading activity. The addition of calf serum, porcine serum, or silkworm hemolymph to soft-agar medium stimulated S. aureus colony-spreading activity. Gel filtration column chromatography of calf serum produced a high molecular weight fraction and a low molecular weight fraction, both of which exhibited colony-spreading stimulatory activity. In the low molecular weight fraction, we identified the stimulatory factor as bovine serum albumin. The stimulatory fraction in the high molecular weight fraction was identified as high-density lipoprotein (HDL) particles. Delipidation of HDL abolished the stimulatory activity of HDL. Phosphatidylcholine, which is the major lipid component in HDL particles, stimulated the colony-spreading activity. Other phosphatidylcholine-containing lipoprotein particles, low-density lipoprotein and very low-density lipoprotein, also showed colony-spreading stimulatory activity. These findings suggest that S. aureus colony-spreading activity is stimulated by albumin and lipoprotein particles in mammalian serum.	[Omae, Yosuke; Sekimizu, Kazuhisa; Kaito, Chikara] Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Bunkyo Ku, Tokyo, Japan	University of Tokyo	Kaito, C (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Bunkyo Ku, Tokyo, Japan.	kaito@mol.f.u-tokyo.ac.jp	Kaito, Chikara/W-1815-2019; Kaito, Chikara/G-1248-2017	Kaito, Chikara/0000-0002-2895-3386; Kaito, Chikara/0000-0002-2895-3386	Genome Pharmaceutical Institute;  [23249009];  [24590519];  [25117507]	Genome Pharmaceutical Institute; ; ; 	This study was supported by Grants-in-Aid for Scientific Research (23249009, 24590519, 25117507). This study was supported in part by the Genome Pharmaceutical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERLOF E, 1991, BIOCHEMISTRY-US, V30, P8986; BRUMLEY GW, 1967, J CLIN INVEST, V46, P863, DOI 10.1172/JCI105586; Fanali G, 2012, MOL ASPECTS MED, V33, P209, DOI 10.1016/j.mam.2011.12.002; Gokara M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008834; Hyka N, 2001, BLOOD, V97, P2381, DOI 10.1182/blood.V97.8.2381; Kaito C, 2007, J BACTERIOL, V189, P2553, DOI 10.1128/JB.01635-06; Kaito C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003269; Kaito C, 2011, MICROB PATHOGENESIS, V51, P142, DOI 10.1016/j.micpath.2011.04.007; Kaito C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001267; Kaito C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003921; Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106; Naimi TS, 2001, CLIN INFECT DIS, V33, P990, DOI 10.1086/322693; Nguyen D, 2013, BIOCHEMISTRY-US, V52, P1963, DOI 10.1021/bi400032y; NOBLE RP, 1968, J LIPID RES, V9, P693; Omae Y, 2012, J BIOL CHEM, V287, P15570, DOI 10.1074/jbc.M112.357848; Piknova B, 2002, CURR OPIN STRUC BIOL, V12, P487, DOI 10.1016/S0959-440X(02)00352-4; Schmidt HHJ, 1997, CLIN CHIM ACTA, V268, P41, DOI 10.1016/S0009-8981(97)00155-1; SKIPSKI VP, 1967, BIOCHEM J, V104, P340, DOI 10.1042/bj1040340; Surewaard BGJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002606; Tsompanidou E, 2013, APPL ENVIRON MICROB, V79, P886, DOI 10.1128/AEM.03157-12; Tsompanidou E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044646; Ueda T, 2011, MICROB PATHOGENESIS, V51, P178, DOI 10.1016/j.micpath.2011.04.003; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656	23	4	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97670	10.1371/journal.pone.0097670	http://dx.doi.org/10.1371/journal.pone.0097670			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831518	gold, Green Submitted, Green Published			2022-12-27	WOS:000336789500100
J	Been, RA; Linden, MA; Hager, CJ; DeCoursin, KJ; Abrahante, JE; Landman, SR; Steinbach, M; Sarver, AL; Largaespada, DA; Starr, TK				Been, Raha A.; Linden, Michael A.; Hager, Courtney J.; DeCoursin, Krista J.; Abrahante, Juan E.; Landman, Sean R.; Steinbach, Michael; Sarver, Aaron L.; Largaespada, David A.; Starr, Timothy K.			Genetic Signature of Histiocytic Sarcoma Revealed by a Sleeping Beauty Transposon Genetic Screen in Mice	PLOS ONE			English	Article							IDENTIFIES GENES; STEM-CELLS; CANCER; LYMPHOMA; MUTAGENESIS; EXPRESSION; MUTATIONS; BACH2; SUSCEPTIBILITY; PROTEIN	Histiocytic sarcoma is a rare, aggressive neoplasm that responds poorly to therapy. Histiocytic sarcoma is thought to arise from macrophage precursor cells via genetic changes that are largely undefined. To improve our understanding of the etiology of histiocytic sarcoma we conducted a forward genetic screen in mice using the Sleeping Beauty transposon as a mutagen to identify genetic drivers of histiocytic sarcoma. Sleeping Beauty mutagenesis was targeted to myeloid lineage cells using the Lysozyme2 promoter. Mice with activated Sleeping Beauty mutagenesis had significantly shortened lifespan and the majority of these mice developed tumors resembling human histiocytic sarcoma. Analysis of transposon insertions identified 27 common insertion sites containing 28 candidate cancer genes. Several of these genes are known drivers of hematological neoplasms, like Raf1, Fli1, and Mitf, while others are well-known cancer genes, including Nf1, Myc, Jak2, and Pten. Importantly, several new potential drivers of histiocytic sarcoma were identified and could serve as targets for therapy for histiocytic sarcoma patients.	[Been, Raha A.; Hager, Courtney J.; DeCoursin, Krista J.; Abrahante, Juan E.; Sarver, Aaron L.; Largaespada, David A.; Starr, Timothy K.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Been, Raha A.] Univ Minnesota, Coll Vet Med, St Paul, MN 55108 USA; [Been, Raha A.] Univ Minnesota, Dept Comparat & Mol Biosci, St Paul, MN 55108 USA; [Abrahante, Juan E.; Starr, Timothy K.] Univ Minnesota, Minneapolis, MN USA; [Linden, Michael A.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Largaespada, David A.; Starr, Timothy K.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; [Landman, Sean R.; Steinbach, Michael] Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Starr, TK (corresponding author), Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA.	star0044@umn.edu	Starr, Tim/AAX-9342-2021	Linden, Michael/0000-0002-7433-1676; Burnett, Courtney/0000-0003-4779-0049; Starr, Timothy/0000-0002-6308-3451; Steinbach, Michael/0000-0002-7309-6395; Abrahante, Juan/0000-0002-9074-4307	NCI [R01 CA113636]; Leukemia and Lymphoma Society [LLS 7019-04]; NIH [T32EB008389, 4R00CA151672-02]; Integrative Training in Neuroimaging; University of Minnesota Interdisciplinary Doctoral Fellowship; Masonic Cancer Center; American Cancer Society [PF-06-282-01-MGO]; Masonic Cancer Center shared resources [NIH P30 CA077598]; NATIONAL CANCER INSTITUTE [R01CA113636, P30CA077598, R00CA151672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB008389] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Integrative Training in Neuroimaging; University of Minnesota Interdisciplinary Doctoral Fellowship; Masonic Cancer Center; American Cancer Society(American Cancer Society); Masonic Cancer Center shared resources; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	RAB and DAL were supported by grants from the NCI (R01 CA113636) and the Leukemia and Lymphoma Society (LLS 7019-04). SL was supported by NIH Grant T32EB008389, Integrative Training in Neuroimaging, and by a University of Minnesota Interdisciplinary Doctoral Fellowship. JEA was supported by an SP3 grant from the Masonic Cancer Center. TKS was supported by a grant from the American Cancer Society (PF-06-282-01-MGO), the NIH (4R00CA151672-02), Masonic Cancer Center shared resources (NIH P30 CA077598) and generous assistance from the Masonic Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS AT, 1981, CANCER RES, V41, P2063; Agrawal R., 1993, SIGMOD Record, V22, P207, DOI 10.1145/170036.170072; AGRAWAL R, 1993, IEEE T KNOWL DATA EN, V5, P914, DOI 10.1109/69.250074; Agrawal R., 1994, P 20 INT C VER LARG, P487; AGRESTI A, 1992, STAT SCI, V7, P131, DOI DOI 10.1214/SS/1177011454; Alonso-Dominguez JM, 2012, CASE REP HEMATOL, V2012, DOI 10.1155/2012/428279; ARAI E, 1993, J CUTAN PATHOL, V20, P115, DOI 10.1111/j.1600-0560.1993.tb00226.x; Berger M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056408; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Bie L, 2012, CLIN NEUROL NEUROSUR, V114, P356, DOI 10.1016/j.clineuro.2011.11.005; Carpenter B, 2004, MOL CELL BIOL, V24, P537, DOI 10.1128/MCB.24.2.537-549.2004; Carrasco DR, 2006, CANCER CELL, V9, P379, DOI 10.1016/j.ccr.2006.03.028; Castro ECC, 2010, PEDIATR DEVEL PATHOL, V13, P225, DOI 10.2350/09-03-0622-OA.1; Cherry SR, 2000, MOL CELL BIOL, V20, P7419, DOI 10.1128/MCB.20.20.7419-7426.2000; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Collier LS, 2009, CANCER RES, V69, P8429, DOI 10.1158/0008-5472.CAN-09-1760; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; Copie-Bergman C, 1998, AM J SURG PATHOL, V22, P1386, DOI 10.1097/00000478-199811000-00009; Dupuy AJ, 2009, CANCER RES, V69, P8150, DOI 10.1158/0008-5472.CAN-09-1135; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Eischen CM, 2002, CANCER RES, V62, P2184; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Faust N, 2000, BLOOD, V96, P719; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hao X, 2010, VET PATHOL, V47, P434, DOI 10.1177/0300985810363705; Haq R, 2011, J CLIN ONCOL, V29, P3474, DOI 10.1200/JCO.2010.32.6223; Hedan B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-201; Hornick JL, 2004, AM J SURG PATHOL, V28, P1133, DOI 10.1097/01.pas.0000131541.95394.23; Huang CX, 2014, BLOOD, V123, P1012, DOI 10.1182/blood-2013-07-518605; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Jones DTW, 2009, ONCOGENE, V28, P2119, DOI 10.1038/onc.2009.73; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Karki S, 2000, J BIOL CHEM, V275, P4834, DOI 10.1074/jbc.275.7.4834; Keng VW, 2009, NAT BIOTECHNOL, V27, P264, DOI 10.1038/nbt.1526; Keng VW, 2012, HEPATOLOGY; Kornblau SM, 2011, BLOOD, V118, P5604, DOI 10.1182/blood-2011-04-348052; Koso H, 2012, P NATL ACAD SCI USA, V109, pE2998, DOI 10.1073/pnas.1215899109; Kumar R, 2011, PEDIATR BLOOD CANCER, V56, P307, DOI 10.1002/pbc.22810; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lund AH, 2002, NAT GENET, V32, P160, DOI 10.1038/ng956; Mann KM, 2012, P NATL ACAD SCI USA, V109, P5934, DOI 10.1073/pnas.1202490109; March HN, 2011, NATURE GENETICS; Martin-Caballero J, 2001, CANCER RES, V61, P6234; Mashima R, 2010, LAB INVEST; Matallanas David, 2011, Genes Cancer, V2, P232, DOI 10.1177/1947601911407323; McGrail M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018826; Mori M, 2010, INT J HEMATOL, V92, P168, DOI 10.1007/s12185-010-0603-z; Muto A, 2002, J BIOL CHEM, V277, P20724, DOI 10.1074/jbc.M112003200; O'Donnell KA, 2012, P NATL ACAD SCI US; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; Pasquier N, 1999, LECT NOTES COMPUT SC, V1540, P398; Paulo P, 2012, GENE CHROMOSOME CANC, V51, P240, DOI 10.1002/gcc.20948; Pileri SA, 2002, HISTOPATHOLOGY, V41, P1, DOI 10.1046/j.1365-2559.2002.01418.x; Quintana RM, 2012, J INVESTIGATIVE DERM; Riggi N, 2007, CANCER LETT, V254, P1, DOI 10.1016/j.canlet.2006.12.009; Sakane-Ishikawa E, 2005, J CLIN ONCOL, V23, P8012, DOI 10.1200/JCO.2005.02.1626; Sarver AL, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-154; Shearin AL, 2012, CANCER EPIDEM BIOMAR, V21, P1019, DOI 10.1158/1055-9965.EPI-12-0190-T; Starr TK, 2011, P NATL ACAD SCI USA, V108, P5765, DOI 10.1073/pnas.1018012108; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swerdlow SH, 2008, WHO CLASSIFICATION T, V15, P439; TCGARN, 2013, NEW ENGLAND J MED; Vieira SAD, 2001, GENE CHROMOSOME CANC, V32, P353, DOI 10.1002/gcc.1200; Vos JA, 2005, MODERN PATHOL, V18, P693, DOI 10.1038/modpathol.3800346; Wang ED, 2010, LEUKEMIA LYMPHOMA, V51, P802, DOI 10.3109/10428191003699845; Ward JM, 2004, TOXICOL PATHOL, V32, P710, DOI 10.1080/01926230490885706; West S, 2008, NUCLEIC ACIDS RES, V36, P905, DOI 10.1093/nar/gkm1112; Xu Jianming, 2002, Rev Endocr Metab Disord, V3, P185, DOI 10.1023/A:1020016208071; Yang J, 2010, CANCER BIOL THER, V9, P967, DOI 10.4161/cbt.9.12.11635; Yoshimura S, 2010, J CELL BIOL, V191, P367, DOI 10.1083/jcb.201008051; Yu XD, 2002, J NATL CANCER I, V94, P504; Zaki M. J., 1998, 3 ACM SIGMOD WORKSH, P71; Zebisch A, 2006, CANCER RES, V66, P3401, DOI 10.1158/0008-5472.CAN-05-0115	78	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97280	10.1371/journal.pone.0097280	http://dx.doi.org/10.1371/journal.pone.0097280			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827933	Green Published, Green Submitted, gold			2022-12-27	WOS:000336857400073
J	Kouba, M; Bartos, L; Zarybnicka, M				Kouba, Marek; Bartos, Ludek; Zarybnicka, Marketa			Perching of Tengmalm's Owl (Aegolius funereus) Nestlings at the Nest Box Entrance: Effect of Time of the Day, Age, Wing Length and Body Weight	PLOS ONE			English	Article							SIBLING COMPETITION; REPRODUCTIVE SUCCESS; BEGGING BEHAVIOR; SEX-DIFFERENCES; FOOD ABUNDANCE; BOREAL OWLS; TYTO-ALBA; BUDGERIGARS; MOUNTAINS; VIGILANCE	The behaviour of the nestlings of nocturnal cavity-nesting species has relatively rarely been studied in detail because of problems connected with use of the technical devices required to provide long-term monitoring of individuals. However, long-term observation of nestling behaviour is crucial in order to identify different types of behaviour which may be caused by sibling competition at the end of nesting period. We studied behaviour of 43 Tengmalm's owl (Aegolius funereus) nestlings at 14 nests using a camera and a chip system. The nestlings perched at the nest box entrance from an average age of 28 days from hatching (range 24-34 days) until fledging, spending around 2 hours per day here in total, in periods ranging from a few seconds to 147 min (7.6 +/- 10.9 min, mean +/- SD). We found that individual duration of perching at the nest box entrance was significantly influenced by nestlings' age and wing length and that the duration of perching at the nest box entrance significantly decreased with time of night. However, during daylight hours, time of day had no effect on either probability or duration of nestlings' perching. We suggest daylight perching at the nest box entrance results from nestlings' preparation for fledging, while individuals perching here during the night may gain an advantageous position for obtaining food from the parents; another possibility at all times of day is that nestlings can reaffirm their social dominance status by monopolizing the nest box entrance.	[Kouba, Marek; Zarybnicka, Marketa] Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Suchdol, Czech Republic; [Bartos, Ludek] Czech Univ Life Sci Prague, Dept Anim Sci & Ethol, Fac Agrobiol Food & Nat Resources, Suchdol, Czech Republic; [Bartos, Ludek] Inst Anim Sci, Dept Ethol, Prague, Czech Republic	Czech University of Life Sciences Prague; Czech University of Life Sciences Prague; Czech Research Institute of Animal Science	Kouba, M (corresponding author), Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Suchdol, Czech Republic.	marekkouba8@gmail.com	Kouba, Marek/A-1350-2019; ZÃrybnickÃ, MarkÃ©ta/AAM-3181-2020	Kouba, Marek/0000-0003-2262-5733; Zarybnicka, Marketa/0000-0001-5883-0988	Czech University of Life Sciences Prague (CIGA) [20104205, 20144203]; Ministry of Education, Youth and Sports of the Czech Republic [MSMT 1321/213205]; Ministry of Agriculture of the Czech Republic [MZERO 0714]	Czech University of Life Sciences Prague (CIGA); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic)	This study was supported by the Czech University of Life Sciences Prague (CIGA Grant No. 20104205 and 20144203), the Ministry of Education, Youth and Sports of the Czech Republic (MSMT 1321/213205), and Ministry of Agriculture of the Czech Republic (MZERO 0714). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEZOUSKA V, 2005, ITCE 2005 C, P173; Ctyroky P, 1971, SYLVIA, V19, P83; Drdakova Marketa, 2003, Sylvia, V39, P35; Drdakova-Zarybnicka M., 2005, BUTEO, V14, P37; Dreiss AN, 2014, J EVOLUTION BIOL, V27, P63, DOI 10.1111/jeb.12277; Dreiss A, 2010, ANIM BEHAV, V80, P1049, DOI 10.1016/j.anbehav.2010.09.012; Dreiss AN, 2013, J AVIAN BIOL, V44, P359, DOI 10.1111/j.1600-048X.2013.00066.x; Dreiss AN, 2013, BEHAV ECOL, V24, P717, DOI 10.1093/beheco/ars210; Eldegard K, 2012, J ORNITHOL, V153, P385, DOI 10.1007/s10336-011-0753-7; Eldegard K, 2010, BEHAV ECOL SOCIOBIOL, V64, P815, DOI 10.1007/s00265-009-0898-z; GLUTZ BUN, 1980, HDB VOGEL MITTELEURO, V9; GOTTLANDER K, 1987, ORNIS SCAND, V18, P269, DOI 10.2307/3676895; HAYWARD GD, 1993, WILDLIFE MONOGR, P1; Hofstetter SH, 1998, WILSON BULL, V110, P86; KACELNIK A, 1995, P ROY SOC B-BIOL SCI, V259, P259, DOI 10.1098/rspb.1995.0038; KILNER R, 1995, P ROY SOC B-BIOL SCI, V260, P343, DOI 10.1098/rspb.1995.0102; Kilner RM, 2002, BEHAV ECOL SOCIOBIOL, V52, P400, DOI 10.1007/s00265-002-0533-8; Klaus S., 1975, Zoologische Jb (Syst), V102, P485; Kloubec B., 1990, TICHODROMA, V3, P103; Konig C, 2008, OWLS WORLD; KORPIMAKI E, 1991, OECOLOGIA, V85, P543, DOI 10.1007/BF00323767; KORPIMAKI E, 1984, Ornis Fennica, V61, P80; KORPIMAKI E, 1992, J ANIM ECOL, V61, P103, DOI 10.2307/5513; Korpimaki E, 1981, BIOL, V13, P1; Kouba M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095594; Kouba M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067034; Kouba Marek, 2012, Sylvia, V48, P115; Lopez BC, 2010, J RAPTOR RES, V44, P40, DOI 10.3356/JRR-09-32.1; MCRAE SB, 1993, BEHAV ECOL SOCIOBIOL, V33, P101; Mock D. W., 1997, EVOLUTION SIBLING RI; Ostreiher R, 2001, BEHAV ECOL SOCIOBIOL, V49, P340, DOI 10.1007/s002650000308; Pedersen D, 2013, ORNIS FENNICA, V90, P117; Penteriani V, 2005, IBIS, V147, P155, DOI 10.1111/j.1474-919x.2004.00381.x; Pokorny J., 2000, Buteo, V11, P107; Pykal Jiri, 1994, P537; RICKLEFS RE, 1966, WILSON BULL, V78, P47; Roulin A, 2000, P ROY SOC B-BIOL SCI, V267, P459, DOI 10.1098/rspb.2000.1022; Roulin A, 2001, BEHAV ECOL, V12, P506, DOI 10.1093/beheco/12.4.506; Roulin A, 2007, ANIM BEHAV, V74, P1099, DOI 10.1016/j.anbehav.2007.01.027; Roulin A, 2009, ANIM BEHAV, V77, P717, DOI 10.1016/j.anbehav.2008.12.004; RYDEN O, 1980, Z TIERPSYCHOL, V53, P209; SMITH HG, 1991, BEHAV ECOL SOCIOBIOL, V29, P307, DOI 10.1007/BF00163989; STAMPS J, 1989, ETHOLOGY, V81, P177; STAMPS J, 1985, BEHAVIOUR, V94, P1, DOI 10.1163/156853985X00253; Stein MF, 1986, THESIS U MICHIGAN MI; Tanner M, 2007, ANIM BEHAV, V74, P977, DOI 10.1016/j.anbehav.2006.11.034; Tao J., 2002, MIXED MODEL ANAL USI; TEATHER KL, 1992, BEHAV ECOL SOCIOBIOL, V31, P81, DOI 10.1007/BF00166340; Vacik R, 1991, SYLVIA, V28, P95; Welsch R, 1980, REGRESSION DIAGNOSTI; WRIGHT J, 1989, BEHAV ECOL SOCIOBIOL, V25, P171, DOI 10.1007/BF00302916; Wuntke B, 2003, J ORNITHOL, V144, P81, DOI 10.1007/BF02465519; Zarybnicka M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036932; Zarybnicka Marketa, 2008, Sylvia, V44, P51; Zarybnicka M, 2009, ACTA ORNITHOL, V44, P81, DOI 10.3161/000164509X464911; Zarybnicka M, 2009, FOLIA ZOOL, V58, P104; Zarybnicka M, 2009, J ORNITHOL, V150, P231, DOI 10.1007/s10336-008-0342-6	57	5	5	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97504	10.1371/journal.pone.0097504	http://dx.doi.org/10.1371/journal.pone.0097504			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828567	gold, Green Published, Green Submitted			2022-12-27	WOS:000336857400103
J	Liu, XB; Ma, L; Zhang, AH; Zhang, YH; Jiang, J; Ma, W; Zhang, LM; Ren, WC; Kong, XJ				Liu, Xiu-Bo; Ma, Ling; Zhang, Ai-Hua; Zhang, Yan-He; Jiang, Jing; Ma, Wei; Zhang, Lei-Ming; Ren, Wei-Chao; Kong, Xiang-Jun			High-Throughput Analysis and Characterization of Astragalus membranaceus Transcriptome Using 454 GS FLX	PLOS ONE			English	Article							RESPONSES; CHINA	Astragalus membranaceus (Fisch.) Bge (AR), one of the most important medicinal plants in Asia, was found to exhibit various bioactivities. Due to limited genomic and transcriptomic data, the biosynthetic pathway of the major bioactive compound in AR, is currently unclear. In this study, 454 GS FLX technology was employed to produce a substantial expressed sequence tag (EST) dataset from the AR. In all, 742721 high-quality reads from the AR were produced using Roche GS FLX Titanium. A total of 9893 unique sequences were obtained and annotated by a similarity search against the public databases, and involved in the secondary metabolic pathway, which would facilitate deciphering the molecular mechanism of secondary metabolism in AR. The assembled sequences were annotated with gene names and Gene Ontology (GO) terms. GO revealed the unique sequences that could be assigned to 34 vocabularies. In the KEGG mapping, unique sequences were established as associated with 46 biochemical pathways. These results provided the largest EST collections in AR and will contribute to biosynthetic and biochemical studies that lead to drug improvement. With respect to the genes related to metabolism and biosynthesis pathway were also found. Our work demonstrated the utility of 454 GS FLX as a method for the rapid and cost-effective identification of AR transcriptome, and this EST dataset will be a powerful resource for further studies such as taxonomy, molecular breeding, and secondary metabolism in AR.	[Liu, Xiu-Bo; Zhang, Ai-Hua; Zhang, Yan-He; Ma, Wei; Zhang, Lei-Ming; Ren, Wei-Chao] Heilongjiang Univ Chinese Med, Harbin, Peoples R China; [Liu, Xiu-Bo; Jiang, Jing; Ma, Wei] Northeast Forestry Univ, Minist Educ, Key Lab Forest Tree Genet Improvement & Biotechno, Harbin, Peoples R China; [Ma, Ling] Northeast Forestry Univ, Harbin, Peoples R China; [Kong, Xiang-Jun] Qiqihar Med Univ, Affiliated Hosp 1, Qiqihar, Peoples R China	Heilongjiang University of Chinese Medicine; Northeast Forestry University - China; Northeast Forestry University - China; Qiqihar Medical University	Ma, W (corresponding author), Heilongjiang Univ Chinese Med, Harbin, Peoples R China.	88788891@qq.com	ma, wei/GVU-3235-2022		Key Program of Natural Science Foundation of State [81274010]; Heilongjiang province outstanding youth fund [JC201101]	Key Program of Natural Science Foundation of State(National Natural Science Foundation of China (NSFC)); Heilongjiang province outstanding youth fund	This work was supported by grants from the Key Program of Natural Science Foundation of State (Grant No. 81274010) and Heilongjiang province outstanding youth fund (Grant No. JC201101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bezier A, 2009, SCIENCE, V323, P926, DOI 10.1126/science.1166788; Chen W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045541; Cuzick J, 2012, BRIT J CANCER, V106, P1095, DOI 10.1038/bjc.2012.39; Du HW, 2014, J CHROMATOGR SCI, V52, P226, DOI 10.1093/chromsci/bmt016; Du XG, 2012, INT IMMUNOPHARMACOL, V14, P463, DOI 10.1016/j.intimp.2012.09.006; Gad HA, 2013, PHYTOCHEM ANALYSIS, V24, P1, DOI 10.1002/pca.2378; He L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062922; Hong MJ, 2013, J PHARM PHARMACOL, V65, P142, DOI 10.1111/j.2042-7158.2012.01570.x; Kang SC, 2013, BIOL TRACE ELEM RES, V151, P68, DOI 10.1007/s12011-012-9527-1; Lai PKK, 2014, PHYTOTHER RES, V28, P395, DOI 10.1002/ptr.5002; Lee DY, 2013, MOLECULES, V18, P3725, DOI 10.3390/molecules18043725; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Liu J, 2013, ACTA PHARMACOL SIN, V34, P137, DOI 10.1038/aps.2012.133; Liu YM, 2013, PHARMACOGN MAG, V9, P331, DOI 10.4103/0973-1296.117829; Ning J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063741; Okuda S, 2009, NATURE, V458, P357, DOI 10.1038/nature07882; Qin QJ, 2012, INT J MOL SCI, V13, P8379, DOI 10.3390/ijms13078379; Stanton-Geddes J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065688; Sun H, 2012, CHIN J NAT MEDICINES, V10, P196, DOI 10.3724/SP.J.1009.2012.00196; Wei XC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064481; Yang N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061820; Yao MC, 2000, J CHROMATOGR SCI, V38, P325, DOI 10.1093/chromsci/38.8.325; Zulak KG, 2009, MOL CELL PROTEOMICS, V8, P86, DOI 10.1074/mcp.M800211-MCP200	23	12	22	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e95831	10.1371/journal.pone.0095831	http://dx.doi.org/10.1371/journal.pone.0095831			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828103	Green Published, Green Submitted, gold			2022-12-27	WOS:000336857400016
J	Pan, XB; Lu, TT; Wu, F; Jin, LG; Zhang, Y; Shi, LH; Li, XK; Lin, ZF				Pan, Xuebo; Lu, Tingting; Wu, Fan; Jin, Leigang; Zhang, Yi; Shi, Lihua; Li, Xiaokun; Lin, Zhuofeng			Circulating Complement-C1q TNF-Related Protein 1 Levels Are Increased in Patients with Type 2 Diabetes and Are Associated with Insulin Sensitivity in Chinese Subjects	PLOS ONE			English	Article							ADIPOSE-TISSUE; GENDER-DIFFERENCES; GLUCOSE-TOLERANCE; ADIPONECTIN; CTRP1; HOMEOSTASIS; PROGRESSION; EXPRESSION; RESISTANCE; ADIPOKINE	Background: Complement-C1q TNF-related protein 1 (CTRP1), a member of the CTRP superfamily, possesses anti-inflammatory and anti-diabetic effects in mice. However, the clinical relevance of CTRP1 has been seldom explored. The current study aimed to investigate the association of circulating CTRP1 and type 2 diabetes mellitus (T2DM) in a Chinese population. Design and Methods: Serum CTRP1 and adiponectin levels of 96 T2DM patients and 85 healthy subjects were determined by ELISA, and their associations with adiposity, glucose and lipid profiles were studied. In a subgroup of this study, the 75-g oral glucose tolerance test (OGTT) was performed in 20 healthy and 20 T2DM subjects to evaluate the relationship among serum levels of CTRP1 and adiponectin, insulin secretion and insulin sensitivity. Results: Serum CTRP1 levels were significantly increased in patients with T2DM, compared with healthy controls (p<0.001). Similar to adiponectin, serum levels of CTRP1 were significantly correlated to several parameters involved in glucose metabolism and insulin resistance, and independently associated with fasting glucose levels (p<0.05) after BMI and gender adjustments. Furthermore, CTRP1 levels were positively correlated to insulin secretion, while negatively to insulin sensitivity, as measured by OGTT. Conclusion: CTRP1 is a novel adipokine associated with T2DM in humans. The paradoxical increase of serum CTRP1 levels in T2DM subjects may be due to a compensatory response to the adverse glucose and lipid metabolism, which warrants further investigation.	[Pan, Xuebo; Lu, Tingting; Jin, Leigang; Zhang, Yi; Shi, Lihua; Li, Xiaokun; Lin, Zhuofeng] Wenzhou Med Univ, Sch Pharm, Wenzhou, Peoples R China; [Wu, Fan; Li, Xiaokun] Jilin Agr Univ, Engn Res Ctr Bioreactor & Pharmaceut Dev, Changchun, Peoples R China	Wenzhou Medical University; Jilin Agricultural University	Lin, ZF (corresponding author), Wenzhou Med Univ, Sch Pharm, Wenzhou, Peoples R China.	zhuofenglin@wzmc.edu.cn		Leigang, Jin/0000-0002-6916-4009	Key Project in New drug discovery of MOST, China [2011ZX0 9102-004-03]; Natural Science Project of Zhejiang Province [Y2110339]; Scientific Technological Projects of Wenzhou [H20100026, Y20090016]	Key Project in New drug discovery of MOST, China; Natural Science Project of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Scientific Technological Projects of Wenzhou	The work has been supported Key Project in New drug discovery of MOST, China (grant No. 2011ZX0 9102-004-03); Natural Science Project of Zhejiang Province (Grant No: Y2110339) and Scientific Technological Projects of Wenzhou (H20100026 and Y20090016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Bottner A, 2004, J CLIN ENDOCR METAB, V89, P4053, DOI 10.1210/jc.2004-0303; CEDERHOLM J, 1990, DIABETES RES CLIN PR, V10, P167, DOI 10.1016/0168-8227(90)90040-Z; Chalupova L, 2013, CLIN BIOCHEM, V46, P73, DOI 10.1016/j.clinbiochem.2012.09.006; Fernandez-Real JM, 2004, DIABETES CARE, V27, P739, DOI 10.2337/diacare.27.3.739; Hotta K, 2001, DIABETES, V50, P1126, DOI 10.2337/diabetes.50.5.1126; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Hwang YC, 2014, INT J OBESITY, V38, P1207, DOI 10.1038/ijo.2013.242; Jeon JH, 2008, FASEB J, V22, P1502, DOI 10.1096/fj.07-9412com; Kim KY, 2006, FEBS LETT, V580, P3953, DOI 10.1016/j.febslet.2006.06.034; Kishore U, 2004, TRENDS IMMUNOL, V25, P551, DOI 10.1016/j.it.2004.08.006; Li HT, 2009, J CLIN ENDOCR METAB, V94, P2151, DOI 10.1210/jc.2008-2331; Li YJ, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/981896; Lin ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015534; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Ouchi N, 2000, CIRCULATION, V102, P1296, DOI 10.1161/01.CIR.102.11.1296; Peterson JM, 2013, AM J PHYSIOL-REG I, V305, pR522, DOI 10.1152/ajpregu.00110.2013; Peterson JM, 2012, J BIOL CHEM, V287, P1576, DOI 10.1074/jbc.M111.278333; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; Saltevo J, 2009, GENDER MED, V6, P463, DOI 10.1016/j.genm.2009.09.006; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Seldin MM, 2012, J BIOL CHEM, V287, P11968, DOI 10.1074/jbc.M111.336834; Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6; Tschritter O, 2003, DIABETES, V52, P239, DOI 10.2337/diabetes.52.2.239; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Woo YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036868; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yoo HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055744	30	34	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e94478	10.1371/journal.pone.0094478	http://dx.doi.org/10.1371/journal.pone.0094478			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827430	gold, Green Published, Green Submitted			2022-12-27	WOS:000336857400009
J	Carpenter, RE; Maruska, KP; Becker, L; Fernald, RD				Carpenter, Russ E.; Maruska, Karen P.; Becker, Lisa; Fernald, Russell D.			Social Opportunity Rapidly Regulates Expression of CRF and CRF Receptors in the Brain during Social Ascent of a Teleost Fish, Astatotilapia burtoni	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; AFRICAN CICHLID FISH; DORSAL RAPHE NUCLEUS; BASS DICENTRARCHUS-LABRAX; PITUITARY-GONADAL AXIS; MEDIAL PREOPTIC AREA; MESSENGER-RNA LEVELS; SEROTONERGIC NEURONS; HAPLOCHROMIS-BURTONI; FEMALE RAT	In social animals, hierarchical rank governs food availability, territorial rights and breeding access. Rank order can change rapidly and typically depends on dynamic aggressive interactions. Since the neuromodulator corticotrophin releasing factor (CRF) integrates internal and external cues to regulate the hypothalamic-pituitary adrenal (HPA) axis, we analyzed the CRF system during social encounters related to status. We used a particularly suitable animal model, African cichlid fish, Astatotilapia burtoni, whose social status regulates reproduction. When presented with an opportunity to rise in rank, subordinate A. burtoni males rapidly change coloration, behavior, and their physiology to support a new role as dominant, reproductively active fish. Although changes in gonadotropin-releasing hormone (GnRH1), the key reproductive molecular actor, have been analyzed during social ascent, little is known about the roles of CRF and the HPA axis during transitions. Experimentally enabling males to ascend in social rank, we measured changes in plasma cortisol and the CRF system in specific brain regions 15 minutes after onset of social ascent. Plasma cortisol levels in ascending fish were lower than subordinate conspecifics, but similar to levels in dominant animals. In the preoptic area (POA), where GnRH1 cells are located, and in the pituitary gland, CRF and CRF1 receptor mRNA levels are rapidly down regulated in ascending males compared to subordinates. In the Vc/Vl, a forebrain region where CRF cell bodies are located, mRNA coding for both CRFR1 and CRFR2 receptors is lower in ascending fish compared to stable subordinate conspecifics. The rapid time course of these changes (within minutes) suggests that the CRF system is involved in the physiological changes associated with shifts in social status. Since CRF typically has inhibitory effects on the neuroendocrine reproductive axis in vertebrates, this attenuation of CRF activity may allow rapid activation of the reproductive axis and facilitate the transition to dominance.	[Carpenter, Russ E.; Maruska, Karen P.; Becker, Lisa; Fernald, Russell D.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University	Carpenter, RE (corresponding author), Program Writing & Rhetor, Stanford, CA 94305 USA.	russ1@stanford.edu			National Institutes of Health (NIH) [F32HD063234, F32NS061431, NS034950]; National Science Foundation (NSF) [IOS-0923588]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD063234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034950, R37NS034950, F32NS061431, R56NS034950] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by National Institutes of Health (NIH) Grants F32HD063234 (REC), F32NS061431 (KPM), NS034950 (RDF), and National Science Foundation (NSF) IOS-0923588 (RDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au TM, 2006, BEHAV BRAIN RES, V170, P342, DOI 10.1016/j.bbr.2006.02.027; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; Breen KM, 2008, ENDOCRINOLOGY, V149, P767, DOI 10.1210/en.2007-0773; Burmeister SS, 2007, HORM BEHAV, V51, P164, DOI 10.1016/j.yhbeh.2006.09.008; Burmeister SS, 2009, BRAIN BEHAV EVOLUT, V74, P110, DOI 10.1159/000235613; Burmeister SS, 2005, PLOS BIOL, V3, P1996, DOI 10.1371/journal.pbio.0030363; Bushnik TL, 1995, BRAIN BEHAV EVOLUT, V46, P371, DOI 10.1159/000113287; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Campbell RE, 2007, ENDOCRINOLOGY, V148, P5884, DOI 10.1210/en.2007-0854; Carpenter RE, 2007, HORM BEHAV, V52, P600, DOI 10.1016/j.yhbeh.2007.07.012; Carrasco GA, 2003, EUR J PHARMACOL, V463, P235, DOI 10.1016/S0014-2999(03)01285-8; Cerda-Reverter JM, 2001, J MORPHOL, V247, P217, DOI 10.1002/1097-4687(200103)247:3<217::AID-JMOR1013>3.0.CO;2-U; Chen CC, 2008, GEN COMP ENDOCR, V157, P148, DOI 10.1016/j.ygcen.2008.04.003; Clements S, 2003, HORM BEHAV, V43, P214, DOI 10.1016/S0018-506X(02)00027-2; Clotfelter ED, 2010, FISH PHYSIOL BIOCHEM, V36, P933, DOI 10.1007/s10695-009-9370-2; Cooper MA, 2009, NEUROSCIENCE, V161, P680, DOI 10.1016/j.neuroscience.2009.03.084; Cooper MA, 2007, PSYCHOPHARMACOLOGY, V194, P297, DOI 10.1007/s00213-007-0849-1; Dahlbom SJ, 2012, BEHAV BRAIN RES, V228, P333, DOI 10.1016/j.bbr.2011.12.011; DAVIS MR, 1990, J NEUROBIOL, V21, P1180, DOI 10.1002/neu.480210804; Densmore VS, 2003, J CLIN ENDOCR METAB, V88, P2126, DOI 10.1210/jc.2002-021359; Desjardins JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032781; Dobson H, 2000, ANIM REPROD SCI, V60, P743, DOI 10.1016/S0378-4320(00)00080-4; Doyon C, 2005, J ENDOCRINOL, V186, P123, DOI 10.1677/joe.1.06142; Doyon C, 2003, GEN COMP ENDOCR, V133, P260, DOI 10.1016/S0016-6480(03)00195-3; Dudas B, 2006, J NEUROENDOCRINOL, V18, P79, DOI 10.1111/j.1365-2826.2005.01398.x; Ebling FJP, 2005, REPRODUCTION, V129, P675, DOI 10.1530/rep.1.00367; Ferin M, 2006, STRESS, V62, P2627; FERNALD R D, 1977, Environmental Biology of Fishes, V2, P299, DOI 10.1007/BF00005997; FERNALD RD, 1977, ANIM BEHAV, V25, P964, DOI 10.1016/0003-3472(77)90048-3; FERNALD RD, 1985, J COMP NEUROL, V238, P202, DOI 10.1002/cne.902380207; Fernald RD, 2012, P NATL ACAD SCI USA, V109, P17194, DOI 10.1073/pnas.1202552109; Flett P, 1994, ONCORHYNCHUS MYKISS, P399; Fox HE, 1997, J NEUROSCI, V17, P6463; GOLDSMITH PC, 1994, ENDOCRINOLOGY, V134, P858, DOI 10.1210/en.134.2.858; Grone BP, 2012, HORM BEHAV, V62, P18, DOI 10.1016/j.yhbeh.2012.04.012; Hoffman CS, 2002, BRAIN RES, V946, P96, DOI 10.1016/S0006-8993(02)02867-6; Hofmann HA, 1999, P NATL ACAD SCI USA, V96, P14171, DOI 10.1073/pnas.96.24.14171; Hornung JP, 2003, J CHEM NEUROANAT, V26, P331, DOI 10.1016/j.jchemneu.2003.10.002; Jasoni CL, 2005, NEUROENDOCRINOLOGY, V82, P320, DOI 10.1159/000093155; Li XF, 2011, J NEUROENDOCRINOL, V23, P3, DOI 10.1111/j.1365-2826.2010.02071.x; LIPOSITS Z, 1987, HISTOCHEMISTRY, V86, P541, DOI 10.1007/BF00489545; Lorenzi V, 2009, PHYSIOL BEHAV, V97, P476, DOI 10.1016/j.physbeh.2009.03.026; Lowry CA, 2006, GEN COMP ENDOCR, V146, P19, DOI 10.1016/j.ygcen.2005.12.006; Lowry CA, 2000, J NEUROSCI, V20, P7728; MACLUSKY NJ, 1988, BRAIN RES, V439, P391, DOI 10.1016/0006-8993(88)91501-6; Majzoub JA, 2006, EUR J ENDOCRINOL, V155, pS71, DOI 10.1530/eje.1.02247; MALER L, 1991, J CHEM NEUROANAT, V4, P1, DOI 10.1016/0891-0618(91)90030-G; Maruska KP, 2013, J NEUROENDOCRINOL, V25, P145, DOI 10.1111/j.1365-2826.2012.02382.x; Maruska KP, 2011, PHYSIOLOGY, V26, P412, DOI 10.1152/physiol.00032.2011; Maruska KP, 2011, ENDOCRINOLOGY, V152, P291, DOI 10.1210/en.2010-0876; Maruska KP, 2010, BEHAV BRAIN RES, V213, P208, DOI 10.1016/j.bbr.2010.04.058; Maruska KP, 2010, HORM BEHAV, V58, P230, DOI 10.1016/j.yhbeh.2010.03.011; Maruska KP, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-58; Maruska KP, 2013, INTEGR COMP BIOL, P1; Mitter K, 2009, COMP BIOCHEM PHYS B, V153, P340, DOI 10.1016/j.cbpb.2009.04.009; Munchrath LA, 2010, J COMP NEUROL, V518, P3302, DOI 10.1002/cne.22401; NIKOLARAKIS KE, 1986, BRAIN RES, V377, P388, DOI 10.1016/0006-8993(86)90887-5; Parent AS, 2005, ENDOCRINE, V28, P281, DOI 10.1385/ENDO:28:3:281; Pepels PPLM, 2004, GEN COMP ENDOCR, V139, P251, DOI 10.1016/j.ygcen.2004.09.013; PLANT TM, 1989, P NATL ACAD SCI USA, V86, P2506, DOI 10.1073/pnas.86.7.2506; RIVEST S, 1993, NEUROENDOCRINOLOGY, V57, P236, DOI 10.1159/000126365; RIVIER C, 1991, BIOL REPROD, V45, P523, DOI 10.1095/biolreprod45.4.523; Rodaros D, 2007, NEUROSCIENCE, V150, P8, DOI 10.1016/j.neuroscience.2007.09.043; Rupp B, 1996, ANAT EMBRYOL, V194, P187; SAPOLSKY RM, 1989, ARCH GEN PSYCHIAT, V46, P1047; SAWCHENKO PE, 1983, BRAIN RES, V277, P355, DOI 10.1016/0006-8993(83)90945-9; SAWCHENKO PE, 1985, FED PROC, V44, P221; SIRINATHSINGHJI DJS, 1985, BRAIN RES, V336, P45, DOI 10.1016/0006-8993(85)90414-7; SIRINATHSINGHJI DJS, 1986, BRAIN RES, V375, P49, DOI 10.1016/0006-8993(86)90957-1; Sisk CL, 2004, NAT NEUROSCI, V7, P1040, DOI 10.1038/nn1326; Staub DR, 2006, BRAIN RES, V1070, P77, DOI 10.1016/j.brainres.2005.10.096; SUH BY, 1988, J CLIN ENDOCR METAB, V66, P733, DOI 10.1210/jcem-66-4-733; Summers CH, 2005, PHYSIOL BIOCHEM ZOOL, V78, P679, DOI 10.1086/432139; SUTER DE, 1988, AM J PHYSIOL, V254, pE595, DOI 10.1152/ajpendo.1988.254.5.E595; Teles MC, 2013, BEHAV BRAIN RES, V253, P17, DOI 10.1016/j.bbr.2013.07.012; TRUDEAU VL, 1993, J NEUROENDOCRINOL, V5, P129, DOI 10.1111/j.1365-2826.1993.tb00372.x; VANDENPOL AN, 1993, J BIOL RHYTHM, V8, pS11; Waselus M, 2009, BIOL PSYCHIAT, V66, P76, DOI 10.1016/j.biopsych.2009.02.014; WILLIAMS CL, 1990, NEUROENDOCRINOLOGY, V52, P133, DOI 10.1159/000125563; WINBERG S, 1993, COMP BIOCHEM PHYS C, V106, P597, DOI 10.1016/0742-8413(93)90216-8; Winberg S, 1997, BRAIN BEHAV EVOLUT, V49, P230, DOI 10.1159/000112994; Yamamoto N, 1998, NEUROSCI RES, V31, P31, DOI 10.1016/S0168-0102(98)00022-4; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047; Zhao S, 2010, AM J PHYSIOL-ENDOC M, V298, pE524, DOI 10.1152/ajpendo.00597.2009	84	27	27	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96632	10.1371/journal.pone.0096632	http://dx.doi.org/10.1371/journal.pone.0096632			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824619	gold, Green Submitted, Green Published			2022-12-27	WOS:000336369200026
J	Fontana, JM; Christos, PJ; Michelini, Z; Negri, D; Cara, A; Salvatore, M				Fontana, Judith M.; Christos, Paul J.; Michelini, Zuleika; Negri, Donatella; Cara, Andrea; Salvatore, Mirella			Mucosal Immunization with Integrase-Defective Lentiviral Vectors Protects against Influenza Virus Challenge in Mice	PLOS ONE			English	Article							CYTOTOXIC T-LYMPHOCYTES; A VIRUS; IMMUNE-RESPONSES; GENE-TRANSFER; NUCLEOPROTEIN GENE; IN-VITRO; VACCINE; CELLS; INDUCTION; DELIVERY	Recent reports highlight the potential for integrase-defective lentiviral vectors (IDLV) to be developed as vaccines due to their ability to elicit cell-mediated and humoral immune responses after intramuscular administration. Differently from their integrase-competent counterpart, whose utility for vaccine development is limited by the potential for insertional mutagenesis, IDLV possess a mutation in their integrase gene that prevents genomic integration. Instead, they are maintained as episomal DNA circles that retain the ability to stably express functional proteins. Despite their favorable profile, it is unknown whether IDLV elicit immune responses after intranasal administration, a route that could be advantageous in the case of infection with a respiratory agent. Using influenza as a model, we constructed IDLV expressing the influenza virus nucleoprotein (IDLV-NP), and tested their ability to generate NP-specific immune responses and protect from challenge in vivo. We found that administration of IDLV-NP elicited NP-specific T cell and antibody responses in BALB/c mice. Importantly, IDLV-NP was protective against homologous and heterosubtypic influenza virus challenge only when given by the intranasal route. This is the first report demonstrating that IDLV can induce protective immunity after intranasal administration, and suggests that IDLV may represent a promising vaccine platform against infectious agents.	[Fontana, Judith M.; Christos, Paul J.; Salvatore, Mirella] Cornell Univ, Weill Med Coll, Dept Publ Hlth, New York, NY 10021 USA; [Salvatore, Mirella] Cornell Univ, Weill Med Coll, Dept Med, New York, NY 10021 USA; [Michelini, Zuleika; Cara, Andrea] Ist Super Sanita, Dept Therapeut Res & Med Evaluat, I-00161 Rome, Italy; [Negri, Donatella] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy	Cornell University; Cornell University; Istituto Superiore di Sanita (ISS); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS)	Salvatore, M (corresponding author), Cornell Univ, Weill Med Coll, Dept Publ Hlth, New York, NY 10021 USA.	mis2053@med.cornell.edu	Michelini, Zuleika/J-9003-2016; Cara, Andrea/M-4865-2015; Cara, Andrea/AAA-4238-2021; Negri, Donatella/M-4362-2015; Salvatore, Mirella/K-6691-2016; michelini, zuleika/Q-4383-2019	Michelini, Zuleika/0000-0001-6841-7396; Cara, Andrea/0000-0003-4967-1895; Cara, Andrea/0000-0003-4967-1895; Negri, Donatella/0000-0002-3437-9288; Salvatore, Mirella/0000-0002-8296-0376; michelini, zuleika/0000-0001-6841-7396; Minkoff, Judith/0000-0002-7379-2753	National Institute of Allergy and Infectious Diseases [1R21AI073926-01A2]; Feldstein Medical Foundation; Stony Wold-Herbert Fund Research Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073926] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Feldstein Medical Foundation; Stony Wold-Herbert Fund Research Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institute of Allergy and Infectious Diseases (1R21AI073926-01A2) and from the Feldstein Medical Foundation to M.S. J.M.F. is a recipient of a Stony Wold-Herbert Fund Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apolonia L, 2007, MOL THER, V15, P1947, DOI 10.1038/sj.mt.6300281; Banasik MB, 2010, GENE THER, V17, P150, DOI 10.1038/gt.2009.135; Beignon AS, 2009, J VIROL, V83, P10963, DOI 10.1128/JVI.01284-09; Belyakov IM, 1998, J CLIN INVEST, V102, P2072, DOI 10.1172/JCI5102; Brave A, 2007, MOL PHARMACEUT, V4, P18, DOI 10.1021/mp060098+; Buffa V, 2006, VIRAL IMMUNOL, V19, P690, DOI 10.1089/vim.2006.19.690; Buffa V, 2006, J GEN VIROL, V87, P1625, DOI 10.1099/vir.0.81706-0; Carragher DM, 2008, J IMMUNOL, V181, P4168, DOI 10.4049/jimmunol.181.6.4168; Cmielewski P, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-84; Copreni E, 2010, VIRUSES-BASEL, V2, P1577, DOI 10.3390/v2081577; Coutant F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048644; Deng Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062684; ENGELMAN A, 1995, J VIROL, V69, P2729, DOI 10.1128/JVI.69.5.2729-2736.1995; Epstein SL, 2005, VACCINE, V23, P5404, DOI 10.1016/j.vaccine.2005.04.047; Epstein SL, 1997, J IMMUNOL, V158, P1222; Esslinger C, 2003, J CLIN INVEST, V111, P1673, DOI 10.1172/JCI200317098; FARNET CM, 1991, J VIROL, V65, P6942, DOI 10.1128/JVI.65.12.6942-6952.1991; Gambotto A, 2000, GENE THER, V7, P2036, DOI 10.1038/sj.gt.3301335; Gillirn-Ross L, 2005, J GEN VIROL, V86, P765, DOI 10.1099/vir.0.80570-0; Goldman MJ, 1997, HUM GENE THER, V8, P2261, DOI 10.1089/hum.1997.8.18-2261; Grasso F, 2013, INT J CANCER, V132, P335, DOI 10.1002/ijc.27676; Guo LN, 2010, ARCH VIROL, V155, P1765, DOI 10.1007/s00705-010-0756-3; He YK, 2005, J IMMUNOL, V174, P3808, DOI 10.4049/jimmunol.174.6.3808; Iglesias MC, 2006, J GENE MED, V8, P265, DOI 10.1002/jgm.837; Laidlaw BJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003207; LaMere MW, 2011, J IMMUNOL, V186, P4331, DOI 10.4049/jimmunol.1003057; Li Z, 2013, J VIROL, V87, P5985, DOI 10.1128/JVI.00120-13; Limberis M, 2002, HUM GENE THER, V13, P1961, DOI 10.1089/10430340260355365; Luo J, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-286; Mbawuike IN, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-44; Mochizuki H, 1998, J VIROL, V72, P8873, DOI 10.1128/JVI.72.11.8873-8883.1998; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nayak S, 2010, GENE THER, V17, P295, DOI 10.1038/gt.2009.148; Negri DRM, 2007, MOL THER, V15, P1716, DOI 10.1038/sj.mt.6300241; Negri DRM, 2011, EXPERT OPIN BIOL TH, V11, P739, DOI 10.1517/14712598.2011.571670; Negri DRM, 2010, HUM GENE THER, V21, P1029, DOI 10.1089/hum.2009.200; Price GE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013162; Price GE, 2009, VACCINE, V27, P6512, DOI 10.1016/j.vaccine.2009.08.053; Rawlins EL, 2008, AM J PHYSIOL-LUNG C, V295, pL231, DOI 10.1152/ajplung.90209.2008; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rose MA, 2012, EXPERT REV VACCINES, V11, P595, DOI [10.1586/erv.12.31, 10.1586/ERV.12.31]; ROTZSCHKE O, 1990, NATURE, V348, P252, DOI 10.1038/348252a0; Salmon Patrick, 2007, Curr Protoc Hum Genet, VChapter 12, DOI 10.1002/0471142905.hg1210s54; Schambach A, 2006, GENE THER, V13, P641, DOI 10.1038/sj.gt.3302698; SHU LL, 1993, J VIROL, V67, P2723, DOI 10.1128/JVI.67.5.2723-2729.1993; Southam DS, 2002, AM J PHYSIOL-LUNG C, V282, pL833, DOI 10.1152/ajplung.00173.2001; Suda T, 2011, ANTIVIR RES, V91, P252, DOI 10.1016/j.antiviral.2011.06.008; TAYLOR PM, 1986, IMMUNOLOGY, V58, P417; TOBITA K, 1975, MED MICROBIOL IMMUN, V162, P23, DOI 10.1007/BF02123574; TOWNSEND ARM, 1984, J EXP MED, V160, P552, DOI 10.1084/jem.160.2.552; Ulmer JB, 1998, J VIROL, V72, P5648, DOI 10.1128/JVI.72.7.5648-5653.1998; Vargas J, 2004, HUM GENE THER, V15, P361, DOI 10.1089/104303404322959515; YEWDELL JW, 1985, P NATL ACAD SCI USA, V82, P1785, DOI 10.1073/pnas.82.6.1785; YU SF, 1986, P NATL ACAD SCI USA, V83, P3194, DOI 10.1073/pnas.83.10.3194; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	55	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97270	10.1371/journal.pone.0097270	http://dx.doi.org/10.1371/journal.pone.0097270			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824623	Green Submitted, Green Published, gold			2022-12-27	WOS:000336369200084
J	Niu, L; Li, GL; Lin, SL				Niu, Liang; Li, Guoliang; Lin, Shili			Statistical Models for Detecting Differential Chromatin Interactions Mediated by a Protein	PLOS ONE			English	Article							PROSTATE-CANCER; TRANSCRIPTION; PROMOTER; ORGANIZATION; AGREEMENT; LOCUS; GENE	Chromatin interactions mediated by a protein of interest are of great scientific interest. Recent studies show that protein-mediated chromatin interactions can have different intensities in different types of cells or in different developmental stages of a cell. Such differences can be associated with a disease or with the development of a cell. Thus, it is of great importance to detect protein-mediated chromatin interactions with different intensities in different cells. A recent molecular technique, Chromatin Interaction Analysis by Paired-End Tag Sequencing (ChIA-PET), which uses formaldehyde cross-linking and paired-end sequencing, is able to detect genome-wide chromatin interactions mediated by a protein of interest. Here we proposed two models (One-Step Model and Two-Step Model) for two sample ChIA-PET count data (one biological replicate in each sample) to identify differential chromatin interactions mediated by a protein of interest. Both models incorporate the data dependency and the extent to which a fragment pair is related to a pair of DNA loci of interest to make accurate identifications. The One-Step Model makes use of the data more efficiently but is more computationally intensive. An extensive simulation study showed that the models can detect those differentially interacted chromatins and there is a good agreement between each classification result and the truth. Application of the method to a two-sample ChIA-PET data set illustrates its utility. The two models are implemented as an R package MDM (available at http://www.stat.osu.edu/similar to statgen/SOFTWARE/MDM).	[Niu, Liang; Lin, Shili] Ohio State Univ, Dept Stat, Columbus, OH 43210 USA; [Li, Guoliang] Huazhong Agr Univ, Coll Life Sci & Technol, Natl Key Lab Crop Genet Improvement, Ctr Syst Biol,Ctr Bioinformat,Coll Life Sci & Tec, Wuhan, Hubei, Peoples R China	University System of Ohio; Ohio State University; Huazhong Agricultural University	Lin, SL (corresponding author), Ohio State Univ, Dept Stat, Columbus, OH 43210 USA.	shili@stat.osu.edu	Li, Guoliang/D-8014-2012	Li, Guoliang/0000-0003-1601-6640	National Science Foundation [DMS-1042946]; Fundamental Research Funds for the Central Universities [2662014PY001]	National Science Foundation(National Science Foundation (NSF)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	LN and SL were supported by the National Science Foundation grant DMS-1042946. GL was supported by the Fundamental Research Funds for the Central Universities [2662014PY001]. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Decker KF, 2012, NUCLEIC ACIDS RES, V40, P10765, DOI 10.1093/nar/gks888; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gong FR, 2011, NUCLEIC ACIDS RES, V39, P4640, DOI 10.1093/nar/gkr023; Guo Y, 2012, P NATL ACAD SCI USA, V109, P21081, DOI 10.1073/pnas.1219280110; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Jiang HM, 2008, MOL CELL BIOL, V28, P907, DOI 10.1128/MCB.00909-07; Jing HI, 2008, MOL CELL, V29, P232, DOI 10.1016/j.molcel.2007.11.020; Junier I, 2012, NUCLEIC ACIDS RES, V40, P7718, DOI 10.1093/nar/gks536; Kohwi-Shigematsu T, 2012, METHODS, V58, P243, DOI 10.1016/j.ymeth.2012.06.019; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Niu L, 2013, 876 OH STAT U DEP ST; Obinata D, 2012, INT J CANCER, V130, P1021, DOI 10.1002/ijc.26043; Raftery A. E., 1995, PRACTICAL MARKOV CHA, P115; Rousseau M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-414; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056	20	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97560	10.1371/journal.pone.0097560	http://dx.doi.org/10.1371/journal.pone.0097560			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835279	Green Published, gold, Green Submitted			2022-12-27	WOS:000339614800051
J	Bertolini, M; Zilio, F; Rossi, A; Kleditzsch, P; Emelianov, VE; Gilhar, A; Keren, A; Meyer, KC; Wang, E; Funk, W; McElwee, K; Paus, R				Bertolini, Marta; Zilio, Federica; Rossi, Alfredo; Kleditzsch, Patrick; Emelianov, Vladimir E.; Gilhar, Amos; Keren, Aviad; Meyer, Katja C.; Wang, Eddy; Funk, Wolfgang; McElwee, Kevin; Paus, Ralf			Abnormal Interactions between Perifollicular Mast Cells and CD8+T-Cells May Contribute to the Pathogenesis of Alopecia Areata	PLOS ONE			English	Article							CLASS-I EXPRESSION; GROWTH-FACTOR-BETA; HAIR FOLLICLE; T-CELLS; IMMUNE PRIVILEGE; COSTIMULATORY MOLECULES; GENE-EXPRESSION; CD30 LIGAND; PERIPHERAL TOLERANCE; AUTOIMMUNE-DISEASE	Alopecia areata (AA) is a CD8+ T-cell dependent autoimmune disease of the hair follicle (HF) in which the collapse of HF immune privilege (IP) plays a key role. Mast cells (MCs) are crucial immunomodulatory cells implicated in the regulation of T cell-dependent immunity, IP, and hair growth. Therefore, we explored the role of MCs in AA pathogenesis, focusing on MC interactions with CD8+ T-cells in vivo, in both human and mouse skin with AA lesions. Quantitative (immuno)histomorphometry revealed that the number, degranulation and proliferation of perifollicular MCs are significantly increased in human AA lesions compared to healthy or non-lesional control skin, most prominently in subacute AA. In AA patients, perifollicular MCs showed decreased TGF beta 1 and IL-10 but increased tryptase immunoreactivity, suggesting that MCs switch from an immuno-inhibitory to a pro-inflammatory phenotype. This concept was supported by a decreased number of IL-10+ and PD-L1+ MCs, while OX40L+, CD30L+, 4-1BBL+ or ICAM-1+ MCs were increased in AA. Lesional AA-HFs also displayed significantly more peri-and intrafollicular-CD8+ T-cells as well as more physical MC/CD8+ T-cell contacts than healthy or non-lesional human control skin. During the interaction with CD8+ T-cells, AA MCs prominently expressed MHC class I and OX40L, and sometimes 4-1BBL or ICAM-1, suggesting that MC may present autoantigens to CD8+ T-cells and/or co-stimulatory signals. Abnormal MC numbers, activities, and interactions with CD8+ T-cells were also seen in the grafted C3H/HeJ mouse model of AA and in a new humanized mouse model for AA. These phenomenological in vivo data suggest the novel AA pathobiology concept that perifollicular MCs are skewed towards pro-inflammatory activities that facilitate cross-talk with CD8+ T-cells in this disease, thus contributing to triggering HF-IP collapse in AA. If confirmed, MCs and their CD8+ T-cell interactions could become a promising new therapeutic target in the future management of AA.	[Bertolini, Marta; Zilio, Federica; Meyer, Katja C.; Paus, Ralf] Med Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany; [Bertolini, Marta; Paus, Ralf] Univ Munster, Dept Dermatol, D-48149 Munster, Germany; [Rossi, Alfredo] Univ Roma La Sapienza, Dept Internal Med & Med Specialties, Rome, Italy; [Kleditzsch, Patrick] Univ Rostock, Dept Obstet & Gynaecol, D-18055 Rostock, Germany; [Emelianov, Vladimir E.] Chuvash State Univ, Dept Pharmacol Clin Pharmacol & Biochem, Sch Med, Cheboksary, Russia; [Gilhar, Amos; Keren, Aviad] Technion Israel Inst Technol, Rappaport Fac Med, Lab Skin Res, Haifa, Israel; [Gilhar, Amos] Flieman Med Ctr, Haifa, Israel; [Wang, Eddy; McElwee, Kevin] Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 1M9, Canada; [Funk, Wolfgang] Klin Dr Koslowski, Munich, Germany; [Paus, Ralf] Univ Manchester, Inst Inflammat & Repair, Manchester, Lancs, England	University of Lubeck; University of Munster; Sapienza University Rome; University of Rostock; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of British Columbia; University of Manchester	Paus, R (corresponding author), Med Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany.	ralf.paus@manchester.ac.uk	Wang, Eddy Hsi Chun/AAD-2759-2019; Paus, Ralf/B-5279-2015; Rossi, Alfredo/K-1725-2018	Wang, Eddy Hsi Chun/0000-0001-7785-1442; Paus, Ralf/0000-0002-3492-9358; Rossi, Alfredo/0000-0002-7442-3423; McElwee, Kevin/0000-0003-1020-3832; Emelianov, Vladimir/0000-0003-1720-1741; Bertolini, Marta/0000-0002-5927-6998	DFG [GRK1727/1]; University of Manchester; Associazione Associazione Nazionale Mediterranea Alopecia Areata	DFG(German Research Foundation (DFG)); University of Manchester; Associazione Associazione Nazionale Mediterranea Alopecia Areata	This project was supported in part by a grant from DFG to RP and a PhD fellowship to MB (GRK1727/1) as well as by faculty funds to RP from the University of Manchester and by funds from the Associazione Associazione Nazionale Mediterranea Alopecia Areata funds to RP and MB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceves SS, 2010, J ALLERGY CLIN IMMUN, V126, P1198, DOI 10.1016/j.jaci.2010.08.050; Algermissen B, 1994, Exp Dermatol, V3, P290, DOI 10.1111/j.1600-0625.1994.tb00291.x; Alli R, 2012, J IMMUNOL, V188, P477, DOI 10.4049/jimmunol.1100657; BACCAREDDA-BOY A., 1959, PANMINERVA MED, V1, P198; Bertolini M, 2013, EXP DERMATOL, V22, P593, DOI 10.1111/exd.12205; Bodemer C, 2000, J INVEST DERMATOL, V114, P112, DOI 10.1046/j.1523-1747.2000.00828.x; BOTCHKAREV VA, 1995, ARCH DERMATOL RES, V287, P683, DOI 10.1007/BF00371743; Brown MA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00147; Buckley MG, 1999, J PATHOL, V189, P138, DOI 10.1002/(SICI)1096-9896(199909)189:1<138::AID-PATH400>3.0.CO;2-H; Cabrera CM, 2013, SCAND J IMMUNOL, V78, P306, DOI 10.1111/sji.12088; Catley MC, 2011, PHARMACOL THERAPEUT, V132, P333, DOI 10.1016/j.pharmthera.2011.09.005; Cetin ED, 2009, AM J DERMATOPATH, V31, P53, DOI 10.1097/DAD.0b013e318185a66e; Chacon JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060031; Chacon-Salinas R, 2011, J IMMUNOL, V186, P25, DOI 10.4049/jimmunol.1001657; Chan CY, 2013, IMMUNITY, V38, P349, DOI 10.1016/j.immuni.2012.10.019; Cherwinski HM, 2005, J IMMUNOL, V174, P1348, DOI 10.4049/jimmunol.174.3.1348; Christy AL, 2013, J AUTOIMMUN, V42, P50, DOI 10.1016/j.jaut.2012.11.003; Crilly A, 2012, ANN RHEUM DIS, V71, P1049, DOI 10.1136/annrheumdis-2011-200703; Croft M, 2010, ANNU REV IMMUNOL, V28, P57, DOI 10.1146/annurev-immunol-030409-101243; D'Ovidio R, 1988, G Ital Dermatol Venereol, V123, P569; de Vries VC, 2009, AM J TRANSPLANT, V9, P2270, DOI 10.1111/j.1600-6143.2009.02755.x; de Vries VC, 2009, CURR OPIN ORGAN TRAN, V14, P332, DOI 10.1097/MOT.0b013e32832ce87a; Diaconu NC, 2007, CANCER IMMUNOL IMMUN, V56, P1407, DOI 10.1007/s00262-007-0290-7; dos Santos RV, 2010, BRIT J DERMATOL, V162, P674, DOI 10.1111/j.1365-2133.2009.09516.x; Finn DF, 2013, BRIT J PHARMACOL, V170, P23, DOI 10.1111/bph.12138; FINZI A F, 1964, Minerva Dermatol, V39, P99; Fischer M, 2006, J CLIN INVEST, V116, P2748, DOI 10.1172/JCI24274; Frenzel L, 2013, JOINT BONE SPINE, V80, P141, DOI 10.1016/j.jbspin.2012.08.013; Freyschmidt-Paul P, 2006, BRIT J DERMATOL, V155, P515, DOI 10.1111/j.1365-2133.2006.07377.x; Frossi B, 2010, TRENDS IMMUNOL, V31, P97, DOI 10.1016/j.it.2009.12.007; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; Gan PY, 2012, J AM SOC NEPHROL, V23, P1955, DOI 10.1681/ASN.2012060572; Gilfillan AM, 2011, CRIT REV IMMUNOL, V31, P475, DOI 10.1615/CritRevImmunol.v31.i6.30; Gilhar A, 1998, J CLIN INVEST, V101, P62, DOI 10.1172/JCI551; Gilhar A, 2013, J INVEST DERMATOL, V133, P2088, DOI 10.1038/jid.2013.141; Gilhar A, 2013, J INVEST DERMATOL, V133, P844, DOI 10.1038/jid.2012.365; Gilhar A, 2012, NEW ENGL J MED, V366, P1515, DOI 10.1056/NEJMra1103442; Gizinski AM, 2010, BEST PRACT RES CL RH, V24, P463, DOI 10.1016/j.berh.2009.12.015; GORDON JR, 1994, J EXP MED, V180, P2027, DOI 10.1084/jem.180.6.2027; Gri G, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00120; Groux H, 1998, J IMMUNOL, V160, P3188; Gruss HJ, 1996, AM J PATHOL, V149, P469; Gupta MA, 1997, ACTA DERM-VENEREOL, V77, P296; Harries MJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3671; Harries MJ, 2013, J PATHOL, V231, P236, DOI 10.1002/path.4233; Harvima IT, 2011, ACTA DERM-VENEREOL, V91, P644, DOI 10.2340/00015555-1197; Hernandez-Hernandez L, 2012, ALLERGOL IMMUNOPATH, V40, P385, DOI 10.1016/j.aller.2012.04.004; Horie R, 1998, SEMIN IMMUNOL, V10, P457, DOI 10.1006/smim.1998.0156; Hugle T, 2011, ARTHRITIS RHEUM-US, V63, P795, DOI 10.1002/art.30190; Ilves T, 2013, J EUR ACAD DERMATOL, V27, pE197, DOI 10.1111/j.1468-3083.2012.04587.x; Inui S, 2007, J DERMATOL, V34, P852, DOI 10.1111/j.1346-8138.2007.00401.x; Ishii N, 2010, ADV IMMUNOL, V105, P63, DOI 10.1016/S0065-2776(10)05003-0; Ito N, 2005, FASEB J, V19, P1332, DOI 10.1096/fj.04-1968fje; Ito N, 2010, J INVEST DERMATOL, V130, P995, DOI 10.1038/jid.2009.387; Ito T, 2005, BRIT J DERMATOL, V152, P623, DOI 10.1111/j.1365-2133.2005.06453.x; Ito T, 2004, AM J PATHOL, V164, P623, DOI 10.1016/S0002-9440(10)63151-3; Ito T, 2008, J INVEST DERMATOL, V128, P1196, DOI 10.1038/sj.jid.5701183; Ito T, 2013, J DERMATOL SCI, V72, P327, DOI 10.1016/j.jdermsci.2013.07.014; Ito T, 2013, J DERMATOL SCI, V72, P68, DOI 10.1016/j.jdermsci.2013.04.029; Kalesnikoff J, 2011, METHODS MOL BIOL, V677, P207, DOI 10.1007/978-1-60761-869-0_15; Kang H, 2010, J INVEST DERMATOL, V130, P2677, DOI 10.1038/jid.2010.180; Karra L, 2009, CURR OPIN IMMUNOL, V21, P708, DOI 10.1016/j.coi.2009.09.010; Kashiwakura J, 2004, J IMMUNOL, V173, P5247, DOI 10.4049/jimmunol.173.8.5247; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; King Lloyd E. Jr., 2008, V10, P280, DOI 10.1159/000131749; Kinori M, 2011, INVEST OPHTH VIS SCI, V52, P4447, DOI 10.1167/iovs.10-7154; Kloepper JE, 2013, J INVEST DERMATOL, V133, P1666, DOI 10.1038/jid.2013.17; Kober J, 2008, EUR J IMMUNOL, V38, P2678, DOI 10.1002/eji.200838250; Kumamoto T, 2003, BLOOD, V102, P1654, DOI 10.1182/blood-2003-02-0449; Li QY, 2014, CELL BIOCHEM FUNCT, V32, P183, DOI 10.1002/cbf.2991; Liu XB, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/627831; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; Magarinos NJ, 2013, J IMMUNOL, V191, P1404, DOI 10.4049/jimmunol.1300856; Matzer F, 2011, ACTA DERM-VENEREOL, V91, P318, DOI 10.2340/00015555-1031; Maurer M, 1997, LAB INVEST, V77, P319; Maurer M, 2003, EXP DERMATOL, V12, P886, DOI 10.1111/j.0906-6705.2003.0109a.x; Maurer M, 1995, Exp Dermatol, V4, P266, DOI 10.1111/j.1600-0625.1995.tb00256.x; McElwee KJ, 2013, EXP DERMATOL, V22, P609, DOI 10.1111/exd.12209; McElwee KJ, 1996, BRIT J DERMATOL, V135, P211, DOI 10.1111/j.1365-2133.1996.tb01149.x; McElwee KJ, 2005, J INVEST DERMATOL, V124, P947, DOI 10.1111/j.0022-202X.2005.23692.x; Meyer KC, 2008, BRIT J DERMATOL, V159, P1077, DOI 10.1111/j.1365-2133.2008.08818.x; Michael ES, 2013, AM J PHYSIOL-GASTR L, V304, pG516, DOI 10.1152/ajpgi.00296.2012; Molin D, 2001, BRIT J HAEMATOL, V114, P616, DOI 10.1046/j.1365-2141.2001.02977.x; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Nagai H, 2006, ARCH DERMATOL RES, V298, P131, DOI 10.1007/s00403-006-0668-y; Nakae S, 2006, J IMMUNOL, V176, P2238, DOI 10.4049/jimmunol.176.4.2238; Ohyama M, 2010, J DERMATOL SCI, V58, P154, DOI 10.1016/j.jdermsci.2010.03.009; PAUS R, 1993, YALE J BIOL MED, V66, P541; Paus R, 2005, TRENDS IMMUNOL, V26, P32, DOI 10.1016/j.it.2004.09.014; PAUS R, 1994, DEV BIOL, V163, P230, DOI 10.1006/dbio.1994.1139; Paus R, 2009, J INVEST DERMATOL, V129, P1324, DOI 10.1038/jid.2009.111; Pejler G, 2010, BLOOD, V115, P4981, DOI 10.1182/blood-2010-01-257287; Petukhova L, 2010, NATURE, V466, P113, DOI 10.1038/nature09114; Podojil JR, 2013, BIODRUGS, V27, P1, DOI 10.1007/s40259-012-0001-6; RANKI A, 1984, J INVEST DERMATOL, V83, P7, DOI 10.1111/1523-1747.ep12261627; Reber LL, 2012, TRENDS IMMUNOL, V33, P613, DOI 10.1016/j.it.2012.09.008; Rosenblum MD, 2006, J DERMATOL SCI, V41, P165, DOI 10.1016/j.jdermsci.2005.11.003; Ruckert R, 1998, J INVEST DERMATOL, V111, P25, DOI 10.1046/j.1523-1747.1998.00228.x; Rygiel TF, 2012, CURR OPIN IMMUNOL, V24, P233, DOI 10.1016/j.coi.2012.01.002; Saresella M, 2012, CURR MOL MED, V12, P259, DOI 10.2174/156652412799218903; Sayama Koichi, 2002, BMC Immunol, V3, P5, DOI 10.1186/1471-2172-3-5; Sayed BA, 2008, ANNU REV IMMUNOL, V26, P705, DOI 10.1146/annurev.immunol.26.021607.090320; Shao Z, 2011, J LEUKOCYTE BIOL, V89, P21, DOI 10.1189/jlb.0510315; Shin K, 2009, J IMMUNOL, V182, P647, DOI 10.4049/jimmunol.182.1.647; Skokos D, 2001, J IMMUNOL, V166, P868, DOI 10.4049/jimmunol.166.2.868; Soyer OU, 2013, ALLERGY, V68, P161, DOI 10.1111/all.12085; Spath U, 1970, Z Haut Geschlechtskr, V45, P435; St John AL, 2013, J IMMUNOL, V190, P4458, DOI 10.4049/jimmunol.1203420; Stelekati E, 2009, IMMUNITY, V31, P665, DOI 10.1016/j.immuni.2009.08.022; Sugawara K, 2012, J ALLERGY CLIN IMMUN, V129, P726, DOI 10.1016/j.jaci.2011.11.009; Tete S, 2012, J BIOL REG HOMEOS AG, V26, P193; Theoharides TC, 2007, ADV EXP MED BIOL, V601, P423; Tsai M, 2011, ADV EXP MED BIOL, V716, P186, DOI 10.1007/978-1-4419-9533-9_11; Tsuboi Hiromi, 1999, Journal of Dermatology (Tokyo), V26, P797; Vinay DS, 2012, MOL CANCER THER, V11, P1062, DOI 10.1158/1535-7163.MCT-11-0677; Voehringer D, 2013, NAT REV IMMUNOL, V13, P362, DOI 10.1038/nri3427; Wahl SM, 2006, IMMUNOL REV, V213, P213, DOI 10.1111/j.1600-065X.2006.00437.x; Waldmann H, 2006, NATURE, V442, P987, DOI 10.1038/nature05165; Walker ME, 2012, BBA-MOL BASIS DIS, V1822, P57, DOI 10.1016/j.bbadis.2011.02.009; Wang C, 2009, IMMUNOL REV, V229, P192, DOI 10.1111/j.1600-065X.2009.00765.x; Wang E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062935; Wang XJ, 2014, J INVEST DERMATOL, V134, P736, DOI 10.1038/jid.2013.368; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Weinberg AD, 2011, IMMUNOL REV, V244, P218, DOI 10.1111/j.1600-065X.2011.01069.x; Whiting DA, 2003, ARCH DERMATOL, V139, P1555, DOI 10.1001/archderm.139.12.1555; Wu CX, 2011, CELL IMMUNOL, V271, P118, DOI 10.1016/j.cellimm.2011.06.013; Wu YL, 2012, INT J BIOL SCI, V8, P1420, DOI 10.7150/ijbs.5273; Yano S, 2002, ACTA DERM-VENEREOL, V82, P82, DOI 10.1080/00015550252948077; Zhang ZL, 2013, DIGEST DIS SCI, V58, P1497, DOI 10.1007/s10620-013-2599-8	130	77	79	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e94260	10.1371/journal.pone.0094260	http://dx.doi.org/10.1371/journal.pone.0094260			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24832234	Green Submitted, Green Published, gold			2022-12-27	WOS:000336789500003
J	Chen, YK; Yang, XB; Yang, Q; Li, DH; Long, WX; Luo, WQ				Chen, Yukai; Yang, Xiaobo; Yang, Qi; Li, Donghai; Long, Wenxing; Luo, Wenqi			Factors Affecting the Distribution Pattern of Wild Plants with Extremely Small Populations in Hainan Island, China	PLOS ONE			English	Article							THREATENED PLANTS; SPECIES-DIVERSITY; LAND-USE; ROADS; CONSERVATION; COMMUNITIES; TOPOGRAPHY; GRADIENT; REINTRODUCTION; MOUNTAINS	Understanding which factors affect the distribution pattern of extremely small populations is essential to the protection and propagation of rare and endangered plant species. In this study, we established 108 plots covering the entire Hainan Island, and measured the appearance frequency and species richness of plant species with extremely small populations, as well as the ecological environments and human disturbances during 2012-2013. We explored how the ecological environments and human activities affected the distribution pattern of these extremely small populations. Results showed that the extremely small populations underwent human disturbances and threats, and they were often found in fragmental habitats. The leading factors changing the appearance frequency of extremely small populations differed among plant species, and the direct factors making them susceptible to extinction were human disturbances. The peak richness of extremely small populations always occurred at the medium level across environmental gradients, and their species richness always decreased with increasing human disturbances. However, the appearance frequencies of three orchid species increased with the increasing human disturbances. Our study thus indicate that knowledge on how the external factors, such as the ecological environment, land use type, roads, human activity, etc., affect the distribution of the extremely small populations should be taken for the better protecting them in the future.	[Chen, Yukai; Yang, Xiaobo; Yang, Qi; Li, Donghai; Long, Wenxing; Luo, Wenqi] Hainan Univ, Key Lab Protect & Dev Utilizat Trop Crop Germplas, Minist Educ, Coll Hort & Landscapes, Haikou 570228, Hainan, Peoples R China	Hainan University	Yang, XB (corresponding author), Hainan Univ, Key Lab Protect & Dev Utilizat Trop Crop Germplas, Minist Educ, Coll Hort & Landscapes, Haikou 570228, Hainan, Peoples R China.	yanfengxb@163.com	; Long, Wenxing/P-1440-2018	Luo, Wenqi/0000-0002-7454-0961; Long, Wenxing/0000-0002-9195-5878	National Natural Science Foundation of China [31060073]; Traditional Chinese medicine resources protection and utilization in some representative area of Hainan province [201207002-03]; Second national key protected plant resources survey in Hainan province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Traditional Chinese medicine resources protection and utilization in some representative area of Hainan province; Second national key protected plant resources survey in Hainan province	This work was financially supported by grants from the National Natural Science Foundation of China (31060073), the Traditional Chinese medicine resources protection and utilization in some representative area of Hainan province (201207002-03), and the Second national key protected plant resources survey in Hainan province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht MA, 2010, RESTOR ECOL, V18, P235, DOI 10.1111/j.1526-100X.2009.00584.x; Allan E, 2011, P NATL ACAD SCI USA, V108, P17034, DOI 10.1073/pnas.1104015108; Amat ME, 2013, J NAT CONSERV, V21, P262, DOI 10.1016/j.jnc.2013.02.001; Amat ME, 2013, J HERED, V104, P692, DOI 10.1093/jhered/est042; BEERS TW, 1966, J FOREST, V64, P691; Brooker RW, 2006, NEW PHYTOL, V171, P271, DOI 10.1111/j.1469-8137.2006.01752.x; Compilation Group of China's Biodiversity, 1998, CHINAS BIODIVERSITY; [崔艳 CUI Yan], 2006, [广西植物, Guihaia], V26, P660; Fiedler P. L., 1992, Conservation biology: the theory and practice of nature conservation, preservation, and management., P23; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Forman RTT, 2000, CONSERV BIOL, V14, P31, DOI 10.1046/j.1523-1739.2000.99299.x; Francisco-Ortega J, 2000, AM J BOT, V87, P909, DOI 10.2307/2656988; Frankham R, 1997, HEREDITY, V78, P311, DOI 10.1038/hdy.1997.46; Frazer G.W., 1999, GAP LIGHT ANALYZER V; [高建国 Gao Jianguo], 2012, [生态学报, Acta Ecologica Sinica], V32, P5287; Garcia MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044657; Gelbard JL, 2003, CONSERV BIOL, V17, P420, DOI 10.1046/j.1523-1739.2003.01408.x; Groom M.J., 2006, PRINCIPLES CONSERVAT; Guo ZM, 2006, AGROFOREST SYST, V66, P117, DOI 10.1007/s10457-005-4676-2; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; IUCN (International Union for Conservation of Nature), 2013, THE IUCN RED LIST OF; Jiang HY, 2011, TROPICAL FORESTRY, V39, P40; Jiang Mingxi, 2002, Yingyong Shengtai Xuebao, V13, P1373; KAREIVA P, 1995, NATURE, V373, P299, DOI 10.1038/373299a0; Kessler M, 2002, J BIOGEOGR, V29, P1159, DOI 10.1046/j.1365-2699.2002.00773.x; Kessler M, 2001, J BIOGEOGR, V28, P611, DOI 10.1046/j.1365-2699.2001.00577.x; KRUCKEBERG AR, 1985, ANNU REV ECOL SYST, V16, P447, DOI 10.1146/annurev.es.16.110185.002311; Lauterbach D, 2011, PLANT BIOLOGY, V13, P667, DOI 10.1111/j.1438-8677.2010.00418.x; Lenzen M, 2009, CONSERV BIOL, V23, P294, DOI 10.1111/j.1523-1739.2008.01126.x; Leps J, 2003, MULTIVARIATE ANAL EC; Levine JM, 2010, ECOLOGY, V91, P130, DOI 10.1890/08-2039.1; Martens SN, 2000, ECOL MODEL, V126, P79, DOI 10.1016/S0304-3800(99)00188-X; Mason Herbert L., 1946, MADROnO, V8, P209; Neel MC, 2013, CONSERV BIOL, V27, P385, DOI 10.1111/cobi.12008; ODUM E P, 1971, P574; [乔琦 QIAO Qi], 2011, [生态学报, Acta Ecologica Sinica], V31, P4709; Qiu Y, 2001, J HYDROL, V240, P243, DOI 10.1016/S0022-1694(00)00362-0; Reckinger C, 2010, RESTOR ECOL, V18, P904, DOI 10.1111/j.1526-100X.2009.00522.x; Reed RA, 1996, CONSERV BIOL, V10, P1098, DOI 10.1046/j.1523-1739.1996.10041098.x; Reid T., 2013, OPEN J FORESTRY, V3, P70, DOI DOI 10.4236/OJF.2013.32012; Ren H, 2012, AMBIO, V41, P913, DOI 10.1007/s13280-012-0284-3; Ren H, 2010, PLANT SPEC BIOL, V25, P43, DOI 10.1111/j.1442-1984.2009.00261.x; Sasaki T, 2011, OECOLOGIA, V166, P761, DOI 10.1007/s00442-011-1916-1; Singh KN, 2008, J MT SCI-ENGL, V5, P73, DOI 10.1007/s11629-008-0073-4; [宋萍 Song Ping], 2005, [山地学报, Journal of Mountain Science], V23, P631; Spooner PG, 2005, BIOL CONSERV, V122, P231, DOI 10.1016/j.biocon.2004.07.012; State Forestry Administration of China, 2011, THE SAVING AND CONSE; Tokuchi N, 1999, ECOL RES, V14, P361, DOI 10.1046/j.1440-1703.1999.00309.x; Tong Yuewei, 2013, Shengwu Duoyangxing, V21, P269, DOI 10.3724/SP.J.1003.2013.09008; Victor JE, 2003, S AFR J SCI, V99, P437; [王伯荪 WANG BoSun], 2007, [生态学报, Acta Ecologica Sinica], V27, P1690; Wang GH, 2003, PLANT ECOL, V165, P169, DOI 10.1023/A:1022236115186; Watkins RZ, 2003, CONSERV BIOL, V17, P411, DOI 10.1046/j.1523-1739.2003.01285.x; WHITTAKER RH, 1965, ECOLOGY, V46, P429, DOI 10.2307/1934875; Xu Xiao, 2005, Ying Yong Sheng Tai Xue Bao, V16, P985; Yuan Jin-Feng, 2011, Bulletin of Botanical Research, V31, P61; Zang RG, 2009, ACTA OECOL, V35, P462, DOI 10.1016/j.actao.2008.12.006; Zhang HD, 2001, ECOLOGIC SCI, V20, P1; [张文辉 Zhang Wenhui], 2002, [生态学报, Acta Ecologica Sinica], V22, P1512; Zhang YB, 2008, BIODIVERS CONSERV, V17, P1783, DOI 10.1007/s10531-008-9384-6	60	21	27	7	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97751	10.1371/journal.pone.0097751	http://dx.doi.org/10.1371/journal.pone.0097751			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830683	Green Submitted, Green Published, gold			2022-12-27	WOS:000336789500111
J	Gambetta, D; Przepiorka, W				Gambetta, Diego; Przepiorka, Wojtek			Natural and Strategic Generosity as Signals of Trustworthiness	PLOS ONE			English	Article							COMPETITIVE ALTRUISM; EXPERIMENTAL TESTS; TRUST; REPUTATION; RECIPROCITY; EVOLUTION; CUES; FAIRNESS; GAME	We exploit the fact that generosity and trustworthiness are highly correlated and the former can thus be a sign of the latter. Subjects decide between a generous and a mean split in a dictator game. Some of them are informed from the start that afterwards they will participate in a trust game and that their choice in the dictator game may matter; others are not informed in advance. In the trust game, before trusters decide whether or not to trust, some trustees can reveal (or conceal) only their true choice in the dictator game, while others can say to trusters, truthfully or otherwise, what they chose. We find that a generous choice made naturally by uninformed trustees and reliably revealed is more effective in persuading trusters to trust than a generous choice that could be strategic or a lie. Moreover, we find that, when they can, mean subjects lie and go on to be untrustworthy.	[Gambetta, Diego] European Univ Inst, Dept Polit & Social Sci, Fiesole, FI, Italy; [Gambetta, Diego; Przepiorka, Wojtek] Univ Oxford Nuffield Coll, Oxford OX1 1NF, England; [Przepiorka, Wojtek] Univ Oxford, Dept Sociol, Oxford, England	European University Institute; University of Oxford; University of Oxford	Przepiorka, W (corresponding author), Univ Oxford Nuffield Coll, Oxford OX1 1NF, England.	wojtek.przepiorka@sociology.ox.ac.uk	Przepiorka, Wojtek/I-3438-2019	Przepiorka, Wojtek/0000-0001-9432-8696	Swiss National Science Foundation [100017_124877]; Nuffield College financial office	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Nuffield College financial office	This research was supported by the Swiss National Science Foundation, grant number 100017_124877 (http://www.snf.ch), and the Nuffield College financial office (http://www.nuffield.ox.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy O, 2012, J EXP SOC PSYCHOL, V48, P45, DOI 10.1016/j.jesp.2011.07.009; Albert M, 2007, EXP ECON, V10, P53, DOI 10.1007/s10683-006-9131-3; Anderhub V, 2002, J ECON BEHAV ORGAN, V48, P197, DOI 10.1016/S0167-2681(01)00216-5; Ashraf N, 2006, EXP ECON, V9, P193, DOI 10.1007/s10683-006-9122-4; Bacharach M., 2001, TRUST SOC, P148; Bacharach M, 2007, THEOR DECIS, V63, P349, DOI 10.1007/s11238-007-9043-5; Barclay P, 2004, EVOL HUM BEHAV, V25, P209, DOI 10.1016/j.evolhumbehav.2004.04.002; Barclay P, 2007, P ROY SOC B-BIOL SCI, V274, P749, DOI 10.1098/rspb.2006.0209; Bateson M, 2006, BIOL LETTERS, V2, P412, DOI 10.1098/rsbl.2006.0509; Baumard N, 2013, BEHAV BRAIN SCI, V36, P59, DOI 10.1017/S0140525X11002202; Belot M, 2010, 2010001 NUFF CTR EXP; Bird RB, 2005, CURR ANTHROPOL, V46, P221, DOI 10.1086/427115; Blanco M, 2011, GAME ECON BEHAV, V72, P321, DOI 10.1016/j.geb.2010.09.008; Bolle F, 2007, J INST THEOR ECON, V163, P428, DOI 10.1628/093245607781871408; Bolton G.E., 2004, ANAL KRITIK, V26, P185; Bolton GE, 2004, MANAGE SCI, V50, P1587, DOI 10.1287/mnsc.1030.0199; Bracht J, 2009, J PUBLIC ECON, V93, P1036, DOI 10.1016/j.jpubeco.2009.06.004; Brandts J, 2011, EXP ECON, V14, P375, DOI 10.1007/s10683-011-9272-x; CAMERER C, 1988, ECONOMETRICA, V56, P1, DOI 10.2307/1911840; Casari M, 2009, ECON LETT, V103, P157, DOI 10.1016/j.econlet.2009.03.012; Charness G, 2006, ECONOMETRICA, V74, P1579, DOI 10.1111/j.1468-0262.2006.00719.x; Chaudhuri A, 2007, SOUTH ECON J, V73, P959, DOI 10.2307/20111937; Dasgupta P., 1988, TRUST MAKING BREAKIN, P49; Elfenbein DW, 2012, REV ECON STUD, V79, P1441, DOI 10.1093/restud/rds012; Ellingsen T, 2010, GAME ECON BEHAV, V68, P95, DOI 10.1016/j.geb.2009.04.021; Ernest-Jones M, 2011, EVOL HUM BEHAV, V32, P172, DOI 10.1016/j.evolhumbehav.2010.10.006; ESHEL I, 1982, P NATL ACAD SCI-BIOL, V79, P1331, DOI 10.1073/pnas.79.4.1331; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fehr E, 2010, P ROY SOC B-BIOL SCI, V277, P1315, DOI 10.1098/rspb.2009.1900; Fehrler S, 2013, EVOL HUM BEHAV, V34, P139, DOI 10.1016/j.evolhumbehav.2012.11.005; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Frank R. H., 1988, PASSIONS REASON STRA; Frank RH, 2006, EMPATHY FAIRNESS NOV, P197; Gintis H, 2001, J THEOR BIOL, V213, P103, DOI 10.1006/jtbi.2001.2406; Gneezy U, 2005, AM ECON REV, V95, P384, DOI 10.1257/0002828053828662; Goffman E., 1969, STRATEGIC INTERACTIO; Goffman Erving, 1959, MISE SCENE VIE QUOTI; Gurven M, 2004, BEHAV BRAIN SCI, V27, P543, DOI 10.1017/S0140525X04000123; Haley KJ, 2005, EVOL HUM BEHAV, V26, P245, DOI 10.1016/j.evolhumbehav.2005.01.002; Ho B, 2012, MANAGE SCI, V58, P141, DOI 10.1287/mnsc.1110.1410; Hume D, 1738, TREATISE HUMAN NATUR; Hurkens S, 2009, EXP ECON, V12, P180, DOI 10.1007/s10683-008-9208-2; Kreps DM, 1990, PERSPECTIVES POSITIV, P90, DOI [DOI 10.1017/CBO9780511571657.006, 10.1017/CBO9780511571657.006]; McCabe KA, 2003, J ECON BEHAV ORGAN, V52, P267, DOI 10.1016/S0167-2681(03)00003-9; ORBELL J, 1991, AM POLIT SCI REV, V85, P515, DOI 10.2307/1963172; Przepiorka W, 2013, EUR SOCIOL REV, V29, P1010, DOI 10.1093/esr/jcs078; Raub W, 2004, RATION SOC, V16, P319, DOI 10.1177/1043463104044682; Schniter E, 2013, J ECON BEHAV ORGAN, V94, P242, DOI 10.1016/j.jebo.2012.09.011; Simpson B, 2008, SOC PSYCHOL QUART, V71, P37, DOI 10.1177/019027250807100106; Smith E.A., 2005, MORAL SENTIMENTS MAT, V6, P115; Snijders C, 1999, GAMES AND HUMAN BEHAVIOR, P355; Spence A. M., 1974, MARKET SIGNALING INF; Sperber D, 2012, MIND LANG, V27, P495, DOI 10.1111/mila.12000; Stanca L, 2009, J ECON BEHAV ORGAN, V71, P233, DOI 10.1016/j.jebo.2009.04.009; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Vieth M, 2009, THESIS ICS UTRECHT	56	26	26	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97533	10.1371/journal.pone.0097533	http://dx.doi.org/10.1371/journal.pone.0097533			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3UI	24831097	Green Published, gold, Green Submitted			2022-12-27	WOS:000336789500076
J	Hallstrom, H; Wolk, A; Glynn, A; Michaelsson, K; Byberg, L				Hallstrom, Helena; Wolk, Alicja; Glynn, Anders; Michaelsson, Karl; Byberg, Liisa			Coffee Consumption and Risk of Fracture in the Cohort of Swedish Men (COSM)	PLOS ONE			English	Article							BONE-MINERAL DENSITY; TOTAL PHYSICAL-ACTIVITY; HIGH-TRAUMA FRACTURES; HIP FRACTURE; CALCIUM ECONOMY; OLDER WOMEN; CAFFEINE; OSTEOPOROSIS; HEALTH; QUESTIONNAIRE	Background: Recent research in a large cohort of women showed that coffee consumption is not associated with increased risk of fracture. Whether this is the case also among men is less clear. Methods: In the Cohort of Swedish Men (COSM) study, 42,978 men aged 45-79 years old at baseline in 1997 answered a self-administered food frequency questionnaire covering coffee consumption and a medical and lifestyle questionnaire covering potential confounders. Our main outcomes first fracture at any site and first hip fracture were collected from the National Patient Registry in Sweden. The association between coffee consumption and fracture risk was investigated using Cox's proportional hazards regression. Results: During a mean follow-up of 11.2 years, 5,066 men had a first fracture at any site and of these, 1,186 (23%) were hip fractures. There was no association between increasing coffee consumption (per 200 ml) and rate of any fracture (hazard ratio [HR] 1.00; 95% confidence interval [CI] 0.99-1.02) or hip fracture (HR 1.02; 95% CI 0.99-1.06) after adjustment for potential confounders. For men consuming >= 4 cups of coffee/day compared to those consuming <1 cup of coffee/day, HR for any type of fracture was 0.91 (95% CI 0.80-1.02) and for hip fracture: 0.89 (95% CI 0.70-1.14). Conclusions: High coffee consumption was not associated with an increased risk of fractures in this large cohort of Swedish men.	[Hallstrom, Helena; Michaelsson, Karl; Byberg, Liisa] Uppsala Univ, Dept Surg Sci, Sect Orthopaed, Uppsala, Sweden; [Wolk, Alicja] Karolinska Inst, Inst Environm Med, Div Nutr Epidemiol, S-10401 Stockholm, Sweden; [Glynn, Anders] Natl Food Agcy, Risk & Benefit Assessment Dept, Uppsala, Sweden	Uppsala University; Karolinska Institutet; Swedish National Food Agency	Byberg, L (corresponding author), Uppsala Univ, Dept Surg Sci, Sect Orthopaed, Uppsala, Sweden.	liisa.byberg@surgsci.uu.se	Michaelsson, Karl/AAM-9094-2021	Michaelsson, Karl/0000-0003-2815-1217	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was funded by the Swedish Research Council. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson HC, 2004, TEMANORD, V2004, P565; BARGERLUX MJ, 1995, OSTEOPOROSIS INT, V5, P97, DOI 10.1007/BF01623310; Bergstrom L., 1991, Var Foda, V43, P439; Calltorp J, 1996, LANCET, V347, P587, DOI 10.1016/S0140-6736(96)91278-7; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen Z, 2003, AM J EPIDEMIOL, V158, P772, DOI 10.1093/aje/kwg214; Discacciati A, 2013, ANN ONCOL, V24, P1912, DOI 10.1093/annonc/mdt105; Dy CJ, 2011, CLIN ORTHOP RELAT R, V469, P1906, DOI 10.1007/s11999-011-1849-3; European Coffee Federation, 2013, EUR COFF REP 2012 13; Fenton TR, 2009, J BONE MINER RES, V24, P1835, DOI [10.1359/jbmr.090515, 10.1359/JBMR.090515]; Fredholm BB, 1999, PHARMACOL REV, V51, P83; Hallstrom H, 2013, AM J EPIDEMIOL, V178, P898, DOI 10.1093/aje/kwt062; Hallstrom H, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-12; Hanley DA, 2013, J CLIN DENSITOM, V16, P420, DOI 10.1016/j.jocd.2013.08.014; Hansson LM, 2000, NUTR CANCER, V36, P1, DOI 10.1207/S15327914NC3601_1; Heaney RP, 2002, FOOD CHEM TOXICOL, V40, P1263, DOI 10.1016/S0278-6915(02)00094-7; Hegarty VM, 2000, AM J CLIN NUTR, V71, P1003; Heinzl H, 1997, COMPUT METH PROG BIO, V54, P201, DOI 10.1016/S0169-2607(97)00043-6; Jarvinen TLN, 2008, BRIT MED J, V336, P124, DOI 10.1136/bmj.39428.470752.AD; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Kanis J, 1999, OSTEOPOROSIS INT, V9, P45, DOI 10.1007/s001980050115; Kanis JA, 2012, OSTEOPOROSIS INT, V23, P2239, DOI 10.1007/s00198-012-1964-3; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P737, DOI 10.1007/s00198-004-1640-3; KIEL DP, 1990, AM J EPIDEMIOL, V132, P675, DOI 10.1093/oxfordjournals.aje.a115709; Lane NE, 2006, AM J OBSTET GYNECOL, V194, pS3, DOI 10.1016/j.ajog.2005.08.047; Larsson SC, 2006, EUR J CANCER, V42, P2590, DOI 10.1016/j.ejca.2006.04.015; Liu HF, 2012, ARCH MED SCI, V8, P776, DOI 10.5114/aoms.2012.31612; Lu PZ, 2008, INT J MOL SCI, V9, P698, DOI 10.3390/ijms9050698; Mackey DC, 2007, JAMA-J AM MED ASSOC, V298, P2381, DOI 10.1001/jama.298.20.2381; Mandel HG, 2002, FOOD CHEM TOXICOL, V40, P1231, DOI 10.1016/S0278-6915(02)00093-5; Mangano KM, 2014, CURR OPIN CLIN NUTR, V17, P69, DOI 10.1097/MCO.0000000000000013; MASSEY LK, 1990, NUTR RES, V10, P741, DOI 10.1016/S0271-5317(05)80823-1; Messerer M, 2004, J NUTR, V134, P1800, DOI 10.1093/jn/134.7.1800; Meyer HE, 1997, AM J EPIDEMIOL, V145, P117, DOI 10.1093/oxfordjournals.aje.a009082; Michaelsson K, 2003, NEW ENGL J MED, V348, P287, DOI 10.1056/NEJMoa021171; Norman A, 2002, INT J OBESITY, V26, P670, DOI 10.1038/sj.ijo.0801955; Norman A, 2001, INT J OBESITY, V25, P682, DOI 10.1038/sj.ijo.0801597; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rapuri PB, 2007, J STEROID BIOCHEM, V103, P368, DOI 10.1016/j.jsbmb.2006.12.037; Sanders KM, 1998, J BONE MINER RES, V13, P1337, DOI 10.1359/jbmr.1998.13.8.1337; Trimpou P, 2010, OSTEOPOROSIS INT, V21, P409, DOI 10.1007/s00198-009-0961-7; Tsuang Yang-Hwei, 2006, J Orthop Surg Res, V1, P7, DOI 10.1186/1749-799X-1-7; Wagner H, 2009, AM J EPIDEMIOL, V169, P143, DOI 10.1093/aje/kwn379; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Wu CH, 2002, ARCH INTERN MED, V162, P1001, DOI 10.1001/archinte.162.9.1001; Zhou Y, 2010, BRIT J PHARMACOL, V161, P1542, DOI 10.1111/j.1476-5381.2010.00998.x	46	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97770	10.1371/journal.pone.0097770	http://dx.doi.org/10.1371/journal.pone.0097770			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830750	Green Submitted, Green Published, gold			2022-12-27	WOS:000336789500113
J	Hu, JL; Li, YL; Cheng, WB; Yang, Z; Wang, F; Lv, P; Niu, C; Hou, YM; Yan, Y; Ge, JB				Hu, Jialu; Li, Yinliang; Cheng, Wenbo; Yang, Zhen; Wang, Fang; Lv, Peng; Niu, Conway; Hou, Yuemei; Yan, Yan; Ge, Junbo			A Comparison of the Efficacy of Surgical Renal Denervation and Pharmacologic Therapies in Post-Myocardial Infarction Heart Failure	PLOS ONE			English	Article							SYMPATHETIC DENERVATION	Objective: Although renal denervation (RD) has been shown to be effective in treating post-myocardial Infarction (MI) heart failure (HF) in animal models and clinical trials, its utility as a standalone treatment without traditional drug treatment for post-MI HF still needs to be investigated. Methods: Rats were randomly assigned into seven experimental groups: N group (control group with no MI and no RD, n = 10), MI group (MI, n = 20), RD group (renal denervation, n = 10), RD-3d+MI group (RD performed three days before MI, n = 15), beta-blocker-3d+MI group (Metoprolol treated three days before MI, n = 15), ACEI-3d+MI group (Perindopril treated three days before MI, n = 15), and ARB-3d+MI group (Losartan treated three days before MI, n = 15). Cardiac function, autonomic nervous system parameters, and neuroendocrine activities were evaluated 8 weeks post MI. Results: Compared to beta-blockers, ACEIs, and ARBs, RD alone provided significantly better cardiac remodeling and function, enhanced water and sodium excretion, and improved autonomic modulation. Conclusions: In this post-MI HF animal model, surgical RD provides effective autonomic modulation, inhibition of the RAAS, improved cardiac remodeling, and preserved renal function, without affecting normal circulation and cardiopulmonary function in normal rats. Compared to beta-blocker, ACEI, and ARB single-drug therapies, RD alone is more efficacious. These results suggest that RD may be an effective treatment option for HF, especially in patients who have contraindications to drug therapy.	[Hu, Jialu; Li, Yinliang; Yang, Zhen; Yan, Yan; Ge, Junbo] Fudan Univ, Zhongshan Hosp, Dept Cardiol, Shanghai 200433, Peoples R China; [Cheng, Wenbo; Wang, Fang; Hou, Yuemei] Shanghai Jiao Tong Univ, Dept Cardiol, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China; [Lv, Peng] Fudan Univ, Zhongshan Hosp, Dept Diagnost Radiol, Shanghai 200433, Peoples R China; [Niu, Conway] Fudan Univ, Shanghai Med Coll, Shanghai 200433, Peoples R China	Fudan University; Shanghai Jiao Tong University; Fudan University; Fudan University	Hou, YM (corresponding author), Shanghai Jiao Tong Univ, Dept Cardiol, Affiliated Peoples Hosp 6, South Campus, Shanghai 200030, Peoples R China.	houyuemei@sina.com; yan.yan@zs-hospital.sh.cn; ge.junbo@zs-hospital.sh.cn		Niu, Conway/0000-0002-0078-5173	International Science and Technology Cooperation Project of the Ministry of Science and Technology of China [2011DFA32860]; Shanghai Science and Technology Commission Research Projects [10411956900]	International Science and Technology Cooperation Project of the Ministry of Science and Technology of China; Shanghai Science and Technology Commission Research Projects	This study was supported by the International Science and Technology Cooperation Project of the Ministry of Science and Technology of China (2011DFA32860) and the Shanghai Science and Technology Commission Research Projects (10411956900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandt MC, 2012, J AM COLL CARDIOL, V59, P901, DOI 10.1016/j.jacc.2011.11.034; Davies JE, 2013, INT J CARDIOL, V162, P189, DOI 10.1016/j.ijcard.2012.09.019; DiBona GF, 2004, AM J PHYSIOL-RENAL, V286, pF1209, DOI 10.1152/ajprenal.00010.2004; Fox M, 2007, HEALTH TECHNOL ASSES, V11, P1; Hu JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045986; Igawa A, 2000, AM J PHYSIOL, V278, P1134; Jorde Ulrich P, 2006, Cardiol Rev, V14, P81, DOI 10.1097/01.crd.0000201550.94389.50; Krum H, 2009, LANCET, V373, P1275, DOI 10.1016/S0140-6736(09)60566-3; Linz D, 2013, HEART RHYTHM, V10, P1525, DOI 10.1016/j.hrthm.2013.07.015; Lymperopoulos A, 2013, CIRC RES, V113, P739, DOI 10.1161/CIRCRESAHA.113.300308; Nozawa T, 2002, HEART VESSELS, V16, P51, DOI 10.1007/s380-002-8317-8; Sadowski J, 2011, HYPERTENSION, V57, P911, DOI 10.1161/HYPERTENSIONAHA.110.163014; Sobotka PA, 2012, CURR CARDIOL REP, V14, P285, DOI 10.1007/s11886-012-0258-x	13	24	25	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e96996	10.1371/journal.pone.0096996	http://dx.doi.org/10.1371/journal.pone.0096996			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830442	Green Published, gold, Green Submitted			2022-12-27	WOS:000336789500028
J	Miyoshi, K; Kasahara, K; Murakami, S; Takeshima, M; Kumamoto, N; Sato, A; Miyazaki, I; Matsuzaki, S; Sasaoka, T; Katayama, T; Asanuma, M				Miyoshi, Ko; Kasahara, Kyosuke; Murakami, Shinki; Takeshima, Mika; Kumamoto, Natsuko; Sato, Asako; Miyazaki, Ikuko; Matsuzaki, Shinsuke; Sasaoka, Toshikuni; Katayama, Taiichi; Asanuma, Masato			Lack of Dopaminergic Inputs Elongates the Primary Cilia of Striatal Neurons	PLOS ONE			English	Article							PROTEIN-COUPLED-RECEPTORS; ADENYLYL-CYCLASE; INTRAFLAGELLAR TRANSPORT; BASAL GANGLIA; LOCALIZATION; DISEASE; LENGTH; BRAIN; IDENTIFICATION; INTERNEURONS	In the rodent brain, certain G protein-coupled receptors and adenylyl cyclase type 3 are known to localize to the neuronal primary cilium, a primitive sensory organelle protruding singly from almost all neurons. A recent chemical screening study demonstrated that many compounds targeting dopamine receptors regulate the assembly of Chlamydomonas reinhardtii flagella, structures which are analogous to vertebrate cilia. Here we investigated the effects of dopaminergic inputs loss on the architecture of neuronal primary cilia in the rodent striatum, a brain region that receives major dopaminergic projections from the midbrain. We first analyzed the lengths of neuronal cilia in the dorsolateral striatum of hemi-parkinsonian rats with unilateral lesions of the nigrostriatal dopamine pathway. In these rats, the striatal neuronal cilia were significantly longer on the lesioned side than on the non-lesioned side. In mice, the repeated injection of reserpine, a dopamine-depleting agent, elongated neuronal cilia in the striatum. The combined administration of agonists for dopamine receptor type 2 (D2) with reserpine attenuated the elongation of striatal neuronal cilia. Repeated treatment with an antagonist of D2, but not of dopamine receptor type 1 (D1), elongated the striatal neuronal cilia. In addition, D2-null mice displayed longer neuronal cilia in the striatum compared to wild-type controls. Reserpine treatment elongated the striatal neuronal cilia in D1-null mice but not in D2-null mice. Repeated treatment with a D2 agonist suppressed the elongation of striatal neuronal cilia on the lesioned side of hemi-parkinsonian rats. These results suggest that the elongation of striatal neuronal cilia following the lack of dopaminergic inputs is attributable to the absence of dopaminergic transmission via D2 receptors. Our results provide the first evidence that the length of neuronal cilia can be modified by the lack of a neurotransmitter's input.	[Miyoshi, Ko; Matsuzaki, Shinsuke; Katayama, Taiichi] Osaka Univ, United Grad Sch Child Dev, Dept Child Dev & Mol Brain Sci, Suita, Osaka, Japan; [Miyoshi, Ko; Matsuzaki, Shinsuke] Osaka Univ, United Grad Sch Child Dev, Mol Res Ctr Childrens Mental Dev, Suita, Osaka, Japan; [Miyoshi, Ko; Kasahara, Kyosuke; Murakami, Shinki; Takeshima, Mika; Miyazaki, Ikuko; Asanuma, Masato] Okayama Univ, Dept Brain Sci, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; [Kumamoto, Natsuko] Nagoya City Univ, Grad Sch Med Sci, Dept Neurobiol & Anat, Nagoya, Aichi, Japan; [Sato, Asako] Kitasato Univ, Sch Med, Dept Lab Anim Sci, Sagamihara, Kanagawa 228, Japan; [Matsuzaki, Shinsuke] Osaka Univ, Dept Anat & Neurosci, Grad Sch Med, Suita, Osaka, Japan; [Sasaoka, Toshikuni] Niigata Univ, Brain Res Inst, Ctr Bioresource Based Res, Dept Comparat & Expt Med, Niigata, Japan	Osaka University; Osaka University; Okayama University; Nagoya City University; Kitasato University; Osaka University; Niigata University	Miyoshi, K (corresponding author), Osaka Univ, United Grad Sch Child Dev, Dept Child Dev & Mol Brain Sci, Suita, Osaka, Japan.	miyoshi@ugscd.osaka-u.ac.jp	, 笹岡俊邦/N-9152-2015	, 笹岡俊邦/0000-0002-7797-4394	Japanese Ministry of Education, Culture, Sports, Science and Technology [24111533, 21591082, 22590934, 25461279]; Grants-in-Aid for Scientific Research [24659431] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in part, by Grants-in-aid for Scientific Research on Innovative Areas "Brain Environment'' (KAKENHI #24111533; MA) and for Scientific Research (C) (KAKENHI #21591082; MA and #22590934, #25461279; IM) from the Japanese Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara AA, 2003, BRAIN RES, V986, P22, DOI 10.1016/S0006-8993(03)03165-2; Avasthi P, 2012, ACS CHEM BIOL, V7, P911, DOI 10.1021/cb200349v; BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; Berbari NF, 2008, MOL BIOL CELL, V19, P1540, DOI 10.1091/mbc.E07-09-0942; Berbari NF, 2007, J NEUROSCI RES, V85, P1095, DOI 10.1002/jnr.21209; Besschetnova TY, 2010, CURR BIOL, V20, P182, DOI 10.1016/j.cub.2009.11.072; Bishop GA, 2007, J COMP NEUROL, V505, P562, DOI 10.1002/cne.21510; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; Domire JS, 2011, CELL MOL LIFE SCI, V68, P2951, DOI 10.1007/s00018-010-0603-4; Einstein EB, 2010, J NEUROSCI, V30, P4306, DOI 10.1523/JNEUROSCI.5295-09.2010; Fuchs JL, 2004, CELL BIOL INT, V28, P111, DOI 10.1016/j.cellbi.2003.11.008; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Green JA, 2010, CELL MOL LIFE SCI, V67, P3287, DOI 10.1007/s00018-010-0425-4; Hamon M, 1999, NEUROPSYCHOPHARMACOL, V21, pS68, DOI 10.1038/sj.npp.1395368; Han YG, 2010, CURR OPIN NEUROBIOL, V20, P58, DOI 10.1016/j.conb.2009.12.002; Handel M, 1999, NEUROSCIENCE, V89, P909, DOI 10.1016/S0306-4522(98)00354-6; Iwanaga T, 2011, BIOMED RES-TOKYO, V32, P225, DOI 10.2220/biomedres.32.225; Kawaguchi Y, 1997, NEUROSCI RES, V27, P1, DOI 10.1016/S0168-0102(96)01134-0; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Lee JH, 2010, NEUROBIOL DIS, V38, P167, DOI 10.1016/j.nbd.2009.12.022; Lee JE, 2011, CURR OPIN NEUROL, V24, P98, DOI 10.1097/WCO.0b013e3283444d05; LEVEY AI, 1993, P NATL ACAD SCI USA, V90, P8861, DOI 10.1073/pnas.90.19.8861; Loktev AV, 2013, CELL REP, V5, P1316, DOI 10.1016/j.celrep.2013.11.011; Louvi A, 2011, NEURON, V69, P1046, DOI 10.1016/j.neuron.2011.03.002; Marley A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046647; Marley A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010902; Marshall WF, 2001, J CELL BIOL, V155, P405, DOI 10.1083/jcb.200106141; Miyazaki I, 2000, NEUROSCI LETT, V293, P65, DOI 10.1016/S0304-3940(00)01488-9; Miyoshi K, 2011, ACTA MED OKAYAMA, V65, P279; Miyoshi K, 2009, BIOCHEM BIOPH RES CO, V388, P757, DOI 10.1016/j.bbrc.2009.08.099; Mukhopadhyay S, 2013, CELL, V152, P210, DOI 10.1016/j.cell.2012.12.026; Ou Y, 2009, EXP CELL RES, V315, P2802, DOI 10.1016/j.yexcr.2009.06.028; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Rymar VV, 2004, J COMP NEUROL, V469, P325, DOI 10.1002/cne.11008; Savchenko VL, 2000, NEUROSCIENCE, V96, P195, DOI 10.1016/S0306-4522(99)00538-2; Sharma N, 2011, MOL BIOL CELL, V22, P806, DOI 10.1091/mbc.E10-03-0269; SMITH AD, 1990, TRENDS NEUROSCI, V13, P259; Soetedjo L, 2013, BIOL OPEN, V2, DOI 10.1242/bio.20134747; Stanic D, 2009, BRAIN RES, V1249, P101, DOI 10.1016/j.brainres.2008.10.024; Tran AH, 2008, J NEUROSCI, V28, P13390, DOI 10.1523/JNEUROSCI.2680-08.2008; Wang ZS, 2011, J NEUROSCI, V31, P5557, DOI 10.1523/JNEUROSCI.6561-10.2011; Whitfield JF, 2009, CELL SIGNAL, V21, P1351, DOI 10.1016/j.cellsig.2009.02.013; Yamaguchi H, 1996, GENES CELLS, V1, P253, DOI 10.1046/j.1365-2443.1996.d01-238.x	45	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97918	10.1371/journal.pone.0097918	http://dx.doi.org/10.1371/journal.pone.0097918			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830745	Green Published, gold, Green Submitted			2022-12-27	WOS:000336789500132
J	Saenz, FR; Ory, V; AlOtaiby, M; Rosenfield, S; Furlong, M; Cavalli, LR; Johnson, MD; Liu, XF; Schlegel, R; Wellstein, A; Riegel, AT				Saenz, Francisco R.; Ory, Virginie; AlOtaiby, Maram; Rosenfield, Sonia; Furlong, Mary; Cavalli, Luciane R.; Johnson, Michael D.; Liu, Xuefeng; Schlegel, Richard; Wellstein, Anton; Riegel, Anna T.			Conditionally Reprogrammed Normal and Transformed Mouse Mammary Epithelial Cells Display a Progenitor-Cell-Like Phenotype	PLOS ONE			English	Article							CANCER STEM-CELLS; BREAST-CANCER; MESENCHYMAL TRANSITION; ROCK INHIBITOR; SELF-RENEWAL; TUMORIGENESIS; SENESCENCE; GENERATION; INSIGHTS; DISEASE	Mammary epithelial (ME) cells cultured under conventional conditions senesce after several passages. Here, we demonstrate that mouse ME cells isolated from normal mammary glands or from mouse mammary tumor virus (MMTV)-Neu-induced mammary tumors, can be cultured indefinitely as conditionally reprogrammed cells (CRCs) on irradiated fibroblasts in the presence of the Rho kinase inhibitor Y-27632. Cell surface progenitor-associated markers are rapidly induced in normal mouse ME-CRCs relative to ME cells. However, the expression of certain mammary progenitor subpopulations, such as CD49f(+) ESA(+) CD44(+), drops significantly in later passages. Nevertheless, mouse ME-CRCs grown in a three-dimensional extracellular matrix gave rise to mammary acinar structures. ME-CRCs isolated from MMTV-Neu transgenic mouse mammary tumors express high levels of HER2/neu, as well as tumor-initiating cell markers, such as CD44(+), CD49f(+), and ESA(+) (EpCam). These patterns of expression are sustained in later CRC passages. Early and late passage ME-CRCs from MMTV-Neu tumors that were implanted in the mammary fat pads of syngeneic or nude mice developed vascular tumors that metastasized within 6 weeks of transplantation. Importantly, the histopathology of these tumors was indistinguishable from that of the parental tumors that develop in the MMTV-Neu mice. Application of the CRC system to mouse mammary epithelial cells provides an attractive model system to study the genetics and phenotype of normal and transformed mouse epithelium in a defined culture environment and in vivo transplant studies.	[Saenz, Francisco R.; Ory, Virginie; AlOtaiby, Maram; Rosenfield, Sonia; Cavalli, Luciane R.; Johnson, Michael D.; Wellstein, Anton; Riegel, Anna T.] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA; [Furlong, Mary; Liu, Xuefeng; Schlegel, Richard] Georgetown Univ, Dept Pathol, Lombardi Comprehens Canc Ctr, Washington, DC USA	Georgetown University; Georgetown University	Riegel, AT (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA.	ariege01@georgetown.edu	Saenz, Francisco/ABE-7477-2020; Cavalli, Luciane R/J-6100-2012; Al-Otaiby, Maram/AAX-4283-2021	Saenz, Francisco/0000-0003-4738-4710; Al-Otaiby, Maram/0000-0002-6383-2301; Wellstein, Anton/0000-0002-0570-4950; Cavalli, Luciane Regina/0000-0001-5619-9037	National Institutes of Health/National Cancer Institute [CA113477]; Development Grant under CCSG National Cancer Institute [P30CA051008]; Cherry Blossom Breast Cancer Foundation Grant; Susan G Komen Training Grant [PBTDR12228366];  [CA177466];  [CA180524]; NATIONAL CANCER INSTITUTE [T32CA009686, R33CA177466, P30CA051008, R01CA113477] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Development Grant under CCSG National Cancer Institute; Cherry Blossom Breast Cancer Foundation Grant; Susan G Komen Training Grant; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded in part by National Institutes of Health/National Cancer Institute grants CA113477 (ATR), Development Grant (ATR) under CCSG Number P30CA051008 from the National Cancer Institute, CA177466 (RS and AW), CA180524 (XL) and by the Cherry Blossom Breast Cancer Foundation Grant (XL). FS is supported by Susan G Komen Training Grant PBTDR12228366. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batts TD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027841; Castro DJ, 2013, STEM CELLS, V31, P12, DOI 10.1002/stem.1224; Chapman S, 2010, J CLIN INVEST, V120, P2619, DOI 10.1172/JCI42297; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Fereshteh MP, 2008, CANCER RES, V68, P3697, DOI 10.1158/0008-5472.CAN-07-6702; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Itahana K, 2004, BIOGERONTOLOGY, V5, P1, DOI 10.1023/B:BGEN.0000017682.96395.10; Jeselsohn R, 2010, CANCER CELL, V17, P65, DOI 10.1016/j.ccr.2009.11.024; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Li Y, 2005, J MAMMARY GLAND BIOL, V10, P17, DOI 10.1007/s10911-005-2537-2; Lindeman GJ, 2010, ASIA-PAC J CLIN ONCO, V6, P89, DOI 10.1111/j.1743-7563.2010.01279.x; Liu JC, 2007, CANCER RES, V67, P8671, DOI 10.1158/0008-5472.CAN-07-1486; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Lo PK, 2012, ONCOGENE, V31, P2614, DOI [10.1038/onc.2011.439, 10.1038/onc.2012.147]; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Matulka LA, 2007, DEV BIOL, V303, P29, DOI 10.1016/j.ydbio.2006.12.017; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Oh A, 2004, CANCER RES, V64, P8299, DOI 10.1158/0008-5472.CAN-04-0354; Owens TW, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00225; Pakzad M, 2010, STEM CELL REV REP, V6, P96, DOI 10.1007/s12015-009-9103-z; Palechor-Ceron N, 2013, AM J PATHOL, V183, P1862, DOI 10.1016/j.ajpath.2013.08.009; Roig AI, 2010, GASTROENTEROLOGY, V138, P1012, DOI 10.1053/j.gastro.2009.11.052; Rosenfield SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047876; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Stingl J, 2006, NATURE, V5; Suprynowicz FA, 2012, P NATL ACAD SCI USA, V109, P20035, DOI 10.1073/pnas.1213241109; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Wright WE, 2000, NAT MED, V6, P849, DOI 10.1038/78592; Yuan H, 2012, NEW ENGL J MED, V367, P1220, DOI 10.1056/NEJMoa1203055	32	24	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97666	10.1371/journal.pone.0097666	http://dx.doi.org/10.1371/journal.pone.0097666			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831228	gold, Green Published, Green Submitted			2022-12-27	WOS:000336789500098
J	Wang, SG; Hibberd, ML; Pettersson, S; Lee, YK				Wang, Shugui; Hibberd, Martin Lloyd; Pettersson, Sven; Lee, Yuan Kun			Enterococcus faecalis from Healthy Infants Modulates Inflammation through MAPK Signaling Pathways	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; INTESTINAL EPITHELIAL-CELLS; LACTIC-ACID BACTERIA; FACTOR 4E EIF4E; PRETERM INFANTS; GUT MICROBIOTA; KINASE; COLONIZATION; NEUTROPHILS; MICROFLORA	Colonizing commensal bacteria after birth are required for the proper development of the gastrointestinal tract. It is believed that bacterial colonization pattern in neonatal gut affects gut barrier function and immune system maturation. Studies on the development of faecal microbiota in infants showed that the neonatal gut was first colonized with enterococci followed by other microbiota such as Bifidobacterium. Other studies showed that babies who developed allergy were less often colonized with Enterococcus during the first month of life as compared to healthy infants. Many studies have been conducted to elucidate how bifidobacteria or lactobacilli, some of which are considered probiotic, regulate infant gut immunity. However, fewer studies have been focused on enterococi. In our study, we demonstrate that E. faecalis, isolated from healthy newborns, suppress inflammatory responses activated in vivo and in vitro. We found E. faecalis attenuates proinflammatory cytokine secretions, especially IL-8, through JNK and p38 signaling pathways. This finding shed light on how the first colonizer, E. faecalis, regulates inflammatory responses in the host.	[Wang, Shugui; Lee, Yuan Kun] Natl Univ Singapore, Dept Microbiol, Singapore 117548, Singapore; [Wang, Shugui; Pettersson, Sven] Natl Canc Ctr Singapore, Div Cellular & Mol Res, Singapore, Singapore; [Hibberd, Martin Lloyd] Genome Inst Singapore, Singapore, Singapore; [Pettersson, Sven] Karolinska Inst, Microbiol & Tumor Biol Ctr, Stockholm, Sweden	National University of Singapore; National Cancer Centre Singapore (NCCS); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Karolinska Institutet	Lee, YK (corresponding author), Natl Univ Singapore, Dept Microbiol, Singapore 117548, Singapore.	yuan_kun_lee@nuhs.edu.sg	Pettersson, Sven/F-9511-2015	Hibberd, Martin/0000-0001-8587-1849	National Research Foundation EWI Incentive for Research and Innovation Scheme	National Research Foundation EWI Incentive for Research and Innovation Scheme	The work is supported by National Research Foundation EWI Incentive for Research and Innovation Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Are A, 2008, P NATL ACAD SCI USA, V105, P1943, DOI 10.1073/pnas.0711734105; BAGGIOLINI M, 1989, J CLIN INVEST, V84, P1045, DOI 10.1172/JCI114265; Bjorksten B, 2001, J ALLERGY CLIN IMMUN, V108, P516, DOI 10.1067/mai.2001.118130; BRAEGGER CP, 1992, LANCET, V339, P89, DOI 10.1016/0140-6736(92)90999-J; BREESE EJ, 1994, GASTROENTEROLOGY, V106, P1455, DOI 10.1016/0016-5085(94)90398-0; Carey CM, 2013, CAN J MICROBIOL, V59, P9, DOI 10.1139/cjm-2012-0446; Chang SH, 2006, AM J RESP CELL MOL, V35, P528, DOI 10.1165/rcmb.2005-0477OC; Chen LL, 2009, WORLD J GASTROENTERO, V15, P321, DOI 10.3748/wjg.15.321; Conner-Kerr T A, 1998, Ostomy Wound Manage, V44, P50; DJEU JY, 1990, J IMMUNOL, V144, P2205; Edelson MB, 1999, PEDIATRICS, V103, P766, DOI 10.1542/peds.103.4.766; Fanaro S, 2003, ACTA PAEDIATR, V92, P48; Gewolb IH, 1999, ARCH DIS CHILD-FETAL, V80, pF167, DOI 10.1136/fn.80.3.F167; Hollenbach E, 2004, FASEB J, V18, P1550, DOI 10.1096/fj.04-1642fje; HUBER AR, 1991, SCIENCE, V254, P99, DOI 10.1126/science.1718038; Hufnagel M, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-107; Ihara E, 2009, MOL PHARMACOL, V75, P1031, DOI 10.1124/mol.108.049858; ISEKI K, 1987, Hokkaido Journal of Medical Science, V62, P895; Jijon HB, 2002, AM J PHYSIOL-CELL PH, V283, pC31, DOI 10.1152/ajpcell.00113.2001; Jijon HB, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/207398; Kalliomaki M, 2012, J PEDIATR GASTR NUTR, V54, P727, DOI 10.1097/MPG.0b013e318241cfa8; Lin HY, 2013, J FORMOS MED ASS; Madan JC, 2012, CURR OPIN PEDIATR, V24, P753, DOI 10.1097/MOP.0b013e32835a1ac8; Morowitz MJ, 2011, P NATL ACAD SCI USA, V108, P1128, DOI 10.1073/pnas.1010992108; MURCH SH, 1993, GUT, V34, P1705, DOI 10.1136/gut.34.12.1705; Normann E, 2013, ACTA PAEDIATR, V102, P129, DOI 10.1111/apa.12059; Nueno-Palop C, 2011, INT J FOOD MICROBIOL, V145, P390, DOI 10.1016/j.ijfoodmicro.2010.12.029; Orrhage K, 1999, ACTA PAEDIATR, V88, P47; Otte JM, 2004, GASTROENTEROLOGY, V126, P1054, DOI 10.1053/j.gastro.2004.01.007; Perez-Cano FJ, 2010, IMMUNOBIOLOGY, V215, P996, DOI 10.1016/j.imbio.2010.01.004; Pinholt M, 2013, CLIN MICROBIOL INFEC; Rafferty BJ, 2012, CELL IMMUNOL, V280, P148, DOI 10.1016/j.cellimm.2012.12.003; Robyn J, 2012, BENEF MICROBES, V3, P299, DOI 10.3920/BM2012.0021; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schwiertz A, 2003, PEDIATR RES, V54, P393, DOI 10.1203/01.PDR.0000078274.74607.7A; Shon WJ, 2005, J ENDODONT, V31, P369, DOI 10.1097/01.don.0000145420.29539.78; Shveygert M, 2010, MOL CELL BIOL, V30, P5160, DOI 10.1128/MCB.00448-10; Sjogren YM, 2009, CLIN EXP ALLERGY, V39, P1842, DOI 10.1111/j.1365-2222.2009.03326.x; Stewart CJ, 2012, ACTA PAEDIATR, V101, P1121, DOI 10.1111/j.1651-2227.2012.02801.x; Wang SG, 2008, WORLD J GASTROENTERO, V14, P1067, DOI 10.3748/wjg.14.1067; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wolf A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029256; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Zhou S, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-231	44	67	75	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97523	10.1371/journal.pone.0097523	http://dx.doi.org/10.1371/journal.pone.0097523			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830946	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000336789500075
J	Yung, LC; Fei, CC; Mandeep, JS; Abdullah, HB; Wee, LK				Yung, Lai Chin; Fei, Cheong Choke; Mandeep, J. S.; Abdullah, Huda Binti; Wee, Lai Khin			Synthesis of a Nano-Silver Metal Ink for Use in Thick Conductive Film Fabrication Applied on a Semiconductor Package	PLOS ONE			English	Article							EPOXY MOLDING COMPOUND; AG-TI; TEMPERATURE; ADHESION	The success of printing technology in the electronics industry primarily depends on the availability of metal printing ink. Various types of commercially available metal ink are widely used in different industries such as the solar cell, radio frequency identification (RFID) and light emitting diode (LED) industries, with limited usage in semiconductor packaging. The use of printed ink in semiconductor IC packaging is limited by several factors such as poor electrical performance and mechanical strength. Poor adhesion of the printed metal track to the epoxy molding compound is another critical factor that has caused a decline in interest in the application of printing technology to the semiconductor industry. In this study, two different groups of adhesion promoters, based on metal and polymer groups, were used to promote adhesion between the printed ink and the epoxy molding substrate. The experimental data show that silver ink with a metal oxide adhesion promoter adheres better than silver ink with a polymer adhesion promoter. This result can be explained by the hydroxyl bonding between the metal oxide promoter and the silane grouping agent on the epoxy substrate, which contributes a greater adhesion strength compared to the polymer adhesion promoter. Hypotheses of the physical and chemical functions of both adhesion promoters are described in detail.	[Yung, Lai Chin; Fei, Cheong Choke] Infineon Technol Malaysia Sdn Bhd 56645D, Melaka Operat, Free Trade Zone, Batu Berendam, Melaka, Malaysia; [Yung, Lai Chin; Mandeep, J. S.; Abdullah, Huda Binti] Univ Kebangsaan Malaysia, Dept Elect Elect & Syst Engn, Fac Engn & Built Environm, Bangi 43600, Selangor, Malaysia; [Wee, Lai Khin] Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur, Malaysia	Universiti Kebangsaan Malaysia; Universiti Malaya	Yung, LC (corresponding author), Infineon Technol Malaysia Sdn Bhd 56645D, Melaka Operat, Free Trade Zone, Batu Berendam, Melaka, Malaysia.	ChinYung.Lai@infineon.com	Singh, Mandeep/AAC-8680-2020; singh, mandeep/W-7242-2019; Lai, Khin Wee/A-2997-2011	Lai, Khin Wee/0000-0002-8602-0533	National University of Malaysia; Infineon Technologies (Malaysia) Sdn Bhd; Infineon Technologies (Malaysia)	National University of Malaysia; Infineon Technologies (Malaysia) Sdn Bhd; Infineon Technologies (Malaysia)	This evaluation work was support by National University of Malaysia and Infineon Technologies (Malaysia) Sdn Bhd. Infineon Technologies (Malaysia) only provided the scholarship for their employee, Lai Chin Yung but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelbary A., 2004, ALEXANDRIA ENG J, V43, P615; ASHBY MF, 1974, ACTA METALL MATER, V22, P275, DOI 10.1016/0001-6160(74)90167-9; Chen SW, 2005, MATER TRANS, V46, P2536, DOI 10.2320/matertrans.46.2536; Ding LF, 2009, COMP MATER SCI, V45, P247, DOI 10.1016/j.commatsci.2008.09.021; Fischer P, 2004, THIN SOLID FILMS, V453, P139, DOI 10.1016/j.tsf.2003.11.152; Greer JR, 2007, ACTA MATER, V55, P6345, DOI 10.1016/j.actamat.2007.07.040; Hang T, 2007, J ELECTRON MATER, V36, P1594, DOI 10.1007/s11664-007-0292-4; Ismagilov ZR, 2009, RUSS CHEM REV+, V78, P873, DOI 10.1070/RC2009v078n09ABEH004082; Kamyshny A., 2011, OPEN APPL PHYS J, V4, P19, DOI [10.2174/1874183501104010019, DOI 10.2174/1874183501104010019]; Knoerr M., 2010, P 2010 6 INT C INTEG, P1; Krebs FC, 2009, ORG ELECTRON, V10, P761, DOI 10.1016/j.orgel.2009.03.009; Kumpulainen T, 2011, OPT LASER TECHNOL, V43, P570, DOI 10.1016/j.optlastec.2010.08.002; Moon KS, 2005, J ELECTRON MATER, V34, P168, DOI 10.1007/s11664-005-0229-8; Ni MZ, 2012, MICROELECTRON RELIAB, V52, P206, DOI 10.1016/j.microrel.2011.07.095; Perelaer J, 2008, J MATER CHEM, V18, P3209, DOI 10.1039/b720032c; Perelaer J, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/16/165303; Qi WH, 2002, J MATER SCI LETT, V21, P1743, DOI 10.1023/A:1020904317133; Schroder K. A., 2011, NAN C EXP 2011, V2, P220; Thierry C, 2002, Substrate with a photocatalytic coating based on titanium dioxide and organic dispersions based on titanium dioxide, Patent No. [US 6362121 B1, 6362121]; van der Eijk C, 2008, SCRIPTA MATER, V58, P779, DOI 10.1016/j.scriptamat.2007.12.017; Wang T, 2007, J ELECTRON MATER, V36, P1333, DOI 10.1007/s11664-007-0230-5; Wong CKY, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3167358; Xie GQ, 2003, METALL MATER TRANS A, V34A, P2655, DOI 10.1007/s11661-003-0024-1	23	13	13	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97484	10.1371/journal.pone.0097484	http://dx.doi.org/10.1371/journal.pone.0097484			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830317	gold, Green Submitted, Green Published			2022-12-27	WOS:000336789500066
J	Ascenzi, P; Leboffe, L; Pesce, A; Ciaccio, C; Sbardella, D; Bolognesi, M; Coletta, M				Ascenzi, Paolo; Leboffe, Loris; Pesce, Alessandra; Ciaccio, Chiara; Sbardella, Diego; Bolognesi, Martino; Coletta, Massimo			Nitrite-Reductase and Peroxynitrite Isomerization Activities of Methanosarcina acetivorans Protoglobin	PLOS ONE			English	Article							GLOBIN-COUPLED SENSORS; MYCOBACTERIUM-LEPRAE; ANAEROBIC CONDITIONS; OXYGEN-AFFINITY; CARBON-MONOXIDE; LIGAND-BINDING; HEMOGLOBIN; OXIDE; REACTIVITY; MECHANISM	Within the globin superfamily, protoglobins (Pgb) belong phylogenetically to the same cluster of two-domain globin-coupled sensors and single-domain sensor globins. Multiple functional roles have been postulated for Methanosarcina acetivorans Pgb (Ma-Pgb), since the detoxification of reactive nitrogen and oxygen species might co-exist with enzymatic activity(ies) to facilitate the conversion of CO to methane. Here, the nitrite-reductase and peroxynitrite isomerization activities of the CysE20Ser mutant of Ma-Pgb (Ma-Pgb*) are reported and analyzed in parallel with those of related heme-proteins. Kinetics of nitrite-reductase activity of ferrous Ma-Pgb* (Ma-Pgb*-Fe(II)) is biphasic and values of the second-order rate constant for the reduction of NO2- to NO and the concomitant formation of nitrosylated Ma-Pgb*-Fe(II) (Ma-Pgb*-Fe(II)-NO) are k(app1) = 9.6 +/- 0.2 M-1 s(-1) and k(app2) = 1.2 +/- 0.1 M-1 s(-1) (at pH 7.4 and 20 degrees C). The k(app1) and k(app2) values increase by about one order of magnitude for each pH unit decrease, between pH 8.3 and 6.2, indicating that the reaction requires one proton. On the other hand, kinetics of peroxynitrite isomerization catalyzed by ferric Ma-Pgb* (Ma-Pgb*-Fe(III)) is monophasic and values of the second order rate constant for peroxynitrite isomerization by Ma-Pgb*-Fe(III) and of the first order rate constant for the spontaneous conversion of peroxynitrite to nitrate are h(app) = 3.8x10(4) M-1 s(-1) and h(0) = 2.86 x 10(-1) s(-1) (at pH 7.4 and 20 degrees C). The pH-dependence of h(on) and h(0) values reflects the acid-base equilibrium of peroxynitrite (pK(a) = 6.7 and 6.9, respectively; at 20 degrees C), indicating that HOONO is the species that reacts preferentially with the heme-Fe(III) atom. These results highlight the potential role of Pgbs in the biosynthesis and scavenging of reactive nitrogen and oxygen species.	[Ascenzi, Paolo; Leboffe, Loris] Univ Roma Tre, Interdept Lab Electron Microscopy, Rome, Italy; [Ascenzi, Paolo] Natl Inst Biostruct & Biosyst, Rome, Italy; [Pesce, Alessandra] Univ Genoa, Dept Phys, Genoa, Italy; [Ciaccio, Chiara; Sbardella, Diego; Coletta, Massimo] Univ Roma Tor Vergata, Dept Clin Sci & Translat Med, Rome, Italy; [Ciaccio, Chiara; Sbardella, Diego; Coletta, Massimo] Interuniv Consortium Res Chem Met Biol Syst, Bari, Italy; [Bolognesi, Martino] Univ Milan, Dept Biosci, Milan, Italy	Roma Tre University; University of Genoa; University of Rome Tor Vergata; University of Milan	Ascenzi, P (corresponding author), Univ Roma Tre, Interdept Lab Electron Microscopy, Rome, Italy.	ascenzi@uniroma3.it	Sbardella, Diego/N-9187-2015; Bolognesi, Martino/B-7924-2017; Coletta, Massimo/N-9049-2015; Pesce, Alessandra/A-3660-2015; Sbardella, Diego/K-7519-2016; Coletta, Massimiliano/GSN-5927-2022; Leboffe, Loris/K-7838-2016	Bolognesi, Martino/0000-0002-9253-5170; Sbardella, Diego/0000-0002-9924-7761; Leboffe, Loris/0000-0001-8272-1896; COLETTA, Massimiliano/0000-0002-5489-9467	Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy [PRIN 20109MXHMR_001]; Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy (Universita Roma Tre, CAL)	Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy(Ministry of Education, Universities and Research (MIUR)); Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy (Universita Roma Tre, CAL)	This work was partially supported by grants from the Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy (PRIN 20109MXHMR_001 and Universita Roma Tre, CAL 2013) to PA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzetti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033614; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; Ascenzi P, 2009, BIOCHEM BIOPH RES CO, V380, P392, DOI 10.1016/j.bbrc.2009.01.088; Ascenzi P, 2006, BIOCHEM BIOPH RES CO, V351, P528, DOI 10.1016/j.bbrc.2006.10.060; Ascenzi P, 2013, J BIOL INORG CHEM, V18, P939, DOI 10.1007/s00775-013-1040-2; Ascenzi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069762; Ascenzi P, 2013, BIOCHEM BIOPH RES CO, V430, P1301, DOI 10.1016/j.bbrc.2012.11.122; Ascenzi P, 2011, BIOCHEM BIOPH RES CO, V415, P463, DOI 10.1016/j.bbrc.2011.10.094; Ascenzi P, 2011, J BIOL INORG CHEM, V16, P97, DOI 10.1007/s00775-010-0706-2; Ascenzi P, 2009, J BIOL CHEM, V284, P31006, DOI 10.1074/jbc.M109.010736; Bikiel DE, 2010, J PHYS CHEM B, V114, P8536, DOI 10.1021/jp102135p; Bohle DS, 1996, METHOD ENZYMOL, V269, P302; Bolognesi M, 1997, PROG BIOPHYS MOL BIO, V68, P29, DOI 10.1016/S0079-6107(97)00017-5; BRANCACCIO A, 1994, J BIOL CHEM, V269, P13843; Ciaccio C, 2013, BBA-PROTEINS PROTEOM, V1834, P1813, DOI 10.1016/j.bbapap.2013.02.026; Coppola D, 2013, BBA-PROTEINS PROTEOM, V1834, P1923, DOI 10.1016/j.bbapap.2013.02.018; DOYLE MP, 1981, J BIOL CHEM, V256, P2393; Ferry JG, 2006, MOL BIOL EVOL, V23, P1286, DOI 10.1093/molbev/msk014; Forti F, 2011, J PHYS CHEM B, V115, P13771, DOI 10.1021/jp208562b; Freitas TAK, 2005, J INORG BIOCHEM, V99, P23, DOI 10.1016/j.jinorgbio.2004.10.024; Freitas TAK, 2004, P NATL ACAD SCI USA, V101, P6675, DOI 10.1073/pnas.0308657101; Freitas TAK, 2003, FEBS LETT, V552, P99, DOI 10.1016/S0014-5793(03)00923-2; Goldstein S, 2005, CHEM REV, V105, P2457, DOI 10.1021/cr0307087; Goldstein S, 2008, METHOD ENZYMOL, V436, P49, DOI 10.1016/S0076-6879(08)36004-2; Grubina R, 2008, J BIOL CHEM, V283, P3628, DOI 10.1074/jbc.M705222200; Helbo S, 2012, AM J PHYSIOL-REG I, V302, pR693, DOI 10.1152/ajpregu.00501.2011; Herold S, 2004, J AM CHEM SOC, V126, P6945, DOI 10.1021/ja0493300; Herold S, 2004, J BIOL CHEM, V279, P22841, DOI 10.1074/jbc.M313732200; Herold S, 2003, BIOCHEMISTRY-US, V42, P14036, DOI 10.1021/bi0350349; Herold S, 2003, CHEM RES TOXICOL, V16, P390, DOI 10.1021/tx025595l; Herold S, 2001, J AM CHEM SOC, V123, P4085, DOI 10.1021/ja010111d; Huang KT, 2005, J BIOL CHEM, V280, P31126, DOI 10.1074/jbc.M501496200; Huang Z, 2005, J CLIN INVEST, V115, P2099, DOI 10.1172/JCI24650; Koppenol WH, 1996, METHOD ENZYMOL, V269, P296; Lessner DJ, 2006, P NATL ACAD SCI USA, V103, P17921, DOI 10.1073/pnas.0608833103; Li HT, 2012, J BIOL CHEM, V287, P36623, DOI 10.1074/jbc.M112.342378; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Nardini M, 2008, EMBO REP, V9, P157, DOI 10.1038/sj.embor.7401153; Oelgeschlager E, 2008, ARCH MICROBIOL, V190, P257, DOI 10.1007/s00203-008-0382-6; PERUTZ MF, 1979, ANNU REV BIOCHEM, V48, P327, DOI 10.1146/annurev.bi.48.070179.001551; Pesce A, 2013, ADV MICROB PHYSIOL, V63, P49, DOI 10.1016/B978-0-12-407693-8.00002-9; Pesce A, 2013, ADV MICROB PHYSIOL, V63, P79, DOI 10.1016/B978-0-12-407693-8.00003-0; Pesce A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066144; Pesce A, 2011, IUBMB LIFE, V63, P287, DOI 10.1002/iub.484; Petersen MG, 2008, J INORG BIOCHEM, V102, P1777, DOI 10.1016/j.jinorgbio.2008.05.008; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfeiffer S, 1997, J BIOL CHEM, V272, P3465, DOI 10.1074/jbc.272.6.3465; Rother M, 2004, P NATL ACAD SCI USA, V101, P16929, DOI 10.1073/pnas.0407486101; Salhany JM, 2008, BIOCHEMISTRY-US, V47, P6059, DOI 10.1021/bi8000819; Shiva S, 2007, CIRC RES, V100, P654, DOI 10.1161/01.RES.0000260171.52224.6b; Sturms R, 2011, BIOCHEMISTRY-US, V50, P3873, DOI 10.1021/bi2004312; Tiso M, 2012, BIOCHEMISTRY-US, V51, P5285, DOI 10.1021/bi300570v; Tiso M, 2011, J BIOL CHEM, V286, P18277, DOI 10.1074/jbc.M110.159541; Vinogradov SN, 2007, GENE, V398, P132, DOI 10.1016/j.gene.2007.02.041; Vinogradov SN, 2013, BBA-PROTEINS PROTEOM, V1834, P1789, DOI 10.1016/j.bbapap.2013.03.021	55	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e95391	10.1371/journal.pone.0095391	http://dx.doi.org/10.1371/journal.pone.0095391			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827820	Green Published, gold			2022-12-27	WOS:000336857400012
J	Garza, MC; Monzon, M; Marin, B; Badiola, JJ; Monleon, E				Carmen Garza, Maria; Monzon, Marta; Marin, Belen; Jose Badiola, Juan; Monleon, Eva			Distribution of Peripheral PrPSc in Sheep with Naturally Acquired Scrapie	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; CELLULAR PRION PROTEIN; CERVUS-ELAPHUS-NELSONI; MAMMARY-GLAND; TISSUE DISTRIBUTION; LYMPHOID-TISSUES; SUFFOLK SHEEP; ACCUMULATION; PATHOGENESIS; DISEASE	Accumulation of prion protein (PrPSc) in the central nervous system is the hallmark of transmissible spongiform encephalopathies. However, in some of these diseases such as scrapie or chronic wasting disease, the PrPSc can also accumulate in other tissues, particularly in the lymphoreticular system. In recent years, PrPSc in organs other than nervous and lymphoid have been described, suggesting that distribution of this protein in affected individuals may be much larger than previously thought. In the present study, 11 non-nervous/non-lymphoid organs from 16 naturally scrapie infected sheep in advanced stages of the disease were examined for the presence of PrPSc. Fourteen infected sheep were of the ARQ/ARQ PRNP genotype and 2 of the VRQ/VRQ, where the letters A, R, Q, and V represent the codes for amino-acids alanine, arginine, glutamine and valine, respectively. Adrenal gland, pancreas, heart, skin, urinary bladder and mammary gland were positive for PrPSc by immunohistochemistry and IDEXX HerdChek scrapie/BSE Antigen EIA Test in at least one animal. Lung, liver, kidney and skeletal muscle exhibited PrPSc deposits by immunohistochemistry only. To our knowledge, this is the first report regarding the presence of PrPSc in the heart, pancreas and urinary bladder in naturally acquired scrapie infections. In some other organs examined, in which PrPSc had been previously detected, PrPSc immunolabeling was observed to be associated with new structures within those organs. The results of the present study illustrate a wide dissemination of PrPSc in both ARQ/ARQ and VRQ/VRQ infected sheep, even when the involvement of the lymphoreticular system is scarce or absent, thus highlighting the role of the peripheral nervous system in the spread of PrPSc.	[Carmen Garza, Maria; Monzon, Marta; Marin, Belen; Jose Badiola, Juan; Monleon, Eva] Univ Zaragoza, Ctr Encefalopatias Espongiformes & Enfermedades E, Zaragoza, Spain; [Carmen Garza, Maria] Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB T6G 2M7, Canada; [Monleon, Eva] Univ Zaragoza, Dept Anat & Histol Humanas, Zaragoza, Spain	University of Zaragoza; University of Alberta; University of Zaragoza	Monleon, E (corresponding author), Univ Zaragoza, Ctr Encefalopatias Espongiformes & Enfermedades E, Zaragoza, Spain.	emonleon@unizar.es	Garza, M Carmen/ABI-8266-2020; MONZÓN, MARTA/R-6162-2017	Garza, M Carmen/0000-0001-7098-2327; MONZÓN, MARTA/0000-0002-2787-9671	Gobierno de Aragon [218-315/3]; FEDER [CONCOTSA EFA205/11]; FPU doctoral grant from the Spanish Ministry of Education [AP2007-03842]	Gobierno de Aragon(Gobierno de Aragon); FEDER(European Commission); FPU doctoral grant from the Spanish Ministry of Education(German Research Foundation (DFG))	This study was supported by the Gobierno de Aragon (grant 218-315/3) and FEDER (CONCOTSA EFA205/11). Dr. Garza was supported by a FPU doctoral grant from the Spanish Ministry of Education (grant AP2007-03842). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin C, 2004, J GEN VIROL, V85, P2103, DOI 10.1099/vir.0.80047-0; Andreoletti O, 2000, J GEN VIROL, V81, P3115, DOI 10.1099/0022-1317-81-12-3115; Andreoletti O, 2004, NAT MED, V10, P591, DOI 10.1038/nm1055; Bailey JD, 2008, J ENDOCRINOL, V197, P251, DOI 10.1677/JOE-07-0516; Beekes M, 2007, FEBS J, V274, P588, DOI 10.1111/j.1742-4658.2007.05631.x; Bessen RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028026; Caplazi P, 2004, J VET DIAGN INVEST, V16, P489, DOI 10.1177/104063870401600601; Crozet C, 2007, J INFECT DIS, V195, P997, DOI 10.1086/512085; Didier A, 2008, BIOCHEM BIOPH RES CO, V369, P841, DOI 10.1016/j.bbrc.2008.02.108; Didier A, 2006, J HISTOCHEM CYTOCHEM, V54, P1255, DOI 10.1369/jhc.5A6880.2006; Ersdal C, 2005, VET PATHOL, V42, P258, DOI 10.1354/vp.42-3-258; Everest SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019737; Gonzalez L, 2008, VET REC, V162, P397, DOI 10.1136/vr.162.13.397; Gough KC, 2010, PRION, V4, P275, DOI 10.4161/pri.4.4.13678; Gregori L, 2008, EMERG INFECT DIS, V14, P1406, DOI 10.3201/eid1409.080259; Groschup MH, 1999, ACTA NEUROPATHOL, V98, P453, DOI 10.1007/s004010051108; Herzog C, 2004, LANCET, V363, P422, DOI 10.1016/S0140-6736(04)15487-1; Hunter N, 1997, VET REC, V140, P59, DOI 10.1136/vr.140.3.59; Jeffrey M, 2007, NEUROPATH APPL NEURO, V33, P373, DOI 10.1111/j.1365-2990.2007.00868.x; Jeffrey M, 2004, CURR TOP MICROBIOL, V284, P65; Jeffrey M, 2002, J COMP PATHOL, V127, P264, DOI 10.1053/jcpa.2002.0592; Jeffrey M, 2001, J COMP PATHOL, V125, P48, DOI 10.1053/jcpa.2001.0476; Jewell JE, 2006, J GEN VIROL, V87, P3443, DOI 10.1099/vir.0.81777-0; KIMBERLIN RH, 1983, J NEUROL SCI, V61, P315, DOI 10.1016/0022-510X(83)90165-X; Lacroux C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000238; Lee AM, 2011, VIROLOGY, V411, P1, DOI 10.1016/j.virol.2010.12.012; Lezmi S, 2006, ACTA BIOCHIM POL, V53, P399; Lezmi S, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-41; Ligios C, 2005, NAT MED, V11, P1137, DOI 10.1038/nm1105-1137; Ligios C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000859; Maestrale C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062830; McGovern G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058620; Monleon E, 2004, J HISTOCHEM CYTOCHEM, V52, P145, DOI 10.1177/002215540405200201; Monleon E, 2011, VET MICROBIOL, V147, P237, DOI 10.1016/j.vetmic.2010.06.028; O'Rourke KI, 2000, J CLIN MICROBIOL, V38, P3254, DOI 10.1128/JCM.38.9.3254-3259.2000; Okada H, 2012, J HISTOCHEM CYTOCHEM, V60, P290, DOI 10.1369/0022155412437218; PATTISON I. H., 1960, JOUR COMP PATHOL AND THERAP, V70, P182, DOI 10.1016/S0368-1742(60)80018-5; Peden AH, 2006, AM J PATHOL, V168, P927, DOI 10.2353/ajpath.2006.050788; Salazar E, 2010, VET RES, V41, DOI 10.1051/vetres/2010030; Sigurdson CJ, 2001, J GEN VIROL, V82, P2327, DOI 10.1099/0022-1317-82-10-2327; Siso S, 2008, J PATHOL, V215, P126, DOI 10.1002/path.2336; Spraker TR, 2006, J VET DIAGN INVEST, V18, P553, DOI 10.1177/104063870601800605; Thomzig A, 2007, PLOS PATHOG, V3, P659, DOI 10.1371/journal.ppat.0030066; Trifilo MJ, 2006, SCIENCE, V313, P94, DOI 10.1126/science.1128635; Tuo WB, 2002, P NATL ACAD SCI USA, V99, P6310, DOI 10.1073/pnas.072071199; van Keulen LJM, 1999, J COMP PATHOL, V121, P55, DOI 10.1053/jcpa.1998.0300; van Keulen LJM, 2000, ARCH VIROL, P57; Vargas F, 2005, VET REC, V156, P318, DOI 10.1136/vr.156.10.318; Vascellari M, 2007, J VIROL, V81, P4872, DOI 10.1128/JVI.02148-06; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; World Health Organization, 2010, WHO GUID TISS INF DI	51	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97768	10.1371/journal.pone.0097768	http://dx.doi.org/10.1371/journal.pone.0097768			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828439	Green Submitted, Green Published, gold			2022-12-27	WOS:000336857400120
J	Craig, VJ; Polverino, F; Laucho-Contreras, ME; Shi, YY; Liu, YS; Osorio, JC; Tesfaigzi, Y; Pinto-Plata, V; Gochuico, BR; Rosas, IO; Owen, CA				Craig, Vanessa J.; Polverino, Francesca; Laucho-Contreras, Maria E.; Shi, Yuanyuan; Liu, Yushi; Osorio, Juan C.; Tesfaigzi, Yohannes; Pinto-Plata, Victor; Gochuico, Bernadette R.; Rosas, Ivan O.; Owen, Caroline A.			Mononuclear Phagocytes and Airway Epithelial Cells: Novel Sources of Matrix Metalloproteinase-8 (MMP-8) in Patients with Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							HUMAN NEUTROPHIL COLLAGENASE; TISSUE INHIBITOR; EXPRESSION; INFLAMMATION; DISEASE; MICE; FIBROBLASTS; SARCOIDOSIS; APOPTOSIS; INJURY	Objectives: Matrix metalloproteinase-8 (MMP-8) promotes lung fibrotic responses to bleomycin in mice. Although prior studies reported that MMP-8 levels are increased in plasma and bronchoalveolar lavage fluid (BALF) samples from IPF patients, neither the bioactive forms nor the cellular sources of MMP-8 in idiopathic pulmonary fibrosis (IPF) patients have been identified. It is not known whether MMP-8 expression is dys-regulated in IPF leukocytes or whether MMP-8 plasma levels correlate with IPF outcomes. Our goal was to address these knowledge gaps. Methods: We measured MMP-8 levels and forms in blood and lung samples from IPF patients versus controls using ELISAs, western blotting, and qPCR, and assessed whether MMP-8 plasma levels in 73 IPF patients correlate with rate of lung function decline and mortality. We used immunostaining to localize MMP-8 expression in IPF lungs. We quantified MMP-8 levels and forms in blood leukocytes from IPF patients versus controls. Results: IPF patients have increased BALF, whole lung, and plasma levels of soluble MMP-8 protein. Active MMP-8 is the main form elevated in IPF lungs. MMP-8 mRNA levels are increased in monocytes from IPF patients, but IPF patients and controls have similar levels of MMP-8 in PMNs. Surprisingly, macrophages and airway epithelial cells are the main cells expressing MMP-8 in IPF lungs. Plasma and BALF MMP-8 levels do not correlate with decline in lung function and/or mortality in IPF patients. Conclusion: Blood and lung MMP-8 levels are increased in IPF patients. Active MMP-8 is the main form elevated in IPF lungs. Surprisingly, blood monocytes, lung macrophages, and airway epithelial cells are the main cells in which MMP-8 is upregulated in IPF patients. Plasma and BALF MMP-8 levels are unlikely to serve as a prognostic biomarker for IPF patients. These results provide new information about the expression patterns of MMP-8 in IPF patients.	[Craig, Vanessa J.; Polverino, Francesca; Laucho-Contreras, Maria E.; Shi, Yuanyuan; Liu, Yushi; Osorio, Juan C.; Pinto-Plata, Victor; Rosas, Ivan O.; Owen, Caroline A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Polverino, Francesca] Univ Parma, Dept Clin & Expt Med, I-43100 Parma, Italy; [Polverino, Francesca; Shi, Yuanyuan; Liu, Yushi; Rosas, Ivan O.; Owen, Caroline A.] Lovelace Resp Res Inst, Pulm Fibrosis Program, Albuquerque, NM USA; [Tesfaigzi, Yohannes; Owen, Caroline A.] Lovelace Resp Res Inst, Chron Obstruct Pulm Dis Program, Albuquerque, NM USA; [Gochuico, Bernadette R.] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Parma; University Hospital of Parma; Lovelace Respiratory Research Institute; Lovelace Respiratory Research Institute; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Owen, CA (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA.	cowen@rics.bwh.harvard.edu	Polverino, Francesca/AAL-7997-2020; Liu, Yushi/A-1533-2014; Polverino, Francesca/F-3816-2017	Liu, Yushi/0000-0003-4185-4187; Polverino, Francesca/0000-0001-9686-5698; Osorio, Juan C/0000-0001-8090-1551	Public Health Service, National Heart, Lung, and Blood Institute Grants [HL63137, HL086814, HL111835]; NIH [2T32 HL007633-26, 5T32 HD007466-15]; American Thoracic Society/Pulmonary Fibrosis Foundation; Brigham and Women's Hospital-Lovelace Respiratory Research Institute Consortium; Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007466] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL111835, P01HL114501, T32HL007633, R01HL063137, R01HL086814] Funding Source: NIH RePORTER	Public Health Service, National Heart, Lung, and Blood Institute Grants; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Thoracic Society/Pulmonary Fibrosis Foundation; Brigham and Women's Hospital-Lovelace Respiratory Research Institute Consortium; Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Public Health Service, National Heart, Lung, and Blood Institute Grants HL63137, HL086814, HL111835, NIH 2T32 HL007633-26, NIH 5T32 HD007466-15 (www.grants.gov); the American Thoracic Society/Pulmonary Fibrosis Foundation (www.thoracic.org); and the Brigham and Women's Hospital-Lovelace Respiratory Research Institute Consortium (http://brighamandwomens.org and http://www.lrri.org). This work was supported, in part, by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquilante CL, 2007, CLIN CHIM ACTA, V379, P48, DOI 10.1016/j.cca.2006.12.006; Bahr TM, 2013, AM J RESP CELL MOL, V49, P316, DOI 10.1165/rcmb.2012-0230OC; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Collard HR, 2003, AM J RESP CRIT CARE, V168, P538, DOI 10.1164/rccm.200211-1311OC; Cox SW, 2006, ORAL DIS, V12, P34, DOI 10.1111/j.1601-0825.2005.01153.x; Craig VJ, 2013, J IMMUNOL, V190, P4283, DOI 10.4049/jimmunol.1201043; Decock J, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-77; Garcia-Prieto E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013242; Gribbin J, 2006, THORAX, V61, P980, DOI 10.1136/thx.2006.062836; Gueders MM, 2005, J IMMUNOL, V175, P2589, DOI 10.4049/jimmunol.175.4.2589; Gunther A, 2012, EUR RESPIR REV, V21, P152, DOI 10.1183/09059180.00001012; Hanemaaijer R, 1997, J BIOL CHEM, V272, P31504, DOI 10.1074/jbc.272.50.31504; HARRIS ED, 1984, COLLAGEN REL RES, V4, P493; HASTY KA, 1987, J BIOL CHEM, V262, P10048; HASTY KA, 1986, J BIOL CHEM, V261, P5645; Henry MT, 2002, EUR RESPIR J, V20, P1220, DOI 10.1183/09031936.02.00022302; Herazo-Maya JD, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005964; Herman MP, 2001, CIRCULATION, V104, P1899, DOI 10.1161/hc4101.097419; Kato R, 2005, CIRC J, V69, P1035, DOI 10.1253/circj.69.1035; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Knolle MD, 2013, J IMMUNOL, V190, P6434, DOI 10.4049/jimmunol.1202329; Korfei M, 2008, AM J RESP CRIT CARE, V178, P838, DOI 10.1164/rccm.200802-313OC; Liu JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053392; Maher TM, 2010, AM J RESP CRIT CARE, V182, P73, DOI 10.1164/rccm.200905-0674OC; McKeown S, 2009, EUR RESPIR J, V33, P77, DOI 10.1183/09031936.00060708; MURPHY G, 1977, BIOCHEM J, V162, P195, DOI 10.1042/bj1620195; National Heart Lung and Blood Institute, 2012, EV EFF PREDN AZ N AC; Navaratnam V, 2011, THORAX, V66, P462, DOI 10.1136/thx.2010.148031; Nkyimbeng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073279; Noble PW, 2011, LANCET, V377, P1760, DOI 10.1016/S0140-6736(11)60405-4; Obayashi Y, 1997, CHEST, V112, P1338, DOI 10.1378/chest.112.5.1338; Overbeek SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055612; Owen CA, 2004, J IMMUNOL, V172, P7791, DOI 10.4049/jimmunol.172.12.7791; Owen CA, 2003, AM J RESP CELL MOL, V29, P283, DOI 10.1165/rcmb.2003-0034OC; Prikk K, 2001, J PATHOL, V194, P232, DOI 10.1002/path.849; Quintero PA, 2010, J IMMUNOL, V184, P1575, DOI 10.4049/jimmunol.0900290; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Richeldi L, 2011, NEW ENGL J MED, V365, P1079, DOI 10.1056/NEJMoa1103690; Rosas IO, 2008, PLOS MED, V5, P623, DOI 10.1371/journal.pmed.0050093; Salminen HJ, 2002, ANN RHEUM DIS, V61, P591, DOI 10.1136/ard.61.7.591; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SMYTHE G, 2005, BIOINFORMATICS COMPU; Stijn W, 2013, ANN THORAC MED, V8, P38, DOI 10.4103/1817-1737.105718; Van Lint P, 2005, J IMMUNOL, V175, P7642, DOI 10.4049/jimmunol.175.11.7642; Zhou T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044818	45	26	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97485	10.1371/journal.pone.0097485	http://dx.doi.org/10.1371/journal.pone.0097485			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828408	Green Published, gold, Green Submitted			2022-12-27	WOS:000336857400099
J	Elhaddad, NS; Hunt, L; Sloan, J; Gray, JE				Elhaddad, Nagat S.; Hunt, Lee; Sloan, Jennifer; Gray, Julie E.			Light-Induced Stomatal Opening Is Affected by the Guard Cell Protein Kinase APK1b	PLOS ONE			English	Article							MEMBRANE H+-ATPASE; ARABIDOPSIS-THALIANA; ABSCISIC-ACID; PHOSPHORYLATION; TRANSFORMATION; CO2	Guard cells allow land plants to survive under restricted or fluctuating water availability. They control the exchange of gases between the external environment and the interior of the plant by regulating the aperture of stomatal pores in response to environmental stimuli such as light intensity, and are important regulators of plant productivity. Their turgor driven movements are under the control of a signalling network that is not yet fully characterised. A reporter gene fusion confirmed that the Arabidopsis APK1b protein kinase gene is predominantly expressed in guard cells. Infrared gas analysis and stomatal aperture measurements indicated that plants lacking APK1b are impaired in their ability to open their stomata on exposure to light, but retain the ability to adjust their stomatal apertures in response to darkness, abscisic acid or lack of carbon dioxide. Stomatal opening was not specifically impaired in response to either red or blue light as both of these stimuli caused some increase in stomatal conductance. Consistent with the reduction in maximum stomatal conductance, the relative water content of plants lacking APK1b was significantly increased under both well-watered and drought conditions. We conclude that APK1b is required for full stomatal opening in the light but is not required for stomatal closure.	[Elhaddad, Nagat S.; Hunt, Lee; Sloan, Jennifer; Gray, Julie E.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Gray, JE (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.	j.e.gray@sheffield.ac.uk	Gray, Julie E/B-4271-2014; Hunt, Lee/A-1279-2008	Gray, Julie E/0000-0001-9972-5156; Hunt, Lee/0000-0001-6781-0540; Sloan, Jennifer/0000-0003-0334-3722	Libyan government; Biotechnology and Biological Sciences Research Council [BB/I002154/1]; BBSRC [BB/I002154/1] Funding Source: UKRI	Libyan government; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by a studentship from the Libyan government and Biotechnology and Biological Sciences Research Council grant BB/I002154/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Desclos-Theveniau M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002513; Fuglsang AT, 2007, PLANT CELL, V19, P1617, DOI 10.1105/tpc.105.035626; Gaxiola RA, 2001, P NATL ACAD SCI USA, V98, P11444, DOI 10.1073/pnas.191389398; Geiger D, 2010, P NATL ACAD SCI USA, V107, P8023, DOI 10.1073/pnas.0912030107; Goring DR, 2004, SCIENCE, V303, P1474, DOI 10.1126/science.1095764; Hashimoto M, 2006, NAT CELL BIOL, V8, P391, DOI 10.1038/ncb1387; Hayashi M, 2011, PLANT CELL PHYSIOL, V52, P1238, DOI 10.1093/pcp/pcr072; HIRAYAMA T, 1992, PLANT MOL BIOL, V20, P653, DOI 10.1007/BF00046450; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Leonhardt N, 2004, PLANT CELL, V16, P596, DOI 10.1105/tpc.019000; Li XM, 2011, J CHEM ECOL, V37, P779, DOI 10.1007/s10886-011-9975-7; Mori IC, 2006, PLOS BIOL, V4, P1749, DOI 10.1371/journal.pbio.0040327; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Pandey S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.28; Shimazaki K, 2007, ANNU REV PLANT BIOL, V58, P219, DOI 10.1146/annurev.arplant.57.032905.105434; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Svennelid F, 1999, PLANT CELL, V11, P2379, DOI 10.1105/tpc.11.12.2379; Takemiya A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3094; Veronese P, 2006, PLANT CELL, V18, P257, DOI 10.1105/tpc.105.035576; Webb AAR, 1997, PLANT PHYSIOL, V114, P1557, DOI 10.1104/pp.114.4.1557; Yang YZ, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-6	23	16	20	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97161	10.1371/journal.pone.0097161	http://dx.doi.org/10.1371/journal.pone.0097161			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828466	gold, Green Published, Green Accepted			2022-12-27	WOS:000336857400061
J	Goranson, SP; Gozdzik, W; Harbut, P; Ryniak, S; Zielinski, S; Haegerstrand, CG; Kubler, A; Hedenstierna, G; Frostell, C; Albert, J				Goranson, Sofie Paues; Gozdzik, Waldemar; Harbut, Piotr; Ryniak, Stanislaw; Zielinski, Stanislaw; Haegerstrand, Caroline Gillis; Kubler, Andrzej; Hedenstierna, Goran; Frostell, Claes; Albert, Johanna			Organ Dysfunction among Piglets Treated with Inhaled Nitric Oxide and Intravenous Hydrocortisone during Prolonged Endotoxin Infusion	PLOS ONE			English	Article							SEVERE SEPSIS; UNITED-STATES; GLUCOCORTICOIDS; EPIDEMIOLOGY; INHALATION; RESPONSES; ISCHEMIA; EXPOSURE; MODELS; KIDNEY	Objective: It has previously been shown that a combination of inhaled nitric oxide (iNO) and intravenous (IV) steroid attenuates endotoxin-induced organ damage in a 6-hour porcine endotoxemia model. We aimed to further explore these effects in a 30-hour model with attention to clinically important variables. Design: Randomized controlled trial. Setting: University animal laboratory. Subjects: Domestic piglets (n = 30). Interventions: Animals were randomized into 5 groups (n = 6 each): 1) Controls, 2) LPS-only (endotoxin/lipopolysaccharide (LPS) infusion), 3) LPS + iNO, 4) LPS + IV steroid, 5) LPS + iNO + IV steroid. Measurements and Main Results: Exposure to LPS temporarily increased pulmonary artery mean pressure and impeded renal function with elevated serum creatinine and acidosis compared to a control group over the 30-hour study period. Double treatment with both iNO and IV steroid tended to blunt the deterioration in renal function, although the only significant effect was on Base Excess (p = 0.045). None of the LPS + iNO + IV steroid treated animals died during the study period, whereas one animal died in each of the other LPS-infused groups. Conclusions: This study suggests that combined early therapy with iNO and IV steroid is associated with partial protection of kidney function after 30 hours of experimental LPS infusion.	[Goranson, Sofie Paues; Harbut, Piotr; Ryniak, Stanislaw; Haegerstrand, Caroline Gillis; Frostell, Claes; Albert, Johanna] Karolinska Inst, Danderyd Hosp, Dept Anesthesia & Intens Care, Stockholm, Sweden; [Gozdzik, Waldemar; Zielinski, Stanislaw; Kubler, Andrzej] Wroclaw Univ Med, Dept Anesthesiol & Intens Therapy, Wroclaw, Poland; [Hedenstierna, Goran] Univ Uppsala Hosp, Dept Med Sci, Uppsala, Sweden	Danderyds Hospital; Karolinska Institutet; Wroclaw Medical University; Uppsala University; Uppsala University Hospital	Hedenstierna, G (corresponding author), Univ Uppsala Hosp, Dept Med Sci, Uppsala, Sweden.	goran.hedenstierna@medsci.uu.se	Harbut, Piotr/GLR-3158-2022	Paues Goranson, Sofie/0000-0003-3952-8550; Zielinski, Stanislaw/0000-0002-0856-472X; Hedenstierna, Goran/0000-0002-2923-6012; Gozdzik, Waldemar/0000-0001-8668-1641; Harbut, Piotr/0000-0002-0943-7837	Per and Lena Sjoberg Foundation; Knut and Alice Wallenberg Foundation; Stockholm County Council; CF Research and Consulting AB; Swedish Research Council [5315]	Per and Lena Sjoberg Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Stockholm County Council(Stockholm County Council); CF Research and Consulting AB; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was supported by a grant from the Per and Lena Sjoberg Foundation, by The Knut and Alice Wallenberg Foundation, Stockholm County Council, CF Research and Consulting AB and the Swedish Research Council (no 5315). The funders, except CF Research and Consulting AB, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CF Research and Consulting AB participated in data collection and preparation of the manuscript but had no influence on study design, data analysis and text in the final manuscript.	Albert J, 2007, INTENS CARE MED, V33, P1594, DOI 10.1007/s00134-007-0666-3; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bellomo R, 2007, INTENS CARE MED, V33, P409, DOI 10.1007/s00134-006-0478-x; Bogdan CT, 2000, IMMUNOL REV, V173, P17, DOI 10.1034/j.1600-065X.2000.917307.x; Brun-Buisson C, 2004, INTENS CARE MED, V30, P580, DOI 10.1007/s00134-003-2121-4; Chadda Karim, 2002, Annals of Medicine, V34, P582, DOI 10.1080/078538902321117805; Da JP, 2007, CRIT CARE MED, V35, P26, DOI 10.1097/01.CCM.0000250319.91575.BB; EVANS MJ, 1972, ARCH ENVIRON HEALTH, V24, P180, DOI 10.1080/00039896.1972.10666067; FROSTELL C, 1991, CIRCULATION, V83, P2038, DOI 10.1161/01.CIR.83.6.2038; Gozdzik W, 2009, ACTA PHYSIOL, V195, P495, DOI 10.1111/j.1748-1716.2008.01908.x; Gozdzik W, 2012, BRIT J ANAESTH, V108, P101; Hallstrom L, 2011, ACTA ANAESTH SCAND, V55, P20, DOI 10.1111/j.1399-6576.2010.02297.x; Hallstrom L, 2008, CRIT CARE MED, V36, P3043, DOI 10.1097/CCM.0b013e318186f5b2; Kang JL, 2002, J APPL PHYSIOL, V92, P795, DOI 10.1152/japplphysiol.00202.2001; Kinsella JP, 1997, PEDIATR RES, V41, P457, DOI 10.1203/00006450-199704000-00002; Krafft P, 1996, CHEST, V109, P486, DOI 10.1378/chest.109.2.486; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mathru M, 2007, ANESTHESIOLOGY, V106, P275, DOI 10.1097/00000542-200702000-00015; Ostermann M, 2007, CRIT CARE MED, V35, P1837, DOI 10.1097/01.CCM.0000277041.13090.0A; Persson BP, 2011, J VASC RES, V48, P206, DOI 10.1159/000319796; Phillips L, 2009, J INVEST SURG, V22, P46, DOI 10.1080/08941930802709470; Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872; Poli-De-Figueiredo LF, 2008, SHOCK, V30, P53, DOI 10.1097/SHK.0b013e318181a343; Rivers EP, 2013, SHOCK, V39, P127, DOI 10.1097/SHK.0b013e31827dafa7; ROSSAINT R, 1993, EUR HEART J, V14, P133; Wang HM, 2008, EUR SURG RES, V40, P305, DOI 10.1159/000121471; Weitzberg E, 2010, ANESTHESIOLOGY, V113, P1460, DOI 10.1097/ALN.0b013e3181fcf3cc; Winters BD, 2010, CRIT CARE MED, V38, P1276, DOI 10.1097/CCM.0b013e3181d8cc1d; Yang Shumei, 2004, Current Vascular Pharmacology, V2, P1, DOI 10.2174/1570161043476483	29	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96594	10.1371/journal.pone.0096594	http://dx.doi.org/10.1371/journal.pone.0096594			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827456	gold, Green Published, Green Submitted			2022-12-27	WOS:000336857400029
J	Logue, EC; Bloch, N; Dhuey, E; Zhang, RN; Cao, P; Herate, C; Chauveau, L; Hubbard, SR; Landau, NR				Logue, Eric C.; Bloch, Nicolin; Dhuey, Erica; Zhang, Ruonan; Cao, Ping; Herate, Cecile; Chauveau, Lise; Hubbard, Stevan R.; Landau, Nathaniel R.			A DNA Sequence Recognition Loop on APOBEC3A Controls Substrate Specificity	PLOS ONE			English	Article							BIOCHEMICAL-ANALYSIS; HIV-1 RESTRICTION; CRYSTAL-STRUCTURE; VIRUS; DEAMINASE; RNA; FAMILY; GAG; HYPERMUTATION; PROTEINS	APOBEC3A (A3A), one of the seven-member APOBEC3 family of cytidine deaminases, lacks strong antiviral activity against lentiviruses but is a potent inhibitor of adeno-associated virus and endogenous retroelements. In this report, we characterize the biochemical properties of mammalian cell-produced and catalytically active E. coli-produced A3A. The enzyme binds to single-stranded DNA with a K-d of 150 nM and forms dimeric and monomeric fractions. A3A, unlike APOBEC3G (A3G), deaminates DNA substrates nonprocessively. Using a panel of oligonucleotides that contained all possible trinucleotide contexts, we identified the preferred target sequence as TC (A/G). Based on a three-dimensional model of A3A, we identified a putative binding groove that contains residues with the potential to bind substrate DNA and to influence target sequence specificity. Taking advantage of the sequence similarity to the catalytic domain of A3G, we generated A3A/A3G chimeric proteins and analyzed their target site preference. We identified a recognition loop that altered A3A sequence specificity, broadening its target sequence preference. Mutation of amino acids in the predicted DNA binding groove prevented substrate binding, confirming the role of this groove in substrate binding. These findings shed light on how APOBEC3 proteins bind their substrate and determine which sites to deaminate.	[Logue, Eric C.; Bloch, Nicolin; Dhuey, Erica; Zhang, Ruonan; Herate, Cecile; Chauveau, Lise; Landau, Nathaniel R.] NYU Sch Med, Dept Microbiol, New York, NY 10003 USA; [Cao, Ping; Hubbard, Stevan R.] NYU Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY USA; [Hubbard, Stevan R.] NYU Sch Med, Dept Biochem & Mol Pharmacol, New York, NY USA	New York University; New York University; New York University	Landau, NR (corresponding author), NYU Sch Med, Dept Microbiol, New York, NY 10003 USA.	nathaniel.landau@med.nyu.edu	Chauveau, Lise/AAC-4598-2020	Chauveau, Lise/0000-0002-2671-4488; Hubbard, Stevan/0000-0002-2707-9383; Dhuey, Erica/0000-0002-5961-0722	NIH [AI074967-06, AI058864]; Cancer Research Institute; Vilcek Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074967, R01AI058864] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; Vilcek Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the NIH grant AI074967-06 and AI058864, and by a postdoctoral fellowship to ECL from the Cancer Research Institute. NB is supported by a fellowship from the Vilcek Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar RS, 2008, J BIOL CHEM, V283, P2518, DOI 10.1074/jbc.M706436200; Alce TM, 2004, J BIOL CHEM, V279, P34083, DOI 10.1074/jbc.C400235200; Berger A, 2010, J BIOL CHEM, V285, P12248, DOI 10.1074/jbc.M109.090977; Berger G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002221; Bogerd HP, 2006, NUCLEIC ACIDS RES, V34, P89, DOI 10.1093/nar/gkj416; Bulliard Y, 2011, J VIROL, V85, P1765, DOI 10.1128/JVI.01651-10; Byeon IJL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2883; Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Douaisi M, 2004, BIOCHEM BIOPH RES CO, V321, P566, DOI 10.1016/j.bbrc.2004.07.005; Ellinger P, 2012, J STRUCT BIOL, V178, P350, DOI 10.1016/j.jsb.2012.04.006; Goila-Gaur R, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-61; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Khan MA, 2005, J VIROL, V79, P5870, DOI 10.1128/JVI.79.9.5870-5874.2005; Kohli RM, 2009, J BIOL CHEM, V284, P22898, DOI 10.1074/jbc.M109.025536; Koning FA, 2011, J VIROL, V85, P13448, DOI 10.1128/JVI.00775-11; Land AM, 2013, J BIOL CHEM, V288, P17253, DOI 10.1074/jbc.M113.458661; Landry S, 2011, EMBO REP, V12, P444, DOI 10.1038/embor.2011.46; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Levin MK, 2005, NAT STRUCT MOL BIOL, V12, P429, DOI 10.1038/nsmb920; Love RP, 2012, J BIOL CHEM, V287, P30812, DOI 10.1074/jbc.M112.393181; Luo K, 2004, J VIROL, V78, P11841, DOI 10.1128/JVI.78.21.11841-11852.2004; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mitra M, 2014, NUCLEIC ACIDS RES, V42, P1095, DOI 10.1093/nar/gkt945; Narvaiza I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000439; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Ooms M, 2012, J VIROL, V86, P6097, DOI 10.1128/JVI.06570-11; Peng G, 2007, BLOOD, V110, P393, DOI 10.1182/blood-2006-10-051763; Pham P, 2013, J BIOL CHEM, V288, P29294, DOI 10.1074/jbc.M113.504175; Schafer A, 2004, VIROLOGY, V328, P163, DOI 10.1016/j.virol.2004.08.006; Schmitt K, 2011, VIROLOGY, V419, P24, DOI 10.1016/j.virol.2011.07.017; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; Thielen BK, 2010, J BIOL CHEM, V285, P27753, DOI 10.1074/jbc.M110.102822; Wang T, 2008, VIROLOGY, V377, P71, DOI 10.1016/j.virol.2008.04.012; Wang T, 2007, J VIROL, V81, P13112, DOI 10.1128/JVI.00892-07; Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4; Wiegand HL, 2007, J VIROL, V81, P13694, DOI 10.1128/JVI.01646-07; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Zennou W, 2004, J VIROL, V78, P12058, DOI 10.1128/JVI.78.21.12058-12061.2004; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707	47	34	36	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97062	10.1371/journal.pone.0097062	http://dx.doi.org/10.1371/journal.pone.0097062			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827831	Green Published, gold, Green Submitted			2022-12-27	WOS:000336857400052
J	Sidney, K; Ryan, K; Diwan, V; De Costa, A				Sidney, Kristi; Ryan, Kayleigh; Diwan, Vishal; De Costa, Ayesha			Utilization of a State Run Public Private Emergency Transportation Service Exclusively for Childbirth: The Janani (Maternal) Express Program in Madhya Pradesh, India	PLOS ONE			English	Article							MORTALITY; BARRIERS; ACCESS; CARE	Background: In 2009 the state government of Madhya Pradesh, India launched an emergency obstetric transportation service, Janani Express Yojana (JEY), to support the cash transfer program that promotes institutional delivery. JEY, a large scale public private partnership, lowers geographical access barriers to facility based care. The state contracts and pays private agencies to provide emergency transportation at no cost to the user. The objective was to study (a) the utilization of JEY among women delivering in health facilities, (b) factors associated with usage, (c) the timeliness of the service. Methods: A cross sectional facility based study was conducted in facilities that carried out > ten deliveries a month. Researchers who spent five days in each facility administered a questionnaire to all women who gave birth there to elicit socio-demographic characteristics and transport related details. Results: 35% of women utilised JEY to reach a facility, however utilization varied between study districts. Uptake was highest among women from rural areas (44%), scheduled tribes (55%), and poorly educated women (40%). Living in rural areas and belonging to scheduled tribes were significant predictors for JEY usage. Almost 1/3 of JEY users (n = 104) experienced a transport related delay. Discussion: The JEY service model complements the cash transfer program by providing transport to a facility to give birth. A study of the distribution of utilization in population subgroups suggests the intervention was successful in reaching the most vulnerable population, promoting equity in access. While 1/3 of women utilized the service and it saved them money; 30% experienced significant transport related delays in reaching a facility, which is comparable to women using public transportation. Further research is needed to understand why utilization is low, to explore if there is a need for service expansion at the community level and to improve the overall time efficiency of JEY.	[Sidney, Kristi; Ryan, Kayleigh; Diwan, Vishal; De Costa, Ayesha] Karolinska Inst, Stockholm, Sweden; [Diwan, Vishal] RD Gardi Med Coll, Ujjain, Madhya Pradesh, India; [Diwan, Vishal; De Costa, Ayesha] RD Gardi Med Coll, Int Ctr Hlth Res, Ujjain, Madhya Pradesh, India	Karolinska Institutet	Sidney, K (corresponding author), Karolinska Inst, Stockholm, Sweden.	Kristi.sidney@ki.se	Annerstedt, Kristi/AAJ-8678-2020	Annerstedt, Kristi/0000-0002-8798-4027; Diwan, Vishal/0000-0001-7948-8579; De Costa, Ayesha/0000-0003-1869-5990	European Union Framework Progrmme 7	European Union Framework Progrmme 7	The study was financially supported by a grant under the European Union Framework Progrmme 7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babinard J, 2006, MATERNAL CHILD MORTA, P1; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Gabrysch S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000394; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Gething PW, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-991; Government of India, 2012, ANN HLTH SURV B 2011; Government of India, 2011, PROV POP TOT MADH PR; Government of India, 2002, POV LIN BPL 2002 CEN; Government of India planning commission, 2013, PRESS NOT POV EST 20; Government of Madhya Pradesh, 2000, POP POL MADH PRAD; Government of Madhya Pradesh, 2007, MADH PRAD HUM DEV RE; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hussein J, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001264; International Institute for Population Sciences (IIPS), 2010, DISTR LEV HOUS FAC S; International Institute for Population Sciences (IIPS), 2006, DISTR LEV HOUS FAC S; Jahn A, 2001, REFERRAL PREGNANCY C; Jehan K, 2012, REPROD HEALTH MATTER, V20, P142, DOI 10.1016/S0968-8080(12)39609-2; Kedia S, 2012, JANANI EXPRESS YOJAN; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Mavalankar DV, 2005, AM J PUBLIC HEALTH, V95, P200, DOI 10.2105/AJPH.2003.036715; Ministry of Health and Family Welfare, 2006, JAN SUR YOJ REV GUID; National Rural Health Mission, 2013, JAN EXPR REP JAN MAR; National Rural Health Mission, 2013, ACCR SOC HLTH ACT; Richard F, 2010, AM J PUBLIC HEALTH, V100, P1845, DOI 10.2105/AJPH.2009.179689; Schmidt CO, 2008, INT J PUBLIC HEALTH, V53, P165, DOI 10.1007/s00038-008-7068-3; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; United Nations Population Fund India, 2009, CONC ASS JAN SUR YOJ; Wilson A, 2013, INT J GYNECOL OBSTET, V122, P192, DOI 10.1016/j.ijgo.2013.03.030; World Health Organization (WHO); UNFPA; UNICEF; Columbia University. Mailman School of Public Health, 2009, MON EM OBST CAR HDB	29	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96287	10.1371/journal.pone.0096287	http://dx.doi.org/10.1371/journal.pone.0096287			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4TJ	24828520	Green Published, Green Submitted, gold			2022-12-27	WOS:000336857400023
J	Choi, JE; Hur, W; Kim, JH; Li, TZ; Lee, EB; Lee, SW; Kang, W; Shin, EC; Wakita, T; Yoon, SK				Choi, Jung Eun; Hur, Wonhee; Kim, Jung-Hee; Li, Tian Zhu; Lee, Eun Byul; Lee, Sung Won; Kang, Wonseok; Shin, Eui-Cheol; Wakita, Takaji; Yoon, Seung Kew			MicroRNA-27a Modulates HCV Infection in Differentiated Hepatocyte-Like Cells from Adipose Tissue-Derived Mesenchymal Stem Cells	PLOS ONE			English	Article							HEPATITIS-C VIRUS; EXPRESSION; REPLICATION; GENERATION; SUPPORT	Background and Aims: Despite the discovery of hepatitis C virus (HCV) entry factor, the mechanism by which it is regulated by miRNAs remains unclear. Adipose tissue-derived human mesenchymal stem cells (AT-hMSCs) have been widely used for differentiated hepatocyte-like cells (DHCs). Here, we established an in vitro HCV infection model using DHCs from AT-hMSCs and identified miRNAs that modulate HCV infectivity. Methods: AT-hMSCs were differentiated into DHCs using the conditional media, and evaluated for hepatocyte characteristics using RT-PCR, immunocytochemistry, periodic acid-Schiff staining, and a urea synthesis assay. The expression of HCV candidate receptors was also verified using immunocytochemistry. The levels of candidate miRNAs targeting HCV receptors were then determined by relative quantitative RT-PCR (rqRT-PCR). Finally, DHCs were infected using HCVcc and serum from HCV-infected patients, and infectivity of the virus was measured by rqRT-PCR and transmission electron microscopy (TEM). Results: The expected changes in morphology, function and hepatic gene expression were observed during hepatic differentiation. Moreover, the expression of candidate HCV entry factors and miR-27a were altered during hepatic differentiation. The infection and replication of HCV occurred efficiently in DHCs treated with HCVcc or infected with serum from HCV-infected patients. In addition, HCV infectivity was suppressed in miR-27a-transfected DHCs, due to the inhibition of LDLR expression by miR-27a. Conclusions: Our results demonstrate that AT-hMSCs are a good source of DHCs, which are suitable for in vitro cultivation of HCV. Furthermore, these results suggest that miR-27a modulates HCV infectivity by regulating LDLR expression.	[Choi, Jung Eun; Hur, Wonhee; Kim, Jung-Hee; Li, Tian Zhu; Lee, Eun Byul; Lee, Sung Won; Yoon, Seung Kew] Catholic Univ, Liver Res Ctr, Seoul, South Korea; [Choi, Jung Eun; Hur, Wonhee; Kim, Jung-Hee; Li, Tian Zhu; Lee, Eun Byul; Lee, Sung Won; Yoon, Seung Kew] Catholic Univ Korea, WHO Collaborating Ctr Viral Hepatitis, Seoul, South Korea; [Kang, Wonseok; Shin, Eui-Cheol] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Lab Immunol & Infect Dis, Taejon 305701, South Korea; [Wakita, Takaji] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan	Catholic University of Korea; Catholic University of Korea; Korea Advanced Institute of Science & Technology (KAIST); National Institute of Infectious Diseases (NIID)	Yoon, SK (corresponding author), Catholic Univ, Liver Res Ctr, Seoul, South Korea.	yoonsk@catholic.ac.kr	Shin, Eui-Cheol/C-1690-2011	Shin, Eui-Cheol/0000-0002-6308-9503	Bio R&D program through the National Research Foundation of Korea - Ministry of Education, Science and Technology [2012-001941]	Bio R&D program through the National Research Foundation of Korea - Ministry of Education, Science and Technology	This study was supported by the Bio R&D program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2012-001941). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Baer PC, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/812693; Banas A, 2007, HEPATOLOGY, V46, P219, DOI 10.1002/hep.21704; Chen YX, 2010, LIVER TRANSPLANT, V16, P1086, DOI 10.1002/lt.22111; Cheng JC, 2012, CELL MOL LIFE SCI, V69, P2621, DOI 10.1007/s00018-012-0940-6; Cui LN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044737; Dussupt V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000339; Fukuhara T, 2012, J VIROL, V86, P7918, DOI 10.1128/JVI.00567-12; Gottwein JM, 2007, P NATL ACAD SCI USA, V104, P13215, DOI 10.1073/pnas.0705890104; Hou WH, 2010, HEPATOLOGY, V51, P1494, DOI 10.1002/hep.23401; Huang CK, 2013, BBA-MOL CELL RES, V1833, P1222, DOI 10.1016/j.bbamcr.2013.01.007; Hur W, 2012, NUTR RES, V32, P778, DOI 10.1016/j.nutres.2012.06.017; Ishida H, 2011, BIOCHEM BIOPH RES CO, V412, P92, DOI 10.1016/j.bbrc.2011.07.049; Jopling CL, 2010, VIRUSES-BASEL, V2, P1382, DOI 10.3390/v2071382; Kagawa T, 2010, HEPAT RES TREAT, V2010, P275; Kambara H, 2012, J VIROL, V86, P1382, DOI 10.1128/JVI.06242-11; Keskinen P, 1999, VIROLOGY, V263, P364, DOI 10.1006/viro.1999.9983; Kim CW, 2013, CLIN MOL HEPATOL, V19, P17, DOI 10.3350/cmh.2013.19.1.17; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Mitjavila-Garcia MT, 2005, ADV DRUG DELIVER REV, V57, P1935, DOI 10.1016/j.addr.2005.06.001; Murakami Y, 2009, J HEPATOL, V50, P453, DOI 10.1016/j.jhep.2008.06.010; Narbus CM, 2011, J VIROL, V85, P12087, DOI 10.1128/JVI.05843-11; Nazari-Shafti TZ, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-3; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ploss A, 2010, P NATL ACAD SCI USA, V107, P3141, DOI 10.1073/pnas.0915130107; Roelandt P, 2012, J HEPATOL, V57, P246, DOI 10.1016/j.jhep.2012.03.030; Romao JM, 2011, EXP BIOL MED, V236, P997, DOI 10.1258/ebm.2011.011101; Schwartz RE, 2012, P NATL ACAD SCI USA, V109, P2544, DOI 10.1073/pnas.1121400109; Shirasaki T, 2013, J VIROL, V87, P5270, DOI 10.1128/JVI.03022-12; Sidorkiewicz M, 2010, ACTA VIROL, V54, P75, DOI 10.4149/av_2010_01_75; Sourisseau M, 2013, GASTROENTEROLOGY; Sundin M, 2006, BONE MARROW TRANSPL, V37, P1051, DOI 10.1038/sj.bmt.1705368; Talens-Visconti R, 2006, WORLD J GASTROENTERO, V12, P5834, DOI 10.3748/wjg.v12.i36.5834; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Walker Michelle P., 2003, Antiviral Chemistry & Chemotherapy, V14, P1; Wu XF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002617; Yoshida T, 2011, BIOCHEM BIOPH RES CO, V416, P119, DOI 10.1016/j.bbrc.2011.11.007; Zeng Y, 2012, FEBS LETT, V586, P2375, DOI 10.1016/j.febslet.2012.05.049; Zhang Z, 2012, OSTEOARTHR CARTILAGE, V20, P1638, DOI 10.1016/j.joca.2012.08.024; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	41	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e91958	10.1371/journal.pone.0091958	http://dx.doi.org/10.1371/journal.pone.0091958			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824429	Green Published, Green Submitted, gold			2022-12-27	WOS:000336369200001
J	Cornwall, CE; Boyd, PW; McGraw, CM; Hepburn, CD; Pilditch, CA; Morris, JN; Smith, AM; Hurd, CL				Cornwall, Christopher E.; Boyd, Philip W.; McGraw, Christina M.; Hepburn, Christopher D.; Pilditch, Conrad A.; Morris, Jaz N.; Smith, Abigail M.; Hurd, Catriona L.			Diffusion Boundary Layers Ameliorate the Negative Effects of Ocean Acidification on the Temperate Coralline Macroalga Arthrocardia corymbosa	PLOS ONE			English	Article							GIANT-KELP; MACROCYSTIS-PYRIFERA; WATER MOTION; SCLERACTINIAN CORAL; NITROGEN UPTAKE; NUTRIENT SOURCE; CARBONIC-ACID; ULVA-PERTUSA; LOWERED PH; PHOTOSYNTHESIS	Anthropogenically-modulated reductions in pH, termed ocean acidification, could pose a major threat to the physiological performance, stocks, and biodiversity of calcifiers and may devalue their ecosystem services. Recent debate has focussed on the need to develop approaches to arrest the potential negative impacts of ocean acidification on ecosystems dominated by calcareous organisms. In this study, we demonstrate the role of a discrete (i.e. diffusion) boundary layer (DBL), formed at the surface of some calcifying species under slow flows, in buffering them from the corrosive effects of low pH seawater. The coralline macroalga Arthrocardia corymbosa was grown in a multifactorial experiment with two mean pH levels (8.05 'ambient' and 7.65 a worst case 'ocean acidification' scenario projected for 2100), each with two levels of seawater flow (fast and slow, i.e. DBL thin or thick). Coralline algae grown under slow flows with thick DBLs (i.e., unstirred with regular replenishment of seawater to their surface) maintained net growth and calcification at pH 7.65 whereas those in higher flows with thin DBLs had net dissolution. Growth under ambient seawater pH (8.05) was not significantly different in thin and thick DBL treatments. No other measured diagnostic (recruit sizes and numbers, photosynthetic metrics, % C, % N, % MgCO3) responded to the effects of reduced seawater pH. Thus, flow conditions that promote the formation of thick DBLs, may enhance the subsistence of calcifiers by creating localised hydrodynamic conditions where metabolic activity ameliorates the negative impacts of ocean acidification.	[Cornwall, Christopher E.; Morris, Jaz N.; Hurd, Catriona L.] Univ Otago, Dept Bot, Dunedin, New Zealand; [Boyd, Philip W.] Natl Inst Water & Atmospher Res NIWA, Ctr Phys & Chem Oceanog, Dunedin, New Zealand; [McGraw, Christina M.] Clark Univ, Sch Chem & Biochem, Worcester, MA 01610 USA; [Hepburn, Christopher D.; Smith, Abigail M.] Univ New England, Sch Sci & Technol, Armidale, NSW, Australia; [Pilditch, Conrad A.] Univ Waikato, Dept Biol Sci, Hamilton, New Zealand; [Hurd, Catriona L.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia	University of Otago; Clark University; University of New England; University of Waikato; University of Tasmania	Cornwall, CE (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	chris.cornwall@utas.edu.au	Boyd, Philip W/J-7624-2014; Smith, Abigail M/F-7714-2011; Hurd, Catriona/J-2411-2013; Cornwall, Christopher Edward/J-3982-2012	Boyd, Philip W/0000-0001-7850-1911; Smith, Abigail M/0000-0001-6468-9124; Hurd, Catriona/0000-0001-9965-4917; Cornwall, Christopher Edward/0000-0002-6154-4082; McGraw, Christina/0000-0001-5841-0748	University of Otago Doctoral Scholarship; University of Otago Postgraduate Publishing Bursary; Performance Based Research Fund from the Department of Botany, University of Otago; University of Otago Research Grant; New Zealand MPI grant; New Zealand Foundation for Research Science Technology [UOOX0802]; Royal Society of New Zealand Marsden grant [UOO0914]	University of Otago Doctoral Scholarship; University of Otago Postgraduate Publishing Bursary; Performance Based Research Fund from the Department of Botany, University of Otago; University of Otago Research Grant; New Zealand MPI grant; New Zealand Foundation for Research Science Technology(New Zealand Foundation for Research, Science and Technology); Royal Society of New Zealand Marsden grant(Royal Society of New ZealandMarsden Fund (NZ))	C.E.C was supported by a University of Otago Doctoral Scholarship and a University of Otago Postgraduate Publishing Bursary, C.L.H. was funded by a Performance Based Research Fund from the Department of Botany, University of Otago, and a University of Otago Research Grant. P.W.B. was funded by a New Zealand MPI grant to Coasts and oceans. C.M.M was funded by a New Zealand Foundation for Research Science & Technology (Grant UOOX0802). C.L.H. and P.W.B. were funded by a Royal Society of New Zealand Marsden grant (UOO0914). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Horani FA, 2003, J EXP MAR BIOL ECOL, V288, P1, DOI 10.1016/S0022-0981(02)00578-6; Al-Horani FA, 2003, MAR BIOL, V142, P419, DOI 10.1007/s00227-002-0981-8; Anthony KRN, 2013, BIOGEOSCIENCES, V10, P4897, DOI 10.5194/bg-10-4897-2013; Anthony KRN, 2011, GLOBAL CHANGE BIOL, V17, P3655, DOI 10.1111/j.1365-2486.2011.02510.x; AXELSSON L, 1988, MAR BIOL, V97, P287, DOI 10.1007/BF00391314; Barr NG, 2008, AQUAT BIOL, V3, P179, DOI 10.3354/ab00079; Bjork M, 2004, MAR ECOL PROG SER, V284, P109, DOI 10.3354/meps284109; BOROWITZKA MA, 1987, CRIT REV PLANT SCI, V6, P1, DOI 10.1080/07352688709382246; BOROWITZKA MA, 1978, MAR BIOL, V46, P295, DOI 10.1007/BF00391400; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Chan NCS, 2013, GLOBAL CHANGE BIOL, V19, P282, DOI 10.1111/gcb.12011; Connell SD, 2003, MAR BIOL, V142, P1065, DOI 10.1007/s00227-003-1021-z; Cornelisen CD, 2007, LIMNOL OCEANOGR, V52, P820, DOI 10.4319/lo.2007.52.2.0820; Cornelisen CD, 2006, MAR ECOL PROG SER, V312, P1, DOI 10.3354/meps312001; Cornelisen CD, 2009, MAR ECOL PROG SER, V386, P71, DOI 10.3354/meps08065; Cornwall CE, 2013, THESIS U OTAGO DUNED; Cornwall CE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2201; Cornwall CE, 2013, LIMNOL OCEANOGR, V58, P121, DOI 10.4319/lo.2013.58.1.0121; Cornwall CE, 2012, J PHYCOL, V48, P137, DOI 10.1111/j.1529-8817.2011.01085.x; de Beer D, 2000, MAR ECOL PROG SER, V194, P75, DOI 10.3354/meps194075; Delille B, 2009, ESTUAR COAST SHELF S, V81, P114, DOI 10.1016/j.ecss.2008.10.004; Denny MW, 2010, ANNU REV MAR SCI, V2, P89, DOI 10.1146/annurev-marine-120308-081011; Denny MW, 2000, MARINE COMMUNITY ECO; Dickson A.G., 2007, GUIDE BEST PRACTICES, V3; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Dufault AM, 2012, P ROY SOC B-BIOL SCI, V279, P2951, DOI 10.1098/rspb.2011.2545; Dworjanyn SA, 2006, MAR ECOL PROG SER, V318, P153, DOI 10.3354/meps318153; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Ferrari MCO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031478; Findlay HS, 2009, MAR ECOL PROG SER, V389, P193, DOI 10.3354/meps08141; Flynn KJ, 2012, NAT CLIM CHANGE, V2, P510, DOI 10.1038/NCLIMATE1489; Fram JP, 2008, LIMNOL OCEANOGR, V53, P1589, DOI 10.4319/lo.2008.53.4.1589; Gattuso J.-P., 2010, GUIDE BEST PRACTICES, P41, DOI DOI 10.1016/J.JOMS.2003.10.009; Gaylord B, 2007, LIMNOL OCEANOGR, V52, P1838, DOI 10.4319/lo.2007.52.5.1838; Gaylord B, 2012, J EXP BIOL, V215, P997, DOI 10.1242/jeb.059824; GERARD VA, 1984, MAR BIOL, V84, P189, DOI 10.1007/BF00393004; Gordon R, 2004, MAR BIOL, V145, P21, DOI 10.1007/s00227-004-1305-y; Gray BE, 2004, PAC SCI, V58, P47, DOI [10.1353/PSC.2004.0005, DOI 10.1353/PSC.2004.0005]; Hepburn CD, 2011, GLOBAL CHANGE BIOL, V17, P2488, DOI 10.1111/j.1365-2486.2011.02411.x; Hofmann GE, 2010, ANNU REV ECOL EVOL S, V41, P127, DOI 10.1146/annurev.ecolsys.110308.120227; Huang I, 2011, LIMNOL OCEANOGR, V56, P1453, DOI 10.4319/lo.2011.56.4.1453; Hurd CL, 2011, GLOBAL CHANGE BIOL, V17, P3254, DOI 10.1111/j.1365-2486.2011.02473.x; Hurd CL, 2011, J PHYCOL, V47, P341, DOI 10.1111/j.1529-8817.2011.00958.x; Hurd CL, 2009, J PHYCOL, V45, P1236, DOI 10.1111/j.1529-8817.2009.00768.x; Hurd CL, 1996, MAR BIOL, V126, P205, DOI 10.1007/BF00347445; Hurd CL, 2000, J PHYCOL, V36, P453, DOI 10.1046/j.1529-8817.2000.99139.x; Irving AD, 2004, MAR BIOL, V144, P361, DOI 10.1007/s00227-003-1202-9; Jokiel PL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0031; KAIN JM, 1976, J MAR BIOL ASSOC UK, V56, P267, DOI 10.1017/S0025315400018907; Kleypas JA, 2011, GLOBAL CHANGE BIOL, V17, P3667, DOI 10.1111/j.1365-2486.2011.02530.x; Kregting LT, 2008, J PHYCOL, V44, P320, DOI 10.1111/j.1529-8817.2008.00484.x; Kregting LT, 2011, AQUAT BIOL, V14, P41, DOI 10.3354/ab00369; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; KUHL M, 1995, MAR ECOL PROG SER, V117, P159, DOI 10.3354/meps117159; LaRoche J., 2010, GUIDE BEST PRACTICES, P81; Le Quesne WJF, 2012, FISH FISH, V13, P333, DOI 10.1111/j.1467-2979.2011.00423.x; LESSER MP, 1994, J EXP MAR BIOL ECOL, V178, P153, DOI 10.1016/0022-0981(94)90034-5; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Longstaff BJ, 2002, PHOTOSYNTH RES, V74, P281, DOI 10.1023/A:1021279627409; Manzello DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041715; Martone PT, 2012, J PHYCOL, V48, P859, DOI 10.1111/j.1529-8817.2012.01190.x; McGraw CM, 2010, LIMNOL OCEANOGR-METH, V8, P686, DOI 10.4319/lom.2010.8.686; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Nelson WA, 2009, MAR FRESHWATER RES, V60, P787, DOI 10.1071/MF08335; Nishihara GN, 2007, LIMNOL OCEANOGR-METH, V5, P88, DOI 10.4319/lom.2007.5.88; Nishihara GN, 2009, LIMNOL OCEANOGR, V54, P1874, DOI 10.4319/lo.2009.54.6.1874; Olischlager M, 2012, BOT MAR, V55, P511, DOI 10.1515/bot-2012-0163; PEARCE CM, 1991, J EXP MAR BIOL ECOL, V147, P147, DOI 10.1016/0022-0981(91)90179-Z; Pearson GA, 1998, ECOLOGY, V79, P1725; Pelejero C, 2010, TRENDS ECOL EVOL, V25, P332, DOI 10.1016/j.tree.2010.02.002; R Core Development Team, 2008, R LANG ENV STAT COMP; Rasband W., 2006, IMAGEJ; Rau GH, 2012, NAT CLIM CHANGE, V2, P720, DOI 10.1038/NCLIMATE1555; Raven J, 2005, OCEAN ACIDIFICATION; REED DC, 1984, ECOLOGY, V65, P937, DOI 10.2307/1938066; Ries J, 2011, NAT CLIM CHANGE, V1, P294, DOI 10.1038/nclimate1204; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Ritchie RJ, 2008, PHOTOSYNTHETICA, V46, P115, DOI 10.1007/s11099-008-0019-7; Roberts R, 2001, J SHELLFISH RES, V20, P571; Roberts RD, 2007, J SHELLFISH RES, V26, P745, DOI 10.2983/0730-8000(2007)26[745:EOWVAB]2.0.CO;2; Rodolfo-Metalpa R, 2011, NAT CLIM CHANGE, V1, P308, DOI 10.1038/NCLIMATE1200; Roleda MY, 2012, GLOBAL CHANGE BIOL, V18, P854, DOI 10.1111/j.1365-2486.2011.02594.x; ROWLEY RJ, 1989, MAR BIOL, V100, P485, DOI 10.1007/BF00394825; Russell BD, 2012, MAR BIOL, V159, P2633, DOI 10.1007/s00227-011-1863-8; Russell BD, 2012, BIOL LETTERS, V8, P164, DOI 10.1098/rsbl.2011.0779; Russell BD, 2011, J PHYCOL, V47, P744, DOI 10.1111/j.1529-8817.2011.01002.x; Sampath-Wiley P, 2007, J APPL PHYCOL, V19, P123, DOI 10.1007/s10811-006-9118-7; Sardene V, 2013, PLOS ONE, V8; Schaffelke B, 1999, J PHYCOL, V35, P1150, DOI 10.1046/j.1529-8817.1999.3561150.x; SHASHAR N, 1993, BIOL BULL, V185, P455, DOI 10.2307/1542485; Smith AM, 1998, MAR GEOL, V151, P27, DOI 10.1016/S0025-3227(98)00055-3; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Stewart HL, 2003, ECOLOGY, V84, P2999, DOI 10.1890/02-0092; Tait LW, 2014, J EXP MAR BIOL ECOL, V454, P1, DOI 10.1016/j.jembe.2014.01.016; Vogel S, 1994, LIFE MOVING FLUIDS; Walsby AE, 1997, NEW PHYTOL, V136, P189, DOI 10.1046/j.1469-8137.1997.00736.x; Wernberg T, 2011, J EXP MAR BIOL ECOL, V400, P264, DOI 10.1016/j.jembe.2011.02.017; WHEELER WN, 1980, MAR BIOL, V56, P103, DOI 10.1007/BF00397128	99	89	89	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97235	10.1371/journal.pone.0097235	http://dx.doi.org/10.1371/journal.pone.0097235			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824089	Green Submitted, gold, Green Published			2022-12-27	WOS:000336369200078
J	Li, X; Shen, L; Tan, HZ				Li, Xun; Shen, Lin; Tan, Hongzhuan			Polymorphisms and Plasma Level of Transforming Growth Factor-Beta 1 and Risk for Preeclampsia: A Systematic Review	PLOS ONE			English	Review							REGULATORY T-CELLS; GENE POLYMORPHISMS; TGF-BETA-1 GENE; PERIPHERAL-BLOOD; NORMAL-PREGNANCY; TGF-BETA; ASSOCIATION; GROWTH-FACTOR-BETA-1; WOMEN; FACTOR-BETA(1)	Background: Transforming growth factor-beta 1 (TGF-beta 1) is thought to be involved in the pathogenesis of preeclampsia (PE), but the results are inconsistent among studies. This article aims to compile an overview of the studies about the associations of TGF-beta 1 polymorphism and plasma level with PE risk and to provide recommendations for future research. Methods and Results: The databases PubMed, Embase and Web of Science were searched up to December 2013. Five studies investigating the associations of four polymorphisms with the risks of PE were involved. A meta-analysis was conducted for the 869T>C polymorphism and PE risk. The results show that genotype TT of 869T>C polymorphism is a protective factor of PE (pooled odds ratio = 0.73, 95% CI: 0.56, 0.95). Eight case-control studies reported the plasma level of TGF-beta 1. The substantial heterogeneity among studies may be attributed to the differences in the blood sample processing and the TGF-beta 1 analysis kits. The results suggest that plasma TGF-beta 1 level in the second trimester was significantly lower in the PE group than in the normal pregnancy group, but was significantly higher in the PE group during the third trimester. Conclusions: The current results support that the TGF-beta 1 869 T>C polymorphism was associated with the risk of PE. However, the number of eligible studies is small and more studies are needed to clarify whether this association can be detected on larger sample sizes and different populations. Owing to the heterogeneity between studies, no conclusion on the association between plasma TGF-beta 1 level and PE risk can be drawn from this review. Further studies about the TGF-beta 1 levels at different stages of pregnancy and the development of TGF-beta 1 assay methodology are required to reveal the role of TGF-beta 1 in the pathological development of PE.	[Li, Xun; Shen, Lin; Tan, Hongzhuan] Cent S Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China	Central South University	Tan, HZ (corresponding author), Cent S Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China.	tanhz99@qq.com			Hunan Provincial Innovation Foundation for Postgraduate [CX2013B098]	Hunan Provincial Innovation Foundation for Postgraduate	This work was supported by Hunan Provincial Innovation Foundation for Postgraduate (CX2013B098) awarded to the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Aguilar-Duran M, 2014, PREGNANCY HYPERTENS, V4, P14, DOI 10.1016/j.preghy.2013.07.007; ASSOIAN RK, 1983, J BIOL CHEM, V258, P7155; Awad MR, 1998, TRANSPLANTATION, V66, P1014, DOI 10.1097/00007890-199810270-00009; de Lima THB, 2009, HYPERTENS RES, V32, P565, DOI 10.1038/hr.2009.58; Bell MJ, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-82; Benian A, 2002, OBSTET GYNECOL, V100, P327, DOI 10.1016/S0029-7844(02)02077-X; Bierie B, 2010, CYTOKINE GROWTH F R, V21, P49, DOI 10.1016/j.cytogfr.2009.11.008; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Buurma AJ, 2013, HUM REPROD UPDATE; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Chen Q, 2010, J PATHOL, V221, P87, DOI 10.1002/path.2690; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Clark DA, 1998, INT J BIOCHEM CELL B, V30, P293, DOI 10.1016/S1357-2725(97)00128-3; Clark S. L., 2008, AM J OBSTET GYNECOL, V199, P36; Clarke GM, 2011, NAT PROTOC, V6, P121, DOI 10.1038/nprot.2010.182; Clausen T, 2002, PLACENTA, V23, P380, DOI 10.1053/plac.2002.0828; Daher S, 2006, AM J REPROD IMMUNOL, V55, P130, DOI 10.1111/j.1600-0897.2005.00341.x; Darmochwal-Kolarz D, 2012, J REPROD IMMUNOL, V93, P75, DOI 10.1016/j.jri.2012.01.006; Djurovic S, 1997, CLIN GENET, V52, P371; Dobaczewski M, 2011, J MOL CELL CARDIOL, V51, P600, DOI 10.1016/j.yjmcc.2010.10.033; Enquobahrie DA, 2005, J MATERN-FETAL NEO M, V17, P343, DOI 10.1080/14767050500132450; Feizollahzadeh S, 2012, J REPROD IMMUNOL, V94, P216, DOI 10.1016/j.jri.2012.02.006; Grainger DJ, 1999, HUM MOL GENET, V8, P93, DOI 10.1093/hmg/8.1.93; Grainger DJ, 2000, CYTOKINE GROWTH F R, V11, P133, DOI 10.1016/S1359-6101(99)00037-4; Grandone E, 1997, THROMB HAEMOSTASIS, V77, P1052; He F, 2010, BLOOD PRESSURE, V19, P225, DOI 10.3109/08037051003768254; Hennessy A, 2002, CLIN EXP PHARMACOL P, V29, P968, DOI 10.1046/j.1440-1681.2002.03763.x; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Huber A, 2002, ACTA OBSTET GYN SCAN, V81, P168, DOI 10.1034/j.1600-0412.2002.810214.x; Kanasaki K, 2009, KIDNEY INT, V76, P831, DOI 10.1038/ki.2009.284; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; Kim SY, 2010, AM J REPROD IMMUNOL, V63, P291, DOI 10.1111/j.1600-0897.2009.00795.x; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lenfant C, 2001, J Clin Hypertens (Greenwich), V3, P75; Lewis Cathryn M, 2002, Brief Bioinform, V3, P146, DOI 10.1093/bib/3.2.146; Lim JH, 2009, PRENATAL DIAG, V29, P471, DOI 10.1002/pd.2217; LYALL F, 1994, J HYPERTENS, V12, P1339; Madazli R, 2003, ACTA OBSTET GYN SCAN, V82, P797, DOI 10.1034/j.1600-0412.2003.00206.x; Mantel PY, 2011, METHODS MOL BIOL, V677, P303, DOI 10.1007/978-1-60761-869-0_21; Muy-Rivera M, 2004, AM J HYPERTENS, V17, P334, DOI 10.1016/j.amjhyper.2003.12.010; Naicker T, 2002, J Obstet Gynaecol, V22, P279; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Saito S, 2010, IMMUNOL CELL BIOL, V88, P615, DOI 10.1038/icb.2010.68; Sakaguchi S, 2005, NATURE IMMUNOLOGY, V6; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Santner-Nanan B, 2009, J IMMUNOL, V183, P7023, DOI 10.4049/jimmunol.0901154; Sasaki Y, 2007, CLIN EXP IMMUNOL, V149, P139, DOI 10.1111/j.1365-2249.2007.03397.x; Peracoli MTS, 2008, J REPROD IMMUNOL, V79, P79, DOI 10.1016/j.jri.2008.08.001; Simpson H, 2002, PLACENTA, V23, P44, DOI 10.1053/plac.2001.0746; Sohda S, 1997, J MED GENET, V34, P525, DOI 10.1136/jmg.34.6.525; Staines-Urias E, 2012, INT J EPIDEMIOL, V41, P1764, DOI 10.1093/ije/dys162; Stanczuk GA, 2007, ACTA OBSTET GYN SCAN, V86, P903, DOI 10.1080/00016340701416945; Steinborn A, 2008, CLIN IMMUNOL, V129, P401, DOI 10.1016/j.clim.2008.07.032; Syrris P, 1998, CLIN SCI, V95, P659, DOI 10.1042/cs0950659; Szarka A, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-59; Thorlund K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039471; Toldi G, 2012, AM J REPROD IMMUNOL, V68, P175, DOI 10.1111/j.1600-0897.2012.01145.x; Toldi G, 2011, AM J REPROD IMMUNOL, V66, P223, DOI 10.1111/j.1600-0897.2011.00987.x; WAKEFIELD LM, 1995, CLIN CANCER RES, V1, P129; Walker JJ, 2000, LANCET, V356, P1260, DOI 10.1016/S0140-6736(00)02800-2; Wang XM, 2013, ARCH MED RES, V44, P159, DOI 10.1016/j.arcmed.2013.01.011; WHITEHEAD A, 1991, STAT MED, V10, P1665, DOI 10.1002/sim.4780101105; Wilson ML, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.05.038; Xu HY, 2010, MOL CELL BIOCHEM, V335, P13, DOI 10.1007/s11010-009-0235-x; Zhang CL, 2013, HUM REPROD UPDATE, V19, P376, DOI 10.1093/humupd/dmt013	67	16	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97230	10.1371/journal.pone.0097230	http://dx.doi.org/10.1371/journal.pone.0097230			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24823830	Green Published, Green Submitted, gold			2022-12-27	WOS:000336369200076
J	Sun, N; Chan, FY; Lu, YJ; Neves, MAC; Lui, HK; Wang, Y; Chow, KY; Chan, KF; Yan, SC; Leung, YC; Abagyan, R; Chan, TH; Wong, KY				Sun, Ning; Chan, Fung-Yi; Lu, Yu-Jing; Neves, Marco A. C.; Lui, Hok-Kiu; Wang, Yong; Chow, Ka-Yan; Chan, Kin-Fai; Yan, Siu-Cheong; Leung, Yun-Chung; Abagyan, Ruben; Chan, Tak-Hang; Wong, Kwok-Yin			Rational Design of Berberine-Based FtsZ Inhibitors with Broad-Spectrum Antibacterial Activity	PLOS ONE			English	Article							DIVISION PROTEIN FTSZ; SMALL-MOLECULE INHIBITORS; CELL-DIVISION; STRUCTURAL INSIGHTS; IN-VITRO; IDENTIFICATION; CYTOKINESIS; DERIVATIVES; STRATEGIES; RESISTANCE	Inhibition of the functional activity of Filamenting temperature-sensitive mutant Z (FtsZ) protein, an essential and highly conserved bacterial cytokinesis protein, is a promising approach for the development of a new class of antibacterial agents. Berberine, a benzylisoquinoline alkaloid widely used in traditional Chinese and native American medicines for its antimicrobial properties, has been recently reported to inhibit FtsZ. Using a combination of in silico structure-based design and in vitro biological assays, 9-phenoxyalkyl berberine derivatives were identified as potent FtsZ inhibitors. Compared to the parent compound berberine, the derivatives showed a significant enhancement of antibacterial activity against clinically relevant bacteria, and an improved potency against the GTPase activity and polymerization of FtsZ. The most potent compound 2 strongly inhibited the proliferation of Gram-positive bacteria, including methicillin-resistant S. aureus and vancomycin-resistant E. faecium, with MIC values between 2 and 4 mu g/mL, and was active against the Gram-negative E. coli and K. pneumoniae, with MIC values of 32 and 64 mu g/mL respectively. The compound perturbed the formation of cytokinetic Z-ring in E. coli. Also, the compound interfered with in vitro polymerization of S. aureus FtsZ. Taken together, the chemical modification of berberine with 9-phenoxyalkyl substituent groups greatly improved the antibacterial activity via targeting FtsZ.	[Sun, Ning; Chan, Fung-Yi; Lu, Yu-Jing; Lui, Hok-Kiu; Wang, Yong; Chow, Ka-Yan; Chan, Kin-Fai; Yan, Siu-Cheong; Leung, Yun-Chung; Chan, Tak-Hang; Wong, Kwok-Yin] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Kowloon, Hong Kong, Peoples R China; [Sun, Ning; Chan, Fung-Yi; Lu, Yu-Jing; Lui, Hok-Kiu; Wang, Yong; Chow, Ka-Yan; Chan, Kin-Fai; Yan, Siu-Cheong; Leung, Yun-Chung; Chan, Tak-Hang; Wong, Kwok-Yin] Hong Kong Polytech Univ, State Key Lab Chirosci, Kowloon, Hong Kong, Peoples R China; [Lu, Yu-Jing] Guangdong Univ Technol, Sch Chem Engn & Light Ind, Guangzhou, Guangdong, Peoples R China; [Chan, Fung-Yi; Neves, Marco A. C.; Abagyan, Ruben] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Abagyan, Ruben] Molsoft LLC, San Diego, CA USA	Hong Kong Polytechnic University; Hong Kong Polytechnic University; Guangdong University of Technology; University of California System; University of California San Diego	Wong, KY (corresponding author), Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Kowloon, Hong Kong, Peoples R China.	kwok-yin.wong@polyu.edu.hk	Wong, Kwok-Yin/O-5948-2014	Wong, Kwok-Yin/0000-0003-4984-7109; Leung, Yun-chung/0000-0003-3590-7027; Neves, Marco/0000-0003-0525-7318; Chan, Kin-Fai/0000-0003-1475-288X; Yan, Siu-cheoong/0000-0001-7486-3069; Chan, Fung Yi/0000-0002-4770-9768; Wang, Yong/0000-0002-1292-0459	Research Grants Council [PolyU 5030/11P]; Special Equipment Grant of the University Grants Committee,Innovation and Technology Commission [SEG_PolyU01]; Hong Kong Polytechnic University	Research Grants Council(Hong Kong Research Grants Council); Special Equipment Grant of the University Grants Committee,Innovation and Technology Commission; Hong Kong Polytechnic University(Hong Kong Polytechnic University)	This work was supported by the Research Grants Council (PolyU 5030/11P), the Special Equipment Grant of the University Grants Committee (SEG_PolyU01), Innovation and Technology Commission, and The Hong Kong Polytechnic University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Anderson DE, 2012, ACS CHEM BIOL, V7, P1918, DOI 10.1021/cb300340j; Andreu JM, 2010, J BIOL CHEM, V285, P14239, DOI 10.1074/jbc.M109.094722; Beuria TK, 2005, BIOCHEMISTRY-US, V44, P16584, DOI 10.1021/bi050767+; Beuria TK, 2003, J BIOL CHEM, V278, P3735, DOI 10.1074/jbc.M205760200; Beuria TK, 2009, BIOCHEM J, V423, P61, DOI 10.1042/BJ20090817; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Boberek JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013745; Chan FY, 2013, J CHEM INF MODEL, V53, P2131, DOI 10.1021/ci400203f; Clardy J, 2006, NAT BIOTECHNOL, V24, P1541, DOI 10.1038/nbt1266; Czaplewski LG, 2009, BIOORG MED CHEM LETT, V19, P524, DOI 10.1016/j.bmcl.2008.11.021; Domadia P, 2007, BIOCHEM PHARMACOL, V74, P831, DOI 10.1016/j.bcp.2007.06.029; Domadia PN, 2008, BIOCHEMISTRY-US, V47, P3225, DOI 10.1021/bi7018546; Haydon DJ, 2008, SCIENCE, V321, P1673, DOI 10.1126/science.1159961; Huang L, 2010, BIOORGAN MED CHEM, V18, P1244, DOI 10.1016/j.bmc.2009.12.035; Huang Q, 2006, J MED CHEM, V49, P463, DOI 10.1021/jm050920y; Imanshahidi M, 2008, PHYTOTHER RES, V22, P999, DOI 10.1002/ptr.2399; Ito H, 2006, MICROBIOL IMMUNOL, V50, P759, DOI 10.1111/j.1348-0421.2006.tb03851.x; Iwasa K, 1996, EUR J MED CHEM, V31, P469, DOI 10.1016/0223-5234(96)85167-1; Lappchen T, 2008, CHEM BIOL, V15, P189, DOI 10.1016/j.chembiol.2007.12.013; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Levy SB, 1998, NEW ENGL J MED, V338, P1376, DOI 10.1056/NEJM199805073381909; Li ZR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001411; Lock RL, 2008, NAT REV DRUG DISCOV, V7, P324, DOI 10.1038/nrd2510; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Lu YJ, 2011, CHEM COMMUN, V47, P4971, DOI 10.1039/c1cc00020a; Margalit DN, 2004, P NATL ACAD SCI USA, V101, P11821, DOI 10.1073/pnas.0404439101; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Matsui T, 2012, ACTA CRYSTALLOGR D, V68, P1175, DOI 10.1107/S0907444912022640; McGovern SL, 2002, J MED CHEM, V45, P1712, DOI 10.1021/jm010533y; NEU HC, 1992, SCIENCE, V257, P1064, DOI 10.1126/science.257.5073.1064; Neves MAC, 2012, J COMPUT AID MOL DES, V26, P675, DOI 10.1007/s10822-012-9547-0; Nicola G, 2008, J COMPUT BIOL, V15, P231, DOI 10.1089/cmb.2007.0178; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Oliva MA, 2004, NAT STRUCT MOL BIOL, V11, P1243, DOI 10.1038/nsmb855; Oliva MA, 2007, J MOL BIOL, V373, P1229, DOI 10.1016/j.jmb.2007.08.056; Plaza A, 2010, J AM CHEM SOC, V132, P9069, DOI 10.1021/ja102100h; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; Ruiz-Avila LB, 2013, ACS CHEM BIOL; Schaffner-Barbero C, 2012, ACS CHEM BIOL, V7, P268, DOI 10.1021/cb2003626; Scheffers DJ, 2002, BIOCHEMISTRY-US, V41, P521, DOI 10.1021/bi011370i; Schmeller T, 1997, PHYTOCHEMISTRY, V44, P257, DOI 10.1016/S0031-9422(96)00545-6; Stokes NR, 2005, J BIOL CHEM, V280, P39709, DOI 10.1074/jbc.M506741200; Tan CM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003592; Wayne P, 2006, M07A7 CLSI; Yin J, 2008, METABOLISM, V57, P712, DOI 10.1016/j.metabol.2008.01.013; Zhang LJ, 2011, J MICROBIOL, V49, P834, DOI 10.1007/s12275-011-1051-z; Zhang WJ, 2007, BIOORGAN MED CHEM, V15, P5493, DOI 10.1016/j.bmc.2007.05.050	48	73	76	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97514	10.1371/journal.pone.0097514	http://dx.doi.org/10.1371/journal.pone.0097514			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824618	gold, Green Published, Green Submitted			2022-12-27	WOS:000336369200125
J	Buness, A; Roth, A; Herrmann, A; Schmitz, O; Kamp, H; Busch, K; Suter, L				Buness, Andreas; Roth, Adrian; Herrmann, Annika; Schmitz, Oliver; Kamp, Hennicke; Busch, Kristina; Suter, Laura			Identification of Metabolites, Clinical Chemistry Markers and Transcripts Associated with Hepatotoxicity	PLOS ONE			English	Article							INDUCED LIVER-INJURY; KIDNEY INJURY; BIOMARKERS; METABOLOMICS; NEPHROTOXICITY; DISCOVERY; TOXICITY; PROTEIN; EGR-1	Early and accurate pre-clinical and clinical biomarkers of hepatotoxicity facilitate the drug development process and the safety monitoring in clinical studies. We selected eight known model compounds to be administered to male Wistar rats to identify biomarkers of drug induced liver injury (DILI) using transcriptomics, metabolite profiling (metabolomics) and conventional endpoints. We specifically explored early biomarkers in serum and liver tissue associated with histopathologically evident acute hepatotoxicity. A tailored data analysis strategy was implemented to better differentiate animals with no treatment-related findings in the liver from animals showing evident hepatotoxicity as assessed by histopathological analysis. From the large number of assessed parameters, our data analysis strategy allowed us to identify five metabolites in serum and five in liver tissue, 58 transcripts in liver tissue and seven clinical chemistry markers in serum that were significantly associated with acute hepatotoxicity. The identified markers comprised metabolites such as taurocholic acid and putrescine (measured as sum parameter together with agmatine), classical clinical chemistry markers like AST (aspartate aminotransferase), ALT (alanine aminotransferase), and bilirubin, as well as gene transcripts like Igfbp1 (insulin-like growth factor-binding protein 1) and Egr1 (early growth response protein 1). The response pattern of the identified biomarkers was concordant across all types of parameters and sample matrices. Our results suggest that a combination of several of these biomarkers could significantly improve the robustness and accuracy of an early diagnosis of hepatotoxicity.	[Buness, Andreas; Roth, Adrian; Herrmann, Annika; Suter, Laura] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland; [Schmitz, Oliver] Metanomics GmbH, Berlin, Germany; [Busch, Kristina] Metan Hlth GmbH, Berlin, Germany; [Kamp, Hennicke] BASF SE, Ludwigshafen, Germany	Roche Holding; BASF	Buness, A (corresponding author), F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland.	a.buness@gmx.de	Suter-Dick, Laura/A-9093-2019	Suter-Dick, Laura/0000-0002-1449-3913	F. Hoffmann-La Roche Ltd; Metanomics Health GmbH	F. Hoffmann-La Roche Ltd(Hoffmann-La Roche); Metanomics Health GmbH	This work was funded by Non-Clinical Safety, F. Hoffmann-La Roche Ltd, and Metanomics Health GmbH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azmi J, 2005, XENOBIOTICA, V35, P839, DOI 10.1080/00498250500297940; BERK PD, 1978, AM J MED, V64, P311, DOI 10.1016/0002-9343(78)90061-X; Bollard ME, 2001, ANAL BIOCHEM, V295, P194, DOI 10.1006/abio.2001.5211; Boudonck KJ, 2009, TOXICOL PATHOL, V37, P280, DOI 10.1177/0192623309332992; DeLigio JT, 2009, CANCER BIOL THER, V8, P1889, DOI 10.4161/cbt.8.20.9804; Dieterle F, 2010, NAT BIOTECHNOL, V28, P463, DOI 10.1038/nbt.1622; Ennulat D, 2010, TOXICOL SCI, V116, P397, DOI 10.1093/toxsci/kfq144; Friedman S L, 1996, Prog Liver Dis, V14, P101; Goodsaid FM, 2009, CLIN PHARMACOL THER, V86, P490, DOI 10.1038/clpt.2009.149; Huang J, 2010, PHARMACOGENOMICS J, V10, P267, DOI 10.1038/tpj.2010.33; Kamp H, 2012, BIOANALYSIS, V4, P2291, DOI [10.4155/BIO.12.214, 10.4155/bio.12.214]; Leu JIJ, 2007, GENE DEV, V21, P3095, DOI 10.1101/gad.1567107; Leu JI, 2003, MOL CELL BIOL, V23, P1251, DOI 10.1128/MCB.23.4.1251-1259.2003; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Navarro VJ, 2006, NEW ENGL J MED, V354, P731, DOI 10.1056/NEJMra052270; Ozer J, 2008, TOXICOLOGY, V245, P194, DOI 10.1016/j.tox.2007.11.021; Pritchard MT, 2005, ALCOHOL CLIN EXP RES, V29, p146S, DOI 10.1097/01.alc.0000189286.81943.51; Ravenzwaay B, 2010, USE METABOLOMICS CAN, P141, DOI [10.1007/978-90-481-2675-0_8, DOI 10.1007/978-90-481-2675-0_]; Robertson DG, 2011, TOXICOL SCI, V120, pS146, DOI 10.1093/toxsci/kfq358; Roessner U, 2000, PLANT J, V23, P131, DOI 10.1046/j.1365-313x.2000.00774.x; Strauss V, 2009, TOXICOL LETT, V191, P88, DOI 10.1016/j.toxlet.2009.08.004; Sun J., 2013, J MOL BIOMARKERS DIA, pS1; Temple R, 2006, PHARMACOEPIDEM DR S, V15, P241, DOI 10.1002/pds.1211; Vaidya VS, 2010, NAT BIOTECHNOL, V28, P478, DOI 10.1038/nbt.1623; van Ravenzwaay B, 2007, TOXICOL LETT, V172, P21, DOI 10.1016/j.toxlet.2007.05.021; Xu YL, 2010, J BIOL CHEM, V285, P23231, DOI 10.1074/jbc.M110.117457; Zhang AH, 2012, PHARMAZIE, V67, P99, DOI 10.1691/ph.2012.1104	27	21	22	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97249	10.1371/journal.pone.0097249	http://dx.doi.org/10.1371/journal.pone.0097249			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836604	Green Published, Green Submitted, gold			2022-12-27	WOS:000339614800033
J	Jamil, T; Kruk, C; ter Braak, CJF				Jamil, Tahira; Kruk, Carla; ter Braak, Cajo J. F.			A Unimodal Species Response Model Relating Traits to Environment with Application to Phytoplankton Communities	PLOS ONE			English	Article							BAYESIAN VARIABLE SELECTION; CLIMATE-CHANGE; LAKE; STRATEGIES; HABITAT; CLASSIFICATION; VARIABILITY; REGRESSION; DIVERSITY; ECOLOGY	In this paper we attempt to explain observed niche differences among species (i.e. differences in their distribution along environmental gradients) by differences in trait values (e.g. volume) in phytoplankton communities. For this, we propose the trait-modulated Gaussian logistic model in which the niche parameters (optimum, tolerance and maximum) are made linearly dependent on species traits. The model is fitted to data in the Bayesian framework using OpenBUGS (Bayesian inference Using Gibbs Sampling) to identify according to which environmental variables there is niche differentiation among species and traits. We illustrate the method with phytoplankton community data of 203 lakes located within four climate zones and associated measurements on 11 environmental variables and six morphological species traits of 60 species. Temperature and chlorophyll-a (with opposite signs) described well the niche structure of all species. Results showed that about 25% of the variance in the niche centres with respect to chlorophyll-a were accounted for by traits, whereas niche width and maximum could not be predicted by traits. Volume, mucilage, flagella and siliceous exoskeleton are found to be the most important traits to explain the niche centres. Species were clustered in two groups with different niches structures, group 1 high temperature-low chlorophyll-a species and group 2 low temperature-high chlorophyll-a species. Compared to group 2, species in group 1 had larger volume but lower surface area, had more often flagella but neither mucilage nor siliceous exoskeleton. These results might help in understanding the effect of environmental changes on phytoplankton community. The proposed method, therefore, can also apply to other aquatic or terrestrial communities for which individual traits and environmental conditioning factors are available.	[Jamil, Tahira; ter Braak, Cajo J. F.] Univ Wageningen & Res Ctr, Wageningen, Netherlands; [Jamil, Tahira] COMSATS Inst Informat Technol, Dept Math, Islamabad, Pakistan; [Kruk, Carla] Fac deCiencias, Lab Ethol Ecol & Evolut, IIBCE Funct Ecol Aquat Syst, Montevideo, Uruguay	Wageningen University & Research; COMSATS University Islamabad (CUI); Instituto de Investigaciones Biologicas Clemente Estable Uruguay	ter Braak, CJF (corresponding author), Univ Wageningen & Res Ctr, Wageningen, Netherlands.	cajo.terbraak@wur.nl	Braak, Cajo J. F. ter/G-7006-2011	Braak, Cajo J. F. ter/0000-0002-0414-8745; Kruk, Carla/0000-0003-0760-1186	Higher Education Commission, Pakistan, through Netherlands Organization for International Cooperation in Higher Education (NUFFIC), The Netherlands	Higher Education Commission, Pakistan, through Netherlands Organization for International Cooperation in Higher Education (NUFFIC), The Netherlands(Netherlands Government)	Tahira Jamil is funded by Higher Education Commission, Pakistan, through Netherlands Organization for International Cooperation in Higher Education (NUFFIC), The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Brown PJ, 1998, J R STAT SOC B, V60, P627, DOI 10.1111/1467-9868.00144; BURNS CW, 1968, LIMNOL OCEANOGR, V13, P675, DOI 10.4319/lo.1968.13.4.0675; Celeux G, 2006, BAYESIAN ANAL, V1, P651, DOI 10.1214/06-BA122; Conley DJ, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001894; Doledec S, 1996, ENVIRON ECOL STAT, V3, P143, DOI 10.1007/BF02427859; Falkowski PG, 2003, GLO CH IGBP, P99; Fenchel T, 2004, BIOSCIENCE, V54, P777, DOI 10.1641/0006-3568(2004)054[0777:TUOSSP]2.0.CO;2; Ferber LR, 2004, FRESHWATER BIOL, V49, P690, DOI 10.1111/j.1365-2427.2004.01218.x; Follows MJ, 2007, SCIENCE, V315, P1843, DOI 10.1126/science.1138544; Gauch Jr HG, 1982, MULTIVARIATE ANAL CO; GEORGE EI, 1993, J AM STAT ASSOC, V88, P881, DOI 10.2307/2290777; Gimenez O, 2009, ENVIRON ECOL STAT SE, V3, P883, DOI 10.1007/978-0-387-78151-8_41; Green PJ, 1995, BIOMETRIKA, V82, P711, DOI 10.2307/2337340; GREEN RH, 1971, ECOLOGY, V52, P543, DOI 10.2307/1934142; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Grosbois V, 2009, ECOLOGY, V90, P2922, DOI 10.1890/08-1657.1; Hamm CE, 2003, NATURE, V421, P841, DOI 10.1038/nature01416; Huang YX, 2011, ANN APPL STAT, V5, P551, DOI 10.1214/10-AOAS376; Hubbell SP, 2008, UNIFIED NEUTRAL THEO; Jamil T, 2013, J VEG SCI, V24, P988, DOI 10.1111/j.1654-1103.2012.12036.x; Jamil T, 2013, PEERJ, V1, DOI 10.7717/peerj.95; Jongman RHG, 1995, DATA ANAL COMMUNITY; KEDDY PA, 1992, FUNCT ECOL, V6, P621, DOI 10.2307/2389954; Kirk J.T.O, 1996, LIGHT PHOTOSYNTHESIS; Kosten S, 2011, GLOBAL CHANGE BIOL; Kosten S, 2009, ECOSYSTEMS, V12, P1117, DOI 10.1007/s10021-009-9277-x; Kosten S, 2009, ECOL APPL, V19, P1791, DOI 10.1890/08-0906.1; Kruk C, 2011, LIMNOL OCEANOGR, V56, P110, DOI 10.4319/lo.2011.56.1.0110; Kruk C, 2012, HYDROBIOLOGIA, V698, P191, DOI 10.1007/s10750-012-1072-6; Kruk C, 2010, FRESHWATER BIOL, V55, P614, DOI 10.1111/j.1365-2427.2009.02298.x; Kruk C, 2009, FRESHWATER BIOL, V54, P2628, DOI 10.1111/j.1365-2427.2009.02274.x; Kuo L., 1998, SANKHYA, V60, P65, DOI DOI 10.1186/1471-2105-12-186; Lahoz-Monfort JJ, 2011, METHODS ECOL EVOL, V2, P116, DOI 10.1111/j.2041-210X.2010.00050.x; Lampert W., 1987, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V45, P143; Lampert W, 2007, LIMNOECOLOGY, V2ed; Lehman J.T., 1988, P369; LEWIS WM, 1976, SCIENCE, V192, P885, DOI 10.1126/science.192.4242.885; Litchman E, 2008, ANNU REV ECOL EVOL S, V39, P615, DOI 10.1146/annurev.ecolsys.39.110707.173549; LURling M, 2012, FRESHWATER BIOL; MALTHUS TJ, 1989, FRESHWATER BIOL, V22, P383, DOI 10.1111/j.1365-2427.1989.tb01112.x; Margalef R, 1978, OCEANOLOGICA ACTA, V1; Mazzeo N, 2003, HYDROBIOLOGIA, V506, P591, DOI 10.1023/B:HYDR.0000008571.40893.77; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Miller AJ, 2002, SUBSET SELECTION REG, DOI DOI 10.1201/9781420035933; Moss B, 2011, INLAND WATERS, V1, P101, DOI 10.5268/IW-1.2.359; Naselli-Flores L, 2007, HYDROBIOLOGIA, V578, P87, DOI 10.1007/s10750-006-0436-1; O'Hara RB, 2009, BAYESIAN ANAL, V4, P85, DOI 10.1214/09-BA403; Oksanen J, 2002, ECOL MODEL, V157, P119, DOI 10.1016/S0304-3800(02)00190-4; Oksanen J, 2001, ECOLOGY, V82, P1191, DOI 10.2307/2679914; OKSANEN J, 1988, Journal of Paleolimnology, V1, P39; Padisak J, 2003, HYDROBIOLOGIA, V501, P219, DOI 10.1023/A:1026255328741; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Paerl HW, 2011, SCI TOTAL ENVIRON, V409, P1739, DOI 10.1016/j.scitotenv.2011.02.001; Park T, 2008, J AM STAT ASSOC, V103, P681, DOI 10.1198/016214508000000337; Pearsall WH, 1950, MOUNTAINS MOORLANDS; Pinheiro J, 2001, MIXED EFFECTS MODELS; Reynolds C, 2006, FRESHWATER BIOL, V14, P111; Reynolds C.S., 1988, P388; Reynolds C. S., 1997, VEGETATION PROCESS P; Reynolds CS, 2007, HYDROBIOLOGIA, V578, P37, DOI 10.1007/s10750-006-0431-6; REYNOLDS CS, 1981, PHILOS T ROY SOC B, V293, P419, DOI 10.1098/rstb.1981.0081; Reynolds CS, 1998, HYDROBIOLOGIA, V370, P11, DOI 10.1023/A:1017062213207; REYNOLDS CS, 1987, SCHWEIZ Z HYDROL, V49, P220, DOI 10.1007/BF02538504; Reynolds CS, 2002, J PLANKTON RES, V24, P417, DOI 10.1093/plankt/24.5.417; REYNOLDS CS, 1984, FRESHWATER BIOL, V14, P111, DOI 10.1111/j.1365-2427.1984.tb00027.x; Reynolds CS, 1997, HYDROBIOLOGIA, V349, P5, DOI 10.1023/A:1003020823129; Ruhland K, 2008, GLOBAL CHANGE BIOL, V14, P2740, DOI 10.1111/j.1365-2486.2008.01670.x; Scheffer M, 2006, P NATL ACAD SCI USA, V103, P6230, DOI 10.1073/pnas.0508024103; Segura AM, 2011, P ROY SOC B-BIOL SCI, V278, P2355, DOI 10.1098/rspb.2010.2464; Smetacek V, 2001, NATURE, V411, P745, DOI 10.1038/35081210; Smol JP, 2005, P NATL ACAD SCI USA, V102, P4397, DOI 10.1073/pnas.0500245102; SOUTHWOOD TRE, 1977, J ANIM ECOL, V46, P337; SOUTHWOOD TRE, 1988, OIKOS, V52, P3, DOI 10.2307/3565974; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Sturtz S, 2011, R2OPENBUGS PACKAGE R; Tansley AG, 1939, BRIT ISLANDS THEIR V; Ter Braak C. J. F., 1988, Classification and Related Methods of Data Analysis. Proceedings of the First Conference of the International Federation of Classification Societies (IFCS), P551; ter Braak CJF, 2012, ECOLOGY, V93, P1525, DOI 10.1890/12-0126.1; TERBRAAK CJF, 1986, VEGETATIO, V65, P3; TERBRAAK CJF, 1995, AQUAT SCI, V57, P255, DOI 10.1007/BF00877430; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; TILMAN D, 1986, ARCH HYDROBIOL, V106, P473; TOWNSEND CR, 1994, FRESHWATER BIOL, V31, P265, DOI 10.1111/j.1365-2427.1994.tb01740.x; Van Buuren S., 2011, MICE MULTIVARIATE IM; Vergnon R, 2009, ECOL LETT, V12, P1079, DOI 10.1111/j.1461-0248.2009.01364.x; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Violle C, 2009, J PLANT ECOL-UK, V2, P87, DOI 10.1093/jpe/rtp007; VOLLENWEIDER R A, 1976, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V33, P53; Weithoff G, 2003, FRESHWATER BIOL, V48, P1669, DOI 10.1046/j.1365-2427.2003.01116.x; Winder M, 2009, P ROY SOC B-BIOL SCI, V276, P427, DOI 10.1098/rspb.2008.1200; Yuan M, 2005, J AM STAT ASSOC, V100, P1215, DOI 10.1198/016214505000000367	94	19	19	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97583	10.1371/journal.pone.0097583	http://dx.doi.org/10.1371/journal.pone.0097583			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835582	Green Submitted, Green Published, gold			2022-12-27	WOS:000339614800053
J	Melamed, D				Melamed, David			Community Structures in Bipartite Networks: A Dual-Projection Approach	PLOS ONE			English	Article							COMPLEX NETWORKS	Identifying communities or clusters in networked systems has received much attention across the physical and social sciences. Most of this work focuses on single layer or one-mode networks, including social networks between people or hyperlinks between websites. Multilayer or multi-mode networks, such as affiliation networks linking people to organizations, receive much less attention in this literature. Common strategies for discovering the community structure of multi-mode networks identify the communities of each mode simultaneously. Here I show that this combined approach is ineffective at discovering community structures when there are an unequal number of communities between the modes of a multi-mode network. I propose a dual-projection alternative for detecting communities in multi-mode networks that overcomes this shortcoming. The evaluation of synthetic networks with known community structures reveals that the dual-projection approach outperforms the combined approach when there are a different number of communities in the various modes. At the same time, results show that the dual-projection approach is as effective as the combined strategy when the number of communities is the same between the modes.	Univ S Carolina, Dept Sociol, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Melamed, D (corresponding author), Univ S Carolina, Dept Sociol, Columbia, SC 29208 USA.	melamed@mailbox.sc.edu						[Anonymous], [No title captured], DOI DOI 10.1145/1772690.1772853; Barber MJ, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.066102; BREIGER RL, 1974, SOC FORCES, V53, P181, DOI 10.2307/2576011; Carley KM, 2003, CITESEER, P133; Duch J, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.027104; Everett MG, 2013, SOC NETWORKS, V35, P204, DOI 10.1016/j.socnet.2012.05.004; FARARO TJ, 1984, SOC NETWORKS, V6, P141, DOI 10.1016/0378-8733(84)90015-7; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Freeman LC, 2003, DYNAMIC SOCIAL NETWORK MODELING AND ANALYSIS, P39; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guimera R, 2005, SCIENCE, V308, P697, DOI 10.1126/science.1106340; Guimera R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036102; Jensen Kurt, 2007, International Journal on Software Tools for Technology Transfer, V9, P213, DOI 10.1007/s10009-007-0038-x; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Melamed D, 2013, CONNECTIONS, V33, P18; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Pons P, 2005, LECT NOTES COMPUT SC, V3733, P284; Porter MA., 2009, NOT AM MATH SOC, V56, P1082, DOI DOI 10.1103/PHYSREVE.69.066133; Psorakis I, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066114; Reichardt J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.218701; Shen HW, 2009, PHYSICA A, V388, P1706, DOI 10.1016/j.physa.2008.12.021; Strehl A., 2003, Journal of Machine Learning Research, V3, P583, DOI 10.1162/153244303321897735; Wang XH, 2009, PHYSICA A, V388, P5045, DOI 10.1016/j.physa.2009.08.032; Xie JR, 2013, ACM COMPUT SURV, V45, DOI 10.1145/2501654.2501657; Zhan WH, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066120; Zhang P, 2008, PHYSICA A, V387, P6869, DOI 10.1016/j.physa.2008.09.006; Zhang SH, 2007, PHYSICA A, V374, P483, DOI 10.1016/j.physa.2006.07.023	29	31	32	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97823	10.1371/journal.pone.0097823	http://dx.doi.org/10.1371/journal.pone.0097823			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836376	Green Submitted, Green Published, gold			2022-12-27	WOS:000339614800071
J	Roisin, S; Laurent, C; Denis, O; Dramaix, M; Nonhoff, C; Hallin, M; Byl, B; Struelens, MJ				Roisin, Sandrine; Laurent, Christine; Denis, Olivier; Dramaix, Michele; Nonhoff, Claire; Hallin, Marie; Byl, Baudouin; Struelens, Marc J.			Impact of Rapid Molecular Screening at Hospital Admission on Nosocomial Transmission of Methicillin-Resistant Staphylococcus aureus: Cluster Randomised Trial	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; PREEMPTIVE CONTACT ISOLATION; SURGICAL WARDS; CRITICAL-CARE; UNIVERSAL; SURVEILLANCE; ACQUISITION; CARRIAGE; SURGERY; COSTS	Design: Cluster randomised crossover trial with seven wards randomly allocated to intervention or control arm. Setting: Medical and surgical wards of a university hospital with active MRSA control programme. Participants: All patients hospitalized >48 h in study wards and screened for MRSA on admission and discharge Intervention: Rapid PCR-based screening test for MRSA compared with control screening test by enrichment culture using chromogenic agar. Objective: We determined the benefit of PCR-detection versus culture-based detection of MRSA colonisation upon patient admission on early implementation of isolation precautions and reduction of hospital transmission of MRSA. Main outcome: Cumulative rate of MRSA hospital acquisition of in patients screened negative on admission. Randomization: The sequential order of inclusion of study wards in each arm was randomised by assigning a number to each ward and using a computer generated list of random numbers. Findings: Of 3704 eligible patients, 67.8% were evaluable for the study. Compared with culture, PCR-screening reduced the median test reporting time from admission from 88 to 11 hours (p < 0.001) and the median time from admission to isolation from 96 to 25 hours (p < 0.001). MRSA acquisition was detected in 36 patients (3.2%) in the control arm and 34 (3.2%) in the intervention arm. The incidence density rate of hospital acquired MRSA was 2.82 and 2.57/1,000 exposed patient-days in the control and intervention arm, respectively (risk ratio 0.91 (95% confidence interval, 0.60-1.39). Poisson regression model adjusted for colonisation pressure, compliance with hand hygiene and antibiotic use indicated a RR 0.99 (95% CI, 0.69 to 1.44). Interpretation: Universal PCR screening for MRSA on admission to medical and surgical wards in an endemic setting shortened the time to implement isolation precautions but did not reduce nosocomial acquisition of MRSA. registration:	[Roisin, Sandrine; Denis, Olivier; Nonhoff, Claire; Hallin, Marie; Struelens, Marc J.] Univ Libre Brussels, Erasme Hosp, Dept Clin Microbiol, Brussels, Belgium; [Roisin, Sandrine; Laurent, Christine; Byl, Baudouin] Univ Libre Brussels, Erasme Hosp, Brussels, Belgium; [Dramaix, Michele; Nonhoff, Claire; Byl, Baudouin] Univ Libre Brussels, Sch Publ Hlth, Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles	Roisin, S (corresponding author), Univ Libre Brussels, Erasme Hosp, Dept Clin Microbiol, Brussels, Belgium.	sroisin@ulb.ac.be		Struelens, Marc/0000-0001-5150-4944	Cepheid Europe; Federal public service, public health, food safety and environment	Cepheid Europe; Federal public service, public health, food safety and environment	The authors received funding from a commercial source "Cepheid Europe'' by providing the GeneXpert instrument and reagent during the study period. This work was supported by the Federal public service, public health, food safety and environment. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belgian Infection Control Society (BICS), 2005, GUID CONTR PREV METH; Bootsma MCJ, 2006, P NATL ACAD SCI USA, V103, P5620, DOI 10.1073/pnas.0510077103; Conterno LO, 2007, INFECT CONT HOSP EP, V28, P1134, DOI 10.1086/520099; Cookson B, 2011, INT J ANTIMICROB AG, V37, P195, DOI 10.1016/j.ijantimicag.2010.10.023; Cunningham R, 2007, J HOSP INFECT, V65, P24, DOI 10.1016/j.jhin.2006.09.019; Harbarth S, 2008, JAMA-J AM MED ASSOC, V299, P1149, DOI 10.1001/jama.299.10.1149; Harbarth S, 2006, CRIT CARE, V10, DOI 10.1186/cc3982; Hardy K, 2010, CLIN MICROBIOL INFEC, V16, P333, DOI 10.1111/j.1469-0691.2009.02899.x; Hayes RJ, 2009, INTERD STAT, P3; Herdman MT, 2009, J CLIN MICROBIOL, V47, P4102, DOI 10.1128/JCM.01332-09; Jarlier V, 2010, ARCH INTERN MED, V170, P552, DOI 10.1001/archinternmed.2010.32; Jeyaratnam D, 2008, BMJ-BRIT MED J, V336, P927, DOI 10.1136/bmj.39525.579063.BE; Jog S, 2008, J HOSP INFECT, V69, P124, DOI 10.1016/j.jhin.2008.02.008; Keshtgar MRS, 2008, BRIT J SURG, V95, P381, DOI 10.1002/bjs.6013; Kock R, 2010, EUROSURVEILLANCE, V15, P12, DOI 10.2807/ese.15.41.19688-en; Leonhardt KK, 2011, INFECT CONT HOSP EP, V32, P797, DOI 10.1086/660875; Morgan DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022190; Murthy A, 2010, CLIN MICROBIOL INFEC, V16, P1747, DOI 10.1111/j.1469-0691.2010.03220.x; Peterson LR, 2010, J CLIN MICROBIOL, V48, P683, DOI 10.1128/JCM.02516-09; Robicsek A, 2008, ANN INTERN MED, V148, P409, DOI 10.7326/0003-4819-148-6-200803180-00003; Roisin S, 2012, EUR J CLIN MICROBIOL, V31, P873, DOI 10.1007/s10096-011-1387-7; Struelens MJ, 2009, CLIN MICROBIOL INFEC, V15, P112, DOI 10.1111/j.1469-0691.2009.02698.x; Tacconelli E, 2009, LANCET INFECT DIS, V9, P546, DOI 10.1016/S1473-3099(09)70150-1; Uckay I, 2008, INFECT CONT HOSP EP, V29, P1077, DOI 10.1086/591452; Wassenberg MWM, 2011, CLIN MICROBIOL INFEC, V17, P1704, DOI 10.1111/j.1469-0691.2011.03502.x; Wolk DM, 2009, J CLIN MICROBIOL, V47, P3933, DOI 10.1128/JCM.00601-09	26	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e96310	10.1371/journal.pone.0096310	http://dx.doi.org/10.1371/journal.pone.0096310			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836438	Green Published, gold, Green Submitted			2022-12-27	WOS:000339614800013
J	Ruggiero, A; Dattelbaum, JD; Staiano, M; Berisio, R; D'Auria, S; Vitagliano, L				Ruggiero, Alessia; Dattelbaum, Jonathan D.; Staiano, Maria; Berisio, Rita; D'Auria, Sabato; Vitagliano, Luigi			A Loose Domain Swapping Organization Confers a Remarkable Stability to the Dimeric Structure of the Arginine Binding Protein from Thermotoga maritima	PLOS ONE			English	Article							RIBONUCLEASE-A; CRYSTAL-STRUCTURES; CLOSED FORMS; TRANSPORTER; DYNAMICS; RECEPTOR; SYSTEMS; REVEAL; MODEL; RNASE	The arginine binding protein from Thermatoga maritima (TmArgBP), a substrate binding protein (SBP) involved in the ABC system of solute transport, presents a number of remarkable properties. These include an extraordinary stability to temperature and chemical denaturants and the tendency to form multimeric structures, an uncommon feature among SBPs involved in solute transport. Here we report a biophysical and structural characterization of the TmArgBP dimer. Our data indicate that the dimer of the protein is endowed with a remarkable stability since its full dissociation requires high temperature as well as SDS and urea at high concentrations. In order to elucidate the atomic level structural properties of this intriguing protein, we determined the crystallographic structures of the apo and the arginine-bound forms of TmArgBP using MAD and SAD methods, respectively. The comparison of the liganded and unliganded models demonstrates that TmArgBP tertiary structure undergoes a very large structural re-organization upon arginine binding. This transition follows the Venus Fly-trap mechanism, although the entity of the re-organization observed in TmArgBP is larger than that observed in homologous proteins. Intriguingly, TmArgBP dimerizes through the swapping of the C-terminal helix. This dimer is stabilized exclusively by the interactions established by the swapping helix. Therefore, the TmArgBP dimer combines a high level of stability and conformational freedom. The structure of the TmArgBP dimer represents an uncommon example of large tertiary structure variations amplified at quaternary structure level by domain swapping. Although the biological relevance of the dimer needs further assessments, molecular modelling suggests that the two TmArgBP subunits may simultaneously interact with two distinct ABC transporters. Moreover, the present protein structures provide some clues about the determinants of the extraordinary stability of the biomolecule. The availability of an accurate 3D model represents a powerful tool for the design of new TmArgBP suited for biotechnological applications.	[Ruggiero, Alessia; Berisio, Rita; Vitagliano, Luigi] CNR, Inst Biostruct & Bioimaging, I-80125 Naples, Italy; [Dattelbaum, Jonathan D.] Univ Richmond, Dept Chem, Richmond, VA 23173 USA; [Staiano, Maria; D'Auria, Sabato] IBP CNR, Lab Mol Sensing, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Richmond; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR)	Berisio, R (corresponding author), CNR, Inst Biostruct & Bioimaging, I-80125 Naples, Italy.	rita.berisio@unina.it; luigi.vitagliano@unina.it	d'auria, sabato/C-3565-2015; Ruggiero, Alessia/GRJ-9538-2022; STAIANO, MARIA/B-9584-2015	d'auria, sabato/0000-0001-9320-494X; Ruggiero, Alessia/0000-0002-3508-385X; STAIANO, MARIA/0000-0003-0223-1825; Berisio, Rita/0000-0001-5025-6483	Regione Campania; Progetto POR	Regione Campania(Regione Campania); Progetto POR	This study was supported by Regione Campania and Progetto POR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alicea I, 2011, J MOL BIOL, V414, P356, DOI 10.1016/j.jmb.2011.09.047; Anfinsen C B, 1975, Adv Protein Chem, V29, P205, DOI 10.1016/S0065-3233(08)60413-1; Ausili A, 2013, J PHOTOCH PHOTOBIO B, V118, P66, DOI 10.1016/j.jphotobiol.2012.11.004; Ausili Alessio, 2013, Life-Basel, V3, P149, DOI 10.3390/life3010149; Bergdoll M, 1997, STRUCTURE, V5, P391, DOI 10.1016/S0969-2126(97)00196-2; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Bulut H, 2012, EUR J CELL BIOL, V91, P318, DOI 10.1016/j.ejcb.2011.12.004; Cambillau C, 2000, J BIOL CHEM, V275, P32383, DOI 10.1074/jbc.C000497200; Cuneo MJ, 2008, J BIOL CHEM, V283, P32812, DOI 10.1074/jbc.M803595200; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Deacon LJ, 2014, BIOCHIMIE, V99, P208, DOI 10.1016/j.biochi.2013.12.011; Deignan JL, 2008, MOL GENET METAB, V93, P7, DOI 10.1016/j.ymgme.2007.08.123; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esposito L, 2000, PROTEIN SCI, V9, P2038; Esposito L, 2005, J MOL BIOL, V347, P483, DOI 10.1016/j.jmb.2005.01.065; Esposito L, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/326914; Gonin S, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-11; Gotte G, 2006, BBA-PROTEINS PROTEOM, V1764, P44, DOI 10.1016/j.bbapap.2005.10.011; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Karplus PA, 1996, PROTEIN SCI, V5, P1406, DOI 10.1002/pro.5560050719; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Lee RA, 2003, BIOINFORMATICS, V19, P1290, DOI 10.1093/bioinformatics/btg137; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Liu YS, 1998, P NATL ACAD SCI USA, V95, P3437, DOI 10.1073/pnas.95.7.3437; Liu YS, 2001, NAT STRUCT BIOL, V8, P211, DOI 10.1038/84941; Luchansky MS, 2010, MOL BIOSYST, V6, P142, DOI 10.1039/b908412f; Makhatadze GI, 2004, J MOL BIOL, V336, P929, DOI 10.1016/j.jmb.2003.12.058; MAO B, 1982, J BIOL CHEM, V257, P1131; MAZZARELLA L, 1995, P NATL ACAD SCI USA, V92, P3799, DOI 10.1073/pnas.92.9.3799; Merlino A, 2005, BIOPHYS J, V88, P2003, DOI 10.1529/biophysj.104.048611; Merlino A, 2004, BIOPHYS J, V86, P2383, DOI 10.1016/S0006-3495(04)74295-2; Nenci A, 2001, PROTEIN SCI, V10, P2017, DOI 10.1110/ps.14101; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Ruggiero A, 2011, ACTA CRYSTALLOGR F, V67, P1462, DOI 10.1107/S1744309111037341; Schneider E, 2012, EUR J CELL BIOL, V91, P311, DOI 10.1016/j.ejcb.2011.02.008; Scire A, 2010, MOL BIOSYST, V6, P687, DOI 10.1039/b922092e; Shi R, 2009, PROTEINS, V75, P598, DOI 10.1002/prot.22272; Stamp AL, 2011, PROTEINS, V79, P2352, DOI 10.1002/prot.23060; Vahedi-Faridi A, 2008, J MOL BIOL, V375, P448, DOI 10.1016/j.jmb.2007.10.049; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2	42	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e96560	10.1371/journal.pone.0096560	http://dx.doi.org/10.1371/journal.pone.0096560			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24832102	Green Submitted, Green Published, gold			2022-12-27	WOS:000336789500023
J	Whelan, MC; Casey, G; Larkin, JO; Guinn, BA; O'Sullivan, GC; Tangney, M				Whelan, Maria C.; Casey, Garrett; Larkin, John O.; Guinn, Barbara-Ann; O'Sullivan, Gerald C.; Tangney, Mark			Oral Tolerance to Cancer Can Be Abrogated by T Regulatory Cell Inhibition	PLOS ONE			English	Article							IMMUNE TOLERANCE; IMMUNOTHERAPY; ESOPHAGEAL; INDUCTION; SURVIVAL	Oral administration of tumour cells induces an immune hypo-responsiveness known as oral tolerance. We have previously shown that oral tolerance to a cancer is tumour antigen specific, non-cross-reactive and confers a tumour growth advantage. We investigated the utilisation of regulatory T cell (Treg) depletion on oral tolerance to a cancer and its ability to control tumour growth. Balb/C mice were gavage fed homogenised tumour tissue - JBS fibrosarcoma (to induce oral tolerance to a cancer), or PBS as control. Growth of subcutaneous JBS tumours were measured; splenic tissue excised and flow cytometry used to quantify and compare systemic Tregs and T effector (Teff) cell populations. Prior to and/or following tumour feeding, mice were intraperitoneally administered anti-CD25, to inactivate systemic Tregs, or given isotype antibody as a control. Mice which were orally tolerised prior to subcutaneous tumour induction, displayed significantly higher systemic Treg levels (14% vs 6%) and faster tumour growth rates than controls (p<0.05). Complete regression of tumours were only seen after Treg inactivation and occurred in all groups - this was not inhibited by tumour feeding. The cure rates for Treg inactivation were 60% during tolerisation, 75% during tumour growth and 100% during inactivation for both tolerisation and tumour growth. Depletion of Tregs gave rise to an increased number of Teff cells. Treg depletion post-tolerisation and post-tumour induction led to the complete regression of all tumours on tumour bearing mice. Oral administration of tumour tissue, confers a tumour growth advantage and is accompanied by an increase in systemic Treg levels. The administration of anti-CD25 Ab decreased Treg numbers and caused an increase in Teffs. Most notably Treg cell inhibition overcame established oral tolerance with consequent tumor regression, especially relevant to foregut cancers where oral tolerance is likely to be induced by the shedding of tumour tissue into the gut.	[Whelan, Maria C.; Casey, Garrett; Larkin, John O.; O'Sullivan, Gerald C.; Tangney, Mark] Natl Univ Ireland Univ Coll Cork, BioSci Inst, Cork Canc Res Ctr, Cork, Ireland; [Guinn, Barbara-Ann] Univ Bedfordshire, Dept Life Sci, Luton, Beds, England	University College Cork; University of Bedfordshire	Tangney, M (corresponding author), Natl Univ Ireland Univ Coll Cork, BioSci Inst, Cork Canc Res Ctr, Cork, Ireland.	m.tangney@ucc.ie	Guinn, Barbara/AAB-7403-2021; Guinn, Barbara-Ann/AHC-8282-2022	Guinn, Barbara/0000-0003-0639-4541; Guinn, Barbara-Ann/0000-0003-0639-4541; Tangney, Mark/0000-0002-6314-1260	Cancer Research Ireland [CRI06OSUG]; Royal College of Surgeons Edinburgh; Royal College of Surgeons Ireland; Cork Cancer Research Centre	Cancer Research Ireland; Royal College of Surgeons Edinburgh; Royal College of Surgeons Ireland; Cork Cancer Research Centre	This work was funded through a research grant to GOS and MT from Cancer Research Ireland (CRI06OSUG). MW was funded by a fellowship from the Royal College of Surgeons Edinburgh and the Royal College of Surgeons Ireland. The authors also acknowledge support from the Cork Cancer Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boncheva V, 2013, CANCER GENE THER, V20, P157, DOI 10.1038/cgt.2013.5; Castro AB, 2012, CELL IMMUNOL, V280, P171, DOI 10.1016/j.cellimm.2012.12.004; Castro-Sanchez P, 2013, BRIT J NUTR, V109, pS3, DOI 10.1017/S0007114512005223; Chen L, 2007, MOL THER, V15, P2194, DOI 10.1038/sj.mt.6300310; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; Collins SA, 2008, CURR GENE THER, V8, P66, DOI 10.2174/156652308784049345; Curiel T.J., 2006, CANC IMMUNITY, V6, P20; Faria AMC, 1999, ADV IMMUNOL, V73, P153, DOI 10.1016/S0065-2776(08)60787-7; KHARE SD, 1995, J IMMUNOL, V155, P3653; Larkin J, 2006, MED HYPOTHESES, V66, P541, DOI 10.1016/j.mehy.2005.09.021; Micheli A, 2003, ANN ONCOL, V14, pV28, DOI 10.1093/annonc/mdg752; Murphy J, 2000, AM J GASTROENTEROL, V95, P3607; Needham DJ, 2006, BIOCHEM BIOPH RES CO, V343, P684, DOI 10.1016/j.bbrc.2006.03.018; Nishikawa H, 2014, CURR OPIN IMMUNOL, V27, P1, DOI 10.1016/j.coi.2013.12.005; NUSSENBLATT RB, 1990, J IMMUNOL, V144, P1689; O'Brien MG, 2003, DIS ESOPHAGUS, V16, P218, DOI 10.1046/j.1442-2050.2003.00332.x; Wang HY, 2007, CURR OPIN IMMUNOL, V19, P217, DOI 10.1016/j.coi.2007.02.004; Wang XM, 2013, ADV DRUG DELIVER REV, V65, P759, DOI 10.1016/j.addr.2012.10.013; Weiner HL, 1997, ANNU REV MED, V48, P341; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x; Whelan MC, 2010, CANCER GENE THER, V17, P501, DOI 10.1038/cgt.2010.8; Zhang YW, 2013, WORLD J GASTROENTERO, V19, P5598, DOI 10.3748/wjg.v19.i34.5598	22	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97602	10.1371/journal.pone.0097602	http://dx.doi.org/10.1371/journal.pone.0097602			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24832130	Green Published, Green Submitted, gold			2022-12-27	WOS:000336789500084
J	Zhang, SC; Dong, ZQ; Peng, ZS; Lu, F				Zhang, Shengchang; Dong, Ziqing; Peng, Zhangsong; Lu, Feng			Anti-Aging Effect of Adipose-Derived Stem Cells in a Mouse Model of Skin Aging Induced by D-Galactose	PLOS ONE			English	Article							ADVANCED GLYCATION; STROMAL CELLS; GROWTH-FACTOR; MYOCARDIAL-INFARCTION; ANGIOGENIC EFFICACY; OXIDATIVE STRESS; DIFFERENTIATION; TISSUE; IMPROVEMENT; EXPRESSION	Introduction: Glycation products accumulate during aging of slowly renewing tissue, including skin, and are suggested as an important mechanism underlying the skin aging process. Adipose-derived cells are widely used in the clinic to treat ischemic diseases and enhance wound healing. Interestingly, adipose-derived stem cells (ASCs) are also effective in anti-aging therapy, although the mechanism underlying their effects remains unknown. The purpose of the present study was to examine the anti-aging effect of ASCs in a D-galactose-induced aging animal model and to clarify the underlying mechanism. Materials and Methods: Six-week-old nude mice were subcutaneously injected with D-gal daily for 8 weeks. Two weeks after completion of treatment, mice were randomized to receive subcutaneous injections of 10(6) green fluorescent protein (GFP)-expressing ASCs, aminoguanidine (AG) or phosphate-buffered saline (PBS). Control mice received no treatment. We examined tissue histology and determined the activity of senescence-associated molecular markers such as superoxide dismutase (SOD) and malondialdehyde (MDA). Results: Transplanted ASCs were detectable for 14 days and their GFP signal disappeared at day 28 after injection. ASCs inhibited advanced glycation end product (AGE) levels in our animal model as well as increased the SOD level and decreased the MDA level, all of which act to reverse the aging phenotype in a similar way to AG, an inhibitor of AGE formation. Furthermore, ASCs released angiogenic factors in vivo such as vascular endothelial growth factor, suggesting a skin trophic effect. Conclusions: These results demonstrate that ASCs may contribute to the regeneration of skin during aging. In addition, the data shows that ASCs provide a functional benefit by glycation suppression, antioxidation, and trophic effects in a mouse model of aging.	[Zhang, Shengchang; Dong, Ziqing; Peng, Zhangsong; Lu, Feng] Southern Med Univ, Nanfang Hosp, Dept Plast & Cosmet Surg, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Lu, F (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Plast & Cosmet Surg, Guangzhou, Guangdong, Peoples R China.	doctorlufeng@hotmail.com			National Nature Science Foundation of China [81171834, 81071589]; Medical Scientific Research Foundation of Guangdong Province [A2013449, A2011453]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Scientific Research Foundation of Guangdong Province	This work was financially supported by the National Nature Science Foundation of China (81171834, 81071589), Medical Scientific Research Foundation of Guangdong Province (A2013449, A2011453). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado BA, 2012, TISSUE ENG PT A, V18, P806, DOI [10.1089/ten.tea.2011.0391, 10.1089/ten.TEA.2011.0391]; Baregamian N, 2006, J SURG RES, V136, P31, DOI 10.1016/j.jss.2006.04.028; Bhang SH, 2009, STEM CELLS, V27, P1976, DOI 10.1002/stem.115; Bonta M, 2013, ROM J MORPHOL EMBRYO, V54, P797; Cassino TR, 2012, TISSUE ENG PT A, V18, P1101, DOI [10.1089/ten.tea.2011.0285, 10.1089/ten.TEA.2011.0285]; Chen HY, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-33; Coleman SR, 2006, PLAST RECONSTR SURG, V118, p108S, DOI 10.1097/01.prs.0000234610.81672.e7; Desai VD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086865; Farage MA, 2008, AGING CLIN EXP RES, V20, P195; Fisher GJ, 2009, AM J PATHOL, V174, P101, DOI 10.2353/ajpath.2009.080599; Frye EB, 1998, J BIOL CHEM, V273, P18714, DOI 10.1074/jbc.273.30.18714; Gil P, 2002, GERONTOLOGY, V48, P209, DOI 10.1159/000058352; Glogau RG, 1997, DERMATOL CLIN, V15, P555, DOI 10.1016/S0733-8635(05)70465-4; Huebschmann AG, 2006, DIABETES CARE, V29, P1420, DOI 10.2337/dc05-2096; Johnson FB, 1999, CELL, V96, P291, DOI 10.1016/S0092-8674(00)80567-X; Kaida Y, 2013, DIABETES, V62, P3241, DOI 10.2337/db12-1608; Kapur SK, 2013, BIOCHIMIE, V95, P2222, DOI 10.1016/j.biochi.2013.06.001; Kilroy GE, 2007, J CELL PHYSIOL, V212, P702, DOI 10.1002/jcp.21068; Kim WS, 2007, J DERMATOL SCI, V48, P15, DOI 10.1016/j.jdermsci.2007.05.018; Kim WS, 2009, J DERMATOL SCI, V53, P96, DOI 10.1016/j.jdermsci.2008.08.007; Konno M, 2010, BIOCHEM BIOPH RES CO, V400, P461, DOI 10.1016/j.bbrc.2010.08.029; Kraus A, 2013, PLAST RECONSTR SURG, V132, p754E, DOI 10.1097/PRS.0b013e3182a48b46; Lee TJ, 2012, MICROVASC RES, V84, P1, DOI 10.1016/j.mvr.2012.04.004; Leslie SK, 2013, BIOMATERIALS, V34, P8172, DOI 10.1016/j.biomaterials.2013.07.017; Liochev SI, 1997, FREE RADICAL BIO MED, V23, P668, DOI 10.1016/S0891-5849(97)00060-9; MAKITA Z, 1992, J BIOL CHEM, V267, P5133; Mao GX, 2010, BIOMED ENVIRON SCI, V23, P161, DOI 10.1016/S0895-3988(10)60047-5; Mazo M, 2012, CELL TRANSPLANT, V21, P1023, DOI 10.3727/096368911X623862; Meliga E, 2007, CELL TRANSPLANT, V16, P963, DOI 10.3727/096368907783338190; Mojallal A, 2009, PLAST RECONSTR SURG, V124, P765, DOI 10.1097/PRS.0b013e3181b17b8f; Morcos M, 2008, AGING CELL, V7, P260, DOI 10.1111/j.1474-9726.2008.00371.x; Nauta A, 2013, MOL THER, V21, P445, DOI 10.1038/mt.2012.234; Ramos GA, 2007, CELL TRANSPLANT, V16, P951, DOI 10.3727/096368907783338208; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Sahar DE, 2012, J CRANIOFAC SURG, V23, P913, DOI 10.1097/SCS.0b013e31824e5cd8; Schlotterer A, 2009, DIABETES, V58, P2450, DOI 10.2337/db09-0567; Sell DR, 2000, FASEB J, V14, P145, DOI 10.1096/fasebj.14.1.145; Semba RD, 2010, J GERONTOL A-BIOL, V65, P963, DOI 10.1093/gerona/glq074; Sen A, 2001, J CELL BIOCHEM, V81, P312, DOI 10.1002/1097-4644(20010501)81:2<312::AID-JCB1046>3.0.CO;2-Q; Shibuki H, 2002, INVEST OPHTH VIS SCI, V43, P528; Song X, 1999, MECH AGEING DEV, V108, P239, DOI 10.1016/S0047-6374(99)00022-6; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; Suga H, 2014, ANN PLAS SURG, V72, P234, DOI 10.1097/SAP.0b013e318264fd6a; Tian J, 2005, P NATL ACAD SCI USA, V102, P11846, DOI 10.1073/pnas.0504759102; Vieira NM, 2010, CELL TRANSPLANT, V19, P279, DOI 10.3727/096368909X481764; Wei HF, 2005, BEHAV BRAIN RES, V157, P245, DOI 10.1016/j.bbr.2004.07.003; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	47	59	69	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97573	10.1371/journal.pone.0097573	http://dx.doi.org/10.1371/journal.pone.0097573			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831697	Green Submitted, gold, Green Published			2022-12-27	WOS:000336789500080
J	Garcia, JE; Greentree, AD; Shrestha, M; Dorin, A; Dyer, AG				Garcia, Jair E.; Greentree, Andrew D.; Shrestha, Mani; Dorin, Alan; Dyer, Adrian G.			Flower Colours through the Lens: Quantitative Measurement with Visible and Ultraviolet Digital Photography	PLOS ONE			English	Article							SIGNALS; POLLINATORS; REFLECTANCE; VEGETATION; SELECTION; PATTERN; VISION	Background: The study of the signal-receiver relationship between flowering plants and pollinators requires a capacity to accurately map both the spectral and spatial components of a signal in relation to the perceptual abilities of potential pollinators. Spectrophotometers can typically recover high resolution spectral data, but the spatial component is difficult to record simultaneously. A technique allowing for an accurate measurement of the spatial component in addition to the spectral factor of the signal is highly desirable. Methodology/Principal findings: Consumer-level digital cameras potentially provide access to both colour and spatial information, but they are constrained by their non-linear response. We present a robust methodology for recovering linear values from two different camera models: one sensitive to ultraviolet (UV) radiation and another to visible wavelengths. We test responses by imaging eight different plant species varying in shape, size and in the amount of energy reflected across the UV and visible regions of the spectrum, and compare the recovery of spectral data to spectrophotometer measurements. There is often a good agreement of spectral data, although when the pattern on a flower surface is complex a spectrophotometer may underestimate the variability of the signal as would be viewed by an animal visual system. Conclusion: Digital imaging presents a significant new opportunity to reliably map flower colours to understand the complexity of these signals as perceived by potential pollinators. Compared to spectrophotometer measurements, digital images can better represent the spatio-chromatic signal variability that would likely be perceived by the visual system of an animal, and should expand the possibilities for data collection in complex, natural conditions. However, and in spite of its advantages, the accuracy of the spectral information recovered from camera responses is subject to variations in the uncertainty levels, with larger uncertainties associated with low radiance levels.	[Garcia, Jair E.; Dyer, Adrian G.] RMIT Univ, Sch Media & Commun, Melbourne, Vic, Australia; [Greentree, Andrew D.] RMIT Univ, Sch Appl Sci, Melbourne, Vic, Australia; [Shrestha, Mani; Dorin, Alan] Monash Univ, Fac Informat Technol, Clayton, Vic, Australia	Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT); Monash University	Garcia, JE (corresponding author), RMIT Univ, Sch Media & Commun, Melbourne, Vic, Australia.	jair.garcia@rmit.edu.au	Greentree, Andrew D/A-8503-2008; Shrestha, Mani/P-7045-2015	Greentree, Andrew D/0000-0002-3505-9163; Dorin, Alan/0000-0002-5456-4835; Garcia, Jair/0000-0001-8456-4759; Shrestha, Mani/0000-0002-6165-8418	Australian Research Council [DP0878968, DP130100015]	Australian Research Council(Australian Research Council)	AGD was supported by Australian Research Council DP0878968/DP130100015. AD was supported by Australian Research Council DP130100015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adobe Systems Incorporated, 2005, TECHNICAL REPORT; Alsam A, 2007, J OPT SOC AM A, V24, P2505, DOI 10.1364/JOSAA.24.002505; AUTRUM H, 1964, Z VERGL PHYSIOL, V48, P357, DOI 10.1007/BF00299270; Barnard K, 2002, COLOR RES APPL, V27, P152, DOI 10.1002/col.10050; Barth FG, 1985, INSECTS OWNERS BIOL; Bischoff M, 2013, NEW ZEAL J BOT, V51, P181, DOI 10.1080/0028825X.2013.806933; Chiao CC, 2009, J EXP BIOL, V212, P2269, DOI 10.1242/jeb.030734; CHITTKA L, 1992, J COMP PHYSIOL A, V171, P171, DOI 10.1007/BF00188925; Chittka L, 1999, NATURWISSENSCHAFTEN, V86, P361, DOI 10.1007/s001140050636; CHITTKA L, 1994, VISION RES, V34, P1489, DOI 10.1016/0042-6989(94)90151-1; Chittka L, 2001, COGNITIVE ECOLOGY OF POLLINATION: ANIMAL BEHAVIOUR AND FLORAL EVOLUTION, P106, DOI 10.1017/CBO9780511542268.007; Dafni A, 1997, BIOL REV, V72, P239, DOI 10.1017/S0006323196005002; Darwin CR, 1876, EFFECTS CROSS SELF F; DAUMER K, 1958, Z VERGL PHYSIOL, V41, P49; Dyer AG, 2012, P ROY SOC B-BIOL SCI, V279, P3606, DOI 10.1098/rspb.2012.0827; Dyer AG, 2004, J COMP PHYSIOL A, V190, P105, DOI 10.1007/s00359-003-0475-2; Dyer AG, 1996, J BIOMEDICAL IMAGING, V2, P6; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; Endler JA, 2005, BIOL J LINN SOC, V86, P405, DOI 10.1111/j.1095-8312.2005.00540.x; Endler JA, 2012, BIOL J LINN SOC, V107, P233, DOI 10.1111/j.1095-8312.2012.01937.x; Gao F, 2003, REMOTE SENS ENVIRON, V86, P198, DOI 10.1016/S0034-4257(03)00100-7; Garcia JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079534; Garcia JE, 2014, J FORENSIC SCI, V59, P117, DOI 10.1111/1556-4029.12274; Garcia JE, 2013, J EXP BIOL, V216, P4290, DOI 10.1242/jeb.094045; Holst GC., 2007, CMOS CCD SENSORS CAM; Indsto JO, 2000, MONOCOTS SYSTEMATICS, P326; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; Kendal D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072296; KEVAN PG, 1979, AM J BOT, V66, P749, DOI 10.2307/2442421; Kevan PG, 2001, J EXP BIOL, V204, P2571; Knuth P., 1891, BOT CENTRALBL, V48, P160; Kuhn A., 1927, Z VERGL PHYSIOL, V5, P762, DOI DOI 10.1007/BF00302277; Lubbock SJ, 1881, J LINN SOC LOND ZOOL, V16, P110; Lutz FE, 1924, ANN NY ACAD SCI, V29, P233; Lythgoe J.N., 1979, ECOLOGY VISION; Martinez-Verdu F, 2002, J IMAGING SCI TECHN, V46, P15; Menzel R, 1990, COLOR VISION OWNER V; Morawetz L, 2013, J COMP PHYSIOL A, V199, P817, DOI 10.1007/s00359-013-0843-5; Myers RD, 2010, TECHNICAL REPORT; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; Pike TW, 2011, BEHAV ECOL SOCIOBIOL, V65, P849, DOI 10.1007/s00265-010-1097-7; Ray S, 2011, MANUAL PHOTOGRAPHY, P43; Richtmyer FK, 1923, J OPT SOC AM REV SCI, V7, P151, DOI 10.1364/JOSA.7.000151; ROUJEAN JL, 1992, J GEOPHYS RES-ATMOS, V97, P20455, DOI 10.1029/92JD01411; Salvaggio N., 2009, BASIC PHOTOGRAPHIC M; Shrestha M, 2014, J ECOL, V102, P126, DOI 10.1111/1365-2745.12185; Shrestha M, 2013, NEW PHYTOL, V198, P301, DOI 10.1111/nph.12135; Stevens M, 2007, BIOL J LINN SOC, V90, P211, DOI 10.1111/j.1095-8312.2007.00725.x; Stockman A, 2000, VISION RES, V40, P1711, DOI 10.1016/S0042-6989(00)00021-3; Streisfeld MA, 2007, J EVOLUTION BIOL, V20, P122, DOI 10.1111/j.1420-9101.2006.01216.x; Strutt JW, 1874, NATURE, V11, P6; Vignolini S, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0394; Vorobyev M, 1997, ISRAEL J PLANT SCI, V45, P93, DOI 10.1080/07929978.1997.10676676; Vukusic P, 2009, J R SOC INTERFACE, V6, pS133, DOI 10.1098/rsif.2008.0386.focus; Vukusic P, 2003, NATURE, V424, P852, DOI 10.1038/nature01941; Waddington K.D., 1983, P213; Westland S, 2012, COLOR SCI USING MATL; Whitney HM, 2009, SCIENCE, V323, P130, DOI 10.1126/science.1166256; Williams S, 2007, J OPHTHALMIC PHOTOGR, V29, P10; Wyszecki G., 2000, COLOR SCI CONCEPTS M; Young MJ, 2011, J ANIM ECOL, V80, P183, DOI 10.1111/j.1365-2656.2010.01759.x	61	31	32	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96646	10.1371/journal.pone.0096646	http://dx.doi.org/10.1371/journal.pone.0096646			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827828	Green Published, gold			2022-12-27	WOS:000336857400032
J	Weddell, JC; Imoukhuede, PI				Weddell, Jared C.; Imoukhuede, P. I.			Quantitative Characterization of Cellular Membrane-Receptor Heterogeneity through Statistical and Computational Modeling	PLOS ONE			English	Article								Cell population heterogeneity can affect cellular response and is a major factor in drug resistance. However, there are few techniques available to represent and explore how heterogeneity is linked to population response. Recent high-throughput genomic, proteomic, and cellomic approaches offer opportunities for profiling heterogeneity on several scales. We have recently examined heterogeneity in vascular endothelial growth factor receptor (VEGFR) membrane localization in endothelial cells. We and others processed the heterogeneous data through ensemble averaging and integrated the data into computational models of anti-angiogenic drug effects in breast cancer. Here we show that additional modeling insight can be gained when cellular heterogeneity is considered. We present comprehensive statistical and computational methods for analyzing cellomic data sets and integrating them into deterministic models. We present a novel method for optimizing the fit of statistical distributions to heterogeneous data sets to preserve important data and exclude outliers. We compare methods of representing heterogeneous data and show methodology can affect model predictions up to 3.9-fold. We find that VEGF levels, a target for tuning angiogenesis, are more sensitive to VEGFR1 cell surface levels than VEGFR2; updating VEGFR1 levels in the tumor model gave a 64% change in free VEGF levels in the blood compartment, whereas updating VEGFR2 levels gave a 17% change. Furthermore, we find that subpopulations of tumor cells and tumor endothelial cells (tEC) expressing high levels of VEGFR (>35,000 VEGFR/cell) negate anti-VEGF treatments. We show that lowering the VEGFR membrane insertion rate for these subpopulations recovers the anti-angiogenic effect of anti-VEGF treatment, revealing new treatment targets for specific tumor cell subpopulations. This novel method of characterizing heterogeneous distributions shows for the first time how different representations of the same data set lead to different predictions of drug efficacy.	[Weddell, Jared C.; Imoukhuede, P. I.] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Weddell, JC (corresponding author), Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA.	Jwedde3@illinois.edu	Imoukhuede, P I/T-7580-2017	Imoukhuede, P I/0000-0002-4257-1085	NIH National Cancer Institute Research Supplements to Promote Diversity; American Cancer Society, Illinois Division Basic Research Grant	NIH National Cancer Institute Research Supplements to Promote Diversity; American Cancer Society, Illinois Division Basic Research Grant(American Cancer Society)	This work was supported by: NIH National Cancer Institute Research Supplements to Promote Diversity; American Cancer Society, Illinois Division Basic Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghaeepour N, 2011, CYTOM PART A, V79A, P6, DOI 10.1002/cyto.a.21007; [Anonymous], 2010, MOL SYST BIOL, V41, P369; [Anonymous], 2003, B CHIN ACAD SCI, V18, P9; [Anonymous], 2006, MIGRATION NEWS, V13, P9; Berthaut A, 2009, MOL VIS, V15, P1997; Bishop JE, 1997, BD BIOSCIENCES; Boedigheimer MJ, 2008, CYTOM PART A, V73A, P421, DOI 10.1002/cyto.a.20553; Booth PJ, 2004, J MOL BIOL, V344, P1109; Brinkman RR, 2009, ADV BIOINFORMAT, V2009; Chiu CS, 2002, J NEUROSCI, V22, P10251; CLAUSS M, 1990, J EXP MED, V172, P1535, DOI 10.1084/jem.172.6.1535; Cruts M, 1996, HUM MOL GENET, V5, P1449, DOI 10.1093/hmg/5.Supplement_1.1449; De Bock K, 2011, CURR OPIN GENET DEV, V21, P73, DOI 10.1016/j.gde.2010.10.008; DEBRABANDER HF, 1994, ANALYST, V119, P2581, DOI 10.1039/an9941902581; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Eo Soo-Heang, 2012, BMC Res Notes, V5, P236, DOI 10.1186/1756-0500-5-236; Finley SD, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00196; Finley SD, 2013, JNCI-J NATL CANCER I, V105, P802, DOI 10.1093/jnci/djt093; Finley SD, 2012, AAPS J, V14, P500, DOI 10.1208/s12248-012-9363-4; Finley SD, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-193; GABHANN F, 2010, MICROCIRCULATION, V17, P333; Ghosh D, 2009, BIOSTATISTICS, V10, P60, DOI 10.1093/biostatistics/kxn015; Hanley WD, 2006, FASEB J, V20, P337, DOI 10.1096/fj.05-4574fje; He B, 2013, IEEE T BIO-MED ENG, V60, P589, DOI 10.1109/TBME.2013.2244886; Henderson AM, 2001, J BIOL CHEM, V276, P6169, DOI 10.1074/jbc.M008506200; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Hood JD, 2002, SCIENCE, V296, P2404, DOI 10.1126/science.1070200; Imoukhuede PI, 2013, AM J PHYSIOL-HEART C, V304, pH1085, DOI 10.1152/ajpheart.00514.2012; Imoukhuede PI, 2011, EXP CELL RES, V317, P955, DOI 10.1016/j.yexcr.2010.12.014; Imoukhuede PI, 2014, CANCER MED-US, V3, P225, DOI 10.1002/cam4.188; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Kanno S, 2000, ONCOGENE, V19, P2138, DOI 10.1038/sj.onc.1203533; Kearney JB, 2004, BLOOD, V103, P4527, DOI 10.1182/blood-2003-07-2315; Kumanogoh A, 2013, NAT REV IMMUNOL, V13, P802, DOI 10.1038/nri3545; Kushner EJ, 2013, CURR OPIN HEMATOL, V20, P231, DOI 10.1097/MOH.0b013e328360614b; Kut C, 2007, BRIT J CANCER, V97, P978, DOI 10.1038/sj.bjc.6603923; Le Meur N, 2013, CURR OPIN BIOTECH, V24, P105, DOI 10.1016/j.copbio.2012.09.003; Lee-Montiel FT, 2013, J MATER CHEM B, V1, P6434, DOI 10.1039/c3tb20904k; Leys C, 2013, J EXP SOC PSYCHOL, V49, P764, DOI 10.1016/j.jesp.2013.03.013; Lugli E, 2010, CYTOM PART A, V77A, P705, DOI 10.1002/cyto.a.20901; Mac Gabhann F, 2004, AM J PHYSIOL-HEART C, V286, pH153, DOI 10.1152/ajpheart.00254.2003; Mac Gabhann F, 2007, AM J PHYSIOL-HEART C, V292, pH459, DOI 10.1152/ajpheart.00637.2006; Mac Gabhann F, 2007, BIOPHYS CHEM, V128, P125, DOI 10.1016/j.bpc.2007.03.010; Maurer MH, 2003, NEUROSCI LETT, V344, P165, DOI 10.1016/S0304-3940(03)00407-5; Nagy JA, 2012, CLIN EXP METASTAS, V29, P657, DOI 10.1007/s10585-012-9500-6; Nagy JA, 2010, SEMIN THROMB HEMOST, V36, P321, DOI 10.1055/s-0030-1253454; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Pannu KK, 2001, CYTOMETRY, V45, P250, DOI 10.1002/1097-0320(20011201)45:4<250::AID-CYTO10021>3.0.CO;2-T; Peel D, 2004, FINITE MIXTURE MODEL; Popel AS, 2013, PLOS ONE, V8; Popel AS, 2012, PLOS ONE, V7; POSNER I, 1992, J BIOL CHEM, V267, P20638; Quinn G, 2000, BIOCHEM BIOPH RES CO, V276, P1089, DOI 10.1006/bbrc.2000.3602; Resat H, 2003, BIOPHYS J, V85, P730, DOI 10.1016/S0006-3495(03)74516-0; Roederer M, 2001, CYTOMETRY, V45, P37, DOI 10.1002/1097-0320(20010901)45:1<37::AID-CYTO1142>3.0.CO;2-E; SATERBAK A, 1993, BIOPHYS J, V65, P243, DOI 10.1016/S0006-3495(93)81077-4; Sato T, 2014, J GASTROENTEROL, V49, P455, DOI 10.1007/s00535-013-0869-z; Saunders NA, 2012, EMBO MOL MED, V4, P675, DOI 10.1002/emmm.201101131; Sawano A, 2001, BLOOD, V97, P785, DOI 10.1182/blood.V97.3.785; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Seely JF, 1997, AM STAT, V51, P55, DOI 10.2307/2684696; Serini G, 2003, NATURE, V424, P391, DOI 10.1038/nature01784; Slacka MD, 2008, P NATL ACAD SCI USA, V105, P19306, DOI 10.1073/pnas.0807038105; Stefanini MO, 2010, CANCER RES, V70, P9886, DOI 10.1158/0008-5472.CAN-10-1419; Sugiyama Y, 2005, NAT METHODS, V2, P677, DOI 10.1038/NMETH783; Tan WH, 2013, CELL SIGNAL, V25, P2496, DOI 10.1016/j.cellsig.2013.08.015; Trieglaff O, 2009, BIODATA MINING, V2; Tsentralfarband fun die bundistishe organisatsyonen in Amerika, 1905, KEMFER, V1, P1; Williams CK, 2006, BLOOD, V107, P931, DOI 10.1182/blood-2005-03-1000; Wu FT, 2008, BMC SYST BIOL, V2; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1434, DOI 10.1021/bi00379a034; Yu JQ, 2004, J BIOL CHEM, V279, P50446, DOI 10.1074/jbc.M409221200; Zhang LJ, 2001, CAN J FOREST RES, V31, P1654, DOI 10.1139/x01-086; Zhu XF, 2002, GENET EPIDEMIOL, V23, P181, DOI 10.1002/gepi.210; Zimmerman N, 2009, ADV BIOINFORMAT, V2009	76	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97271	10.1371/journal.pone.0097271	http://dx.doi.org/10.1371/journal.pone.0097271			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827582	gold, Green Submitted, Green Published			2022-12-27	WOS:000336857400070
J	Xu, H; Zhang, YM; Sun, H; Chen, SH; Wang, FM				Xu, Hong; Zhang, Yamin; Sun, Hua; Chen, Suhui; Wang, Fuming			Effects of Acupuncture at GV20 and ST36 on the Expression of Matrix Metalloproteinase 2, Aquaporin 4, and Aquaporin 9 in Rats Subjected to Cerebral Ischemia/Reperfusion Injury	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; ISCHEMIC-STROKE; ARTERY OCCLUSION; EDEMA; ELECTROACUPUNCTURE; DAMAGE; MODEL; MICE	Background/Purpose: Ischemic stroke is characterized by high morbidity and mortality worldwide. Matrix metalloproteinase 2 (MMP2), aquaporin (AQP) 4, and AQP9 are linked to permeabilization of the blood-brain barrier (BBB) in cerebral ischemia/reperfusion injury (CIRI). BBB disruption, tissue inflammation, and MMP/AQP upregulation jointly provoke brain edema/swelling after CIRI, while acupuncture and electroacupuncture can alleviate CIRI symptoms. This study evaluated the hypothesis that acupuncture and electroacupuncture can similarly exert neuroprotective actions in a rat model of middle cerebral artery occlusion (MCAO) by modulating MMP2/AQP4/APQ9 expression and inflammatory cell infiltration. Methods: Eighty 8-week-old Sprague-Dawley rats were randomly divided into sham group S, MCAO model group M, acupuncture group A, electroacupuncture group EA, and edaravone group ED. The MCAO model was established by placement of a suture to block the middle carotid artery, and reperfusion was triggered by suture removal in all groups except group S. Acupuncture and electroacupuncture were administered at acupoints GV20 (governing vessel-20) and ST36 (stomach-36). Rats in groups A, EA, and ED received acupuncture, electroacupuncture, or edaravone, respectively, immediately after MCAO. Neurological function (assessed using the Modified Neurological Severity Score), infarct volume, MMP2/AQP4/AQP9 mRNA and protein expression, and inflammatory cell infiltration were all evaluated at 24 h post-reperfusion. Results: Acupuncture and electroacupuncture significantly decreased infarct size and improved neurological function. Furthermore, target mRNA and protein levels and inflammatory cell infiltration were significantly reduced in groups A, EA, and ED vs. group M. However, MMP2/AQP levels and inflammatory cell infiltration were generally higher in groups A and EA than in group ED except MMP2 mRNA levels. Conclusions: Acupuncture and electroacupuncture at GV20 and ST36 both exercised neuroprotective actions in a rat model of MCAO, with no clear differences between groups A and EA. Therefore, acupuncture and electroacupuncture might find utility as adjunctive and complementary treatments to supplement conventional therapy for ischemic stroke.	[Xu, Hong; Zhang, Yamin; Sun, Hua; Chen, Suhui; Wang, Fuming] Chinese Acad Med Sci, PUMC, PUMCH, Dept Tradit Chinese Med, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital	Sun, H (corresponding author), Chinese Acad Med Sci, PUMC, PUMCH, Dept Tradit Chinese Med, Beijing 100730, Peoples R China.	sunhuahe@vip.sina.com			The National Natural Science Foundation of China [81273850]; Peking Union Medical College Hospital [2010150]	The National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Peking Union Medical College Hospital	This work was supported by: 1. The National Natural Science Foundation of China (No. 81273850) http://www.nsfc.gov.cn/.2. Peking Union Medical College Hospital (No. 2010150 http://www.pumch.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amantea D, 2009, FEBS J, V276, P13, DOI 10.1111/j.1742-4658.2008.06766.x; Badaut J, 2004, NEUROSCIENCE, V128, P27, DOI 10.1016/j.neuroscience.2004.05.042; Badaut J, 2007, METAB BRAIN DIS, V22, P251, DOI 10.1007/s11011-007-9057-2; Beck K, 2012, CELL TISSUE RES, V347, P187, DOI 10.1007/s00441-011-1228-0; Candelario-Jalil E, 2009, CURR OPIN INVEST DR, V10, P644; Chen Shi-xin, 2011, Zhongguo Zhong Xi Yi Jie He Za Zhi, V31, P784; Chen Su-Hui, 2012, Zhen Ci Yan Jiu, V37, P470; Feng Hao-rong, 2010, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V26, P12; Feng HR, 2010, ZHONGGUO YING YONG S, V26, P18; Fukuda AM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-279; Hwang IK, 2010, J VET MED SCI, V72, P279, DOI 10.1292/jvms.09-0374; Inoue I, 2009, ACUPUNCT MED, V27, P155, DOI 10.1136/aim.2009.000430; Isahaya K, 2012, J STROKE CEREBROVASC, V21, P102, DOI 10.1016/j.jstrokecerebrovasdis.2010.05.009; Kim JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056736; Krueger M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056419; Kurzepa J, 2013, INT J NEUROSCI; Lan L, 2013, INT J MOL MED, V31, P75, DOI 10.3892/ijmm.2012.1184; Lapergue B, 2013, STROKE, V44, P699, DOI 10.1161/STROKEAHA.112.667832; Lee JY, 2014, NEUROPHARMACOLOGY, V79, P161, DOI 10.1016/j.neuropharm.2013.11.011; Lee K, 2012, EUR J PHARMACOL, V689, P89, DOI 10.1016/j.ejphar.2012.05.028; Li Zhan-Biao, 2013, Zhen Ci Yan Jiu, V38, P106; Liu SY, 2009, AM J CHINESE MED, V37, P483, DOI 10.1142/S0192415X09006990; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Nagahiro Shinji, 1998, Journal of Medical Investigation, V45, P57; Okuno K, 2008, ACTA NEUROCHIR SUPPL, V102, P431, DOI 10.1007/978-3-211-85578-2_84; Pandian JD, 2007, INT J STROKE, V2, P17, DOI 10.1111/j.1747-4949.2007.00089.x; Ribeiro MD, 2006, J NEUROSCI RES, V83, P1231, DOI 10.1002/jnr.20819; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Rosenberg Gary A, 2007, Neurosurg Focus, V22, pE4; Shehadah A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054083; Shen PF, 2012, AM J CHINESE MED, V40, P685, DOI 10.1142/S0192415X12500516; Tian GH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/482947; Walcott BP, 2012, NEUROTHERAPEUTICS, V9, P65, DOI 10.1007/s13311-011-0087-4; Wang GB, 2013, NEUROSCI LETT, V543, P72, DOI 10.1016/j.neulet.2013.02.067; Wong V, 2013, COCHRANE DB SYST REV, V1, pD7968; Wu Y, 2012, J MOL NEUROSCI, V46, P483, DOI 10.1007/s12031-011-9620-5; Xu DY, 2008, PLANTA MED, V74, P816, DOI 10.1055/s-2008-1074557; [徐虹 Xu Hong], 2010, [基础医学与临床, Basic & Clinical Medicine], V30, P731; Xu Neng-gui, 2002, Zhongguo Zhong Xi Yi Jie He Za Zhi, V22, P295; Yang Y, 2013, J CEREBR BLOOD F MET, V33, P1104, DOI 10.1038/jcbfm.2013.56; Yang Y, 2011, METHODS MOL BIOL, V762, P333, DOI 10.1007/978-1-61779-185-7_24; Zelenina M, 2010, NEUROCHEM INT, V57, P468, DOI 10.1016/j.neuint.2010.03.022; Zeng XW, 2012, BRAIN RES, V1437, P127, DOI 10.1016/j.brainres.2011.12.012	45	33	43	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97488	10.1371/journal.pone.0097488	http://dx.doi.org/10.1371/journal.pone.0097488			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828425	gold, Green Published, Green Submitted			2022-12-27	WOS:000336857400100
J	Korkala, EAE; Hugg, TT; Jaakkola, JJK				Korkala, Essi A. E.; Hugg, Timo T.; Jaakkola, Jouni J. K.			Awareness of Climate Change and the Dietary Choices of Young Adults in Finland: A Population-Based Cross-Sectional Study	PLOS ONE			English	Article							RESPIRATORY SYMPTOMS; FOOD-CONSUMPTION; HOME DAMPNESS; MITIGATION; HEALTH; ENERGY; ASTHMA; DETERMINANTS; AGRICULTURE; EFFICIENCY	Climate change is a major public health threat that is exacerbated by food production. Food items differ substantially in the amount of greenhouse gases their production generates and therefore individuals, if willing, can mitigate climate change through dietary choices. We conducted a population-based cross-sectional study to assess if the understanding of climate change, concern over climate change or socio-economic characteristics are reflected in the frequencies of climate-friendly food choices. The study population comprised 1623 young adults in Finland who returned a self-administered questionnaire (response rate 64.0%). We constructed a Climate-Friendly Diet Score (CFDS) ranging theoretically from -14 to 14 based on the consumption of 14 food items. A higher CFDS indicated a climate-friendlier diet. Multivariate linear regression analyses on the determinants of CFDS revealed that medium concern raised CFDS on average by 0.51 points (95% confidence interval (CI) 0.03, 0.98) and high concern by 1.30 points (95% CI 0.80, 1.80) compared to low concern. Understanding had no effect on CFDS on its own. Female gender raised CFDS by 1.92 (95% CI 1.59, 2.25). Unemployment decreased CFDS by 0.92 (95% CI -1.68, -0.15). Separate analyses of genders revealed that high concern over climate change brought about a greater increase in CFDS in females than in males. Good understanding of climate change was weakly connected to climate-friendly diet among females only. Our results indicate that increasing awareness of climate change could lead to increased consumption of climate-friendly food, reduction in GHG emissions, and thus climate change mitigation.	[Korkala, Essi A. E.; Hugg, Timo T.; Jaakkola, Jouni J. K.] Univ Oulu, Ctr Environm & Resp Hlth Res, Oulu, Finland; [Korkala, Essi A. E.; Hugg, Timo T.; Jaakkola, Jouni J. K.] Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland; [Korkala, Essi A. E.; Hugg, Timo T.; Jaakkola, Jouni J. K.] Univ Oulu, Oulu, Finland; [Hugg, Timo T.; Jaakkola, Jouni J. K.] Univ Oulu, Inst Hlth Sci, Oulu, Finland	University of Oulu; University of Oulu; University of Oulu; University of Oulu	Jaakkola, JJK (corresponding author), Univ Oulu, Ctr Environm & Resp Hlth Res, Oulu, Finland.	jouni.jaakkola@oulu.fi	Hugg, Timo/P-5531-2018; Jaakkola, Jouni J.K./G-4314-2012	Hugg, Timo/0000-0003-2558-1780; Jaakkola, Jouni/0000-0003-4168-4683	Academy of Finland [129419, 138691, 266314]	Academy of Finland(Academy of Finland)	This work was supported by Academy of Finland (grant no. 129419 of SALVE research program and grants no. 138691 and no. 266314). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agho K, 2010, ENVIRON RES, V110, P756, DOI 10.1016/j.envres.2010.09.007; Aitken C, 2011, GLOBAL ENVIRON CHANG, V21, P752, DOI 10.1016/j.gloenvcha.2011.01.002; Aston LM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001072; Carlsson-Kanyama A, 2003, ECOL ECON, V44, P293, DOI 10.1016/S0921-8009(02)00261-6; Carlsson-Kanyama A, 1998, FOOD POLICY, V23, P277, DOI 10.1016/S0306-9192(98)00037-2; Carlsson-Kanyama A, 2009, AM J CLIN NUTR, V89, pS1704, DOI 10.3945/ajcn.2009.26736AA; Costello A, 2009, LANCET, V373, P1693, DOI [10.1016/S0140-6736(09)60935-1, 10.1016/S0140-6736(09)60929-6]; Darmon N, 2008, AM J CLIN NUTR, V87, P1107, DOI 10.1093/ajcn/87.5.1107; European Commission, 2008, SPEC EUR, V300; Fielding KS, 2012, ENVIRON EDUC RES, V18, P171, DOI 10.1080/13504622.2011.592936; Friel S, 2009, LANCET, V374, P2016, DOI 10.1016/S0140-6736(09)61753-0; Goh KM, 2011, BIOL AGRIC HORTIC, V27, P205, DOI 10.1080/01448765.2011.9756648; Gonzalez AD, 2011, FOOD POLICY, V36, P562, DOI 10.1016/j.foodpol.2011.07.003; Grizzetti B, 2013, ENVIRON SCI POLICY, V33, P186, DOI 10.1016/j.envsci.2013.05.013; Hansen B, 2001, AGR ECOSYST ENVIRON, V83, P11, DOI 10.1016/S0167-8809(00)00257-7; Hyrkas H, 2014, RESP MED, V108, P63, DOI 10.1016/j.rmed.2013.10.019; IPCC, 2007, CONTRIBUTION WORKING; Jaakkola JJK, 2005, ENVIRON HEALTH PERSP, V113, P357, DOI 10.1289/ehp.7242; JAAKKOLA JJK, 1993, J EXPO ANAL ENV EPID, V3, P129; Makiniemi JP, 2013, APPETITE, V66, P54, DOI 10.1016/j.appet.2013.01.026; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; McMichael AJ, 2007, LANCET, V370, P1253, DOI 10.1016/S0140-6736(07)61256-2; Nijdam D, 2012, FOOD POLICY, V37, P760, DOI 10.1016/j.foodpol.2012.08.002; Nilsson K, 2010, INT J LIFE CYCLE ASS, V15, P916, DOI 10.1007/s11367-010-0220-3; Peltonen M, 2008, KANSALLINEN FINRISKI; Popp A, 2010, GLOBAL ENVIRON CHANG, V20, P451, DOI 10.1016/j.gloenvcha.2010.02.001; Roos E, 1998, SOC SCI MED, V46, P1519, DOI 10.1016/S0277-9536(98)00032-X; Scarborough P, 2012, EUR J CLIN NUTR, V66, P710, DOI 10.1038/ejcn.2012.34; Scialabba NEH, 2010, RENEW AGR FOOD SYST, V25, P158, DOI 10.1017/S1742170510000116; Semenza JC, 2008, AM J PREV MED, V35, P479, DOI 10.1016/j.amepre.2008.08.020; Semenza JC, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-46; Stehfest E, 2009, CLIMATIC CHANGE, V95, P83, DOI 10.1007/s10584-008-9534-6; STEPTOE A, 1995, APPETITE, V25, P267, DOI 10.1006/appe.1995.0061; Stolze M., 2000, ENV IMPACTS ORGANIC; Sundblad E, 2014, REV EUR PSY IN PRESS; Tervonen K, 2009, ILMASTALKOOT TUTKIMU; Whitmarsh L, 2011, GLOBAL ENVIRON CHANG, V21, P56, DOI 10.1016/j.gloenvcha.2010.07.011; Whitmarsh L, 2010, J ENVIRON PSYCHOL, V30, P305, DOI 10.1016/j.jenvp.2010.01.003	39	9	10	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97480	10.1371/journal.pone.0097480	http://dx.doi.org/10.1371/journal.pone.0097480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AH8EY	24824363	Green Published, Green Submitted, gold			2022-12-27	WOS:000336369200121
J	Ling, H; Wu, QB; Guo, JL; Xu, LP; Que, YX				Ling, Hui; Wu, Qibin; Guo, Jinlong; Xu, Liping; Que, Youxiong			Comprehensive Selection of Reference Genes for Gene Expression Normalization in Sugarcane by Real Time Quantitative RT-PCR	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; INTERNAL REFERENCE GENES; HOUSEKEEPING GENES; VALIDATION; MICROSATELLITES; IDENTIFICATION; SORGHUM; STRESS	The increasingly used real time quantitative reverse transcription-PCR (qRT-PCR) method for gene expression analysis requires one or several reference gene(s) acting as normalization factor(s). In order to facilitate gene expression studies in sugarcane (Saccharum officinarum), a non-model plant with limited genome information, the stability of 13 candidate reference genes was evaluated. The geNorm, NormFinder and deltaCt methods were used for selecting stably expressed internal controls across different tissues and under various experimental treatments. These results revealed that, among these 13 candidate reference genes, GAPDH, eEF-1a and eIF-4 alpha were the most stable and suitable for use as normalization factors across all various experimental samples. In addition, APRT could be a candidate for examining the relationship between gene copy number and transcript levels in sugarcane tissue samples. According to the results evaluated by geNorm, combining CUL and eEF-1 alpha in hormone treatment experiments; CAC and CUL in abiotic stress tests; GAPDH, eEF-1 alpha and CUL in all treatment samples plus CAC, CUL, APRT and TIPS-41 in cultivar tissues as groups for normalization would lead to more accurate and reliable expression quantification in sugarcane. This is the first systematic validation of reference genes for quantification of transcript expression profiles in sugarcane. This study should provide useful information for selecting reference genes for more accurate quantification of gene expression in sugarcane and other plant species.	[Ling, Hui; Wu, Qibin; Guo, Jinlong; Xu, Liping; Que, Youxiong] Fujian Agr & Forestry Univ, Key Lab Sugarcane Biol & Genet Breeding, Minist Agr, Fuzhou, Fujian, Peoples R China	Fujian Agriculture & Forestry University; Ministry of Agriculture & Rural Affairs	Xu, LP (corresponding author), Fujian Agr & Forestry Univ, Key Lab Sugarcane Biol & Genet Breeding, Minist Agr, Fuzhou, Fujian, Peoples R China.	xlpmail@126.com; queyouxiong@hotmail.com		Que, Youxiong/0000-0003-1111-5834	National Natural Science Foundation of China [31271782]; Research Funds for Distinguished Young Scientists in Fujian Provincial Department of Education [K80MKT04A]; Research Funds for Distinguished Young Scientists in Fujian Agriculture and Forestry University [xjq201202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Funds for Distinguished Young Scientists in Fujian Provincial Department of Education; Research Funds for Distinguished Young Scientists in Fujian Agriculture and Forestry University	This work was funded by National Natural Science Foundation of China (31271782), Research Funds for Distinguished Young Scientists in Fujian Provincial Department of Education (K80MKT04A) and Research Funds for Distinguished Young Scientists in Fujian Agriculture and Forestry University (xjq201202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALJANABI SM, 1994, THEOR APPL GENET, V88, P933, DOI 10.1007/BF00220799; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Casu RE, 2012, PLANT CELL REP, V31, P167, DOI 10.1007/s00299-011-1150-7; Chandna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036918; Cheavegatti-Gianotto Adriana, 2011, Trop Plant Biol, V4, P62, DOI 10.1007/s12042-011-9068-3; Chen L, 2011, PLANTA, V234, P377, DOI 10.1007/s00425-011-1410-3; Chen X, 2010, ANAL BIOCHEM, V405, P138, DOI 10.1016/j.ab.2010.05.032; Cui SJ, 2011, J GENET, V90, P503, DOI 10.1007/s12041-011-0113-7; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; De Santis C, 2011, MAR BIOTECHNOL, V13, P170, DOI 10.1007/s10126-010-9277-z; Die JV, 2010, PLANTA, V232, P145, DOI 10.1007/s00425-010-1158-1; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Fan CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056573; Figueira T. R. e S., 2008, Tropical Plant Biology, V1, P108, DOI 10.1007/s12042-008-9009-y; Gamm M, 2011, MOL GENET GENOMICS, V285, P273, DOI 10.1007/s00438-011-0607-2; Gaut BS, 1997, P NATL ACAD SCI USA, V94, P6809, DOI 10.1073/pnas.94.13.6809; Goulao LF, 2012, PLANT MOL BIOL REP, V30, P741, DOI 10.1007/s11105-011-0382-6; Guimaraes CT, 1997, P NATL ACAD SCI USA, V94, P14261, DOI 10.1073/pnas.94.26.14261; Guo JL, 2012, PLANT CELL REP, V31, P1801, DOI 10.1007/s00299-012-1293-1; Gutierrez L, 2008, PLANT CELL, V20, P1734, DOI 10.1105/tpc.108.059774; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Iskandar HM, 2004, PLANT MOL BIOL REP, V22, P325, DOI 10.1007/BF02772676; Jacob F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059180; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; James BT, 2012, MOL BREEDING, V30, P661, DOI 10.1007/s11032-011-9651-1; Jarosova J, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-146; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Kumar K, 2013, PLANT CELL TISS ORG, V115, P13, DOI 10.1007/s11240-013-0335-x; Li HP, 2011, PLANT SCI, V181, P132, DOI 10.1016/j.plantsci.2011.04.014; Li QF, 2010, PLANT MOL BIOL REP, V28, P49, DOI 10.1007/s11105-009-0124-1; Lilly ST, 2011, MOL PLANT MICROBE IN, V24, P294, DOI 10.1094/MPMI-10-10-0236; Long XY, 2010, PLANT MOL BIOL, V74, P307, DOI 10.1007/s11103-010-9666-8; Lovdal T, 2009, ANAL BIOCHEM, V387, P238, DOI 10.1016/j.ab.2009.01.024; Manoli A, 2012, J PLANT PHYSIOL, V169, P807, DOI 10.1016/j.jplph.2012.01.019; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Podevin N, 2012, MOL BREEDING, V30, P1237, DOI 10.1007/s11032-012-9711-1; Que YX, 2009, CHINESE J TROP CROP, V30, P276; Ramgareeb S, 2010, PLANT CELL TISS ORG, V100, P175, DOI 10.1007/s11240-009-9634-7; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Saha GC, 2013, PLANT MOL BIOL REP, V31, P1109, DOI 10.1007/s11105-013-0579-y; Schmidt GW, 2010, MOL GENET GENOMICS, V283, P233, DOI 10.1007/s00438-010-0511-1; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Singh RK, 2011, EUPHYTICA, V182, P335, DOI 10.1007/s10681-011-0484-0; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wan HJ, 2010, ANAL BIOCHEM, V399, P257, DOI 10.1016/j.ab.2009.12.008; WOLFE KH, 1989, P NATL ACAD SCI USA, V86, P6201, DOI 10.1073/pnas.86.16.6201; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Zhang K, 2013, J BIOTECHNOL, V168, P7, DOI 10.1016/j.jbiotec.2013.08.008; Zhu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044405	52	102	115	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97469	10.1371/journal.pone.0097469	http://dx.doi.org/10.1371/journal.pone.0097469			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24823940	Green Published, Green Submitted, gold			2022-12-27	WOS:000336369200118
J	Poole, CB; Gu, WF; Kumar, S; Jin, JM; Davis, PJ; Bauche, D; McReynolds, LA				Poole, Catherine B.; Gu, Weifeng; Kumar, Sanjay; Jin, Jingmin; Davis, Paul J.; Bauche, David; McReynolds, Larry A.			Diversity and Expression of MicroRNAs in the Filarial Parasite, Brugia malayi	PLOS ONE			English	Article							C-ELEGANS; RNAS; GENOME; TARGETS; PROTEIN; CONSERVATION; SEQUENCES; ARGONAUTE; LONGEVITY; MIRBASE	Human filarial parasites infect an estimated 120 million people in 80 countries worldwide causing blindness and the gross disfigurement of limbs and genitals. An understanding of RNA-mediated regulatory pathways in these parasites may open new avenues for treatment. Toward this goal, small RNAs from Brugia malayi adult females, males and microfilariae were cloned for deep-sequencing. From similar to 30 million sequencing reads, 145 miRNAs were identified in the B. malayi genome. Some microRNAs were validated using the p19 RNA binding protein and qPCR. B. malayi miRNAs segregate into 99 families each defined by a unique seed sequence. Sixty-one of the miRNA families are highly conserved with homologues in arthropods, vertebrates and helminths. Of those miRNAs not highly conserved, homologues of 20 B. malayi miRNA families were found in vertebrates. Nine B. malayi miRNA families appear to be filarial-specific as orthologues were not found in other organisms. The miR-2 family is the largest in B. malayi with 11 members. Analysis of the sequences shows that six members result from a recent expansion of the family. Library comparisons found that 1/3 of the B. malayi miRNAs are differentially expressed. For example, miR-71 is 5-7X more highly expressed in microfilariae than adults. Studies suggest that in C. elegans, miR-71 may enhance longevity by targeting the DAF-2 pathway. Characterization of B. malayi miRNAs and their targets will enhance our understanding of their regulatory pathways in filariads and aid in the search for novel therapeutics.	[Poole, Catherine B.; Jin, Jingmin; Bauche, David; McReynolds, Larry A.] New England Biolabs Inc, Div RNA Biol, Ipswich, MA 01938 USA; [Poole, Catherine B.; Kumar, Sanjay; Davis, Paul J.; McReynolds, Larry A.] New England Biolabs Inc, Div Parasitol, Ipswich, MA USA; [Gu, Weifeng] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA; [Bauche, David] Canc Res Ctr Lyon, Lyon, France	New England Biolabs; New England Biolabs; University of Massachusetts System; University of Massachusetts Worcester; UNICANCER; Centre Leon Berard	McReynolds, LA (corresponding author), New England Biolabs Inc, Div RNA Biol, Ipswich, MA 01938 USA.	mcreynolds@neb.com	Kumar, Sanjay/AAO-2593-2021; bauche, david/M-2409-2019		New England Biolabs; NIH [5R01, GM 058800]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058800] Funding Source: NIH RePORTER	New England Biolabs; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by New England Biolabs and DNA sequencing was performed at the University of Massachusetts Medical School funded by NIH- 5R01, GM 058800 and the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Addiss DG, 2000, TROP MED SCI PRACT, V1, P151; Alvarez-Saavedra E, 2010, CURR BIOL, V20, P367, DOI 10.1016/j.cub.2009.12.051; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Basyuk E, 2003, NUCLEIC ACIDS RES, V31, P6593, DOI 10.1093/nar/gkg855; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Boulias K, 2012, CELL METAB, V15, P439, DOI 10.1016/j.cmet.2012.02.014; Bourguinat C, 2008, MOL BIOCHEM PARASIT, V158, P101, DOI 10.1016/j.molbiopara.2007.11.017; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; de Lencastre A, 2010, CURR BIOL, V20, P2159, DOI 10.1016/j.cub.2010.11.015; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Desjardins CA, 2013, NAT GENET, V45, P495, DOI 10.1038/ng.2585; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Godel C, 2012, FASEB J, V26, P4650, DOI 10.1096/fj.12-205096; Grad Y, 2003, MOL CELL, V11, P1253, DOI 10.1016/S1097-2765(03)00153-9; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gu WF, 2009, MOL CELL, V36, P231, DOI 10.1016/j.molcel.2009.09.020; Hafner M, 2011, RNA, V17, P1697, DOI 10.1261/rna.2799511; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hussain M, 2011, P NATL ACAD SCI USA, V108, P9250, DOI 10.1073/pnas.1105469108; Ibanez-Ventoso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002818; Isik Meltem, 2010, Silence, V1, P5, DOI 10.1186/1758-907X-1-5; Jin JM, 2010, BIOTECHNIQUES, V48, pXVII, DOI 10.2144/000113364; Kato M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r54; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kumaraswami V, 2000, TROP MED SCI PRACT, V1, P103; Labib M, 2013, J AM CHEM SOC, V135, P3027, DOI 10.1021/ja308216z; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Le Bechec A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-67; Leaman D, 2005, CELL, V121, P1097, DOI 10.1016/j.cell.2005.04.016; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Martinez NJ, 2008, GENE DEV, V22, P2535, DOI 10.1101/gad.1678608; MCREYNOLDS LA, 1986, P NATL ACAD SCI USA, V83, P797, DOI 10.1073/pnas.83.3.797; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; Molyneux DH, 2001, CURR OPIN INFECT DIS, V14, P155, DOI 10.1097/00001432-200104000-00008; Obad S, 2011, NAT GENET, V43, P371, DOI 10.1038/ng.786; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; PONNUDURAI T, 1975, J HELMINTHOL, V49, P25; Poole CB, 2010, MOL BIOCHEM PARASIT, V169, P87, DOI 10.1016/j.molbiopara.2009.10.004; Prochnik SE, 2007, DEV GENES EVOL, V217, P73, DOI 10.1007/s00427-006-0116-1; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Sapio MR, 2005, DEV BIOL, V282, P231, DOI 10.1016/j.ydbio.2005.03.011; Scott AL, 2000, TROP MED SCI PRACT, V1, P5; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Simonsen PE, 2009, MANSONS TROPICAL DIS, P1477; Wang JB, 2011, GENOME RES, V21, P1462, DOI 10.1101/gr.121426.111; Wanunu M, 2010, NAT NANOTECHNOL, V5, P807, DOI [10.1038/nnano.2010.202, 10.1038/NNANO.2010.202]; Weese D, 2009, GENOME RES, V19, P1646, DOI 10.1101/gr.088823.108; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x; WHO, 1992, 5 WHO EXP COMM FIL, P1; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Williams SA, 2000, INT J PARASITOL, V30, P411, DOI 10.1016/S0020-7519(00)00014-X; Winter AD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-4; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhang L, 2009, DEVELOPMENT, V136, P3043, DOI 10.1242/dev.039008; Zhuang FL, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1263; Zisoulis DG, 2010, NAT STRUCT MOL BIOL, V17, P173, DOI 10.1038/nsmb.1745	75	20	22	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96498	10.1371/journal.pone.0096498	http://dx.doi.org/10.1371/journal.pone.0096498			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824352	Green Published, gold			2022-12-27	WOS:000336369200022
J	Schultz, AL; Malcolm, HA; Bucher, DJ; Linklater, M; Smith, SDA				Schultz, Arthur L.; Malcolm, Hamish A.; Bucher, Daniel J.; Linklater, Michelle; Smith, Stephen D. A.			Depth and Medium-Scale Spatial Processes Influence Fish Assemblage Structure of Unconsolidated Habitats in a Subtropical Marine Park	PLOS ONE			English	Article							GREAT-BARRIER-REEF; UNDERWATER VIDEO STATIONS; DEMERSAL FISH; COMMUNITY STRUCTURE; CONTINENTAL-SHELF; TROPICAL FISH; ROCKY SHORES; EAST-COAST; SURF-ZONE; BIODIVERSITY	Where biological datasets are spatially limited, abiotic surrogates have been advocated to inform objective planning for Marine Protected Areas. However, this approach assumes close correlation between abiotic and biotic patterns. The Solitary Islands Marine Park, northern NSW, Australia, currently uses a habitat classification system (HCS) to assist with planning, but this is based only on data for reefs. We used Baited Remote Underwater Videos (BRUVs) to survey fish assemblages of unconsolidated substrata at different depths, distances from shore, and across an along-shore spatial scale of 10 s of km (2 transects) to examine how well the HCS works for this dominant habitat. We used multivariate regression modelling to examine the importance of these, and other environmental factors (backscatter intensity, fine-scale bathymetric variation and rugosity), in structuring fish assemblages. There were significant differences in fish assemblages across depths, distance from shore, and over the medium spatial scale of the study: together, these factors generated the optimum model in multivariate regression. However, marginal tests suggested that backscatter intensity, which itself is a surrogate for sediment type and hardness, might also influence fish assemblages and needs further investigation. Species richness was significantly different across all factors: however, total MaxN only differed significantly between locations. This study demonstrates that the pre-existing abiotic HCS only partially represents the range of fish assemblages of unconsolidated habitats in the region.	[Schultz, Arthur L.; Smith, Stephen D. A.] So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia; [Malcolm, Hamish A.] New South Wales Dept Primary Ind, Coffs Harbour, NSW, Australia; [Schultz, Arthur L.; Bucher, Daniel J.; Smith, Stephen D. A.] So Cross Univ, Sch Environm Sci & Engn, Marine Ecol Res Ctr, Lismore, NSW, Australia; [Linklater, Michelle] Off Environm & Heritage, Div Sci, Coastal & Marine Unit, Woolongong, NSW, Australia	Southern Cross University; NSW Department of Primary Industries; Southern Cross University; Office of Environment & Heritage - New South Wales	Schultz, AL (corresponding author), So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia.	a.schultz.22@student.edu.au	Smith, Stephen D A/I-1945-2012	Smith, Stephen D A/0000-0002-3372-5441; Bucher, Daniel/0000-0002-7640-4496; Linklater, Michelle/0000-0003-1995-6689	Southern Cross University	Southern Cross University	Funding was supplied by a postgraduate (PhD) research budget from Southern Cross University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2004, J EXP MAR BIOL ECOL, V305, P191, DOI 10.1016/j.jembe.2003.12.011; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; AYVAZIAN SG, 1995, MAR BIOL, V122, P527, DOI 10.1007/BF00350675; Beentjes MP, 2002, NEW ZEAL J MAR FRESH, V36, P197, DOI 10.1080/00288330.2002.9517080; Blamey LK, 2009, AQUAT CONSERV, V19, P645, DOI 10.1002/aqc.1014; Brown CJ, 2011, ESTUAR COAST SHELF S, V92, P502, DOI 10.1016/j.ecss.2011.02.007; Butler AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011831; Cappo M, 2004, J EXP MAR BIOL ECOL, V302, P123, DOI 10.1016/j.jembe.2003.10.006; Cappo M, 2007, MAR ECOL PROG SER, V350, P209, DOI 10.3354/meps07189; Connell SD, 1999, ESTUAR COAST SHELF S, V48, P483, DOI 10.1006/ecss.1998.0438; Curley BG, 2002, MAR FRESHWATER RES, V53, P1197, DOI 10.1071/MF01199; Dalleau M, 2010, CONSERV BIOL, V24, P541, DOI 10.1111/j.1523-1739.2009.01394.x; Fernandes L, 2005, CONSERV BIOL, V19, P1733, DOI 10.1111/j.1523-1739.2005.00302.x; Ferrier S, 2002, SYST BIOL, V51, P331, DOI 10.1080/10635150252899806; Fitzpatrick BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039634; Friedlander AM, 1998, J EXP MAR BIOL ECOL, V224, P1, DOI 10.1016/S0022-0981(97)00164-0; Garcia CB, 1998, MAR ECOL PROG SER, V174, P13, DOI 10.3354/meps174013; Gladstone W, 2002, BIOL CONSERV, V104, P211, DOI 10.1016/S0006-3207(01)00167-7; Gladstone W, 2007, AQUAT CONSERV, V17, P71, DOI 10.1002/aqc.759; Gorley C.K., 2006, GETTING STARTED PRIM; GRAY CA, 1994, AUST J MAR FRESH RES, V45, P665; HARRIOTT VJ, 1994, MAR ECOL PROG SER, V109, P67, DOI 10.3354/meps109067; Harrison M, 2012, MAR BIODIVERS, V42, P203, DOI 10.1007/s12526-011-0105-0; Harvey ES, 2012, J EXP MAR BIOL ECOL, V426, P78, DOI 10.1016/j.jembe.2012.05.019; Harvey ES, 2007, MAR ECOL PROG SER, V350, P245, DOI 10.3354/meps07192; Hyndes GA, 1999, MAR BIOL, V134, P335, DOI 10.1007/s002270050551; Hyndes GA, 2005, ESTUAR COAST SHELF S, V63, P633, DOI 10.1016/j.ecss.2005.01.008; Jordan A., 2010, SEABED HABITAT MAPPI, P209; Kendall MS, 2004, AQUAT CONSERV, V14, P113, DOI 10.1002/aqc.601; Leathwick JR, 2006, ECOL MODEL, V199, P188, DOI 10.1016/j.ecolmodel.2006.05.022; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Long BG, 1997, SEABED CURRENT STRES; Malcolm HA, 2012, OCEAN COAST MANAGE, V59, P1, DOI 10.1016/j.ocecoaman.2011.12.001; Malcolm HA, 2007, MAR ECOL PROG SER, V350, P277, DOI 10.3354/meps07195; Malcolm HA, 2011, AQUAT CONSERV, V21, P173, DOI 10.1002/aqc.1165; Malcolm HA, 2011, DEEP-SEA RES PT II, V58, P616, DOI 10.1016/j.dsr2.2010.09.030; Malcolm Hamish A., 2010, Marine Biodiversity, V40, P181, DOI 10.1007/s12526-010-0042-3; Malcolm HA, 2010, AQUAT CONSERV, V20, P83, DOI 10.1002/aqc.1055; Mau R, 1998, DISTRIBUTION SELECTE; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Moore CH, 2011, ECOGRAPHY, V34, P425, DOI 10.1111/j.1600-0587.2010.06436.x; Moore CH, 2010, MAR BIOL, V157, P2717, DOI 10.1007/s00227-010-1531-4; Moore CH, 2009, ICES J MAR SCI, V66, P2068, DOI 10.1093/icesjms/fsp205; NSW Marine Park Authority, 2010, SEAB HAB MAPP SOL IS; Owen V, 2010, 2010 M AUSTR MAR SCI; Possingham H, 1998, QUANTITATIVE METHODS FOR CONSERVATION BIOLOGY, P291; Rattray A, 2009, ESTUAR COAST SHELF S, V84, P237, DOI 10.1016/j.ecss.2009.06.023; Roberts CM, 2003, ECOL APPL, V13, pS215; ROBERTSON AI, 1984, J EXP MAR BIOL ECOL, V84, P265, DOI 10.1016/0022-0981(84)90185-0; Roff JC, 2002, AQUAT CONSERV, V12, P635, DOI 10.1002/aqc.513; Roughan M, 2002, CONT SHELF RES, V22, P2551, DOI 10.1016/S0278-4343(02)00101-2; Rule MJ, 2007, J EXP MAR BIOL ECOL, V345, P38, DOI 10.1016/j.jembe.2007.01.006; Schultz AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049437; Shears NT, 2002, OECOLOGIA, V132, P131, DOI 10.1007/s00442-002-0920-x; Smith SDA, 2005, BIODIVERS CONSERV, V14, P3565, DOI 10.1007/s10531-004-0828-3; Smith SDA, 1996, AUST J ECOL, V21, P144, DOI 10.1111/j.1442-9993.1996.tb00595.x; Smith SDA, 2008, MAR POLLUT BULL, V56, P525, DOI 10.1016/j.marpolbul.2007.11.016; Snelgrove P, 1997, AMBIO, V26, P578; Stevens T, 2005, MAR FRESHWATER RES, V56, P111, DOI 10.1071/MF04233; Stevens T, 2004, BIOL CONSERV, V119, P351, DOI 10.1016/j.biocon.2003.12.001; Stevens T, 2002, COAST MANAGE, V30, P237, DOI 10.1080/08920750290042183; Travers MJ, 2010, J BIOGEOGR, V37, P148, DOI 10.1111/j.1365-2699.2009.02183.x; Travers MJ, 2012, MAR ECOL PROG SER, V446, P221, DOI 10.3354/meps09501; Ward TJ, 1999, ECOL APPL, V9, P691; White J, 2013, J EXP MAR BIOL ECOL, V448, P281, DOI 10.1016/j.jembe.2013.08.004; Williams A, 2001, MAR FRESHWATER RES, V52, P513, DOI 10.1071/MF00017; Wright D.J., 2005, ARCGIS BENTHIC TERRA; Zacharias MA, 2001, J BIOGEOGR, V28, P471, DOI 10.1046/j.1365-2699.2001.00559.x; Zann LP, 2000, MAR POLLUT BULL, V41, P188, DOI 10.1016/S0025-326X(00)00110-7	71	27	27	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96798	10.1371/journal.pone.0096798	http://dx.doi.org/10.1371/journal.pone.0096798			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824998	Green Submitted, Green Published, gold			2022-12-27	WOS:000336369200032
J	Shen, B; Fang, T; Yang, TX; Jones, G; Irwin, DM; Zhang, SY				Shen, Bin; Fang, Tao; Yang, Tianxiao; Jones, Gareth; Irwin, David M.; Zhang, Shuyi			Relaxed Evolution in the Tyrosine Aminotransferase Gene Tat in Old World Fruit Bats (Chiroptera: Pteropodidae)	PLOS ONE			English	Article							RICHNER-HANHART-SYNDROME; PARACELLULAR ABSORPTION; ROUSETTUS-AEGYPTIACUS; NECTAR; METABOLISM; FUEL; IDENTIFICATION; RECOMBINATION; DEFICIENCY; SIGNATURES	Frugivorous and nectarivorous bats fuel their metabolism mostly by using carbohydrates and allocate the restricted amounts of ingested proteins mainly for anabolic protein syntheses rather than for catabolic energy production. Thus, it is possible that genes involved in protein (amino acid) catabolism may have undergone relaxed evolution in these fruit-and nectar-eating bats. The tyrosine aminotransferase (TAT, encoded by the Tat gene) is the rate-limiting enzyme in the tyrosine catabolic pathway. To test whether the Tat gene has undergone relaxed evolution in the fruit-and nectar-eating bats, we obtained the Tat coding region from 20 bat species including four Old World fruit bats (Pteropodidae) and two New World fruit bats (Phyllostomidae). Phylogenetic reconstructions revealed a gene tree in which all echolocating bats (including the New World fruit bats) formed a monophyletic group. The phylogenetic conflict appears to stem from accelerated TAT protein sequence evolution in the Old World fruit bats. Our molecular evolutionary analyses confirmed a change in the selection pressure acting on Tat, which was likely caused by a relaxation of the evolutionary constraints on the Tat gene in the Old World fruit bats. Hepatic TAT activity assays showed that TAT activities in species of the Old World fruit bats are significantly lower than those of insectivorous bats and omnivorous mice, which was not caused by a change in TAT protein levels in the liver. Our study provides unambiguous evidence that the Tat gene has undergone relaxed evolution in the Old World fruit bats in response to changes in their metabolism due to the evolution of their special diet.	[Shen, Bin; Fang, Tao; Yang, Tianxiao; Zhang, Shuyi] E China Normal Univ, Inst Adv Interdisciplinary Res, Inst Mol Ecol & Evolut, Shanghai 200062, Peoples R China; [Jones, Gareth] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Irwin, David M.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	East China Normal University; University of Bristol; University of Toronto	Zhang, SY (corresponding author), E China Normal Univ, Inst Adv Interdisciplinary Res, Inst Mol Ecol & Evolut, Shanghai 200062, Peoples R China.	syzhang@bio.ecnu.edu.cn		Irwin, David/0000-0001-6131-4933	Key Construction Program of the National '985 Project' and '211 Project' and Shanghai Excellent Academic Leaders Project [11XD1402000]; Biotechnology and Biological Sciences Research Council (BBSRC) Chinese; Ministry of Education of the P. R. China [MXRZZ2012008]; BBSRC [BB/G530392/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G530392/1] Funding Source: researchfish	Key Construction Program of the National '985 Project' and '211 Project' and Shanghai Excellent Academic Leaders Project; Biotechnology and Biological Sciences Research Council (BBSRC) Chinese(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Ministry of Education of the P. R. China(Ministry of Education, China); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Key Construction Program of the National '985 Project' and '211 Project' and Shanghai Excellent Academic Leaders Project (Grant No. 11XD1402000) to SZ. GJ was supported by a Biotechnology and Biological Sciences Research Council (BBSRC) Chinese Partnering award. BS was supported by the Academic Scholarship for PhD Candidates granted by the Ministry of Education of the P. R. China (MXRZZ2012008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHEMIDAN AI, 1995, OPHTHALMIC GENET, V16, P21, DOI 10.3109/13816819509057850; Altringham J D, 1996, BATS BIOL BEHAV, P2; Amitai O, 2010, J EXP BIOL, V213, P2693, DOI 10.1242/jeb.043505; BERNAL J, 1995, EUR J ENDOCRINOL, V133, P390, DOI 10.1530/eje.0.1330390; Betts M.J., 2007, BIOINFORMATICS GENET, DOI [10.1002/9780470059180.ch13, DOI 10.1002/0470867302.CH14]; Birdsey GM, 2005, P ROY SOC B-BIOL SCI, V272, P833, DOI 10.1098/rspb.2004.3011; Caviedes-Vidal E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001425; Caviedes-Vidal E, 2007, P NATL ACAD SCI USA, V104, P19132, DOI 10.1073/pnas.0703159104; Charfeddine C, 2006, MOL GENET METAB, V88, P184, DOI 10.1016/j.ymgme.2006.02.006; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688]; Datzmann T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-165; Davies K T J, 2012, Heredity (Edinb), V108, P480, DOI 10.1038/hdy.2011.119; DIAMONDSTONE TI, 1966, ANAL BIOCHEM, V16, P395, DOI 10.1016/0003-2697(66)90220-X; DICKSON AJ, 1981, FEBS LETT, V127, P28, DOI 10.1016/0014-5793(81)80333-X; DOYLE JJ, 1992, SYST BOT, V17, P144, DOI 10.2307/2419070; Ebara S, 2008, BRIT J NUTR, V99, P503, DOI 10.1017/S0007114507812025; Fernstrom JD, 2007, J NUTR, V137, p1548S; Fernstrom JD, 2007, J NUTR, V137, p1539S; GOTTSBERGER G, 1984, PLANT SYST EVOL, V145, P55, DOI 10.1007/BF00984031; GRANNER DK, 1977, J BIOL CHEM, V252, P3891; HERBST LH, 1986, BIOTROPICA, V18, P39, DOI 10.2307/2388360; Holland B, 1992, MCCANCE WIDDOWSONS C; Huhn R, 1998, HUM GENET, V102, P305, DOI 10.1007/s004390050696; Kelm DH, 2011, P ROY SOC B-BIOL SCI, V278, P3490, DOI 10.1098/rspb.2011.0465; KORNER A, 1982, SCIENCE, V217, P1163, DOI 10.1126/science.6810464; Kunz TH, 2003, BAT ECOLOGY, P3; Li G, 2008, P NATL ACAD SCI USA, V105, P13959, DOI 10.1073/pnas.0802097105; Liu Y, 2012, MOL BIOL EVOL, V29, P1507, DOI 10.1093/molbev/mss013; Liu Y, 2012, MOL BIOL EVOL, V29, P1441, DOI 10.1093/molbev/msr310; Liu Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026618; Maydan G, 2006, J INHERIT METAB DIS, V29, P620, DOI 10.1007/s10545-006-0407-8; Mehere P, 2010, PROTEIN CELL, V1, P1023, DOI 10.1007/s13238-010-0128-5; Meissner T, 2008, PEDIATR DERMATOL, V25, P378, DOI 10.1111/j.1525-1470.2008.00687.x; Michelmore AJ, 1998, GEN COMP ENDOCR, V110, P319, DOI 10.1006/gcen.1998.7077; Minami-Hori M, 2006, J DERMATOL SCI, V41, P82, DOI 10.1016/j.jdermsci.2005.10.007; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; NATT E, 1987, HUM GENET, V77, P352, DOI 10.1007/BF00291426; NATT E, 1992, P NATL ACAD SCI USA, V89, P9297, DOI 10.1073/pnas.89.19.9297; Nei M., 2000, MOL EVOLUTION PHYLOG; Neuweiler G., 2000, BIOL BATS; NITSCH D, 1993, P NATL ACAD SCI USA, V90, P5479, DOI 10.1073/pnas.90.12.5479; Pan YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062039; Parker J, 2013, NATURE, V502, P228, DOI 10.1038/nature12511; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 2002, J MOL EVOL, V54, P396, DOI 10.1007/s00239-001-0034-9; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Protzek AOP, 2010, COMP BIOCHEM PHYS A, V157, P142, DOI 10.1016/j.cbpa.2010.05.016; RETTENMEIER R, 1990, NUCLEIC ACIDS RES, V18, P3853, DOI 10.1093/nar/18.13.3853; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Salway JG, 2004, METABOLISM GLANCE, P90; Shen B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062307; Shen B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033197; Shen B, 2011, J MOL EVOL, V73, P109, DOI 10.1007/s00239-011-9460-5; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; SHINOMIYA T, 1984, P NATL ACAD SCI-BIOL, V81, P1346, DOI 10.1073/pnas.81.5.1346; Shriner D, 2003, GENET RES, V81, P115, DOI 10.1017/S0016672303006128; Simmons N., 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Sivaraman S, 2006, FEBS J, V273, P1920, DOI 10.1111/j.1742-4658.2006.05202.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STELLWAGEN RH, 1992, J BIOL CHEM, V267, P23713; Suarez RK, 2009, COMP BIOCHEM PHYS A, V153, P136, DOI 10.1016/j.cbpa.2009.01.015; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tracy CR, 2007, J EXP BIOL, V210, P1726, DOI 10.1242/jeb.02766; Tsagkogeorga G, 2013, CURR BIOL, V23, P2262, DOI 10.1016/j.cub.2013.09.014; VANTONDER SV, 1975, BRIT J NUTR, V34, P397, DOI 10.1017/S0007114575000463; Voigt CC, 2007, FUNCT ECOL, V21, P913, DOI 10.1111/j.1365-2435.2007.01321.x; Voigt CC, 2008, OECOLOGIA, V157, P31, DOI 10.1007/s00442-008-1057-3; Voigt CC, 2011, BIOTROPICA, V43, P108, DOI 10.1111/j.1744-7429.2010.00632.x; Welch KC, 2008, J EXP BIOL, V211, P310, DOI 10.1242/jeb.012252; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2002, NAT GENET, V30, P411, DOI 10.1038/ng852; Zhou XM, 2012, SYST BIOL, V61, P150, DOI 10.1093/sysbio/syr089	77	2	4	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97483	10.1371/journal.pone.0097483	http://dx.doi.org/10.1371/journal.pone.0097483			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824435	Green Published, Green Submitted, gold			2022-12-27	WOS:000336369200122
J	Ball, CB; Rodriguez, KF; Stumpo, DJ; Ribeiro-Neto, F; Korach, KS; Blackshear, PJ; Birnbaumer, L; Ramos, SBV				Ball, Christopher B.; Rodriguez, Karina F.; Stumpo, Deborah J.; Ribeiro-Neto, Fernando; Korach, Kenneth S.; Blackshear, Perry J.; Birnbaumer, Lutz; Ramos, Silvia B. V.			The RNA-Binding Protein, ZFP36L2, Influences Ovulation and Oocyte Maturation	PLOS ONE			English	Article							LUTEINIZING-HORMONE RECEPTOR; HUMAN CHORIONIC-GONADOTROPIN; EARLY EMBRYONIC-DEVELOPMENT; MESSENGER-RIBONUCLEIC-ACID; OVARIAN FOLLICULAR-FLUID; TO-CELL COMMUNICATION; MEIOTIC ARREST; CYCLIC-AMP; IN-VITRO; GRAAFIAN-FOLLICLES	ZFP36L2 protein destabilizes AU-rich element-containing transcripts and has been implicated in female fertility. In the C57BL/6NTac mouse, a mutation in Zfp36l2 that results in the decreased expression of a form of ZFP36L2 in which the 29 N-terminal amino acid residues have been deleted, Delta N-ZFP36L2, leads to fertilized eggs that arrest at the two-cell stage. Interestingly, homozygous Delta N-Zfp36l2 females in the C57BL/6NTac strain release 40% fewer eggs than the WT littermates (Ramos et al., 2004), suggesting an additional defect in ovulation and/or oocyte maturation. Curiously, the same Delta N-Zfp36l2 mutation into the SV129 strain resulted in anovulation, prompting us to investigate a potential problem in ovulation and oocyte maturation. Remarkably, only 20% of Delta N-Zfp36l2 oocytes in the 129S6/SvEvTac strain matured ex vivo, suggesting a defect on the oocyte meiotic maturation process. Treatment of Delta N-Zfp36l2 oocytes with a PKA inhibitor partially rescued the meiotic arrested oocytes. Furthermore, cAMP levels were increased in Delta N-Zfp36l2 oocytes, linking the cAMP/PKA pathway and Delta N-Zfp36l2 with meiotic arrest. Since ovulation and oocyte maturation are both triggered by LHR signaling, the downstream pathway was investigated. Adenylyl cyclase activity was increased in Delta N-Zfp36l2 ovaries only upon LH stimulation. Moreover, we discovered that ZFP36L2 interacts with the 3'UTR of LHR mRNA and that decreased expression levels of Zfp36l2 correlates with higher levels of LHR mRNA in synchronized ovaries. Furthermore, overexpression of ZFP36L2 decreases the endogenous expression of LHR mRNA in a cell line. Therefore, we propose that lack of the physiological down regulation of LHR mRNA levels by ZFP36L2 in the ovaries is associated with anovulation and oocyte meiotic arrest.	[Ball, Christopher B.; Ramos, Silvia B. V.] Univ N Carolina, Sch Med, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Chapel Hill, NC 27515 USA; [Rodriguez, Karina F.; Korach, Kenneth S.] NIEHS, Lab Reprod & Dev Toxicol, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA; [Stumpo, Deborah J.; Ribeiro-Neto, Fernando; Blackshear, Perry J.] NIEHS, Lab Signal Transduct, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA; [Blackshear, Perry J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Blackshear, Perry J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Birnbaumer, Lutz] NIEHS, Neurobiol Lab, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Ramos, SBV (corresponding author), Univ N Carolina, Sch Med, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Chapel Hill, NC 27515 USA.	sramos@med.unc.edu	Blackshear, Perry J./C-6206-2019	Blackshear, Perry J./0000-0002-9561-8529; Korach, Kenneth/0000-0002-7765-418X	National Institutes of Health [K08 HD069597]; Institute for Biological Recognition and Catalysis, Inc.; UNC TraCS [550KR11128]; NIH, NIEHS [Z01-ES70065, Z01-ES090080-15, Z01-ES101643]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD069597] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101643, ZIAES070065, ZIAES090080, Z01ES101643, Z01ES070065, Z01ES090080] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Biological Recognition and Catalysis, Inc.; UNC TraCS; NIH, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Health Grant K08 HD069597 (to S. B. R.); Institute for Biological Recognition and Catalysis, Inc. (to S. B. R.), UNC TraCS grant # 550KR11128 (to S. B. R.) and by the Intramural Research Program of the NIH, NIEHS Z01-ES70065 (to K. S. K.), Z01-ES090080-15 (to P.J.B.) and Z01-ES101643 (to L. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSTERDAM A, 1975, J CELL BIOL, V67, P894, DOI 10.1083/jcb.67.3.894; BOCKAERT J, 1976, J BIOL CHEM, V251, P2653; BORNSLAEGER EA, 1986, DEV BIOL, V114, P453, DOI 10.1016/0012-1606(86)90209-5; Byers SL, 2006, THERIOGENOLOGY, V65, P1716, DOI 10.1016/j.theriogenology.2005.09.016; CHO WK, 1974, J EXP ZOOL, V187, P383, DOI 10.1002/jez.1401870307; Conti M, 2002, MOL CELL ENDOCRINOL, V187, P153, DOI 10.1016/S0303-7207(01)00686-4; DEKEL N, 1981, DEV BIOL, V86, P356, DOI 10.1016/0012-1606(81)90193-7; DEKEL N, 1978, P NATL ACAD SCI USA, V75, P4369, DOI 10.1073/pnas.75.9.4369; DOWNS SM, 1984, ENDOCRINOLOGY, V114, P418, DOI 10.1210/endo-114-2-418; Edry I, 2006, MOL CELL ENDOCRINOL, V252, P102, DOI 10.1016/j.mce.2006.03.009; EPPIG JJ, 1993, METHOD ENZYMOL, V225, P77; EPPIG JJ, 1985, BIOL REPROD, V33, P1041, DOI 10.1095/biolreprod33.5.1041; Ferrell JE, 1999, BIOESSAYS, V21, P833, DOI 10.1002/(SICI)1521-1878(199910)21:10<833::AID-BIES5>3.0.CO;2-P; FRASER LR, 1975, BIOL REPROD, V13, P513, DOI 10.1095/biolreprod13.5.513; GRANOT I, 1994, J BIOL CHEM, V269, P30502; Hodson DJ, 2010, NAT IMMUNOL, V11, P717, DOI 10.1038/ni.1901; HOFFMAN YM, 1991, ENDOCRINOLOGY, V128, P388, DOI 10.1210/endo-128-1-388; HSUEH AJW, 1984, ENDOCR REV, V5, P76, DOI 10.1210/edrv-5-1-76; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; LAPOLT PS, 1990, ENDOCRINOLOGY, V126, P3277, DOI 10.1210/endo-126-6-3277; Maclean KN, 1998, BRIT J BIOMED SCI, V55, P184; Masuda K, 2009, AGING-US, V1, P681, DOI 10.18632/aging.100073; Menon KMJ, 2007, MOL CELL ENDOCRINOL, V260, P109, DOI 10.1016/j.mce.2006.03.046; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; Nair AK, 2002, J BIOL CHEM, V277, P21468, DOI 10.1074/jbc.M111653200; NIE XF, 1995, GENE, V152, P285, DOI 10.1016/0378-1119(94)00696-P; OLSIEWSKI PJ, 1983, DEV BIOL, V100, P287, DOI 10.1016/0012-1606(83)90223-3; Pakarainen T, 2005, MOL ENDOCRINOL, V19, P2591, DOI 10.1210/me.2005-0075; PENG XR, 1991, ENDOCRINOLOGY, V129, P3200, DOI 10.1210/endo-129-6-3200; Pincus G, 1935, J EXP MED, V62, P665, DOI 10.1084/jem.62.5.665; Practice Committee of the American Society for Reproductive Medicine, 2006, Fertil Steril, V86, pS228; Puett D, 2005, ANN NY ACAD SCI, V1061, P41, DOI 10.1196/annals.1336.006; Ramos SBV, 2004, DEVELOPMENT, V131, P4883, DOI 10.1242/dev.01336; Ramos SBV, 2012, J BIOL CHEM, V287, P13116, DOI 10.1074/jbc.M111.330837; RICHARDS JS, 1994, ENDOCR REV, V15, P725, DOI 10.1210/er.15.6.725; Rodriguez KF, 2002, REPRODUCTION, V123, P799, DOI 10.1530/reprod/123.6.799; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; SCHROEDER AC, 1989, GAMETE RES, V24, P81, DOI 10.1002/mrd.1120240111; SCHULTZ RM, 1983, DEV BIOL, V97, P264, DOI 10.1016/0012-1606(83)90085-4; Stumpo DJ, 2009, BLOOD, V114, P2401, DOI 10.1182/blood-2009-04-214619; Treguer K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054550; TSAFRIRI A, 1976, ENDOCRINOLOGY, V98, P655, DOI 10.1210/endo-98-3-655; URNER F, 1983, ENDOCRINOLOGY, V113, P1170, DOI 10.1210/endo-113-3-1170; Vaccari S, 2008, DEV BIOL, V316, P124, DOI 10.1016/j.ydbio.2008.01.018; VARNUM BC, 1991, MOL CELL BIOL, V11, P1754, DOI 10.1128/MCB.11.3.1754; Zegers-Hochschild F, 2009, HUM REPROD, V24, P2683, DOI 10.1093/humrep/dep343; Zegers-Hochschild F, 2008, INFERTILITY INT ENCY, P576; Zhang LB, 2013, NATURE, V499, P92, DOI 10.1038/nature12215	48	25	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97324	10.1371/journal.pone.0097324	http://dx.doi.org/10.1371/journal.pone.0097324			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830504	Green Published, Green Submitted, gold			2022-12-27	WOS:000336789500049
J	Chen, JH; Chen, YC; Mao, CL; Chiou, JM; Tsao, CK; Tsai, KS				Chen, Jen-Hau; Chen, Yen-Ching; Mao, Chien-Lin; Chiou, Jeng-Min; Tsao, Chwen Keng; Tsai, Keh-Sung			Association between Secreted Phosphoprotein-1 (SPP1) Polymorphisms and Low Bone Mineral Density in Women	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; UNRELATED INDIVIDUALS; SEQUENCE VARIANTS; CELL-SURVIVAL; HIP FRACTURE; IN-VITRO; OSTEOPONTIN; OSTEOPOROSIS; RISK; MASS	Background: A recent meta-analysis found that secreted phosphoprotein-1 (SPP1) can predict the risk of both osteoporosis and fracture. No study has explored the association of SPP1 haplotype-tagging single nucleotide polymorphisms (htSNPs) and haplotypes with bone mineral density (BMD). Methods: This is a cross-sectional study. A total of 1,313 healthy Taiwanese women aged 40 to 55 years were recruited from MJ Health Management Institute from 2009 to 2010. BMD was dichotomized into high and low BMD groups. Three common (allele frequency >= 5%) htSNPs were selected to examine the association between sequence variants of SPP1 and BMD. Results: Homozygosity for the T allele of rs4754 were protective from low BMD [TT vs. CC: adjusted OR (AOR) = 0.58, 95% confidence interval (CI) = 0.83-0.89]. A protective effect was also found for women carrying 2 copies of Hap3 TCT (AOR = 0.57, 95% CI = 0.34-0.95). Menopausal status marginally interacted with SPP1 rs6839524 on BMD (p = 0.049). Postmenopausal women carrying variant rs6839524 (GG+GC vs. CC: AOR = 2.35, 95% CI = 1.06-5.20) or Hap1 TGC (AOR = 2.36, 95% CI = 1.06-5.24) were associated with 2.4-fold risk of low BMD. For women with low BMI (<18.5 kg/m(2)), variant rs6839524 (AOR = 7.64) and Hap1 (AOR = 6.42) were associated with increased risk of low BMD. These findings did not reach statistical significance after correction for multiple tests. Conclusions: SPP1 htSNP protected against low BMD in middle-aged women. SPP1 genetic markers may be important for the prediction of osteoporosis at an early age.	[Chen, Jen-Hau; Tsai, Keh-Sung] Natl Taiwan Univ Hosp, Dept Geriatr & Gerontol, Taipei, Taiwan; [Chen, Jen-Hau; Tsai, Keh-Sung] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Chen, Jen-Hau; Chen, Yen-Ching; Mao, Chien-Lin] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Chiou, Jeng-Min] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Tsao, Chwen Keng] MJ Hlth Management Inst, Taipei, Taiwan; [Tsai, Keh-Sung] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University Hospital	Tsai, KS (corresponding author), Natl Taiwan Univ Hosp, Dept Geriatr & Gerontol, Taipei, Taiwan.	kstsaimd1128@ntuh.gov.tw	Chen, Jen-Hau/AFP-2878-2022; Chiou, Jeng-Min/AAQ-3736-2021; Chen, Yen-Ching/D-1098-2010	Chen, Yen-Ching/0000-0002-8159-7202; TSAI, KEH-SUNG/0000-0001-8528-1566; Chiou, Jeng-Min/0000-0003-4554-9454	National Science Council [98-2314-B-002-081, 99-2314-B-002-128, 101-2118-M-001-011-MY3]	National Science Council(Ministry of Science and Technology, Taiwan)	Funding for the study was provided by National Science Council grants 98-2314-B-002-081, 99-2314-B-002-128, and 101-2118-M-001-011-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, NAT GENET, V29, P353; Barrett-Connor E, 2005, J BONE MINER RES, V20, P185, DOI 10.1359/JBMR.041007; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bidoli E, 1998, EUR J EPIDEMIOL, V14, P153, DOI 10.1023/A:1007496126098; Castro Jonathan P, 2005, Nutr Metab (Lond), V2, P9, DOI 10.1186/1743-7075-2-9; Chang IC, 2010, OSTEOPOROSIS INT, V21, P1401, DOI 10.1007/s00198-009-1107-7; Chen YC, 2005, CANCER RES, V65, P11771, DOI 10.1158/0008-5472.CAN-05-2078; Choi ST, 2008, RHEUMATOLOGY, V47, P1775, DOI 10.1093/rheumatology/ken385; Dawson-Hughes B, 2011, OSTEOPOROS INT; Denhardt D, 1993, FASEB J; Denhardt DT, 1998, J CELL BIOCHEM, P92, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<92::AID-JCB13>3.0.CO;2-A; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Feng Y, 2005, OSTEOPOROSIS INT, V16, P1917, DOI 10.1007/s00198-005-1962-9; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gravallese EM, 2003, J CLIN INVEST, V112, P147, DOI 10.1172/JCI200310109; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; Kanis JA, 2000, BONE, V27, P585, DOI 10.1016/S8756-3282(00)00381-1; Kawase T, 2007, BLOOD, V110, P1055, DOI 10.1182/blood-2007-02-075911; Kiel DP, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S14; Moore M, 1991, BIOCHEMISTRY; Morin S, 2009, OSTEOPOROSIS INT, V20, P363, DOI 10.1007/s00198-008-0688-x; Moyer RA, 2011, NEUROPSYCHOPHARMACOL, V36, P753, DOI 10.1038/npp.2010.208; Nock NL, 2011, INT J CANCER, V129, P956, DOI 10.1002/ijc.25722; O'Regan AW, 1999, J IMMUNOL, V162, P1024; REINHOLT FP, 1990, P NATL ACAD SCI USA, V87, P4473, DOI 10.1073/pnas.87.12.4473; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Richards JB, 2009, ANN INTERN MED, V151, P528, DOI 10.7326/0003-4819-151-8-200910200-00006; Rittling SR, 1998, J BONE MINER RES, V13, P1101, DOI 10.1359/jbmr.1998.13.7.1101; Saarelainen J, 2011, J BONE MINER METAB; Sanchez-Riera L, 2010, BEST PRACT RES CL RH, V24, P793, DOI 10.1016/j.berh.2010.10.003; SATOH Y, 1995, CALCIFIED TISSUE INT, V57, P258, DOI 10.1007/BF00298880; Sayed-Tabatabaei FA, 2005, STROKE, V36, P2351, DOI 10.1161/01.STR.0000185719.66735.dd; Standal T, 2004, EXP ONCOL, V26, P179; Stram DO, 2003, HUM HERED, V55, P179, DOI 10.1159/000073202; Styrkarsdottir U, 2009, NAT GENET, V41, P15, DOI 10.1038/ng.284; SUGIMOTO T, 1992, J BONE MINER RES, V7, P153; Taylor BC, 2005, HUM GENET, V116, P525, DOI 10.1007/s00439-005-1258-3; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P427, DOI 10.1007/s00198-006-0253-4; You YS, 2013, J BONE MINERAL RES; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986; Zohar R, 1998, EUR J ORAL SCI, V106, P401, DOI 10.1111/j.1600-0722.1998.tb02206.x	42	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97428	10.1371/journal.pone.0097428	http://dx.doi.org/10.1371/journal.pone.0097428			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831687	gold, Green Submitted, Green Published			2022-12-27	WOS:000336789500058
J	Corzo-Leon, DE; Alvarado-Matute, T; Colombo, AL; Cornejo-Juarez, P; Cortes, J; Echevarria, JI; Guzman-Blanco, M; Macias, AE; Nucci, M; Ostrosky-Zeichner, L; Ponce-de-Leon, A; Queiroz-Telles, F; Santolaya, ME; Thompson-Moya, L; Tiraboschi, IN; Zurita, J; Sifuentes-Osornio, J				Corzo-Leon, Dora E.; Alvarado-Matute, Tito; Colombo, Arnaldo L.; Cornejo-Juarez, Patricia; Cortes, Jorge; Echevarria, Juan I.; Guzman-Blanco, Manuel; Macias, Alejandro E.; Nucci, Marcio; Ostrosky-Zeichner, Luis; Ponce-de-Leon, Alfredo; Queiroz-Telles, Flavio; Santolaya, Maria E.; Thompson-Moya, Luis; Tiraboschi, Iris N.; Zurita, Jeannete; Sifuentes-Osornio, Jose			Surveillance of Candida spp Bloodstream Infections: Epidemiological Trends and Risk Factors of Death in Two Mexican Tertiary Care Hospitals	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; INTENSIVE-CARE; INVASIVE CANDIDIASIS; ANTIFUNGAL THERAPY; FUNGAL-INFECTIONS; DISEASES SOCIETY; 2009 UPDATE; FLUCONAZOLE; MANAGEMENT; MORTALITY	Introduction: Larger populations at risk, broader use of antibiotics and longer hospital stays have impacted on the incidence of Candida sp. bloodstream infections (CBSI). Objective: To determine clinical and epidemiologic characteristics of patients with CBSI in two tertiary care reference medical institutions in Mexico City. Design: Prospective and observational laboratory-based surveillance study conducted from 07/2008 to 06/2010. Methods: All patients with CBSI were included. Identification and antifungal susceptibility were performed using CLSI M27-A3 standard procedures. Frequencies, Mann-Whitney U test or T test were used as needed. Risk factors were determined with multivariable analysis and binary logistic regression analysis. Results: CBSI represented 3.8% of nosocomial bloodstream infections. Cumulative incidence was 2.8 per 1000 discharges (incidence rate: 0.38 per 1000 patient-days). C. albicans was the predominant species (46%), followed by C. tropicalis (26%). C. glabrata was isolated from patients with diabetes (50%), and elderly patients. Sixty-four patients (86%) received antifungals. Amphotericin-B deoxycholate (AmBD) was the most commonly used agent (66%). Overall mortality rate reached 46%, and risk factors for death were APACHE II score >= 16 (OR = 6.94, CI95% = 2.34-20.58, p<0.0001), and liver disease (OR = 186.11, CI95% = 7.61-4550.20, p = 0.001). Full susceptibility to fluconazole, AmBD and echinocandins among C. albicans, C. tropicalis, and C. parapsilosis was observed. Conclusions: The cumulative incidence rate in these centers was higher than other reports from tertiary care hospitals from Latin America. Knowledge of local epidemiologic patterns permits the design of more specific strategies for prevention and preemptive therapy of CBSI.	[Corzo-Leon, Dora E.; Macias, Alejandro E.; Ponce-de-Leon, Alfredo; Sifuentes-Osornio, Jose] Salvador Zubiran Natl Inst Med Sci & Nutr, Dept Med, Mexico City, DF, Mexico; [Alvarado-Matute, Tito] Hosp Escuela Tegucigalpa, Tegucigalpa, Honduras; [Colombo, Arnaldo L.] Univ Fed Sao Paulo, Escola Paulista Med, Div Infect Dis, Sao Paulo, Brazil; [Cornejo-Juarez, Patricia] Natl Canc Inst, Div Infect Dis, Mexico City, DF, Mexico; [Cortes, Jorge] Univ Nacl Colombia, Dept Internal Med, Bogota, Colombia; [Echevarria, Juan I.] Univ Peruana Cayetano Heredia, Dept Med, Lima, Peru; [Guzman-Blanco, Manuel] Hosp Vargas Caracas, Caracas, Venezuela; [Guzman-Blanco, Manuel] Ctr Med Caracas, Caracas, Venezuela; [Nucci, Marcio] Univ Fed Rio de Janeiro, Univ Hosp, Rio De Janeiro, Brazil; [Ostrosky-Zeichner, Luis] Univ Texas Med Sch Houston, Mem Hermann Texas Med Ctr, Dept Med, Houston, TX USA; [Queiroz-Telles, Flavio] Univ Fed Parana, Hosp Clin, BR-80060000 Curitiba, Parana, Brazil; [Santolaya, Maria E.] Univ Chile, Fac Med, Hosp Luis Calvo Mackenna, Dept Pediat, Santiago 7, Chile; [Thompson-Moya, Luis] Univ Desarrollo, Clin Alemana, Dept Med, Santiago, Chile; [Tiraboschi, Iris N.] Hosp Clin Jose San Martin, Infect Dis Unit, Buenos Aires, DF, Argentina; [Zurita, Jeannete] Pontificia Univ Catolica Ecuador, Fac Med, Hosp Vozandes, Quito, Ecuador	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidade Federal de Sao Paulo (UNIFESP); Universidad Nacional de Colombia; Universidad Peruana Cayetano Heredia; Universidade Federal do Rio de Janeiro; University of Texas System; University of Texas Health Science Center Houston; Universidade Federal do Parana; Universidad de Chile; Clinica Alemana; Universidad del Desarrollo; University of Buenos Aires; Hospital de Clinicas Jose de San Martin; Pontificia Universidad Catolica del Ecuador	Sifuentes-Osornio, J (corresponding author), Salvador Zubiran Natl Inst Med Sci & Nutr, Dept Med, Mexico City, DF, Mexico.	jose.sifuenteso@innsz.mx	Colombo, Arnaldo Lopes/H-4397-2012; Colombo, Arnaldo Lopes/V-4417-2019; Macías, Alejandro Molina/HHS-2363-2022; Corzo-Leon, Dora/AAA-6114-2019; Nucci, Marcio/G-4515-2012	Colombo, Arnaldo Lopes/0000-0003-0793-8491; Corzo-Leon, Dora/0000-0003-4012-1045; Ponce-de-Leon, Alfredo/0000-0003-2640-2916; ostrosky-zeichner, luis/0000-0002-4784-7589; Cortes, Jorge/0000-0002-0882-9652; Sifuentes-Osornio, Jose/0000-0001-9584-1360; Macias, Alejandro/0000-0002-6573-4350; Nucci, Marcio/0000-0003-4867-0014	Pfizer Inc. [INF-168]	Pfizer Inc.(Pfizer)	This study was fully supported by Pfizer Inc. (institutional grant number INF-168). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala-Gaytan Juan Jacobo, 2010, Rev Med Inst Mex Seguro Soc, V48, P145; Bassetti M, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-21; Chow JK, 2008, CLIN INFECT DIS, V46, P1206, DOI 10.1086/529435; CLSI, 2008, M27A3 CLSI; Colombo AL, 2007, INFECT CONT HOSP EP, V28, P570, DOI 10.1086/513615; Colombo AL, 2006, J CLIN MICROBIOL, V44, P2816, DOI 10.1128/JCM.00773-06; Dimopoulos G, 2007, EUR J CLIN MICROBIOL, V26, P377, DOI 10.1007/s10096-007-0316-2; Faiz S, 2009, EUR J CLIN MICROBIOL, V28, P689, DOI 10.1007/s10096-008-0666-4; Garey KW, 2006, CLIN INFECT DIS, V43, P25, DOI 10.1086/504810; Gonzalez GM, 2008, J CLIN MICROBIOL, V46, P2902, DOI 10.1128/JCM.00937-08; Horn DL, 2009, CLIN INFECT DIS, V48, P1695, DOI 10.1086/599039; Leroy O, 2009, CRIT CARE MED, V37, P1612, DOI 10.1097/CCM.0b013e31819efac0; Lipsett PA, 2006, CRIT CARE MED, V34, pS215, DOI 10.1097/01.CCM.0000231883.93001.E0; Lortholary O, 2011, ANTIMICROB AGENTS CH, V55, P532, DOI 10.1128/AAC.01128-10; Macias AE, 2010, AM J INFECT CONTROL, V38, P217, DOI 10.1016/j.ajic.2009.08.015; Marchetti O, 2004, CLIN INFECT DIS, V38, P311, DOI 10.1086/380637; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Mikulska M, 2012, INFECTION, V40, P271, DOI 10.1007/s15010-011-0229-y; Mikulska M, 2009, BIOL BLOOD MARROW TR, V15, P47, DOI 10.1016/j.bbmt.2008.10.024; Nucci M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059373; Nucci M, 2010, CLIN INFECT DIS, V51, P561, DOI 10.1086/655683; Ostrosky-Zeichner L, 2006, CRIT CARE MED, V34, P857, DOI 10.1097/01.CCM.0000201897.78123.44; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Pappas PG, 2003, CLIN INFECT DIS, V37, P634, DOI 10.1086/376906; Patel GP, 2009, AM J THER, V16, P508, DOI 10.1097/MJT.0b013e3181a1afb7; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller MA, 2012, J CLIN MICROBIOL, V50, P2846, DOI 10.1128/JCM.00937-12; Pfaller MA, 2010, J CLIN MICROBIOL, V48, P1366, DOI 10.1128/JCM.02117-09; Pfaller MA, 2001, J CLIN MICROBIOL, V39, P3254, DOI 10.1128/JCM.39.9.3254-3259.2001; Raad I, 2004, CLIN INFECT DIS, V38, P1119, DOI 10.1086/382874; Shorr AF, 2007, CRIT CARE MED, V35, P1077, DOI 10.1097/01.CCM.0000259379.97694.00; VOLKOW P, 1994, CLIN INFECT DIS, V18, P719, DOI 10.1093/clinids/18.5.719; Wenzel RP, 2005, CLIN INFECT DIS, V41, pS389, DOI 10.1086/430923; Zaas AK, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2006.02.029	34	20	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97325	10.1371/journal.pone.0097325	http://dx.doi.org/10.1371/journal.pone.0097325			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830654	Green Published, Green Submitted, gold			2022-12-27	WOS:000336789500050
J	Lee, FJ; Amin, J; Carr, A				Lee, Frederick J.; Amin, Janaki; Carr, Andrew			Efficacy of Initial Antiretroviral Therapy for HIV-1 Infection in Adults: A Systematic Review and Meta-Analysis of 114 Studies with up to 144 Weeks' Follow-Up	PLOS ONE			English	Review							HYPERSENSITIVITY REACTIONS; SAFETY; NAIVE; EFAVIRENZ; COMBINATION; ATAZANAVIR; LAMIVUDINE; TENOFOVIR/EMTRICITABINE; ABACAVIR/LAMIVUDINE; EMTRICITABINE	Background: A comprehensive assessment of initial HIV-1 treatment success may inform study design and treatment guidelines. Methods: Group-based, systematic review and meta-analysis of initial antiretroviral therapy studies, in adults, of >= 48 weeks duration, reported through December 31, 2012. Size-weighted, intention-to-treat efficacy was calculated. Parameters of study design/eligibility, participant and treatment characteristics were abstracted. Multivariable, random effects, linear regression models with backwards, stepwise selection were then used to identify variables associated with efficacy. Outcome Measures: Antiviral efficacy (undetectable plasma viral load) and premature cessation of therapy. Results: 114 studies were included (216 treatment groups; 40,124 participants; mean CD4 count 248 cells/mu L [SD 81]; mean HIV-1 plasma viral load log(10) 4.9 [SD 0.2]). Mean efficacy across all groups was 60% (SD 16) over a mean 82 weeks' follow-up (SD 38). Efficacy declined over time: 66% (SD 16) at 48 weeks, 60% (SD 16) at 96 weeks, 52% (SD 18) at 144 weeks. The most common reason for treatment cessation was participant decision (11%, SD 6.6). Efficacy was higher with 'Preferred' than 'Alternative' regimens (as defined by 2013 United States antiretroviral guidelines): 75% vs. 65%, respectively, difference 10%; 95% CI 7.6 to 15.4; p<0.001. In 98 groups (45%) reporting efficacy stratified by pre-treatment viral load (< or >= 100,000 copies/mL), efficacy was greater for the lower stratum (70% vs. 62%, respectively, difference 8.4%; 95% CI 6.0 to 10.9; p<0.001). This difference persisted within 'Preferred' regimens. Greatest efficacy was associated with use of tenofovir-emtricitabine (vs. other nucleoside analogue backbones) and integrase strand transfer inhibitors (vs. other third drug classes). Conclusion: Initial antiretroviral treatments for HIV-1 to date appear to have suboptimal long-term efficacy, but are more effective when commenced at plasma viral loads <100,000 copies/mL. Rising viral load should be considered an indication for starting treatment. Integrase inhibitors offer a treatment advantage (vs. other third drug classes).	[Lee, Frederick J.; Carr, Andrew] St Vincents Ctr Appl Med Res, Clin Res Program, Sydney, NSW, Australia; [Amin, Janaki] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Carr, Andrew] St Vincents Hosp, HIV Immunol & Infect Dis Unit, Sydney, NSW 2010, Australia	University of New South Wales Sydney; Kirby Institute; St Vincents Hospital Sydney	Lee, FJ (corresponding author), St Vincents Ctr Appl Med Res, Clin Res Program, Sydney, NSW, Australia.	flee3@stvincents.com.au		Amin, Janaki/0000-0003-2161-9366	National Health and Medical Research Council of Australia [1017991]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Frederick J. Lee currently receives research funding from the National Health and Medical Research Council of Australia (Grant Number 1017991), which supported this work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abgrall S, 2013, AIDS, V27, P803, DOI 10.1097/QAD.0b013e32835cb997; [Anonymous], 2012, EUR AIDS CLIN SOC EA; Australasian Society for HIV Medicine, 2013, AUSTR COMM US DEP HL; Bansi L, 2009, J INFECT DIS, V200, P710, DOI 10.1086/605024; Bartlett JA, 2006, AIDS, V20, P2051, DOI 10.1097/01.aids.0000247578.08449.ff; Campbell TB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001290; Carr A, 2009, AIDS, V23, P343, DOI 10.1097/QAD.0b013e32831db232; CHANG CN, 1992, J BIOL CHEM, V267, P13938; Cohen CJ, 2012, JAIDS-J ACQ IMM DEF, V60, P33, DOI 10.1097/QAI.0b013e31824d006e; Department of Health and Human Services (DHHS) Panel on Antiretroviral Guidelines for Adults and Adolescents, 2012, GUIDELINES USE ANTIR; Department of Health and Human Services (DHHS) Panel on Antiretroviral Guidelines for Adults and Adolescents, 2013, REC INT INH US ANT T; Department of Health and Human Services (DHHS) Panel on Antiretroviral Guidelines for Adults and Adolescents, 2007, GUIDELINES USE ANTIR; Department of Health and Human Services (DHHS) Panel on Antiretroviral Guidelines for Adults and Adolescents, 2006, GUIDELINES USE ANTIR; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Gotuzzo E, 2012, JAIDS-J ACQ IMM DEF, V61, P73, DOI 10.1097/QAI.0b013e318263277e; Havlir DV, 2004, CLIN INFECT DIS, V38, P1599, DOI 10.1086/420932; Hetherington S, 2002, LANCET, V359, P1121, DOI 10.1016/S0140-6736(02)08158-8; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jansson J, 2013, AIDS, V27, P1245, DOI 10.1097/QAD.0b013e32835e163d; Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X; Mbuagbaw LCE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004246.pub3; Messiaen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052562; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; PAFF MT, 1994, ANTIMICROB AGENTS CH, V38, P1230, DOI 10.1128/AAC.38.6.1230; Perez-Molina JA, 2012, J ANTIMICROB CHEMOTH, V67, P312, DOI 10.1093/jac/dkr478; Post FA, 2010, JAIDS-J ACQ IMM DEF, V55, P49, DOI 10.1097/QAI.0b013e3181dd911e; Qaqish R, 2010, J INT AIDS SOC S4, V13, P58; Rockstroh JK, 2013, JAIDS-J ACQ IMM DEF, V63, P77, DOI 10.1097/QAI.0b013e31828ace69; Sax PE, 2009, NEW ENGL J MED, V361, P2230, DOI 10.1056/NEJMoa0906768; Squires K, 2004, JAIDS-J ACQ IMM DEF, V36, P1011, DOI 10.1097/00126334-200408150-00003; Squires KE, 2010, HIV CLIN TRIALS, V11, P69, DOI 10.1310/hct1102-69; Stellbrink HJ, 2013, AIDS, V27, P1771, DOI 10.1097/QAD.0b013e3283612419; Stephan C, 2013, HIV MED, V14, P284, DOI 10.1111/hiv.12004; Symonds W, 2002, CLIN THER, V24, P565, DOI 10.1016/S0149-2918(02)85132-3; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Wang LH, 2004, AIDS RES HUM RETROV, V20, P1173, DOI 10.1089/aid.2004.20.1173; World Health Organization, 2013, CONSOLIDATED GUIDELI; World Health Organization, 2012, TECHN UPD TREATM OPT; Yuen GJ, 2004, ANTIMICROB AGENTS CH, V48, P176, DOI 10.1128/AAC.48.1.176-182.2004	39	64	65	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97482	10.1371/journal.pone.0097482	http://dx.doi.org/10.1371/journal.pone.0097482			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830290	Green Published, Green Submitted, gold			2022-12-27	WOS:000336789500065
J	Menezes, K; Nascimento, MA; Goncalves, JP; Cruz, AS; Lopes, DV; Curzio, B; Bonamino, M; de Menezes, JRL; Borojevic, R; Rossi, MID; Coelho-Sampaio, T				Menezes, Karla; Nascimento, Marcos Assis; Goncalves, Juliana Pena; Cruz, Aline Silva; Lopes, Daiana Vieira; Curzio, Bianca; Bonamino, Martin; Lacerda de Menezes, Joao Ricardo; Borojevic, Radovan; Doria Rossi, Maria Isabel; Coelho-Sampaio, Tatiana			Human Mesenchymal Cells from Adipose Tissue Deposit Laminin and Promote Regeneration of Injured Spinal Cord in Rats	PLOS ONE			English	Article							HUMAN BONE-MARROW; STEM-CELLS; FUNCTIONAL RECOVERY; STROMAL CELLS; TRANSPLANTATION; PRECURSOR; BRAIN; GENE; COMBINATION; ACTIVATION	Cell therapy is a promising strategy to pursue the unmet need for treatment of spinal cord injury (SCI). Although several studies have shown that adult mesenchymal cells contribute to improve the outcomes of SCI, a descripton of the pro-regenerative events triggered by these cells is still lacking. Here we investigated the regenerative properties of human adipose tissue derived stromal cells (hADSCs) in a rat model of spinal cord compression. Cells were delivered directly into the spinal parenchyma immediately after injury. Human ADSCs promoted functional recovery, tissue preservation, and axonal regeneration. Analysis of the cord tissue showed an abundant deposition of laminin of human origin at the lesion site and spinal midline; the appearance of cell clusters composed of neural precursors in the areas of laminin deposition, and the appearance of blood vessels with separated basement membranes along the spinal axis. These effects were also observed after injection of hADSCs into non-injured spinal cord. Considering that laminin is a well-known inducer of axonal growth, as well a component of the extracellular matrix associated to neural progenitors, we propose that it can be the paracrine factor mediating the pro-regenerative effects of hADSCs in spinal cord injury.	[Menezes, Karla; Cruz, Aline Silva; Lopes, Daiana Vieira; Lacerda de Menezes, Joao Ricardo; Doria Rossi, Maria Isabel; Coelho-Sampaio, Tatiana] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil; [Nascimento, Marcos Assis; Goncalves, Juliana Pena] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil; [Curzio, Bianca; Bonamino, Martin] Natl Canc Inst, Rio De Janeiro, Brazil; [Borojevic, Radovan] Excellion, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; National Cancer Institute (Inca)	Coelho-Sampaio, T (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.	tcsampaio@histo.ufrj.br	Rossi, Maria Isabel D/J-4802-2012; Borojevic, Radovan/V-8500-2019; Menezes, João R. L./D-5668-2012	Rossi, Maria Isabel D/0000-0003-3432-8453; Borojevic, Radovan/0000-0002-2393-7280; Assis Nascimento, Marcos/0000-0002-9830-9801; Vieira Lopes Alves, Daiana/0000-0002-1936-1952	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ). KM and JPG are recipients of fellowships from CNPq, and MAN and DVL received fellowships from Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES) and FAPERJ, respectively. ASC received an undergraduate fellowship from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Alfaro-Cervello C, 2012, J COMP NEUROL, V520, P3528, DOI 10.1002/cne.23104; Ankeny DP, 2004, EXP NEUROL, V190, P17, DOI 10.1016/J.expneurol.2004.05.045; Arboleda D, 2011, CELL MOL NEUROBIOL, V31, P1113, DOI 10.1007/s10571-011-9712-3; Baptista L. S., 2007, J STEM CELLS, P73; Baptista LS, 2009, OBES SURG, V19, P1304, DOI 10.1007/s11695-009-9899-2; Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Belvindrah R, 2007, J NEUROSCI, V27, P2704, DOI 10.1523/JNEUROSCI.2991-06.2007; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Bonamino M, 2004, GENE THER, V11, P85, DOI 10.1038/sj.gt.3302141; Bradbury EJ, 2002, EXP NEUROL, V235, P1; Burns AS, 2012, J SPINAL CORD MED, V35, P3, DOI 10.1179/2045772311Y.0000000043; Busch SA, 2011, J NEUROSCI, V31, P944, DOI 10.1523/JNEUROSCI.3566-10.2011; Carlson KB, 2011, GLIA, V59, P267, DOI 10.1002/glia.21099; Castelo-Branco MTL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033360; Chen X, 2003, INVEST OPHTH VIS SCI, V44, P2834, DOI 10.1167/iovs.02-1333; Chopp M, 2000, NEUROREPORT, V11, P3001, DOI 10.1097/00001756-200009110-00035; Cizkova D, 2006, CELL MOL NEUROBIOL, V26, P1167, DOI 10.1007/s10571-006-9093-1; DeVivo MJ, 2012, SPINAL CORD, V50, P365, DOI 10.1038/sc.2011.178; Fuhrmann T, 2010, NEUROSCI LETT, V474, P37, DOI 10.1016/j.neulet.2010.03.002; Fukada S, 2008, EXP CELL RES, V314, P193, DOI 10.1016/j.yexcr.2007.09.020; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; HAMANN GF, 1995, STROKE, V26, P2120, DOI 10.1161/01.STR.26.11.2120; Hatami M, 2009, CYTOTHERAPY, V11, P618, DOI 10.1080/14653240903005802; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Ideguchi M, 2010, J NEUROSCI, V30, P894, DOI 10.1523/JNEUROSCI.4318-09.2010; Kan I, 2011, STEM CELL REV REP, V7, P404, DOI 10.1007/s12015-010-9190-x; Kazanis I, 2010, J NEUROSCI, V30, P9771, DOI 10.1523/JNEUROSCI.0700-10.2010; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004; Krueger M, 2010, GLIA, V58, P1, DOI 10.1002/glia.20898; Lathia JD, 2007, J COMP NEUROL, V505, P630, DOI 10.1002/cne.21520; Le Blanc K, 2012, NAT REV IMMUNOL, V12, P383, DOI 10.1038/nri3209; Lebkowski Jane, 2011, Regen Med, V6, P11, DOI 10.2217/rme.11.77; Lima LG, 2011, THROMB HAEMOSTASIS, V106, P712, DOI 10.1160/TH11-03-0143; Loulier K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000176; McDonald JW, 2002, PROG BRAIN RES, V137, P299; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; MENEZES JRL, 1994, J NEUROSCI, V14, P5399; Menezes K, 2010, FASEB J, V24, P4513, DOI 10.1096/fj.10-157628; Mercier F, 2002, J COMP NEUROL, V451, P170, DOI 10.1002/cne.10342; Mercier F, 2011, NEUROGENESIS IN THE ADULT BRAIN I: NEUROBIOLOGY, P109, DOI 10.1007/978-4-431-53933-9_4; Nakajima H, 2012, J NEUROTRAUM, V29, P1614, DOI 10.1089/neu.2011.2109; Nakanishi C, 2011, CIRC J, V75, P2260, DOI 10.1253/circj.CJ-11-0246; Oh JS, 2011, CELL TRANSPLANT, V20, P837, DOI 10.3727/096368910X539083; Osaka M, 2010, BRAIN RES, V1343, P226, DOI 10.1016/j.brainres.2010.05.011; Pal R, 2010, CYTOTHERAPY, V12, P792, DOI 10.3109/14653249.2010.487899; Park HW, 2010, GLIA, V58, P1118, DOI 10.1002/glia.20992; Park SS, 2012, CYTOTHERAPY, V14, P584, DOI 10.3109/14653249.2012.658913; Paul G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035577; Pedram MS, 2010, SPINAL CORD, V48, P457, DOI 10.1038/sc.2009.153; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Ruff CA, 2012, EXP NEUROL, V235, P78, DOI 10.1016/j.expneurol.2011.02.010; Scuteri A, 2011, CURR STEM CELL RES T, V6, P82, DOI 10.2174/157488811795495486; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Siler U, 2000, BLOOD, V96, P4194; Sixt M, 2001, J CELL BIOL, V153, P933, DOI 10.1083/jcb.153.5.933; Steffenhagen C, 2012, STEM CELLS DEV, V21, P1838, DOI 10.1089/scd.2011.0137; Stratman AN, 2012, MICROSC MICROANAL, V18, P68, DOI 10.1017/S1431927611012402; Takigawa T, 2010, J NEUROTRAUM, V27, P739, DOI 10.1089/neu.2009.1111; Wright KT, 2011, STEM CELLS, V29, P169, DOI 10.1002/stem.570; Wyatt TJ, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/207230; Zhang W, 2010, BRAIN RES, V1359, P256, DOI 10.1016/j.brainres.2010.08.072; Zhou ZL, 2013, CYTOTHERAPY, V15, P434, DOI 10.1016/j.jcyt.2012.11.015; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859; Zurita M, 2008, TRANSPLANTATION, V86, P845, DOI 10.1097/TP.0b013e318186198f	68	44	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e96020	10.1371/journal.pone.0096020	http://dx.doi.org/10.1371/journal.pone.0096020			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830794	Green Submitted, gold, Green Published			2022-12-27	WOS:000336789500013
J	Smith, MW; Ghindilis, AL; Seoudi, IA; Smith, K; Billharz, R; Simon, HM				Smith, Maria W.; Ghindilis, Andrei L.; Seoudi, Ihab A.; Smith, Kenneth; Billharz, Rosalind; Simon, Holly M.			A New Restriction Endonuclease-Based Method for Highly-Specific Detection of DNA Targets from Methicillin-Resistant Staphylococcus aureus	PLOS ONE			English	Article							TIME PCR ASSAY; UNITED-STATES; ELECTROCHEMICAL DETECTION; RAPID DETECTION; MRSA DETECTION; IDENTIFICATION; INFECTIONS; HYBRIDIZATION; RECOGNITION; DIAGNOSTICS	PCR multiplexing has proven to be challenging, and thus has provided limited means for pathogen genotyping. We developed a new approach for analysis of PCR amplicons based on restriction endonuclease digestion. The first stage of the restriction enzyme assay is hybridization of a target DNA to immobilized complementary oligonucleotide probes that carry a molecular marker, horseradish peroxidase (HRP). At the second stage, a target-specific restriction enzyme is added, cleaving the target-probe duplex at the corresponding restriction site and releasing the HRP marker into solution, where it is quantified colorimetrically. The assay was tested for detection of the methicillin-resistant Staphylococcus aureus (MRSA) pathogen, using the mecA gene as a target. Calibration curves indicated that the limit of detection for both target oligonucleotide and PCR amplicon was approximately 1 nM. Sequences of target oligonucleotides were altered to demonstrate that (i) any mutation of the restriction site reduced the signal to zero; (ii) double and triple point mutations of sequences flanking the restriction site reduced restriction to 50-80% of the positive control; and (iii) a minimum of a 16-bp target-probe dsDNA hybrid was required for significant cleavage. Further experiments showed that the assay could detect the mecA amplicon from an unpurified PCR mixture with detection limits similar to those with standard fluorescence-based qPCR. Furthermore, addition of a large excess of heterologous genomic DNA did not affect amplicon detection. Specificity of the assay is very high because it involves two biorecognition steps. The proposed assay is low-cost and can be completed in less than 1 hour. Thus, we have demonstrated an efficient new approach for pathogen detection and amplicon genotyping in conjunction with various end-point and qPCR applications. The restriction enzyme assay may also be used for parallel analysis of multiple different amplicons from the same unpurified mixture in broad-range PCR applications.	[Smith, Maria W.; Simon, Holly M.] Oregon Hlth & Sci Univ, Ctr Coastal Margin Observat & Predict, Portland, OR 97201 USA; [Smith, Maria W.; Simon, Holly M.] Oregon Hlth & Sci Univ, Inst Environm Hlth, Portland, OR 97201 USA; [Smith, Maria W.; Ghindilis, Andrei L.; Smith, Kenneth] Cascade Biosyst Inc, Colfax, WI USA; [Seoudi, Ihab A.] Hamad Med Corp, Doha, Qatar; [Billharz, Rosalind] Pacific Lutheran Univ, Dept Biol, Tacoma, WA 98447 USA	Oregon Health & Science University; Oregon Health & Science University; Hamad Medical Corporation; Pacific Lutheran University	Smith, MW (corresponding author), Oregon Hlth & Sci Univ, Ctr Coastal Margin Observat & Predict, Portland, OR 97201 USA.	mariyasmit@hotmail.com	Ghindilis, Andrey/AAT-6810-2021	Gindilis, Andrei/0000-0002-1931-6422; Smit, Mariya/0000-0001-7458-4545	Qatar National Research Fund (a member of the Qatar Foundation) [NPRP 5-593-3-149]; National Science Foundation [OCE 0424602]	Qatar National Research Fund (a member of the Qatar Foundation); National Science Foundation(National Science Foundation (NSF))	This publication was made possible by NPRP 5-593-3-149 grant from the Qatar National Research Fund (a member of the Qatar Foundation. The statements made herein are solely the responsibility of the authors. Support was provided by the National Science Foundation, grant OCE 0424602. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barken KB, 2007, CLIN CHIM ACTA, V384, P1, DOI 10.1016/j.cca.2007.07.004; Becker K, 2013, J CLIN MICROBIOL, V51, P1917, DOI 10.1128/JCM.00075-13; Bekkaoui F, 1999, DIAGN MICR INFEC DIS, V34, P83, DOI 10.1016/S0732-8893(99)00012-7; Desjardins M, 2006, J CLIN MICROBIOL, V44, P1219, DOI 10.1128/JCM.44.4.1219-1223.2006; Dill K, 2004, BIOSENS BIOELECTRON, V20, P736, DOI 10.1016/j.bios.2004.06.049; Evertsson U, 2000, APMIS, V108, P385, DOI 10.1034/j.1600-0463.2000.d01-73.x; Ghindilis AL, 2007, BIOSENS BIOELECTRON, V22, P1853, DOI 10.1016/j.bios.2006.06.024; Hanssen AM, 2006, FEMS IMMUNOL MED MIC, V46, P8, DOI 10.1111/j.1574-695X.2005.00009.x; Hardy K, 2010, CLIN MICROBIOL INFEC, V16, P333, DOI 10.1111/j.1469-0691.2009.02899.x; Highlander SK, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-99; Huletsky A, 2004, J CLIN MICROBIOL, V42, P1875, DOI 10.1128/JCM.42.5.1875-1884.2004; HUSS VAR, 1983, SYST APPL MICROBIOL, V4, P184, DOI 10.1016/S0723-2020(83)80048-4; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P3677; Jen-Jacobson Linda, 1997, Biopolymers, V44, P153, DOI 10.1002/(SICI)1097-0282(1997)44:2<153::AID-BIP4>3.0.CO;2-U; Jonas D, 2002, J CLIN MICROBIOL, V40, P1821, DOI 10.1128/JCM.40.5.1821-1823.2002; Kelley K, 2013, J CLIN MICROBIOL, V51, P2033, DOI 10.1128/JCM.00196-13; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lazcka O, 2007, BIOSENS BIOELECTRON, V22, P1205, DOI 10.1016/j.bios.2006.06.036; LESSER DR, 1990, SCIENCE, V250, P776, DOI 10.1126/science.2237428; Levi K, 2003, J CLIN MICROBIOL, V41, P3890, DOI 10.1128/JCM.41.8.3890-3892.2003; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; McDonald RR, 2005, J CLIN MICROBIOL, V43, P6147, DOI 10.1128/JCM.43.12.6147-6149.2005; Noskin GA, 2005, ARCH INTERN MED, V165, P1756, DOI 10.1001/archinte.165.15.1756; Pingoud A, 1997, EUR J BIOCHEM, V246, P1, DOI 10.1111/j.1432-1033.1997.t01-6-00001.x; Soge OO, 2009, J ANTIMICROB CHEMOTH, V64, P1148, DOI 10.1093/jac/dkp368; van Hal SJ, 2007, J CLIN MICROBIOL, V45, P2486, DOI 10.1128/JCM.00139-07; Wolk D, 2001, INFECT DIS CLIN N AM, V15, P1157, DOI 10.1016/S0891-5520(05)70190-2; Yang S, 2004, LANCET INFECT DIS, V4, P337, DOI 10.1016/S1473-3099(04)01044-8	31	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97826	10.1371/journal.pone.0097826	http://dx.doi.org/10.1371/journal.pone.0097826			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831802	gold, Green Submitted, Green Published			2022-12-27	WOS:000336789500121
J	Tai, TS; Pai, SY; Ho, IC				Tai, Tzong-Shyuan; Pai, Sung-Yun; Ho, I-Cheng			Itm2a, a Target Gene of GATA-3, Plays a Minimal Role in Regulating the Development and Function of T Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GATA-3; DIFFERENTIATION; EXPRESSION; MAINTENANCE; ACTIVATION; BRITISH; CD8	The integral membrane protein 2a (Itm2a) is one of the BRICHOS domain-containing proteins and is structurally related to Itm2b and Itm2c. It is expressed preferentially in the T lineage among hematopoietic cells and is induced by MHC-mediated positive selection. However, its transcriptional regulation and function are poorly understood. Here we showed Itm2a to be a target gene of GATA-3, a T cell-specific transcription factor. Deficiency of Itm2a had little impact on the development and function of polyclonal T cells but resulted in a partial defect in the development of thymocytes bearing a MHC class I-restricted TCR, OT-I. In addition, Itm2a-deficient mice displayed an attenuated T helper cell-dependent immune response in vivo. We further demonstrated that Itm2b but not Itm2c was also expressed in T cells, and was induced upon activation, albeit following a kinetic different from that of Itm2a. Thus, functional redundancy between Itm2a and Itm2b may explain the minimal phenotype of Itm2a deficiency.	[Tai, Tzong-Shyuan; Ho, I-Cheng] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Tai, Tzong-Shyuan; Pai, Sung-Yun; Ho, I-Cheng] Harvard Univ, Sch Med, Boston, MA USA; [Tai, Tzong-Shyuan] I Shou Univ, E Da Hosp, Dept Med Res, Kaohsiung, Taiwan; [Pai, Sung-Yun] Childrens Hosp, Dept Pediat, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Pai, Sung-Yun] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; E-Da Hospital; I Shou University; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute	Ho, IC (corresponding author), Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA.	iho@partners.org	Pai, Sung-Yun/AAH-7762-2019	Pai, Sung-Yun/0000-0002-0158-8147	National Institutes of Health [AI097725, AI050601]; Charles H. Hood Foundation Child Health Research Award Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI050601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles H. Hood Foundation Child Health Research Award Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by a R03 grant (AI097725 to ICH) and a K08 award (AI050601 to SYP) from National Institutes of Health, and an award (to SYP) from Charles H. Hood Foundation Child Health Research Award Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi SI, 2003, FASEB J, V17, P373, DOI 10.1096/fj.03-0730fje; Deleersnijder W, 1996, J BIOL CHEM, V271, P19475, DOI 10.1074/jbc.271.32.19475; He LW, 2005, J IMMUNOL METHODS, V304, P43, DOI 10.1016/j.jim.2005.06.005; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; Hedlund Joel, 2009, BMC Res Notes, V2, P180, DOI 10.1186/1756-0500-2-180; Herman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179; Ho IC, 2009, NAT REV IMMUNOL, V9, P125, DOI 10.1038/nri2476; Kirchner J, 1999, J EXP MED, V190, P217, DOI 10.1084/jem.190.2.217; Kishikawa H, 2001, J IMMUNOL, V167, P4414, DOI 10.4049/jimmunol.167.8.4414; Knight SD, 2013, BIOCHEMISTRY-US, V52, P7523, DOI 10.1021/bi400908x; Lagha M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063143; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Martin L, 2008, J BIOL CHEM, V283, P1644, DOI 10.1074/jbc.M706661200; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Pai SY, 2004, P NATL ACAD SCI USA, V101, P1993, DOI 10.1073/pnas.0308697100; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Tai TS, 2013, J IMMUNOL, V190, P428, DOI 10.4049/jimmunol.1201361; Vidal R, 2000, P NATL ACAD SCI USA, V97, P4920, DOI 10.1073/pnas.080076097; Vidal R, 1999, NATURE, V399, P776; Wang L, 2008, NAT IMMUNOL, V9, P1122, DOI 10.1038/ni.1647; Wang YQ, 2013, NAT IMMUNOL, V14, P714, DOI 10.1038/ni.2623; Wang YQ, 2011, IMMUNITY, V35, P337, DOI 10.1016/j.immuni.2011.08.012; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128	26	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e96535	10.1371/journal.pone.0096535	http://dx.doi.org/10.1371/journal.pone.0096535			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831988	Green Published, gold, Green Submitted			2022-12-27	WOS:000336789500022
J	Todros-Dawda, I; Kveberg, L; Vaage, JT; Inngjerdingen, M				Todros-Dawda, Izabela; Kveberg, Lise; Vaage, John T.; Inngjerdingen, Marit			The Tetraspanin CD53 Modulates Responses from Activating NK Cell Receptors, Promoting LFA-1 Activation and Dampening NK Cell Effector Functions	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; HEPATITIS-C VIRUS; RAT LYMPHOCYTES-T; MONOCLONAL-ANTIBODIES; SIGNAL-TRANSDUCTION; HOMOTYPIC ADHESION; CD81 TAPA-1; EXPRESSION; ANTIGEN; ASSOCIATION	NK cells express several tetraspanin proteins, which differentially modulate NK cell activities. The tetraspanin CD53 is expressed by all resting NK cells and was previously shown to decrease NK cell cytotoxicity upon ligation. Here, we show that CD53 ligation reduced degranulation of rat NK cells in response to tumour target cells, evoked redirected inhibition of killing of Fc-bearing targets, and reduced the IFN-gamma response induced by plate-bound antibodies towards several activating NK cell receptors (Ly49s3, NKR-P1A, and NKp46). CD53 induced activation of the beta 2 integrin LFA-1, which was further enhanced upon co-stimulation with activating NK cell receptors. Concordant with a role for CD53 in increasing NK cell adhesiveness, CD53 ligation induced a strong homotypic adhesion between NK cells. Further, the proliferative capacity of NK cells to a suboptimal dose of IL-2 was enhanced by CD53 ligation. Taken together, these data suggest that CD53 may shift NK cell responses from effector functions towards a proliferation phase.	[Inngjerdingen, Marit] Univ Oslo, Rikshosp, Dept Immunol, Oslo Univ Hosp, N-0027 Oslo, Norway; Univ Oslo, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo	Inngjerdingen, M (corresponding author), Univ Oslo, Rikshosp, Dept Immunol, Oslo Univ Hosp, N-0027 Oslo, Norway.	mariti@medisin.uio.no	Kveberg, Lise/AAG-1739-2019	Kveberg, Lise/0000-0001-9308-0641; Vaage, John T./0000-0003-0988-5768	South-Eastern Norway Regional Health Authority [2008100 BT]	South-Eastern Norway Regional Health Authority	This work was supported by the South-Eastern Norway Regional Health Authority grant number 2008100 BT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Barrena S, 2005, LEUKEMIA, V19, P1376, DOI 10.1038/sj.leu.2403822; BELL GM, 1992, J EXP MED, V175, P527, DOI 10.1084/jem.175.2.527; Bos SD, 2010, EUR J HUM GENET, V18, P953, DOI 10.1038/ejhg.2010.52; Bryceson YT, 2008, CURR OPIN IMMUNOL, V20, P344, DOI 10.1016/j.coi.2008.03.005; Bryceson YT, 2010, METHODS MOL BIOL, V612, P335, DOI 10.1007/978-1-60761-362-6_23; Byrnes KR, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-130; Cao L, 1997, IMMUNOBIOLOGY, V197, P70, DOI 10.1016/S0171-2985(97)80058-7; CARMO AM, 1995, EUR J IMMUNOL, V25, P2090, DOI 10.1002/eji.1830250743; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Cherukuri A, 2004, J IMMUNOL, V172, P370, DOI 10.4049/jimmunol.172.1.370; CLARK SJ, 1988, J EXP MED, V167, P1861, DOI 10.1084/jem.167.6.1861; Crotta S, 2006, EUR J IMMUNOL, V36, P919, DOI 10.1002/eji.200535527; Crotta S, 2002, J EXP MED, V195, P35, DOI 10.1084/jem.20011124; DAWE CJ, 1957, AM J PATHOL, V33, P603; Fleming TJ, 1997, J EXP MED, V186, P1307, DOI 10.1084/jem.186.8.1307; Inngjerdingen M, 2011, TISSUE ANTIGENS, V78, P81, DOI 10.1111/j.1399-0039.2011.01714.x; Jockers JJ, 2006, ALLERGY, V61, P1419, DOI 10.1111/j.1398-9995.2006.01191.x; KIESSLING R, 1975, EUR J IMMUNOL, V5, P112, DOI 10.1002/eji.1830050208; Kim EO, 2010, J BIOL CHEM, V285, P41755, DOI 10.1074/jbc.M110.137976; Kim TR, 2004, MOL CELLS, V17, P125; Konstandin MH, 2007, J IMMUNOL METHODS, V327, P30, DOI 10.1016/j.jim.2007.07.005; Kramer B, 2009, EUR J IMMUNOL, V39, P3447, DOI 10.1002/eji.200939234; Kveberg L, 2006, IMMUNOGENETICS, V58, P905, DOI 10.1007/s00251-006-0154-x; Kveberg L, 2006, J IMMUNOL, V176, P4133, DOI 10.4049/jimmunol.176.7.4133; Lazo PA, 1997, CELL IMMUNOL, V178, P132, DOI 10.1006/cimm.1997.1139; Lee H, 2013, BBA-GEN SUBJECTS, V1830, P3011, DOI 10.1016/j.bbagen.2012.12.030; Lee KM, 2006, BLOOD, V107, P3181, DOI 10.1182/blood-2005-01-0185; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Levy S, 1998, ANNU REV IMMUNOL, V16, P89, DOI 10.1146/annurev.immunol.16.1.89; Long EO, 2013, ANNU REV IMMUNOL, V31, P227, DOI 10.1146/annurev-immunol-020711-075005; Mannion BA, 1996, J IMMUNOL, V157, P2039; MASELLISSMITH A, 1990, J IMMUNOL, V144, P1607; Mollinedo F, 1997, CLIN DIAGN LAB IMMUN, V4, P229, DOI 10.1128/CDLI.4.2.229-231.1997; Naper C, 2002, J IMMUNOL, V169, P22, DOI 10.4049/jimmunol.169.1.22; OLWEUS J, 1993, J IMMUNOL, V151, P707; Pedersen-Lane JH, 2007, J LEUKOCYTE BIOL, V81, P934, DOI 10.1189/jlb.0806533; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Puls KL, 2002, INT IMMUNOL, V14, P249, DOI 10.1093/intimm/14.3.249; RASMUSSEN AM, 1994, J IMMUNOL, V153, P4997; REYNOLDS CW, 1984, J IMMUNOL, V132, P534; ROTHLEIN R, 1986, J EXP MED, V163, P1132, DOI 10.1084/jem.163.5.1132; Sabatos CA, 2008, IMMUNITY, V29, P238, DOI 10.1016/j.immuni.2008.05.017; SCHMIDT RE, 1988, J IMMUNOL, V140, P991; SEAMAN WE, 1987, P NATL ACAD SCI USA, V84, P4239, DOI 10.1073/pnas.84.12.4239; Shibagaki N, 1999, EUR J IMMUNOL, V29, P4081, DOI 10.1002/(SICI)1521-4141(199912)29:12<4081::AID-IMMU4081>3.3.CO;2-9; SLUPSKY JR, 1989, J BIOL CHEM, V264, P12289; Todd SC, 1996, J EXP MED, V184, P2055, DOI 10.1084/jem.184.5.2055; VAAGE JT, 1994, J EXP MED, V180, P641, DOI 10.1084/jem.180.2.641; Veillette A, 2006, IMMUNOL REV, V214, P22, DOI 10.1111/j.1600-065X.2006.00453.x; Yunta M, 2003, ONCOGENE, V22, P1219, DOI 10.1038/sj.onc.1206183; Zhuo M, 2010, EUR J IMMUNOL, V40, P1748, DOI 10.1002/eji.200939779	52	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97844	10.1371/journal.pone.0097844	http://dx.doi.org/10.1371/journal.pone.0097844			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24832104	gold, Green Submitted, Green Published			2022-12-27	WOS:000336789500124
J	Xu, J; Meng, KX; Zhang, R; Yang, H; Liao, C; Zhu, WL; Jiao, JD				Xu, Jia; Meng, Kexin; Zhang, Rui; Yang, He; Liao, Chang; Zhu, Wenliang; Jiao, Jundong			The Use of Functional Chemical-Protein Associations to Identify Multi-Pathway Renoprotectants	PLOS ONE			English	Article							DIABETIC-NEPHROPATHY; MULTITARGET DRUGS; OXIDATIVE STRESS; RENAL ISCHEMIA; CURCUMIN; AUTOPHAGY; MECHANISMS; KIDNEY; INJURY; DISCOVERY	Typically, most nephropathies can be categorized as complex human diseases in which the cumulative effect of multiple minor genes, combined with environmental and lifestyle factors, determines the disease phenotype. Thus, multi-target drugs would be more likely to facilitate comprehensive renoprotection than single-target agents. In this study, functional chemical-protein association analysis was performed to retrieve multi-target drugs of high pathway wideness from the STITCH 3.1 database. Pathway wideness of a drug evaluated the efficiency of regulation of Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways in quantity. We identified nine experimentally validated renoprotectants that exerted remarkable impact on KEGG pathways by targeting a limited number of proteins. We selected curcumin as an illustrative compound to display the advantage of multi-pathway drugs on renoprotection. We compared curcumin with hemin, an agonist of heme oxygenase-1 (HO-1), which significantly affects only one KEGG pathway, porphyrin and chlorophyll metabolism (adjusted p = 1.5x10(-5)). At the same concentration (10 mu M), both curcumin and hemin equivalently mitigated oxidative stress in H2O2-treated glomerular mesangial cells. The benefit of using hemin was derived from its agonistic effect on HO-1, providing relief from oxidative stress. Selective inhibition of HO-1 completely blocked the action of hemin but not that of curcumin, suggesting simultaneous multi-pathway intervention by curcumin. Curcumin also increased cellular autophagy levels, enhancing its protective effect; however, hemin had no effects. Based on the fact that the dysregulation of multiple pathways is implicated in the etiology of complex diseases, we proposed a feasible method for identifying multi-pathway drugs from compounds with validated targets. Our efforts will help identify multi-pathway agents capable of providing comprehensive protection against renal injuries.	[Xu, Jia; Meng, Kexin; Zhang, Rui; Yang, He; Liao, Chang; Jiao, Jundong] Harbin Med Univ, Affiliated Hosp 2, Dept Nephrol, Harbin, Peoples R China; [Xu, Jia] Harbin Med Univ, Affiliated Hosp 4, Dept Nephrol, Harbin, Peoples R China; [Zhu, Wenliang] Harbin Med Univ, Affiliated Hosp 2, Inst Clin Pharmacol, Harbin, Peoples R China; [Jiao, Jundong] Harbin Med Univ, Inst Nephrol, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University	Jiao, JD (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Nephrol, Harbin, Peoples R China.	jiaojundong@163.com			National Nature Science Foundation of China [31071016]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science Foundation of China (31071016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernd A, 2014, PHYTOCHEM REV, V13, P183, DOI 10.1007/s11101-013-9296-2; Bolisetty S, 2010, J AM SOC NEPHROL, V21, P1702, DOI 10.1681/ASN.2010030238; Chargui A, 2011, TOXICOL SCI, V121, P31, DOI 10.1093/toxsci/kfr031; Chok Mohammed Koussai, 2009, Inflammation & Allergy Drug Targets, V8, P252; Csermely P, 2005, TRENDS PHARMACOL SCI, V26, P178, DOI 10.1016/j.tips.2005.02.007; Dulbecco P, 2013, WORLD J GASTROENTERO, V19, P9256, DOI 10.3748/wjg.v19.i48.9256; El Sabbahy M, 2011, WIRES SYST BIOL MED, V3, P606, DOI 10.1002/wsbm.133; Fogo AB, 2007, PEDIATR NEPHROL, V22, P2011, DOI 10.1007/s00467-007-0524-0; Han J, 2012, AUTOPHAGY, V8, P812, DOI 10.4161/auto.19471; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang J, 2013, MOL CELL ENDOCRINOL, V365, P231, DOI 10.1016/j.mce.2012.10.024; Jacob A, 2013, IMMUNOLOGY, V139, P328, DOI 10.1111/imm.12079; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kanwar YS, 2008, EXP BIOL MED, V233, P4, DOI 10.3181/0705-MR-134; Kiffin R, 2006, ANTIOXID REDOX SIGN, V8, P152, DOI 10.1089/ars.2006.8.152; Kuhn M, 2012, NUCLEIC ACIDS RES, V40, pD876, DOI 10.1093/nar/gkr1011; Lee H, 2013, BRIT J NUTR, V110, P69, DOI 10.1017/S0007114512004734; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Li CW, 2013, EXP BIOL MED, V238, P744, DOI 10.1177/1535370213493705; Li D, 2013, KIDNEY BLOOD PRESS R, V38, P61, DOI 10.1159/000355755; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Ma XH, 2010, PHARM RES-DORDR, V27, P739, DOI 10.1007/s11095-010-0065-2; Millan MJ, 2006, PHARMACOL THERAPEUT, V110, P135, DOI 10.1016/j.pharmthera.2005.11.006; Morsy MA, 2013, ADV PHARM SCI, V2013, DOI DOI 10.1155/2013/387071; Mueller TF, 2012, J NEPHROL, V25, P589, DOI 10.5301/jn.5000205; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Paccosi S, 2012, PHARMACOL RES, V66, P526, DOI 10.1016/j.phrs.2012.09.006; Pan Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079084; Patrakka J, 2010, BIOCHEM BIOPH RES CO, V396, P164, DOI 10.1016/j.bbrc.2010.04.069; Petrelli A, 2008, CURR MED CHEM, V15, P422; Ryter SW, 2013, CURR PHARM DESIGN, V19, P2747; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Salahudeen AK, 2011, TRANSPLANTATION, V91, P176, DOI 10.1097/TP.0b013e3181fffff2; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Sraer JD, 1996, KIDNEY INT, V49, P267, DOI 10.1038/ki.1996.38; Tapia E, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/269039; Trujillo J, 2013, REDOX BIOL, V1, P448, DOI 10.1016/j.redox.2013.09.003; Ueki M, 2013, J BIOSCI BIOENG, V115, P547, DOI 10.1016/j.jbiosc.2012.11.007; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Wang LW, 2011, NEW ENGL J MED, V364, P1144, DOI 10.1056/NEJMra1010600; Wang XJ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003119; Waseem M, 2013, CELL BIOCHEM FUNCT, V31, P678, DOI 10.1002/cbf.2955; Yang C, 2008, AM J PHYSIOL-RENAL, V294, pF777, DOI 10.1152/ajprenal.00590.2007; Yeh JH, 2013, TRANSPL P, V45, P3542, DOI 10.1016/j.transproceed.2013.09.004; Yu W, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-528; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007; Zhang DM, 2012, FOOD CHEM, V134, P2184, DOI 10.1016/j.foodchem.2012.04.026; Zhang DW, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/636053; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008	51	5	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97906	10.1371/journal.pone.0097906	http://dx.doi.org/10.1371/journal.pone.0097906			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830678	Green Published, Green Submitted, gold			2022-12-27	WOS:000336789500131
J	Cosentino, RO; Aguero, F				Cosentino, Raul O.; Agueero, Fernan			Genetic Profiling of the Isoprenoid and Sterol Biosynthesis Pathway Genes of Trypanosoma cruzi	PLOS ONE			English	Article							CHAGAS-DISEASE; NUCLEOTIDE-SEQUENCES; CRYSTAL-STRUCTURES; ERGOSTEROL BIOSYNTHESIS; POPULATION-STRUCTURE; MULTIPLE-ALIGNMENT; SQUALENE SYNTHASE; BRUCEI-GAMBIENSE; STRUCTURAL BASIS; INHIBITORS	In Trypanosoma cruzi the isoprenoid and sterol biosynthesis pathways are validated targets for chemotherapeutic intervention. In this work we present a study of the genetic diversity observed in genes from these pathways. Using a number of bioinformatic strategies, we first identified genes that were missing and/or were truncated in the T. cruzi genome. Based on this analysis we obtained the complete sequence of the ortholog of the yeast ERG26 gene and identified a non-orthologous homolog of the yeast ERG25 gene (sterol methyl oxidase, SMO), and we propose that the orthologs of ERG25 have been lost in trypanosomes (but not in Leishmanias). Next, starting from a set of 16 T. cruzi strains representative of all extant evolutionary lineages, we amplified and sequenced similar to 24 Kbp from 22 genes, identifying a total of 975 SNPs or fixed differences, of which 28% represent non-synonymous changes. We observed genes with a density of substitutions ranging from those close to the average (similar to 2.5/100 bp) to some showing a high number of changes (11.4/100 bp, for the putative lathosterol oxidase gene). All the genes of the pathway are under apparent purifying selection, but genes coding for the sterol C14-demethylase, the HMG-CoA synthase, and the HMG-CoA reductase have the lowest density of missense SNPs in the panel. Other genes (TcPMK, TcSMO-like) have a relatively high density of non-synonymous SNPs (2.5 and 1.9 every 100 bp, respectively). However, none of the non-synonymous changes identified affect a catalytic or ligand binding site residue. A comparative analysis of the corresponding genes from African trypanosomes and Leishmania shows similar levels of apparent selection for each gene. This information will be essential for future drug development studies focused on this pathway.	[Cosentino, Raul O.; Agueero, Fernan] Univ San Martin, CONICET, Inst Invest Biotecnol, Inst Tecnol Chascomus, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Aguero, F (corresponding author), Univ San Martin, CONICET, Inst Invest Biotecnol, Inst Tecnol Chascomus, Buenos Aires, DF, Argentina.	fernan@unsam.edu.ar	Filho, Fernando C/Q-8021-2018; Aguero, Fernan/F-5606-2013	Cosentino, Raul Oscar/0000-0003-2124-8198; Aguero, Fernan/0000-0003-1331-5741	National Agency for the Promotion of Science and Technology of Argentina [PICT-2005-38209, PICT-2010-1479]; National Research Council of Argentina (CONICET) [PIP-5454]; Special Programme for Research and Training in Tropical Diseases (WHO / UNDP / UNICEF / World Bank) [A50830]; University of San Martin	National Agency for the Promotion of Science and Technology of Argentina(ANPCyT); National Research Council of Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Special Programme for Research and Training in Tropical Diseases (WHO / UNDP / UNICEF / World Bank); University of San Martin	This work was supported by grants from the National Agency for the Promotion of Science and Technology of Argentina (Grants PICT-2005-38209 and PICT-2010-1479, http://www.agencia.gob.ar), the National Research Council of Argentina (CONICET, Grant PIP-5454, http://www.conicet.gob.ar), and the Special Programme for Research and Training in Tropical Diseases (WHO / UNDP / UNICEF / World Bank, Grant A50830, http://www.who.int/tdr). ROC is now a fellow of CONICET and was also supported during this work by a fellowship from the University of San Martin. FA is a member of the Research Career of CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Ackermann AA, 2009, NUCLEIC ACIDS RES, V37, pD544, DOI 10.1093/nar/gkn874; Andrade LO, 1999, MOL BIOCHEM PARASIT, V100, P163, DOI 10.1016/S0166-6851(99)90035-X; Andrade LO, 2010, MEM I OSWALDO CRUZ, V105, P834, DOI 10.1590/S0074-02762010000600018; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Barnabe C, 2000, PARASITOLOGY, V120, P513, DOI 10.1017/S0031182099005661; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bielawski JP, 2004, J MOL EVOL, V59, P121, DOI 10.1007/s00239-004-2597-8; Bouvier F, 2005, PROG LIPID RES, V44, P357, DOI 10.1016/j.plipres.2005.09.003; Braga MV, 2005, MICROSC MICROANAL, V11, P506, DOI 10.1017/S143192760505035X; Brisse S, 2001, INT J PARASITOL, V31, P1218, DOI 10.1016/S0020-7519(01)00238-7; Brisse S, 2000, INT J PARASITOL, V30, P35, DOI 10.1016/S0020-7519(99)00168-X; Brisse S, 2003, INFECT GENET EVOL, V2, P173, DOI 10.1016/S1567-1348(02)00097-7; Buckner FS, 2012, INT J PARASITOL-DRUG, V2, P236, DOI 10.1016/j.ijpddr.2011.12.002; Buckner FS, 2003, MOL BIOCHEM PARASIT, V132, P75, DOI 10.1016/j.molbiopara.2003.07.004; Buckner FS, 2001, ANTIMICROB AGENTS CH, V45, P1210, DOI 10.1128/AAC.45.4.1210-1215.2001; Buscaglia CA, 2003, MICROBES INFECT, V5, P419, DOI 10.1016/S1286-4579(03)00050-9; Byres E, 2007, J MOL BIOL, V371, P540, DOI 10.1016/j.jmb.2007.05.094; Castillo Ramirez S, 2011, PLOS PATHOG, V7; Chang Q, 2008, PROTEINS, V73, P254, DOI 10.1002/prot.22151; Chen CK, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000651; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Coppens I, 2000, ANNU REV MICROBIOL, V54, P129, DOI 10.1146/annurev.micro.54.1.129; Cosentino RO, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001777; de Freitas JM, 2006, PLOS PATHOG, V2, P226, DOI 10.1371/journal.ppat.0020024; Delye C, 1997, APPL ENVIRON MICROB, V63, P2966; Desmond E, 2009, GENOME BIOL EVOL, V1, P364, DOI 10.1093/gbe/evp036; Duffy CW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002526; Eargle J, 2006, BIOINFORMATICS, V22, P504, DOI 10.1093/bioinformatics/bti825; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Flores-Lopez CA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001272; FLORINCHRISTENSEN M, 1990, BIOCHEM BIOPH RES CO, V166, P1441, DOI 10.1016/0006-291X(90)91028-Q; Franzen O, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000984; Gabelli SB, 2006, PROTEINS, V62, P80, DOI 10.1002/prot.20754; Gerpe A, 2008, BIOORGAN MED CHEM, V16, P569, DOI 10.1016/j.bmc.2007.07.031; Gerpe A, 2009, BIOORGAN MED CHEM, V17, P7500, DOI 10.1016/j.bmc.2009.09.013; Gordon D, 2003, CURR PROTOC BIOINFOR, V2, P43, DOI DOI 10.1002/0471250953.BI1102S02; Houten SM, 2001, MOL GENET METAB, V72, P273, DOI 10.1006/mgme.2000.3133; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hurtado-Guerrrero R, 2002, FEBS LETT, V510, P141, DOI 10.1016/S0014-5793(01)03238-0; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jackson AP, 2012, P NATL ACAD SCI USA, V109, P3416, DOI 10.1073/pnas.1117313109; Jackson AP, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000658; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kelly SL, 1999, FEMS MICROBIOL LETT, V180, P171, DOI 10.1111/j.1574-6968.1999.tb08792.x; Kessler RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055497; Koffi M, 2009, P NATL ACAD SCI USA, V106, P209, DOI 10.1073/pnas.0811080106; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304; Kursula P, 2005, J MOL BIOL, V347, P189, DOI 10.1016/j.jmb.2005.01.018; Lauthier JJ, 2012, INFECT GENET EVOL, V12, P350, DOI 10.1016/j.meegid.2011.12.008; Lepesheva GI, 2011, ADV PARASIT, V75, P65, DOI 10.1016/B978-0-12-385863-4.00004-6; Lepesheva GI, 2011, BBA-PROTEINS PROTEOM, V1814, P88, DOI 10.1016/j.bbapap.2010.06.006; Lepesheva GI, 2010, J BIOL CHEM, V285, P25582, DOI 10.1074/jbc.M110.133215; Lepesheva GI, 2010, J BIOL CHEM, V285, P1773, DOI 10.1074/jbc.M109.067470; Lepesheva GI, 2006, J BIOL CHEM, V281, P3577, DOI 10.1074/jbc.M510317200; Lewis MD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001363; Lewis MD, 2009, AM J TROP MED HYG, V81, P1041, DOI 10.4269/ajtmh.2009.09-0305; Liendo A, 1999, MOL BIOCHEM PARASIT, V104, P81, DOI 10.1016/S0166-6851(99)00129-2; Lorente SO, 2004, ANTIMICROB AGENTS CH, V48, P2937, DOI 10.1128/AAC.48.8.2937-2950.2004; Lukes J, 2007, P NATL ACAD SCI USA, V104, P9375, DOI 10.1073/pnas.0703678104; Lupetti A, 2002, TRENDS MOL MED, V8, P76, DOI 10.1016/S1471-4914(02)02280-3; Machado CA, 2001, P NATL ACAD SCI USA, V98, P7396, DOI 10.1073/pnas.121187198; Magaraci F, 2003, J MED CHEM, V46, P4714, DOI 10.1021/jm021114j; Marcili A, 2009, INFECT GENET EVOL, V9, P1265, DOI 10.1016/j.meegid.2009.07.003; Minning TA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-370; Morio F, 2010, DIAGN MICR INFEC DIS, V66, P373, DOI 10.1016/j.diagmicrobio.2009.11.006; Nes CR, 2012, BIOCHEM J, V443, P267, DOI 10.1042/BJ20111849; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Oliaro-Bosso S, 2004, LIPIDS, V39, P1007, DOI 10.1007/s11745-004-1323-2; Oliaro-Bosso S, 2007, CHEMMEDCHEM, V2, P226, DOI 10.1002/cmdc.200600234; Pandit J, 2000, J BIOL CHEM, V275, P30610, DOI 10.1074/jbc.M004132200; Park WKC, 2008, BIOORG MED CHEM LETT, V18, P1151, DOI 10.1016/j.bmcl.2007.11.124; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Pojer F, 2006, P NATL ACAD SCI USA, V103, P11491, DOI 10.1073/pnas.0604935103; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Ravel C, 2006, INT J PARASITOL, V36, P1383, DOI 10.1016/j.ijpara.2006.06.019; Roberts CW, 2003, MOL BIOCHEM PARASIT, V126, P129, DOI 10.1016/S0166-6851(02)00280-3; Rocha EPC, 2006, J THEOR BIOL, V239, P226, DOI 10.1016/j.jtbi.2005.08.037; Rodrigues-Poveda CA, 2012, ANTIMICROB AGENTS CH, V56, P4483, DOI 10.1128/AAC.00796-12; Rogers MB, 2011, GENOME RES, V21, P2129, DOI 10.1101/gr.122945.111; Rosso VS, 2011, BIOORGAN MED CHEM, V19, P2211, DOI 10.1016/j.bmc.2011.02.037; Sealey-Cardona M, 2007, ANTIMICROB AGENTS CH, V51, P2123, DOI 10.1128/AAC.01454-06; Sgraja T, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-20; Silva DT, 2006, INT J ANTIMICROB AG, V27, P530, DOI 10.1016/j.ijantimicag.2005.12.012; Smith TK, 2010, MOL BIOCHEM PARASIT, V172, P66, DOI 10.1016/j.molbiopara.2010.04.001; Sperling P, 2003, PROSTAG LEUKOTR ESS, V68, P73, DOI 10.1016/S0952-3278(02)00258-2; Thoma R, 2004, NATURE, V432, P118, DOI 10.1038/nature02993; Tibayrenc M, 2002, TRENDS PARASITOL, V18, P405, DOI 10.1016/S1471-4922(02)02357-7; Tibayrenc M, 2013, TRENDS PARASITOL, V29, P264, DOI 10.1016/j.pt.2013.03.007; URBINA JA, 1993, ANTIMICROB AGENTS CH, V37, P580, DOI 10.1128/AAC.37.3.580; Urbina JA, 1996, SCIENCE, V273, P969, DOI 10.1126/science.273.5277.969; Urbina JA, 2003, TRENDS PARASITOL, V19, P495, DOI 10.1016/j.pt.2003.09.001; Urbina JA, 2009, MEM I OSWALDO CRUZ, V104, P311, DOI 10.1590/S0074-02762009000900041; Vacchina P, 2012, MOL BIOCHEM PARASIT, V184, P29, DOI 10.1016/j.molbiopara.2012.04.005; Vago AR, 2000, AM J PATHOL, V156, P1805, DOI 10.1016/S0002-9440(10)65052-3; Westenberger SJ, 2005, GENETICS, V171, P527, DOI 10.1534/genetics.104.038745; Wolf YI, 2012, GENOME BIOL EVOL, V4, P1286, DOI 10.1093/gbe/evs100; Yeo M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001049; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	100	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96762	10.1371/journal.pone.0096762	http://dx.doi.org/10.1371/journal.pone.0096762			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828104	Green Published, gold, Green Submitted			2022-12-27	WOS:000336857400036
J	Harriff, MJ; Cansler, ME; Toren, KG; Canfield, ET; Kwak, S; Gold, MC; Lewinsohn, DM				Harriff, Melanie J.; Cansler, Meghan E.; Toren, Katelynne Gardner; Canfield, Elizabeth T.; Kwak, Stephen; Gold, Marielle C.; Lewinsohn, David M.			Human Lung Epithelial Cells Contain Mycobacterium tuberculosis in a Late Endosomal Vacuole and Are Efficiently Recognized by CD8(+) T Cells	PLOS ONE			English	Article							PHAGOSOME MATURATION; INTERFERON-GAMMA; ANTIGEN; LYMPHOCYTES; ARREST; IRON; RAB5	Mycobacterium tuberculosis (Mtb) is transmitted via inhalation of aerosolized particles. While alveolar macrophages are thought to play a central role in the acquisition and control of this infection, Mtb also has ample opportunity to interact with the airway epithelium. In this regard, we have recently shown that the upper airways are enriched with a population of non-classical, MR1-restricted, Mtb-reactive CD8(+) T cells (MAIT cells). Additionally, we have demonstrated that Mtb-infected epithelial cells lining the upper airways are capable of stimulating IFN gamma production by MAIT cells. In this study, we demonstrate that airway epithelial cells efficiently stimulate IFN gamma release by MAIT cells as well as HLA-B45 and HLA-E restricted T cell clones. Characterization of the intracellular localization of Mtb in epithelial cells indicates that the vacuole occupied by Mtb in epithelial cells is distinct from DC in that it acquires Rab7 molecules and does not retain markers of early endosomes such as Rab5. The Mtb vacuole is also heterogeneous as there is a varying degree of association with Lamp1 and HLA-I. Although the Mtb vacuole shares markers associated with the late endosome, it does not acidify, and the bacteria are able to replicate within the cell. This work demonstrates that Mtb infected lung epithelial cells are surprisingly efficient at stimulating IFN gamma release by CD8(+) T cells.	[Harriff, Melanie J.; Gold, Marielle C.; Lewinsohn, David M.] Portland VA Med Ctr, Portland, OR 97239 USA; [Harriff, Melanie J.; Canfield, Elizabeth T.; Kwak, Stephen; Gold, Marielle C.; Lewinsohn, David M.] Oregon Hlth & Sci Univ, Dept Pulm & Crit Care Med, Portland, OR 97201 USA; [Cansler, Meghan E.; Toren, Katelynne Gardner] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA; [Gold, Marielle C.; Lewinsohn, David M.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Harriff, MJ (corresponding author), Portland VA Med Ctr, Portland, OR 97239 USA.	harriffm@ohsu.edu; lewinsod@ohsu.edu	; Lewinsohn, David/I-4936-2013	Slater, Marielle/0000-0003-2505-3291; Lewinsohn, David/0000-0001-9906-9494	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development; Portland VA Medical Center; National Institutes of Health (NIH) [AI048090]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048090] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development(US Department of Veterans Affairs); Portland VA Medical Center(US Department of Veterans Affairs); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, with resources and the use of facilities at the Portland VA Medical Center (Merit Review, DM Lewinsohn; Career Development Award, MJH), and the National Institutes of Health (NIH) grant, AI048090 (DM Lewinsohn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anes E, 2003, NAT CELL BIOL, V5, P793, DOI 10.1038/ncb1036; Arriaga AK, 2002, CLIN EXP IMMUNOL, V128, P229, DOI 10.1046/j.1365-2249.2002.01832.x; Bermudez LE, 1996, INFECT IMMUN, V64, P1400, DOI 10.1128/IAI.64.4.1400-1406.1996; Burgdorf S, 2008, CURR OPIN IMMUNOL, V20, P89, DOI 10.1016/j.coi.2007.12.002; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Fine KL, 2012, CELL MICROBIOL, V14, P1402, DOI 10.1111/j.1462-5822.2012.01804.x; Fratti RA, 2001, J CELL BIOL, V154, P631, DOI 10.1083/jcb.200106049; Garin J, 2001, J CELL BIOL, V152, P165, DOI 10.1083/jcb.152.1.165; Georgel P, 2011, MOL IMMUNOL, V48, P769, DOI 10.1016/j.molimm.2010.12.002; Gold MC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000407; Grotzke JE, 2005, MICROBES INFECT, V7, P776, DOI 10.1016/j.micinf.2005.03.001; Grotzke JE, 2010, J IMMUNOL, V185, P4336, DOI 10.4049/jimmunol.1000801; Heinzel AS, 2002, J EXP MED, V196, P1473, DOI 10.1084/jem.20020609; Le Bourhis L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003681; Lee HM, 2009, J CLIN IMMUNOL, V29, P795, DOI 10.1007/s10875-009-9319-3; Lennon-Dumenil AM, 2002, J EXP MED, V196, P529, DOI 10.1084/jem.20020327; Lewinsohn DM, 2006, J IMMUNOL, V177, P437, DOI 10.4049/jimmunol.177.1.437; Lewinsohn DM, 2000, J IMMUNOL, V165, P925, DOI 10.4049/jimmunol.165.2.925; MCDONOUGH KA, 1995, INFECT IMMUN, V63, P4802, DOI 10.1128/IAI.63.12.4802-4811.1995; Olakanmi O, 2002, J BIOL CHEM, V277, P49727, DOI 10.1074/jbc.M209768200; Philips JA, 2008, CELL MICROBIOL, V10, P2408, DOI 10.1111/j.1462-5822.2008.01239.x; Reichman LB, 2000, LUNG BIOL HLTH DIS T, P898; ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83; Roy S, 2004, IMMUNOLOGY, V112, P471, DOI 10.1046/j.1365-2567.2004.01905.x; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Schaible UE, 2002, J EXP MED, V196, P1507, DOI 10.1084/jem.20020897; Sharma M, 2007, IMMUNOL CELL BIOL, V85, P229, DOI 10.1038/sj.icb.7100037; Shen LJ, 2006, CURR OPIN IMMUNOL, V18, P85, DOI 10.1016/j.coi.2005.11.003; Stewart GR, 2003, NAT REV MICROBIOL, V1, P97, DOI 10.1038/nrmicro749; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Vergne I, 2004, MOL BIOL CELL, V15, P751, DOI 10.1091/mbc.E03-05-0307; Verver S, 2004, LANCET, V363, P212, DOI 10.1016/S0140-6736(03)15332-9; Via LE, 1997, J BIOL CHEM, V272, P13326, DOI 10.1074/jbc.272.20.13326; Wong J, 2007, AM J PHYSIOL-LUNG C, V293, pL1385, DOI 10.1152/ajplung.00207.2007	36	64	67	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97515	10.1371/journal.pone.0097515	http://dx.doi.org/10.1371/journal.pone.0097515			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828674	gold, Green Published, Green Submitted			2022-12-27	WOS:000336857400104
J	Zhang, B; Liang, XL; Ye, LS; Wang, YG				Zhang, Bo; Liang, Xiaolu; Ye, Liaosha; Wang, Yungui			No Chemopreventive Effect of Nonsteroidal Anti-Inflammatory Drugs on Nonmelanoma Skin Cancer: Evidence from Meta-Analysis	PLOS ONE			English	Article							RISK; ASPIRIN; METASTASIS	Background: Nonmelanoma skin cancer (NMSC), which includes squamous cell carcinoma (SCC) and basal cell carcinoma (BCC), is the most common form of cancer, and its incidence is increasing. Nonsteroidal anti-inflammatory drugs (NSAIDs) have been reported to be chemopreventive for NMSC. However, the results from published studies were controversial. Methods: We searched the PubMed and Embase databases for relevant studies. Moreover, relevant reviews regarding the use of NSAIDs for NMSC patients were examined for potential inclusive studies. To measure the effects of NSAIDs, the relative risk (RR) was analyzed. Results: A Total of 8 studies were included in our meta-analysis. We found that NSAIDs use was not associated with a reduced risk of SCC or BCC under the random effects model (pooled RR = 0.86, 95% CI, 0.73-1.02, P = 0.085; pooled RR = 0.94, 95% CI 0.85-1.04, P = 0.266; respectively). Conclusion: From the included studies, we found no statistically significant chemopreventive effect on NMSC of NSAIDs. This finding warrants more prospective studies evaluating the relationship between NSAIDs and NMSC.	[Zhang, Bo; Wang, Yungui] Third Mil Med Univ, Training Div, Chongqing, Peoples R China; [Zhang, Bo; Ye, Liaosha] Beijing Mil Command, Gen Hosp, Dept Med Adm, Beijing, Peoples R China; [Liang, Xiaolu] Beijing Mil Command, Gen Hosp, Dept Ultrasonog, Beijing, Peoples R China	Army Medical University; Seventh Medical Center of Chinese PLA General Hospital; Seventh Medical Center of Chinese PLA General Hospital	Zhang, B (corresponding author), Third Mil Med Univ, Training Div, Chongqing, Peoples R China.	keyanke@sina.com; wangyunguitmmu@126.com						Algra AM, 2012, LANCET ONCOL, V13, P518, DOI 10.1016/S1470-2045(12)70112-2; Asgari MM, 2010, ARCH DERMATOL, V146, P388, DOI 10.1001/archdermatol.2009.374; Borenstein M, 2009, INTRO META ANAL; Cahoon EK, 2012, INT J CANCER, V130, P2939, DOI 10.1002/ijc.26286; Clouser MC, 2009, PHARMACOEPIDEM DR S, V18, P276, DOI 10.1002/pds.1718; Diepgen TL, 2012, BRIT J DERMATOL, V167, P76, DOI 10.1111/j.1365-2133.2012.11090.x; Einspahr JG, 2003, RECENT RESULTS CANC, V163, P151; Einspahr JG, 2002, CRIT REV ONCOL HEMAT, V41, P269, DOI 10.1016/S1040-8428(01)00185-8; Elmets CA, 2010, JNCI-J NATL CANCER I, V102, P1835, DOI 10.1093/jnci/djq442; Grau MV, 2006, INT J CANCER, V119, P682, DOI 10.1002/ijc.21878; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huang CS, 1997, J BIOL CHEM, V272, P26325, DOI 10.1074/jbc.272.42.26325; Jeter JM, 2012, CANCER CAUSE CONTROL, V23, P1451, DOI 10.1007/s10552-012-0019-6; Johannesdottir SA, 2012, CANCER-AM CANCER SOC, V118, P4768, DOI 10.1002/cncr.27406; Lomas A, 2012, BRIT J DERMATOL, V166, P1069, DOI 10.1111/j.1365-2133.2012.10830.x; Marks F, 2003, RECENT RESULTS CANC, V163, P46; McCaffrey P, 2006, LANCET ONCOL, V7, P16, DOI 10.1016/S1470-2045(05)70523-4; Ohtsuka H, 2011, J SKIN CANCER, V2011, DOI 10.1155/2011/293926; Patel Rita V, 2011, J Clin Aesthet Dermatol, V4, P20; Peyrin-Biroulet L, 2011, GASTROENTEROLOGY, V141, P1621, DOI 10.1053/j.gastro.2011.06.050; Rothwell PM, 2012, LANCET, V379, P1591, DOI 10.1016/S0140-6736(12)60209-8; Sun L, 2011, DIS ESOPHAGUS, V24, P544, DOI 10.1111/j.1442-2050.2011.01198.x; Torti DC, 2011, J AM ACAD DERMATOL, V65, P304, DOI 10.1016/j.jaad.2010.05.042; Wang WH, 2003, JNCI-J NATL CANCER I, V95, P1784, DOI 10.1093/jnci/djg106	24	16	17	5	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96887	10.1371/journal.pone.0096887	http://dx.doi.org/10.1371/journal.pone.0096887			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828489	gold, Green Published, Green Submitted			2022-12-27	WOS:000336857400042
J	D'Andrea, MM; Amisano, F; Giani, T; Conte, V; Ciacci, N; Ambretti, S; Santoriello, L; Rossolini, GM				D'Andrea, Marco Maria; Amisano, Francesco; Giani, Tommaso; Conte, Viola; Ciacci, Nagaia; Ambretti, Simone; Santoriello, Luisa; Rossolini, Gian Maria			Diversity of Capsular Polysaccharide Gene Clusters in Kpc-Producing Klebsiella pneumoniae Clinical Isolates of Sequence Type 258 Involved in the Italian Epidemic	PLOS ONE			English	Article							GENOME SEQUENCE; ST11; ENTEROBACTERIACEAE; CARBAPENEMASES; DISSEMINATION; VIRULENCE; OUTBREAK; ST258; EMERGENCE; STRAINS	Strains of Klebsiella pneumoniae producing KPC-type beta-lactamases (KPC-Kp) are broadly disseminating worldwide and constitute a major healthcare threat given their extensively drug resistant phenotypes and ability to rapidly disseminate in healthcare settings. In this work we report on the characterization of two different capsular polysaccharide (CPS) gene clusters, named cps(BO-4) and cps(207-2), from two KPC-Kp clinical strains from Italy belonging in sequence type (ST) 258, which is one of the most successful ST of KPC-Kp spreading worldwide. While cps(BO-4) was different from known 78 K-types according to the recently proposed typing schemes based on the wzi or wzc gene sequences, cps(207-2) was classified as K41 by one of these methods. Bioinformatic analysis revealed that they were represented in the genomic sequences of KPC-Kp from strains of ST258 from different countries, and cps(BO-4) was also detected in a KPC-Kp strain of ST442 from Brazil. Investigation of a collection of 46 ST258 and ST512 (a single locus variant of ST258) clinical strains representative of the recent Italian epidemic of KPC-Kp by means of a multiplex PCR typing approach revealed that cpsBO-4 was the most prevalent type, being detected both in ST258 and ST512 strains with a countrywide distribution, while cps207-2 was only detected in ST258 strains with a more restricted distribution.	[D'Andrea, Marco Maria; Amisano, Francesco; Giani, Tommaso; Conte, Viola; Ciacci, Nagaia; Rossolini, Gian Maria] Univ Siena, Dept Med Biotechnol, I-53100 Siena, Italy; [Ambretti, Simone] St Orsola Malpighi Univ Hosp, Operat Unit Clin Microbiol, Bologna, Italy; [Santoriello, Luisa] S Corona Hosp, Microbiol Unit, Pietra Ligure, Italy; [Rossolini, Gian Maria] Univ Florence, Dept Expt & Clin Med, Florence, Italy; [Rossolini, Gian Maria] Florence Careggi Univ Hosp, Clin Microbiol & Virol Unit, Florence, Italy	University of Siena; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Florence; University of Florence; Azienda Ospedaliero Universitaria Careggi	Rossolini, GM (corresponding author), Univ Siena, Dept Med Biotechnol, Via Laterina 8, I-53100 Siena, Italy.	gianmaria.rossolini@unisi.it	D'Andrea, Marco Maria/H-6351-2019; Giani, Tommaso/AGB-2032-2022	D'Andrea, Marco Maria/0000-0003-3187-3210; Giani, Tommaso/0000-0001-7293-058X; CONTE, VIOLA/0000-0002-6759-3061; ROSSOLINI, Gian Maria/0000-0002-9386-0434; Amisano, Francesco/0000-0003-0822-4909	European Community [HEALTH-F3-2011-282004, HEALTH-F3-2009-241742]	European Community(European Commission)	This study was partially funded by the European Community projects EVOTAR and TEMPO test-QC contracts HEALTH-F3-2011-282004 and HEALTH-F3-2009-241742, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade LN, 2011, ANTIMICROB AGENTS CH, V55, P3579, DOI 10.1128/AAC.01783-10; Auch AF, 2010, STAND GENOMIC SCI, V2, P142, DOI 10.4056/sigs.541628; Brisse S, 2004, J CLIN MICROBIOL, V42, P3388, DOI 10.1128/JCM.42.8.3388-3398.2004; Brisse S, 2013, J CLIN MICROBIOL, V51, P4073, DOI 10.1128/JCM.01924-13; Brisse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004982; Broberg CA, 2013, GENOME ANNOUNC, V1, DOI [10.1128/genomeA, DOI 10.1128/GENOMEA]; Cannatelli A, 2013, ANTIMICROB AGENTS CH, V57, P5521, DOI 10.1128/AAC.01480-13; Chen L, 2014, ANTIMICROB AGENTS CH; Chmelnitsky I, 2012, J BACTERIOL, V194, P6014, DOI 10.1128/JB.01546-12; Comandatore F, 2013, GENOME ANNOUNC, V1, DOI [10.1128/genomeA, DOI 10.1128/GEN0MEA]; Cortes G, 2002, INFECT IMMUN, V70, P2583, DOI 10.1128/IAI.70.5.2583-2590.2002; Deleo FR, 2014, P NATL ACAD SCI USA, V111, P4988, DOI 10.1073/pnas.1321364111; Diago-Navarro E, 2014, J INFECT DIS; Giani T, 2013, EURO SURVEILL, V18; Gomez SA, 2011, CLIN MICROBIOL INFEC, V17, P1520, DOI 10.1111/j.1469-0691.2011.03600.x; Hong SK, 2013, J CLIN MICROBIOL, V51, P3877, DOI 10.1128/JCM.01730-13; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kubler-Kielb J, 2013, CARBOHYD RES, V369, P6, DOI 10.1016/j.carres.2012.12.018; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lauderdale TL, 2012, ANTIMICROB AGENTS CH, V56, P2207, DOI 10.1128/AAC.05576-11; Li JJ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-373; Liu PL, 2012, J BACTERIOL, V194, P1841, DOI 10.1128/JB.00043-12; MIZUTA K, 1983, INFECT IMMUN, V40, P56, DOI 10.1128/IAI.40.1.56-61.1983; Munoz-Price LS, 2013, LANCET INFECT DIS, V13, P785, DOI 10.1016/S1473-3099(13)70190-7; NELSON K, 1994, P NATL ACAD SCI USA, V91, P10227, DOI 10.1073/pnas.91.21.10227; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; ORSKOV I, 1984, METHOD MICROBIOL, V14, P143, DOI 10.1016/S0580-9517(08)70449-5; Pan YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080670; Ramos PIP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-54; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Qi Y, 2011, J ANTIMICROB CHEMOTH, V66, P307, DOI 10.1093/jac/dkq431; Rahn A, 1999, J BACTERIOL, V181, P2307, DOI 10.1128/JB.181.7.2307-2313.1999; Shu HY, 2009, MICROBIOL-SGM, V155, P4170, DOI 10.1099/mic.0.029017-0; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Turton JF, 2008, FEMS MICROBIOL LETT, V284, P247, DOI 10.1111/j.1574-6968.2008.01208.x; Turton JF, 2010, J MED MICROBIOL, V59, P541, DOI 10.1099/jmm.0.015198-0; Tzouvelekis LS, 2013, ANTIMICROB AGENTS CH, V57, P5144, DOI 10.1128/AAC.01052-13; Tzouvelekis LS, 2012, CLIN MICROBIOL REV, V25, P682, DOI 10.1128/CMR.05035-11; Yang J, 2013, CLIN MICROBIOL INFEC, V19, pE509, DOI 10.1111/1469-0691.12275	41	26	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96827	10.1371/journal.pone.0096827	http://dx.doi.org/10.1371/journal.pone.0096827			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24823690	Green Published, gold, Green Submitted			2022-12-27	WOS:000336369200036
J	Dodenhof, T; Dietz, F; Franken, S; Grunwald, I; Kelm, S				Dodenhof, Tanja; Dietz, Frank; Franken, Sebastian; Grunwald, Ingo; Kelm, Sorge			Splice Variants of Perlucin from Haliotis laevigata Modulate the Crystallisation of CaCO3	PLOS ONE			English	Article							NACRE PROTEIN PERLUCIN; MATRIX PROTEIN; BIOMINERALIZATION PROTEINS; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; BINDING-PROTEIN; SOLUBLE MATRIX; ORGANIC MATRIX; SHELL MATRIX; PEARL OYSTER	Perlucin is one of the proteins of the organic matrix of nacre (mother of pearl) playing an important role in biomineralisation. This nacreous layer can be predominately found in the mollusc lineages and is most intensively studied as a compound of the shell of the marine Australian abalone Haliotis laevigata. A more detailed analysis of Perlucin will elucidate some of the still unknown processes in the complex interplay of the organic/inorganic compounds involved in the formation of nacre as a very interesting composite material not only from a life science-based point of view. Within this study we discovered three unknown Perlucin splice variants of the Australian abalone H. laevigata. The amplified cDNAs vary from 562 to 815 base pairs and the resulting translation products differ predominantly in the absence or presence of a varying number of a 10 mer peptide C-terminal repeat. The splice variants could further be confirmed by matrix-assisted laser desorption ionisation time of flight mass spectrometry (MALDI-ToF MS) analysis as endogenous Perlucin, purified from decalcified abalone shell. Interestingly, we observed that the different variants expressed as maltose-binding protein (MBP) fusion proteins in E. coli showed strong differences in their influence on precipitating CaCO3 and that these differences might be due to a splice variant-specific formation of large protein aggregates influenced by the number of the 10 mer peptide repeats. Our results are evidence for a more complex situation with respect to Perlucin functional regulation by demonstrating that Perlucin splice variants modulate the crystallisation of calcium carbonate. The identification of differentially behaving Perlucin variants may open a completely new perspective for the field of nacre biomineralisation.	[Dodenhof, Tanja; Dietz, Frank; Kelm, Sorge] Univ Bremen, Dept Biol & Chem, Ctr Biomol Interact Bremen, D-28359 Bremen, Germany; [Franken, Sebastian] Univ Bonn, Dept Biochem & Mol Biol, Bonn, Germany; [Grunwald, Ingo] Fraunhofer Inst Mfg Technol & Adv Mat IFAM, Dept Adhes & Chem Polymers, Bremen, Germany	University of Bremen; University of Bonn; Fraunhofer Gesellschaft	Kelm, S (corresponding author), Univ Bremen, Dept Biol & Chem, Ctr Biomol Interact Bremen, D-28359 Bremen, Germany.	skelm@uni-bremen.de	Kelm, Soerge/C-5403-2013; Grunwald, Ingo/C-5662-2012	Kelm, Soerge/0000-0001-5277-9421; Franken, Sebastian/0000-0003-4844-6389	Rosa-Luxenburg Foundation	Rosa-Luxenburg Foundation	This work was supported by Rosa-Luxenburg Foundation (Fellowship to TD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle LB, 2002, MACROMOLECULES, V35, P1877, DOI 10.1021/ma011202y; Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; Amos FF, 2011, BIOMACROMOLECULES, V12, P1883, DOI 10.1021/bm200231c; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Blank S, 2003, J MICROSC-OXFORD, V212, P280, DOI 10.1111/j.1365-2818.2003.01263.x; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Collino S, 2008, BIOMACROMOLECULES, V9, P1909, DOI 10.1021/bm8001599; DAUPHIN Y, 1989, Bulletin of the Geological Institutions of the University of Uppsala, V15, P7; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; Drummond A., 2011, GENEIOUS V5 5; ERBEN HK, 1974, NATURE, V248, P128, DOI 10.1038/248128a0; Evans AG, 2001, J MATER RES, V16, P2475, DOI 10.1557/JMR.2001.0339; Evans JS, 2012, BIOINFORMATICS, V28, P3182, DOI 10.1093/bioinformatics/bts604; Freer A, 2014, MAR BIOTECHNOL, V16, P34, DOI 10.1007/s10126-013-9516-1; FRITZ M, 1994, NATURE, V371, P49, DOI 10.1038/371049a0; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Fu G, 2005, ADV MATER, V17, P2678, DOI 10.1002/adma.200500633; Fu G, 2005, BIOMACROMOLECULES, V6, P1289, DOI 10.1021/bm049314v; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Hakansson K, 1999, STRUCTURE, V7, P255, DOI 10.1016/S0969-2126(99)80036-7; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hecker A, 2003, FEBS LETT, V535, P49, DOI 10.1016/S0014-5793(02)03856-5; Heinemann F, 2011, MAT SCI ENG C-MATER, V31, P99, DOI 10.1016/j.msec.2010.08.005; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kim IW, 2004, LANGMUIR, V20, P11664, DOI 10.1021/la0481400; Levi-Kalisman Y, 2001, J STRUCT BIOL, V135, P8, DOI 10.1006/jsbi.2001.4372; Liu XJ, 2012, P ROY SOC B-BIOL SCI, V279, P1000, DOI 10.1098/rspb.2011.1661; Mann K, 2000, EUR J BIOCHEM, V267, P5257, DOI 10.1046/j.1432-1327.2000.01602.x; Mann K, 2007, BIOPHYS J, V93, P1246, DOI 10.1529/biophysj.106.100636; Michenfelder M, 2003, BIOPOLYMERS, V70, P522, DOI 10.1002/bip.10536; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Miyamoto H, 2013, ZOOL SCI, V30, P801, DOI 10.2108/zsj.30.801; Miyashita T, 2000, MAR BIOTECHNOL, V2, P409; Nakahara H., 1983, BIOMINERALIZATION BI, P225; Nielsen BB, 1997, FEBS LETT, V412, P388, DOI 10.1016/S0014-5793(97)00664-9; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Parham SN, 2001, EMBO J, V20, P2111, DOI 10.1093/emboj/20.9.2111; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; Ponce CB, 2011, CRYST GROWTH DES, V11, P4690, DOI 10.1021/cg201015w; Rademaker H, 2011, BEILSTEIN J NANOTECH, V2, P222, DOI 10.3762/bjnano.2.26; Samata T, 1999, FEBS LETT, V462, P225, DOI 10.1016/S0014-5793(99)01387-3; Samata T, 2008, FEBS J, V275, P2977, DOI 10.1111/j.1742-4658.2008.06453.x; Shen XY, 1997, J BIOL CHEM, V272, P32472, DOI 10.1074/jbc.272.51.32472; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thakar K, 2008, FEBS J, V275, P1411, DOI 10.1111/j.1742-4658.2008.06303.x; Treccani L, 2006, BIOPHYS J, V91, P2601, DOI 10.1529/biophysj.106.086108; Wang N, 2008, COMP BIOCHEM PHYS B, V149, P354, DOI 10.1016/j.cbpb.2007.10.007; Weber E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046653; WEINER S, 1980, FEBS LETT, V111, P311, DOI 10.1016/0014-5793(80)80817-9; WEIS WI, 1994, STRUCTURE, V2, P1227, DOI 10.1016/S0969-2126(94)00124-3; Weiss IM, 2000, BIOCHEM BIOPH RES CO, V267, P17, DOI 10.1006/bbrc.1999.1907; Weiss IM, 2001, BIOCHEM BIOPH RES CO, V285, P244, DOI 10.1006/bbrc.2001.5170; Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609; WHEELER AP, 1981, SCIENCE, V212, P1397, DOI 10.1126/science.212.4501.1397; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Wustman B, 2010, CONNECTIVE TISSUE RE, V44, P10; Wustman BA, 2004, BIOPOLYMERS, V74, P363, DOI 10.1002/bip.20086; Yano M, 2007, BIOCHEM BIOPH RES CO, V362, P158, DOI 10.1016/j.bbrc.2007.07.172; Zhang B, 2002, BIOPOLYMERS, V63, P358, DOI 10.1002/bip.10069	61	17	17	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97126	10.1371/journal.pone.0097126	http://dx.doi.org/10.1371/journal.pone.0097126			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824517	Green Submitted, gold, Green Published			2022-12-27	WOS:000336369200062
J	Sreekumar, V; Dennis, S; Doxas, I; Zhuang, YW; Belkin, M				Sreekumar, Vishnu; Dennis, Simon; Doxas, Isidoros; Zhuang, Yuwen; Belkin, Mikhail			The Geometry and Dynamics of Lifelogs: Discovering the Organizational Principles of Human Experience	PLOS ONE			English	Article							RECURRENCE PLOTS	A correlation dimension analysis of people's visual experiential streams captured by a smartphone shows that visual experience is two-scaled with a smaller dimension at shorter length scales than at longer length scales. The bend between the two scales is a phase transition point where the lower scale primarily captures relationships within the same context and the higher dimensional scale captures relationships between different contexts. The dimensionality estimates are confirmed using Takens' delay embedding procedure on the image stream, while the randomly permuted stream is shown to be space-filling thereby establishing that the two-scaled structure is a consequence of the dynamics. We note that the structure of visual experience closely resembles the structure of another domain of experience: natural language discourse. The emergence of an identical structure across different domains of human experience suggests that the two-scaled geometry reflects a general organizational principle.	[Sreekumar, Vishnu] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Dennis, Simon] Univ Newcastle, Sch Psychol, Newcastle, NSW 2300, Australia; [Doxas, Isidoros] Univ Colorado, Ctr Integrated Plasma Studies, Boulder, CO 80309 USA; [Zhuang, Yuwen; Belkin, Mikhail] Ohio State Univ, Dept Comp Sci & Engn, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University of Newcastle; University of Colorado System; University of Colorado Boulder; University System of Ohio; Ohio State University	Dennis, S (corresponding author), Univ Newcastle, Sch Psychol, Newcastle, NSW 2300, Australia.	simon.dennis@gmail.com	Sreekumar, Vishnu/I-9516-2016	Sreekumar, Vishnu/0000-0002-5366-1633; Dennis, Simon/0000-0002-1890-1187	Air Force Office of Scientific Research (AFOSR) [FA9550-09-1-0614]	Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was partially supported by Air Force Office of Scientific Research (AFOSR) grant FA9550-09-1-0614. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Andrew AH, 2013, INT CONF PER COMP, P408, DOI 10.4108/icst.pervasivehealth.2013.252134; Chiu GS, 2002, THESIS S FRASER U; Doxas I, 2010, P NATL ACAD SCI USA, V107, P4866, DOI 10.1073/pnas.0908315107; ECKMANN JP, 1987, EUROPHYS LETT, V4, P973, DOI 10.1209/0295-5075/4/9/004; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; GRASSBERGER P, 1983, PHYSICA D, V9, P189, DOI 10.1016/0167-2789(83)90298-1; GRASSBERGER P, 1983, PHYS REV LETT, V50, P346, DOI 10.1103/PhysRevLett.50.346; Griffiths TL, 2007, PSYCHOL REV, V114, P211, DOI 10.1037/0033-295X.114.2.211; Huang J, 1997, PROC CVPR IEEE, P762, DOI 10.1109/CVPR.1997.609412; Kintsch W, 2006, HDB LATENT SEMANTIC; Landauer TK, 1998, DISCOURSE PROCESS, V25, P259, DOI 10.1080/01638539809545028; Landauer TK, 1997, PSYCHOL REV, V104, P211, DOI 10.1037/0033-295X.104.2.211; MANDELBROT B, 1967, SCIENCE, V156, P636, DOI 10.1126/science.156.3775.636; Marwan N, 2007, PHYS REP, V438, P237, DOI 10.1016/j.physrep.2006.11.001; Moskowitz DS, 2006, J PSYCHIATR NEUROSCI, V31, P13; Schreiber T., 1999, PHYS REP, V308, P1; Sreekumar V, 2010, P 32 ANN M COGN SCI; Swan M, 2009, INT J ENV RES PUB HE, V6, P492, DOI 10.3390/ijerph6020492; Takens F, 1981, DYNAMICAL SYSTEMS TU, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; Vazquez-Prokopec GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058802	21	15	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97166	10.1371/journal.pone.0097166	http://dx.doi.org/10.1371/journal.pone.0097166			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824825	Green Published, Green Submitted, gold			2022-12-27	WOS:000336369200067
J	Duan, CX; Li, DD; Sun, SL; Wang, XM; Zhu, ZD				Duan, Can-xing; Li, Dan-dan; Sun, Su-li; Wang, Xiao-ming; Zhu, Zhen-dong			Rapid Development of Microsatellite Markers for Callosobruchus chinensis Using Illumina Paired-End Sequencing	PLOS ONE			English	Article							EST-SSR MARKERS; TRANSCRIPTOME ANALYSIS; HUMAN GENOME; COLEOPTERA; L.; TRINUCLEOTIDE; REVEALS; BEETLE; PLANTS; GENES	Background: The adzuki bean weevil, Callosobruchus chinensis L., is one of the most destructive pests of stored legume seeds such as mungbean, cowpea, and adzuki bean, which usually cause considerable loss in the quantity and quality of stored seeds during transportation and storage. However, a lack of genetic information of this pest results in a series of genetic questions remain largely unknown, including population genetic structure, kinship, biotype abundance, and so on. Co-dominant microsatellite markers offer a great resolving power to determine these events. Here, we report rapid microsatellite isolation from C. chinensis via high-throughput sequencing. Principal Findings: In this study, 94,560,852 quality-filtered and trimmed reads were obtained for the assembly of genome using Illumina paired-end sequencing technology. In total, the genome with total length of 497,124,785 bp, comprising 403,113 high quality contigs was generated with de novo assembly. More than 6800 SSR loci were detected and a suit of 6303 primer pair sequences were designed and 500 of them were randomly selected for validation. Of these, 196 pair of primers, i.e. 39.2%, produced reproducible amplicons that were polymorphic among 8 C. chinensis genotypes collected from different geographical regions. Twenty out of 196 polymorphic SSR markers were used to analyze the genetic diversity of 18 C. chinensis populations. The results showed the twenty SSR loci were highly polymorphic among these populations. Conclusions: This study presents a first report of genome sequencing and de novo assembly for C. chinensis and demonstrates the feasibility of generating a large scale of sequence information and SSR loci isolation by Illumina paired-end sequencing. Our results provide a valuable resource for C. chinensis research. These novel markers are valuable for future genetic mapping, trait association, genetic structure and kinship among C. chinensis.	[Duan, Can-xing; Li, Dan-dan; Sun, Su-li; Wang, Xiao-ming; Zhu, Zhen-dong] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Zhu, ZD (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China.	zhuzhendong@caas.cn			Institute of Crop Sciences, CAAS [2060302-2-13]; Modern Agro-industry Technology Research System, Ministry of Agriculture of China [CARS-09]	Institute of Crop Sciences, CAAS; Modern Agro-industry Technology Research System, Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs)	This work was supported by the Public Welfare Special Fund (2060302-2-13) from Institute of Crop Sciences, CAAS and Modern Agro-industry Technology Research System (CARS-09) from the Ministry of Agriculture of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Ze-Wei, 2009, Yichuan, V31, P311, DOI 10.3724/SP.J.1005.2009.00311; Bai XD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011370; Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; Castoe TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030953; Castoe TA, 2010, MOL ECOL RESOUR, V10, P341, DOI 10.1111/j.1755-0998.2009.02750.x; Chaubey MK, 2008, J OLEO SCI, V57, P171, DOI 10.5650/jos.57.171; Choudhary S, 2009, THEOR APPL GENET, V118, P591, DOI 10.1007/s00122-008-0923-z; Collins LJ, 2008, GENOME INFORM SER, V21, P3; Creste S, 2001, PLANT MOL BIOL REP, V19, P299, DOI 10.1007/BF02772828; Dutta S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-17; EDWARDS A, 1991, AM J HUM GENET, V49, P746; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Feldmeyer B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-317; Fu N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057686; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; GASTIER JM, 1995, HUM MOL GENET, V4, P1829, DOI 10.1093/hmg/4.10.1829; Iorizzo M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-389; Kageyama D, 2010, J STORED PROD RES, V46, P13, DOI 10.1016/j.jspr.2009.07.003; KIMURA M, 1964, GENETICS, V49, P725; Kondo N, 1999, ZOOL SCI, V16, P955, DOI 10.2108/zsj.16.955; LAGERCRANTZ U, 1993, NUCLEIC ACIDS RES, V21, P1111, DOI 10.1093/nar/21.5.1111; Lewontin R.C., 1972, EVOL BIOL, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Malausa T, 2011, MOL ECOL RESOUR, V11, P638, DOI 10.1111/j.1755-0998.2011.02992.x; Mishra Dheeraj, 2006, J Oleo Sci, V56, P1; Mizrachi E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-681; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nahdy MS, 1998, J STORED PROD RES, V34, P207, DOI 10.1016/S0022-474X(97)00043-X; Natarajan P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-191; Ossowski S, 2008, GENOME RES, V18, P2024, DOI 10.1101/gr.080200.108; Ott J., 1991, ANAL HUMAN GENETIC L; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Rosenkranz R, 2008, GENOMICS, V92, P187, DOI 10.1016/j.ygeno.2008.05.011; Rozen S, 2000, Methods Mol Biol, V132, P365; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shahin Arwa, 2012, BMC Res Notes, V5, P79, DOI 10.1186/1756-0500-5-79; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837; SHINODA K, 1991, APPL ENTOMOL ZOOL, V26, P91; Sunnucks P, 2000, TRENDS ECOL EVOL, V15, P199, DOI 10.1016/S0169-5347(00)01825-5; Talekar NS, 1988, P 2 INT S MUNGB AVRD, P329; TAUTZ D, 1984, NUCLEIC ACIDS RES, V12, P4127, DOI 10.1093/nar/12.10.4127; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Tuda M, 2004, B ENTOMOL RES, V94, P75, DOI 10.1079/BER2003277; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Wang B, 2010, NUCLEIC ACIDS RES, V38, P5075, DOI 10.1093/nar/gkq256; Wang H, 2010, PROTEOMICS, V10, P2972, DOI 10.1002/pmic.201000056; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang QQ, 2010, GENOMICS, V96, P369, DOI 10.1016/j.ygeno.2010.08.009; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; XuJ J, 2007, THESIS YANGZHOU U YA; Yang T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-602; Zenoni S, 2010, PLANT PHYSIOL, V152, P1787, DOI 10.1104/pp.109.149716	54	18	22	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e95458	10.1371/journal.pone.0095458	http://dx.doi.org/10.1371/journal.pone.0095458			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835431	gold, Green Submitted, Green Published			2022-12-27	WOS:000339614800008
J	Fayolle, SL; Droit-Volet, S				Fayolle, Sophie L.; Droit-Volet, Sylvie			Time Perception and Dynamics of Facial Expressions of Emotions	PLOS ONE			English	Article							TEMPORAL DISCRIMINATION; NEURAL MECHANISMS; SMILE DYNAMICS; RECOGNITION; MOVEMENT; DURATION; MIMICRY; INTENSITY; DISPLAYS; MOTION	Two experiments were run to examine the effects of dynamic displays of facial expressions of emotions on time judgments. The participants were given a temporal bisection task with emotional facial expressions presented in a dynamic or a static display. Two emotional facial expressions and a neutral expression were tested and compared. Each of the emotional expressions had the same affective valence (unpleasant), but one was high-arousing (expressing anger) and the other low-arousing (expressing sadness). Our results showed that time judgments are highly sensitive to movements in facial expressions and the emotions expressed. Indeed, longer perceived durations were found in response to the dynamic faces and the high-arousing emotional expressions compared to the static faces and low-arousing expressions. In addition, the facial movements amplified the effect of emotions on time perception. Dynamic facial expressions are thus interesting tools for examining variations in temporal judgments in different social contexts.	[Fayolle, Sophie L.; Droit-Volet, Sylvie] Univ Blaise Pascal, CNRS, UMR 6024, Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite Clermont Auvergne (UCA)	Droit-Volet, S (corresponding author), Univ Blaise Pascal, CNRS, UMR 6024, Clermont Ferrand, France.	Sylvie.DROIT-VOLET@univ-bpclermont.fr			French Agence Nationale de la Recherche (ANR) [ANR-11-EMCO-01201]	French Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	This work was supported by a grant from the French Agence Nationale de la Recherche (ANR) for research into emotion, cognition and behavior (ANR-11-EMCO-01201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2000, J NEUROSCI, V20, P2683; Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Allan LG, 2002, Q J EXP PSYCHOL-B, V55, P43, DOI 10.1080/02724990143000162; Ambadar Z, 2005, PSYCHOL SCI, V16, P403, DOI 10.1111/j.0956-7976.2005.01548.x; Angrilli A, 1997, PERCEPT PSYCHOPHYS, V59, P972, DOI 10.3758/BF03205512; Bar-Haim Y, 2010, COGNITION EMOTION, V24, P255, DOI 10.1080/02699930903387603; BASSILI JN, 1979, J PERS SOC PSYCHOL, V37, P2049, DOI 10.1037/0022-3514.37.11.2049; Beckmann JS, 2009, J EXP PSYCHOL ANIM B, V35, P525, DOI 10.1037/a0015891; BENSON PJ, 1993, PERCEPTION, V22, P257, DOI 10.1068/p220257; Biele C, 2006, EXP BRAIN RES, V171, P1, DOI 10.1007/s00221-005-0254-0; Bould E, 2008, BRIT J PSYCHOL, V99, P167, DOI 10.1348/000712607X206702; BROWN SW, 1995, PERCEPT PSYCHOPHYS, V57, P105, DOI 10.3758/BF03211853; Chambon M, 2008, J EXP SOC PSYCHOL, V44, P672, DOI 10.1016/j.jesp.2007.04.014; Conway LG, 2004, J EXP SOC PSYCHOL, V40, P113, DOI 10.1016/S0022-1031(03)00089-1; Craig AD, 2009, PHILOS T R SOC B, V364, P1933, DOI 10.1098/rstb.2009.0008; Damasio A, 2000, FEELING WHAT HAPPENS; Darwin C., 1998, EXPRESS EMOT MAN, V3rd; Decety J, 1999, TRENDS COGN SCI, V3, P172, DOI 10.1016/S1364-6613(99)01312-1; Doi H, 2009, NEUROSCI LETT, V457, P97, DOI 10.1016/j.neulet.2009.04.004; Droit-Volet S, 2004, COGNITION EMOTION, V18, P849, DOI 10.1080/02699930341000194; Droit-Volet S., 2013, TIMING TIME PERCEPT, V1, P99, DOI [10.1163/22134468-00002004, DOI 10.1163/22134468-00002004]; Droit-Volet S, 2007, TRENDS COGN SCI, V11, P504, DOI 10.1016/j.tics.2007.09.008; Droit-Volet S, 2013, J PHYSIOL-PARIS, V107, P255, DOI 10.1016/j.jphysparis.2013.03.005; Droit-Volet S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00417; Droit-Volet S, 2009, PHILOS T R SOC B, V364, P1943, DOI 10.1098/rstb.2009.0013; DROITVOLET S, SUBJECTIVE IN PRESS; Effron DA, 2006, EMOTION, V6, P1, DOI 10.1037/1528-3542.6.1.1; Ekman P., 1976, PICTURES FACIAL AFFE; Fraisse, 1967, PSYCHOL TEMPS; Frijda N. H., 2007, LAWS EMOTION; Frijda N. H., 1986, EMOTIONS STUDIES EMO; GIBBON J, 1984, ANN NY ACAD SCI, V423, P52, DOI 10.1111/j.1749-6632.1984.tb23417.x; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; Gil S., 2011, ATTENTION REPRESENTA; Gil S, 2007, EMOTION, V7, P219, DOI 10.1037/1528-3542.7.1.219; Gil S, 2012, COGNITION EMOTION, V26, P847, DOI 10.1080/02699931.2011.625401; Gil S, 2011, SCAND J PSYCHOL, V52, P138, DOI 10.1111/j.1467-9450.2010.00858.x; Grommet EK, 2011, BEHAV PROCESS, V86, P88, DOI 10.1016/j.beproc.2010.10.003; Harwood NK, 1999, AM J MENT RETARD, V104, P270, DOI 10.1352/0895-8017(1999)104<0270:ROFEEF>2.0.CO;2; Kaiser S, 2009, TRAITE PSYCHOL EMOTI, P109; Killeen P. R., 1997, TIME BEHAV PSYCHOL N, P79, DOI [10.1016/S0166-4115(97)80055-6, DOI 10.1016/S0166-4115(97)80055-6]; Krumhuber E, 2007, J NONVERBAL BEHAV, V31, P39, DOI 10.1007/s10919-006-0019-x; Krumhuber EG, 2013, EMOT REV, V5, P41, DOI 10.1177/1754073912451349; Krumhuber EG, 2009, EMOTION, V9, P807, DOI 10.1037/a0017844; Lang P.J., 2008, A8 U FLOR; Lazarus R.S., 1991, EMOTION ADAPTATION; LHAMON WT, 1975, B PSYCHONOMIC SOC, V5, P53, DOI 10.3758/BF03336701; Lui MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021829; Maringer M, 2011, EMOTION, V11, P181, DOI 10.1037/a0022596; Matthews WJ, 2011, J EXP PSYCHOL HUMAN, V37, P1617, DOI 10.1037/a0022193; Matthews WJ, 2011, J EXP PSYCHOL HUMAN, V37, P303, DOI 10.1037/a0019961; Meissner K, 2011, BIOL PSYCHOL, V86, P289, DOI 10.1016/j.biopsycho.2011.01.001; Mella N, 2011, BRAIN COGNITION, V75, P182, DOI 10.1016/j.bandc.2010.11.012; Nather FC, 2011, PLOS ONE, V6, P1; Niedenthal PM, 2001, COGNITION EMOTION, V15, P853, DOI 10.1080/02699930143000194; Noulhiane M, 2007, EMOTION, V7, P697, DOI 10.1037/1528-3542.7.4.697; Ogden RS, 2013, COGNITION EMOTION, V27, P1292, DOI 10.1080/02699931.2013.769426; Piaget P., 1946, DEV NOTION TEMPS CHE; Sato W, 2007, COGNITION, V104, P1, DOI 10.1016/j.cognition.2006.05.001; Shi ZH, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00024; Tipples J, 2008, EMOTION, V8, P127, DOI 10.1037/1528-3542.8.1.127; Tipples J, 2011, EMOTION, V11, P74, DOI 10.1037/a0022015; TREISMAN M, 1963, PSYCHOL MONOGR, V77, P1, DOI 10.1037/h0093864; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Wang L, 2012, P NATL ACAD SCI USA, V109, pE673, DOI 10.1073/pnas.1115515109; Wehrle T, 2000, J PERS SOC PSYCHOL, V78, P105, DOI 10.1037/0022-3514.78.1.105; Wittmann M, 2013, NAT REV NEUROSCI, V14, P217, DOI 10.1038/nrn3452	67	27	30	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97944	10.1371/journal.pone.0097944	http://dx.doi.org/10.1371/journal.pone.0097944			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1NZ	24835285	Green Published, Green Submitted, gold			2022-12-27	WOS:000339614800089
J	Gardiner, RZ; Doran, E; Strickland, K; Carpenter-Bundhoo, L; Frere, C				Gardiner, Riana Zanarivero; Doran, Erik; Strickland, Kasha; Carpenter-Bundhoo, Luke; Frere, Celine			A Face in the Crowd: A Non-Invasive and Cost Effective Photo-Identification Methodology to Understand the Fine Scale Movement of Eastern Water Dragons	PLOS ONE			English	Article							HOME-RANGE SIZE; ELK CERVUS-ELAPHUS; HABITAT USE; BODY TEMPERATURES; MICROHABITAT USE; LIZARD; DIMORPHISM; PATTERNS; OVERLAP; FIELD	Ectothermic vertebrates face many challenges of thermoregulation. Many species rely on behavioral thermoregulation and move within their landscape to maintain homeostasis. Understanding the fine-scale nature of this regulation through tracking techniques can provide a better understanding of the relationships between such species and their dynamic environments. The use of animal tracking and telemetry technology has allowed the extensive collection of such data which has enabled us to better understand the ways animals move within their landscape. However, such technologies do not come without certain costs: they are generally invasive, relatively expensive, can be too heavy for small sized animals and unreliable in certain habitats. This study provides a cost-effective and non-invasive method through photo-identification, to determine fine scale movements of individuals. With our methodology, we have been able to find that male eastern water dragons (Intellagama leuseurii) have home ranges one and a half times larger than those of females. Furthermore, we found intraspecific differences in the size of home ranges depending on the time of the day. Lastly, we found that location mostly influenced females' home ranges, but not males and discuss why this may be so. Overall, we provide valuable information regarding the ecology of the eastern water dragon, but most importantly demonstrate that non-invasive photo-identification can be successfully applied to the study of reptiles.	[Gardiner, Riana Zanarivero; Doran, Erik; Strickland, Kasha; Frere, Celine] Univ Sunshine Coast, GeneCol Res Ctr, Maroochydore, Qld, Australia; [Carpenter-Bundhoo, Luke] Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Falmouth, Cornwall, England; [Frere, Celine] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia	University of the Sunshine Coast; University of Exeter; University of Queensland	Frere, C (corresponding author), Univ Sunshine Coast, GeneCol Res Ctr, Maroochydore, Qld, Australia.	cfrere@usc.edu.au	Frere, Celine Henria/B-4905-2013; Gardiner, Riana/X-2362-2019; Strickland, Kasha/AAR-5132-2021; Frere, Celine Henria/GYJ-3882-2022	Frere, Celine Henria/0000-0002-9671-2138; Gardiner, Riana/0000-0001-7782-8664; Carpenter-Bundhoo, Luke/0000-0002-9637-5231	biosciences department of the University of Exeter	biosciences department of the University of Exeter	The authors received internal funding from the biosciences department of the University of Exeter (no grant number). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADOLPH SC, 1990, ECOLOGY, V71, P315, DOI 10.2307/1940271; Anderson DP, 2005, LANDSCAPE ECOL, V20, P257, DOI 10.1007/s10980-005-0062-8; Baird TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041819; Beck DD, 2003, HERPETOL MONOGR, V17, P111, DOI 10.1655/0733-1347(2003)017[0111:HUBGMT]2.0.CO;2; Biebouw K, 2009, INT J PRIMATOL, V30, P367, DOI 10.1007/s10764-009-9349-y; BUTTEMER WA, 1993, OECOLOGIA, V96, P56, DOI 10.1007/BF00318031; Cabrera MP, 2013, ZOOL ANZ, V252, P299, DOI 10.1016/j.jcz.2012.08.003; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Calsbeek R, 2002, J ANIM ECOL, V71, P513, DOI 10.1046/j.1365-2656.2002.00619.x; Carter AJ, 2009, ANIM BEHAV, V77, P839, DOI 10.1016/j.anbehav.2008.12.007; Carter KD, 2013, ANIM BEHAV, V85, P385, DOI 10.1016/j.anbehav.2012.11.011; CLUTTONBROCK TH, 1992, Q REV BIOL, V67, P437, DOI 10.1086/417793; CLUTTONBROCK TH, 1995, ANIM BEHAV, V49, P1345, DOI 10.1006/anbe.1995.0166; Cook R., 2004, TERRAPENE C CAROLINA, V1, P197, DOI DOI 10.1163/157075403323012197; Dubey S, 2011, AUSTRAL ECOL, V36, P68, DOI 10.1111/j.1442-9993.2010.02119.x; ERLINGE S, 1990, J MAMMAL, V71, P597, DOI 10.2307/1381799; Firth BT, 1998, PHYSIOL ZOOL, V71, P303, DOI 10.1086/515919; Fisher DO, 1999, ANIM BEHAV, V58, P121, DOI 10.1006/anbe.1999.1119; Fitzgerald LA, 2011, J THERM BIOL, V36, P160, DOI 10.1016/j.jtherbio.2011.01.003; Frair JL, 2010, PHILOS T R SOC B, V365, P2187, DOI 10.1098/rstb.2010.0084; Frair JL, 2005, LANDSCAPE ECOL, V20, P273, DOI 10.1007/s10980-005-2075-8; Frere CH, 2010, ANIM BEHAV, V80, P481, DOI 10.1016/j.anbehav.2010.06.007; Fryxell JM, 2008, P NATL ACAD SCI USA, V105, P19114, DOI 10.1073/pnas.0801737105; Georges A, 2013, ANIM CONSERV, V16, P493, DOI 10.1111/acv.12080; Gifford ME, 2012, J THERM BIOL, V37, P496, DOI 10.1016/j.jtherbio.2012.05.003; Glazier DS, 2005, BIOL REV, V80, P611, DOI 10.1017/S1464793105006834; GRANT BW, 1990, ECOLOGY, V71, P2323, DOI 10.2307/1938643; Greer A.E., 1989, BIOL EVOLUTION AUSTR; Harlow Henry J., 2010, International Journal of Zoology, V2010, P1, DOI 10.1155/2010/921371; Jachowski DS, 2010, WILDLIFE BIOL, V16, P66, DOI 10.2981/09-034; Kasper CB, 2012, MAMM BIOL, V77, P358, DOI 10.1016/j.mambio.2012.03.006; Kelley EA, 2013, AM J PHYS ANTHROPOL, V150, P122, DOI 10.1002/ajpa.22184; Kjellander P, 2004, OECOLOGIA, V139, P478, DOI 10.1007/s00442-004-1529-z; Knapp C, 2005, ANIM CONSERV, V8, P239; Laidre KL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2371; Perez-Garcia JM, 2013, J ORNITHOL, V154, P63, DOI 10.1007/s10336-012-0871-x; Maria-Carneiro T, 2013, J THERM BIOL, V38, P41; Melville J, 2001, AUSTRAL ECOL, V26, P660, DOI 10.1046/j.1442-9993.2001.01152.x; Merrill E, 2010, PHILOS T R SOC B, V365, P2279, DOI 10.1098/rstb.2010.0077; Michael DR, 2010, AUSTRAL ECOL, V35, P862, DOI 10.1111/j.1442-9993.2009.02092.x; Miles DB, 2000, EVOLUTION, V54, P1386; Moorcroft PR, 2008, ENCY ECOLOGY, V1, P174; Perry G, 2002, ECOLOGY, V83, P1870, DOI 10.2307/3071771; Pinheiro J. C., 2004, NLME LINEAR NONLINEA, V3, P1; Price-Rees S, 2013, ANIM BIOTELEMETRY, V1, P1; Pusey A.E., 1987, P250; RAUCH N, 1985, BEHAV ECOL SOCIOBIOL, V16, P125, DOI 10.1007/BF00295146; Rauset GR, 2013, OECOLOGIA, V172, P701, DOI 10.1007/s00442-012-2546-y; ROSE B, 1982, J HERPETOL, V16, P253, DOI 10.2307/1563718; Sacchi R, 2010, AMPHIBIA-REPTILIA, V31, P489, DOI 10.1163/017353710X521546; Schradin C, 2010, ANIM BEHAV, V79, P195, DOI 10.1016/j.anbehav.2009.10.027; Schulke O, 2010, CURR BIOL, V20, P2207, DOI 10.1016/j.cub.2010.10.058; Sreekar R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055935; Sterck EHM, 1997, AM J PRIMATOL, V42, P179, DOI 10.1002/(SICI)1098-2345(1997)42:3<179::AID-AJP2>3.0.CO;2-U; STEVENSON RD, 1985, AM NAT, V126, P362, DOI 10.1086/284423; Stockley P, 2011, BIOL REV, V86, P341, DOI 10.1111/j.1469-185X.2010.00149.x; Uchino BN, 2006, J BEHAV MED, V29, P377, DOI 10.1007/s10865-006-9056-5; Uzal A, 2013, EUR J WILDLIFE RES, V59, P563, DOI 10.1007/s10344-013-0705-z; van Beest FM, 2011, J ANIM ECOL, V80, P771, DOI 10.1111/j.1365-2656.2011.01829.x; Van Tienhoven AM, 2007, J APPL ECOL, V44, P273, DOI 10.1111/j.1365-2664.2006.01273.x; Wang M, 2007, ECOL MODEL, V205, P397, DOI 10.1016/j.ecolmodel.2007.03.003; Wroblewski EE, 2009, ANIM BEHAV, V77, P873, DOI 10.1016/j.anbehav.2008.12.014; Zschokke S, 2002, CAN J ZOOL, V80, P2014, DOI [10.1139/z02-183, 10.1139/Z02-183]	63	28	30	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e96992	10.1371/journal.pone.0096992	http://dx.doi.org/10.1371/journal.pone.0096992			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835073	Green Submitted, Green Published, gold			2022-12-27	WOS:000339614800024
J	Pang, C; Jia, LL; Hou, XH; Gao, X; Liu, W; Bao, YQ; Jia, WP				Pang, Can; Jia, Lili; Hou, Xuhong; Gao, Xin; Liu, Wei; Bao, Yuqian; Jia, Weiping			The Significance of Screening for Microvascular Diseases in Chinese Community-Based Subjects with Various Metabolic Abnormalities	PLOS ONE			English	Article							C-REACTIVE PROTEIN; INTERNATIONAL-DIABETES-FEDERATION; MACROVASCULAR COMPLICATIONS; INCREASED PREVALENCE; RISK-FACTORS; POPULATION; MICROALBUMINURIA; RETINOPATHY; ALBUMINURIA; SIGNS	Background: To assess the association of albuminuria and retinopathy with metabolic syndrome (MetS) and the related metabolic components defined by various criteria in Chinese community-based subjects. Methods: A total of 3240 Chinese subjects were recruited from urban communities and classified into subgroups with isolated or concomitant state of the two microvascular diseases. MetS was defined according to the standard of International Diabetes Federation, the National Cholesterol Education Program's Adult Treatment Panel III and Chinese Diabetes Society (CDS), separately. Albuminuria was defined as an elevated morning urine albumin-to-creatinine ratio. Retinopathy were identified with nonmydriatic retinal photographs according to the Diabetic Retinopathy Disease Severity Scale. Logistic regression was performed to analyze the contributive risk factors. Results: The subgroup of isolated retinopathy was the oldest (P<0.05), with higher blood pressure (P<0.001) and larger waist circumference (P<0.05). After adjusting for age, sex and other metabolic components, individuals with blood pressure over 130/85 mmHg were prone to have isolated albuminuria (OR: 1.51, P = 0.0001); while individuals with fasting plasma glucose over 5.6 mmol/L were in high risk of retinopathy concomitant with albuminria (OR: 3.04, P = 0.006). Larger waist circumference was a potential risk factors for isolated albuminuria and isolated retinopathy, though not significant after further adjustment of other metabolic components. The risk for albuminuria and retinopathy increased with the aggregation of three or more metabolic components. However, the MetS per se did not have synergic effect and only the MetS defined by CDS remained as a risk factor. Conclusions: Albuminuria and retinopathy were highly associated with accumulated metabolic abnormalities including sub-clinical elevated blood pressure and elevated fasting plasma glucose.	[Pang, Can; Hou, Xuhong; Bao, Yuqian; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Diabet Inst,Shanghai Key Lab Diabet Mell, Dept Endocrinol & Metab,Shanghai Clin Ctr Metab D, Shanghai 200030, Peoples R China; [Jia, Lili] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Ophthalmol, Shanghai 200030, Peoples R China; [Gao, Xin] Fudan Univ, Affiliated Zhongshan Hosp, Dept Endocrinol & Metab, Shanghai 200433, Peoples R China; [Liu, Wei] Shanghai Jiao Tong Univ, Affiliated Renji Hosp, Dept Endocrinol & Metab, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Fudan University; Shanghai Jiao Tong University	Jia, WP (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Diabet Inst,Shanghai Key Lab Diabet Mell, Dept Endocrinol & Metab,Shanghai Clin Ctr Metab D, Shanghai 200030, Peoples R China.	wpjia@sjtu.edu.cn	Jia, Weiping/B-7483-2012		Drug Innovation Program of National Science and Technology Project [2011ZX09307-001-02]; Integrated Control Project of chronic diseases from Shanghai Hospital Development Center [SHDC12012302]; Training Program for Young Clinician from Shanghai Municipal Health Bureau [[2012]114]	Drug Innovation Program of National Science and Technology Project; Integrated Control Project of chronic diseases from Shanghai Hospital Development Center; Training Program for Young Clinician from Shanghai Municipal Health Bureau	This study was supported by Drug Innovation Program of National Science and Technology Project (No. 2011ZX09307-001-02), Integrated Control Project of chronic diseases from Shanghai Hospital Development Center (No. SHDC12012302) and Training Program for Young Clinician from Shanghai Municipal Health Bureau (No. [2012]114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani M, 2006, ISR MED ASSOC J, V8, P378; Bao YQ, 2008, ATHEROSCLEROSIS, V201, P378, DOI 10.1016/j.atherosclerosis.2008.03.001; Bonadonna RC, 2006, DIABETES CARE, V29, P2701, DOI 10.2337/dc06-0942; Costa LA, 2004, DIABETIC MED, V21, P252, DOI 10.1111/j.1464-5491.2004.01124.x; DAVIS JE, 1978, DIABETES, V27, P102, DOI 10.2337/diabetes.27.2.102; Ford ES, 2005, DIABETES CARE, V28, P2745, DOI 10.2337/diacare.28.11.2745; group C.D.S.M.S.R.C, 2004, CHIN J DIABETES, V12, P151, DOI [10.3321/j.issn:1006-6187.2004.03.002, DOI 10.3321/J.ISSN:1006-6187.2004.03.002]; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hanai K, 2008, DIABETES RES CLIN PR, V79, P318, DOI 10.1016/j.diabres.2007.08.032; Isomaa B, 2001, DIABETOLOGIA, V44, P1148, DOI 10.1007/s001250100615; Iwasaki T, 2008, DIABETES RES CLIN PR, V79, P427, DOI [10.1016/j.diabres.2007.10.035, 10.1016/j.diabres.2007.06.014]; Jia W P, 2002, Obes Rev, V3, P157; Jia WP, 2009, NEPHROL DIAL TRANSPL, V24, P3724, DOI 10.1093/ndt/gfp349; Jiang LP, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-118; Kawasaki R, 2008, BRIT J OPHTHALMOL, V92, P161, DOI 10.1136/bjo.2007.127449; Kilpatrick ES, 2007, DIABETES CARE, V30, P707, DOI 10.2337/dc06-1982; Kshirsagar AV, 2008, AM J CARDIOL, V101, P401, DOI 10.1016/j.amjcard.2007.08.041; Lim LS, 2010, INVEST OPHTH VIS SCI, V51, P4458, DOI 10.1167/iovs.09-4939; Lu B, 2007, DIABETES RES CLIN PR, V75, P184, DOI 10.1016/j.diabres.2006.06.024; Nakamura M, 2004, INTERNAL MED, V43, P919, DOI 10.2169/internalmedicine.43.919; Pang C, 2012, DIABETES-METAB RES, V28, P276, DOI 10.1002/dmrr.1307; Raman R, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-67; Sabanayagam C, 2010, NEPHROL DIAL TRANSPL, V25, P1167, DOI 10.1093/ndt/gfp591; van der Velde M, 2012, NEPHROL DIAL TRANSPL, V27, P2275, DOI 10.1093/ndt/gfr634; Wang JJ, 2003, HYPERTENSION, V42, P534, DOI 10.1161/01.HYP.0000090122.38230.41; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Wong TY, 2004, INVEST OPHTH VIS SCI, V45, P2949, DOI 10.1167/iovs.04-0069	27	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97928	10.1371/journal.pone.0097928	http://dx.doi.org/10.1371/journal.pone.0097928			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835219	Green Published, Green Submitted, gold			2022-12-27	WOS:000339614800085
J	Jackson, C; Mangtani, P; Hawker, J; Olowokure, B; Vynnycky, E				Jackson, Charlotte; Mangtani, Punam; Hawker, Jeremy; Olowokure, Babatunde; Vynnycky, Emilia			The Effects of School Closures on Influenza Outbreaks and Pandemics: Systematic Review of Simulation Studies	PLOS ONE			English	Review							SOCIAL MIXING PATTERNS; MITIGATION STRATEGIES; NONPHARMACEUTICAL INTERVENTIONS; COMMUNITY MITIGATION; DISEASE TRANSMISSION; INFECTIOUS-DISEASES; SPREAD; IMPACT; CONTACTS; MODEL	Background: School closure is a potential intervention during an influenza pandemic and has been investigated in many modelling studies. Objectives: To systematically review the effects of school closure on influenza outbreaks as predicted by simulation studies. Methods: We searched Medline and Embase for relevant modelling studies published by the end of October 2012, and handsearched key journals. We summarised the predicted effects of school closure on the peak and cumulative attack rates and the duration of the epidemic. We investigated how these predictions depended on the basic reproduction number, the timing and duration of closure and the assumed effects of school closures on contact patterns. Results: School closures were usually predicted to be most effective if they caused large reductions in contact, if transmissibility was low (e. g. a basic reproduction number <2), and if attack rates were higher in children than in adults. The cumulative attack rate was expected to change less than the peak, but quantitative predictions varied (e. g. reductions in the peak were frequently 20-60% but some studies predicted >90% reductions or even increases under certain assumptions). This partly reflected differences in model assumptions, such as those regarding population contact patterns. Conclusions: Simulation studies suggest that school closure can be a useful control measure during an influenza pandemic, particularly for reducing peak demand on health services. However, it is difficult to accurately quantify the likely benefits. Further studies of the effects of reactive school closures on contact patterns are needed to improve the accuracy of model predictions.	[Jackson, Charlotte; Mangtani, Punam; Vynnycky, Emilia] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Jackson, Charlotte; Vynnycky, Emilia] Publ Hlth England, Stat Modelling & Econ Dept, London, England; [Hawker, Jeremy] Publ Hlth England, Field Epidemiol Serv, Birmingham, W Midlands, England; [Olowokure, Babatunde] Publ Hlth England, West Midlands Publ Hlth England Ctr, Birmingham, W Midlands, England	University of London; London School of Hygiene & Tropical Medicine; Public Health England; Public Health England; Public Health England	Jackson, C (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England.	c.r.jackson@ucl.ac.uk		Jackson, Charlotte/0000-0001-8544-7685; Mangtani, Punam/0000-0001-7074-2999	Public Health England; NIHR; National Institute for Health Research [RTF/01/038] Funding Source: researchfish	Public Health England; NIHR(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was partially funded by the Health Protection Agency (now known as Public Health England). Charlotte Jackson was supported by an NIHR Research Training Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aledort JE, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-208; Andradottir S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S1-S1; Araz OM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-449; Baguelin M, 2010, VACCINE, V28, P2370, DOI 10.1016/j.vaccine.2010.01.002; Barrett C, 2011, EPIDEMICS-NETH, V3, P19, DOI 10.1016/j.epidem.2010.11.002; Bell D, 2006, EMERG INFECT DIS, V12, P88; Bolton KJ, 2012, B WORLD HEALTH ORGAN, V90, P264, DOI 10.2471/BLT.11.093419; Carrat F, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-26; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Cauchemez S, 2011, P NATL ACAD SCI USA, V108, P2825, DOI 10.1073/pnas.1008895108; Cauchemez S, 2009, LANCET INFECT DIS, V9, P473, DOI 10.1016/S1473-3099(09)70176-8; Chao DL, 2011, AM J EPIDEMIOL, V173, P1121, DOI 10.1093/aje/kwq497; Chao DL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000656; Crawford JM, 2010, EMERG INFECT DIS, V16, P8, DOI 10.3201/eid1601.091167; Cruz-Pacheco G, 2009, EUROSURVEILLANCE, V14; Davey VJ, 2008, EMERG INFECT DIS, V14, P365, DOI 10.3201/eid1403.070673; Davey VJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002606; degli Atti MLC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001790; Eames KTD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002425; Eames KTD, 2011, EPIDEMICS-NETH, V3, P103, DOI 10.1016/j.epidem.2011.03.003; Eames KT, 2013, EPIDEMIOL INFECT, P1; Earn DJD, 2012, ANN INTERN MED, V156, P173, DOI 10.7326/0003-4819-156-3-201202070-00005; ECDC Antimicrobial Resistance and Healthcare-Associated Infections Programme, 2009, EURO SURVEILL, V14; ELVEBACK LR, 1976, AM J EPIDEMIOL, V103, P152, DOI 10.1093/oxfordjournals.aje.a112213; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Ghosh S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014307; Glass K, 2007, EPIDEMIOLOGY, V18, P623, DOI 10.1097/EDE.0b013e31812713b4; Glass RJ, 2006, EMERG INFECT DIS, V12, P1671, DOI 10.3201/eid1211.060255; Grefenstette JJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-940; Haber MJ, 2007, EMERG INFECT DIS, V13, P581, DOI 10.3201/eid1304.060828; Halder N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022087; Halder N, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-221; Halder N, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-168; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; Hens N, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-187; Hens N, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-5; Hollingsworth TD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001076; Horby P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016965; House T, 2011, P ROY SOC B-BIOL SCI, V278, P2753, DOI 10.1098/rspb.2010.2688; Jackson C, 2011, EMERG INFECT DIS, V17, P245, DOI 10.3201/eid1702.100458; Jackson C, 2010, AM J EPIDEMIOL, V171, P465, DOI 10.1093/aje/kwp394; Johnstone-Robertson SP, 2011, AM J EPIDEMIOL, V174, P1246, DOI 10.1093/aje/kwr251; Kelso JK, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-117; Kirkbride JB, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001998; Lee BY, 2010, J PUBLIC HEALTH MAN, V16, P252, DOI 10.1097/PHH.0b013e3181ce594e; Lee VJ, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-76; Lum ME, 2009, MED J AUSTRALIA, V191, P502, DOI 10.5694/j.1326-5377.2009.tb02914.x; Mao L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024706; Melegaro A, 2011, EPIDEMICS-NETH, V3, P143, DOI 10.1016/j.epidem.2011.04.001; Mikolajczyk RT, 2008, EPIDEMIOL INFECT, V136, P813, DOI 10.1017/S0950268807009181; Miller JF, 2010, MNEMOSYNE SUPPL, V321, P1, DOI 10.1163/ej.9789004177550.i-248.6; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Milne GJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061504; Milne GJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004005; Mniszewski SM, 2008, COMPUT MATH ORGAN TH, V14, P209, DOI 10.1007/s10588-008-9027-1; Morimoto Tomoko, 2010, Environmental Health and Preventive Medicine, V15, P151, DOI 10.1007/s12199-009-0122-9; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Organizaci6n Mundial de la Salud, 2009, RED TRANSM PAND H1N1; Perlroth DJ, 2010, CLIN INFECT DIS, V50, P165, DOI 10.1086/649867; Rizzo C, 2008, EPIDEMIOL INFECT, V136, P1650, DOI 10.1017/S095026880800037X; Roberts MG, 2007, J R SOC INTERFACE, V4, P325, DOI 10.1098/rsif.2006.0176; Sander B, 2009, VALUE HEALTH, V12, P226, DOI 10.1111/j.1524-4733.2008.00437.x; Sato Tomoki, 2013, Nihon Koshu Eisei Zasshi, V60, P204, DOI 10.11236/jph.60.4_204; Suh Mina, 2010, J Prev Med Public Health, V43, P109, DOI 10.3961/jpmph.2010.43.2.109; Sypsa V, 2009, EUROSURVEILLANCE, V14; Vynnycky E, 2008, EPIDEMIOL INFECT, V136, P166, DOI 10.1017/S0950268807008369; Vynnycky E, 2007, INT J EPIDEMIOL, V36, P881, DOI 10.1093/ije/dym071; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Wallinga J, 2010, P NATL ACAD SCI USA, V107, P923, DOI 10.1073/pnas.0908491107; Wu JT, 2010, EMERG INFECT DIS, V16, P538, DOI 10.3201/eid1603.091216; Yang Y, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-199; Yasuda H, 2005, JPN J INFECT DIS, V58, pS14; Yasuda H, 2009, EURO SURVEILLANCE B, V14; Yasuda H, 2008, J URBAN HEALTH, V85, P619, DOI 10.1007/s11524-008-9264-0; Zhang TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032203; Zhang TY, 2011, J PUBLIC HEALTH POL, V32, P180, DOI 10.1057/jphp.2011.1	78	83	86	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97297	10.1371/journal.pone.0097297	http://dx.doi.org/10.1371/journal.pone.0097297			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830407	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000336789500047
J	Johansson, D; Laursen, F; Ferno, A; Fosseidengen, JE; Klebert, P; Stien, LH; Vagseth, T; Oppedal, F				Johansson, David; Laursen, Frida; Ferno, Anders; Fosseidengen, Jan Erik; Klebert, Pascal; Stien, Lars Helge; Vagseth, Tone; Oppedal, Frode			The Interaction between Water Currents and Salmon Swimming Behaviour in Sea Cages	PLOS ONE			English	Article							ATLANTIC SALMON; SITE SELECTION; SALAR L.; PERFORMANCE; FISH	Positioning of sea cages at sites with high water current velocities expose the fish to a largely unknown environmental challenge. In this study we observed the swimming behaviour of Atlantic salmon (Salmo salar L.) at a commercial farm with tidal currents altering between low, moderate and high velocities. At high current velocities the salmon switched from the traditional circular polarized group structure, seen at low and moderate current velocities, to a group structure where all fish kept stations at fixed positions swimming against the current. This type of group behaviour has not been described in sea cages previously. The structural changes could be explained by a preferred swimming speed of salmon spatially restricted in a cage in combination with a behavioural plasticity of the fish.	[Johansson, David; Laursen, Frida; Fosseidengen, Jan Erik; Stien, Lars Helge; Vagseth, Tone; Oppedal, Frode] Inst Marine Res, Matredal, Norway; [Laursen, Frida; Ferno, Anders] Univ Bergen, Dept Biol, Bergen, Norway; [Klebert, Pascal] Sintef Fisheries & Aquaculture, Trondheim, Norway	Institute of Marine Research - Norway; University of Bergen; SINTEF	Johansson, D (corresponding author), Inst Marine Res, Matredal, Norway.	davidjo@imr.no	klebert, pascal/DSX-4164-2022	Oppedal, Frode/0000-0001-8625-0331	Research Council of Norway [207116/E40]; Norwegian Ministry of Fisheries	Research Council of Norway(Research Council of Norway); Norwegian Ministry of Fisheries	The study was supported by Research Council of Norway (http://www.forskningsradet.no/en/Home_page/1177315753906) grant no. 207116/E40 and by the Norwegian Ministry of Fisheries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benetti DD, 2010, MAR TECHNOL SOC J, V44, P22, DOI 10.4031/MTSJ.44.3.11; BRETT JR, 1964, J FISH RES BOARD CAN, V21, P1183, DOI 10.1139/f64-103; Crawley M.J., 2007, R BOOK, P627, DOI [10.1002/9780470515075.ch19, DOI 10.1002/9780470515075.CH19]; Deitch EJ, 2006, J EXP BIOL, V209, P1310, DOI 10.1242/jeb.02105; Dempster T, 2009, AQUACULTURE, V288, P254, DOI 10.1016/j.aquaculture.2008.12.003; Drenner SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031311; Fore M, 2009, AQUACULTURE, V288, P196, DOI 10.1016/j.aquaculture.2008.11.031; Fredheim A, 2009, BASICS, P914, DOI 10.1533/9781845696474.6.914; Gansel LC, 2012, J OFFSHORE MECH ARCT, V134, DOI 10.1115/1.4003695; Herskin J, 1998, J FISH BIOL, V53, P366, DOI 10.1006/jfbi.1998.0708; Holmer M, 2010, AQUACULT ENV INTERAC, V1, P57, DOI 10.3354/aei00007; Johansson D, 2007, AQUACULTURE, V265, P271, DOI 10.1016/j.aquaculture.2006.12.047; JUELL JE, 1995, REV FISH BIOL FISHER, V5, P320, DOI 10.1007/BF00043005; Klebert P, 2013, OCEAN ENG, V58, P260, DOI 10.1016/j.oceaneng.2012.11.006; Lijalad M, 2009, AQUACULTURE, V290, P145, DOI 10.1016/j.aquaculture.2009.01.039; Loverich GF, 1997, OPEN OCEAN AQUACULTU, P131; McKenzie DJ, 1998, FISH PHYSIOL BIOCHEM, V19, P111, DOI 10.1023/A:1007779619087; Oppedal F, 2011, AQUACULTURE, V311, P1, DOI 10.1016/j.aquaculture.2010.11.020; Perez OM, 2003, AQUACULT ENG, V29, P1, DOI 10.1016/S0144-8609(03)00031-1; Remen M, 2012, AQUACULTURE, V326, P148, DOI 10.1016/j.aquaculture.2011.11.036; Stien LH, 2013, REV AQUACULT, V5, P33, DOI 10.1111/j.1753-5131.2012.01083.x; SUTTERLIN AM, 1979, J FISH RES BOARD CAN, V36, P948, DOI 10.1139/f79-132	22	62	63	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97635	10.1371/journal.pone.0097635	http://dx.doi.org/10.1371/journal.pone.0097635			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830443	Green Published, gold			2022-12-27	WOS:000336789500089
J	Johnson, JE; Johnson, FB				Johnson, Jay E.; Johnson, F. Brad			Methionine Restriction Activates the Retrograde Response and Confers Both Stress Tolerance and Lifespan Extension to Yeast, Mouse and Human Cells	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; CELLULAR SENESCENCE; GENE-EXPRESSION; AGING PRIMATES; TRANSFER-RNA; DWARF MICE; KAPPA-B; RESISTANCE; TOR	A methionine-restricted diet robustly improves healthspan in key model organisms. For example, methionine restriction reduces age-related pathologies and extends lifespan up to 45% in rodents. However, the mechanisms underlying these benefits remain largely unknown. We tested whether the yeast chronological aging assay could model the benefits of methionine restriction, and found that this intervention extends lifespan when enforced by either dietary or genetic approaches, and furthermore, that the observed lifespan extension is due primarily to reduced acid accumulation. In addition, methionine restriction-induced lifespan extension requires the activity of the retrograde response, which regulates nuclear gene expression in response to changes in mitochondrial function. Consistent with an involvement of stress-responsive retrograde signaling, we also found that methionine-restricted yeast are more stress tolerant than control cells. Prompted by these findings in yeast, we tested the effects of genetic methionine restriction on the stress tolerance and replicative lifespans of cultured mouse and human fibroblasts. We found that such methionine-restricted mammalian cells are resistant to numerous cytotoxic stresses, and are substantially longer-lived than control cells. In addition, similar to yeast, the extended lifespan of methionine-restricted mammalian cells is associated with NF kappa B-mediated retrograde signaling. Overall, our data suggest that improved stress tolerance and extension of replicative lifespan may contribute to the improved healthspan observed in methionine-restricted rodents, and also support the possibility that manipulation of the pathways engaged by methionine restriction may improve healthspan in humans.	[Johnson, Jay E.; Johnson, F. Brad] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Johnson, F. Brad] Univ Penn, Inst Aging, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Johnson, FB (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	johnsonb@mail.med.upenn.edu			National Institutes of Health [P01-AG031862, R01-AG021521]; NATIONAL INSTITUTE ON AGING [R01AG021521, P01AG031862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (http://www.nih.gov/)grants P01-AG031862 and R01-AG021521. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Albertini E, 2012, AGING-US, V4, P664, DOI 10.18632/aging.100491; Amoros M, 2001, MOL MICROBIOL, V39, P1523, DOI 10.1046/j.1365-2958.2001.02339.x; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522; Biswas G, 2003, J CELL BIOL, V161, P507, DOI 10.1083/jcb.200211104; Brachmann CB, 1998, YEAST, V14, P115; Burtner CR, 2009, CELL CYCLE, V8, P1256, DOI 10.4161/cc.8.8.8287; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Fabrizio Paola, 2007, Methods Mol Biol, V371, P89; Fabrizio P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001024; FESNEAU C, 1975, BIOCHIMIE, V57, P49, DOI 10.1016/S0300-9084(75)80109-X; Gems D, 2008, CELL METAB, V7, P200, DOI 10.1016/j.cmet.2008.01.001; Guaragnella N, 2006, FEBS LETT, V580, P6880, DOI 10.1016/j.febslet.2006.11.050; Guaragnella N, 2013, BBA-MOL CELL RES, V1833, P2765, DOI 10.1016/j.bbamcr.2013.07.017; Guaragnella N, 2010, FEBS LETT, V584, P224, DOI 10.1016/j.febslet.2009.11.072; Harper JM, 2007, AGING CELL, V6, P1, DOI 10.1111/j.1474-9726.2006.00255.x; Harper JM, 2006, MECH AGEING DEV, V127, P687, DOI 10.1016/j.mad.2006.04.002; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Herker E, 2004, J CELL BIOL, V164, P501, DOI 10.1083/jcb.200310014; Hershman SG, 2008, NUCLEIC ACIDS RES, V36, P144, DOI 10.1093/nar/gkm986; Hinojosa CA, 2012, EXP GERONTOL, V47, P958, DOI 10.1016/j.exger.2012.08.013; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Hwang GW, 2007, BIOCHEM BIOPH RES CO, V363, P873, DOI 10.1016/j.bbrc.2007.09.064; Jazwinski SM, 2013, BBA-MOL CELL RES, V1833, P400, DOI 10.1016/j.bbamcr.2012.02.010; Jazwinski SM, 2000, ANN NY ACAD SCI, V908, P21; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; Jiang JC, 2000, FASEB J, V14, P2135; Jurk D, 2012, AGING CELL, V11, P996, DOI 10.1111/j.1474-9726.2012.00870.x; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; KJELLINS.K, 1969, J BACTERIOL, V100, P679; Kofman AE, 2012, AGING-US, V4, P279, DOI 10.18632/aging.100451; Kreiling JA, 2011, AGING CELL, V10, P292, DOI 10.1111/j.1474-9726.2010.00666.x; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991; Longo VD, 1996, J BIOL CHEM, V271, P12275, DOI 10.1074/jbc.271.21.12275; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Maddineni S, 2013, EXP BIOL MED, V238, P392, DOI 10.1177/1535370213477988; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; McCarty MF, 2009, MED HYPOTHESES, V72, P125, DOI 10.1016/j.mehy.2008.07.044; Mei YD, 2010, MOL CELL, V37, P668, DOI 10.1016/j.molcel.2010.01.023; Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x; Motorin Y, 1999, RNA, V5, P1105, DOI 10.1017/S1355838299982201; Murakami S, 2003, FASEB J, V17, P1565, DOI 10.1096/fj.02-1092fje; ORENTREICH N, 1993, J NUTR, V123, P269; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; RICHIE JP, 1994, FASEB J, V8, P1302, DOI 10.1096/fasebj.8.15.8001743; Salmon AB, 2005, AM J PHYSIOL-ENDOC M, V289, pE23, DOI 10.1152/ajpendo.00575.2004; Sanchez-Roman I, 2013, EXP GERONTOL, V48, P1030, DOI 10.1016/j.exger.2013.02.021; Sanz A, 2006, FASEB J, V20, P1064, DOI 10.1096/fj.05-5568com; Shih VFS, 2011, CELL RES, V21, P86, DOI 10.1038/cr.2010.161; SINGH A, 1974, J BACTERIOL, V118, P911, DOI 10.1128/JB.118.3.911-918.1974; Vitvitsky V, 2013, MECH AGEING DEV, V134, P321, DOI 10.1016/j.mad.2013.05.004; Warringer J, 2003, YEAST, V20, P53, DOI 10.1002/yea.931; Wei M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040013; Weindruch R, 1997, NEW ENGL J MED, V337, P986, DOI 10.1056/NEJM199710023371407; Welch AZ, 2013, MOL BIOL CELL, V24, P115, DOI 10.1091/mbc.E12-07-0524; Wilkinson JE, 2012, AGING CELL, V11, P675, DOI 10.1111/j.1474-9726.2012.00832.x; Wu P, 1998, GENE, V220, P109, DOI 10.1016/S0378-1119(98)00330-8; Wu ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079319	64	62	64	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97729	10.1371/journal.pone.0097729	http://dx.doi.org/10.1371/journal.pone.0097729			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830393	Green Published, Green Submitted, gold			2022-12-27	WOS:000336789500107
J	Kaminski, L; Eichler, J				Kaminski, Lina; Eichler, Jerry			Haloferax volcanii N-Glycosylation: Delineating the Pathway of dTDP-rhamnose Biosynthesis	PLOS ONE			English	Article							S-LAYER GLYCOPROTEIN; UDP-L-RHAMNOSE; PROTEIN GLYCOSYLATION; DIPHOSPHATE 4-KETO-6-DEOXY-D-GLUCOSE; CARBOHYDRATE-METABOLISM; ENZYMATIC SYNTHESIS; MEVALONATE PATHWAY; D-GLUCOSE; ARCHAEA; IDENTIFICATION	In the halophilic archaea Haloferax volcanii, the surface (S)-layer glycoprotein can be modified by two distinct N-linked glycans. The tetrasaccharide attached to S-layer glycoprotein Asn-498 comprises a sulfated hexose, two hexoses and a rhamnose. While Agl11-14 have been implicated in the appearance of the terminal rhamnose subunit, the precise roles of these proteins have yet to be defined. Accordingly, a series of in vitro assays conducted with purified Agl11-Agl14 showed these proteins to catalyze the stepwise conversion of glucose-1-phosphate to dTDP-rhamnose, the final sugar of the tetrasaccharide glycan. Specifically, Agl11 is a glucose-1-phosphate thymidylyltransferase, Agl12 is a dTDP-glucose-4,6-dehydratase and Agl13 is a dTDP-4-dehydro-6-deoxy-glucose-3,5-epimerase, while Agl14 is a dTDP-4-dehydrorhamnose reductase. Archaea thus synthesize nucleotide-activated rhamnose by a pathway similar to that employed by Bacteria and distinct from that used by Eukarya and viruses. Moreover, a bioinformatics screen identified homologues of agl11-14 clustered in other archaeal genomes, often as part of an extended gene cluster also containing aglB, encoding the archaeal oligosaccharyltransferase. This points to rhamnose as being a component of N-linked glycans in Archaea other than Hfx. volcanii.	[Kaminski, Lina; Eichler, Jerry] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel	Ben Gurion University	Eichler, J (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	jeichler@bgu.ac.il	EICHLER, JERRY/F-2351-2012	EICHLER, JERRY/0000-0001-9409-8026	Israel Science Foundation [8/11]; U. S. Army Research Office [W911NF-11-1-520]; Negev-Zin Associates Scholarship	Israel Science Foundation(Israel Science Foundation); U. S. Army Research Office; Negev-Zin Associates Scholarship	J.E. is supported by the Israel Science Foundation (grant 8/11) and the U. S. Army Research Office (W911NF-11-1-520). L.K. is the recipient of a Negev-Zin Associates Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Qarn M, 2008, J BACTERIOL, V190, P3140, DOI 10.1128/JB.00056-08; Abu-Qarn M, 2007, J MOL BIOL, V374, P1224, DOI 10.1016/j.jmb.2007.10.042; Abu-Qarn M, 2006, MOL MICROBIOL, V61, P511, DOI 10.1111/j.1365-2958.2006.05252.x; Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001; Bell SD, 2001, CURR OPIN MICROBIOL, V4, P208, DOI 10.1016/S1369-5274(00)00190-9; Benelli D, 2011, BIOCHEM SOC T, V39, P89, DOI 10.1042/BST0390089; Brasen C, 2014, MICROBIOL MOL BIOL R, V78, P89, DOI 10.1128/MMBR.00041-13; Chothi MP, 2010, J VIROL, V84, P8829, DOI 10.1128/JVI.00770-10; Christendat D, 2000, J BIOL CHEM, V275, P24608, DOI 10.1074/jbc.C000238200; Cohen-Rosenzweig C, 2012, J BACTERIOL, V194, P6909, DOI 10.1128/JB.01716-12; Eichler J, 2013, NAT REV MICROBIOL, V11, P151, DOI 10.1038/nrmicro2957; Giraud MF, 2000, CURR OPIN STRUC BIOL, V10, P687, DOI 10.1016/S0959-440X(00)00145-7; GLASER L, 1961, J BIOL CHEM, V236, P1795; Graninger M, 1999, J BIOL CHEM, V274, P25069, DOI 10.1074/jbc.274.35.25069; Grochowski LL, 2006, J BACTERIOL, V188, P3192, DOI 10.1128/JB.188.9.3192-3198.2006; Guan ZQ, 2012, ENVIRON MICROBIOL, V14, P743, DOI 10.1111/j.1462-2920.2011.02625.x; Holden HM, 2003, J BIOL CHEM, V278, P43885, DOI 10.1074/jbc.R300025200; Kaminski L, 2013, MBIO, V4, DOI 10.1128/mBio.00716-13; Kaminski L, 2013, MOL PHYLOGENET EVOL, V68, P327, DOI 10.1016/j.ympev.2013.03.024; Kaminski L, 2010, ARCHAEA, V2010, DOI 10.1155/2010/315108; Kaminski L, 2010, J BACTERIOL, V192, P5572, DOI 10.1128/JB.00705-10; KAMSTEEG J, 1978, FEBS LETT, V91, P281, DOI 10.1016/0014-5793(78)81192-2; Kuntz C, 1997, GLYCOBIOLOGY, V7, P897, DOI 10.1093/glycob/7.7.897; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; LECHNER J, 1989, ANNU REV BIOCHEM, V58, P173, DOI 10.1146/annurev.bi.58.070189.001133; Magidovich H, 2010, MOL MICROBIOL, V76, P190, DOI 10.1111/j.1365-2958.2010.07090.x; Maki M, 2004, GLYCOBIOLOGY, V14, p1R, DOI 10.1093/glycob/cwh040; Martinez V, 2012, J BIOL CHEM, V287, P879, DOI 10.1074/jbc.M111.287367; MELO A, 1968, J BIOL CHEM, V243, P1475; Nishimura H, 2013, J BIOCHEM, V153, P415, DOI 10.1093/jb/mvt006; Nothaft H, 2013, J BIOL CHEM, V288, P6912, DOI 10.1074/jbc.R112.417857; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Oka T, 2007, J BIOL CHEM, V282, P5389, DOI 10.1074/jbc.M610196200; OKAZAKI R, 1962, J BIOL CHEM, V237, P3014; PAZUR JH, 1961, J BIOL CHEM, V236, P1780; Phillips G, 2010, J BIOL CHEM, V285, P12706, DOI 10.1074/jbc.M110.102236; Plavner N, 2008, J BACTERIOL, V190, P8045, DOI 10.1128/JB.01200-08; Sakuraba H, 2004, CHEM REC, V3, P281, DOI 10.1002/tcr.10066; Sato T, 2011, CURR OPIN MICROBIOL, V14, P307, DOI 10.1016/j.mib.2011.04.014; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Siebers B, 2005, CURR OPIN MICROBIOL, V8, P695, DOI 10.1016/j.mib.2005.10.014; SNIPES CE, 1977, J BIOL CHEM, V252, P8113; SPROTT GD, 1983, J BIOL CHEM, V258, P4026; Teramoto M., 2012, ADV APPL BIOTECHNOLO, DOI [10.5772/29196, DOI 10.5772/29196]; Tsukioka Y, 1997, J BACTERIOL, V179, P1126, DOI 10.1128/jb.179.4.1126-1134.1997; VanNice JC, 2014, J BACTERIOL, V196, P1055, DOI 10.1128/JB.01230-13; Wang JF, 2009, PLANT PHYSIOL BIOCH, V47, P86, DOI 10.1016/j.plaphy.2008.10.011; Watt G, 2004, PLANT PHYSIOL, V134, P1337, DOI 10.1104/pp.103.037192; Yurist-Doutsch S, 2008, MOL MICROBIOL, V69, P1234, DOI 10.1111/j.1365-2958.2008.06352.x; Yurist-Doutsch S, 2010, MOL MICROBIOL, V75, P1047, DOI 10.1111/j.1365-2958.2009.07045.x; Zhang ZL, 2005, J BIOL CHEM, V280, P9698, DOI 10.1074/jbc.M411211200	51	11	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97441	10.1371/journal.pone.0097441	http://dx.doi.org/10.1371/journal.pone.0097441			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831810	gold, Green Published, Green Submitted			2022-12-27	WOS:000336789500059
J	Frosch, C; Kraus, RHS; Angst, C; Allgower, R; Michaux, J; Teubner, J; Nowak, C				Frosch, Christiane; Kraus, Robert H. S.; Angst, Christof; Allgoewer, Rainer; Michaux, Johan; Teubner, Jana; Nowak, Carsten			The Genetic Legacy of Multiple Beaver Reintroductions in Central Europe	PLOS ONE			English	Article							CASTOR-FIBER; EURASIAN BEAVER; POPULATION-STRUCTURE; MITOCHONDRIAL-DNA; COMPUTER-PROGRAM; AMERICAN BEAVER; CONSERVATION; CANADENSIS; SOFTWARE; BRITAIN	The comeback of the Eurasian beaver (Castor fiber) throughout western and central Europe is considered a major conservation success. Traditionally, several subspecies are recognised by morphology and mitochondrial haplotype, each linked to a relict population. During various reintroduction programs in the 20th century, beavers from multiple source localities were released and now form viable populations. These programs differed in their reintroduction strategies, i.e., using pure subspecies vs. mixed source populations. This inhomogeneity in management actions generated ongoing debates regarding the origin of present beaver populations and appropriate management plans for the future. By sequencing of the mitochondrial control region and microsatellite genotyping of 235 beaver individuals from five selected regions in Germany, Switzerland, Luxembourg, and Belgium we show that beavers from at least four source origins currently form admixed, genetically diverse populations that spread across the study region. While regional occurrences of invasive North American beavers (n = 20) were found, all but one C. fiber bore the mitochondrial haplotype of the autochthonous western Evolutionary Significant Unit (ESU). Considering this, as well as the viability of admixed populations and the fact that the fusion of different lineages is already progressing in all studied regions, we argue that admixture between different beaver source populations should be generally accepted.	[Frosch, Christiane; Kraus, Robert H. S.; Nowak, Carsten] Senckenberg Res Inst, Conservat Genet Grp, Gelnhausen, Germany; [Frosch, Christiane; Kraus, Robert H. S.; Nowak, Carsten] Nat Hist Museum, Gelnhausen, Germany; [Angst, Christof] Ctr Suisse Cartog Faune CSCF, Neuchatel, Switzerland; [Allgoewer, Rainer] Buro Okosyst Forsch, Muhlacker, Germany; [Michaux, Johan] Inst Zool, Unite Rech Zoogeog, Liege, Belgium; [Teubner, Jana] Nat Schutzstat Zippelsforde, Zippelsforde, Germany; [Nowak, Carsten] Biodivers & Climate Res Ctr BiK F, Frankfurt, Germany	Senckenberg Gesellschaft fur Naturforschung (SGN); Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN)	Frosch, C (corresponding author), Senckenberg Res Inst, Conservat Genet Grp, Gelnhausen, Germany.	cfrosch@senckenberg.de	Nowak, Carsten/A-4466-2014; Kraus, Robert/F-1188-2011	Nowak, Carsten/0000-0002-3139-1951; Kraus, Robert/0000-0002-8743-7082	Regierungsprasidium Darmstadt, Hesse, Germany; Johanna Samel-Stiftung; Frankfurt Zoological Society; Leibniz Association [SAW-2011-SGN-3]; Hesse's LOEWE excellence initiative	Regierungsprasidium Darmstadt, Hesse, Germany; Johanna Samel-Stiftung; Frankfurt Zoological Society; Leibniz Association; Hesse's LOEWE excellence initiative	This study was financially supported by the Regierungsprasidium Darmstadt, Hesse, Germany. CF received funding from the Johanna Samel-Stiftung and the Frankfurt Zoological Society. RHSK was funded by grant SAW-2011-SGN-3 from the Leibniz Association. Additional funding comes from Hesse's LOEWE excellence initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EC, 2002, GENETICS, V160, P1217; Bartel M, 2012, WILDTIER INFORMATION; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Crawford JC, 2008, J MAMMAL, V89, P575, DOI 10.1644/07-MAMM-A-251R1.1; De Barba M, 2010, MOL ECOL, V19, P3938, DOI 10.1111/j.1365-294X.2010.04791.x; Dewas M, 2012, MAMMAL REV, V42, P144, DOI 10.1111/j.1365-2907.2011.00196.x; Djoschkin WW, 1972, BIBER ALTEN NEUEN WE, P437; Dolch D, 2002, NATURSCHUTZ LANDSCHA, V11, P220; Ducroz JF, 2005, J MAMMAL, V86, P1059, DOI 10.1644/1545-1542(2005)86[1059:GVAPSO]2.0.CO;2; Durka W, 2005, MOL ECOL, V14, P3843, DOI 10.1111/j.1365-294X.2005.02704.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; ELLEGREN H, 1993, P NATL ACAD SCI USA, V90, P8150, DOI 10.1073/pnas.90.17.8150; Enserink M, 2006, SCIENCE, V314, P746, DOI 10.1126/science.314.5800.746; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frosch C, 2011, EUR J WILDLIFE RES, V57, P679, DOI 10.1007/s10344-010-0486-6; Gippoliti S, 2007, INT ZOO YB, V41; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Halley DJ, 2002, MAMMAL REV, V32, P153, DOI 10.1046/j.1365-2907.2002.00106.x; Halley D, 2012, BALT FOR, V18, P168; Halley Duncan J., 2003, Lutra, V46, P91; Halley DJ, 2011, MAMMAL REV, V41, P40, DOI 10.1111/j.1365-2907.2010.00167.x; Heidecke D., 1986, HERCYNIA NF LEIPZIG, V22, P146; Hermann N, 2013, J NAT CONSERV, V21, P125, DOI 10.1016/j.jnc.2012.11.008; Herr Jan, 2009, Lutra, V52, P123; Horn S, 2014, MOL ECOL, V23, P1717, DOI 10.1111/mec.12691; Horn Susanne, 2010, Artenschutzreport, V26, P72; Horn S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014622; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kuemmerle T, 2011, J APPL ECOL, V48, P317, DOI 10.1111/j.1365-2664.2010.01954.x; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; LAVROV L S, 1973, Zoologicheskii Zhurnal, V52, P734; Linnell JDC, 2009, REINTRODUCTION TOP O; Macdonald DW, 1995, MAMMAL REV, V25, P161, DOI 10.1111/j.1365-2907.1995.tb00443.x; McEwing R, 2014, EUR J WILDLIFE RES, V60, P547, DOI 10.1007/s10344-014-0803-6; MORITZ C, 1994, MOL ECOL, V3, P401, DOI 10.1111/j.1365-294X.1994.tb00080.x; Nolet BA, 1996, BIOL CONSERV, V75, P125, DOI 10.1016/0006-3207(95)00063-1; Nolet BA, 1998, BIOL CONSERV, V83, P165, DOI 10.1016/S0006-3207(97)00066-9; Parker H, 2012, WILDLIFE BIOL, V18, P354, DOI 10.2981/12-007; Pelz-Serrano K, 2009, MOL ECOL RESOUR, V9, P551, DOI 10.1111/j.1755-0998.2008.02364.x; Piechocki R., 1977, Bzitrage Jagd-Wildforsch., V10, P332; Pritchard JK, 2000, GENETICS, V155, P945; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Saveljev Alexander, 2002, Acta Zoologica Lituanica, V12, P397; Schwab G, 2002, EUROPEAN BEAVER NEW, P51; Senn H, 2013, MOL ECOL, V22, P3141, DOI 10.1111/mec.12242; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valiere N., 2002, MOL ECOL NOTES, V10, P1046, DOI DOI 10.1046/J.1471-8286.2002.00228.X-I2; Wahlund S, 1928, HEREDITAS, V11, P65, DOI 10.1111/j.1601-5223.1928.tb02483.x	52	34	35	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97619	10.1371/journal.pone.0097619	http://dx.doi.org/10.1371/journal.pone.0097619			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827835	Green Published, gold			2022-12-27	WOS:000336857400112
J	Haack, RA; Britton, KO; Brockerhoff, EG; Cavey, JF; Garrett, LJ; Kimberley, M; Lowenstein, F; Nuding, A; Olson, LJ; Turner, J; Vasilaky, KN				Haack, Robert A.; Britton, Kerry O.; Brockerhoff, Eckehard G.; Cavey, Joseph F.; Garrett, Lynn J.; Kimberley, Mark; Lowenstein, Frank; Nuding, Amelia; Olson, Lars J.; Turner, James; Vasilaky, Kathryn N.			Effectiveness of the International Phytosanitary Standard ISPM No. 15 on Reducing Wood Borer Infestation Rates in Wood Packaging Material Entering the United States	PLOS ONE			English	Article							EMERALD ASH BORER; HEAT-TREATMENT; EXOTIC BARK; AMBROSIA BEETLES; COLEOPTERA; ESTABLISHMENT; INVASIONS; IMPACTS; FORESTS; INSECT	Numerous bark- and wood-infesting insects have been introduced to new countries by international trade where some have caused severe environmental and economic damage. Wood packaging material (WPM), such as pallets, is one of the high risk pathways for the introduction of wood pests. International recognition of this risk resulted in adoption of International Standards for Phytosanitary Measures No. 15 (ISPM15) in 2002, which provides treatment standards for WPM used in international trade. ISPM15 was originally developed by members of the International Plant Protection Convention to "practically eliminate" the risk of international transport of most bark and wood pests via WPM. The United States (US) implemented ISPM15 in three phases during 2005-2006. We compared pest interception rates of WPM inspected at US ports before and after US implementation of ISPM15 using the US Department of Agriculture AQIM (Agriculture Quarantine Inspection Monitoring) database. Analyses of records from 2003-2009 indicated that WPM infestation rates declined 36-52% following ISPM15 implementation, with results varying in statistical significance depending on the selected starting parameters. Power analyses of the AQIM data indicated there was at least a 95% chance of detecting a statistically significant reduction in infestation rates if they dropped by 90% post-ISPM15, but the probability fell as the impact of ISPM15 lessened. We discuss several factors that could have reduced the apparent impact of ISPM15 on lowering WPM infestation levels, and suggest ways that ISPM15 could be improved. The paucity of international interception data impeded our ability to conduct more thorough analyses of the impact of ISPM15, and demonstrates the need for well-planned sampling programs before and after implementation of major phytosanitary policies so that their effectiveness can be assessed. We also present summary data for bark- and wood-boring insects intercepted on WPM at US ports during 1984-2008.	[Haack, Robert A.] US Forest Serv, USDA, No Res Stn, Lansing, MI USA; [Britton, Kerry O.] US Forest Serv, USDA, Arlington, VA USA; [Brockerhoff, Eckehard G.] Scion NZ Forest Res Inst, Christchurch, New Zealand; [Cavey, Joseph F.] US Anim & Plant Hlth Inspect Serv, USDA, Plant Hlth Programs, Natl Identificat Serv, Riverdale, MD USA; [Garrett, Lynn J.] US Anim & Plant Hlth Inspect Serv, USDA, Ctr Plant Hlth Sci & Technol, Raleigh, NC USA; [Kimberley, Mark] Scion New Zealand Forest Res Inst, Rotorua, New Zealand; [Lowenstein, Frank] New England Forestry Fdn, Littleton, MA USA; [Nuding, Amelia] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA; [Olson, Lars J.] Univ Maryland, College Pk, MD 20742 USA; [Turner, James] AgResearch Ltd, Ruakura Res Ctr, Hamilton, New Zealand; [Vasilaky, Kathryn N.] Columbia Univ, Earth Inst, New York, NY USA; [Vasilaky, Kathryn N.] Columbia Univ, Int Res Inst Climate & Soc, New York, NY USA	United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service; Scion; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; University System of Maryland; University of Maryland College Park; AgResearch - New Zealand; Columbia University; Columbia University	Haack, RA (corresponding author), US Forest Serv, USDA, No Res Stn, Lansing, MI USA.	rhaack@fs.fed.us	Brockerhoff, Eckehard Gustav/C-1528-2009; Turner, James Alan/AAU-9221-2020	Brockerhoff, Eckehard Gustav/0000-0002-5962-3208; Turner, James Alan/0000-0003-4396-3280	Nature Conservancy; National Science Foundation [EF-0553768]; University of California Santa Barbara; State of California; New Zealand Foundation for Research and Technology [C02X0501, C04X0302]	Nature Conservancy; National Science Foundation(National Science Foundation (NSF)); University of California Santa Barbara(University of California System); State of California; New Zealand Foundation for Research and Technology(New Zealand Foundation for Research, Science and Technology)	The Working Group "Effects of trade policy on management of non-native forest pests and pathogens" was supported by a grant from The Nature Conservancy to the National Center for Ecological Analysis and Synthesis, which is a Center funded by the National Science Foundation (Grant #EF-0553768), the University of California Santa Barbara, and the State of California. Partial funding was provided by the New Zealand Foundation for Research and Technology through contracts C02X0501 (Better Border Biosecurity) and C04X0302 (Forest Biosecurity and Protection) to the author EGB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EA, 2002, CAN J PLANT PATHOL, V24, P103, DOI 10.1080/07060660309506983; Aukema JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024587; Aukema JE, 2010, BIOSCIENCE, V60, P886, DOI 10.1525/bio.2010.60.11.5; Brockerhoff EG, 2014, ECOLOGY, V95, P594, DOI 10.1890/13-0465.1; Brockerhoff EG, 2006, CAN J FOREST RES, V36, P289, DOI [10.1139/x05-250, 10.1139/X05-250]; Bulman L. S., 1992, New Zealand Journal of Forestry Science, V22, P32; Bulman L. S., 1998, New Zealand Journal of Forestry Science, V28, P335; Costello C, 2003, AM J AGR ECON, V85, P964, DOI 10.1111/1467-8276.00500; Cross David J., 1991, New Zealand Journal of Forestry Science, V21, P235; Deacon JW, 2006, FUNGAL BIOL-UK; Evans HF, 2007, ALIEN INVASIVE SPECI, P149; Gandhi KJK, 2010, BIOL INVASIONS, V12, P1839, DOI 10.1007/s10530-009-9594-1; Goebel PC, 2010, J ECON ENTOMOL, V103, P597, DOI 10.1603/EC09264; Haack R.A., 1987, P449; Haack R. A., 2011, Bulletin OEPP, V41, P39, DOI 10.1111/j.1365-2338.2010.02432.x; Haack RA, 2006, CAN J FOREST RES, V36, P269, DOI 10.1139/x05-249; Haack RA, 1997, J FOREST, V95, P11; Haack RA, 2009, J ECON ENTOMOL, V102, P1075, DOI 10.1603/029.102.0328; Haack RA, 2013, CABI INVASIVE SER, P48, DOI 10.1079/9781845938291.0048; Haack Robert A., 2003, Integrated Pest Management Reviews, V6, P253, DOI 10.1023/A:1025715200538; Haack RA, 2010, ANNU REV ENTOMOL, V55, P521, DOI 10.1146/annurev-ento-112408-085427; Holmes TP, 2009, ANN NY ACAD SCI, V1162, P18, DOI 10.1111/j.1749-6632.2009.04446.x; Horridge M, 2008, EXERCISES CONTRIBUTI; International Plant Protection Convention, 2006, INT STAND PHYT MEAS, V15; International Plant Protection Convention, 2012, INT STAND PHYT MEAS; International Plant Protection Convention, 2011, INT STAND PHYT MEAS, V15; International Plant Protection Convention, 2009, INT STAND PHYT MEAS, V15; International Plant Protection Convention, 2013, INT STAND PHYT MEAS, V15; International Plant Protection Convention, 2002, PUBL UN FAO, V15; International Plant Protection Convention, 2001, INT STAND PHYT MEAS; Kenis M, 2007, B ENTOMOL RES, V97, P489, DOI 10.1017/S0007485307005184; Leal I, 2010, BCX419 NAT RES CAN C; Liebhold AM, 2012, FRONT ECOL ENVIRON, V10, P135, DOI 10.1890/110198; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; McCullouch DG, 2007, J ECON ENTOMOL, V100, P1304, DOI 10.1603/0022-0493(2007)100[1304:EOCGAH]2.0.CO;2; McCullough DG, 2006, BIOL INVASIONS, V8, P611, DOI 10.1007/s10530-005-1798-4; Mushrow L, 2004, FOREST CHRON, V80, P224, DOI 10.5558/tfc80224-2; Myers SW, 2009, J ECON ENTOMOL, V102, P2048, DOI 10.1603/029.102.0605; National Research Council, 2002, PRED INV NON PLANTS; Nzokou P, 2008, FOREST PROD J, V58, P68; Olson L. J., 2006, Agricultural and Resource Economics Review, V35, P178; Ramsfield TD, 2010, CAN J PLANT PATHOL, V32, P368, DOI 10.1080/07060661.2010.499269; Salvage R, 1999, NAT STAK TIMB PEST C; Sanchez-Salinas PF, 2007, THESIS U TALCA CHILE; SAS Institute, 2008, SAS STAT 9 2 US GUID; Smith RS., 1991, USE HEAT TREATMENT E; Sobek S, 2011, AGR FOREST ENTOMOL, V13, P333, DOI 10.1111/j.1461-9563.2011.00523.x; Strutt A, 2013, FOREST POLICY ECON, V27, P54, DOI 10.1016/j.forpol.2012.11.003; Tubajika KM, 2008, P SUDD OAK DEATH 3 S, P477; U.S. Department of Agriculture, 2011, AGR QUAR INSP MON AQ; United States Census Bureau, 2012, TRAD GOODS MEX; United States Department of Agriculture, 2013, WOOD PACK MAT; United States Department of Agriculture Animal and Plant Health Inspection Service, 2004, FED REGISTER, V69, P55719; United States Department of Agriculture Animal and Plant Health Inspection Service, 2014, PPQ MAN AGR CLEAR 03; United States Department of Agriculture Animal and Plant Health Inspection Service, 1998, FED REGISTER, V63, P50100; United States Department of Agriculture Animal and Plant Health Inspection Service, 2003, IMP SOL WOOD PACK MA; US Government Accountability Office, 2006, GAO06353; Viljoen J, 2002, STOCK TAKE TIMBER TR; Williams F., 2010, EC COST INVASIVE NON; Zahid MI, 2008, AUSTRAL FOR, V71, P287, DOI 10.1080/00049158.2008.10675047	60	103	110	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96611	10.1371/journal.pone.0096611	http://dx.doi.org/10.1371/journal.pone.0096611			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827724	Green Published, Green Submitted, gold			2022-12-27	WOS:000336857400031
J	Jagga, Z; Gupta, D				Jagga, Zeenia; Gupta, Dinesh			Supervised Learning Classification Models for Prediction of Plant Virus Encoded RNA Silencing Suppressors	PLOS ONE			English	Article							VIRAL SUPPRESSORS; PROTEIN; INTERFERENCE; STRATEGY; SIZE	Viral encoded RNA silencing suppressor proteins interfere with the host RNA silencing machinery, facilitating viral infection by evading host immunity. In plant hosts, the viral proteins have several basic science implications and biotechnology applications. However in silico identification of these proteins is limited by their high sequence diversity. In this study we developed supervised learning based classification models for plant viral RNA silencing suppressor proteins in plant viruses. We developed four classifiers based on supervised learning algorithms: J48, Random Forest, LibSVM and Naive Bayes algorithms, with enriched model learning by correlation based feature selection. Structural and physicochemical features calculated for experimentally verified primary protein sequences were used to train the classifiers. The training features include amino acid composition; auto correlation coefficients; composition, transition, and distribution of various physicochemical properties; and pseudo amino acid composition. Performance analysis of predictive models based on 10 fold cross-validation and independent data testing revealed that the Random Forest based model was the best and achieved 86.11% overall accuracy and 86.22% balanced accuracy with a remarkably high area under the Receivers Operating Characteristic curve of 0.95 to predict viral RNA silencing suppressor proteins. The prediction models for plant viral RNA silencing suppressors can potentially aid identification of novel viral RNA silencing suppressors, which will provide valuable insights into the mechanism of RNA silencing and could be further explored as potential targets for designing novel antiviral therapeutics. Also, the key subset of identified optimal features may help in determining compositional patterns in the viral proteins which are important determinants for RNA silencing suppressor activities. The best prediction model developed in the study is available as a freely accessible web server pVsupPred at http://bioinfo.icgeb.res.in/pvsup/.	[Jagga, Zeenia; Gupta, Dinesh] Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, Bioinformat Facil, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Gupta, D (corresponding author), Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, Bioinformat Facil, Aruna Asaf Ali Marg, New Delhi, India.	dinesh@icgeb.res.in	Gupta, Dinesh/C-1079-2009; Gupta, Dinesh/AAW-4243-2020	Gupta, Dinesh/0000-0002-7548-8835; Gupta, Dinesh/0000-0002-7548-8835	Department of Biotechnology (DBT, India); University Grants Commission (UGC, India)	Department of Biotechnology (DBT, India)(Department of Biotechnology (DBT) India); University Grants Commission (UGC, India)(University Grants Commission, India)	The authors thank the Department of Biotechnology (DBT, India) for the grant for "Bioinformatics Infrastructure Facility" at ICGEB, New Delhi. ZJ acknowledges the University Grants Commission (UGC, India) for the Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandalakshmi R, 1998, P NATL ACAD SCI USA, V95, P13079, DOI 10.1073/pnas.95.22.13079; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Bivalkar-Mehla S, 2011, VIRUS RES, V155, P1, DOI 10.1016/j.virusres.2010.10.003; Bortolamiol D, 2008, PLANT SIGNAL BEHAV, V3, P657, DOI 10.4161/psb.3.9.5758; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burgyan J, 2011, TRENDS PLANT SCI, V16, P265, DOI 10.1016/j.tplants.2011.02.010; Cao DS, 2013, BIOINFORMATICS, V29, P960, DOI 10.1093/bioinformatics/btt072; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chao JA, 2005, NAT STRUCT MOL BIOL, V12, P952, DOI 10.1038/nsmb1005; Chen HY, 2008, EMBO REP, V9, P754, DOI 10.1038/embor.2008.118; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Chou KC, 2009, CURR PROTEOMICS, V6, P262, DOI 10.2174/157016409789973707; Csorba T, 2009, ADV VIRUS RES, V75, P35, DOI 10.1016/S0065-3527(09)07502-2; de Vries W, 2008, INT J BIOCHEM CELL B, V40, P2007, DOI 10.1016/j.biocel.2008.04.015; Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Haas G, 2008, EMBO J, V27, P2102, DOI 10.1038/emboj.2008.129; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hall M. A., 1999, Proceedings of the Twelfth International Florida AI Research Society Conference, P235; Japkowicz N, 2000, IC-AI'2000: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, VOL 1-III, P111; Jiang L, 2012, SCI CHINA LIFE SCI, V55, P109, DOI 10.1007/s11427-012-4279-x; Karjee Sumona, 2008, V442, P187, DOI 10.1007/978-1-59745-191-8_14; Larranaga P, 2006, BRIEF BIOINFORM, V7, P86, DOI 10.1093/bib/bbk007; Li WZ, 2002, BIOINFORMATICS, V18, P77, DOI 10.1093/bioinformatics/18.1.77; Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282; Merai Z, 2005, J VIROL, V79, P7217, DOI 10.1128/JVI.79.11.7217-7226.2005; Merai Z, 2006, J VIROL, V80, P5747, DOI 10.1128/JVI.01963-05; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Rahman J, 2012, APPL BIOCHEM BIOTECH, V167, P758, DOI 10.1007/s12010-012-9702-z; Ramnani P, 2013, ANAL CHEM, V85, P8061, DOI 10.1021/ac4018346; Rauschhuber C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01363; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Silhavy D, 2002, EMBO J, V21, P3070, DOI 10.1093/emboj/cdf312; Sioud M, 2007, ADV DRUG DELIVER REV, V59, P153, DOI 10.1016/j.addr.2007.03.006; Sokolova M, 2009, INFORM PROCESS MANAG, V45, P427, DOI 10.1016/j.ipm.2009.03.002; Song LP, 2011, PROTEIN CELL, V2, P273, DOI 10.1007/s13238-011-1037-y; Sun YM, 2007, PATTERN RECOGN, V40, P3358, DOI 10.1016/j.patcog.2007.04.009; Tarca AL, 2007, PLOS COMPUT BIOL, V3, P953, DOI 10.1371/journal.pcbi.0030116; Vapnik V., 1998, STAT LEARNING THEORY, V3, DOI DOI 10.1007/978-1-4419-1428-6_5864; Voinnet O, 2005, NAT REV GENET, V6, P206, DOI 10.1038/nrg1555; Witten I.H., 2005, DATA MINING PRACTICA; Wu QF, 2010, CELL HOST MICROBE, V8, P12, DOI 10.1016/j.chom.2010.06.009; Yasser E-M, 2005, WLSVM INTEGRATING LI	44	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97446	10.1371/journal.pone.0097446	http://dx.doi.org/10.1371/journal.pone.0097446			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828116	Green Published, Green Submitted, gold			2022-12-27	WOS:000336857400096
J	Shearer, AG; Altman, T; Rhee, CD				Shearer, Alexander G.; Altman, Tomer; Rhee, Christine D.			Finding Sequences for over 270 Orphan Enzymes	PLOS ONE			English	Article							METABOLIC-ACTIVITIES; DATABASE; RESOURCE; GENE; IDENTIFICATION; GENOMICS; UNIPROT; LIVER; ACID	Despite advances in sequencing technology, there are still significant numbers of well-characterized enzymatic activities for which there are no known associated sequences. These `orphan enzymes' represent glaring holes in our biological understanding, and it is a top priority to reunite them with their coding sequences. Here we report a methodology for resolving orphan enzymes through a combination of database search and literature review. Using this method we were able to reconnect over 270 orphan enzymes with their corresponding sequence. This success points toward how we can systematically eliminate the remaining orphan enzymes and prevent the introduction of future orphan enzymes.	[Shearer, Alexander G.; Rhee, Christine D.] Clover Collect, Mountain View, CA 94041 USA; [Altman, Tomer] Stanford Univ, Stanford, CA 94305 USA	Stanford University	Shearer, AG (corresponding author), Clover Collect, Mountain View, CA 94041 USA.	agshearer@clovercollective.com	Altman, Tomer/P-8089-2019	Altman, Tomer/0000-0002-6521-5454	National Institute of General Medical Sciences [GM086755]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086755] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by grant GM086755 from the National Institute of General Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304; BARNES S, 1989, J LIPID RES, V30, P529; Barrett Alan J., 1997, European Journal of Biochemistry, V250, P1; BEEDLE AS, 1974, BIOCHEM J, V139, P205, DOI 10.1042/bj1390205; Caspi R, 2013, COMMUNICATION; Caspi R, 2012, NUCLEIC ACIDS RES, V40, pD742, DOI 10.1093/nar/gkr1014; Chen LF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r17; Chen LF, 2007, TRENDS BIOTECHNOL, V25, P343, DOI 10.1016/j.tibtech.2007.06.001; Devoid Scott, 2013, Methods Mol Biol, V985, P17, DOI 10.1007/978-1-62703-299-5_2; Ferrer L, 2011, BIOINFORMATICS, V27, P2478, DOI 10.1093/bioinformatics/btr428; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Karp PD, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-401; Koivistoinen OM, 2008, FEBS J, V275, P2482, DOI 10.1111/j.1742-4658.2008.06392.x; Lee TJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-170; Lespinet O, 2005, SCIENCE, V307, P42; Lespinet O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-436; Li LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081956; Liang CG, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat043; Liberal R, 2013, BIOINFORMATICS, V29, P154, DOI 10.1093/bioinformatics/btt236; Mao XZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051252; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Moss GP, NAME CLASSIFY YOUR E; O'Donovan C, 2011, METHODS MOL BIOL, V694, P25, DOI 10.1007/978-1-60761-977-2_2; Pouliot Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-244; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Ramkissoon KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084508; Rhee SY, 2008, NAT REV GENET, V9, P509, DOI 10.1038/nrg2363; SCHLESINGER M, 1961, J BIOL CHEM, V236, P2421; Schomburg I, 2013, NUCLEIC ACIDS RES, V41, pD764, DOI 10.1093/nar/gks1049; Smith AAT, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002540; Thomas P, 2012, NUCLEIC ACIDS RES, V40, pW585, DOI 10.1093/nar/gks563; Yamada T, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.13	34	14	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97250	10.1371/journal.pone.0097250	http://dx.doi.org/10.1371/journal.pone.0097250			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24826896	Green Published, gold, Green Submitted			2022-12-27	WOS:000336857400066
J	Tembe, N; Joaquim, O; Alfai, E; Sitoe, N; Viegas, E; Macovela, E; Goncalves, E; Osman, N; Andersson, S; Jani, I; Nilsson, C				Tembe, Nelson; Joaquim, Orvalho; Alfai, Eunice; Sitoe, Nadia; Viegas, Edna; Macovela, Eulalia; Goncalves, Emilia; Osman, Nafissa; Andersson, Soren; Jani, Ilesh; Nilsson, Charlotta			Reference Values for Clinical Laboratory Parameters in Young Adults in Maputo, Mozambique	PLOS ONE			English	Article							IMMUNOHEMATOLOGICAL REFERENCE RANGES; REFERENCE INTERVALS; LYMPHOCYTE SUBSETS; WOMEN; HIV; POPULATION; PREVALENCE; COUNTS; CD4	Background: Clinical laboratory reference values from North American and European populations are currently used in most Africans countries due to the absence of locally derived reference ranges, despite previous studies reporting significant differences between populations. Our aim was to define reference ranges for both genders in 18 to 24 year-old Mozambicans in preparation for clinical vaccine trials. Methods: A cross-sectional study including 257 volunteers (102 males and 155 females) between 18 and 24 years was performedat a youth clinic in Maputo, Mozambique. All volunteers were clinically healthy and human immunodeficiency virus, Hepatitis B virus and syphilis negative. Median and 95% reference ranges were calculated for immunological, hematological and chemistry parameters. Ranges were compared with those reported based on populations in other African countries and the US. The impact of applying US NIH Division of AIDS (DAIDS) toxicity tables was assessed. Results: The immunology ranges were comparable to those reported for the US and western Kenya. There were significant gender differences in CD4(+) T cell values 713 cells/mu L in males versus 824 cells/mu L in females (p < 0.0001). Hematologic values differed from the US values but were similar to reports of populations in western Kenya and Uganda. The lower and upper limits of the ranges for hemoglobin, hematocrit, red blood cells, white blood cells and lymphocytes were somewhat lower than those from these African countries. The chemistry values were comparable to US values, with few exceptions. The upper limits for ALT, AST, bilirubin, cholesterol and triglycerides were higher than those from the US. DAIDStables for adverse events predicted 297 adverse events and 159 (62%) of the volunteers would have been excluded. Conclusion: This study is the first to determine normal laboratory parameters in Mozambique. Our results underscore the necessity of establishing region-specific clinical reference ranges for proper patient management and safe conduct of clinical trials.	[Tembe, Nelson; Joaquim, Orvalho; Alfai, Eunice; Sitoe, Nadia; Viegas, Edna; Jani, Ilesh] Inst Nacl Sau, Maputo, Mozambique; [Tembe, Nelson; Viegas, Edna; Nilsson, Charlotta] Karolinska Inst, Dept Lab Med, Huddinge, Sweden; [Tembe, Nelson; Viegas, Edna; Macovela, Eulalia; Goncalves, Emilia; Osman, Nafissa] Eduardo Mondlane Univ, Fac Med, Maputo, Mozambique; [Macovela, Eulalia; Goncalves, Emilia; Osman, Nafissa] Hosp Cent Maputo, Maputo, Mozambique; [Andersson, Soren] Orebro Univ Hosp, Orebro, Sweden; [Nilsson, Charlotta] Publ Hlth Agcy Sweden, Solna, Sweden; [Nilsson, Charlotta] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden	Karolinska Institutet; Eduardo Mondlane University; Orebro University; Public Health Agency of Sweden; Karolinska Institutet	Tembe, N (corresponding author), Inst Nacl Sau, Maputo, Mozambique.	nelson.temble@Ki.se	Augusto, Orvalho/J-8767-2019	Augusto, Orvalho/0000-0002-0005-3968; Jani, Ilesh/0000-0002-6880-6655; Sitoe, Nadia/0000-0001-7310-8221	The Regional HIV/AIDS Team for Africa; Embassy of Sweden; Sida [2150012801]	The Regional HIV/AIDS Team for Africa; Embassy of Sweden; Sida	This study was supported by funding from The Regional HIV/AIDS Team for Africa, Embassy of Sweden, Lusaka jointly funded by Sweden and Norway (Sida contribution number 2150012801). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augusto G, 2009, AM J TROP MED HYG, V81, P799, DOI 10.4269/ajtmh.2009.08-0344; BAIN B, 1984, J CLIN PATHOL, V37, P188, DOI 10.1136/jcp.37.2.188; Bain BJ, 1996, J CLIN PATHOL, V49, P664, DOI 10.1136/jcp.49.8.664; Chernick M. R., 2011, INTRO BOOTSTRAP METH; Clerici M, 2000, AIDS, V14, P2083, DOI 10.1097/00002030-200009290-00003; Clinical and Laboratory Standards Institute, 2008, C28A3 CLIN LAB STAND, V28; CMM, 2010, SOC EC; Coskun A, 2013, ACCREDIT QUAL ASSUR, V18, P51, DOI 10.1007/s00769-012-0948-5; DAIDS, 2004, DIV AIDS TABL GRAD S; Dosoo DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036308; Eller LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003919; Kibaya RS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003327; Kratz A, 2004, NEW ENGL J MED, V351, P1548, DOI 10.1056/NEJMcpc049016; Lugada ES, 2004, CLIN DIAGN LAB IMMUN, V11, P29, DOI 10.1128/CDLI.11.1.29-34.2004; Maini MK, 1996, GENITOURIN MED, V72, P27; Melo J, 2008, TROP MED INT HEALTH, V13, P17, DOI [10.1111/j-1365-3156.2007.01972.x, 10.1111/j.1365-3156.2007.01972.x]; Menard D, 2003, CLIN DIAGN LAB IMMUN, V10, P443, DOI 10.1128/CDLI.10.3.443-445.2003; Mgone CS, 2010, TROP MED INT HEALTH, V15, P973, DOI 10.1111/j.1365-3156.2010.02567.x; Mgone CS, 2009, TROP MED INT HEALTH, V14, P1327, DOI 10.1111/j.1365-3156.2009.02391.x; Oladepo DK, 2009, CLIN VACCINE IMMUNOL, V16, P1374, DOI 10.1128/CVI.00378-08; Omosa-Manyonyi GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014580; R Core Team, 2021, R LANGUAGE ENV STAT; Rudy BJ, 2002, CLIN DIAGN LAB IMMUN, V9, P959, DOI 10.1128/CDLI.9.5.959-965.2002; Saathoff E, 2008, TROP MED INT HEALTH, V13, P612, DOI 10.1111/j.1365-3156.2008.02047.x; Schnabl Kareena, 2008, Clin Biochem Rev, V29, P89; Stevens W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002043; Subhashree AR, 2012, J CLIN DIAGN RES, V6, P1675, DOI 10.7860/JCDR/2012/4882.2630; Tsegaye A, 1999, CLIN DIAGN LAB IMMUN, V6, P410, DOI 10.1128/CDLI.6.3.410-414.1999; Urassa WK, 2003, J IMMUNOL METHODS, V277, P65, DOI 10.1016/S0022-1759(03)00174-1; Vicente EM, 2009, GEOLOGICAL SOC LONDO, P22; Wakeman L, 2007, INT J LAB HEMATOL, V29, P279, DOI 10.1111/j.1365-2257.2006.00883.x; WILLCOX MC, 1986, J MED GENET, V23, P151, DOI 10.1136/jmg.23.2.151; Zeh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021040	33	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97391	10.1371/journal.pone.0097391	http://dx.doi.org/10.1371/journal.pone.0097391			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827458	gold, Green Published			2022-12-27	WOS:000336857400089
J	Yuan, JJ; Liu, YY; Ding, NX; Yang, JM				Yuan, Jiajin; Liu, Yingying; Ding, Nanxiang; Yang, Jiemin			The Regulation of Induced Depression during a Frustrating Situation: Benefits of Expressive Suppression in Chinese Individuals	PLOS ONE			English	Article							MEASURING EXPERIENTIAL AVOIDANCE; POSTTRAUMATIC-STRESS-DISORDER; EMOTION REGULATION; THOUGHT SUPPRESSION; NEGATIVE AFFECT; UNIPOLAR DEPRESSION; SOCIAL-CONSEQUENCES; MAJOR DEPRESSION; MOOD DISORDERS; SELF-ESTEEM	Background: Studies from European-American cultures consistently reported that expressive suppression was associated with worse emotional consequence (e.g. depression) in comparison with acceptance. However, this conclusion may not apply to Chinese, as suppressing emotional displays to maintain relational harmony is culturally valued in East Asian countries. Thus, the present study examined the effects of suppression and acceptance on the depressive mood induced by a frustrating task in a Chinese sample. Method: Sixty-four subjects were randomly assigned to one of three instructions: suppression, acceptance or no-regulation during a frustrating arithmetic task. The experience of depressive emotion and skin conductance response (SCR) were recorded during pre-frustration baseline, frustration induction and post-frustration recovery phases, respectively. Results: Compared with the control and acceptance instructions, suppression instruction was associated with decreased depressive experiences and smaller SCR activity during frustration. There were no significant differences between acceptance and control groups in both subjective depression and SCR activity during frustration. Moreover, the suppression group showed a better emotional recovery after the frustrating task, in comparison with the acceptance and control groups. Correlation analyses verified that SCR reactivity was a reliable index of experienced depression during the frustration. Conclusions: Expressive suppression is effective in reducing depressive experiences and depression-related physiological activity (SCR) when Chinese people are involved. By contrast, the acceptance of depressive emotion in Chinese people does not produce a similar regulation effect. These findings suggest that cultural context should be considered in understanding the emotional consequences of suppression and acceptance strategies.	[Yuan, Jiajin; Yang, Jiemin] Southwest Univ, Minist Educ, Key Lab Cognit & Personal SWU, Chongqing, Peoples R China; Southwest Univ, Sch Psychol, Chongqing, Peoples R China	Southwest University - China; Southwest University - China	Yuan, JJ (corresponding author), Southwest Univ, Minist Educ, Key Lab Cognit & Personal SWU, Chongqing, Peoples R China.	yuanjiajin168@126.com; yangjiemin85@126.com	洁敏, 杨/AAB-5609-2022; LIU, YING/GZL-7252-2022		National Natural Science Foundation of China [NSFC31170989, 31371042]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the National Natural Science Foundation of China (NSFC31170989 and 31371042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RB, 2005, EMOTION, V5, P3, DOI 10.1037/1528-3542.5.1.3; Angst J, 1997, J AFFECT DISORDERS, V45, P31, DOI 10.1016/S0165-0327(97)00057-8; Association AP DSM-IV APA on, 2000, DIAGN STAT MAN MENT; Auger RW, 2005, PRO SCH COUNS, V8, P344; Baars M, 2011, DEPRESS RES TREAT, V2011; Baumgartner T, 2006, INT J PSYCHOPHYSIOL, V60, P34, DOI 10.1016/j.ijpsycho.2005.04.007; Beck A.T., 1979, COGNITIVE THERAPY EM; Beck A.T., 1967, DEPRESSION CLIN EXPT; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Block-Lerner J, 2009, COGN BEHAV PRACT, V16, P443, DOI 10.1016/j.cbpra.2009.04.005; BLUMBERG SH, 1986, J PERS SOC PSYCHOL, V51, P852, DOI 10.1037/0022-3514.51.4.852; Boelen PA, 2008, J PSYCHOPATHOL BEHAV, V30, P241, DOI 10.1007/s10862-008-9082-4; Britton JC, 2006, NEUROIMAGE, V31, P397, DOI 10.1016/j.neuroimage.2005.11.027; Butler EA, 2007, EMOTION, V7, P30, DOI 10.1037/1528-3542.7.1.30; Butler EA, 2009, EMOT REV, V1, P86, DOI 10.1177/1754073908099131; Butler EA, 2009, J CROSS CULT PSYCHOL, V40, P510, DOI 10.1177/0022022109332845; Campbell-Sills L, 2006, EMOTION, V6, P587, DOI 10.1037/1528-3542.6.4.587; Campbell-Sills L, 2006, BEHAV RES THER, V44, P1251, DOI 10.1016/j.brat.2005.10.001; CIOFFI D, 1993, J PERS SOC PSYCHOL, V64, P274, DOI 10.1037/0022-3514.64.2.274; Consedine NS, 2002, REV GEN PSYCHOL, V6, P204, DOI 10.1037//1089-2680.6.2.204; Cuijpers P, 2004, J AFFECT DISORDERS, V79, P71, DOI 10.1016/S0165-0327(02)00348-8; De Leersnyder J, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00055; Dunn BD, 2009, BEHAV RES THER, V47, P761, DOI 10.1016/j.brat.2009.05.007; Eifert GH, 2003, J BEHAV THER EXP PSY, V34, P293, DOI 10.1016/j.jbtep.2003.11.001; Elliott R, 1998, PSYCHOL MED, V28, P559, DOI 10.1017/S0033291798006709; Gilbert P, 2006, J COGN PSYCHOTHER, V20, P183, DOI 10.1891/jcop.20.2.183; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; GOODWIN AM, 1982, BEHAV RES THER, V20, P373, DOI 10.1016/0005-7967(82)90097-3; Gross J., 2007, HDB EMOTION REGULATI, V2nd, P1; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gross JJ, 2002, PSYCHOPHYSIOLOGY, V39, P281, DOI 10.1017/S0048577201393198; Gross JJ, 1997, J ABNORM PSYCHOL, V106, P95, DOI 10.1037/0021-843X.106.1.95; Gross JJ., 1998, REV GEN PSYCHOL, V2, P271, DOI 10.1037/1089-2680.2.3.271; Hall CA, 1978, DAI, V38, P6153; Hayes S. C, 2011, ACCEPTANCE COMMITMEN; Hayes S. C., 1994, ACCEPTANCE CHANGE CO; Hayes SC, 2004, PSYCHOL REC, V54, P553, DOI 10.1007/BF03395492; Hayes SC, 2006, BEHAV RES THER, V44, P1, DOI 10.1016/j.brat.2005.06.006; Hayes SC, 1996, J CONSULT CLIN PSYCH, V64, P1152, DOI 10.1037/0022-006X.64.6.1152; Hayes SC, 1999, PSYCHOL REC, V49, P33, DOI 10.1007/BF03395305; Hofmann SG, 2009, BEHAV RES THER, V47, P389, DOI 10.1016/j.brat.2009.02.010; Holzapfel N, 2008, J AFFECT DISORDERS, V105, P53, DOI 10.1016/j.jad.2007.04.009; Janeck AS, 1999, COGNITIVE THER RES, V23, P497, DOI 10.1023/A:1018720404750; Kashdan TB, 2006, BEHAV RES THER, V44, P1301, DOI 10.1016/j.brat.2005.10.003; Kashdan TB, 2009, J ANXIETY DISORD, V23, P185, DOI 10.1016/j.janxdis.2008.06.006; Khalfa S, 2002, NEUROSCI LETT, V328, P145, DOI 10.1016/S0304-3940(02)00462-7; KOVACS M, 1984, ARCH GEN PSYCHIAT, V41, P643, DOI 10.1001/archpsyc.1984.01790180013001; KREGER DW, 1995, PSYCHOL REP, V76, P345, DOI 10.2466/pr0.1995.76.1.345; Kringelbach ML, 2009, TRENDS COGN SCI, V13, P479, DOI 10.1016/j.tics.2009.08.006; Levitt JT, 2004, BEHAV THER, V35, P747, DOI 10.1016/S0005-7894(04)80018-2; Liverant GI, 2008, BEHAV RES THER, V46, P1201, DOI 10.1016/j.brat.2008.08.001; Lovibond S.H., 1996, MANUAL DEPRESSION AN, DOI DOI 10.1037/T01004-000; Mackinnon A, 1999, PERS INDIV DIFFER, V27, P405, DOI 10.1016/S0191-8869(98)00251-7; Matsumoto D, 2008, J PERS SOC PSYCHOL, V94, P925, DOI 10.1037/0022-3514.94.6.925; Mauss IB, 2010, BIOL PSYCHOL, V84, P521, DOI 10.1016/j.biopsycho.2009.09.010; McCracken LM, 1998, PAIN, V74, P21, DOI 10.1016/S0304-3959(97)00146-2; Moser JS, 2006, PSYCHOPHYSIOLOGY, V43, P292, DOI 10.1111/j.1469-8986.2006.00402.x; Nummenmaa L, 2004, EMOTION, V4, P207, DOI 10.1037/1528-3542.4.2.207; Orcutt HK, 2005, J SOC CLIN PSYCHOL, V24, P1003, DOI 10.1521/jscp.2005.24.7.1003; Phan KL, 2004, NEUROIMAGE, V21, P768, DOI 10.1016/j.neuroimage.2003.09.072; Plumb JC, 2004, J BEHAV THER EXP PSY, V35, P245, DOI 10.1016/j.jbtep.2004.04.011; Richards JM, 2000, J PERS SOC PSYCHOL, V79, P410, DOI 10.1037//0022-3514.79.3.410; Roemer L, 2005, COGNITIVE THER RES, V29, P71, DOI 10.1007/s10608-005-1650-2; Rood L, 2012, J ABNORM CHILD PSYCH, V40, P73, DOI 10.1007/s10802-011-9544-0; SALKOVSKIS PM, 1994, BEHAV RES THER, V32, P1, DOI 10.1016/0005-7967(94)90077-9; Santesso DL, 2012, SOC COGN AFFECT NEUR, V7, P794, DOI 10.1093/scan/nsr054; SCHLOSBERG H, 1954, PSYCHOL REV, V61, P81, DOI 10.1037/h0054570; Schmitt DP, 2005, J PERS SOC PSYCHOL, V89, P623, DOI 10.1037/0022-3514.89.4.623; Shallcross AJ, 2010, BEHAV RES THER, V48, P921, DOI 10.1016/j.brat.2010.05.025; Soto JA, 2005, EMOTION, V5, P154, DOI 10.1037/1528-3542.5.2.154; Soto JA, 2011, EMOTION, V11, P1450, DOI 10.1037/a0023340; Spielberger C., 1983, STAI MANUAL; Svaldi J, 2012, PSYCHIAT RES, V200, P404, DOI 10.1016/j.psychres.2012.06.030; Szasz PL, 2011, BEHAV RES THER, V49, P114, DOI 10.1016/j.brat.2010.11.011; TRINDER H, 1994, BEHAV RES THER, V32, P833, DOI 10.1016/0005-7967(94)90163-5; Tull MT, 2004, J NERV MENT DIS, V192, P754, DOI 10.1097/01.nmd.0000144694.30121.89; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WATSON D, 1988, J ABNORM PSYCHOL, V97, P346, DOI 10.1037/0021-843X.97.3.346; WEGNER DM, 1987, J PERS SOC PSYCHOL, V53, P5, DOI 10.1037/0022-3514.53.1.5; WEGNER DM, 1995, J PERS SOC PSYCHOL, V68, P782, DOI 10.1037/0022-3514.68.5.782; WEGNER DM, 1994, J PERS, V62, P615, DOI 10.1111/j.1467-6494.1994.tb00311.x; WENZLAFF RM, 1988, J PERS SOC PSYCHOL, V55, P882, DOI 10.1037/0022-3514.55.6.882; Westermann R, 1996, EUR J SOC PSYCHOL, V26, P557, DOI 10.1002/(SICI)1099-0992(199607)26:4<557::AID-EJSP769>3.0.CO;2-4; Wierzbicka A., 1994, EMOTION CULTURE EMPI, P133, DOI DOI 10.1037/10152-004; Yeung DY, 2012, J GERONTOL B-PSYCHOL, V67, P666, DOI 10.1093/geronb/gbr159; Yuan JJ, 2007, NEUROPSYCHOLOGIA, V45, P2764, DOI 10.1016/j.neuropsychologia.2007.04.018; Yuan JJ, 2012, BIOL PSYCHOL, V89, P240, DOI 10.1016/j.biopsycho.2011.10.015	87	26	32	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97420	10.1371/journal.pone.0097420	http://dx.doi.org/10.1371/journal.pone.0097420			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4TJ	24827934	Green Submitted, Green Published, gold			2022-12-27	WOS:000336857400093
J	Aviv, RI; Kelly, AG; Jahromi, BS; Benesch, CG; Young, KC				Aviv, Richard I.; Kelly, Adam G.; Jahromi, Babak S.; Benesch, Curtis G.; Young, Kate C.			The Cost-Utility of CT Angiography and Conventional Angiography for People Presenting with Intracerebral Hemorrhage	PLOS ONE			English	Article							CONTRAST-INDUCED NEPHROPATHY; CAROTID-ENDARTERECTOMY; INTRACRANIAL HEMORRHAGE; CATHETER ANGIOGRAPHY; CEREBRAL-ANGIOGRAPHY; COMPUTED-TOMOGRAPHY; STROKE; RISK; ANGIOPLASTY; VALIDATION	Objective: To determine the optimal imaging strategy for ICH incorporating CTA or DSA with and without a NCCT risk stratification algorithm. Methods: A Markov model included costs, outcomes, prevalence of a vascular lesion, and the sensitivity and specificity of a risk stratification algorithm from the literature. The four imaging strategies were: (a) CTA screening of the entire cohort; (b) CTA only in those where NCCT suggested a high or indeterminate likelihood of a lesion; (c) DSA screening of the entire cohort and (d) DSA only for those with a high or indeterminate suspicion of a lesion following NCCT. Branch d was the comparator. Results: Age of the cohort and the probability of an underlying lesion influenced the choice of optimal imaging strategy. With a low suspicion for a lesion (<12%), branch (a) was the optimal strategy for a willingness-to-pay of $100,000/QALY. Branch (a) remained the optimal strategy in younger people (<35 years) with a risk below 15%. If the probability of a lesion was >15%, branch (b) became preferred strategy. The probabilistic sensitivity analysis showed that branch (b) was the optimal choice 70-72% of the time over varying willingness-to-pay values. Conclusions: CTA has a clear role in the evaluation of people presenting with ICH, though the choice of CTA everyone or CTA using risk stratification depends on age and likelihood of finding a lesion.	[Aviv, Richard I.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Med Imaging, Div Neuroradiol, Toronto, ON, Canada; [Kelly, Adam G.; Benesch, Curtis G.; Young, Kate C.] Univ Rochester, Dept Neurol, Rochester, NY USA; [Kelly, Adam G.; Benesch, Curtis G.; Young, Kate C.] Univ Rochester, Dept Neurosurg, Rochester, NY USA; [Jahromi, Babak S.; Young, Kate C.] Univ Rochester, Dept Imaging Sci, Rochester, NY USA	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Rochester; University of Rochester; University of Rochester	Aviv, RI (corresponding author), Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Med Imaging, Div Neuroradiol, Toronto, ON, Canada.	Richard.Aviv@sunnybrook.ca	Demchuk, Andrew M/E-1103-2012	Demchuk, Andrew M/0000-0002-4930-7789; Jahromi, Babak S./0000-0001-5064-5278	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007338] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACR Committee on Drugs and Contrast Media, 2013, ACR MAN CONTR MED VE; Almandoz JED, 2010, AM J NEURORADIOL, V31, P1653, DOI 10.3174/ajnr.A2156; Almandoz JED, 2009, AM J NEURORADIOL, V30, P1213, DOI 10.3174/ajnr.A1546; Almandoz JED, 2012, NEUROSURGERY, V70, P131, DOI 10.1227/NEU.0b013e31822fbf43; [Anonymous], 2011, 2011 MEDICARE PHYS F; [Anonymous], 2012, REIMBURSEMENT INFORM; Aulicky P, 2010, J NEUROL NEUROSUR PS, V81, P783, DOI 10.1136/jnnp.2009.184002; Bruce RJ, 2009, AM J ROENTGENOL, V192, P711, DOI 10.2214/AJR.08.1413; Christensen MC, 2009, STROKE, V40, P1677, DOI 10.1161/STROKEAHA.108.538967; CRAMER BC, 1985, ARCH INTERN MED, V145, P87, DOI 10.1001/archinte.145.1.87; Cronenwett JL, 1997, J VASC SURG, V25, P298, DOI 10.1016/S0741-5214(97)70351-3; Gerlach UA, 2012, CURR OPIN ORGAN TRAN, V17, P258, DOI 10.1097/MOT.0b013e3283534d7b; Gold MR, 1996, COST EFFECTIVENESS H; HALPIN SFS, 1994, J NEUROL NEUROSUR PS, V57, P1180, DOI 10.1136/jnnp.57.10.1180; Hartmann A, 1998, STROKE, V29, P931, DOI 10.1161/01.STR.29.5.931; HELLER CA, 1991, MED J AUSTRALIA, V155, P329, DOI 10.5694/j.1326-5377.1991.tb142293.x; Hopyan JJ, 2008, AM J NEURORADIOL, V29, P1826, DOI 10.3174/ajnr.A1257; Kadkhodayan Y, 2007, NEURORADIOLOGY, V49, P933, DOI 10.1007/s00234-007-0278-1; Kadkhodayan Y, 2012, J NEUROINTERV SURG, V4, DOI 10.1136/neurintsurg-2011-010077; Kent KC, 1997, J VASC SURG, V25, P310; Khosravani H, AJNR AM J N IN PRESS; Kilaru S, 2003, J VASC SURG, V37, P331, DOI 10.1067/mva.2003.124; Krol AL, 2007, STROKE, V38, P2364, DOI 10.1161/STROKEAHA.107.482778; Kuntz KM, 1996, CIRCULATION, V94, P194; Langner S, 2008, AM J NEURORADIOL, V29, P1525, DOI 10.3174/ajnr.A1164; Lima FO, 2010, AM J NEURORADIOL, V31, P817, DOI 10.3174/ajnr.A1927; Mayer SA, 2005, NEW ENGL J MED, V352, P777, DOI 10.1056/NEJMoa042991; McGillicuddy EA, 2010, J TRAUMA, V68, P294, DOI 10.1097/TA.0b013e3181cf7e40; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Oleinik A, 2009, STROKE, V40, P2393, DOI 10.1161/STROKEAHA.108.546127; Olsen Jon C., 1996, Journal of Emergency Medicine, V14, P543, DOI 10.1016/S0736-4679(96)00125-4; ONDRA SL, 1990, J NEUROSURG, V73, P387, DOI 10.3171/jns.1990.73.3.0387; OSTER G, 1994, STROKE, V25, P1149, DOI 10.1161/01.STR.25.6.1149; Post PN, 2002, STROKE, V33, P749, DOI 10.1161/hs0302.103624; Romero JM, 2009, EMERG RADIOL, V16, P195, DOI 10.1007/s10140-008-0785-3; Tippins RB, 2000, RADIOLOGY, V216, P481, DOI 10.1148/radiology.216.2.r00au23481; TOFFOL GJ, 1986, STROKE, V17, P881, DOI 10.1161/01.STR.17.5.881; Tremblay LN, 2005, J TRAUMA, V59, P1162, DOI 10.1097/01.ta.0000194694.71607.0c; van Asch CJJ, 2013, STROKE, V44, P2904, DOI 10.1161/STROKEAHA.113.002386; van Beijnum J, 2011, JAMA-J AM MED ASSOC, V306, P2011, DOI 10.1001/jama.2011.1632; Beijnum J, 2009, BRAIN, V132, P537, DOI 10.1093/brain/awn318; Vermeer SE, 2002, NEUROLOGY, V59, P205, DOI 10.1212/WNL.59.2.205; Wong GKC, 2011, STROKE, V42, P211, DOI 10.1161/STROKEAHA.110.592337; Yeung R, 2009, CAN J NEUROL SCI, V36, P176, DOI 10.1017/S0317167100006533; Yin DP, 1998, J VASC SURG, V27, P245, DOI 10.1016/S0741-5214(98)70355-6; Yoon DY, 2009, AM J NEURORADIOL, V30, P962, DOI 10.3174/ajnr.A1471; Young KC, NEUROLOGY C IN PRESS, V3, P413; Zhu XL, 1997, STROKE, V28, P1406, DOI 10.1161/01.STR.28.7.1406	48	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96496	10.1371/journal.pone.0096496	http://dx.doi.org/10.1371/journal.pone.0096496			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824194	Green Published, gold, Green Submitted			2022-12-27	WOS:000336369200021
J	Lauro, FM; Eloe-Fadrosh, EA; Richter, TKS; Vitulo, N; Ferriera, S; Johnson, JH; Bartlett, DH				Lauro, Federico M.; Eloe-Fadrosh, Emiley A.; Richter, Taylor K. S.; Vitulo, Nicola; Ferriera, Steven; Johnson, Justin H.; Bartlett, Douglas H.			Ecotype Diversity and Conversion in Photobacterium profundum Strains	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; DEEP-SEA; GENOME SEQUENCE; MICROBIAL ASSEMBLAGES; FLAGELLAR SYSTEMS; ESCHERICHIA-COLI; CODON USAGES; PRESSURE; BACTERIUM; MUTAGENESIS	Photobacterium profundum is a cosmopolitan marine bacterium capable of growth at low temperature and high hydrostatic pressure. Multiple strains of P. profundum have been isolated from different depths of the ocean and display remarkable differences in their physiological responses to pressure. The genome sequence of the deep-sea piezopsychrophilic strain Photobacterium profundum SS9 has provided some clues regarding the genetic features required for growth in the deep sea. The sequenced genome of Photobacterium profundum strain 3TCK, a non-piezophilic strain isolated from a shallow-water environment, is now available and its analysis expands the identification of unique genomic features that correlate to environmental differences and define the Hutchinsonian niche of each strain. These differences range from variations in gene content to specific gene sequences under positive selection. Genome plasticity between Photobacterium bathytypes was investigated when strain 3TCK-specific genes involved in photorepair were introduced to SS9, demonstrating that horizontal gene transfer can provide a mechanism for rapid colonisation of new environments.	[Lauro, Federico M.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Lauro, Federico M.] Nanyang Technol Univ, SCELSE, Singapore 639798, Singapore; [Eloe-Fadrosh, Emiley A.; Richter, Taylor K. S.; Bartlett, Douglas H.] Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA; [Vitulo, Nicola] Univ Padua, CRIBI, Ctr Biotechnol, Padua, Italy; [Ferriera, Steven; Johnson, Justin H.] J Craig Venter Inst, Rockville, MD USA	University of New South Wales Sydney; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Padua; J. Craig Venter Institute	Lauro, FM (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	flauro@unsw.edu.au	Eloe-Fadrosh, Emiley/AAP-8019-2021; Lauro, Federico/X-2420-2019; Vitulo, Nicola/GVT-2319-2022	Lauro, Federico/0000-0002-8373-1014; Eloe-Fadrosh, Emiley/0000-0002-8162-1276; Vitulo, Nicola/0000-0002-9571-0747	Australian Research Council [DE120102610]; National Science Foundation [EF0827051]; National Aeronautics and Space Administration [NNX11AG10G]	Australian Research Council(Australian Research Council); National Science Foundation(National Science Foundation (NSF)); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA))	The draft genome sequence of Photobacterium profundum 3TCK was obtained at the J. Craig Venter Institute as a part of the Moore Foundation Microbial Genome Sequencing Project (http://camera.calit2.net/microgenome/). FML is supported by a fellowship from the Australian Research Council (DE120102610). DHB is supported by grants from the National Science Foundation (EF0827051) and National Aeronautics and Space Administration (NNX11AG10G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain K, 2002, INT J SYST EVOL MICR, V52, P1331, DOI 10.1099/00207713-52-4-1331; Allen MA, 2009, ISME J, V3, P1012, DOI 10.1038/ismej.2009.45; Bale SJ, 1997, INT J SYST BACTERIOL, V47, P515, DOI 10.1099/00207713-47-2-515; Bartlett DH, 2002, BBA-PROTEIN STRUCT M, V1595, P367, DOI 10.1016/S0167-4838(01)00357-0; BETTER M, 1983, J BACTERIOL, V155, P311, DOI 10.1128/JB.155.1.311-316.1983; BIDDLE JF, 2005, P ODP SCI RESULTS, V201, P1; Brown MV, 2009, ISME J, V3, P1374, DOI 10.1038/ismej.2009.86; Campanaro S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-122; Campanaro S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-567; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; CHI E, 1993, J BACTERIOL, V175, P7533, DOI 10.1128/JB.175.23.7533-7540.1993; Davis JJ, 2011, MOL BIOL EVOL, V28, P211, DOI 10.1093/molbev/msq185; Davis JJ, 2010, MOL BIOL EVOL, V27, P800, DOI 10.1093/molbev/msp281; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; DeLong EF, 1997, APPL ENVIRON MICROB, V63, P2105, DOI 10.1128/AEM.63.5.2105-2108.1997; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Egan ES, 2003, CELL, V114, P521, DOI 10.1016/S0092-8674(03)00611-1; Eloe EA, 2008, APPL ENVIRON MICROB, V74, P6298, DOI 10.1128/AEM.01316-08; Eloe EA, 2011, APPL ENVIRON MICROB, V77, P8145, DOI 10.1128/AEM.05204-11; Eloe EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020388; Goldberg SMD, 2006, P NATL ACAD SCI USA, V103, P11240, DOI 10.1073/pnas.0604351103; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Huson D H, 2001, Bioinformatics, V17 Suppl 1, pS132; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Karlin S, 1998, MOL MICROBIOL, V29, P1341, DOI 10.1046/j.1365-2958.1998.01008.x; Khelaifia S, 2011, INT J SYST EVOL MICR, V61, P2706, DOI 10.1099/ijs.0.028670-0; Kurland CG, 2003, P NATL ACAD SCI USA, V100, P9658, DOI 10.1073/pnas.1632870100; Lauro FM, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00304-13; Lauro FM, 2008, J BACTERIOL, V190, P1699, DOI 10.1128/JB.01176-07; Lauro FM, 2008, EXTREMOPHILES, V12, P15, DOI 10.1007/s00792-006-0059-5; Lauro FM, 2007, APPL ENVIRON MICROB, V73, P838, DOI 10.1128/AEM.01726-06; Lauro FM, 2005, BIOTECHNIQUES, V38, P708, DOI 10.2144/05385BM06; Le Bihan T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060897; LUTZ L, 1986, FASEB J, V45, P1784; McCarter LL, 2004, J MOL MICROB BIOTECH, V7, P18, DOI 10.1159/000077866; MURRAY NE, 1977, MOL GEN GENET, V150, P53, DOI 10.1007/BF02425325; Mutreja A, 2011, NATURE, V477, P462, DOI 10.1038/nature10392; Nakasone K, 2000, EXTREMOPHILES, V4, P209, DOI 10.1007/PL00010713; Nogi Y, 1998, EXTREMOPHILES, V2, P1, DOI 10.1007/s007920050036; Okada K, 2005, J BACTERIOL, V187, P752, DOI 10.1128/JB.187.2.752-757.2005; Pei AN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005437; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Rodriguez-Brito B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-162; Selby CP, 2006, P NATL ACAD SCI USA, V103, P17696, DOI 10.1073/pnas.0607993103; Shulse CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020146; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Tamburini C, 2006, AQUAT MICROB ECOL, V43, P267, DOI 10.3354/ame043267; Todo T, 1999, MUTAT RES-DNA REPAIR, V434, P89, DOI 10.1016/S0921-8777(99)00013-0; Vanlint D, 2011, MBIO, V2, DOI 10.1128/mBio.00130-10; Vetrovsky T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057923; Vezzi A, 2005, SCIENCE, V307, P1459, DOI 10.1126/science.1103341; Wall Dennis P., 2007, V396, P95; Wilkins D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3457; Witte U, 2003, NATURE, V424, P763, DOI 10.1038/nature01799; Worthington EN, 2003, J BIOL CHEM, V278, P39143, DOI 10.1074/jbc.M305792200; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yasui A, 1998, BIOESSAYS, V20, P291, DOI 10.1002/(SICI)1521-1878(199804)20:4<291::AID-BIES5>3.0.CO;2-T; Yayanos AA, 2001, METHOD MICROBIOL, V30, P615; YAYANOS AA, 1982, REV SCI INSTRUM, V53, P704, DOI 10.1063/1.1137011; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2	62	11	11	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96953	10.1371/journal.pone.0096953	http://dx.doi.org/10.1371/journal.pone.0096953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824441	Green Published, gold			2022-12-27	WOS:000336369200043
J	Liu, L; Rezvani, HR; Back, JH; Hosseini, M; Tang, XW; Zhu, Y; Mahfouf, W; Raad, H; Raji, G; Athar, M; Kim, AL; Bickers, DR				Liu, Liang; Rezvani, Hamid Reza; Back, Jung Ho; Hosseini, Mohsen; Tang, Xiuwei; Zhu, Yucui; Mahfouf, Walid; Raad, Houssam; Raji, Grace; Athar, Mohammad; Kim, Arianna L.; Bickers, David R.			Inhibition of p38 MAPK Signaling Augments Skin Tumorigenesis via NOX2 Driven ROS Generation	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; PROMOTES CELL-SURVIVAL; HISTONE H3; DNA-DAMAGE; INDUCED PHOSPHORYLATION; GENE-EXPRESSION; CANCER; P38-ALPHA; P53; MECHANISMS	p38 mitogen-activated protein kinases (MAPKs) respond to a wide range of extracellular stimuli. While the inhibition of p38 signaling is implicated in the impaired capacity to repair ultraviolet (UV)-induced DNA damage-a primary risk factor for human skin cancers-its mechanism of action in skin carcinogenesis remains unclear, as both anti-proliferative and survival functions have been previously described. In this study, we utilized cultured keratinocytes, murine tumorigenesis models, and human cutaneous squamous cell carcinoma (SCC) specimens to assess the effect of p38 in this regard. UV irradiation of normal human keratinocytes increased the expression of all four p38 isoforms (alpha/beta/gamma/delta); whereas irradiation of p53-deficient A431 keratinocytes derived from a human SCC selectively decreased p38 alpha, without affecting other isoforms. p38 alpha levels are decreased in the majority of human cutaneous SCCs assessed by tissue microarray, suggesting a tumor-suppressive effect of p38 alpha in SCC pathogenesis. Genetic and pharmacological inhibition of p38 alpha and in A431 cells increased cell proliferation, which was in turn associated with increases in NAPDH oxidase (NOX2) activity as well as intracellular reactive oxygen species (ROS). These changes led to enhanced invasiveness of A431 cells as assessed by the matrigel invasion assay. Chronic treatment of p53(-/-)/SKH-1 mice with the p38 inhibitor SB203580 accelerated UV-induced SCC carcinogenesis and increased the expression of NOX2. NOX2 knockdown suppressed the augmented growth of A431 xenografts treated with SB203580. These findings indicate that in the absence of p53, p38 alpha deficiency drives SCC growth and progression that is associated with enhanced NOX2 expression and ROS formation.	[Liu, Liang; Back, Jung Ho; Tang, Xiuwei; Zhu, Yucui; Raji, Grace; Kim, Arianna L.; Bickers, David R.] Columbia Univ, Med Ctr, Dept Dermatol, New York, NY 10027 USA; [Rezvani, Hamid Reza; Hosseini, Mohsen; Mahfouf, Walid; Raad, Houssam] Univ Bordeaux, Bordeaux, France; [Rezvani, Hamid Reza; Hosseini, Mohsen; Mahfouf, Walid; Raad, Houssam] INSERM, Bordeaux, France; [Athar, Mohammad] Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL USA	Columbia University; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Alabama System; University of Alabama Birmingham	Bickers, DR (corresponding author), Columbia Univ, Med Ctr, Dept Dermatol, New York, NY 10027 USA.	ak309@columbia.edu	Rezvani, Hamid Reza/G-3734-2013; Hosseini, Mohsen/AAB-1170-2020; Hosseini, Mohsen/N-4087-2015	Rezvani, Hamid Reza/0000-0001-8067-1338; Hosseini, Mohsen/0000-0002-1686-8512; Hosseini, Mohsen/0000-0002-1686-8512	Center for Environmental Health in Northern Manhattan [P30 ES009089]; Columbia University Skin Disease Research Center [P30AR44535, R01ES020344, R01CA130998]; NATIONAL CANCER INSTITUTE [R01CA138998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR044535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020344] Funding Source: NIH RePORTER	Center for Environmental Health in Northern Manhattan; Columbia University Skin Disease Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by a pilot grant from the Center for Environmental Health in Northern Manhattan (P30 ES009089), Columbia University Skin Disease Research Center grant P30AR44535, R01ES020344, and R01CA130998. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Ambrosino C, 2001, BIOL CELL, V93, P47, DOI 10.1016/S0248-4900(01)01124-8; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bito T, 2012, J DERMATOL SCI, V68, P3, DOI 10.1016/j.jdermsci.2012.06.006; Black APB, 2003, CLIN EXP IMMUNOL, V132, P379, DOI 10.1046/j.1365-2249.2003.02159.x; Block K, 2012, NAT REV CANCER, V12, P627, DOI 10.1038/nrc3339; Bossi O, 2008, J CELL BIOCHEM, V105, P194, DOI 10.1002/jcb.21817; BRASH DE, 1991, P NATL ACAD SCI USA, V88, P10124, DOI 10.1073/pnas.88.22.10124; Chen Y, 2005, FEBS LETT, V579, P3683, DOI 10.1016/j.febslet.2005.05.053; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Dashti SR, 2001, J BIOL CHEM, V276, P8059, DOI 10.1074/jbc.C000862200; Dickinson SE, 2011, MOL CARCINOGEN, V50, P469, DOI 10.1002/mc.20734; Haider AS, 2006, J INVEST DERMATOL, V126, P869, DOI 10.1038/sj.jid.5700157; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; James TT, 2012, J PHARMACOL EXP THER, V340, P237, DOI 10.1124/jpet.111.186775; Junttila MR, 2007, ONCOGENE, V26, P5267, DOI 10.1038/sj.onc.1210332; Kamata T, 2009, CANCER SCI, V100, P1382, DOI 10.1111/j.1349-7006.2009.01207.x; Kang MA, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.134; Kim AL, 2005, J INVEST DERMATOL, V124, P1318, DOI 10.1111/j.0022-202X.2005.23747.x; Kim AL, 2002, PHOTOCHEM PHOTOBIOL, V75, P58, DOI 10.1562/0031-8655(2002)075<0058:SSAOCE>2.0.CO;2; Kim H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039691; Kim KH, 2011, J INVEST DERMATOL, V131, P195, DOI 10.1038/jid.2010.250; Liu K, 2013, CANC RES; Liu KD, 2013, CANCER RES, V73, P2181, DOI 10.1158/0008-5472.CAN-12-3408; Maraldi T, 2009, FREE RADICAL RES, V43, P1111, DOI 10.1080/10715760903186132; Ming M, 2011, CANCER RES, V71, P5287, DOI 10.1158/0008-5472.CAN-10-4614; Mitsushita J, 2004, CANCER RES, V64, P3580, DOI 10.1158/0008-5472.CAN-03-3909; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Phong MS, 2010, MOL CELL BIOL, V30, P3816, DOI 10.1128/MCB.00949-09; Qiang L, 2013, J BIOL CHEM, V288, P1603, DOI 10.1074/jbc.M112.415224; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Rezvani HR, 2011, BBA-BIOENERGETICS, V1807, P609, DOI 10.1016/j.bbabio.2010.12.006; Rezvani HR, 2011, J CLIN INVEST, V121, P195, DOI 10.1172/JCI40087; Scharffetter-Kochanek K, 1997, BIOL CHEM, V378, P1247; Schindler EM, 2009, CANCER RES, V69, P4648, DOI 10.1158/0008-5472.CAN-08-4455; Tan GY, 2012, J BIOL CHEM, V287, P33036, DOI 10.1074/jbc.M112.383273; Thornton TM, 2009, INT J BIOL SCI, V5, P44, DOI 10.7150/ijbs.5.44; Trempolec N, 2013, CELL, V152, P656, DOI [10.1016/j.cell.2013.01.029, 10.1016/j.cell.2013.01.047]; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Xu J, 2001, BIOCHEM J, V355, P437, DOI 10.1042/0264-6021:3550437; Zhong SP, 2000, J BIOL CHEM, V275, P20980, DOI 10.1074/jbc.M909934199; Zhong SP, 2001, J BIOL CHEM, V276, P12932, DOI 10.1074/jbc.M010931200	44	24	25	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97245	10.1371/journal.pone.0097245	http://dx.doi.org/10.1371/journal.pone.0097245			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824222	Green Published, gold, Green Submitted			2022-12-27	WOS:000336369200079
J	Pieperhoff, S; Wilson, KS; Baily, J; de Mora, K; Maqsood, S; Vass, S; Taylor, J; Del-Pozo, J; MacRae, CA; Mullins, JJ; Denvir, MA				Pieperhoff, Sebastian; Wilson, Kathryn S.; Baily, James; de Mora, Kim; Maqsood, Sana; Vass, Sharron; Taylor, Jonathan; Del-Pozo, Jorge; MacRae, Calum A.; Mullins, John J.; Denvir, Martin A.			Heart on a Plate: Histological and Functional Assessment of Isolated Adult Zebrafish Hearts Maintained in Culture	PLOS ONE			English	Article							MYOCARDIUM; REGENERATION; CARDIOMYOCYTES; FISHES	The zebrafish is increasingly used for cardiovascular genetic and functional studies. We present a novel protocol to maintain and monitor whole isolated beating adult zebrafish hearts in culture for long-term experiments. Excised whole adult zebrafish hearts were transferred directly into culture dishes containing optimized L-15 Leibovitz growth medium and maintained for 5 days. Hearts were assessed daily using video-edge analysis of ventricle function using low power microscopy images. High-throughput histology techniques were used to assess changes in myocardial architecture and cell viability. Mean spontaneous Heart rate (HR, min 21) declined significantly between day 0 and day 1 in culture (96.7619.5 to 45.2 +/- 68.2 min 21, mean +/- SD, p = 0.001), and thereafter declined more slowly to 27.6 +/- 7.2 min 21 on day 5. Ventricle wall motion amplitude (WMA) did not change until day 4 in culture (day 0, 46.7613.0 mm vs day 4, 16.961.9 mm, p = 0.08). Contraction velocity (CV) declined between day 0 and day 3 (35.6614.8 vs 15.265.3 mms 21, respectively, p = 0.012) while relaxation velocity (RV) declined quite rapidly (day 0, 72.5 +/- 611.9 vs day 1, 29.5 +/- 65.8 mms 21, p = 0.03). HR and WMA responded consistently to isoproterenol from day 0 to day 5 in culture while CV and RV showed less consistent responses to beta-agonist. Cellular architecture and cross-striation pattern of cardiomyocytes remained unchanged up to day 3 in culture and thereafter showed significant deterioration with loss of striation pattern, pyknotic nuclei and cell swelling. Apoptotic markers within the myocardium became increasingly frequent by day 3 in culture. Whole adult zebrafish hearts can be maintained in culture-medium for up to 3 days. However, after day-3 there is significant deterioration in ventricle function and heart rate accompanied by significant histological changes consistent with cell death and loss of cardiomyocyte cell integrity. Further studies are needed to assess whether this preparation can be optimised for longer term survival.	[Pieperhoff, Sebastian; Wilson, Kathryn S.; Baily, James; de Mora, Kim; Maqsood, Sana; Vass, Sharron; Mullins, John J.; Denvir, Martin A.] Univ Edinburgh, Queens Med Res Inst, UoE BHF Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [Taylor, Jonathan] Univ Glasgow, Dept Phys & Astron, Glasgow, Lanark, Scotland; [Del-Pozo, Jorge] Univ Edinburgh, Royal Dick Sch Vet Studies, Div Vet Clin Sci, Hosp Small Anim,Easter Bush Vet Ctr, Roslin, Midlothian, Scotland; [MacRae, Calum A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc,Broad Inst MIT & Harvard, Boston, MA 02115 USA	University of Edinburgh; University of Glasgow; University of Edinburgh; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Massachusetts Institute of Technology (MIT); Broad Institute	Denvir, MA (corresponding author), Univ Edinburgh, Queens Med Res Inst, UoE BHF Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland.	martin.denvir@ed.ac.uk	Denvir, Martin A/ABA-3141-2021	Mullins, John/0000-0001-5745-5258; Wilson, Kathryn/0000-0003-3241-5836; Vass, Sharron/0000-0003-4201-2002	British Heart Foundation Research Excellence Award (CoRE)	British Heart Foundation Research Excellence Award (CoRE)	This work was funded by The British Heart Foundation Research Excellence Award (CoRE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRIONUEVO WR, 1999, AM J PHYSIOL-REG I, V276, P505; DAVIE PS, 1991, CAN J ZOOL, V69, P1993, DOI 10.1139/z91-278; Denvir MA, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-21; Fabritz L, 2011, J AM COLL CARDIOL, V57, P740, DOI 10.1016/j.jacc.2010.09.046; Farrell AP, 2011, ENCYCLOPEDIA OF FISH PHYSIOLOGY: FROM GENOME TO ENVIRONMENT, VOLS 1-3, P998; FARRELL AP, 1983, J EXP BIOL, V107, P415; Gupta V, 2012, NATURE, V484, P479, DOI 10.1038/nature11045; Hecker L, 2008, ZEBRAFISH, V5, P319, DOI 10.1089/zeb.2008.0550; Hu N, 2001, ANAT REC, V264, P1, DOI 10.1002/ar.1111; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; MacRae CA, 2010, EXPERT OPIN DRUG DIS, V5, P619, DOI 10.1517/17460441.2010.492826; Milan DJ, 2006, AM J PHYSIOL-HEART C, V291, pH269, DOI 10.1152/ajpheart.00960.2005; MILLHOUS.EW, 1971, J CELL BIOL, V48, P1, DOI 10.1083/jcb.48.1.1; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Pieperhoff S, 2009, J ANAT, V215, P536, DOI 10.1111/j.1469-7580.2009.01129.x; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Sedmera D, 2000, ANAT RECORD, V258, P319, DOI 10.1002/(SICI)1097-0185(20000401)258:4<319::AID-AR1>3.0.CO;2-O; Shiels HA, 2006, J GEN PHYSIOL, V128, P37, DOI 10.1085/jgp.200609543; TOTA B, 1983, COMP BIOCHEM PHYS A, V76, P423, DOI 10.1016/0300-9629(83)90442-5; Wiechert S, 2003, AM J PHYSIOL-HEART C, V285, pH907, DOI 10.1152/ajpheart.00856.2002	21	20	20	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96771	10.1371/journal.pone.0096771	http://dx.doi.org/10.1371/journal.pone.0096771			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824845	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000336369200030
J	Torne-Noguera, A; Rodrigo, A; Arnan, X; Osorio, S; Barril-Graells, H; da Rocha, LC; Bosch, J				Torne-Noguera, Anna; Rodrigo, Anselm; Arnan, Xavier; Osorio, Sergio; Barril-Graells, Helena; da Rocha-Filho, Leo Correia; Bosch, Jordi			Determinants of Spatial Distribution in a Bee Community: Nesting Resources, Flower Resources, and Body Size	PLOS ONE			English	Article							POLLINATOR DIVERSITY; FORAGING RANGES; HYMENOPTERA; SCALE; CONSERVATION; SPECIALIZATION; AVAILABILITY; POPULATIONS; ABUNDANCE; SERVICES	Understanding biodiversity distribution is a primary goal of community ecology. At a landscape scale, bee communities are affected by habitat composition, anthropogenic land use, and fragmentation. However, little information is available on local-scale spatial distribution of bee communities within habitats that are uniform at the landscape scale. We studied a bee community along with floral and nesting resources over a 32 km(2) area of uninterrupted Mediterranean scrubland. Our objectives were (i) to analyze floral and nesting resource composition at the habitat scale. We ask whether these resources follow a geographical pattern across the scrubland at bee-foraging relevant distances; (ii) to analyze the distribution of bee composition across the scrubland. Bees being highly mobile organisms, we ask whether bee composition shows a homogeneous distribution or else varies spatially. If so, we ask whether this variation is irregular or follows a geographical pattern and whether bees respond primarily to flower or to nesting resources; and (iii) to establish whether body size influences the response to local resource availability and ultimately spatial distribution. We obtained 6580 specimens belonging to 98 species. Despite bee mobility and the absence of environmental barriers, our bee community shows a clear geographical pattern. This pattern is mostly attributable to heterogeneous distribution of small (<55 mg) species (with presumed smaller foraging ranges), and is mostly explained by flower resources rather than nesting substrates. Even then, a large proportion (54.8%) of spatial variability remains unexplained by flower or nesting resources. We conclude that bee communities are strongly conditioned by local effects and may exhibit spatial heterogeneity patterns at a scale as low as 500-1000 m in patches of homogeneous habitat. These results have important implications for local pollination dynamics and spatial variation of plant-pollinator networks.	[Torne-Noguera, Anna; Rodrigo, Anselm; Arnan, Xavier; Osorio, Sergio; Barril-Graells, Helena; Bosch, Jordi] CREAF, Cerdanyola Del Valles, Catalunya, Spain; [Rodrigo, Anselm] Univ Autonoma Barcelona, Unitat Ecol, Cerdanyola Del Valles, Catalunya, Spain; [Arnan, Xavier] Tech Univ Darmstadt, Fachbereich Biol, Darmstadt, Germany; [da Rocha-Filho, Leo Correia] Univ Sao Paulo, Dept Biol, BR-14049 Ribeirao Preto, Brazil	Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Autonomous University of Barcelona; Technical University of Darmstadt; Universidade de Sao Paulo	Torne-Noguera, A (corresponding author), CREAF, Cerdanyola Del Valles, Catalunya, Spain.	a.torne@creaf.uab.cat	Correia da Rocha Filho, Leo/O-6088-2015; Rodrigo, Anselm/AFL-9450-2022; Arnan, Xavier/N-7829-2013; Rodrigo, Anselm/AAH-1553-2022; Bosch, Jordi/K-8752-2016	Correia da Rocha Filho, Leo/0000-0002-3431-6009; Arnan, Xavier/0000-0002-9904-274X; Torne-Noguera, Anna/0000-0003-4517-8163; Osorio-Canadas, Sergio/0000-0002-0650-5566; Rodrigo, Anselm/0000-0001-6341-0363; Bosch, Jordi/0000-0002-8088-9457	Spanish Ministry of Science and Innovation (MICINN) [CGL2005-00491, CGL2009-12646, CSD2008-0040]; FPI fellowship [BES-2010-042520]; Diputacio de Barcelona; FI fellowship from Generalitat de Catalunya [2012 FI SO080484]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq-141022/2007-8]	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FPI fellowship(Spanish Government); Diputacio de Barcelona; FI fellowship from Generalitat de Catalunya(Generalitat de Catalunya); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by the Spanish Ministry of Science and Innovation (MICINN, projects CGL2005-00491, CGL2009-12646 and CSD2008-0040; FPI fellowship (BES-2010-042520) to A.T-N., and a PTA grant to H.B-G.), as well as by funds from the Diputacio de Barcelona. S.O. was supported by an FI fellowship (2012 FI SO080484) from Generalitat de Catalunya, and L.C.R.-F. by a scholarship from "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico" (CNPq-141022/2007-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2010, DIVERS DISTRIB, V16, P476, DOI 10.1111/j.1472-4642.2010.00654.x; AGREN J, 1988, OECOLOGIA, V76, P175, DOI 10.1007/BF00379950; Antonini Y, 2000, REV ETOLOGIA, V2, P111; ARROYO J, 1990, Lagascalia, V16, P25; Beekman M, 2000, FUNCT ECOL, V14, P490, DOI 10.1046/j.1365-2435.2000.00443.x; Bhattacharya M, 2003, BIOL CONSERV, V109, P37, DOI 10.1016/S0006-3207(02)00130-1; Bosch J, 2006, BEHAV ECOL SOCIOBIOL, V60, P26, DOI 10.1007/s00265-005-0134-4; Brosi BJ, 2008, J APPL ECOL, V45, P773, DOI 10.1111/j.1365-2664.2007.01412.x; Brunet J, 2006, EVOLUTION, V60, P234, DOI 10.1111/j.0014-3820.2006.tb01102.x; Carvell C, 2012, OIKOS, V121, P734, DOI 10.1111/j.1600-0706.2011.19832.x; Castagneyrol B, 2012, ECOLOGY, V93, P2115, DOI 10.1890/11-1300.1; Ebeling A, 2008, OIKOS, V117, P1808, DOI 10.1111/j.1600-0706.2008.16819.x; Ebeling A, 2012, OECOLOGIA, V169, P453, DOI 10.1007/s00442-011-2205-8; Eltz T, 2003, FOREST ECOL MANAG, V172, P301, DOI 10.1016/S0378-1127(01)00792-7; Frund J, 2010, OIKOS, V119, P1581, DOI 10.1111/j.1600-0706.2010.18450.x; Fukami Tadashi, 2010, P45; Gathmann A, 2002, J ANIM ECOL, V71, P757, DOI 10.1046/j.1365-2656.2002.00641.x; GATHMANN A, 1994, OECOLOGIA, V98, P8, DOI 10.1007/BF00326084; Gomez JM, 2007, OECOLOGIA, V153, P597, DOI 10.1007/s00442-007-0758-3; Goulson D, 2009, BUMBLEBEES BEHAV ECO; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Grundel R, 2010, ECOL APPL, V20, P1678, DOI 10.1890/08-1792.1; Guedot C, 2009, ECOL ENTOMOL, V34, P158, DOI 10.1111/j.1365-2311.2008.01054.x; HERRERA CM, 1995, ECOLOGY, V76, P1516, DOI 10.2307/1938153; HERRERA CM, 1988, BIOL J LINN SOC, V35, P95, DOI 10.1111/j.1095-8312.1988.tb00461.x; HOLLING CS, 1992, ECOL MONOGR, V62, P447, DOI 10.2307/2937313; INOUYE DW, 1991, AM J BOT, V78, P997, DOI 10.2307/2445179; Janovsky Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077361; Kwaiser KS, 2008, AGR ECOSYST ENVIRON, V124, P200, DOI 10.1016/j.agee.2007.09.012; Leps J, 2003, MULTIVARIATE ANAL EC; Minckley RL, 1999, BIOL J LINN SOC, V67, P119, DOI 10.1111/j.1095-8312.1999.tb01933.x; Morales JM, 2008, OIKOS, V117, P1362, DOI 10.1111/j.0030-1299.2008.16737.x; Mouquet N., 2005, METACOMMUNITIES SPAT, P237; Muller A, 2006, BIOL CONSERV, V130, P604, DOI 10.1016/j.biocon.2006.01.023; Murray TE, 2012, J APPL ECOL, V49, P998, DOI 10.1111/j.1365-2664.2012.02175.x; Osborne JL, 1999, J APPL ECOL, V36, P519, DOI 10.1046/j.1365-2664.1999.00428.x; Popic TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066665; Potts SG, 2005, ECOL ENTOMOL, V30, P78, DOI 10.1111/j.0307-6946.2005.00662.x; Potts SG, 2004, ENTOMOL EXP APPL, V113, P103, DOI 10.1111/j.0013-8703.2004.00212.x; Potts SG, 2003, ECOLOGY, V84, P2628, DOI 10.1890/02-0136; Price MV, 2005, ECOLOGY, V86, P2106, DOI 10.1890/04-1274; R Development Core Team, 2010, R LANG ENV STAT COMP; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Resetarits WJ, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P374; Ricketts TH, 2008, ECOL LETT, V11, P499, DOI 10.1111/j.1461-0248.2008.01157.x; RICKLEFS RE, 1987, SCIENCE, V235, P167, DOI 10.1126/science.235.4785.167; Roulston TH, 2011, ANNU REV ENTOMOL, V56, P293, DOI 10.1146/annurev-ento-120709-144802; Schaffers AP, 2008, ECOLOGY, V89, P782, DOI 10.1890/07-0361.1; Smith AR, 2012, ECOL ENTOMOL, V37, P309, DOI 10.1111/j.1365-2311.2012.01367.x; Steffan-Dewenter I, 2002, ECOLOGY, V83, P1421, DOI 10.1890/0012-9658(2002)083[1421:SDEOLC]2.0.CO;2; Steffan-Dewenter I, 2008, J APPL ECOL, V45, P737, DOI 10.1111/j.1365-2664.2008.01483.x; VENABLES WN, 1998, MODERN APPL STAT S P; Viana Blandina F., 2012, Journal of Pollination Ecology, V7, P31; Vicens N, 2000, ENVIRON ENTOMOL, V29, P69, DOI 10.1603/0046-225X-29.1.69; VISSCHER PK, 1982, ECOLOGY, V63, P1790, DOI 10.2307/1940121; Walther-Hellwig K, 2000, J INSECT BEHAV, V13, P239, DOI 10.1023/A:1007740315207; Westphal C, 2008, ECOL MONOGR, V78, P653, DOI 10.1890/07-1292.1; Westphal C, 2006, ECOL ENTOMOL, V31, P389, DOI 10.1111/j.1365-2311.2006.00801.x; Westrich P, 1990, SPEZIELLER E; Westrich Paul, 1996, Linnean Society Symposium Series, V18, P1; Winfree R, 2009, ECOLOGY, V90, P2068, DOI 10.1890/08-1245.1; YANEGA D, 1990, BEHAV ECOL SOCIOBIOL, V27, P37, DOI 10.1007/BF00183311; Zurbuchen A, 2010, BIOL CONSERV, V143, P669, DOI 10.1016/j.biocon.2009.12.003	63	76	80	2	160	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97255	10.1371/journal.pone.0097255	http://dx.doi.org/10.1371/journal.pone.0097255			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824445	Green Published, gold, Green Submitted			2022-12-27	WOS:000336369200081
J	Al Baqlani, SA; Sy, BT; Ratsch, BA; Al Naamani, K; Al Awaidy, S; Al Busaidy, S; Pauli, G; Bock, CT				Al Baqlani, Said Ali; Bui Tien Sy; Ratsch, Boris A.; Al Naamani, Khalid; Al Awaidy, Salah; Al Busaidy, Suleiman; Pauli, Georg; Bock, C. -Thomas			Molecular Epidemiology and Genotyping of Hepatitis B Virus of HBsAg-Positive Patients in Oman	PLOS ONE			English	Article							SURFACE-ANTIGEN VARIANTS; CLINICAL-SIGNIFICANCE; DRUG-RESISTANT; MUTATIONS; MUTANTS; INFECTION; PREVALENCE; PROTEIN; UPDATE; SUBGENOTYPES	Background: Hepatitis B virus (HBV) infection is a major global health burden with distinct geographic public health significance. Oman is a country with intermediate HBV carrier prevalence; however, little is known about the incidence of HBV variants in circulation. We investigated the HBV genotype distribution, the occurrence of antiviral resistance, and HBV surface antigen (HBsAg) escape mutations in HBsAg-positive patients in Oman. Methods: Serum samples were collected from 179 chronically HBV-infected patients enrolled in various gastroenterology clinics in Oman. HBV genotypes were determined by sequencing and phylogenetic analysis. Mutations in the HBV polymerase and the HBsAg gene were characterized by mutational analysis. Results: HBV genotypes D (130/170; 76.47%) and A (32/170; 18.28%) are predominant in Oman. The HBV genotypes C and E were less frequent (each 1.18%), while the HBV genotypes B, G, F, and H were not detected. Four patients revealed HBV genotype mixtures (HBV-A/D and D/C). The analyses of vaccine escape mutations yield that 148/170 (87.06%) HBV sequences were wild type. 22/170 (12.94%) HBV sequences showed mutations in the "a'' determinant of the HBsAg domain. Two patients showed the described HBV vaccine escape mutation sP120T. 8/146 (5.48%) HBV isolates harbored mutations in the HBV polymerase known to confer resistance against antiviral therapy. Especially the lamivudine resistance mutations rtL180M/rtM204V and rtM204I were detected. Conclusion: This study shows the distribution of HBV genotypes, therapy resistance, and vaccine escape mutations in HBV-infected patients in Oman. Our findings will have a major impact on therapy management and diagnostics of chronic HBV infections in Oman to control HBV infection in this intermediate HBV-endemic country.	[Al Baqlani, Said Ali; Al Busaidy, Suleiman] Minist Hlth, Cent Publ Hlth Lab, Muscat, Oman; [Bui Tien Sy; Ratsch, Boris A.; Pauli, Georg; Bock, C. -Thomas] Robert Koch Inst, Dept Infect Dis, Berlin, Germany; [Bui Tien Sy] Vietnam Mil Med Univ, Hanoi, Vietnam; [Bui Tien Sy] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Al Naamani, Khalid] Minist Def, Armed Forces Hosp, Muscat, Oman; [Al Awaidy, Salah] Minist Hlth, Off Undersecretary Hlth Affairs, Muscat, Oman	Robert Koch Institute; Eberhard Karls University of Tubingen	Bock, CT (corresponding author), Robert Koch Inst, Dept Infect Dis, Berlin, Germany.	bockC@rki.de	Awaidy, Salah Al/AAF-5884-2020; Bock, C.-Thomas/A-3518-2012	Awaidy, Salah Al/0000-0001-5112-3893; Ratsch, Boris/0000-0003-0478-1652; Bock, C.-Thomas/0000-0002-2773-486X	Vietnam Ministry of Education and Training, Vietnam [322]	Vietnam Ministry of Education and Training, Vietnam	BT Sy was supported by a scholarship from project 322 of Vietnam Ministry of Education and Training, Vietnam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Awaidy S, 2006, J INFECTION, V52, P202, DOI 10.1016/j.jinf.2005.05.006; Al Awaidy ST, 2013, AM J TROP MED HYG, V89, P811, DOI 10.4269/ajtmh.13-0333; Amini-Bavil-Olyaee S, 2005, J MED VIROL, V76, P318, DOI 10.1002/jmv.20362; Bahri O, 2006, J MED VIROL, V78, P353, DOI 10.1002/jmv.20554; Bartholomeusz A, 2001, HEPATOLOGY, V34, P432, DOI 10.1053/jhep.2001.26764; Baxa DM, 2013, J HEPATOL, V58, P212, DOI 10.1016/j.jhep.2012.09.014; Blitz L, 1998, J CLIN MICROBIOL, V36, P648, DOI 10.1128/JCM.36.3.648-651.1998; Bock CT, 2002, GASTROENTEROLOGY, V122, P264, DOI 10.1053/gast.2002.31015; Brunetto MR, 2013, J HEPATOL; CARMAN WF, 1995, LANCET, V345, P1406, DOI 10.1016/S0140-6736(95)92599-6; Carman WF, 1997, HEPATOLOGY, V26, P1658, DOI 10.1002/hep.510260640; Carman WF, 1997, J VIRAL HEPATITIS, V4, P11, DOI 10.1111/j.1365-2893.1997.tb00155.x; Cassidy A, 2011, EXPERT REV VACCINES, V10, P1709, DOI [10.1586/ERV.11.151, 10.1586/erv.11.151]; Chang MH, 2014, RECENT RESULTS CANC, V193, P75, DOI 10.1007/978-3-642-38965-8_5; Chu CJ, 2002, HEPATOLOGY, V35, P1274, DOI 10.1053/jhep.2002.33161; Cooksley WGE, 2010, J VIRAL HEPATITIS, V17, P601, DOI 10.1111/j.1365-2893.2010.01326.x; Degertekin B, 2009, CURR OPIN GASTROEN, V25, P180, DOI 10.1097/MOG.0b013e328324f478; Deterding K, 2008, J MED VIROL, V80, P1707, DOI 10.1002/jmv.21294; Dunford L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039027; Fung SK, 2004, HEPATOLOGY, V40, P790, DOI 10.1002/hep.20455; Ghany MG, 1998, HEPATOLOGY, V27, P213, DOI 10.1002/hep.510270133; Hannoun C, 2002, J INFECT DIS, V186, P752, DOI 10.1086/342599; Hsu HY, 1999, HEPATOLOGY, V30, P1312, DOI 10.1002/hep.510300511; Kaminski G, 2006, MED PRIN PRACT, V15, P368, DOI 10.1159/000094271; Kao JH, 2002, J GASTROEN HEPATOL, V17, P643, DOI 10.1046/j.1440-1746.2002.02737.x; Kao JH, 2005, LANCET, V366, P1337, DOI 10.1016/S0140-6736(05)67544-7; Khedive A, 2013, J VIRAL HEPATITIS, V20, P494, DOI 10.1111/jvh.12045; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Locarnini S, 2003, SEMIN LIVER DIS, V23, P5, DOI 10.1055/s-2003-37587; Locarnini SA, 2010, ANTIVIR THER, V15, P451, DOI 10.3851/IMP1499; Lok ASF, 2009, GASTROEN CLIN BIOL, V33, P911, DOI 10.1016/j.gcb.2009.06.001; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Ma Q, 2012, J MED VIROL, V84, P198, DOI 10.1002/jmv.23183; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Mayerat C, 1999, J VIRAL HEPATITIS, V6, P299, DOI 10.1046/j.1365-2893.1999.00174.x; McMahon BJ, 2009, HEPATOL INT, V3, P334, DOI 10.1007/s12072-008-9112-z; Mohammadnejad L, 2012, ARCH IRAN MED, V15, P446, DOI 012157/AIM.0014; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; OON CJ, 1995, VACCINE, V13, P699, DOI 10.1016/0264-410X(94)00080-7; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Pollicino T, 1997, HEPATOLOGY, V26, P495, DOI 10.1002/hep.510260235; Sallam TA, 2004, J MED VIROL, V73, P23, DOI 10.1002/jmv.20056; Sanchez-Tapias JM, 2002, GASTROENTEROLOGY, V123, P1848, DOI 10.1053/gast.2002.37041; Saudy N, 2003, J MED VIROL, V70, P529, DOI 10.1002/jmv.10427; Shi YH, 2012, JPN J INFECT DIS, V65, P476, DOI 10.7883/yoken.65.476; Stuyver L, 2000, J GEN VIROL, V81, P67, DOI 10.1099/0022-1317-81-1-67; Sunbul M, 2005, WORLD J GASTROENTERO, V11, P1976, DOI 10.3748/wjg.v11.i13.1976; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teo CG, 2010, ANTIVIR THER, V15, P445, DOI 10.3851/IMP1556; Toan NL, 2006, HEPATOLOGY, V43, P1375, DOI 10.1002/hep.21188; Torresi J, 2002, J CLIN VIROL, V25, P97, DOI 10.1016/S1386-6532(02)00049-5; Tujios SR, 2013, CURR OPIN GASTROEN, V29, P250, DOI 10.1097/MOG.0b013e32835ff1e9; Weber B, 2005, J CLIN VIROL, V32, P102, DOI 10.1016/j.jcv.2004.10.008; Westland C, 2003, GASTROENTEROLOGY, V125, P107, DOI 10.1016/S0016-5085(03)00700-5; Yin JH, 2008, CARCINOGENESIS, V29, P1685, DOI 10.1093/carcin/bgm301; Zuckerman JN, 2003, ANTIVIR RES, V60, P75, DOI 10.1016/j.antiviral.2003.08.013	56	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97759	10.1371/journal.pone.0097759	http://dx.doi.org/10.1371/journal.pone.0097759			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835494	Green Published, gold			2022-12-27	WOS:000339614800067
J	Mulders, WHAM; Barry, KM; Robertson, D				Mulders, Wilhelmina H. A. M.; Barry, Kristin M.; Robertson, Donald			Effects of Furosemide on Cochlear Neural Activity, Central Hyperactivity and Behavioural Tinnitus after Cochlear Trauma in Guinea Pig	PLOS ONE			English	Article							NOISE-INDUCED TINNITUS; AUDITORY BRAIN-STEM; ACOUSTIC TRAUMA; HEARING-LOSS; INFERIOR COLLICULUS; ELECTRICAL-ACTIVITY; GENE-EXPRESSION; ROUND-WINDOW; NUCLEUS; RATS	Cochlear trauma causes increased spontaneous activity (hyperactivity) to develop in central auditory structures, and this has been suggested as a neural substrate for tinnitus. Using a guinea pig model we have previously demonstrated that for some time after cochlear trauma, central hyperactivity is dependent on peripheral afferent drive and only later becomes generated intrinsically within central structures. Furosemide, a loop diuretic, reduces spontaneous firing of auditory afferents. We investigated in our guinea pig model the efficacy of furosemide in reducing 1) spontaneous firing of auditory afferents, using the spectrum of neural noise (SNN) from round window recording, 2) hyperactivity in inferior colliculus, using extracellular single neuron recordings and 3) tinnitus at early time-points after cochlear trauma. Tinnitus was assessed using gap prepulse inhibition of acoustic startle (GPIAS). Intraperitoneal furosemide, but not saline, caused a marked decrease in both SNN and central hyperactivity. Intracochlear perfusion with furosemide similarly reversed central hyperactivity. In animals in which GPIAS measurements suggested the presence of tinnitus (reduced GPIAS), this could be reversed with an intraperitoneal injection with furosemide but not saline. The results are consistent with furosemide reducing central hyperactivity and behavioural signs of tinnitus by acting peripherally to decrease spontaneous firing of auditory afferents. The data support the notion that hyperactivity may be involved in the generation of tinnitus and further suggest that there may be a therapeutic window after cochlear trauma using drug treatments that target peripheral spontaneous activity.	[Mulders, Wilhelmina H. A. M.; Barry, Kristin M.; Robertson, Donald] Univ Western Australia, Sch Anat Physiol & Human Biol, Auditory Lab, Crawley, WA, Australia	University of Western Australia	Mulders, WHAM (corresponding author), Univ Western Australia, Sch Anat Physiol & Human Biol, Auditory Lab, Crawley, WA, Australia.	helmy.mulders@uwa.edu.au		Barry, Kristin/0000-0003-3177-6146; Barry, Kristin/0000-0002-1601-0997	Royal National Institute for Deaf People (UK) [G55]; Medical Health and Research Infrastructure Fund; University of Western Australia; RNID [G55] Funding Source: researchfish	Royal National Institute for Deaf People (UK); Medical Health and Research Infrastructure Fund; University of Western Australia; RNID	Supported by grants from the Royal National Institute for Deaf People (UK) G55, the Medical Health and Research Infrastructure Fund (WA) and The University of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpini Dario, 2004, Int Tinnitus J, V10, P91; Andersson G, 2004, J CLIN PSYCHOL, V60, P171, DOI 10.1002/jclp.10243; AXELSSON A, 1989, British Journal of Audiology, V23, P53, DOI 10.3109/03005368909077819; Bauer CA, 2013, HEARING RES, V295, P130, DOI 10.1016/j.heares.2012.03.009; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Brozoski TJ, 2005, HEARING RES, V206, P227, DOI 10.1016/j.heares.2004.12.013; Cesarani Antonio, 2002, Int Tinnitus J, V8, P111; DAVIS M, 1974, J COMP PHYSIOL PSYCH, V87, P571, DOI 10.1037/h0036985; De Ridder D, 2011, P NATL ACAD SCI USA, V108, P8075, DOI 10.1073/pnas.1018466108; Dehmel S, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00042; Dong S, 2009, NEUROSCIENCE, V159, P1164, DOI 10.1016/j.neuroscience.2009.01.043; Dong SY, 2010, EUR J NEUROSCI, V31, P1616, DOI 10.1111/j.1460-9568.2010.07183.x; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Eggermont JJ, 2000, HEARING RES, V142, P89, DOI 10.1016/S0378-5955(00)00024-1; Faraday MM, 2000, PHARMACOL BIOCHEM BE, V66, P375, DOI 10.1016/S0091-3057(00)00212-4; Finlayson PG, 2009, HEARING RES, V256, P104, DOI 10.1016/j.heares.2009.07.006; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gu JW, 2010, J NEUROPHYSIOL, V104, P3361, DOI 10.1152/jn.00226.2010; Ingham NJ, 2006, EUR J NEUROSCI, V24, P2515, DOI 10.1111/j.1460-9568.2006.05134.x; JOHNSTONE JR, 1979, J ACOUST SOC AM, V65, P254, DOI 10.1121/1.382244; Kraus KS, 2010, NEUROSCIENCE, V167, P1216, DOI 10.1016/j.neuroscience.2010.02.071; Lanting CP, 2009, HEARING RES, V255, P1, DOI 10.1016/j.heares.2009.06.009; LIBERMAN MC, 1984, HEARING RES, V16, P43, DOI 10.1016/0378-5955(84)90024-8; Lobarinas E, 2013, HEARING RES, V295, P150, DOI 10.1016/j.heares.2012.06.001; Lockwood AH, 1999, SCAND AUDIOL, V28, P47; McMahon CM, 2002, HEARING RES, V173, P134, DOI 10.1016/S0378-5955(02)00281-2; Melcher JR, 2000, J NEUROPHYSIOL, V83, P1058, DOI 10.1152/jn.2000.83.2.1058; MERRILL EG, 1972, MED BIOL ENG, V10, P662, DOI 10.1007/BF02476084; Middleton JW, 2011, P NATL ACAD SCI USA, V108, P7601, DOI 10.1073/pnas.1100223108; Mrena R, 2009, INT J AUDIOL, V48, P394, DOI 10.1080/14992020902777225; Mulders WHAM, 2013, HEARING RES, V298, P104, DOI 10.1016/j.heares.2012.12.008; Mulders WHAM, 2011, NEUROSCIENCE, V192, P753, DOI 10.1016/j.neuroscience.2011.06.046; Mulders WHAM, 2011, J COMP NEUROL, V519, P2637, DOI 10.1002/cne.22644; Mulders WHAM, 2009, NEUROSCIENCE, V164, P733, DOI 10.1016/j.neuroscience.2009.08.036; Mulders WHAM, 2010, J NEUROSCI, V30, P9578, DOI 10.1523/JNEUROSCI.2289-10.2010; NAKAI Y, 1982, ACTA OTO-LARYNGOL, V94, P37, DOI 10.3109/00016488209128887; Norena A, 2002, AUDIOL NEURO-OTOL, V7, P358, DOI 10.1159/000066156; Norena AJ, 2003, HEARING RES, V183, P137, DOI 10.1016/S0378-5955(03)00225-9; Patuzzi RB, 2004, HEARING RES, V190, P87, DOI 10.1016/S0378-5955(03)00405-2; Risey, 1995, Int Tinnitus J, V1, P99; ROBERTSON D, 1989, J COMP NEUROL, V282, P456, DOI 10.1002/cne.902820311; Robertson D, 2013, HEARING RES, V295, P124, DOI 10.1016/j.heares.2012.02.002; Ruttiger L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057247; RYBAK LP, 1982, HEARING RES, V7, P223, DOI 10.1016/0378-5955(82)90015-6; Salvi R, 2009, DRUG FUTURE, V34, P381, DOI 10.1358/dof.2009.034.05.1362442; Seki S, 2003, HEARING RES, V180, P28, DOI 10.1016/S0378-5955(03)00074-1; SEWELL WF, 1984, J PHYSIOL-LONDON, V347, P685, DOI 10.1113/jphysiol.1984.sp015090; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; Turner JG, 2006, BEHAV NEUROSCI, V120, P188, DOI 10.1037/0735-7044.120.1.188; Vio MM, 2005, DRUG DISCOV TODAY, V10, P1263, DOI 10.1016/S1359-6446(05)03594-4; Vogler DP, 2011, J NEUROSCI, V31, P6639, DOI 10.1523/JNEUROSCI.6538-10.2011; Wang H, 2009, NEUROSCIENCE, V164, P747, DOI 10.1016/j.neuroscience.2009.08.026; Yankaskas K, 2013, HEARING RES, V295, P3, DOI 10.1016/j.heares.2012.04.016; Zacharek MA, 2002, HEARING RES, V172, P137, DOI 10.1016/S0378-5955(02)00575-0; Zhang JS, 2011, JARO-J ASSOC RES OTO, V12, P185, DOI 10.1007/s10162-010-0246-z	55	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97948	10.1371/journal.pone.0097948	http://dx.doi.org/10.1371/journal.pone.0097948			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835470	Green Submitted, gold, Green Published			2022-12-27	WOS:000339614800090
J	Wang, XG; Dong, J; Wu, Q				Wang, Xiaogang; Dong, Jing; Wu, Qiang			Evaluation of Anterior Segment Parameters and Possible Influencing Factors in Normal Subjects Using a Dual Scheimpflug Analyzer	PLOS ONE			English	Article							CENTRAL CORNEAL THICKNESS; LASER REFRACTIVE SURGERY; CHAMBER DEPTH; INTRAOCULAR-PRESSURE; OPTICAL-QUALITY; AXIAL LENGTH; TEAR FILM; CURVATURE; ABERRATIONS; KERATOCONUS	Purpose: To investigate normal anterior segment parameters and analyze the possible influencing factors using a dual Scheimpflug system. Setting: Department of Ophthalmology, Affiliated Sixth People's Hospital Shanghai Jiao Tong University, Shanghai, China. Design: A prospective observational case series. Methods: A total of 153 normal subjects (153 eyes) were studied. The anterior segment parameters, including the central corneal thickness (CCT), anterior chamber depth (ACD), pupil diameter (PD), keratoconus prediction index (KPI), simulated keratometry (SimK) values, anterior instantaneous curvature (AIC), posterior axial curvature (PAC), corneal eccentricity, total corneal power (TCP), axial curvature (AC), total corneal wavefront (TCW), high order aberration (HOA), and spherical aberration (SA), were determined using a dual Scheimpflug analyzer. Results: The CCT and ACD were both negatively correlated with age (r = -0.203, p = 0.012; r = -0.589, p<0.001). There was no significant difference in the refractive indices of AIC and SimK. Compared with the negative correlation of HOA and SA (r = -0.358, p<0.001), a positive correlation was found between TCW and HOA (r = 0.561, p<0.001). Unlike the decreased tendency of AC, the TCP increased gradually from the center to the periphery in the central 8 mm diameter. TCP showed a significant correlation with AC in the analyzed area. Conclusions: AIC and SimK provide different information in clinic, but the refractive indices of them showed no difference in this healthy study population, and age should be considered when using CCT and ACD values.	[Wang, Xiaogang; Wu, Qiang] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China; [Wang, Xiaogang] Shanxi Eye Hosp, Taiyuan, Shanxi, Peoples R China; [Dong, Jing] Shanxi Med Univ, Hosp 1, Taiyuan, Shanxi, Peoples R China	Shanghai Jiao Tong University; Shanxi Medical University; Shanxi Medical University	Wu, Q (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China.	movie6521@gmail.com						Al-Mohtaseb ZN, 2013, GRAEF ARCH CLIN EXP, V251, P1855, DOI 10.1007/s00417-013-2280-0; Alio JL, 2008, J CATARACT REFR SURG, V34, P1727, DOI 10.1016/j.jcrs.2008.06.025; Alio JL, 2008, AM J OPHTHALMOL, V145, P65, DOI 10.1016/j.ajo.2007.08.025; Applegate RA, 2010, J REFRACT SURG, V26, P796, DOI 10.3928/1081597X-20100921-05; Aramberri J, 2012, J CATARACT REFR SURG, V38, P1934, DOI 10.1016/j.jcrs.2012.06.049; Asgari S, 2013, CORNEA, V32, P25, DOI 10.1097/ICO.0b013e31824d0e40; Brandt JD, 2001, OPHTHALMOLOGY, V108, P1779, DOI 10.1016/S0161-6420(01)00760-6; Buhren J, 2010, INVEST OPHTH VIS SCI, V51, P3424, DOI 10.1167/iovs.09-4960; Camellin M, 2012, J REFRACT SURG, V28, P275, DOI 10.3928/1081597X-20120221-03; Chen MJ, 2009, J CHIN MED ASSOC, V72, P133, DOI 10.1016/S1726-4901(09)70038-3; Denoyer A, 2012, OPHTHALMOLOGY, V119, P1811, DOI 10.1016/j.ophtha.2012.03.004; Eysteinsson T, 2002, ACTA OPHTHALMOL SCAN, V80, P11, DOI 10.1034/j.1600-0420.2002.800103.x; Foster PJ, 1997, AM J OPHTHALMOL, V124, P53, DOI 10.1016/S0002-9394(14)71644-7; Foster PJ, 1998, OPHTHALMOLOGY, V105, P969, DOI 10.1016/S0161-6420(98)96021-3; Harris WF, 2006, OPHTHAL PHYSL OPT, V26, P497, DOI 10.1111/j.1475-1313.2006.00382.x; Hashemi H, 2007, J CATARACT REFR SURG, V33, P841, DOI 10.1016/j.jcrs.2007.01.019; Hosseini HRJ, 2010, CORNEA, V29, P1091, DOI 10.1097/ICO.0b013e3181cf98e5; Klein SA, 1997, OPTOMETRY VISION SCI, V74, P931, DOI 10.1097/00006324-199711000-00027; Ladi JS, 2010, INDIAN J OPHTHALMOL, V58, P385, DOI 10.4103/0301-4738.67045; Lekskul Manapon, 2005, J Med Assoc Thai, V88 Suppl 3, pS175; MAEDA N, 1994, INVEST OPHTH VIS SCI, V35, P2749; MAURICE DM, 1951, BRIT J OPHTHALMOL, V35, P169, DOI 10.1136/bjo.35.3.169; Mishima S, 1968, Surv Ophthalmol, V13, P57; Montes-Mico R, 2010, OCUL SURF, V8, P185, DOI 10.1016/S1542-0124(12)70233-1; Oliveira C, 2007, BRIT J OPHTHALMOL, V91, P37, DOI 10.1136/bjo.2006.102061; Oliveira CM, 2012, J CATARACT REFR SURG, V38, P343, DOI 10.1016/j.jcrs.2011.11.016; Prado P, 2009, OPHTHAL PHYSL OPT, V29, P264, DOI 10.1111/j.1475-1313.2009.00652.x; Prasad A, 2011, CORNEA, V30, P553, DOI 10.1097/ICO.0b013e3181fb880c; Queiros A, 2010, OPTOMETRY VISION SCI, V87, P432, DOI 10.1097/OPX.0b013e3181da8628; Rufer F, 2010, ACTA OPHTHALMOL, V88, P885, DOI 10.1111/j.1755-3768.2009.01588.x; Saad A, 2012, INVEST OPHTH VIS SCI, V53, P2978, DOI 10.1167/iovs.11-8803; Savini G, 2011, J CATARACT REFR SURG, V37, P302, DOI 10.1016/j.jcrs.2010.07.039; Savini G, 2009, J REFRACT SURG, V25, P534, DOI 10.3928/1081597X-20090512-07; Schlegel Z, 2009, J REFRACT SURG, V25, pS951, DOI 10.3928/1081597X-20090915-10; Smolek MK, 1997, INVEST OPHTH VIS SCI, V38, P2290; Wang L, 2010, J CATARACT REFR SURG, V36, P425, DOI 10.1016/j.jcrs.2009.09.034; Wang XG, 2013, OPHTHALMOLOGY, V120, P703, DOI 10.1016/j.ophtha.2012.09.034; Wang Y, 2009, CLIN EXP OPTOM, V92, P267, DOI 10.1111/j.1444-0938.2009.00354.x; Yi Jeong-Ho, 2008, Korean J Ophthalmol, V22, P242, DOI 10.3341/kjo.2008.22.4.242	39	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97913	10.1371/journal.pone.0097913	http://dx.doi.org/10.1371/journal.pone.0097913			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24834914	Green Published, Green Submitted, gold			2022-12-27	WOS:000339614800083
J	Singh, A; Haris, M; Cai, KJ; Kogan, F; Hariharan, H; Reddy, R				Singh, Anup; Haris, Mohammad; Cai, Kejia; Kogan, Feliks; Hariharan, Hari; Reddy, Ravinder			High Resolution T1 rho Mapping of In Vivo Human Knee Cartilage at 7T	PLOS ONE			English	Article							HIGH-FIELD MRI; ARTICULAR-CARTILAGE; 1.5 TESLA; 3 T; T-1-RHO; QUANTIFICATION; OSTEOARTHRITIS; COMPENSATION; ARTIFACTS; ECHO	Purpose: Spin lattice relaxation time in rotating frame (T1 rho) mapping of human knee cartilage has shown promise in detecting biochemical changes during osteoarthritis. Due to higher field strength, MRI at 7T has advantages in term of SNR compared to clinical MR scanners and this can be used to increase in image resolution. Objective of current study was to evaluate the feasibility of high resolution T1 rho mapping of in vivo human knee cartilage at 7T MR scanner. Materials and Methods: In this study we have used a T1 rho prepared GRE pulse sequence for obtaining high resolution (in plan resolution = 0.2 mm(2)) T1 rho MRI of human knee cartilage at 7T. The effect of a global and localized reference frequency and reference voltage setting on B-0, B-1 and T1 rho maps in cartilage was evaluated. Test-retest reliability results of T1 rho values from asymptomatic subjects as well as T1 rho maps from abnormal cartilage of two human subjects are presented. These results are compared with T1 rho MRI data obtained from 3T. Results: Our approach enabled acquisition of 3D-T1 rho data within allowed SAR limits at 7T. SNR of cartilage on T1 rho weighted images was greater than 90. Off-resonance effects present in the cartilage B-0, B-1 and T1 rho maps obtained using global shim and reference frequency and voltage setting, were reduced by the proposed localized reference frequency and voltage setting. T1 rho values of cartilage obtained with the localized approach were reproducible. Abnormal knee cartilage showed elevated T1 rho values in affected regions. T1 rho values at 7T were significantly lower (p<0.05) compared to those obtained at 3T. Conclusion: In summary, by using proposed localized frequency and voltage setting approach, high-resolution 3D-T1 rho maps of in vivo human knee cartilage can be obtained in clinically acceptable scan times (<30 min) and SAR constraints, which provides the ability to characterize cartilage molecular integrity.	[Singh, Anup; Haris, Mohammad; Cai, Kejia; Kogan, Feliks; Hariharan, Hari; Reddy, Ravinder] Univ Penn, Dept Radiol, CMROI, Philadelphia, PA 19104 USA; [Singh, Anup] Indian Inst Technol Delhi, Ctr Biomed Engn, Delhi, India; [Haris, Mohammad] Sidra Med & Res Ctr, Res Branch, Doha, Qatar; [Cai, Kejia] Univ Illinois, Chicago, IL USA	University of Pennsylvania; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Sidra Medical & Research Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Singh, A (corresponding author), Univ Penn, Dept Radiol, CMROI, Philadelphia, PA 19104 USA.	anups.minhas@gmail.com	Kogan, Feliks/AAH-5814-2019	Reddy, Ravinder/0000-0003-4580-2392; Haris, Mohammad/0000-0002-4945-2935; Kogan, Feliks/0000-0003-0580-7308; Singh, Anup/0000-0001-6744-8326	NIAMS [NIH-R01AR45404]; NIH-NIBIB [P41EB015893]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015893] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH-NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was performed at an NIH-NIBIB supported Biomedical Technology Research Center (P41EB015893) and was supported by NIAMS grant NIH-R01AR45404. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akella SVS, 2004, MAGN RESON MED, V52, P1103, DOI 10.1002/mrm.20241; Blanco FJ, 1998, ARTHRITIS RHEUM, V41, P284, DOI 10.1002/1529-0131(199802)41:2<284::AID-ART12>3.0.CO;2-T; Borthakur A, 2004, J MAGN RESON IMAGING, V19, P403, DOI 10.1002/jmri.20016; Borthakur A, 2003, J MAGN RESON IMAGING, V17, P730, DOI 10.1002/jmri.10296; Chang G, 2012, J MAGN RESON IMAGING, V35, P441, DOI 10.1002/jmri.23506; Cohen ZA, 1999, OSTEOARTHR CARTILAGE, V7, P95, DOI 10.1053/joca.1998.0165; Firbank MJ, 1999, PHYS MED BIOL, V44, pN261, DOI 10.1088/0031-9155/44/12/403; Goto H, 2012, EUR J RADIOL, V81, pE796, DOI 10.1016/j.ejrad.2012.03.022; Kim M, 2009, MAGN RESON MED, V61, P1441, DOI 10.1002/mrm.21873; Li X, 2007, OSTEOARTHR CARTILAGE, V15, P789, DOI 10.1016/j.joca.2007.01.011; Pakin SK, 2006, J MAGN RESON IMAGING, V24, P1357, DOI 10.1002/jmri.20733; Pakin SK, 2006, ACAD RADIOL, V13, P1135, DOI 10.1016/j.acra.2006.06.007; Redfield AG, 1955, PHYS REV, V98, P13; Regatte RR, 2007, J MAGN RESON IMAGING, V25, P262, DOI 10.1002/jmri.20814; Regatte RR, 2004, ACAD RADIOL, V11, P741, DOI 10.1016/j.acra.2004.03.051; Saarakkala S, 2010, OSTEOARTHR CARTILAGE, V18, P73, DOI 10.1016/j.joca.2009.08.003; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Singh A, 2012, MAGN RESON MED, V68, P588, DOI 10.1002/mrm.23250; Wang N, 2012, MAGN RESON MATER PHY, V25, P297, DOI 10.1007/s10334-011-0288-1; Wheaton AJ, 2005, MAGNET RESON MED, V54, P1087, DOI 10.1002/mrm.20678; Wheaton AJ, 2004, MAGNET RESON MED, V52, P1453, DOI 10.1002/mrm.20268; Witschey WRT, 2008, J MAGN RESON IMAGING, V28, P744, DOI 10.1002/jmri.21444; Witschey WRT, 2007, MAGN RESON MED, V57, P2, DOI 10.1002/mrm.21134; Witschey WRT, 2010, MAGN RESON MED, V63, P1376, DOI 10.1002/mrm.22272; Witschey WRT, 2009, MAGN RESON MED, V62, P993, DOI 10.1002/mrm.22092; Witschey WRT, 2007, J MAGN RESON, V186, P75, DOI 10.1016/j.jmr.2007.01.015; Young AA, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1898	27	38	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97486	10.1371/journal.pone.0097486	http://dx.doi.org/10.1371/journal.pone.0097486			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830386	Green Published, gold, Green Submitted			2022-12-27	WOS:000336789500067
J	Youcef, G; Olivier, A; L'Huillier, CPJ; Labat, C; Fay, R; Tabcheh, L; Toupance, S; Rodriguez-Gueant, RM; Bergerot, D; Jaisser, F; Lacolley, P; Zannad, F; Vallar, L; Pizard, A				Youcef, Gina; Olivier, Arnaud; L'Huillier, Clement P. J.; Labat, Carlos; Fay, Renaud; Tabcheh, Lina; Toupance, Simon; Rodriguez-Gueant, Rosa-Maria; Bergerot, Damien; Jaisser, Frederic; Lacolley, Patrick; Zannad, Faiez; Vallar, Laurent; Pizard, Anne			Simultaneous Characterization of Metabolic, Cardiac, Vascular and Renal Phenotypes of Lean and Obese SHHF Rats	PLOS ONE			English	Article							ARTERIAL STIFFNESS; RISK-FACTORS; HEART; MODEL; EXPRESSION; RESISTANCE; RECEPTOR	Individuals with metabolic syndrome (MetS) are prone to develop heart failure (HF). However, the deleterious effects of MetS on the continuum of events leading to cardiac remodeling and subsequently to HF are not fully understood. This study characterized simultaneously MetS and cardiac, vascular and renal phenotypes in aging Spontaneously Hypertensive Heart Failure lean (SHHF+/? regrouping and (+/cp) rats) and obese (SHHFcp/cp, "cp" defective mutant allele of the leptin receptor gene) rats. We aimed to refine the milestones and their onset during the progression from MetS to HF in this experimental model We found that SHHFcp/cp but not SHHF+/? rats developed dyslipidemia, as early as 1.5 months of age. This early alteration in the lipidic profile was detectable concomitantly to impaired renal function (polyuria, proteinuria but no glycosuria) and reduced carotid distensibility as compared to SHHF+/? rats. By 3 months of age SHHFcp/cp animals developed severe obesity associated with dislipidemia and hypertension defining the onset of MetS. From 6 months of age, SHHF+/? rats developed concentric left ventricular hypertrophy (LVH) while SHHFcp/cp rats developed eccentric LVH apparent from progressive dilation of the LV dimensions. By 14 months of age only SHHFcp/cp rats showed significantly higher central systolic blood pressure and a reduced ejection fraction resulting in systolic dysfunction as compared to SHHF+/?. In summary, the metabolic and hemodynamic mechanisms participating in the faster decline of cardiac functions in SHHFcp/cp rats are established long before their physiological consequences are detectable. Our results suggest that the molecular mechanisms triggered within the first three months after birth of SHHFcp/cp rats should be targeted preferentially by therapeutic interventions in order to mitigate the later HF development.	[Youcef, Gina; Olivier, Arnaud; L'Huillier, Clement P. J.; Labat, Carlos; Toupance, Simon; Lacolley, Patrick; Zannad, Faiez; Pizard, Anne] UMRS U1116 Inserm, Vandoeuvre Les Nancy, France; [Youcef, Gina; Olivier, Arnaud; L'Huillier, Clement P. J.; Labat, Carlos; Tabcheh, Lina; Toupance, Simon; Rodriguez-Gueant, Rosa-Maria; Lacolley, Patrick; Zannad, Faiez; Pizard, Anne] Federat Rech 3209, Nancy, France; [Youcef, Gina; Olivier, Arnaud; L'Huillier, Clement P. J.; Labat, Carlos; Tabcheh, Lina; Toupance, Simon; Rodriguez-Gueant, Rosa-Maria; Lacolley, Patrick; Zannad, Faiez; Pizard, Anne] Univ Lorraine, Nancy, France; [Youcef, Gina; Vallar, Laurent] Ctr Rech Publ Sante, Genom Res Unit, Strassen, Luxembourg; [Olivier, Arnaud; Fay, Renaud; Toupance, Simon; Rodriguez-Gueant, Rosa-Maria; Jaisser, Frederic; Lacolley, Patrick; Zannad, Faiez] CHU Nancy, Nancy, France; [Olivier, Arnaud; Fay, Renaud; Toupance, Simon; Jaisser, Frederic; Zannad, Faiez; Pizard, Anne] CIC 1433, Vandoeuvre Les Nancy, France; [Tabcheh, Lina] UMR 7365 CNRS, Vandoeuvre Les Nancy, France; [Rodriguez-Gueant, Rosa-Maria] U954 Inserm, Vandoeuvre Les Nancy, France; [Bergerot, Damien] HEGP, PARCC, CIC 9201, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Luxembourg Institute of Health; CHU de Nancy; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Pizard, A (corresponding author), UMRS U1116 Inserm, Vandoeuvre Les Nancy, France.	anne.pizard@inserm.fr	Labat, Carlos/F-7492-2010; Zannad, Faiez/K-4649-2019; Jaisser, Frederic/P-4287-2017; Lacolley, Patrick/G-3118-2013; Pizard, Anne CM/P-4754-2016	Labat, Carlos/0000-0002-5275-3405; Jaisser, Frederic/0000-0001-9051-1901; Pizard, Anne CM/0000-0003-2705-6365; Toupance, Simon/0000-0001-7441-567X; Vallar, Laurent/0000-0002-4404-1010	Inserm; Region Lorraine; "Comite Lorrain" of the "Fondation pour la Recherche Medicale";  [261409]	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Lorraine(Region Grand-Est); "Comite Lorrain" of the "Fondation pour la Recherche Medicale"(Region Grand-Est); 	Dr A. Pizard acknowledges Inserm, Region Lorraine, the "Comite Lorrain" of the "Fondation pour la Recherche Medicale" and FP7-HEALTH-2010 # 261409 MEDIA program for their financial supports to carry this project. G. Youcef is supported by a salary fellowship from AFR PhD grants, Luxembourg. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Altschuld RA, 2003, PROG EXP CARDIOL, V5, P67; Ardehali H, 2012, EUR J HEART FAIL, V14, P120, DOI 10.1093/eurjhf/hfr173; Aroor AR, 2012, HEART FAIL CLIN, V8, P609, DOI 10.1016/j.hfc.2012.06.005; Aspelund T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013957; Benetos A, 2002, AM J HYPERTENS, V15, P1101, DOI 10.1016/S0895-7061(02)03029-7; Bountioukos M, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2006.02.031; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Caprio M, 2007, FASEB J, V21, P2185, DOI 10.1096/fj.06-7970com; Caprio M, 2011, ENDOCRINOLOGY, V152, P113, DOI 10.1210/en.2010-0674; De Pergola G, 2013, ENDOCR METAB IMMUNE; Ebong IA, 2013, OBESITY SILVER SPRIN; Fellmann L, 2013, PHARMACOL THERAPEUT, V137, P331, DOI 10.1016/j.pharmthera.2012.11.004; Friedman JE, 1997, HORM METAB RES, V29, P214, DOI 10.1055/s-2007-979024; Greenhouse DD, 1990, FRONTIERS DIABETES 3, VVIII, P375; Griffin KA, 2007, AM J PHYSIOL-RENAL, V293, pF1605, DOI 10.1152/ajprenal.00511.2006; HASS GJ, 1995, AM HEART J, V130, P806, DOI 10.1016/0002-8703(95)90081-0; Heyen JRR, 2002, AM J PHYSIOL-HEART C, V283, pH1775, DOI 10.1152/ajpheart.00305.2002; Holycross BJ, 1997, AM J PHYSIOL-HEART C, V273, pH228, DOI 10.1152/ajpheart.1997.273.1.H228; Horwich TB, 2010, J AM COLL CARDIOL, V55, P283, DOI 10.1016/j.jacc.2009.07.029; HOVERSLAND RC, 1992, INT J OBESITY, V16, P977; Ingelsson E, 2005, J AM COLL CARDIOL, V46, P2054, DOI 10.1016/j.jacc.2005.07.059; Kim SH, 1998, YONSEI MED J, V39, P453, DOI 10.3349/ymj.1998.39.5.453; Lacolley P, 2002, CIRCULATION, V106, P2848, DOI 10.1161/01.CIR.0000039328.33137.6C; Lazzarini V, 2013, EUR J HEART FAIL; Marti CN, 2012, J AM COLL CARDIOL, V60, P1455, DOI 10.1016/j.jacc.2011.11.082; Masson S, 2011, EUR J CLIN INVEST, V41, P1330, DOI 10.1111/j.1365-2362.2011.02548.x; McCune SA, 1990, ILAR J, V32, P23; McCune SA, 1990, FRONTIERS DIABETES R, V6, P397; McCune SA, 1995, LESSONS ANIMAL DIABE, P255; MEIER DA, 1995, OBES RES, V3, P465, DOI 10.1002/j.1550-8528.1995.tb00176.x; Przybylski R, 2010, NUTR METAB CARDIOVAS, V20, P641, DOI 10.1016/j.numecd.2009.07.009; Radin MJ, 2003, MOL CELL BIOCHEM, V242, P57, DOI 10.1023/A:1021181527060; RADIN MJ, 1992, J CARDIOVASC PHARM, V19, P464, DOI 10.1097/00005344-199203000-00026; Reffelmann T, 2003, BASIC RES CARDIOL, V98, P275, DOI 10.1007/s00395-003-0401-3; Simpson CR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026573; Sloboda N, 2012, J GERONTOL A-BIOL, V67, P927, DOI 10.1093/gerona/glr236; Van Berendoncks An M, 2011, Curr Heart Fail Rep, V8, P113, DOI 10.1007/s11897-011-0056-6	37	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e96452	10.1371/journal.pone.0096452	http://dx.doi.org/10.1371/journal.pone.0096452			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831821	Green Published, gold, Green Submitted			2022-12-27	WOS:000336789500021
J	Zhu, W; Gao, YF; Chang, CF; Wan, JR; Zhu, SS; Wang, J				Zhu, Wei; Gao, Yufeng; Chang, Che-Feng; Wan, Jie-ru; Zhu, Shan-shan; Wang, Jian			Mouse Models of Intracerebral Hemorrhage in Ventricle, Cortex, and Hippocampus by Injections of Autologous Blood or Collagenase	PLOS ONE			English	Article							TUFTSIN FRAGMENT 1-3; TAIL SUSPENSION TEST; BRAIN-INJURY; RECOGNITION MEMORY; RAT MODEL; MICE; STROKE; EDEMA; INFLAMMATION; MECHANISMS	Intracerebral hemorrhage (ICH) is a devastating condition. Existing preclinical ICH models focus largely on striatum but neglect other brain areas such as ventricle, cortex, and hippocampus. Clinically, however, hemorrhagic strokes do occur in these other brain regions. In this study, we established mouse hemorrhagic models that utilize stereotactic injections of autologous whole blood or collagenase to produce ventricular, cortical, and hippocampal injury. We validated and characterized these models by histology, immunohistochemistry, and neurobehavioral tests. In the intraventricular hemorrhage (IVH) model, C57BL/6 mice that received unilateral ventricular injections of whole blood demonstrated bilateral ventricular hematomas, ventricular enlargement, and brain edema in the ipsilateral cortex and basal ganglia at 72 h. Unilateral injections of collagenase (150 U/ml) caused reproducible hematomas and brain edema in the frontal cortex in the cortical ICH (c-ICH) model and in the hippocampus in the hippocampal ICH (h-ICH) model. Immunostaining revealed cellular inflammation and neuronal death in the periventricular regions in the IVH brain and in the perihematomal regions in the c-ICH and h-ICH brains. Locomotor abnormalities measured with a 24-point scoring system were present in all three models, especially on days 1, 3, and 7 post-ICH. Locomotor deficits measured by the wire-hanging test were present in models of IVH and c-ICH, but not h-ICH. Interestingly, mice in the c-ICH model demonstrated emotional abnormality, as measured by the tail suspension test and forced swim test, whereas h-ICH mice exhibited memory abnormality, as measured by the novel object recognition test. All three ICH models generated reproducible brain damage, brain edema, inflammation, and consistent locomotor deficits. Additionally, the c-ICH model produced emotional deficits and the h-ICH model produced cognitive deficits. These three models closely mimic human ICH and should be useful for investigating the pathophysiology of ICH in ventricle, cortex, and hippocampus and for evaluating potential therapeutic strategies.	[Zhu, Wei] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Emergency Med, Wuhan 430074, Hubei, Peoples R China; [Zhu, Wei; Gao, Yufeng; Chang, Che-Feng; Wang, Jian] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Wan, Jie-ru] IIT, Coll Sci, Dept Biol Sci, Chicago, IL 60616 USA; [Zhu, Shan-shan] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA	Huazhong University of Science & Technology; Johns Hopkins University; Illinois Institute of Technology; Johns Hopkins University	Wang, J (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA.	jwang79@jhmi.edu	Wang, Jian/I-4874-2019	Wang, Jian/0000-0003-2291-640X; Chang, Che-Feng/0000-0002-3211-1739	AHA [13GRNT15730001]; NIH [K01AG031926, R01NS078026, R01AT007317]; National Center for Complementary & Integrative Health [R01AT007317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG031926] Funding Source: NIH RePORTER	AHA(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by AHA 13GRNT15730001, NIH K01AG031926, R01NS078026, and R01AT007317. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronowski J, 2011, STROKE, V42, P1781, DOI 10.1161/STROKEAHA.110.596718; Bai F, 2001, PHARMACOL BIOCHEM BE, V70, P187, DOI 10.1016/S0091-3057(01)00599-8; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Can A, 2012, JOVE-J VIS EXP, DOI 10.3791/3769; Can A, 2012, JOVE-J VIS EXP, DOI 10.3791/3638; Cervo L, 2005, J NEUROSCI, V25, P8165, DOI 10.1523/JNEUROSCI.1816-05.2005; Chen Z, 2011, STROKE, V42, P465, DOI 10.1161/STROKEAHA.110.602755; Chu K, 2004, J CEREBR BLOOD F MET, V24, P926, DOI 10.1097/01.WCB.0000130866.25040.7D; Cohen SJ, 2013, CURR BIOL, V23, P1685, DOI 10.1016/j.cub.2013.07.002; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Feron F, 2005, BRAIN RES BULL, V65, P141, DOI 10.1016/j.brainresbull.2004.12.007; Gertz K, 2006, CIRC RES, V99, P1132, DOI 10.1161/01.RES.0000250175.14861.77; Hattori K, 2000, STROKE, V31, P1939, DOI 10.1161/01.STR.31.8.1939; Keep RF, 2012, LANCET NEUROL, V11, P720, DOI 10.1016/S1474-4422(12)70104-7; Kirkman MA, 2011, J CEREBR BLOOD F MET, V31, P2135, DOI 10.1038/jcbfm.2011.124; Kleinig TJ, 2009, BRAIN RES, V1287, P164, DOI 10.1016/j.brainres.2009.06.077; Krafft PR, 2012, INT J STROKE, V7, P398, DOI 10.1111/j.1747-4949.2012.00838.x; Lan X, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-98; Liesz Arthur, 2011, Exp Transl Stroke Med, V3, P11, DOI 10.1186/2040-7378-3-11; Lockridge A, 2013, BEHAV BRAIN RES, V246, P168, DOI 10.1016/j.bbr.2013.02.032; Lodhia KR, 2006, ACTA NEUROCHIR SUPPL, V96, P207; MacLellan CL, 2012, J CEREBR BLOOD F MET, V32, P612, DOI 10.1038/jcbfm.2012.8; Masuda T, 2010, BRAIN RES, V1355, P228, DOI 10.1016/j.brainres.2010.07.101; Matsushita K, 2000, J CEREBR BLOOD F MET, V20, P396, DOI 10.1097/00004647-200002000-00022; Moxon-Emre I, 2011, J NEUROPATH EXP NEUR, V70, P218, DOI 10.1097/NEN.0b013e31820d94a5; Renard CE, 2004, PROG NEURO-PSYCHOPH, V28, P1255, DOI 10.1016/j.pnpbp.2004.06.010; Rogove AD, 2002, CELL DEATH DIFFER, V9, P801, DOI 10.1038/sj.cdd.4401041; ROSENBERG GA, 1990, STROKE, V21, P801, DOI 10.1161/01.STR.21.5.801; Rynkowski MA, 2008, NAT PROTOC, V3, P122, DOI 10.1038/nprot.2007.513; Song S, 2008, ACTA NEUROCHIR SUPPL, V105, P13; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; van Rossum D, 2004, METAB BRAIN DIS, V19, P393, DOI 10.1023/B:MEBR.0000043984.73063.d8; Wang J, 2005, BRAIN, V128, P1622, DOI 10.1093/brain/awh489; Wang J, 2005, STROKE, V36, P613, DOI 10.1161/01.STR.0000155729.12931.8f; Wang J, 2003, ANN NEUROL, V54, P655, DOI 10.1002/ana.10750; Wang J, 2008, BRAIN RES, V1222, P214, DOI 10.1016/j.brainres.2008.05.058; Wang JA, 2007, BRAIN, V130, P1643, DOI 10.1093/brain/awm095; Wang JA, 2007, FREE RADICAL BIO MED, V43, P408, DOI 10.1016/j.freeradbiomed.2007.04.020; Wang J, 2007, J CEREBR BLOOD F MET, V27, P894, DOI 10.1038/sj.jcbfm.9600403; Wang J, 2006, NEUROBIOL DIS, V22, P473, DOI 10.1016/j.nbd.2005.12.009; Wang JA, 2010, PROG NEUROBIOL, V92, P463, DOI 10.1016/j.pneurobio.2010.08.001; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Wu H, 2012, NEUROBIOL DIS, V45, P388, DOI 10.1016/j.nbd.2011.08.028; Wu H, 2011, J CEREBR BLOOD F MET, V31, P1243, DOI 10.1038/jcbfm.2010.209; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xi GH, 2001, STROKE, V32, P162, DOI 10.1161/01.STR.32.1.162; Xi GH, 1998, STROKE, V29, P2580, DOI 10.1161/01.STR.29.12.2580	48	66	69	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97423	10.1371/journal.pone.0097423	http://dx.doi.org/10.1371/journal.pone.0097423			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831292	Green Published, gold, Green Submitted			2022-12-27	WOS:000336789500056
J	Chung, TW; Choi, HJ; Kim, SJ; Kwak, CH; Song, KH; Jin, UH; Chang, YC; Chang, HW; Lee, YC; Ha, KT; Kim, CH				Chung, Tae-Wook; Choi, Hee-Jung; Kim, Seok-Jo; Kwak, Choong-Hwan; Song, Kwon-Ho; Jin, Un-Ho; Chang, Young-Chae; Chang, Hyeun Wook; Lee, Young-Choon; Ha, Ki-Tae; Kim, Cheorl-Ho			The Ganglioside GM3 Is Associated with Cisplatin-Induced Apoptosis in Human Colon Cancer Cells	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; CARCINOMA-CELLS; ACTIVATION; DEATH; 12-LIPOXYGENASE; EXPRESSION; INDUCTION; SYNTHASE; KINASE; DNA	Cisplatin (cis-diamminedichloroplatinum, CDDP) is a well-known chemotherapeutic agent for the treatment of several cancers. However, the precise mechanism underlying apoptosis of cancer cells induced by CDDP remains unclear. In this study, we show mechanistically that CDDP induces GM3-mediated apoptosis of HCT116 cells by inhibiting cell proliferation, and increasing DNA fragmentation and mitochondria-dependent apoptosis signals. CDDP induced apoptosis within cells through the generation of reactive oxygen species (ROS), regulated the ROS-mediated expression of Bax, Bcl-2, and p53, and induced the degradation of the poly (ADP-ribosyl) polymerase (PARP). We also checked expression levels of different gangliosides in HCT116 cells in the presence or absence of CDDP. Interestingly, among the gangliosides, CDDP augmented the expression of only GM3 synthase and its product GM3. Reduction of the GM3 synthase level through ectopic expression of GM3 small interfering RNA (siRNA) rescued HCT116 cells from CDDP-induced apoptosis. This was evidenced by inhibition of apoptotic signals by reducing ROS production through the regulation of 12-lipoxigenase activity. Furthermore, the apoptotic sensitivity to CDDP was remarkably increased in GM3 synthase-transfected HCT116 cells compared to that in controls. In addition, GM3 synthase-transfected cells treated with CDDP exhibited an increased accumulation of intracellular ROS. These results suggest the CDDP-induced oxidative apoptosis of HCT116 cells is mediated by GM3.	[Chung, Tae-Wook; Choi, Hee-Jung; Kim, Seok-Jo; Kwak, Choong-Hwan; Song, Kwon-Ho; Jin, Un-Ho; Kim, Cheorl-Ho] Sungkyunkwan Univ, Dept Biol Sci, Mol & Cellular Glycobiol Lab, Suwon, Kyunggi Do, South Korea; [Choi, Hee-Jung; Ha, Ki-Tae] Pusan Natl Univ, Sch Korean Med, Div Appl Med, Yangsan, Gyeongsangnam D, South Korea; [Chang, Young-Chae] Catholic Univ Daegu, Sch Med, Res Inst Biomed Engn, Taegu, South Korea; [Chang, Young-Chae] Catholic Univ Daegu, Sch Med, Dept Med, Taegu, South Korea; [Chang, Hyeun Wook] Yeungnam Univ, Fac Pharm, Kyungsan, South Korea; [Lee, Young-Choon] Dong A Univ, Fac Med Biotechnol, Pusan, South Korea	Sungkyunkwan University (SKKU); Pusan National University; Catholic University of Daegu; Catholic University of Daegu; Yeungnam University; Dong A University	Ha, KT (corresponding author), Pusan Natl Univ, Sch Korean Med, Div Appl Med, Yangsan, Gyeongsangnam D, South Korea.	hagis@pusan.ac.kr; chkimbio@skku.edu	Kim, Cheorl-Ho/T-6753-2019	Kim, Cheorl-Ho/0000-0002-6323-0714; Chung, Tae-Wook/0000-0001-5243-5020	Basic Science Research Program through National Research Foundation of Korea (NRF) grant - Ministry of Education, Science and Technology (MEST) of Korea [NRF-2013R1A1A2005387]; Personalized Tumor Engineering Research Center grant [2008-062611]	Basic Science Research Program through National Research Foundation of Korea (NRF) grant - Ministry of Education, Science and Technology (MEST) of Korea; Personalized Tumor Engineering Research Center grant	The present study has been supported by the Basic Science Research Program through National Research Foundation of Korea (NRF) grant funded by the Ministry of Education, Science and Technology (MEST) of Korea (NRF-2013R1A1A2005387) and Personalized Tumor Engineering Research Center grant (2008-062611). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGGARWAL SK, 1983, J HISTOCHEM CYTOCHEM, V31, P307, DOI 10.1177/31.2.6300219; BABA A, 1989, J BIOL CHEM, V264, P15790; Basu S, 2004, GLYCOCONJUGATE J, V20, P563; Benhar M, 2001, MOL CELL BIOL, V21, P6913, DOI 10.1128/MCB.21.20.6913-6926.2001; BRIGHTMAN AO, 1992, BIOCHIM BIOPHYS ACTA, V1105, P109, DOI 10.1016/0005-2736(92)90168-L; Burger KNJ, 1999, BBA-BIOMEMBRANES, V1419, P43, DOI 10.1016/S0005-2736(99)00052-8; Chahlavi A, 2005, CANCER RES, V65, P5428, DOI 10.1158/0008-5472.CAN-04-4395; Choi HJ, 2006, GLYCOBIOLOGY, V16, P573, DOI 10.1093/glycob/cwj105; Choi HJ, 2003, FEBS LETT, V555, P204, DOI 10.1016/S0014-5793(03)01227-4; Choudhary S, 2013, BIOCHEM BIOPH RES CO, V436, P325, DOI 10.1016/j.bbrc.2013.05.102; Chung TW, 2009, GLYCOBIOLOGY, V19, P229, DOI 10.1093/glycob/cwn114; Chung TW, 2005, GLYCOBIOLOGY, V15, P233, DOI 10.1093/glycob/cwh156; d'Azzo A, 2006, CELL DEATH DIFFER, V13, P404, DOI 10.1038/sj.cdd.4401834; DeMaria R, 1997, SCIENCE, V277, P1652, DOI 10.1126/science.277.5332.1652; Dent P, 2001, CLIN CANCER RES, V7, P775; FISHER DE, 1994, CELL, V78, P539, DOI 10.1016/0092-8674(94)90518-5; Fujimoto Y, 2005, J NEURO-ONCOL, V71, P99, DOI 10.1007/s11060-004-9602-3; Garofalo T, 2005, CELL DEATH DIFFER, V12, P1378, DOI 10.1038/sj.cdd.4401672; Gershenson DM, 2007, J CLIN ONCOL, V25, P2938, DOI 10.1200/JCO.2007.10.8738; GRUNICKE H, 1992, PHARMACOL THERAPEUT, V55, P1, DOI 10.1016/0163-7258(92)90027-W; Hakomori S, 2003, CURR OPIN HEMATOL, V10, P16, DOI 10.1097/00062752-200301000-00004; Hakomori S, 2000, GLYCOCONJUGATE J, V17, P627, DOI 10.1023/A:1011086929064; Hakomori SI, 1998, ANN NY ACAD SCI, V845, P1, DOI 10.1111/j.1749-6632.1998.tb09657.x; Iaffaioli RV, 2007, ANN ONCOL, V18, P153, DOI 10.1093/annonc/mdm246; Iwamori M, 2005, GLYCOCONJUGATE J, V22, P119, DOI 10.1007/s10719-005-0363-9; Jamieson ER, 1999, CHEM REV, V99, P2467, DOI 10.1021/cr980421n; Kakugawa Y, 2002, P NATL ACAD SCI USA, V99, P10718, DOI 10.1073/pnas.152597199; Kepp O, 2007, EMBO J, V26, P825, DOI 10.1038/sj.emboj.7601533; Kim C, 2008, BMB REP, V41, P555, DOI 10.5483/BMBRep.2008.41.8.555; Kim HJ, 2010, J NEUROSCI, V30, P3933, DOI 10.1523/JNEUROSCI.6054-09.2010; Kiura K, 1998, ANTICANCER RES, V18, P2957; Kopp HG, 2006, DRUGS, V66, P641, DOI 10.2165/00003495-200666050-00005; Kristal BS, 1999, J BIOL CHEM, V274, P23169, DOI 10.1074/jbc.274.33.23169; Levin S, 1999, TOXICOL PATHOL, V27, P484, DOI 10.1177/019262339902700419; Li DC, 2004, CANCER SCI, V95, P644, DOI 10.1111/j.1349-7006.2004.tb03323.x; Li YH, 1997, NEURON, V19, P453, DOI 10.1016/S0896-6273(00)80953-8; Ma R, 2003, GLYCOCONJUGATE J, V20, P319, DOI 10.1023/B:GLYC.0000033628.39302.ae; Martins NM, 2008, J APPL TOXICOL, V28, P337, DOI 10.1002/jat.1284; MASUDA H, 1994, BIOCHEM BIOPH RES CO, V203, P1175, DOI 10.1006/bbrc.1994.2306; McNeish IA, 2003, EXP CELL RES, V286, P186, DOI 10.1016/S0014-4827(03)00073-9; MIYASHITA T, 1994, ONCOGENE, V9, P1799; Moore DH, 2006, CURR OPIN ONCOL, V18, P516, DOI 10.1097/01.cco.0000239893.21161.51; Nakatsuji Y, 2001, EXP NEUROL, V168, P290, DOI 10.1006/exnr.2000.7602; Nojiri H, 2002, CANCER DETECT PREV, V26, P114, DOI 10.1016/S0361-090X(02)00033-8; Noll ENE, 2001, EXP NEUROL, V168, P300, DOI 10.1006/exnr.2000.7603; Ozeki Y, 1999, BRIT J PHARMACOL, V128, P1699, DOI 10.1038/sj.bjp.0702976; Razzaque MS, 1999, HISTOCHEM CELL BIOL, V111, P359, DOI 10.1007/s004180050368; Rebillard A, 2007, CANCER RES, V67, P7865, DOI 10.1158/0008-5472.CAN-07-0353; RUBIN E, 1992, CANCER RES, V52, P878; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Sohn H, 2006, FASEB J, V20, P1248, DOI 10.1096/fj.05-4911fje; Thayyullathil F, 2008, FREE RADICAL BIO MED, V45, P1403, DOI 10.1016/j.freeradbiomed.2008.08.014; Wang P, 2006, CELL SIGNAL, V18, P1528, DOI 10.1016/j.cellsig.2005.12.004; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; Watanabe R, 2002, CANCER RES, V62, P3850; Zhang YM, 2006, J BIOL CHEM, V281, P9460, DOI 10.1074/jbc.M510650200	56	24	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e92786	10.1371/journal.pone.0092786	http://dx.doi.org/10.1371/journal.pone.0092786			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24829158	Green Submitted, Green Published, gold			2022-12-27	WOS:000336857400005
J	Santiago, JJ; McNaughton, LJ; Koleini, N; Ma, X; Bestvater, B; Nickel, BE; Fandrich, RR; Wigle, JT; Freed, DH; Arora, RC; Kardami, E				Santiago, Jon-Jon; McNaughton, Leslie J.; Koleini, Navid; Ma, Xin; Bestvater, Brian; Nickel, Barbara E.; Fandrich, Robert R.; Wigle, Jeffrey T.; Freed, Darren H.; Arora, Rakesh C.; Kardami, Elissavet			High Molecular Weight Fibroblast Growth Factor-2 in the Human Heart Is a Potential Target for Prevention of Cardiac Remodeling	PLOS ONE			English	Article							II TYPE-2 RECEPTOR; UNCONVENTIONAL PROTEIN SECRETION; LEFT-VENTRICULAR DYSFUNCTION; HUMAN PERICARDIAL FLUID; ANGIOTENSIN-II; FACTOR FGF-2; CARDIOVASCULAR-DISEASE; HYPERTROPHIC RESPONSE; NUCLEAR-LOCALIZATION; BIOLOGICAL FUNCTIONS	Fibroblast growth factor 2 (FGF-2) is a multifunctional protein synthesized as high (Hi-) and low (Lo-) molecular weight isoforms. Studies using rodent models showed that Hi-and Lo-FGF-2 exert distinct biological activities: after myocardial infarction, rat Lo-FGF-2, but not Hi-FGF-2, promoted sustained cardioprotection and angiogenesis, while Hi-FGF-2, but not Lo-FGF-2, promoted myocardial hypertrophy and reduced contractile function. Because there is no information regarding Hi-FGF-2 in human myocardium, we undertook to investigate expression, regulation, secretion and potential tissue remodeling-associated activities of human cardiac (atrial) Hi-FGF-2. Human patient-derived atrial tissue extracts, as well as pericardial fluid, contained Hi-FGF-2 isoforms, comprising, respectively, 53%(+/-20 SD) and 68% (+/-25 SD) of total FGF-2, assessed by western blotting. Human atrial tissue-derived primary myofibroblasts (hMFs) expressed and secreted predominantly Hi-FGF-2, at about 80% of total. Angiotensin II (Ang II) up-regulated Hi-FGF-2 in hMFs, via activation of both type 1 and type 2 Ang II receptors; the ERK pathway; and matrix metalloprotease-2. Treatment of hMFs with neutralizing antibodies selective for human Hi-FGF-2 (neu-Ab(Hi-FGF-2)) reduced accumulation of proteins associated with fibroblast-tomyofibroblast conversion and fibrosis, including a-smooth muscle actin, extra-domain A fibronectin, and procollagen. Stimulation of hMFs with recombinant human Hi-FGF-2 was significantly more potent than Lo-FGF-2 in upregulating inflammation-associated proteins such as pro-interleukin-1 beta and plasminogen-activator-inhibitor-1. Culture media conditioned by hMFs promoted cardiomyocyte hypertrophy, an effect that was prevented by neu-Ab (Hi-FGF-2) in vitro. In conclusion, we have documented that Hi-FGF-2 represents a substantial fraction of FGF-2 in human cardiac (atrial) tissue and in pericardial fluid, and have shown that human Hi-FGF-2, unlike Lo-FGF-2, promotes deleterious (pro-fibrotic, proinflammatory, and pro-hypertrophic) responses in vitro. Selective targeting of Hi-FGF-2 production may, therefore, reduce pathological remodelling in the human heart.	[Santiago, Jon-Jon; McNaughton, Leslie J.; Koleini, Navid; Ma, Xin; Bestvater, Brian; Nickel, Barbara E.; Fandrich, Robert R.; Wigle, Jeffrey T.; Freed, Darren H.; Arora, Rakesh C.; Kardami, Elissavet] Univ Manitoba, Inst Cardiovasc Sci, St Boniface Hosp Res Ctr, Winnipeg, MB, Canada; [Ma, Xin; Fandrich, Robert R.; Kardami, Elissavet] Univ Manitoba, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada; [Santiago, Jon-Jon; Koleini, Navid; Kardami, Elissavet] Univ Manitoba, Dept Physiol, Winnipeg, MB, Canada; [Wigle, Jeffrey T.] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada; [Freed, Darren H.; Arora, Rakesh C.] Univ Manitoba, Dept Surg, Winnipeg, MB R3T 2N2, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba	Kardami, E (corresponding author), Univ Manitoba, Inst Cardiovasc Sci, St Boniface Hosp Res Ctr, Winnipeg, MB, Canada.	ekardami@sbrc.ca	Koleini, Navid/AAA-1204-2020; Wigle, Jeffrey/G-2005-2014	Koleini, Navid/0000-0003-3021-3894; Freed, Darren/0000-0002-6239-1444; Kardami, Elissavet/0000-0002-3198-8432; Wigle, Jeffrey/0000-0002-4985-7684	Canadian Institutes for Health Research [FRN74733]; National Sciences and Engineering Research Council of Canada; Heart and Stroke Foundation of Manitoba	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Heart and Stroke Foundation of Manitoba	This work was funded through an operating research grant granted by the Canadian Institutes for Health Research to Elissavet Kardami (FRN74733). Jon-Jon Santiago's salary was provided by a studentship award by the National Sciences and Engineering Research Council of Canada, and Leslie McNaughton's salary by a studentship from the Heart and Stroke Foundation of Manitoba. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadie R, 2010, J NUTR, V140, P1438, DOI 10.3945/jn.110.123091; Aranguiz-Urroz P, 2009, AM J HYPERTENS, V22, P569, DOI 10.1038/ajh.2009.32; Arnaud E, 1999, MOL CELL BIOL, V19, P505; Backhaus R, 2004, J CELL SCI, V117, P1727, DOI 10.1242/jcs.01027; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Boldt A, 2006, BASIC RES CARDIOL, V101, P261, DOI 10.1007/s00395-005-0571-2; Bommer William J, 2008, Prev Cardiol, V11, P215, DOI 10.1111/j.1751-7141.2008.00004.x; BUGLER B, 1991, MOL CELL BIOL, V11, P573, DOI 10.1128/MCB.11.1.573; Burstein B, 2008, CIRCULATION, V117, P1630, DOI 10.1161/CIRCULATIONAHA.107.748053; Chlebova K, 2009, CELL MOL LIFE SCI, V66, P225, DOI 10.1007/s00018-008-8440-4; CLARKE MSF, 1995, CIRC RES, V76, P927, DOI 10.1161/01.RES.76.6.927; Claus P, 2003, J BIOL CHEM, V278, P479, DOI 10.1074/jbc.M206056200; Corda S, 1997, CIRC RES, V81, P679; Cui TX, 2001, CARDIOVASC RES, V49, P863, DOI 10.1016/S0008-6363(00)00299-6; Cushing MC, 2008, FASEB J, V22, P1769, DOI 10.1096/fj.07-087627; Dahl JP, 2000, BIOCHEMISTRY-US, V39, P14877, DOI 10.1021/bi001073y; Delrieu I, 2000, FEBS LETT, V468, P6, DOI 10.1016/S0014-5793(00)01189-3; Dinarello CA, 2002, CLIN EXP RHEUMATOL, V20, pS1; Ding L, 2002, J BIOL CHEM, V277, P31056, DOI 10.1074/jbc.M203658200; Dobaczewski M, 2010, J MOL CELL CARDIOL, V48, P504, DOI 10.1016/j.yjmcc.2009.07.015; Doble BW, 2004, J CELL SCI, V117, P507, DOI 10.1242/jcs.00889; DOBLE BW, 1990, BIOCHEM BIOPH RES CO, V173, P1116, DOI 10.1016/S0006-291X(05)80901-5; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Ferrario CM, 2006, J RENIN-ANGIO-ALDO S, V7, P3, DOI 10.3317/jraas.2006.003; Fujita M, 1998, Angiogenesis, V2, P105, DOI 10.1023/A:1009062712441; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Goette A, 2000, CIRCULATION, V101, P2678, DOI 10.1161/01.CIR.101.23.2678; Hinescu ME, 2006, J CELL MOL MED, V10, P243, DOI 10.1111/j.1582-4934.2006.tb00306.x; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Ichihara S, 2001, CIRCULATION, V104, P346, DOI 10.1161/01.CIR.104.3.346; Iwakura A, 2000, HEART VESSELS, V15, P112, DOI 10.1007/PL00007264; Jaffre F, 2009, CIRC RES, V104, P113, DOI 10.1161/CIRCRESAHA.108.180976; Jiang ZS, 2007, J MOL CELL CARDIOL, V42, P222, DOI 10.1016/j.yjmcc.2006.09.002; Kardami E, 2004, CARDIOVASC RES, V63, P458, DOI 10.1016/j.cardiores.2004.04.024; Kardami E, 2007, HEART FAIL REV, V12, P267, DOI 10.1007/s10741-007-9027-0; Kawaguchi M, 2011, CIRCULATION, V123, P594, DOI 10.1161/CIRCULATIONAHA.110.982777; Kawano H, 2000, CIRCULATION, V101, P1130, DOI 10.1161/01.CIR.101.10.1130; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Lemarie CA, 2010, J RENIN-ANGIO-ALDO S, V11, P19, DOI 10.1177/1470320309347785; Liao SY, 2010, J MOL CELL CARDIOL, V48, P1245, DOI 10.1016/j.yjmcc.2010.01.014; Liao S, 2009, DEV DYNAM, V238, P249, DOI 10.1002/dvdy.21677; Ma X, 2007, J CELL PHYSIOL, V213, P690, DOI 10.1002/jcp.21139; Maltseva O, 2001, INVEST OPHTH VIS SCI, V42, P2490; Matsusaka T, 1997, ANNU REV PHYSIOL, V59, P395, DOI 10.1146/annurev.physiol.59.1.395; Muro AF, 2008, AM J RESP CRIT CARE, V177, P638, DOI 10.1164/rccm.200708-1291OC; Pasumarthi KBS, 1996, CIRC RES, V78, P126, DOI 10.1161/01.RES.78.1.126; Pellieux C, 2001, J CLIN INVEST, V108, P1843, DOI 10.1172/JCI200113627; Piotrowicz RS, 1999, J CELL PHYSIOL, V178, P144, DOI 10.1002/(SICI)1097-4652(199902)178:2<144::AID-JCP3>3.0.CO;2-Z; Piotrowicz RS, 2001, J BIOL CHEM, V276, P3963, DOI 10.1074/jbc.M004868200; Porrello ER, 2009, FRONT BIOSCI-LANDMRK, V14, P958, DOI 10.2741/3289; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Santiago JJ, 2011, CARDIOVASC RES, V89, P139, DOI 10.1093/cvr/cvq261; Santiago JJ, 2010, DEV DYNAM, V239, P1573, DOI 10.1002/dvdy.22280; Schultz JE, 1999, J CLIN INVEST, V104, P709, DOI 10.1172/JCI7315; SHIMASAKI S, 1988, BIOCHEM BIOPH RES CO, V157, P256, DOI 10.1016/S0006-291X(88)80041-X; Srisakuldee W, 2009, CARDIOVASC RES, V83, P672, DOI 10.1093/cvr/cvp142; Stroth U, 2000, MOL BRAIN RES, V78, P175, DOI 10.1016/S0169-328X(00)00093-0; Tanaka T, 1998, J AM COLL CARDIOL, V31, P399, DOI 10.1016/S0735-1097(97)00482-8; Tholozan FMD, 2007, MOL BIOL CELL, V18, P4222, DOI 10.1091/mbc.E06-05-0416; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tsutsumi Y, 1998, CIRC RES, V83, P1035, DOI 10.1161/01.RES.83.10.1035; Turner N, 2013, VASCUL PHARM; Vagner S, 1996, J CELL BIOL, V135, P1391, DOI 10.1083/jcb.135.5.1391; Valtink M, 2012, INVEST OPHTH VIS SCI, V53, P3207, DOI 10.1167/iovs.12-9423; Weber KT, 2013, NAT REV CARDIOL, V10, P15, DOI 10.1038/nrcardio.2012.158; Wu M, 2007, MATRIX BIOL, V26, P463, DOI 10.1016/j.matbio.2007.02.005; Xu SQ, 2011, HYPERTENSION, V58, P310, DOI 10.1161/HYPERTENSIONAHA.111.172031; Yu PJ, 2008, ONCOGENE, V27, P2594, DOI 10.1038/sj.onc.1210899; Yu PJ, 2007, J CELL BIOCHEM, V100, P1100, DOI 10.1002/jcb.21116; Zhang SL, 1999, LAB INVEST, V79, P395	70	44	44	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97281	10.1371/journal.pone.0097281	http://dx.doi.org/10.1371/journal.pone.0097281			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827991	Green Submitted, gold, Green Published			2022-12-27	WOS:000336857400074
J	Adachi, K; Nakamura, R; Osada, Y; Senba, M; Tamada, K; Hamano, S				Adachi, Keishi; Nakamura, Risa; Osada, Yoshio; Senba, Masachika; Tamada, Koji; Hamano, Shinjiro			Involvement of IL-18 in the Expansion of Unique Hepatic T Cells with Unconventional Cytokine Profiles during Schistosoma mansoni Infection	PLOS ONE			English	Article							LIVER-INJURY; IFN-GAMMA; NKT CELLS; TH2 POLARIZATION; IMMUNE-RESPONSE; GENE-EXPRESSION; TH1/TH2 BALANCE; B-VIRUS; RECEPTOR; INTERLEUKIN-18	Infection with schistosomes invokes severe fibrotic granulomatous responses in the liver of the host. Schistosoma mansoni infection induces dramatic fluctuations in Th1 or Th2 cytokine responses systemically; Th1 reactions are provoked in the early phase, whilst Th2 responses become dominant after oviposition begins. In the liver, various unique immune cells distinct from those of conventional immune competent organs or tissues exist, resulting in a unique immunological environment. Recently, we demonstrated that S. mansoni infection induces unique CD4(+) T cell populations exhibiting unconventional cytokine profiles in the liver of mice during the period between Th1- and Th2-phases, which we term the transition phase. They produce both IFN-gamma and IL-4 or both IFN-gamma and IL-13 simultaneously. Moreover, T cells secreting triple cytokines IFN-gamma, IL-13 and IL-4 were also induced. We term these cells Multiple Cytokine Producing Hepatic T cells (MCPHT cells). During the transition phase, when MCPHT cells increase, IL-18 secretion was up-regulated in the liver and sera. In S. mansoni-infected IL-18-deficient mice, expansion of MCPHT cells was curtailed. Thus our data suggest that IL-18 produced during S. mansoni infection play a role in the expansion of MCPHT cells.	[Adachi, Keishi; Nakamura, Risa; Hamano, Shinjiro] Nagasaki Univ, Dept Parasitol, Inst Trop Med NEKKEN, Nagasaki 852, Japan; [Adachi, Keishi; Hamano, Shinjiro] Nagasaki Univ, Global Ctr Excellence Program, Nagasaki 852, Japan; [Osada, Yoshio] Univ Occupat & Environm Hlth, Dept Immunol & Parasitol, Kitakyushu, Fukuoka 807, Japan; [Senba, Masachika] Nagasaki Univ, Dept Pathol, Inst Trop Med NEKKEN, Nagasaki 852, Japan; [Tamada, Koji] Yamaguchi Univ, Grad Sch Med, Dept Immunol & Cell Signaling Anal, Ube, Yamaguchi 755, Japan	Nagasaki University; Nagasaki University; University of Occupational & Environmental Health - Japan; Nagasaki University; Yamaguchi University	Hamano, S (corresponding author), Nagasaki Univ, Dept Parasitol, Inst Trop Med NEKKEN, Nagasaki 852, Japan.	shinjiro@nagasaki-u.ac.jp	adachi, keishi/AAT-7471-2020; Hamano, Shinjiro/A-7932-2011	Hamano, Shinjiro/0000-0003-3881-8337	JSPS KAKENHI [24790402, 25670204]; Health Labour Sciences Research Grant [H20-Shinkoh-Ippan-016, H23-Shinkoh-Ippan-014]; Global COE Program, Nagasaki University; MEXT; Grants-in-Aid for Scientific Research [25670204] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Health Labour Sciences Research Grant(Ministry of Health, Labour and Welfare, Japan); Global COE Program, Nagasaki University; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grants-in-Aid for Scientific Research Number 24790402 (to K.A.), 25670204 (to S.H.), (http://www.jsps.go.jp/english/e-grants/index.html), a Health Labour Sciences Research Grant (H20-Shinkoh-Ippan-016, H23-Shinkoh-Ippan-014 to S.H.) (http://www.mhlw.go.jp/english/), and the Global COE Program, Nagasaki University, supported by MEXT (to S.H.) (http://www-sdc.med.nagasaki-u.ac.jp/gcoe/activities/publication/200901_e.html, http://www.jsps.go.jp/english/e-globalcoe/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo T, 2000, IMMUNOL REV, V174, P135, DOI 10.1034/j.1600-0528.2002.017415.x; Adachi K, 2004, INT IMMUNOL, V16, P787, DOI 10.1093/intimm/dxh080; Adachi K, 2001, J IMMUNOL, V167, P5928, DOI 10.4049/jimmunol.167.10.5928; Adachi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082698; Adachi K, 2011, P NATL ACAD SCI USA, V108, P1549, DOI 10.1073/pnas.1017340108; Akira S, 2000, CURR OPIN IMMUNOL, V12, P59, DOI 10.1016/S0952-7915(99)00051-5; Alonzo ES, 2011, CURR OPIN IMMUNOL, V23, P220, DOI 10.1016/j.coi.2010.12.016; Andrade ZA, 2009, PARASITE IMMUNOL, V31, P656, DOI 10.1111/j.1365-3024.2009.01157.x; Born TL, 1998, J BIOL CHEM, V273, P29445, DOI 10.1074/jbc.273.45.29445; Charlton B, 1995, CURR OPIN IMMUNOL, V7, P793, DOI 10.1016/0952-7915(95)80050-6; CHEN Z, 1993, EMBO J, V12, P1161, DOI 10.1002/j.1460-2075.1993.tb05757.x; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Crispe IN, 2011, J HEPATOL, V54, P357, DOI 10.1016/j.jhep.2010.10.005; Crispe IN, 2003, NAT REV IMMUNOL, V3, P51, DOI 10.1038/nri981; Everts B, 2012, J EXP MED, V209, P1753, DOI 10.1084/jem.20111381; Everts B, 2009, J EXP MED, V206, P1673, DOI 10.1084/jem.20082460; Gately MK, 1998, ANNU REV IMMUNOL, V16, P495, DOI 10.1146/annurev.immunol.16.1.495; Gracie JA, 2003, J LEUKOCYTE BIOL, V73, P213, DOI 10.1189/jlb.0602313; Hayashi N, 1999, J IMMUNOL, V163, P6702; Hesse M, 2000, AM J PATHOL, V157, P945, DOI 10.1016/S0002-9440(10)64607-X; Hesse M, 2001, J IMMUNOL, V167, P6533, DOI 10.4049/jimmunol.167.11.6533; Infante-Duarte C, 1999, SPRINGER SEMIN IMMUN, V21, P317, DOI 10.1007/s002810050070; Jankovic D, 2001, TRENDS IMMUNOL, V22, P450, DOI 10.1016/S1471-4906(01)01975-5; King CH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001321; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Kovalovsky D, 2010, J IMMUNOL, V184, P6746, DOI 10.4049/jimmunol.1000776; Kreslavsky T, 2009, P NATL ACAD SCI USA, V106, P12453, DOI 10.1073/pnas.0903895106; LIBLAU RS, 1995, IMMUNOL TODAY, V16, P34, DOI 10.1016/0167-5699(95)80068-9; Mallevaey T, 2006, J IMMUNOL, V176, P2476, DOI 10.4049/jimmunol.176.4.2476; Mallevaey T, 2007, INFECT IMMUN, V75, P2171, DOI 10.1128/IAI.01178-06; MODOLELL M, 1995, EUR J IMMUNOL, V25, P1101, DOI 10.1002/eji.1830250436; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Naka T, 2001, IMMUNITY, V14, P535, DOI 10.1016/S1074-7613(01)00132-7; Nakahira M, 2011, INT IMMUNOL, V23, P761, DOI 10.1093/intimm/dxr087; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Osada Y, 2005, PARASITOL INT, V54, P29, DOI 10.1016/j.parint.2004.08.004; Osada Y, 2009, INT J PARASITOL, V39, P457, DOI 10.1016/j.ijpara.2008.08.007; Pearce EJ, 2004, IMMUNOL REV, V201, P117, DOI 10.1111/j.0105-2896.2004.00187.x; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; ROMAGNANI S, 1994, ANNU REV IMMUNOL, V12, P227, DOI 10.1146/annurev.iy.12.040194.001303; Sareneva T, 2000, J IMMUNOL, V165, P1933, DOI 10.4049/jimmunol.165.4.1933; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Shimokawa C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082025; Sims JE, 2002, CURR OPIN IMMUNOL, V14, P117, DOI 10.1016/S0952-7915(01)00306-5; Smeltz RB, 2001, J EXP MED, V194, P143, DOI 10.1084/jem.194.2.143; Sprent J, 2011, NAT IMMUNOL, V12, P478, DOI 10.1038/ni.2018; Steinfelder S, 2009, J EXP MED, V206, P1681, DOI 10.1084/jem.20082462; Sugimoto T, 2004, J EXP MED, V199, P535, DOI 10.1084/jem.20031368; Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9; Terada M, 2006, P NATL ACAD SCI USA, V103, P8816, DOI 10.1073/pnas.0602900103; Thomson AW, 2010, NAT REV IMMUNOL, V10, P753, DOI 10.1038/nri2858; Tsutsui H, 2000, IMMUNOL REV, V174, P192, DOI 10.1034/j.1600-0528.2002.017418.x; Tsutsui H, 1999, IMMUNITY, V11, P359, DOI 10.1016/S1074-7613(00)80111-9; Tsutsui H, 2004, IMMUNOL REV, V202, P115, DOI 10.1111/j.0105-2896.2004.00205.x; ULLMAN KS, 1990, ANNU REV IMMUNOL, V8, P421, DOI 10.1146/annurev.immunol.8.1.421; Wynn TA, 2004, IMMUNOL REV, V201, P156, DOI 10.1111/j.0105-2896.2004.00176.x; Xu DM, 1998, J EXP MED, V188, P1485, DOI 10.1084/jem.188.8.1485; Yoshimoto T, 2003, J EXP MED, V197, P997, DOI 10.1084/jem.20021701; Yoshimoto T, 1998, J IMMUNOL, V161, P3400; Zaccone P, 2003, EUR J IMMUNOL, V33, P1439, DOI 10.1002/eji.200323910	62	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96042	10.1371/journal.pone.0096042	http://dx.doi.org/10.1371/journal.pone.0096042			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824897	gold, Green Published, Green Submitted			2022-12-27	WOS:000336369200009
J	Bai, BY; Liu, XX; Kou, Y				Bai, Bao-yu; Liu, Xiao-xiao; Kou, Yu			Belief in a Just World Lowers Perceived Intention of Corruption: The Mediating Role of Perceived Punishment	PLOS ONE			English	Article							PERCEPTION; BRIBERY; JUSTICE; DISTINCTION; ORIENTATION; ATTITUDES; BUSINESS; IMPACT; GOALS; SELF	Corruption can be unfair and detrimental to societies; however, little is known regarding how individuals perceive corruption. We aim to understand how psychological factors, such as lay belief of the world, influence perceived intention of corruptive behavior. As corruption undermines justice, we hypothesize that belief in a just world to others (BJW-others) reduces perceived intention of corruptive behaviors. We conducted two correlational studies and one experimental study in China. Using hypothetical scenarios, perception toward bribery taking and nepotistic practices were assessed. In Study 1 and Study 2, we consistently found that BJW-others negatively predicted perceived intention of corruption, and this pattern was mediated by perceived likelihood of punishment. We further replicate this result in Study 3 by priming BJW-others, demonstrating its causal effect. The results indicate that BJW as one lay belief can be important in influencing people's attitudes toward corruption. Implications for future research and anti-corruption policies are also discussed.	[Bai, Bao-yu; Kou, Yu] Beijing Normal Univ, Inst Dev Psychol, Beijing 100875, Peoples R China; [Liu, Xiao-xiao] Nanyang Technol Univ, Nanyang Business Sch, Singapore 639798, Singapore	Beijing Normal University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Kou, Y (corresponding author), Beijing Normal Univ, Inst Dev Psychol, Beijing 100875, Peoples R China.	yu_kou1@163.com			MOE Project of Key Research Institutes of Humanities and Social Science at Universities [10JJDXLX002]; National Natural Science Foundation of China [71071021]; Fundamental Research Funds for the Central Universities, China	MOE Project of Key Research Institutes of Humanities and Social Science at Universities; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities)	This research was supported by the MOE Project of Key Research Institutes of Humanities and Social Science at Universities (10JJDXLX002), the National Natural Science Foundation of China (71071021), and the Fundamental Research Funds for the Central Universities, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink K, 2002, J LAW ECON ORGAN, V18, P428, DOI 10.1093/jleo/18.2.428; Abbink K, 2006, INTERNATIONAL HANDBOOK ON THE ECONOMICS OF CORRUPTION, P418; Anderson CJ, 2003, AM J POLIT SCI, V47, P91, DOI 10.1111/1540-5907.00007; Ashkanasy NM, 2006, BUS ETHICS Q, V16, P449, DOI 10.5840/beq200616447; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Begue L, 2003, J PERS, V71, P435, DOI 10.1111/1467-6494.7103007; Begue L, 2002, PERS INDIV DIFFER, V32, P375, DOI 10.1016/S0191-8869(00)00224-5; Bizer GY, 2012, PERS INDIV DIFFER, V52, P428, DOI 10.1016/j.paid.2011.11.002; Brown AJ, 2006, MEASURING CORRUPTION, P57; Cabelkova I, 2004, APPL ECON, V36, P383, DOI 10.1080/00036840410001674303; CARROLL JS, 1987, J PERS SOC PSYCHOL, V52, P107, DOI 10.1037/0022-3514.52.1.107; Coffeia I, 2007, EUR J PSYCHOL EDUC, V22, P421; Correia I, 2009, AUST J PSYCHOL, V61, P220, DOI 10.1080/00049530802579515; Dalbert C., 2001, JUSTICE MOTIVE PERSO; Davis JH, 2003, J BUS ETHICS, V43, P275, DOI 10.1023/A:1023038901080; Di Tella R, 2009, BROOKINGS PAP ECO AC, P285; Donchev D, 2007, DO CORRUPTION UNPUB; Dong B, 2012, J ECON PSYCHOL, V33, P609, DOI 10.1016/j.joep.2011.12.001; Ebneter DS, 2011, PERS INDIV DIFFER, V51, P618, DOI 10.1016/j.paid.2011.05.029; Frank B, 2000, J ECON BEHAV ORGAN, V43, P101, DOI 10.1016/S0167-2681(00)00111-6; Furnham A, 2003, PERS INDIV DIFFER, V34, P795, DOI 10.1016/S0191-8869(02)00072-7; Gupta S., 2002, ECON GOV, V3, P23, DOI DOI 10.1007/S101010100039; Hafer CL, 2005, PSYCHOL BULL, V131, P128, DOI 10.1037/0033-2909.131.1.128; Hafer CL, 2000, PERS SOC PSYCHOL B, V26, P1059, DOI 10.1177/01461672002611004; Hanf M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026990; Higgins E.T., 1996, SOCIAL PSYCHOL HDB B, P133; Jain AK, 2001, J ECON SURV, V15, P71, DOI 10.1111/1467-6419.00133; Ko KK, 2011, J CONTEMP CHINA, V20, P359, DOI 10.1080/10670564.2011.565170; Kogut T, 2011, J EXP SOC PSYCHOL, V47, P748, DOI 10.1016/j.jesp.2011.02.011; Lambsdorff J.G., 1998, EC CORRUPTION, P81; Lee WS, 2013, J ECON PSYCHOL, V39, P287, DOI 10.1016/j.joep.2013.09.006; Lerner M., 1980, BELIEF JUST WORLD FU, DOI DOI 10.1007/978-1-4899-0448-5; Li S, 2006, ETHICS BEHAV, V16, P199, DOI 10.1207/s15327019eb1603_2; Lipkus IM, 1996, PERS SOC PSYCHOL B, V22, P666, DOI 10.1177/0146167296227002; Liu XX, 2015, MANAGE ORGAN REV, V11, P145, DOI 10.1017/mor.2015.1; Mazar N, 2011, PSYCHOL SCI, V22, P843, DOI 10.1177/0956797611412389; Morris MW, 2001, PERS SOC PSYCHOL REV, V5, P169, DOI 10.1207/S15327957PSPR0502_7; Ogus A, 2004, LAW POLICY, V26, P329, DOI DOI 10.1111/J.1467-9930.2004.00181.X; Otto K, 2005, J RES PERS, V39, P559, DOI 10.1016/j.jrp.2005.01.004; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Rose-Ackerman S, 2006, INTERNATIONAL HANDBOOK ON THE ECONOMICS OF CORRUPTION, pXIV; Sanyal R, 2005, J BUS ETHICS, V59, P139, DOI 10.1007/s10551-005-3406-z; Seligson MA, 2002, J POLIT, V64, P408, DOI 10.1111/1468-2508.00132; Sutton RM, 2005, PERS INDIV DIFFER, V39, P637, DOI 10.1016/j.paid.2005.02.010; Sutton RM, 2007, BRIT J SOC PSYCHOL, V46, P649, DOI 10.1348/014466606X166220; Tian Q, 2008, J BUS ETHICS, V80, P437, DOI 10.1007/s10551-007-9429-x; You JS, 2005, AM SOCIOL REV, V70, P136	48	14	15	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97075	10.1371/journal.pone.0097075	http://dx.doi.org/10.1371/journal.pone.0097075			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1NZ	24835428	Green Published, gold			2022-12-27	WOS:000339614800027
J	Lugade, V; Lin, V; Farley, A; Chou, LS				Lugade, Vipul; Lin, Victor; Farley, Arthur; Chou, Li-Shan			An Artificial Neural Network Estimation of Gait Balance Control in the Elderly Using Clinical Evaluations	PLOS ONE			English	Article							DWELLING OLDER-ADULTS; RISK-FACTORS; GO TEST; FALLS; PEOPLE; PROBABILITY; POPULATION; PREVENTION; PATTERNS; WALKING	The use of motion analysis to assess balance is essential for determining the underlying mechanisms of falls during dynamic activities. Clinicians evaluate patients using clinical examinations of static balance control, gait performance, cognition, and neuromuscular ability. Mapping these data to measures of dynamic balance control, and the subsequent categorization and identification of community dwelling elderly fallers at risk of falls in a quick and inexpensive manner is needed. The purpose of this study was to demonstrate that given clinical measures, an artificial neural network (ANN) could determine dynamic balance control, as defined by the interaction of the center of mass (CoM) with the base of support (BoS), during gait. Fifty-six elderly adults were included in this study. Using a feed-forward neural network with back propagation, combinations of five functional domains, the number of hidden layers and error goals were evaluated to determine the best parameters to assess dynamic balance control. Functional domain input parameters included subject characteristics, clinical examinations, cognitive performance, muscle strength, and clinical balance performance. The use of these functional domains demonstrated the ability to quickly converge to a solution, with the network learning the mapping within 5 epochs, when using up to 30 hidden nodes and an error goal of 0.001. The ability to correctly identify the interaction of the CoM with BoS demonstrated correlation values up to 0.89 (P<.001). On average, using all clinical measures, the ANN was able to estimate the dynamic CoM to BoS distance to within 1 cm and BoS area to within 75 cm(2). Our results demonstrated that an ANN could be trained to map clinical variables to biomechanical measures of gait balance control. A neural network could provide physicians and patients with a cost effective means to identify dynamic balance issues and possible risk of falls from routinely collected clinical examinations.	[Lugade, Vipul; Chou, Li-Shan] Univ Oregon, Dept Human Physiol, Eugene, OR 97403 USA; [Lin, Victor] Rehabil Med Associates Eugene Springfield PC, Eugene, OR USA; [Farley, Arthur] Univ Oregon, Dept Comp & Informat Sci, Eugene, OR 97403 USA	University of Oregon; University of Oregon	Chou, LS (corresponding author), Univ Oregon, Dept Human Physiol, Eugene, OR 97403 USA.	chou@uoregon.edu		Lugade, Vipul/0000-0001-7226-6260	International Society of Biomechanics Student Dissertation Grant; University of Oregon	International Society of Biomechanics Student Dissertation Grant; University of Oregon	This study was funded by the International Society of Biomechanics Student Dissertation Grant (to V. Lugade) and the University of Oregon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton JG, 1997, GAIT POSTURE, V5, P28, DOI 10.1016/S0966-6362(96)01070-3; BERG K, 1989, Physiotherapy Canada, V41, P304; Bhatt T, 2011, ARCH PHYS MED REHAB, V92, P799, DOI 10.1016/j.apmr.2010.12.032; Cesari M, 2002, J GERONTOL A-BIOL, V57, pM722, DOI 10.1093/gerona/57.11.M722; Chau T, 2001, GAIT POSTURE, V13, P102, DOI 10.1016/S0966-6362(00)00095-3; Chou LS, 2003, GAIT POSTURE, V18, P125, DOI 10.1016/S0966-6362(02)00067-X; CORRIGAN JD, 1987, J CLIN PSYCHOL, V43, P402, DOI 10.1002/1097-4679(198707)43:4<402::AID-JCLP2270430411>3.0.CO;2-E; GABELL A, 1985, ERGONOMICS, V28, P965, DOI 10.1080/00140138508963219; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; HAGAN MT, 1994, IEEE T NEURAL NETWOR, V5, P989, DOI 10.1109/72.329697; Hahn ME, 2005, ANN BIOMED ENG, V33, P811, DOI 10.1007/s10439-005-2867-7; Hahn ME, 2005, J BIOMECH, V38, P717, DOI 10.1016/j.jbiomech.2004.05.012; Herman T, 2010, J GERONTOL A-BIOL, V65, P1086, DOI 10.1093/gerona/glq077; Lord SR, 2001, FALLS OLDER PEOPLE; Lugade V, 2011, GAIT POSTURE, V33, P406, DOI 10.1016/j.gaitpost.2010.12.013; Michalski R, 2011, ACTA BIOENGINEERING, V13; Miller A, 2009, GAIT POSTURE, V29, P542, DOI 10.1016/j.gaitpost.2008.12.003; NASHNER L, 1978, BRAIN RES, V150, P403, DOI 10.1016/0006-8993(78)90291-3; PATLA AE, 1992, CAN J PUBLIC HEALTH, V83, pS29; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; SATTIN RW, 1990, AM J EPIDEMIOL, V131, P1028, DOI 10.1093/oxfordjournals.aje.a115594; SEPULVEDA F, 1993, J BIOMECH, V26, P101, DOI 10.1016/0021-9290(93)90041-C; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Shumway-Cook A, 2000, PHYS THER, V80, P896, DOI 10.1093/ptj/80.9.896; ShumwayCook A, 1997, PHYS THER, V77, P812, DOI 10.1093/ptj/77.8.812; Simon SR, 2004, J BIOMECH, V37, P1869, DOI 10.1016/j.jbiomech.2004.02.047; Steffen TM, 2002, PHYS THER, V82, P128, DOI 10.1093/ptj/82.2.128; Tariq SH, 2006, AM J GERIAT PSYCHIAT, V14, P900, DOI 10.1097/01.JGP.0000221510.33817.86; TINETTI ME, 1989, NEW ENGL J MED, V320, P1055; Turcu A, 2004, GERONTOLOGY, V50, P303, DOI 10.1159/000079128; WHIPPLE RH, 1987, J AM GERIATR SOC, V35, P13, DOI 10.1111/j.1532-5415.1987.tb01313.x; Woollacott MH, 1997, PHYS THER, V77, P646, DOI 10.1093/ptj/77.6.646; Wu WL, 2000, CLIN BIOMECH, V15, P143, DOI 10.1016/S0268-0033(99)00037-6	35	13	13	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97595	10.1371/journal.pone.0097595	http://dx.doi.org/10.1371/journal.pone.0097595			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1NZ	24836062	Green Published, gold, Green Submitted			2022-12-27	WOS:000339614800055
J	Jenni-Eiermann, S; Jenni, L; Smith, S; Costantini, D				Jenni-Eiermann, Susanne; Jenni, Lukas; Smith, Shona; Costantini, David			Oxidative Stress in Endurance Flight: An Unconsidered Factor in Bird Migration	PLOS ONE			English	Article							GLUTATHIONE-PEROXIDASE ACTIVITY; ANTIOXIDANT CAPACITY; SKELETAL-MUSCLE; REACTIVE OXYGEN; EXERCISE; PROTEIN; TISSUES; PASSERINES; MECHANISMS; INTENSITY	Migrating birds perform extraordinary endurance flights, up to 200 h non-stop, at a very high metabolic rate and while fasting. Such an intense and prolonged physical activity is normally associated with an increased production of reactive oxygen and nitrogen species (RONS) and thus increased risk of oxidative stress. However, up to now it was unknown whether endurance flight evokes oxidative stress. We measured a marker of oxidative damage (protein carbonyls, PCs) and a marker of enzymatic antioxidant capacity (glutathione peroxidase, GPx) in the European robin (Erithacus rubecula), a nocturnal migrant, on its way to the non-breeding grounds. Both markers were significantly higher in European robins caught out of their nocturnal flight than in conspecifics caught during the day while resting. Independently of time of day, both markers showed higher concentrations in individuals with reduced flight muscles. Adults had higher GPx concentrations than first-year birds on their first migration. These results show for the first time that free-flying migrants experience oxidative stress during endurance flight and up-regulate one component of antioxidant capacity. We discuss that avoiding oxidative stress may be an overlooked factor shaping bird migration strategies, e. g. by disfavouring long nonstop flights and an extensive catabolism of the flight muscles.	[Jenni-Eiermann, Susanne; Jenni, Lukas] Swiss Ornithol Inst, Sempach, Switzerland; [Smith, Shona; Costantini, David] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Costantini, David] Univ Antwerp, Dept Biol, Antwerp, Belgium	Swiss Ornithological Institute; University of Glasgow; University of Antwerp	Jenni-Eiermann, S (corresponding author), Swiss Ornithol Inst, Sempach, Switzerland.	susi.jenni@vogelwarte.ch		Jenni-Eiermann, Susanne/0000-0002-0610-3428; Costantini, David/0000-0002-8140-8790	Swiss Ornithological Institute	Swiss Ornithological Institute	The study was financed by the Swiss Ornithological Institute which is a private foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RG, 1992, J NUTR, V122, P631, DOI 10.1093/jn/122.suppl_3.631; Bairlein F., 1995, MANUAL FIELD METHODS; Baydas G, 2002, NEUROSCI LETT, V323, P195, DOI 10.1016/S0304-3940(02)00144-1; Beer-Ljubic B, 2012, ARCH TIERZUCHT, V55, P485, DOI 10.5194/aab-55-485-2012; Berzosa C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/540458; Bolshakov CV, 2007, ANIM BEHAV, V74, P855, DOI 10.1016/j.anbehav.2006.10.024; CALLOW M, 1986, EUR J APPL PHYSIOL O, V55, P654, DOI 10.1007/BF00423212; CAO GH, 1995, ARCH BIOCHEM BIOPHYS, V320, P106, DOI 10.1006/abbi.1995.1347; Costantini D, 2008, ECOL LETT, V11, P1238, DOI 10.1111/j.1461-0248.2008.01246.x; Costantini D, 2008, J EXP BIOL, V211, P377, DOI 10.1242/jeb.012856; Costantini D, 2007, COMP BIOCHEM PHYS C, V144, P363, DOI 10.1016/j.cbpc.2006.11.005; Costantini D, 2013, J EXP BIOL, V216, P2213, DOI 10.1242/jeb.083154; Costantini D, 2010, ECOL LETT, V13, P1435, DOI 10.1111/j.1461-0248.2010.01531.x; de Farias JM, 2013, HORM METAB RES, V45, P190, DOI 10.1055/s-0032-1323740; Falsone K, 2009, HORM BEHAV, V56, P548, DOI 10.1016/j.yhbeh.2009.09.009; FINLEY JW, 1991, BIOL TRACE ELEM RES, V29, P181, DOI 10.1007/BF03032676; Gerson AR, 2011, SCIENCE, V333, P1434, DOI 10.1126/science.1210449; Gill RE, 2009, P ROY SOC B-BIOL SCI, V276, P447, DOI 10.1098/rspb.2008.1142; Guglielmo CG, 2002, AM J PHYSIOL-REG I, V282, pR1405, DOI 10.1152/ajpregu.00267.2001; Halliwell B., 2007, FREE RADICALS BIOL M; Jackson MJ, 2007, J APPL PHYSIOL, V102, P1664, DOI 10.1152/japplphysiol.01102.2006; Jenni L., 1984, Ornithologische Beobachter, V81, P183; JENNI L, 1992, ORNIS SCAND, V23, P251, DOI 10.2307/3676646; JENNI L, 1989, BIRD STUDY, V36, P1, DOI 10.1080/00063658909476996; Jenni L, 1998, J AVIAN BIOL, V29, P521, DOI 10.2307/3677171; Jenni L, 2000, AM J PHYSIOL-REG I, V278, pR1182, DOI 10.1152/ajpregu.2000.278.5.R1182; Jenni L., 1994, BIOL MOULT BIRDS; Jenni-Eiermann Susanne, 2012, P171; JENNIEIERMANN S, 1992, PHYSIOL ZOOL, V65, P112, DOI 10.1086/physzool.65.1.30158242; JENNIEIERMANN S, 1991, J COMP PHYSIOL B, V161, P465; KAISER A, 1993, J FIELD ORNITHOL, V64, P246; Komenda-Zehnder S, 2010, J AVIAN BIOL, V41, P434, DOI 10.1111/j.1600-048X.2010.04891.x; Kvist A, 2001, NATURE, V413, P730, DOI 10.1038/35099556; Leeuwenburgh C, 2001, CURR MED CHEM, V8, P829, DOI 10.2174/0929867013372896; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Liechti F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3554; Margonis K, 2007, FREE RADICAL BIO MED, V43, P901, DOI 10.1016/j.freeradbiomed.2007.05.022; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Nikolaidis MG, 2012, J EXP BIOL, V215, P1615, DOI 10.1242/jeb.067470; Pablos MI, 1998, NEUROCHEM INT, V32, P69, DOI 10.1016/S0197-0186(97)00043-0; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Rey B, 2008, AM J PHYSIOL-REG I, V295, pR92, DOI 10.1152/ajpregu.00271.2007; SALO DC, 1991, FREE RADICAL BIO MED, V11, P239, DOI 10.1016/0891-5849(91)90119-N; Schmaljohann H, 2007, P R SOC B, V274, P735, DOI 10.1098/rspb.2006.0011; Schwilch R, 2002, J EXP BIOL, V205, P687; Surai P. F., 2002, NATURAL ANTIOXIDANTS; Sureda A, 2009, BRIT J SPORT MED, V43, P186, DOI 10.1136/bjsm.2007.043943; Szkudelski T, 2004, J PHYSIOL BIOCHEM, V60, P1, DOI 10.1007/BF03168215; Vazquez-Medina JP, 2011, J EXP BIOL, V214, P2903, DOI 10.1242/jeb.057935	50	77	78	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97650	10.1371/journal.pone.0097650	http://dx.doi.org/10.1371/journal.pone.0097650			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830743	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000336789500093
J	Park, IH; Geno, KA; Sherwood, LK; Nahm, MH; Beall, B				Park, In Ho; Geno, K. Aaron; Sherwood, Logan K.; Nahm, Moon H.; Beall, Bernard			Population-Based Analysis of Invasive Nontypeable Pneumococci Reveals That Most Have Defective Capsule Synthesis Genes	PLOS ONE			English	Article							SEQUENTIAL MULTIPLEX PCR; STREPTOCOCCUS-PNEUMONIAE; UNITED-STATES; SEROTYPE; DISEASE; LOCUS; MUTATIONS; CONJUNCTIVITIS; IDENTIFICATION; OUTBREAK	Since nasopharyngeal carriage of pneumococcus precedes invasive pneumococcal disease, characteristics of carriage isolates could be incorrectly assumed to reflect those of invasive isolates. While most pneumococci express a capsular polysaccharide, nontypeable pneumococci are sometimes isolated. Carriage nontypeables tend to encode novel surface proteins in place of a capsular polysaccharide synthetic locus, the cps locus. In contrast, capsular polysaccharide is believed to be indispensable for invasive pneumococcal disease, and nontypeables from population-based invasive pneumococcal disease surveillance have not been extensively characterized. We received 14,328 invasive pneumococcal isolates through the Active Bacterial Core surveillance program during 2006-2009. Isolates that were nontypeable by Quellung serotyping were characterized by PCR serotyping, sequence analyses of the cps locus, and multilocus sequence typing. Eighty-eight isolates were Quellung-nontypeable (0.61%). Of these, 79 (89.8%) contained cps loci. Twenty-two nontypeables exhibited serotype 8 cps loci with defects, primarily within wchA. Six of the remaining nine isolates contained previously-described aliB homologs in place of cps loci. Multilocus sequence typing revealed that most nontypeables that lacked capsular biosynthetic genes were related to established non-encapsulated lineages. Thus, invasive pneumococcal disease caused by nontypeable pneumococcus remains rare in the United States, and while carriage nontypeables lacking cps loci are frequently isolated, such nontypeable are extremely rare in invasive pneumococcal disease. Most invasive nontypeable pneumococci possess defective cps locus genes, with an over-representation of defective serotype 8 cps variants.	[Park, In Ho; Geno, K. Aaron; Nahm, Moon H.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Sherwood, Logan K.; Beall, Bernard] Ctr Dis Control & Prevent, Resp Dis Branch, Atlanta, GA 30333 USA; [Nahm, Moon H.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; Centers for Disease Control & Prevention - USA; University of Alabama System; University of Alabama Birmingham	Beall, B (corresponding author), Ctr Dis Control & Prevent, Resp Dis Branch, Atlanta, GA 30333 USA.	bbeall@cdc.gov		Geno, Aaron/0000-0002-0799-4189; Nahm, Moon/0000-0002-6922-1042	Centers for Disease Control and Prevention; National Institutes of Health [AI-31473]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI031473, R01AI031473] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Centers for Disease Control and Prevention and the National Institutes of Health (AI-31473 to MHN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Beall BW, 2011, J INFECT DIS, V203, P1360, DOI 10.1093/infdis/jir052; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Bratcher PE, 2010, MICROBIOL-SGM, V156, P555, DOI 10.1099/mic.0.034116-0; Buck JM, 2006, PEDIATR INFECT DIS J, V25, P906, DOI 10.1097/01.inf.0000238143.96607.ec; Calix JJ, 2012, J BIOL CHEM, V287, P27885, DOI 10.1074/jbc.M112.380451; Calix JJ, 2012, CLIN INFECT DIS, V54, P794, DOI 10.1093/cid/cir953; Calix JJ, 2011, J INFECT DIS, V204, P1585, DOI 10.1093/infdis/jir593; Calix JJ, 2010, J INFECT DIS, V202, P29, DOI 10.1086/653123; Carvalho MD, 2009, J CLIN MICROBIOL, V47, P554, DOI 10.1128/JCM.01919-08; Dias CA, 2007, J MED MICROBIOL, V56, P1185, DOI 10.1099/jmm.0.47347-0; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Gertz RE, 2003, J CLIN MICROBIOL, V41, P4194, DOI 10.1128/JCM.41.9.4194-4216.2003; Hathaway LJ, 2004, J BACTERIOL, V186, P3721, DOI 10.1128/JB.186.12.3721-3729.2004; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; James DBA, 2012, J BACTERIOL, V194, P6479, DOI 10.1128/JB.01135-12; Jarva H, 2003, MOL IMMUNOL, V40, P95, DOI 10.1016/S0161-5890(03)00108-1; Keller LE, 2013, INFECT IMMUN, V81, P173, DOI 10.1128/IAI.00755-12; Llull D, 1999, J EXP MED, V190, P241, DOI 10.1084/jem.190.2.241; Martin M, 2003, NEW ENGL J MED, V348, P1112, DOI 10.1056/NEJMoa022521; Mavroidi A, 2007, J BACTERIOL, V189, P7841, DOI 10.1128/JB.00836-07; Melchiorre S, 2012, MICROBIOL-SGM, V158, P338, DOI 10.1099/mic.0.054270-0; Morona JK, 1999, J BACTERIOL, V181, P3599, DOI 10.1128/JB.181.11.3599-3605.1999; Munoz R, 1999, J BACTERIOL, V181, P6214; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Park IH, 2007, INFECT IMMUN, V75, P4482, DOI 10.1128/IAI.00510-07; Park IH, 2012, MBIO, V3, DOI 10.1128/mBio.00035-12; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Poehling KA, 2006, JAMA-J AM MED ASSOC, V295, P1668, DOI 10.1001/jama.295.14.1668; Salter SJ, 2012, MICROBIOL-SGM, V158, P1560, DOI 10.1099/mic.0.056580-0; Scott JR, 2012, J INFECT DIS, V206, P73, DOI 10.1093/infdis/jis307; Waite RD, 2003, MICROBIOL-SGM, V149, P497, DOI 10.1099/mic.0.26011-0; Waite RD, 2001, MOL MICROBIOL, V42, P1223, DOI 10.1046/j.1365-2958.2001.02674.x; Wang L, 1996, J BACTERIOL, V178, P2598, DOI 10.1128/jb.178.9.2598-2604.1996; Weatherholtz R, 2010, CLIN INFECT DIS, V50, P1238, DOI 10.1086/651680; Xayarath B, 2007, J BACTERIOL, V189, P3369, DOI 10.1128/JB.01938-06; Yu JG, 2011, CLIN VACCINE IMMUNOL, V18, P1900, DOI 10.1128/CVI.05312-11	37	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97825	10.1371/journal.pone.0097825	http://dx.doi.org/10.1371/journal.pone.0097825			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831650	Green Published, Green Submitted, gold			2022-12-27	WOS:000336789500120
J	Ashfaq, M; Hebert, PDN; Mirza, JH; Khan, AM; Zafar, Y; Mirza, MS				Ashfaq, Muhammad; Hebert, Paul D. N.; Mirza, Jawwad H.; Khan, Arif M.; Zafar, Yusuf; Mirza, M. Sajjad			Analyzing Mosquito (Diptera: Culicidae) Diversity in Pakistan by DNA Barcoding	PLOS ONE			English	Article							AEDES-ALBOPICTUS DIPTERA; STEGOMYIA AEGYPTI L.; WEST NILE VIRUS; ANNULARIS COMPLEX; GENETIC DIVERSITY; SPECIES COMPLEX; ANOPHELES; VECTOR; IDENTIFICATION; MITOCHONDRIAL	Background: Although they are important disease vectors mosquito biodiversity in Pakistan is poorly known. Recent epidemics of dengue fever have revealed the need for more detailed understanding of the diversity and distributions of mosquito species in this region. DNA barcoding improves the accuracy of mosquito inventories because morphological differences between many species are subtle, leading to misidentifications. Methodology/Principal Findings: Sequence variation in the barcode region of the mitochondrial COI gene was used to identify mosquito species, reveal genetic diversity, and map the distribution of the dengue-vector species in Pakistan. Analysis of 1684 mosquitoes from 491 sites in Punjab and Khyber Pakhtunkhwa during 2010-2013 revealed 32 species with the assemblage dominated by Culex quinquefasciatus (61% of the collection). The genus Aedes (Stegomyia) comprised 15% of the specimens, and was represented by six taxa with the two dengue vector species, Ae. albopictus and Ae. aegypti, dominant and broadly distributed. Anopheles made up another 6% of the catch with An. subpictus dominating. Barcode sequence divergence in conspecific specimens ranged from 0-2.4%, while congeneric species showed from 2.3-17.8% divergence. A global haplotype analysis of disease-vectors showed the presence of multiple haplotypes, although a single haplotype of each dengue-vector species was dominant in most countries. Geographic distribution of Ae. aegypti and Ae. albopictus showed the later species was dominant and found in both rural and urban environments. Conclusions: As the first DNA-based analysis of mosquitoes in Pakistan, this study has begun the construction of a barcode reference library for the mosquitoes of this region. Levels of genetic diversity varied among species. Because of its capacity to differentiate species, even those with subtle morphological differences, DNA barcoding aids accurate tracking of vector populations.	[Ashfaq, Muhammad; Hebert, Paul D. N.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Mirza, Jawwad H.; Khan, Arif M.; Mirza, M. Sajjad] Natl Inst Biotechnol & Genet Engn, Faisalabad, Pakistan; [Zafar, Yusuf] Pakistan Atom Energy Commiss, Islamabad, Pakistan	University of Guelph; Pakistan Institute of Engineering & Applied Science; Pakistan Atomic Energy Commission	Ashfaq, M (corresponding author), Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada.	mashfaq@uoguelph.ca	Hebert, Paul DN/C-4161-2013; Ashfaq, Muhammad/J-4723-2019; zafar, YUSUF/F-5154-2015	Hebert, Paul DN/0000-0002-3081-6700; Ashfaq, Muhammad/0000-0003-1351-4126; 	Engaging Developing Nations in the International Barcode of Life (iBOL) Project, from IDRC [106106-001]; Government of Canada through Genome Canada; Ontario Genomics Institute	Engaging Developing Nations in the International Barcode of Life (iBOL) Project, from IDRC; Government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute	This research was enabled by grant 106106-001, Engaging Developing Nations in the International Barcode of Life (iBOL) Project, from IDRC. Sequence analysis was enabled by a grant from the Government of Canada through Genome Canada and the Ontario Genomics Institute in support of iBOL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar M. S., 2012, Dengue Bulletin, V36, P87; Alam MT, 2007, PARASITOL RES, V100, P943, DOI 10.1007/s00436-006-0375-9; Amerasinghe FP, 2002, J MED ENTOMOL, V39, P28, DOI 10.1603/0022-2585-39.1.28; Anderson JR, 2005, GENETICS, V169, P1529, DOI 10.1534/genetics.104.033639; Angel Bennet, 2008, Journal of Vector Borne Diseases, V45, P56; Ashfaq M, 2013, MOL ECOL RESOUR, V13, P832, DOI 10.1111/1755-0998.12131; ASLAMKHAN M, 1971, Mosquito Systematics News Letter, V3, P147; Atrie B, 1999, ANN ENTOMOL SOC AM, V92, P243, DOI 10.1093/aesa/92.2.243; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bagny L, 2009, J MED ENTOMOL, V46, P1541, DOI 10.1603/033.046.0644; Bass Chris, 2010, Malar Res Treat, V2010, P190434, DOI 10.4061/2010/190434; Beebe NW, 2005, COMMUN DIS INTELL, V29, P299; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Bossuyt F, 2004, SCIENCE, V306, P479, DOI 10.1126/science.1100167; Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785; Chan YC, 1995, T ROY SOC TROP MED H, V89, P619, DOI 10.1016/0035-9203(95)90412-3; Chen B, 2002, MED VET ENTOMOL, V16, P253, DOI 10.1046/j.1365-2915.2002.00373.x; Coetzee M, 2000, PARASITOL TODAY, V16, P74, DOI 10.1016/S0169-4758(99)01563-X; Cywinska A, 2006, MED VET ENTOMOL, V20, P413, DOI 10.1111/j.1365-2915.2006.00653.x; Delatte H, 2008, VECTOR-BORNE ZOONOT, V8, P25, DOI 10.1089/vbz.2007.0649; Dhananjeyan KJ, 2010, TROP BIOMED, V27, P47; Engler O, 2013, INT J ENV RES PUB HE, V10, P4869, DOI 10.3390/ijerph10104869; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fansiri T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003621; Fu YX, 1997, GENETICS, V147, P915; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Harbach R.E., 1988, Contributions of the American Entomological Institute, V24, P1; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hemmerter S, 2009, MOL PHYLOGENET EVOL, V50, P317, DOI 10.1016/j.ympev.2008.11.016; Ilahi I., 2013, International Journal of Innovation and Applied Studies, V2, P454; Ishak Hasanuddin, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P844; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Kamgang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020257; Kang D, 2013, MOL ECOL RESOUR, V13, P369, DOI 10.1111/1755-0998.12083; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Krzywinski J, 2003, ANNU REV ENTOMOL, V48, P111, DOI 10.1146/annurev.ento.48.091801.112647; Kumar NP, 2007, J MED ENTOMOL, V44, P1, DOI 10.1603/0022-2585(2007)44[1:DBCDSO]2.0.CO;2; Kumar NP, 2013, MOL ECOL RESOUR, V13, P354, DOI 10.1111/1755-0998.12076; LaDeau SL, 2013, INT J ENV RES PUB HE, V10, P1505, DOI 10.3390/ijerph10041505; Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Low VL, 2014, MED VET ENTOMOL, V28, P157, DOI 10.1111/mve.12022; Manonmani A, 2001, ACTA TROP, V78, P3, DOI 10.1016/S0001-706X(00)00154-6; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Moore M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002175; Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627; Muhammad Mukhtar, 2011, Dengue Bulletin, V35, P99; Munstermann LE, 1997, ANNU REV ENTOMOL, V42, P351, DOI 10.1146/annurev.ento.42.1.351; Mwangangi JM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-13; Naeem-Ullah U, 2010, PAK J AGR SCI, V47, P124; Olanratmanee P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001913; Otranto D, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-S1-S2; PANT C, 1987, INSECT SCI APPL, V8, P655, DOI 10.1017/S174275840002275X; Pfeiler E, 2013, SCI WORLD J, DOI 10.1155/2013/724609; Pollitt LC, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-440; Porco D, 2010, MOL ECOL RESOUR, V10, P942, DOI 10.1111/j.1755-0998.2010.2839.x; Proft J, 1999, PARASITOL RES, V85, P837, DOI 10.1007/s004360050642; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Raharimalala FN, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-56; Rasheed SB, 2013, MED VET ENTOMOL, V27, P430, DOI 10.1111/mve.12001; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Reinert JF, 2000, J AM MOSQUITO CONTR, V16, P175; Reinert JF, 2009, ZOOL J LINN SOC-LOND, V157, P700, DOI 10.1111/j.1096-3642.2009.00570.x; REISEN W K, 1978, Southeast Asian Journal of Tropical Medicine and Public Health, V9, P587; REISEN WK, 1982, T ROY SOC TROP MED H, V76, P437, DOI 10.1016/0035-9203(82)90131-6; Santos J. M. M. dos, 2011, Open Tropical Medicine Journal, V4, P11, DOI 10.2174/1874315301104010011; Savage HM, 2004, J AM MOSQUITO CONTR, V20, P208; Shakoor Muhammad T, 2012, WHO South East Asia J Public Health, V1, P229, DOI 10.4103/2224-3151.207018; Sharma AK, 2010, ACTA TROP, V116, P89, DOI 10.1016/j.actatropica.2010.06.003; Sharma AK, 2013, J MOSQUITO RES, V3, P58; Shepard JJ, 2006, J MED ENTOMOL, V43, P443, DOI 10.1603/0022-2585(2006)43[443:MPAERA]2.0.CO;2; Singh OP, 2004, AM J TROP MED HYG, V70, P27, DOI 10.4269/ajtmh.2004.70.27; Stark K, 2012, EUROSURVEILLANCE, V17, P2; Strutzenberger P, 2011, INSECT SCI, V18, P349, DOI 10.1111/j.1744-7917.2010.01366.x; Surendran SN, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-239; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teacher AGF, 2011, MOL ECOL RESOUR, V11, P151, DOI 10.1111/j.1755-0998.2010.02890.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thongsripong P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002507; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; Walton C, 1999, BIOL J LINN SOC, V68, P241, DOI 10.1111/j.1095-8312.1999.tb01168.x; Wan QH, 2004, ELECTROPHORESIS, V25, P2165, DOI 10.1002/elps.200305922; Wang G, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039700, 10.1371/journal.pone.0051764, 10.1371/journal.pone.0047051]; Werblow A, 2013, PARASITOL RES, V112, P2495, DOI 10.1007/s00436-013-3418-z; Wilkerson RC, 2004, J MED ENTOMOL, V41, P392, DOI 10.1603/0022-2585-41.3.392; ZAVORTINK TJ, 1990, J AM MOSQUITO CONTR, V6, P593	90	81	90	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97268	10.1371/journal.pone.0097268	http://dx.doi.org/10.1371/journal.pone.0097268			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827460	Green Submitted, Green Published, gold			2022-12-27	WOS:000336857400069
J	Gomes, PDFC; Panel, N; Laine, E; Pascutti, PG; Solary, E; Tchertanov, L				Figueiredo Celestino Gomes, Priscila Da Silva; Panel, Nicolas; Laine, Elodie; Pascutti, Pedro Geraldo; Solary, Eric; Tchertanov, Luba			Differential Effects of CSF-1R D802V and KIT D816V Homologous Mutations on Receptor Tertiary Structure and Allosteric Communication	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; STRUCTURE PREDICTION SERVER; TYROSINE KINASE-ACTIVITY; GENERALIZED BORN MODEL; GROWTH-FACTOR RECEPTOR; LOCAL FEATURE ANALYSIS; MOLECULAR-DYNAMICS; C-FMS; SIGNAL-TRANSDUCTION; STATISTICAL-THEORY	The colony stimulating factor-1 receptor (CSF-1R) and the stem cell factor receptor KIT, type III receptor tyrosine kinases (RTKs), are important mediators of signal transduction. The normal functions of these receptors can be compromised by gain-of-function mutations associated with different physiopatological impacts. Whereas KIT D816V/H mutation is a well-characterized oncogenic event and principal cause of systemic mastocytosis, the homologous CSF-1R D802V has not been identified in human cancers. The KIT D816V oncogenic mutation triggers resistance to the RTK inhibitor Imatinib used as first line treatment against chronic myeloid leukemia and gastrointestinal tumors. CSF-1R is also sensitive to Imatinib and this sensitivity is altered by mutation D802V. Previous in silico characterization of the D816V mutation in KIT evidenced that the mutation caused a structure reorganization of the juxtamembrane region (JMR) and facilitated its departure from the kinase domain (KD). In this study, we showed that the equivalent CSF-1R D802V mutation does not promote such structural effects on the JMR despite of a reduction on some key H-bonds interactions controlling the JMR binding to the KD. In addition, this mutation disrupts the allosteric communication between two essential regulatory fragments of the receptors, the JMR and the A-loop. Nevertheless, the mutation-induced shift towards an active conformation observed in KIT D816V is not observed in CSF-1R D802V. The distinct impact of equivalent mutation in two homologous RTKs could be associated with the sequence difference between both receptors in the native form, particularly in the JMR region. A local mutation-induced perturbation on the A-loop structure observed in both receptors indicates the stabilization of an inactive non-inhibited form, which Imatinib cannot bind.	[Figueiredo Celestino Gomes, Priscila Da Silva; Panel, Nicolas; Laine, Elodie; Tchertanov, Luba] Ecole Normale Super, Lab Biol & Pharmacol, Cachan, France; [Figueiredo Celestino Gomes, Priscila Da Silva; Pascutti, Pedro Geraldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil; [Solary, Eric] Inst Gustave Roussy, Villejuif, France; [Solary, Eric] Univ Paris Sud, Fac Med, F-94275 Le Kremlin Bicetre, France; [Tchertanov, Luba] Ecole Normale Super, Ctr Math & Leurs Applicat, Cachan, France	UDICE-French Research Universities; Universite Paris Saclay; Universidade Federal do Rio de Janeiro; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Tchertanov, L (corresponding author), Ecole Normale Super, Lab Biol & Pharmacol, Cachan, France.	Luba.Tchertanov@lbpa.ens-cachan.fr	, Tchertanov/CAF-3310-2022; Laine, Elodie/AAW-7458-2021; Pascutti, Pedro/AAP-7752-2020	Laine, Elodie/0000-0003-4870-6304; Pascutti, Pedro/0000-0002-5454-560X; da Silva Figueiredo Celestino Gomes, Priscila/0000-0001-7370-9596; Solary, Eric/0000-0002-8629-1341	Ecole Normale Superieure (ENS) de Cachan; Centre National de la Recherche Scientifique (CNRS); French State Agency for Innovation (OSEO); Fondation de France; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Ligue Nationale Contre le Cancer (equipe labellisee)	Ecole Normale Superieure (ENS) de Cachan; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); French State Agency for Innovation (OSEO); Fondation de France(Fondation de France); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Ligue Nationale Contre le Cancer (equipe labellisee)(Ligue nationale contre le cancer)	This work was supported by Ecole Normale Superieure (ENS) de Cachan, Centre National de la Recherche Scientifique (CNRS), the French State Agency for Innovation (OSEO), Fondation de France and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). ES team is supported by the Ligue Nationale Contre le Cancer (equipe labellisee). The funders had no role in study design, data collection and analysis, decision to published, or preparation of the manuscript.	Allain A, 2014, FARADAY DISCUSS, V169, P303, DOI 10.1039/c4fd00024b; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bashford D, 2000, ANNU REV PHYS CHEM, V51, P129, DOI 10.1146/annurev.physchem.51.1.129; Batista PR, 2010, PHYS CHEM CHEM PHYS, V12, P2850, DOI 10.1039/b919148h; Berendsen HJC, 2000, CURR OPIN STRUC BIOL, V10, P165, DOI 10.1016/S0959-440X(00)00061-0; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BIOU V, 1988, PROTEIN ENG, V2, P185, DOI 10.1093/protein/2.3.185; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BRUSCHWEILER R, 1995, J CHEM PHYS, V102, P3396, DOI 10.1063/1.469213; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Chennubhotla C, 2008, MOL BIOSYST, V4, P287, DOI 10.1039/b717819k; Chennubhotla C, 2007, PLOS COMPUT BIOL, V3, P1716, DOI 10.1371/journal.pcbi.0030172; Chennubhotla C, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100075; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Corless CL, 2005, J CLIN ONCOL, V23, P5357, DOI 10.1200/JCO.2005.14.068; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano WL, 2004, ABSTR PAP AM CHEM S, V228, pU313; Dibb NJ, 2004, NAT REV CANCER, V4, P718, DOI 10.1038/nrc1434; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Frost MJ, 2002, MOL CANCER THER, V1, P1115; Gajiwala KS, 2009, P NATL ACAD SCI USA, V106, P1542, DOI 10.1073/pnas.0812413106; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; GLOVER HR, 1995, ONCOGENE, V11, P1347; Griffith J, 2004, MOL CELL, V13, P169, DOI 10.1016/S1097-2765(03)00505-7; He Y., 2012, E HLTH TELECOMM SYST, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0046900; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; HONEGGER AM, 1990, J CELL BIOL, V110, P1541, DOI 10.1083/jcb.110.5.1541; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hubbard SR, 2007, CURR OPIN CELL BIOL, V19, P117, DOI 10.1016/j.ceb.2007.02.010; Hume DA, 2012, BLOOD, V119, P1810, DOI 10.1182/blood-2011-09-379214; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jorgensen WL, 1998, J COMPUT CHEM, V19, P1179, DOI 10.1002/(SICI)1096-987X(19980730)19:10<1179::AID-JCC6>3.0.CO;2-J; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Laine E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002661; Laine E, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002068; Landau M, 2008, BBA-REV CANCER, V1785, P12, DOI 10.1016/j.bbcan.2007.08.001; Li SQ, 2003, J BIOL CHEM, V278, P26007, DOI 10.1074/jbc.M302425200; Lyman E, 2006, BIOPHYS J, V91, P164, DOI 10.1529/biophysj.106.082941; MARGOLIS B, 1990, MOL CELL BIOL, V10, P435, DOI 10.1128/MCB.10.2.435; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Meyers MJ, 2010, BIOORG MED CHEM LETT, V20, P1543, DOI 10.1016/j.bmcl.2010.01.078; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Mol CD, 2003, J BIOL CHEM, V278, P31461, DOI 10.1074/jbc.C300186200; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; Morley GM, 1999, ONCOGENE, V18, P3076, DOI 10.1038/sj.onc.1202646; Onufriev A, 2000, J PHYS CHEM B, V104, P3712, DOI 10.1021/jp994072s; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Pandini A, 2012, FASEB J, V26, P868, DOI 10.1096/fj.11-190868; Pardanani A, 2013, AM J HEMATOL, V88, P612, DOI 10.1002/ajh.23459; Patsialou A, 2009, CANCER RES, V69, P9498, DOI 10.1158/0008-5472.CAN-09-1868; Penev PS, 1996, NETWORK-COMP NEURAL, V7, P477, DOI 10.1088/0954-898X/7/3/002; PERAHIA D, 1995, COMPUT CHEM, V19, P241, DOI 10.1016/0097-8485(95)00011-G; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Piazza F, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/4/046014; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Rademakers R, 2012, NAT GENET, V44, P200, DOI 10.1038/ng.1027; Robinson DR, 2000, ONCOGENE, V19, P5548, DOI 10.1038/sj.onc.1203957; ROSNET O, 1993, CRIT REV ONCOGENESIS, V4, P595; ROSNET O, 1993, BLOOD, V82, P1110, DOI 10.1182/blood.V82.4.1110.bloodjournal8241110; Roussel MF, 2003, CELL CYCLE, V2, P5, DOI 10.4161/cc.2.1.295; Soares MJ, 2009, MODERN PATHOL, V22, P744, DOI 10.1038/modpathol.2009.43; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Swords R, 2012, LEUKEMIA, V26, P2176, DOI 10.1038/leu.2012.114; Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1; Taylor JR, 2006, ONCOGENE, V25, P147, DOI 10.1038/sj.onc.1209007; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Van Gunsteren WF, 1988, MOL SIMULAT, V1, P173, DOI 10.1080/08927028808080941; Verstraete K, 2012, NAT REV CANCER, V12, P753, DOI 10.1038/nrc3371; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Walter M, 2007, J MOL BIOL, V367, P839, DOI 10.1016/j.jmb.2007.01.036; Wan SZ, 2011, J COMPUT CHEM, V32, P2843, DOI 10.1002/jcc.21866; Yamamoto Y, 2001, BLOOD, V97, P2434, DOI 10.1182/blood.V97.8.2434; Yu WF, 2012, J BIOL CHEM, V287, P13694, DOI 10.1074/jbc.M112.355610; Zhang ZY, 2006, PROTEINS, V64, P391, DOI 10.1002/prot.20983	88	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97519	10.1371/journal.pone.0097519	http://dx.doi.org/10.1371/journal.pone.0097519			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828813	Green Submitted, gold, Green Published			2022-12-27	WOS:000336857400105
J	Iihara, K; Nishimura, K; Kada, A; Nakagawara, J; Ogasawara, K; Ono, J; Shiokawa, Y; Aruga, T; Miyachi, S; Nagata, I; Toyoda, K; Matsuda, S; Miyamoto, Y; Suzuki, A; Ishikawa, KB; Kataoka, H; Nakamura, F; Kamitani, S				Iihara, Koji; Nishimura, Kunihiro; Kada, Akiko; Nakagawara, Jyoji; Ogasawara, Kuniaki; Ono, Junichi; Shiokawa, Yoshiaki; Aruga, Toru; Miyachi, Shigeru; Nagata, Izumi; Toyoda, Kazunori; Matsuda, Shinya; Miyamoto, Yoshihiro; Suzuki, Akifumi; Ishikawa, Koichi B.; Kataoka, Hiroharu; Nakamura, Fumiaki; Kamitani, Satoru			Effects of Comprehensive Stroke Care Capabilities on In-Hospital Mortality of Patients with Ischemic and Hemorrhagic Stroke: J-ASPECT Study	PLOS ONE			English	Article							GUIDELINES-STROKE; RECOMMENDATIONS; CONSCIOUSNESS; MULTICENTER; PERFORMANCE; VALIDATION; OUTCOMES; CENTERS; SYSTEM; ATTACK	Background: The effectiveness of comprehensive stroke center (CSC) capabilities on stroke mortality remains uncertain. We performed a nationwide study to examine whether CSC capabilities influenced in-hospital mortality of patients with ischemic and hemorrhagic stroke. Methods and Results: Of the 1,369 certified training institutions in Japan, 749 hospitals responded to a questionnaire survey regarding CSC capabilities that queried the availability of personnel, diagnostic techniques, specific expertise, infrastructure, and educational components recommended for CSCs. Among the institutions that responded, data on patients hospitalized for stroke between April 1, 2010 and March 31, 2011 were obtained from the Japanese Diagnosis Procedure Combination database. In-hospital mortality was analyzed using hierarchical logistic regression analysis adjusted for age, sex, level of consciousness on admission, comorbidities, and the number of fulfilled CSC items in each component and in total. Data from 265 institutions and 53,170 emergency-hospitalized patients were analyzed. Mortality rates were 7.8% for patients with ischemic stroke, 16.8% for patients with intracerebral hemorrhage (ICH), and 28.1% for patients with subarachnoid hemorrhage (SAH). Mortality adjusted for age, sex, and level of consciousness was significantly correlated with personnel, infrastructural, educational, and total CSC scores in patients with ischemic stroke. Mortality was significantly correlated with diagnostic, educational, and total CSC scores in patients with ICH and with specific expertise, infrastructural, educational, and total CSC scores in patients with SAH. Conclusions: CSC capabilities were associated with reduced in-hospital mortality rates, and relevant aspects of care were found to be dependent on stroke type.	[Iihara, Koji] Kyushu Univ, Grad Sch Med Sci, Dept Neurosurg, Fukuoka 812, Japan; [Nishimura, Kunihiro; Miyamoto, Yoshihiro] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Med & Epidemiol Informat, Suita, Osaka, Japan; [Kada, Akiko] Nagoya Med Ctr, Natl Hosp Org, Clin Res Ctr, Nagoya, Aichi, Japan; [Nakagawara, Jyoji] Natl Cerebral & Cardiovasc Ctr, Integrat Stroke Imaging Ctr, Suita, Osaka, Japan; [Ogasawara, Kuniaki] Iwate Med Univ, Dept Neurosurg, Morioka, Iwate 020, Japan; [Ono, Junichi] Chiba Cardiovasc Ctr, Ichihara, Chiba, Japan; [Shiokawa, Yoshiaki] Kyorin Univ, Dept Neurosurg, Mitaka, Tokyo, Japan; [Aruga, Toru] Showa Univ Hosp, Tokyo, Japan; [Miyachi, Shigeru] Nagoya Univ, Dept Neurosurg, Nagoya, Aichi 4648601, Japan; [Nagata, Izumi] Nagasaki Univ, Dept Neurosurg, Nagasaki 852, Japan; [Toyoda, Kazunori] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Suita, Osaka, Japan; [Matsuda, Shinya] Univ Occupat & Environm Hlth, Dept Prevent Med & Community Hlth, Kitakyushu, Fukuoka 807, Japan; [Suzuki, Akifumi] Res Inst Brain & Blood Vessels, Akita 0100874, Japan; [Ishikawa, Koichi B.] Natl Canc Ctr, Ctr Canc Control & Informat Serv, Tokyo 104, Japan; [Kataoka, Hiroharu] Natl Cerebral & Cardiovasc Ctr, Dept Neurosurg, Suita, Osaka, Japan; [Nakamura, Fumiaki; Kamitani, Satoru] Univ Tokyo, Dept Publ Hlth, Tokyo, Japan	Kyushu University; National Cerebral & Cardiovascular Center - Japan; Nagoya Medical Center; National Cerebral & Cardiovascular Center - Japan; Iwate Medical University; Kyorin University; Showa University; Nagoya University; Nagasaki University; National Cerebral & Cardiovascular Center - Japan; University of Occupational & Environmental Health - Japan; National Cancer Center - Japan; National Cerebral & Cardiovascular Center - Japan; University of Tokyo	Iihara, K (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Neurosurg, Fukuoka 812, Japan.	kiihara@ns.med.kyushu-u.ac.jp	Kataoka, Hiroharu/GPT-3596-2022; Toyoda, Kazunori/J-3828-2015	Toyoda, Kazunori/0000-0002-8346-9845; Kamitani, Satoru/0000-0001-7188-2141; Matsuda, Shinya/0000-0002-8472-8909	Ministry of Health, Labour, and Welfare of Japan	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by Grants-in-Aid from the Ministry of Health, Labour, and Welfare of Japan (Principal Investigator: Koji Iihara). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts MJ, 2005, STROKE, V36, P1597, DOI 10.1161/01.STR.0000170622.07210.b4; Alberts MJ, 2000, JAMA-J AM MED ASSOC, V283, P3102, DOI 10.1001/jama.283.23.3102; Ali SF, 2013, STROKE, V44, P3148, DOI 10.1161/STROKEAHA.113.002493; [Anonymous], 2007, NEA, V70, P4; [Anonymous], 2011, VITAL STAT JAPAN; Cramer SC, 2012, STROKE, V43, P1089, DOI 10.1161/STROKEAHA.111.635334; Cucchiara BL, 2004, CRIT CARE MED, V32, P241, DOI 10.1097/01.CCM.0000104113.36384.81; Fonarow GC, 2012, JAMA-J AM MED ASSOC, V308, P257, DOI 10.1001/jama.2012.7870; Hemphill JC, 2009, NEUROLOGY, V73, P1088, DOI 10.1212/WNL.0b013e3181b8b332; Leifer D, 2011, STROKE, V42, P849, DOI 10.1161/STR.0b013e318208eb99; Leys D, 2007, STROKE, V38, P2985, DOI 10.1161/STROKEAHA.107.487967; Localio AR, 2001, ANN INTERN MED, V135, P112, DOI 10.7326/0003-4819-135-2-200107170-00012; OHTA T, 1986, J NEUROSURG, V64, P420, DOI 10.3171/jns.1986.64.3.0420; Ohta T, 1974, No Shinkei Geka, V2, P623; Qureshi AI, 2013, J STROKE CEREBROVASC, V22, P661, DOI 10.1016/j.jstrokecerebrovasdis.2012.03.015; Qureshi AI, 2012, CEREBROVASC DIS EXTR, V2, P1, DOI 10.1159/000335097; Reeves MJ, 2010, STROKE, V41, P1573, DOI 10.1161/STROKEAHA.109.577171; Saposnik G, 2009, STROKE, V40, P3321, DOI 10.1161/STROKEAHA.109.554907; Schwamm LH, 2009, CIRCULATION, V119, P107, DOI 10.1161/CIRCULATIONAHA.108.783688; Seghieri C, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-170; Shahian DM, 2008, CIRCULATION, V117, P1955, DOI 10.1161/CIRCULATIONAHA.107.747873; Smith EE, 2010, NEUROLOGY, V75, P456, DOI 10.1212/WNL.0b013e3181ebdd8d; Smith EE, 2010, CIRCULATION, V122, P1496, DOI 10.1161/CIRCULATIONAHA.109.932822; TEASDALE G, 1974, LANCET, V2, P81; Weimar C, 2006, J NEUROL NEUROSUR PS, V77, P601, DOI 10.1136/jnnp.2005.081117; Yasunaga H, 2005, INT HEART J, V46, P855, DOI 10.1536/ihj.46.855	26	48	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96819	10.1371/journal.pone.0096819	http://dx.doi.org/10.1371/journal.pone.0096819			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828409	gold, Green Submitted, Green Published			2022-12-27	WOS:000336857400039
J	Klomp, A; Vaclavu, L; Meerhoff, GF; Reneman, L; Lucassen, PJ				Klomp, Anne; Vaclavu, Lena; Meerhoff, Gideon F.; Reneman, Liesbeth; Lucassen, Paul J.			Effects of Chronic Fluoxetine Treatment on Neurogenesis and Tryptophan Hydroxylase Expression in Adolescent and Adult Rats	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; HIPPOCAMPAL NEUROGENESIS; CELL-PROLIFERATION; DENTATE GYRUS; MAJOR DEPRESSION; PROGENITOR CELLS; RAPHE NUCLEI; SEROTONIN; STRESS; AGE	The antidepressant drug fluoxetine (Prozac) has been increasingly prescribed to children and adolescents with depressive disorders despite a lack of thorough understanding of its therapeutic effects in the paediatric population and of its putative neurodevelopmental effects. Within the framework of PRIOMEDCHILD ERA-NET, we investigated; a) effects of chronic fluoxetine treatment on adult hippocampal neurogenesis, a structural readout relevant for antidepressant action and hippocampal development; b) effects on tryptophan hydroxylase (TPH) expression, a measure of serotonin synthesis; c) whether treatment effects during adolescence differed from treatment at an adult age, and d) whether they were subregion-specific. Stereological quantification of the number of proliferating (Ki-67+) cells and of the number of young migratory neurons (doublecortin+), revealed a significant age-by-treatment interaction effect, indicating that fluoxetine affects both proliferation and neurogenesis in adolescent-treated rats differently than it does in adult-treated rats. In terms of subregional differences, fluoxetine enhanced proliferation mainly in the dorsal parts of the hippocampus, and neurogenesis in both the suprapyramidal and infrapyramidal blades of the dentate gyrus in adolescent-treated rats, while no such differences were seen in adult-treated rats. Fluoxetine exerted similar age-by-treatment interaction effects on TPH cells mainly in the ventral portion of the dorsal raphe nucleus. We conclude that fluoxetine exerts divergent effects on structural plasticity and serotonin synthesis in adolescent versus adult-treated rats. These preliminary data indicate a differential sensitivity of the adolescent brain to this drug and thus warrant further research into their behavioural and translational aspects. Together with recent related findings, they further call for caution in prescribing these drugs to the adolescent population.	[Vaclavu, Lena; Meerhoff, Gideon F.; Lucassen, Paul J.] Univ Amsterdam, Swammerdam Inst Life Sci, Ctr Neurosci, Amsterdam, Netherlands; [Klomp, Anne; Reneman, Liesbeth] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Lucassen, PJ (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Ctr Neurosci, Amsterdam, Netherlands.	P.J.Lucassen@uva.nl	Lucassen, Paul/ABA-3113-2020; Václavů, Lena/AAX-5212-2020; Vaclavu, Lena/AAE-9192-2021	Lucassen, Paul/0000-0001-9708-9133; Václavů, Lena/0000-0001-8617-7752; Reneman, Liesbeth/0000-0002-5912-9971	PRIOMEDCHILD ERA-NET; Academic Medical Center (ePOD project); HersenStichting Nederland; ISAO	PRIOMEDCHILD ERA-NET; Academic Medical Center (ePOD project); HersenStichting Nederland; ISAO	LR and PJL are supported by PRIOMEDCHILD ERA-NET. LR is supported by the Academic Medical Center (ePOD project). PJL is further supported by the HersenStichting Nederland and ISAO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SL, 2004, INT J DEV NEUROSCI, V22, P423, DOI 10.1016/j.ijdevneu.2004.06.002; Andersen SL, 2008, TRENDS NEUROSCI, V31, P183, DOI 10.1016/j.tins.2008.01.004; Bach-Mizrachi H, 2006, NEUROPSYCHOPHARMACOL, V31, P814, DOI 10.1038/sj.npp.1300897; Balu DT, 2010, EXP CLIN PSYCHOPHARM, V18, P71, DOI 10.1037/a0017295; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Baudry A, 2011, CURR OPIN NEUROBIOL, V21, P858, DOI 10.1016/j.conb.2011.03.005; Beasley CM, 2000, J CLIN PSYCHIAT, V61, P722, DOI 10.4088/JCP.v61n1003; BOADLEBIBER MC, 1993, PROG BIOPHYS MOL BIO, V60, P1, DOI 10.1016/0079-6107(93)90009-9; Boldrini M, 2012, BIOL PSYCHIAT, V72, P562, DOI 10.1016/j.biopsych.2012.04.024; Bouet V, 2012, PSYCHOPHARMACOLOGY, V221, P329, DOI 10.1007/s00213-011-2580-1; Bridge JA, 2007, JAMA-J AM MED ASSOC, V297, P1683, DOI 10.1001/jama.297.15.1683; Choi MR, 2012, J CHEM NEUROANAT, V43, P96, DOI 10.1016/j.jchemneu.2012.01.001; Couillard-Despres S, 2009, MOL PSYCHIATR, V14, P856, DOI 10.1038/mp.2008.147; Cowen DS, 2008, BRAIN RES, V1228, P14, DOI 10.1016/j.brainres.2008.06.059; Czeh B, 2007, EUR ARCH PSY CLIN N, V257, P250, DOI 10.1007/s00406-007-0728-0; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Dygalo NN, 2006, PHARMACOL BIOCHEM BE, V85, P220, DOI 10.1016/j.pbb.2006.08.004; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Fike JR, 2007, NEUROSURG CLIN N AM, V18, P115, DOI 10.1016/j.nec.2006.10.010; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Guirado R, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-5; Hansen F, 2011, NEUROSCI LETT, V499, P59, DOI 10.1016/j.neulet.2011.05.032; Hanson ND, 2011, PSYCHONEUROENDOCRINO, V36, P1520, DOI 10.1016/j.psyneuen.2011.04.006; Heine VM, 2004, NEUROBIOL AGING, V25, P361, DOI 10.1016/S0197-4580(03)00090-3; Heine VM, 2004, EUR J NEUROSCI, V19, P131, DOI 10.1046/j.1460-9568.2003.03100.x; Hetrick S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004851.pub2; Hodes GE, 2009, NEUROSCIENCE, V163, P609, DOI 10.1016/j.neuroscience.2009.06.057; Jayatissa MN, 2006, NEUROPSYCHOPHARMACOL, V31, P2395, DOI 10.1038/sj.npp.1301041; Jinno S, 2011, HIPPOCAMPUS, V21, P467, DOI 10.1002/hipo.20762; Jureidini JN, 2004, BMJ-BRIT MED J, V328, P879, DOI 10.1136/bmj.328.7444.879; Kapornai K, 2008, CURR OPIN PSYCHIATR, V21, P1, DOI 10.1097/YCO.0b013e3282f25b01; Klomp A, 2012, NEUROIMAGE, V59, P218, DOI 10.1016/j.neuroimage.2011.07.082; Kodamo M, 2004, BIOL PSYCHIAT, V56, P570, DOI 10.1016/j.biopsych.2004.07.008; Lucassen PJ, 2010, EUR NEUROPSYCHOPHARM, V20, P1, DOI 10.1016/j.euroneuro.2009.08.003; Lucassen PJ, 2010, NEUROPHARMACOLOGY, V58, P940, DOI 10.1016/j.neuropharm.2010.01.012; MacGillivray L, 2010, NEUROSCIENCE, V171, P407, DOI 10.1016/j.neuroscience.2010.08.055; Maciag D, 2006, NEUROPSYCHOPHARMACOL, V31, P47, DOI 10.1038/sj.npp.1300823; Malberg JE, 2003, NEUROPSYCHOPHARMACOL, V28, P1562, DOI 10.1038/sj.npp.1300234; Marcussen AB, 2008, ACTA NEUROL SCAND, V117, P94, DOI 10.1111/j.1600-0404.2007.00910.x; Marlatt Michael W, 2013, Curr Top Behav Neurosci, V15, P313, DOI 10.1007/7854_2012_237; Marlatt MW, 2012, DEV NEUROBIOL, V72, P943, DOI 10.1002/dneu.22009; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; Migliarini S, 2013, MOL PSYCHIATR, V18, P1106, DOI 10.1038/mp.2012.128; Navailles S, 2008, J COMP NEUROL, V509, P372, DOI 10.1002/cne.21775; Nollet M, 2012, NEUROPSYCHOPHARMACOL, V37, P2210, DOI 10.1038/npp.2012.70; Olivier JDA, 2011, PROG NEURO-PSYCHOPH, V35, P1400, DOI 10.1016/j.pnpbp.2010.09.013; Oomen CA, 2010, J NEUROSCI, V30, P6635, DOI 10.1523/JNEUROSCI.0247-10.2010; Paizanis E, 2010, INT J NEUROPSYCHOPH, V13, P759, DOI 10.1017/S1461145709990514; Perera TD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017600; Pineyro G, 1999, PHARMACOL REV, V51, P533; Pinnock SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013652; Rayen I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024003; Rind HB, 2000, NEUROSCIENCE, V101, P665, DOI 10.1016/S0306-4522(00)00402-4; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Sass A, 2012, BEHAV BRAIN RES, V228, P169, DOI 10.1016/j.bbr.2011.12.006; Satvat E, 2012, NEUROPHARMACOLOGY, V62, P1627, DOI 10.1016/j.neuropharm.2011.11.025; Scharfman HE, 2002, J COMP NEUROL, V454, P424, DOI 10.1002/cne.10449; Schoenfeld Timothy J, 2013, Curr Top Behav Neurosci, V15, P139, DOI 10.1007/7854_2012_233; Shishkina GT, 2007, NEUROSCIENCE, V150, P404, DOI 10.1016/j.neuroscience.2007.09.017; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Stranahan AM, 2006, NAT NEUROSCI, V9, P526, DOI 10.1038/nn1668; Surget A, 2011, MOL PSYCHIATR, V16, P1177, DOI 10.1038/mp.2011.48; Suri D, 2013, BIOL PSYCHIAT, V73, P658, DOI 10.1016/j.biopsych.2012.10.023; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tamamaki N, 1997, EXP BRAIN RES, V116, P250, DOI 10.1007/PL00005753; Tanti A, 2012, NEUROPHARMACOLOGY, V63, P374, DOI 10.1016/j.neuropharm.2012.04.022; Tordera RM, 2002, EUR J PHARMACOL, V442, P63, DOI 10.1016/S0014-2999(02)01504-2; Van Bokhoven P, 2011, EUR J NEUROSCI, V33, P1833, DOI 10.1111/j.1460-9568.2011.07668.x; Vitalis T, 2003, DEV NEUROSCI-BASEL, V25, P245, DOI 10.1159/000072272; Von Frijtag JC, 2002, DEV PSYCHOBIOL, V41, P58, DOI 10.1002/dev.10057; Wegerer V, 1999, J CHILD ADOL PSYCHOP, V9, P13, DOI 10.1089/cap.1999.9.13; Wenthur CJ, 2014, ACS CHEM NEUROSCI, V5, P14, DOI 10.1021/cn400186j; WhitakerAzmitia PM, 1996, BEHAV BRAIN RES, V73, P19	73	44	45	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97603	10.1371/journal.pone.0097603	http://dx.doi.org/10.1371/journal.pone.0097603			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827731	Green Submitted, Green Published, gold			2022-12-27	WOS:000336857400111
J	Koss, MJ; Hoffmann, J; Nguyen, N; Pfister, M; Mischak, H; Mullen, W; Husi, H; Rejdak, R; Koch, F; Jankowski, J; Krueger, K; Bertelmann, T; Klein, J; Schanstra, JP; Siwy, J				Koss, Michael Janusz; Hoffmann, Janosch; Nguyen, Nauke; Pfister, Marcel; Mischak, Harald; Mullen, William; Husi, Holger; Rejdak, Robert; Koch, Frank; Jankowski, Joachim; Krueger, Katharina; Bertelmann, Thomas; Klein, Julie; Schanstra, Joost P.; Siwy, Justyna			Proteomics of Vitreous Humor of Patients with Exudative Age-Related Macular Degeneration	PLOS ONE			English	Article							AQUEOUS-HUMOR; PROTEINS; NEOVASCULARIZATION; RHEOPHERESIS; TRANSFERRIN; EXPRESSION; BIOMARKERS; DISCOVERY; FLUID	Background: There is absence of specific biomarkers and an incomplete understanding of the pathophysiology of exudative age-related macular degeneration (AMD). Methods and Findings: Eighty-eight vitreous samples (73 from patients with treatment naive AMD and 15 control samples from patients with idiopathic floaters) were analyzed with capillary electrophoresis coupled to mass spectrometry in this retrospective case series to define potential candidate protein markers of AMD. Nineteen proteins were found to be upregulated in vitreous of AMD patients. Most of the proteins were plasma derived and involved in biological (ion) transport, acute phase inflammatory reaction, and blood coagulation. A number of proteins have not been previously associated to AMD including alpha-1-antitrypsin, fibrinogen alpha chain and prostaglandin H2-D isomerase. Alpha-1-antitrypsin was validated in vitreous of an independent set of AMD patients using Western blot analysis. Further systems biology analysis of the data indicated that the observed proteomic changes may reflect upregulation of immune response and complement activity. Conclusions: Proteome analysis of vitreous samples from patients with AMD, which underwent an intravitreal combination therapy including a core vitrectomy, steroids and bevacizumab, revealed apparent AMD-specific proteomic changes. The identified AMD-associated proteins provide some insight into the pathophysiological changes associated with AMD.	[Koss, Michael Janusz; Nguyen, Nauke; Koch, Frank] Goethe Univ Frankfurt, Dept Ophthalmol, D-60054 Frankfurt, Germany; [Koss, Michael Janusz; Pfister, Marcel] Doheny Eye Inst, Los Angeles, CA 90033 USA; [Koss, Michael Janusz] Heidelberg Univ, Dept Ophthalmol, Heidelberg, Germany; [Hoffmann, Janosch; Mischak, Harald; Klein, Julie; Schanstra, Joost P.; Siwy, Justyna] Mosa Diagnost, Hannover, Germany; [Mischak, Harald; Mullen, William; Husi, Holger] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Rejdak, Robert] Lublin Univ, Dept Gen Ophthalmol, Lublin, Poland; [Jankowski, Joachim; Krueger, Katharina; Siwy, Justyna] Charite, Dept Nephrol Endocrinol & Transplantat Med, D-13353 Berlin, Germany; [Bertelmann, Thomas] Philipps Univ, Dept Ophthalmol, Marburg, Germany; [Schanstra, Joost P.] Inst Cardiovasc & Metab Dis, INSERM, U1048, Toulouse, France; [Schanstra, Joost P.] Univ Toulouse 3, F-31062 Toulouse, France	Goethe University Frankfurt; Doheny Eye Institute; Ruprecht Karls University Heidelberg; University of Glasgow; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Philipps University Marburg; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Koss, MJ (corresponding author), Goethe Univ Frankfurt, Dept Ophthalmol, D-60054 Frankfurt, Germany.	Michael.koss@me.com	Klein, Julie/ABE-2622-2020; Mullen, William/GWC-8078-2022; Klein, Julie/M-7088-2017; Schanstra, Joost P/X-7724-2018	Klein, Julie/0000-0002-3279-0559; Klein, Julie/0000-0002-3279-0559; Schanstra, Joost P/0000-0002-7471-372X; Siwy, Justyna/0000-0003-1407-2534; Mischak, Harald/0000-0003-0323-0306; Mullen, William/0000-0002-5685-1563; Rejdak, Robert/0000-0003-3321-2723	Adolf Messer Stiftung in Konigstein, Hessen, Germany	Adolf Messer Stiftung in Konigstein, Hessen, Germany	The study was financed in part by the Adolf Messer Stiftung in Konigstein, Hessen, Germany; No additional external funding was received for this study. http://www.adolf-messer-stiftung.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamis AP, 1996, ARCH OPHTHALMOL-CHIC, V114, P66, DOI 10.1001/archopht.1996.01100130062010; Angi M, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/148039; Augustin AJ, 2007, RETINA-J RET VIT DIS, V27, P133, DOI 10.1097/IAE.0b013e3180323de7; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett KL, 2011, J PROTEOMICS, V74, P151, DOI 10.1016/j.jprot.2010.10.002; Boehm N, 2012, BRAIN BEHAV IMMUN, V26, P96, DOI 10.1016/j.bbi.2011.07.241; Chowdhury UR, 2011, INVEST OPHTH VIS SCI, V52, P6443, DOI 10.1167/iovs.11-7409; Chowers I, 2006, INVEST OPHTH VIS SCI, V47, P2135, DOI 10.1167/iovs.05-1135; Cryan LM, 2008, PROTEOM CLIN APPL, V2, P762, DOI 10.1002/prca.200780094; Ecker SM, 2012, MOL VIS, V18, P1658; Ecker SM, 2011, MOL VIS, V17, P2856; Evans JR, 2001, PROG RETIN EYE RES, V20, P227, DOI 10.1016/S1350-9462(00)00023-9; Funk M, 2009, OPHTHALMOLOGY, V116, P2393, DOI 10.1016/j.ophtha.2009.05.039; Garcia-Ramirez M, 2007, DIABETOLOGIA, V50, P1294, DOI 10.1007/s00125-007-0627-y; Grossniklaus HE, 2004, AM J OPHTHALMOL, V137, P496, DOI 10.1016/j.ajo.2003.09.042; Grus FH, 2007, PROTEOM CLIN APPL, V1, P876, DOI 10.1002/prca.200700105; Jantos-Siwy J, 2009, J PROTEOME RES, V8, P268, DOI 10.1021/pr800401m; Kim SJ, 2006, CURR EYE RES, V31, P231, DOI 10.1080/02713680600557030; Kim TW, 2012, J PROTEOME RES, V11, P4034, DOI 10.1021/pr300080s; Kisic B, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/467130; Klingel R, 2002, THER APHER, V6, P271, DOI 10.1046/j.1526-0968.2002.00418.x; Klingel R, 2010, THER APHER DIAL, V14, P276, DOI 10.1111/j.1744-9987.2010.00807.x; Koch FH, 2011, ARCH OPHTHALMOL-CHIC, V129, P1599, DOI 10.1001/archophthalmol.2011.341; Koss MJ, 2010, OPHTHALMOLOGICA, V224, P72, DOI 10.1159/000235724; Metzger J, 2013, GUT, V62, P122, DOI 10.1136/gutjnl-2012-302047; Mischak H, 2007, PROTEOM CLIN APPL, V1, P792, DOI 10.1002/prca.200700043; Mischak H, 2013, CLIN BIOCHEM, V46, P432, DOI 10.1016/j.clinbiochem.2012.09.025; Mischak H, 2011, PROTEOM CLIN APPL, V5, P9, DOI 10.1002/prca.201000058; Morohoshi K, 2012, EXP MOL PATHOL, V93, P193, DOI 10.1016/j.yexmp.2012.03.007; Morohoshi K, 2012, EXP MOL PATHOL, V92, P64, DOI 10.1016/j.yexmp.2011.09.017; Neuhoff NV, 2004, RAPID COMMUN MASS SP, V18, P149, DOI 10.1002/rcm.1294; Noma H, 2008, EYE, V22, P42, DOI 10.1038/sj.eye.6702498; Pfister M, 2012, OPHTHALMOLOGE Z DTSC; Spaide RF, 2006, AM J OPHTHALMOL, V141, P149, DOI 10.1016/j.ajo.2005.07.025; Stefansson E, 2006, ACTA OPHTHALMOL SCAN, V84, P718, DOI 10.1111/j.1600-0420.2006.00778.x; Stefansson E, 2009, GRAEF ARCH CLIN EXP, V247, P147, DOI 10.1007/s00417-008-0980-7; Theodorescu D, 2006, LANCET ONCOL, V7, P230, DOI 10.1016/S1470-2045(06)70584-8; Walia S, 2010, SEMIN OPHTHALMOL, V25, P289, DOI 10.3109/08820538.2010.518912; Wohlrab W, 2004, HYALURONSAEURE HAUT; Wysokinski D, 2013, EXP EYE RES, V106, P14, DOI 10.1016/j.exer.2012.10.003; Yamane K, 2003, MOL CELL PROTEOMICS, V2, P1177, DOI 10.1074/mcp.M300038-MCP200; Zurbig P, 2006, ELECTROPHORESIS, V27, P2111, DOI 10.1002/elps.200500827	42	56	59	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96895	10.1371/journal.pone.0096895	http://dx.doi.org/10.1371/journal.pone.0096895			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828575	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000336857400043
J	Qin, SS; Li, Q; Zhou, J; Liu, ZJ; Su, N; Wilson, J; Lu, ZM; Deng, DJ				Qin, Sisi; Li, Qiang; Zhou, Jing; Liu, Zhao-jun; Su, Na; Wilson, James; Lu, Zhe-ming; Deng, Dajun			Homeostatic Maintenance of Allele-Specific p16 Methylation in Cancer Cells Accompanied by Dynamic Focal Methylation and Hydroxymethylation	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; ORAL EPITHELIAL DYSPLASIA; ABERRANT DNA METHYLATION; DE-NOVO METHYLATION; CPG ISLAND; MALIGNANT-TRANSFORMATION; PROMOTER METHYLATION; LUNG-CANCER; DEMETHYLATION; PROGRESSION	Aim: p16 Methylation frequently occurs in carcinogenesis. While it has been hypothesized that the p16 methylation states are dynamically maintained in cancer cells, direct evidence supporting this hypothesis has not been available until now. Methods: A fusion cell model was established which reprogrammed the native DNA methylation pattern of the cells. The methylation status of the p16 alleles was then repeatedly quantitatively analyzed in the fusion monoclonal, parental cancer cell lines (p16-completely methylated-AGS and unmethylated-MGC803), and HCT116 non-fusion cell using DHPLC and bisulfite sequencing. Histone methylation was analyzed using chromatin immuno-precipitation (ChIP)-PCR. P16 expression status was determined using immuno-staining and RT-PCR. Results: The methylation status for the majority of the p16 alleles was stably maintained in the fusion monoclonal cells after up to 60 passages. Most importantly, focal de novo methylation, demethylation, and hydroxymethylation were consistently observed within about 27% of the p16 alleles in the fusion monoclones, but not the homozygously methylated or unmethylated parental cells. Furthermore, subclones of the monoclones consistently maintained the same p16 methylation pattern. A similar phenomenon was also observed using the p16 hemi-methylated HCT116 non-fusion cancer cell line. Interestingly, transcription was not observed in p16 alleles that were hydroxymethylated with an antisense-strand-specific pattern. Also, the levels of H3K9 and H3K4 trimethylation in the fusion cells were found to be slightly lower than the parental AGS and MGC803 cells, respectively. Conclusion: The present study provides the first direct evidence confirming that the methylation states of p16 CpG islands is not only homeostatically maintained, but also accompanied by a dynamic process of transient focal methylation, demethylation, and hydroxymethylation in cancer cells.	[Qin, Sisi; Li, Qiang; Zhou, Jing; Liu, Zhao-jun; Su, Na; Lu, Zhe-ming; Deng, Dajun] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Div Canc Etiol, Beijing 100871, Peoples R China; [Wilson, James] Georgia Regents Univ, GRU Canc Ctr, Augusta, GA USA	Peking University; University System of Georgia; Augusta University	Lu, ZM (corresponding author), Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Div Canc Etiol, Beijing 100871, Peoples R China.	zheminglu@163.com; dengdajun@bjmu.edu.cn	Deng, Dajun/D-4605-2009; liu, zhao/GXV-6141-2022	Deng, Dajun/0000-0001-5161-5943; 	National Natural Science Foundation of China [31261140372, 81171900]; National Basic Research Program of China [2011CB504201, 2010CB529303]; Beijing Natural Science Foundation of China [7122033]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Beijing Natural Science Foundation of China(Beijing Natural Science Foundation)	This work is supported by National Natural Science Foundation of China [Grant 31261140372 and 81171900], National Basic Research Program of China [Grant 2011CB504201 and 2010CB529303], and Beijing Natural Science Foundation of China [Grant 7122033]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai H, 2003, MUTAT RES-GEN TOX EN, V535, P73, DOI 10.1016/S1383-5718(02)00288-7; Belinsky SA, 2006, CANCER RES, V66, P3338, DOI 10.1158/0008-5472.CAN-05-3408; Belinsky SA, 1998, P NATL ACAD SCI USA, V95, P11891, DOI 10.1073/pnas.95.20.11891; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bhattacharyya S, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt601; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Cao J, 2009, CLIN CANCER RES, V15, P5178, DOI 10.1158/1078-0432.CCR-09-0580; Deng DJ, 2013, CHINESE SCI BULL, V58, P1, DOI 10.1007/s11434-012-5578-0; Deng DJ, 2010, ADV GENET, V71, P125, DOI [10.1016/S0065-2660(10)71005-1, 10.1016/B978-0-12-380864-6.00005-5]; Deng DJ, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.3.e13; Dong CX, 2009, INT J CANCER, V124, P434, DOI 10.1002/ijc.23891; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Egger G, 2007, CANCER RES, V67, P346, DOI 10.1158/0008-5472.CAN-06-2845; GONZALEZZULUETA M, 1995, CANCER RES, V55, P4531; Hackett JA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0328; Hahn MA, 2013, CELL REP, V3, P291, DOI 10.1016/j.celrep.2013.01.011; Hall GL, 2008, CANCER EPIDEM BIOMAR, V17, P2174, DOI 10.1158/1055-9965.EPI-07-2867; HERMAN JG, 1995, CANCER RES, V55, P4525; Hinshelwood RA, 2009, HUM MOL GENET, V18, P3098, DOI 10.1093/hmg/ddp251; Jin Z, 2009, CANCER RES, V69, P4112, DOI 10.1158/0008-5472.CAN-09-0028; Kim S, 2002, NAT CELL BIOL, V4, P826, DOI 10.1038/ncb863; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Li Q, 2010, PLOS ONE, V5; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lu ZM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035928; Luo DY, 2006, LAB INVEST, V86, P591, DOI 10.1038/labinvest.3700415; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; Pan K, 2003, HUM MUTAT, V22, P388, DOI 10.1002/humu.10271; Perri F, 2007, AM J GASTROENTEROL, V102, P1361, DOI 10.1111/j.1572-0241.2007.01284.x; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Song CX, 2013, TRENDS BIOCHEM SCI, V38, P480, DOI 10.1016/j.tibs.2013.07.003; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Sun Y, 2004, CLIN CANCER RES, V10, P5087, DOI 10.1158/1078-0432.CCR-03-0622; Thomson JP, 2013, NUCLEIC ACIDS RES, V41, P5639, DOI 10.1093/nar/gkt232; WANG KH, 1983, ACTA BIOL EXP SINICA, V16, P257; Wen L, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r49; Wong DJ, 1999, MOL CELL BIOL, V19, P5642; Wu H, 2011, CELL CYCLE, V10, P2428, DOI 10.4161/cc.10.15.16930; Yao JY, 2010, J BIOL CHEM, V285, P18828, DOI 10.1074/jbc.M109.077974; Yu M, 2012, NAT PROTOC, V7, P2159, DOI 10.1038/nprot.2012.137; Zhang BZ, 2012, HUM GENE THER, V23, P1071, DOI 10.1089/hum.2012.070	42	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97785	10.1371/journal.pone.0097785	http://dx.doi.org/10.1371/journal.pone.0097785			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828678	Green Published, gold, Green Submitted			2022-12-27	WOS:000336857400123
J	Donelson, JM; McCormick, MI; Booth, DJ; Munday, PL				Donelson, Jennifer M.; McCormick, Mark I.; Booth, David J.; Munday, Philip L.			Reproductive Acclimation to Increased Water Temperature in a Tropical Reef Fish	PLOS ONE			English	Article							FEMALE ATLANTIC SALMON; CLIMATE-CHANGE; THERMAL TOLERANCE; DEVELOPMENTAL PLASTICITY; PHENOTYPIC PLASTICITY; GROWTH; MARINE; DAMSELFISH; SENSITIVITY; CAPACITY	Understanding the capacity of organisms to cope with projected global warming through acclimation and adaptation is critical to predicting their likely future persistence. While recent research has shown that developmental acclimation of metabolic attributes to ocean warming is possible, our understanding of the plasticity of key fitness-associated traits, such as reproductive performance, is lacking. We show that while the reproductive ability of a tropical reef fish is highly sensitive to increases in water temperature, reproductive capacity at +1.5 degrees C above present-day was improved to match fish maintained at present-day temperatures when fish complete their development at the higher temperature. However, reproductive acclimation was not observed in fish reared at +3.0 degrees C warmer than present-day, suggesting limitations to the acclimation possible within one generation. Surprisingly, the improvements seen in reproduction were not predicted by the oxygen-and capacity-limited thermal tolerance hypothesis. Specifically, pairs reared at +1.5 degrees C, which showed the greatest capacity for reproductive acclimation, exhibited no acclimation of metabolic attributes. Conversely, pairs reared at +3.0 degrees C, which exhibited acclimation in resting metabolic rate, demonstrated little capacity for reproductive acclimation. Our study suggests that understanding the acclimation capacity of reproductive performance will be critically important to predicting the impacts of climate change on biological systems.	[Donelson, Jennifer M.; Booth, David J.] Univ Technol Sydney, Sch Environm, Sydney, NSW 2007, Australia; [Donelson, Jennifer M.; McCormick, Mark I.; Munday, Philip L.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Donelson, Jennifer M.; McCormick, Mark I.; Munday, Philip L.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia	University of Technology Sydney; James Cook University; James Cook University	Donelson, JM (corresponding author), Univ Technol Sydney, Sch Environm, Sydney, NSW 2007, Australia.	jennifermarie.donelson@uts.edu.au	Munday, Philip L/F-5443-2011; McCormick, Mark I/J-8301-2014; Donelson, Jennifer/M-5531-2018	Munday, Philip L/0000-0001-9725-2498; McCormick, Mark I/0000-0001-9289-1645; Booth, David/0000-0002-8256-1412; Donelson, Jennifer/0000-0002-0039-5300	CSIRO Climate Adaptation Flagship; Australian Coral Reef Society; GBRMPA Science for Management Awards; ARC Centre of Excellence for Coral Reef Studies	CSIRO Climate Adaptation Flagship(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Australian Coral Reef Society; GBRMPA Science for Management Awards; ARC Centre of Excellence for Coral Reef Studies(Australian Research Council)	This study was supported by funding from the CSIRO Climate Adaptation Flagship, the Australian Coral Reef Society, the GBRMPA Science for Management Awards, and the ARC Centre of Excellence for Coral Reef Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaenssens B, 2012, GLOBAL CHANGE BIOL, V18, P1797, DOI 10.1111/j.1365-2486.2012.02672.x; Alvarez D, 2007, OIKOS, V116, P1144, DOI 10.1111/j.2007.0030-1299.15861.x; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Burel C, 1996, J FISH BIOL, V49, P678, DOI 10.1111/j.1095-8649.1996.tb00064.x; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Clark TD, 2013, J EXP BIOL, V216, P2771, DOI 10.1242/jeb.084251; DAVIES PR, 1986, AQUACULTURE, V52, P137, DOI 10.1016/0044-8486(86)90033-5; Dawson A, 2008, PHILOS T R SOC B, V363, P1621, DOI 10.1098/rstb.2007.0004; Donelson JM, 2012, NAT CLIM CHANGE, V2, P30, DOI 10.1038/NCLIMATE1323; Donelson JM, 2012, CORAL REEFS, V31, P753, DOI 10.1007/s00338-012-0899-7; Donelson JM, 2010, MAR ECOL PROG SER, V401, P233, DOI 10.3354/meps08366; Donelson JM, 2012, J ANIM ECOL, V81, P1126, DOI 10.1111/j.1365-2656.2012.01982.x; Donelson JM, 2011, GLOBAL CHANGE BIOL, V17, P1712, DOI 10.1111/j.1365-2486.2010.02339.x; Donelson JM, 2009, BIOL LETTERS, V5, P262, DOI 10.1098/rsbl.2008.0642; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Eliason EJ, 2011, SCIENCE, V332, P109, DOI 10.1126/science.1199158; Fischer K, 2003, P ROY SOC B-BIOL SCI, V270, P2051, DOI 10.1098/rspb.2003.2470; Franklin CE, 2009, SCIENCE, V323, P876, DOI 10.1126/science.323.5916.876b; FRY F. E. J., 1967, P375; Gagliano M, 2007, OIKOS, V116, P111, DOI 10.1111/j.2006.0030-1299.15418.x; Gienapp P, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0289; Grans A, 2014, J EXP BIOL, V217, P711, DOI 10.1242/jeb.096743; Grenchik MK, 2013, CORAL REEFS, V32, P85, DOI 10.1007/s00338-012-0949-1; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hobday AJ, 2011, MAR FRESHWATER RES, V62, P1000, DOI 10.1071/MF10302; Hoey AS, 2004, OECOLOGIA, V139, P23, DOI 10.1007/s00442-004-1489-3; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Kavanagh KD, 2000, B MAR SCI, V66, P321; King HR, 2007, J FISH BIOL, V70, P190, DOI 10.1111/j.1095-8649.2006.01295.x; King HR, 2003, AQUACULTURE, V219, P797, DOI 10.1016/S0044-8486(02)00647-6; Lough J., 2007, CLIMATE CHANGE GREAT, P15; McCormick MI, 2007, ECOLOGY, V88, P1562, DOI 10.1890/06-0830; Merila J, 2012, BIOESSAYS, V34, P811, DOI 10.1002/bies.201200054; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Morgan IJ, 2001, P ROY SOC B-BIOL SCI, V268, P295, DOI 10.1098/rspb.2000.1365; Munday PL, 2013, ECOL LETT, V16, P1488, DOI 10.1111/ele.12185; Pankhurst NW, 2010, J FISH BIOL, V76, P69, DOI 10.1111/j.1095-8649.2009.02484.x; Pankhurst NW, 2011, MAR FRESHWATER RES, V62, P1015, DOI 10.1071/MF10269; Pankhurst NW, 1999, GEN COMP ENDOCR, V115, P53, DOI 10.1006/gcen.1999.7285; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Perez-Dominguez R., 2010, EVOLUTION, V64, P2450, DOI DOI 10.1111/J.1558-5646.2010.00994.X; Portner HO, 2010, J FISH BIOL, V77, P1745, DOI 10.1111/j.1095-8649.2010.02783.x; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Salinas S, 2012, ECOL LETT, V15, P159, DOI 10.1111/j.1461-0248.2011.01721.x; Scott GR, 2012, P NATL ACAD SCI USA, V109, P14247, DOI 10.1073/pnas.1205012109; Stillwell RC, 2005, ECOLOGY, V86, P924, DOI 10.1890/04-0547; Sunday JM, 2011, P ROY SOC B-BIOL SCI, V278, P1823, DOI 10.1098/rspb.2010.1295; Van Der Kraak Glen, 1997, Society for Experimental Biology Seminar Series, V61, P159; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Zeh JA, 2012, GLOBAL CHANGE BIOL, V18, P1833, DOI 10.1111/j.1365-2486.2012.02640.x	53	54	56	1	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97223	10.1371/journal.pone.0097223	http://dx.doi.org/10.1371/journal.pone.0097223			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24823490	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000336369200074
J	Horn, RL; Kuehn, R; Drechsel, V; Cowley, DE				Horn, Rebekah L.; Kuehn, Ralph; Drechsel, Victoria; Cowley, David E.			Discriminating between the Effects of Founding Events and Reproductive Mode on the Genetic Structure of Triops Populations (Branchiopoda: Notostraca)	PLOS ONE			English	Article							FRESH-WATER INVERTEBRATES; AQUATIC INVERTEBRATES; MOLECULAR ECOLOGY; CANCRIFORMIS BOSC; SEX-RATIO; DISPERSAL; CRUSTACEA; EVOLUTION; DIFFERENTIATION; MITOCHONDRIAL	Crustaceans that initially colonize a freshwater temporary pond can strongly bias the subsequent genetic composition of the population, causing nearby populations to be genetically distinct. In addition, these crustaceans have various reproductive modes that can influence genetic differentiation and diversity within and between populations. We report on two species of tadpole shrimp, Triops newberryi and Triops longicaudatus "short'', with different reproductive modes. Reproduction in the tadpole shrimp can occur clonally (parthenogenesis), with self fertilization (hermaphroditism), or through outcrossing of hermaphrodites with males (androdioecy). For all these reproductive modes, population genetic theory predicts decreased genetic diversity and increased population differentiation. Here we use mitochondrial control region (mtCR) sequences and nuclear microsatellite loci to determine if the difference in reproductive mode affects the high genetic structure typical of persistent founder effects. Previous authors indicated that T. newberryi is androdioecious because populations are composed of hermaphrodites and males, and T. longicaudatus "short'' is hermaphroditic or parthenogenetic because males are absent. In our data, T. newberryi and T. longicaudatus "short'' populations were highly structured genetically over short geographic distances for mtCR sequences and microsatellite loci (T. newberryi: Phi(ST) = 0.644, F-ST = 0.252, respectively; T. I. "short'': invariant mtCR sequences, F-ST = 0.600). Differences between the two Triops species in a number of diversity measures were generally consistent with expectations from population genetic theory regarding reproductive mode; however, three of four comparisons were not statistically significant. We conclude the high genetic differentiation between populations is likely due to founder effects and results suggest both species are composed of selfing hermaphrodites with some level of outcrossing; the presence of males in T. newberryi does not appreciably reduce inbreeding. We cannot exclude the possibility that males in T. newberryi are non-reproductive individuals and the two species have the same mating system.	[Horn, Rebekah L.; Kuehn, Ralph; Cowley, David E.] New Mexico State Univ, Dept Fish Wildlife & Conservat Ecol, Las Cruces, NM 88003 USA; [Horn, Rebekah L.; Kuehn, Ralph; Cowley, David E.] New Mexico State Univ, Program Mol Biol, Las Cruces, NM 88003 USA; [Kuehn, Ralph; Drechsel, Victoria] Tech Univ Munich, Dept Anim Sci, Chair Zool, Unit Mol Zool, Freising Weihenstephan, Germany	New Mexico State University; New Mexico State University; Technical University of Munich	Cowley, DE (corresponding author), New Mexico State Univ, Dept Fish Wildlife & Conservat Ecol, Las Cruces, NM 88003 USA.	dcowley@nmsu.edu		Kuehn, Ralph/0000-0001-9518-0590; Horn, Rebekah/0000-0001-7076-2105	New Mexico Agricultural Experiment Station; Cooperative State Research, Education and Extension Service; US Department of Agriculture - New Mexico State University [2008-34461-19061, 2008-40549-04328]; Texas A & M University System	New Mexico Agricultural Experiment Station; Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); US Department of Agriculture - New Mexico State University; Texas A & M University System	The research was supported by the New Mexico Agricultural Experiment Station and by support to DEC from the Cooperative State Research, Education and Extension Service, US Department of Agriculture under Agreement numbers 2008-34461-19061 and 2008-40549-04328 in cooperation with New Mexico State University and the Texas A & M University System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar A, 2012, CONSERV GENET, V13, P1577, DOI 10.1007/s10592-012-0405-3; Beladjal L, 2009, J CRUSTACEAN BIOL, V29, P266, DOI 10.1651/08-3059R.1; Belkhir K, 2004, GENETIX 4 05 LOGICIE; Bohonak AJ, 2003, ECOL LETT, V6, P783, DOI 10.1046/j.1461-0248.2003.00486.x; BOILEAU MG, 1992, J EVOLUTION BIOL, V5, P25, DOI 10.1046/j.1420-9101.1992.5010025.x; Caceres CE, 2002, OECOLOGIA, V131, P402, DOI 10.1007/s00442-002-0897-5; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Charlesworth D, 2001, CURR OPIN GENET DEV, V11, P685, DOI 10.1016/S0959-437X(00)00254-9; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cohen GM, 2003, OIKOS, V103, P603, DOI 10.1034/j.1600-0706.2003.12660.x; David P, 2007, MOL ECOL, V16, P2474, DOI 10.1111/j.1365-294X.2007.03330.x; De Meester L, 2002, ACTA OECOL, V23, P121, DOI 10.1016/S1146-609X(02)01145-1; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Drummond A., 2011, GENEIOUS V5 5; ELLEGREN H, 1995, NAT GENET, V11, P360, DOI 10.1038/ng1295-360; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frisch D, 2007, AQUAT SCI, V69, P568, DOI 10.1007/s00027-007-0915-0; Galtier N, 2000, GENETICS, V155, P981; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Green AJ, 2008, FRESHWATER BIOL, V53, P380, DOI 10.1111/j.1365-2427.2007.01901.x; Green AJ, 2005, DIVERS DISTRIB, V11, P149, DOI 10.1111/j.1366-9516.2005.00147.x; Hebert PDN, 1996, FRESHWATER BIOL, V35, P311, DOI 10.1046/j.1365-2427.1996.00501.x; Hedrick P.W., 2011, GENETICS POPULATIONS, V4th ed.; HOGAN B, 1986, MANIPULATING MOUSE E; Holsinger KE, 2000, P NATL ACAD SCI USA, V97, P7037, DOI 10.1073/pnas.97.13.7037; Ishida S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-52; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Korn M, 2010, ORG DIVERS EVOL, V10, P409, DOI 10.1007/s13127-010-0026-y; LONGHURST AR, 1954, NATURE, V173, P781, DOI 10.1038/173781b0; Macdonald KS, 2011, J CRUSTACEAN BIOL, V31, P468, DOI 10.1651/10-3411.1; Mantovani B, 2008, HEREDITY, V100, P496, DOI 10.1038/hdy.2008.3; Montero-Pau J, 2008, LIMNOL OCEANOGR-METH, V6, P218, DOI 10.4319/lom.2008.6.218; MORITZ C, 1994, MOL ECOL, V3, P401, DOI 10.1111/j.1365-294X.1994.tb00080.x; Ngan EC, 2006, THESIS SAN DIEGO STA; Palsson S, 2000, MOL ECOL, V9, P1075, DOI 10.1046/j.1365-294x.2000.00969.x; Pannell JR, 2002, ANNU REV ECOL SYST, V33, P397, DOI 10.1146/annurev.ecolsys.33.010802.150419; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard VL, 2007, CONSERV GENET, V8, P1311, DOI 10.1007/s10592-006-9280-0; PROCTOR VW, 1964, ECOLOGY, V45, P656, DOI 10.2307/1936124; R Core Team, 2012, R LANG ENV STAT COMP; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Sassaman C, 1997, HYDROBIOLOGIA, V359, P125, DOI 10.1023/A:1003168416080; SASSAMAN C, 1991, HYDROBIOLOGIA, V212, P169, DOI 10.1007/BF00025998; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; SLATKIN M, 1989, EVOLUTION, V43, P1349, DOI 10.1111/j.1558-5646.1989.tb02587.x; Stoeckle BC, 2013, J CRUSTACEAN BIOL, V33, P48, DOI 10.1163/1937240X-00002118; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; van Leeuwen CHA, 2012, J BIOGEOGR, V39, P2031, DOI 10.1111/jbi.12004; Vanschoenwinkel B, 2008, FRESHWATER BIOL, V53, P2264, DOI 10.1111/j.1365-2427.2008.02071.x; Vanschoenwinkel B, 2008, ECOGRAPHY, V31, P567, DOI 10.1111/j.0906-7590.2008.05442.x; Vanschoenwinkel B, 2008, OIKOS, V117, P125, DOI 10.1111/j.2007.0030-1299.16349.x; Vanschoenwinkel B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034998; Vanschoenwinkel B, 2011, FRESHWATER BIOL, V56, P1606, DOI 10.1111/j.1365-2427.2011.02600.x; Vanschoenwinkel B, 2009, HYDROBIOLOGIA, V635, P363, DOI 10.1007/s10750-009-9929-z; Velona A, 2009, ITAL J ZOOL, V76, P366, DOI 10.1080/11250000902785314; Waterkeyn A, 2010, AQUAT CONSERV, V20, P580, DOI 10.1002/aqc.1122; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; WRIGHT S, 1951, ANN EUGENIC, V15, P323; ZAFFAGNINI F, 1980, MONIT ZOOL ITAL, V14, P1; Zierold T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-161; Zierold T, 2009, FRESHWATER BIOL, V54, P1392, DOI 10.1111/j.1365-2427.2009.02191.x	66	4	4	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97473	10.1371/journal.pone.0097473	http://dx.doi.org/10.1371/journal.pone.0097473			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824220	Green Published, Green Submitted, gold			2022-12-27	WOS:000336369200120
J	Skandarajah, A; Reber, CD; Switz, NA; Fletcher, DA				Skandarajah, Arunan; Reber, Clay D.; Switz, Neil A.; Fletcher, Daniel A.			Quantitative Imaging with a Mobile Phone Microscope	PLOS ONE			English	Article							REAL-TIME; BANDWIDTH; SYSTEM; DIAGNOSIS; IMAGES	Use of optical imaging for medical and scientific applications requires accurate quantification of features such as object size, color, and brightness. High pixel density cameras available on modern mobile phones have made photography simple and convenient for consumer applications; however, the camera hardware and software that enables this simplicity can present a barrier to accurate quantification of image data. This issue is exacerbated by automated settings, proprietary image processing algorithms, rapid phone evolution, and the diversity of manufacturers. If mobile phone cameras are to live up to their potential to increase access to healthcare in low-resource settings, limitations of mobile phone-based imaging must be fully understood and addressed with procedures that minimize their effects on image quantification. Here we focus on microscopic optical imaging using a custom mobile phone microscope that is compatible with phones from multiple manufacturers. We demonstrate that quantitative microscopy with micron-scale spatial resolution can be carried out with multiple phones and that image linearity, distortion, and color can be corrected as needed. Using all versions of the iPhone and a selection of Android phones released between 2007 and 2012, we show that phones with greater than 5 MP are capable of nearly diffraction-limited resolution over a broad range of magnifications, including those relevant for single cell imaging. We find that automatic focus, exposure, and color gain standard on mobile phones can degrade image resolution and reduce accuracy of color capture if uncorrected, and we devise procedures to avoid these barriers to quantitative imaging. By accommodating the differences between mobile phone cameras and the scientific cameras, mobile phone microscopes can be reliably used to increase access to quantitative imaging for a variety of medical and scientific applications.	[Skandarajah, Arunan; Reber, Clay D.; Fletcher, Daniel A.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Switz, Neil A.; Fletcher, Daniel A.] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Fletcher, Daniel A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Fletcher, DA (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	fletch@berkeley.edu		Switz, Neil/0000-0002-3639-4588	Microsoft Research, Intel Corporation; Bill and Melinda Gates Foundation; Blum Center at UC Berkeley; NSF Graduate Research Fellowship; NAS through an NSF IGERT	Microsoft Research, Intel Corporation; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Blum Center at UC Berkeley; NSF Graduate Research Fellowship(National Science Foundation (NSF)); NAS through an NSF IGERT	This work was supported by grants from Microsoft Research, Intel Corporation, the Bill and Melinda Gates Foundation, and the Blum Center at UC Berkeley. AS has been funded by the NSF Graduate Research Fellowship, and NAS has been supported through an NSF IGERT grant to the UC Berkeley Biophysics Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, PS3ISO12052 NEMA; [Anonymous], 2011, UN ACC MAL DIAGN TES; Bellina L, 2009, DIAGN PATHOL, V4, DOI 10.1186/1746-1596-4-19; Bogoch II, 2013, AM J TROP MED HYG, V88, P626, DOI 10.4269/ajtmh.12-0742; Breslauer DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006320; Chang J, 2012, LECT NOTES COMPUT SC, V7512, P345, DOI 10.1007/978-3-642-33454-2_43; Ebner M., 2007, COMPUTER VISION; Flint AC, 2012, BMC MED IMAGING, V12, DOI 10.1186/1471-2342-12-24; Frean J, 2007, T ROY SOC TROP MED H, V101, P1053, DOI 10.1016/j.trstmh.2007.06.008; Gallegos D, 2013, LAB CHIP, V13, P2124, DOI 10.1039/c3lc40991k; Gonzalez RC, 2007, DIGITAL IMAGE PROCES, P162; Hirakawa K, 2006, IMAGE PROCESS IEEE T, V15, P1; Inoue S, 1997, VIDEO MICROSCOPY FUN, P26; Kao WC, 2006, IEEE T CONSUM ELECTR, V52, P1144, DOI 10.1109/TCE.2006.273126; Kayser K, 2008, DIAGN PATHOL, V3, DOI 10.1186/1746-1596-3-17; Kehtarnavaz N, 2002, REAL-TIME IMAGING, V8, P379, DOI 10.1006/rtim.2001.0287; KELLY DH, 1965, APPL OPTICS, V4, P435, DOI 10.1364/AO.4.000435; Kim Y, 2002, IEEE T CONSUM ELECTR, V48, P428, DOI 10.1109/TCE.2002.1037024; Kroemer S, 2011, BRIT J DERMATOL, V164, P973, DOI 10.1111/j.1365-2133.2011.10208.x; Krupinski EA, 2012, J DIGIT IMAGING, V25, P738, DOI 10.1007/s10278-012-9479-1; Kukkonen H, 1993, VISION RES, V33; Kuno T, 1998, IEEE T CONSUM ELECTR, V44, P192, DOI 10.1109/30.663747; Martinez AW, 2008, ANAL CHEM, V80, P3699, DOI 10.1021/ac800112r; Mckay C, 2008, INT CONF ACOUST SPEE, P1657, DOI 10.1109/ICASSP.2008.4517945; Mudanyali O, 2012, LAB CHIP, V12, P2678, DOI [10.1039/c2lc40235a, 10.1039/c21c40235a]; Ochs M, 2013, AM J PHYSIOL-LUNG C, V305, pL15, DOI 10.1152/ajplung.00429.2012; Omnivision, 2012, OV8830 8 MEG PROD BR; Ramakrishnan B, 2006, DIGIT SIGNAL PROCESS, V16, P825, DOI 10.1016/j.dsp.2006.05.004; Ramanath R, 2005, IEEE SIGNAL PROC MAG, V22, P34, DOI 10.1109/MSP.2005.1407713; Razdan S, 2006, UROLOGY, V67, P665, DOI 10.1016/j.urology.2005.10.005; Rea MS, 2008, COLOR RES APPL, V33, P192, DOI 10.1002/col.20399; Rogers JR, 2008, 3 BAR RESOLUTION VER; Sharma G, 1997, IEEE T IMAGE PROCESS, V6, P901, DOI 10.1109/83.597268; Shen MY, 1998, J VIS COMMUN IMAGE R, V9, P2, DOI 10.1006/jvci.1997.0378; Sluder G, 2007, METHOD CELL BIOL, V81, P1; Smith W. J., 2008, MODERN OPTICAL ENG; Smith ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017150; Smutek D, 2005, Prague Med Rep, V106, P5; Stelzer EHK, 1998, J MICROSC-OXFORD, V189, P15, DOI 10.1046/j.1365-2818.1998.00290.x; Tseng D, 2010, LAB CHIP, V10, P1787, DOI 10.1039/c003477k; Tuijn CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028348; Xiao K, 2012, DISPLAYS, P1; Yamada M, 2003, NEUROSURGERY, V52, P986, DOI 10.1227/01.NEU.0000053152.45258.74; Young IT, 1996, IEEE ENG MED BIOL, V15, P59, DOI 10.1109/51.482844	45	116	119	4	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96906	10.1371/journal.pone.0096906	http://dx.doi.org/10.1371/journal.pone.0096906			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824072	Green Published, Green Submitted, gold			2022-12-27	WOS:000336369200040
J	Li, Y; Liu, J; Wang, W; Zhao, D				Li, Yan; Liu, Jing; Wang, Wei; Zhao, Dong			The Association between Within-Visit Blood Pressure Variability and Carotid Artery Atherosclerosis in General Population	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; ORTHOSTATIC HYPERTENSION; ORGAN DAMAGE; RISK; DISEASE; AGENTS; TOOL	Objectives: To determine whether within-visit blood pressure (BP) variability based on three measurements over minutes is associated with increased carotid intima-media thickness (IMT) and plaque in a general population. Methods: A cross-sectional survey was performed in 2007, and a total of 1222 Beijing community residents aged 50-79 years belonging to part of the Chinese Multi-Provincial Cohort Study (CMCS) were recruited in this study. BP was measured three times at 5-minute intervals during a single visit, and the maximum absolute difference (MAD) between any two readings of three measurements was used to indicate within-visit BP variability. Carotid IMT and plaque scanned by B-mode ultrasound were identified as the surrogate end points in the intermediate stage of atherosclerosis. Results: After adjustment for established cardiovascular risk factors, the odds ratio (OR) (95% confidence interval (CI)) for increased carotid IMT and internal carotid plaque associated with the highest within-visit diastolic BP (DBP) variability (MAD > mean + standard deviation (SD)) compared with participants in the lowest within-visit DBP variability (MAD <= mean -SD) was 4.92 (1.48-16.42) and 6.07 (1.31-28.10), respectively, in the normotensives (P = 0.01; P = 0.02). The OR (95% CI) for internal carotid plaque associated with the highest within-visit systolic BP (SBP) variability (MAD <= mean + SD) compared with participants in the lowest within-visit SBP variability (MAD <= mean -SD) was 3.54 (1.26-10.00) in the hypertensives on antihypertensive therapy (P = 0.02). Conclusions: Within-visit DBP variability was associated with increased carotid IMT and internal carotid plaque in the normotensive population, and within-visit SBP variability was associated with internal carotid plaque in hypertensive patients undergoing antihypertensive therapy.	[Li, Yan; Liu, Jing; Wang, Wei; Zhao, Dong] Capital Med Univ, Beijing An Zhen Hosp, Dept Epidemiol, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing, Peoples R China	Capital Medical University	Li, Y (corresponding author), Capital Med Univ, Beijing An Zhen Hosp, Dept Epidemiol, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing, Peoples R China.	torrancely@sina.com	Zhao, D/AAX-5040-2021	Li, Yan/0000-0003-1032-2292	National Program on Key Basic Research Project of China [2012CB517806]; China National Grants for Science and Technology [2011BAI09B01, 2011BAI11B03]; Pfizer Investigator Initiated Research (INSPIIRE); Beijing Natural Science Foundation [7123208]	National Program on Key Basic Research Project of China(National Basic Research Program of China); China National Grants for Science and Technology; Pfizer Investigator Initiated Research (INSPIIRE); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This study was supported by the National Program on Key Basic Research Project of China (contract No. 2012CB517806), China National Grants for Science and Technology (contracts No. 2011BAI09B01 and No. 2011BAI11B03), Pfizer Investigator Initiated Research (INSPIIRE) and Beijing Natural Science Foundation (7123208). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brondolo E, 2009, J OCCUP HEALTH PSYCH, V14, P110, DOI 10.1037/a0014768; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Fessel J, 2006, NAT CLIN PRACT NEPHR, V2, P424, DOI 10.1038/ncpneph0228; Kario K, 2009, CIRC J, V73, P1002, DOI 10.1253/circj.CJ-09-0286; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Lipsitz LA, 2005, HYPERTENSION, V45, P216, DOI 10.1161/01.HYP.0000153094.09615.11; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; Mancia G, 2001, J HYPERTENS, V19, P1981, DOI 10.1097/00004872-200111000-00008; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Miao CY, 2006, J HYPERTENS, V24, P1125, DOI 10.1097/01.hjh.0000226203.57818.88; Muntner P, 2012, J CLIN HYPERTENS, V14, P165, DOI 10.1111/j.1751-7176.2011.00581.x; Muntner P, 2011, HYPERTENSION, V57, P160, DOI 10.1161/HYPERTENSIONAHA.110.162255; Nagai M, 2011, J AM SOC HYPERTENS, V5, P184, DOI 10.1016/j.jash.2011.03.001; Nissen SE, 2004, JAMA-J AM MED ASSOC, V292, P2217, DOI 10.1001/jama.292.18.2217; Pavek K, 2009, BLOOD PRESSURE, V18, P30, DOI 10.1080/08037050902812648; Pickering TG, 2005, CIRCULATION, V111, P697, DOI 10.1161/01.CIR.0000154900.76284.F6; PROGRESS Collaborat Grp, 2001, LANCET, V358, P1556; Rothwell PM, 2010, LANCET NEUROL, V9, P469, DOI 10.1016/S1474-4422(10)70066-1; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Schlaich MP, 2004, CIRCULATION, V110, P3680, DOI 10.1161/01.CIR.0000149748.79945.52; Simon A, 2002, J HYPERTENS, V20, P159, DOI 10.1097/00004872-200202000-00001; STRANDGAARD S, 1973, BMJ-BRIT MED J, V1, P507, DOI 10.1136/bmj.1.5852.507; Tatasciore A, 2007, HYPERTENSION, V50, P325, DOI 10.1161/HYPERTENSIONAHA.107.090084; Touboul PJ, 2012, CEREBROVASC DIS, V34, P290, DOI 10.1159/000343145	24	11	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97760	10.1371/journal.pone.0097760	http://dx.doi.org/10.1371/journal.pone.0097760			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835667	Green Published, Green Submitted, gold			2022-12-27	WOS:000339614800068
J	O'Brien, HD; Williams, SH				O'Brien, Haley D.; Williams, Susan H.			Using Biplanar Fluoroscopy to Guide Radiopaque Vascular Injections: A New Method for Vascular Imaging	PLOS ONE			English	Article							SYSTEM; VISUALIZATION; VENTILATION; KINEMATICS; ANATOMY; HEAD	Studying vascular anatomy, especially in the context of relationships with hard tissues, is of great interest to biologists. Vascular studies have provided significant insight into physiology, function, phylogenetic relationships, and evolutionary patterns. Injection of resin or latex into the vascular system has been a standard technique for decades. There has been a recent surge in popularity of more modern methods, especially radiopaque latex vascular injection followed by CT scanning and digital "dissection.'' This technique best displays both blood vessels and bone, and allows injections to be performed on cadaveric specimens. Vascular injection is risky, however, because it is not a standardizable technique, as each specimen is variable with regard to injection pressure and timing. Moreover, it is not possible to view the perfusion of injection medium throughout the vascular system of interest. Both data and rare specimens can therefore be lost due to poor or excessive perfusion. Here, we use biplanar video fluoroscopy as a technique to guide craniovascular radiopaque latex injection. Cadaveric domestic pigs (Sus scrofa domestica) and white-tailed deer (Odocoileus virginianus) were injected with radiopaque latex under guidance of fluoroscopy. This method was found to enable adjustments, in real-time, to the rate, location, and pressure at which latex is injected in order to avoid data and specimen loss. In addition to visualizing the injection process, this technique can be used to determine flow patterns, and has facilitated the development of consistent markers for complete perfusion.	[O'Brien, Haley D.] Ohio Univ, Dept Biol Sci, Grad Program Ecol & Evolutionary Biol, Athens, OH 45701 USA; [Williams, Susan H.] Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA	Ohio University; Ohio University	O'Brien, HD (corresponding author), Ohio Univ, Dept Biol Sci, Grad Program Ecol & Evolutionary Biol, Athens, OH 45701 USA.	ho128009@ohio.edu		Williams, Susan/0000-0003-4167-678X; O'Brien, Haley/0000-0002-8758-6571	National Science Foundation [DBI-0922988]; Ohio Board of Regents, Ohio University; Heritage College; American Society of Mammalogists; Ohio University Student Enhancement Award; Ohio University Graduate Student Senate Original Work Grant	National Science Foundation(National Science Foundation (NSF)); Ohio Board of Regents, Ohio University; Heritage College; American Society of Mammalogists; Ohio University Student Enhancement Award; Ohio University Graduate Student Senate Original Work Grant	Support for this project was provided by a National Science Foundation grant (DBI-0922988), the Ohio Board of Regents, Ohio University (ohio.edu) and the Heritage College of Osteopathic (oucom.ohiou.edu) Medicine to SHW. Support was also provided by the American Society of Mammalogists Grants-In-Aid of Research (mammalsociety.org), the Ohio University Student Enhancement Award (ohio.edu), and the Ohio University Graduate Student Senate Original Work Grant (ohio.edu/gss) to HDO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams F., 1849, GENUINE WORKS HIPPOC; BALDWIN BA, 1963, J ANAT, V97, P203; Bamel S S, 1975, Anat Anz, V137, P440; BRAINERD EL, 1993, BIOL J LINN SOC, V49, P163, DOI 10.1006/bijl.1993.1028; BRAINERD EL, 1989, SCIENCE, V246, P1593, DOI 10.1126/science.246.4937.1593; Breasted J.H., 1930, E SMITH SURG PAPYRUS; BUGGE J, 1963, ACTA ANAT, V54, P177, DOI 10.1159/000142445; Caputa M, 2004, J THERM BIOL, V29, P691, DOI 10.1016/j.jtherbio.2004.08.079; Carlisle A, 1800, COMMUNICATIONS, V90, P98; CARLTON C, 1977, ANAT REC, V189, P91, DOI 10.1002/ar.1091890107; Costidis A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00243; DANIEL PM, 1953, PHILOS T ROY SOC B, V237, P173, DOI 10.1098/rstb.1953.0003; FOLKOW LP, 1988, J ZOOL, V216, P417, DOI 10.1111/j.1469-7998.1988.tb02439.x; Geisler J. H., 1998, EMERGENCE WHALES EVO; Holliday CM, 2006, ANAT REC PART A, V288A, P1031, DOI 10.1002/ar.a.20374; Keefe DF, 2008, COMPUT GRAPH FORUM, V27, P863, DOI 10.1111/j.1467-8659.2008.01218.x; Khoury Amal, 2007, Am J Orthop (Belle Mead NJ), V36, P582; KILGORE DL, 1976, J COMP PHYSIOL, V110, P209, DOI 10.1007/BF00689309; KRUGER RA, 1979, RADIOLOGY, V130, P49, DOI 10.1148/130.1.49; Kruger RA, 1978, INVEST RADIOL, V14, P279; Lawson MA, 1991, P SOC PHOTO-OPT INS, V256, P1445; Lesbre MF-X, 1903, ARCH MUSEUM HIST NAT, V8, P1; MacPhee R. D. E., 1986, COMP PRIM B, V1, P219; Massimini DF, 2009, THESIS MIT CAMBRIDGE; Meinertz T, 1969, Mikroskopie, V25, P227; MIDTGARD U, 1984, J MORPHOL, V179, P135, DOI 10.1002/jmor.1051790203; Mitchell G, 2008, J THEOR BIOL, V252, P98, DOI 10.1016/j.jtbi.2008.01.017; Nickel R., 1963, ZENTRALBL VET A, V10, P89, DOI [10.1111/j.1439-0442.1963.tb00009.x, DOI 10.1111/J.1439-0442.1963.TB00009.X]; O'Donoghue CH, 1921, PHILOS T R SOC LON B, V210, P175, DOI 10.1098/rstb.1921.0006; Sedlmayr JC, 2002, ANAT RECORD, V267, P330, DOI 10.1002/ar.10133; SUCKLING JA, 1969, NATURE, V221, P379, DOI 10.1038/221379a0; TAYEB M. A. F., 1951, BRIT VET JOUR, V107, P147; Villavicencio AT, 2005, J SPINAL DISORD TECH, V18, P369, DOI 10.1097/01.bsd.0000168511.67189.64; Wible J.R., 1986, Journal of Vertebrate Paleontology, V6, P313; Wible JR, 1984, THESIS DUKE U; Wible JR, 1983, PALAEONTOL POLON, V28, P281; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; You BM, 2001, IEEE T MED IMAGING, V20, P514, DOI 10.1109/42.929617; Zangerl R, 1989, PALEOTECHNIQUES SPEC, P156	39	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97940	10.1371/journal.pone.0097940	http://dx.doi.org/10.1371/journal.pone.0097940			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835249	Green Published, gold, Green Submitted			2022-12-27	WOS:000339614800088
J	Rubinstein, NJ; Anderson, AJ; Ma-Wyatt, A; Walland, MJ; McKendrick, AM				Rubinstein, Nikki J.; Anderson, Andrew J.; Ma-Wyatt, Anna; Walland, Mark J.; McKendrick, Allison M.			The Effects of Ageing and Visual Field Loss on Pointing to Visual Targets	PLOS ONE			English	Article							FEEDBACK-CONTROL; GLAUCOMA; EYE; INFORMATION; ECCENTRICITY; LOCALIZATION; IMPAIRMENT; PRECISION; MOVEMENTS; VERNIER	Purpose: To investigate the effect of ageing on visuomotor function and subsequently evaluate the effect of visual field loss on such function in older adults. Methods: Two experiments were performed: 1) to determine the effect of ageing on visual localisation and subsequent pointing precision, and 2) to determine the effect of visual field loss on these outcome measures. For Experiment 1, we measured visual localisation and pointing precision radially at visual eccentricities of 5, 10 and 15 degrees in 25 older (60-72 years) and 25 younger (20-31 years) adults. In the pointing task, participants were asked to point to a target on a touchscreen at a natural pace that prioritised accuracy of the touch. In Experiment 2, a subset of these tasks were performed at 15 degrees eccentricity under both monocular and binocular conditions, by 8 glaucoma (55-76 years) and 10 approximately age-matched controls (61-72 years). Results: Visual localisation and pointing precision was unaffected by ageing (p>0.05) and visual field loss (p>0.05), although movement time was increased in glaucoma (p = 0.01). Conclusion: Visual localisation and pointing precision to high contrast stimuli within the central 15 degrees of vision are unaffected by ageing. Even in the presence of significant visual field loss, older adults with glaucoma are able perform such tasks with reasonable precision provided the target can be perceived and movement time is not restricted.	[Rubinstein, Nikki J.; Anderson, Andrew J.; McKendrick, Allison M.] Univ Melbourne, Dept Optometry & Vis Sci, Parkville, Vic 3052, Australia; [Ma-Wyatt, Anna] Univ Adelaide, Sch Psychol, Adelaide, SA, Australia; [Walland, Mark J.] Victoria Parade Eye Consultants, Fitzroy, Vic, Australia	University of Melbourne; University of Adelaide	McKendrick, AM (corresponding author), Univ Melbourne, Dept Optometry & Vis Sci, Parkville, Vic 3052, Australia.	allisonm@unimelb.edu.au	McKendrick, Allison M/A-2114-2008	McKendrick, Allison/0000-0003-1972-1222; Anderson, Andrew/0000-0001-7015-0061	Australian Research Council Future Fellowship [ARC FT0990930, ARC FT120100407]	Australian Research Council Future Fellowship(Australian Research Council)	Funded by Australian Research Council Future Fellowship to author AMM (ARC FT0990930) and AJA (ARC FT120100407), http://www.arc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM JJ, 1993, ACTA PSYCHOL, V84, P135, DOI 10.1016/0001-6918(93)90024-L; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Coats RO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047222; Coats RO, 2011, EXP BRAIN RES, V214, P139, DOI 10.1007/s00221-011-2813-x; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Folstein MF., 2000, MINIMENTAL STATE EXA; Garcia-Suarez L, 2004, VISION RES, V44, P1039, DOI 10.1016/j.visres.2003.11.018; Gegenfurtner KR, 2007, J VISION, V7, DOI 10.1167/7.5.11; HALLETT PE, 1976, VISION RES, V16, P107, DOI 10.1016/0042-6989(76)90084-5; Hardy LH., 1937, AM ACAD OPHTHALMOL O, V30, P491; Hood DC, 2007, PROG RETIN EYE RES, V26, P688, DOI 10.1016/j.preteyeres.2007.08.001; KALESNYKAS RP, 1994, VISION RES, V34, P517, DOI 10.1016/0042-6989(94)90165-1; Kotecha A, 2009, INVEST OPHTH VIS SCI, V50, P203, DOI 10.1167/iovs.08-2496; Latham K, 1998, CURR EYE RES, V17, P1010, DOI 10.1076/ceyr.17.10.1010.5237; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; Li RW-H, 2003, J VIS, V3, P353; Ma-Wyatt A, 2007, EXP BRAIN RES, V179, P55, DOI 10.1007/s00221-006-0767-1; Ma-Wyatt A, 2006, VISION RES, V46, P4675, DOI 10.1016/j.visres.2006.08.009; McKendrick AM, 2002, INVEST OPHTH VIS SCI, V43, P1393; Nelson-Quigg JM, 2000, INVEST OPHTH VIS SCI, V41, P2212; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PROTEAU L, 1994, J GERONTOL, V49, pP100, DOI 10.1093/geronj/49.3.P100; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rand MK, 2011, BEHAV BRAIN RES, V219, P39, DOI 10.1016/j.bbr.2010.12.008; Rossit S, 2008, EXP BRAIN RES, V185, P1, DOI 10.1007/s00221-007-1126-6; Sarlegna FR, 2006, NEUROSCI LETT, V403, P309, DOI 10.1016/j.neulet.2006.05.003; Seidler-Dobrin RD, 1998, EXP BRAIN RES, V119, P467, DOI 10.1007/s002210050362; Simmerman J S, 1984, J Am Optom Assoc, V55, P50; Verrel J, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.07.006; WARABI T, 1986, EXP NEUROL, V92, P686, DOI 10.1016/0014-4886(86)90309-2; Wensor MD, 1998, OPHTHALMOLOGY, V105, P733, DOI 10.1016/S0161-6420(98)94031-3; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wiecek E, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00472	34	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97190	10.1371/journal.pone.0097190	http://dx.doi.org/10.1371/journal.pone.0097190			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1NZ	24836047	Green Submitted, gold, Green Published			2022-12-27	WOS:000339614800030
J	Alsiary, R; Bruning-Richardson, A; Bond, J; Morrison, EE; Wilkinson, N; Bell, SM				Alsiary, Rawiah; Bruening-Richardson, Anke; Bond, Jacquelyn; Morrison, Ewan E.; Wilkinson, Nafisa; Bell, Sandra M.			Deregulation of Microcephalin and ASPM Expression Are Correlated with Epithelial Ovarian Cancer Progression	PLOS ONE			English	Article							ABNORMAL SPINDLE-LIKE; CENTROSOMAL PROTEIN; CELL PROLIFERATION; MUTATIONS; GENE; ENCODES; PATHWAY; BIOLOGY; KINASE; RING	Mutations in the MCPH1 (Microcephalin) and ASPM (abnormal spindle-like microcephaly associated) genes cause primary microcephaly. Both are centrosomal associated proteins involved in mitosis. Microcephalin plays an important role in DNA damage response and ASPM is required for correct division of proliferative neuro-epithelial cells of the developing brain. Reduced MCPH1 mRNA expression and ASPM mRNA over-expression have been implicated in the development of human carcinomas. Epithelial ovarian cancer (EOC) is characterised by highly aneuploid tumours. Previously we have reported low Microcephalin and high ASPM protein levels and associations with clinico-pathological parameters in malignant cells from ascitic fluids. To confirm these previous findings on a larger scale Microcephalin and ASPM expression levels and localisations were evaluated by immunohistochemistry in two cohorts; a training set of 25 samples and a validation set of 322 EOC tissue samples. Results were correlated to the associated histopathological data. In normal ovarian tissues the Microcephalin nuclear staining pattern was consistently strong. In the cancer tissues, we identified low nuclear Microcephalin expression in high grade and advanced stage tumours (p<0.0001 and p = 0.0438 respectively). ASPM had moderate to high nuclear and low to moderate cytoplasmic expression in normal tissue. Cytoplasmic ASPM expression decreased with tumour grade and stage in the serous subtype of EOC (p = 0.023 and p = 0.011 respectively). Cytoplasmic ASPM increased with tumour stage in the endometrioid subtype (p = 0.023). Increasing tumour invasiveness (T3) and lymph node involvement (N1) also correlated with a decrease in cytoplasmic ASPM in EOC (p = 0.02 and p = 0.04 respectively). We have validated previous findings of deregulated expression of Microcephalin and ASPM in EOC by confirming associations for low nuclear Microcephalin levels and high cytoplasmic ASPM levels in a larger scale tumour tissue study. Microcephalin and ASPM may prove useful biomarkers in EOC.	[Alsiary, Rawiah; Bond, Jacquelyn; Morrison, Ewan E.; Bell, Sandra M.] Univ Leeds, Leeds Inst Biomed & Clin Sci, Leeds, W Yorkshire, England; [Bruening-Richardson, Anke] Univ Leeds, Leeds Inst Canc & Pathol, Leeds, W Yorkshire, England; [Wilkinson, Nafisa] Leeds Teaching Hosp NHS Trust, St Jamess Inst Oncol, Leeds, W Yorkshire, England	University of Leeds; University of Leeds; Saint James's University Hospital; University of Leeds	Bell, SM (corresponding author), Univ Leeds, Leeds Inst Biomed & Clin Sci, Leeds, W Yorkshire, England.	medsmb@leeds.ac.uk		Bruning-Richardson, Anke/0000-0002-9862-9805; Bell, Sandra/0000-0002-3022-9864	Yorkshire Cancer Research [L328]; University of Leeds; Saudi Arabian Ministry of Higher Education; Wellbeing of Women	Yorkshire Cancer Research; University of Leeds; Saudi Arabian Ministry of Higher Education; Wellbeing of Women(Wellbeing of Women (WoW))	This work and Dr. Bruning-Richardson were funded by Yorkshire Cancer Research [L328] to Drs Morrison, Bond and Bell. The University of Leeds supports Dr. Bell, Dr Bond and Dr. Morrison. Dr. Alsiary by a scholarship from the Saudi Arabian Ministry of Higher Education, Dr. Wilkinson by Leeds Teaching Hospitals NHS Trust. Dr. Wilkinson holds funding from Wellbeing of Women. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Rehim DM, 2005, INT J CANCER, V116, P340, DOI 10.1002/ijc.21004; Aicardi J, 1998, DIS NERVOUS SYSTEM C, P90; ALLRED DC, 1993, J NATL CANCER I, V85, P200, DOI 10.1093/jnci/85.3.200; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Avides MD, 2001, NAT CELL BIOL, V3, P421, DOI 10.1038/35070110; Bhattacharya N, 2013, ANN SURG ONCOL, V20, pS424, DOI 10.1245/s10434-012-2715-6; Bikeye SNN, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-1; Bond J, 2006, CURR OPIN CELL BIOL, V18, P95, DOI 10.1016/j.ceb.2005.11.004; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Bremnes RM, 2002, J CLIN ONCOL, V20, P2417, DOI 10.1200/JCO.2002.08.159; Bruning-Richardson A, 2011, BRIT J CANCER, V104, P1602, DOI 10.1038/bjc.2011.117; Despierre E, 2010, GYNECOL ONCOL, V117, P358, DOI 10.1016/j.ygyno.2010.02.012; Drozdov I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035510; Ferlay J, 2008, CANC INCIDENCE MORTA; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; Gavvovidis I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040387; Genin A, 2012, HUM MOL GENET, V21, P5306, DOI 10.1093/hmg/dds386; Guernsey DL, 2010, AM J HUM GENET, V87, P40, DOI 10.1016/j.ajhg.2010.06.003; Hagemann C, 2008, ONCOL REP, V20, P301, DOI 10.3892/or_00000007; Hermanek P, 2001, CME J GYNECOLOGIC ON, V2, P267; Higgins J, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-85; Hussain MS, 2012, AM J HUM GENET, V90, P871, DOI 10.1016/j.ajhg.2012.03.016; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Jo YH, 2013, GENE, V517, P184, DOI 10.1016/j.gene.2012.12.088; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Kouprina N, 2005, HUM MOL GENET, V14, P2155, DOI 10.1093/hmg/ddi220; Kumar A, 2009, AM J HUM GENET, V84, P286, DOI 10.1016/j.ajhg.2009.01.017; Lin SY, 2005, P NATL ACAD SCI USA, V102, P15105, DOI 10.1073/pnas.0507722102; Lin SY, 2003, CELL, V113, P881, DOI 10.1016/S0092-8674(03)00430-6; Nicholas AK, 2010, NAT GENET, V42, P1010, DOI 10.1038/ng.682; Paramasivam M, 2007, CELL CYCLE, V6, P1605, DOI 10.4161/cc.6.13.4356; Peyre M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012932; Ponting CP, 2006, BIOINFORMATICS, V22, P1031, DOI 10.1093/bioinformatics/btl022; Rai R, 2006, CANCER CELL, V10, P145, DOI 10.1016/j.ccr.2006.07.002; Rhoads A, 2005, ETHN DIS S5, V15; Richardson J, 2011, BREAST CANCER RES TR, V127, P639, DOI 10.1007/s10549-010-1019-4; Rodriguez JA, 2004, EXP CELL RES, V293, P14, DOI 10.1016/j.yexcr.2003.09.027; Sir JH, 2011, NAT GENET, V43, P1147, DOI 10.1038/ng.971; Trimborn M, 2004, AM J HUM GENET, V75, P261, DOI 10.1086/422855; Venkatesh T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054643; Wang WY, 2013, GASTROENTEROLOGY, V145, P1110, DOI 10.1053/j.gastro.2013.07.040; Wu XL, 2009, CANCER RES, V69, P5531, DOI 10.1158/0008-5472.CAN-08-4834; Zhong XY, 2005, CELL CYCLE, V4, P1227, DOI 10.4161/cc.4.9.2029	44	25	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97059	10.1371/journal.pone.0097059	http://dx.doi.org/10.1371/journal.pone.0097059			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830737	Green Published, Green Submitted, gold			2022-12-27	WOS:000336789500032
J	Kerr, KA; Christy, JH; Joly-Lopez, Z; Luque, J; Collin, R; Guichard, F				Kerr, Kecia A.; Christy, John H.; Joly-Lopez, Zoe; Luque, Javier; Collin, Rachel; Guichard, Frederic			Reproducing on Time When Temperature Varies: Shifts in the Timing of Courtship by Fiddler Crabs	PLOS ONE			English	Article							CLIMATE-CHANGE; ADAPTIVE SIGNIFICANCE; BEHAVIORAL THERMOREGULATION; WARMING WORLD; UCA; PHENOLOGY; CYCLES; RESPONSES; PATTERNS; RELEASE	Many species reproduce when conditions are most favorable for the survival of young. Numerous intertidal fish and invertebrates release eggs or larvae during semilunar, large amplitude, nocturnal tides when these early life stages are best able to escape predation by fish that feed near the shore during the day. Remarkably, some species, including the fiddler crabs Uca terpsichores and Uca deichmanni, maintain this timing throughout the year as temperature, and thus the rate of embryonic development, vary. The mechanisms that allow such precision in the timing of the production of young are poorly known. A preliminary study suggested that when temperature decreases, U. terpsichores mate earlier in the tidal amplitude cycle such that larvae are released at the appropriate time. We tested this idea by studying the timing of courtship in U. terpsichores and U. deichmanni as temperature varied annually during two years, at 5 locations that differed in the temperature of the sediment where females incubate their eggs. Uca terpsichores courted earlier at locations where sediment temperature declined seasonally but not where sediment temperature remained elevated throughout the year. In contrast, clear shifts in courtship timing were not observed for U. deichmanni despite variation in sediment temperature. We discuss other mechanisms by which this species may maintain reproductive timing. These two species are likely to be affected differently by changes in the frequency and intensity of cold periods that are expected to accompany climate change.	[Kerr, Kecia A.; Joly-Lopez, Zoe; Guichard, Frederic] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Kerr, Kecia A.; Christy, John H.; Luque, Javier; Collin, Rachel] Smithsonian Trop Res Inst, Panama City, Panama; [Kerr, Kecia A.; Collin, Rachel; Guichard, Frederic] McGill Univ, McGill STRI Neotrop Environm Opt NEO, Montreal, PQ, Canada; [Luque, Javier] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	McGill University; Smithsonian Institution; Smithsonian Tropical Research Institute; McGill University; University of Alberta	Kerr, KA (corresponding author), Smithsonian Trop Res Inst, Panama City, Panama.	kecia.kerr@mail.mcgill.ca	Collin, Rachel/Q-7100-2019; Guichard, Frederic/B-6188-2015; Collin, Rachel/G-2001-2010	Collin, Rachel/0000-0001-5103-4460; Guichard, Frederic/0000-0002-7369-482X; Luque, Javier/0000-0002-4391-5951	Society of Integrative and Comparative Biology; McGill Neotropical Environment Option; Natural Sciences and Engineering Research Council of Canada; Quebec- Ocean	Society of Integrative and Comparative Biology; McGill Neotropical Environment Option; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Quebec- Ocean	This work was funded by a Society of Integrative and Comparative Biology Grant-in-Aid of Research to K. K.; a McGill Neotropical Environment Option Grant-in-Aid of Research to K.K.; the Natural Sciences and Engineering Research Council of Canada (Research grant to F.G. and PGSD to K.K.); and Quebec- Ocean funding of F.G. and K.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asoh K, 2002, ENVIRON BIOL FISH, V64, P379, DOI 10.1023/A:1016177512353; BAKUN A, 1990, SCIENCE, V247, P198, DOI 10.1126/science.247.4939.198; Bertram DF, 2001, PROG OCEANOGR, V49, P283, DOI 10.1016/S0079-6611(01)00027-1; Both C, 2009, J ANIM ECOL, V78, P73, DOI 10.1111/j.1365-2656.2008.01458.x; BROWN SK, 1985, J EXP MAR BIOL ECOL, V90, P27, DOI 10.1016/0022-0981(85)90072-3; Burgess SC, 2011, J EXP BIOL, V214, P2329, DOI 10.1242/jeb.054718; Cazelles B, 2008, OECOLOGIA, V156, P287, DOI 10.1007/s00442-008-0993-2; Chapperon C, 2011, FUNCT ECOL, V25, P1040, DOI 10.1111/j.1365-2435.2011.01859.x; Chapperon C, 2011, GLOBAL CHANGE BIOL, V17, P1740, DOI 10.1111/j.1365-2486.2010.02356.x; Christopher CE, 2008, J CRUSTACEAN BIOL, V28, P328, DOI 10.1651/0278-0372(2008)028[0328:ITHCOF]2.0.CO;2; Christy JH, 2003, REV CHIL HIST NAT, V76, P177; CHRISTY JH, 1982, BIOL BULL, V163, P251, DOI 10.2307/1541264; CHRISTY JH, 1978, SCIENCE, V199, P453, DOI 10.1126/science.199.4327.453; Christy JH, 2002, BEHAV ECOL, V13, P366, DOI 10.1093/beheco/13.3.366; Christy JH, 2001, BEHAVIOUR, V138, P1065, DOI 10.1163/156853901753287145; Christy JH, 2011, INTEGR COMP BIOL, V51, P62, DOI 10.1093/icb/icr013; D'Croz L, 2007, ESTUAR COAST SHELF S, V73, P325, DOI 10.1016/j.ecss.2007.01.013; Dale RK, 2007, ESTUAR COAST SHELF S, V72, P283, DOI 10.1016/j.ecss.2006.10.024; Danilowicz BS, 1995, B MAR SCI, V57, P624; Derivera CE, 2005, ANIM BEHAV, V70, P289, DOI 10.1016/j.anbehav.2004.10.027; Doi H, 2008, CLIM RES, V36, P181, DOI 10.3354/cr00741; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; FOSTER SA, 1987, MAR BIOL, V95, P333, DOI 10.1007/BF00409563; Garcia-Reyes M, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005576; Georges A, 2005, PHYSIOL BIOCHEM ZOOL, V78, P18, DOI 10.1086/425200; Ghalambor Cameron K., 2010, P90; Gimenez L, 2011, J EXP MAR BIOL ECOL, V400, P227, DOI 10.1016/j.jembe.2011.02.036; Gouhier TC, 2013, CONDUCT UNIVARIATE B; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Hodgson JA, 2011, GLOBAL CHANGE BIOL, V17, P1289, DOI 10.1111/j.1365-2486.2010.02308.x; Iles AC, 2012, GLOBAL CHANGE BIOL, V18, P783, DOI 10.1111/j.1365-2486.2011.02567.x; JOHNSON RALPH GORDON, 1965, LIMNOL OCEANOGR, V10, P114; Kahn AT, 2013, BEHAV ECOL, V24, P906, DOI 10.1093/beheco/art017; Kearney M, 2009, P NATL ACAD SCI USA, V106, P3835, DOI 10.1073/pnas.0808913106; Kellmeyer K, 2001, J EXP MAR BIOL ECOL, V260, P169, DOI 10.1016/S0022-0981(01)00259-3; Kerr KA, 2014, MAR ECOL PROG SER, V503, P99, DOI 10.3354/meps10735; Kerr KA, 2012, MAR ECOL PROG SER, V459, P1, DOI 10.3354/meps09832; Kokita T, 2000, MAR ECOL PROG SER, V199, P263, DOI 10.3354/meps199263; Kordas RL, 2011, J EXP MAR BIOL ECOL, V400, P218, DOI 10.1016/j.jembe.2011.02.029; Les HL, 2009, PHYSIOL BIOCHEM ZOOL, V82, P105, DOI 10.1086/590263; McNamara JM, 2008, PHILOS T R SOC B, V363, P301, DOI 10.1098/rstb.2007.2141; Milner RNC, 2010, BEHAV ECOL, V21, P311, DOI 10.1093/beheco/arp196; Morgan SG, 1996, MAR ECOL PROG SER, V139, P105, DOI 10.3354/meps139105; Morgan SG, 2011, MAR ECOL PROG SER, V425, P103, DOI 10.3354/meps08969; Murai M, 2005, ANIM BEHAV, V70, P1093, DOI 10.1016/j.anbehav.2005.02.019; Nakasone Y, 1998, J CRUSTACEAN BIOL, V18, P70, DOI 10.2307/1549522; Narayan N, 2010, OCEAN SCI, V6, P815, DOI 10.5194/os-6-815-2010; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; PERRINS CM, 1970, IBIS, V112, P242, DOI 10.1111/j.1474-919X.1970.tb00096.x; PICCOLO MC, 1993, ESTUAR COAST SHELF S, V36, P345, DOI 10.1006/ecss.1993.1021; Pike DA, 2012, FUNCT ECOL, V26, P469, DOI 10.1111/j.1365-2435.2011.01946.x; Pincebourde S, 2009, AM NAT, V174, P890, DOI 10.1086/648065; Primack RB, 2009, BIOL CONSERV, V142, P2569, DOI 10.1016/j.biocon.2009.06.003; R Core Development Team, 2011, R LANG ENV STAT COMP; Raffel TR, 2013, NAT CLIM CHANGE, V3, P146, DOI [10.1038/nclimate1659, 10.1038/NCLIMATE1659]; Reaney LT, 2007, BEHAV ECOL SOCIOBIOL, V61, P1515, DOI 10.1007/s00265-007-0383-5; Richardson AJ, 2008, ICES J MAR SCI, V65, P279, DOI 10.1093/icesjms/fsn028; Rombough PJ, 1996, GLOBAL WARMING IMPLI, P177; Schmidt AJ, 2012, ANIM BEHAV, V84, P333, DOI 10.1016/j.anbehav.2012.04.023; Shine R, 2008, PHILOS T R SOC B, V363, P363, DOI 10.1098/rstb.2007.2144; Skov MW, 2005, ECOLOGY, V86, P1164, DOI 10.1890/04-0917; SMITH WK, 1973, PHYSIOL ZOOL, V46, P186, DOI 10.1086/physzool.46.3.30155601; Snyder MA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017647; Thurman CL, 2004, BIOL RHYTHM RES, V35, P43, DOI 10.1080/09291010412331313232; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; van Asch M, 2007, ANNU REV ENTOMOL, V52, P37, DOI 10.1146/annurev.ento.52.110405.091418; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Visser ME, 2006, OECOLOGIA, V147, P164, DOI 10.1007/s00442-005-0299-6; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WEAR RG, 1974, J MAR BIOL ASSOC UK, V54, P745, DOI 10.1017/S0025315400022918; Weaver A, 2002, J CRUSTACEAN BIOL, V22, P429, DOI 10.1651/0278-0372(2002)022[0429:HROUTE]2.0.CO;2; WILSON K, 1983, ESTUAR COAST SHELF S, V17, P581, DOI 10.1016/0272-7714(83)90010-0; Windsor A, 2005, J THERM BIOL, V30, P37, DOI 10.1016/j.jtherbio.2004.06.006; Yamahira K, 1997, MAR ECOL PROG SER, V155, P239, DOI 10.3354/meps155239; ZUCKER N, 1983, MAR BEHAV PHYSIOL, V10, P57, DOI 10.1080/10236248309378606; ZUCKER N, 1974, AM MIDL NAT, V91, P224, DOI 10.2307/2424524; ZUCKER N, 1978, BIOL BULL, V155, P410, DOI 10.2307/1540961	79	19	19	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97593	10.1371/journal.pone.0097593	http://dx.doi.org/10.1371/journal.pone.0097593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24832079	Green Published, gold, Green Submitted			2022-12-27	WOS:000336789500083
J	Rong, WN; Chen, X; Zhao, KX; Liu, YN; Liu, XX; Ha, SP; Liu, WZ; Kang, XL; Sheng, XL; Zhao, C				Rong, Weining; Chen, Xue; Zhao, Kanxing; Liu, Yani; Liu, Xiaoxing; Ha, Shaoping; Liu, Wenzhou; Kang, Xiaoli; Sheng, Xunlun; Zhao, Chen			Novel and Recurrent MYO7A Mutations in Usher Syndrome Type 1 and Type 2	PLOS ONE			English	Article							MYOSIN-VIIA GENE; SYNDROME-TYPE-II; RETINITIS-PIGMENTOSA; READ ALIGNMENT; MOTOR DOMAIN; LONG ISOFORM; SYNDROME 1B; DEAFNESS; PROTEIN; PRODUCT	Usher syndrome (USH) is a group of disorders manifested as retinitis pigmentosa and bilateral sensorineural hearing loss, with or without vestibular dysfunction. Here, we recruited three Chinese families affected with autosomal recessive USH for detailed clinical evaluations and for mutation screening in the genes associated with inherited retinal diseases. Using targeted next-generation sequencing (NGS) approach, three new alleles and one known mutation in MYO7A gene were identified in the three families. In two families with USH type 1, novel homozygous frameshift variant p.Pro194Hisfs*13 and recurrent missense variant p. Thr165Met were demonstrated as the causative mutations respectively. Crystal structural analysis denoted that p.Thr165Met would very likely change the tertiary structure of the protein encoded by MYO7A. In another family affected with USH type 2, novel biallelic mutations in MYO7A, c.[1343+1G>A];[2837T>G] or p.[?];[Met946Arg], were identified with clinical significance. Because MYO7A, to our knowledge, has rarely been correlated with USH type 2, our findings therefore reveal distinguished clinical phenotypes associated with MYO7A. We also conclude that targeted NGS is an effective approach for genetic diagnosis for USH, which can further provide better understanding of genotype-phenotype relationship of the disease.	[Rong, Weining; Liu, Yani; Ha, Shaoping; Liu, Wenzhou; Sheng, Xunlun] Ningxia Peoples Hosp, Ningxia Eye Hosp, Ningxia, Peoples R China; [Chen, Xue; Liu, Xiaoxing; Zhao, Chen] Nanjing Med Univ, Dept Ophthalmol, State Key Lab Reprod Med, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Chen, Xue] Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Hong Kong, Hong Kong, Peoples R China; [Zhao, Kanxing] Tianjin Med Univ, Tianjin Eye Hosp, Tianjin Key Lab Ophthalmol & Visual Sci, Tianjin, Peoples R China; [Kang, Xiaoli] Shanghai Jiao Tong Univ, Dept Ophthalmol, Xinhua Hosp, Sch Med, Shanghai 200030, Peoples R China; [Zhao, Chen] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China	Nanjing Medical University; Chinese University of Hong Kong; Tianjin Medical University; Shanghai Jiao Tong University; Sun Yat Sen University	Sheng, XL (corresponding author), Ningxia Peoples Hosp, Ningxia Eye Hosp, Ningxia, Peoples R China.	shengxunlun@163.com; dr.zhaochen@gmail.com			National Key Basic Research Program of China (973 Program) [2013CB967500]; National Natural Science Foundation of China [81222009, 81170856, 81160124, 81260154, 81170867]; Thousand Youth Talents Program of China; Jiangsu Outstanding Young Investigator Program [BK2012046]; Jiangsu Province's Key Provincial Talents Program [RC201149]; Fundamental Research Funds of the State Key Laboratory of Ophthalmology; Jiangsu Province's Scientific Research Innovation Program for Postgraduates [CXZZ13_05]; Applied Research Program of the Science and Technology Commission Foundation of Tianjin [013111411]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Thousand Youth Talents Program of China; Jiangsu Outstanding Young Investigator Program; Jiangsu Province's Key Provincial Talents Program; Fundamental Research Funds of the State Key Laboratory of Ophthalmology; Jiangsu Province's Scientific Research Innovation Program for Postgraduates; Applied Research Program of the Science and Technology Commission Foundation of Tianjin; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by National Key Basic Research Program of China (973 Program, 2013CB967500); National Natural Science Foundation of China (81222009, 81170856, 81160124, 81260154, and 81170867); Thousand Youth Talents Program of China (to CZ); Jiangsu Outstanding Young Investigator Program (BK2012046); Jiangsu Province's Key Provincial Talents Program (RC201149); the Fundamental Research Funds of the State Key Laboratory of Ophthalmology (to CZ); Jiangsu Province's Scientific Research Innovation Program for Postgraduates (CXZZ13_05 to XC); Applied Research Program of the Science and Technology Commission Foundation of Tianjin (013111411 to KZ); and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Aller E, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041764; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bharadwaj AK, 2000, EXP EYE RES, V71, P173, DOI 10.1006/exer.2000.0863; Bitner-Glindzicz M, 2000, NAT GENET, V26, P56, DOI 10.1038/79178; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; Bonnet C, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-21; BOUGHMAN JA, 1983, J CHRON DIS, V36, P595, DOI 10.1016/0021-9681(83)90147-9; Chen X, 2014, HUM MOL GENET; Chen XJ, 2013, INVEST OPHTH VIS SCI, V54, P2186, DOI 10.1167/iovs.12-10967; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; DAHL SP, 1993, J MED GENET, V30, P843, DOI 10.1136/jmg.30.10.843; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Eudy JD, 1998, SCIENCE, V280, P1753, DOI 10.1126/science.280.5370.1753; Friedman TB, 2011, ADV OTO-RHINO-LARYNG, V70, P56, DOI 10.1159/000322473; Frio TR, 2008, J CLIN INVEST, V118, P1519, DOI 10.1172/JCI34211; Gibbs D, 2004, J CELL SCI, V117, P6473, DOI 10.1242/jcs.01580; Gibbs D, 2003, P NATL ACAD SCI USA, V100, P6481, DOI 10.1073/pnas.1130432100; Gibbs D, 2010, INVEST OPHTH VIS SCI, V51, P1130, DOI 10.1167/iovs.09-4032; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; Hope CI, 1997, BRIT J OPHTHALMOL, V81, P46, DOI 10.1136/bjo.81.1.46; Jaijo T, 2006, Hum Mutat, V27, P290, DOI 10.1002/humu.9404; Jaijo T, 2011, CLIN GENET, V79, P282, DOI 10.1111/j.1399-0004.2010.01454.x; Joensuu T, 2001, AM J HUM GENET, V69, P673, DOI 10.1086/323610; Kambara T, 1999, J BIOL CHEM, V274, P16400, DOI 10.1074/jbc.274.23.16400; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kimberling WJ, 2010, GENET MED, V12, P512, DOI 10.1097/GIM.0b013e3181e5afb8; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu F, 2013, MOL VIS, V19, P695; Liu X, 2001, EXP EYE RES, V72, P351, DOI 10.1006/exer.2000.0963; Liu XR, 1999, J NEUROSCI, V19, P6267; Liu XR, 1997, CELL MOTIL CYTOSKEL, V37, P240, DOI 10.1002/(SICI)1097-0169(1997)37:3<240::AID-CM6>3.3.CO;2-2; Liu XR, 1998, NAT GENET, V19, P117, DOI 10.1038/470; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Liu XZ, 1998, AM J HUM GENET, V63, P909, DOI 10.1086/302026; Liu XZ, 1997, NAT GENET, V17, P268, DOI 10.1038/ng1197-268; Mburu P, 2003, NAT GENET, V34, P421, DOI 10.1038/ng1208; Millan JM, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/417217; Oshima A, 2008, Hum Mutat, V29, pE37, DOI 10.1002/humu.20761; Ouyang XM, 2005, HUM GENET, V116, P292, DOI 10.1007/s00439-004-1227-2; Riazuddin S, 2008, HUM MUTAT, V29, P502, DOI 10.1002/humu.20677; Riazuddin S, 2012, NAT GENET, V44, P1265, DOI 10.1038/ng.2426; Roux AF, 2006, J MED GENET, V43, P763, DOI 10.1136/jmg.2006.041954; Saihan Z, 2009, CURR OPIN NEUROL, V22, P19, DOI 10.1097/WCO.0b013e3283218807; Schneider E, 2009, HUM MOL GENET, V18, P655, DOI 10.1093/hmg/ddn395; Wang X, 2011, HUM MUTAT, V32, P1450, DOI 10.1002/humu.21587; Weil D, 2003, HUM MOL GENET, V12, P463, DOI 10.1093/hmg/ddg051; Weil D, 1997, NAT GENET, V16, P191, DOI 10.1038/ng0697-191; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Weston MD, 2004, AM J HUM GENET, V74, P357, DOI 10.1086/381685; Williams DS, 2008, VISION RES, V48, P433, DOI 10.1016/j.visres.2007.08.015; Williams DS, 2011, BIOCHEM SOC T, V39, P1207, DOI 10.1042/BST0391207; Wolfrum U, 2003, ADV EXP MED BIOL, V533, P133; Yan D, 2010, J HUM GENET, V55, P327, DOI 10.1038/jhg.2010.29; Yan D, 2009, J HUM GENET, V54, P732, DOI 10.1038/jhg.2009.107; Yoshimura H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090688; Zhang X, 2013, EYE, V27, P1204, DOI 10.1038/eye.2013.137; Zhao C, 2006, HUM GENET, V119, P617, DOI 10.1007/s00439-006-0168-3	60	32	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97808	10.1371/journal.pone.0097808	http://dx.doi.org/10.1371/journal.pone.0097808			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831256	gold, Green Published, Green Submitted			2022-12-27	WOS:000336789500118
J	Sarvari, M; Kocsis, P; Deli, L; Gajari, D; David, S; Pozsgay, Z; Hegedus, N; Tihanyi, K; Liposits, Z				Sarvari, Miklos; Kocsis, Pal; Deli, Levente; Gajari, David; David, Szabolcs; Pozsgay, Zsofia; Hegedus, Nikolett; Tihanyi, Karoly; Liposits, Zsolt			Ghrelin Modulates the fMRI BOLD Response of Homeostatic and Hedonic Brain Centers Regulating Energy Balance in the Rat	PLOS ONE			English	Article							HORMONE SECRETAGOGUE-RECEPTOR; VENTRAL TEGMENTAL AREA; GROWTH-HORMONE; MESSENGER-RNA; ENDOCANNABINOID SYSTEM; NUCLEUS-ACCUMBENS; FEMALE RATS; GHS-R; REWARD; HYPOTHALAMUS	The orexigenic gut-brain peptide, ghrelin and its G-protein coupled receptor, the growth hormone secretagogue receptor 1a (GHS-R1A) are pivotal regulators of hypothalamic feeding centers and reward processing neuronal circuits of the brain. These systems operate in a cooperative manner and receive a wide array of neuronal hormone/transmitter messages and metabolic signals. Functional magnetic resonance imaging was employed in the current study to map BOLD responses to ghrelin in different brain regions with special reference on homeostatic and hedonic regulatory centers of energy balance. Experimental groups involved male, ovariectomized female and ovariectomized estradiol-replaced rats. Putative modulation of ghrelin signaling by endocannabinoids was also studied. Ghrelin-evoked effects were calculated as mean of the BOLD responses 30 minutes after administration. In the male rat, ghrelin evoked a slowly decreasing BOLD response in all studied regions of interest (ROI) within the limbic system. This effect was antagonized by pretreatment with GHS-R1A antagonist JMV2959. The comparison of ghrelin effects in the presence or absence of JMV2959 in individual ROIs revealed significant changes in the prefrontal cortex, nucleus accumbens of the telencephalon, and also within hypothalamic centers like the lateral hypothalamus, ventromedial nucleus, paraventricular nucleus and suprachiasmatic nucleus. In the female rat, the ghrelin effects were almost identical to those observed in males. Ovariectomy and chronic estradiol replacement had no effect on the BOLD response. Inhibition of the endocannabinoid signaling by rimonabant significantly attenuated the response of the nucleus accumbens and septum. In summary, ghrelin can modulate hypothalamic and mesolimbic structures controlling energy balance in both sexes. The endocannabinoid signaling system contributes to the manifestation of ghrelin's BOLD effect in a region specific manner. In females, the estradiol milieu does not influence the BOLD response to ghrelin.	[Sarvari, Miklos; Liposits, Zsolt] Hungarian Acad Sci, Inst Expt Med, Lab Endocrine Neurobiol, Budapest, Hungary; [Kocsis, Pal; Deli, Levente; Gajari, David; David, Szabolcs; Pozsgay, Zsofia; Hegedus, Nikolett; Tihanyi, Karoly] Gedeon Richter Chem Works Ltd, Preclin Imaging Ctr, Budapest, Hungary; [Liposits, Zsolt] Pazmany Peter Catholic Univ, Fac Informat Technol, Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Gedeon Richter Chemistry Works	Sarvari, M (corresponding author), Hungarian Acad Sci, Inst Expt Med, Lab Endocrine Neurobiol, Budapest, Hungary.	sarvari@koki.hu	David, Szabolcs/A-1628-2018; Liposits, Zsolt/K-8145-2019	David, Szabolcs/0000-0003-0316-3895; Liposits, Zsolt/0000-0002-3508-2750	National Science Foundation of Hungary [OTKA K100722]; National Development Agency of Hungary [NFU-BONUS-HU08/2-2011-0006]; European Community [245009]	National Science Foundation of Hungary; National Development Agency of Hungary; European Community(European Commission)	This research was supported by the National Science Foundation of Hungary (OTKA K100722) and the National Development Agency of Hungary (NFU-BONUS-HU08/2-2011-0006). The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement No. 245009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Andrews ZB, 2011, TRENDS NEUROSCI, V34, P31, DOI 10.1016/j.tins.2010.10.001; Banks WA, 2002, J PHARMACOL EXP THER, V302, P822, DOI 10.1124/jpet.102.034827; Bennett PA, 1997, ENDOCRINOLOGY, V138, P4552, DOI 10.1210/en.138.11.4552; Cano SC, 2012, CNS DRUGS, V26, P281, DOI 10.2165/11599890-000000000-00000; Carlini VP, 2010, PEPTIDES, V31, P1190, DOI 10.1016/j.peptides.2010.02.021; Carlini VP, 2002, BIOCHEM BIOPH RES CO, V299, P739, DOI 10.1016/S0006-291X(02)02740-7; Castaneda TR, 2010, FRONT NEUROENDOCRIN, V31, P44, DOI 10.1016/j.yfrne.2009.10.008; Clegg DJ, 2007, DIABETES, V56, P1051, DOI 10.2337/db06-0015; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Cowley MA, 2003, EUR J PHARMACOL, V480, P3, DOI 10.1016/j.ejphar.2003.08.087; Cummings DE, 2007, ADDICT BIOL, V12, P1, DOI 10.1111/j.1369-1600.2007.00053.x; DAHLSTRO.A, 1964, ACTA PHYSIOL SCAND, V62, P485, DOI 10.1111/j.1748-1716.1964.tb10446.x; Date Y, 2005, ENDOCRINOLOGY, V146, P3518, DOI 10.1210/en.2004-1240; Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656; Dickson SL, 2011, MOL CELL ENDOCRINOL, V340, P80, DOI 10.1016/j.mce.2011.02.017; Egecioglu E, 2010, ADDICT BIOL, V15, P304, DOI 10.1111/j.1369-1600.2010.00216.x; Farkas I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078178; GPaC Watson, 1998, RAT BRAIN STEREOTAXI; Guan XM, 1997, MOL BRAIN RES, V48, P23, DOI 10.1016/S0169-328X(97)00071-5; Hansson C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050409; Harrold JA, 2008, BRAIN RES, V1196, P59, DOI 10.1016/j.brainres.2007.12.055; Helmling S, 2006, DRUG NEWS PERSPECT, V19, P13, DOI 10.1358/dnp.2006.19.1.965870; Horvath TL, 2012, MOL METAB, V1, P79, DOI 10.1016/j.molmet.2012.08.003; Horvath TL, 2003, CURR TOP MED CHEM, V3, P921, DOI 10.2174/1568026033452230; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; Bermudez-Silva FJ, 2012, J PSYCHOPHARMACOL, V26, P114, DOI 10.1177/0269881111408458; Jerlhag E, 2006, ADDICT BIOL, V11, P45, DOI 10.1111/j.1369-1600.2006.00002.x; Jerlhag E, 2010, PSYCHOPHARMACOLOGY, V211, P415, DOI 10.1007/s00213-010-1907-7; Jerlhag E, 2009, P NATL ACAD SCI USA, V106, P11318, DOI 10.1073/pnas.0812809106; Jones RB, 2012, GUT, V61, P1543, DOI 10.1136/gutjnl-2011-301323; Jung KM, 2012, CELL METAB, V15, P299, DOI 10.1016/j.cmet.2012.01.021; Kanoski SE, 2013, BIOL PSYCHIAT, V73, P915, DOI 10.1016/j.biopsych.2012.07.002; Katona I, 2012, ANNU REV NEUROSCI, V35, P529, DOI 10.1146/annurev-neuro-062111-150420; Kocsis P, 2013, BRAIN RES BULL, V99, P34, DOI 10.1016/j.brainresbull.2013.09.008; Kojima M, 2002, CURR OPIN PHARMACOL, V2, P665, DOI 10.1016/S1471-4892(02)00220-5; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; Kojima M, 2013, ENDOCR DEV, V25, P1, DOI 10.1159/000346036; Kola B, 2005, J BIOL CHEM, V280, P25196, DOI 10.1074/jbc.C500175200; Kola B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001797; Kola B, 2006, TRENDS ENDOCRIN MET, V17, P205, DOI 10.1016/j.tem.2006.05.006; Kroemer NB, 2013, ADDICT BIOL, V18, P855, DOI 10.1111/j.1369-1600.2012.00489.x; Kuo YT, 2007, J NEUROSCI, V27, P12341, DOI 10.1523/JNEUROSCI.2391-07.2007; Lage R, 2010, FASEB J, V24, P2670, DOI 10.1096/fj.09-150672; Lopez M, 2008, CELL METAB, V7, P389, DOI 10.1016/j.cmet.2008.03.006; Malik S, 2008, CELL METAB, V7, P400, DOI 10.1016/j.cmet.2008.03.007; Mechoulam R, 2013, ANNU REV PSYCHOL, V64, P21, DOI 10.1146/annurev-psych-113011-143739; Menyhert J, 2006, BRAIN RES, V1125, P31, DOI 10.1016/j.brainres.2006.09.048; Menzies JRW, 2013, ENDOCR DEV, V25, P101, DOI 10.1159/000346058; Mitchell V, 2001, J COMP NEUROL, V429, P469, DOI 10.1002/1096-9861(20010115)429:3<469::AID-CNE8>3.0.CO;2-#; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Naleid AM, 2005, PEPTIDES, V26, P2274, DOI 10.1016/j.peptides.2005.04.025; OADES RD, 1987, BRAIN RES REV, V12, P117, DOI 10.1016/0165-0173(87)90011-7; Olszewski PK, 2003, PEPTIDES, V24, P597, DOI 10.1016/S0196-9781(03)00105-0; Perello M, 2010, BIOL PSYCHIAT, V67, P880, DOI 10.1016/j.biopsych.2009.10.030; Romero-Pico A, 2013, NEUROPSYCHOPHARMACOL, V38, P1296, DOI 10.1038/npp.2013.28; Sarvari M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-82; Seoane LM, 2000, EUR J ENDOCRINOL, V143, pR7, DOI 10.1530/eje.0.143R007; Shuto Y, 2002, J CLIN INVEST, V109, P1429, DOI 10.1172/JCI0213300; Skibicka KP, 2012, ADDICT BIOL, V17, P95, DOI 10.1111/j.1369-1600.2010.00294.x; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Tucci SA, 2004, BRIT J PHARMACOL, V143, P520, DOI 10.1038/sj.bjp.0705968; Tzschentke TM, 2000, CRIT REV NEUROBIOL, V14, P131; van der Lely AJ, 2004, ENDOCR REV, V25, P426, DOI 10.1210/er.2002-0029; Velasquez DA, 2011, DIABETES, V60, P1177, DOI 10.2337/db10-0802; Vengeliene V, 2013, ADDICT BIOL, V18, P897, DOI 10.1111/adb.12114; Wellman PJ, 2008, REGUL PEPTIDES, V146, P33, DOI 10.1016/j.regpep.2007.07.007; Wellman PJ, 2012, ADDICT BIOL, V17, P908, DOI 10.1111/j.1369-1600.2011.00392.x; Willesen MG, 1999, NEUROENDOCRINOLOGY, V70, P306, DOI 10.1159/000054491; Zeltser LM, 2012, NAT NEUROSCI, V15, P1336, DOI 10.1038/nn.3219; Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823; Zigman JM, 2005, J CLIN INVEST, V115, P3564, DOI 10.1172/JCI26002	73	14	14	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97651	10.1371/journal.pone.0097651	http://dx.doi.org/10.1371/journal.pone.0097651			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830778	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000336789500094
J	Werner-Klein, M; Proske, J; Werno, C; Schneider, K; Hofmann, HS; Rack, B; Buchholz, S; Ganzer, R; Blana, A; Seelbach-Gobel, B; Nitsche, U; Mannel, DN; Klein, CA				Werner-Klein, Melanie; Proske, Judith; Werno, Christian; Schneider, Katharina; Hofmann, Hans-Stefan; Rack, Brigitte; Buchholz, Stefan; Ganzer, Roman; Blana, Andreas; Seelbach-Goebel, Birgit; Nitsche, Ulrich; Maennel, Daniela N.; Klein, Christoph A.			Immune Humanization of Immunodeficient Mice Using Diagnostic Bone Marrow Aspirates from Carcinoma Patients	PLOS ONE			English	Article							LYMPHOID-SYSTEM MICE; TUMOR-CELLS; CLINICAL-SIGNIFICANCE; PERIPHERAL-BLOOD; BREAST-CANCER; MODEL	Tumor xenografts in immunodeficient mice, while routinely used in cancer research, preclude studying interactions of immune and cancer cells or, if humanized by allogeneic immune cells, are of limited use for tumor-immunological questions. Here, we explore a novel way to generate cancer models with an autologous humanized immune system. We demonstrate that hematopoietic stem and progenitor cells (HSPCs) from bone marrow aspirates of non-metastasized carcinoma patients, which are taken at specialized centers for diagnostic purposes, can be used to generate a human immune system in NOD-scid IL2r gamma(null) (NSG) and HLA-I expressing NSG mice (NSG-HLA-A2/HHD) comprising both, lymphoid and myeloid cell lineages. Using NSG-HLA-A2/HHD mice, we show that responsive and self-tolerant human T cells develop and human antigen presenting cells can activate human T cells. As critical factors we identified the low potential of bone marrow HSPCs to engraft, generally low HSPC numbers in patient-derived bone marrow samples, cryopreservation and routes of cell administration. We provide here an optimized protocol that uses a minimum number of HSPCs, preselects high-quality bone marrow samples defined by the number of initially isolated leukocytes and intra-femoral or intra-venous injection. In conclusion, the use of diagnostic bone marrow aspirates from non-metastasized carcinoma patients for the immunological humanization of immunodeficient mice is feasible and opens the chance for individualized analyses of anti-tumoral T cell responses.	[Werner-Klein, Melanie; Proske, Judith; Maennel, Daniela N.] Univ Regensburg, Inst Immunol, D-93053 Regensburg, Germany; [Werno, Christian; Klein, Christoph A.] Fraunhofer Inst Toxicol & Expt Med, Project Grp Personalized Tumor Therapy, Regensburg, Germany; [Schneider, Katharina; Klein, Christoph A.] Univ Regensburg, D-93053 Regensburg, Germany; [Hofmann, Hans-Stefan] Univ Regensburg, Dept Thorac Surg, D-93053 Regensburg, Germany; [Rack, Brigitte] Univ Munich, Dept Gynecol & Obstet, Munich, Germany; [Buchholz, Stefan] Univ Med Ctr Regensburg, Dept Gynecol & Obstet, Regensburg, Germany; [Ganzer, Roman] Univ Leipzig, Dept Urol, D-04109 Leipzig, Germany; [Blana, Andreas] Fuerth Hosp, Dept Urol, Furth, Germany; [Seelbach-Goebel, Birgit] Univ Regensburg, Clin Gynecol & Obstet St Hedwig, D-93053 Regensburg, Germany; [Nitsche, Ulrich] Tech Univ Munich, Klinikum Rechts Isar, Dept Surg, D-80290 Munich, Germany	University of Regensburg; Fraunhofer Gesellschaft; University of Regensburg; University of Regensburg; University of Munich; University of Regensburg; Leipzig University; University of Regensburg; Technical University of Munich	Werner-Klein, M (corresponding author), Univ Regensburg, Inst Immunol, D-93053 Regensburg, Germany.	melanie.werner-klein@ukr.de		Klein, Christoph A./0000-0001-7128-1725	Deutsche Forschungsgemeinschaft [WE 4632/1-1]; Dr. Josef Steiner cancer foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Dr. Josef Steiner cancer foundation	The work was supported by the Deutsche Forschungsgemeinschaft (WE 4632/1-1 to MWK) and the Dr. Josef Steiner cancer foundation (to CAK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre MC, 2010, J IMMUNOL, V185, P2710, DOI 10.4049/jimmunol.1000583; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Brehm MA, 2010, CLIN IMMUNOL, V135, P84, DOI 10.1016/j.clim.2009.12.008; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Fehm T, 2006, CANCER-AM CANCER SOC, V107, P885, DOI 10.1002/cncr.22076; Gille C, 2012, HUM IMMUNOL, V73, P346, DOI 10.1016/j.humimm.2012.01.006; Kalscheuer H, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003481; King MA, 2009, CLIN EXP IMMUNOL, V157, P104, DOI 10.1111/j.1365-2249.2009.03933.x; Lepus CM, 2009, HUM IMMUNOL, V70, P790, DOI 10.1016/j.humimm.2009.06.005; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Manz MG, 2007, IMMUNITY, V26, P537, DOI 10.1016/j.immuni.2007.05.001; Matsumura B, 2003, EXP HEMATOL, V31, P789, DOI 10.1016/S0301-472X(03)00193-0; MOSIER DE, 1988, NATURE, V335, P256, DOI 10.1038/335256a0; O'Connell RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012009; Pang WW, 2011, P NATL ACAD SCI USA, V108, P20012, DOI 10.1073/pnas.1116110108; Pierga JY, 2004, CLIN CANCER RES, V10, P1392, DOI 10.1158/1078-0432.CCR-0102-03; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Rongvaux A, 2013, ANNU REV IMMUNOL, V31, P635, DOI 10.1146/annurev-immunol-032712-095921; Scholbach J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046772; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311; Shultz LD, 2010, P NATL ACAD SCI USA, V107, P13022, DOI 10.1073/pnas.1000475107; Ueda T, 2001, INT J HEMATOL, V73, P457, DOI 10.1007/BF02994007; van Lent AU, 2009, J IMMUNOL, V183, P7645, DOI 10.4049/jimmunol.0902019; Verlinden S F, 1998, Stem Cells, V16 Suppl 1, P205; Watanabe Y, 2009, INT IMMUNOL, V21, P843, DOI 10.1093/intimm/dxp050; Wege AK, 2011, INT J CANCER, V129, P2194, DOI 10.1002/ijc.26159; Wiedswang G, 2006, INT J CANCER, V118, P2013, DOI 10.1002/ijc.21576; Willinger T, 2011, TRENDS IMMUNOL, V32, P321, DOI 10.1016/j.it.2011.04.005	29	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97860	10.1371/journal.pone.0097860	http://dx.doi.org/10.1371/journal.pone.0097860			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830425	gold, Green Published, Green Submitted			2022-12-27	WOS:000336789500128
J	Zhang, P; Tang, M; Zhong, T; Lin, Y; Zong, T; Zhong, CX; Zhang, BP; Ren, M; Kuang, HB				Zhang, Peng; Tang, Min; Zhong, Ting; Lin, Yan; Zong, Teng; Zhong, Chengxue; Zhang, BaoPing; Ren, Min; Kuang, HaiBin			Expression and Function of Kisspeptin during Mouse Decidualization	PLOS ONE			English	Article							METASTASIS SUPPRESSOR GENE; PROLACTIN-RELATED PROTEIN; SIGNALING PATHWAY; RECEPTOR GPR54; KISS-1; TROPHOBLAST; PREGNANCY; IMPLANTATION; TAMOXIFEN; PLACENTA	Background: Plasma kisspeptin levels dramatically increased during the first trimester of human pregnancy, which is similar to pregnancy specific glycoprotein-human chorionic gonadotropin. However, its particular role in the implantation and decidualization has not been fully unraveled. Here, the study was conducted to investigate the expression and function of kisspeptin in mouse uterus during early pregnancy and decidualization. Methodology/Principal Findings: Quantitative PCR results demonstrated that Kiss1 and GPR54 mRNA levels showed dynamic increase in the mouse uterus during early pregnancy and artificially induced decidualization in vivo. KISS-1 and GPR54 proteins were spatiotemporally expressed in decidualizing stromal cells in intact pregnant females, as well as in pseudopregnant mice undergoing artificially induced decidualization. In the ovariectomized mouse uterus, the expression of Kiss1 mRNA was upregulated after progesterone or/and estradiol treatment. Moreover, in a stromal cell culture model, the expression of Kiss1 and GPR54 mRNA gradually rise with the progression of stromal cell decidualization, whereas the attenuated expression of Kiss1 using small interfering RNA approaches significantly blocked the progression of stromal cell decidualization. Conclusion: our results demonstrated that Kiss1/GPR54 system was involved in promoting uterine decidualization during early pregnancy in mice.	[Zhang, Peng; Zhong, Ting; Zong, Teng; Zhong, Chengxue; Zhang, BaoPing; Ren, Min; Kuang, HaiBin] Nanchang Univ, Sch Med, Dept Physiol, Nanchang, Jiangxi, Peoples R China; [Tang, Min] Nanchang Univ, Sch Med, Dept Cell Biol, Nanchang, Jiangxi, Peoples R China; [Lin, Yan] Hosp Jixi Prov People, Dept Obstet & Gynecol, Nanchang, Jiangxi, Peoples R China; [Zhong, Ting] Gannan Med Univ, Affiliated Hosp 1, Dept Reprod Med, Ganzhou, Jiangxi, Peoples R China	Nanchang University; Nanchang University; Gannan Medical University	Kuang, HB (corresponding author), Nanchang Univ, Sch Med, Dept Physiol, Nanchang, Jiangxi, Peoples R China.	kuanghaibin@ncu.edu.cn		Kuang, haibin/0000-0003-4711-5449	National Natural Science Foundation of China [31260248, 81270668, 30960118, 30760071]; 555 project of Jiangxi Province Gan Po Excellence; Foundation of the Education Department of Jiangxi Province [GJJ12071]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 555 project of Jiangxi Province Gan Po Excellence; Foundation of the Education Department of Jiangxi Province	This work was supported by the National Natural Science Foundation of China (31260248, 81270668, 30960118 and 30760071) and The 555 project of Jiangxi Province Gan Po Excellence and the Foundation of the Education Department of Jiangxi Province (GJJ12071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilban M, 2004, J CELL SCI, V117, P1319, DOI 10.1242/jcs.00971; Cartwright JE, 2012, J ENDOCRINOL, V214, P79, DOI 10.1530/JOE-12-0091; Chen Q, 2009, MOL HUM REPROD, V15, P215, DOI 10.1093/molehr/gap009; d'Anglemont de Tassigny X, 2007, P NATL ACAD SCI USA, V104, P10714, DOI 10.1073/pnas.0704114104; Das SK, 1999, J MOL ENDOCRINOL, V22, P91, DOI 10.1677/jme.0.0220091; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Dhillo WS, 2006, AM J PHYSIOL-ENDOC M, V291, pE878, DOI 10.1152/ajpendo.00555.2005; Funes S, 2003, BIOCHEM BIOPH RES CO, V312, P1357, DOI 10.1016/j.bbrc.2003.11.066; GU Y, 1994, ENDOCRINOLOGY, V135, P1422, DOI 10.1210/en.135.4.1422; Hiden U, 2007, REV ENDOCR METAB DIS, V8, P31, DOI 10.1007/s11154-007-9030-8; Horikoshi Y, 2003, J CLIN ENDOCR METAB, V88, P914, DOI 10.1210/jc.2002-021235; Klinge CM, 2002, ENDOCRINOLOGY, V143, P853, DOI 10.1210/en.143.3.853; Lee DK, 1999, FEBS LETT, V446, P103, DOI 10.1016/S0014-5793(99)00009-5; Lee JH, 1996, JNCI-J NATL CANCER I, V88, P1731, DOI 10.1093/jnci/88.23.1731; Li QX, 2007, J BIOL CHEM, V282, P31725, DOI 10.1074/jbc.M704723200; Muir AI, 2001, J BIOL CHEM, V276, P28969, DOI 10.1074/jbc.M102743200; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Park DW, 2012, AM J REPROD IMMUNOL, V67, P132, DOI 10.1111/j.1600-0897.2011.01073.x; Peng J, 2013, FERTIL STERIL, V99, P1436, DOI 10.1016/j.fertnstert.2012.12.008; Prasad M, 2005, GYNECOL ONCOL, V96, P25, DOI 10.1016/j.ygyno.2004.08.046; Ramathal CY, 2010, SEMIN REPROD MED, V28, P17, DOI 10.1055/s-0029-1242989; Reynolds RM, 2009, REPRODUCTION, V138, P1, DOI 10.1530/REP-09-0026; Roseweir AK, 2009, HUM REPROD UPDATE, V15, P203, DOI 10.1093/humupd/dmn058; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Teklenburg G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010258; Tena-Sempere M, 2006, NEUROENDOCRINOLOGY, V83, P275, DOI 10.1159/000095549; Terao Y, 2004, BBA-GENE STRUCT EXPR, V1678, P102, DOI 10.1016/j.bbaexp.2004.02.005; Ushizawa K, 2010, MOL CELL ENDOCRINOL, V323, P277, DOI 10.1016/j.mce.2010.03.008; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Zhang L, 2009, CELL TISSUE RES, V338, P413, DOI 10.1007/s00441-009-0884-9; Zhang S, 2013, MOL ASPECTS MED, V34, P939, DOI 10.1016/j.mam.2012.12.011	31	37	40	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97647	10.1371/journal.pone.0097647	http://dx.doi.org/10.1371/journal.pone.0097647			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830702	Green Submitted, Green Published, gold			2022-12-27	WOS:000336789500092
J	Cardenas-Morales, L; Gron, G; Sim, EJ; Stingl, JC; Kammer, T				Cardenas-Morales, Lizbeth; Groen, Georg; Sim, Eun-Jin; Stingl, Julia C.; Kammer, Thomas			Neural Activation in Humans during a Simple Motor Task Differs between BDNF Polymorphisms	PLOS ONE			English	Article							FACTOR VAL66MET POLYMORPHISM; NEUROTROPHIC FACTOR; CORTICAL EXCITABILITY; FINGER MOVEMENTS; HUMAN-MEMORY; PLASTICITY; BRAIN; CORTEX; HANDEDNESS; STIMULATION	The BDNF Val66Met polymorphism has been linked to decreased synaptic plasticity involved in motor learning tasks. We investigated whether individual differences in this polymorphism may promote differences in neural activity during a two-alternative forced-choice motor performance. In two separate sessions, the BOLD signal from 22 right-handed healthy men was measured during button presses with the left and right index finger upon visual presentation of an arrow. 11 men were Val66Val carriers (ValVal group), the other 11 men carried either the Val66Met or the Met66Met polymorphism (Non-ValVal group). Reaction times, resting and active motor thresholds did not differ between ValVal and Non-ValVal groups. Compared to the ValVal group the Non-ValVal group showed significantly higher BOLD signals in the right SMA and motor cingulate cortex during motor performance. This difference was highly consistent for both hands and across all four sessions. Our finding suggests that this BDNF polymorphism may not only influence complex performance during motor learning but is already associated with activation differences during rather simple motor tasks. The higher BOLD signal observed in Non-ValVal subjects suggests the presence of cumulative effects of the polymorphism on the motor system, and may reflect compensatory functional activation mediating equal behavioral performance between groups.	[Cardenas-Morales, Lizbeth; Groen, Georg; Sim, Eun-Jin; Kammer, Thomas] Univ Ulm, Dept Psychiat, D-89069 Ulm, Germany; [Cardenas-Morales, Lizbeth] Max Planck Inst Neurol Res, D-50931 Cologne, Germany; [Cardenas-Morales, Lizbeth] Univ Cologne, Dept Neurol, D-50931 Cologne, Germany; [Stingl, Julia C.] Univ Ulm, Inst Pharmacol Nat Prod & Clin Pharmacol, D-89069 Ulm, Germany; [Stingl, Julia C.] Fed Inst Drugs & Med Devices, Res Dept, Bonn, Germany	Ulm University; Max Planck Society; University of Cologne; Ulm University	Kammer, T (corresponding author), Univ Ulm, Dept Psychiat, D-89069 Ulm, Germany.	thomas.kammer@uni-ulm.de	Stingl, Julia C./ABA-7201-2020; Kammer, Thomas/K-2168-2012	Stingl, Julia C./0000-0002-1566-8156; Kammer, Thomas/0000-0002-2769-5645; Gron, Georg/0000-0002-0282-3575				Abler B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054447; Allen SJ, 2006, CLIN SCI, V110, P175, DOI 10.1042/CS20050161; Antal A, 2010, BRAIN STIMUL, V3, P230, DOI 10.1016/j.brs.2009.12.003; Banner H, 2011, EUR J NEUROSCI, V33, P968, DOI 10.1111/j.1460-9568.2010.07550.x; Benjamini Y, 2001, ANN STAT, V29, P1165; Beste C, 2010, J NEUROSCI, V30, P10727, DOI 10.1523/JNEUROSCI.2493-10.2010; Cardenas-Morales L, 2013, CEREB CORTEX, DOI [10.1093/cercor/bht1023, DOI 10.1093/CERCOR/BHT1023]; Carvalho AL, 2008, BRIT J PHARMACOL, V153, pS310, DOI 10.1038/sj.bjp.0707509; Cheeran B, 2008, J PHYSIOL-LONDON, V586, P5717, DOI 10.1113/jphysiol.2008.159905; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Desai NS, 1999, LEARN MEMORY, V6, P284; Dietrich T, 2001, NEUROIMAGE, V13, P425, DOI 10.1006/nimg.2001.0703; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Fritsch B, 2010, NEURON, V66, P198, DOI 10.1016/j.neuron.2010.03.035; Gottschalk W, 1998, J NEUROSCI, V18, P6830; Gruber O, 2012, EUR ARCH PSY CLIN N, V262, P23, DOI 10.1007/s00406-011-0214-6; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Hartmann M, 2001, EMBO J, V20, P5887, DOI 10.1093/emboj/20.21.5887; KIM SG, 1993, SCIENCE, V261, P615, DOI 10.1126/science.8342027; Kleim JA, 2006, NAT NEUROSCI, V9, P735, DOI 10.1038/nn1699; Mastroeni C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057957; McHughen SA, 2010, CEREB CORTEX, V20, P1254, DOI 10.1093/cercor/bhp189; Mima T, 1999, BRAIN, V122, P1989, DOI 10.1093/brain/122.10.1989; Mori F, 2012, J NEUROSCI, V32, P873, DOI 10.1523/JNEUROSCI.2531-11.2012; Mori F, 2011, J NEUROPHYSIOL, V106, P1637, DOI 10.1152/jn.00318.2011; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pearson-Fuhrhop KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061197; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; RAO SM, 1995, NEUROLOGY, V45, P919, DOI 10.1212/WNL.45.5.919; Shimizu E, 2004, AM J MED GENET B, V126B, P122, DOI 10.1002/ajmg.b.20118; Solodkin A, 2001, EUR J NEUROL, V8, P425, DOI 10.1046/j.1468-1331.2001.00242.x; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Toni I, 1999, CEREB CORTEX, V9, P35, DOI 10.1093/cercor/9.1.35; Voti PL, 2011, EXP BRAIN RES, V212, P91, DOI 10.1007/s00221-011-2700-5; Ziemann U, 1997, ELECTROMYOGR MOTOR C, V105, P430, DOI 10.1016/S0924-980X(97)00050-7; Ziemann U, 1998, J NEUROSCI, V18, P1115	36	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96722	10.1371/journal.pone.0096722	http://dx.doi.org/10.1371/journal.pone.0096722			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828051	Green Submitted, gold, Green Published			2022-12-27	WOS:000336857400035
J	Kim, J; Nagami, S; Lee, KH; Park, SJ				Kim, Juri; Nagami, Sara; Lee, Kyu-Ho; Park, Soon-Jung			Characterization of Microtubule-Binding and Dimerization Activity of Giardia lamblia End-Binding 1 Protein	PLOS ONE			English	Article							STRUCTURAL BASIS; PLUS-END; EB1; INTESTINALIS; DYNAMICS; TRACKING; TUBULIN; GENE; LOCALIZATION; INTERPHASE	End-binding 1 (EB1) proteins are evolutionarily conserved components of microtubule (MT) plus-end tracking protein that regulate MT dynamics. Giardia lamblia, with two nuclei and cytoskeletal structures, requires accurate MT distribution for division. In this study, we show that a single EB1 homolog gene of G. lamblia regulates MT dynamics in mitosis. The haemagglutinin-tagged G. lamblia EB1 (GlEB1) localizes to the nuclear envelopes and median bodies, and is transiently present in mitotic spindles of dividing cells. Knockdown of GlEB1 expression using the morpholinos-based anti-EB1 oligonucleotides, resulted in a significant defect in mitosis of Giardia trophozoites. The MT-binding assays using recombinant GlEB1 (rGlEB1) proteins demonstrated that rGlEB1(102-238), but not rGlEB1(1-184), maintains an MT-binding ability comparable with that of the full length protein, rGlEB1(1-238). Size exclusion chromatography showed that rGlEB1 is present as a dimer formed by its C-terminal domain and a disulfide bond. In vitro-mutagenesis of GlEB1 indicated that an intermolecular disulfide bond is made between cysteine #13 of the two monomers. Complementation assay using the BIM1 knockout mutant yeast, the yeast homolog of mammalian EB1, indicated that expression of the C13S mutant GlEB1 protein cannot rescue the mitotic defect of the BIM1 mutant yeast. These results suggest that dimerization of GlEB1 via the 13th cysteine residues plays a role during mitosis in Giardia.	[Kim, Juri; Park, Soon-Jung] Yonsei Univ, Coll Med, Dept Environm Med Biol, Seoul, South Korea; [Kim, Juri; Park, Soon-Jung] Yonsei Univ, Coll Med, Inst Trop Med, Brain Korea PLUS Project Med Sci 21, Seoul, South Korea; [Nagami, Sara; Lee, Kyu-Ho] Sogang Univ, Dept Life Sci, Seoul, South Korea; [Nagami, Sara; Lee, Kyu-Ho] Sogang Univ, Interdisciplinary Program Integrated Biotechnol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Sogang University; Sogang University	Park, SJ (corresponding author), Yonsei Univ, Coll Med, Dept Environm Med Biol, Seoul, South Korea.	sjpark615@yuhs.ac		Kim, Juri/0000-0001-8270-7584; Park, Soon-Jung/0000-0002-0423-1944	National Research Foundation (NRF) of the Ministry of Education, Science, and Technology, Korea [2009-0078120, 2012R1A1A2004874]	National Research Foundation (NRF) of the Ministry of Education, Science, and Technology, Korea	This work was supported by the Basic Science Research Programs (No. 2009-0078120 and No. 2012R1A1A2004874) through the National Research Foundation (NRF) of the Ministry of Education, Science, and Technology, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Bae SS, 2009, EXP PARASITOL, V122, P11, DOI 10.1016/j.exppara.2009.01.005; Ban R, 2009, J BIOL CHEM, V284, P28367, DOI 10.1074/jbc.M109.000273; Beihauer JD, 1997, J CELL BIOL, V139, P717; Bieling P, 2008, J CELL BIOL, V183, P1223, DOI 10.1083/jcb.200809190; Carpenter ML, 2009, EUKARYOT CELL, V8, P916, DOI 10.1128/EC.00041-09; Dawson SC, 2007, EUKARYOT CELL, V6, P2354, DOI 10.1128/EC.00128-07; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Elmendorf HG, 2003, INT J PARASITOL, V33, P3, DOI 10.1016/S0020-7519(02)00228-X; Hayashi I, 2005, MOL CELL, V19, P449, DOI 10.1016/j.molcel.2005.06.034; Hayashi I, 2003, J BIOL CHEM, V278, P36430, DOI 10.1074/jbc.M305773200; Hofstetrova K, 2010, EXP PARASITOL, V124, P159, DOI 10.1016/j.exppara.2009.09.004; Honnappa S, 2005, EMBO J, V24, P261, DOI 10.1038/sj.emboj.7600529; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; KANE AV, 1991, J PARASITOL, V77, P974, DOI 10.2307/3282752; Kang K, 2010, PARASITOL RES, V106, P723, DOI 10.1007/s00436-009-1687-3; KEISTER DB, 1983, T ROY SOC TROP MED H, V77, P487, DOI 10.1016/0035-9203(83)90120-7; Kim J, 2006, PARASITOL RES, V98, P138, DOI 10.1007/s00436-005-0040-8; Kim J, 2008, PARASITOL INT, V57, P465, DOI 10.1016/j.parint.2008.05.008; Kim J, 2008, PARASITOL RES, V103, P1459, DOI 10.1007/s00436-008-1131-0; Kim J, 2009, KOREAN J PARASITOL, V47, P287, DOI 10.3347/kjp.2009.47.3.287; Komaki S, 2010, J CELL SCI, V123, P451, DOI 10.1242/jcs.062703; Komarova Y, 2009, J CELL BIOL, V184, P691, DOI 10.1083/jcb.200807179; Mishima M, 2007, P NATL ACAD SCI USA, V104, P10346, DOI 10.1073/pnas.0703876104; MOWATT MR, 1995, MOL MICROBIOL, V15, P955, DOI 10.1111/j.1365-2958.1995.tb02364.x; Nohynkova E, 2000, EUR J CELL BIOL, V79, P438, DOI 10.1078/0171-9335-00066; Poxleitner MK, 2008, EUKARYOT CELL, V7, P569, DOI 10.1128/EC.00415-07; Sagolla MS, 2006, J CELL SCI, V119, P4889, DOI 10.1242/jcs.03276; Slep KC, 2005, J CELL BIOL, V168, P587, DOI 10.1083/jcb.200410114; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; SOGIN ML, 1989, SCIENCE, V243, P75, DOI 10.1126/science.2911720; Sun CH, 2000, MOL BIOCHEM PARASIT, V105, P51, DOI 10.1016/S0166-6851(99)00163-2; Svard S, 2011, METHODS MOL BIOL, V761, P201, DOI 10.1007/978-1-61779-182-6_13; Tirnauer JS, 2000, J CELL BIOL, V149, P761, DOI 10.1083/jcb.149.4.761; Weisbrich A, 2007, NAT STRUCT MOL BIOL, V14, P959, DOI 10.1038/nsmb1291; Zimniak T, 2009, J CELL BIOL, V186, P379, DOI 10.1083/jcb.200901036	37	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97850	10.1371/journal.pone.0097850	http://dx.doi.org/10.1371/journal.pone.0097850			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828878	Green Submitted, Green Published, gold			2022-12-27	WOS:000336857400125
J	Komers, R; Xu, B; Fu, Y; McClelland, A; Kantharidis, P; Mittal, A; Cohen, HT; Cohen, DM				Komers, Radko; Xu, Bei; Fu, Yi; McClelland, Aaron; Kantharidis, Phillip; Mittal, Amit; Cohen, Herbert T.; Cohen, David M.			Transcriptome-Based Analysis of Kidney Gene Expression Changes Associated with Diabetes in OVE26 Mice, in the Presence and Absence of Losartan Treatment	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM-STRESS; THIOREDOXIN-INTERACTING PROTEIN; TISSUE GROWTH-FACTOR; ANGIOTENSIN-RECEPTOR BLOCKADE; LOW-DENSITY-LIPOPROTEIN; HIPPEL-LINDAU-DISEASE; ER STRESS; ENDOTHELIAL DYSFUNCTION; METABOLIC SYNDROME; OXIDATIVE-STRESS	Diabetes is among the most common causes of end-stage renal disease, although its pathophysiology is incompletely understood. We performed next-generation sequencing-based transcriptome analysis of renal gene expression changes in the OVE26 murine model of diabetes (age 15 weeks), relative to non-diabetic control, in the presence and absence of short-term (seven-day) treatment with the angiotensin receptor blocker, losartan (n = 3-6 biological replicates per condition). We detected 1438 statistically significant changes in gene expression across conditions. Of the 638 genes dysregulated in diabetes relative to the non-diabetic state, >70% were down-regulation events. Unbiased functional annotation of genes up-and down-regulated by diabetes strongly associated (p<1x10(-8)) with terms for oxidative stress and for endoplasmic reticulum stress/protein folding. Most of the individual gene products up-or down-regulated with diabetes were unaffected by losartan treatment; however, of the gene products dysregulated in diabetes and influenced by losartan treatment, the vast majority of changes were in the direction of amelioration rather than exacerbation of the diabetic dysregulation. This group of losartan-protected genes associated strongly with annotation terms for endoplasmic reticulum stress, heat shock proteins, and chaperone function, but not oxidative stress; therefore, the losartan-unaffected genes suggest avenues for additional therapeutic opportunity in diabetes. Interestingly, the gene product most highly upregulated by diabetes (>52-fold), encoded by the cationic amino acid transporter Slc7a12, and the gene product most highly downregulated by diabetes (>99%) - encoded by the "pseudogene" Gm6300 - are adjacent in the murine genome, are members of the SLC7 gene family, and are likely paralogous. Therefore, diabetes activates a near-total genetic switch between these two paralogs. Other individual-level changes in gene expression are potentially relevant to diabetic pathophysiology, and novel pathways are suggested. Genes unaffected by diabetes alone but exhibiting increased renal expression with losartan produced a signature consistent with malignant potential.	[Komers, Radko; Xu, Bei; Fu, Yi; Cohen, David M.] Oregon Hlth & Sci Univ, Dept Med, Div Nephrol & Hypertens, Portland, OR 97201 USA; [Komers, Radko; Xu, Bei; Fu, Yi; Cohen, David M.] Portland VA Med Ctr, Portland, OR USA; [Mittal, Amit; Cohen, Herbert T.] Boston Univ, Sch Med, Nephrol Sect, Boston, MA 02118 USA; [McClelland, Aaron; Kantharidis, Phillip] Baker IDI Heart & Diabet Inst, Diabet Div, JDRF Danielle Alberti Mem Ctr Diabet Complicat, Melbourne, Vic, Australia	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Boston University; Baker Heart and Diabetes Institute	Cohen, DM (corresponding author), Oregon Hlth & Sci Univ, Dept Med, Div Nephrol & Hypertens, Portland, OR 97201 USA.	cohend@ohsu.edu			National Institutes of Health; Department of Veterans Affairs; American Diabetes Association	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); American Diabetes Association(American Diabetes Association)	This work was supported by grants from the National Institutes of Health, the Department of Veterans Affairs, and the American Diabetes Association (to DMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arca M, 2013, CURR OPIN LIPIDOL, V24, P313, DOI 10.1097/MOL.0b013e3283630cf0; Arumugam S, 2012, TOXICOLOGY, V291, P139, DOI 10.1016/j.tox.2011.11.008; Bangalore S, 2011, LANCET ONCOL, V12, P65, DOI 10.1016/S1470-2045(10)70260-6; Beroukhim R, 2009, CANCER RES, V69, P4674, DOI 10.1158/0008-5472.CAN-09-0146; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Bindra RS, 2002, CANCER RES, V62, P3014; Blondeau JP, 2002, GENE, V286, P241, DOI 10.1016/S0378-1119(02)00435-3; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Chairoungdua A, 2001, J BIOL CHEM, V276, P49390, DOI 10.1074/jbc.M107517200; Chakraborty S, 2009, J AM SOC HYPERTENS, V3, P119, DOI 10.1016/j.jash.2008.11.002; Chang CH, 2011, J CLIN ONCOL, V29, P3001, DOI 10.1200/JCO.2011.35.1908; Chen GZ, 2012, AM J PHYSIOL-ENDOC M, V303, pE563, DOI 10.1152/ajpendo.00591.2011; Chen GZ, 2011, PROSTAG OTH LIPID M, V96, P63, DOI 10.1016/j.prostaglandins.2011.06.009; Cheng JZ, 2010, KIDNEY INT, V78, P668, DOI 10.1038/ki.2010.214; Chiang CK, 2011, MOL MED, V17, P1295, DOI 10.2119/molmed.2011.00131; Choi KM, 2012, DIABETES, V61, P2932, DOI 10.2337/db12-0217; COHEN DM, 1991, AM J PHYSIOL, V261, pC594, DOI 10.1152/ajpcell.1991.261.4.C594; Collins FS, 2007, SCI AM, V296, P50, DOI 10.1038/scientificamerican0307-50; Cooper ME, 1998, LANCET, V352, P213, DOI 10.1016/S0140-6736(98)01346-4; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Degrandi D, 2007, J IMMUNOL, V179, P7729, DOI 10.4049/jimmunol.179.11.7729; Dhahbi JM, 2004, P NATL ACAD SCI USA, V101, P5524, DOI 10.1073/pnas.0305300101; Dikalov SI, 2008, FREE RADICAL BIO MED, V45, P1340, DOI 10.1016/j.freeradbiomed.2008.08.013; Eagle ARR, 2005, HUM GENET, V118, P12, DOI 10.1007/s00439-005-0019-7; Eid AA, 2009, DIABETES, V58, P1201, DOI 10.2337/db08-1536; EPSTEIN PN, 1989, CELL, V58, P1067, DOI 10.1016/0092-8674(89)90505-9; Feng YX, 2005, CELL PHYSIOL BIOCHEM, V16, P237, DOI 10.1159/000089849; Fotiadis D, 2013, MOL ASPECTS MED, V34, P139, DOI 10.1016/j.mam.2012.10.007; Gao X, 2010, BIOCHEM BIOPH RES CO, V399, P31, DOI 10.1016/j.bbrc.2010.07.027; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; Gorin Y, 2013, CLIN SCI, V125, P361, DOI 10.1042/CS20130065; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hetz C, 2011, PHYSIOL REV, V91, P1219, DOI 10.1152/physrev.00001.2011; Hirayama A, 2012, ANAL BIOANAL CHEM, V404, P3101, DOI 10.1007/s00216-012-6412-x; Hofmann C, 2011, INFLAMM BOWEL DIS, V17, P2462, DOI 10.1002/ibd.21647; Hoorn EJ, 2011, J AM SOC NEPHROL, V22, P605, DOI 10.1681/ASN.2010080827; Hu WK, 2012, EXP DIABETES RES, DOI 10.1155/2012/507986; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hui XY, 2009, J BIOL CHEM, V284, P14050, DOI 10.1074/jbc.M109.001107; Jaffa MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044714; Kassan M, 2012, ARTERIOSCL THROM VAS, V32, P1652, DOI 10.1161/ATVBAHA.112.249318; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kawakami T, 2013, J PATHOL, V229, P221, DOI 10.1002/path.4121; Kidmose RT, 2012, P NATL ACAD SCI USA, V109, P15425, DOI 10.1073/pnas.1208031109; Knoll KE, 2005, PHYSIOL GENOMICS, V21, P222, DOI 10.1152/physiolgenomics.00231.2004; Komers R, 2006, DIABETES, V55, P1651, DOI 10.2337/db05-1595; Kosugi M, 2006, CLIN CANCER RES, V12, P2888, DOI 10.1158/1078-0432.CCR-05-2213; Lakshmanan AP, 2011, EUR J PHARM SCI, V44, P627, DOI 10.1016/j.ejps.2011.10.009; Leclerc E, 2007, J BIOL CHEM, V282, P31317, DOI 10.1074/jbc.M703951200; Li B, 2012, EXP DIABETES RES, DOI 10.1155/2012/216512; LIANES P, 1994, J NATL CANCER I, V86, P1325, DOI 10.1093/jnci/86.17.1325; Lindenmeyer MT, 2008, J AM SOC NEPHROL, V19, P2225, DOI 10.1681/ASN.2007121313; Liu GG, 2008, BIOCHEM BIOPH RES CO, V370, P651, DOI 10.1016/j.bbrc.2008.04.031; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003280; Lokman FE, 2011, J NEPHROL, V24, P778, DOI 10.5301/JN.2011.6382; Lopes-Virella MF, 2008, DIABETES CARE, V31, P2006, DOI 10.2337/dc08-0659; Mathew R, 2005, AM J PHYSIOL-RENAL, V289, pF911, DOI 10.1152/ajprenal.00037.2005; Mauer M, 2009, NEW ENGL J MED, V361, P40, DOI 10.1056/NEJMoa0808400; Miller RA, 2002, MOL ENDOCRINOL, V16, P2657, DOI 10.1210/me.2002-0142; Miwa T, 2002, AM J PATHOL, V161, P1077, DOI 10.1016/S0002-9440(10)64268-X; Miyajima A, 2002, CANCER RES, V62, P4176; Miyamoto S, 2012, DIABETES, V61, P897, DOI 10.2337/db11-0402; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Neuhofer W, 2005, CONTRIB NEPHROL, V148, P21, DOI 10.1159/000086041; Oxenkrug GF, 2010, ANN NY ACAD SCI, V1199, P1, DOI 10.1111/j.1749-6632.2009.05356.x; Park IS, 1998, AM J KIDNEY DIS, V32, P1000, DOI 10.1016/S0272-6386(98)70075-7; Puntarulo S, 1998, FREE RADICAL BIO MED, V24, P1324, DOI 10.1016/S0891-5849(97)00463-2; Reisman SA, 2012, J AM SOC NEPHROL, V23, P1663, DOI 10.1681/ASN.2012050457; Riser BL, 2001, RENAL FAILURE, V23, P459, DOI 10.1081/JDI-100104729; Riser BL, 2000, J AM SOC NEPHROL, V11, P25, DOI 10.1681/ASN.V11125; Ritz E, 2013, MED CLIN N AM, V97, P19, DOI 10.1016/j.mcna.2012.10.008; Shah A, 2013, J BIOL CHEM, V288, P6835, DOI 10.1074/jbc.M112.419101; SHOPLAND DR, 1991, JNCI-J NATL CANCER I, V83, P1142, DOI 10.1093/jnci/83.16.1142; Sipahi I, 2010, LANCET ONCOL, V11, P627, DOI 10.1016/S1470-2045(10)70106-6; Tanaka N, 2012, BRIT J CANCER, V106, P290, DOI 10.1038/bjc.2011.565; Teo KK, 2013, J HYPERTENS, V31, P1532, DOI 10.1097/HJH.0b013e328362b7fa; Teo KK, 2011, J HYPERTENS, V29, P623, DOI 10.1097/HJH.0b013e328344a7de; Thimmulappa RK, 2002, CANCER RES, V62, P5196; Thomson SC, 2001, J CLIN INVEST, V107, P217, DOI 10.1172/JCI10963; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tsukamoto Y, 1996, J CLIN INVEST, V98, P1930, DOI 10.1172/JCI118994; Uhal BD, 2013, AM J PHYSIOL-LUNG C, V305, pL33, DOI 10.1152/ajplung.00001.2013; Vallon V, 2011, COMPR PHYSIOL, V1, P1175, DOI 10.1002/cphy.c100049; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wang SN, 2001, KIDNEY INT, V60, P96, DOI 10.1046/j.1523-1755.2001.00776.x; Wu J, 2013, J ENDOCRINOL INVEST, V36, P453, DOI 10.3275/8764; Wu J, 2010, AM J PATHOL, V176, P2163, DOI 10.2353/ajpath.2010.090386; Xu JX, 2010, AM J PHYSIOL-RENAL, V299, pF487, DOI 10.1152/ajprenal.00018.2010; Yang L, 2011, NEPHRON EXP NEPHROL, V119, pE8, DOI 10.1159/000324407; Yao DC, 2010, DIABETES, V59, P249, DOI 10.2337/db09-0801; Yoon C, 2011, CAN MED ASSOC J, V183, pE1073, DOI 10.1503/cmaj.101497; Young CN, 2012, J CLIN INVEST, V122, P3960, DOI 10.1172/JCI64583; Zatyka M, 2002, CANCER RES, V62, P3803; Zheng SR, 2011, NEPHRON EXP NEPHROL, V119, pE21, DOI 10.1159/000327586; Zheng SR, 2004, DIABETES, V53, P3248, DOI 10.2337/diabetes.53.12.3248; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831; Zhou YJ, 2010, VITAM HORM, V83, P151, DOI 10.1016/S0083-6729(10)83006-7; Zhou YJ, 2009, J BIOL CHEM, V284, P11152, DOI 10.1074/jbc.M900754200	99	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96987	10.1371/journal.pone.0096987	http://dx.doi.org/10.1371/journal.pone.0096987			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827579	gold, Green Published, Green Submitted			2022-12-27	WOS:000336857400050
J	Kupz, A; Curtiss, R; Bedoui, S; Strugnell, RA				Kupz, Andreas; Curtiss, Roy, III; Bedoui, Sammy; Strugnell, Richard A.			In Vivo IFN-gamma Secretion by NK Cells in Response to Salmonella Typhimurium Requires NLRC4 Inflammasomes	PLOS ONE			English	Article							MEMORY CD8(+) T; HOST-DEFENSE; INFECTION; ADULTS; MICE	Natural killer (NK) cells are a critical part of the innate immune defense against viral infections and for the control of tumors. Much less is known about how NK cells contribute to anti-bacterial immunity. NK cell-produced interferon gamma (IFN-gamma) contributes to the control of early exponential replication of bacterial pathogens, however the regulation of these events remains poorly resolved. Using a mouse model of invasive Salmonellosis, here we report that the activation of the intracellular danger sensor NLRC4 by Salmonella-derived flagellin within CD11c(+) cells regulates early IFN-gamma secretion by NK cells through the provision of interleukin 18 (IL-18), independently of Toll-like receptor (TLR)-signaling. Although IL18-signalling deficient NK cells improved host protection during S. Typhimurium infection, this increased resistance was inferior to that provided by wild-type NK cells. These findings suggest that although NLRC4 inflammasome-driven secretion of IL-18 serves as a potent activator of NK cell mediated IFN-gamma secretion, IL18-independent NK cell-mediated mechanisms of IFN-gamma secretion contribute to in vivo control of Salmonella replication.	[Kupz, Andreas; Bedoui, Sammy; Strugnell, Richard A.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Curtiss, Roy, III] Arizona State Univ, Ctr Infect Dis & Vaccinol, Tempe, AZ USA; [Kupz, Andreas] Max Planck Inst Infect Biol, Berlin, Germany; [Kupz, Andreas] James Cook Univ, Queensland Trop Hlth Alliance Res Lab, Cairns, Qld, Australia	University of Melbourne; Arizona State University; Arizona State University-Tempe; Max Planck Society; James Cook University	Kupz, A (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia.	kupz@mpiib-berlin.mpg.de	Kupz, Andreas/J-3844-2014	Strugnell, Richard/0000-0003-0614-5641; BEDOUI, SAMMY/0000-0002-7443-0543; Kupz, Andreas/0000-0002-9259-7873	National Health and Medical Research Council of Australia (NHMRC) [APP606788, APP628464, APP1052764, R01AI60557]; Bill and Melinda Gates Foundation [37863]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060557] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Health and Medical Research Council of Australia (NH&MRC) https://www.nhmrc.gov.au/ [Program Grant: Fighting Infection, exploiting host-pathogen interactions APP606788 to R.A.S., Career Development Award APP628464 to S. B., CJ Martin Biomedical Early Career Fellowship APP1052764 to A.K.]; and IH R01AI60557 and Bill and Melinda Gates Foundation Grant no. 37863 to R. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Dougan G, 2011, IMMUNOL REV, V240, P196, DOI 10.1111/j.1600-065X.2010.00999.x; Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146; Gordon MA, 2010, CLIN INFECT DIS, V50, P953, DOI 10.1086/651080; Hess J, 1996, J IMMUNOL, V156, P3321; Huntington ND, 2009, J EXP MED, V206, P25, DOI 10.1084/jem.20082013; Jouanguy E, 1999, CURR OPIN IMMUNOL, V11, P346, DOI 10.1016/S0952-7915(99)80055-7; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kastenmuller W, 2012, CELL, V150, P1235, DOI 10.1016/j.cell.2012.07.021; Khan SA, 1998, MOL MICROBIOL, V29, P571, DOI 10.1046/j.1365-2958.1998.00952.x; Kupz A, 2013, P NATL ACAD SCI USA, V110, P2252, DOI 10.1073/pnas.1222047110; Kupz A, 2012, NAT IMMUNOL, V13, P162, DOI 10.1038/ni.2195; Pegram HJ, 2008, J IMMUNOL, V181, P3449, DOI 10.4049/jimmunol.181.5.3449; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Soudja SM, 2012, IMMUNITY, V37, P549, DOI 10.1016/j.immuni.2012.05.029	16	27	27	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97418	10.1371/journal.pone.0097418	http://dx.doi.org/10.1371/journal.pone.0097418			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827856	Green Published, Green Accepted, gold			2022-12-27	WOS:000336857400092
J	Rodovalho, CD; Lyra, ML; Ferro, M; Bacci, M				Rodovalho, Cynara de Melo; Lyra, Mariana Lucio; Ferro, Milene; Bacci, Mauricio, Jr.			The Mitochondrial Genome of the Leaf-Cutter Ant Atta laevigata: A Mitogenome with a Large Number of Intergenic Spacers	PLOS ONE			English	Article							TRANSFER-RNA GENES; PHYLOGENETIC UTILITY; APIS-MELLIFERA; DNA-SEQUENCE; HYMENOPTERA; ORGANIZATION; EVOLUTION; ANNOTATION; VISUALIZATION; POLYMORPHISM	In this paper we describe the nearly complete mitochondrial genome of the leaf-cutter ant Atta laevigata, assembled using transcriptomic libraries from Sanger and Illumina next generation sequencing (NGS), and PCR products. This mitogenome was found to be very large (18,729 bp), given the presence of 30 non-coding intergenic spacers (IGS) spanning 3,808 bp. A portion of the putative control region remained unsequenced. The gene content and organization correspond to that inferred for the ancestral pancrustacea, except for two tRNA gene rearrangements that have been described previously in other ants. The IGS were highly variable in length and dispersed through the mitogenome. This pattern was also found for the other hymenopterans in particular for the monophyletic Apocrita. These spacers with unknown function may be valuable for characterizing genome evolution and distinguishing closely related species and individuals. NGS provided better coverage than Sanger sequencing, especially for tRNA and ribosomal subunit genes, thus facilitating efforts to fill in sequence gaps. The results obtained showed that data from transcriptomic libraries contain valuable information for assembling mitogenomes. The present data also provide a source of molecular markers that will be very important for improving our understanding of genomic evolutionary processes and phylogenetic relationships among hymenopterans.	[Rodovalho, Cynara de Melo; Ferro, Milene; Bacci, Mauricio, Jr.] UNESP Univ Estadual Paulista, Ctr Estudos Insetos Sociais, Sao Paulo, Brazil; [Rodovalho, Cynara de Melo] FIOCRUZ Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil; [Lyra, Mariana Lucio] UNESP Univ Estadual Paulista, Dept Zool, Sao Paulo, Brazil; [Bacci, Mauricio, Jr.] UNESP Univ Estadual Paulista, Dept Bioquim & Microbiol, Sao Paulo, Brazil	Universidade Estadual Paulista; Fundacao Oswaldo Cruz; Universidade Estadual Paulista; Universidade Estadual Paulista	Bacci, M (corresponding author), UNESP Univ Estadual Paulista, Ctr Estudos Insetos Sociais, Sao Paulo, Brazil.	mbacci@rc.unesp.br	Lyra, Mariana Lucio/O-6405-2014; Bacci, Mauricio/C-4960-2013	Lyra, Mariana Lucio/0000-0002-7863-4965; Bacci, Mauricio/0000-0002-5619-1411; Rodovalho, Cynara/0000-0002-4927-0672; Ferro, Milene/0000-0002-3960-9062	FAPESP [2011/06367-8, 11/50226-0]; CNPq [311562/2012-4, 487639/2012-0]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by FAPESP 2011/06367-8, FAPESP 11/50226-0, CNPq 311562/2012-4, and CNPq 487639/2012-0 grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjos N., 1998, GUIA PRATICO FORMIGA; AVISE JC, 1995, CONSERV BIOL, V9, P686, DOI 10.1046/j.1523-1739.1995.09030686.x; Bacci M, 2009, MOL PHYLOGENET EVOL, V51, P427, DOI 10.1016/j.ympev.2008.11.005; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boore JL, 1998, NATURE, V392, P667, DOI 10.1038/33577; Borgmeier T, 1950, MEMORIAS I O CRUZ, V48; Cameron SL, 2008, GENOME, V51, P800, DOI 10.1139/G08-066; Castro LR, 2005, MOL PHYLOGENET EVOL, V34, P469, DOI 10.1016/j.ympev.2004.11.005; Castro LR, 2006, GENOME, V49, P752, DOI 10.1139/G06-030; Cha SY, 2007, GENE, V392, P206, DOI 10.1016/j.gene.2006.12.031; Chiotis M, 2000, MOL PHYLOGENET EVOL, V17, P108, DOI 10.1006/mpev.2000.0821; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cook CE, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-105; CROZIER RH, 1993, GENETICS, V133, P97; Delabie Jacques H.C., 1998, Agrotropica, V9, P49; Dowton M, 2009, MOL BIOL EVOL, V26, P1607, DOI 10.1093/molbev/msp072; Dowton M, 2009, MOL PHYLOGENET EVOL, V52, P512, DOI 10.1016/j.ympev.2009.04.001; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Durham AM, 2005, BIOINFORMATICS, V21, P2812, DOI 10.1093/bioinformatics/bti424; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emblem A, 2012, GENE, V506, P344, DOI 10.1016/j.gene.2012.06.040; Flook PK, 1995, J MOL EVOL, V41, P928, DOI 10.1007/BF00173173; Fowler H.G., 1986, P123; Franck P, 1998, EVOLUTION, V52, P1119, DOI [10.2307/2411242, 10.1111/j.1558-5646.1998.tb01839.x]; Gotzek D, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-300; Hahn C, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt371; Hasegawa E, 2011, MYRMECOL NEWS, V15, P85; Hernandez J. V., 1995, Anais da Sociedade Entomologica do Brasil, V24, P287; Holldobler B., 1990, pi; Hong MY, 2008, GENES GENOM, V30, P307; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; HYMAN BC, 1988, GENETICS, V120, P707; Jex AR, 2010, NUCLEIC ACIDS RES, V38, P522, DOI 10.1093/nar/gkp883; Kahvejian A, 2008, NAT BIOTECHNOL, V26, P1125, DOI 10.1038/nbt1494; Kaltenpoth M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032826; Keller L, 1998, INSECT SOC, V45, P235, DOI 10.1007/s000400050084; Klopfstein S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069344; Kronauer DJC, 2004, MOL PHYLOGENET EVOL, V32, P416, DOI 10.1016/j.ympev.2004.03.011; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Lessinger AC, 2000, INSECT MOL BIOL, V9, P521, DOI 10.1046/j.1365-2583.2000.00215.x; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mao M, 2012, GENOME, V55, P194, DOI [10.1139/G2012-005, 10.1139/g2012-005]; Margam VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016444; Martins J, 2007, INSECT MOL BIOL, V16, P777, DOI 10.1111/j.1365-2583.2007.00771.x; Nardi F, 2001, MOL BIOL EVOL, V18, P1293, DOI 10.1093/oxfordjournals.molbev.a003914; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Rambaut A., 2007, TRACER V1 4; Rodovalho Cynara M., 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-203; Scheffler IE, 2008, MITOCHONDRIA, 2NDEDITION, P1; Silvestre D, 2008, GENET MOL BIOL, V31, P451, DOI 10.1590/S1415-47572008000300010; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; SNYDER M, 1987, P NATL ACAD SCI USA, V84, P7595, DOI 10.1073/pnas.84.21.7595; Solomon SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002738; Su ZQ, 2011, EXPERT REV MOL DIAGN, V11, P333, DOI [10.1586/ERM.11.3, 10.1586/erm.11.3]; Suen G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002007; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023008; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Vasconcelos HL, 1997, J TROP ECOL, V13, P357, DOI 10.1017/S0266467400010567; Viana LR, 2004, NEOTROP ENTOMOL, V33, P391, DOI 10.1590/S1519-566X2004000300019; Wall PK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-347; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang AR, 2013, MITOCHONDR DNA, V24, P208, DOI 10.3109/19401736.2012.744986; Wei SJ, 2015, MITOCHONDR DNA, V26, P157, DOI 10.3109/19401736.2013.819501; Wei SJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-371; Wei SJ, 2010, MOL BIOL REP, V37, P1931, DOI 10.1007/s11033-009-9640-1; Wei SJ, 2009, GENOME, V52, P308, DOI [10.1139/G09-008, 10.1139/g09-008]; Wetterer JK, 1998, MOL PHYLOGENET EVOL, V9, P42, DOI 10.1006/mpev.1997.0466; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yukuhiro K, 2002, MOL BIOL EVOL, V19, P1385, DOI 10.1093/oxfordjournals.molbev.a004200; Zanetti R, 2008, CIENC AGROTEC, V32, P1313, DOI 10.1590/S1413-70542008000400043; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang C, 2008, ACTA BIOCH BIOPH SIN, V40, P7, DOI 10.1111/j.1745-7270.2008.00375.x	81	27	27	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97117	10.1371/journal.pone.0097117	http://dx.doi.org/10.1371/journal.pone.0097117			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828084	gold, Green Published, Green Submitted			2022-12-27	WOS:000336857400055
J	Schnitzler, A; Arnold, C; Cornille, A; Bachmann, O; Schnitzler, C				Schnitzler, Annik; Arnold, Claire; Cornille, Amandine; Bachmann, Olivier; Schnitzler, Christophe			Wild European Apple (Malus sylvestris (L.) Mill.) Population Dynamics: Insight from Genetics and Ecology in the Rhine Valley. Priorities for a Future Conservation Programme	PLOS ONE			English	Article							DOMESTICATED APPLE; SOFTWARE; HISTORY; FORESTS; BORKH.; TREES	The increasing fragmentation of forest habitats and the omnipresence of cultivars potentially threaten the genetic integrity of the European wild apple (Malus sylvestris (L.) Mill). However, the conservation status of this species remains unclear in Europe, other than in Belgium and the Czech Republic, where it has been declared an endangered species. The population density of M. sylvestris is higher in the forests of the upper Rhine Valley (France) than in most European forests, with an unbalanced age-structure, an overrepresentation of adults and a tendency to clump. We characterize here the ecology, age-structure and genetic diversity of wild apple populations in the Rhine Valley. We use these data to highlight links to the history of this species and to propose guidelines for future conservation strategies. In total, 255 individual wild apple trees from six forest stands (five floodplain forests and one forest growing in drier conditions) were analysed in the field, collected and genotyped on the basis of data for 15 microsatellite markers. Genetic analyses showed no escaped cultivars and few hybrids with the cultivated apple. Excluding the hybrids, the genetically "pure" populations displayed high levels of genetic diversity and a weak population structure. Age-structure and ecology studies of wild apple populations identified four categories that were not randomly distributed across the forests, reflecting the history of the Rhine forest over the last century. The Rhine wild apple populations, with their ecological strategies, high genetic diversity, and weak traces of crop-to-wild gene flow associated with the history of these floodplain forests, constitute candidate populations for inclusion in future conservation programmes for European wild apple.	[Schnitzler, Annik] Univ Lorraine, CNRS, UMR 7360, LIEC, Metz, France; [Arnold, Claire] Univ Lausanne, Unictr, Lausanne, Switzerland; [Cornille, Amandine] CNRS, UMR 8079, F-91405 Orsay, France; [Cornille, Amandine] Univ Paris 11, UMR 8079, Orsay, France; [Bachmann, Olivier] Univ Neuchatel, Lab Evolutionary Bot, CH-2000 Neuchatel, Switzerland; [Arnold, Claire] Univ Neuchatel, Lab Soil & Vegetat, CH-2000 Neuchatel, Switzerland; [Schnitzler, Christophe] Univ Strasbourg, Sport Sci Fac, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lorraine; University of Lausanne; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; University of Neuchatel; University of Neuchatel; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Schnitzler, A (corresponding author), Univ Lorraine, CNRS, UMR 7360, LIEC, Metz, France.	annik.schnitzler@univ-lorraine.fr	Arnold, Claire/AAC-7330-2022	Arnold, Claire/0000-0002-1179-0728				Braun-Blanquet J., 1964, PFLANZENSOZIOLOGIE; CAMPBELL CS, 1991, SYST BOT, V16, P333, DOI 10.2307/2419284; Carbiener R., 1970, Vegetation, V20, P97, DOI 10.1007/BF01965530; Coart E, 2006, MOL ECOL, V15, P2171, DOI 10.1111/j.1365-294X.2006.02924.x; Coart E, 2003, MOL ECOL, V12, P845, DOI 10.1046/j.1365-294X.2003.01778.x; Cornille A, 2013, MOL ECOL, V22, P2249, DOI 10.1111/mec.12231; Cornille A, 2014, TRENDS GENET, V30, P57, DOI 10.1016/j.tig.2013.10.002; Cornille A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002703; Diekmann M, 1994, ACTA PHYTOGEOGR SUIC, V80; Dister E, 1983, VERH ZOOL BOT GES OS, V123, P13; Dzhangaliev A. D., 2003, Horticultural Reviews, V29, P305, DOI 10.1002/9780470650868.ch3; Ellenberg H., 1988, VEGETATION ECOLOGY C; Ellstrand NC, 1999, ANNU REV ECOL SYST, V30, P539, DOI 10.1146/annurev.ecolsys.30.1.539; Falinski J.B., 1986, GEOBOTANY, V8, P1; Forsline PL, 2002, HORTICULTURAL REV, V29, P1; Gehu JM, 1974, FORETS ACIDIPHILES, P133; GRAUDAL L, 1995, FOREST ECOL MANAG, V73, P117, DOI 10.1016/0378-1127(94)03497-K; Hardtle W, 1996, TUEXENIA, V16, P25; Harrison N, 2011, NAT GENET, V43, P1043, DOI 10.1038/ng.935; Horvat I., 1974, VEGETATION SUDOSTEUR, V4; JANSSENS GA, 1995, THEOR APPL GENET, V91, P691, DOI 10.1007/BF00223298; Kleinschmit J, 1998, NOBL HARDW NETW IPGR, P51; Kugler H., 1970, BLUTENOKOLOGIE; Larsen AS, 2006, TREE GENET GENOMES, V2, P86, DOI 10.1007/s11295-005-0030-0; Linder R, 1959, B SOC BOT FR, V106, P131; Oldeman R. A. A., 1990, FORESTS; Paul P, 1979, REV GEOGR EST, V3-4, P273; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Piegay H, 2001, DYNAMIQUE CONT SEDIE, P1; Pritchard JK, 2000, GENETICS, V155, P945; Rameau JC, 1975, FORETS ACIDIPHILES, P319; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; SCHNITZLER A, 1995, J VEG SCI, V6, P479, DOI 10.2307/3236346; SCHNITZLER A, 1994, FOREST ECOL MANAG, V68, P385, DOI 10.1016/0378-1127(94)90059-0; Schnitzler A, 2008, FLOODPLAIN FORESTS T, P442; Schnitzler A, 2006, B ASS AMIS JARDIN BO, V2, P57; Schnitzler A, 2006, FOREST ECOL MANAG, V236, P12, DOI 10.1016/j.foreco.2006.05.060; Sissingh G, 1975, FORETS ACIDIPHILES, P363; Stephan BR, 2003, EUFORGEN TECHNICAL G; Striedter K., 1988, THESIS U DUSSELDORF; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; Tremolieres M, 1998, B ECOL, V22, P317; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Wagner I, 1996, MITT DTSCH DENDROL G, V82, P87; Walter JM, 1979, ACTA OECOL, V14, P345	45	18	21	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96596	10.1371/journal.pone.0096596	http://dx.doi.org/10.1371/journal.pone.0096596			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827575	Green Published, gold, Green Submitted			2022-12-27	WOS:000336857400030
J	Truong, TN; Li, H; Hong, YK; Chen, L				Truong, Tan N.; Li, Hannah; Hong, Young-Kwon; Chen, Lu			Novel Characterization and Live Imaging of Schlemm's Canal Expressing Prox-1	PLOS ONE			English	Article							LYMPHATIC VESSELS; ENDOTHELIAL-CELLS; EYE; VASCULATURE; INDUCTION; MARKERS; SYSTEM; LYVE-1; MOUSE; GENE	Schlemm's canal is an important structure of the conventional aqueous humor outflow pathway and is critically involved in regulating the intraocular pressure. In this study, we report a novel finding that prospero homeobox protein 1 (Prox-1), the master control gene for lymphatic development, is expressed in Schlemm's canal. Moreover, we provide a novel in vivo method of visualizing Schlemm's canal using a transgenic mouse model of Prox-1-green fluorescent protein (GFP). The anatomical location of Prox-1+ Schlemm's canal was further confirmed by in vivo gonioscopic examination and ex vivo immunohistochemical analysis. Additionally, we show that the Schlemm's canal is distinguishable from typical lymphatic vessels by lack of lymphatic vessel endothelial hyaluronan receptor (LYVE-1) expression and absence of apparent sprouting reaction when inflammatory lymphangiogenesis occurred in the cornea. Taken together, our findings offer new insights into Schlemm's canal and provide a new experimental model for live imaging of this critical structure to help further our understanding of the aqueous humor outflow. This may lead to new avenues toward the development of novel therapeutic intervention for relevant diseases, most notably glaucoma.	[Truong, Tan N.; Chen, Lu] Univ Calif Berkeley, Grad Grp Vis Sci, Berkeley, CA 94720 USA; [Truong, Tan N.; Li, Hannah; Chen, Lu] Univ Calif Berkeley, Ctr Eye Dis & Dev, Program Vis Sci, Berkeley, CA 94720 USA; [Truong, Tan N.; Li, Hannah; Chen, Lu] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; [Hong, Young-Kwon] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Surg, Los Angeles, CA 90033 USA; [Hong, Young-Kwon] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Chen, Lu] Univ Calif San Francisco, Francis I Proctor Fdn Res Ophthalmol, San Francisco, CA 94143 USA; [Chen, Lu] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Schepens Eye Res Inst, Boston, MA USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Southern California; University of Southern California; University of California System; University of California San Francisco; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute	Chen, L (corresponding author), Univ Calif Berkeley, Grad Grp Vis Sci, Berkeley, CA 94720 USA.	chenlu@berkeley.edu			National Institutes of Health; University of California at Berkeley; NATIONAL EYE INSTITUTE [R01EY017392] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California at Berkeley; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work is supported in part by research grants from National Institutes of Health and the University of California at Berkeley. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Birke K, 2010, INVEST OPHTH VIS SCI, V51, P344, DOI 10.1167/iovs.08-3307; Camelo S, 2006, INVEST OPHTH VIS SCI, V47, P1039, DOI 10.1167/iovs.05-1041; Chen L, 2005, INVEST OPHTH VIS SCI, V46, P4536, DOI 10.1167/iovs.05-0975; Chen L, 2004, NAT MED, V10, P813, DOI 10.1038/nm1078; Chen L, 2009, LYMPHOLOGY, V42, P66; Choi I, 2011, BLOOD, V117, P362, DOI 10.1182/blood-2010-07-298562; Cook C, 2012, CAN J OPHTHALMOL, V47, P223, DOI 10.1016/j.jcjo.2012.02.003; Foets B., 1992, GRAEFES ARCH CLIN EX, V30, P269; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Grimaldo S, 2011, INVEST OPHTH VIS SCI, V52, P4808, DOI 10.1167/iovs.10-6580; HAMANAKA T, 1992, EXP EYE RES, V55, P479, DOI 10.1016/0014-4835(92)90121-8; Heimark RL, 2002, CURR EYE RES, V25, P299, DOI 10.1076/ceyr.25.5.299.13495; KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566; Kriehuber E, 2001, J EXP MED, V194, P797, DOI 10.1084/jem.194.6.797; MAEPEA O, 1992, EXP EYE RES, V54, P879, DOI 10.1016/0014-4835(92)90151-H; Perkumas KM, 2012, EXP EYE RES, V96, P82, DOI 10.1016/j.exer.2011.12.017; Ramos RF, 2007, J GLAUCOMA, V16, P391, DOI 10.1097/IJG.0b013e3180654ac6; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Smith R S, 2001, BMC Dev Biol, V1, P3, DOI 10.1186/1471-213X-1-3; Smith R.S., 2002, SYSTEMATIC EVALUATIO; Smith RS, 2002, MOL VIS, V8, P26; Tam ALC, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/42/425101; Truong T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021918; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Wigle JT, 2002, EMBO J, V21, P1505, DOI 10.1093/emboj/21.7.1505; Yucel YH, 2009, EXP EYE RES, V89, P810, DOI 10.1016/j.exer.2009.08.010; Yuen D, 2011, CELL RES, V21, P1745, DOI 10.1038/cr.2011.178	29	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e98245	10.1371/journal.pone.0098245	http://dx.doi.org/10.1371/journal.pone.0098245			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827370	Green Submitted, Green Published, gold			2022-12-27	WOS:000336857400128
J	Ambrogi, F; Fornili, M; Boracchi, P; Trerotola, M; Relli, V; Simeone, P; La Sorda, R; Lattanzio, R; Querzoli, P; Pedriali, M; Piantelli, M; Biganzoli, E; Alberti, S				Ambrogi, Federico; Fornili, Marco; Boracchi, Patrizia; Trerotola, Marco; Relli, Valeria; Simeone, Pasquale; La Sorda, Rossana; Lattanzio, Rossano; Querzoli, Patrizia; Pedriali, Massimo; Piantelli, Mauro; Biganzoli, Elia; Alberti, Saverio			Trop-2 Is a Determinant of Breast Cancer Survival	PLOS ONE			English	Article							CELL-SURFACE GLYCOPROTEIN; DNA METHYLATION PREVENTS; HUMAN CARCINOMAS; P53 STATUS; EXPRESSION; OVEREXPRESSION; PROGNOSIS; ANTIGENS; GENE	Trop-2 is a calcium signal transducer that drives tumor growth. Anti-Trop-2 antibodies with selective reactivity versus Trop-2 maturation stages allowed to identify two different pools of Trop-2, one localized in the cell membrane and one in the cytoplasm. Of note, membrane-localized/functional Trop-2 was found to be differentially associated with determinants of tumor aggressiveness and distinct breast cancer subgroups. These findings candidated Trop-2 states to having an impact on cancer progression. We tested this model in breast cancer. A large, consecutive human breast cancer case series (702 cases; 8 years median follow-up) was analyzed by immunohistochemistry with anti-Trop-2 antibodies with selective reactivity for cytoplasmic-retained versus functional, membrane-associated Trop-2. We show that membrane localization of Trop-2 is an unfavorable prognostic factor for overall survival (1+ versus 0 for all deaths: hazard ratio, 1.63; P = 0.04), whereas intracellular Trop-2 has a favorable impact on prognosis, with an adjusted hazard ratio for all deaths of 0.48 (high versus low; P = 0.003). A corresponding impact of intracellular Trop-2 was found on disease relapse (high versus low: hazard ratio, 0.51; P = 0.004). Altogether, we demonstrate that the Trop-2 activation states are critical determinants of tumor progression and are powerful indicators of breast cancer patients survival.	[Ambrogi, Federico; Fornili, Marco; Boracchi, Patrizia; Biganzoli, Elia] Univ Milan, Dept Clin Sci & Community Hlth, Unit Med Stat Biometry & Bioinformat Giulio A Mac, Milan, Italy; [Trerotola, Marco; Relli, Valeria; Simeone, Pasquale; La Sorda, Rossana; Lattanzio, Rossano; Piantelli, Mauro; Alberti, Saverio] Univ G dAnnunzio, Fdn G DAnnunzio, Dept Biomed Sci, Unit Canc Pathol, Chieti, Italy; [Trerotola, Marco; Relli, Valeria; Simeone, Pasquale; La Sorda, Rossana; Lattanzio, Rossano; Piantelli, Mauro; Alberti, Saverio] Univ G dAnnunzio, Fdn G DAnnunzio, CeSI, Chieti, Italy; [La Sorda, Rossana; Lattanzio, Rossano; Piantelli, Mauro] Univ G DAnnunzio, CeSI, MediaPharma Srl, Chieti, Italy; [Querzoli, Patrizia; Pedriali, Massimo] Univ Ferrara, Dept Expt & Diagnost Med, Surg Pathol Sect, I-44100 Ferrara, Italy; [Biganzoli, Elia] Fdn IRCCS, Ist Nazl Tumori, Milan, Italy; [Alberti, Saverio] Univ G dAnnunzio, Dept Neurosci Imaging & Clin Sci Physiol & Physio, Chieti, Italy; [Alberti, Saverio] Oncoxx Biotech Srl, Chieti, Italy	University of Milan; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; University of Ferrara; Fondazione IRCCS Istituto Nazionale Tumori Milan; G d'Annunzio University of Chieti-Pescara	Alberti, S (corresponding author), Univ G dAnnunzio, Fdn G DAnnunzio, Dept Biomed Sci, Unit Canc Pathol, Chieti, Italy.	s.alberti@unich.it	Fornili, Marco/AAJ-7660-2021; Patrizia, Boracchi/AAB-8851-2019; Trerotola, Marco/J-9015-2016; Alberti, Saverio/M-4511-2014; Lattanzio, Rossano/K-1927-2018; Simeone, Pasquale/K-7549-2016; Biganzoli, Elia/J-1678-2012; Ambrogi, Federico/D-4294-2015	Trerotola, Marco/0000-0003-1855-7002; Alberti, Saverio/0000-0002-4647-6042; Lattanzio, Rossano/0000-0001-9803-4476; Simeone, Pasquale/0000-0003-4430-480X; Biganzoli, Elia/0000-0003-1202-5873; boracchi, patrizia/0000-0001-8506-2005; Ambrogi, Federico/0000-0001-9358-011X; Fornili, Marco/0000-0002-5713-3926; QUERZOLI, Patrizia/0000-0003-2873-8894; Pedriali, Massimo/0000-0003-3113-7352	Fondazione of the Cassa di Risparmio della Provincia di Chieti; EU NoE Biopattern [FP6-2002-IST-1, 508803]; Oncoxx Biotech, Compagnia di San Paolo; Italian Ministry of Health [RicOncol RF-EMR-2006-361866]; Italian Association for Cancer Research (AIRC, Italy)	Fondazione of the Cassa di Risparmio della Provincia di Chieti; EU NoE Biopattern; Oncoxx Biotech, Compagnia di San Paolo(Compagnia di San Paolo); Italian Ministry of Health(Ministry of Health, Italy); Italian Association for Cancer Research (AIRC, Italy)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Fondazione of the Cassa di Risparmio della Provincia di Chieti, the EU NoE Biopattern (FP6-2002-IST-1 no. 508803), Oncoxx Biotech, Compagnia di San Paolo, the Italian Ministry of Health (RicOncol RF-EMR-2006-361866), and the Italian Association for Cancer Research (AIRC, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTI S, 1994, P NATL ACAD SCI USA, V91, P5833, DOI 10.1073/pnas.91.13.5833; ALBERTI S, 1988, P NATL ACAD SCI USA, V85, P8391, DOI 10.1073/pnas.85.22.8391; ALBERTI S, 1992, HYBRIDOMA, V11, P539, DOI 10.1089/hyb.1992.11.539; Alberti S, 2012, JPN J CLIN ONCOL, V42, P1128, DOI 10.1093/jjco/hys159; Ambrogi F, 2006, CLIN CANCER RES, V12, P781, DOI 10.1158/1078-0432.CCR-05-0763; Ambrogi F, 2013, BREAST CANC CANC CLI, V2, P41; Bardou VJ, 2003, J CLIN ONCOL, V21, P1973, DOI 10.1200/JCO.2003.09.099; Biganzoli E, 2003, ANN ONCOL, V14, P1484, DOI 10.1093/annonc/mdg422; Biganzoli E, 2010, CURR BREAST CANCER R, V2, P96, DOI 10.1007/s12609-010-0013-5; Biganzoli E, 2011, JPN J CLIN ONCOL, V41, P172, DOI 10.1093/jjco/hyq227; Blazar M, 2001, MOL CELL BIOL, V21, P2570, DOI 10.1128/MCB.21.7.2570-2580.2001; Cimoli G, 2004, BBA-REV CANCER, V1705, P103, DOI 10.1016/j.bbcan.2004.10.001; Duffy MJ, 2006, CRIT REV CL LAB SCI, V43, P325, DOI 10.1080/10408360600739218; FORNARO M, 1995, INT J CANCER, V62, P610, DOI 10.1002/ijc.2910620520; Guerra E, 2013, ONCOGENE, V32, P1594, DOI 10.1038/onc.2012.151; Guerra E, 2008, CANCER RES, V68, P8113, DOI 10.1158/0008-5472.CAN-07-6135; HELLEMANS P, 1995, BRIT J CANCER, V72, P354, DOI 10.1038/bjc.1995.338; KLEIN CE, 1990, J INVEST DERMATOL, V95, P74, DOI 10.1111/1523-1747.ep12873988; Lin H, 2012, EXP MOL PATHOL; LIPINSKI M, 1981, P NATL ACAD SCI-BIOL, V78, P5147, DOI 10.1073/pnas.78.8.5147; MAKUCH RW, 1982, J CHRON DIS, V35, P437, DOI 10.1016/0021-9681(82)90058-3; Marubini E, 1995, ANAL SURVIVAL DATA C; Mirza AN, 2002, ANN SURG, V235, P10, DOI 10.1097/00000658-200201000-00003; Querzoli P, 2010, BRIT J CANCER, V103, P1835, DOI 10.1038/sj.bjc.6605991; Ripani E, 1998, INT J CANCER, V76, P671; SCHON MP, 1993, INT J CANCER, V55, P988, DOI 10.1002/ijc.2910550619; Spizzo G, 2002, INT J CANCER, V98, P883, DOI 10.1002/ijc.10270; Stoyanova T, 2012, GENE DEV, V26, P2271, DOI 10.1101/gad.196451.112; Tinari N, 2006, CLIN CANCER RES, V12, P1501, DOI 10.1158/1078-0432.CCR-05-0978; Trerotola M, 2013, ONCOGENE, V32, P222, DOI 10.1038/onc.2012.36; Trerotola M, 2013, CANCER RES, V73, P3155, DOI 10.1158/0008-5472.CAN-12-3266; Zanna P, 2007, CANCER-AM CANCER SOC, V110, P452, DOI 10.1002/cncr.22785	32	83	87	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96993	10.1371/journal.pone.0096993	http://dx.doi.org/10.1371/journal.pone.0096993			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824621	Green Submitted, Green Published, gold			2022-12-27	WOS:000336369200046
J	Anbalagan, S; Hesse, RA; Hause, BM				Anbalagan, Srivishnupriya; Hesse, Richard A.; Hause, Ben M.			First Identification and Characterization of Porcine Enterovirus G in the United States	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; WILD BOARS; PICORNAVIRUSES; RECOMBINATION; TESCHOVIRUSES; FEATURES; VIRUS; PIGS	Porcine enterovirus G (EV-G) is a member of the family Picornavirdae, genus Enterovirus. To date, eleven EV-G types (EV-G1 through EV-G11) have been identified in pigs from Asia and Europe however they have never been reported in North America. In this study, we isolated and characterized the complete genome of NP/2013/USA, an EV-G from a porcine diarrhea sample from the United States. The complete genome consists of 7,390 nucleotides excluding the 39 poly(A) tail, and has an open reading frame that encodes a 2,169 amino acid polyprotein. NP/2013/USA was most similar at the nucleotide (84%) and amino acid (95%) level to the HM131607, an EV-G1 type isolated from China in 2012.	[Anbalagan, Srivishnupriya; Hause, Ben M.] Newport Labs Inc, Worthington, MN 56187 USA; [Hesse, Richard A.] Kansas State Univ, Dept Diagnost Med & Pathobiol, Manhattan, KS 66506 USA	Kansas State University	Hause, BM (corresponding author), Newport Labs Inc, Worthington, MN 56187 USA.	bhause@newportlabs.com			Newport Laboratories	Newport Laboratories	This work was funded by Newport Laboratories who, in consultation with the collaborating authors, contributed to the study design, data collection and analysis, decision to publish and preparation of the manuscript.	Adams MJ, 2013, ARCH VIROL, V158, P2023, DOI 10.1007/s00705-013-1688-5; Agol VI, 1999, VIRUS RES, V62, P129, DOI 10.1016/S0168-1702(99)00037-4; Anbalagan S, 2013, J GEN VIROL; AUERBACH J, 1994, J VET MED B, V41, P277, DOI 10.1111/j.1439-0450.1994.tb00228.x; Boros A, 2012, J GEN VIROL, V93, P1941, DOI 10.1099/vir.0.041335-0; Boros A, 2012, ARCH VIROL, V157, P981, DOI 10.1007/s00705-012-1255-5; Boros A, 2011, INFECT GENET EVOL, V11, P1096, DOI 10.1016/j.meegid.2011.04.003; Buitrago D, 2010, J VET DIAGN INVEST, V22, P763, DOI 10.1177/104063871002200519; Chen Q, 2013, J CLIN MICROBIOL; Huang YW, 2013, MBIO, V4, DOI 10.1128/mBio.00737-13; Khetsuriani N, 2006, PEDIATR INFECT DIS J, V25, P889, DOI 10.1097/01.inf.0000237798.07462.32; KNOWLES NJ, 1979, ARCH VIROL, V62, P201, DOI 10.1007/BF01317552; Krumbholz A, 2002, J VIROL, V76, P5813, DOI 10.1128/JVI.76.11.5813-5821.2002; La Rosa G, 2006, J VET MED B, V53, P257, DOI 10.1111/j.1439-0450.2006.00955.x; Lukashev AN, 2010, REV MED VIROL, V20, P327, DOI 10.1002/rmv.660; Moon HJ, 2012, J VIROL, V86, P10250, DOI 10.1128/JVI.01548-12; Nguyen DV, 2013, J GEN VIROL; Palmquist JM, 2002, J VET DIAGN INVEST, V14, P476, DOI 10.1177/104063870201400605; Prodelalova J, 2012, INFECT GENET EVOL, V12, P1447, DOI 10.1016/j.meegid.2012.04.025; Shan TL, 2011, J VIROL, V85, P11697, DOI 10.1128/JVI.05217-11; Simmonds P, 2006, J VIROL, V80, P11124, DOI 10.1128/JVI.01076-06; Sozzi E, 2010, TRANSBOUND EMERG DIS, V57, P434, DOI 10.1111/j.1865-1682.2010.01170.x; Stevenson GW, 2013, J VET DIAGN INVEST, V25, P649, DOI 10.1177/1040638713501675; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Yang SX, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-99; Zell R, 1999, J GEN VIROL, V80, P2299, DOI 10.1099/0022-1317-80-9-2299; Zhang W, 2012, J VIROL, V86, P7008, DOI 10.1128/JVI.00711-12	27	30	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97517	10.1371/journal.pone.0097517	http://dx.doi.org/10.1371/journal.pone.0097517			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824640	Green Published, Green Submitted, gold			2022-12-27	WOS:000336369200126
J	Giordano, JC; Parpinelli, MA; Cecatti, JG; Haddad, SM; Costa, ML; Surita, FG; Silva, JLPE; Sousa, MH				Giordano, Juliana C.; Parpinelli, Mary A.; Cecatti, Jose G.; Haddad, Samira M.; Costa, Maria L.; Surita, Fernanda G.; Pinto e Silva, Joao L.; Sousa, Maria H.			The Burden of Eclampsia: Results from a Multicenter Study on Surveillance of Severe Maternal Morbidity in Brazil	PLOS ONE			English	Article							NEAR-MISS; MORTALITY; PREECLAMPSIA; PREGNANCY; DEATH; INTERVENTIONS; NETWORK; HEALTH; UNIT; CARE	Objective: Maternal mortality (MM) is a core indicator of disparities in women's rights. The study of Near Miss strategic to identifying the breakdowns in obstetrical care. In absolute numbers, both MM and occurrence of eclampsia are rare events. We aim to assess the obstetric care indicators and main predictors for severe maternal outcome from eclampsia (SMO: maternal death plus maternal near miss). Methods: Secondary analysis of a multicenter, cross-sectional study, including 27 centers from all geographic regions of Brazil, from 2009 to 2010. 426 cases of eclampsia were identified and classified according to the outcomes: SMO and non-SMO. We classified facilities as coming from low-and high-income regions and calculated the WHO's obstetric health indicators. SPSS and Stata softwares were used to calculate the prevalence ratios (PR) and respective 95% confidence interval (CI) to assess maternal characteristics, clinical and obstetrical history, and access to health services as predictors for SMO, subsequently correlating them with the corresponding perinatal outcomes, also applying multiple regression analysis (adjusted for cluster effect). Results: Prevalence of and mortality indexes for eclampsia in higher and lower income regions were 0.2%/ 0.8% and 8.1%/22%, respectively. Difficulties in access to health care showed that ICU admission (adjPR 3.61; 95% CI 1.77-7.35) and inadequate monitoring (adjPR 2.31; 95% CI 1.48-3.59) were associated with SMO. Conclusions: Morbidity and mortality associated with eclampsia were high in Brazil, especially in lower income regions. Promoting quality maternal health care and improving the availability of obstetric emergency care are essential actions to relieve the burden of eclampsia.	[Giordano, Juliana C.; Parpinelli, Mary A.; Cecatti, Jose G.; Haddad, Samira M.; Costa, Maria L.; Surita, Fernanda G.; Pinto e Silva, Joao L.] Univ Campinas UNICAMP, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil; [Cecatti, Jose G.; Sousa, Maria H.] Ctr Studies Reprod Hlth Campinas CEMICAMP, Campinas, SP, Brazil	Universidade Estadual de Campinas	Parpinelli, MA (corresponding author), Univ Campinas UNICAMP, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil.	parpinelli@caism.unicamp.br	Surita, Fernanda Garanhani/H-9575-2012; Cecatti, Jose Guilherme/M-5945-2013; Sousa, Maria/HCI-9642-2022; Costa, Maria Laura/I-4980-2019	Surita, Fernanda Garanhani/0000-0003-4335-0337; Cecatti, Jose Guilherme/0000-0003-1285-8445; Costa, Maria Laura/0000-0001-8280-3234	CNPq/DECIT (The National Research Council and the Department of Science and Technology of the Brazilian Ministry of Health) [402702/2008-5]	CNPq/DECIT (The National Research Council and the Department of Science and Technology of the Brazilian Ministry of Health)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The study was financially supported by CNPq/DECIT (The National Research Council and the Department of Science and Technology of the Brazilian Ministry of Health), grant number 402702/2008-5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abalos E, 2013, EUR J OBSTET GYN R B, V170, P1, DOI 10.1016/j.ejogrb.2013.05.005; Brazil, 2010, MILL DEV GOALS NAT R; DATASUS, INF HLTH VIT STAT; DONNER A, 1994, AM J EPIDEMIOL, V140, P279, DOI 10.1093/oxfordjournals.aje.a117247; Duley L, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000127.pub2; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Firoz T, 2011, BEST PRACT RES CL OB, V25, P537, DOI 10.1016/j.bpobgyn.2011.04.002; Fong A, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.05.050; Ghulmiyyah L, 2012, SEMIN PERINATOL, V36, P56, DOI 10.1053/j.semperi.2011.09.011; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Haddad SM, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-101; Haddad SM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-283; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Khosla AH, 2000, INT J GYNECOL OBSTET, V68, P163, DOI 10.1016/S0020-7292(99)00185-X; Knight HE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063846; Knight M, 2007, BJOG-INT J OBSTET GY, V114, P1072, DOI 10.1111/j.1471-0528.2007.01423.x; Kullberg G, 2002, HYPERTENS PREGNANCY, V21, P13, DOI 10.1081/PRG-120002906; Mantel GD, 1998, BRIT J OBSTET GYNAEC, V105, P985, DOI 10.1111/j.1471-0528.1998.tb10262.x; McDonald SD, 2012, INT J GYNECOL OBSTET, V118, P90, DOI 10.1016/j.ijgo.2012.01.028; Morikawa M, 2012, INT J GYNECOL OBSTET, V117, P66, DOI 10.1016/j.ijgo.2011.11.009; Neto AFO, 2009, INT J GYNECOL OBSTET, V105, P252, DOI 10.1016/j.ijgo.2009.01.025; Parpinelli, 2009, REPROD HLTH, V24, P15, DOI [DOI 10.1186/1742-4755-6-15, 10.1186/1742-4755-6-15]; Pattinson R, 2009, B WORLD HEALTH ORGAN, V87, P734, DOI 10.2471/BLT.09.071001; PNUD Brazil, 2010, PROGR UN DEV; Ronsmans C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S8; Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007; Schutte JM, 2008, BJOG-INT J OBSTET GY, V115, P732, DOI 10.1111/j.1471-0528.2008.01702.x; Sousa Maria H, 2008, Reprod Health, V5, P6, DOI 10.1186/1742-4755-5-6; Souza JP, 2010, BJOG-INT J OBSTET GY, V117, P1586, DOI 10.1111/j.1471-0528.2010.02746.x; Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8; UN, 2013, MILL DEV GOALS; Waterstone M, 2001, BMJ-BRIT MED J, V322, P1089, DOI 10.1136/bmj.322.7294.1089; World Health Organization (WHO), 2011, EV QUAL CAR SEV PREG	33	35	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97401	10.1371/journal.pone.0097401	http://dx.doi.org/10.1371/journal.pone.0097401			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24825164	Green Published, Green Submitted, gold			2022-12-27	WOS:000336369200109
J	Honsdorf, N; March, TJ; Berger, B; Tester, M; Pillen, K				Honsdorf, Nora; March, Timothy John; Berger, Bettina; Tester, Mark; Pillen, Klaus			High-Throughput Phenotyping to Detect Drought Tolerance QTL in Wild Barley Introgression Lines	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; WATER-USE EFFICIENCY; ARABIDOPSIS-THALIANA; AGRONOMIC TRAITS; EXOTIC ALLELES; SPRING BARLEY; POWDERY MILDEW; PLANT-GROWTH; LEAF GROWTH; IDENTIFICATION	Drought is one of the most severe stresses, endangering crop yields worldwide. In order to select drought tolerant genotypes, access to exotic germplasm and efficient phenotyping protocols are needed. In this study the high-throughput phenotyping platform "The Plant Accelerator'', Adelaide, Australia, was used to screen a set of 47 juvenile (six week old) wild barley introgression lines (S42ILs) for drought stress responses. The kinetics of growth development was evaluated under early drought stress and well watered treatments. High correlation (r = 0.98) between image based biomass estimates and actual biomass was demonstrated, and the suitability of the system to accurately and non-destructively estimate biomass was validated. Subsequently, quantitative trait loci (QTL) were located, which contributed to the genetic control of growth under drought stress. In total, 44 QTL for eleven out of 14 investigated traits were mapped, which for example controlled growth rate and water use efficiency. The correspondence of those QTL with QTL previously identified in field trials is shown. For instance, six out of eight QTL controlling plant height were also found in previous field and glasshouse studies with the same introgression lines. This indicates that phenotyping juvenile plants may assist in predicting adult plant performance. In addition, favorable wild barley alleles for growth and biomass parameters were detected, for instance, a QTL that increased biomass by approximately 36%. In particular, introgression line S42IL-121 revealed improved growth under drought stress compared to the control Scarlett. The introgression line showed a similar behavior in previous field experiments, indicating that S42IL-121 may be an attractive donor for breeding of drought tolerant barley cultivars.	[Honsdorf, Nora; Pillen, Klaus] Univ Halle Wittenberg, Inst Agr & Nutr Sci, Chair Plant Breeding, D-06108 Halle, Saale, Germany; [Honsdorf, Nora] Interdisciplinary Ctr Crop Plant Res IZN, Halle, Saale, Germany; [March, Timothy John] Univ Adelaide, Sch Agr Food & Wine, Adelaide, SA, Australia; [Berger, Bettina] Univ Adelaide, Adelaide, SA, Australia; [Tester, Mark] King Abdullah Univ Sci & Technol, Ctr Desert Agr, Thuwal, Saudi Arabia	Martin Luther University Halle Wittenberg; University of Adelaide; University of Adelaide; King Abdullah University of Science & Technology	Pillen, K (corresponding author), Univ Halle Wittenberg, Inst Agr & Nutr Sci, Chair Plant Breeding, D-06108 Halle, Saale, Germany.	klaus.pillen@landw.uni-halle.de	Pillen, Klaus/I-6511-2012; Tester, Mark/J-2368-2017; Berger, Bettina/AAH-1190-2021	Pillen, Klaus/0000-0003-4646-6351; Tester, Mark/0000-0002-5085-8801; Berger, Bettina/0000-0003-1195-4478	Interdisciplinary Centre for Crop Plant Research (IZN; German Plant Genome Research Initiative (GABI) of the Federal Ministry of Education and Research (BMBF [0313125B]; Group of Eight Australia Germany Joint Research Co-operation Scheme; German Academic Exchange Service; Group of Eight, Australia	Interdisciplinary Centre for Crop Plant Research (IZN; German Plant Genome Research Initiative (GABI) of the Federal Ministry of Education and Research (BMBF(Federal Ministry of Education & Research (BMBF)); Group of Eight Australia Germany Joint Research Co-operation Scheme; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Group of Eight, Australia	This work was supported by the Interdisciplinary Centre for Crop Plant Research (IZN), Halle (Saale) (http://www.uni-halle.de/izn/), the German Plant Genome Research Initiative (GABI) of the Federal Ministry of Education and Research (BMBF, project 0313125B) (www.gabi.de/), and Group of Eight Australia Germany Joint Research Co-operation Scheme, funded by the German Academic Exchange Service (www. daad. de) and the Group of Eight, Australia (http://www.go8. edu.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum M, 2003, THEOR APPL GENET, V107, P1215, DOI 10.1007/s00122-003-1357-2; Becker H, 2011, PFLANZENZUCHTUNG; Berger B, 2010, J EXP BOT, V61, P3519, DOI 10.1093/jxb/erq201; Cattivelli L, 2008, FIELD CROP RES, V105, P1, DOI 10.1016/j.fcr.2007.07.004; Chen J, 2011, PLANT CELL ENVIRON, V34, P2009, DOI 10.1111/j.1365-3040.2011.02397.x; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Diab AA, 2004, THEOR APPL GENET, V109, P1417, DOI 10.1007/s00122-004-1755-0; Druka A, 2011, BARLEY PRODUCTION IM; El Hafid R, 1998, AGRONOMIE, V18, P181, DOI 10.1051/agro:19980302; Elberse IAM, 2004, HEREDITY, V93, P22, DOI 10.1038/sj.hdy.6800467; FISCHER RA, 1978, AUST J AGR RES, V29, P897, DOI 10.1071/AR9780897; Golzarian MR, 2011, PLANT METHODS, V7, P11; Gottwald S, 2004, MOL GENET GENOMICS, V271, P426, DOI 10.1007/s00438-004-0993-9; Granier C, 2006, NEW PHYTOL, V169, P623, DOI 10.1111/j.1469-8137.2005.01609.x; Jana S, 2005, ABIOTIC STRESSES PLA; Jansen M, 2009, FUNCT PLANT BIOL, V36, P902, DOI 10.1071/FP09095; Jia QJ, 2009, FUNCT INTEGR GENOMIC, V9, P255, DOI 10.1007/s10142-009-0120-4; Karsai I, 2006, PLANT BREEDING, V125, P468, DOI 10.1111/j.1439-0523.2006.01266.x; LAURIE DA, 1995, GENOME, V38, P575, DOI 10.1139/g95-074; Leister D, 1999, PLANT PHYSIOL BIOCH, V37, P671, DOI 10.1016/S0981-9428(00)80097-2; LOPEZCASTANEDA C, 1994, FIELD CROP RES, V37, P63, DOI 10.1016/0378-4290(94)90082-5; Lu ZJ, 1998, J EXP BOT, V49, P1945, DOI 10.1093/jexbot/49.329.1945; Munns R, 2010, J EXP BOT, V61, P3499, DOI 10.1093/jxb/erq199; Naz AA, 2012, PLANT BREEDING, V131, P392, DOI 10.1111/j.1439-0523.2012.01972.x; Pennisi E, 2008, SCIENCE, V320, P171, DOI 10.1126/science.320.5873.171; Pillen K, 2003, THEOR APPL GENET, V107, P340, DOI 10.1007/s00122-003-1253-9; Poorter H, 2005, OECOLOGIA, V142, P360, DOI 10.1007/s00442-004-1705-1; Rajendran K, 2009, PLANT CELL ENVIRON, V32, P237, DOI 10.1111/j.1365-3040.2008.01916.x; Saal B, 2011, EUPHYTICA, V177, P223, DOI 10.1007/s10681-010-0252-6; SAS Institute, 2008, SAS ENT GUID WIND RE; Schmalenbach I, 2009, THEOR APPL GENET, V118, P483, DOI 10.1007/s00122-008-0915-z; Schmalenbach I, 2008, THEOR APPL GENET, V117, P1093, DOI 10.1007/s00122-008-0847-7; Schmalenbach I, 2011, G3-GENES GENOM GENET, V1, P187, DOI 10.1534/g3.111.000182; Schmalenbach I, 2009, THEOR APPL GENET, V118, P1411, DOI 10.1007/s00122-009-0991-8; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Tanksley SD, 1996, THEOR APPL GENET, V92, P191, DOI 10.1007/BF00223376; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Teulat B, 2002, THEOR APPL GENET, V106, P118, DOI 10.1007/s00122-002-1028-8; Tyagi K, 2011, PAK J BOT, V43, P475; von Korff M, 2006, THEOR APPL GENET, V112, P1221, DOI 10.1007/s00122-006-0223-4; von Korff M, 2005, THEOR APPL GENET, V111, P583, DOI 10.1007/s00122-005-2049-x; von Korff M, 2004, THEOR APPL GENET, V109, P1736, DOI 10.1007/s00122-004-1818-2; von Korff M, 2008, MOL BREEDING, V21, P81, DOI 10.1007/s11032-007-9110-1; von Korff M, 2010, THEOR APPL GENET, V121, P1455, DOI 10.1007/s00122-010-1401-y; Wang GW, 2010, THEOR APPL GENET, V120, P1559, DOI 10.1007/s00122-010-1276-y; Wang Y, 2012, MOL BREEDING, V29, P661, DOI 10.1007/s11032-011-9580-z; Yin X, 1999, THEOR APPL GENET, V99, P244, DOI 10.1007/s001220051230; Zamir D, 2001, NAT REV GENET, V2, P983, DOI 10.1038/35103590; Zhao J, 2010, EUPHYTICA, V172, P395, DOI 10.1007/s10681-009-0064-8	49	148	158	1	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97047	10.1371/journal.pone.0097047	http://dx.doi.org/10.1371/journal.pone.0097047			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24823485	Green Published, gold, Green Submitted			2022-12-27	WOS:000336369200054
J	Tian, ET; Zeng, FQ; MacKay, K; Roslinsky, V; Cheng, BF				Tian, Entang; Zeng, Fangqin; MacKay, Kimberly; Roslinsky, Vicky; Cheng, Bifang			Detection and Molecular Characterization of Two FAD3 Genes Controlling Linolenic Acid Content and Development of Allele-Specific Markers in Yellow Mustard (Sinapis alba)	PLOS ONE			English	Article							SEED QUALITY TRAITS; OIL; RESISTANCE; IDENTIFICATION; TRIPLICATION; SEQUENCE; L.	Development of yellow mustard (Sinapis alba L.) with superior quality traits (low erucic and linolenic acid contents, and low glucosinolate content) can make this species as a potential oilseed crop. We have recently isolated three inbred lines Y1127, Y514 and Y1035 with low (3.8%), medium (12.3%) and high (20.8%) linolenic acid (C18:3) content, respectively, in this species. Inheritance studies detected two fatty acid desaturase 3 (FAD3) gene loci controlling the variation of C18:3 content. QTL mapping revealed that the two FAD3 gene loci responsible for 73.0% and 23.4% of the total variation and were located on the linkage groups Sal02 and Sal10, respectively. The FAD3 gene on Sal02 was referred to as SalFAD3.LA1 and that on Sal10 as SalFAD3.LA2. The dominant and recessive alleles were designated as LA(1) and la(1) for SalFAD3.LA1, and LA(2) and la(2) for SalFAD3.LA2. Cloning and alignment of the coding and genomic DNA sequences revealed that the SalFAD3.LA1 and SalFAD3.LA2 genes each contained 8 exons and 7 introns.LA(1) had a coding DNA sequence (CDS) of 1143 bp encoding a polypeptide of 380 amino acids, whereas la(1) was a loss-of-function allele due to an insertion of 584 bp in exon 3. Both LA(2) and la(2) had a CDS of 1152 bp encoding a polypeptide of 383 amino acids. Allele-specific markers for LA(1), la(1), LA(2) and la(2) co-segregated with the C18:3 content in the F-2 populations and will be useful for improving fatty acid composition through marker assisted selection in yellow mustard breeding.	[Tian, Entang; Zeng, Fangqin; MacKay, Kimberly; Roslinsky, Vicky; Cheng, Bifang] Agr & Agri Food Canada, Saskatoon Res Ctr, Saskatoon, SK, Canada	Agriculture & Agri Food Canada	Cheng, BF (corresponding author), Agr & Agri Food Canada, Saskatoon Res Ctr, Saskatoon, SK, Canada.	bifang.cheng@agr.gc.ca		Tian, Entang/0000-0002-9039-3666; MacKay, Kimberly/0000-0001-6417-725X	Developing Innovative Agri-Products Initiative of the Growing Canadian Agri-Innovations Program (DIAP); Growing Forward II - Agri-Innovation Program Mustard 21 Canada Inc. [AIP-P027]; Agriculture Development Fund (ADF) of Saskatchewan, Canada [20100032]	Developing Innovative Agri-Products Initiative of the Growing Canadian Agri-Innovations Program (DIAP); Growing Forward II - Agri-Innovation Program Mustard 21 Canada Inc.; Agriculture Development Fund (ADF) of Saskatchewan, Canada	The condiment yellow mustard breeding and research programs are supported by the Developing Innovative Agri-Products Initiative of the Growing Canadian Agri-Innovations Program (DIAP), Growing Forward II - Agri-Innovation Program (AIP-P027), Mustard 21 Canada Inc. and the Agriculture Development Fund (ADF) of Saskatchewan (grant No 20100032), Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baux A, 2008, EUR J AGRON, V29, P102, DOI 10.1016/j.eja.2008.04.005; BODNARYK RP, 1991, CAN J PLANT SCI, V71, P13, DOI 10.4141/cjps91-002; Bundrock T, 1998, THESIS U SASKATCHEWA; Cheng Bifang, 2012, Plants (Basel), V1, P16, DOI 10.3390/plants1010016; DOWNEY R. K., 1963, CANADIAN JOUR PLANT SCI, V43, P271; ECKER R, 1993, EUPHYTICA, V69, P45, DOI 10.1007/BF00021724; Elliott RH, 1999, P 10 INT RAP C CAMB; Gugel RK, 1997, BRASS 97 INT SOC HOR, P222; Hu XY, 2006, THEOR APPL GENET, V113, P497, DOI 10.1007/s00122-006-0315-1; Javidfar F, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-142; Katepa-Mupondwa F, 2006, CAN J PLANT SCI, V86, P1015, DOI 10.4141/P05-185; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lysak MA, 2005, GENOME RES, V15, P516, DOI 10.1101/gr.3531105; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Mikolajczyk K, 2010, PLANT BREEDING, V129, P502, DOI 10.1111/j.1439-0523.2009.01730.x; Nelson MN, 2006, GENOME, V49, P230, DOI 10.1139/G05-099; NISHIUCHI T, 1994, PLANT PHYSIOL, V105, P767, DOI 10.1104/pp.105.2.767; Panjabi P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-113; PLEINES S, 1989, THEOR APPL GENET, V78, P793, DOI 10.1007/BF00266660; Rahman H, 2013, THEOR APPL GENET, V126, P1587, DOI 10.1007/s00122-013-2076-y; Rajcan I, 2002, EUPHYTICA, V123, P401, DOI 10.1023/A:1015057923578; RANEY P, 1995, P 9 INT RAP C CAMBR, V2, P416; ROBBELEN G, 1975, Z PFLANZENZUCHT, V75, P93; Scarth R, 2006, CROP SCI, V46, P1225, DOI 10.2135/cropsci2005.08-0245; SIEBERT PD, 1995, NUCLEIC ACIDS RES, V23, P1087, DOI 10.1093/nar/23.6.1087; Somers DJ, 1998, THEOR APPL GENET, V96, P897, DOI 10.1007/s001220050817; THIES W, 1971, Z PFLANZENZUCHTUNG, V65, P181; THOMPSON KF, 1963, NATURE, V198, P209, DOI 10.1038/198209a0; Van Ooijen J.W., 2009, MAPQTL 6 SOFTWARE MA; Van Ooijen JW, 2006, JOINMAP VERSION 4 0; Yang L, 2007, BIOINFORMATICS, V23, P2174, DOI 10.1093/bioinformatics/btm296; Yang QY, 2012, THEOR APPL GENET, V125, P715, DOI 10.1007/s00122-012-1863-1	32	12	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97430	10.1371/journal.pone.0097430	http://dx.doi.org/10.1371/journal.pone.0097430			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24823372	Green Published, gold, Green Submitted			2022-12-27	WOS:000336369200113
J	Bley, AS; Correa, JCF; Dos Reis, AC; Rabelo, NDD; Marchetti, PH; Lucareli, PRG				Bley, Andre Serra; Ferrari Correa, Joao Carlos; Dos Reis, Amir Curcio; Dos Anjos Rabelo, Nayra Deise; Marchetti, Paulo Henrique; Garcia Lucareli, Paulo Roberto			Propulsion Phase of the Single Leg Triple Hop Test in Women with Patellofemoral Pain Syndrome: A Biomechanical Study	PLOS ONE			English	Article							LOWER-EXTREMITY KINEMATICS; MUSCLE-ACTIVATION; HIP STRENGTH; JOINT KINEMATICS; KNEE KINEMATICS; VERTICAL JUMP; FEMALES; MECHANICS; PERSPECTIVE; PRESSURES	Asymmetry in the alignment of the lower limbs during weight-bearing activities is associated with patellofemoral pain syndrome (PFPS), caused by an increase in patellofemoral (PF) joint stress. High neuromuscular demands are placed on the lower limb during the propulsion phase of the single leg triple hop test (SLTHT), which may influence biomechanical behavior. The aim of the present cross-sectional study was to compare kinematic, kinetic and muscle activity in the trunk and lower limb during propulsion in the SLTHT using women with PFPS and pain free controls. The following measurements were made using 20 women with PFPS and 20 controls during propulsion in the SLTHT: kinematics of the trunk, pelvis, hip, and knee; kinetics of the hip, knee and ankle; and muscle activation of the gluteus maximus (GM), gluteus medius (GMed), biceps femoris (BF) and vastus lateralis (VL). Differences between groups were calculated using three separate sets of multivariate analysis of variance for kinematics, kinetics, and electromyographic data. Women with PFPS exhibited ipsilateral trunk lean; greater trunk flexion; greater contralateral pelvic drop; greater hip adduction and internal rotation; greater ankle pronation; greater internal hip abductor and ankle supinator moments; lower internal hip, knee and ankle extensor moments; and greater GM, GMed, BL, and VL muscle activity. The results of the present study are related to abnormal movement patterns in women with PFPS. We speculated that these findings constitute strategies to control a deficient dynamic alignment of the trunk and lower limb and to avoid PF pain. However, the greater BF and VL activity and the extensor pattern found for the hip, knee, and ankle of women with PFPS may contribute to increased PF stress.	[Bley, Andre Serra; Ferrari Correa, Joao Carlos; Dos Reis, Amir Curcio; Dos Anjos Rabelo, Nayra Deise; Garcia Lucareli, Paulo Roberto] Univ Nove de Julho, Human Mot Anal Lab, Dept Rehabil Sci, Sao Paulo, Brazil; [Marchetti, Paulo Henrique] Univ Metodista Piracicaba, UNIMEP, Post Grad Program Human Movement Sci, Sao Paulo, Brazil; [Marchetti, Paulo Henrique] Fac Phys Educ YMCA, Sao Paulo, Brazil	Universidade Nove de Julho; Universidade Metodista de Piracicaba	Lucareli, PRG (corresponding author), Univ Nove de Julho, Human Mot Anal Lab, Dept Rehabil Sci, Sao Paulo, Brazil.	paulolucareli@uninove.br	Correa, Joao/D-9312-2015; Lucareli, Paulo Roberto Garcia/D-3965-2009	Correa, Joao/0000-0002-8642-9814; Lucareli, Paulo Roberto Garcia/0000-0002-7148-575X				Aminaka N, 2011, J ELECTROMYOGR KINES, V21, P645, DOI 10.1016/j.jelekin.2011.03.007; Augustsson J, 2006, SCAND J MED SCI SPOR, V16, P111, DOI 10.1111/j.1600-0838.2005.00446.x; Barre A, 2014, COMPUT METH PROG BIO, V114, DOI 10.1016/j.cmpb.2014.01.012; Barton CJ, 2013, BRIT J SPORT MED, V47, P207, DOI 10.1136/bjsports-2012-090953; Barton CJ, 2009, GAIT POSTURE, V30, P405, DOI 10.1016/j.gaitpost.2009.07.109; Bizzini M, 2003, J ORTHOP SPORT PHYS, V33, P4, DOI 10.2519/jospt.2003.33.1.4; Blache Y, 2013, SCAND J MED SCI SPOR, V23, pe121, DOI 10.1111/sms.12042; Blackburn JT, 2009, J ATHL TRAINING, V44, P174, DOI 10.4085/1062-6050-44.2.174; Bolgla LA, 2008, J ORTHOP SPORT PHYS, V38, P12, DOI 10.2519/jospt.2008.2462; Bolgla LA, 2011, INT J SPORTS PHYS TH, V6, P285; Brechter JH, 2002, GAIT POSTURE, V16, P115, DOI 10.1016/S0966-6362(02)00090-5; Cates W, 2009, CLIN SPORT MED, V28, P63, DOI 10.1016/j.csm.2008.09.003; Collado H, 2010, CLIN SPORT MED, V29, P379, DOI 10.1016/j.csm.2010.03.012; Coventry E, 2006, CLIN BIOMECH, V21, P1090, DOI 10.1016/j.clinbiomech.2006.07.004; Crossley KM, 2004, ARCH PHYS MED REHAB, V85, P815, DOI 10.1016/S0003-9993(03)00613-0; da Cunha RA, 2013, J ORTHOP SPORT PHYS, V43, P332, DOI 10.2519/jospt.2013.4228; DAVIS RB, 1991, HUM MOVEMENT SCI, V10, P575, DOI 10.1016/0167-9457(91)90046-Z; Draper CE, 2012, J ORTHOP RES, V30, P209, DOI 10.1002/jor.21523; Earl JE, 2007, J ORTHOP SPORT PHYS, V37, P245, DOI 10.2519/jospt.2007.2202; Elias JJ, 2011, CLIN BIOMECH, V26, P841, DOI 10.1016/j.clinbiomech.2011.03.016; Fitzgerald GK, 2001, J ORTHOP SPORT PHYS, V31, P588, DOI 10.2519/jospt.2001.31.10.588; Fukuda TY, 2012, J ORTHOP SPORT PHYS, V42, P823, DOI 10.2519/jospt.2012.4184; Halabchi Farzin, 2013, Asian J Sports Med, V4, P85, DOI 10.5812/asjsm.34488; Hamilton RT, 2008, J ATHL TRAINING, V43, P144, DOI 10.4085/1062-6050-43.2.144; Hara M, 2008, HUM MOVEMENT SCI, V27, P636, DOI 10.1016/j.humov.2008.04.001; Hara M, 2006, J BIOMECH, V39, P2503, DOI 10.1016/j.jbiomech.2005.07.030; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Ireland ML, 2003, J ORTHOP SPORT PHYS, V33, P671, DOI 10.2519/jospt.2003.33.11.671; Jacobs CA, 2007, J ATHL TRAINING, V42, P76; Jeon HS, 2001, J ORTHOP SPORT PHYS, V31, P122, DOI 10.2519/jospt.2001.31.3.122; KADABA MP, 1990, J ORTHOP RES, V8, P383, DOI 10.1002/jor.1100080310; Kaya D, 2011, KNEE SURG SPORT TR A, V19, P242, DOI 10.1007/s00167-010-1290-2; Lankhorst NE, 2012, J ORTHOP SPORT PHYS, V42, P81, DOI 10.2519/jospt.2012.3803; Lee TQ, 2003, J ORTHOP SPORT PHYS, V33, P686, DOI 10.2519/jospt.2003.33.11.686; Lephart SM, 2002, CLIN ORTHOP RELAT R, P162; Li G, 2004, J ORTHOP RES, V22, P801, DOI 10.1016/j.orthres.2003.11.011; Macrum E, 2012, J SPORT REHABIL, V21, P144, DOI 10.1123/jsr.21.2.144; Nakagawa TH, 2012, J ORTHOP SPORT PHYS, V42, P491, DOI 10.2519/jospt.2012.3987; Nakagawa TH, 2012, MED SCI SPORT EXER, V44, P1747, DOI 10.1249/MSS.0b013e318256903a; Pappas E, 2012, SPORTS HEALTH, V4, P115, DOI 10.1177/1941738111432097; Petschnig R, 1998, J ORTHOP SPORT PHYS, V28, P23, DOI 10.2519/jospt.1998.28.1.23; Pollard CD, 2010, CLIN BIOMECH, V25, P142, DOI 10.1016/j.clinbiomech.2009.10.005; Portney LG, 2000, FDN CLIN RES APPL PR, V2; Powers CM, 2010, J ORTHOP SPORT PHYS, V40, P42, DOI 10.2519/jospt.2010.3337; Powers CM, 2003, J ORTHOP SPORT PHYS, V33, P639, DOI 10.2519/jospt.2003.33.11.639; Salsich GB, 2012, J ORTHOP SPORT PHYS, V42, P1017, DOI 10.2519/jospt.2012.4231; Souza RB, 2010, J ORTHOP SPORT PHYS, V40, P277, DOI 10.2519/jospt.2010.3215; Souza RB, 2009, J ORTHOP SPORT PHYS, V39, P12, DOI 10.2519/jospt.2009.2885; Thomee R, 1999, SPORTS MED, V28, P245, DOI 10.2165/00007256-199928040-00003; Willson JD, 2008, CLIN BIOMECH, V23, P203, DOI 10.1016/j.clinbiomech.2007.08.025; Willson JD, 2009, J SPORT REHABIL, V18, P76, DOI 10.1123/jsr.18.1.76; Witvrouw E, 2014, BRIT J SPORT MED, V48, P411, DOI 10.1136/bjsports-2014-093450	52	27	28	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97606	10.1371/journal.pone.0097606	http://dx.doi.org/10.1371/journal.pone.0097606			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830289	Green Submitted, gold, Green Published			2022-12-27	WOS:000336789500085
J	Li, XL; Wei, HX; Zhang, H; Peng, HJ; Lindsay, DS				Li, Xue-Lan; Wei, Hai-Xia; Zhang, Hao; Peng, Hong-Juan; Lindsay, David S.			A Meta Analysis on Risks of Adverse Pregnancy Outcomes in Toxoplasma gondii Infection	PLOS ONE			English	Article							EARLY POSTNATAL DIAGNOSIS; TO-CHILD TRANSMISSION; CONGENITAL TOXOPLASMOSIS; PRENATAL-DIAGNOSIS; MULTICENTER; WOMEN; PREVENTION	Objective: Quantified risks of congenital Toxoplasma gondii infection and abnormal pregnancy outcomes following primary maternal infection were evaluated with meta-analysis based on published studies. Methods: The related literatures were searched in multiple literature databases regardless of languages. Odds ratio (OR) and 95% confidence interval (CI) were used to evaluate the risks of vertical transmission of Toxoplasma gondii and abnormal pregnancy outcomes following primary maternal infection with meta-analysis. Results: 53 of the 2632 searched literatures were included in our analysis. The incidence of abnormal pregnancy outcomes in T. gondii infected pregnant women (infected group) was significantly higher than that in the uninfected pregnant women (control group) (OR = 5.10; 95% CI, 3.85-6.75). Toxoplasma gondii infection rate in the abnormal-pregnancy-outcome group was significantly higher than in the normal-pregnancy group (OR = 3.71; 95% CI, 3.31-4.15). The pooled rate of vertical transmission was 20% (95% CI, 15%-26%) in maternal infection of T. gondii. The incidences of vertical transmission in women who were infected in the first, second or third trimester of pregnancy were 5% (95% CI, 2%-16%), 13% (95% CI, 7%-23%), and 32% (95% CI, 24%-41%), respectively. The rates of vertical transmission in women who were treated with spiramycin-only, PSF (pyrimethamine + sulfadiazine + folinic acid) or PS (pyrimethamine + sulfadiazine) combined with spiramycin, or other untypical treatments were 13% (95% CI, 7%-22%), 13%(95% CI, 7%-25%), and 24%(95% CI, 18%-32%), respectively. Conclusions: Toxoplasma gondii infection can result in adverse pregnancy outcomes in pregnant women. The pooled rate of vertical transmission was 20% in maternal infection and the incidences of vertical transmission increased in the first, second or third trimester of pregnancy. The pooled rates of transmission in groups treated with spiramycin-only, PSF or PS combined with spiramycin, or other untypical treatments were not significantly different.	[Li, Xue-Lan; Wei, Hai-Xia; Zhang, Hao; Peng, Hong-Juan] Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Pathogen Biol, Guangzhou, Guangdong, Peoples R China; [Zhang, Hao] Southern Med Univ, Dept Infect Dis, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China; [Zhang, Hao] Southern Med Univ, Hepatol Unit, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China; [Lindsay, David S.] Virginia Tech, Dept Biomed Sci & Pathobiol, VA MD Reg Coll Vet Med, Blacksburg, VA USA	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Virginia Polytechnic Institute & State University	Peng, HJ (corresponding author), Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Pathogen Biol, Guangzhou, Guangdong, Peoples R China.	hongjuan@smu.edu.cn; lindsayd@vt.edu	Lindsay, David S/G-8891-2016; Peng, Hongjuan/GYV-5462-2022	Lindsay, David S/0000-0002-0592-8321; 	National Natural Science Foundation of China [81071377, 81271866]; Research Fund for the Doctoral Program of Higher Education of China [20104433120014]; Guangdong Province talent introduction of special funds [2011-67]; Guangdong provincial key scientific and technological project [2011B010500003]; Guangdong Province College Students Renovation Experimental Program [1212111020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Guangdong Province talent introduction of special funds; Guangdong provincial key scientific and technological project; Guangdong Province College Students Renovation Experimental Program	Supported by the funding of National Natural Science Foundation of China (No. 81071377, 81271866), the Research Fund for the Doctoral Program of Higher Education of China (20104433120014), Guangdong Province talent introduction of special funds (2011-67), Guangdong provincial key scientific and technological project (2011B010500003), the Guangdong Province College Students Renovation Experimental Program (1212111020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljumaili ZKM, 2013, IRAQ INT J INFECT MI, V2, P70; Antsaklis A, 2002, PRENATAL DIAG, V22, P1107, DOI 10.1002/pd.476; BERREBI A, 1994, LANCET, V344, P36, DOI 10.1016/S0140-6736(94)91054-5; Berrebi A, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.002; Bojar I, 2010, ANN AGR ENV MED, V17, P209; Buffolano W, 2005, J CLIN MICROBIOL, V43, P5916, DOI 10.1128/JCM.43.12.5916-5924.2005; Cao MG, 2004, QILU J MED LAB SCI, V15, P30; Chen HM, 2004, J PUBLIC HLTH, V15, P14; Chen HM, 2004, J PUBLIC HLTH, V15, P19; Chen MR, 2006, MED IND INFORM, V3, P34; Chen XJ, 2007, J CHANGCHUN U TRADIT, V23, P92; Dar FK, 1997, EUR J EPIDEMIOL, V13, P567, DOI 10.1023/A:1007392703037; Das Sarkar M, 2012, J HEALTH POPUL NUTR, V30, P87, DOI 10.3329/jhpn.v30i1.11287; DESMONTS G, 1974, NEW ENGL J MED, V290, P1110, DOI 10.1056/NEJM197405162902003; DESMONTS G, 1974, B NEW YORK ACAD MED, V50, P146; Di Carlo Paola, 2005, Infez Med, V13, P72; Dubey JP, 2009, INT J PARASITOL, V39, P877, DOI 10.1016/j.ijpara.2009.01.005; Dubey JP., 2022, TOXOPLASMOSIS ANIMAL, V3rd, P1; Dunn D, 1999, LANCET, V353, P1829, DOI 10.1016/S0140-6736(98)08220-8; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fang L, 2012, CHINESE J BIRTH HLTH, V20, P71; Fang L, 2012, CHINESE J BIRTH HLTH, V20, P78; Foulon W, 1999, AM J OBSTET GYNECOL, V181, P843, DOI 10.1016/S0002-9378(99)70311-X; Foulon W, 1999, AM J OBSTET GYNECOL, V180, P410, DOI 10.1016/S0002-9378(99)70224-3; Freeman K, 2005, BJOG-INT J OBSTET GY, V112, P31, DOI 10.1111/j.1471-0528.2004.00299.x; Gilbert R, 2001, EPIDEMIOL INFECT, V127, P113, DOI 10.1017/S095026880100560X; Gratzl R, 1998, EUR J CLIN MICROBIOL, V17, P853, DOI 10.1007/s100960050206; Guo EP, 2008, MODERN PREVENTIVE ME, V35, P3823; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HOHLFELD P, 1994, NEW ENGL J MED, V331, P695, DOI 10.1056/NEJM199409153311102; HOLLIMAN RE, 1995, J HOSP INFECT, V30, P179, DOI 10.1016/0195-6701(95)90018-7; Hotop A, 2012, CLIN INFECT DIS, V54, P1545, DOI 10.1093/cid/cis234; Hu CM, 2004, PRACTICAL PREVENTIVE, V11, P356; Jenum PA, 1998, J CLIN MICROBIOL, V36, P2900, DOI 10.1128/JCM.36.10.2900-2906.1998; Jones JL, 2001, OBSTET GYNECOL SURV, V56, P296, DOI 10.1097/00006254-200105000-00025; Kishore J, 2011, J INFECT DEV COUNTR, V5, P868, DOI 10.3855/jidc.1533; Lebech M, 1999, LANCET, V353, P1834, DOI 10.1016/S0140-6736(98)11281-3; Li BY, 2006, MATERN CHILD HLTH J, V21, P1628; Liu J, 2004, CHINESE J CHILD HLTH, V12, P313; Logar J, 2002, SCAND J INFECT DIS, V34, P201, DOI 10.1080/00365540110080386; Long Cong, 2011, Journal of Tropical Medicine (Guangzhou), V11, P1281; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mombro M, 2003, EUR J PEDIATR, V162, P703, DOI 10.1007/s00431-003-1248-1; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Moyo SR, 1995, INT J GYNECOL OBSTET, V51, P211, DOI 10.1016/0020-7292(95)02526-X; Naessens A, 1999, J PEDIATR-US, V135, P714, DOI 10.1016/S0022-3476(99)70090-9; Nimri L, 2004, AM J TROP MED HYG, V71, P831, DOI 10.4269/ajtmh.2004.71.831; Olariu TR, 2011, PEDIATR INFECT DIS J, V30, P1056, DOI 10.1097/INF.0b013e3182343096; PRATLONG F, 1994, PRENATAL DIAG, V14, P191, DOI 10.1002/pd.1970140309; Prusa AR, 2013, NEONATOLOGY, V103, P27, DOI 10.1159/000342625; Qiu JZ, 2011, CHINESE J CLIN RATIO, V04, P100; Ricci M, 2003, J Matern Fetal Neonatal Med, V14, P398, DOI 10.1080/14767050412331312250; Robert Koch Institute, 2007, EPIDEMIOL B, V42, P390; Robert-Gangneux F, 1999, J CLIN MICROBIOL, V37, P2893, DOI 10.1128/JCM.37.9.2893-2898.1999; Sahwi S Y, 1995, J Obstet Gynaecol (Tokyo 1995), V21, P145; Su CK, 2002, CHINESE J BIRTH HLTH, V10, P78; Suo QingLi, 2011, Modern Preventive Medicine, V38, P863; Suo QL, 2011, MODERN PREVENTIVE ME, V38, P868; Torgerson PR, 2013, B WORLD HEALTH ORGAN, V91, P501, DOI 10.2471/BLT.12.111732; Wallon M, 2013, CLIN INFECT DIS, V56, P1223, DOI 10.1093/cid/cit032; Wang J, 2011, J SHENYANG MED COLL, V13, P81; Wang JY, 2011, CHINESE J CLIN RATIO, V04, P97; Wang KB, 2012, LAB MED CLIN, V9, P1449; Wang ShuPing, 2008, Journal of Tropical Medicine (Guangzhou), V8, P505; Wei SZ, 2005, CHINESE J BIRTH HLTH, V13, P108; Wen Liang-zhen, 2003, Zhonghua Fu Chan Ke Za Zhi, V38, P331; Weng H, 2009, CHINESE J BIRTH HLTH, V17, P78; Xie DC, 2006, J GUANGXI U CHINESE, V9, P42; Xue C L, 2000, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V18, P55; Yan Q, 2006, MODERN MED HLTH, V22, P1654; Yang AJ, 2005, PRACTICAL PREVENTIVE, V12, P1434; Ye HZ, 2005, CHINESE PRIMARY HLTH, V19, P12; Yuan WenYing, 2009, Maternal and Child Health Care of China, V24, P4416; Zhan HY, 2008, CHINESE J BIRTH HLTH, V16, P72; Zhang Y, 2002, J TIANJIN MED U, V8, P469; 杨琼芬, 2003, [中华流行病学杂志, Chinese Journal of Epidemiology], V24, P853	76	36	46	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97775	10.1371/journal.pone.0097775	http://dx.doi.org/10.1371/journal.pone.0097775			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830795	Green Published, gold, Green Submitted			2022-12-27	WOS:000336789500114
J	Toda, H; Boku, S; Nakagawa, S; Inoue, T; Kato, A; Takamura, N; Song, N; Nibuya, M; Koyama, T; Kusumi, I				Toda, Hiroyuki; Boku, Shuken; Nakagawa, Shin; Inoue, Takeshi; Kato, Akiko; Takamura, Naoki; Song, Ning; Nibuya, Masashi; Koyama, Tsukasa; Kusumi, Ichiro			Maternal Separation Enhances Conditioned Fear and Decreases the mRNA Levels of the Neurotensin Receptor 1 Gene with Hypermethylation of This Gene in the Rat Amygdala	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; ROSTRAL VENTROMEDIAL MEDULLA; ANXIETY DISORDERS; PROTEIN-SYNTHESIS; CENTRAL NUCLEUS; MEMORY; EXTINCTION; MECHANISMS; EXPRESSION; RECONSOLIDATION	Stress during postnatal development is associated with an increased risk for depression, anxiety disorders, and substance abuse later in life, almost as if mental illness is able to be programed by early life stressors. Recent studies suggest that such "programmed" effects can be caused by epigenetic regulation. With respect to conditioned fear, previous studies have indicated that early life stress influences its development in adulthood, whereas no potential role of epigenetic regulation has been reported. Neurotensin (NTS) is an endogenous neuropeptide that has receptors densely located in the amygdala and hippocampus. Recently, NTS systems have constituted an emerging target for the treatment of anxiety. The aim of the present work is to clarify whether the NTS system is involved in the disturbance of conditioned fear in rats stressed by maternal separation (MS). The results showed that MS enhanced freezing behaviors in fear-conditioned stress and reduced the gene expression of NTS receptor (NTSR) 1 but not of NTS or NTSR2 in the amygdalas of adult rats. The microinjection of a NTSR1 antagonist into the amygdala increased the percentage of freezing in conditioned fear, whereas the microinjection of NTSR1 agonist decreased freezing. These results suggest that NTSR1 in the amygdala may play a role in the effects of MS on conditioned fear stress in adult rats. Moreover, MS increased DNA methylation in the promoter region of NTSR1 in the amygdala. Taken together, MS may leave epigenetic marks in the NTSR1 gene in the amygdala, which may enhance conditioned fear in adulthood. The MS-induced alternations of DNA methylation in the promoter region of NTSR1 in the amygdala may be associated with vulnerability to the development of anxiety disorders and depression in adulthood.	[Toda, Hiroyuki; Nibuya, Masashi] Natl Def Med Coll, Dept Psychiat, Tokorozawa, Saitama 359, Japan; [Toda, Hiroyuki; Nakagawa, Shin; Inoue, Takeshi; Kato, Akiko; Song, Ning; Koyama, Tsukasa; Kusumi, Ichiro] Hokkaido Univ, Grad Sch Med, Dept Psychiat, Sapporo, Hokkaido, Japan; [Boku, Shuken] Albert Einstein Coll Med, Dept Psychiat & Behav Sci, Bronx, NY 10467 USA; [Takamura, Naoki] Dainippon Sumitomo Pharma Co Ltd, Pharmaceut Labs, Osaka, Japan; [Song, Ning] China Med Univ, Hosp 1, Dept Psychiat, Shenyang, Peoples R China	National Defense Medical College - Japan; Hokkaido University; Yeshiva University; Albert Einstein College of Medicine; Dainippon Sumitomo Pharmaceutical Company; China Medical University	Nakagawa, S (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Psychiat, Sapporo, Hokkaido, Japan.	snakaga@med.hokudai.ac.jp	Inoue, Takeshi/D-7431-2012; Boku, Shuken/H-2776-2017; Inoue, Takeshi/X-8057-2019	Inoue, Takeshi/0000-0001-5248-1289; Nibuya, Masashi/0000-0002-8292-2302	JSPS KAKENHI [18591269, 24791248]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by JSPS KAKENHI Grant Numbers 18591269 (Shin Nakagawa) and 24791248 (Hiroyuki Toda). http://kaken.nii.ac.jp/d/r/60360905.ja.html http://research-er.jp/researchers/view/00610677/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisa B, 2009, PSYCHONEUROENDOCRINO; Alexander MJ, 1998, J COMP NEUROL, V402, P475; Bentz D, 2010, J ANXIETY DISORD, V24, P223, DOI 10.1016/j.janxdis.2009.10.011; Binder EB, 2001, PHARMACOL REV, V53, P453; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Buhler AV, 2008, PAIN, V135, P280, DOI 10.1016/j.pain.2007.06.010; Buhler AV, 2005, PAIN, V114, P285, DOI 10.1016/j.pain.2004.12.031; CARTER RB, 1991, PAIN, V47, P211, DOI 10.1016/0304-3959(91)90207-E; Classen CC, 2005, TRAUMA VIOLENCE ABUS, V6, P103, DOI 10.1177/1524838005275087; CLINESCHMIDT BV, 1979, EUR J PHARMACOL, V54, P129, DOI 10.1016/0014-2999(79)90415-1; Cougle JR, 2010, PSYCHIAT RES, V177, P150, DOI 10.1016/j.psychres.2009.03.008; Cuthbert BN, 2003, PSYCHOPHYSIOLOGY, V40, P407, DOI 10.1111/1469-8986.00043; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; Erabi K, 2007, INT J NEUROPSYCHOPH, V10, P369, DOI 10.1017/S1461145706006675; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; GULLY D, 1993, P NATL ACAD SCI USA, V90, P65, DOI 10.1073/pnas.90.1.65; Hashimoto S, 1996, PSYCHOPHARMACOLOGY, V123, P182, DOI 10.1007/BF02246175; Hatzinger M, 1996, NEUROENDOCRINOLOGY, V64, P349, DOI 10.1159/000127138; Holly EN, 2011, EUR NEUROPSYCHOPHARM; Imanaka A, 2006, BEHAV BRAIN RES, V173, P129, DOI 10.1016/j.bbr.2006.06.012; Inoue T, 2004, EUR J PHARMACOL, V497, P311, DOI 10.1016/j.ejphar.2004.06.061; INOUE T, 1993, PHARMACOL BIOCHEM BE, V44, P371, DOI 10.1016/0091-3057(93)90476-A; Inoue T, 2006, ANN REPORT PHARMACOP, V38, P23; Inoue T, 2011, PROG NEURO-PSYCHOPH, V35, P1810, DOI 10.1016/j.pnpbp.2011.09.002; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; KAHN D, 1980, ENDOCRINOLOGY, V107, P47, DOI 10.1210/endo-107-1-47; Kalinichev M, 2002, PHARMACOL BIOCHEM BE, V73, P131, DOI 10.1016/S0091-3057(02)00781-5; Kawano KI, 2008, SYNAPSE, V62, P259, DOI 10.1002/syn.20487; Lang AJ, 2008, BEHAV MED, V33, P125, DOI 10.3200/BMED.33.4.125-136; Laszlo K, 2012, BEHAV BRAIN RES, V226, P597, DOI 10.1016/j.bbr.2011.08.041; Laszlo K, 2010, BEHAV BRAIN RES, V210, P280, DOI 10.1016/j.bbr.2010.02.038; Laszlo K, 2010, BEHAV BRAIN RES, V208, P430, DOI 10.1016/j.bbr.2009.12.022; Li XB, 2006, EUR J PHARMACOL, V532, P74, DOI 10.1016/j.ejphar.2005.12.008; Maeno H, 1996, MOL BRAIN RES, V40, P97; Maren S, 2011, NEURON, V70, P830, DOI 10.1016/j.neuron.2011.04.023; Matsumoto M, 2008, PHARMACOL BIOCHEM BE, V89, P247, DOI 10.1016/j.pbb.2007.12.017; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Meaney MJ, 2007, TRENDS MOL MED, V13, P269, DOI 10.1016/j.molmed.2007.05.003; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Myers KM, 2002, NEURON, V36, P567, DOI 10.1016/S0896-6273(02)01064-4; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Nishith P, 2000, J ABNORM PSYCHOL, V109, P20, DOI 10.1037/0021-843X.109.1.20; Parsons RG, 2013, NAT NEUROSCI, V16, P146, DOI 10.1038/nn.3296; PAXINOS G, 1997, RAT BRAIN STREOTAXIC; Petrie KA, 2004, NEUROPSYCHOPHARMACOL, V29, P1878, DOI 10.1038/sj.npp.1300494; PLOTSKY PM, 1993, MOL BRAIN RES, V18, P195, DOI 10.1016/0169-328X(93)90189-V; Prus AJ, 2014, PROG NEURO-PSYCHOPH, V49, P78, DOI 10.1016/j.pnpbp.2013.11.011; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Rakyan VK, 2001, BIOCHEM J, V356, P1, DOI 10.1042/0264-6021:3560001; Rao U, 2008, BIOL PSYCHIAT, V64, P521, DOI 10.1016/j.biopsych.2008.05.012; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Roussy G, 2008, J NEUROCHEM, V105, P1100, DOI 10.1111/j.1471-4159.2007.05205.x; Roussy G, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-38; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; Sarrett P, 2002, J BIOL CHEM, V277, P36233, DOI 10.1074/jbc.M202586200; Schechter DS, 2013, DEV PSYCHOBIOL; Shilling PD, 2008, PHARMACOL BIOCHEM BE, V90, P748, DOI 10.1016/j.pbb.2008.05.025; Stevenson CW, 2009, BEHAV BRAIN RES; Suri D, 2013, BIOL PSYCHIAT, V73, P658, DOI 10.1016/j.biopsych.2012.10.023; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; TREIT D, 1993, PHARMACOL BIOCHEM BE, V44, P463, DOI 10.1016/0091-3057(93)90492-C; Vianna MRM, 2001, P NATL ACAD SCI USA, V98, P12251, DOI 10.1073/pnas.211433298; Wang SH, 2009, NAT NEUROSCI, V12, P905, DOI 10.1038/nn.2350; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wilensky AE, 2000, J NEUROSCI, V20, P7059, DOI 10.1523/JNEUROSCI.20-18-07059.2000; Wise LA, 2001, LANCET, V358, P881, DOI 10.1016/S0140-6736(01)06072-X; Yamada D, 2010, PHARM BIOCH BEHAV; Yamada M, 1998, LIFE SCI, V62, pPL375; Yamamoto S, 2009, DEPRESS ANXIETY, V26, P1110, DOI 10.1002/da.20629	69	44	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97421	10.1371/journal.pone.0097421	http://dx.doi.org/10.1371/journal.pone.0097421			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831231	Green Published, gold			2022-12-27	WOS:000336789500055
J	Vilasi, S; Carrotta, R; Mangione, MR; Campanella, C; Librizzi, F; Randazzo, L; Martorana, V; Gammazza, AM; Ortore, MG; Vilasi, A; Pocsfalvi, G; Burgio, G; Corona, D; Piccionello, AP; Zummo, G; Bulone, D; de Macario, EC; Macario, AJL; San Biagio, PL; Cappello, F				Vilasi, Silvia; Carrotta, Rita; Mangione, Maria Rosalia; Campanella, Claudia; Librizzi, Fabio; Randazzo, Loredana; Martorana, Vincenzo; Gammazza, Antonella Marino; Ortore, Maria Grazia; Vilasi, Annalisa; Pocsfalvi, Gabriella; Burgio, Giosalba; Corona, Davide; Piccionello, Antonio Palumbo; Zummo, Giovanni; Bulone, Donatella; de Macario, Everly Conway; Macario, Alberto J. L.; San Biagio, Pier Luigi; Cappello, Francesco			Human Hsp60 with Its Mitochondrial Import Signal Occurs in Solution as Heptamers and Tetradecamers Remarkably Stable over a Wide Range of Concentrations	PLOS ONE			English	Article							CHAPERONIN PROTEIN HSP60; GROEL; HEAT-SHOCK-PROTEIN-60; COMPLEX; CANCER; CHAPERONOPATHIES; RECONSTITUTION; IDENTIFICATION; LOCALIZATION; AGGREGATION	It has been established that Hsp60 can accumulate in the cytosol in various pathological conditions, including cancer and chronic inflammatory diseases. Part or all of the cytosolic Hsp60 could be naive, namely, bear the mitochondrial import signal (MIS), but neither the structure nor the in solution oligomeric organization of this cytosolic molecule has still been elucidated. Here we present a detailed study of the structure and self-organization of naive cytosolic Hsp60 in solution. Results were obtained by different biophysical methods (light and X ray scattering, single molecule spectroscopy and hydrodynamics) that all together allowed us to assay a wide range of concentrations of Hsp60. We found that Naive Hsp60 in aqueous solution is assembled in very stable heptamers and tetradecamers at all concentrations assayed, without any trace of monomer presence.	[Vilasi, Silvia; Carrotta, Rita; Mangione, Maria Rosalia; Librizzi, Fabio; Randazzo, Loredana; Martorana, Vincenzo; Piccionello, Antonio Palumbo; Bulone, Donatella; San Biagio, Pier Luigi; Cappello, Francesco] CNR, Inst Biophys, Palermo, Italy; [Campanella, Claudia; Gammazza, Antonella Marino; Zummo, Giovanni; Cappello, Francesco] Univ Palermo, Dept Expt Biomed & Clin Neurosci, Palermo, Italy; [Campanella, Claudia; Gammazza, Antonella Marino; Macario, Alberto J. L.; Cappello, Francesco] Euro Mediterranean Inst Sci & Technol, Palermo, Italy; [Ortore, Maria Grazia] Marche Polytech Univ, Dept Life & Environm Sci, Ancona, Italy; [Ortore, Maria Grazia] Marche Polytech Univ, Natl Interuniv Consortium Phys Sci Matter, Ancona, Italy; [Vilasi, Annalisa; Pocsfalvi, Gabriella] CNR, Inst Biosci & Bioresources, Naples, Italy; [Burgio, Giosalba; Corona, Davide; Piccionello, Antonio Palumbo] Univ Palermo, Dept Biol Chem & Pharmaceut Sci & Technol, Palermo, Italy; [de Macario, Everly Conway; Macario, Alberto J. L.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [de Macario, Everly Conway; Macario, Alberto J. L.] Columbus Ctr, Inst Marine & Environm Technol, Baltimore, MD USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Palermo; Marche Polytechnic University; Marche Polytechnic University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR); University of Palermo; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology	San Biagio, PL (corresponding author), CNR, Inst Biophys, Palermo, Italy.	pierluigi.sanbiagio@cnr.it	Pocsfalvi, Gabriella/C-4948-2015; Gammazza, Antonella Marino/AAV-3123-2020; ortore, maria grazia/A-8530-2008; bulone, donatella/AAB-6116-2022; Randazzo, Loredana Antonella/P-3070-2018; Ortore, Maria Grazia/AAC-2869-2019; Librizzi, Fabio/L-9187-2015; ortore, maria grazia/H-7635-2015; Piccionello, Antonio Palumbo/V-6634-2017; Cappello, Francesco/F-9153-2012	Pocsfalvi, Gabriella/0000-0001-6065-3853; ortore, maria grazia/0000-0002-2719-6184; bulone, donatella/0000-0002-5841-9133; Randazzo, Loredana Antonella/0000-0002-9424-3665; Librizzi, Fabio/0000-0003-4900-382X; ortore, maria grazia/0000-0002-2719-6184; Piccionello, Antonio Palumbo/0000-0003-4402-5798; VILASI, SILVIA/0000-0002-9926-7199; Mangione, Maria Rosalia/0000-0002-3466-2569; Marino Gammazza, Antonella/0000-0002-1683-3803; SAN BIAGIO, PIER LUIGI/0000-0002-4622-7361; Martorana, Vincenzo/0000-0001-7092-6077; Carrotta, Rita/0000-0003-4628-2819; Cappello, Francesco/0000-0001-9288-1148	Italian grant FIRB "Future in research" [RBFR12SIPT MIND]; Euro-Mediterranean Institute of Science and Technology (Italy)	Italian grant FIRB "Future in research"; Euro-Mediterranean Institute of Science and Technology (Italy)	This work has been supported by Italian grant FIRB "Future in research" RBFR12SIPT MIND: "Multidisciplinary Investigations for the development of Neuro-protective Drugs". FC and AJLM were partially supported by Euro-Mediterranean Institute of Science and Technology (Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, CHAPERONOPATHIES DIS; Arai M, 2003, PROTEIN SCI, V12, P672, DOI 10.1110/ps.0233603; Azem A, 1995, P NATL ACAD SCI USA, V92, P12021, DOI 10.1073/pnas.92.26.12021; Becker T, 2012, TRENDS BIOCHEM SCI, V37, P85, DOI 10.1016/j.tibs.2011.11.004; BERNE B. J., 1976, DYNAMIC LIGHT SCATTE; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Bulone D, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000111; Burgio G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000089; Campanella C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042008; Cappello F, 2014, EXPERT OPIN THER TAR, V18, P185, DOI 10.1517/14728222.2014.856417; Cappello F, 2013, CURR PHARM DESIGN, V19, P452, DOI 10.2174/138161213804143653; Cappello F, 2011, METHODS MOL BIOL, V787, P245, DOI 10.1007/978-1-61779-295-3_18; Carrotta R, 2012, BBA-GEN SUBJECTS, V1820, P124, DOI 10.1016/j.bbagen.2011.11.010; Carrotta R, 2012, J PHYS CHEM B, V116, P14700, DOI 10.1021/jp307417x; Cechetto JD, 2000, J HISTOCHEM CYTOCHEM, V48, P45, DOI 10.1177/002215540004800105; Chandra D, 2007, J BIOL CHEM, V282, P31289, DOI 10.1074/jbc.M702777200; CHENG MY, 1990, NATURE, V348, P455, DOI 10.1038/348455a0; Clare DK, 2012, CELL, V149, P113, DOI 10.1016/j.cell.2012.02.047; Corrao S, 2010, LIFE SCI, V86, P145, DOI 10.1016/j.lfs.2009.11.004; Corsale C, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/24/244103; David Sabrina, 2013, Front Biosci (Elite Ed), V5, P768; Desmetz C, 2008, J PROTEOME RES, V7, P3830, DOI 10.1021/pr800130d; Dickson R, 2000, J BIOL CHEM, V275, P11829, DOI 10.1074/jbc.275.16.11829; Ellis RJ, 2007, ADV EXP MED BIOL, V594, P1; Elson EL, 2011, BIOPHYS J, V101, P2855, DOI 10.1016/j.bpj.2011.11.012; GOROVITS B, 1995, J BIOL CHEM, V270, P2061, DOI 10.1074/jbc.270.5.2061; Guinier A., 1955, SMALL ANGLE SCATTERI; Gupta S, 2005, J CELL MOL MED, V9, P51, DOI 10.1111/j.1582-4934.2005.tb00336.x; Heuberger EHML, 2002, J MOL BIOL, V317, P591, DOI 10.1006/jmbi.2002.5416; HOROVITZ A, 1993, J BIOL CHEM, V268, P9957; HUTCHINSON EG, 1989, EMBO J, V8, P1485, DOI 10.1002/j.1460-2075.1989.tb03532.x; Inobe T, 2008, BIOPHYS J, V94, P1392, DOI 10.1529/biophysj.107.114710; Itoh H, 2002, EUR J BIOCHEM, V269, P5931, DOI 10.1046/j.1432-1033.2002.03317.x; JINDAL S, 1989, MOL CELL BIOL, V9, P2279, DOI 10.1128/MCB.9.5.2279; Kirchhoff SR, 2002, CIRCULATION, V105, P2899, DOI 10.1161/01.CIR.0000019403.35847.23; Levy-Rimler G, 2001, EUR J BIOCHEM, V268, P3465, DOI 10.1046/j.1432-1327.2001.02243.x; Lewthwaite J, 2002, CIRCULATION, V106, P196, DOI 10.1161/01.CIR.0000021121.26290.2C; Macario AJL, 1999, MICROBIOL MOL BIOL R, V63, P923, DOI 10.1128/MMBR.63.4.923-967.1999; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; Martin J, 1998, BIOCHEMISTRY-MOSCOW+, V63, P374; MCMULLIN TW, 1988, MOL CELL BIOL, V8, P371, DOI 10.1128/MCB.8.1.371; MENDOZA JA, 1994, J BIOL CHEM, V269, P2447; Merendino AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009247; Michaelsson J, 2002, J EXP MED, V196, P1403, DOI 10.1084/jem.20020797; Nielsen KL, 1998, MOL CELL, V2, P93, DOI 10.1016/S1097-2765(00)80117-3; Nisemblat S, 2014, ACTA CRYSTALLOGR F, V70, P116, DOI 10.1107/S2053230X1303389X; Ortore MG, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.061904; Osterloh A, 2004, J BIOL CHEM, V279, P47906, DOI 10.1074/jbc.M408440200; Pace A, 2013, CURR PHARM DESIGN, V19, P2757, DOI 10.2174/1381612811319150011; Parnas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050318; Parnas A, 2009, J BIOL CHEM, V284, P28198, DOI 10.1074/jbc.M109.031997; Perkins JR, 2010, STRUCTURE, V18, P1233, DOI 10.1016/j.str.2010.08.007; Pusey PN, 2002, N-HOLLAND D, P3; Rea IM, 2001, EXP GERONTOL, V36, P341, DOI 10.1016/S0531-5565(00)00215-1; Samali A, 1999, EMBO J, V18, P2040, DOI 10.1093/emboj/18.8.2040; SINGH B, 1990, BIOCHEM BIOPH RES CO, V169, P391, DOI 10.1016/0006-291X(90)90344-M; Soltys BJ, 1996, EXP CELL RES, V222, P16, DOI 10.1006/excr.1996.0003; Soltys BJ, 1998, MITOCHONDRIAL MOL CH, P69; SQUIRE PG, 1968, BIOCHEMISTRY-US, V7, P4261, DOI 10.1021/bi00852a018; STEPANEK P, 1993, DYNAMIC LIGHT SCATTE; Sun Z, 2003, J MOL BIOL, V332, P715, DOI 10.1016/S0022-2836(03)00830-1; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Viitanen PV, 1998, METHOD ENZYMOL, V290, P203, DOI 10.1016/S0076-6879(98)90020-9; VIITANEN PV, 1992, J BIOL CHEM, V267, P695; Weber F, 1998, NAT STRUCT BIOL, V5, P977, DOI 10.1038/2952; YBARRA J, 1995, J BIOL CHEM, V270, P22962, DOI 10.1074/jbc.270.39.22962; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3	67	43	45	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97657	10.1371/journal.pone.0097657	http://dx.doi.org/10.1371/journal.pone.0097657			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830947	Green Submitted, Green Published, gold			2022-12-27	WOS:000336789500096
J	David, M; Sahay, D; Mege, F; Descotes, F; Leblanc, R; Ribeiro, J; Clezardin, P; Peyruchaud, O				David, Marion; Sahay, Debashish; Mege, Florence; Descotes, Francoise; Leblanc, Raphael; Ribeiro, Johnny; Clezardin, Philippe; Peyruchaud, Olivier			Identification of Heparin-Binding EGF-Like Growth Factor (HB-EGF) as a Biomarker for Lysophosphatidic Acid Receptor Type 1 (LPA(1)) Activation in Human Breast and Prostate Cancers	PLOS ONE			English	Article							BONE METASTASES; NEUROPATHIC PAIN; EPITHELIAL-CELLS; GENE-EXPRESSION; AUTOTAXIN; PROTEIN; ANTAGONIST; FIBROSIS; PROMOTES; SUBTYPE	Lysophosphatidic acid (LPA) is a natural bioactive lipid with growth factor-like functions due to activation of a series of six G protein-coupled receptors (LPA(1-6)). LPA receptor type 1 (LPA(1)) signaling influences the pathophysiology of many diseases including cancer, obesity, rheumatoid arthritis, as well as lung, liver and kidney fibrosis. Therefore, LPA(1) is an attractive therapeutic target. However, most mammalian cells co-express multiple LPA receptors whose co-activation impairs the validation of target inhibition in patients because of missing LPA receptor-specific biomarkers. LPA(1) is known to induce IL-6 and IL-8 secretion, as also do LPA(2) and LPA(3). In this work, we first determined the LPA induced early-gene expression profile in three unrelated human cancer cell lines expressing different patterns of LPA receptors (PC3: LPA(1,2,3,6); MDA-MB-231: LPA(1,2); MCF-7: LPA(2,6)). Among the set of genes upregulated by LPA only in LPA(1)-expressing cells, we validated by QPCR and ELISA that upregulation of heparin-binding EGF-like growth factor (HB-EGF) was inhibited by LPA(1-3) antagonists (Ki16425, Debio0719). Upregulation and downregulation of HB-EGF mRNA was confirmed in vitro in human MDA-B02 breast cancer cells stably overexpressing LPA(1) (MDA-B02/LPA(1)) and downregulated for LPA(1) (MDA-B02/shLPA(1)), respectively. At a clinical level, we quantified the expression of LPA(1) and HB-EGF by QPCR in primary tumors of a cohort of 234 breast cancer patients and found a significantly higher expression of HB-EGF in breast tumors expressing high levels of LPA(1). We also generated human xenograph prostate tumors in mice injected with PC3 cells and found that a five-day treatment with Ki16425 significantly decreased both HB-EGF mRNA expression at the primary tumor site and circulating human HB-EGF concentrations in serum. All together our results demonstrate that HB-EGF is a new and relevant biomarker with potentially high value in quantifying LPA(1) activation state in patients receiving anti-LPA(1) therapies.	[David, Marion] Fac Med Toulouse, INSERM, U1037, F-31073 Toulouse, France; [David, Marion] Inst Claudius Regaud, Toulouse, France; [Sahay, Debashish; Mege, Florence; Leblanc, Raphael; Ribeiro, Johnny; Clezardin, Philippe; Peyruchaud, Olivier] INSERM, U1033, F-69008 Lyon, France; [Sahay, Debashish; Leblanc, Raphael; Ribeiro, Johnny; Clezardin, Philippe; Peyruchaud, Olivier] Univ Lyon 1, F-69622 Villeurbanne, France; [Sahay, Debashish; Leblanc, Raphael; Ribeiro, Johnny; Clezardin, Philippe; Peyruchaud, Olivier] Fac Med Lyon Est, Lyon, France; [Mege, Florence] Hosp Civils Lyon, Hop Edouard Herriot, Lyon, France; [Descotes, Francoise] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Pierre Benite, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Claudius Regaud; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; CHU Lyon	Peyruchaud, O (corresponding author), INSERM, U1033, F-69008 Lyon, France.	Olivier.peyruchaud@inserm.fr	Clezardin, Philippe/M-8071-2014; Sahay, Debashish/U-7130-2019	Clezardin, Philippe/0000-0003-0149-4463; Sahay, Debashish/0000-0002-4473-6402; Leblanc, Raphael/0000-0002-1976-9587; Peyruchaud, Olivier/0000-0002-5393-4945	INSERM; Comite Departemental de la Loire de la Ligue Nationale Contre le Cancer, Lyon Science Transfer; French Association pour la Recherche sur le Cancer ARC; ARC; Seventh Framework Programme (FP7) [264817-BONE-NET]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Comite Departemental de la Loire de la Ligue Nationale Contre le Cancer, Lyon Science Transfer; French Association pour la Recherche sur le Cancer ARC(Fondation ARC pour la Recherche sur le Cancer); ARC(Australian Research Council); Seventh Framework Programme (FP7)(European Commission)	This study was supported by grants from the INSERM (OP and PC), the Comite Departemental de la Loire de la Ligue Nationale Contre le Cancer, Lyon Science Transfer, and the French Association pour la Recherche sur le Cancer ARC (OP). MD is a recipient of a fellowship from ARC. DS is a recipient of a fellowship from the Seventh Framework Programme (FP7/2007-2013) under agreement n o 264817-BONE-NET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SZ, 1998, J BIOL CHEM, V273, P7906, DOI 10.1074/jbc.273.14.7906; Boucharaba A, 2004, J CLIN INVEST, V114, P1714, DOI 10.1172/JCI200422123; Boucharaba A, 2006, P NATL ACAD SCI USA, V103, P9643, DOI 10.1073/pnas.0600979103; Cabello-Verrugio C, 2011, CELL SIGNAL, V23, P449, DOI 10.1016/j.cellsig.2010.10.019; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Choi KU, 2010, INT J CANC; Coulouarn C, 2008, HEPATOLOGY, V47, P2059, DOI 10.1002/hep.22283; David M, 2014, J BIOL CHEM; David M, 2012, INT J ONCOL, V40, P1133, DOI 10.3892/ijo.2011.1309; Dusaulcy R, 2009, J PHYSIOL BIOCHEM, V65, P345, DOI 10.1007/BF03185929; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fang XJ, 2004, J BIOL CHEM, V279, P9653, DOI 10.1074/jbc.M306662200; Fukushima N, 2007, NEUROCHEM INT, V50, P302, DOI 10.1016/j.neuint.2006.09.008; Gennero I, 2011, BONE, V49, P395, DOI 10.1016/j.bone.2011.04.018; Guo F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019756; Hama K, 2004, J BIOL CHEM, V279, P17634, DOI 10.1074/jbc.M313927200; Heise CE, 2001, MOL PHARMACOL, V60, P1173, DOI 10.1124/mol.60.6.1173; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Inoue M, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-6; Kanda H, 2008, NAT IMMUNOL, V9, P415, DOI 10.1038/ni1573; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; Marshall JC, 2012, J NATL CANC I; Miyabe Y, 2013, ARTHRITIS RHEUM-US, V65, P2037, DOI 10.1002/art.37991; Moolenaar WH, 2000, ANN NY ACAD SCI, V905, P1; Mutoh T, 2012, BRIT J PHARMACOL, V165, P829, DOI 10.1111/j.1476-5381.2011.01622.x; Noguchi K, 2009, CURR OPIN PHARMACOL, V9, P15, DOI 10.1016/j.coph.2008.11.010; Ohta H, 2003, MOL PHARMACOL, V64, P994, DOI 10.1124/mol.64.4.994; Peyruchaud O, 2003, J BIOL CHEM, V278, P45826, DOI 10.1074/jbc.M309024200; Peyruchaud O, 2001, J BONE MINER RES, V16, P2027, DOI 10.1359/jbmr.2001.16.11.2027; Pradere JP, 2007, J AM SOC NEPHROL, V18, P3110, DOI 10.1681/ASN.2007020196; Sakamoto S, 2004, ENDOCRINOLOGY, V145, P2929, DOI 10.1210/en.2003-1350; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; Umata T, 2001, J BIOL CHEM, V276, P30475, DOI 10.1074/jbc.M103673200; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Wiedmaier N, 2008, INT J MED MICROBIOL, V298, P231, DOI 10.1016/j.ijmm.2007.06.001; Wilson CA, 2005, BREAST CANCER RES, V7, pR1058, DOI 10.1186/bcr1343; Xue JX, 2010, ONCOL REP, V24, P1515, DOI 10.3892/or_00001013; Ye XQ, 2005, NATURE, V435, P104, DOI 10.1038/nature03505; Yu SX, 2008, JNCI-J NATL CANCER I, V100, P1630, DOI 10.1093/jnci/djn378; Zhao YT, 2006, J BIOL CHEM, V281, P19501, DOI 10.1074/jbc.M511224200	42	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97771	10.1371/journal.pone.0097771	http://dx.doi.org/10.1371/journal.pone.0097771			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828490	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000336857400121
J	Pluskal, T; Ueno, M; Yanagida, M				Pluskal, Tomas; Ueno, Masaru; Yanagida, Mitsuhiro			Genetic and Metabolomic Dissection of the Ergothioneine and Selenoneine Biosynthetic Pathway in the Fission Yeast, S. pombe, and Construction of an Overproduction System	PLOS ONE			English	Article							GLOBAL TRANSCRIPTIONAL RESPONSES; SEXUAL-DIFFERENTIATION; REGULATORY NETWORK; ORGANIC SELENIUM; PROTEIN; EXPRESSION; ENCODES; COPPER; CELLS; ROLES	Ergothioneine is a small, sulfur-containing metabolite (229 Da) synthesized by various species of bacteria and fungi, which can accumulate to millimolar levels in tissues or cells (e.g. erythrocytes) of higher eukaryotes. It is commonly marketed as a dietary supplement due to its proposed protective and antioxidative functions. In this study we report the genes forming the two-step ergothioneine biosynthetic pathway in the fission yeast, Schizosaccharomyces pombe. We identified the first gene, egt1(+) (SPBC1604.01), by sequence homology to previously published genes from Neurospora crassa and Mycobacterium smegmatis. We showed, using metabolomic analysis, that the Delta egt1 deletion mutant completely lacked ergothioneine and its precursors (trimethyl histidine/hercynine and hercynylcysteine sulfoxide). Since the second step of ergothioneine biosynthesis has not been characterized in eukaryotes, we examined four putative homologs (Nfs1/SPBC21D10.11c, SPAC11D3.10, SPCC777.03c, and SPBC660.12c) of the corresponding mycobacterial enzyme EgtE. Among deletion mutants of these genes, only one (Delta SPBC660.12c, designated Delta egt2) showed a substantial decrease in ergothioneine, accompanied by accumulation of its immediate precursor, hercynylcysteine sulfoxide. Ergothioneine-deficient strains exhibited no phenotypic defects during vegetative growth or quiescence. To effectively study the role of ergothioneine, we constructed an egt1(+) overexpression system by replacing its native promoter with the nmt1(+) promoter, which is inducible in the absence of thiamine. We employed three versions of the nmt1 promoter with increasing strength of expression and confirmed corresponding accumulations of ergothioneine. We quantified the intracellular concentration of ergothioneine in S. pombe (0.3, 157.4, 41.6, and up to 1606.3 mu M in vegetative, nitrogen-starved, glucose-starved, and egt1(+)-overexpressing cells, respectively) and described its gradual accumulation under long-term quiescence. Finally, we demonstrated that the ergothioneine pathway can also synthesize selenoneine, a selenium-containing derivative of ergothioneine, when the culture medium is supplemented with selenium. We further found that selenoneine biosynthesis involves a novel intermediate compound, hercynylselenocysteine.	[Pluskal, Tomas; Yanagida, Mitsuhiro] Grad Univ OIST, Okinawa Inst Sci & Technol, Cell Unit G0, Onna Son, Okinawa, Japan; [Pluskal, Tomas; Ueno, Masaru] Hiroshima Univ, Dept Mol Biotechnol, Grad Sch Adv Sci Matter, Higashihiroshima, Hiroshima 724, Japan	Okinawa Institute of Science & Technology Graduate University; Hiroshima University	Yanagida, M (corresponding author), Grad Univ OIST, Okinawa Inst Sci & Technol, Cell Unit G0, Onna Son, Okinawa, Japan.	myanagid@gmail.com	Pluskal, Tomáš/C-6247-2012; Ueno, Masaru/G-3990-2019	Pluskal, Tomáš/0000-0002-6940-3006; 	Okinawa Institute of Science and Technology Promotion Corporation; Okinawa Institute of Science and Technology Graduate University	Okinawa Institute of Science and Technology Promotion Corporation; Okinawa Institute of Science and Technology Graduate University(Okinawa Institute of Science & Technology Graduate University)	This study was funded by the Okinawa Institute of Science and Technology Promotion Corporation (until October 2011) and Okinawa Institute of Science and Technology Graduate University (from November 2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKANMU D, 1991, ARCH BIOCHEM BIOPHYS, V288, P10, DOI 10.1016/0003-9861(91)90158-F; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Beaudoin J, 2001, J BIOL CHEM, V276, P15472, DOI 10.1074/jbc.M011256200; Bello MH, 2012, FUNGAL GENET BIOL, V49, P160, DOI 10.1016/j.fgb.2011.12.007; Bushel PR, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-93; Cheah IK, 2012, BBA-MOL BASIS DIS, V1822, P784, DOI 10.1016/j.bbadis.2011.09.017; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Chen ES, 2003, MOL CELL, V11, P175, DOI 10.1016/S1097-2765(03)00011-X; Ey J, 2007, J AGR FOOD CHEM, V55, P6466, DOI 10.1021/jf071328f; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; GENGHOF DS, 1970, J BACTERIOL, V103, P475, DOI 10.1128/JB.103.2.475-478.1970; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Grundemann D, 2005, P NATL ACAD SCI USA, V102, P5256, DOI 10.1073/pnas.0408624102; HARTMAN PE, 1990, METHOD ENZYMOL, V186, P310; Hentges P, 2005, YEAST, V22, P1013, DOI 10.1002/yea.1291; Horie S, 1998, MOL CELL BIOL, V18, P2118, DOI 10.1128/MCB.18.4.2118; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; LEONE E, 1951, NATURE, V168, P205, DOI 10.1038/168205b0; LEUPOLD U., 1950, Comptes rendus des Travaux du Laboratoire Carlsberg, V24, P381; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Markova NG, 2009, FREE RADICAL BIO MED, V46, P1168, DOI 10.1016/j.freeradbiomed.2009.01.021; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Mata J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r217; Mata J, 2006, P NATL ACAD SCI USA, V103, P15517, DOI 10.1073/pnas.0603403103; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; MELVILLE DB, 1954, J BIOL CHEM, V206, P221; Mercier A, 2006, EUKARYOT CELL, V5, P1866, DOI 10.1128/EC.00199-06; MITCHISON JM, 1957, EXP CELL RES, V13, P244, DOI 10.1016/0014-4827(57)90005-8; NURSE P, 1975, NATURE, V256, P547, DOI 10.1038/256547a0; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paul BD, 2010, CELL DEATH DIFFER, V17, P1134, DOI 10.1038/cdd.2009.163; Pluskal T, 2011, FEBS J, V278, P1299, DOI 10.1111/j.1742-4658.2011.08050.x; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Pluskal T, 2010, MOL BIOSYST, V6, P182, DOI 10.1039/b908784b; Rustici G, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r73; Sajiki K, 2013, METABOLITES, V3, P1118, DOI 10.3390/metabo3041118; Sajiki K, 2009, J CELL SCI, V122, P1418, DOI 10.1242/jcs.046466; Sanso M, 2008, EUKARYOT CELL, V7, P826, DOI 10.1128/EC.00465-07; Seebeck FP, 2010, J AM CHEM SOC, V132, P6632, DOI 10.1021/ja101721e; Shimanuki M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078545; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Shires TK, 1997, COMP BIOCHEM PHYS C, V117, P117, DOI 10.1016/S0742-8413(96)00223-X; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SUGIMOTO A, 1991, GENE DEV, V5, P1990, DOI 10.1101/gad.5.11.1990; Takeda K, 2010, P NATL ACAD SCI USA, V107, P3540, DOI 10.1073/pnas.0911055107; Watanabe Y, 1996, MOL CELL BIOL, V16, P704; Wood V, 2012, NUCLEIC ACIDS RES, V40, pD695, DOI 10.1093/nar/gkr853; Yamashita M, 2013, BIOL TRACE ELEM RES, V156, P36, DOI 10.1007/s12011-013-9846-x; Yamashita Yumiko, 2010, World J Biol Chem, V1, P144, DOI 10.4331/wjbc.v1.i5.144; Yamashita Y, 2010, J BIOL CHEM, V285, P18134, DOI 10.1074/jbc.C110.106377; Yanagida M, 2009, TRENDS CELL BIOL, V19, P705, DOI 10.1016/j.tcb.2009.09.006; Zhu BZ, 2011, CHEM RES TOXICOL, V24, P30, DOI 10.1021/tx100214t	53	64	74	5	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97774	10.1371/journal.pone.0097774	http://dx.doi.org/10.1371/journal.pone.0097774			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828577	Green Submitted, gold, Green Published			2022-12-27	WOS:000336857400122
J	Armijo-Olivo, S; Ospina, M; da Costa, BR; Egger, M; Saltaji, H; Fuentes, J; Ha, C; Cummings, GG				Armijo-Olivo, Susan; Ospina, Maria; da Costa, Bruno R.; Egger, Matthias; Saltaji, Humam; Fuentes, Jorge; Ha, Christine; Cummings, Greta G.			Poor Reliability between Cochrane Reviewers and Blinded External Reviewers When Applying the Cochrane Risk of Bias Tool in Physical Therapy Trials	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; SYSTEMATIC REVIEWS; METHODOLOGICAL QUALITY; EMPIRICAL-EVIDENCE; CLINICAL-TRIALS; INTENTION; EFFICACY; TREAT; METAANALYSES; CONCLUSIONS	Objectives: To test the inter-rater reliability of the RoB tool applied to Physical Therapy (PT) trials by comparing ratings from Cochrane review authors with those of blinded external reviewers. Methods: Randomized controlled trials (RCTs) in PT were identified by searching the Cochrane Database of Systematic Reviews for meta-analysis of PT interventions. RoB assessments were conducted independently by 2 reviewers blinded to the RoB ratings reported in the Cochrane reviews. Data on RoB assessments from Cochrane reviews and other characteristics of reviews and trials were extracted. Consensus assessments between the two reviewers were then compared with the RoB ratings from the Cochrane reviews. Agreement between Cochrane and blinded external reviewers was assessed using weighted kappa (kappa). Results: In total, 109 trials included in 17 Cochrane reviews were assessed. Inter-rater reliability on the overall RoB assessment between Cochrane review authors and blinded external reviewers was poor (kappa = 0.02, 95%Cl: -0.06, 0.06]). Inter-rater reliability on individual domains of the RoB tool was poor (median kappa = 0.19), ranging from kappa = -0.04 ("Other bias'') to kappa = 0.62 ("Sequence generation''). There was also no agreement (kappa = -0.29, 95%Cl: -0.81, 0.35]) in the overall RoB assessment at the meta-analysis level. Conclusions: Risk of bias assessments of RCTs using the RoB tool are not consistent across different research groups. Poor agreement was not only demonstrated at the trial level but also at the meta-analysis level. Results have implications for decision making since different recommendations can be reached depending on the group analyzing the evidence. Improved guidelines to consistently apply the RoB tool and revisions to the tool for different health areas are needed.	[Armijo-Olivo, Susan; Cummings, Greta G.] Univ Alberta, Fac Nursing, CLEAR Connecting Leadership & Res Outcome Res Pro, Edmonton, AB, Canada; [Armijo-Olivo, Susan] Univ Alberta, Fac Rehabil Med, Dept Phys Therapy, Edmonton, AB, Canada; [Ospina, Maria] Univ Alberta, Fac Med & Dent, Dept Emergency Med, Emergency Med Strateg Clin Network,Alberta Hlth S, Edmonton, AB, Canada; [da Costa, Bruno R.] Florida Int Univ, Dept Phys Therapy, Miami, FL 33199 USA; [Egger, Matthias] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Saltaji, Humam] Univ Alberta, Sch Dent, Orthodont Grad Program, Edmonton, AB, Canada; [Fuentes, Jorge] Univ Alberta, Fac Rehabil Med, Edmonton, AB, Canada; [Fuentes, Jorge] Catholic Univ Maule, Dept Phys Therapy, Talca, Maule, Chile; [Ha, Christine] Univ Alberta, Fac Rehabil Med, Rehabil Res Ctr, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; State University System of Florida; Florida International University; University of Bern; University of Alberta; University of Alberta; Universidad Catolica del Maule; University of Alberta	Armijo-Olivo, S (corresponding author), Univ Alberta, Fac Nursing, CLEAR Connecting Leadership & Res Outcome Res Pro, Edmonton, AB, Canada.	sla4@ualberta.ca	Saltaji, Humam/N-6539-2014; Contreras, Jorge Fuentes/AAN-5633-2021; Cummings, Greta G/B-4121-2009	Saltaji, Humam/0000-0002-8978-458X; Contreras, Jorge Fuentes/0000-0003-0626-3656; Cummings, Greta G/0000-0002-0668-6176; Egger, Matthias/0000-0001-7462-5132; R. da Costa, Bruno/0000-0002-1786-6332; Ospina, Maria/0000-0001-9305-7521	Canadian Institutes of Health Research (CIHR); Alberta Innovates Health; Alberta Innovates [201300026] Funding Source: researchfish	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health; Alberta Innovates	This project is funded by the Canadian Institutes of Health Research (CIHR), Alberta Innovates Health solution through a knowledge translation initiative grant, the Knowledge Translation (KT) Canada research Stipend program, and the Physiotherapy Foundation of Canada (PFC) through a B. E. Schnurr Memorial Fund Award. The funding bodies had no input in the design, collection, analysis, and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication.	Abraha I, 2010, BMJ-BRIT MED J, V341, P33; Armijo-Olivo S, 2012, J EVAL CLIN PRACT, V18, P12, DOI 10.1111/j.1365-2753.2010.01516.x; Armijo-Olivo S, 2009, PHYS THER REV, V14, P36, DOI 10.1179/174328809X405928; Boutron I, 2012, J CLIN EPIDEMIOL, V65, P236, DOI 10.1016/j.jclinepi.2011.09.006; Byrt T, 1996, EPIDEMIOLOGY, V7, P561, DOI 10.1097/00001648-199609000-00030; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Davies P, 2010, COCHRANE DATABASE SY; Effing T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002990.pub2; Egger M, 2003, Health Technol Assess, V7, P1; EMERSON JD, 1990, CONTROL CLIN TRIALS, V11, P339, DOI 10.1016/0197-2456(90)90175-2; Fransen M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007912; Furlan AD, 2009, SPINE, V34, P1929, DOI 10.1097/BRS.0b013e3181b1c99f; Graham N, 2011, SPINE; Handoll-Helen HG, 2009, COCHRANE DATABASE SY, DOI 101002; Hartling L, 2013, J CLIN EPIDEMIOL, V66, P973, DOI 10.1016/j.jclinepi.2012.07.005; Hartling L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017242; Hartling L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4012; Harvey LA, 2010, COCHRANE DATABASE SY; Herbison P, 2006, J CLIN EPIDEMIOL, V59, P1249, DOI 10.1016/j.jclinepi.2006.03.008; Hewitt CE, 2010, J CLIN EPIDEMIOL, V63, P1264, DOI 10.1016/j.jclinepi.2010.01.010; Higgins J.P.T, 2011, BMJ, V343; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Katalinic OM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007455.pub2; Kjaergard LL, 2002, BMJ-BRIT MED J, V325, P249, DOI 10.1136/bmj.325.7358.249; Kramer MS, 2006, COCHRANE DATABASE SY, DOI 101002/14651858CD000180pub2; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lundh A, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-22; Manheimer E, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001977.pub2; Manzoli L, 2007, PEDIATR INFECT DIS J, V26, P97, DOI 10.1097/01.inf.0000253053.01151.bd; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D, 1999, Health Technol Assess, V3, pi; MOHER D, 1995, CONTROL CLIN TRIALS, V16, P62, DOI 10.1016/0197-2456(94)00031-W; Nfiesch E, 2009, BMJ-BRIT MED J, V339, P679; Olivo SA, 2008, PHYS THER, V88, P156, DOI 10.2522/ptj.20070147; Orozco LJ, 2008, COCHRANE DATABASE SY; Ostelo-Raymond WJG, 2008, COHRANE DATABASE SYS, V2008; Pildal J, 2007, INT J EPIDEMIOL, V36, P847, DOI 10.1093/ije/dym087; Puhan M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005305.pub2; Rutjes-Anne WS, 2009, COCHRANE DB SYST REV; Rutjes-Anne WS, 2010, COCHRANE DATABASE SY, DOI 101002/14651858CD00; Savovic J, 2012, ANN INTERN MED, V157, P429, DOI 10.7326/0003-4819-157-6-201209180-00537; Schaafsma F, 2010, COCHRANE DATABASE SY; Schuck P, 2004, QUAL LIFE RES, V13, P571, DOI 10.1023/B:QURE.0000021318.92272.2a; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Sirtori V, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004433.pub2; States RA, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006075.pub2; Taylor RS, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007130.pub2; Trowman R, 2007, J CLIN EPIDEMIOL, V60, P1229, DOI 10.1016/j.jclinepi.2007.03.014; Unnebrink K, 2001, STAT MED, V20, P3931, DOI 10.1002/sim.1149; Villari P, 2004, VACCINE, V22, P3475, DOI 10.1016/j.vaccine.2004.01.068; WHO, 2011, WHO TECH REP SER, V959, P1; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; Wright CC, 2003, J CLIN EPIDEMIOL, V56, P833, DOI 10.1016/S0895-4356(03)00155-0	53	73	77	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96920	10.1371/journal.pone.0096920	http://dx.doi.org/10.1371/journal.pone.0096920			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824199	gold, Green Published, Green Submitted			2022-12-27	WOS:000336369200041
J	Qin, J; Fang, N; Lou, JN; Zhang, WJ; Xu, SQ; Liu, HL; Fang, Q; Wang, Z; Liu, J; Men, XL; Peng, L; Chen, L				Qin, Jun; Fang, Ni; Lou, Jinning; Zhang, Wenjian; Xu, Shiqing; Liu, Honglin; Fang, Qing; Wang, Zai; Liu, Jiang; Men, Xiuli; Peng, Liang; Chen, Li			TRB3 Is Involved in Free Fatty Acid-Induced INS-1-Derived Cell Apoptosis via the Protein Kinase C delta Pathway	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; TRIBBLES HOMOLOG; INSULIN-RESISTANCE; ER STRESS; PKC-DELTA; ACTIVATION; DEATH; DROSOPHILA; PHOSPHORYLATION; MORPHOGENESIS	Chronic exposure to free fatty acids (FFAs) may induce beta cell apoptosis in type 2 diabetes. However, the precise mechanism by which FFAs trigger b cell apoptosis is still unclear. Tribbles homolog 3 (TRB3) is a pseudokinase inhibiting Akt, a key mediator of insulin signaling, and contributes to insulin resistance in insulin target tissues. This paper outlined the role of TRB3 in FFAs-induced INS-1 beta cell apoptosis. TRB3 was promptly induced in INS-1 cells after stimulation by FFAs, and this was accompanied by enhanced INS-1 cell apoptosis. The overexpression of TRB3 led to exacerbated apoptosis triggered by FFAs in INS-1-derived cell line and the subrenal capsular transplantation animal model. In contrast, cell apoptosis induced by FFAs was attenuated when TRB3 was knocked down. Moreover, we observed that activation and nuclear accumulation of protein kinase C (PKC) delta was enhanced by upregulation of TRB3. Preventing PKC delta nuclear translocation and PKC delta selective antagonist both significantly lessened the pro-apoptotic effect. These findings suggest that TRB3 was involved in lipoapoptosis of INS-1 beta cell, and thus could be an attractive pharmacological target in the prevention and treatment of T2DM.	[Qin, Jun; Chen, Li] Shandong Univ, Qilu Hosp, Dept Endocrinol, Jinan 250100, Shandong, Peoples R China; [Fang, Ni; Lou, Jinning; Zhang, Wenjian; Xu, Shiqing; Liu, Honglin; Fang, Qing; Wang, Zai; Peng, Liang] China Japan Friendship Hosp, Inst Clin Med Sci, Beijing, Peoples R China; [Liu, Jiang] China Japan Friendship Hosp, Dept Neurosurg, Beijing, Peoples R China; [Men, Xiuli] North China Coal Med Univ, Dept Pathophysiol, Tangshan, Peoples R China	Shandong University; China-Japan Friendship Hospital; China-Japan Friendship Hospital; North China University of Science & Technology	Peng, L (corresponding author), China Japan Friendship Hosp, Inst Clin Med Sci, Beijing, Peoples R China.	pengliang8028@163.com; chenli3@medmail.com.cn	liu, honglin/HDN-0409-2022	liu, honglin/0000-0002-1254-3163	National Nature Science Foundation of China [81200616, 81370943]; Beijing Natural Science Foundation of China [7122160]; National Basic Research Program of China [2012CB966402]; Medical and Health Science and Technology Development Projects of Shandong Province [2011HD005]; Key New Drug Creation & Manufacturing Program [2011ZX09102-010-03]; China-Japan Friendship Hospital Youth Science and Technology Excellence Project [2014-QNYC-A-05]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation of China(Beijing Natural Science Foundation); National Basic Research Program of China(National Basic Research Program of China); Medical and Health Science and Technology Development Projects of Shandong Province; Key New Drug Creation & Manufacturing Program; China-Japan Friendship Hospital Youth Science and Technology Excellence Project	This work was supported by grants from National Nature Science Foundation of China (81200616 & 81370943), Beijing Natural Science Foundation of China (7122160), National Basic Research Program of China (2012CB966402), Medical and Health Science and Technology Development Projects of Shandong Province (2011HD005), Key New Drug Creation & Manufacturing Program (2011ZX09102-010-03) and China-Japan Friendship Hospital Youth Science and Technology Excellence Project (2014-QNYC-A-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Martin MA, 2010, MOL NUTR FOOD RES, V54, P956, DOI 10.1002/mnfr.200900159; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Bezy O, 2007, MOL CELL BIOL, V27, P6818, DOI 10.1128/MCB.00375-07; Bharti A, 1998, MOL CELL BIOL, V18, P6719, DOI 10.1128/MCB.18.11.6719; Carpenter L, 2002, DIABETES, V51, P317, DOI 10.2337/diabetes.51.2.317; Carpenter L, 2001, J BIOL CHEM, V276, P5368, DOI 10.1074/jbc.M010036200; Cheng Q, 2011, J MOL ENDOCRINOL, V47, P13, DOI 10.1530/JME-10-0106; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Cnop M, 2001, DIABETES, V50, P1771, DOI 10.2337/diabetes.50.8.1771; Cross T, 2000, ONCOGENE, V19, P2331, DOI 10.1038/sj.onc.1203555; Cunha DA, 2012, DIABETES, V61, P2763, DOI 10.2337/db12-0123; DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Eitel K, 2003, DIABETES, V52, P991, DOI 10.2337/diabetes.52.4.991; Emoto Y, 1995, EMBO J, V14, P6148, DOI 10.1002/j.1460-2075.1995.tb00305.x; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Grosshans J, 2000, CELL, V101, P523, DOI 10.1016/S0092-8674(00)80862-4; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; Han YQ, 1997, J BIOL CHEM, V272, P9825; Hennige AM, 2010, DIABETES, V59, P119, DOI 10.2337/db09-0512; Hu XR, 2005, J MOL ENDOCRINOL, V35, P73, DOI 10.1677/jme.1.01764; Hua F, 2011, J CELL SCI, V124, P3235, DOI 10.1242/jcs.082875; Humphrey RK, 2010, J BIOL CHEM, V285, P22426, DOI 10.1074/jbc.M110.123786; Iynedjian PB, 2005, BIOCHEM J, V386, P113, DOI 10.1042/BJ20041425; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Liu JR, 2010, AM J PHYSIOL-ENDOC M, V298, pE565, DOI 10.1152/ajpendo.00467.2009; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Mata J, 2000, CELL, V101, P511, DOI 10.1016/S0092-8674(00)80861-2; Nicoletti-Carvalho JE, 2010, J ENDOCRINOL, V206, P183, DOI 10.1677/JOE-09-0356; Ord D, 2007, EXP CELL RES, V313, P3556, DOI 10.1016/j.yexcr.2007.07.017; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Okamoto H, 2007, DIABETES, V56, P1350, DOI 10.2337/db06-1448; PAOLISSO G, 1995, DIABETOLOGIA, V38, P1213, DOI 10.1007/BF00422371; Peng L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049258; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Qian B, 2008, J ENDOCRINOL, V199, P407, DOI 10.1677/JOE-08-0331; Ranta F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028828; Schwarzer R, 2006, CELL SIGNAL, V18, P899, DOI 10.1016/j.cellsig.2005.08.002; Seher TC, 2000, CURR BIOL, V10, P623, DOI 10.1016/S0960-9822(00)00502-9; Soltoff SP, 2001, J BIOL CHEM, V276, P37986; Tang M, 2008, CELL MOL LIFE SCI, V65, P2924, DOI 10.1007/s00018-008-8255-3; Wang HY, 2005, J CELL SCI, V118, P3905, DOI 10.1242/jcs.02513; Yoshida K, 2003, EMBO J, V22, P1431, DOI 10.1093/emboj/cdg134; Yuan HP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015726; Zhou YD, 2012, HUM MOL GENET, V21, P196, DOI 10.1093/hmg/ddr454	45	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96089	10.1371/journal.pone.0096089	http://dx.doi.org/10.1371/journal.pone.0096089			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824999	Green Published, gold, Green Submitted			2022-12-27	WOS:000336369200010
J	Urantowka, AD; Mackiewicz, P; Strzala, T				Urantowka, Adam Dawid; Mackiewicz, Pawel; Strzala, Tomasz			Phylogeny of Amazona barbadensis and the Yellow-Headed Amazon Complex (Aves: Psittacidae): A New Look at South American Parrot Evolution	PLOS ONE			English	Article							COSTA-RICA; BIOGEOGRAPHY; LOWLAND; CLIMATE; OCHROCEPHALA; GLACIATION; VEGETATION; SPECIATION; FOREST	The Yellow-shouldered Amazon (Amazona barbadensis) is the sole parrot of the genus Amazona that inhabits only dry forests. Its population has been dropping; therefore it has been the topic of many studies and conservation efforts. However, the phylogenetic relationship of this species to potential relatives classified within the Yellow-Headed Amazon (YHA) complex are still not clear. Therefore, we used more extensive data sets, including the newly sequenced mitochondrial genome of A. barbadensis, to conduct phylogenetic analyses. Various combinations of genes and many phylogenetic approaches showed that A. barbadensis clustered significantly with A. ochrocephala ochrocephala from Colombia and Venezuela, which created the Northern South American (NSA) lineage, clearly separated from two other lineages within the YHA complex, the Central (CA) and South American (SA). Tree topology tests and exclusion of rapidly evolving sites provided support for a NSA+SA grouping. We propose an evolutionary scenario for the YHA complex and its colonization of the American mainland. The NSA lineage likely represents the most ancestral lineage, which derived from Lesser Antillean Amazons and colonized the northern coast of Venezuela about a million years ago. Then, Central America was colonized through the Isthmus of Panama, which led to the emergence of the CA lineage. The southward expansion to South America and the origin of the SA lineage happened almost simultaneously. However, more intensive or prolonged gene flow or migrations have led to much weaker geographic differentiation of genetic markers in the SA than in the CA lineage.	[Urantowka, Adam Dawid; Strzala, Tomasz] Wroclaw Univ Environm & Life Sci, Fac Biol, Dept Genet, Wroclaw, Poland; [Mackiewicz, Pawel] Univ Wroclaw, Fac Biotechnol, Dept Genom, PL-50138 Wroclaw, Poland	Wroclaw University of Environmental & Life Sciences; University of Wroclaw	Urantowka, AD (corresponding author), Wroclaw Univ Environm & Life Sci, Fac Biol, Dept Genet, Wroclaw, Poland.	adam.urantowka@up.wroc.pl	Strzała, Tomasz/P-3357-2019; Strzała, Tomasz/F-4578-2011	Strzała, Tomasz/0000-0002-7761-1630; Strzała, Tomasz/0000-0002-7761-1630; Urantowka, Adam/0000-0003-1144-0549				American Ornithologists Union, 2013, CHECKL N AM BIRDS; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; AYRES JM, 1992, AM NAT, V140, P531, DOI 10.1086/285427; Behling H, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P335; BirdLife International, 2012, IUCN 2012 IUCN RED L; Braun DD, 2004, DEV QUA SCI, V2, P237, DOI 10.1016/S1571-0866(04)80201-X; Bush MB, 2009, DEV PALEOENVIRON RES, V14, P113, DOI 10.1007/978-90-481-2672-9_5; BUSH MB, 1994, J BIOGEOGR, V21, P5, DOI 10.2307/2845600; BUSH MB, 1990, J VEG SCI, V1, P105, DOI 10.2307/3236060; Clements JF, 2013, EBIRD CLEMENTS CHECK; Coates AG, 1997, CENTRAL AM NATURAL C, P1, DOI DOI 10.2307/J.CTT1XP3SDF; Cohen KM, 2011, GLOBAL CHRONOSTRATIG; Colinvaux PA, 2000, J QUATERNARY SCI, V15, P347, DOI 10.1002/1099-1417(200005)15:4<347::AID-JQS537>3.0.CO;2-A; Cowling SA, 2004, J QUATERNARY SCI, V19, P733, DOI 10.1002/jqs.881; Cowling SA, 2001, QUATERNARY RES, V55, P140, DOI 10.1006/qres.2000.2197; Criscuolo A, 2011, MOL PHYLOGENET EVOL, V61, P944, DOI 10.1016/j.ympev.2011.08.029; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Eberhard JR, 2004, AUK, V121, P318, DOI 10.1642/0004-8038(2004)121[0318:PABOTA]2.0.CO;2; Forshaw Joseph, 2010, P15; Gill F, 2013, IOC WORLD BIRD LIST; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Haffer J, 2001, AMAZONIANA, V16, P579; HOOGHIEMSTRA H, 1992, J QUATERNARY SCI, V7, P205, DOI 10.1002/jqs.3390070303; Horn SP, 2003, BIOTROPICA, V35, P434, DOI 10.1111/j.1744-7429.2003.tb00598.x; HOWELL S N G, 1992, Bulletin of the British Ornithologists' Club, V112, P42; Howell S. N. G., 1995, GUIDE BIRDS MEXICO N; Huelsenbeck JP, 2004, MOL BIOL EVOL, V21, P1123, DOI 10.1093/molbev/msh123; Islebe GA, 1997, QUATERNARY SCI REV, V16, P589, DOI 10.1016/S0277-3791(96)00051-0; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Juniper T, 1998, PARROTS GUIDE PARROT; Lachniet MS, 2004, DEV QUA SCI, V2, P135; Lousada S. A., 1996, COTINGA, V5, P46; Lutz HL, 2013, MOL PHYLOGENET EVOL, V69, P873, DOI 10.1016/j.ympev.2013.06.017; Briceno-Linares JM, 2011, BIOL CONSERV, V144, P1188, DOI 10.1016/j.biocon.2010.12.010; Maslin M, 2005, T I BRIT GEOGR, V30, P477, DOI 10.1111/j.1475-5661.2005.00181.x; Navarro-SiguenzaI AG, 2004, BIOTA NEOTROP, V4, P2; Ottens-Wainright Patricia, 2004, Journal of Caribbean Ornithology, V17, P23; Peterson AT, 2007, MOL PHYLOGENET EVOL, V45, P1042, DOI 10.1016/j.ympev.2007.08.019; Ribas CC, 2007, IBIS, V149, P564, DOI 10.1111/j.1474-919X.2007.00681.x; Ribas CC, 2012, P BIOL SCI, V279, P9; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Russello MA, 2004, MOL PHYLOGENET EVOL, V30, P421, DOI 10.1016/S1055-7903(03)00192-1; Schodde R, 2013, ZOOTAXA, V3691, P591, DOI 10.11646/zootaxa.3691.5.5; Schweizer M, 2011, J BIOGEOGR, V38, P2176, DOI 10.1111/j.1365-2699.2011.02555.x; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Urantowka Adam Dawid, 2013, Mitochondrial DNA, V24, P411, DOI 10.3109/19401736.2013.766177; Weir JT, 2006, EVOLUTION, V60, P842	50	6	6	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97228	10.1371/journal.pone.0097228	http://dx.doi.org/10.1371/journal.pone.0097228			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24823658	Green Submitted, Green Published, gold			2022-12-27	WOS:000336369200075
J	Wang, QG; Bao, DC; Guo, YL; Lu, JM; Lu, ZJ; Xu, YZ; Zhang, KH; Liu, HB; Meng, HJ; Jiang, MX; Qiao, XJ; Huang, HD				Wang, Qinggang; Bao, Dachuan; Guo, Yili; Lu, Junmeng; Lu, Zhijun; Xu, Yaozhan; Zhang, Kuihan; Liu, Haibo; Meng, Hongjie; Jiang, Mingxi; Qiao, Xiujuan; Huang, Handong			Species Associations in a Species-Rich Subtropical Forest Were Not Well-Explained by Stochastic Geometry of Biodiversity	PLOS ONE			English	Article							SPATIAL ASSOCIATIONS	The stochastic dilution hypothesis has been proposed to explain species coexistence in species-rich communities. The relative importance of the stochastic dilution effects with respect to other effects such as competition and habitat filtering required to be tested. In this study, using data from a 25-ha species-rich subtropical forest plot with a strong topographic structure at Badagongshan in central China, we analyzed overall species associations and fine-scale species interactions between 2,550 species pairs. The result showed that: (1) the proportion of segregation in overall species association analysis at 2 m neighborhood in this plot followed the prediction of the stochastic dilution hypothesis that segregations should decrease with species richness but that at 10 m neighborhood was higher than the prediction. (2) The proportion of no association type was lower than the expectation of stochastic dilution hypothesis. (3) Fine-scale species interaction analyses using Heterogeneous Poisson processes as null models revealed a high proportion (47%) of significant species effects. However, the assumption of separation of scale of this method was not fully met in this plot with a strong fine-scale topographic structure. We also found that for species within the same families, fine-scale positive species interactions occurred more frequently and negative ones occurred less frequently than expected by chance. These results suggested effects of environmental filtering other than species interaction in this forest. (4) We also found that arbor species showed a much higher proportion of significant fine-scale species interactions (66%) than shrub species (18%). We concluded that the stochastic dilution hypothesis only be partly supported and environmental filtering left discernible spatial signals in the spatial associations between species in this species-rich subtropical forest with a strong topographic structure.	[Wang, Qinggang; Bao, Dachuan; Guo, Yili; Lu, Junmeng; Lu, Zhijun; Xu, Yaozhan; Zhang, Kuihan; Liu, Haibo; Meng, Hongjie; Jiang, Mingxi; Qiao, Xiujuan; Huang, Handong] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan, Hubei, Peoples R China; [Wang, Qinggang; Guo, Yili; Lu, Junmeng; Xu, Yaozhan; Zhang, Kuihan; Liu, Haibo; Meng, Hongjie] Univ Chinese Acad Sci, Life Sci Coll, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Jiang, MX (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan, Hubei, Peoples R China.	mxjiang@wbgcas.cn	; , Xiujuan/M-6966-2013	Lu, Zhijun/0000-0002-9688-3025; , Xiujuan/0000-0003-4647-399X	National Natural Science Foundation of China [31070465, 31200329]; Chinese Forest Biodiversity Monitoring Network [29200931131101919]; Division Of Environmental Biology [1354741] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Forest Biodiversity Monitoring Network; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was financially supported by National Natural Science Foundation of China (Grant no. 31070465 and 31200329) and Chinese Forest Biodiversity Monitoring Network (29200931131101919). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bunge J., J AM STAT ASSOC, V88, P364, DOI 10.2307/2290733; Clements F.E., 1916, PLANT SUCCESSION ANA; Condit R., 1998, Tropical forest census plots: methods and results from Barro Colorado Island, Panama and a comparison with other plots.; CONNELL J H, 1971, P298; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; Diamond J.M., 1975, P342; Diggle P., 2003, STAT ANAL SPATIAL PO; Gleason H.A., 1926, B TORREY BOT CLUB, V53, P7, DOI DOI 10.2307/2479933; Gotelli N.J., 1996, NULL MODELS ECOLOGY; Gotzenberger L, 2012, BIOL REV, V87, P111, DOI 10.1111/j.1469-185X.2011.00187.x; Greig-Smith P., 1983, QUANTITATIVE PLANT E; Hubbell S.P., 1986, COMMUNITY ECOLOGY, P314; Hubbell Stephen P., 2001, V32, pi; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Lan GY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0046074, 10.1371/annotation/974531b0-9da4-4575-b3d1-955b0163fde0]; Lieberman M, 2007, OIKOS, V116, P377, DOI 10.1111/j.2006.0030-1299.15370.x; Liu B, 1983, J CENTRAL S FORESTRY, V3, P141; Liu XB, 2012, ECOL LETT, V15, P111, DOI 10.1111/j.1461-0248.2011.01715.x; Loosmore NB, 2006, ECOLOGY, V87, P1925, DOI 10.1890/0012-9658(2006)87[1925:SIUTGO]2.0.CO;2; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; LOTWICK HW, 1982, J ROY STAT SOC B MET, V44, P406; Luo ZR, 2012, J PLANT ECOL, V5, P346, DOI 10.1093/jpe/rtr048; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; McGill BJ, 2010, ECOL LETT, V13, P627, DOI 10.1111/j.1461-0248.2010.01449.x; Perry GLW, 2009, OIKOS, V118, P161, DOI 10.1111/j.1600-0706.2008.16947.x; Perry GLW, 2014, OIKOS, V123, P99, DOI 10.1111/j.1600-0706.2013.00400.x; PIELOU EC, 1962, J ECOL, V50, P357, DOI 10.2307/2257448; Plotkin JB, 2000, J THEOR BIOL, V207, P81, DOI 10.1006/jtbi.2000.2158; R Development Core Team, 2012, R LANG ENV STAT COMP; Stoll P., 2000, GEOMETRY ECOLOGICAL, P11, DOI DOI 10.1017/CBO9780511525537.003; Stoyan D., 1994, FRACTALS RANDOM SHAP; Tilman D., 1982, Monographs in Population Biology, pi; Tofts R, 2000, P ROY SOC B-BIOL SCI, V267, P363, DOI 10.1098/rspb.2000.1010; Ulrich W, 2010, ECOL RES, V25, P375, DOI 10.1007/s11284-009-0661-y; Volkov I, 2009, P NATL ACAD SCI USA, V106, P13854, DOI 10.1073/pnas.0903244106; Wang XG, 2010, J ECOL, V98, P674, DOI 10.1111/j.1365-2745.2010.01644.x; Weiher E, 1999, ECOLOGICAL ASSEBLY R; Wiegand T, 2014, CH HALL CRC APP ENV, P1; Wiegand T, 2004, OIKOS, V104, P209, DOI 10.1111/j.0030-1299.2004.12497.x; Wiegand T, 2007, AM NAT, V170, pE77, DOI 10.1086/521240; Wiegand T, 2012, P ROY SOC B-BIOL SCI, V279, P3312, DOI 10.1098/rspb.2012.0376; Wills C, 1997, P NATL ACAD SCI USA, V94, P1252, DOI 10.1073/pnas.94.4.1252	42	5	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97300	10.1371/journal.pone.0097300	http://dx.doi.org/10.1371/journal.pone.0097300			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824996	Green Published, Green Submitted, gold			2022-12-27	WOS:000336369200089
J	Wu, BY; Gong, DH; Xu, B; He, QP; Liu, ZH; Ji, DX				Wu, Buyun; Gong, Dehua; Xu, Bin; He, Qunpeng; Liu, Zhihong; Ji, Daxi			Decreased Platelet Count in Patients Receiving Continuous Veno-Venous Hemofiltration: A Single-Center Retrospective Study	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; HEPARIN-INDUCED THROMBOCYTOPENIA; RENAL-REPLACEMENT THERAPY; RISK; CARE; PREVALENCE; ARGATROBAN; ANDROGEN; FAILURE; SEPSIS	Background: A decreased platelet count may occur and portend a worse outcome in patients receiving continuous renal replacement therapy (CRRT). We aim to investigate the incidence of decreased platelet count and related risk factors in patients receiving CRRT. Methods: In this retrospective study, we screened all patients receiving continuous veno-venous hemofiltration (CWH) at Jinling Hospital between November 2008 and October 2012. The patients were included who received uninterrupted CVVH for more than 72 h and had records of blood test for 4 consecutive days after ruling out pre-existing conditions that may affect the platelet count. Platelet counts before and during CVVH, illness severity, CVVH settings, and outcomes were analyzed. Results: The study included 125 patients. During the 3-day CVVH, 44.8% and 16% patients had a mild decline (20-49.9%) and severe decline (>= 50%) in the platelet count, respectively; 37.6% and 16.0% patients had mild thrombocytopenia (platelet count 50.1-100x10(9)/L) and severe thrombocytopenia (platelet count <= 50x10(9)/L), respectively. Patients with a severe decline in the platelet count had a significantly lower survival rate than patients without a severe decline in the platelet count (35.0% versus 59.0%, P = 0.012), while patients with severe thrombocytopenia had a survival rate similar to those without severe thrombocytopenia (45.0% versus 57.1%, P = 0.308). Female gender, older age, and longer course of the disease were independent risk factors for a severe decline in the platelet count. Conclusions: A decline in the platelet count and thrombocytopenia are quite common in patients receiving CVVH. The severity of the decline in the platelet count rather than the absolute count during CVVH may be associated with hospital mortality. Knowing the risk factors for a severe decline in the platelet count may allow physicians to prevent such an outcome.	[Wu, Buyun; Gong, Dehua; Xu, Bin; He, Qunpeng; Liu, Zhihong; Ji, Daxi] Nanjing Univ, Sch Med, Natl Clin Res Ctr Kidney Dis, Jinling Hosp, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University	Ji, DX (corresponding author), Nanjing Univ, Sch Med, Natl Clin Res Ctr Kidney Dis, Jinling Hosp, Nanjing 210008, Jiangsu, Peoples R China.	dr_jdx@163.com		Wu, Buyun/0000-0002-4874-9171; Liu, Zhi-Hong/0000-0001-6093-0726	Natural Science Foundation of China [81070608]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (Grant No. 81070608). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alatri A, 2012, THROMB RES, V129, P426, DOI 10.1016/j.thromres.2011.11.041; Ben Hamida C, 2003, INTENS CARE MED, V29, P756, DOI 10.1007/s00134-003-1727-x; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Crowther MA, 2005, J CRIT CARE, V20, P348, DOI 10.1016/j.jcrc.2005.09.008; Daugirdas JT, 2012, KIDNEY INT, V82, P147, DOI 10.1038/ki.2012.130; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Finkel KW, 2009, SEMIN DIALYSIS, V22, P155, DOI 10.1111/j.1525-139X.2008.00550.x; Hui P, 2011, CHEST, V139, P271, DOI 10.1378/chest.10-2243; Joannidis M, 2007, CRIT CARE, V11, DOI 10.1186/cc5937; Junqueira DRG, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007557.pub2; Kiaii M, 2011, JAMA-J AM MED ASSOC, V306, P1679, DOI 10.1001/jama.2011.1499; Kramer AA, 2007, CRIT CARE MED, V35, P2052, DOI 10.1097/01.CCM.0000275267.64078.B0; Li SJ, 2007, STEROIDS, V72, P875, DOI 10.1016/j.steroids.2007.07.007; Link A, 2008, CRIT CARE, V12, DOI 10.1186/cc6998; Liu SX, 2010, BLOOD PURIFICAT, V29, P375, DOI 10.1159/000314649; Livingston DH, 2003, ANN SURG, V238, P748, DOI 10.1097/01.sla.0000094441.38807.09; Moreau D, 2007, CHEST, V131, P1735, DOI 10.1378/chest.06-2233; Mulder J, 2003, INT J ARTIF ORGANS, V26, P906, DOI 10.1177/039139880302601006; Palsson R, 1999, KIDNEY INT, V55, P1991, DOI 10.1046/j.1523-1755.1999.00444.x; Post JB, 2010, AM J KIDNEY DIS, V55, pE25, DOI 10.1053/j.ajkd.2009.10.059; RONCO C, 1995, CRIT CARE MED, V23, P99, DOI 10.1097/00003246-199501000-00018; Ronco C, 2004, BLOOD PURIFICAT, V22, P164, DOI 10.1159/000074937; Saugel B, 2010, CRIT CARE, V14, DOI 10.1186/cc9024; Strauss R, 2002, CRIT CARE MED, V30, P1765, DOI 10.1097/00003246-200208000-00015; Tolwani A, 2012, NEW ENGL J MED, V367, P2505, DOI 10.1056/NEJMct1206045; Valente C, 2013, CLINICS, V68, P803, DOI 10.6061/clinics/2013(06)13; WATTEL E, 1994, BRIT J HAEMATOL, V87, P205, DOI 10.1111/j.1365-2141.1994.tb04895.x	27	16	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97286	10.1371/journal.pone.0097286	http://dx.doi.org/10.1371/journal.pone.0097286			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824815	Green Submitted, Green Published, gold			2022-12-27	WOS:000336369200086
J	Babuin, MF; Campestre, MP; Rocco, R; Bordenave, CD; Escaray, FJ; Antonelli, C; Calzadilla, P; Garriz, A; Serna, E; Carrasco, P; Ruiz, OA; Menendez, AB				Florencia Babuin, Maria; Paula Campestre, Maria; Rocco, Ruben; Bordenave, Cesar D.; Escaray, Francisco J.; Antonelli, Cristian; Calzadilla, Pablo; Garriz, Andres; Serna, Eva; Carrasco, Pedro; Ruiz, Oscar A.; Menendez, Ana B.			Response to Long-Term NaHCO3-Derived Alkalinity in Model Lotus japonicus Ecotypes Gifu B-129 and Miyakojima MG-20: Transcriptomic Profiling and Physiological Characterization	PLOS ONE			English	Article							CARBONIC-ANHYDRASE ACTIVITY; GENE-EXPRESSION; PLASMA-MEMBRANE; CHLOROPHYLL FLUORESCENCE; PUCCINELLIA-TENUIFLORA; ARABIDOPSIS-THALIANA; FUNCTIONAL-ANALYSIS; STRESS TOLERANCE; CDNA MICROARRAY; PLANT-CELLS	The current knowledge regarding transcriptomic changes induced by alkalinity on plants is scarce and limited to studies where plants were subjected to the alkaline salt for periods not longer than 48 h, so there is no information available regarding the regulation of genes involved in the generation of a new homeostatic cellular condition after long-term alkaline stress. Lotus japonicus is a model legume broadly used to study many important physiological processes including biotic interactions and biotic and abiotic stresses. In the present study, we characterized phenotipically the response to alkaline stress of the most widely used L. japonicus ecotypes, Gifu B-129 and MG-20, and analyzed global transcriptome of plants subjected to 10 mM NaHCO3 during 21 days, by using the Affymetrix Lotus japonicus GeneChip (R). Plant growth assessment, gas exchange parameters, chlorophyll a fluorescence transient (OJIP) analysis and metal accumulation supported the notion that MG-20 plants displayed a higher tolerance level to alkaline stress than Gifu B-129. Overall, 407 and 459 probe sets were regulated in MG-20 and Gifu B-129, respectively. The number of probe sets differentially expressed in roots was higher than that of shoots, regardless the ecotype. Gifu B-129 and MG-20 also differed in their regulation of genes that could play important roles in the generation of a new Fe/Zn homeostatic cellular condition, synthesis of plant compounds involved in stress response, protein-degradation, damage repair and root senescence, as well as in glycolysis, gluconeogenesis and TCA. In addition, there were differences between both ecotypes in the expression patterns of putative transcription factors that could determine distinct arrangements of flavonoid and isoflavonoid compounds. Our results provided a set of selected, differentially expressed genes deserving further investigation and suggested that the L. japonicus ecotypes could constitute a useful model to search for common and distinct tolerance mechanisms to long-term alkaline stress response in plants.	[Florencia Babuin, Maria; Paula Campestre, Maria; Rocco, Ruben; Bordenave, Cesar D.; Escaray, Francisco J.; Antonelli, Cristian; Calzadilla, Pablo; Garriz, Andres; Ruiz, Oscar A.; Menendez, Ana B.] Univ Nacl Gen San Martin, Inst Tecnol Chascomus, Inst Invest Biotechnol, Consejo Nacl Invest Cient & Tecn IIB INTECH UNSAM, Chascomus, Argentina; [Serna, Eva] Univ Valencia, Unidad Cent Invest Med INCLIVA, Valencia, Spain; [Carrasco, Pedro] Univ Valencia, Dept Bioquim & Biol Vegetal, Valencia, Spain; [Menendez, Ana B.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Biodiversidad & Biol Expt, Buenos Aires, DF, Argentina	University of Valencia; University of Valencia; University of Buenos Aires	Menendez, AB (corresponding author), Univ Nacl Gen San Martin, Inst Tecnol Chascomus, Inst Invest Biotechnol, Consejo Nacl Invest Cient & Tecn IIB INTECH UNSAM, Chascomus, Argentina.	anamen@bg.fcen.uba.ar	Bordenave, César Daniel/AAB-5407-2021; Calzadilla, Pablo/AAY-6108-2021; Carrasco, Pedro/P-3333-2014; serna, eva/Z-1433-2019	Bordenave, César Daniel/0000-0002-5582-4942; Carrasco, Pedro/0000-0001-7900-6146; serna, eva/0000-0002-2968-3349; Escaray, Francisco Jose/0000-0001-7413-3541	Agencia Nacional depromocion Cientifica y Tecnologica/FONCyT PICTs [2034, 1611]	Agencia Nacional depromocion Cientifica y Tecnologica/FONCyT PICTs	This work was supported by grants from the Agencia Nacional depromocion Cientifica y Tecnologica/FONCyT PICTs 2034 and 1611. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadia J, 2011, PLANT PHYSIOL BIOCH, V49, P471, DOI 10.1016/j.plaphy.2011.01.026; Agati G, 2011, J PLANT PHYSIOL, V168, P204, DOI 10.1016/j.jplph.2010.07.016; Aglawe S. B., 2012, Physiology and Molecular Biology of Plants, V18, P287, DOI 10.1007/s12298-012-0135-5; Alam SM., 1999, HDB PLANT CROP STRES, V2, P51; ALLEN RD, 1995, PLANT PHYSIOL, V107, P1049, DOI 10.1104/pp.107.4.1049; Alleva K, 2006, J EXP BOT, V57, P609, DOI 10.1093/jxb/erj046; Ariel F, 2010, PLANT CELL, V22, P2171, DOI 10.1105/tpc.110.074823; Balachandran S, 1997, P NATL ACAD SCI USA, V94, P14150, DOI 10.1073/pnas.94.25.14150; BARAKIVA A, 1969, J HORTIC SCI BIOTECH, V44, P359, DOI 10.1080/00221589.1969.11514318; Bordenave CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083199; Cakmak I, 2000, NEW PHYTOL, V146, P185, DOI 10.1046/j.1469-8137.2000.00630.x; Calatayud A, 2001, ENVIRON POLLUT, V115, P283, DOI 10.1016/S0269-7491(01)00101-4; Callard D, 1996, PLANT PHYSIOL, V112, P705, DOI 10.1104/pp.112.2.705; Chen LS, 2004, J AM SOC HORTIC SCI, V129, P738, DOI 10.21273/JASHS.129.5.0738; Chinnusamy V, 2005, CROP SCI, V45, P437, DOI 10.2135/cropsci2005.0437; Cho CW, 2009, BIOL PLANTARUM, V53, P461, DOI 10.1007/s10535-009-0086-z; Coudert Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-387; Paz RC, 2012, J PLANT GROWTH REGUL, V31, P448, DOI 10.1007/s00344-011-9254-4; Dannenhoffer JM, 1997, PLANTA, V201, P405, DOI 10.1007/s004250050083; Di Rienzo J.A., 2011, INFOSTAT VERSION 201; Diaz P, 2010, NEW PHYTOL, V188, P1001, DOI 10.1111/j.1469-8137.2010.03440.x; Dietz KJ, 2006, J EXP BOT, V57, P1697, DOI 10.1093/jxb/erj160; Dos Santos CV, 2006, TRENDS PLANT SCI, V11, P329, DOI 10.1016/j.tplants.2006.05.005; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; Escaray FJ, 2012, PLANT SCI, V182, P121, DOI 10.1016/j.plantsci.2011.03.016; Field B, 2006, PLANT MOL BIOL, V60, P717, DOI 10.1007/s11103-005-5547-y; Ge Y, 2011, FUNCT INTEGR GENOMIC, V11, P369, DOI 10.1007/s10142-010-0191-2; Ge Y, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-153; Geisler M, 2006, FEBS LETT, V580, P1094, DOI 10.1016/j.febslet.2005.11.054; GOFF SA, 1992, GENE DEV, V6, P864, DOI 10.1101/gad.6.5.864; Golldack D, 2002, J BIOL CHEM, V277, P5541, DOI 10.1074/jbc.M106197200; Gonzalez-Moreno S, 2008, REB, V27, P119, DOI DOI 10.1093/JXB/ERT208; Guerinot ML, 2000, BBA-BIOMEMBRANES, V1465, P190, DOI 10.1016/S0005-2736(00)00138-3; Guo PG, 2009, J EXP BOT, V60, P3531, DOI 10.1093/jxb/erp194; HANDBERG K, 1992, PLANT J, V2, P487, DOI 10.1111/j.1365-313X.1992.00487.x; Hashiguchi M, 2011, INTERDISCIPLINARY BI, V3, P4; Hoagland D.R., 1950, WATER CULTURE METHOD, V347, P29; Huang TL, 2012, PLANT MOL BIOL, V80, P587, DOI 10.1007/s11103-012-9969-z; Escudero-Almanza DJ, 2012, CHIL J AGR RES, V72, P140, DOI 10.4067/S0718-58392012000100022; Jin H, 2008, PLANT SCI, V175, P784, DOI 10.1016/j.plantsci.2008.07.016; Kim J, 2006, FEBS LETT, V580, P5251, DOI 10.1016/j.febslet.2006.08.050; Kobae Y, 2006, PLANT CELL PHYSIOL, V47, P309, DOI 10.1093/pcp/pcj001; Li HY, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-170; Li JY, 2010, PLANT CELL, V22, P1633, DOI 10.1105/tpc.110.075242; LICHTENTHALER FW, 1987, CARBOHYD RES, V164, P1, DOI 10.1016/0008-6215(87)80114-3; Liu YQ, 2001, PLANT PHYSIOL, V127, P1788, DOI 10.1104/pp.010593; Lohse M, 2010, PLANT PHYSIOL, V153, P642, DOI 10.1104/pp.109.152553; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; Mazel A, 2004, PLANT PHYSIOL, V134, P118, DOI 10.1104/pp.103.025379; Mukherjee I, 2006, PLANTA, V223, P1178, DOI 10.1007/s00425-005-0165-0; Narusaka Y, 2004, PLANT MOL BIOL, V55, P327, DOI 10.1007/s11103-004-0685-1; Nesi N, 2001, PLANT CELL, V13, P2099, DOI 10.1105/tpc.13.9.2099; NIELSEN KA, 2005, CYTOCHROME P450 STRU, P553; Nikolic M, 2007, FUNCT PLANT BIOL, V34, P402, DOI 10.1071/FP07022; Paolocci F, 2007, PLANT PHYSIOL, V143, P504, DOI 10.1104/pp.106.090886; Paolocci F, 2011, J EXP BOT, V62, P1189, DOI 10.1093/jxb/erq344; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pich A, 2001, PLANTA, V213, P967, DOI 10.1007/s004250100573; Pietrini F, 2005, AGR ECOSYST ENVIRON, V106, P189, DOI 10.1016/j.agee.2004.10.007; Prakash JSS, 2003, INDIAN J BIOCHEM BIO, V40, P160; Rabbani MA, 2003, PLANT PHYSIOL, V133, P1755, DOI 10.1104/pp.103.025742; READ SM, 1983, PLANTA, V158, P119, DOI 10.1007/BF00397704; Rengel Z, 1995, J PLANT PHYSIOL, V147, P251, DOI 10.1016/S0176-1617(11)81513-0; Rogers EE, 2002, PLANT CELL, V14, P1787, DOI 10.1105/tpc.001495; Roosta HR, 2011, J PLANT NUTR, V34, P717, DOI 10.1080/01904167.2011.540687; Rowley ER, 2011, PLANT ABIOTIC STRESS, P346; SACHS MM, 1986, ANNU REV PLANT PHYS, V37, P363, DOI 10.1146/annurev.pp.37.060186.002051; Sanchez DH, 2008, PLANT J, V53, P973, DOI 10.1111/j.1365-313X.2007.03381.x; Sato S, 2008, DNA RES, V15, P227, DOI 10.1093/dnares/dsn008; Shelton D, 2012, PLANT PHYSIOL, V159, P531, DOI 10.1104/pp.112.194753; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Silverstone AL, 1998, PLANT CELL, V10, P155, DOI 10.1105/tpc.10.2.155; Strasser R.J., 2000, PROBING PHOTOSYNTHES, P445; Stukkens Y, 2005, PLANT PHYSIOL, V139, P341, DOI 10.1104/pp.105.062372; Tanji KK, 1996, AGR SALINITY ASSESSM; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Thomas C, 2000, PLANT CELL, V12, P519, DOI 10.1105/tpc.12.4.519; Usadel B, 2005, PLANT PHYSIOL, V138, P1195, DOI 10.1104/pp.105.060459; VIERSTRA RD, 1993, ANNU REV PLANT PHYS, V44, P385, DOI 10.1146/annurev.pp.44.060193.002125; Wang YC, 2008, PLANT MOL BIOL REP, V26, P241, DOI 10.1007/s11105-008-0037-4; Wang YC, 2007, PLANT PHYSIOL BIOCH, V45, P567, DOI 10.1016/j.plaphy.2007.05.006; Wang YC, 2007, J PLANT PHYSIOL, V164, P78, DOI 10.1016/j.jplph.2005.12.006; Yoshida K, 2010, PLANT CELL PHYSIOL, V51, P912, DOI 10.1093/pcp/pcq067; Zhang X, 2011, PLANT CELL PHYSIOL, V52, P138, DOI 10.1093/pcp/pcq180; Zocchi G, 2007, J EXP BOT, V58, P993, DOI 10.1093/jxb/erl259	85	19	20	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97106	10.1371/journal.pone.0097106	http://dx.doi.org/10.1371/journal.pone.0097106			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835559	Green Submitted, gold, Green Published			2022-12-27	WOS:000339614800028
J	Jensen, KJ; Sondergaard, M; Andersen, A; Sartono, E; Martins, C; Garly, ML; Eugen-Olsen, J; Ullum, H; Yazdanbakhsh, M; Aaby, P; Benn, CS; Erikstrup, C				Jensen, Kristoffer Jarlov; Sondergaard, Mia; Andersen, Andreas; Sartono, Erliyani; Martins, Cesario; Garly, May-Lill; Eugen-Olsen, Jesper; Ullum, Henrik; Yazdanbakhsh, Maria; Aaby, Peter; Benn, Christine Stabell; Erikstrup, Christian			A Randomized Trial of an Early Measles Vaccine at 41/2 Months of Age in Guinea-Bissau: Sex-Differential Immunological Effects	PLOS ONE			English	Article							VITAMIN-A SUPPLEMENTATION; CHILDHOOD MORTALITY; CYTOKINE PRODUCTION; RESPONSES; CHILDREN; BIRTH; MICE	Background: After measles vaccine (MV), all-cause mortality is reduced more than can be explained by the prevention of measles, especially in females. Objective: We aimed to study the biological mechanisms underlying the observed non-specific and sex-differential effects of MV on mortality. Methods: Within a large randomised trial of MV at 4.5 months of age blood samples were obtained before and six weeks after randomisation to early MV or no early MV. We measured concentrations of cytokines and soluble receptors from plasma (interleukin-1 receptor agonist (IL-1Ra), IL-6, IL-8, IL-10, tumor necrosis factor (TNF)-alpha, monocyte chemoattractant protein (MCP)-1, soluble urokinase-type plasminogen activator receptor), and secreted cytokines (interferon-gamma, TNF-alpha, IL-5, IL-10, IL-13, IL-17) after in vitro challenge with innate agonists and recall antigens. We analysed the effect of MV in multiple imputation regression, overall and stratified by sex. The majority of the infants had previously been enrolled in a randomised trial of neonatal vitamin A. Post hoc we explored the potential effect modification by neonatal vitamin A. Results: Overall, MV versus no MV was associated with higher plasma MCP-1 levels, but the effect was only significant among females. Additionally, MV was associated with increased plasma IL-1Ra. MV had significantly positive effects on plasma IL-1Ra and IL-8 levels in females, but not in males. These effects were strongest in vitamin A supplemented infants. Vitamin A shifted the effect of MV in a pro-inflammatory direction. Conclusions: In this explorative study we found indications of sex-differential effects of MV on several of the plasma biomarkers investigated; in particular MV increased levels in females, most strongly in vitamin A recipients. The findings support that sex and micronutrient supplementation should be taken into account when analysing vaccine effects.	[Jensen, Kristoffer Jarlov; Andersen, Andreas; Aaby, Peter; Benn, Christine Stabell] Statens Serum Inst, Bandim Hlth Project, Res Ctr Vitamins & Vaccines CVIVA, DK-2300 Copenhagen, Denmark; [Jensen, Kristoffer Jarlov] Univ Southern Denmark, Fac Hlth Sci, Dept Cardiovasc & Renal Res, Odense, Denmark; [Jensen, Kristoffer Jarlov; Sondergaard, Mia; Martins, Cesario; Garly, May-Lill; Aaby, Peter; Benn, Christine Stabell] INDEPTH Network, Bandim Hlth Project, Bissau, Guinea Bissau; [Sartono, Erliyani; Yazdanbakhsh, Maria] Leiden Univ, Med Ctr, Leiden, Netherlands; [Eugen-Olsen, Jesper] Copenhagen Univ Hosp, Clin Res Ctr, Hvidovre, Denmark; [Ullum, Henrik] Rigshosp, Dept Clin Immunol, DK-2100 Copenhagen, Denmark; [Benn, Christine Stabell] Univ Southern Denmark, Odense Univ Hosp, Inst Clin Res, OPEN, Odense, Denmark; [Erikstrup, Christian] Aarhus Univ Hosp, Dept Clin Immunol, DK-8000 Aarhus, Denmark	Statens Serum Institut; University of Southern Denmark; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Southern Denmark; Odense University Hospital; Aarhus University	Jensen, KJ (corresponding author), Statens Serum Inst, Bandim Hlth Project, Res Ctr Vitamins & Vaccines CVIVA, DK-2300 Copenhagen, Denmark.	kjj@ssi.dk	Yazdanbakhsh, Maria/AAI-3996-2020	Yazdanbakhsh, Maria/0000-0002-7666-1441; Ullum, Henrik/0000-0001-7306-9058; Aaby, Peter/0000-0001-8331-1389; Eugen-Olsen, Jesper/0000-0002-4630-4275; Jensen, Kristoffer Jarlov/0000-0001-9687-5706; Sondergaard, Mia Johanna/0000-0002-9382-3748; Erikstrup, Christian/0000-0001-6551-6647	Novo Nordisk Foundation; Fonden til Laegevidenskabens Fremme; Danish Medical Research Council; Augustinus Fonden; Beckett fonden; Dagmar Marshalls fond; Aase og Ejnar Danielsens fond; ERC [ERC-2009-StG-243149]; University of Southern Denmark; Danish Council of Independent Research [09-066317]; Danish National Research Foundation [DNRF108]; DANIDA	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Fonden til Laegevidenskabens Fremme; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Augustinus Fonden; Beckett fonden; Dagmar Marshalls fond; Aase og Ejnar Danielsens fond; ERC(European Research Council (ERC)European Commission); University of Southern Denmark; Danish Council of Independent Research(Det Frie Forskningsrad (DFF)); Danish National Research Foundation(Danmarks Grundforskningsfond); DANIDA	The present study received support from Novo Nordisk Foundation, Fonden til Laegevidenskabens Fremme, Danish Medical Research Council, Augustinus Fonden, Beckett fonden, Dagmar Marshalls fond and the Aase og Ejnar Danielsens fond. PA holds a research professorship grant from the Novo Nordisk Foundation. CSB is funded by an ERC Starting Grant (ERC-2009-StG-243149). KJJ was supported by a grant from University of Southern Denmark and by a Female Research Leader grant (no.09-066317) from the Danish Council of Independent Research to CSB. CVIVA is funded by the Danish National Research Foundation (DNRF108). The Bandim Health Project received support from DANIDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaby P, 2004, INT J EPIDEMIOL, V33, P367, DOI 10.1093/ije/dyh004; AABY P, 1995, BRIT MED J, V311, P481, DOI 10.1136/bmj.311.7003.481; Aaby P, 2012, BMJ OPEN, V2; Aaby P, 2011, J INFECT DIS, V204, P245, DOI 10.1093/infdis/jir240; Aaby P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6495; Andersen A, 2012, STAT ANAL POPULATION; Baggiolini M, 2001, J INTERN MED, V250, P91, DOI 10.1046/j.1365-2796.2001.00867.x; Benn CS, 2008, VACCINE, V26, P4111, DOI 10.1016/j.vaccine.2008.04.021; Benn CS, 2009, VACCINE, V27, P2891, DOI 10.1016/j.vaccine.2009.02.080; Benn CS, 2003, INT J EPIDEMIOL, V32, P822, DOI 10.1093/ije/dyg208; Chae P, 2002, INFECT IMMUN, V70, P3164, DOI 10.1128/IAI.70.6.3164-3169.2002; ECKMANN L, 1993, INFECT IMMUN, V61, P4569, DOI 10.1128/IAI.61.11.4569-4574.1993; Eriksson M, 2007, CLIN EXP IMMUNOL, V150, P469, DOI 10.1111/j.1365-2249.2007.03515.x; Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4; Jorgensen MJ, 2012, BR J NUTR, P1; Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Newson RB, 2010, STATA J, V10, P568, DOI 10.1177/1536867X1101000403; Njie-Jobe J, 2012, VACCINE, V30, P2543, DOI 10.1016/j.vaccine.2012.01.083; Ostrowski SR, 2005, J INFECT DIS, V191, P1331, DOI 10.1086/428854; Ovsyannikova IG, 2003, VACCINE, V21, P3946, DOI 10.1016/S0264-410X(03)00272-X; Peters W, 2000, J IMMUNOL, V165, P7072, DOI 10.4049/jimmunol.165.12.7072; Rager-Zisman B, 2004, CLIN DIAGN LAB IMMUN, V11, P913, DOI 10.1128/CDLI.11.5.913-918.2004; Schnorr JJ, 2001, VACCINE, V19, P1503, DOI 10.1016/S0264-410X(00)00349-2; Snopov SA, 2005, ARCH VIROL, V150, P1729, DOI 10.1007/s00705-005-0561-6; Uh HW, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-59	26	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97536	10.1371/journal.pone.0097536	http://dx.doi.org/10.1371/journal.pone.0097536			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835247	Green Published, gold, Green Submitted			2022-12-27	WOS:000339614800049
J	Cantera, R; Ferreiro, MJ; Aransay, AM; Barrio, R				Cantera, Rafael; Jose Ferreiro, Maria; Maria Aransay, Ana; Barrio, Rosa			Global Gene Expression Shift during the Transition from Early Neural Development to Late Neuronal Differentiation in Drosophila melanogaster	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; EARLY BRAIN-DEVELOPMENT; NEUROMUSCULAR-JUNCTION; POSTEMBRYONIC NEUROBLASTS; TRANSCRIPTOME ANALYSIS; PATTERN; EMBRYOGENESIS; PATHWAY; GROWTH; GLIA	Regulation of transcription is one of the mechanisms involved in animal development, directing changes in patterning and cell fate specification. Large temporal data series, based on microarrays across the life cycle of the fly Drosophila melanogaster, revealed the existence of groups of genes which expression increases or decreases temporally correlated during the life cycle. These groups of genes are enriched in different biological functions. Here, instead of searching for temporal coincidence in gene expression using the entire genome expression data, we searched for temporal coincidence in gene expression only within predefined catalogues of functionally related genes and investigated whether a catalogue's expression profile can be used to generate larger catalogues, enriched in genes necessary for the same function. We analyzed the expression profiles from genes already associated with early neurodevelopment and late neurodifferentiation, at embryonic stages 16 and 17 of Drosophila life cycle. We hypothesized that during this interval we would find global downregulation of genes important for early neuronal development together with global upregulation of genes necessary for the final differentiation of neurons. Our results were consistent with this hypothesis. We then investigated if the expression profile of gene catalogues representing particular processes of neural development matched the temporal sequence along which these processes occur. The profiles of genes involved in patterning, neurogenesis, axogenesis or synaptic transmission matched the prediction, with largest transcript values at the time when the corresponding biological process takes place in the embryo. Furthermore, we obtained catalogues enriched in genes involved in temporally matching functions by performing a genome-wide systematic search for genes with their highest expression levels at the corresponding embryonic intervals. These findings imply the use of gene expression data in combination with known biological information to predict the involvement of functionally uncharacterized genes in particular biological events.	[Cantera, Rafael] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden; [Cantera, Rafael; Jose Ferreiro, Maria] IIBCE, Montevideo, Uruguay; [Maria Aransay, Ana] CIC bioGUNE, Derio, Spain; [Maria Aransay, Ana] CIBERehd, Derio, Spain; [Barrio, Rosa] CIC bioGUNE, Derio, Spain	Stockholm University; Instituto de Investigaciones Biologicas Clemente Estable Uruguay; CIC bioGUNE; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIC bioGUNE	Cantera, R (corresponding author), Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden.	rcantera@zoologi.su.se; rbarrio@cicbiogune.es	Barrio, Rosa/F-8712-2011; Aransay, Ana M./F-8086-2011	Barrio, Rosa/0000-0002-9663-0669; Aransay, Ana M./0000-0002-8271-612X	Tryggers Foundation; Spanish MICINN [BFU2011-25986]; Consolider Program [CSD2007-00825120]; Department of Education of the Basque Government [PI2012/42]; Department of Industry of the Basque Government [PI2012/42]; Bizkaia County	Tryggers Foundation; Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consolider Program(Spanish Government); Department of Education of the Basque Government; Department of Industry of the Basque Government; Bizkaia County	RC thanks the Tryggers Foundation for their support. RB thanks the Spanish MICINN (BFU2011-25986) and the Consolider Program (CSD2007-00825120), the Departments of Education and Industry of the Basque Government (PI2012/42), and the Bizkaia County. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenhein B, 2006, DEV BIOL, V296, P545, DOI 10.1016/j.ydbio.2006.04.460; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Baines RA, 2006, SEMIN CELL DEV BIOL, V17, P12, DOI 10.1016/j.semcdb.2005.11.003; Baines RA, 1998, J NEUROSCI, V18, P4673; Bayat V, 2011, CURR OPIN NEUROBIOL, V21, P182, DOI 10.1016/j.conb.2010.08.014; Berger C, 2012, CELL REP, V2, P407, DOI 10.1016/j.celrep.2012.07.008; Blauth K, 2010, INT REV CEL MOL BIO, V283, P93, DOI 10.1016/S1937-6448(10)83003-5; BROADIE KS, 1993, J NEUROSCI, V13, P144; CANAL I, 1986, J NEUROGENET, V3, P293, DOI 10.3109/01677068609106856; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Costa V, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/853916; DOE CQ, 1992, DEVELOPMENT, V116, P855; Dorfman R, 2001, DEVELOPMENT, V128, P965; Edenfeld G, 2005, CURR OPIN NEUROBIOL, V15, P34, DOI 10.1016/j.conb.2005.01.007; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; HARTENSTEIN V, 1984, ROUX ARCH DEV BIOL, V193, P308, DOI 10.1007/BF00848159; Hooper SD, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100112; ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q; JACOBS JR, 1989, J NEUROSCI, V9, P2412; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Ferreiro MJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-483; Kassahn KS, 2011, INTEGR BIOL-UK, V3, P522, DOI 10.1039/c0ib00062k; Keshishian H, 2004, TRENDS NEUROSCI, V27, P143, DOI 10.1016/j.tins.2004.01.004; KIDOKORO Y, 1994, NEUROSCI RES, V19, P143, DOI 10.1016/0168-0102(94)90137-6; MAROY P, 1988, J INSECT PHYSIOL, V34, P633, DOI 10.1016/0022-1910(88)90071-6; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; Minidorff EN, 2007, GENETICS, V176, P2247, DOI 10.1534/genetics.107.072819; NUSSLEINVOLHARD C, 1991, DEVELOPMENT, P1; Papatsenko I, 2010, BIOINFORMATICS, V26, P2731, DOI 10.1093/bioinformatics/btq513; Pareek CS, 2011, J APPL GENET, V52, P413, DOI 10.1007/s13353-011-0057-x; PROKOP A, 1991, DEVELOPMENT, V111, P79; Prokop A, 2013, J CELL SCI, V126, P2331, DOI 10.1242/jcs.126912; Rewitz KF, 2013, CURR TOP DEV BIOL, V103, P1, DOI 10.1016/B978-0-12-385979-2.00001-0; Rolls MM, 2011, DEV NEUROBIOL, V71, P419, DOI 10.1002/dneu.20836; Ruiz-Canada C, 2006, INT REV NEUROBIOL, V75, P217, DOI 10.1016/S0074-7742(06)75010-3; SINK H, 1991, DEVELOPMENT, V112, P307; Soustelle L, 2007, NEURON GLIA BIOL, V3, P5, DOI 10.1017/S1740925X07000464; Technau GM, 2006, DEV DYNAM, V235, P861, DOI 10.1002/dvdy.20566; Technau GM, 2008, ADV EXP MED BIOL, pv; Truman James W., 1993, P1245; TRUMAN JW, 1990, J NEUROBIOL, V21, P1072, DOI 10.1002/neu.480210711; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; Tsachaki M, 2012, DEV DYNAM, V241, P40, DOI 10.1002/dvdy.22738; Urbach R, 2004, BIOESSAYS, V26, P739, DOI 10.1002/bies.20062; Urbach R, 2003, DEVELOPMENT, V130, P3589, DOI 10.1242/dev.00528; White KP, 1999, SCIENCE, V286, P2179, DOI 10.1126/science.286.5447.2179; Yamanaka N, 2013, ANNU REV ENTOMOL, V58, P497, DOI 10.1146/annurev-ento-120811-153608; Yoshida S, 2005, DEVELOPMENT, V132, P4587, DOI 10.1242/dev.02040; Yoshihara M, 1997, J NEUROSCI, V17, P8408; Yuva-Aydemir Y, 2011, J NEUROSCI, V31, P7005, DOI 10.1523/JNEUROSCI.0459-11.2011	52	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97703	10.1371/journal.pone.0097703	http://dx.doi.org/10.1371/journal.pone.0097703			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830291	Green Submitted, Green Published, gold			2022-12-27	WOS:000336789500105
J	Ding, GY; Gao, L; Li, XW; Zhou, MG; Liu, QY; Ren, HY; Jiang, BF				Ding, Guoyong; Gao, Lu; Li, Xuewen; Zhou, Maigeng; Liu, Qiyong; Ren, Hongyan; Jiang, Baofa			A Mixed Method to Evaluate Burden of Malaria Due to Flooding and Waterlogging in Mengcheng County, China: A Case Study	PLOS ONE			English	Article							CASE-CROSSOVER; AIR-POLLUTION; EL-NINO; METEOROLOGICAL FACTORS; CLIMATIC VARIABLES; SEEKING BEHAVIOR; RAPID ASSESSMENT; TRANSMISSION; EXPOSURE; RISK	Background: Malaria is a highly climate-sensitive vector-borne infectious disease that still represents a significant public health problem in Huaihe River Basin. However, little comprehensive information about the burden of malaria caused by flooding and waterlogging is available from this region. This study aims to quantitatively assess the impact of flooding and waterlogging on the burden of malaria in a county of Anhui Province, China. Methods: A mixed method evaluation was conducted. A case-crossover study was firstly performed to evaluate the relationship between daily number of cases of malaria and flooding and waterlogging from May to October 2007 in Mengcheng County, China. Stratified Cox models were used to examine the lagged time and hazard ratios (HRs) of the risk of flooding and waterlogging on malaria. Years lived with disability (YLDs) of malaria attributable to flooding and waterlogging were then estimated based on the WHO framework of calculating potential impact fraction in the Global Burden of Disease study. Results: A total of 3683 malaria were notified during the study period. The strongest effect was shown with a 25-day lag for flooding and a 7-day lag for waterlogging. Multivariable analysis showed that an increased risk of malaria was significantly associated with flooding alone [adjusted hazard ratio (AHR) = 1.467, 95% CI = 1.257, 1.713], waterlogging alone (AHR = 1.879, 95% CI = 1.696, 2.121), and flooding and waterlogging together (AHR = 2.926, 95% CI = 2.576, 3.325). YLDs per 1000 of malaria attributable to flooding alone, waterlogging alone and flooding and waterlogging together were 0.009 per day, 0.019 per day and 0.022 per day, respectively. Conclusion: Flooding and waterlogging can lead to higher burden of malaria in the study area. Public health action should be taken to avoid and control a potential risk of malaria epidemics after these two weather disasters.	[Ding, Guoyong; Gao, Lu; Jiang, Baofa] Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Jinan 250100, Shandong, Peoples R China; [Ding, Guoyong] Taishan Med Coll, Sch Publ Hlth, Dept Occupat & Environm Hlth, Tai An, Shandong, Peoples R China; [Ding, Guoyong; Gao, Lu; Li, Xuewen; Liu, Qiyong; Jiang, Baofa] Shandong Univ, Climate Change & Hlth Ctr, Jinan 250100, Shandong, Peoples R China; [Li, Xuewen] Shandong Univ, Sch Publ Hlth, Dept Environm & Hlth, Jinan 250100, Shandong, Peoples R China; [Zhou, Maigeng] China CDC, Natl Ctr Chron & Noncommunicable Dis Control & Pr, Beijing, Peoples R China; [Liu, Qiyong] China CDC, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Ren, Hongyan] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University; Chinese Center for Disease Control & Prevention; National Center for Chronic & Noncommunicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Jiang, BF (corresponding author), Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Jinan 250100, Shandong, Peoples R China.	bjiang@sdu.edu.cn	Zhou, Maigeng/HCH-7703-2022	Li, Xuewen/0000-0003-0841-8658	National Basic Research Program of China (973 Program) [2012CB955502]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Basic Research Program of China (973 Program) (Grant No. 2012CB955502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaya SW, 2009, GLOBAL HEALTH ACTION, V2, DOI 10.3402/gha.v2i0.2019; Ahmed F, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/963525; Alemu A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-30; [Anonymous], 1995, ECOSYST HEALLTH; [Anonymous], WHO ENV BURDEN DIS S; [Anonymous], 2011, METEOROL ENV SCI; [Anonymous], YB METEROROLOGICAL D; [Anonymous], 2001, NATL BURDEN DIS STUD; [Anonymous], CHIN AGR DIS INF DAT; [Anonymous], 2011, ANN DISASTER STAT RE; [Anonymous], 2000, ACTA TROP; [Anonymous], FLOOD COMM DIS FACT; [Anonymous], J TROPICAL MED; Barati M, 2012, ASIAN PAC J TROP MED, V5, P789, DOI 10.1016/S1995-7645(12)60145-X; Bateson TF, 1999, EPIDEMIOLOGY, V10, P539, DOI 10.1097/00001648-199909000-00013; Bezirtzoglou C, 2011, ANAEROBE, V17, P337, DOI 10.1016/j.anaerobe.2011.05.016; Bi P, 2003, PUBLIC HEALTH REP, V118, P65, DOI 10.1016/S0033-3549(04)50218-2; Bouma MJ, 1997, JAMA-J AM MED ASSOC, V278, P1772, DOI 10.1001/jama.278.21.1772; CEDENO JEM, 1986, DISASTERS, V10, P107, DOI 10.1111/j.1467-7717.1986.tb00575.x; Craig MH, 2004, TROP MED INT HEALTH, V9, P1247, DOI 10.1111/j.1365-3156.2004.01340.x; Duo-quan Wang, 2013, PLoS One, V8, pe68766, DOI 10.1371/journal.pone.0068766; Gagnon AS, 2002, INT J BIOMETEOROL, V46, P81, DOI 10.1007/s00484-001-0119-6; Gao HW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043686; Garg A, 2009, ENVIRON MANAGE, V43, P779, DOI 10.1007/s00267-008-9242-z; Githeko AK, 2000, B WORLD HEALTH ORGAN, V78, P1136; GUERI M, 1986, DISASTERS, V10, P118, DOI 10.1111/j.1467-7717.1986.tb00577.x; Harrison BA, 2009, J AM MOSQUITO CONTR, V25, P265, DOI 10.2987/08-5754.1; Hashizume M, 2006, PUBLIC HEALTH, V120, P444, DOI 10.1016/j.puhe.2005.11.007; Hoshen MB, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-32; Huang F, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-54; Janes H, 2005, EPIDEMIOLOGY, V16, P717, DOI 10.1097/01.ede.0000181315.18836.9d; Kent RJ, 2007, AM J TROP MED HYG, V76, P267, DOI 10.4269/ajtmh.2007.76.267; Kondo Hisayoshi, 2002, Prehosp Disaster Med, V17, P126; Kouadio IK, 2012, EXPERT REV ANTI-INFE, V10, P95, DOI [10.1586/ERI.11.155, 10.1586/eri.11.155]; Lee JT, 1999, ENVIRON HEALTH PERSP, V107, P633, DOI 10.2307/3434454; Li XL, 2007, T ROY SOC TROP MED H, V101, P299, DOI 10.1016/j.trstmh.2006.05.011; Liu XB, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-221; Maclure M, 2000, ANNU REV PUBL HEALTH, V21, P193, DOI 10.1146/annurev.publhealth.21.1.193; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Majambere S, 2010, AM J TROP MED HYG, V82, P176, DOI 10.4269/ajtmh.2010.09-0373; MATHUR K K, 1992, Indian Journal of Malariology, V29, P1; McCarthy MC, 1996, J MED VIROL, V48, P141, DOI 10.1002/(SICI)1096-9071(199602)48:2&lt;141::AID-JMV4&gt;3.0.CO;2-9; Mouchet J, 1996, LANCET, V348, P1735, DOI 10.1016/S0140-6736(05)65860-6; Mouchet J, 1998, J AM MOSQUITO CONTR, V14, P121; Pawar A. B., 2008, Journal of Vector Borne Diseases, V45, P325; RUSSAC PA, 1986, DISASTERS, V10, P112, DOI 10.1111/j.1467-7717.1986.tb00576.x; Saenz R, 1995, Prehosp Disaster Med, V10, P154; Shen Y.Z., 2006, J PATHOG BIOL, V4, P301; Sidley P, 2000, BRIT MED J, V320, P669, DOI 10.1136/bmj.320.7236.669; TELLERIA AV, 1986, DISASTERS, V10, P88, DOI 10.1111/j.1467-7717.1986.tb00574.x; Theander TG, 1998, T ROY SOC TROP MED H, V92, P589, DOI 10.1016/S0035-9203(98)90775-1; Turin TC, 2012, NEUROEPIDEMIOLOGY, V38, P84, DOI 10.1159/000335654; Viera AJ, 2008, SOUTH MED J, V101, P730, DOI 10.1097/SMJ.0b013e31817a7ee4; Wang S, 2011, EPIDEMIOLOGY, V22, P568, DOI 10.1097/EDE.0b013e31821d09cd; Wang SV, 2011, AM J EPIDEMIOL, V174, P118, DOI 10.1093/aje/kwr038; Watson JT, 2007, EMERG INFECT DIS, V13, P1, DOI 10.3201/eid1301.060779; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WOODRUFF BA, 1990, DISASTERS, V14, P151, DOI 10.1111/j.1467-7717.1990.tb01056.x; Yang GJ, 2010, GEOSPATIAL HEALTH, V5, P11, DOI 10.4081/gh.2010.183; Ye Y, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-101; Zhou SS, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-337	61	22	23	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97520	10.1371/journal.pone.0097520	http://dx.doi.org/10.1371/journal.pone.0097520			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3UI	24830808	Green Submitted, gold, Green Published			2022-12-27	WOS:000336789500074
J	Etienne, S; Guthrie, M; Goillandeau, M; Nguyen, TH; Orignac, H; Gross, C; Boraud, T				Etienne, Stephanie; Guthrie, Martin; Goillandeau, Michel; Tho Hai Nguyen; Orignac, Hugues; Gross, Christian; Boraud, Thomas			Easy Rider: Monkeys Learn to Drive a Wheelchair to Navigate through a Complex Maze	PLOS ONE			English	Article							MEMORY-SYSTEMS; CAUDATE-NUCLEUS; DORSAL STRIATUM; SPATIAL MEMORY; WATER MAZE; PATH-INTEGRATION; BASAL GANGLIA; HIPPOCAMPUS; PARALLEL; PLACE	The neurological bases of spatial navigation are mainly investigated in rodents and seldom in primates. The few studies led on spatial navigation in both human and non-human primates are performed in virtual, not in real environments. This is mostly because of methodological difficulties inherent in conducting research on freely-moving monkeys in real world environments. There is some incertitude, however, regarding the extrapolation of rodent spatial navigation strategies to primates. Here we present an entirely new platform for investigating real spatial navigation in rhesus monkeys. We showed that monkeys can learn a pathway by using different strategies. In these experiments three monkeys learned to drive the wheelchair and to follow a specified route through a real maze. After learning the route, probe tests revealed that animals successively use three distinct navigation strategies based on i) the place of the reward, ii) the direction taken to obtain reward or iii) a cue indicating reward location. The strategy used depended of the options proposed and the duration of learning. This study reveals that monkeys, like rodents and humans, switch between different spatial navigation strategies with extended practice, implying well-conserved brain learning systems across different species. This new task with freely driving monkeys provides a good support for the electrophysiological and pharmacological investigation of spatial navigation in the real world by making possible electrophysiological and pharmacological investigations.	[Etienne, Stephanie; Guthrie, Martin; Goillandeau, Michel; Tho Hai Nguyen; Orignac, Hugues; Gross, Christian; Boraud, Thomas] Univ Bordeaux, Inst Malad Neurodegenerat UMR 5293, Bordeaux, France; [Goillandeau, Michel; Tho Hai Nguyen; Orignac, Hugues; Gross, Christian; Boraud, Thomas] CNRS, Inst Malad Neurodegenerat UMR 5293, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Boraud, T (corresponding author), Univ Bordeaux, Inst Malad Neurodegenerat UMR 5293, Bordeaux, France.	Thomas.boraud@u-bordeaux2.fr			CNRS; Agence Nationale de la Recherche [ANR-MNPS-017-01 PAC Monkey]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by CNRS and Agence Nationale de la Recherche (ANR-MNPS-017-01 PAC Monkey). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 1996, CEREB CORTEX, V6, P823, DOI 10.1093/cercor/6.6.823; Burgess N, 2008, ANN NY ACAD SCI; Burgess N, 2008, ANN NY ACAD SCI, V1124, P77, DOI 10.1196/annals.1440.002; DeCoteau WE, 2000, BEHAV NEUROSCI, V114, P1096, DOI 10.1037//0735-7044.114.6.1096; Devan BD, 1999, J NEUROSCI, V19, P2789; Devan BD, 1996, NEUROBIOL LEARN MEM, V66, P305, DOI 10.1006/nlme.1996.0072; Devan BD, 1999, BEHAV BRAIN RES, V100, P5, DOI 10.1016/S0166-4328(98)00107-7; Doeller CF, 2008, P NATL ACAD SCI USA, V105, P5915, DOI 10.1073/pnas.0801489105; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Escola L, 2003, BRAIN, V126, P95, DOI 10.1093/brain/awg004; Etienne AS, 2004, HIPPOCAMPUS, V14, P180, DOI 10.1002/hipo.10173; Fouquet C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067232; Gillner S, 1998, J COGNITIVE NEUROSCI, V10, P445, DOI 10.1162/089892998562861; Iaria G, 2003, J NEUROSCI, V23, P5945; Khamassi M, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00079; Killian NJ, 2012, NATURE, V491, P761, DOI 10.1038/nature11587; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; Lavenex PB, 2009, HIPPOCAMPUS, V19, P8, DOI 10.1002/hipo.20485; Ludvig N, 2003, BEHAV BRAIN RES, V140, P175, DOI 10.1016/S0166-4328(02)00325-X; MCDONALD RJ, 1994, BEHAV NEURAL BIOL, V61, P260, DOI 10.1016/S0163-1047(05)80009-3; MCDONALD RJ, 1993, BEHAV NEUROSCI, V107, P3, DOI 10.1037/0735-7044.107.1.3; Mizumori SJY, 2005, INTEGR COMP BIOL, V45, P547, DOI 10.1093/icb/45.3.547; Moussa R, 2011, LEARN MEMORY, V18, P444, DOI 10.1101/lm.2123811; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; PACKARD MG, 1989, J NEUROSCI, V9, P1465; Packard MG, 1996, NEUROBIOL LEARN MEM, V65, P65, DOI 10.1006/nlme.1996.0007; Packard MG, 1999, P NATL ACAD SCI USA, V96, P12881, DOI 10.1073/pnas.96.22.12881; Retailleau A, 2012, J PHYSIOL-PARIS, V106, P72, DOI 10.1016/j.jphysparis.2011.10.002; Rolls ET, 2005, NEURAL NETWORKS, V18, P1229, DOI 10.1016/j.neunet.2005.08.006; SAINTCYR JA, 1988, BRAIN, V111, P941, DOI 10.1093/brain/111.4.941; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Washburn DA, 2003, ANIM COGN, V6, P161, DOI 10.1007/s10071-003-0173-z; White NM, 2002, NEUROBIOL LEARN MEM, V77, P125, DOI 10.1006/nlme.2001.4008; Wickens JR, 2007, ANN NY ACAD SCI, V1104, P192, DOI 10.1196/annals.1390.016; Wiener JM, 2011, EXP BRAIN RES, V208, P61, DOI 10.1007/s00221-010-2460-7; Yin HH, 2004, LEARN MEMORY, V11, P459, DOI 10.1101/lm.81004; Zhang B, 2008, J NEUROSCI METH, V170, P111, DOI 10.1016/j.jneumeth.2007.12.017	37	6	6	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e96275	10.1371/journal.pone.0096275	http://dx.doi.org/10.1371/journal.pone.0096275			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831130	Green Published, Green Submitted, gold			2022-12-27	WOS:000336789500016
J	Kuwahara, A; Sakai, H; Xu, YJ; Itoh, Y; Hirabayashi, Y; Gotoh, Y				Kuwahara, Atsushi; Sakai, Hiroshi; Xu, Yuanjiang; Itoh, Yasuhiro; Hirabayashi, Yusuke; Gotoh, Yukiko			Tcf3 Represses Wnt-beta-Catenin Signaling and Maintains Neural Stem Cell Population during Neocortical Development	PLOS ONE			English	Article							REGULATES NEURONAL DIFFERENTIATION; WNT/BETA-CATENIN; FATE DETERMINATION; PRECURSOR CELLS; N-MYC; TARGET; SPECIFICATION; TRANSCRIPTION; PROLIFERATION; NEUROGENESIS	During mouse neocortical development, the Wnt-beta-catenin signaling pathway plays essential roles in various phenomena including neuronal differentiation and proliferation of neural precursor cells (NPCs). Production of the appropriate number of neurons without depletion of the NPC population requires precise regulation of the balance between differentiation and maintenance of NPCs. However, the mechanism that suppresses Wnt signaling to prevent premature neuronal differentiation of NPCs is poorly understood. We now show that the HMG box transcription factor Tcf3 (also known as Tcf7l1) contributes to this mechanism. Tcf3 is highly expressed in undifferentiated NPCs in the mouse neocortex, and its expression is reduced in intermediate neuronal progenitors (INPs) committed to the neuronal fate. We found Tcf3 to be a repressor of Wnt signaling in neocortical NPCs in a reporter gene assay. Tcf3 bound to the promoter of the proneural bHLH gene Neurogenin1 (Neurog1) and repressed its expression. Consistent with this, Tcf3 repressed neuronal differentiation and increased the self-renewal activity of NPCs. We also found that Wnt signal stimulation reduces the level of Tcf3, and increases those of Tcf1 (also known as Tcf7) and Lef1, positive mediators of Wnt signaling, in NPCs. Together, these results suggest that Tcf3 antagonizes Wnt signaling in NPCs, thereby maintaining their undifferentiated state in the neocortex and that Wnt signaling promotes the transition from Tcf3-mediated repression to Tcf1/Lef1-mediated enhancement of Wnt signaling, constituting a positive feedback loop that facilitates neuronal differentiation.	[Kuwahara, Atsushi; Sakai, Hiroshi; Xu, Yuanjiang; Itoh, Yasuhiro; Hirabayashi, Yusuke; Gotoh, Yukiko] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Cell Signaling, Tokyo, Japan	University of Tokyo	Hirabayashi, Y (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Cell Signaling, Tokyo, Japan.	yhira@iam.u-tokyo.ac.jp	Kuwahara, Atsushi/ABB-5872-2021	Kuwahara, Atsushi/0000-0003-2418-7853; Ito, Yasuhiro/0000-0001-8590-9122; Hirabayashi, Yusuke/0000-0003-3950-6781	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Innovative Areas 'Neural Diversity and Neocortical Organization' of MEXT; Japan Science and Technology Agency; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [22123003] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Innovative Areas 'Neural Diversity and Neocortical Organization' of MEXT; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (A) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan, Innovative Areas 'Neural Diversity and Neocortical Organization' of MEXT, by Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency, by the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Medina R, 2009, DEVELOPMENT, V136, P3301, DOI 10.1242/dev.041772; Amoyel M, 2005, DEVELOPMENT, V132, P775, DOI 10.1242/dev.01616; Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Backman M, 2005, DEV BIOL, V279, P155, DOI 10.1016/j.ydbio.2004.12.010; Bain J, 2007, BIOCH J, V408; Cadigan KM, COLD SPRING HARB PER, V4; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Choe Y, DEV NEUROSCI; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; Ferrell JE, 2002, CURRENT OPINION CELL, V14; Fotaki V, 2011, J COMP NEUROL, V519, P1640, DOI 10.1002/cne.22592; Gribble SL, 2009, DEVELOPMENT, V136, P781, DOI 10.1242/dev.027995; Harrison-Uy SJ, 2012, COLD SPRING HARBOR P, V4; Hikasa H, 2010, DEV CELL, V19, P521, DOI 10.1016/j.devcel.2010.09.005; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Hirabayashi Y, 2005, NEUROSCI RES, V51, P331, DOI 10.1016/j.neures.2005.01.004; Hirabayashi Y, 2010, NAT REV NEUROSCI, V11, P377, DOI 10.1038/nrn2810; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; Hoppler S, 2007, J CELL SCI, V120, P385, DOI 10.1242/jcs.03363; Hovanes K, 2001, NATURE GENETICS, V28; Hovanes K, 2000, NUCL ACIDS RES, V28; Ishii Y, 1998, DEV DYNAM, V213, P464, DOI 10.1002/(SICI)1097-0177(199812)213:4<464::AID-AJA11>3.0.CO;2-Z; Israsena N, 2004, DEV BIOL, V268, P220, DOI 10.1016/j.ydbio.2003.12.024; Ivaniutsin U, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-3; Kaykas A, 2004, NAT CELL BIOL, V6, P52, DOI 10.1038/ncb1081; Kim CH, 2000, NATURE, V407, P913, DOI 10.1038/35038097; Kratochwil K, 2002, GENES DEV, V16; Kuwahara A, 2010, DEVELOPMENT, V137, P1035, DOI 10.1242/dev.046417; Lange C, 2011, NEUROSCIENCE LETT, V488; Lee JE, 2006, DEVELOPMENT, V133, P4451, DOI 10.1242/dev.02613; Li TWH, 2006, MOL CELLULAR BIOL, V26; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Liu F, 2005, DEVELOPMENT, V132, P5375, DOI 10.1242/dev.02152; Lyu J, 2008, DEV CELL, V15, P773, DOI 10.1016/j.devcel.2008.10.004; Machon O, 2003, NEUROSCIENCE, V122, P129, DOI 10.1016/S0306-4522(03)00519-0; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; Merrill BJ, 2004, DEVELOPMENT, V131, P263, DOI 10.1242/dev.00935; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Munji RN, 2011, J NEUROSCI, V31, P1676, DOI 10.1523/JNEUROSCI.5404-10.2011; Murray JT, 2004, BIOCH J, V384; Mutch CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012376; Najdi R, 2009, ONCOGENE, V28, P4133, DOI 10.1038/onc.2009.271; Nguyen H, 2009, NATURE GENETICS, V41; Nguyen H, 2006, CELL, V127, P171, DOI 10.1016/j.cell.2006.07.036; Ohtsuka T, 2011, STEM CELLS, V29, P1817, DOI 10.1002/stem.731; Pereira L, 2006, MOL CELL BIOL, V26, P7479, DOI 10.1128/MCB.00368-06; Reya T, 2000, IMMUNITY, V13, P15, DOI 10.1016/S1074-7613(00)00004-2; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Salomonis N, 2010, P NATL ACAD SCI USA, V107, P10514, DOI 10.1073/pnas.0912260107; Shu WG, 2005, DEV BIOL, V283, P226, DOI 10.1016/j.ydbio.2005.04.014; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Solberg N, 2012, MOL CELLULAR BIOCH, V365; Sunabori T, 2008, J CELL SCI, V121, P1204, DOI 10.1242/jcs.025064; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Theodorou E, 2009, GENE DEV, V23, P575, DOI 10.1101/gad.1772509; Valenta T, 2011, GENE DEV, V25, P2631, DOI 10.1101/gad.181289.111; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Woodhead GJ, 2006, J NEUROSCI, V26, P12620, DOI 10.1523/JNEUROSCI.3180-06.2006; Wray J, 2011, NATURE CELL BIOL, V13; Wu CI, 2012, DEVELOPMENT, V139, P2118, DOI 10.1242/dev.076067; Yi F, 2011, NATURE CELL BIOL, V13; Yi F, 2008, STEM CELLS, V26, P1951, DOI 10.1634/stemcells.2008-0229; Zhang JN, 2010, DEV CELL, V18, P472, DOI 10.1016/j.devcel.2009.12.025; Zhong J, 2011, DEVELOPMENT, V138; Zhou CJ, 2006, NEUROSCIENCE, V142, P1119, DOI 10.1016/j.neuroscience.2006.07.007	70	52	54	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e94408	10.1371/journal.pone.0094408	http://dx.doi.org/10.1371/journal.pone.0094408			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24832538	gold, Green Published, Green Submitted			2022-12-27	WOS:000336789500004
J	Luiz, DP; Santos, CD; Bonetti, AM; Brandeburgo, MAM				Luiz, Denis Prudencio; Santos Junior, Celio Dias; Bonetti, Ana Maria; Manfredi Brandeburgo, Malcom Antonio			Tollip or Not Tollip: What Are the Evolving Questions behind It?	PLOS ONE			English	Article							AMINO-ACID SUBSTITUTION; LEGIONELLA-PNEUMOPHILA; RECOMBINANT SEQUENCES; PROTEIN; SERVER; SELECTION; MODELS; IMMUNOSENESCENCE; IDENTIFICATION; INTERLEUKIN-1	Tollip plays an important role in the interleukin-1 receptor IL-1R and Toll pathways. As a modulator of the immune pathway, it indirectly controls the amount of antimicrobial peptides. This could indicate a vital step in maintaining animal immune systems and preventing infection. Evolutionary questions are crucial to understanding the conservation and functioning of the biochemical pathways like the Tollip-mediated one. Through an analysis of 36 sequences of the Tollip protein from different animal taxa, downloaded from Kyoto Encyclopedia of Genes and Genomes (KEGG) databank, we inferred diverse evolutionary parameters, such as molecular selection and structure conservation, by analyzing residue by residue, beyond the canonical parameters to this type of study, as maximum likelihood trees. We found that Tollip presented different trends in its evolving history. In primates, the protein is becoming more unstable, just the opposite is observed in the arthropod group. The most interesting finding was the concentration of positively selected residues at amino terminal ends. Some observed topological incongruences in maximum likelihood trees of complete and curated Tollip data sets could be explained through horizontal transfers, evidenced by recombination detection. These results suggest that there is more to be researched and understood about this protein.	[Luiz, Denis Prudencio; Santos Junior, Celio Dias; Bonetti, Ana Maria; Manfredi Brandeburgo, Malcom Antonio] Univ Fed Uberlandia, Genet Lab, Genet & Biochem Inst, BR-38400 Uberlandia, MG, Brazil	Universidade Federal de Uberlandia	Luiz, DP (corresponding author), Univ Fed Uberlandia, Genet Lab, Genet & Biochem Inst, Av Engenheiro Dinz 1178,CP 593, BR-38400 Uberlandia, MG, Brazil.	prudenis@yahoo.com.br	Santos-Júnior, Célio D./F-5580-2013; Bonetti, Ana/V-3811-2019	Santos-Júnior, Célio D./0000-0002-1974-1736; 	funding agency: CAPES; funding agency: CNPq; funding agency: FAPEMIG; funding agency: FAU/UFU	funding agency: CAPES; funding agency: CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); funding agency: FAPEMIG; funding agency: FAU/UFU	This work was supported by the following funding agencies: CAPES, CNPq, FAPEMIG, FAU/UFU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi J, 1996, J MOL EVOL, V42, P459; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Azurmendi HF, 2010, MOL CELLS, V30, P581, DOI 10.1007/s10059-010-0145-5; BJELLQVIST B, 1994, ELECTROPHORESIS, V15, P529, DOI 10.1002/elps.1150150171; Brady A, 2011, NAT METHODS, V8, P367, DOI 10.1038/nmeth0511-367; Brissoni B, 2006, CURR BIOL, V16, P2265, DOI 10.1016/j.cub.2006.09.062; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Bulut Y, 2001, J IMMUNOL, V167, P987, DOI 10.4049/jimmunol.167.2.987; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; Coscolla M, 2006, ENVIRON MICROBIOL, V8, P1056, DOI 10.1111/j.1462-2920.2006.00997.x; Costa J, 2010, ENVIRON MICROBIOL, V12, P2711, DOI 10.1111/j.1462-2920.2010.02240.x; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Didierlaurent A, 2006, MOL CELL BIOL, V26, P735, DOI 10.1128/MCB.26.3.735-742.2006; Doron-Faigenboim A, 2005, BIOINFORMATICS, V21, P2101, DOI 10.1093/bioinformatics/bti259; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Franceschi C, 2000, VACCINE, V18, P1717, DOI 10.1016/S0264-410X(99)00513-7; Galperin MY, 2012, NUCLEIC ACIDS RES, V40, pD1, DOI 10.1093/nar/gkr1196; Garcia-Boronat M, 2008, NUCLEIC ACIDS RES, V36, pW35, DOI 10.1093/nar/gkn211; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Grenfell B. T., 1995, ECOLOGY INFECT DIS N; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ishihara S, 2009, J GASTROENTEROL, V44, P1097, DOI 10.1007/s00535-009-0141-8; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kimura M., 1983, NEUTRAL THEORY MOL E; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pD266, DOI 10.1093/nar/gki001; Li T, 2004, MOL IMMUNOL, V41, P85, DOI 10.1016/j.molimm.2004.03.009; Maddison DR, 2007, ZOOTAXA, P19, DOI 10.11646/zootaxa.1668.1.4; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Maser P, 2001, PLANT PHYSIOL, V126, P1646, DOI 10.1104/pp.126.4.1646; MasonGamer RJ, 1996, SYST BIOL, V45, P524, DOI 10.1093/sysbio/45.4.524; Maydt J, 2006, BIOINFORMATICS, V22, P1064, DOI 10.1093/bioinformatics/btl057; Milne I, 2004, BIOINFORMATICS, V20, P1806, DOI 10.1093/bioinformatics/bth155; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; Mount D, 2002, BIOINFORMATICS SEQUE, P480; Muller L, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-12; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Piao W, 2009, J LEUKOCYTE BIOL, V86, P863, DOI 10.1189/jlb.0309189; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Price P. W., 1980, EVOLUTIONARY BIOL PA; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Schimming TT, 2007, BMC DERMATOL, V7, DOI 10.1186/1471-5945-7-3; Segers K, 2007, P NATL ACAD SCI USA, V104, P12697, DOI 10.1073/pnas.0701051104; Shah JA, 2012, J IMMUNOL, V189, P1737, DOI 10.4049/jimmunol.1103541; SMITH JM, 1992, J MOL EVOL, V34, P126; Speakman JR, 2005, J EXP BIOL, V208, P1717, DOI 10.1242/jeb.01556; Stern A, 2007, NUCLEIC ACIDS RES, V35, pW506, DOI 10.1093/nar/gkm382; Swanson WJ, 2003, MOL BIOL EVOL, V20, P18, DOI 10.1093/oxfordjournals.molbev.a004233; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; White CR, 2005, J EXP BIOL, V208, P1611, DOI 10.1242/jeb.01501; Wren JD, 2008, BIOINFORMATICS, V24, P2127, DOI 10.1093/bioinformatics/btn464; Yang Z, 2007, HDB STAT GENETICS, P381; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 1998, MOL BIOL EVOL, V15, P1600, DOI 10.1093/oxfordjournals.molbev.a025888; Yeh GY, 2003, DIABETES CARE, V26, P1277, DOI 10.2337/diacare.26.4.1277; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; ZUCKERKANDL EMILE, 1965, P97	70	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97219	10.1371/journal.pone.0097219	http://dx.doi.org/10.1371/journal.pone.0097219			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828816	Green Published, Green Submitted, gold			2022-12-27	WOS:000336857400064
J	Putz, K; Trathan, PN; Pedrana, J; Collins, MA; Poncet, S; Luthi, B				Puetz, Klemens; Trathan, Phil N.; Pedrana, Julieta; Collins, Martin A.; Poncet, Sally; Luethi, Benno			Post-Fledging Dispersal of King Penguins (Aptenodytes patagonicus) from Two Breeding Sites in the South Atlantic	PLOS ONE			English	Article							DIEL VERTICAL MIGRATION; WINTER MIGRATION; FALKLAND ISLANDS; FORAGING AREAS; SPHENISCUS-MAGELLANICUS; EUDYPTES-CHRYSOCOME; SATELLITE TRACKING; MACQUARIE ISLAND; DIVING BEHAVIOR; HABITAT	Most studies concerning the foraging ecology of marine vertebrates are limited to breeding adults, although other life history stages might comprise half the total population. For penguins, little is known about juvenile dispersal, a period when individuals may be susceptible to increased mortality given their naive foraging behaviour. Therefore, we used satellite telemetry to study king penguin fledglings (n = 18) from two sites in the Southwest Atlantic in December 2007. The two sites differed with respect to climate and proximity to the Antarctic Polar Front (APF), a key oceanographic feature generally thought to be important for king penguin foraging success. Accordingly, birds from both sites foraged predominantly in the vicinity of the APF. Eight king penguins were tracked for periods greater than 120 days; seven of these (three from the Falkland Islands and four from South Georgia) migrated into the Pacific. Only one bird from the Falkland Islands moved into the Indian Ocean, visiting the northern limit of the winter pack-ice. Three others from the Falkland Islands migrated to the eastern coast of Tierra del Fuego before travelling south. Derived tracking parameters describing their migratory behaviour showed no significant differences between sites. Nevertheless, generalized linear habitat modelling revealed that juveniles from the Falkland Islands spent more time in comparatively shallow waters with low sea surface temperature, sea surface height and chlorophyll variability. Birds from South Georgia spent more time in deeper waters with low sea surface temperature and sea surface height, but high concentrations of chlorophyll. Our results indicate that inexperienced king penguins, irrespective of the location of their natal site in relation to the position of the APF, develop their foraging skills progressively over time, including specific adaptations to the environment around their prospective breeding site.	[Puetz, Klemens] Antarctic Res Trust, Bremervorde, Germany; [Trathan, Phil N.; Collins, Martin A.] British Antarctic Survey, NERC, Cambridge CB3 0ET, England; [Pedrana, Julieta] CONICET INTA, Balcarce, Argentina; [Luethi, Benno] Antarctic Res Trust Switzerland, Forch, Switzerland	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Instituto Nacional de Tecnologia Agropecuaria (INTA)	Putz, K (corresponding author), Antarctic Res Trust, Bremervorde, Germany.	puetz@antarctic-research.de	Collins, Martin A/J-8560-2017; , Martin/ABE-6728-2020	Puetz, Klemens/0000-0003-1375-2669; pedrana, julieta/0000-0002-0908-7865	Britta Labhard Co.; Charlotte Fritz Lehmann; Zoo Zurich; Vontobel-Stiftung; NERC [bas0100025] Funding Source: UKRI; Natural Environment Research Council [bas0100025] Funding Source: researchfish	Britta Labhard Co.; Charlotte Fritz Lehmann; Zoo Zurich; Vontobel-Stiftung; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The Antarctic Research Trust is grateful to all who have contributed to this project, in particular the following sponsors of individual penguins: Roland Amstutz, Lesley Baxter, Ruth & Walter Egli, Katharina Heckers, Rita & Guido Heule, Ursula & Urs Hurlimann, Britta Labhard & Co., Charlotte & Fritz Lehmann, Hans-Ulrich Schneebeli, Marcel Schonenberger, Dagmar Schultz, Ulrike Stimmel, Barbel Strehmel, Vontobel-Stiftung, Sylke Wicker, Elisabeth Zellweger and Zoo Zurich. The authors wish to acknowledge use of the Maptool program, a product of SEATURTLE.ORG, for analysis and graphics in this article (information is available at www.seaturtle.org). The editor and the reviewers provided highly valuable comments that have been essential for improving the text, tables and figures.	Ainley D.G., 1991, Journal of Marine Systems, V2, P111, DOI 10.1016/0924-7963(91)90017-O; Alderman R, 2010, MAR ECOL PROG SER, V405, P271, DOI 10.3354/meps08590; Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; Amo L, 2013, MAR ECOL PROG SER, V474, P277, DOI 10.3354/meps10081; BANNASCH R, 1994, J EXP BIOL, V194, P83; Bannasch R, 1995, PENGUINS: ECOLOGY AND MANAGEMENT, P141; Berthold P, 1996, CONTROL BIRD MIGRATI; BirdLife International, 2004, GLOB PROC TRACK WORK; Biuw M, 2010, ANTARCT SCI, V22, P157, DOI 10.1017/S0954102009990605; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; Boersma PD, 2002, AQUAT CONSERV, V12, P63, DOI 10.1002/aqc.477; Bost CA, 2009, J MARINE SYST, V78, P363, DOI 10.1016/j.jmarsys.2008.11.022; Bost CA, 1997, MAR ECOL PROG SER, V150, P21, DOI 10.3354/meps150021; Bost CA, 2004, MAR ECOL PROG SER, V283, P293, DOI 10.3354/meps283293; Bost CA, 2002, MAR ECOL PROG SER, V227, P51, DOI 10.3354/meps227051; Bost CA, 2013, PENGUINS: NATURAL HISTORY AND CONSERVATION, P7; Burger J, 1980, BEHAV MARINE BIRDS; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Charrassin JB, 2001, MAR ECOL PROG SER, V221, P285, DOI 10.3354/meps221285; Cherel Y, 2002, POLAR BIOL, V25, P898, DOI 10.1007/s00300-002-0419-2; CHEREL Y, 1993, POLAR BIOL, V13, P355; Chiaradia Andre, 2005, Polar Bioscience, V18, P46; Clarke J, 2003, MAR ECOL PROG SER, V248, P267, DOI 10.3354/meps248267; *CLS SERV ARG, 1996, US MAN; Clutton-Brock T. H., 1988, REPROD SUCCESS; Croxall JP, 2005, SCIENCE, V307, P249, DOI 10.1126/science.1106042; DRENT RH, 1980, ARDEA, V68, P225; Eastman J. R., 2009, IDRISI TAIGA; Engler R, 2004, J APPL ECOL, V41, P263, DOI 10.1111/j.0021-8901.2004.00881.x; Field IC, 2005, OECOLOGIA, V142, P127, DOI 10.1007/s00442-004-1704-2; Harrell FE, 2001, REGRESSION MODELING; Huin N, 2008, FALKLAND ISLAND SEAB; James MC, 2005, ECOL LETT, V8, P195, DOI 10.1111/j.1461-0248.2004.00710.x; Juares MA, 2013, ANTARCT SCI; KNOX GA, 1994, BIOL SO OCEAN; Kooyman GL, 2007, AQUAT CONSERV, V17, pS37, DOI 10.1002/aqc.930; Kooyman GL, 1996, NATURE, V383, P397, DOI 10.1038/383397a0; LANCRAFT TM, 1991, POLAR BIOL, V11, P157; Le Vaillant M, 2012, J EXP BIOL, V215, P3685, DOI 10.1242/jeb.071175; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Maslennikov V.V., 1993, Antarktika, V32, P86; McCullagh P, 1989, GEN LINEAR MODELS; McPherson JM, 2004, J APPL ECOL, V41, P811, DOI 10.1111/j.0021-8901.2004.00943.x; Moore GJ, 1999, POLAR BIOL, V21, P376, DOI 10.1007/s003000050376; Murtaugh PA, 1996, ECOL APPL, V6, P132, DOI 10.2307/2269559; Olsson O, 1997, POLAR BIOL, V18, P161, DOI 10.1007/s003000050172; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; PETERSON RG, 1989, J GEOPHYS RES-OCEANS, V94, P10817, DOI 10.1029/JC094iC08p10817; Petry MV, 2013, POLAR BIOL, V36, P603, DOI 10.1007/s00300-012-1277-1; Piatkowski U, 2001, FISH RES, V52, P79, DOI 10.1016/S0165-7836(01)00232-6; Pistorius PA, 2012, ANTARCT SCI, V24, P435, DOI 10.1017/S0954102012000302; Putz K, 2007, MAR BIOL, V152, P1227, DOI 10.1007/s00227-007-0770-5; Putz K, 2000, IBIS, V142, P614, DOI 10.1111/j.1474-919X.2000.tb04461.x; Putz K, 2005, MAR BIOL, V147, P281, DOI 10.1007/s00227-005-1577-x; Putz K, 1998, ECOLOGY, V79, P1905, DOI 10.2307/176698; Putz K, 2003, J AVIAN BIOL, V34, P139, DOI 10.1034/j.1600-048X.2003.03100.x; Putz K, 2002, AQUAT CONSERV, V12, P75, DOI 10.1002/aqc.478; Putz K, 2002, MAR ECOL PROG SER, V240, P273, DOI 10.3354/meps240273; Putz K., 1999, Marine Ornithology, V27, P77; Putz K, 2002, CONDOR, V104, P528, DOI 10.1650/0010-5422(2002)104[0528:SATVIT]2.0.CO;2; Putz K, 2006, POLAR BIOL, V29, P735, DOI 10.1007/s00300-006-0110-0; R Core Team, 2018, R LANG ENV STAT COMP; Riotte-Lambert L, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1434; Rodhouse PG, 1998, MAR ECOL PROG SER, V168, P13, DOI 10.3354/meps168013; Sakamoto Y., 1986, AKAIKE INFORM CRITER; SANDERS S, 2006, IMPORTANT BIRD AREAS; Scheffer A, 2010, MAR ECOL PROG SER, V465, P281; Scheffer A, 2012, MAR ECOL PROG SER, V465, P281, DOI 10.3354/meps09884; Shillinger GL, 2012, MAR ECOL PROG SER, V457, P165, DOI 10.3354/meps09816; Thiebot JB, 2014, ENDANGER SPECIES RES, V23, P263, DOI 10.3354/esr00564; Thiebot JB, 2013, ANTARCT SCI, V25, P536, DOI 10.1017/S0954102012001198; Thiebot JB, 2011, ANTARCT SCI, V23, P117, DOI 10.1017/S0954102010000957; Trathan PN, 2008, MAR ECOL PROG SER, V370, P285, DOI 10.3354/meps07638; Trebilco R, 2008, BIOL CONSERV, V141, P2942, DOI 10.1016/j.biocon.2008.07.027; WARHAM J, 1990, PETRELS THEIR ECOLOG; Weimerskirch H, 2006, J AVIAN BIOL, V37, P23, DOI 10.1111/j.2006.0908-8857.03675.x; Weimerskirch H, 2005, J ANIM ECOL, V74, P285, DOI 10.1111/j.1365-2656.2005.00922.x; WEIMERSKIRCH H, 1992, IBIS, V134, P107, DOI 10.1111/j.1474-919X.1992.tb08387.x; Wienecke B, 2006, POLAR BIOL, V29, P424, DOI 10.1007/s00300-005-0074-5; Wienecke B, 2010, MAR ECOL PROG SER, V410, P269, DOI 10.3354/meps08629; Wienecke B, 2002, ENVIRON MANAGE, V29, P662, DOI 10.1007/s00267-0015-1; Williams T.D., 1995, PENGUINS; Wilson RP, 1997, WILDLIFE SOC B, V25, P101; Wilson RP, 2004, J EXP BIOL, V207, P2649, DOI 10.1242/jeb.01067; WILSON RP, 1993, MAR ECOL PROG SER, V94, P101; Yoda K, 2004, P ROY SOC B-BIOL SCI, V271, pS240, DOI 10.1098/rsbl.2003.0157; Yoda K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019602; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	88	18	18	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97164	10.1371/journal.pone.0097164	http://dx.doi.org/10.1371/journal.pone.0097164			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828545	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000336857400062
J	Bauer, A; Neumann, S; Karger, A; Henning, AK; Maisner, A; Lamp, B; Dietzel, E; Kwasnitschka, L; Balkema-Buschmann, A; Keil, GM; Finke, S				Bauer, Anja; Neumann, Sebastian; Karger, Axel; Henning, Ann-Kristin; Maisner, Andrea; Lamp, Boris; Dietzel, Erik; Kwasnitschka, Linda; Balkema-Buschmann, Anne; Keil, Guenther M.; Finke, Stefan			ANP32B Is a Nuclear Target of Henipavirus M Proteins	PLOS ONE			English	Article							VIRUS MATRIX PROTEIN; NIPAH-VIRUS; INFECTED-CELLS; EXPORT PATHWAY; MESSENGER-RNAS; IN-VIVO; LOCALIZATION; EXPRESSION; HENDRA; PARAMYXOVIRUSES	Membrane envelopment and budding of negative strand RNA viruses (NSVs) is mainly driven by viral matrix proteins (M). In addition, several M proteins are also known to be involved in host cell manipulation. Knowledge about the cellular targets and detailed molecular mechanisms, however, is poor for many M proteins. For instance, Nipah Virus (NiV) M protein trafficking through the nucleus is essential for virus release, but nuclear targets of NiV M remain unknown. To identify cellular interactors of henipavirus M proteins, tagged Hendra Virus (HeV) M proteins were expressed and M-containing protein complexes were isolated and analysed. Presence of acidic leucine-rich nuclear phosphoprotein 32 family member B (ANP32B) in the complex suggested that this protein represents a direct or indirect interactor of the viral matrix protein. Over-expression of ANP32B led to specific nuclear accumulation of HeV M, providing a functional link between ANP32B and M protein. ANP32B-dependent nuclear accumulation was observed after plasmid-driven expression of HeV and NiV matrix proteins and also in NiV infected cells. The latter indicated that an interaction of henipavirus M protein with ANP32B also occurs in the context of virus replication. From these data we conclude that ANP32B is a nuclear target of henipavirus M that may contribute to virus replication. Potential effects of ANP32B on HeV nuclear shuttling and host cell manipulation by HeV M affecting ANP32B functions in host cell survival and gene expression regulation are discussed.	[Bauer, Anja; Neumann, Sebastian; Karger, Axel; Henning, Ann-Kristin; Keil, Guenther M.; Finke, Stefan] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Mol Biol, Greifswald, Germany; [Kwasnitschka, Linda; Balkema-Buschmann, Anne] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Novel & Emerging Infect Dis, Greifswald, Germany; [Maisner, Andrea; Lamp, Boris; Dietzel, Erik] Univ Marburg, Inst Virol, D-35032 Marburg, Germany	Friedrich Loeffler Institute; Friedrich Loeffler Institute; Philipps University Marburg	Finke, S (corresponding author), Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Mol Biol, Greifswald, Germany.	stefan.finke@fli.bund.de	Karger, Axel/AAA-9102-2020	Karger, Axel/0000-0002-0054-7394; Finke, Stefan/0000-0001-8716-2341	Friedrich-Loeffler-Institut; Deutsche Forschungsgemeinschaft [DFG FI941/3-1]	Friedrich-Loeffler-Institut; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by institutional funding of the Friedrich-Loeffler-Institut (www.fli.bund.de) and by the Deutsche Forschungsgemeinschaft through grant DFG FI941/3-1 (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 1998, J VIROL, V72, P8413, DOI 10.1128/JVI.72.10.8413-8419.1998; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Basler CF, 2012, CURR TOP MICROBIOL, V359, P123, DOI 10.1007/82_2012_209; Berhane Y, 2006, J VIROL METHODS, V132, P59, DOI 10.1016/j.jviromet.2005.09.005; Bodem J, 2011, J VIROL, V85, P2333, DOI 10.1128/JVI.01518-10; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Ciancanelli MJ, 2006, J VIROL, V80, P12070, DOI 10.1128/JVI.01743-06; Escaffre O, 2013, J INFECT DEV COUNTR, V7, P308, DOI 10.3855/jidc.3648; Faria PA, 2005, MOL CELL, V17, P93, DOI 10.1016/j.molcel.2004.11.023; Field HE, 2007, CURR TOP MICROBIOL, V315, P133; Freed EO, 2002, J VIROL, V76, P4679, DOI 10.1128/JVI.76.10.4679-4687.2002; Fries B, 2007, J BIOL CHEM, V282, P4504, DOI 10.1074/jbc.M608849200; Ghildyal R, 2003, ARCH VIROL, V148, P1419, DOI 10.1007/s00705-003-0112-y; Ghildyal R, 2006, FEMS MICROBIOL REV, V30, P692, DOI 10.1111/j.1574-6976.2006.00025.x; Ghildyal R, 2009, J VIROL, V83, P5353, DOI 10.1128/JVI.02374-08; Heger P, 2001, TRAFFIC, V2, P544, DOI 10.1034/j.1600-0854.2001.20804.x; Lamp B, 2013, J VIROL, V87, P3143, DOI 10.1128/JVI.02696-12; Lo MK, 2012, CURR TOP MICROBIOL, V359, P41, DOI 10.1007/82_2012_211; LYLES DS, 1988, J VIROL, V62, P4387, DOI 10.1128/JVI.62.11.4387-4392.1988; McCormack Joseph G, 2005, Respir Care Clin N Am, V11, P59, DOI 10.1016/j.rcc.2004.10.006; Moll M, 2004, J VIROL, V78, P9705, DOI 10.1128/JVI.78.18.9705-9712.2004; Mori K, 2009, MOL BIOL CELL, V20, P218, DOI 10.1091/mbc.E08-04-0428; Munemasa Y, 2008, MOL CELL BIOL, V28, P1171, DOI 10.1128/MCB.01396-07; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Orbanz J, 2010, ARCH VIROL, V155, P1631, DOI 10.1007/s00705-010-0743-8; Pasdeloup D, 2005, VIROLOGY, V334, P284, DOI 10.1016/j.virol.2005.02.005; Patch JR, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-1; Patch JR, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-137; PEEPLES ME, 1988, VIROLOGY, V162, P255, DOI 10.1016/0042-6822(88)90418-7; Pegoraro G, 2006, J VIROL, V80, P6855, DOI 10.1128/JVI.00383-06; Pernet O, 2012, CURR TOP MICROBIOL, V359, P59, DOI 10.1007/82_2012_222; Pollin R, 2013, CELL MICROBIOL, V15, P200, DOI 10.1111/cmi.12037; Rajani KR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002929; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schutz S, 2006, J MOL BIOL, V358, P997, DOI 10.1016/j.jmb.2006.02.041; Shen SM, 2010, CARCINOGENESIS, V31, P419, DOI 10.1093/carcin/bgp320; Sorokin AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1439, DOI 10.1134/S0006297907130032; Stachowiak B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030855; Tatham MH, 2011, RNA, V4, prs4; Wang YE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001186; Xu YH, 2004, BIOCHEM BIOPH RES CO, V315, P664, DOI 10.1016/j.bbrc.2004.01.115; YOSHIDA T, 1976, VIROLOGY, V71, P143, DOI 10.1016/0042-6822(76)90101-X	42	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97233	10.1371/journal.pone.0097233	http://dx.doi.org/10.1371/journal.pone.0097233			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24823948	Green Published, gold, Green Submitted			2022-12-27	WOS:000336369200077
J	Braunisch, V; Coppes, J; Arlettaz, R; Suchant, R; Zellweger, F; Bollmann, K				Braunisch, Veronika; Coppes, Joy; Arlettaz, Raphael; Suchant, Rudi; Zellweger, Florian; Bollmann, Kurt			Temperate Mountain Forest Biodiversity under Climate Change: Compensating Negative Effects by Increasing Structural Complexity	PLOS ONE			English	Article							CAPERCAILLIE TETRAO-UROGALLUS; 3-TOED WOODPECKER; HABITAT SELECTION; RANGE SHIFTS; FORAGING ECOLOGY; HAZEL GROUSE; CONSERVATION; MANAGEMENT; MODEL; CONNECTIVITY	Species adapted to cold-climatic mountain environments are expected to face a high risk of range contractions, if not local extinctions under climate change. Yet, the populations of many endothermic species may not be primarily affected by physiological constraints, but indirectly by climate-induced changes of habitat characteristics. In mountain forests, where vertebrate species largely depend on vegetation composition and structure, deteriorating habitat suitability may thus be mitigated or even compensated by habitat management aiming at compositional and structural enhancement. We tested this possibility using four cold-adapted bird species with complementary habitat requirements as model organisms. Based on species data and environmental information collected in 300 1-km(2) grid cells distributed across four mountain ranges in central Europe, we investigated (1) how species' occurrence is explained by climate, landscape, and vegetation, (2) to what extent climate change and climate-induced vegetation changes will affect habitat suitability, and (3) whether these changes could be compensated by adaptive habitat management. Species presence was modelled as a function of climate, landscape and vegetation variables under current climate; moreover, vegetation-climate relationships were assessed. The models were extrapolated to the climatic conditions of 2050, assuming the moderate IPCC-scenario A1B, and changes in species' occurrence probability were quantified. Finally, we assessed the maximum increase in occurrence probability that could be achieved by modifying one or multiple vegetation variables under altered climate conditions. Climate variables contributed significantly to explaining species occurrence, and expected climatic changes, as well as climate-induced vegetation trends, decreased the occurrence probability of all four species, particularly at the low-altitudinal margins of their distribution. These effects could be partly compensated by modifying single vegetation factors, but full compensation would only be achieved if several factors were changed in concert. The results illustrate the possibilities and limitations of adaptive species conservation management under climate change.	[Braunisch, Veronika; Coppes, Joy; Suchant, Rudi] Forest Res Inst Baden Wurttemberg, Freiburg, Germany; [Braunisch, Veronika; Arlettaz, Raphael] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland; [Arlettaz, Raphael] Swiss Ornithol Inst, Valais Field Stn, Sion, Switzerland; [Zellweger, Florian; Bollmann, Kurt] Swiss Fed Inst Forest Snow & Landscape Res, Birmensdorf, Switzerland; [Zellweger, Florian] Swiss Fed Inst Technol, Inst Terr Ecosyst, Zurich, Switzerland	University of Bern; Swiss Ornithological Institute; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Swiss Federal Institutes of Technology Domain; ETH Zurich	Braunisch, V (corresponding author), Forest Res Inst Baden Wurttemberg, Freiburg, Germany.	veronika.braunisch@iee.unibe.ch	Zellweger, Florian/C-5712-2016; Braunisch, Veronika/AAH-8260-2020; Arlettaz, Raphaël/O-2182-2016	Zellweger, Florian/0000-0003-1265-9147; Braunisch, Veronika/0000-0001-7035-4662; Arlettaz, Raphaël/0000-0001-6360-5339; Coppes, Joy/0000-0002-5295-8638	Baden-Wurttemberg Fund for Environmental Research (Germany); research programme Forest and Climate Change of the Swiss Federal Institute for Forest, Snow, and Landscape Research WSL; Federal Office for the Environment FOEN (Switzerland)	Baden-Wurttemberg Fund for Environmental Research (Germany); research programme Forest and Climate Change of the Swiss Federal Institute for Forest, Snow, and Landscape Research WSL; Federal Office for the Environment FOEN (Switzerland)	The work was funded by the Baden-Wurttemberg Fund for Environmental Research (http://www.mlr. baden-wuerttemberg.de/Forschung/68711.html) (Germany) and by the research programme "Forest and Climate Change'' of the Swiss Federal Institute for Forest, Snow, and Landscape Research WSL (http://www.wsl.ch/index_EN) and the Federal Office for the Environment FOEN (http://www.bafu.admin.ch/?lang=en) (Switzerland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angert AL, 2011, ECOL LETT, V14, P677, DOI 10.1111/j.1461-0248.2011.01620.x; Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Barbet-Massin M, 2010, ECOGRAPHY, V33, P878, DOI 10.1111/j.1600-0587.2010.06181.x; Beaumont LJ, 2007, GLOBAL CHANGE BIOL, V13, P1368, DOI 10.1111/j.1365-2486.2007.01357.x; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; Bergmann HH, 1996, MAGDEBURG NEUE BREHM, V77; Blattner Martin, 1998, Ornithologische Beobachter, V95, P11; Bollmann K., 2009, Schweizerische Zeitschrift fur Forstwesen, V160, P53, DOI 10.3188/szf.2009.0053; Bollmann K, 2013, INTEGRATIVE APPROACH, P18; Bollmann K, 2010, CLIMATE LAND USE CHA, P28; Bollmann Kurt, 2008, Ornithologische Beobachter, V105, P53; Braunisch V, 2008, FOREST ECOL MANAG, V256, P1209, DOI 10.1016/j.foreco.2008.06.027; Braunisch V, 2008, ECOL MODEL, V214, P153, DOI 10.1016/j.ecolmodel.2008.02.001; Braunisch V, 2007, WILDLIFE BIOL, V13, P21, DOI 10.2981/0909-6396(2007)13[21:AMFETH]2.0.CO;2; Braunisch V, 2013, ECOGRAPHY, V36, P971, DOI 10.1111/j.1600-0587.2013.00138.x; Braunisch V, 2010, MOL ECOL, V19, P3664, DOI 10.1111/j.1365-294X.2010.04703.x; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Butler R, 2004, BIOL CONSERV, V119, P305, DOI 10.1016/j.biocon.2003.11.014; CAS J., 1998, ZBORNIK, V57, P5; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Diaz-Nieto J, 2005, CLIMATIC CHANGE, V69, P245, DOI 10.1007/s10584-005-1157-6; Dormann CF, 2007, BASIC APPL ECOL, V8, P387, DOI 10.1016/j.baae.2006.11.001; ESRI, 2008, ARCGIS DESKT REL 9 3; Fayt P, 1999, ORNIS FENNICA, V76, P135; Fu PD, 2002, COMPUT ELECTRON AGR, V37, P25, DOI 10.1016/S0168-1699(02)00115-1; Furstenau C, 2007, EUR J FOREST RES, V126, P225, DOI 10.1007/s10342-006-0114-x; Glutz von Blotzheim U. N., 1973, HDB VOGEL MITTELEURO, V5; Gonseth Y., 2001, BIOGEOGRAPHISCHEN RE; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Halonen M, 2007, ORNIS FENNICA, V84, P105; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Hess R., 1983, Ornithologische Beobachter, V80, P153; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HOGSTAD O, 1970, Nytt Magasin for Zoologi (Oslo), V18, P221; HOSMER DW, 2000, WILEY PS TX, P1; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Hulme PE, 2005, J APPL ECOL, V42, P784, DOI 10.1111/j.1365-2664.2005.01082.x; Imbeau L, 2002, J WILDLIFE MANAGE, V66, P222, DOI 10.2307/3802888; Jeltsch F, 2011, AGR ECOSYST ENVIRON, V145, P49, DOI 10.1016/j.agee.2010.12.019; Jenness J., 2006, TOPOGRAPHIC POSITION; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Jump AS, 2005, ECOL LETT, V8, P1010, DOI 10.1111/j.1461-0248.2005.00796.x; Kaempfer-Lauenstein A, 1995, MEHR WILDNIS FUER HA, P6; Kormann U, 2012, BIOL CONSERV, V152, P241, DOI 10.1016/j.biocon.2012.04.011; Kujala H, 2013, CONSERV LETT, V6, P73, DOI 10.1111/j.1755-263X.2012.00299.x; KULLBERG C, 1995, ORNIS FENNICA, V72, P72; Lawler JJ, 2006, GLOBAL CHANGE BIOL, V12, P1568, DOI 10.1111/j.1365-2486.2006.01191.x; McElhinny C, 2005, FOREST ECOL MANAG, V218, P1, DOI 10.1016/j.foreco.2005.08.034; McGarigal K., 2002, FRAGSTATS SPATIAL PA, DOI DOI 10.1016/S0022-3913(12)00047-9; Meloun M, 2002, ANALYST, V127, P433, DOI 10.1039/b110779h; Mikkola H., 1983, P1; Mikusek R., 2001, Buteo, V12, P47; Mikusinski G, 2001, CONSERV BIOL, V15, P208, DOI 10.1046/j.1523-1739.2001.99236.x; Morsdorf F, 2010, REMOTE SENS ENVIRON, V114, P1403, DOI 10.1016/j.rse.2010.01.023; Murphy EC, 1998, J WILDLIFE MANAGE, V62, P1359, DOI 10.2307/3802002; Noss RF, 2001, CONSERV BIOL, V15, P578, DOI 10.1046/j.1523-1739.2001.015003578.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pechacek P, 2004, BIOL CONSERV, V116, P333, DOI 10.1016/S0006-3207(03)00203-9; Pechacek P, 1995, SPECHTE PICIDAE NATI; Pechacek P, 2006, ANN ZOOL FENN, V43, P165; Pechacek Peter, 1993, Vogelwelt, V114, P165; PICOZZI N, 1992, J APPL ECOL, V29, P751, DOI 10.2307/2404485; Rebelo H, 2010, GLOBAL CHANGE BIOL, V16, P561, DOI 10.1111/j.1365-2486.2009.02021.x; Renaud V, 2011, THEOR APPL CLIMATOL, V105, P119, DOI 10.1007/s00704-010-0361-0; Rhim SJ, 2001, WILDLIFE BIOL, V7, P257, DOI 10.2981/wlb.2001.030; Roberge JM, 2006, BIOL CONSERV, V130, P134, DOI 10.1016/j.biocon.2005.12.008; Ruge K, 1999, TICHODROMA, V12, P116; Sachot S, 2003, BIOL CONSERV, V112, P373, DOI 10.1016/S0006-3207(02)00334-8; Schaublin S, 2011, J ORNITHOL, V152, P179, DOI 10.1007/s10336-010-0563-3; Schleyer A., 2001, PHOTOGRAMMETRIC WEEK, P217; Segelbacher G, 2003, MOL ECOL, V12, P1773, DOI 10.1046/j.1365-294X.2003.01873.x; Selas V, 2000, WILDLIFE BIOL, V6, P1; Sergio F, 2003, J AVIAN BIOL, V34, P144, DOI 10.1034/j.1600-048X.2003.03104.x; STORCH I, 1993, OECOLOGIA, V95, P257, DOI 10.1007/BF00323498; Storch I, 1995, HABITAT REQUIREMENTS, P151; Strom H, 2001, ORNIS FENNICA, V78, P145; Suchant R., 2008, RAHMENBEDINGUNGEN HA; Suchant Rudi, 2004, Ecological Bulletins, V51, P455; Suter W, 2002, CONSERV BIOL, V16, P778, DOI 10.1046/j.1523-1739.2002.01129.x; SWENSON JE, 1993, ECOGRAPHY, V16, P37, DOI 10.1111/j.1600-0587.1993.tb00057.x; Swenson JE, 1995, ECOLOGY HAZEL GROUSE; Synes NW, 2011, GLOBAL ECOL BIOGEOGR, V20, P904, DOI 10.1111/j.1466-8238.2010.00635.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x; Wilson RJ, 2005, ECOL LETT, V8, P1138, DOI 10.1111/j.1461-0248.2005.00824.x; Zellweger F, 2013, FOREST ECOL MANAG, V307, P303, DOI [10.1016/j.foreco.2013.07.023, 10.1016/j.]; Zimmermann N.E., 2001, MLP CLIMATE BIOPHYSI	91	57	59	1	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97718	10.1371/journal.pone.0097718	http://dx.doi.org/10.1371/journal.pone.0097718			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24823495	Green Published, Green Submitted, gold			2022-12-27	WOS:000336369200134
J	Gomez-Sebastian, S; Lopez-Vidal, J; Escribano, JM				Gomez-Sebastian, Silvia; Lopez-Vidal, Javier; Escribano, Jose M.			Significant Productivity Improvement of the Baculovirus Expression Vector System by Engineering a Novel Expression Cassette	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; CALIFORNICA MULTIPLE NUCLEOPOLYHEDROVIRUS; EARLY PROTEIN IE0; DNA-REPLICATION; TRANSCRIPTIONAL ACTIVATION; TRANSACTIVATOR IE1; HOMOLOGOUS DNA; INSECT LARVAE; IN-VIVO; GENE	Here we describe the development of a baculovirus vector expression cassette containing rearranged baculovirus-derived genetic regulatory elements. This newly designed expression cassette conferred significant production improvements to the baculovirus expression vector system (BEVS), including prolonged cell integrity after infection, improved protein integrity, and around 4-fold increase in recombinant protein production yields in insect cells with respect to a standard baculovirus vector. The expression cassette consisted of a cDNA encoding for the baculovirus transactivation factors IE1 and IE0, expressed under the control of the polyhedrin promoter, and a homologous repeated transcription enhancer sequence operatively cis-linked to the p10 promoter or to chimeric promoters containing p10. The prolonged cell integrity observed in cells infected by baculoviruses harbouring the novel expression cassette reduced the characteristic proteolysis and aberrant forms frequently found in baculovirus-derived recombinant proteins. The new expression cassette developed here has the potential to significantly improve the productivity of the BEVS.	[Gomez-Sebastian, Silvia; Lopez-Vidal, Javier] Alternat Gene Express SL ALGENEX, Madrid, Spain; [Escribano, Jose M.] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotechnol, Madrid, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Escribano, JM (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotechnol, Madrid, Spain.	escriban@inia.es	Gómez-Sebastián, Silvia/ABC-5878-2020; Gomez-Sebastian, Silvia/AAA-4441-2019	Gómez-Sebastián, Silvia/0000-0002-7326-3181; 	Spanish Ministry of Economy and Competitiveness [CSD2006-00007-2, RTA2010-00084-C02-01]; company Alternative Gene Expression S.L. (ALGENEX)	Spanish Ministry of Economy and Competitiveness(Spanish Government); company Alternative Gene Expression S.L. (ALGENEX)	This work was supported by the grant CSD2006-00007-2 and RTA2010-00084-C02-01 from the Spanish Ministry of Economy and Competitiveness and by funds from the company Alternative Gene Expression S.L. (ALGENEX). Alternative Gene Expression provided support in the form of salaries for authors SGV and JLV but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Cerutti M, 2012, MABS-AUSTIN, V4, P294, DOI 10.4161/mabs.19942; CHISHOLM GE, 1988, J VIROL, V62, P3193, DOI 10.1128/JVI.62.9.3193-3200.1988; CHOI J, 1995, J VIROL, V69, P4548, DOI 10.1128/JVI.69.7.4548-4551.1995; Cox MMJ, 2012, VACCINE, V30, P1759, DOI 10.1016/j.vaccine.2012.01.016; Dai XJ, 2004, J GEN VIROL, V85, P573, DOI 10.1099/vir.0.19747-0; Drugmand JC, 2012, BIOTECHNOL ADV, V30, P1140, DOI 10.1016/j.biotechadv.2011.09.014; Fath-Goodin A, 2006, ADV VIRUS RES, V68, P75, DOI 10.1016/S0065-3527(06)68002-0; Garaicoechea L, 2008, J VIROL, V82, P9753, DOI 10.1128/JVI.00436-08; Gomez-Casado E, 2011, PROTEIN EXPRES PURIF, V79, P35, DOI 10.1016/j.pep.2011.03.007; Gomez-Sebastian S, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-59; Gotoh T, 2001, J BIOSCI BIOENG, V92, P248, DOI 10.1263/jbb.92.248; GUARINO LA, 1986, J VIROL, V60, P224, DOI 10.1128/JVI.60.1.224-229.1986; GUARINO LA, 1986, J VIROL, V57, P563, DOI 10.1128/JVI.57.2.563-571.1986; GUARINO LA, 1987, J VIROL, V61, P2091, DOI 10.1128/JVI.61.7.2091-2099.1987; GUARINO LA, 1986, J VIROL, V60, P215, DOI 10.1128/JVI.60.1.215-223.1986; GUARINO LA, 1994, VIROLOGY, V200, P328, DOI 10.1006/viro.1994.1197; HILLPERKINS MS, 1990, J GEN VIROL, V71, P971, DOI 10.1099/0022-1317-71-4-971; Hitchman RB, 2010, BIOTECHNOL APPL BIOC, V56, P85, DOI 10.1042/BA20090130; Hitchman Richard B, 2009, Recent Pat Biotechnol, V3, P46; Ho Y, 2004, BIOCHEM J, V382, P695, DOI 10.1042/BJ20040007; Hom LG, 2000, VIROLOGY, V277, P178, DOI 10.1006/viro.2000.0586; Huijskens I, 2004, VIROLOGY, V323, P120, DOI 10.1016/j.virol.2004.03.001; Ikonomou L, 2003, APPL MICROBIOL BIOT, V62, P1, DOI 10.1007/s00253-003-1223-9; Ito E, 2004, VIROLOGY, V329, P337, DOI 10.1016/j.virol.2004.08.035; Kaba SA, 2004, J VIROL METHODS, V122, P113, DOI 10.1016/j.jviromet.2004.07.006; KOOL M, 1994, P NATL ACAD SCI USA, V91, P11212, DOI 10.1073/pnas.91.23.11212; KOVACS GR, 1991, VIROLOGY, V185, P633, DOI 10.1016/0042-6822(91)90534-I; Kremer A, 1998, VIROLOGY, V249, P336, DOI 10.1006/viro.1998.9288; LaCount DJ, 1997, J VIROL, V71, P1530, DOI 10.1128/JVI.71.2.1530-1537.1997; LEISY DJ, 1995, VIROLOGY, V208, P742, DOI 10.1006/viro.1995.1206; Liu L, 2008, PROTEIN EXPRES PURIF, V62, P21, DOI 10.1016/j.pep.2008.07.010; Lopez-Vidal J, 2013, J BIOTECHNOL, V165, P201, DOI 10.1016/j.jbiotec.2013.03.012; Lu LQ, 2005, J VIROL, V79, P10077, DOI 10.1128/JVI.79.15.10077-10082.2005; Lu LQ, 2003, J VIROL, V77, P535, DOI 10.1128/JVI.77.1.535-545.2003; Luria N, 2012, VIRUSES-BASEL, V4, P761, DOI 10.3390/v4050761; Nagamine T, 2008, J VIROL, V82, P6409, DOI 10.1128/JVI.00490-08; Naggie S, 1998, BIOTECHNOL PROGR, V14, P227, DOI 10.1021/bp980002b; Nettleship JE, 2010, J STRUCT BIOL, V172, P55, DOI 10.1016/j.jsb.2010.02.006; NISSEN MS, 1989, J VIROL, V63, P493, DOI 10.1128/JVI.63.2.493-503.1989; Okano K, 1999, J VIROL, V73, P110, DOI 10.1128/JVI.73.1.110-119.1999; PASSARELLI AL, 1993, J VIROL, V67, P2149, DOI 10.1128/JVI.67.4.2149-2158.1993; PEARSON M, 1992, SCIENCE, V257, P1382, DOI 10.1126/science.1529337; Pengelley SC, 2006, PROTEIN EXPRES PURIF, V48, P173, DOI 10.1016/j.pep.2006.04.016; PULLEN SS, 1995, J VIROL, V69, P156, DOI 10.1128/JVI.69.1.156-165.1995; Rapp JC, 1998, J VIROL, V72, P10197, DOI 10.1128/JVI.72.12.10197-10206.1998; Rodems SM, 1997, J VIROL, V71, P9270, DOI 10.1128/JVI.71.12.9270-9277.1997; RODEMS SM, 1995, J VIROL, V69, P5368, DOI 10.1128/JVI.69.9.5368-5375.1995; RODEMS SM, 1993, J VIROL, V67, P5776, DOI 10.1128/JVI.67.10.5776-5785.1993; Romier C, 2006, ACTA CRYSTALLOGR D, V62, P1232, DOI 10.1107/S0907444906031003; Schultz KLW, 2009, J VIROL, V83, P262, DOI 10.1128/JVI.01827-08; SMITH GE, 1983, MOL CELL BIOL, V3, P2156, DOI 10.1128/MCB.3.12.2156; Stewart TM, 2005, J VIROL, V79, P4619, DOI 10.1128/JVI.79.8.4619-4629.2005; Taggart DJ, 2012, J VIROL, V86, P6575, DOI 10.1128/JVI.00373-12; Thomas CJ, 1998, J VIROL, V72, P10207, DOI 10.1128/JVI.72.12.10207-10212.1998; Ulmer JB, 2006, NAT BIOTECHNOL, V24, P1377, DOI 10.1038/nbt1261; Vega CG, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003334	56	36	40	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96562	10.1371/journal.pone.0096562	http://dx.doi.org/10.1371/journal.pone.0096562			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824596	Green Published, gold, Green Submitted			2022-12-27	WOS:000336369200025
J	Rehn, M; Carnahan, A; Merk, H; Kuhlmann-Berenzon, S; Galanis, I; Linde, A; Nyren, O				Rehn, Moa; Carnahan, AnnaSara; Merk, Hanna; Kuhlmann-Berenzon, Sharon; Galanis, Ilias; Linde, Annika; Nyren, Olof			Evaluation of an Internet-Based Monitoring System for Influenza-Like Illness in Sweden	PLOS ONE			English	Article							GENERAL-POPULATION; SURVEILLANCE; NETHERLANDS; EXPERIENCE	To complement traditional influenza surveillance with data on disease occurrence not only among care-seeking individuals, the Swedish Institute for Communicable Disease Control (SMI) has tested an Internet-based monitoring system (IMS) with self-recruited volunteers submitting weekly on-line reports about their health in the preceding week, upon weekly reminders. We evaluated IMS acceptability and to which extent participants represented the Swedish population. We also studied the agreement of data on influenza-like illness (ILI) occurrence from IMS with data from a previously evaluated population-based system (PBS) with an actively recruited random sample of the population who spontaneously report disease onsets in real-time via telephone/Internet, and with traditional general practitioner based sentinel and virological influenza surveillance, in the 2011-2012 and 2012-2013 influenza seasons. We assessed acceptability by calculating the participation proportion in an invited IMS-sample and the weekly reporting proportion of enrolled self-recruited IMS participants. We compared distributions of socio-demographic indicators of self-recruited IMS participants to the general Swedish population using chi-square tests. Finally, we assessed the agreement of weekly incidence proportions (%) of ILI in IMS and PBS with cross-correlation analyses. Among 2,511 invited persons, 166 (6.6%) agreed to participate in the IMS. In each season, 2,552 and 2,486 self-recruited persons participated in the IMS respectively. The weekly reporting proportion among self-recruited participants decreased from 87% to 23% (2011-2012) and 82% to 45% (2012-2013). Women, highly educated, and middle-aged persons were overrepresented among self-recruited IMS participants (p, 0.01). IMS (invited and self-recruited) and PBS weekly incidence proportions correlated strongest when no lags were applied (r = 0.71 and r = 0.69, p, 0.05). This evaluation revealed socio-demographic misrepresentation and limited compliance among the self-recruited IMS participants. Yet, IMS offered a reasonable representation of the temporal ILI pattern in the community overall during the 2011-2012 and 2012-2013 influenza seasons and could be a simple tool for collecting community-based ILI data.	[Rehn, Moa; Carnahan, AnnaSara; Merk, Hanna; Kuhlmann-Berenzon, Sharon; Galanis, Ilias; Linde, Annika] Publ Hlth Agcy Sweden, Solna, Sweden; [Rehn, Moa] European Ctr Dis Prevent & Control ECDC, EPIET, Stockholm, Sweden; [Merk, Hanna; Nyren, Olof] Karolinska Inst, Dept Med Epidemiol & Biostat, Solna, Sweden	Public Health Agency of Sweden; European Centre for Disease Prevention & Control; Karolinska Institutet	Rehn, M (corresponding author), Publ Hlth Agcy Sweden, Solna, Sweden.	moa.rehn@folkhalsomyndigheten.se	Kühlmann-Berenzon, Sharon/J-1554-2019	Kühlmann-Berenzon, Sharon/0000-0002-8138-1196	European Commission Seventh Framework Programme [EPIWORK 231807]; Swedish Institute for Communicable Disease Control; European Programme for Intervention Epidemiology Training (EPIET); European Centre for Disease Prevention and Control (ECDC); Swedish Institute for Communicable Disease Control (SMI)	European Commission Seventh Framework Programme(European Commission); Swedish Institute for Communicable Disease Control; European Programme for Intervention Epidemiology Training (EPIET); European Centre for Disease Prevention and Control (ECDC); Swedish Institute for Communicable Disease Control (SMI)	This study was supported by the European Commission Seventh Framework Programme (grant number EPIWORK 231807) (http://cordis. europa.eu/fp7/home_en.html) and the Swedish Institute for Communicable Disease Control (http://smi.se/). The first author is a fellow of the European Programme for Intervention Epidemiology Training (EPIET). The fellowship is funded by the European Centre for Disease Prevention and Control (ECDC) and the Swedish Institute for Communicable Disease Control (SMI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajardi P, 2014, J MED INTERNET RES, V16, P190, DOI 10.2196/jmir.3010; Bethlehem J., 2009, APPL SURVEY METHODS; Bexelius C, 2010, EUR J EPIDEMIOL, V25, P693, DOI 10.1007/s10654-010-9484-y; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brooks-Pollock E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-68; Carstensen B, 2010, COMP CLIN MEASUREMEN; Chatfield C., 2004, ANAL TIME SERIES INT; European Center for Disease control (ECDC), 2013, EISN INFL SURV; Friesema IHM, 2009, VACCINE, V27, P6353, DOI 10.1016/j.vaccine.2009.05.042; German R R, 2001, MMWR Recomm Rep, V50, P1; German RR, 2001, MMWR RECOMM REP, V50, pCE31; Marquet RL, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-242; Merk H, 2013, THESIS KAROLINSKA I; Merk H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061644; Paolotti D, 2014, CLIN MICROBIOL INFEC, V20, P17, DOI 10.1111/1469-0691.12477; Porta M, 2008, DICT EPIDEMIOLOGY; Punpanich W, 2012, INT J INFECT DIS, V16, pE714, DOI 10.1016/j.ijid.2012.05.1025; Statistic Sweden (SCB), 2013, UND LEVN DAT INT AND; Swedish Institute for Communicable Disease Control (SMI), 2013, INFL SWED SEAS 2011; Swedish Institute for Communicable Disease Control (SMI), 2013, INFL SWED SEAS 2012; Swedish Institute for Communicable Disease Control (SMI), 2013, WEEKL REP LAB CONF R; Tilston NL, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-650; van Noort S P, 2007, Euro Surveill, V12, pE5; Vandendijck Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064156	24	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96740	10.1371/journal.pone.0096740	http://dx.doi.org/10.1371/journal.pone.0096740			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824806	gold, Green Published, Green Submitted			2022-12-27	WOS:000336369200029
J	Shang, J; Lui, S; Meng, YJ; Zhu, HR; Qiu, CJ; Gong, QY; Liao, W; Zhang, W				Shang, Jing; Lui, Su; Meng, Yajing; Zhu, Hongru; Qiu, Changjian; Gong, Qiyong; Liao, Wei; Zhang, Wei			Alterations in Low-Level Perceptual Networks Related to Clinical Severity in PTSD after an Earthquake: A Resting-State fMRI Study	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; FUNCTIONAL CONNECTIVITY; DEFAULT MODE; DISSOCIATIVE RESPONSES; BRAIN ACTIVITY; MEMORY; EMOTION; CORTEX; DYSREGULATION; MECHANISMS	Background: Several task-based functional MRI (fMRI) studies have highlighted abnormal activation in specific regions involving the low-level perceptual (auditory, visual, and somato-motor) network in posttraumatic stress disorder (PTSD) patients. However, little is known about whether the functional connectivity of the low-level perceptual and higher-order cognitive (attention, central-execution, and default-mode) networks change in medication-naive PTSD patients during the resting state. Methods: We investigated the resting state networks (RSNs) using independent component analysis (ICA) in 18 chronic Wenchuan earthquake-related PTSD patients versus 20 healthy survivors (HSs). Results: Compared to the HSs, PTSD patients displayed both increased and decreased functional connectivity within the salience network (SN), central executive network (CEN), default mode network (DMN), somato-motor network (SMN), auditory network (AN), and visual network (VN). Furthermore, strengthened connectivity involving the inferior temporal gyrus (ITG) and supplementary motor area (SMA) was negatively correlated with clinical severity in PTSD patients. Limitations: Given the absence of a healthy control group that never experienced the earthquake, our results cannot be used to compare alterations between the PTSD patients, physically healthy trauma survivors, and healthy controls. In addition, the breathing and heart rates were not monitored in our small sample size of subjects. In future studies, specific task paradigms should be used to reveal perceptual impairments. Conclusions: These findings suggest that PTSD patients have widespread deficits in both the low-level perceptual and higher-order cognitive networks. Decreased connectivity within the low-level perceptual networks was related to clinical symptoms, which may be associated with traumatic reminders causing attentional bias to negative emotion in response to threatening stimuli and resulting in emotional dysregulation.	[Shang, Jing; Meng, Yajing; Zhu, Hongru; Qiu, Changjian; Zhang, Wei] Sichuan Univ, Dept Psychiat, West China Hosp, Mental Hlth Ctr, Chengdu, Sichuan, Peoples R China; [Lui, Su; Gong, Qiyong] Sichuan Univ, Huaxi MR Res Ctr HMRRC, West China Hosp, Chengdu, Sichuan, Peoples R China; [Lui, Su] Wenzhou Med Univ, Affiliated Hosp 2, Dept Radiol, Wenzhou, Zhejiang, Peoples R China; [Liao, Wei] Hangzhou Normal Univ, CCBD, Hangzhou, Zhejiang, Peoples R China	Sichuan University; Sichuan University; Wenzhou Medical University; Hangzhou Normal University	Lui, S (corresponding author), Sichuan Univ, Huaxi MR Res Ctr HMRRC, West China Hosp, Chengdu, Sichuan, Peoples R China.	lusuwcums@tom.com; weizhang27@163.com	Zhu, Hongru/U-3186-2017; Gong, Qiyong/W-3052-2019; Lui, Su/S-9132-2019	Zhu, Hongru/0000-0001-8420-581X; Gong, Qiyong/0000-0002-5912-4871; 	National High-tech R&D Program of China (863 Programme) [2008AA022601]; National Natural Science Foundation [81222018, 81371527]	National High-tech R&D Program of China (863 Programme); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	Funding of the research was provided by the National High-tech R&D Program of China (863 Programme 2008AA022601 for Wei Zhang) and National Natural Science Foundation (Grant Nos. 81222018, 81371527 for Su Lui). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Bartels A, 2005, NEUROIMAGE, V24, P339, DOI 10.1016/j.neuroimage.2004.08.044; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bigler ED, 2007, DEV NEUROPSYCHOL, V31, P217, DOI 10.1080/87565640701190841; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bluhm RL, 2009, J PSYCHIATR NEUROSCI, V34, P187; Bremner J D, 1999, Semin Clin Neuropsychiatry, V4, P249; BREMNER JD, 1992, AM J PSYCHIAT, V149, P328; Bremner JD, 1999, AM J PSYCHIAT, V156, P1787; Brewin CR, 2010, PSYCHOL REV, V117, P210, DOI 10.1037/a0018113; Brewin CR, 1996, PSYCHOL REV, V103, P670, DOI 10.1037/0033-295X.103.4.670; Brewin CR, 2001, INT REV PSYCHIATR, V13, P159, DOI 10.1080/09540260120074019; Butefisch CM, 2000, P NATL ACAD SCI USA, V97, P3661, DOI 10.1073/pnas.050350297; Calhoun V, 2001, NEUROIMAGE, V13, pS88; Calhoun VD, 2009, NEUROIMAGE, V45, pS163, DOI 10.1016/j.neuroimage.2008.10.057; Cunnington R, 2005, HUM MOVEMENT SCI, V24, P644, DOI 10.1016/j.humov.2005.10.001; D'Argembeau A, 2005, NEUROIMAGE, V25, P616, DOI 10.1016/j.neuroimage.2004.11.048; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Daniels JK, 2010, J PSYCHIATR NEUROSCI, V35, P258, DOI 10.1503/jpn.090010; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Ding JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026596; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Downar J, 2002, J NEUROPHYSIOL, V87, P615, DOI 10.1152/jn.00636.2001; Elzinga BM, 2007, PSYCHOL MED, V37, P235, DOI 10.1017/S0033291706008932; Molina ME, 2010, WORLD J BIOL PSYCHIA, V11, P493, DOI 10.3109/15622970701472094; Flatten G, 2004, GMS PSYCHOSOCIAL MED, V1; Frewen PA, 2006, ANN NY ACAD SCI, V1071, P110, DOI 10.1196/annals.1364.010; Frings L, 2006, EXP BRAIN RES, V173, P661, DOI 10.1007/s00221-006-0408-8; Fujii T, 2004, NEUROIMAGE, V21, P1596, DOI 10.1016/j.neuroimage.2004.01.005; Gardini S, 2006, NEUROIMAGE, V30, P645, DOI 10.1016/j.neuroimage.2005.10.012; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hopper JW, 2007, J TRAUMA STRESS, V20, P713, DOI 10.1002/jts.20284; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Lanius RA, 2006, J PSYCHIATR RES, V40, P709, DOI 10.1016/j.jpsychires.2005.07.007; Lanius RA, 2010, ACTA PSYCHIAT SCAND, V121, P33, DOI 10.1111/j.1600-0447.2009.01391.x; Lanius RA, 2002, BIOL PSYCHIAT, V52, P305, DOI 10.1016/S0006-3223(02)01367-7; Lanius RA, 2005, BIOL PSYCHIAT, V57, P873, DOI 10.1016/j.biopsych.2005.01.011; Liao W, 2010, NEUROIMAGE, V52, P1549, DOI 10.1016/j.neuroimage.2010.05.010; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Lui S, 2009, P NATL ACAD SCI USA, V106, P15412, DOI 10.1073/pnas.0812751106; Lundstrom BN, 2005, NEUROIMAGE, V27, P824, DOI 10.1016/j.neuroimage.2005.05.008; Mueser KT, 2001, PSYCHOL ASSESSMENT, V13, P110, DOI 10.1037/1040-3590.13.1.110; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Nyberg L, 2000, P NATL ACAD SCI USA, V97, P11120, DOI 10.1073/pnas.97.20.11120; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Patel R, 2012, NEUROSCI BIOBEHAV R, V36, P2130, DOI 10.1016/j.neubiorev.2012.06.003; Pine DS, 2005, AM J PSYCHIAT, V162, P291, DOI 10.1176/appi.ajp.162.2.291; Rauschecker JP, 2010, NEURON, V66, P819, DOI 10.1016/j.neuron.2010.04.032; Rioult-Pedotti MS, 1998, NAT NEUROSCI, V1, P230, DOI 10.1038/678; Rosenkranz JA, 2002, J NEUROSCI, V22, P324, DOI 10.1523/JNEUROSCI.22-01-00324.2002; Sander D, 2005, NEUROIMAGE, V28, P848, DOI 10.1016/j.neuroimage.2005.06.023; Schmahmann JD, 2006, BRAIN, V129, P290, DOI 10.1093/brain/awh729; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sripada RK, 2012, PSYCHOSOM MED, V74, P904, DOI 10.1097/PSY.0b013e318273bf33; Vythilingam M, 2007, PSYCHOL MED, V37, P1445, DOI 10.1017/S003329170700092X; Wang ZG, 2011, BRAIN RES, V1374, P134, DOI 10.1016/j.brainres.2010.12.034; Whalley MG, 2013, BRAIN COGNITION, V81, P151, DOI 10.1016/j.bandc.2012.10.002; Wheeler ME, 2000, P NATL ACAD SCI USA, V97, P11125, DOI 10.1073/pnas.97.20.11125; Yehuda R, 2002, NEW ENGL J MED, V346, P108, DOI 10.1056/NEJMra012941; Ziemann U, 2004, J NEUROSCI, V24, P1666, DOI 10.1523/JNEUROSCI.5016-03.2004	66	56	59	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96834	10.1371/journal.pone.0096834	http://dx.doi.org/10.1371/journal.pone.0096834			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24823717	gold, Green Published, Green Submitted			2022-12-27	WOS:000336369200037
J	Wagner, D; Newbury, S; Kass, P; Hurley, K				Wagner, Denae; Newbury, Sandra; Kass, Philip; Hurley, Kate			Elimination Behavior of Shelter Dogs Housed in Double Compartment Kennels	PLOS ONE			English	Article							ANIMAL SHELTERS; CATS; ADOPTION; STRESS	For animals in confinement housing the housing structure has tremendous potential to impact well being. Dogs in animal shelters are often housed in one of two types of confinement housing - single kennels and rooms or double compartment kennels and rooms most often separated by a guillotine door. This study examines the effect of housing on the location of elimination behavior in dogs housed in double compartment kennels were the majority of the dogs were walked daily. One side of the kennel contained the food, water and bed and the other side was empty and available except during cleaning time. Location of urination and defecation was observed daily for 579 dogs housed in indoor double compartment kennels for a total of 4440 days of observation. There were 1856 days (41.9%) when no elimination was noted in the kennel. Feces, urine or both were observed in the kennel on 2584 days (58.1%). When elimination occurred in the kennel the probability of fecal elimination on the opposite side of the bed/food/water was 72.5% (95% CI 69.05% to 75.69%). The probability of urination on the opposite side of the bed/food/water was 77.4% (95% CI 74.33% to 80.07%). This study demonstrates the strong preference of dogs to eliminate away from the area where they eat, drink and sleep. Double compartment housing not only allows this - it allows staff the ability to provide safe, efficient, humane daily care and confers the added benefits of reducing risks for disease transmission for the individual dog as well as the population.	[Wagner, Denae; Newbury, Sandra; Hurley, Kate] Univ Calif Davis, Sch Vet Med, Koret Shelter Med Program, Davis, CA 95616 USA; [Kass, Philip] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Wagner, D (corresponding author), Univ Calif Davis, Sch Vet Med, Koret Shelter Med Program, Davis, CA 95616 USA.	dcwagner@ucdavis.edu			Koret Foundation; Koret Shelter Medicine Program	Koret Foundation; Koret Shelter Medicine Program	The research was done through the Koret Shelter Medicine Program, which receives funding through the Koret Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisko JJ, 1976, COMMUNICATION CHEM S, P283; Baege B, 1933, HUNDEFORSCH, VI, P3; Fantuzzi JM, 2010, J APPL ANIM WELF SCI, V13, P174, DOI 10.1080/10888700903583467; GOURKOW N, 2001, THESIS U BRIT COLUMB; HART BL, 1992, J PARASITOL, V78, P256, DOI 10.2307/3283472; Hediger H, 1944, PSYCHOL, VIII, P170; Kessler MR, 1999, ANIM WELFARE, V8, P15; Kry K, 2007, ANIM WELFARE, V16, P375; Lord LK, 2008, JAVMA-J AM VET MED A, V233, P1715, DOI 10.2460/javma.233.11.1715; Menzel RM, 1937, WELPE UMWELT; Newbury S, 2010, GUIDELINES STANDARDS; Ottway DS, 2003, ANIM WELFARE, V12, P173; Ross S., 1948, BEHAVIOUR, V2, P144; Salman M. D., 2000, Journal of Applied Animal Welfare Science, V3, P93, DOI 10.1207/S15327604JAWS0302_2; Uexkull JVaS E G., 1931, Z HUNDEFORSCHUNG, VI, P55; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; Wirant SC, 2004, APPL ANIM BEHAV SCI, V85, P335, DOI 10.1016/j.applanim.2003.09.012	17	3	3	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96254	10.1371/journal.pone.0096254	http://dx.doi.org/10.1371/journal.pone.0096254			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24825357	gold, Green Published			2022-12-27	WOS:000336369200012
J	Spriggs, EL; Christin, PA; Edwards, EJ				Spriggs, Elizabeth L.; Christin, Pascal-Antoine; Edwards, Erika J.			C-4 Photosynthesis Promoted Species Diversification during the Miocene Grassland Expansion	PLOS ONE			English	Article							GREAT-PLAINS; PHYLOGENETIC ANALYSES; DOMINATED HABITATS; ISOTOPIC EVIDENCE; PANICEAE POACEAE; EVOLUTION; GENUS; PANICOIDEAE; GRASSES; SPREAD	Identifying how organismal attributes and environmental change affect lineage diversification is essential to our understanding of biodiversity. With the largest phylogeny yet compiled for grasses, we present an example of a key physiological innovation that promoted high diversification rates. C-4 photosynthesis, a complex suite of traits that improves photosynthetic efficiency under conditions of drought, high temperatures, and low atmospheric CO2, has evolved repeatedly in one lineage of grasses and was consistently associated with elevated diversification rates. In most cases there was a significant lag time between the origin of the pathway and subsequent radiations, suggesting that the 'C-4 effect' is complex and derives from the interplay of the C-4 syndrome with other factors. We also identified comparable radiations occurring during the same time period in C-3 Pooid grasses, a diverse, cold-adapted grassland lineage that has never evolved C-4 photosynthesis. The mid to late Miocene was an especially important period of both C-3 and C-4 grass diversification, coincident with the global development of extensive, open biomes in both warm and cool climates. As is likely true for most "key innovations'', the C-4 effect is context dependent and only relevant within a particular organismal background and when particular ecological opportunities became available.	[Spriggs, Elizabeth L.; Christin, Pascal-Antoine; Edwards, Erika J.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA	Brown University	Spriggs, EL (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	elizabeth.spriggs@yale.edu	Christin, Pascal-Antoine/A-6634-2013	Christin, Pascal-Antoine/0000-0001-6292-8734	National Science Foundation grant [IOS0843231]; Marie Curie IOF fellowship [252568]	National Science Foundation grant(National Science Foundation (NSF)); Marie Curie IOF fellowship(European Commission)	This work was supported by National Science Foundation grant IOS0843231 to EJE and a Marie Curie IOF 252568 fellowship to PAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Aliscioni S, 2012, NEW PHYTOL, V193, P304, DOI 10.1111/j.1469-8137.2011.03972.x; Aliscioni SS, 2003, AM J BOT, V90, P796, DOI 10.3732/ajb.90.5.796; Barker NP, 2001, ANN MO BOT GARD, V88, P373, DOI 10.2307/3298585; Bess EC, 2006, SYST BOT, V31, P656, DOI 10.1600/036364406779695898; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Bouchenak-Khelladi Y, 2009, GLOBAL CHANGE BIOL, V15, P2397, DOI 10.1111/j.1365-2486.2009.01860.x; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Catalan P, 1997, MOL PHYLOGENET EVOL, V8, P150, DOI 10.1006/mpev.1997.0416; Catalan P, 2004, MOL PHYLOGENET EVOL, V31, P517, DOI 10.1016/j.ympev.2003.08.025; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Cerros-Tlatilpa R, 2011, AM J BOT, V98, P1868, DOI 10.3732/ajb.1100103; Christin PA, 2008, CURR BIOL, V18, P37, DOI 10.1016/j.cub.2007.11.058; Christin PA, 2014, SYST BIOL, V63, P153, DOI 10.1093/sysbio/syt072; Christin PA, 2013, P NATL ACAD SCI USA, V110, P1381, DOI 10.1073/pnas.1216777110; CLARK LG, 1995, SYST BOT, V20, P436, DOI 10.2307/2419803; Clayton WD, 2006, ONLINE WORLD GRASS F; de Queiroz A, 2002, SYST BIOL, V51, P917, DOI 10.1080/10635150290155980; Donoghue MJ, 2005, PALEOBIOLOGY, V31, P77, DOI 10.1666/0094-8373(2005)031[0077:KICASM]2.0.CO;2; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edwards EJ, 2010, SCIENCE, V328, P587, DOI 10.1126/science.1177216; Edwards EJ, 2010, P NATL ACAD SCI USA, V107, P2532, DOI 10.1073/pnas.0909672107; Ehleringer JR, 1997, OECOLOGIA, V112, P285, DOI 10.1007/s004420050311; FitzJohn RG, 2009, SYST BIOL, V58, P595, DOI 10.1093/sysbio/syp067; Fox DL, 2003, GEOLOGY, V31, P809, DOI 10.1130/G19580.1; Galley C, 2007, EVOLUTION, V61, P864, DOI 10.1111/j.1558-5646.2007.00067.x; Gillespie LJ, 2008, BOTANY, V86, P938, DOI 10.1139/B08-076; Jacobs BF, 1999, ANN MO BOT GARD, V86, P590, DOI 10.2307/2666186; Jacobs Surrey, 2007, Aliso, V23, P349; Jiang H, 2009, J ARID ENVIRON, V73, P765, DOI 10.1016/j.jaridenv.2009.03.011; Kay RF, 1999, P NATL ACAD SCI USA, V96, P13235, DOI 10.1073/pnas.96.23.13235; Labandeir CC, 2011, ENTOMOL AM-NY, V117, P9, DOI 10.1664/10-RA-011.1; Maddison WP, 2007, SYST BIOL, V56, P701, DOI 10.1080/10635150701607033; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; Marazzi B, 2010, EVOLUTION, V64, P3570, DOI 10.1111/j.1558-5646.2010.01086.x; Mason-Gamer RJ, 2004, SYST BIOL, V53, P25, DOI 10.1080/10635150490424402; Morrone O, 2001, NOVON, V11, P429, DOI 10.2307/3393155; Morrone O, 2008, SYST BOT, V33, P66, DOI 10.1600/036364408783887393; Morrone O, 2007, TAXON, V56, P521, DOI 10.1002/tax.562023; Morrone O, 2012, CLADISTICS, V28, P333, DOI 10.1111/j.1096-0031.2011.00384.x; Nel A, 2007, ANN SOC ENTOMOL FR, V43, P349, DOI 10.1080/00379271.2007.10697531; Osborne CP, 2008, J ECOL, V96, P35, DOI 10.1111/j.1365-2745.2007.01323.x; Osborne CP, 2009, P ROY SOC B-BIOL SCI, V276, P1753, DOI 10.1098/rspb.2008.1762; Palazzesi L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2299; Passey BH, 2009, EARTH PLANET SC LETT, V277, P443, DOI 10.1016/j.epsl.2008.11.008; Passey BH, 2002, J GEOL, V110, P123, DOI 10.1086/338280; Pau S, 2013, GLOBAL CHANGE BIOL, V19, P184, DOI 10.1111/gcb.12037; Prasad V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1482; QUADE J, 1995, J HUM EVOL, V28, P373, DOI 10.1006/jhev.1995.1029; QUADE J, 1994, PALAEOGEOGR PALAEOCL, V108, P41, DOI 10.1016/0031-0182(94)90021-3; Quintanar A, 2007, AM J BOT, V94, P1554, DOI 10.3732/ajb.94.9.1554; Retallack GJ, 1997, PALAIOS, V12, P380, DOI 10.2307/3515337; Retallack GJ, 2001, J GEOL, V109, P407, DOI 10.1086/320791; Sage RF, 2012, ANNU REV PLANT BIOL, V63, P19, DOI 10.1146/annurev-arplant-042811-105511; Sage RF, 2011, J EXP BOT, V62, P3155, DOI 10.1093/jxb/err048; Salamin N, 2004, PHYLOGENETIC SUPERTR; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Sede SM, 2009, SYST BOT, V34, P684, DOI 10.1600/036364409790139655; Sede SM, 2009, TAXON, V58, P365, DOI 10.1002/tax.582004; Smith SA, 2008, BIOINFORMATICS, V24, P715, DOI 10.1093/bioinformatics/btm619; Smith SA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-37; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Still CJ, 2014, GLOBAL ECOL BIOGEOGR, V23, P286, DOI 10.1111/geb.12121; Still CJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001807; Stromberg CAE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2508; Stromberg CAE, 2005, P NATL ACAD SCI USA, V102, P11980, DOI 10.1073/pnas.0505700102; Stromberg CAE, 2004, PALAEOGEOGR PALAEOCL, V207, P239, DOI 10.1016/j.palaeo.2003.09.028; Stromberg CAE, 2007, PALAEOGEOGR PALAEOCL, V250, P18, DOI 10.1016/j.palaeo.2007.02.012; Sungkaew S, 2009, J PLANT RES, V122, P95, DOI 10.1007/s10265-008-0192-6; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Valente LM, 2010, P ROY SOC B-BIOL SCI, V277, P1489, DOI 10.1098/rspb.2009.2163; Vamosi SM, 2005, EVOL ECOL RES, V7, P567; Vicentini A, 2008, GLOBAL CHANGE BIOL, V14, P2963, DOI 10.1111/j.1365-2486.2008.01688.x; Zhang YG, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2013.0096	74	69	70	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97722	10.1371/journal.pone.0097722	http://dx.doi.org/10.1371/journal.pone.0097722			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835188	gold, Green Published, Green Submitted			2022-12-27	WOS:000339614800065
J	Lee, SH; Lee, JH; Asahara, T; Kim, YS; Jeong, HC; Ahn, Y; Jung, JS; Kwon, SM				Lee, Sang Hun; Lee, Jun Hee; Asahara, Takayuki; Kim, Yong Sook; Jeong, Hae Chang; Ahn, Youngkeun; Jung, Jin Sup; Kwon, Sang-Mo			Genistein Promotes Endothelial Colony-Forming Cell (ECFC) Bioactivities and Cardiac Regeneration in Myocardial Infarction	PLOS ONE			English	Article							PROGENITOR CELLS; BONE-MARROW; POSTNATAL VASCULOGENESIS; ESTROGEN; TRANSPLANTATION; ISCHEMIA; HEART; NEOVASCULARIZATION; ANGIOGENESIS; DYSFUNCTION	Although stem cell-mediated treatment of ischemic diseases offers significant therapeutic promise, the limitation in the therapeutic efficacy of transplanted stem cells in vivo because of poor engraftment remains a challenge. Several strategies aimed at improving survival and engraftment of stem cells in the ischemic myocardium have been developed, such as cell transplantation in combination with growth factor delivery, genetic modification of stem cells, and/or cell therapy using scaffolds. To improve therapeutic efficacy, we investigated the effects of genistein on the engraftment of transplanted ECFCs in an acute myocardial ischemia model. Results: We found that genistein treatment enhanced ECFCs' migration and proliferation, which was accompanied by increases in the expression of ILK, alpha-parvin, F-actin, and phospholylation of ERK 1/2 signaling. Transplantation of genistein-stimulates ECFCs (GS-ECFCs) into myocardial ischemic sites in vivo induced cellular proliferation and secretion of angiogenic cytokines at the ischemic sites and thereby enhanced neovascularization and decreased myocardial fibrosis as well as improved cardiac function, as shown by echocardiography. Taken together, these data suggest that pretreatment of ECFCs with genistein prior to transplantation can improve the regenerative potential in ischemic tissues, providing a novel strategy in adult stem cell therapy for ischemic diseases.	[Lee, Sang Hun] Soonchunhyang Univ, Seoul Hosp Seoul, Med Sci Res Inst, Seoul, South Korea; [Lee, Sang Hun; Lee, Jun Hee; Kwon, Sang-Mo] Pusan Natl Univ Yangsan, Sch Med, Dept Physiol, Lab Vasc Med & Stem Cell Biol,Med Res Inst, Yangsan, South Korea; [Lee, Jun Hee; Kwon, Sang-Mo] Pusan Natl Univ Yangsan, Sch Med, Dept Physiol, Immunoregulatory Therapeut Grp,Brain Busan Projec, Yangsan, South Korea; [Asahara, Takayuki] RIKEN Ctr Dev Biol, Inst Biomed Res & Innovat, Kobe, Hyogo, Japan; [Kim, Yong Sook] Chonnam Natl Univ Hosp, Heart Res Ctr, Kwangju, South Korea; [Jeong, Hae Chang; Ahn, Youngkeun] Chonnam Natl Univ Hosp, Dept Cardiol, Kwangju, South Korea; [Jung, Jin Sup] Pusan Natl Univ, Sch Med, Dept Physiol, Yangsan, Gyeongnam, South Korea; [Lee, Sang Hun] Soonchunhyang Univ Asan, Dept Med Biosci, Asan, South Korea; [Asahara, Takayuki] Tokai Univ, Sch Med, Dept Regenerat Med Sci, Isehara, Kanagawa 25911, Japan	Soonchunhyang University; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Institute for Biomedical Research & Innovation (IBRI); RIKEN; Chonnam National University; Chonnam National University Hospital; Chonnam National University; Chonnam National University Hospital; Pusan National University; Pusan National University Hospital; Soonchunhyang University; Tokai University	Kwon, SM (corresponding author), Pusan Natl Univ Yangsan, Sch Med, Dept Physiol, Lab Vasc Med & Stem Cell Biol,Med Res Inst, Yangsan, South Korea.	smkwon323@hotmail.com	lee, sang hun/Q-4650-2019	lee, sang hun/0000-0002-9005-5966	National Research Foundation (NRF) - Korean government (MEST) [2007-0052078, 2010-0020260, 2011-0009610]; Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A110374]	National Research Foundation (NRF) - Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This study was supported by a National Research Foundation (NRF) grant funded by the Korean government (MEST) (2007-0052078, 2010-0020260, 2011-0009610) and a grant from the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A110374). The funders had no role in study design, data collection or analysis, the decision to publish, or preparation of the manuscript.	Allred CD, 2001, CANCER RES, V61, P5045; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Badorff C, 2003, CIRCULATION, V107, P1024, DOI 10.1161/01.CIR.0000051460.85800.BB; Bolego C, 2010, FASEB J, V24, P2262, DOI 10.1096/fj.09-139220; Deodato B, 1999, BRIT J PHARMACOL, V128, P1683, DOI 10.1038/sj.bjp.0702973; Fischer KM, 2011, CIRC RES, V108, P960, DOI 10.1161/CIRCRESAHA.110.237156; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Hur J, 2007, CIRCULATION, V116, P1671, DOI 10.1161/CIRCULATIONAHA.107.694778; Ii M, 2005, CIRCULATION, V111, P1114, DOI 10.1161/01.CIR.0000157144.24888.7E; Iwasaki H, 2006, CIRCULATION, V113, P1311, DOI 10.1161/CIRCULATIONAHA.105.541268; Kajstura J, 2005, CIRC RES, V96, P127, DOI 10.1161/01.RES.0000151843.79801.60; Kawamoto A, 2003, CIRCULATION, V107, P461, DOI 10.1161/01.CIR.0000046450.89986.50; Kawamoto A, 2001, CIRCULATION, V103, P634; Kremastinos DT, 2000, ATHEROSCLEROSIS, V150, P81, DOI 10.1016/S0021-9150(99)00389-5; Lee MO, 2012, ARTERIOSCL THROM VAS, V32, P343, DOI 10.1161/ATVBAHA.111.237651; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Li YW, 1999, ONCOGENE, V18, P3166, DOI 10.1038/sj.onc.1202650; Losordo DW, 2011, CIRC RES, V109, P428, DOI 10.1161/CIRCRESAHA.111.245993; Losordo DW, 2001, ARTERIOSCL THROM VAS, V21, P6, DOI 10.1161/01.ATV.21.1.6; Masuda H, 2007, CIRC RES, V101, P598, DOI 10.1161/CIRCRESAHA.106.144006; Miodini P, 1999, BRIT J CANCER, V80, P1150, DOI 10.1038/sj.bjc.6690479; Murasawa S, 2002, CIRCULATION, V106, P1133, DOI 10.1161/01.CIR.0000027584.85865.B4; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Ridopoulos I, 1997, CIRCULATION, V95, P1505; Sakai T, 2003, GENE DEV, V17, P926, DOI 10.1101/gad.255603; Sellke FW, 1996, SURGERY, V120, P182, DOI 10.1016/S0039-6060(96)80286-8; Squadrito F, 2000, CARDIOVASC RES, V45, P454, DOI 10.1016/S0008-6363(99)00359-4; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C; Strehlow K, 2003, CIRCULATION, V107, P3059, DOI 10.1161/01.CIR.0000077911.81151.30; Trachtenberg B, 2011, AM HEART J, V161, P487, DOI 10.1016/j.ahj.2010.11.024; Uemura R, 2006, CIRC RES, V98, P1414, DOI 10.1161/01.RES.0000225952.61196.39; Urbich C, 2005, J MOL CELL CARDIOL, V39, P733, DOI 10.1016/j.yjmcc.2005.07.003; Zemani F, 2008, ARTERIOSCL THROM VAS, V28, P644, DOI 10.1161/ATVBAHA.107.160044; Zuba-Surma EK, 2011, J CELL MOL MED, V15, P1319, DOI 10.1111/j.1582-4934.2010.01126.x	35	29	29	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e96155	10.1371/journal.pone.0096155	http://dx.doi.org/10.1371/journal.pone.0096155			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830850	Green Submitted, gold, Green Published			2022-12-27	WOS:000336789500014
J	Pitzonka, L; Ullas, S; Chinnam, M; Povinelli, BJ; Fisher, DT; Golding, M; Appenheimer, MM; Nemeth, MJ; Evans, S; Goodrich, DW				Pitzonka, Laura; Ullas, Sumana; Chinnam, Meenalakshmi; Povinelli, Benjamin J.; Fisher, Daniel T.; Golding, Michelle; Appenheimer, Michelle M.; Nemeth, Michael J.; Evans, Sharon; Goodrich, David W.			The Thoc1 Encoded Ribonucleoprotein Is Required for Myeloid Progenitor Cell Homeostasis in the Adult Mouse	PLOS ONE			English	Article							MESSENGER-RNA EXPORT; TRANSCRIPTION ELONGATION; COMPLEX; GENE; TREX; IDENTIFICATION; CONTRIBUTES; MACHINERY; PROTEINS; DOMAIN	Co-transcriptionally assembled ribonucleoprotein (RNP) complexes are critical for RNA processing and nuclear export. RNPs have been hypothesized to contribute to the regulation of coordinated gene expression, and defects in RNP biogenesis contribute to genome instability and disease. Despite the large number of RNPs and the importance of the molecular processes they mediate, the requirements for individual RNP complexes in mammalian development and tissue homeostasis are not well characterized. THO is an evolutionarily conserved, nuclear RNP complex that physically links nascent transcripts with the nuclear export apparatus. THO is essential for early mouse embryonic development, limiting characterization of the requirements for THO in adult tissues. To address this shortcoming, a mouse strain has been generated allowing inducible deletion of the Thoc1 gene which encodes an essential protein subunit of THO. Bone marrow reconstitution was used to generate mice in which Thoc1 deletion could be induced specifically in the hematopoietic system. We find that granulocyte macrophage progenitors have a cell autonomous requirement for Thoc1 to maintain cell growth and viability. Lymphoid lineages are not detectably affected by Thoc1 loss under the homeostatic conditions tested. Myeloid lineages may be more sensitive to Thoc1 loss due to their relatively high rate of proliferation and turnover.	[Pitzonka, Laura; Ullas, Sumana; Chinnam, Meenalakshmi; Goodrich, David W.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; [Povinelli, Benjamin J.; Fisher, Daniel T.; Golding, Michelle; Appenheimer, Michelle M.; Nemeth, Michael J.; Evans, Sharon] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute	Goodrich, DW (corresponding author), Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA.	david.goodrich@roswellpark.org			Roswell Park Alliance Foundation; National Blood Foundation; University at Buffalo Mark Diamond Fund [SU 11-14]; Public Health Service grants from the National Institutes of Health [CA125665, CA79765, AI082039]; National Cancer Institute [P30 CA016056]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082039] Funding Source: NIH RePORTER	Roswell Park Alliance Foundation; National Blood Foundation; University at Buffalo Mark Diamond Fund; Public Health Service grants from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support was provided by the Roswell Park Alliance Foundation (B.J.P., M. G., M.J.N., D. W. G.), the National Blood Foundation (B.J.P., M.G., M.J.N.), University at Buffalo Mark Diamond Fund grant SU 11-14 (L. P.), and Public Health Service grants CA125665 (D.W.G.), CA79765 (S.S.E.) and AI082039 (S.S.E.) from the National Institutes of Health. Institutional core facilities utilized in this work were supported by National Cancer Institute grant P30 CA016056. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Chavez S, 2000, EMBO J, V19, P5824, DOI 10.1093/emboj/19.21.5824; Cheng H, 2006, CELL, V127, P1389, DOI 10.1016/j.cell.2006.10.044; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; DANCEY JT, 1976, J CLIN INVEST, V58, P705, DOI 10.1172/JCI108517; Dominguez-Sanchez MS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002386; Dufu K, 2010, GENE DEV, V24, P2043, DOI 10.1101/gad.1898610; Fisher DT, 2011, J CLIN INVEST, V121, P3846, DOI 10.1172/JCI44952; Furumizu C, 2010, RNA, V16, P1809, DOI 10.1261/rna.2265710; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Gomez-Gonzalez B, 2011, EMBO J, V30, P3106, DOI 10.1038/emboj.2011.206; Guria A, 2011, RNA, V17, P1048, DOI 10.1261/rna.2607011; Gwizdek C, 2006, P NATL ACAD SCI USA, V103, P16376, DOI 10.1073/pnas.0607941103; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Li YL, 2007, CANCER RES, V67, P6657, DOI 10.1158/0008-5472.CAN-06-3234; Li YP, 2005, MOL CELL BIOL, V25, P4023, DOI 10.1128/MCB.25.10.4023-4033.2005; Luna R, 2008, CHROMOSOMA, V117, P319, DOI 10.1007/s00412-008-0158-4; Luna R, 2012, BBA-GENE REGUL MECH, V1819, P514, DOI 10.1016/j.bbagrm.2011.11.012; Mancini A, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-1; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Pitzonka L, 2013, MOL CELL BIOL, V33, P3505, DOI 10.1128/MCB.00751-13; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Rehwinkel J, 2004, NAT STRUCT MOL BIOL, V11, P558, DOI 10.1038/nsmb759; Saguez C, 2008, MOL CELL, V31, P91, DOI 10.1016/j.molcel.2008.04.030; Saran S, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-51; Schneiter R, 1999, MOL CELL BIOL, V19, P3415; Song F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057995; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Tran DDH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.409; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Viphakone N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2005; Voynov V, 2006, P NATL ACAD SCI USA, V103, P14423, DOI 10.1073/pnas.0606546103; Wang L, 2013, CELL STEM CELL, V13, P676, DOI 10.1016/j.stem.2013.10.008; Wang XL, 2007, GENESIS, V45, P32, DOI 10.1002/dvg.20262; Wang XL, 2006, MOL CELL BIOL, V26, P4362, DOI 10.1128/MCB.02163-05; Wang XL, 2009, MOL CELL BIOL, V29, P2794, DOI 10.1128/MCB.01633-08; Wellinger RE, 2006, MOL CELL BIOL, V26, P3327, DOI 10.1128/MCB.26.8.3327-3334.2006	40	5	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97628	10.1371/journal.pone.0097628	http://dx.doi.org/10.1371/journal.pone.0097628			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830368	Green Published, Green Submitted, gold			2022-12-27	WOS:000336789500087
J	Romer, D; Roces, F				Roemer, Daniela; Roces, Flavio			Nest Enlargement in Leaf-Cutting Ants: Relocated Brood and Fungus Trigger the Excavation of New Chambers	PLOS ONE			English	Article							ATTA-VOLLENWEIDERI FOREL; INTERNAL STRUCTURE; ADAPTIVE VALUE; COLONY GROWTH; 1893 HYM; HYMENOPTERA; ARCHITECTURE; FORMICIDAE; BEHAVIOR; SIZE	During colony growth, leaf-cutting ants enlarge their nests by excavating tunnels and chambers housing their fungus gardens and brood. Workers are expected to excavate new nest chambers at locations across the soil profile that offer suitable environmental conditions for brood and fungus rearing. It is an open question whether new chambers are excavated in advance, or will emerge around brood or fungus initially relocated to a suitable site in a previously-excavated tunnel. In the laboratory, we investigated the mechanisms underlying the excavation of new nest chambers in the leaf-cutting ant Acromyrmex lundi. Specifically, we asked whether workers relocate brood and fungus to suitable nest locations, and to what extent the relocated items trigger the excavation of a nest chamber and influence its shape. When brood and fungus were exposed to unfavorable environmental conditions, either low temperatures or low humidity, both were relocated, but ants clearly preferred to relocate the brood first. Workers relocated fungus to places containing brood, demonstrating that subsequent fungus relocation spatially follows the brood deposition. In addition, more ants aggregated at sites containing brood. When presented with a choice between two otherwise identical digging sites, but one containing brood, ants' excavation activity was higher at this site, and the shape of the excavated cavity was more rounded and chamber-like. The presence of fungus also led to the excavation of rounder shapes, with higher excavation activity at the site that also contained brood. We argue that during colony growth, workers preferentially relocate brood to suitable locations along a tunnel, and that relocated brood spatially guides fungus relocation and leads to increased digging activity around them. We suggest that nest chambers are not excavated in advance, but emerge through a self-organized process resulting from the aggregation of workers and their density-dependent digging behavior around the relocated brood and fungus.	[Roemer, Daniela; Roces, Flavio] Univ Wurzburg, Bioctr, Dept Behav Physiol & Sociobiol Zool 2, D-97070 Wurzburg, Germany	University of Wurzburg	Romer, D (corresponding author), Univ Wurzburg, Bioctr, Dept Behav Physiol & Sociobiol Zool 2, D-97070 Wurzburg, Germany.	daniela.roemer@uni-wuerzburg.de		Romer, Daniela/0000-0002-7437-2195; Roces, Flavio/0000-0001-9258-3079	German Research Foundation (DFG) [SFB 554/TP E1]; German Research Foundation (DFG); University of Wuerzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This study was partially supported by funds from the German Research Foundation (DFG, grant SFB 554/TP E1). This publication was funded by the German Research Foundation ( DFG) and the University of Wuerzburg in the funding program Open Access Publishing. There were no further external or internal funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 2001, INSECT SOC, V48, P404, DOI 10.1007/PL00001798; Armitage SAO, 2012, EVOLUTION, V66, P1966, DOI 10.1111/j.1558-5646.2011.01568.x; Bollazzi M, 2012, INSECT SOC, V59, P487, DOI 10.1007/s00040-012-0243-9; Bollazzi M, 2010, INSECT SOC, V57, P267, DOI 10.1007/s00040-010-0081-6; Bollazzi M, 2002, INSECT SOC, V49, P153, DOI 10.1007/s00040-002-8295-x; Bollazzi M, 2008, OECOLOGIA, V158, P165, DOI 10.1007/s00442-008-1113-z; Bollazzi M, 2007, ANIM BEHAV, V74, P1349, DOI 10.1016/j.anbehav.2007.02.021; Bonetto AA, 1959, HORMIGAS CORTADOERAS, P77; Buhl J, 2005, BEHAV ECOL SOCIOBIOL, V58, P9, DOI 10.1007/s00265-004-0906-2; Camargo RS, 2011, INSECT SOC, V58, P17, DOI 10.1007/s00040-010-0110-5; Cassill D, 2002, INSECT SOC, V49, P158, DOI 10.1007/s00040-002-8296-9; Clark RM, 2014, BEHAV ECOL SOCIOBIOL, V68, P163, DOI 10.1007/s00265-013-1632-4; Camargo Roberto da Silva, 2004, Rev. Árvore, V28, P309, DOI 10.1590/S0100-67622004000200017; DENEUBOURG JL, 1995, J INSECT BEHAV, V8, P417, DOI 10.1007/BF01995316; Diehl-Fleig E., 1992, P51; Fowler H.G., 1986, P18; Franks NR, 1997, ANIM BEHAV, V54, P779, DOI 10.1006/anbe.1996.0496; Frohle K, 2012, J EXP BIOL, V215, P1642, DOI 10.1242/jeb.066217; Frohle K, 2009, THESIS; Frohle K., 2009, INSECT NEST HUMAN AR, P95; Holldobler B., 1990, pi; Jacoby M., 1955, Zeitschrift fuer Angewandte Entomologie, V37, P129; Jacoby M., 1960, Zeitschrift fuer Angewandte Entomologie, V46, P34; Jacoby M., 1937, Revista de Entomologia Rio de Janeiro, V7, P416; Jacoby M, 1953, Z ANGEW ENTOMOL, V34, P145; Jacoby M, 1936, REV ENTOMOLOGIA, V6, P120; JONKMAN JCM, 1980, Z ANGEW ENTOMOL, V89, P158; JONKMAN JCM, 1980, Z ANGEW ENTOMOL, V89, P217; Kleineidam C, 2000, INSECT SOC, V47, P241, DOI 10.1007/PL00001710; Lapointe SL, 1998, ENVIRON ENTOMOL, V27, P636, DOI 10.1093/ee/27.3.636; Lopes JFS, 2005, INSECT SOC, V52, P333, DOI 10.1007/s00040-005-0816-y; Mikheyev AS, 2004, INSECT SOC, V51, P30, DOI 10.1007/s00040-003-0703-3; Minter NJ, 2012, J R SOC INTERFACE, V9, P586, DOI 10.1098/rsif.2011.0377; Moreira AA, 2004, STUD NEOTROP FAUNA E, V39, P109, DOI 10.1080/01650520412331333756; Moreira AA, 2004, J APPL ENTOMOL, V128, P204, DOI 10.1111/j.1439-0418.2004.00839.x; Moser JC, 2006, ANN ENTOMOL SOC AM, V99, P891, DOI 10.1603/0013-8746(2006)99[891:CEAMOA]2.0.CO;2; MOSER JOHN C., 1963, ANN ENTOMOL SOC AMER, V56, P286, DOI 10.1093/aesa/56.3.286; NAVARRO JG, 1985, BIOTROPICA, V17, P347, DOI 10.2307/2388602; Pereira da Silva V., 1981, REV BRASIL ENTOMOL, V25, P87; Pielstrom S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057040; Pielstrom S, 2012, ANIM BEHAV, V84, P743, DOI 10.1016/j.anbehav.2012.07.008; POWELL RJ, 1986, T BRIT MYCOL SOC, V87, P205, DOI 10.1016/S0007-1536(86)80022-5; QUINLAN RJ, 1978, ECOL ENTOMOL, V3, P221, DOI 10.1111/j.1365-2311.1978.tb00922.x; Rasse P, 2001, J INSECT BEHAV, V14, P433, DOI 10.1023/A:1011163804217; Ritter N, 2009, J MATH IMAGING VIS, V35, P117, DOI 10.1007/s10851-009-0158-x; Roces F, 2000, INSECT SOC, V47, P348, DOI 10.1007/PL00001728; RUDOLPH SG, 1986, ECOL ENTOMOL, V11, P401, DOI 10.1111/j.1365-2311.1986.tb00319.x; Lopes JFS, 2011, SOCIOBIOLOGY, V58, P593; STAHEL GEROLD, 1941, REV ENT [RIO DE JANEIRO], V12, P243; Stahel Gerold, 1939, REV ENT [RIO DE JANEIRO], V10, P27; Sudd J. H., 1969, Zeitschrift fuer Tierpsychologie, V26, P257; Toffin E, 2010, P ROY SOC B-BIOL SCI, V277, P2617, DOI 10.1098/rspb.2010.0176; Toffin E, 2009, P NATL ACAD SCI USA, V106, P18616, DOI 10.1073/pnas.0902685106; Verza SS, 2007, INSECT SOC, V54, P303, DOI 10.1007/s00040-007-0943-8; WEBER NA, 1966, SCIENCE, V153, P587, DOI 10.1126/science.153.3736.587; WEBER NA, 1957, ANAT REC, V128, P638; Wetterer JK, 1998, FLA ENTOMOL, V81, P61, DOI 10.2307/3495996; Zolessi LC., 1978, REV FAC HUMAN CIENC, V1, P9	58	15	15	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97872	10.1371/journal.pone.0097872	http://dx.doi.org/10.1371/journal.pone.0097872			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830633	Green Published, gold, Green Submitted			2022-12-27	WOS:000336789500130
J	Coulon, M; Henry, L; Perret, A; Cousillas, H; Hausberger, M; George, I				Coulon, Marion; Henry, Laurence; Perret, Audrey; Cousillas, Hugo; Hausberger, Martine; George, Isabelle			Assessing Video Presentations as Environmental Enrichment for Laboratory Birds	PLOS ONE			English	Article							STARLINGS STURNUS-VULGARIS; EUROPEAN STARLINGS; STEREOTYPIC BEHAVIOR; DOMESTIC CHICKS; RHESUS-MONKEYS; STIMULATION; WELFARE; IMAGES; RESPONSES; MALES	The aim of the present study was to investigate the effects of video presentations of natural landscapes on European starlings' (Sturnus vulgaris) stereotypic behaviours (SBs) and other abnormal repetitive behaviours (ARBs) and to evaluate the impact of past experience by comparing wild-caught and hand-reared starlings' reactions. Ten wild-caught and five hand-reared starlings were presented 1-hour videos of landscapes twice a day for five successive days, while a control group of eight wild-caught and four hand-reared starlings was presented a grey screen for the same amount of time. The analysis of the starlings' behaviour revealed that the video presentations of landscapes appeared to have a positive but limited and experience-dependent effect on starlings' SBs and other ARBs compared to the controls. Indeed, whereas video presentations seemed to modulate high rates of SBs and ARBs, they did not appear to be enriching enough to prevent the emergence or the development of SBs and ARBs in an impoverished environment. They even appeared to promote a particular type of SB (somersaulting) that is thought to be linked to escape motivation. The fact that this effect was observed in hand-reared starlings suggests that videos of landscapes could elicit motivation to escape even in birds that never experienced outdoor life. These results highlight the importance of investigating stereotypic behaviour both quantitatively and qualitatively in order to provide crucial clues on animal welfare.	[Coulon, Marion; Henry, Laurence; Perret, Audrey; Cousillas, Hugo; Hausberger, Martine; George, Isabelle] Univ Rennes 1, CNRS, UMR Ethol Anim & Humaine 6552, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes	George, I (corresponding author), Univ Rennes 1, CNRS, UMR Ethol Anim & Humaine 6552, Rennes, France.	isabelle.george@univ-rennes1.fr	George, Isabelle/A-7770-2008	George, Isabelle/0000-0002-4842-4959	French ANR (Agence Nationale pour la Recherche) [ANR-09-Blanc-0319-01]; University of Rennes 1; French CNRS	French ANR (Agence Nationale pour la Recherche)(French National Research Agency (ANR)); University of Rennes 1; French CNRS(Centre National de la Recherche Scientifique (CNRS))	This study was supported by a grant of the French ANR (Agence Nationale pour la Recherche) entitled "Intermodalite et imitation: aspects comportementaux et neuronaux (etude chez le bebe et les oiseaux)" (ANR-09-Blanc-0319-01). All authors are supported by the University of Rennes 1 and by the French CNRS. Audrey Perret is a doctoral fellow of the French Ministry of Higher Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher L, 2008, LAB ANIM-UK, V42, P111, DOI 10.1258/la.2007.007006; Benhajali H, 2009, ANIMAL, V3, P1308, DOI 10.1017/S1751731109004820; Bird CD, 2008, ANIM BEHAV, V76, P679, DOI 10.1016/j.anbehav.2008.04.014; Bloomsmith MA, 1990, LAB ANIM, V19, P42; Brilot BO, 2009, BEHAV PROCESS, V82, P256, DOI 10.1016/j.beproc.2009.07.003; Clarke CH, 2000, APPL ANIM BEHAV SCI, V67, P97, DOI 10.1016/S0168-1591(99)00107-0; Clarke CH, 2000, APPL ANIM BEHAV SCI, V66, P107, DOI 10.1016/S0168-1591(99)00071-4; Feenders G, 2012, DEV PSYCHOBIOL, V54, P773, DOI 10.1002/dev.20623; Feenders G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019074; Feenders G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017466; Fureix C., 2011, ISRN Zoology, V2011, P271209, DOI 10.5402/2011/271209; Galoch Zdzislaw, 2006, Ornithological Science, V5, P57, DOI 10.2326/osj.5.57; George Isabelle, 2011, Frontiers in Behavioral Neuroscience, V4, P1, DOI 10.3389/fnbeh.2010.00193; Harris LD, 1999, CONTEMP TOP LAB ANIM, V38, P48; HAUSBERGER M, 1995, J COMP PSYCHOL, V109, P222, DOI 10.1037/0735-7036.109.3.222; Henry L, 2008, CR BIOL, V331, P526, DOI 10.1016/j.crvi.2008.04.005; Henry L, 2013, J COMP PSYCHOL, V127, P1, DOI 10.1037/a0029975; Jones RB, 1996, APPL ANIM BEHAV SCI, V48, P81, DOI 10.1016/0168-1591(95)01003-3; KEIPER RR, 1969, ANIM BEHAV, V17, P114, DOI 10.1016/0003-3472(69)90119-5; Lee Grace H., 2011, Laboratory Primate Newsletter, V50, P7; Maddocks SA, 2002, J AVIAN BIOL, V33, P103, DOI 10.1034/j.1600-048X.2002.330117.x; Mason G, 2007, APPL ANIM BEHAV SCI, V102, P163, DOI 10.1016/j.applanim.2006.05.041; Mason G, 2006, STEREOTYPIC ANIMAL BEHAVIOUR: FUNDAMENTALS AND APPLICATIONS TO WELFARE, 2ND EDIITON, P1, DOI 10.1079/9780851990040.0000; Mason GJ, 2004, ANIM WELFARE, V13, pS57; MASON GJ, 1991, ANIM BEHAV, V41, P1015, DOI 10.1016/S0003-3472(05)80640-2; Meehan CL, 2004, DEV PSYCHOBIOL, V44, P209, DOI 10.1002/dev.20007; NEWBERRY RC, 1995, APPL ANIM BEHAV SCI, V44, P229, DOI 10.1016/0168-1591(95)00616-Z; Odberg F., 1978, P 1 WORLD C ETH APPL, P475; ONEILL P, 1989, HOUSING CARE PSYCHOL, P135; Ophir AG, 2003, ANIM BEHAV, V66, P369, DOI 10.1006/anbe.2003.2229; Platt DM, 1997, APPL ANIM BEHAV SCI, V52, P139, DOI 10.1016/S0168-1591(96)01093-3; Swaddle JP, 2006, ANIM BEHAV, V72, P161, DOI 10.1016/j.anbehav.2005.12.005; Wells DL, 2006, APPL ANIM BEHAV SCI, V100, P327, DOI 10.1016/j.applanim.2005.12.003; Wells DL, 2009, APPL ANIM BEHAV SCI, V118, P1, DOI 10.1016/j.applanim.2009.01.002	34	9	9	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96949	10.1371/journal.pone.0096949	http://dx.doi.org/10.1371/journal.pone.0096949			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827457	Green Published, Green Submitted, gold			2022-12-27	WOS:000336857400049
J	Myojo, M; Nagata, D; Fujita, D; Kiyosue, A; Takahashi, M; Satonaka, H; Morishita, Y; Akimoto, T; Nagai, R; Komuro, I; Hirata, Y				Myojo, Masahiro; Nagata, Daisuke; Fujita, Daishi; Kiyosue, Arihiro; Takahashi, Masao; Satonaka, Hiroshi; Morishita, Yoshiyuki; Akimoto, Tetsu; Nagai, Ryozo; Komuro, Issei; Hirata, Yasunobu			Telmisartan Activates Endothelial Nitric Oxide Synthase via Ser1177 Phosphorylation in Vascular Endothelial Cells	PLOS ONE			English	Article							ANGIOTENSIN RECEPTOR BLOCKERS; REPERFUSION INJURY; P38 MAPK; ISCHEMIA-REPERFUSION; SIGNAL-TRANSDUCTION; INDUCED APOPTOSIS; PATHWAY; AKT; PROLIFERATION; MYOCARDIUM	Because endothelial nitric oxide synthase (eNOS) has anti-inflammatory and anti-arteriosclerotic functions, it has been recognized as one of the key molecules essential for the homeostatic control of blood vessels other than relaxation of vascular tone. Here, we examined whether telmisartan modulates eNOS function through its pleiotropic effect. Administration of telmisartan to mice significantly increased the phosphorylation level of eNOS (Ser1177) in the aortic endothelium, but administration of valsartan had no effect. Similarly, telmisartan treatment of human umbilical vein endothelial cells significantly increased the phosphorylation levels of AMP-activated protein kinase (Thr172) and eNOS and the concentration of intracellular guanosine 3',5'-cyclic monophosphate (cGMP). Furthermore, pretreatment with a p38 mitogen-activated protein kinase (p38 MAPK) inhibitor suppressed the increased phosphorylation level of eNOS and intracellular cGMP concentration. These data show that telmisartan increases eNOS activity through Ser1177 phosphorylation in vascular endothelial cells mainly via p38 MAPK signaling.	[Myojo, Masahiro; Fujita, Daishi; Kiyosue, Arihiro; Takahashi, Masao; Komuro, Issei] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan; [Nagata, Daisuke; Morishita, Yoshiyuki; Akimoto, Tetsu] Jichi Med Univ, Dept Nephrol, Shimotsuke, Tochigi, Japan; [Satonaka, Hiroshi] Dokkyo Med Univ, Dept Cardiol & Nephrol, Mibu, Tochigi, Japan; [Nagai, Ryozo] Jichi Med Univ, Shimotsuke, Tochigi, Japan; [Hirata, Yasunobu] Tokyo Teishin Hosp, Tokyo, Japan	University of Tokyo; Jichi Medical University; Dokkyo Medical University; Jichi Medical University	Nagata, D (corresponding author), Jichi Med Univ, Dept Nephrol, Shimotsuke, Tochigi, Japan.	nagatad@jichi.ac.jp		Vacca, Giovanni/0000-0002-0864-1887; Takahashi, Masao/0000-0002-3799-2256	Ministry of Education, Culture, Sports, Science, and Technology of Japan [22590823, 17659229]; Sankyo Foundation of Life Science; Fugaku Trust for Medical Research	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sankyo Foundation of Life Science; Fugaku Trust for Medical Research	This study was supported by Grants-in-Aid #22590823 (to DN) and #17659229 (to Y.H.), Core Research for Evolutional Science and Technology (to Y.H.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, Sankyo Foundation of Life Science (to D.N.), and by a Research Grant from the Fugaku Trust for Medical Research (to D.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anter E, 2004, J BIOL CHEM, V279, P46637, DOI 10.1074/jbc.M405547200; Bell RM, 2003, J AM COLL CARDIOL, V41, P508, DOI 10.1016/S0735-1097(02)02816-4; Bell RM, 2003, J MOL CELL CARDIOL, V35, P185, DOI 10.1016/S0022-2828(02)00310-3; Benson SC, 2004, HYPERTENSION, V43, P993, DOI 10.1161/01.HYP.0000123072.34629.57; Benson SC, 2008, J HYPERTENS, V26, P973, DOI 10.1097/HJH.0b013e3282f56ba5; Birnbaum Y, 2005, CARDIOVASC RES, V65, P345, DOI 10.1016/j.cardiores.2004.10.018; Corson MA, 1996, CIRC RES, V79, P984, DOI 10.1161/01.RES.79.5.984; Ferrario CM, 2006, AM J CARDIOL, V98, P121, DOI 10.1016/j.amjcard.2006.01.059; Fischer MJE, 1996, INFLAMM RES, V45, P564, DOI 10.1007/BF02342228; Gao F, 2002, CIRCULATION, V105, P1497, DOI 10.1161/01.CIR.0000012529.00367.0F; Giles TD, 2007, REV CARDIOVASC MED, V8, pS14; Gonon AT, 2007, BASIC RES CARDIOL, V102, P80, DOI 10.1007/s00395-006-0613-4; Grossini E, 2009, BRIT J PHARMACOL, V156, P250, DOI 10.1111/j.1476-5381.2008.00024.x; He HB, 2010, HYPERTENSION, V55, P869, DOI 10.1161/HYPERTENSIONAHA.109.143958; Kan WH, 2008, AM J PHYSIOL-HEART C, V294, pH2627, DOI 10.1152/ajpheart.91444.2007; Kawano H, 2003, J AM SOC NEPHROL, V14, P584, DOI 10.1097/01.ASN.0000050415.97942.2F; Kjeldsen SE, 2004, AM HEART J, V148, P747, DOI 10.1016/j.ahj.2004.04.037; Matsuzawa A, 2002, ANTIOXID REDOX SIGN, V4, P415, DOI 10.1089/15230860260196218; MICHEL T, 1993, P NATL ACAD SCI USA, V90, P6252, DOI 10.1073/pnas.90.13.6252; Nagata D, 2004, CIRCULATION, V110, P444, DOI 10.1161/01.CIR.0000136025.96811.76; Nagata D, 2003, J BIOL CHEM, V278, P31000, DOI 10.1074/jbc.M300643200; Nagata D, 1999, KIDNEY INT, V55, P1259, DOI 10.1046/j.1523-1755.1999.00361.x; Nagata D, 2006, HYPERTENSION, V48, P165, DOI 10.1161/01.HYP.0000226054.53527.bb; Nagata D, 2010, HYPERTENS RES, V33, P22, DOI 10.1038/hr.2009.187; Nagata D, 2009, HYPERTENS RES, V32, P133, DOI 10.1038/hr.2008.25; Pitt B, 2002, AM J HYPERTENS, V15, p22S, DOI 10.1016/S0895-7061(01)02275-0; Schmieder RE, 2007, LANCET, V369, P1208, DOI 10.1016/S0140-6736(07)60242-6; Schupp M, 2004, CIRCULATION, V109, P2054, DOI 10.1161/01.CIR.0000127955.36250.65; Tsang A, 2004, CIRC RES, V95, P230, DOI 10.1161/01.RES.0000138303.76488.fe; Wolfrum S, 2004, J CARDIOVASC PHARM, V44, P348, DOI 10.1097/01.fjc.0000137162.14735.30; Yamaguchi K, 2014, CIRC J, V78, P240, DOI 10.1253/circj.CJ-13-0741; Yamakuchi M, 2005, CIRC RES, V96, P1185, DOI 10.1161/01.RES.0000170229.49776.81; Zhang J, 2005, AM J PHYSIOL-HEART C, V288, pH954, DOI 10.1152/ajpheart.00756.2004; Zhu M, 2006, CARDIOVASC RES, V72, P152, DOI 10.1016/j.cardiores.2006.06.027	34	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96948	10.1371/journal.pone.0096948	http://dx.doi.org/10.1371/journal.pone.0096948			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827148	gold, Green Published, Green Submitted			2022-12-27	WOS:000336857400048
J	Zhao, YL; Wang, DY; Zong, L; Zhao, FF; Guan, LP; Zhang, P; Shi, W; Lan, L; Wang, HY; Li, Q; Han, B; Yang, L; Jin, X; Wang, J; Wang, J; Wang, QJ				Zhao, Yali; Wang, Dayong; Zong, Liang; Zhao, Feifan; Guan, Liping; Zhang, Peng; Shi, Wei; Lan, Lan; Wang, Hongyang; Li, Qian; Han, Bing; Yang, Ling; Jin, Xin; Wang, Jian; Wang, Jun; Wang, Qiuju			A Novel DFNA36 Mutation in TMC1 Orthologous to the Beethoven (Bth) Mouse Associated with Autosomal Dominant Hearing Loss in a Chinese Family	PLOS ONE			English	Article							GENE FAMILY; HAIR-CELLS; DEAFNESS; CHANNEL; MECHANOTRANSDUCTION; ALIGNMENT; MODEL	Mutations in the transmembrane channel-like gene 1 (TMC1) can cause both DFNA36 and DFNB7/11 hearing loss. More than thirty DFNB7/11 mutations have been reported, but only three DFNA36 mutations were reported previously. In this study, we found a large Chinese family with 222 family members showing post-lingual, progressive sensorineural hearing loss which were consistent with DFNA36 hearing loss. Auditory brainstem response (ABR) test of the youngest patient showed a special result with nearly normal threshold but prolonged latency, decreased amplitude, and the abnormal waveform morphology. Exome sequencing of the proband found four candidate variants in known hearing loss genes. Sanger sequencing in all family members found a novel variant c. 1253T> A (p. M418K) in TMC1 at DFNA36 that co-segregated with the phenotype. This mutation in TMC1 is orthologous to the mutation found in the hearing loss mouse model named Bth ten years ago. In another 51 Chinese autosomal dominant hearing loss families, we screened the segments containing the dominant mutations of TMC1 and no functional variants were found. TMC1 is expressed in the hair cells in inner ear. Given the already known roles of TMC1 in the mechanotransduction in the cochlea and its expression in inner ear, our results may provide an interesting perspective into its function in inner ear.	[Zhao, Yali; Wang, Dayong; Zong, Liang; Zhao, Feifan; Shi, Wei; Lan, Lan; Wang, Hongyang; Li, Qian; Han, Bing; Wang, Qiuju] Chinese Peoples Liberat Army Gen Hosp, Chinese PLA Inst Otolaryngol, Beijing, Peoples R China; [Zhao, Yali] Capital Med Univ, Beijing Inst Otorhinolaryngol, Beijing Tongren Hosp, Beijing, Peoples R China; [Guan, Liping; Zhang, Peng; Jin, Xin; Wang, Jian; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Yang, Ling] BGI Tianjin, Tianjin, Peoples R China; [Jin, Xin] S China Univ Technol, Sch Biosci & Biotechnol, Guangzhou, Guangdong, Peoples R China	Chinese People's Liberation Army General Hospital; Capital Medical University; Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); South China University of Technology	Wang, QJ (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Chinese PLA Inst Otolaryngol, Beijing, Peoples R China.	wqcr@263.net	Jin, Xin/ABF-1329-2020; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Jin, Xin/0000-0001-7554-4975; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874	National Key Basic Research Program of China [2014CB943001]; National Natural Science Foundation of China [81120108009]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants of the National Key Basic Research Program of China, No. 2014CB943001, the National Natural Science Foundation of China, Major Project, No. 81120108009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Said M, 2010, GENET TEST MOL BIOMA, V14, P307, DOI 10.1089/gtmb.2009.0174; Brownstein Z, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r89; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; de Heer AMR, 2011, AUDIOL NEURO-OTOL, V16, P93, DOI 10.1159/000313282; Duman D, 2011, GENET TEST MOL BIOMA, V15, P29, DOI 10.1089/gtmb.2010.0120; Hildebrand MS, 2010, ANN OTO RHINOL LARYN, V119, P830, DOI 10.1177/000348941011901207; Hilgert N, 2008, CLIN GENET, V74, P223, DOI 10.1111/j.1399-0004.2008.01053.x; Hilgert N, 2009, J HUM GENET, V54, P188, DOI 10.1038/jhg.2009.1; Kalay E, 2005, Hum Mutat, V26, P591, DOI 10.1002/humu.9384; Kawashima Y, 2011, J CLIN INVEST, V121, P4796, DOI 10.1172/JCI60405; Keresztes G, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-24; Kitajiri S, 2007, CLIN GENET, V71, P148, DOI 10.1111/j.1399-0004.2007.00739.x; Kitajiri SI, 2007, CLIN GENET, V72, P546, DOI 10.1111/j.1399-0004.2007.00895.x; Kurima K, 2003, GENOMICS, V82, P300, DOI 10.1016/S0888-7543(03)00154-X; Kurima K, 2002, NAT GENET, V30, P277, DOI 10.1038/ng842; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Mazzoli M., 2003, AUDIOL MED, V1, P148, DOI [10.1080/16513860301713, DOI 10.1080/16513860301713]; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyer Christian G, 2005, Hum Mutat, V25, P100, DOI 10.1002/humu.9302; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; Pan BF, 2013, NEURON, V79, P504, DOI 10.1016/j.neuron.2013.06.019; Santos Regie Lyn P, 2005, Hum Mutat, V26, P396, DOI 10.1002/humu.9374; Sirmaci A, 2009, INT J PEDIATR OTORHI, V73, P699, DOI 10.1016/j.ijporl.2009.01.005; Vreugde S, 2002, NAT GENET, V30, P257, DOI 10.1038/ng848; Yang T, 2010, CLIN GENET, V77, P395, DOI 10.1111/j.1399-0004.2009.01338.x	27	12	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97064	10.1371/journal.pone.0097064	http://dx.doi.org/10.1371/journal.pone.0097064			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827932	Green Submitted, gold, Green Published			2022-12-27	WOS:000336857400053
J	Zhou, ML; Zhang, Q; Wang, JY				Zhou, Miaolei; Zhang, Qi; Wang, Jingyuan			Feedforward-Feedback Hybrid Control for Magnetic Shape Memory Alloy Actuators Based on the Krasnosel'skii-Pokrovskii Model	PLOS ONE			English	Article							HYSTERESIS	As a new type of smart material, magnetic shape memory alloy has the advantages of a fast response frequency and outstanding strain capability in the field of microdrive and microposition actuators. The hysteresis nonlinearity in magnetic shape memory alloy actuators, however, limits system performance and further application. Here we propose a feedforward-feedback hybrid control method to improve control precision and mitigate the effects of the hysteresis nonlinearity of magnetic shape memory alloy actuators. First, hysteresis nonlinearity compensation for the magnetic shape memory alloy actuator is implemented by establishing a feedforward controller which is an inverse hysteresis model based on Krasnosel'skii-Pokrovskii operator. Secondly, the paper employs the classical Proportion Integration Differentiation feedback control with feedforward control to comprise the hybrid control system, and for further enhancing the adaptive performance of the system and improving the control accuracy, the Radial Basis Function neural network self-tuning Proportion Integration Differentiation feedback control replaces the classical Proportion Integration Differentiation feedback control. Utilizing self-learning ability of the Radial Basis Function neural network obtains Jacobian information of magnetic shape memory alloy actuator for the on-line adjustment of parameters in Proportion Integration Differentiation controller. Finally, simulation results show that the hybrid control method proposed in this paper can greatly improve the control precision of magnetic shape memory alloy actuator and the maximum tracking error is reduced from 1.1% in the open-loop system to 0.43% in the hybrid control system.	[Zhou, Miaolei; Zhang, Qi; Wang, Jingyuan] Jilin Univ, Coll Commun Engn, Changchun 130023, Peoples R China	Jilin University	Zhou, ML (corresponding author), Jilin Univ, Coll Commun Engn, Changchun 130023, Peoples R China.	zml@jlu.edu.cn			National Natural Science Foundation of China [51105170]; Program of Science and Technology Development Plan of Jilin province of China [201105015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Science and Technology Development Plan of Jilin province of China	This research is supported by National Natural Science Foundation of China (Grant No.: 51105170), and Program of Science and Technology Development Plan of Jilin province of China (Grant No.: 201105015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KK, 2008, MECHATRONICS, V18, P141, DOI 10.1016/j.mechatronics.2007.10.008; Al Janaideh M, 2013, PHYSICA B, V430, P95, DOI 10.1016/j.physb.2013.07.002; Brown PJ, 2007, J MAGN MAGN MATER, V310, P2755, DOI 10.1016/j.jmmm.2006.10.1037; Ding YL, 2011, APPL MECH MATER, V44-47, P3100, DOI 10.4028/www.scientific.net/AMM.44-47.3100; Dunand DC, 2011, ADV MATER, V23, P216, DOI 10.1002/adma.201002753; Gauthier JY, 2008, SENSOR ACTUAT A-PHYS, V141, P536, DOI 10.1016/j.sna.2007.10.012; Ge P, 1996, IEEE T CONTR SYST T, V4, P209, DOI 10.1109/87.491195; [葛锁良 Ge Suoliang], 2011, [合肥工业大学学报. 自然科学版, Journal of Hefei University of Technology. Natural Science], V34, P1489; Gu GY, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3470117; Han Aiguo, 2005, Journal of Huazhong University of Science and Technology, V33, P4; Karaca HE, 2009, ADV FUNCT MATER, V19, P983, DOI 10.1002/adfm.200801322; Krenke T, 2010, J APPL PHYS, V108, DOI 10.1063/1.3466770; Lechevin N, 2005, P AMER CONTR CONF, P3019, DOI 10.1109/ACC.2005.1470434; Liu L, 2012, IEEE T IND INFORM; Luo H. Y., 2010, SHAPE MEMORY ALLOYS, P61; Nascimento MMSF, 2009, MATER DESIGN, V30, P551, DOI 10.1016/j.matdes.2008.05.062; Nespoli A, 2010, SENSOR ACTUAT A-PHYS, V158, P149, DOI 10.1016/j.sna.2009.12.020; Nguyen BK, 2009, IEEE T CONTR SYST T, V17, P434, DOI 10.1109/TCST.2008.924580; Pereira C, 2000, CONTROL ENG PRACT, V8, P3, DOI 10.1016/S0967-0661(99)00130-6; [曲东升 Qu Dongsheng], 2002, [压电与声光, Plezoelectrics and Acoustooptics], V24, P354; Riccardi L, 2012, MECHATRONICS, V22, P568, DOI 10.1016/j.mechatronics.2011.12.004; Rosenbaum S, 2010, IEEE T MAGN, V46, P3984, DOI 10.1109/TMAG.2010.2071391; Ru CH, 2009, CONTROL ENG PRACT, V17, P1107, DOI 10.1016/j.conengprac.2009.04.013; TAO G, 1995, IEEE T AUTOMAT CONTR, V40, P200, DOI 10.1109/9.341778; Tellinen J, 2002, P 8 INT C ACT BREM G, P566; Ullakko K, 1996, J MATER ENG PERFORM, V5, P405, DOI 10.1007/BF02649344; Visone C, 2010, IEEE T MAGN, V46, P1848, DOI 10.1109/TMAG.2010.2042040; Wang FX, 2005, 2005 IEEE INTERNATIONAL CONFERENCE ON MECHATRONICS, P579; Wang YF, 2006, THESIS CONCORDIA U M; Xiao Mei Sui, 2010, 2010 IEEE Fifth International Conference on Bio-Inspired Computing: Theories and Applications (BIC-TA), P661, DOI 10.1109/BICTA.2010.5645203; [杨林 YANG Lin], 2006, [计算机仿真, Computer Simulation], V23, P270; Zhou ML, 2013, J CENT SOUTH UNIV, V20, P1214, DOI 10.1007/s11771-013-1604-x; Zhou Miaolei, 2013, ScientificWorldJournal, V2013, P865176, DOI 10.1155/2013/865176; Zi Ye, 2012, Proceedings 2012 Japan-Egypt Conference on Electronics, Communications and Computers (JEC-ECC), P97, DOI 10.1109/JEC-ECC.2012.6186964	34	15	18	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97086	10.1371/journal.pone.0097086	http://dx.doi.org/10.1371/journal.pone.0097086			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828010	Green Published, Green Submitted, gold			2022-12-27	WOS:000336857400054
J	Choi, SH; Hong, SB; Hong, HL; Kim, SH; Huh, JW; Sung, H; Lee, SO; Kim, MN; Jeong, JY; Lim, CM; Kim, YS; Woo, JH; Koh, Y				Choi, Sang-Ho; Hong, Sang-Bum; Hong, Hyo-Lim; Kim, Sung-Han; Huh, Jin Won; Sung, Heungsup; Lee, Sang-Oh; Kim, Mi-Na; Jeong, Jin-Yong; Lim, Chae-Man; Kim, Yang Soo; Woo, Jun Hee; Koh, Younsuck			Usefulness of Cellular Analysis of Bronchoalveolar Lavage Fluid for Predicting the Etiology of Pneumonia in Critically III Patients	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; MYELOID CELLS-1; DIAGNOSTIC IMPLICATIONS; PROCALCITONIN; INFECTIONS; UTILITY; DISEASES	Background: The usefulness of bronchoalveolar lavage (BAL) fluid cellular analysis in pneumonia has not been adequately evaluated. This study investigated the ability of cellular analysis of BAL fluid to differentially diagnose bacterial pneumonia from viral pneumonia in adult patients who are admitted to intensive care unit. Methods: BAL fluid cellular analysis was evaluated in 47 adult patients who underwent bronchoscopic BAL following less than 24 hours of antimicrobial agent exposure. The abilities of BAL fluid total white blood cell (WBC) counts and differential cell counts to differentiate between bacterial and viral pneumonia were evaluated using receiver operating characteristic (ROC) curve analysis. Results: Bacterial pneumonia (n = 24) and viral pneumonia (n = 23) were frequently associated with neutrophilic pleocytosis in BAL fluid. BAL fluid median total WBC count (2,815/mu L vs. 300/mu L, P<0.001) and percentage of neutrophils (80.5% vs. 54.0%, P = 0.02) were significantly higher in the bacterial pneumonia group than in the viral pneumonia group. In ROC curve analysis, BAL fluid total WBC count showed the best discrimination, with an area under the curve of 0.855 (95% CI, 0.750-0.960). BAL fluid total WBC count >= 510/mu L had a sensitivity of 83.3%, specificity of 78.3%, positive likelihood ratio ( PLR) of 3.83, and negative likelihood ratio (NLR) of 0.21. When analyzed in combination with serum procalcitonin or C-reactive protein, sensitivity was 95.8%, specificity was 95.7%, PLR was 8.63, and NLR was 0.07. BAL fluid total WBC count >= 510/mu L was an independent predictor of bacterial pneumonia with an adjusted odds ratio of 13.5 in multiple logistic regression analysis. Conclusions: Cellular analysis of BAL fluid can aid early differential diagnosis of bacterial pneumonia from viral pneumonia in critically ill patients.	[Choi, Sang-Ho; Hong, Hyo-Lim; Kim, Sung-Han; Lee, Sang-Oh; Jeong, Jin-Yong; Kim, Yang Soo; Woo, Jun Hee] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Infect Dis, Seoul, South Korea; [Hong, Sang-Bum; Huh, Jin Won; Lim, Chae-Man; Koh, Younsuck] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pulm & Crit Care Med, Seoul, South Korea; [Sung, Heungsup; Kim, Mi-Na] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Lab Med, Seoul, South Korea; [Jeong, Jin-Yong] Univ Ulsan, Coll Med, Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Koh, Y (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pulm & Crit Care Med, Seoul, South Korea.	yskoh@amc.seoul.kr	Lee, Sang-Oh/AGV-5413-2022	Lee, Sang-Oh/0000-0003-1381-8787; Choi, Sang-Ho/0000-0002-4972-4531; Hong, Hyo-Lim/0000-0003-2147-1381	Asan Institute of Life sciences [2014-389]	Asan Institute of Life sciences	This work was supported by Asan Institute of Life sciences grant 2014-389. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand NJ, 2009, CHEST, V135, P641, DOI 10.1378/chest.08-1829; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; CANTRAL DE, 1993, AM J MED, V95, P601, DOI 10.1016/0002-9343(93)90356-T; Carratala J, 2007, ARCH INTERN MED, V167, P1393, DOI 10.1001/archinte.167.13.1393; Choi SH, 2012, AM J RESP CRIT CARE, V186, P325, DOI 10.1164/rccm.201112-2240OC; Christ-Crain M, 2004, LANCET, V363, P600, DOI 10.1016/S0140-6736(04)15591-8; Christ-Crain M, 2005, SWISS MED WKLY, V135, P451; El Solh AA, 2008, INTENS CARE MED, V34, P1012, DOI 10.1007/s00134-008-1087-7; Gibot S, 2004, NEW ENGL J MED, V350, P451, DOI 10.1056/NEJMoa031544; Gibot S, 2007, SCAND J INFECT DIS, V39, P604, DOI 10.1080/00365540701199832; Horonenko G, 2007, CHEST, V132, P58, DOI 10.1378/chest.06-2731; Houck PM, 2004, ARCH INTERN MED, V164, P637, DOI 10.1001/archinte.164.6.637; Huh JW, 2008, CRIT CARE, V12, DOI 10.1186/cc6770; Khilnani G C, 2010, Indian J Chest Dis Allied Sci, V52, P5; Kollef MH, 1999, CHEST, V115, P462, DOI 10.1378/chest.115.2.462; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Masia M, 2005, CHEST, V128, P2223, DOI 10.1378/chest.128.4.2223; Meyer KC, 2012, AM J RESP CRIT CARE, V185, P1004, DOI 10.1164/rccm.201202-0320ST; Nylen ES, 1996, AM J MED SCI, V312, P12, DOI 10.1016/S0002-9629(15)41740-9; Oudhuis GJ, 2009, INTENS CARE MED, V35, P1265, DOI 10.1007/s00134-009-1463-y; Palazzo SJ, 2012, RESP CARE, V57, P2052, DOI 10.4187/respcare.01703; Ramirez P, 2011, CRIT CARE, V15, DOI 10.1186/cc10015; Rano A, 2002, CHEST, V122, P253, DOI 10.1378/chest.122.1.253; Schisterman EF, 2005, EPIDEMIOLOGY, V16, P73, DOI 10.1097/01.ede.0000147512.81966.ba; STERNBERG RI, 1993, AM J MED, V95, P358, DOI 10.1016/0002-9343(93)90303-7; Stolz D, 2007, CHEST, V132, P504, DOI 10.1378/chest.07-0175; THORPE JE, 1987, J INFECT DIS, V155, P855, DOI 10.1093/infdis/155.5.855; Velez L, 2007, RESP MED, V101, P2160, DOI 10.1016/j.rmed.2007.05.017; Wells AU, 2008, THORAX, V63, DOI 10.1136/thx.2008.101691; WINTERBAUER RH, 1993, CHEST, V104, P352, DOI 10.1378/chest.104.2.352	30	19	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97346	10.1371/journal.pone.0097346	http://dx.doi.org/10.1371/journal.pone.0097346			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824328	Green Submitted, Green Published, gold			2022-12-27	WOS:000336369200099
J	Correa, A; Pacheco, S; Mechaly, AE; Obal, G; Behar, G; Mouratou, B; Oppezzo, P; Alzari, PM; Pecorari, F				Correa, Agustin; Pacheco, Sabino; Mechaly, Ariel E.; Obal, Gonzalo; Behar, Ghislaine; Mouratou, Barbara; Oppezzo, Pablo; Alzari, Pedro M.; Pecorari, Frederic			Potent and Specific Inhibition of Glycosidases by Small Artificial Binding Proteins (Affitins)	PLOS ONE			English	Article							CLOSTRIDIUM-THERMOCELLUM; CRYSTAL-STRUCTURE; DOMAIN; DRUG; COMPLEXES; SCAFFOLD; ENZYMES	Glycosidases are associated with various human diseases. The development of efficient and specific inhibitors may provide powerful tools to modulate their activity. However, achieving high selectivity is a major challenge given that glycosidases with different functions can have similar enzymatic mechanisms and active-site architectures. As an alternative approach to small-chemical compounds, proteinaceous inhibitors might provide a better specificity by involving a larger surface area of interaction. We report here the design and characterization of proteinaceous inhibitors that specifically target endoglycosidases representative of the two major mechanistic classes; retaining and inverting glycosidases. These inhibitors consist of artificial affinity proteins, Affitins, selected against the thermophilic CelD from Clostridium thermocellum and lysozyme from hen egg. They were obtained from libraries of Sac7d variants, which involve either the randomization of a surface or the randomization of a surface and an artificially-extended loop. Glycosidase binders exhibited affinities in the nanomolar range with no cross-recognition, with efficient inhibition of lysozyme (K-i = 45 nM) and CelD ( Ki = 95 and 111 nM), high expression yields in Escherichia coli, solubility, and thermal stabilities up to 81.1 degrees C. The crystal structures of glycosidase-Affitin complexes validate our library designs. We observed that Affitins prevented substrate access by two modes of binding; covering or penetrating the catalytic site via the extended loop. In addition, Affitins formed salt-bridges with residues essential for enzymatic activity. These results lead us to propose the use of Affitins as versatile selective glycosidase inhibitors and, potentially, as enzymatic inhibitors in general.	[Correa, Agustin; Oppezzo, Pablo] Inst Pasteur, Recombinant Prot Unit, Montevideo, Uruguay; [Correa, Agustin; Pacheco, Sabino; Mechaly, Ariel E.; Alzari, Pedro M.] Inst Pasteur, Unite Microbiol Struct, CNRS UMR 3528, Paris, France; [Pacheco, Sabino; Behar, Ghislaine; Mouratou, Barbara; Pecorari, Frederic] CNRS, UMR 6299, Nantes, France; [Pacheco, Sabino; Behar, Ghislaine; Mouratou, Barbara; Pecorari, Frederic] Univ Nantes, Nantes, France; [Obal, Gonzalo] Inst Pasteur, Prot Biophys Unit, Montevideo, Uruguay	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Nantes Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo	Pecorari, F (corresponding author), CRCNA, INSERM, UMR 892, Nantes, France.	frederic.pecorari@univ-nantes.fr	Pacheco, Sabino/AFJ-9017-2022; behar, ghislaine/L-4791-2015; Pecorari, Frederic/L-2942-2015	Mechaly, Ariel/0000-0002-5305-7495; Pacheco, Sabino/0000-0002-0208-0046; Alzari, Pedro/0000-0002-4233-1903; Pecorari, Frederic/0000-0002-7854-0643; Correa, Agustin/0000-0003-3849-2744; Oppezzo, Pablo/0000-0003-4194-246X	Institut Pasteur (Paris, France); Agencia Nacional de Investigacion e Innovacion, Uruguay	Institut Pasteur (Paris, France); Agencia Nacional de Investigacion e Innovacion, Uruguay	S.P. was supported by a post-doctoral fellowship of the Institut Pasteur (Paris, France). A.C. was supported by a doctoral program of the Agencia Nacional de Investigacion e Innovacion, Uruguay. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. A	Attucci S, 2006, J PHARMACOL EXP THER, V318, P803, DOI 10.1124/jpet.106.103440; Beehar G, 2013, PROTEIN ENG DES SEL, V26, P267, DOI 10.1093/protein/gzs106; Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; BISCHOFF H, 1995, CLIN INVEST MED, V18, P303; Blanc E., 2011, BUSTER VERSION 2 11; Buddelmeijer N, 2009, J BACTERIOL, V191, P161, DOI 10.1128/JB.01138-08; Campochiaro PA, 2012, AM J OPHTHALMOL; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carlson HA, 2008, J MED CHEM, V51, P6432, DOI 10.1021/jm8006504; CHAUVAUX S, 1992, J BIOL CHEM, V267, P4472; Cheng AC, 2007, NAT BIOTECHNOL, V25, P71, DOI 10.1038/nbt1273; Correa AC, 2014, FRONTIERS MICROBIOLO, V5, P1; Davies GJ, 2005, CURR OPIN STRUC BIOL, V15, P637, DOI 10.1016/j.sbi.2005.10.008; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Desmyter A, 1996, NAT STRUCT BIOL, V3, P803, DOI 10.1038/nsb0996-803; Dimitrov Dimiter S., 2009, V525, P1, DOI 10.1007/978-1-59745-554-1_1; Dimitrova D., 2009, METHOD MOL BIOL, V525, pxiii; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Gebauer M, 2009, CURR OPIN CHEM BIOL, V13, P245, DOI 10.1016/j.cbpa.2009.04.627; Gilbreth RN, 2011, P NATL ACAD SCI USA, V108, P7751, DOI 10.1073/pnas.1102294108; Gloster TM, 2012, NAT CHEM BIOL, V8, P683, DOI [10.1038/nchembio.1029, 10.1038/NCHEMBIO.1029]; Hruska KS, 2008, HUM MUTAT, V29, P567, DOI 10.1002/humu.20676; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; JUY M, 1992, NATURE, V357, P89, DOI 10.1038/357089a0; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Koide A, 2012, J MOL BIOL, V415, P393, DOI 10.1016/j.jmb.2011.12.019; Krehenbrink M, 2008, J MOL BIOL, V383, P1058, DOI 10.1016/j.jmb.2008.09.016; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leeson PD, 2007, NAT REV DRUG DISCOV, V6, P881, DOI 10.1038/nrd2445; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Miranda FF, 2011, BIOSENS BIOELECTRON, V26, P4184, DOI 10.1016/j.bios.2011.04.030; Moorthy NSHN, 2012, MINI-REV MED CHEM, V12, P713; Mouratou B, 2007, P NATL ACAD SCI USA, V104, P17983, DOI 10.1073/pnas.0702963104; Mouratou B, 2012, METHODS MOL BIOL, V805, P315, DOI 10.1007/978-1-61779-379-0_18; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pecorari F, 2008, Patent Publication, Patent No. [EP2099817 (A2), 2099817]; Pecorari F, 2008, Patent Publication, Patent No. [WO2008068637 (A3), 2008068637]; Peng JJ, 2011, CURR MICROBIOL, V63, P523, DOI 10.1007/s00284-011-0012-4; SPEARMAN MA, 1991, CANCER LETT, V60, P185, DOI 10.1016/0304-3835(91)90112-U; Stanfield RL, 2004, SCIENCE, V305, P1770, DOI 10.1126/science.1101148; Steemson JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086050; Stoop AA, 2003, NAT BIOTECHNOL, V21, P1063, DOI 10.1038/nbt860; Tolcher AW, 2011, CLIN CANCER RES, V17, P363, DOI 10.1158/1078-0432.CCR-10-1411; Transue TR, 1998, PROTEINS, V32, P515, DOI 10.1002/(SICI)1097-0134(19980901)32:4<515::AID-PROT9>3.0.CO;2-E; Vasella A, 2002, CURR OPIN CHEM BIOL, V6, P619, DOI 10.1016/S1367-5931(02)00380-0; Williams A, 2003, TRANSFUS APHER SCI, V29, P255, DOI 10.1016/S1473-0502(03)00170-8; Wojcik J, 2010, NAT STRUCT MOL BIOL, V17, P519, DOI 10.1038/nsmb.1793; Wurch T, 2012, TRENDS BIOTECHNOL, V30, P575, DOI 10.1016/j.tibtech.2012.07.006; Yusuf S, 1999, LANCET, V353, P429; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336	55	30	31	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97438	10.1371/journal.pone.0097438	http://dx.doi.org/10.1371/journal.pone.0097438			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24823716	Green Submitted, gold, Green Published			2022-12-27	WOS:000336369200116
J	Gorgolewski, KJ; Lurie, D; Urchs, S; Kipping, JA; Craddock, RC; Milham, MP; Margulies, DS; Smallwood, J				Gorgolewski, Krzysztof J.; Lurie, Dan; Urchs, Sebastian; Kipping, Judy A.; Craddock, R. Cameron; Milham, Michael P.; Margulies, Daniel S.; Smallwood, Jonathan			A Correspondence between Individual Differences in the Brain's Intrinsic Functional Architecture and the Content and Form of Self-Generated Thoughts	PLOS ONE			English	Article							LOW-FREQUENCY FLUCTUATION; SURFACE-BASED ANALYSIS; METAANALYTIC EVIDENCE; PREFRONTAL CORTEX; EXECUTIVE-CONTROL; DEFAULT NETWORK; CEREBRAL-CORTEX; WORKING-MEMORY; MIND; CONNECTIVITY	Although neural activity often reflects the processing of external inputs, intrinsic fluctuations in activity have been observed throughout the brain. These may relate to patterns of self-generated thought that can occur while not performing goal-driven tasks. To understand the relationship between self-generated mental activity and intrinsic neural fluctuations, we developed the New York Cognition Questionnaire (NYC-Q) to assess the content and form of an individual's experiences during the acquisition of resting-state fMRI data. The data were collected as a part of the Nathan Kline Rockland Enhanced sample. We decomposed NYC-Q scores using exploratory factor analysis and found that self-reported thoughts clustered into distinct dimensions of content (future related, past related, positive, negative, and social) and form (words, images, and specificity). We used these components to perform an individual difference analysis exploring how differences in the types of self-generated thoughts relate to whole brain measures of intrinsic brain activity (fractional amplitude of low frequency fluctuations, regional homogeneity, and degree centrality). We found patterns of self-generated thoughts related to changes that were distributed across a wide range of cortical areas. For example, individuals who reported greater imagery exhibited greater low frequency fluctuations in a region of perigenual cingulate cortex, a region that is known to participate in the so-called default-mode network. We also found certain forms of thought were associated with other areas, such as primary visual cortex, the insula, and the cerebellum. For example, individuals who reported greater future thought exhibited less homogeneous neural fluctuations in a region of lateral occipital cortex, a result that is consistent with the claim that particular types of self-generated thought depend on processes that are decoupled from sensory processes. These data provide evidence that self-generated thought is a heterogeneous category of experience and that studying its content can be helpful in understanding brain dynamics.	[Gorgolewski, Krzysztof J.; Urchs, Sebastian; Margulies, Daniel S.] Max Planck Inst Human Cognit & Brain Sci, Max Planck Res Grp Neuroanat & Connect, Leipzig, Germany; [Kipping, Judy A.] Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany; [Lurie, Dan; Craddock, R. Cameron; Milham, Michael P.] Child Mind Inst, New York, NY USA; [Craddock, R. Cameron; Milham, Michael P.] Nathan S Kline Inst Psychiat Res, Orangeburg, NY USA; [Smallwood, Jonathan] Univ York, Dept Psychol, Hesslington, Yorks, England	Max Planck Society; Max Planck Society; Nathan Kline Institute for Psychiatric Research; University of York - UK	Gorgolewski, KJ (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Max Planck Res Grp Neuroanat & Connect, Leipzig, Germany.	krzysztof.gorgolewski@gmail.com	Milham, Michael P/K-9501-2014; Smallwood, Jonathan/ABE-8365-2020; Gorgolewski, Krzysztof Jacek/A-7883-2010; Craddock, Cameron/P-1980-2014; Milham, Michael P./Y-3160-2019; Margulies, Daniel/L-4719-2016	Gorgolewski, Krzysztof Jacek/0000-0003-3321-7583; Craddock, Cameron/0000-0002-4950-1303; Urchs, Sebastian/0000-0001-5504-8579; Lurie, Daniel/0000-0001-8012-6399; Smallwood, Jonathan/0000-0002-7298-2459; Margulies, Daniel/0000-0002-8880-9204				Allen M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00743; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Andrews-Hanna JR, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00900; Andrews-Hanna JR, 2010, J NEUROPHYSIOL, V104, P322, DOI 10.1152/jn.00830.2009; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Baird B, J COGN NEUROSCI; Baird B, 2011, CONSCIOUS COGN, V20, P1604, DOI 10.1016/j.concog.2011.08.007; Barron E, 2011, PSYCHOL SCI, V22, P596, DOI 10.1177/0956797611404083; Baumann O, 2012, NEUROIMAGE, V61, P805, DOI 10.1016/j.neuroimage.2012.03.044; Beckmann C., 2009, NEUROIMAGE, V47, pS148, DOI [10.1016/S1053-8119(09)71511-3, DOI 10.1016/S1053-8119(09)71511-3, 10.1016/s1053-8119(09)71511-3]; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Burgess N, 2008, ANN NY ACAD SCI, V1124, P77, DOI 10.1196/annals.1440.002; Cauda F, 2012, NEUROIMAGE, V62, P343, DOI 10.1016/j.neuroimage.2012.04.012; Chen AC, 2013, P NATL ACAD SCI US; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Cole MW, 2013, NAT NEUROSCI, V16, P1348, DOI 10.1038/nn.3470; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Coull JT, 1996, NEUROPSYCHOLOGIA, V34, P1085, DOI 10.1016/0028-3932(96)00029-2; Cox RW, 1999, MAGNET RESON MED, V42, P1014, DOI 10.1002/(SICI)1522-2594(199912)42:6<1014::AID-MRM4>3.0.CO;2-F; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Critchley HD, 2000, J PHYSIOL-LONDON, V523, P259, DOI 10.1111/j.1469-7793.2000.t01-1-00259.x; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Delamillieure P, 2010, BRAIN RES BULL, V81, P565, DOI 10.1016/j.brainresbull.2009.11.014; Diaz JL, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00739; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Franklin MS, 2013, PSYCHON B REV; Friston K J, 1994, Hum Brain Mapp, V1, P210, DOI 10.1002/hbm.460010306; Gilden D, 1995, AIDS RES HUM RETRO S, V267, P4; Gorgolewski Krzysztof, 2011, Front Neuroinform, V5, P13, DOI 10.3389/fninf.2011.00013; Greicius MD, 2004, J COGNITIVE NEUROSCI, V16, P1484, DOI 10.1162/0898929042568532; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Harrison BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001794; Heavey CL, 2008, CONSCIOUS COGN, V17, P798, DOI 10.1016/j.concog.2007.12.006; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Huijbers W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017463; Huijbers W, 2009, PLOS BIOL, V7, P63, DOI 10.1371/journal.pbio.1000011; Kalisch R, 2014, NEUROSCI BIOBEHAV R, V42, P1, DOI 10.1016/j.neubiorev.2014.02.002; Kam JWY, 2011, J COGNITIVE NEUROSCI, V23, P460, DOI 10.1162/jocn.2010.21443; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kober H, 2008, NEUROIMAGE, V42, P998, DOI 10.1016/j.neuroimage.2008.03.059; Kosslyn S, 1988, AIDS RES HUM RETRO S; Kuhn S., 2013, HUM BRAIN MAPP; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Levinson DB, 2012, PSYCHOL SCI, V23, P375, DOI 10.1177/0956797611431465; Lindquist KA, 2012, BEHAV BRAIN SCI, V35, P121, DOI 10.1017/S0140525X11000446; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Matthews G., 1999, PERSONALITY PSYCHOL, V7, P335, DOI DOI 10.1177/154193120404801107; McVay JC, 2009, J EXP PSYCHOL LEARN, V35, P196, DOI 10.1037/a0014104; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Morin A, 2011, PROCD SOC BEHV, V30, DOI 10.1016/j.sbspro.2011.10.331; Niendam TA, 2012, COGN AFFECT BEHAV NE, V12, P241, DOI 10.3758/s13415-011-0083-5; Nooner KB, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00152; Poerio GL, 2013, CONSCIOUS COGN, V22, P1412, DOI 10.1016/j.concog.2013.09.012; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Preminger S, 2011, NEUROIMAGE, V54, P1692, DOI 10.1016/j.neuroimage.2010.08.036; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reuter M, 2010, NEUROIMAGE, V53, P1181, DOI 10.1016/j.neuroimage.2010.07.020; Revelle W., 2013, PSYCH PROCEDURES PSY; Ruby FJM, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00962; Ruby FJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077554; Rummel J, 2014, PSYCHON B REV; Schooler JW, 2011, TRENDS COGN SCI, V15, P319, DOI 10.1016/j.tics.2011.05.006; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Smallwood J, 2004, CONSCIOUS COGN, V13, P657, DOI 10.1016/j.concog.2004.06.003; Smallwood J, 2003, CONSCIOUS COGN, V12, P169, DOI 10.1016/S1053-8100(02)00003-X; Smallwood J, 2008, J COGNITIVE NEUROSCI, V20, P458, DOI 10.1162/jocn.2008.20037; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Smallwood J, 2013, PSYCHOL BULL, V139, P519, DOI 10.1037/a0030010; Smallwood J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033706; Smallwood J, 2011, COGNITION EMOTION, V25, P1481, DOI 10.1080/02699931.2010.545263; Smallwood J, 2011, CONSCIOUS COGN, V20, P1120, DOI 10.1016/j.concog.2010.12.017; Smallwood J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018298; Smallwood J, 2009, CONSCIOUS COGN, V18, P118, DOI 10.1016/j.concog.2008.11.004; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Song XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044423; Stawarczyk D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00425; Stawarczyk D, 2013, CONSCIOUS COGN, V22, P442, DOI 10.1016/j.concog.2013.01.012; Stawarczyk D, 2011, ACTA PSYCHOL, V136, P370, DOI 10.1016/j.actpsy.2011.01.002; Stawarczyk D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016997; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; TEASDALE JD, 1995, MEM COGNITION, V23, P551, DOI 10.3758/BF03197257; ten Berge JMF, 1999, LINEAR ALGEBRA APPL, V289, P311, DOI 10.1016/S0024-3795(97)10007-6; Wager TD, 2009, NEUROIMAGE, V47, P821, DOI 10.1016/j.neuroimage.2009.05.043; Xu J, 2014, NEUROSCIENCE, V263, P181, DOI 10.1016/j.neuroscience.2014.01.020; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Yang H, 2007, NEUROIMAGE, V36, P144, DOI 10.1016/j.neuroimage.2007.01.054; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012	103	104	105	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97176	10.1371/journal.pone.0097176	http://dx.doi.org/10.1371/journal.pone.0097176			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AH8EY	24824880	Green Published, gold, Green Accepted			2022-12-27	WOS:000336369200068
J	Kloosterman, A; Hierck, B; Westerweel, J; Poelma, C				Kloosterman, Astrid; Hierck, Beerend; Westerweel, Jerry; Poelma, Christian			Quantification of Blood Flow and Topology in Developing Vascular Networks	PLOS ONE			English	Article							PARTICLE IMAGE VELOCIMETRY; IN-VIVO; SHEAR-STRESS; MICROVASCULAR NETWORKS; CHICKEN EMBRYOS; YOLK-SAC; BIFURCATIONS; SYSTEM; HEART; MICROVESSELS	Since fluid dynamics plays a critical role in vascular remodeling, quantification of the hemodynamics is crucial to gain more insight into this complex process. Better understanding of vascular development can improve prediction of the process, and may eventually even be used to influence the vascular structure. In this study, a methodology to quantify hemodynamics and network structure of developing vascular networks is described. The hemodynamic parameters and topology are derived from detailed local blood flow velocities, obtained by in vivo micro-PIV measurements. The use of such detailed flow measurements is shown to be essential, as blood vessels with a similar diameter can have a large variation in flow rate. Measurements are performed in the yolk sacs of seven chicken embryos at two developmental stages between HH 13+ and 17+. A large range of flow velocities (1 mu m/s to 1 mm/s) is measured in blood vessels with diameters in the range of 25-500 mu m. The quality of the data sets is investigated by verifying the flow balances in the branching points. This shows that the quality of the data sets of the seven embryos is comparable for all stages observed, and the data is suitable for further analysis with known accuracy. When comparing two subsequently characterized networks of the same embryo, vascular remodeling is observed in all seven networks. However, the character of remodeling in the seven embryos differs and can be non-intuitive, which confirms the necessity of quantification. To illustrate the potential of the data, we present a preliminary quantitative study of key network topology parameters and we compare these with theoretical design rules.	[Kloosterman, Astrid; Westerweel, Jerry; Poelma, Christian] Delft Univ Technol, Lab Aero & Hydrodynam, Delft, Netherlands; [Hierck, Beerend] Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, Netherlands	Delft University of Technology; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Poelma, C (corresponding author), Delft Univ Technol, Lab Aero & Hydrodynam, Delft, Netherlands.	c.poelma@tudelft.nl	Hierck, Beerend P/A-6488-2013; Westerweel, Jerry/G-9087-2011; Poelma, Christian/A-1913-2014	Hierck, Beerend P/0000-0002-7170-1686; Westerweel, Jerry/0000-0002-2799-5242; Poelma, Christian/0000-0001-8676-9221	Medical Delta initiative	Medical Delta initiative	This work is financially supported by the Medical Delta initiative (www.medicaldelta.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian RJ., 2010, PARTICLE IMAGE VELOC; Al-Kilani A, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.051912; Al-Roubaie S, 2011, AM J PHYSIOL-HEART C, V301, pH2473, DOI 10.1152/ajpheart.00475.2011; AUERBACH R, 1974, DEV BIOL, V41, P391, DOI 10.1016/0012-1606(74)90316-9; Chapman WB, 1918, AM J ANAT, V23, P175, DOI 10.1002/aja.1000230107; Cokelet GR, 1998, MICROCIRCULATION-LON, V5, P61, DOI 10.1080/713773812; Fontanella AN, 2013, MICROCIRCULATION, V20, P724, DOI 10.1111/micc.12072; Fry BC, 2012, MICROCIRCULATION, V19, P530, DOI 10.1111/j.1549-8719.2012.00184.x; Hacking WJG, 1996, AM J PHYSIOL-HEART C, V270, pH364, DOI 10.1152/ajpheart.1996.270.1.H364; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Jain A.K., 1989, FUNDAMENTALS DIGITAL, V3; Jones EAV, 2004, AM J PHYSIOL-HEART C, V287, pH1561, DOI 10.1152/ajpheart.00081.2004; KASSAB GS, 1995, ANN BIOMED ENG, V23, P13, DOI 10.1007/BF02368296; Kloosterman A, 2011, EXP FLUIDS, V50, P1587, DOI 10.1007/s00348-010-1015-9; Kloosterman A., THESIS DELFT U TECHN; Korn J, 2007, J VIS EXP, P306; Lam L, 1992, IEEE T PATTERN ANAL, V14, P879; le Noble F, 2004, DEVELOPMENT, V131, P361, DOI 10.1242/dev.00929; Lee JY, 2010, MICROVASC RES, V80, P402, DOI 10.1016/j.mvr.2010.08.003; Lee JY, 2010, MICROFLUID NANOFLUID, V8, P85, DOI 10.1007/s10404-009-0454-1; Lucitti JL, 2007, DEVELOPMENT, V134, P3317, DOI 10.1242/dev.02883; Meinhart CD, 2000, J FLUID ENG-T ASME, V122, P285, DOI 10.1115/1.483256; Murray CD, 1926, P NATL ACAD SCI USA, V12, P207, DOI 10.1073/pnas.12.3.207; Murray CD, 1926, J GEN PHYSIOL, V9, P835, DOI 10.1085/jgp.9.6.835; Nguyen TH, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.061907; Olsen MG, 2000, EXP FLUIDS, V29, pS166, DOI 10.1007/s003480070018; Osmon, 2005, ATLAS CHICK DEV; Poelma C, 2008, EXP FLUIDS, V45, P703, DOI 10.1007/s00348-008-0476-6; Poelma C, 2010, J R SOC INTERFACE, V7, P91, DOI 10.1098/rsif.2009.0063; Poelma C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045247; Pries A, 2010, MICROCIRCULATION PHI, V15, P753; PRIES AR, 1990, CIRC RES, V67, P826, DOI 10.1161/01.RES.67.4.826; PRIES AR, 1994, CIRC RES, V75, P904, DOI 10.1161/01.RES.75.5.904; SHERMAN TF, 1981, J GEN PHYSIOL, V78, P431, DOI 10.1085/jgp.78.4.431; Soille P., 2004, MORPHOLOGICAL IMAGE, DOI [10.1007/978-3-662-05088-0, DOI 10.1007/978-3-662-05088-0]; Sugii Y, 2002, PHYSIOL MEAS, V23, P403, DOI 10.1088/0967-3334/23/2/315; Taber LA, 2001, J BIOMECH, V34, P121, DOI 10.1016/S0021-9290(00)00173-1; Vennemann P, 2006, J BIOMECH, V39, P1191, DOI 10.1016/j.jbiomech.2005.03.015; Willert C, 2010, MEAS SCI TECHNOL, V21, DOI 10.1088/0957-0233/21/7/075402; ZAMIR M, 1983, J GEN PHYSIOL, V81, P325, DOI 10.1085/jgp.81.3.325; ZAMIR M, 1978, J GEN PHYSIOL, V72, P837, DOI 10.1085/jgp.72.6.837	41	11	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96856	10.1371/journal.pone.0096856	http://dx.doi.org/10.1371/journal.pone.0096856			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24823933	Green Submitted, gold, Green Published			2022-12-27	WOS:000336369200039
J	Lewbart, GA; Hirschfeld, M; Denkinger, J; Vasco, K; Guevara, N; Garcia, J; Munoz, J; Lohmann, KJ				Lewbart, Gregory A.; Hirschfeld, Maximilian; Denkinger, Judith; Vasco, Karla; Guevara, Nataly; Garcia, Juan; Munoz, Juanpablo; Lohmann, Kenneth J.			Blood Gases, Biochemistry, and Hematology of Galapagos Green Turtles (Chelonia Mydas)	PLOS ONE			English	Article							LOGGERHEAD SEA-TURTLES; BAJA-CALIFORNIA-SUR; CARETTA-CARETTA; REFERENCE INTERVALS; NORTH-CAROLINA; RESPIRATORY STATUS; HEALTH INDEXES; PACIFIC COAST; VALUES; CHEMISTRY	The green turtle, Chelonia mydas, is an endangered marine chelonian with a circum-global distribution. Reference blood parameter intervals have been published for some chelonian species, but baseline hematology, biochemical, and blood gas values are lacking from the Galapagos sea turtles. Analyses were done on blood samples drawn from 28 green turtles captured in two foraging locations on San Cristobal Island (14 from each site). Of these turtles, 20 were immature and of unknown sex; the other eight were males ( five mature, three immature). A portable blood analyzer (iSTAT) was used to obtain near immediate field results for pH, lactate, pO(2), pCO(2), HCO3-, Hct, Hb, Na, K, iCa, and Glu. Parameter values affected by temperature were corrected in two ways: (1) with standard formulas; and (2) with auto-corrections made by the iSTAT. The two methods yielded clinically equivalent results. Standard laboratory hematology techniques were employed for the red and white blood cell counts and the hematocrit determination, which was also compared to the hematocrit values generated by the iSTAT. Of all blood analytes, only lactate concentrations were positively correlated with body size. All other values showed no significant difference between the two sample locations nor were they correlated with body size or internal temperature. For hematocrit count, the iSTAT blood analyzer yielded results indistinguishable from those obtained with high-speed centrifugation. The values reported in this study provide baseline data that may be useful in comparisons among populations and in detecting changes in health status among Galapagos sea turtles. The findings might also be helpful in future efforts to demonstrate associations between specific biochemical parameters and disease.	[Lewbart, Gregory A.] N Carolina State Univ, Coll Vet Med, Raleigh, NC 27695 USA; [Hirschfeld, Maximilian; Denkinger, Judith; Vasco, Karla; Guevara, Nataly; Munoz, Juanpablo] Univ San Francisco Quito, Galapagos Sci Ctr, Puerto Baquerizo Moreno, Galapagos, Ecuador; [Garcia, Juan] Galapagos Natl Pk Serv, Puerto Ayora, Galapagos, Ecuador; [Lohmann, Kenneth J.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA	University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill	Lewbart, GA (corresponding author), N Carolina State Univ, Coll Vet Med, Raleigh, NC 27695 USA.	greg_lewbart@ncsu.edu	Karla, Vasco/AAB-1485-2021; Muñoz-Pérez, Juan-Pablo/ACV-8476-2022; Hirschfeld, Maximilian/AAH-3650-2021; Muñoz-Pérez, Juan Pablo/AAG-4114-2022	Muñoz-Pérez, Juan-Pablo/0000-0002-9792-5653; Hirschfeld, Maximilian/0000-0002-9662-7320; Muñoz-Pérez, Juan Pablo/0000-0002-9792-5653; Lewbart, Gregory/0000-0003-0716-1387; Guevara, Nataly/0000-0002-9241-7561				AGUIRRE AA, 1995, PHYSIOL ZOOL, V68, P831, DOI 10.1086/physzool.68.5.30163934; Aguirre AA, 2000, COMP HAEMATOL INT, V10, P132, DOI 10.1007/s005800070004; AGUIRRE AA, 2004, ECOHEALTH, V1, P275, DOI DOI 10.1007/S10393-004-0097-3; Anderson Eric T., 2011, Veterinary Medicine International, V2011, P1, DOI 10.4061/2011/890829; Anderson ET, 2011, J ZOO WILDLIFE MED, V42, P247, DOI 10.1638/2010-0217.1; Anderson NL, 1997, J ZOO WILDLIFE MED, V28, P394; BERKSON H, 1966, COMP BIOCHEM PHYSIOL, V18, P101, DOI 10.1016/0010-406X(66)90335-5; BOLTEN AB, 1992, J WILDLIFE DIS, V28, P407, DOI 10.7589/0090-3558-28.3.407; Brenner D, 2002, J ZOO WILDLIFE MED, V33, P311, DOI 10.1638/1042-7260(2002)033[0311:HSOWAC]2.0.CO;2; Camacho M, 2013, JAVMA-J AM VET MED A, V242, P396, DOI 10.2460/javma.242.3.396; Campbell TW, 1995, AVIAN HEMATOLOGY CYT, P7; Casal AB, 2009, VET CLIN PATH, V38, P213, DOI 10.1111/j.1939-165X.2008.00106.x; Chittick EJ, 2002, J AM VET MED ASSOC, V221, P1019, DOI 10.2460/javma.2002.221.1019; Christopher MM, 1999, J WILDLIFE DIS, V35, P212, DOI 10.7589/0090-3558-35.2.212; Deem SL, 2009, J WILDLIFE DIS, V45, P41, DOI 10.7589/0090-3558-45.1.41; Denkinger J, 2013, OCEAN COAST MANAGE, V80, P29, DOI 10.1016/j.ocecoaman.2013.03.005; Flint M, 2013, CRC MAR BIOL SER, P379; Flint M, 2010, VET J, V185, P299, DOI 10.1016/j.tvjl.2009.06.011; Flint M, 2010, J WILDLIFE DIS, V46, P731, DOI 10.7589/0090-3558-46.3.731; Flint M, 2010, ECOHEALTH, V7, P135, DOI 10.1007/s10393-010-0300-7; FOGHANDERSEN N, 1981, CLIN CHEM, V27, P1264; Fong ChiaLing, 2010, Journal of Veterinary Medicine and Animal Health, V2, P008; Geffre A, 2009, VET CLIN PATH, V38, P288, DOI 10.1111/j.1939-165X.2009.00179.x; Gelli D, 2009, EUR J WILDLIFE RES, V55, P59, DOI 10.1007/s10344-008-0214-7; Gibbons PM, 2013, EXOTIC ANIMALS FORML, V4th, P84; GREEN D, 1993, J HERPETOL, V27, P338, DOI 10.2307/1565159; Hamann Mark, 2006, Endangered Species Research, V2, P81, DOI 10.3354/esr002081; Harms CA, 2007, VET REC, V161, P15, DOI 10.1136/vr.161.1.15; Harms C. A., 2009, Journal of Herpetological Medicine and Surgery, V19, P8; Harms CA, 2003, J WILDLIFE DIS, V39, P366, DOI 10.7589/0090-3558-39.2.366; Hasbun CR, 1998, COMP HAEMATOL INT, V8, P174, DOI 10.1007/BF02642510; Innis C, 2010, CHELONIAN CONSERV BI, V9, P205, DOI 10.2744/CCB-0838.1; Innis CJ, 2007, J COMP PHYSIOL B, V177, P623, DOI 10.1007/s00360-007-0160-9; Innis CJ, 2009, JAVMA-J AM VET MED A, V235, P426, DOI 10.2460/javma.235.4.426; Jean Claire, 2010, Indian Ocean Turtle Newsletter, V11, P8; Keller KA, 2012, JAVMA-J AM VET MED A, V240, P317, DOI 10.2460/javma.240.3.317; Koch V, 2006, BIOL CONSERV, V128, P327, DOI 10.1016/j.biocon.2005.09.038; KRAUS DR, 1980, AM J PHYSIOL, V239, pR254, DOI 10.1152/ajpregu.1980.239.3.R254; Labrada-Martagon V, 2010, CHELONIAN CONSERV BI, V9, P162, DOI 10.2744/CCB-0806.1; Labrada-Martagon V, 2010, CHELONIAN CONSERV BI, V9, P173, DOI 10.2744/CCB-0807.1; Lutcavage ME, 1997, MAR SCI SER; Mancini A, 2011, ORYX, V46, p69e77; Parra Macarena, 2011, Marine Turtle Newsletter, P10; Reisser Julia, 2008, Endangered Species Research, V5, P73, DOI 10.3354/esr00113; Samour JH, 1998, COMP HAEMATOL INT, V8, P102, DOI 10.1007/BF02642499; Santoro M, 2007, VET REC, V161, P818; Schofield G, 2008, J EXP MAR BIOL ECOL, V360, P103, DOI 10.1016/j.jembe.2008.04.005; Seminoff Jeffrey A., 2008, Endangered Species Research, V4, P57, DOI 10.3354/esr00066; Seminoff JA, 2006, MAR ECOL PROG SER, V322, P269, DOI 10.3354/meps322269; Snoddy JE, 2009, J WILDLIFE MANAGE, V73, P1394, DOI 10.2193/2008-472; STABENAU EK, 1993, J EXP BIOL, V180, P311; Stacy NI, 2013, CONSERV PHYSIOL, DOI [10.1093/conphys/cot003, DOI 10.1093/CONPHYS/C0T003]; Wabnitz Colette, 2008, University of British Columbia Fisheries Centre Research Reports, V16, P92; Wibbels T, 1999, IUCN SSC MARINE TURT; Wolf KN, 2008, JAVMA-J AM VET MED A, V233, P470, DOI 10.2460/javma.233.3.470; WOOD FE, 1984, HERPETOLOGICA, V40, P331; Wyneken J, 2013, BIOL SEA TURTLES, VIII, P379; Yilmaz N, 2010, NORTH-WEST J ZOOL, V6, P109; Zarate P, 2002, EVALUACION ACTIVIDAD; Zhang FY, 2011, ASIAN HERPETOL RES, V2, P12, DOI 10.3724/SP.J.1245.2011.00012	60	40	42	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96487	10.1371/journal.pone.0096487	http://dx.doi.org/10.1371/journal.pone.0096487			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824065	Green Published, Green Submitted, gold			2022-12-27	WOS:000336369200020
J	Talekar, SJ; Chochua, S; Nelson, K; Klugman, KP; Quave, CL; Vidal, JE				Talekar, Sharmila J.; Chochua, Sopio; Nelson, Katie; Klugman, Keith P.; Quave, Cassandra L.; Vidal, Jorge E.			220D-F2 from Rubus ulmifolius Kills Streptococcus pneumoniae Planktonic Cells and Pneumococcal Biofilms	PLOS ONE			English	Article							IN-VITRO; BACTERIAL BIOFILMS; ANTIBIOTIC SUSCEPTIBILITIES; STAPHYLOCOCCUS-AUREUS; VIRULENCE FACTORS; GENOME SEQUENCE; COLONIZATION; DISEASE; EPIDEMIOLOGY; RESISTANCE	Streptococcus pneumoniae (pneumococcus) forms organized biofilms to persist in the human nasopharynx. This persistence allows the pneumococcus to produce severe diseases such as pneumonia, otitis media, bacteremia and meningitis that kill nearly a million children every year. While bacteremia and meningitis are mediated by planktonic pneumococci, biofilm structures are present during pneumonia and otitis media. The global emergence of S. pneumoniae strains resistant to most commonly prescribed antibiotics warrants further discovery of alternative therapeutics. The present study assessed the antimicrobial potential of a plant extract, 220D-F2, rich in ellagic acid, and ellagic acid derivatives, against S. pneumoniae planktonic cells and biofilm structures. Our studies first demonstrate that, when inoculated together with planktonic cultures, 220D-F2 inhibited the formation of pneumococcal biofilms in a dose-dependent manner. As measured by bacterial counts and a LIVE/DEAD bacterial viability assay, 100 and 200 mu g/ml of 220D-F2 had significant bactericidal activity against pneumococcal planktonic cultures as early as 3 h post-inoculation. Quantitative MIC's, whether quantified by qPCR or dilution and plating, showed that 80 mu g/ml of 220D-F2 completely eradicated overnight cultures of planktonic pneumococci, including antibiotic resistant strains. When preformed pneumococcal biofilms were challenged with 220D-F2, it significantly reduced the population of biofilms 3 h post-inoculation. Minimum biofilm inhibitory concentration (MBIC)(50) was obtained incubating biofilms with 100 mu g/ml of 220D-F2 for 3 h and 6 h of incubation. 220D-F2 also significantly reduced the population of pneumococcal biofilms formed on human pharyngeal cells. Our results demonstrate potential therapeutic applications of 220D-F2 to both kill planktonic pneumococcal cells and disrupt pneumococcal biofilms.	[Talekar, Sharmila J.; Chochua, Sopio; Klugman, Keith P.; Vidal, Jorge E.] Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30332 USA; [Nelson, Katie; Quave, Cassandra L.] Emory Coll Arts & Sci, Ctr Study Human Hlth, Atlanta, GA USA; [Quave, Cassandra L.] Emory Univ, Sch Med, Dept Dermatol, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health; Emory University	Vidal, JE (corresponding author), Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30332 USA.	jvidalg@emory.edu	Quave, Cassandra/AAD-2066-2020	Quave, Cassandra/0000-0001-9615-7886				Aaron SD, 2002, J CLIN MICROBIOL, V40, P4172, DOI 10.1128/JCM.40.11.4172-4179.2002; Ash SY, 2013, MED CLIN N AM, V97, P647, DOI 10.1016/j.mcna.2013.03.005; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; Baselski V, 2013, J CLIN MICROBIOL, V51, P740, DOI 10.1128/JCM.03383-12; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Cerca N, 2005, J ANTIMICROB CHEMOTH, V56, P331, DOI 10.1093/jac/dki217; Ceri H, 1999, J CLIN MICROBIOL, V37, P1771, DOI 10.1128/JCM.37.6.1771-1776.1999; Clinical and Laboratory Standards Institute (CLSI), 2009, METHODS DILUTION ANT, V8th ed.; Costerton JW, 2011, PLAST RECONSTR SURG, V127, p36S, DOI 10.1097/PRS.0b013e3182001845; Costerton JW, 1999, INT J ANTIMICROB AG, V11, P217, DOI 10.1016/S0924-8579(99)00018-7; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Davis SC, 2008, WOUND REPAIR REGEN, V16, P23, DOI 10.1111/j.1524-475X.2007.00303.x; del Prado G, 2010, DIAGN MICR INFEC DIS, V67, P311, DOI 10.1016/j.diagmicrobio.2010.03.016; Domenech M, 2011, ANTIMICROB AGENTS CH, V55, P4144, DOI 10.1128/AAC.00492-11; Dong W, 2014, ANTIMICROB AGENTS CH, V58, P2459, DOI 10.1128/AAC.02630-13; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Donlan RM, 2001, CLIN INFECT DIS, V33, P1387, DOI 10.1086/322972; Elaissi A, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-81; Garcia-Castillo M, 2007, J ANTIMICROB CHEMOTH, V59, P301, DOI 10.1093/jac/dkl482; Hall-Stoodley L, 2006, JAMA-J AM MED ASSOC, V296, P202, DOI 10.1001/jama.296.2.202; Henriques-Normark B, 2013, COLD SPRING HARB PER, V3; Imamura Y, 2008, ANTIMICROB AGENTS CH, V52, P171, DOI 10.1128/AAC.00387-07; Jedrzejas MJ, 2001, MICROBIOL MOL BIOL R, V65, P187, DOI 10.1128/MMBR.65.2.187-207.2001; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; Levine OS, 2009, AM J EPIDEMIOL, V170, P1067, DOI 10.1093/aje/kwp316; Lynch JP, 2010, CURR OPIN PULM MED, V16, P217, DOI 10.1097/MCP.0b013e3283385653; Marcinkiewicz J, 2013, POL ARCH MED WEWN, V123, P309, DOI 10.20452/pamw.1780; Marks LR, 2012, INFECT IMMUN, V80, P2744, DOI 10.1128/IAI.00488-12; Moscoso M, 2009, INT MICROBIOL, V12, P77, DOI 10.2436/20.1501.01.84; Nieto C, 2003, PLASMID, V49, P281, DOI 10.1016/S0147-619X(03)00020-9; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Pichichero ME, 2013, PEDIATR CLIN N AM, V60, P391, DOI 10.1016/j.pcl.2012.12.007; Quave CL, 2008, J ETHNOPHARMACOL, V118, P418, DOI 10.1016/j.jep.2008.05.005; Quave CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028737; Ramage G, 2006, FEMS YEAST RES, V6, P979, DOI 10.1111/j.1567-1364.2006.00117.x; Sanchez CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028738; Sanchez CJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001044; Shak JR, 2013, MBIO, V4, DOI 10.1128/mBio.00655-13; Shakl JR, 2013, TRENDS MICROBIOL, V21, P129, DOI 10.1016/j.tim.2012.11.005; Shiu WK, 2013, INT J ANTIMICROB AGE; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; Song JH, 2013, EXPERT REV RESP MED, V7, P491, DOI 10.1586/17476348.2013.816572; Song JH, 2012, VACCINE, V30, P2728, DOI 10.1016/j.vaccine.2012.01.091; Stamm WE, 1999, INT J ANTIMICROB AG, V11, P237; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Thomas JG, 2005, BIOFILMS, INFECTION, AND ANTIMICROBIAL THERAPY, P21; Trappetti C, 2009, J INFECT DIS, V199, P1497, DOI 10.1086/598483; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; Vidal JE, 2013, INFECT IMMUN, V81, P1341, DOI 10.1128/IAI.01096-12; Vidal JE, 2011, INFECT IMMUN, V79, P4050, DOI 10.1128/IAI.05186-11; Weimer KED, 2010, J INFECT DIS, V202, P1068, DOI 10.1086/656046; Weycker D, 2010, VACCINE, V28, P4955, DOI 10.1016/j.vaccine.2010.05.030; Wolcott RD, 2010, J WOUND CARE, V19, P45, DOI 10.12968/jowc.2010.19.2.46966; Wolcott R, 2011, PLAST RECONSTR SURG, V127, p28S, DOI 10.1097/PRS.0b013e3181fca244; Wolter N, 2005, ANTIMICROB AGENTS CH, V49, P3554, DOI 10.1128/AAC.49.8.3554-3557.2005; Yadav MK, 2012, MICROB PATHOGENESIS, V53, P219, DOI 10.1016/j.micpath.2012.08.003; Yang F, 2008, INT J ANTIMICROB AG, V32, P386, DOI 10.1016/j.ijantimicag.2008.05.004; Zampini IC, 2012, J ETHNOPHARMACOL, V140, P287, DOI 10.1016/j.jep.2012.01.019	62	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97314	10.1371/journal.pone.0097314	http://dx.doi.org/10.1371/journal.pone.0097314			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24823499	gold, Green Published, Green Submitted			2022-12-27	WOS:000336369200094
J	Yang, M; Eyers, F; Xiang, Y; Guo, M; Young, IG; Rosenberg, HF; Foster, PS				Yang, Ming; Eyers, Fiona; Xiang, Yang; Guo, Man; Young, Ian G.; Rosenberg, Helene F.; Foster, Paul S.			Expression Profiling of Differentiating Eosinophils in Bone Marrow Cultures Predicts Functional Links between MicroRNAs and Their Target mRNAs	PLOS ONE			English	Article							PERIPHERAL-BLOOD EOSINOPHILS; HEMATOPOIETIC STEM-CELLS; MAST-CELLS; PROLIFERATION; INTERLEUKIN-5; IMMUNITY; MIR-196A; TRANSCRIPTION; DEFICIENCY; CHEMOKINE	Background: MicroRNAs (miRNAs) are small non-coding RNAs that regulate complex transcriptional networks underpin immune responses. However, little is known about the specific miRNA networks that control differentiation of specific leukocyte subsets. In this study, we profiled miRNA expression during differentiation of eosinophils from bone marrow (BM) progenitors (bmEos), and correlated expression with potential mRNA targets involved in crucial regulatory functions. Profiling was performed on whole BM cultures to document the dynamic changes in miRNA expression in the BM microenvironment over the differentiation period. miRNA for network analysis were identified in BM cultures enriched in differentiating eosinophils, and chosen for their potential ability to target mRNA of factors that are known to play critical roles in eosinophil differentiation pathways or cell identify. Methodology/Principal Findings: We identified 68 miRNAs with expression patterns that were up-or down-regulated 5-fold or more during bmEos differentiation. By employing TargetScan and MeSH databases, we identified 348 transcripts involved in 30 canonical pathways as potentially regulated by these miRNAs. Furthermore, by applying miRanda and Ingenuity Pathways Analysis (IPA), we identified 13 specific miRNAs that are temporally associated with the expression of IL-5R alpha and CCR3 and 14 miRNAs associated with the transcription factors GATA-1/2, PU.1 and C/EBP epsilon. We have also identified 17 miRNAs that may regulate the expression of TLRs 4 and 13 during eosinophil differentiation, although we could identify no miRNAs targeting the prominent secretory effector, eosinophil major basic protein. Conclusions/Significance: This is the first study to map changes in miRNA expression in whole BM cultures during the differentiation of eosinophils, and to predict functional links between miRNAs and their target mRNAs for the regulation of eosinophilopoiesis. Our findings provide an important resource that will promote the platform for further understanding of the role of these non-coding RNAs in the regulation of eosinophil differentiation and function.	[Yang, Ming; Eyers, Fiona; Foster, Paul S.] Univ Newcastle, Fac Hlth, Ctr Asthma & Resp Dis, Sch Biomed Sci & Pharm, Callaghan, NSW, Australia; [Yang, Ming; Eyers, Fiona; Foster, Paul S.] Hunter Med Res Inst, Callaghan, NSW, Australia; [Xiang, Yang; Guo, Man] Cent S Univ, Xiangya Sch Med, Dept Physiol, Changsha, Hunan, Peoples R China; [Young, Ian G.] Australian Natl Univ, John Curtin Sch Med Res, Dept Mol Bioscience, Canberra, ACT 2601, Australia; [Rosenberg, Helene F.] NIAID, Inflammat Immunobiol Sect, Lab Allerg Dis, NIH, Bethesda, MD 20892 USA	University of Newcastle; Hunter Medical Research Institute; University of Newcastle; Central South University; Australian National University; John Curtin School of Medical Research; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Yang, M (corresponding author), Univ Newcastle, Fac Hlth, Ctr Asthma & Resp Dis, Sch Biomed Sci & Pharm, Callaghan, NSW, Australia.	Ming.Yang@newcastle.edu.au; Paul.Foster@newcastle.edu.au	Foster, Paul/G-5057-2013	, Paul/0000-0002-0827-8299	National Health and Medical Research Council of Australia; Australian Research Council; Cooperative Research Centre for Asthma and Airways; National Institute of Allergy and Infectious Diseases Division of Intramural Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000942, ZIAAI000941] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Cooperative Research Centre for Asthma and Airways(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); National Institute of Allergy and Infectious Diseases Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors are supported by the National Health and Medical Research Council of Australia, the Australian Research Council, the Cooperative Research Centre for Asthma and Airways and National Institute of Allergy and Infectious Diseases Division of Intramural Research. The funding bodies had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bedi R, 2009, BLOOD, V113, P317, DOI 10.1182/blood-2008-02-139741; Bettigole SE, 2013, 8 BIENN S INT EOS SO; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Castro M, 2011, AM J RESP CRIT CARE, V184, P1125, DOI 10.1164/rccm.201103-0396OC; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Chowdhury JB, 2012, J VIROL, V86, P10221, DOI 10.1128/JVI.00882-12; COLLINS PD, 1995, J EXP MED, V182, P1169, DOI 10.1084/jem.182.4.1169; deHaan G, 1997, BLOOD, V89, P1543, DOI 10.1182/blood.V89.5.1543.1543_1543_1550; Du J, 2002, J BIOL CHEM, V277, P43481, DOI 10.1074/jbc.M204777200; Dyer KD, 2008, J IMMUNOL, V181, P4004, DOI 10.4049/jimmunol.181.6.4004; Dyer KD, 2007, J IMMUNOL, V179, P1693, DOI 10.4049/jimmunol.179.3.1693; Dyer KD, 2011, J IMMUNOL METHODS, V369, P91, DOI 10.1016/j.jim.2011.04.009; Foster PS, 2013, IMMUNOL REV, V253, P198, DOI 10.1111/imr.12058; Foster PS, 2001, IMMUNOL REV, V179, P173, DOI 10.1034/j.1600-065X.2001.790117.x; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; Furumoto Y, 2011, BLOOD, V118, P5466, DOI 10.1182/blood-2010-09-309955; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Gerrits A, 2012, BLOOD, V119, P377, DOI 10.1182/blood-2011-01-331686; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; HALLGREN R, 1985, CLIN EXP IMMUNOL, V59, P539; HER E, 1991, J CLIN INVEST, V88, P1982, DOI 10.1172/JCI115524; Hino K, 2008, RNA, V14, P1433, DOI 10.1261/rna.810208; Hirasawa R, 2002, J EXP MED, V195, P1379, DOI 10.1084/jem.20020170; Hu YL, 2010, NUCLEIC ACIDS RES, V38, P5472, DOI 10.1093/nar/gkq337; Humbles AA, 2002, P NATL ACAD SCI USA, V99, P1479, DOI 10.1073/pnas.261462598; Iwasaki H, 2006, GENE DEV, V20, P3010, DOI 10.1101/gad.1493506; Jin Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064434; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kampe M, 2012, INFLAMMATION, V35, P230, DOI 10.1007/s10753-011-9309-5; Kashiyama K, 2012, J INVEST DERMATOL, V132, P1597, DOI 10.1038/jid.2012.22; Kim YJ, 2009, J BONE MINER RES, V24, P816, DOI 10.1359/JBMR.081230; Lee JJ, 2012, J ALLERGY CLIN IMMUN, V130, P572, DOI 10.1016/j.jaci.2012.07.025; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li TR, 2011, CLIN CHIM ACTA, V412, P66, DOI 10.1016/j.cca.2010.09.029; Liu C, 2013, BLOOD; Lu TX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059397; Lu TX, 2013, J IMMUNOL, V190, P1576, DOI 10.4049/jimmunol.1202897; Ma W, 2002, J CLIN INVEST, V109, P621, DOI 10.1172/JCI200214097; Mattes J, 2009, P NATL ACAD SCI USA, V106, P18704, DOI 10.1073/pnas.0905063106; Melo RCN, 2013, ALLERGY, V68, P274, DOI 10.1111/all.12103; Menzies-Gow A, 2003, J ALLERGY CLIN IMMUN, V111, P714, DOI 10.1067/mai.2003.1382; MERTENS AV, 1993, CLIN EXP ALLERGY, V23, P868, DOI 10.1111/j.1365-2222.1993.tb00266.x; Molfino NA, 2012, CLIN EXP ALLERGY, V42, P712, DOI 10.1111/j.1365-2222.2011.03854.x; Mould AW, 1997, J CLIN INVEST, V99, P1064, DOI 10.1172/JCI119234; MullerSieburg CE, 1996, J EXP MED, V183, P1141, DOI 10.1084/jem.183.3.1141; Nagase H, 2003, J IMMUNOL, V171, P3977, DOI 10.4049/jimmunol.171.8.3977; Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403; Oldenburg M, 2012, SCIENCE, V337, P1111, DOI 10.1126/science.1220363; Parsons MJ, 2008, MAMM GENOME, V19, P552, DOI 10.1007/s00335-008-9116-y; Persson CGA, 1997, TRENDS PHARMACOL SCI, V18, P465; Phipps S, 2007, BLOOD, V110, P1578, DOI 10.1182/blood-2007-01-071340; Pin AL, 2012, J BIOL CHEM, V287, P30541, DOI 10.1074/jbc.M112.393561; Plotz SG, 2001, BLOOD, V97, P235, DOI 10.1182/blood.V97.1.235; Ponath PD, 1996, J EXP MED, V183, P2437, DOI 10.1084/jem.183.6.2437; Rasmussen KD, 2010, J EXP MED, V207, P1351, DOI 10.1084/jem.20100458; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Rosenberg HF, 2007, J ALLERGY CLIN IMMUN, V119, P1303, DOI 10.1016/j.jaci.2007.03.048; Rosenberg HF, 2013, NAT REV IMMUNOL, V13, P9, DOI 10.1038/nri3341; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Rusca N, 2012, MOL CELL BIOL, V32, P4432, DOI 10.1128/MCB.00824-12; SANDERSON CJ, 1992, BLOOD, V79, P3101, DOI 10.1182/blood.V79.12.3101.3101; Shinkai A, 1999, J IMMUNOL, V163, P1602; Sun L, 2011, NAT CELL BIOL, V13, P958, DOI 10.1038/ncb2286; Sun M, 2012, MOL CANCER THER, V11, P842, DOI 10.1158/1535-7163.MCT-11-1015; Taghon T, 2007, NAT IMMUNOL, V8, P845, DOI 10.1038/ni1486; Valent P, 2012, J ALLERGY CLIN IMMUN, V130, P607, DOI 10.1016/j.jaci.2012.02.019; von Kockritz-Blickwede M, 2009, J MOL MED, V87, P775, DOI 10.1007/s00109-009-0481-0; Wang XH, 2010, CIRCULATION, V122, P1308, DOI 10.1161/CIRCULATIONAHA.110.964684; Wang Y, 2013, DIABETES, V62, P887, DOI 10.2337/db12-0451; Wenzel SE, 2009, NEW ENGL J MED, V360, P1026, DOI 10.1056/NEJMe0900334; Wong CK, 2013, IMMUNOBIOLOGY, V218, P255, DOI 10.1016/j.imbio.2012.05.019; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P13187, DOI 10.1073/pnas.94.24.13187; Yang LY, 2012, ONCOL REP, V28, P592, DOI 10.3892/or.2012.1823; Yang M, 2008, PHARMACOL THERAPEUT, V117, P94, DOI 10.1016/j.pharmthera.2007.08.004; Yoshida T, 1996, IMMUNITY, V4, P483, DOI 10.1016/S1074-7613(00)80414-8; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; Zimmermann N, 2000, J IMMUNOL, V165, P5839, DOI 10.4049/jimmunol.165.10.5839	81	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97537	10.1371/journal.pone.0097537	http://dx.doi.org/10.1371/journal.pone.0097537			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824797	Green Published, gold, Green Submitted			2022-12-27	WOS:000336369200128
J	Ban, JB; Fan, XW; Huang, Q; Li, BF; Chen, C; Zhang, HC; Xu, SQ				Ban, Jin-Bao; Fan, Xiao-Wu; Huang, Qi; Li, Bin-Feng; Chen, Chen; Zhang, Hua-Chuan; Xu, Shun-Qing			Mono-(2-Ethylhexyl) Phthalate Induces Injury in Human Umbilical Vein Endothelial Cells	PLOS ONE			English	Article							DI(2-ETHYLHEXYL) PHTHALATE; LIPID-PEROXIDATION; INDUCED APOPTOSIS; EXPOSURE; INDUCTION; TOXICITY; STRESS; FAMILY; DEATH; BAX	Mono-(2-ethylhexyl) phthalate (MEHP), the active metabolite of di-(2-ethylhexyl) phthalate (DEHP), is a widespread environmental contaminant and has been proved to have potential adverse effects on the reproductive system, carcinogenicity, liver, kidney and developmental toxicities. However, the effect of MEHP on vascular system remains unclear. The main purpose of this study was to evaluate the cytotoxic effects of MEHP on human umbilical endothelial cells (HUVEC) and its possible molecular mechanism. HUVEC cells were treated with MEHP (0, 6.25, 12.5, 25,50 and 100 mu M), and the cellular apoptosis and mitochondrial membrane potential as well as intracellular reactive oxygen species were determined. In present study, MEHP induced a dose-dependent cell injury in HUVEC cell via an apoptosis pathway as characterized by increased percentage of sub-G1, activation of caspase-3, -8and -9, and increased ratio of Bax/bcl-2 mRNA and protein expression as well as cytochrome C releasing. In addition, there was obvious oxidative stress, represented by decreased glutathione level, increased malondialdehyde level and superoxide dismutase activity. N-Acetylcysteine, as an antioxidant that is a direct reactive oxygen species scavenger, could effectively block MEHP-induced reactive oxygen species generation, mitochondrial membrane potential loss and cell apoptosis. These data indicated that MEHP induced apoptosis in HUVEC cells through a reactive oxygen species-mediated mitochondria-dependent pathway.	[Ban, Jin-Bao; Fan, Xiao-Wu; Huang, Qi; Li, Bin-Feng; Chen, Chen; Zhang, Hua-Chuan] Huazhong Univ Sci & Technol, Dept Gen Thorac Surg, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China; [Xu, Shun-Qing] Huazhong Univ Sci & Technol, Key Lab Environm & Hlth, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Huang, Q (corresponding author), Huazhong Univ Sci & Technol, Dept Gen Thorac Surg, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China.	huangqi6699@gmail.com; xuscience@hotmail.com			National Program on Key Basic Research Project of China (973 Program) [2012CB722401]; National Natural Science Foundation of China [81030051, 21177046]; R&D Special Fund for Public Welfare Industry (Environment) [200909102]; National Science & Technology Pillar Program during the 12th Five-year Plan Period of China [2012BAI 32B03]	National Program on Key Basic Research Project of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); R&D Special Fund for Public Welfare Industry (Environment); National Science & Technology Pillar Program during the 12th Five-year Plan Period of China	This work was supported by the National Program on Key Basic Research Project of China (973 Program) (2012CB722401), the National Natural Science Foundation of China (81030051, 21177046), the R&D Special Fund for Public Welfare Industry (Environment) (200909102), and the National Science & Technology Pillar Program during the 12th Five-year Plan Period of China (2012BAI 32B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa M, 2007, CEREBELLUM, V6, P308, DOI 10.1080/14734220601142878; Briganti S, 2003, J EUR ACAD DERMATOL, V17, P663, DOI 10.1046/j.1468-3083.2003.00751.x; Chen JH, 2006, FOOD CHEM TOXICOL, V44, P567, DOI 10.1016/j.fct.2005.09.004; Chen TA, 2011, TOXICOL LETT, V201, P34, DOI 10.1016/j.toxlet.2010.12.002; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963; ELCOMBE CR, 1986, ENVIRON HEALTH PERSP, V70, P211, DOI 10.2307/3430357; England K, 2005, REDOX REP, V10, P237, DOI 10.1179/135100005X70224; Erkekoglu P, 2010, TOXICOL APPL PHARM, V248, P52, DOI 10.1016/j.taap.2010.07.016; Ferguson KK, 2011, ENVIRON RES, V111, P718, DOI 10.1016/j.envres.2011.02.002; Fiers W, 1999, ONCOGENE, V18, P7719, DOI 10.1038/sj.onc.1203249; Halden RU, 2010, ANNU REV PUBL HEALTH, V31, P179, DOI 10.1146/annurev.publhealth.012809.103714; Ito Y, 2007, J OCCUP HEALTH, V49, P172, DOI 10.1539/joh.49.172; Kavlock R, 2002, REPROD TOXICOL, V16, P529, DOI 10.1016/S0890-6238(02)00032-1; Koo HJ, 2004, J TOXICOL ENV HEAL A, V67, P1901, DOI 10.1080/15287390490513300; Latini G, 2005, CLIN CHIM ACTA, V361, P20, DOI 10.1016/j.cccn.2005.05.003; Lin Y, 2011, AM J PHYSIOL-ENDOC M, V301, pE527, DOI 10.1152/ajpendo.00233.2011; Mates J M, 1999, Front Biosci, V4, pD339; National Toxicology Program, 1982, Natl Toxicol Program Tech Rep Ser, V212, P1; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Poon R, 1997, FOOD CHEM TOXICOL, V35, P225, DOI 10.1016/S0278-6915(96)00064-6; ROBINSON JP, 1988, J LEUKOCYTE BIOL, V43, P304, DOI 10.1002/jlb.43.4.304; Sadowska AM, 2007, PULM PHARMACOL THER, V20, P9, DOI 10.1016/j.pupt.2005.12.007; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Schelman WR, 2004, MOL BRAIN RES, V128, P160, DOI 10.1016/j.molbrainres.2004.06.011; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Sharpe RM, 1995, ENVIRON HEALTH PERSP, V103, P1136, DOI 10.2307/3432610; TOMASZEWSKI KE, 1990, TOXICOLOGY, V65, P49, DOI 10.1016/0300-483X(90)90078-U; Tsujimoto Y, 2003, J CELL PHYSIOL, V195, P158, DOI 10.1002/jcp.10254; Urso ML, 2003, TOXICOLOGY, V189, P41, DOI 10.1016/S0300-483X(03)00151-3; Wang Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015901; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei ZZ, 2012, TOXICOL LETT, V212, P212, DOI 10.1016/j.toxlet.2012.05.023; Yang JS, 2009, FOOD CHEM TOXICOL, V47, P171, DOI 10.1016/j.fct.2008.10.032; Yoshioka Y, 2006, J IMMUNOL, V176, P4675, DOI 10.4049/jimmunol.176.8.4675	34	27	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97607	10.1371/journal.pone.0097607	http://dx.doi.org/10.1371/journal.pone.0097607			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836450	Green Published, Green Submitted, gold			2022-12-27	WOS:000339614800057
J	Du, XF; Li, J; Du, XL				Du, Xiufang; Li, Jia; Du, Xiulian			Testing Risk-Taking Behavior in Chinese Undergraduate Students	PLOS ONE			English	Article							SENSATION SEEKING; GENDER-DIFFERENCES; SCALE; TESTOSTERONE; DECISION; CHILDREN; SAMPLE	The DOSPERT, developed by Weber, Blais and Betz, can be used to measure risk behaviors in a variety of domains. We investigated the use of this scale in China. The participants were 1144 undergraduate students. After we removed some items that were not homogeneous, a principal component analysis extracted six components that accounted for 44.48% of the variance, a value similar to that obtained in the analysis conducted by Weber et al. Chinese undergraduates scored higher on the investment subscale compared with the results of Weber's study. The analysis of individual differences indicated that there was a significant gender difference in the ethical, investment and health/safety subscales, where males scored significantly higher than females. The type of home location was also significant on the ethical and health/safety subscales, where undergraduates from the countryside scored lower than undergraduates from cities and towns on the ethical subscale, and undergraduates from towns scored higher than those from other two areas on the health/safety subscale. Male undergraduates from towns scored higher than male undergraduates from other areas on the gambling subscale.	[Du, Xiufang; Li, Jia] Shandong Normal Univ, Sch Psychol, Jinan, Peoples R China; [Du, Xiulian] Shandong Univ Polit Sci & Law, Dept Foreign Language, Jinan, Peoples R China	Shandong Normal University; Shandong University of Political Science and Law	Du, XF (corresponding author), Shandong Normal Univ, Sch Psychol, Jinan, Peoples R China.	dxflxc@163.com			Excellent Younger Scientist Reward Fund of Shandong Province [BS2010SF026]; Key Subject Funds of Shandong Province, P. R. China	Excellent Younger Scientist Reward Fund of Shandong Province; Key Subject Funds of Shandong Province, P. R. China	This study was supported by the Excellent Younger Scientist Reward Fund of Shandong Province (BS2010SF026) to Professor Xiufang Du (http://www.sdstc.gov.cn/) and the Key Subject Funds of Shandong Province, P. R. China (2011-2015) (http://www.psy.sdnu.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apicella CL, 2008, EVOL HUM BEHAV, V29, P384, DOI 10.1016/j.evolhumbehav.2008.07.001; Blais AR, 2006, JUDGM DECIS MAK, V1, P33; Byrnes JP, 1999, PSYCHOL BULL, V125, P367, DOI 10.1037/0033-2909.125.3.367; Coates JM, 2009, P NATL ACAD SCI USA, V106, P623, DOI 10.1073/pnas.0810907106; Dohmen T, 2005, 1730 I STUD LAB; Donkers B, 2001, J RISK UNCERTAINTY, V22, P165, DOI 10.1023/A:1011109625844; Englestad H, 2006, PREDICTING GAMBLE CH; Field A, 2013, DISCOVERING STAT USI; Guiso L, 2002, J BUS ECON STAT, V20, P241, DOI 10.1198/073500102317351985; Guiso L, 2001, 2728 CEPR; Harris CR, 2006, JUDGM DECIS MAK, V1, P48; HORVATH P, 1993, PERS INDIV DIFFER, V14, P41, DOI 10.1016/0191-8869(93)90173-Z; Hsee CK, 1999, J BEHAV DECIS MAKING, V12, P165, DOI 10.1002/(SICI)1099-0771(199906)12:2<165::AID-BDM316>3.0.CO;2-N; Hu XX, 2012, JUDGM DECIS MAK, V7, P181; Johnson J., 2004, POL PSYCHOL BULL, V35, P153; Jonah BA, 1997, ACCIDENT ANAL PREV, V29, P651, DOI 10.1016/S0001-4575(97)00017-1; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kennedy C, 2000, J Pediatr Nurs, V15, P272, DOI 10.1053/jpdn.2000.8676; [李宏利 Li Hongli], 2010, [心理学报, Acta Psychologica Sinica], V42, P618; Morrongiello BA, 2008, HEALTH PSYCHOL, V27, P498, DOI 10.1037/0278-6133.27.4.498; Morrongiello BA, 2007, INJURY PREV, V13, P20, DOI 10.1136/ip.2005.011296; Rohrmann B., 2002, RISK ATTITUDE SCALES; RUSSO MF, 1991, PERS INDIV DIFFER, V12, P399, DOI 10.1016/0191-8869(91)90056-H; Sapienza P, 2009, P NATL ACAD SCI USA, V106, P15268, DOI 10.1073/pnas.0907352106; Stenstrom E, 2011, PERS INDIV DIFFER, V51, P412, DOI 10.1016/j.paid.2010.07.003; Wang W, 2000, PERS INDIV DIFFER, V28, P169, DOI 10.1016/S0191-8869(99)00092-6; Weber EU, 2002, J BEHAV DECIS MAKING, V15, P263, DOI 10.1002/bdm.414; Weber EU, 2000, APPL PSYCHOL-INT REV, V49, P32, DOI 10.1111/1464-0597.00005; ZUCKERMAN M, 1978, J CONSULT CLIN PSYCH, V46, P139, DOI 10.1037/0022-006X.46.1.139; ZUCKERMAN M, 1979, PSYCHIAT RES, V1, P255, DOI 10.1016/0165-1781(79)90007-6	30	4	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97989	10.1371/journal.pone.0097989	http://dx.doi.org/10.1371/journal.pone.0097989			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1NZ	24836525	Green Published, gold, Green Submitted			2022-12-27	WOS:000339614800095
J	Krasner, NM; Ido, Y; Ruderman, NB; Cacicedo, JM				Krasner, Nadia M.; Ido, Yasuo; Ruderman, Neil B.; Cacicedo, Jose M.			Glucagon-Like Peptide-1 (GLP-1) Analog Liraglutide Inhibits Endothelial Cell Inflammation through a Calcium and AMPK Dependent Mechanism	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ANTIDIABETIC DRUG; OXIDATIVE STRESS; BINDING PROTEIN; TNF-ALPHA; DYSFUNCTION; EXENATIDE; THERAPIES; INCRETIN; ADHESION	Liraglutide is a glucagon-like peptide-1 (GLP-1) mimetic used for the treatment of Type 2 diabetes. Similar to the actions of endogenous GLP-1, liraglutide potentiates the post-prandial release of insulin, inhibits glucagon release and increases satiety. Recent epidemiological studies and clinical trials have suggested that treatment with GLP-1 mimetics may also diminish the risk of cardiovascular disease in diabetic patients. The mechanism responsible for this effect has yet to be determined; however, one possibility is that they might do so by a direct effect on vascular endothelium. Since low grade inflammation of the endothelium is an early event in the pathogenesis of atherosclerotic cardiovascular disease (ASCVD), we determined the effects of liraglutide on inflammation in cultured human aortic endothelial cells (HAECs). Liraglutide reduced the inflammatory responses to TNF alpha and LPS stimulation, as evidenced by both reduced protein expression of the adhesion molecules VCAM-1 and E-Selectin, and THP-1 monocyte adhesion. This was found to result from increased cell Ca2+ and several molecules sensitive to Ca2+ with known anti inflammatory actions in endothelial cells, including CaMKK beta, CaMKI, AMPK, eNOS and CREB. Treatment of the cells with STO-609, a CaMKK inhibitor, diminished both the activation of AMPK, CaMKI and the inhibition of TNF alpha and LPS-induced monocyte adhesion by liraglutide. Likewise, expression of an shRNA against AMPK nullified the anti-inflammatory effects of liraglutide. The results indicate that liraglutide exerts a strong anti-inflammatory effect on HAECs. They also demonstrate that this is due to its ability to increase intracellular Ca2+ and activate CAMKK beta, which in turn activates AMPK.	[Krasner, Nadia M.; Ido, Yasuo; Ruderman, Neil B.; Cacicedo, Jose M.] Boston Univ, Sch Med, Dept Med, Diabet & Metab Res Unit, Boston, MA 02118 USA; [Krasner, Nadia M.; Ido, Yasuo; Ruderman, Neil B.; Cacicedo, Jose M.] Boston Univ, Sch Med, Endocrinol Sect, Boston, MA 02118 USA; [Krasner, Nadia M.] Boston Univ, Sch Med, Dept Med, Program Nutr & Metab, Boston, MA 02118 USA	Boston University; Boston University; Boston University	Krasner, NM (corresponding author), Boston Univ, Sch Med, Dept Med, Diabet & Metab Res Unit, Boston, MA 02118 USA.	nadiakrasner@gmail.com; cacicedo@bu.edu		/0000-0001-8417-9754	NIH/NHLBI [PO1 HL068758]; NIH/NIDDK [R24 DK094749]; Takeda Pharmaceuticals; NHLBI [HL07969]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007969, P01HL068758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK094749] Funding Source: NIH RePORTER	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Takeda Pharmaceuticals(Takeda Pharmaceutical Company Ltd); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH/NHLBI Program Project Grant PO1 HL068758 and NIH/NIDDK R24 Seed Grant R24 DK094749 and funding from Takeda Pharmaceuticals. NMK was supported by NHLBI T32 training grant HL07969. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki C, 2012, J PHARMACOL SCI, V120, P121, DOI 10.1254/jphs.12108FP; Best JH, 2011, DIABETES CARE, V34, P90, DOI 10.2337/dc10-1393; Bullock BP, 1996, ENDOCRINOLOGY, V137, P2968, DOI 10.1210/en.137.7.2968; Cacicedo JM, 2004, BIOCHEM BIOPH RES CO, V324, P1204, DOI 10.1016/j.bbrc.2004.09.177; Ceriello A, 2011, DIABETES CARE, V34, P697, DOI 10.2337/dc10-1949; Chen C, 2013, INFLAMMATION, V36, P309, DOI 10.1007/s10753-012-9548-0; Creely SJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE740, DOI 10.1152/ajpendo.00302.2006; CULLINAN CA, 1994, CELL CALCIUM, V15, P391, DOI 10.1016/0143-4160(94)90014-0; Cuthbertson DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050117; Damdindorj B, 2012, FEBS LETT, V586, P2555, DOI 10.1016/j.febslet.2012.06.034; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; DRUCKER DJ, 1987, P NATL ACAD SCI USA, V84, P3434, DOI 10.1073/pnas.84.10.3434; Flint A, 2011, ADV THER, V28, P213, DOI 10.1007/s12325-010-0110-x; Forst T, 2012, DIABETIC MED, V29, P1115, DOI 10.1111/j.1464-5491.2012.03589.x; Francis H, 2008, AM J PHYSIOL-CELL PH, V295, pC499, DOI 10.1152/ajpcell.00369.2007; Galkina E, 2007, ARTERIOSCL THROM VAS, V27, P2292, DOI 10.1161/ATVBAHA.107.149179; Gaspari T, 2011, DIABETES VASC DIS RE, V8, P117, DOI 10.1177/1479164111404257; HAWLEY SA, 1995, J BIOL CHEM, V270, P27186, DOI 10.1074/jbc.270.45.27186; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Holz GG, 2004, DIABETES, V53, P5, DOI 10.2337/diabetes.53.1.5; Horowitz M, 2012, DIABETES RES CLIN PR, V97, P258, DOI 10.1016/j.diabres.2012.02.016; Horton ES, 2010, DIABETES CARE, V33, P1759, DOI 10.2337/dc09-2062; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Kelly CJ, 2012, NUTR CLIN PRACT, V27, P215, DOI 10.1177/0884533611434934; Koska J, 2010, DIABETES CARE, V33, P1028, DOI 10.2337/dc09-1961; Krasner N, 2011, GLUCAGON LIKE PEPTID; KREYMANN B, 1987, LANCET, V2, P1300; Kwan HY, 2009, CLIN EXP PHARMACOL P, V36, P857, DOI 10.1111/j.1440-1681.2009.05199.x; Lee W, 2013, INFLAMMATION, V36, P94, DOI 10.1007/s10753-012-9523-9; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Liu HB, 2008, J ENDOCRINOL, V196, P57, DOI 10.1677/JOE-07-0387; Marso SP, 2011, DIABETES VASC DIS RE, V8, P237, DOI 10.1177/1479164111408937; Moretto TJ, 2008, CLIN THER, V30, P1448, DOI 10.1016/j.clinthera.2008.08.006; Morrow VA, 2003, J BIOL CHEM, V278, P31629, DOI 10.1074/jbc.M212831200; Nakamura K, 2012, ARTERIOSCL THROM VAS, V32, P2670, DOI 10.1161/ATVBAHA.112.254946; Nauck M, 2003, DIABETES, V52, pA128; Nikolaidis LA, 2004, CIRCULATION, V109, P962, DOI 10.1161/01.CIR.0000120505.91348.58; Niswender K, 2013, DIABETES OBES METAB, V15, P42, DOI 10.1111/j.1463-1326.2012.01673.x; Nordisk N, 2014, PRODUCT MONOGRAPH; Nystrom T, 2004, AM J PHYSIOL-ENDOC M, V287, pE1209, DOI 10.1152/ajpendo.00237.2004; Ou HC, 2012, J VASC SURG, V55, P1104, DOI 10.1016/j.jvs.2011.10.011; Pussinen PJ, 2007, ARTERIOSCL THROM VAS, V27, P1433, DOI 10.1161/ATVBAHA.106.138743; Qin ZY, 2012, ATHEROSCLEROSIS, V221, P2, DOI 10.1016/j.atherosclerosis.2011.09.003; Read PA, 2012, HEART, V98, P408, DOI 10.1136/hrt.2010.219345; Russell-Jones D, 2009, MOL CELL ENDOCRINOL, V297, P137, DOI 10.1016/j.mce.2008.11.018; Schisano B, 2012, REGUL PEPTIDES, V174, P46, DOI 10.1016/j.regpep.2011.11.008; Shiraki A, 2012, ATHEROSCLEROSIS, V221, P375, DOI 10.1016/j.atherosclerosis.2011.12.039; Sokos GG, 2006, J CARD FAIL, V12, P694, DOI 10.1016/j.cardfail.2006.08.211; Stahmann N, 2006, MOL CELL BIOL, V26, P5933, DOI 10.1128/MCB.00383-06; Tran QK, 2000, CARDIOVASC RES, V48, P13, DOI 10.1016/S0008-6363(00)00172-3; Tuttolomondo A, 2012, CURR PHARM DESIGN, V18, P4266, DOI 10.2174/138161212802481237; van Can J, 2013, INT J OBESE; Westhorpe CLV, 2012, EXP MOL PATHOL, V93, P220, DOI 10.1016/j.yexmp.2012.03.014; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Woollard KJ, 2013, CLIN SCI, V125, P221, DOI 10.1042/CS20120576; Wu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035508; Xing JJ, 2013, AM J PATHOL, V182, P1021, DOI 10.1016/j.ajpath.2012.11.022; Yamamizu K, 2011, CIRC J, V75, P253, DOI 10.1253/circj.CJ-10-0915	58	107	115	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97554	10.1371/journal.pone.0097554	http://dx.doi.org/10.1371/journal.pone.0097554			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835252	Green Published, gold, Green Submitted			2022-12-27	WOS:000339614800050
J	Faner, R; Gonzalez, N; Cruz, T; Kalko, SG; Agusti, A				Faner, Rosa; Gonzalez, Nuria; Cruz, Tamara; Graciela Kalko, Susana; Agusti, Alvar			Systemic Inflammatory Response to Smoking in Chronic Obstructive Pulmonary Disease: Evidence of a Gender Effect	PLOS ONE			English	Article							FAMILIAL AGGREGATION; NATURAL-HISTORY; SEX; EXPRESSION; RISK; COPD; SUSCEPTIBILITY; INFECTION; APOPTOSIS; CLONING	Background: Tobacco smoking is the main risk factor of chronic obstructive pulmonary disease (COPD) but not all smokers develop the disease. An abnormal pulmonary and systemic inflammatory response to smoking is thought to play a major pathogenic role in COPD, but this has never been tested directly. Methods: We studied the systemic biomarker and leukocyte transcriptomic response (Affymetrix microarrays) to smoking exposure in 10 smokers with COPD and 10 smokers with normal spirometry. We also studied 10 healthy never smokers (not exposed to smoking) as controls. Because some aspects of COPD may differ in males and females, and the inflammatory response to other stressors (infection) might be different in man and women, we stratified participant recruitment by sex. Differentially expressed genes were validated by q-PCR. Ontology enrichment was evaluated and interaction networks inferred. Results: Principal component analysis identified sex differences in the leukocyte transcriptomic response to acute smoking. In both genders, we identified genes that were differentially expressed in response to smoking exclusively in COPD patients (COPD related signature) or smokers with normal spirometry (Smoking related signature), their ontologies and interaction networks. Conclusions: The use of an experimental intervention (smoking exposure) to investigate the transcriptomic response of peripheral leukocytes in COPD is a step beyond the standard case-control transcriptomic profiling carried out so far, and has facilitated the identification of novel COPD and Smoking expression related signatures which differ in males and females.	[Faner, Rosa; Gonzalez, Nuria; Cruz, Tamara; Agusti, Alvar] Fundacio Privada Clin Recerca Biomed, Barcelona, Spain; [Faner, Rosa; Cruz, Tamara; Agusti, Alvar] IDIBAPS, Barcelona, Spain; [Faner, Rosa; Agusti, Alvar] CIBER Enfermedades Resp CIBERES, Barcelona, Spain; [Graciela Kalko, Susana] IDIBAPS, Bioinformat Core Facil, Barcelona, Spain; [Agusti, Alvar] Univ Barcelona, Hosp Clin, Thorax Inst, Barcelona, Spain; [Agusti, Alvar] FISIB, Mallorca, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona	Agusti, A (corresponding author), Fundacio Privada Clin Recerca Biomed, Barcelona, Spain.	alvar.agusti@clinic.ub.es	Garcia-Navarro, Alvar Agusti/F-4474-2015; Cruz, Tamara/AAH-8835-2019	Garcia-Navarro, Alvar Agusti/0000-0003-3271-3788; Cruz, Tamara/0000-0002-6362-6348; Faner, Rosa/0000-0002-8159-0115; Kalko, Susana/0000-0002-6701-0233	Mutua Madrilena [PI041966/2012]; Fundacio Catalana de Pneumologia (Fucap)-Beca Esteve; Instituto de Salud Carlos III-Fondo de Investigaciones Sanitarias (FIS) [10/00523]; SEPAR [133/2011]	Mutua Madrilena; Fundacio Catalana de Pneumologia (Fucap)-Beca Esteve; Instituto de Salud Carlos III-Fondo de Investigaciones Sanitarias (FIS)(Instituto de Salud Carlos III); SEPAR	Supported, in part, by Mutua Madrilena PI041966/2012, Fundacio Catalana de Pneumologia (Fucap)-Beca Esteve 2011, Instituto de Salud Carlos III-Fondo de Investigaciones Sanitarias (FIS) 10/00523, SEPAR 133/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037483; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Anton IM, 2002, IMMUNITY, V16, P193, DOI 10.1016/S1074-7613(02)00268-6; Aryal S, 2013, TRANSL RES, V162, P208, DOI 10.1016/j.trsl.2013.04.003; Bahr TM, 2013, AM J RESP CELL MOL B; Bailey SL, 2008, CHROMOSOMA, V117, P367, DOI 10.1007/s00412-008-0155-7; Barrero CA, 2013, AM J RESP CRIT CARE, V188, P673, DOI 10.1164/rccm.201302-0342OC; Bhattacharya Soumyaroop, 2011, J Clin Bioinforma, V1, P12, DOI 10.1186/2043-9113-1-12; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; de Torres JP, 2005, CHEST, V128, P2012, DOI 10.1378/chest.128.4.2012; de Torres JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016021; DeMeo DL, 2004, THORAX, V59, P396, DOI 10.1136/thx.2003.012856; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dransfield MT, 2007, CHEST; Eisenreichi A, 2013, ONCOL REP, V30, P462, DOI 10.3892/or.2013.2413; Erbel R, 2008, ATHEROSCLEROSIS, V197, P662, DOI 10.1016/j.atherosclerosis.2007.02.031; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Gawron A, 2012, CANCER CAUSE CONTROL, V23, P1729, DOI 10.1007/s10552-012-9959-0; Gotting C, 2000, J MOL BIOL, V304, P517, DOI 10.1006/jmbi.2000.4261; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jimenez-Marin Angeles, 2009, BMC Proc, V3 Suppl 4, pS6, DOI 10.1186/1753-6561-3-S4-S6; Kohansal R, 2009, AM J RESP CRIT CARE, V180, P3, DOI 10.1164/rccm.200901-0047OC; Lang F, 2013, EXPERT OPIN INV DRUG, V22, P701, DOI 10.1517/13543784.2013.778971; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lomas DA, 2001, RESP RES, V2, P20, DOI 10.1186/rr34; LUO Y, 1995, MOL CELL BIOL, V15, P4115; McDunn JE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001564; Menon R, 2012, J AUTOIMMUN, V38, pJ144, DOI 10.1016/j.jaut.2011.11.004; Park SK, 2010, LUNG CANCER, V68, P20, DOI 10.1016/j.lungcan.2009.05.017; Pennell LM, 2012, J AUTOIMMUN, V38, pJ282, DOI 10.1016/j.jaut.2011.11.013; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; ROCA J, 1986, B EUR PHYSIOPATH RES, V22, P217; Ryter Stefan W, 2010, Expert Rev Respir Med, V4, P573, DOI 10.1586/ers.10.61; Ryu Jeong-Seon, 2011, Korean Journal of Internal Medicine, V26, P427, DOI 10.3904/kjim.2011.26.4.427; Schonthaler HB, 2011, ANN RHEUM DIS, V70, pI109, DOI 10.1136/ard.2010.140533; Silverman EK, 2000, CHEST, V117, p273S, DOI 10.1378/chest.117.5_suppl_1.273S; Smoot M, 2011, BIOINFORMATICS, V27, P1030, DOI 10.1093/bioinformatics/btr045; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; van der Vaart H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-22; van der Vaart H, 2004, THORAX, V59, P713, DOI 10.1136/thx.2003.012468; van Lennep JER, 2002, CARDIOVASC RES, V53, P538, DOI 10.1016/S0008-6363(01)00388-1; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Vogler M, 2012, CELL DEATH DIFFER, V19, P67, DOI 10.1038/cdd.2011.158; Zeng HH, 2012, EUR REV MED PHARMACO, V16, P711; Zhu JH, 2000, CIRCULATION, V102, P2491, DOI 10.1161/01.CIR.102.20.2491	46	37	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97491	10.1371/journal.pone.0097491	http://dx.doi.org/10.1371/journal.pone.0097491			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830457	Green Published, gold, Green Submitted			2022-12-27	WOS:000336789500069
J	Shekoofa, A; Emam, Y; Shekoufa, N; Ebrahimi, M; Ebrahimie, E				Shekoofa, Avat; Emam, Yahya; Shekoufa, Navid; Ebrahimi, Mansour; Ebrahimie, Esmaeil			Determining the Most Important Physiological and Agronomic Traits Contributing to Maize Grain Yield through Machine Learning Algorithms: A New Avenue in Intelligent Agriculture	PLOS ONE			English	Article							KERNEL WATER RELATIONS; PLANT-GROWTH; WEIGHT; NITROGEN	Prediction is an attempt to accurately forecast the outcome of a specific situation while using input information obtained from a set of variables that potentially describe the situation. They can be used to project physiological and agronomic processes; regarding this fact, agronomic traits such as yield can be affected by a large number of variables. In this study, we analyzed a large number of physiological and agronomic traits by screening, clustering, and decision tree models to select the most relevant factors for the prospect of accurately increasing maize grain yield. Decision tree models (with nearly the same performance evaluation) were the most useful tools in understanding the underlying relationships in physiological and agronomic features for selecting the most important and relevant traits (sowing date-location, kernel number per ear, maximum water content, kernel weight, and season duration) corresponding to the maize grain yield. In particular, decision tree generated by C&RT algorithm was the best model for yield prediction based on physiological and agronomical traits which can be extensively employed in future breeding programs. No significant differences in the decision tree models were found when feature selection filtering on data were used, but positive feature selection effect observed in clustering models. Finally, the results showed that the proposed model techniques are useful tools for crop physiologists to search through large datasets seeking patterns for the physiological and agronomic factors, and may assist the selection of the most important traits for the individual site and field. In particular, decision tree models are method of choice with the capability of illustrating different pathways of yield increase in breeding programs, governed by their hierarchy structure of feature ranking as well as pattern discovery via various combinations of features.	[Shekoofa, Avat] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA; [Emam, Yahya; Ebrahimie, Esmaeil] Shiraz Univ, Dept Crop Prod & Plant Breeding, Shiraz, Iran; [Shekoufa, Navid] Amirkabir Univ Technol, Dept Comp Engn & Informat Technol, Tehran, Iran; [Ebrahimi, Mansour] Univ Qom, Sch Basic Sci, Dept Biol, Qom, Iran; [Ebrahimie, Esmaeil] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia	University of North Carolina; North Carolina State University; Shiraz University; Amirkabir University of Technology; University of Adelaide	Ebrahimie, E (corresponding author), Shiraz Univ, Dept Crop Prod & Plant Breeding, Shiraz, Iran.	esmaeil.ebrahimie@adelaide.edu.au	Emam, Yahya/X-2090-2019; Shekoofa, Avat/ABE-4326-2020; Ebrahimie, Esmaeil/AAN-2611-2020; Ebrahimi, Mansour/AAO-9096-2021	Emam, Yahya/0000-0002-7113-8168; Shekoofa, Avat/0000-0002-4309-9026; Ebrahimie, Esmaeil/0000-0002-4431-2861; Ebrahimi, Mansour/0000-0001-7011-2567	Shiraz University	Shiraz University	This study was supported by the grant (AGR-emam) of Shiraz University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullahand M., 2010, INT J MANAGEMENT INF, V14, P57; [Anonymous], ASIAN J HLTH INFO SC; Ashrafi E, 2011, BIOINFORM BIOL INSIG, V5, P59, DOI 10.4137/BBI.S6206; Borras L, 2006, FIELD CROP RES, V95, P223, DOI 10.1016/j.fcr.2005.03.001; Borras L, 2003, ANN BOT-LONDON, V91, P857, DOI 10.1093/aob/mcg090; Borras L, 2010, FIELD CROP RES, V118, P1, DOI 10.1016/j.fcr.2010.04.010; Brown G, 1996, KERNEL DRY WEIGHT LO; Dancey D, 2007, IEEE T SYST MAN CY B, V37, P794, DOI 10.1109/TSMCB.2007.895334; Drummond ST, 2003, T ASAE, V46, P5, DOI 10.13031/2013.12541; Ebrahimi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023146; Ebrahimi M, 2010, CURR BIOINFORM, V5, P195, DOI 10.2174/157489310792006693; Elson J, 2004, ULTRASOUND OBST GYN, V23, P552, DOI 10.1002/uog.1061; Fischer KS., 1984, PHYS TROPICAL FIELD; Fischer RA, 2011, CROP PASTURE SCI, V62, P95, DOI 10.1071/CP10344; Gambin BL, 2006, FIELD CROP RES, V95, P316, DOI 10.1016/j.fcr.2005.04.002; Gambin BL, 2008, AUST J AGR RES, V59, P280, DOI 10.1071/AR07275; Gambin BL, 2007, FIELD CROP RES, V101, P1, DOI 10.1016/j.fcr.2006.09.001; Gautam R, 2006, BIOSYST ENG, V95, P359, DOI 10.1016/j.biosystemseng.2006.07.007; Gromiha MM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-135; Hammann F, 2009, CURR DRUG METAB, V10, P339, DOI 10.2174/138920009788499021; JONES RJ, 1983, CROP SCI, V23, P129, DOI 10.2135/cropsci1983.0011183X002300010038x; Khanna-Chopra R, 1998, EUR J AGRON, V9, P101, DOI 10.1016/S1161-0301(98)00028-8; Lauer JG, 1999, AGRON J, V91, P834, DOI 10.2134/agronj1999.915834x; Liu H, 2008, CH CRC DATA MIN KNOW, P3; Matsumoto K, 1998, LECT NOTES ARTIF INT, V1532, P439; Melchiori RJM, 2008, FIELD CROP RES, V108, P198, DOI 10.1016/j.fcr.2008.05.003; Nielsen RL, 2002, AGRON J, V94, P549; Roddick J. F., 2001, Temporal, Spatial, and Spatio-Temporal Data Mining. First International Workshop, TSDM 2000. Revised Papers (Lecture Notes in Artificial Intelligence Vol.2007), P147; Sala RG, 2007, FIELD CROP RES, V101, P19, DOI 10.1016/j.fcr.2006.09.004; Schulze FH, 2005, WATER SCI TECHNOL, V52, P21, DOI 10.2166/wst.2005.0279; Shekoofa A, 2012, ARCH AGRON SOIL SCI, V58, P777, DOI 10.1080/03650340.2010.546788; Shekoofa A, 2011, AUST J CROP SCI, V5, P162; Shekoofa A, 2011, ANN M FUND LIF SOIL; Shekoofa A, 2011, 11 AS MAIZ C NOV 7 1; Shekoofa A, 2010, THESIS SHIRAZ U SHIR; Sinclair TR, 2010, AGRON J, V102, P475, DOI 10.2134/agronj2009.0195; Subedi KD, 2005, CROP SCI, V45, P2246, DOI 10.2135/cropsci2004.0653; Thai KM, 2009, MOL DIVERS, V13, P321, DOI 10.1007/s11030-009-9117-0; Wang YY, 2008, INT J REMOTE SENS, V29, P2993, DOI 10.1080/01431160701442070; Ye XF, 2009, PHARMACOEPIDEM DR S, V18, P154, DOI 10.1002/pds.1695	40	41	43	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97288	10.1371/journal.pone.0097288	http://dx.doi.org/10.1371/journal.pone.0097288			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830330	Green Published, gold, Green Submitted			2022-12-27	WOS:000336789500046
J	Taylor, SE; Morganti-Kossmann, C; Lifshitz, J; Ziebell, JM				Taylor, Samuel E.; Morganti-Kossmann, Cristina; Lifshitz, Jonathan; Ziebell, Jenna M.			Rod Microglia: A Morphological Definition	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; CELL-DEATH; RAT; ACTIVATION; MOUSE; PHYSIOLOGY; RESPONSES; SENSOR; MICE; CNS	Brain microglial morphology relates to function, with ramified microglia surveying the micro-environment and amoeboid microglia engulfing debris. One subgroup of microglia, rod microglia, have been observed in a number of pathological conditions, however neither a function nor specific morphology has been defined. Historically, rod microglia have been described intermittently as cells with a sausage-shaped soma and long, thin processes, which align adjacent to neurons. More recently, our group has described rod microglia aligning end-to-end with one another to form trains adjacent to neuronal processes. Confusion in the literature regarding rod microglia arises from some reports referring to the sausage-shaped cell body, while ignoring the spatial distribution of processes. Here, we systematically define the morphological characteristics of rod microglia that form after diffuse brain injury in the rat, which differ morphologically from the spurious rod microglia found in uninjured sham. Rod microglia in the diffuse-injured rat brain show a ratio of 1.79 +/- 0.03 cell length: cell width at day 1 post-injury, which increases to 3.35 +/- 0.05 at day 7, compared to sham (1.17 +/- 0.02). The soma length: width differs only at day 7 post-injury (2.92 +/- 0.07 length: width), compared to sham (2.49 +/- 0.05). Further analysis indicated that rod microglia may not elongate in cell length but rather narrow in cell width, and retract planar (side) processes. These morphological characteristics serve as a tool for distinguishing rod microglia from other morphologies. The function of rod microglia remains enigmatic; based on morphology we propose origins and functions for rod microglia after acute neurological insult, which may provide biomarkers or therapeutic targets.	[Taylor, Samuel E.; Morganti-Kossmann, Cristina; Lifshitz, Jonathan; Ziebell, Jenna M.] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ 85006 USA; [Taylor, Samuel E.; Morganti-Kossmann, Cristina; Lifshitz, Jonathan; Ziebell, Jenna M.] Univ Arizona, Coll Med Phoenix, Dept Child Hlth, Phoenix, AZ USA; [Taylor, Samuel E.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Lifshitz, Jonathan] Phoenix VA Healthcare Syst, Phoenix, AZ USA; [Lifshitz, Jonathan] Arizona State Univ, Dept Psychol, Neurosci Program, Tempe, AZ 85287 USA	Barrow Neurological Institute; Phoenix Children's Hospital; University of Arizona; University of Bath; Arizona State University; Arizona State University-Tempe	Ziebell, JM (corresponding author), Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ 85006 USA.	jmziebell@email.arizona.edu	Ziebell, Jenna/Y-4496-2019	Morganti-Kossmann, Cristina/0000-0002-0807-2063; Ziebell, Jenna/0000-0003-2497-4347	National Institute of Neurological Disorders and Stroke of the National Institutes of Health [R01NS065052]; Mission Support Fund at Phoenix Children's Hospital; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065052] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Mission Support Fund at Phoenix Children's Hospital; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Research reported in this publication was supported, in part, by National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award number R01NS065052 and the Mission Support Fund at Phoenix Children's Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachstetter AD, 2013, J NEUROSCI, V33, P6143, DOI 10.1523/JNEUROSCI.5399-12.2013; Beynon SB, 2012, NEUROSCIENCE, V225, P162, DOI 10.1016/j.neuroscience.2012.07.029; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Carthew HL, 2012, NEUROSCIENCE, V214, P78, DOI 10.1016/j.neuroscience.2012.04.028; Cho BP, 2006, GLIA, V53, P92, DOI 10.1002/glia.20265; de Hoz R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083733; Gabrusiewicz K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023902; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; GRAEBER MB, 1994, NEUROPATH APPL NEURO, V20, P178; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hosseini AH, 2009, MED SCI SPORT EXER, V41, P1687, DOI 10.1249/MSS.0b013e31819fcd1b; JORGENSEN MB, 1993, EXP NEUROL, V120, P70, DOI 10.1006/exnr.1993.1041; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lambertsen KL, 2011, J NEUROPATH EXP NEUR, V70, P481, DOI 10.1097/NEN.0b013e31821db3aa; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Learoyd AE, 2012, BEHAV BRAIN RES, V226, P197, DOI 10.1016/j.bbr.2011.09.016; Lifshitz J, 2007, J NEUROPATH EXP NEUR, V66, P218, DOI 10.1097/01.jnen.0000248558.75950.4d; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; McNamara KCS, 2010, J NEUROTRAUM, V27, P695, DOI 10.1089/neu.2009.1237; OHNO M, 1992, DEV BRAIN RES, V67, P37, DOI 10.1016/0165-3806(92)90023-P; Olah M, 2011, CNS NEUROL DISORD-DR, V10, P108, DOI 10.2174/187152711794488575; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Rowe RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082507; Semple BD, 2010, NEUROBIOL DIS, V40, P394, DOI 10.1016/j.nbd.2010.06.015; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Spielmeyer W, 1922, HISTOPATHOLOGIE NERV; Streit WJ, 2006, TRENDS NEUROSCI, V29, P506, DOI 10.1016/j.tins.2006.07.001; Taylor SE, 2013, CURRENT PROTOCOLS ES; Trapp BD, 2007, GLIA, V55, P360, DOI 10.1002/glia.20462; Tremblay ME, 2011, NEURON GLIA BIOL, V7, P67, DOI 10.1017/S1740925X12000038; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; Wake H, 2013, TRENDS NEUROSCI, V36, P209, DOI 10.1016/j.tins.2012.11.007; Wierzba-Bobrowicz T, 2002, FOLIA NEUROPATHOL, V40, P125; Wirenfeldt M, 2009, NEUROBIOL DIS, V34, P432, DOI 10.1016/j.nbd.2009.02.015; Ziebell JM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-247; Ziebell JM, 2011, BRAIN RES, V1414, P94, DOI 10.1016/j.brainres.2011.07.056; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	39	77	80	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97096	10.1371/journal.pone.0097096	http://dx.doi.org/10.1371/journal.pone.0097096			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830807	gold, Green Submitted, Green Published			2022-12-27	WOS:000336789500034
J	de Zwaan, M; Muller, A; Allison, KC; Brahler, E; Hilbert, A				de Zwaan, Martina; Mueller, Astrid; Allison, Kelly C.; Braehler, Elmar; Hilbert, Anja			Prevalence and Correlates of Night Eating in the German General Population	PLOS ONE			English	Article							OBESE	Recently, night eating syndrome (NES) was included into the DSM-5 as an example of "Other Specified Feeding and Eating Disorders." The study provides insight into the population prevalence of NES using a large representative German population sample (n = 2,460) with a wide age range (14-85 years). The prevalence of NES was 1.1% using a cut-off on the Night Eating Questionnaire (NEQ) of 25. A positive screening for NES was positively associated with depression and anxiety, eating disorder psychopathology, and body weight.	[de Zwaan, Martina; Mueller, Astrid] Hannover Med Sch, Dept Psychosomat Med & Psychotherapy, Hannover, Germany; [Allison, Kelly C.] Univ Penn, Ctr Weight & Eating Disorders, Perelman Sch Med, Philadelphia, PA 19104 USA; [Braehler, Elmar] Univ Leipzig, Med Ctr, Dept Med Psychol & Med Sociol, D-04109 Leipzig, Germany; [Braehler, Elmar] Univ Med Ctr Mainz, Dept Psychosomat Med & Psychotherapy, Mainz, Germany; [Hilbert, Anja] Univ Leipzig, Med Ctr, Integrated Res & Treatment Ctr Adipos Dis, Dept Med Psychol & Med Sociol, D-04109 Leipzig, Germany	Hannover Medical School; University of Pennsylvania; Pennsylvania Medicine; Leipzig University; Johannes Gutenberg University of Mainz; Leipzig University	de Zwaan, M (corresponding author), Hannover Med Sch, Dept Psychosomat Med & Psychotherapy, Hannover, Germany.	dezwaan.martina@mh-hannover.de	Braehler, Elmar/C-6535-2009; Allison, Kelly C./O-4174-2019	Braehler, Elmar/0000-0002-2648-2728; Allison, Kelly C./0000-0002-9807-0220	Department of Medical Psychology and Medical Sociology at the University of Leipzig; German Federal Ministry of Education and Research [01EO1001]	Department of Medical Psychology and Medical Sociology at the University of Leipzig; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This research was supported by internal funds by the Department of Medical Psychology and Medical Sociology at the University of Leipzig. AH was supported by grant 01EO1001 from the German Federal Ministry of Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison Kelly C, 2008, Eat Behav, V9, P62, DOI 10.1016/j.eatbeh.2007.03.007; Allison KC, 2010, INT J EAT DISORDER, V43, P241, DOI 10.1002/eat.20693; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Berner LA, 2013, PSYCHOL RES BEHAV MA, V6, P1, DOI 10.2147/PRBM.S31929; de Zwaan M, 2006, INT J EAT DISORDER, V39, P224, DOI 10.1002/eat.20246; FAIRBURN CG, 1994, INT J EAT DISORDER, V16, P363; Gallant AR, 2012, OBES REV, V13, P528, DOI 10.1111/j.1467-789X.2011.00975.x; Hilbert A, 2007, DIAGNOSTICA, V53, P144, DOI 10.1026/0012-1924.53.3.144; Kroenke K, 2009, PSYCHOSOMATICS, V50, P613, DOI 10.1176/appi.psy.50.6.613; Lowe B, 2010, J AFFECT DISORDERS, V122, P86, DOI 10.1016/j.jad.2009.06.019; Lundgren JD, 2006, AM J PSYCHIAT, V163, P156, DOI 10.1176/appi.ajp.163.1.156; Lundgren JD, 2010, PSYCHIAT RES, V175, P233, DOI 10.1016/j.psychres.2008.10.027; Meule A., 2012, OBESITY FACTS, V5, P21; Rand CSW, 1997, INT J EAT DISORDER, V22, P65, DOI 10.1002/(SICI)1098-108X(199707)22:1&lt;65::AID-EAT8&gt;3.0.CO;2-0; Striegel-Moore RH, 2005, INT J EAT DISORDER, V37, P200, DOI 10.1002/eat.20128; STUNKARD AJ, 1955, AM J MED, V19, P78, DOI 10.1016/0002-9343(55)90276-X; Tholin S, 2009, OBESITY, V17, P1050, DOI 10.1038/oby.2008.676; Vander Wal JS, 2012, CLIN PSYCHOL REV, V32, P49, DOI 10.1016/j.cpr.2011.11.001	18	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97667	10.1371/journal.pone.0097667	http://dx.doi.org/10.1371/journal.pone.0097667			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4TJ	24828066	Green Submitted, Green Published, gold			2022-12-27	WOS:000336857400115
J	Fnais, N; Gomes, T; Mahoney, J; Alissa, S; Mamdani, M				Fnais, Naif; Gomes, Tara; Mahoney, James; Alissa, Sami; Mamdani, Muhammad			Temporal Trend of Carpal Tunnel Release Surgery: A Population-Based Time Series Analysis	PLOS ONE			English	Article							GENERAL-POPULATION; PREVALENCE; DIAGNOSIS; CARE	Background: Carpal tunnel release (CTR) is among the most common hand surgeries, although little is known about its pattern. In this study, we aimed to investigate temporal trends, age and gender variation and current practice patterns in CTR surgeries. Methods: We conducted a population-based time series analysis among over 13 million residents of Ontario, who underwent operative management for carpal tunnel syndrome (CTS) from April 1, 1992 to March 31, 2010 using administrative claims data. Results: The primary analysis revealed a fairly stable procedure rate of approximately 10 patients per 10,000 population per year receiving CTRs without any significant, consistent temporal trend (p = 0.94). Secondary analyses revealed different trends in procedure rates according to age. The annual procedure rate among those age >75 years increased from 22 per 10,000 population at the beginning of the study period to over 26 patients per 10,000 population (p < 0.01) by the end of the study period. CTR surgical procedures were approximately two-fold more common among females relative to males (64.9% vs. 35.1 respectively; p < 0.01). Lastly, CTR procedures are increasingly being conducted in the outpatient setting while procedures in the inpatient setting have been declining steadily - the proportion of procedures performed in the outpatient setting increased from 13% to over 30% by 2010 (p < 0.01). Conclusion: Overall, CTR surgical-procedures are conducted at a rate of approximately 10 patients per 10,000 population annually with significant variation with respect to age and gender. CTR surgical procedures in ambulatory-care facilities may soon outpace procedure rates in the in-hospital setting.	[Fnais, Naif] King Saud Univ, Coll Med, Riyadh 11461, Saudi Arabia; [Gomes, Tara] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Gomes, Tara; Mamdani, Muhammad] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Mahoney, James] St Michaels Hosp, Div Plast & Reconstruct Surg, Toronto, ON M5B 1W8, Canada; [Alissa, Sami] Univ Toronto, Div Plast & Reconstruct Surg, Toronto, ON, Canada; [Mamdani, Muhammad] St Michaels Hosp, Appl Hlth Res Ctr, Toronto, ON M5B 1W8, Canada; [Mamdani, Muhammad] St Michaels Hosp, Li KaShing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Mamdani, Muhammad] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada	King Saud University; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Mamdani, M (corresponding author), St Michaels Hosp, Appl Hlth Res Ctr, 30 Bond St, Toronto, ON M5B 1W8, Canada.	mamdanim@smh.ca		Gomes, Tara/0000-0002-1468-1965	King Saud University - Li Ka Shing Knowledge Institute Collaborative Program; Institute for Clinical Evaluative Sciences (ICES); Ontario MOHLTC	King Saud University - Li Ka Shing Knowledge Institute Collaborative Program; Institute for Clinical Evaluative Sciences (ICES)(University of Toronto); Ontario MOHLTC(Ministry of Health and Long-Term Care, Ontario)	This study was supported by the King Saud University - Li Ka Shing Knowledge Institute Collaborative Program (http://ksu-lkski.org/) and the Institute for Clinical Evaluative Sciences (ICES; www.ices.on.ca), which is funded by an annual grant from the Ontario MOHLTC (http://www.health.gov.on.ca/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Omran M, 2003, J VASC SURG, V38, P289, DOI 10.1016/S0741-5214(03)00273-8; [Anonymous], CARP TUNN REL DET; Atroshi I, 1999, JAMA-J AM MED ASSOC, V282, P153, DOI 10.1001/jama.282.2.153; Bell CM, 2006, ARCH INTERN MED, V166, P2525, DOI 10.1001/archinte.166.22.2525; Bland JDP, 2003, J NEUROL NEUROSUR PS, V74, P1674, DOI 10.1136/jnnp.74.12.1674; Concannon MJ, 2000, PLAST RECONSTR SURG, V105, P1662, DOI 10.1097/00006534-200004050-00010; DEKROM MCTFM, 1992, J CLIN EPIDEMIOL, V45, P373, DOI 10.1016/0895-4356(92)90038-O; Fajardo M, 2012, J HAND SURG-AM, V37A, P1599, DOI 10.1016/j.jhsa.2012.04.035; Gelfman R, 2009, NEUROLOGY, V72, P33, DOI 10.1212/01.wnl.0000338533.88960.b9; Graham B, 2008, J BONE JOINT SURG AM, V90A, P2587, DOI 10.2106/JBJS.G.01362; Katims J J, 1989, ASAIO Trans, V35, P280; KATZ JN, 1990, J RHEUMATOL, V17, P1495; Kerwin G, 1996, HAND CLIN, V12, P243; Latinovic R, 2006, J NEUROL NEUROSUR PS, V77, P263, DOI 10.1136/jnnp.2005.066696; Leblanc Martin R, 2007, Hand (N Y), V2, P173, DOI 10.1007/s11552-007-9043-5; LEVINE DW, 1993, J BONE JOINT SURG AM, V75A, P1585, DOI 10.2106/00004623-199311000-00002; LISS GM, 1992, AM J IND MED, V22, P395, DOI 10.1002/ajim.4700220312; Mondelli M, 2002, NEUROLOGY, V58, P289, DOI 10.1212/WNL.58.2.289; National Institute for Occupational Safety and Health (NIOSH), 1997, DHHS NIOSH PUBLICATI, V97; *ONT MIN HLTH, 1992, SCHED BEN PHYS SERV; Palmer DH, 1995, AAOS INSTR COURS LEC, V44, P167; Pindyck RS, 1998, ECONOMETRIC MODELS E, P463; Rempel D, 1998, AM J PUBLIC HEALTH, V88, P1447, DOI 10.2105/AJPH.88.10.1447; Roh YH, 2010, J HAND SURG-AM, V35A, P1410, DOI 10.1016/j.jhsa.2010.05.020; SPINNER RJ, 1989, MAYO CLIN PROC, V64, P829, DOI 10.1016/S0025-6196(12)61756-X; STEVENS JC, 1988, NEUROLOGY, V38, P134, DOI 10.1212/WNL.38.1.134; Szabo, 1994, J Am Acad Orthop Surg, V2, P115; Witt JC, 2004, MUSCLE NERVE, V29, P515, DOI 10.1002/mus.20019	28	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97499	10.1371/journal.pone.0097499	http://dx.doi.org/10.1371/journal.pone.0097499			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828486	gold, Green Published, Green Submitted			2022-12-27	WOS:000336857400102
J	Harper, DM; Alexander, NM; Ahern, DA; Comes, JC; Smith, MS; Heutinck, MA; Handley, SM				Harper, Diane Medved; Alexander, Natalie Marya; Ahern, Debra Ann; Comes, Johanna Claire; Smith, Melissa Smith; Heutinck, Melinda Ann; Handley, Sandra Martin			Women Have a Preference for Their Male Partner to Be HPV Vaccinated	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINE; ACCEPTABILITY; ADOLESCENTS; KNOWLEDGE; ATTITUDES; CHILDREN; PARENTS; LATINO; IMPACT; BOYS	Background: Peer influence and social networking can change female adolescent and young adult behavior. Peer influence on preferences for male human papillomavirus (HPV) vaccination has not been documented. The primary aim of this study was to determine if women had preferences about male sexual partner HPV vaccination receipt. Methods and Findings: A prospective survey of women 18-26 years of age was conducted at an urban university student health clinic. Education about the two HPV vaccines, cervical cancer and genital warts was provided. Women self-reported their demographic and medical history data, as well as their own preferences for HPV vaccine and their preferences for their male partner HPV vaccine using a 5 point Likert scale. 601 women, mean age of 21.5 years (SD 2.4), participated between 2011 and 2012. Nearly 95% of respondents were heterosexual; condoms and contraceptives were used in over half of the population. Regardless of the woman's vaccination status, women had significantly higher (strongly agree/agree) preferences for the male partner being vaccinated with HPV4 than not caring if he was vaccinated (63.6% vs. 13.1%, p<0.001). This preference was repeated for sexual risk factors and past reproductive medical history. Women who received HPV4 compared to those choosing HPV2 had a significantly lower proportion of preferences for not caring if the male partner was vaccinated (13% vs. 22%, p = 0.015). Conclusions: Women preferred a HPV vaccinated male partner. Peer messaging might change the male HPV vaccination uptake.	[Harper, Diane Medved] Univ Missouri Kansas City Sch Med, Dept Biomed & Hlth Informat, Kansas City, MO 64110 USA; [Harper, Diane Medved; Ahern, Debra Ann] Univ Missouri Kansas City Sch Med, Dept Community & Family Med, Kansas City, MO USA; [Harper, Diane Medved] Univ Missouri Kansas City Sch Med, Dept Obstet & Gynecol, Kansas City, MO USA; [Alexander, Natalie Marya] Kansas City Univ Med & Biosci, Dept Family Med, Kansas City, MO USA; [Comes, Johanna Claire; Smith, Melissa Smith; Heutinck, Melinda Ann; Handley, Sandra Martin] Univ Missouri, Univ Missouri Kansas City Student Hlth & Wellness, Kansas City, MO 64110 USA	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; Kansas City University of Medicine & Biosciences; University of Missouri System; University of Missouri Kansas City	Harper, DM (corresponding author), Univ Missouri Kansas City Sch Med, Dept Biomed & Hlth Informat, Kansas City, MO 64110 USA.	diane.m.harper@gmail.com	Harper, Diane M./I-2180-2014	Harper, Diane M./0000-0001-7648-883X				Alexander AB, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-192; Ali MM, 2011, J DEV BEHAV PEDIATR, V32, P563, DOI 10.1097/DBP.0b013e318231cf03; Bogaards JA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001147; Brisson M, 2011, J INFECT DIS, V204, P372, DOI 10.1093/infdis/jir285; Canfell K, 2012, VACCINE, V30, pF157, DOI 10.1016/j.vaccine.2012.06.091; Chesson HW, 2011, VACCINE, V29, P8443, DOI 10.1016/j.vaccine.2011.07.096; Daley MF, 2006, PEDIATRICS, V118, P2280, DOI 10.1542/peds.2006-1946; Dishion TJ, 2005, J ABNORM CHILD PSYCH, V33, P395, DOI 10.1007/s10802-005-3579-z; Dorell Christina, 2012, Morbidity and Mortality Weekly Report, V61, P671; Drolet M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067072; Gangestad SW, 2004, PSYCHOL SCI, V15, P203, DOI 10.1111/j.0956-7976.2004.01503010.x; Gerend MA, 2009, SEX TRANSM DIS, V36, P58, DOI 10.1097/OLQ.0b013e31818606fc; Harper D. M., 2010, J VACCINES VACCIN, V1, P107, DOI [10.4172/2157-7560.1000107, DOI 10.4172/2157-7560.1000107]; Harper DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088493; Heitmann ER, 2012, CURR OBSTET GYNECOL, V1, P95, DOI 10.1007/s13669-012-0017-4; Hilton S, 2013, VACCINE, V31, P2543, DOI 10.1016/j.vaccine.2013.04.023; Kim JJ, 2008, VACCINE, V26, pK76, DOI 10.1016/j.vaccine.2008.06.009; LEIGH WA, 2002, REPROD HLTH AFRICAN, P1; Licht AS, 2010, SEX TRANSM INFECT, V86, P74, DOI 10.1136/sti.2009.037705; Marty R, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-10; Ogilvie GS, 2008, SEX TRANSM INFECT, V84, P318, DOI 10.1136/sti.2007.029389; Oteng B, 2011, SEX TRANSM INFECT, V87, P52, DOI 10.1136/sti.2009.041392; Reiter PL, 2010, SEX TRANSM INFECT, V86, P241, DOI 10.1136/sti.2009.039065; Rice E, 2011, PREV SCI, V12, P80, DOI 10.1007/s11121-010-0191-4; Richmond MJ, 2012, PREV SCI, V13, P267, DOI 10.1007/s11121-011-0261-2; Riedesel J M, 2005, J Pediatr Adolesc Gynecol, V18, P391, DOI 10.1016/j.jpag.2005.09.004; Salvy SJ, 2012, PHYSIOL BEHAV, V106, P369, DOI 10.1016/j.physbeh.2012.03.022; Shen-Gunther J, 2011, GYNECOL ONCOL, V123, P272, DOI 10.1016/j.ygyno.2011.07.094; Smith MA, 2011, VACCINE, V29, P9112, DOI 10.1016/j.vaccine.2011.02.091; StatSoft Inc, 2010, STATISTICA DAT AN SO; Watts LA, 2009, GYNECOL ONCOL, V112, P577, DOI 10.1016/j.ygyno.2008.12.010; Wong LP, 2010, EUR J OBSTET GYN R B, V148, P90, DOI 10.1016/j.ejogrb.2009.10.002; Zimet GD, 2010, GYNECOL ONCOL, V117, pS26, DOI 10.1016/j.ygyno.2010.01.028	34	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97119	10.1371/journal.pone.0097119	http://dx.doi.org/10.1371/journal.pone.0097119			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4TJ	24828237	Green Published, Green Submitted, gold			2022-12-27	WOS:000336857400056
J	Garmendia, J; Viadas, C; Calatayud, L; Mell, JC; Marti-Lliteras, P; Euba, B; Llobet, E; Gil, C; Bengoechea, JA; Redfield, RJ; Linares, J				Garmendia, Junkal; Viadas, Cristina; Calatayud, Laura; Mell, Joshua Chang; Marti-Lliteras, Pau; Euba, Begona; Llobet, Enrique; Gil, Carmen; Antonio Bengoechea, Jose; Redfield, Rosemary J.; Linares, Josefina			Characterization of Nontypable Haemophilus influenzae Isolates Recovered from Adult Patients with Underlying Chronic Lung Disease Reveals Genotypic and Phenotypic Traits Associated with Persistent Infection	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CYSTIC-FIBROSIS PATIENTS; MEMBRANE PROTEIN P2; OUTER-MEMBRANE; PSEUDOMONAS-AERUGINOSA; RESPIRATORY-TRACT; BIOFILM FORMATION; STRUCTURAL-CHARACTERIZATION; EPITHELIAL-CELLS; LIPID-A	Nontypable Haemophilus influenzae (NTHi) has emerged as an important opportunistic pathogen causing infection in adults suffering obstructive lung diseases. Existing evidence associates chronic infection by NTHi to the progression of the chronic respiratory disease, but specific features of NTHi associated with persistence have not been comprehensively addressed. To provide clues about adaptive strategies adopted by NTHi during persistent infection, we compared sequential persistent isolates with newly acquired isolates in sputa from six patients with chronic obstructive lung disease. Pulse field gel electrophoresis (PFGE) identified three patients with consecutive persistent strains and three with new strains. Phenotypic characterisation included infection of respiratory epithelial cells, bacterial self-aggregation, biofilm formation and resistance to antimicrobial peptides (AMP). Persistent isolates differed from new strains in showing low epithelial adhesion and inability to form biofilms when grown under continuous-flow culture conditions in microfermenters. Self-aggregation clustered the strains by patient, not by persistence. Increasing resistance to AMPs was observed for each series of persistent isolates; this was not associated with lipooligosaccharide decoration with phosphorylcholine or with lipid A acylation. Variation was further analyzed for the series of three persistent isolates recovered from patient 1. These isolates displayed comparable growth rate, natural transformation frequency and murine pulmonary infection. Genome sequencing of these three isolates revealed sequential acquisition of single-nucleotide variants in the AMP permease sapC, the heme acquisition systems hgpB, hgpC, hup and hxuC, the 3-deoxy-D-manno-octulosonic acid kinase kdkA, the long-chain fatty acid transporter ompP1, and the phosphoribosylamine glycine ligase purD. Collectively, we frame a range of pathogenic traits and a repertoire of genetic variants in the context of persistent infection by NTHi.	[Garmendia, Junkal; Viadas, Cristina; Euba, Begona; Gil, Carmen] CSIC Univ Publ Navarra Gobierno Navarra, Inst Agrobiotecnol, Mutilva, Spain; [Garmendia, Junkal; Calatayud, Laura; Marti-Lliteras, Pau; Euba, Begona; Llobet, Enrique; Antonio Bengoechea, Jose; Linares, Josefina] Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid, Spain; [Garmendia, Junkal; Marti-Lliteras, Pau; Llobet, Enrique; Antonio Bengoechea, Jose] Fdn Invest Sanitaria Illes Balears, Lab Microbial Pathogenesis, Bunyola, Spain; [Calatayud, Laura; Linares, Josefina] Univ Barcelona, Dept Microbiol, IDIBELL, Univ Hosp Bellvitge, Barcelona, Spain; [Mell, Joshua Chang; Redfield, Rosemary J.] Univ British Columbia, Dept Zool, Vancouver, BC V5Z 1M9, Canada; [Mell, Joshua Chang] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA; [Antonio Bengoechea, Jose] CSIC, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-GN-UPNA - Instituto de Agrobiotecnologia (IDAB); Universidad Publica de Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; University of British Columbia; Drexel University; Consejo Superior de Investigaciones Cientificas (CSIC)	Garmendia, J (corresponding author), CSIC Univ Publ Navarra Gobierno Navarra, Inst Agrobiotecnol, Mutilva, Spain.	juncal.garmendia@unavarra.es	Gil, Carmen/K-3759-2017; Liñares, Josefina/N-9450-2014; Garmendia, Juncal/G-4360-2011	Gil, Carmen/0000-0002-8867-4442; Garmendia, Juncal/0000-0002-7440-2737; Bengoechea, Jose/0000-0002-9677-8751	U. S. National Institutes of Health - ISCIII [5F32AI084427, PS09/00130]; Ministerio Economia y Competitividad (MINECO) [SAF2012-31166]; Dpto. Salud Gobierno Navarra [359/2012]; Ministerio Educacion PRX [12/00191, PS09/01904]; Canadian Institutes of Health Research; CIBERES is an initiative from ISCIII, Spain.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI084427] Funding Source: NIH RePORTER	U. S. National Institutes of Health - ISCIII; Ministerio Economia y Competitividad (MINECO); Dpto. Salud Gobierno Navarra; Ministerio Educacion PRX; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); CIBERES is an initiative from ISCIII, Spain.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	JCM was supported by a postdoctoral fellowship from the U. S. National Institutes of Health (5F32AI084427). This work has been funded by grants from ISCIII PS09/00130, Ministerio Economia y Competitividad (MINECO) SAF2012-31166, Dpto. Salud Gobierno Navarra 359/2012, and Ministerio Educacion PRX 12/00191 to JG, PS09/01904 to JL, and Canadian Institutes of Health Research grant to RJR. CIBERES is an initiative from ISCIII, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2011, J CLIN MICROBIOL, V49, P3728, DOI 10.1128/JCM.05476-11; Alhede M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027943; Aussel L, 2000, FEBS LETT, V465, P87, DOI 10.1016/S0014-5793(99)01722-6; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Boisvert S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r122; Brabetz W, 2000, J BIOL CHEM, V275, P34954, DOI 10.1074/jbc.M005204200; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Cardines R, 2012, INT J MED MICROBIOL, V302, P45, DOI 10.1016/j.ijmm.2011.08.003; Charif D., 2007, SEQINR 10 2 CONTRIBU, P207, DOI [10.1007/978-3-540-35306-5_10, DOI 10.1007/978-3-540-35306-5_10]; Chikhi R, 2013, BIOINFORMATICS; Chin CL, 2005, AM J RESP CRIT CARE, V172, P85, DOI 10.1164/rccm.200412-1687OC; Cholon DM, 2008, INFECT IMMUN, V76, P4463, DOI 10.1128/IAI.00499-08; Chung JCS, 2012, J BACTERIOL, V194, P4857, DOI 10.1128/JB.01050-12; Clark SE, 2013, MOL MICROBIOL, V88, P603, DOI 10.1111/mmi.12214; Coutinho CP, 2011, INFECT IMMUN, V79, P2950, DOI 10.1128/IAI.01366-10; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Dixon K, 2007, J BACTERIOL, V189, P511, DOI 10.1128/JB.00815-06; Domenech A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059027; Evans ME, 1999, ANN PHARMACOTHER, V33, P960, DOI 10.1345/aph.18426; Garmendia J, 2012, EUR RESPIR J, V39, P467, DOI 10.1183/09031936.00061911; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Hancock REW, 1999, ANTIMICROB AGENTS CH, V43, P1317, DOI 10.1128/AAC.43.6.1317; Harper M, 2007, INFECT IMMUN, V75, P3885, DOI 10.1128/IAI.00212-07; Harrison A, 2005, J BACTERIOL, V187, P4627, DOI 10.1128/JB.187.13.4627-4636.2005; Hawdon NA, 2010, FEMS IMMUNOL MED MIC, V59, P207, DOI 10.1111/j.1574-695X.2010.00693.x; Hermsen ED, 2003, INFECT DIS CLIN N AM, V17, P545, DOI 10.1016/S0891-5520(03)00058-8; Hill DJ, 2001, MOL MICROBIOL, V39, P850, DOI 10.1046/j.1365-2958.2001.02233.x; Hiltke TJ, 2003, J INFECT DIS, V188, P114, DOI 10.1086/375724; Hiltke TJ, 2002, J INFECT DIS, V185, P627, DOI 10.1086/339362; Kennemann L, 2011, P NATL ACAD SCI USA, V108, P5033, DOI 10.1073/pnas.1018444108; Lee B, 2005, J CLIN MICROBIOL, V43, P5247, DOI 10.1128/JCM.43.10.5247-5255.2005; Lerner CG, 2005, ANTIMICROB AGENTS CH, V49, P2767, DOI 10.1128/AAC.49.7.2767-2777.2005; Li H, 2013, ARXIV13033997V3991QB; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lieberman TD, 2011, NAT GENET, V43, P1275, DOI 10.1038/ng.997; Lindner B, 2000, METH MOL B, V145, P311; Liu BH, 2012, BIOINFORMATICS, V28, P2870, DOI 10.1093/bioinformatics/bts563; Llobet E, 2011, INFECT IMMUN, V79, P3718, DOI 10.1128/IAI.05226-11; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Lysenko ES, 2000, INFECT IMMUN, V68, P1664, DOI 10.1128/IAI.68.3.1664-1671.2000; Marti-Lliteras P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021133; Mason KM, 2011, J BACTERIOL, V193, P2527, DOI 10.1128/JB.01313-10; Maughan H, 2009, EVOLUTION, V63, P1852, DOI 10.1111/j.1558-5646.2009.00658.x; McCrea KW, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-286; Mell JC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002151; Meng GY, 2011, EMBO J, V30, P3864, DOI 10.1038/emboj.2011.279; Mikhail I, 2005, ANAL BIOCHEM, V340, P303, DOI 10.1016/j.ab.2005.02.020; Mira NP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028831; Mongodin E, 2003, J BACTERIOL, V185, P4638, DOI 10.1128/JB.185.15.4638-4643.2003; Morey P, 2013, INFECT IMMUN, V81, P4100, DOI 10.1128/IAI.00492-13; Morey P, 2011, MICROBIOL-SGM, V157, P234, DOI 10.1099/mic.0.040451-0; Murphy TF, 2004, AM J RESP CRIT CARE, V170, P266, DOI 10.1164/rccm.200403-354OC; Murphy TF, 1999, J INFECT DIS, V180, P404, DOI 10.1086/314870; Murphy TF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025923; Murphy TF, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-7; NICOLAS P, 1995, ANNU REV MICROBIOL, V49, P277, DOI 10.1146/annurev.mi.49.100195.001425; Oertelt C, 2001, EUR J BIOCHEM, V268, P554, DOI 10.1046/j.1432-1327.2001.01891.x; Parameswaran GI, 2012, FUTURE MICROBIOL, V7, P1129, DOI [10.2217/fmb.12.88, 10.2217/FMB.12.88]; Perez-Gutierrez C, 2010, INFECT IMMUN, V78, P2768, DOI 10.1128/IAI.01417-09; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Poje Grant, 2003, Methods Mol Med, V71, P57; Poole J, 2013, J INFECT DIS, V208, P720, DOI 10.1093/infdis/jit240; Power PM, 2009, INFECT GENET EVOL, V9, P216, DOI 10.1016/j.meegid.2008.11.006; Puig C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082515; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rebeil R, 2004, MOL MICROBIOL, V52, P1363, DOI 10.1111/j.1365-2958.2004.04059.x; Reguleiro V, 2009, EUR RESPIR J, V33, P273, DOI 10.1183/09031936.00087708; Roson B, 2000, CLIN INFECT DIS, V31, P869, DOI 10.1086/318151; Samuelsen O, 2005, J ANTIMICROB CHEMOTH, V56, P1126, DOI 10.1093/jac/dki385; Sekhar S, 2009, J MED MICROBIOL, V58, P1428, DOI 10.1099/jmm.0.010355-0; Sethi S, 2004, AM J RESP CRIT CARE, V169, P448, DOI 10.1164/rccm.200308-1181OC; Sethi S, 2010, EUR RESPIR J, V35, P1209, DOI 10.1183/09031936.00081409; Sethi S, 2002, NEW ENGL J MED, V347, P465, DOI 10.1056/NEJMoa012561; Sethi S, 2008, AM J RESP CRIT CARE, V177, P491, DOI 10.1164/rccm.200708-1234OC; Sethi Sanjay, 2009, Proc Am Thorac Soc, V6, P532, DOI 10.1513/pats.200905-025DS; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Starner TD, 2002, INFECT IMMUN, V70, P5287, DOI 10.1128/IAI.70.9.5287-5289.2002; Szelestey BR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003709; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; VAARA M, 1992, MICROBIOL REV, V56, P395, DOI 10.1128/MMBR.56.3.395-411.1992; Wayne P., 2010, CLIN LAB STANDARDS I; Wayne P., 2006, METHODS DILUTION ANT; Webb DC, 1999, PROTEIN EXPRES PURIF, V15, P1, DOI 10.1006/prep.1998.0990; Weiser JN, 1997, INFECT IMMUN, V65, P943, DOI 10.1128/IAI.65.3.943-950.1997; Whitby PW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-6	85	23	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97020	10.1371/journal.pone.0097020	http://dx.doi.org/10.1371/journal.pone.0097020			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824990	Green Published, gold			2022-12-27	WOS:000336369200051
J	Lutambi, AM; Chitnis, N; Briet, OJT; Smith, TA; Penny, MA				Lutambi, Angelina Mageni; Chitnis, Nakul; Briet, Olivier J. T.; Smith, Thomas A.; Penny, Melissa A.			Clustering of Vector Control Interventions Has Important Consequences for Their Effectiveness: A Modelling Study	PLOS ONE			English	Article							AFRICAN MOSQUITOS DIPTERA; TREATED BED NETS; ANOPHELES-GAMBIAE; MALARIA TRANSMISSION; DISPERSAL; FUNESTUS; DYNAMICS	Vector control interventions have resulted in considerable reductions in malaria morbidity and mortality. When universal coverage cannot be achieved for financial or logistical reasons, the spatial arrangement of vector control is potentially important for optimizing benefits. This study investigated the effect of spatial clustering of vector control interventions on reducing the population of biting mosquitoes. A discrete-space continuous-time mathematical model of mosquito population dynamics and dispersal was extended to incorporate vector control interventions of insecticide treated bednets (ITNs), Indoor residual Spraying (IRS), and larviciding. Simulations were run at varying levels of coverage and degree of spatial clustering. At medium to high coverage levels of each of the interventions or in combination was more effective to spatially spread these interventions than to cluster them. Suggesting that when financial resources are limited, unclustered distribution of these interventions is more effective. Although it is often stated that locally high coverage is needed to achieve a community effect of ITNs or IRS, our results suggest that if the coverage of ITNs or IRS are insufficient to achieve universal coverage, and there is no targeting of high risk areas, the overall effects on mosquito densities are much greater if they are distributed in an unclustered way, rather than clustered in specific localities. Also, given that interventions are often delivered preferentially to accessible areas, and are therefore clustered, our model results show this may be inefficient. This study provides evidence that the effectiveness of an intervention can be highly dependent on its spatial distribution. Vector control plans should consider the spatial arrangement of any intervention package to ensure effectiveness is maximized.	[Lutambi, Angelina Mageni; Chitnis, Nakul; Briet, Olivier J. T.; Smith, Thomas A.; Penny, Melissa A.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Lutambi, Angelina Mageni; Chitnis, Nakul; Briet, Olivier J. T.; Smith, Thomas A.; Penny, Melissa A.] Univ Basel, Basel, Switzerland; [Lutambi, Angelina Mageni] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Chitnis, Nakul] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Ifakara Health Institute; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Lutambi, AM (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.	angelina-m.lutambi@unibas.ch	Penny, Melissa A/N-6838-2015; Briët, Olivier/K-1917-2015; Smith, Thomas/B-5569-2015; Chitnis, Nakul/B-3105-2013	Penny, Melissa A/0000-0002-4972-593X; Briët, Olivier/0000-0003-1186-2688; Smith, Thomas/0000-0002-3650-9381; Chitnis, Nakul/0000-0002-1103-9141	Bill and Melinda Gates Foundation provided through Swiss TPH	Bill and Melinda Gates Foundation provided through Swiss TPH	Funding support was from the Bill and Melinda Gates Foundation provided through Swiss TPH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, COCHRANE DB SYST REV; Bayoh MN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-62; Bayoh MN, 2003, B ENTOMOL RES, V93, P375, DOI 10.1079/BER2003259; Chitnis N, 2010, AM J TROPICAL MED HY, V83; Chitnis Nakul, 2008, Journal of Biological Dynamics, V2, P259, DOI 10.1080/17513750701769857; Chouaibou M, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-77; Cummins B, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002500; Eckhoff PA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-303; Edman JD, 1998, J MED ENTOMOL, V35, P578, DOI 10.1093/jmedent/35.4.578; Fillinger U, 2006, TROPICAL MED INT HLT, P11; Gething PW, 2011, PARASITE VECTOR, V92, P2; GILLIES M. T., 1961, BULL ENT RES, V52, P99, DOI 10.1017/S0007485300055309; GILLIES MT, 1978, B ENTOMOL RES, V68, P401, DOI 10.1017/S000748530000938X; GILLIES MT, 1981, B ENTOMOL RES, V71, P65, DOI 10.1017/S0007485300051038; Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324; Gu W, 2006, PNAS, V103; Gu WD, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-256; Gu WD, 2009, T ROY SOC TROP MED H, V103, P1105, DOI 10.1016/j.trstmh.2009.01.006; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; Hiebeler D, 2005, LECT NOTES COMPUT SC, V3515, P360; Hiebeler D, 2000, ECOLOGY, V81, P1629, DOI 10.1890/0012-9658(2000)081[1629:POFLWS]2.0.CO;2; Hiebeler D, 1997, J THEORETICAL BIOL, P187; Holsetein M.H., 1954, MONOGRAPH SERIES, V9; Killeen GF, 2006, AM J TROPICAL MED HY, P74; Killeen GF, 2001, T ROYAL SOC TROPICAL, P95; Kirby MJ, 2009, ACTA TROP, V109, P118, DOI 10.1016/j.actatropica.2008.09.025; Kroeger A, 1995, ACTA TROPICA, P60; Le Menach A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-10; Lee SH, 2007, BIOSYSTEMS, V90; Lutambi AM, 2013, MATH BIOSCI, V241, P198, DOI 10.1016/j.mbs.2012.11.013; Majambere S, 2010, AM J TROPICAL MED HY, P82; Majambere S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-76; McKenzie FE, 2004, AM J TROP MED HYG, V71, P94, DOI 10.4269/ajtmh.2004.71.94; Midega JT, 2007, J MED ENTOMOL, V44, P923, DOI 10.1603/0022-2585(2007)44[923:EDASOA]2.0.CO;2; Muturi EJ, 2008, AM J TROPICAL MED HY, P78; Mwangangi JM, 2011, PARASITOL RES, V108, P1355, DOI 10.1007/s00436-010-2029-1; Nourridine Siewe, 2011, Journal of Biological Dynamics, V5, P335, DOI 10.1080/17513758.2010.508540; Okogun Godwin Ray Anugboba, 2005, Journal of Vector Borne Diseases, V42, P45; Okuyama T, 2008, BASIC APPL ECOL, V9, P135, DOI 10.1016/j.baae.2007.01.007; Otero M, 2008, B MATH BIOL, V70, P1297, DOI 10.1007/s11538-008-9300-y; Oxborough RM, 2008, ANN TROPICAL MED PAR, P102; Papke LE, 1996, J APPL ECONOM, V11, P619, DOI 10.1002/(SICI)1099-1255(199611)11:6<619::AID-JAE418>3.0.CO;2-1; RBM, 2013, MIN ROLL BACK MAL VE; Service MW, 1997, J MED ENTOMOLOGY, V34; Service MW, 2004, MED ENT STUD; Smith DL, 2009, TRENDS PARASITOLOGY, P25; Su M, 2009, ECOL RES, V24, P889, DOI 10.1007/s11284-008-0568-z; Takken W, 2002, TROPICAL MED INT HLT, P7; Thomson NA, 2003, THEOR POPUL BIOL, V64, P271, DOI 10.1016/S0040-5809(03)00088-1; Tsonis AA, 2008, PHYSICA A, V387, P5287, DOI 10.1016/j.physa.2008.05.048; Westerberg L, 2005, ECOL MODEL, V188, P432, DOI 10.1016/j.ecolmodel.2005.02.004; White MT, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-153; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2006, D91 SECURESCM; WHO, 2007, D91 SECURESCM; WHO, 2004, D91 SECURESCM; Worrall E, 2007, TROPICAL MED INT HLT, P12; Yakob L, 2010, T ROY SOC TROP MED H, V104, P669, DOI 10.1016/j.trstmh.2010.07.014; Yakob L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006921; Yaro AS, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-19	60	12	12	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97065	10.1371/journal.pone.0097065	http://dx.doi.org/10.1371/journal.pone.0097065			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24823656	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000336369200055
J	Raineri, E; Dabad, M; Heath, S				Raineri, Emanuele; Dabad, Marc; Heath, Simon			A Note on Exact Differences between Beta Distributions in Genomic (Methylation) Studies	PLOS ONE			English	Article								We apply a known algorithm for computing exactly inequalities between Beta distributions to assess whether a given position in a genome is differentially methylated across samples. We discuss the advantages brought by the adoption of this solution with respect to two approximations (Fisher's test and Z score). The same formalism presented here can be applied in a similar way to variant calling.	[Raineri, Emanuele; Dabad, Marc; Heath, Simon] Ctr Nacl Anal Genom, Barcelona, Catalonia, Spain		Raineri, E (corresponding author), Ctr Nacl Anal Genom, Barcelona, Catalonia, Spain.	emanuele.raineri@gmail.com	Dabad, Marc/Q-9601-2019; Raineri, Emanuele/AAX-7874-2020; Dabad, Marc/M-9522-2015; Heath, Simon C/J-4138-2012	Dabad, Marc/0000-0002-6094-747X; Dabad, Marc/0000-0002-6094-747X; Heath, Simon C/0000-0002-9550-0897	Spanish Ministerio de Ciencia e Innovacion [SAF2011-30391]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	The authors would like to acknowledge the support provided by the Spanish Ministerio de Ciencia e Innovacion (grant SAF2011-30391). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz M., 1965, HDB MATH FUNCTIONS; Calladine C. R., 2004, UNDERSTANDING DNA MO; Cook JD, 2008, D91 SECURESCM; Cook JD, 2005, D91 SECURESCM; Feng H, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku154; Hansen KD, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r83, 10.1186/gb-2012-13-10-R83]; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Sun DQ, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r38	8	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97349	10.1371/journal.pone.0097349	http://dx.doi.org/10.1371/journal.pone.0097349			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824426	gold, Green Published, Green Submitted			2022-12-27	WOS:000336369200100
J	Sandberg, J; Pettersson, KO; Asp, G; Kabakyenga, J; Agardh, A				Sandberg, Jacob; Pettersson, Karen Odberg; Asp, Gustav; Kabakyenga, Jerome; Agardh, Anette			Inadequate Knowledge of Neonatal Danger Signs among Recently Delivered Women in Southwestern Rural Uganda: A Community Survey	PLOS ONE			English	Article							HEALTH-WORKERS; BIRTH-PREPAREDNESS; ANTENATAL CARE; NEWBORN-CARE; SYLHET DISTRICT; MATERNAL HEALTH; MALARIA; MOTHERS; VALIDATION; ILLNESSES	Background: Early detection of neonatal illness is an important step towards improving newborn survival. Every year an estimated 3.07 million children die during their first month of life and about one-third of these deaths occur during the first 24 hours. Ninety-eight percent of all neonatal deaths occur in low- and middle-income countries like Uganda. Inadequate progress has been made globally to reduce the amount of neonatal deaths that would be required to meet Millennium Development Goal 4. Poor knowledge of newborn danger signs delays care seeking. The aim of this study was to explore the knowledge of key newborn danger signs among mothers in southwestern Uganda. Methods: Results from a community survey of 765 recently delivered women were analyzed using univariate and multivariate logistic regressions. Six key danger signs were identified, and spontaneous responses were categorized, tabulated, and analyzed. Results: Knowledge of at least one key danger sign was significantly associated with being birth prepared (adjusted OR 1.7, 95% CI 1.2-2.3). Birth preparedness consisted of saving money, identifying transportation, identifying a skilled birth attendant and buying a delivery kit or materials. Overall, respondents had a poor knowledge of key newborn danger signs: 58.2% could identify one and 14.8% could identify two. We found no association between women attending the recommended number of antenatal care visits and their knowledge of danger signs (adjusted OR 1.0, 95% CI 0.8-1.4), or between women using a skilled birth attendant at delivery and their knowledge of danger signs (adjusted OR 1.2, 95% CI 0.9-1.7). Conclusions: Our findings indicate the need to enhance education of mothers in antenatal care as well as those discharged from health facilities after delivery. Further promotion of birth preparedness is encouraged as part of the continuum of maternal care.	[Sandberg, Jacob; Pettersson, Karen Odberg; Asp, Gustav; Kabakyenga, Jerome; Agardh, Anette] Lund Univ, Dept Clin Sci, Lund, Sweden; [Kabakyenga, Jerome] Mbarara Univ Sci & Technol, Fac Med, Mbarara, Uganda	Lund University; Mbarara University of Science & Technology	Sandberg, J (corresponding author), Lund Univ, Dept Clin Sci, Lund, Sweden.	jacob.sandberg@gmail.com	Sandberg, Jacob/AAL-8640-2021	Sandberg, Jacob/0000-0003-1863-2033	Swedish Agency of International Aid; Health Child Uganda; Global Health Research Initiative	Swedish Agency of International Aid; Health Child Uganda; Global Health Research Initiative	The original project was funded by a grant from Swedish Agency of International Aid, as well as Health Child Uganda and Global Health Research Initiative. This study has not received any funding. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Accorsi S, 2003, SOC SCI MED, V57, P2183, DOI 10.1016/S0277-9536(03)00082-0; Adegoke AA, 2009, BJOG-INT J OBSTET GY, V116, P33, DOI 10.1111/j.1471-0528.2009.02336.x; Agarwal S, 2010, J HEALTH POPUL NUTR, V28, P383; [Anonymous], LEV TRENDS CHILD MOR; [Anonymous], 2013, AFR DEV IND 2012 201; Asp G, 2011, J OBSTET GYNAECOL, V31, P612, DOI 10.3109/01443615.2011.593652; Asp G, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.22904; Awasthi S, 2006, B WORLD HEALTH ORGAN, V84, P819, DOI 10.2471/BLT.05.029207; Azad K, 2010, LANCET, V375, P1193, DOI 10.1016/S0140-6736(10)60142-0; Bang AT, 2005, PEDIATR INFECT DIS J, V24, P335, DOI 10.1097/01.inf.0000157094.43609.17; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Baqui AH, 2007, J HEALTH POPUL NUTR, V25, P179; Baqui AH, 2009, TROP MED INT HEALTH, V14, P1448, DOI 10.1111/j.1365-3156.2009.02397.x; Bhutta ZA, 2010, LANCET, V375, P1142, DOI 10.1016/S0140-6736(10)60324-8; Carlin JB, 2008, LANCET, V371, P135, DOI 10.1016/S0140-6736(08)60106-3; Carroli G, 2001, LANCET, V357, P1565, DOI 10.1016/S0140-6736(00)04723-1; Choi Y, 2010, TROP MED INT HEALTH, V15, P743, DOI 10.1111/j.1365-3156.2010.02532.x; Conrad P, 2012, QUAL HEALTH RES, V22, P619, DOI 10.1177/1049732311431897; Darmstadt GL, 2011, ARCH DIS CHILD, V96, P1140, DOI 10.1136/archdischild-2011-300591; Darmstadt GL, 2009, B WORLD HEALTH ORGAN, V87, P12, DOI 10.2471/BLT.07.050666; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Del Barco R.E., 2004, TOOLS INDICATORS MAT; Dongre AR, 2009, INDIAN J PEDIATR, V76, P691, DOI 10.1007/s12098-009-0106-1; Falade CO, 2005, INT Q COMMUNITY HEAL, V24, P347, DOI 10.2190/GN66-9447-3984-4064; Getahun A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-320; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Hill Z, 2003, TROP MED INT HEALTH, V8, P668, DOI 10.1046/j.1365-3156.2003.01058.x; Houweling TAJ, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-208; Iriso R, 2000, TROP MED INT HEALTH, V5, P706, DOI 10.1046/j.1365-3156.2000.00625.x; Kabakyenga JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035747; Kabakyenga JK, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-33; Khadduri R, 2008, J PERINATOL, V28, P182, DOI 10.1038/sj.jp.7211903; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2010, SEMIN PERINATOL, V34, P371, DOI 10.1053/j.semperi.2010.09.011; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Malata A, 2007, J ADV NURS, V60, P67, DOI 10.1111/j.1365-2648.2007.04380.x; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; Mbarara district local government, 2011, HIGH LOC GOVT STAT A; Ministry of Health Uganda, 2009, ROAD MAP ACC RED MAT; Moran AC, 2006, J HEALTH POPUL NUTR, V24, P489; Nuwaha F, 2002, TROP MED INT HEALTH, V7, P462, DOI 10.1046/j.1365-3156.2002.00877.x; Pakistani Initiative for Mothers and Newborns, 2006, UPP DIR BAS HOUS SUR; Pembe AB, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-12; Pilkington H, 2004, J EPIDEMIOL COMMUN H, V58, P826, DOI 10.1136/jech.2003.016089; Runsewe-Abiodun Iyabo T, 2006, BMC Pediatr, V6, P19, DOI 10.1186/1471-2431-6-19; Singh K, 2013, MATERNAL CHILD HLTH; Tetui M, 2012, PAN AFR MED J, V13; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; The Partnership for Maternal Newborn and Child Health, 2006, OPPORTUNITIES AFRICA; Tripathy P, 2010, LANCET, V375, P1182, DOI 10.1016/S0140-6736(09)62042-0; UBOS and Macro International Inc, 2012, UG DEM HLTH SURV 201, P119; Villar J, 2001, LANCET, V357, P1551, DOI 10.1016/S0140-6736(00)04722-X; Waiswa P, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-213; Waiswa P, 2010, TROP MED INT HEALTH, V15, P964, DOI 10.1111/j.1365-3156.2010.02557.x; Waiswa P, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-9; Weiner EA, 2011, J PERINATOL, V31, P92, DOI 10.1038/jp.2010.108; WHO, 2005, HDB IMCI INT MAN CHI; World Health Organization (WHO), 2004, MAK PREGN SAF CRIT R	58	42	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97253	10.1371/journal.pone.0097253	http://dx.doi.org/10.1371/journal.pone.0097253			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824364	Green Submitted, Green Published, gold			2022-12-27	WOS:000336369200080
J	Khan, NA; Aziz, S; Khan, NA				Khan, Najeeb Alam; Aziz, Shahnila; Khan, Nadeem Alam			Numerical Simulation for the Unsteady MHD Flow and Heat Transfer of Couple Stress Fluid over a Rotating Disk	PLOS ONE			English	Article							OLDROYD-B FLUID; VISCOUS DISSIPATION; VARIABLE PROPERTIES; FIELD; CONE; HALL	The present work is devoted to study the numerical simulation for unsteady MHD flow and heat transfer of a couple stress fluid over a rotating disk. A similarity transformation is employed to reduce the time dependent system of nonlinear partial differential equations (PDEs) to ordinary differential equations (ODEs). The Runge-Kutta method and shooting technique are employed for finding the numerical solution of the governing system. The influences of governing parameters viz. unsteadiness parameter, couple stress and various physical parameters on velocity, temperature and pressure profiles are analyzed graphically and discussed in detail.	[Khan, Najeeb Alam; Aziz, Shahnila; Khan, Nadeem Alam] Univ Karachi, Dept Math Sci, Karachi, Pakistan	University of Karachi	Khan, NA (corresponding author), Univ Karachi, Dept Math Sci, Karachi, Pakistan.	njbalam@yahoo.com	Khan, Najeeb Alam/Q-2160-2019; Khan, Najeeb Alam/AAM-3168-2021	Khan, Najeeb Alam/0000-0001-6242-0658				Ariel PD, 2002, Z ANGEW MATH MECH, V82, P235, DOI 10.1002/1521-4001(200204)82:4<235::AID-ZAMM235>3.0.CO;2-L; Bellout H, 2013, Z ANGEW MATH PHYS, V64, P83, DOI 10.1007/s00033-012-0221-0; Chamkha AJ, 2012, CHEM ENG COMMUN, V199, P122, DOI 10.1080/00986445.2011.575907; Dehghan M, 2009, COMPUT PHYS COMMUN, V180, P1458, DOI 10.1016/j.cpc.2009.03.007; Dehghan M, 2009, APPL NUMER MATH, V59, P1043, DOI 10.1016/j.apnum.2008.05.001; Dinarvand S, 2010, NONLINEAR ANAL-REAL, V11, P1159, DOI 10.1016/j.nonrwa.2009.02.009; Fang T, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2823572; Farooq M, 2011, HEAT TRANSF RES, V42, P737, DOI 10.1615/HeatTransRes.2012000996; Hayat T, 2009, CHAOS SOLITON FRACT, V39, P840, DOI 10.1016/j.chaos.2007.01.067; Jamil M, 2013, THERM SCI, V17, P997, DOI 10.2298/TSCI110731140J; Khan I, 2012, SPEC TOP REV POROUS, V3, P89, DOI 10.1615/SpecialTopicsRevPorousMedia.v3.i1.80; Khan I, 2012, TRANSPORT POROUS MED, V91, P49, DOI 10.1007/s11242-011-9832-8; Khan NA, 2013, ENG COMPUTATION, V30, P399, DOI 10.1108/02644401311314358; Kumar SK, 1987, 321 WINTHR COLL DEP; Lorrain P., 2006, MAGNETO FLUID DYNAMI; Maleque KA, 2005, J HEAT TRANS-T ASME, V127, P1406, DOI 10.1115/1.2098860; Ming CY, 2011, INT COMMUN HEAT MASS, V38, P280, DOI 10.1016/j.icheatmasstransfer.2010.11.013; Nadeem S, 2013, J TAIWAN INST CHEM E, V44, P596, DOI 10.1016/j.jtice.2013.01.007; Osalusi E, 2008, INT COMMUN HEAT MASS, V35, P413, DOI 10.1016/j.icheatmasstransfer.2007.09.002; Osalusi E, 2007, INT COMMUN HEAT MASS, V34, P1017, DOI 10.1016/j.icheatmasstransfer.2007.05.009; Ram P, 2013, RESULTS PHYS, V3, P55, DOI 10.1016/j.rinp.2013.03.002; Ramzan M, 2013, EUROPE PHY J, V128, P1; Rashidi MM, 2012, COMPUT FLUIDS, V54, P1, DOI 10.1016/j.compfluid.2011.08.001; Rashidi MM, 2014, THERM SCI, V18, pS527, DOI 10.2298/TSCI120301155R; Rashidi MM, 2009, NONLINEAR ANAL-REAL, V10, P2346, DOI 10.1016/j.nonrwa.2008.04.018; Sreenadh S., 2011, ADV APPL SCI RES, V2, P215; STOKES VK, 1966, PHYS FLUIDS, V9, P1709, DOI 10.1063/1.1761925; Takhar HS, 2002, INT J THERM SCI, V41, P147, DOI 10.1016/S1290-0729(01)01292-3; Turkyilmazoglu M, 2012, INT J HEAT MASS TRAN, V55, P6959, DOI 10.1016/j.ijheatmasstransfer.2012.05.089; Turkyilmazoglu M, 2012, APPL THERM ENG, V35, P127, DOI 10.1016/j.applthermaleng.2011.10.014; Wiesche SAD, 2007, INT J THERM SCI, V46, P745, DOI 10.1016/j.ijthermalsci.2006.10.013	31	31	32	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e95423	10.1371/journal.pone.0095423	http://dx.doi.org/10.1371/journal.pone.0095423			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835274	Green Submitted, Green Published, gold			2022-12-27	WOS:000339614800007
J	Martin, JW; Chilton-MacNeill, S; Koti, M; van Wijnen, AJ; Squire, JA; Zielenska, M				Martin, Jeffrey W.; Chilton-MacNeill, Susan; Koti, Madhuri; van Wijnen, Andre J.; Squire, Jeremy A.; Zielenska, Maria			Digital Expression Profiling Identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as Potential Predictive Biomarkers for Neo-Adjuvant Chemotherapy Response in Paediatric Osteosarcoma	PLOS ONE			English	Article							TRANSCRIPTION FACTOR RUNX2; HIGH-GRADE OSTEOSARCOMA; CELL-CYCLE KINASES; GENE-EXPRESSION; OSTEOBLAST DIFFERENTIATION; CHROMOSOMAL INSTABILITY; PROTEIN EXPRESSION; PROGNOSTIC-FACTORS; TUMOR-SUPPRESSOR; COPY NUMBER	Osteosarcoma is the most common malignancy of bone, and occurs most frequently in children and adolescents. Currently, the most reliable technique for determining a patients' prognosis is measurement of histopathologic tumor necrosis following pre-operative neo-adjuvant chemotherapy. Unfavourable prognosis is indicated by less than 90% estimated necrosis of the tumor. Neither genetic testing nor molecular biomarkers for diagnosis and prognosis have been described for osteosarcomas. We used the novel nanoString mRNA digital expression analysis system to analyse gene expression in 32 patients with sporadic paediatric osteosarcoma. This system used specific molecular barcodes to quantify expression of a set of 17 genes associated with osteosarcoma tumorigenesis. Five genes, from this panel, which encoded the bone differentiation regulator RUNX2, the cell cycle regulator CDC5L, the TP53 transcriptional inactivator MDM2, the DNA helicase RECQL4, and the cyclin-dependent kinase gene CDK4, were differentially expressed in tumors that responded poorly to neo-adjuvant chemotherapy. Analysis of the signalling relationships of these genes, as well as other expression markers of osteosarcoma, indicated that gene networks linked to RB1, TP53, PI3K, PTEN/Akt, myc and RECQL4 are associated with osteosarcoma. The discovery of these networks provides a basis for further experimental studies of role of the five genes (RUNX2, CDC5L, MDM2, RECQL4, and CDK4) in differential response to chemotherapy.	[Martin, Jeffrey W.; Chilton-MacNeill, Susan; Zielenska, Maria] Hosp Sick Children, Dept Paediat Lab Med, Toronto, ON M5G 1X8, Canada; [van Wijnen, Andre J.] Mayo Clin, Dept Orthoped Surg, Rochester, MN USA; [van Wijnen, Andre J.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA; [Squire, Jeremy A.] Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada; [Koti, Madhuri] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Squire, Jeremy A.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Genet, Ribeirao Preto, SP, Brazil; [Squire, Jeremy A.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Pathol, Ribeirao Preto, SP, Brazil	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Mayo Clinic; Mayo Clinic; McMaster University; Queens University - Canada; Queens University - Canada; Universidade de Sao Paulo; Universidade de Sao Paulo	Squire, JA (corresponding author), Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada.	jsquireinsp@gmail.com	Squire, Jeremy A/A-9352-2012; van Wijnen, Andre J./AAG-3578-2019	Squire, Jeremy A/0000-0002-9863-468X; van Wijnen, Andre J./0000-0002-4458-0946	Canadian Cancer Society [CCRI-020247]; National Institutes of Health [AR049069]	Canadian Cancer Society(Canadian Cancer Society (CCS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the Canadian Cancer Society through grant CCRI-020247. Additional support was provided by National Institutes of Health grant AR049069 (to AvW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein HS, 1998, J BIOL CHEM, V273, P4666, DOI 10.1074/jbc.273.8.4666; Bielack SS, 2002, J CLIN ONCOL, V20, P776, DOI 10.1200/JCO.20.3.776; Broadhead Matthew L., 2011, Sarcoma, V2011, P959248, DOI 10.1155/2011/959248; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Chibon F, 2010, NAT MED, V16, P781, DOI 10.1038/nm.2174; Clark JCM, 2008, J CANCER RES CLIN, V134, P281, DOI 10.1007/s00432-007-0330-x; Cleton-Jansen AM, 2009, BRIT J CANCER, V101, P1909, DOI 10.1038/sj.bjc.6605405; Dalla-Torre CA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-237; Dujardin F, 2011, MODERN PATHOL, V24, P624, DOI 10.1038/modpathol.2010.229; Feugeas O, 1996, J CLIN ONCOL, V14, P467, DOI 10.1200/JCO.1996.14.2.467; Freeman SS, 2008, CANCER-AM CANCER SOC, V113, P1453, DOI 10.1002/cncr.23782; Gallaher B, 2000, CELL MOL BIOL, V46, P79; Gamberi G, 1998, ONCOLOGY-BASEL, V55, P556, DOI 10.1159/000011912; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Helman LJ, 2003, NAT REV CANCER, V3, P685, DOI 10.1038/nrc1168; Janssens Nico, 2004, Mol Diagn, V8, P107, DOI 10.2165/00066982-200408020-00005; Kang MI, 2007, J CELL BIOCHEM, V102, P224, DOI 10.1002/jcb.21291; Kelly AD, 2013, GENOME MED, V5, DOI 10.1186/gm406; Kuijjer ML, 2012, GENE CHROMOSOME CANC, V51, P696, DOI 10.1002/gcc.21956; Kurek KC, 2010, CANCER RES, V70, P5577, DOI 10.1158/0008-5472.CAN-09-4602; Kyriazoglou AI, 2012, CANCER GENET-NY, V205, P332, DOI 10.1016/j.cancergen.2012.04.011; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Lee JS, 2006, J BONE MINER RES, V21, P921, DOI 10.1359/JBMR.060303; Lengner CJ, 2006, J CELL BIOL, V172, P909, DOI 10.1083/jcb.200508130; Liu JC, 2011, J BIOL CHEM, V286, P30057, DOI 10.1074/jbc.M111.241505; Lu XY, 2008, MOL CANCER RES, V6, P937, DOI 10.1158/1541-7786.MCR-07-2115; Lucero CMJ, 2013, J CELL PHYSIOL, V228, P714, DOI 10.1002/jcp.24218; Maire G, 2009, NEOPLASIA, V11, P260, DOI 10.1593/neo.81384; Malkov Vladislav A, 2009, BMC Res Notes, V2, P80, DOI 10.1186/1756-0500-2-80; Malumbres M, 2007, CURR OPIN GENET DEV, V17, P60, DOI 10.1016/j.gde.2006.12.008; Martin J. W., 2011, Sarcoma, V2011, P282745, DOI 10.1155/2011/282745; Martin Jeff W., 2012, Sarcoma, V2012, P627254, DOI 10.1155/2012/627254; Mauro M, 2012, NUCLEIC ACIDS RES, V40, P8348, DOI 10.1093/nar/gks612; Mohseny AB, 2010, GENE CHROMOSOME CANC, V49, P1095, DOI 10.1002/gcc.20817; Namlos Heidi M., 2012, Sarcoma, V2012, P639038, DOI 10.1155/2012/639038; Nathan SS, 2009, MOL BIOL REP, V36, P153, DOI 10.1007/s11033-008-9378-1; Northcott PA, 2012, ACTA NEUROPATHOL, V123, P615, DOI 10.1007/s00401-011-0899-7; Sadikovic B, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-202; Sadikovic B, 2009, HUM MOL GENET, V18, P1962, DOI 10.1093/hmg/ddp117; Sato N, 2000, ANTICANCER RES, V20, P837; Scott MC, 2011, BONE, V49, P356, DOI 10.1016/j.bone.2011.05.008; Selvarajah S, 2008, CYTOGENET GENOME RES, V122, P5, DOI 10.1159/000151310; Shimizu T, 2010, ONCOGENE, V29, P5687, DOI 10.1038/onc.2010.312; Smida J, 2010, CLIN CANCER RES, V16, P4256, DOI 10.1158/1078-0432.CCR-10-0284; Stein GS, 2004, ONCOGENE, V23, P4315, DOI 10.1038/sj.onc.1207676; Teplyuk NM, 2008, J BIOL CHEM, V283, P27585, DOI 10.1074/jbc.M802453200; Terry A, 2004, GENE, V336, P115, DOI 10.1016/j.gene.2004.04.015; Thangavel S, 2010, MOL CELL BIOL, V30, P1382, DOI 10.1128/MCB.01290-09; Thomas DM, 2004, J CELL BIOL, V167, P925, DOI 10.1083/jcb.200409187; Tsuchiya T, 2000, CANCER GENET CYTOGEN, V120, P91, DOI 10.1016/S0165-4608(99)00255-1; Turner NC, 2012, LANCET ONCOL, V13, pE178, DOI 10.1016/S1470-2045(11)70335-7; van der Deen M, 2013, J BIOL CHEM, V288, P21307, DOI 10.1074/jbc.M112.445890; Wang LL, 2003, J NATL CANCER I, V95, P669, DOI 10.1093/jnci/95.9.669; Wang ZX, 2010, BONE, V47, P445, DOI 10.1016/j.bone.2010.05.027; Won KY, 2009, TUMORI J, V95, P311; Wunder JS, 2005, J CLIN ONCOL, V23, P1483, DOI 10.1200/JCO.2005.04.074; Xiao ZS, 1998, GENE, V214, P187, DOI 10.1016/S0378-1119(98)00227-3; Yoshida A, 2012, AM J SURG PATHOL, V36, P423, DOI 10.1097/PAS.0b013e31824230d0; Zhang NX, 2009, EMBO REP, V10, P1029, DOI 10.1038/embor.2009.122	60	65	67	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e95843	10.1371/journal.pone.0095843	http://dx.doi.org/10.1371/journal.pone.0095843			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835790	Green Submitted, Green Published, gold			2022-12-27	WOS:000339614800010
J	Nguyen, KA; Hamzeh-Cognasse, H; Sebban, M; Fromont, E; Chavarin, P; Absi, L; Pozzetto, B; Cognasse, F; Garraud, O				Kim Anh Nguyen; Hamzeh-Cognasse, Hind; Sebban, Marc; Fromont, Elisa; Chavarin, Patricia; Absi, Lena; Pozzetto, Bruno; Cognasse, Fabrice; Garraud, Olivier			A Computerized Prediction Model of Hazardous Inflammatory Platelet Transfusion Outcomes	PLOS ONE			English	Article							ACUTE LUNG INJURY; SOLUBLE CD40 LIGAND; SINGLE-NEEDLE PLATELETPHERESIS; COAT-DERIVED PLATELETS; IN-VITRO; ADDITIVE SOLUTIONS; TRIMA ACCEL; STORAGE; BLOOD; CD154	Background: Platelet component (PC) transfusion leads occasionally to inflammatory hazards. Certain BRMs that are secreted by the platelets themselves during storage may have some responsibility. Methodology/Principal Findings: First, we identified non-stochastic arrangements of platelet-secreted BRMs in platelet components that led to acute transfusion reactions (ATRs). These data provide formal clinical evidence that platelets generate secretion profiles under both sterile activation and pathological conditions. We next aimed to predict the risk of hazardous outcomes by establishing statistical models based on the associations of BRMs within the incriminated platelet components and using decision trees. We investigated a large (n = 65) series of ATRs after platelet component transfusions reported through a very homogenous system at one university hospital. Herein, we used a combination of clinical observations, ex vivo and in vitro investigations, and mathematical modeling systems. We calculated the statistical association of a large variety (n = 17) of cytokines, chemokines, and physiologically likely factors with acute inflammatory potential in patients presenting with severe hazards. We then generated an accident prediction model that proved to be dependent on the level (amount) of a given cytokine-like platelet product within the indicated component, e. g., soluble CD40-ligand (>289.5 pg/109 platelets), or the presence of another secreted factor (IL-13, >0). We further modeled the risk of the patient presenting either a febrile non-hemolytic transfusion reaction or an atypical allergic transfusion reaction, depending on the amount of the chemokine MIP-1 alpha (<20.4 or >20.4 pg/109 platelets, respectively). Conclusions/Significance: This allows the modeling of a policy of risk prevention for severe inflammatory outcomes in PC transfusion.	[Kim Anh Nguyen; Hamzeh-Cognasse, Hind; Pozzetto, Bruno; Cognasse, Fabrice; Garraud, Olivier] Univ Lyon, GIMAP, EA3064, St Etienne, France; [Sebban, Marc; Fromont, Elisa] CNRS, UMR 5516, Lab Hubert Curien, St Etienne, France; [Chavarin, Patricia; Absi, Lena; Cognasse, Fabrice; Garraud, Olivier] EFS Auvergne Loire, St Etienne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite Jean Monnet	Garraud, O (corresponding author), Univ Lyon, GIMAP, EA3064, St Etienne, France.	Olivier.garraud@efs.sante.fr	Cognasse, Fabrice/Z-4401-2019	POZZETTO, Bruno/0000-0002-2603-8467; Fromont, Elisa/0000-0003-0133-3491	National and Regional Blood Bank; EFS Auvergne-Loire, France; Association "Les Amis de Remi," Savigneux, France; French National Agency for Drug Safety and Health Products (ANSM)	National and Regional Blood Bank; EFS Auvergne-Loire, France; Association "Les Amis de Remi," Savigneux, France; French National Agency for Drug Safety and Health Products (ANSM)	Financial support was received through grants from the National and Regional Blood Bank, EFS Auvergne-Loire, France, the Association "Les Amis de Remi," Savigneux, France, and the French National Agency for Drug Safety and Health Products (ANSM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam BL, 2002, CANCER RES, V62, P3609; Adda R, 2012, RAPPORT ACTIVITE HEM, P1; Andre P, 2002, CIRCULATION, V106, P896, DOI 10.1161/01.CIR.0000028962.04520.01; [Anonymous], 2011, INT HAEM NETW PROP S; Apelseth TO, 2006, TRANSFUSION, V46, P800, DOI 10.1111/j.1537-2995.2006.00800.x; Blumberg N, 2003, TRANSFUSION, V43, P291, DOI 10.1046/j.1537-2995.2003.t01-2-00362.x; Blumberg N, 2009, IMMUNOL RES; Blumberg N, 2006, TRANSFUSION, V46, P1813, DOI 10.1111/j.1537-2995.2006.00979.x; Blumberg N, 2012, LANCET, V380, P1287, DOI 10.1016/S0140-6736(12)60983-0; Boehlen F, 2001, TRANSFUSION MED, V11, P403, DOI 10.1046/j.1365-3148.2001.00340.x; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Burgstaler EA, 2004, TRANSFUSION, V44, P1612, DOI 10.1111/j.0041-1132.2004.04129.x; Chavarin P, 2011, VOX SANG, V100, P247, DOI 10.1111/j.1423-0410.2010.01389.x; Cognasse F, 2008, TRANSFUSION, V48, P809, DOI 10.1111/j.1537-2995.2008.01655.x; Cognasse F, 2006, TRANSFUSION, V46, P1184, DOI 10.1111/j.1537-2995.2006.00869.x; Cognasse F, 2009, TRANSFUSION, V49, P91, DOI 10.1111/j.1537-2995.2008.01931.x; Cognasse F, 2008, BLOOD, V112, P4779, DOI 10.1182/blood-2008-05-157578; Connor RI, 1996, J VIROL, V70, P5306, DOI 10.1128/JVI.70.8.5306-5311.1996; Cook DN, 1996, J LEUKOCYTE BIOL, V59, P61, DOI 10.1002/jlb.59.1.61; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Fong KP, 2011, BLOOD, V117, pE15, DOI 10.1182/blood-2010-05-283838; Fontana S, 2006, TRANSFUSION, V46, P2004, DOI 10.1111/j.1537-2995.2006.01009.x; Garraud O, 2012, TRANSFUS CLIN BIOL, V19, P104, DOI 10.1016/j.tracli.2012.02.004; Garraud O, 2013, CRIT CARE, V17, DOI 10.1186/cc12716; Geurts P, 2009, MOL BIOSYST, V5, P1593, DOI 10.1039/b907946g; Hamzeh-Cognasse H, 2013, TRANSFUSION; Heddle N M, 1999, Curr Opin Hematol, V6, P420, DOI 10.1097/00062752-199911000-00012; Kaufman J, 2007, J THROMB HAEMOST, V5, P788, DOI 10.1111/j.1538-7836.2007.02412.x; Khan SY, 2006, BLOOD, V108, P2455, DOI 10.1182/blood-2006-04-017251; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Nguyen KA, 2012, BLOOD TRANSFUS, P1; Nishimura M, 2009, ANN NY ACAD SCI, V1173, P350, DOI 10.1111/j.1749-6632.2009.04738.x; Park JW, 2013, TRANSFUSION, V53, P637, DOI 10.1111/j.1537-2995.2012.03777.x; Phipps RP, 2001, LANCET, V357, P2023, DOI 10.1016/S0140-6736(00)05108-4; Refaai MA, 2011, THROMB RES, V127, P287, DOI 10.1016/j.thromres.2010.10.012; Sahler J, 2012, TRANSFUS CLIN BIOL, V19, P98, DOI 10.1016/j.tracli.2012.02.003; Sahler Julie, 2011, Drug Discov Today Dis Mech, V8, pe9; Sandgren P, 2007, VOX SANG, V93, P27, DOI 10.1111/j.1423-0410.2007.00912.x; Sandgren P, 2010, VOX SANG, V99, P341, DOI 10.1111/j.1423-0410.2010.01364.x; Sandgren P, 2013, TRANSFUSION; Sandgren P, 2008, TRANSFUSION, V48, P688, DOI 10.1111/j.1537-2995.2007.01593.x; Sayah DM, 2012, CRIT CARE CLIN, V28, P363, DOI 10.1016/j.ccc.2012.04.001; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Tinegate H, 2012, BRIT J HAEMATOL, V159, P143, DOI 10.1111/bjh.12017; Toy P, 2005, CRIT CARE MED, V33, P721, DOI 10.1097/01.CCM.0000159849.94750.51; Toy P, 2012, BLOOD, V119, P1757, DOI 10.1182/blood-2011-08-370932; Tung JP, 2012, CRIT CARE, V16, DOI 10.1186/cc11178; Vlahou A, 2003, J BIOMED BIOTECHNOL, P308, DOI 10.1155/S1110724303210032; Wong CK, 2001, CLIN EXP IMMUNOL, V125, P177, DOI 10.1046/j.1365-2249.2001.01602.x	49	36	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97082	10.1371/journal.pone.0097082	http://dx.doi.org/10.1371/journal.pone.0097082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830754	Green Submitted, gold, Green Published			2022-12-27	WOS:000336789500033
J	Miri-Dashe, T; Osawe, S; Tokdung, M; Daniel, N; Choji, RP; Mamman, I; Deme, K; Damulak, D; Abimiku, A				Miri-Dashe, Timzing; Osawe, Sophia; Tokdung, Monday; Daniel, Nenbammun; Choji, Rahila Pam; Mamman, Ille; Deme, Kurt; Damulak, Dapus; Abimiku, Alash'le			Comprehensive Reference Ranges for Hematology and Clinical Chemistry Laboratory Parameters Derived from Normal Nigerian Adults	PLOS ONE			English	Article							REFERENCE VALUES; HEALTHY-ADULTS; POPULATION; COUNT; CD4	Background: Interpretation of laboratory test results with appropriate diagnostic accuracy requires reference or cutoff values. This study is a comprehensive determination of reference values for hematology and clinical chemistry in apparently healthy voluntary non-remunerated blood donors and pregnant women. Methods and findings: Consented clients were clinically screened and counseled before testing for HIV, Hepatitis B, Hepatitis C and Syphilis. Standard national blood donors' questionnaire was administered to consented blood donors. Blood from qualified volunteers was used for measurement of complete hematology and chemistry parameters. Blood samples were analyzed from a total of 383 participants, 124 (32.4%) males, 125 (32.6%) non-pregnant females and 134 pregnant females (35.2%) with a mean age of 31 years. Our results showed that the red blood cells count (RBC), Hemoglobin (HB) and Hematocrit (HCT) had significant gender difference (p = 0.000) but not for total white blood count (p > 0.05) which was only significantly higher in pregnant verses non-pregnant women (p = 0.000). Hemoglobin and Hematocrit values were lower in pregnancy (P = 0.000). Platelets were significantly higher in females than men (p = 0.001) but lower in pregnant women (p = 0.001) with marked difference in gestational period. For clinical chemistry parameters, there was no significant difference for sodium, potassium and chloride (p > 0.05) but gender difference exists for Bicarbonate (HCO3), Urea nitrogen, Creatinine as well as the lipids (p < 0.05). Total bilirubin was significantly higher in males than females (p = 0.000). Significant differences exist for all chemistry parameters between pregnant and non-pregnant women in this study (p < 0.05), except Amylase and total cholesterol (p > 0.05). Conclusions: Hematological and Clinical Chemistry reference ranges established in this study showed significant gender differences. Pregnant women also differed from non-pregnant females and during pregnancy. This is the first of such comprehensive study to establish reference values among adult Nigerians and difference observed underscore the need to establish reference values for different populations.	[Miri-Dashe, Timzing; Osawe, Sophia; Daniel, Nenbammun; Choji, Rahila Pam; Mamman, Ille; Abimiku, Alash'le] Inst Human Virol, Plateau State Human Virol Res Ctr PLASVIREC, Clin Lab Serv, Jos, Plateau State, Nigeria; [Miri-Dashe, Timzing; Osawe, Sophia; Daniel, Nenbammun; Choji, Rahila Pam; Mamman, Ille; Abimiku, Alash'le] Inst Human Virol, Plateau State Human Virol Res Ctr PLASVIREC, Jos, Plateau State, Nigeria; [Tokdung, Monday] Med Lab Sci Council Nigeria, Abuja, Nigeria; [Deme, Kurt; Damulak, Dapus] Plateau State Specialist Hosp 13, Natl Blood Transfus Serv Jos, Jos, Plateau State, Nigeria; [Miri-Dashe, Timzing; Osawe, Sophia; Mamman, Ille; Abimiku, Alash'le] Inst Human Virol, Clin Lab Serv, Abuja, Nigeria; [Abimiku, Alash'le] Univ Maryland, Sch Med, Inst Human Virol, Div Epidemiol & Prevent, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Miri-Dashe, T (corresponding author), Inst Human Virol, Plateau State Human Virol Res Ctr PLASVIREC, Clin Lab Serv, Jos, Plateau State, Nigeria.	tdashe@ihvnigeria.org			PLASVIREC	PLASVIREC	PLASVIREC funded this study through funds generated independently. Support was also received from the Institute of Human Virology Nigeria through supply of reagents for the testing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aina O, 2005, CLIN DIAGN LAB IMMUN, V12, P525, DOI 10.1128/CDLI.12.4.525-530.2005; AZIKIWE AN, 1984, E AFR MED J, V61, P482; BADENHORST CJ, 1995, E AFR MED J, V72, P19; Bain BJ, 1996, J CLIN PATHOL, V49, P664, DOI 10.1136/jcp.49.8.664; Dosoo DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036308; Eller LA, 2008, REFERENCE INTERVALS, V3; GILL GV, 1979, T ROY SOC TROP MED H, V73, P111, DOI 10.1016/0035-9203(79)90142-1; Karita E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004401; Kibaya RS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003327; Kratz A, 2004, NEW ENGL J MED, V351, P1548, DOI 10.1056/NEJMcpc049016; Lugada ES, 2004, CLIN DIAGN LAB IMMUN, V11, P29, DOI 10.1128/CDLI.11.1.29-34.2004; Mine M, 2012, AFR J LAB MED, V1, DOI 10.4102/ajlm.v1i1.5; Ngowi BJ, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-1; Oladepo DK, 2009, CLIN VACCINE IMMUNOL, V16, P1374, DOI 10.1128/CVI.00378-08; Saathoff E, 2008, TROP MED INT HEALTH, V13, P612, DOI 10.1111/j.1365-3156.2008.02047.x; SHAPER AG, 1971, LANCET, V2, P1021; TUGUME SB, 1995, CLIN DIAGN LAB IMMUN, V2, P233, DOI 10.1128/CDLI.2.2.233-235.1995; Urassa WK, 2003, J IMMUNOL METHODS, V277, P65, DOI 10.1016/S0022-1759(03)00174-1; Zeh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021040	19	40	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e93919	10.1371/journal.pone.0093919	http://dx.doi.org/10.1371/journal.pone.0093919			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24832127	Green Published, gold			2022-12-27	WOS:000336789500002
J	Neubauer, S; Dolgova, O; Prag, G; Borriss, R; Makarewicz, O				Neubauer, Svetlana; Dolgova, Olga; Praeg, Gregory; Borriss, Rainer; Makarewicz, Oliwia			Substitutional Analysis of the C-Terminal Domain of AbrB Revealed Its Essential Role in DNA-Binding Activity	PLOS ONE			English	Article							STATE REGULATOR ABRB; BACILLUS-AMYLOLIQUEFACIENS FZB45; CATABOLITE REPRESSION; TRANSCRIPTION FACTORS; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; TRANSPORT OPERON; PROMOTER REGION; GENE-EXPRESSION; SUBTILIS	The global transition state regulator AbrB controls more than 100 genes of the Bacillus relatives and is known to interact with varying DNA-sequences. The DNA-binding domain of the AbrB-like proteins was proposed to be located exclusively within the amino-terminal ends. However, the recognition of DNA, and specificity of the binding mechanism, remains elusive still in view of highly differing recognition sites. Here we present a substitutional analysis to examine the role of the carboxy-terminal domain of AbrB from Bacillus subtilis and Bacillus amyloliquefaciens. Our results demonstrate that the carboxy-terminal domains of AbrB affect the DNA-binding properties of the tetrameric AbrB. Most likely, the C-termini are responsible for the cooperative character observed for AbrB interaction with some DNA targets like tycA and phyC.	[Neubauer, Svetlana; Dolgova, Olga; Praeg, Gregory; Borriss, Rainer; Makarewicz, Oliwia] Humboldt Univ, Inst Biol, D-10099 Berlin, Germany; [Makarewicz, Oliwia] Jena Univ Hosp, Ctr Infect Dis & Infect Control, Jena, Germany	Humboldt University of Berlin; Friedrich Schiller University of Jena	Makarewicz, O (corresponding author), Humboldt Univ, Inst Biol, D-10099 Berlin, Germany.	oliwia.makarewicz@med.uni-jena.de	Borriss, Rainer/C-5026-2012	Borriss, Rainer/0000-0003-3726-1004; Makarewicz, Oliwia/0000-0002-4404-1862	Deutsche Forschungsgemeinschaft, DFG [BO 1113/9-1]; German Ministry for Education and Research, BMBF [01EO1002, 01KI1204]	Deutsche Forschungsgemeinschaft, DFG(German Research Foundation (DFG)); German Ministry for Education and Research, BMBF(Federal Ministry of Education & Research (BMBF))	This work was supported by Deutsche Forschungsgemeinschaft, DFG (grant BO 1113/9-1 to R. B.) and partially by the German Ministry for Education and Research, BMBF (grants 01EO1002 and 01KI1204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asen I, 2009, J MOL BIOL, V386, P962, DOI 10.1016/j.jmb.2008.10.061; Benson LM, 2002, ANAL BIOCHEM, V306, P222, DOI 10.1006/abio.2002.5704; Bobay BG, 2005, FEBS LETT, V579, P5669, DOI 10.1016/j.febslet.2005.09.045; Bobay BG, 2004, BIOCHEMISTRY-US, V43, P16106, DOI 10.1021/bi048399h; Cavanagh J, 2002, BIOCHEMISTRY-US, V41, P7859, DOI 10.1021/bi0202225; Chumsakul O, 2010, NUCL ACIDS RES; Coles M, 2005, STRUCTURE, V13, P919, DOI 10.1016/j.str.2005.03.017; COLL M, 1987, P NATL ACAD SCI USA, V84, P8385, DOI 10.1073/pnas.84.23.8385; FISHER SH, 1994, J BACTERIOL, V176, P1903, DOI 10.1128/jb.176.7.1903-1912.1994; FRIEDRICH K, 1988, FEBS LETT, V229, P197, DOI 10.1016/0014-5793(88)80826-3; FURBASS R, 1991, FEBS LETT, V287, P153, DOI 10.1016/0014-5793(91)80038-5; FURBASS R, 1991, MOL GEN GENET, V225, P347; HAHN J, 1995, J BACTERIOL, V177, P3601, DOI 10.1128/jb.177.12.3601-3605.1995; Hamoen LW, 2003, FEMS MICROBIOL LETT, V218, P299, DOI 10.1111/j.1574-6968.2003.tb11532.x; Hamon MA, 2001, MOL MICROBIOL, V42, P1199, DOI 10.1046/j.1365-2958.2001.02709.x; Kim HJ, 2003, J BACTERIOL, V185, P1672, DOI 10.1128/JB.185.5.1672-1680.2003; Loris R, 2003, J BIOL CHEM, V278, P28252, DOI 10.1074/jbc.M302336200; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; Makarewicz O, 2008, J BACTERIOL, V190, P6467, DOI 10.1128/JB.00430-08; MARAHIEL MA, 1993, MOL MICROBIOL, V7, P631, DOI 10.1111/j.1365-2958.1993.tb01154.x; Moran U, 2010, CELL, V141, P1262, DOI 10.1016/j.cell.2010.06.019; Neubauer S, 2012, MOL GENET GENOMICS, V287, P111, DOI 10.1007/s00438-011-0666-4; Olson AL, 2013, BIOCHEM BIOPH RES CO, V431, P253, DOI 10.1016/j.bbrc.2012.12.124; Phillips ZEV, 2001, FEMS MICROBIOL LETT, V203, P207, DOI 10.1016/S0378-1097(01)00347-0; Qian Q, 2002, FEMS MICROBIOL LETT, V211, P219, DOI 10.1016/S0378-1097(02)00679-1; Sambrook J., 2002, MOL CLONING LAB MANU; Shafikhani SH, 2002, J BACTERIOL, V184, P564, DOI 10.1128/JB.184.2.564-571.2002; SLACK FJ, 1991, MOL MICROBIOL, V5, P1915, DOI 10.1111/j.1365-2958.1991.tb00815.x; STRAUCH MA, 1989, MOL MICROBIOL, V3, P1203, DOI 10.1111/j.1365-2958.1989.tb00270.x; STRAUCH MA, 1989, EMBO J, V8, P1615, DOI 10.1002/j.1460-2075.1989.tb03546.x; STRAUCH MA, 1995, J BACTERIOL, V177, P6727, DOI 10.1128/jb.177.23.6727-6731.1995; STRAUCH MA, 1995, J BACTERIOL, V177, P6999, DOI 10.1128/jb.177.23.6999-7002.1995; STRAUCH MA, 1995, MOL GEN GENET, V246, P756, DOI 10.1007/BF00290723; STRAUCH MA, 1995, J BACTERIOL, V177, P4532, DOI 10.1128/jb.177.15.4532-4536.1995; Strauch MA, 2007, J BACTERIOL, V189, P7720, DOI 10.1128/JB.01081-07; Sullivan DM, 2008, STRUCTURE, V16, P1702, DOI 10.1016/j.str.2008.08.014; Uyar E, 2009, J BACTERIOL, V191, P2388, DOI 10.1128/JB.01594-08; Xu K, 1996, J BIOL CHEM, V271, P2621, DOI 10.1074/jbc.271.5.2621; Xu K, 1996, MOL MICROBIOL, V19, P145, DOI 10.1046/j.1365-2958.1996.358882.x; Xu K, 2001, J BACTERIOL, V183, P4094, DOI 10.1128/JB.183.13.4094-4098.2001; Yao F, 2005, J BACTERIOL, V187, P6354, DOI 10.1128/JB.187.18.6354-6362.2005; ZUBER P, 1987, J BACTERIOL, V169, P2223, DOI 10.1128/jb.169.5.2223-2230.1987	42	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97254	10.1371/journal.pone.0097254	http://dx.doi.org/10.1371/journal.pone.0097254			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24832089	gold, Green Published, Green Submitted			2022-12-27	WOS:000336789500043
J	Thomas, SF; Rooks, P; Rudin, F; Atkinson, S; Goddard, P; Bransgrove, R; Mason, PT; Allen, MJ				Thomas, Simon F.; Rooks, Paul; Rudin, Fabian; Atkinson, Sov; Goddard, Paul; Bransgrove, Rachel; Mason, Paul T.; Allen, Michael J.			The Bactericidal Effect of Dendritic Copper Microparticles, Contained in an Alginate Matrix, on Escherichia coli	PLOS ONE			English	Article							NANOPARTICLES; RESPONSES	Although the bactericidal effect of copper has been known for centuries, there is a current resurgence of interest in the use of this element as an antimicrobial agent. During this study the use of dendritic copper microparticles embedded in an alginate matrix as a rapid method for the deactivation of Escherichia coli ATCC 11775 was investigated. The copper/alginate produced a decrease in the minimum inhibitory concentration from free copper powder dispersed in the media from 0.25 to 0.065 mg/ml. Beads loaded with 4% Cu deactivated 99.97% of bacteria after 90 minutes, compared to a 44.2% reduction in viability in the equivalent free copper powder treatment. There was no observed loss in the efficacy of this method with increasing bacterial loading up to 10(6) cells/ml, however only 88.2% of E. coli were deactivated after 90 minutes at a loading of 10(8) cells/ml. The efficacy of this method was highly dependent on the oxygen content of the media, with a 4.01% increase in viable bacteria observed under anoxic conditions compared to a>99% reduction in bacterial viability in oxygen tensions above 50% of saturation. Scanning electron micrographs (SEM) of the beads indicated that the dendritic copper particles sit as discrete clusters within a layered alginate matrix, and that the external surface of the beads has a scale-like appearance with dendritic copper particles extruding. E. coli cells visualised using SEM indicated a loss of cellular integrity upon Cu bead treatment with obvious visible blebbing. This study indicates the use of microscale dendritic particles of Cu embedded in an alginate matrix to effectively deactivate E. coli cells and opens the possibility of their application within effective water treatment processes, especially in high particulate waste streams where conventional methods, such as UV treatment or chlorination, are ineffective or inappropriate.	[Thomas, Simon F.; Rudin, Fabian; Mason, Paul T.] Plymouth Martine Lab Applicat Ltd, Plymouth, Devon, England; [Rooks, Paul; Atkinson, Sov; Bransgrove, Rachel; Allen, Michael J.] Plymouth Marine Lab, Plymouth, Devon, England; [Goddard, Paul] Prot Technol Ltd, Manchester, Lancs, England	Plymouth Marine Laboratory	Allen, MJ (corresponding author), Plymouth Marine Lab, Plymouth, Devon, England.	mija@pml.ac.uk	Rudin, Fabian S/B-5877-2015; Allen, Michael J/C-1248-2011	Rudin, Fabian S/0000-0003-4539-3074; Allen, Michael J/0000-0001-8504-7171; Thomas, Simon/0000-0002-8474-1230	Bill & Melinda Gates Foundation [OPP1044451, OPP1095464]; NERC [pml010009, pml010002] Funding Source: UKRI; Natural Environment Research Council [pml010009, pml010002] Funding Source: researchfish	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by grants awarded to MJA from the Bill & Melinda Gates Foundation (OPP1044451, OPP1095464). The findings and conclusions contained within are those of the author(s) and do not necessarily reflect positions or policies of the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarghouthi M, 2000, INT J PHARM, V206, P23, DOI 10.1016/S0378-5173(00)00470-1; Anal AK, 2003, DRUG DEV IND PHARM, V29, P713, DOI 10.1081/DDC-120021320; Baker J, 2010, APPL ENVIRON MICROB, V76, P150, DOI 10.1128/AEM.02268-09; Besser JM, 2007, ENVIRON TOXICOL CHEM, V26, P1657, DOI 10.1897/06-571R.1; Chen YG, 2012, ENVIRON SCI TECHNOL, V46, P12452, DOI 10.1021/es302646q; Diaz-Visurraga J, 2012, INT J NANOMED, V7, P3597, DOI 10.2147/IJN.S32648; Dolwet HHA, 1985, J TRACE ELEM MED BIO, V2; Faundez G, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-19; Fung DKC, 2013, J BACTERIOL, V195, P4556, DOI 10.1128/JB.00543-13; GORDON AS, 1994, CAN J MICROBIOL, V40, P408, DOI 10.1139/m94-067; HARWOOD VJ, 1994, APPL ENVIRON MICROB, V60, P1749, DOI 10.1128/AEM.60.6.1749-1753.1994; Held KD, 1996, RADIAT RES, V145, P542, DOI 10.2307/3579272; Holt JG, 2010, BERGEYS MANUAL DETER; Jorge MB, 2013, AQUAT TOXICOL, V126, P137, DOI 10.1016/j.aquatox.2012.10.014; Karlsson HL, 2008, CHEM RES TOXICOL, V21, P1726, DOI 10.1021/tx800064j; Lin YSE, 2002, APPL ENVIRON MICROB, V68, P2711, DOI 10.1128/AEM.68.6.2711-2715.2002; Liu YS, 2009, RADIAT PHYS CHEM, V78, P251, DOI 10.1016/j.radphyschem.2009.01.003; Macomber L, 2007, J BACTERIOL, V189, P1616, DOI 10.1128/JB.01357-06; Rensing C, 2000, P NATL ACAD SCI USA, V97, P652, DOI 10.1073/pnas.97.2.652; Santo CE, 2012, MICROBIOLOGYOPEN, V1, P46, DOI 10.1002/mbo3.2; Sun JC, 2013, MATERIALS, V6, P1285, DOI 10.3390/ma6041285; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Xu Q, 2014, OPT EXPRESS, V22, pA301, DOI 10.1364/OE.22.00A301	23	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e96225	10.1371/journal.pone.0096225	http://dx.doi.org/10.1371/journal.pone.0096225			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831035	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000336789500015
J	Bezabhe, WM; Chalmers, L; Bereznicki, LR; Peterson, GM; Bimirew, MA; Kassie, DM				Bezabhe, Woldesellassie M.; Chalmers, Leanne; Bereznicki, Luke R.; Peterson, Gregory M.; Bimirew, Mekides A.; Kassie, Desalew M.			Barriers and Facilitators of Adherence to Antiretroviral Drug Therapy and Retention in Care among Adult HIV-Positive Patients: A Qualitative Study from Ethiopia	PLOS ONE			English	Article							STIGMA; ART; POPULATION; OUTCOMES; UGANDA	Background: Antiretroviral therapy (ART) has been life saving for hundreds of thousands of Ethiopians. With increased availability of ART in recent years, achievement of optimal adherence and patient retention are becoming the greatest challenges in the management of HIV/AIDS in Ethiopia. However, few studies have explored factors influencing medication adherence to ART and retention in follow-up care among adult Ethiopian HIV-positive patients, especially in the Amhara region of the country, where almost one-third of the country's ART is prescribed. The aim of this qualitative study was to collect such data from patients and healthcare providers in the Amhara region of Ethiopia. Methods: Semi-structured interviews were conducted with 24 patients, of whom 11 had been lost to follow-up and were non-persistent with ART. In addition, focus group discussions were performed with 15 ART nurses and 19 case managers. All interviews and focus groups were audio-recorded, transcribed, and coded for themes and patterns in Amharic using a grounded theory approach. The emergent concepts and categories were translated into English. Results: Economic constraints, perceived stigma and discrimination, fasting, holy water, medication side effects, and dissatisfaction with healthcare services were major reasons for patients being non-adherent and lost to follow-up. Disclosure of HIV status, social support, use of reminder aids, responsibility for raising children, improved health on ART, and receiving education and counseling emerged as facilitators of adherence to ART. Conclusions: Improving adherence and retention requires integration of enhanced treatment access with improved job and food security. Healthcare providers need to be supported to better equip patients to cope with the issues associated with ART. Development of social policies and cooperation between various agencies are required to facilitate optimal adherence to ART, patient retention, and improved patient outcomes.	[Bezabhe, Woldesellassie M.; Chalmers, Leanne; Bereznicki, Luke R.; Peterson, Gregory M.] Univ Tasmania, Sch Med, Div Pharm, Hobart, Tas 7001, Australia; [Bezabhe, Woldesellassie M.] Bahir Dar Univ, Coll Med & Hlth Sci, Gojjam, Ethiopia; [Bimirew, Mekides A.] Felege Hiwot Hosp, Dept Internal Med, Gojjam, Ethiopia; [Kassie, Desalew M.] Gondar Univ Hosp, Dept Internal Med, Gondar, Ethiopia	University of Tasmania; Bahir Dar University	Bezabhe, WM (corresponding author), Univ Tasmania, Sch Med, Div Pharm, Hobart, Tas 7001, Australia.	mwoldesellassie@yahoo.com		Chalmers, Leanne/0000-0002-2477-2190; Peterson, Gregory/0000-0002-6764-3882; Bezabhe, Woldesellassie/0000-0002-3028-6949; Bereznicki, Luke/0000-0003-3974-3437	Tasmanian School of Pharmacy, University of Tasmania	Tasmanian School of Pharmacy, University of Tasmania	The study was financially supported by the Tasmanian School of Pharmacy, University of Tasmania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeneye A K, 2006, World Health Popul, V8, P46; Amhara HIV/AIDS Prevention and Control Coordination Office (HAPCO), 2013, HIV FACTS FIG; Aspeling HE, 2008, INT J NURS PRACT, V14, P3, DOI 10.1111/j.1440-172X.2007.00659.x; Assefa Y, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-81; Balcha Taye T, 2011, J Int Assoc Physicians AIDS Care (Chic), V10, P119, DOI 10.1177/1545109710387674; Bezabhe WM, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003559; Brown L, 2003, AIDS EDUC PREV, V15, P49, DOI 10.1521/aeap.15.1.49.23844; Bygrave H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013198; Charurat M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010584; Coetzee B, 2011, AIDS CARE, V23, P146, DOI 10.1080/09540121.2010.498874; CORBIN J, 1990, Z SOZIOL, V19, P418, DOI 10.1007/BF00988593; Cramer JA, 2008, VALUE HEALTH, V11, P44, DOI 10.1111/j.1524-4733.2007.00213.x; Curioso WH, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-13; Ethiopian Central Statistical Agency, 2012, POP 2011; Federal HIV/AIDS Prevention and Control Office (HAPCO), 2012, COUNTR PROGR REP HIV; Finocchario-Kessler S, 2011, AIDS PATIENT CARE ST, V25, P103, DOI 10.1089/apc.2010.0319; Gibson MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048708; Gonzalez JS, 2007, ANN BEHAV MED, V34, P46, DOI 10.1007/BF02879920; Gusdal AK, 2011, AIDS CARE, V23, P657, DOI 10.1080/09540121.2010.532531; Gusdal AK, 2009, AIDS CARE, V21, P1381, DOI 10.1080/09540120902883119; Katz IT, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18640; Kobin AB, 2011, ANN PHARMACOTHER, V45, P372, DOI 10.1345/aph.1P587; Kuschminder K, 2012, PROFILING ETHIOPIAN; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Lifson Alan R, 2013, J Int Assoc Provid AIDS Care, V12, P32, DOI 10.1177/1545109712456428; Lima V, 2009, SOC SCI MED, V68, P1044, DOI 10.1016/j.socscimed.2008.12.043; Malcolm A., 1998, CRITICAL PUBLIC HLTH, V8, P347, DOI [10.1080/09581599808402920, DOI 10.1080/09581599808402920]; Mamo W, 2012, ISRN AIDS; Mengistu Zuriyash, 2012, Ethiop Med J, V50, P355; Merten S, 2010, TROP MED INT HEALTH, V15, P16, DOI 10.1111/j.1365-3156.2010.02510.x; Murphy DA, 2011, J CONSULT CLIN PSYCH, V79, P203, DOI 10.1037/a0022896; Musumari PM, 2013, AIDS CARE; Mutwa PR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060073; Negash T, 2013, J ASSOC NURSE AIDS C, V24, P530, DOI 10.1016/j.jana.2012.11.004; Olley BO, 2006, AIDS CARE, V18, P1025, DOI 10.1080/09540120600568756; Olupot-Olupot P, 2008, AIDS, V22, P1882, DOI 10.1097/QAD.0b013e3283112ba6; Palar K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061935; Patel Sangita, 2012, Indian J Sex Transm Dis AIDS, V33, P107, DOI 10.4103/0253-7184.102119; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Peltzer K, 2011, AIDS CARE, V23, P60, DOI 10.1080/09540121.2010.498864; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; Portelli MS, 2012, ASIA PAC J PUBLIC HL; Rathavuth Hong VM, 2008, FACTORS ASS PREVALEN; Rotberg RI, 2013, WASH QUART, V36, P111, DOI 10.1080/0163660X.2013.751651; Saether ST, 2007, TROP MED INT HEALTH, V12, P999, DOI 10.1111/j.1365-3156.2007.01879.x; Sasaki Y, 2012, ANN CLIN MICROB ANTI, V11, DOI 10.1186/1476-0711-11-34; Stangl AL, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18734; Stutterheim SE, 2011, AIDS CARE, V23, P195, DOI 10.1080/09540121.2010.498873; Vyankandondera J, 2013, AIDS CARE; Wasti SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035547; Wasti SP, 2012, TROP MED INT HEALTH, V17, P71, DOI 10.1111/j.1365-3156.2011.02888.x; Watt MH, 2009, SOC SCI MED, V68, P1793, DOI 10.1016/j.socscimed.2009.02.037; Weiser S, 2003, JAIDS-J ACQ IMM DEF, V34, P281, DOI 10.1097/00126334-200311010-00004; Weiser SD, 2013, AIDS; Wubshet M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059197; Yakasai AM, 2011, TROP DOCT, V41, P233, DOI 10.1258/td.2011.110130	56	105	108	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97353	10.1371/journal.pone.0097353	http://dx.doi.org/10.1371/journal.pone.0097353			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4TJ	24828585	Green Submitted, Green Published, gold			2022-12-27	WOS:000336857400082
J	Drake, A; Rock, CA; Quinlan, SP; Martin, M; Green, DJ				Drake, Anna; Rock, Christine A.; Quinlan, Sam P.; Martin, Michaela; Green, David J.			Wind Speed during Migration Influences the Survival, Timing of Breeding, and Productivity of a Neotropical Migrant, Setophaga petechia	PLOS ONE			English	Article							SPRING ARRIVAL; POPULATION LIMITATION; REPRODUCTIVE SUCCESS; SEXUAL SELECTION; WINTERING AREAS; MARKED ANIMALS; BIRD MIGRATION; NORTH-AMERICA; CLIMATE; SONGBIRD	Over the course of the annual cycle, migratory bird populations can be impacted by environmental conditions in regions separated by thousands of kilometers. We examine how climatic conditions during discrete periods of the annual cycle influence the demography of a nearctic-neotropical migrant population of yellow warblers (Setophaga petechia), that breed in western Canada and overwinter in Mexico. We demonstrate that wind conditions during spring migration are the best predictor of apparent annual adult survival, male arrival date, female clutch initiation date and, via these timing effects, annual productivity. We find little evidence that conditions during the wintering period influence breeding phenology and apparent annual survival. Our study emphasizes the importance of climatic conditions experienced by migrants during the migratory period and indicates that geography may play a role in which period most strongly impacts migrant populations.	[Drake, Anna; Rock, Christine A.; Quinlan, Sam P.; Martin, Michaela; Green, David J.] Simon Fraser Univ, Dept Biol Sci, Ctr Wildlife Ecol, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Drake, A (corresponding author), Simon Fraser Univ, Dept Biol Sci, Ctr Wildlife Ecol, Burnaby, BC V5A 1S6, Canada.	aedrake@sfu.ca	Green, David J/B-5096-2012		Fish and Wildlife Compensation Program [WSI4639]; Environment Canada; Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN261899]; NSERC	Fish and Wildlife Compensation Program; Environment Canada(CGIAR); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Research support came from The Fish and Wildlife Compensation Program (WSI4639) (www.bchydro.com/bcrp), core funding to the CWE provided by Environment Canada (www.sfu.ca/biology/wildberg), a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grant to D.J.G. (RGPIN261899) and NSERC fellowships to A.D., C.R., S.Q. and M.M. (www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALERSTAM T, 1979, ORNIS SCAND, V10, P76, DOI 10.2307/3676347; Alerstam T, 2011, P ROY SOC B-BIOL SCI, V278, P3074, DOI 10.1098/rspb.2011.0058; BAILLIE SR, 1992, IBIS, V134, P120; Boulet Marylene, 2006, Ornithological Monographs, V61, P29, DOI 10.1642/0078-6594(2006)61[29:IAOGSI]2.0.CO;2; Caso M, 2007, P NATL ACAD SCI USA, V104, P10530, DOI 10.1073/pnas.0701862104; Drake A, 2013, J AVIAN BIOL, V44, P321, DOI 10.1111/j.1600-048X.2013.05828.x; Dugger KM, 2004, CONDOR, V106, P744, DOI 10.1650/7632; Ebird, 2013, EBIRD ONL DAT BIRD D; Erni B, 2005, BEHAV ECOL, V16, P732, DOI 10.1093/beheco/ari046; Faaborg J, 2010, ECOL MONOGR, V80, P3, DOI 10.1890/09-0395.1; Felix Rodney K. Jr., 2008, Studies in Avian Biology, V37, P126; Gauthreaux SA, 1980, P 17 INT ORN C, V17, P517; Giorgi F, 2001, GEOPHYS RES LETT, V28, P3317, DOI 10.1029/2001GL013150; Gordo O, 2005, GLOBAL CHANGE BIOL, V11, P12, DOI 10.1111/j.1365-2486.2004.00875.x; Grosbois V, 2008, BIOL REV, V83, P357, DOI 10.1111/j.1469-185X.2008.00047.x; Hoover JP, 2003, ECOLOGY, V84, P416, DOI 10.1890/0012-9658(2003)084[0416:DRFSFI]2.0.CO;2; Hutto R.L., 1980, P181; Kelly JF, 2005, CONDOR, V107, P197, DOI 10.1650/7805; LaManna JA, 2012, AUK, V129, P734, DOI 10.1525/auk.2012.12017; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Leeper DA, 1998, J N AM BENTHOL SOC, V17, P54, DOI 10.2307/1468051; Liechti F, 2006, J ORNITHOL, V147, P202, DOI 10.1007/s10336-006-0061-9; Lundberg J, 2003, ECOSYSTEMS, V6, P87, DOI 10.1007/s10021-002-0150-4; Macmynowski DP, 2007, GLOBAL CHANGE BIOL, V13, P2239, DOI 10.1111/j.1365-2486.2007.01448.x; Marra PP, 2005, OECOLOGIA, V142, P307, DOI 10.1007/s00442-004-1725-x; Mazerolle DF, 2011, ECOSCIENCE, V18, P18, DOI 10.2980/18-1-3345; McKellar AE, 2013, OECOLOGIA, V172, P595, DOI 10.1007/s00442-012-2520-8; Newton I, 2006, J ORNITHOL, V147, P146, DOI 10.1007/s10336-006-0058-4; Newton I, 2004, IBIS, V146, P197, DOI 10.1111/j.1474-919X.2004.00293.x; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Norris DR, 2004, P ROY SOC B-BIOL SCI, V271, P59, DOI 10.1098/rspb.2003.2569; Nott MP, 2002, GLOBAL ECOL BIOGEOGR, V11, P333, DOI 10.1046/j.1466-822X.2002.00296.x; PERRINS CM, 1970, IBIS, V112, P242, DOI 10.1111/j.1474-919X.1970.tb00096.x; Pyle P, 1997, IDENTIFICATION GUIDE; Renton K, 2004, AUK, V121, P1214, DOI 10.1642/0004-8038(2004)121[1214:CVNPAR]2.0.CO;2; Reudink MW, 2009, P ROY SOC B-BIOL SCI, V276, P1619, DOI 10.1098/rspb.2008.1452; Rock CA, 2013, CAN J ZOOL, V91, P505, DOI 10.1139/cjz-2013-0014; Rockwell SM, 2012, AUK, V129, P744, DOI 10.1525/auk.2012.12003; Saino N, 2004, P ROY SOC B-BIOL SCI, V271, P681, DOI 10.1098/rspb.2003.2656; Sillett TS, 2000, SCIENCE, V288, P2040, DOI 10.1126/science.288.5473.2040; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; Skagen SK, 2005, CONDOR, V107, P212, DOI 10.1650/7807; Studds CE, 2007, CLIM RES, V35, P115, DOI 10.3354/cr00718; Visser ME, 2006, OECOLOGIA, V147, P164, DOI 10.1007/s00442-005-0299-6; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wilson S, 2011, ECOLOGY, V92, P1789, DOI 10.1890/10-1757.1	46	48	48	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97152	10.1371/journal.pone.0097152	http://dx.doi.org/10.1371/journal.pone.0097152			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828427	gold, Green Published, Green Submitted			2022-12-27	WOS:000336857400059
J	Zhang, Z; Wei, SG; Gui, HS; Yuan, ZY; Li, SB				Zhang, Zhe; Wei, Shuguang; Gui, Hongsheng; Yuan, Zuyi; Li, Shengbin			The Contribution of Genetic Diversity to Subdivide Populations Living in the Silk Road of China	PLOS ONE			English	Article							9 STR LOCI; ETHNIC-GROUPS; ORIGIN; REGION; DNA; MTDNA; TREES	There are several indigenous ethnic populations along the silk road in the Northwest of China that display clear differences in culture and social customs, perhaps as a result of geographic isolation and different linguistic traditions. However, extensive trade and other interactions probably facilitated the admixture of different gene pools between these populations over the last two millennia. To further explore the evolutionary relationships of the 13 ethnic populations residing in Northwest China and to reveal the features of population admixture, the 9 most-commonly employed CODIS loci (D3S1358, TH01, D5S818, D13S317, D7S820, CSF1PO, vWA, TPOX, FGA) were selected for genotyping and further analysis. Phylogenetic tree and principal component analysis revealed clear pattern of population differentiation between 4 populations living in Sinkiang Uighur Autonomous Region and other 9 populations dwelled in the upper regions of Silk Road. R matrix regression showed high-level gene flow and population admixture dose exist among these ethic populations in the Northwest region of China. Furthermore, the Mantel test suggests that larger percent of genetic variance (21.58% versus 2.3%) can be explained by geographic isolation than linguistic barriers, which matched with the contribution of geographic factors to other world populations.	[Zhang, Zhe; Yuan, Zuyi; Li, Shengbin] Xi An Jiao Tong Univ, Coll Med, Minist Educ, Key Lab Environm & Gene Related Dis, Xian, Shaanxi, Peoples R China; [Zhang, Zhe; Wei, Shuguang; Gui, Hongsheng; Yuan, Zuyi; Li, Shengbin] Xi An Jiao Tong Univ, Coll Med & Forens, Natl Minist Hlth Forens Sci, Key Lab, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Yuan, ZY (corresponding author), Xi An Jiao Tong Univ, Coll Med, Minist Educ, Key Lab Environm & Gene Related Dis, Xian, Shaanxi, Peoples R China.	zuyiyuan@mail.xjtu.edu.cn; shbinlee@mail.xjtu.edu.cn	Gui, Hongsheng/D-1063-2013	Gui, Hongsheng/0000-0002-0460-7446; Yuan, Zuyi/0000-0002-4141-0298	National Foundation (Ministry of Science and Technology, P.R. of China) [2013FY114300]	National Foundation (Ministry of Science and Technology, P.R. of China)	This research was supported by the National Foundation (2013FY114300; Ministry of Science and Technology, P.R. of China; http://www.most.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbasak BS, 2001, FORENSIC SCI INT, V123, P227, DOI 10.1016/S0379-0738(01)00532-1; Ayub Q, 2003, AM J PHYS ANTHROPOL, V122, P259, DOI 10.1002/ajpa.10234; Barbujani G, 1997, AM J HUM GENET, V61, P1011, DOI 10.1086/301620; Belle EMS, 2007, AM J PHYS ANTHROPOL, V133, P1137, DOI 10.1002/ajpa.20622; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Budowle B, 1999, J FORENSIC SCI, V44, P1277; Budowle B, 2001, J FORENSIC SCI, V46, P453; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Cavalli-Sforza LL, 2005, NAT REV GENET, V6, P333, DOI 10.1038/nrg1579; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; Cavalli-Sforza LL, 2007, ANNU REV GENOM HUM G, V8, P1, DOI 10.1146/annurev.genom.8.080706.092403; Chen LK, 1999, ZHONGGUO MINZUSHI GA; Chen T, 2006, FORENSIC SCI INT, V157, P218, DOI 10.1016/j.forsciint.2005.03.015; Chen T, 2004, FORENSIC SCI INT, V146, P53, DOI 10.1016/j.forsciint.2004.04.004; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Comas D, 1998, AM J HUM GENET, V63, P1824, DOI 10.1086/302133; Du R., 1993, ETHNIC GROUPS CHINA; Harpending HC., 1982, BIOCH ASPECTS EVOLUT; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Jin L, 2000, NAT REV GENET, V1, P126, DOI 10.1038/35038565; LI HJ, 1990, HUM GENET, V86, P231; Ma Yin, 1994, CHINAS MINORITY NATL; National Bureau of Statistics PRoC, 2010, TAB NAT 2010 POP CEN; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Perez-Lezaun A, 1996, HUM GENET, V99, P1; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Reddy BM, 2001, HUM BIOL, V73, P57; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Takezaki N, 2008, GENETICS, V178, P385, DOI 10.1534/genetics.107.081505; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wang XH, 2002, FORENSIC SCI INT, V129, P214, DOI 10.1016/S0379-0738(02)00227-X; Wei YL, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-42; Wu S. D., 1997, ZHONGGUO YIMIN SHI; Xiao FX, 2004, EUR J HUM GENET, V12, P301, DOI 10.1038/sj.ejhg.5201097; [薛付忠 Xue Fuzhong], 2005, [人类学学报, Acta Anthropologica Sinica], V24, P221; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; Yao YG, 2004, MOL BIOL EVOL, V21, P2265, DOI 10.1093/molbev/msh238; Yao YG, 2000, GENES GENET SYST, V75, P173, DOI 10.1266/ggs.75.173; Yuan Hong FY, 2004, CHINESE J FORENSIC M, V19, P290; Zhou RX, 2007, J HUM GENET, V52, P584, DOI 10.1007/s10038-007-0155-0	42	6	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97344	10.1371/journal.pone.0097344	http://dx.doi.org/10.1371/journal.pone.0097344			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828511	Green Published, gold, Green Submitted			2022-12-27	WOS:000336857400081
J	Fortunato, MJ; Ball, CE; Hollinger, K; Patel, NB; Modi, JN; Rajasekaran, V; Nonneman, DJ; Ross, JW; Kennedy, EJ; Selsby, JT; Beedle, AM				Fortunato, Marisa J.; Ball, Charlotte E.; Hollinger, Katrin; Patel, Niraj B.; Modi, Jill N.; Rajasekaran, Vedika; Nonneman, Dan J.; Ross, Jason W.; Kennedy, Eileen J.; Selsby, Joshua T.; Beedle, Aaron M.			Development of Rabbit Monoclonal Antibodies for Detection of Alpha-Dystroglycan in Normal and Dystrophic Tissue	PLOS ONE			English	Article							GLYCOPROTEIN COMPLEX; MUSCLE-FIBERS; LAMININ; GLYCOSYLATION; DISRUPTION; DEFICIENCY; EXPRESSION; MEMBRANE; ISOFORMS	Alpha-dystroglycan requires a rare O-mannose glycan modification to form its binding epitope for extracellular matrix proteins such as laminin. This functional glycan is disrupted in a cohort of muscular dystrophies, the secondary dystroglycanopathies, and is abnormal in some metastatic cancers. The most commonly used reagent for detection of alpha-dystroglycan is mouse monoclonal antibody IIH6, but it requires the functional O-mannose structure for recognition. Therefore, the ability to detect alpha-dystroglycan protein in disease states where it lacks the full O-mannose glycan has been limited. To overcome this hurdle, rabbit monoclonal antibodies against the alpha-dystroglycan C-terminus were generated. The new antibodies, named 5-2, 29-5, and 45-3, detect alpha-dystroglycan from mouse, rat and pig skeletal muscle by Western blot and immunofluorescence. In a mouse model of fukutin-deficient dystroglycanopathy, all antibodies detected low molecular weight alpha-dystroglycan in disease samples demonstrating a loss of functional glycosylation. Alternately, in a porcine model of Becker muscular dystrophy, relative abundance of alpha-dystroglycan was decreased, consistent with a reduction in expression of the dystrophin-glycoprotein complex in affected muscle. Therefore, these new rabbit monoclonal antibodies are suitable reagents for alpha-dystroglycan core protein detection and will enhance dystroglycan-related studies.	[Fortunato, Marisa J.; Kennedy, Eileen J.; Beedle, Aaron M.] Univ Georgia, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA; [Ball, Charlotte E.; Patel, Niraj B.; Modi, Jill N.; Rajasekaran, Vedika] Univ Georgia, Ctr Undergrad Res, Athens, GA 30602 USA; [Hollinger, Katrin; Ross, Jason W.; Selsby, Joshua T.] Iowa State Univ, Dept Anim Sci, Ames, IA USA; [Nonneman, Dan J.] USDA ARS, US Meat Anim Res Ctr, Clay Ctr, NE 68933 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Iowa State University; United States Department of Agriculture (USDA)	Beedle, AM (corresponding author), Univ Georgia, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA.	beedlea@uga.edu	Beedle, Aaron/AAI-7014-2020; Beedle, Aaron M/K-1902-2015	Beedle, Aaron M/0000-0002-1019-3235; Kennedy, Eileen/0000-0001-5610-1677; Selsby, Joshua/0000-0003-3797-7539	University of Georgia College of Pharmacy; National Institutes of Health [R21NS079603, R21RR030232]; NATIONAL CANCER INSTITUTE [K22CA154600] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR030232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS079603] Funding Source: NIH RePORTER	University of Georgia College of Pharmacy; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the University of Georgia College of Pharmacy (AMB) and by funds from the National Institutes of Health R21NS079603 (JTS) and R21RR030232 (JWR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhavan A, 2012, CANCER RES, V72, P2578, DOI 10.1158/0008-5472.CAN-11-3732; Beedle AM, 2012, J CLIN INVEST, V122, P3330, DOI 10.1172/JCI63004; Beedle AM, 2002, J MEMBRANE BIOL, V187, P225, DOI 10.1007/s00232-001-0166-2; BRANCACCIO A, 1995, FEBS LETT, V368, P139, DOI 10.1016/0014-5793(95)00628-M; DiBlasi C, 1996, ACTA NEUROPATHOL, V92, P369; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Esser AK, 2013, J BIOL CHEM, V288, P2132, DOI 10.1074/jbc.M112.432807; Geis T, 2013, NEUROGENETICS, V14, P205, DOI 10.1007/s10048-013-0374-9; Hara Y, 2011, NEW ENGL J MED, V364, P939, DOI 10.1056/NEJMoa1006939; Hayashi YK, 2001, NEUROLOGY, V57, P115, DOI 10.1212/WNL.57.1.115; Herrmann R, 2000, HUM MOL GENET, V9, P2335, DOI 10.1093/oxfordjournals.hmg.a018926; Hollinger K, 2014, FASEB J, V28, P1600, DOI 10.1096/fj.13-241141; Holt KH, 2000, FEBS LETT, V468, P79, DOI 10.1016/S0014-5793(00)01195-9; IBRAGHIMOVBESKROVNAYA O, 1993, HUM MOL GENET, V2, P1651, DOI 10.1093/hmg/2.10.1651; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Jimenez-Mallebrera C, 2003, EUR J PAEDIATR NEURO, V7, P129, DOI 10.1016/S1090-3798(03)00042-4; Kano H, 2002, BIOCHEM BIOPH RES CO, V291, P1283, DOI 10.1006/bbrc.2002.6608; Kunz S, 2001, J CELL BIOL, V155, P301, DOI 10.1083/jcb.200104103; Live D, 2013, CHEMBIOCHEM, V14, P2392, DOI 10.1002/cbic.201300417; Martin LT, 2007, HUM PATHOL, V38, P1657, DOI 10.1016/j.humpath.2007.03.025; MATSUMURA K, 1994, NEUROMUSCULAR DISORD, V4, P115, DOI 10.1016/0960-8966(94)90002-7; McGlone J., 2010, GUIDE CARE USE AGR A, V3rd; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Nonneman DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-233; OHLENDIECK K, 1991, J CELL BIOL, V112, P135, DOI 10.1083/jcb.112.1.135; Pavoni E, 2005, FEBS LETT, V579, P493, DOI 10.1016/j.febslet.2004.10.111; Singh J, 2004, CANCER RES, V64, P6152, DOI 10.1158/0008-5472.CAN-04-1638; Williamson RA, 1997, HUM MOL GENET, V6, P831, DOI 10.1093/hmg/6.6.831; YANG B, 1995, J BIOL CHEM, V270, P11711, DOI 10.1074/jbc.270.20.11711; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512	31	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97567	10.1371/journal.pone.0097567	http://dx.doi.org/10.1371/journal.pone.0097567			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824861	Green Submitted, Green Published, gold			2022-12-27	WOS:000336369200129
J	Takacs, P; Bihari, P; Eros, T; Specziar, A; Szivak, I; Biro, P; Csoma, E				Takacs, Peter; Bihari, Peter; Eros, Tibor; Specziar, Andras; Szivak, Ildiko; Biro, Peter; Csoma, Eszter			Genetic Heterogeneity Reveals On-Going Speciation and Cryptic Taxonomic Diversity of Stream-Dwelling Gudgeons (Teleostei, Cyprinidae) in the Middle Danubian Hydrosystem (Hungary)	PLOS ONE			English	Article							GOBIO-GOBIO; MOLECULAR PHYLOGENY; CENTRAL-EUROPE; GENUS GOBIO; MITOCHONDRIAL; POPULATIONS; SOFTWARE; DIFFERENTIATION; MODEL; FISH	Although stream-dwelling gudgeons (Cyprinidae, genus: Gobio) are widespread in Central Europe, the taxonomy of this group and the distribution of its species are still unexplored in detail. The aims of our study are to ascertain taxonomic composition and distribution of the former Gobio gobio superspecies in the inner area of the Carpathian Basin. Since the presence of cryptic species is suspected in this area, we examined the taxonomic and phylogenetic relationships of Central European Gobio taxa by sequencing the mitochondrial DNA control region (mtCR). Additionally, we characterized the genetic structure of 27 stream-dwelling gudgeon populations of this area by Amplified Fragment Length Polymorphism (AFLP). Results of mtCR analysis proved the presence of three species already known as G. obtusirostris (dominant in NW-Hungary), G. gobio (sporadic) and G. carpathicus (sporadic). Additionally, the analysis revealed the existence of one doubtful taxon, G. sp1 (dominant in NE-Hungary), and a new isolated haplogroup (dominant in SW-Hungary). Although Network analysis showed significant detachment among haplogroups, their genetic distances were quite small. Therefore Bayesian phylogenetic analysis showed weak nodal support for the branching pattern both for newly described haplotypes, and for the already accepted species. AFLP data showed distinct population structure and a clear pattern of isolation was revealed by distance of stocks. At the same time, level of separation was not affected by the altitudinal position of sites. Moreover we found three major clusters of populations which were separated according to hydrographic regions, and corresponded to the findings of mtCR analysis. Our results suggest the on-going speciation of gudgeons in the Carpathian Basin, however the separation of haplogroups seems to only be an intermediate phase. The discovered natural pattern seems to be only slightly influenced by anthropogenic impacts. Additionally our results put into question the suitability of the recently accepted within Gobio genus taxonomy.	[Takacs, Peter; Eros, Tibor; Specziar, Andras; Szivak, Ildiko; Biro, Peter] MTA Ctr Ecol Res, Balaton Limnol Inst, Dept Hydrozool, Tihany, Hungary; [Bihari, Peter] MTA Biol Res Ctr, Inst Genet, Szeged, Hungary; [Csoma, Eszter] Univ Debrecen, Dept Med Microbiol, H-4012 Debrecen, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; Hungarian Balaton Limnological Research Institute; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; University of Debrecen	Takacs, P (corresponding author), MTA Ctr Ecol Res, Balaton Limnol Inst, Dept Hydrozool, Tihany, Hungary.	takacs.peter@okologia.mta.hu	Biro, Peter/CAJ-0232-2022; Eros, Tibor/I-1671-2019; Specziár, András/N-5656-2019; Takács, Péter/A-8082-2016	Biro, Peter/0000-0002-2855-4991; Specziár, András/0000-0001-6341-636X; Takács, Péter/0000-0001-5247-7597	Hungarian Scientific Research Fund [OTKA-NKTH CNK 80140]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	The study was supported by the Hungarian Scientific Research Fund (OTKA-NKTH CNK 80140). "The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript''.	Arntzen JW, 2007, CONTRIB ZOOL, V76, P261, DOI 10.1163/18759866-07604005; Arthofer W, 2010, MOL ECOL RESOUR, V10, P385, DOI 10.1111/j.1755-0998.2009.02751.x; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Banarescu PM, 1999, FRESHWATER FISHES EU, V5/I, P81, DOI DOI 10.1093/0XF0RDJ0URNALS.M0LBEV.A026036; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barluenga M, 2005, MOL ECOL, V14, P1229, DOI 10.1111/j.1365-294X.2005.02468.x; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Cooke GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048800; Coyne J.A., 2004, SPECIATION; Doadrio I., 2004, Graellsia, V60, P107; Drummond A. J., 2011, GENEIOUS V5 4; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Foll M, 2008, GENETICS, V179, P927, DOI 10.1534/genetics.107.084541; Gabris Gy, 2007, FOLDRAJZI ERTESITO, V56, P39; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gutierrez-Rodriguez C, 2007, MOL PHYLOGENET EVOL, V43, P111, DOI 10.1016/j.ympev.2006.10.022; Hanfling B, 1998, HEREDITY, V80, P110; Harka A, 2004, MAGYARORSZAG HALFAUN, P269; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Herman O, 1887, MAGYAR HALASZAT KONY, P847; Holsinger Kent E, 2009, Nat Rev Genet, V10, P639, DOI 10.1038/nrg2611; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Kottelat M, 2005, CYBIUM, V29, P211; Kottelat M., 2007, HDB EUROPEAN FRESHWA, P646; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larson ER, 2012, FRESHWATER BIOL, V57, P1823, DOI 10.1111/j.1365-2427.2012.02841.x; Laszloffy W, 1982, TISZA, P610; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MANTEL N, 1967, CANCER RES, V27, P209; Maric S, 2012, HYDROBIOLOGIA, V691, P225, DOI 10.1007/s10750-012-1076-2; Maric S, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-2; Martonne Erdos K, 2004, MAGYARORSZAG TERMESZ, P245; MAYR E, 1948, ADV GENET, V2, P205, DOI 10.1016/S0065-2660(08)60469-1; Mendel J, 2005, FOLIA ZOOL, V54, P13; Mendel J, 2012, MOL ECOL RES, V12, P972, DOI DOI 10.1111/J.1755-0998.2012.03173.X; Mendel J, 2008, MOL PHYLOGENET EVOL, V47, P1061, DOI 10.1016/j.ympev.2008.03.005; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Naseka A.M., 2006, Zoosystematica Rossica, V15, P185; NEI M, 1974, GENETICS, V76, P379; Neilson ME, 2011, DIVERS DISTRIB, V17, P688, DOI 10.1111/j.1472-4642.2011.00762.x; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Nowak M, 2011, 1 INT C FISH DIV CA, P48; Nowak Michal, 2011, Archives of Polish Fisheries, V19, P37; Nowak Michal, 2008, AACL Bioflux, V1, P27; Payo DA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2660; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Pfenninger M, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-100; Pontin DR, 2012, HYDROBIOLOGIA, V686, P91, DOI 10.1007/s10750-011-0994-8; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK., 2010, DOCUMENTATION STRUCT; Rambaut A., 2009, TRACER VERSION 1 5; Rundell RJ, 2004, MOL PHYLOGENET EVOL, V31, P246, DOI 10.1016/j.ympev.2003.07.014; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Saitoh K, 2006, J MOL EVOL, V63, P826, DOI 10.1007/s00239-005-0293-y; Saitoh K, 2003, J MOL EVOL, V56, P464, DOI 10.1007/s00239-002-2417-y; Sanda R, 2005, FOLIA ZOOL, V54, P73; Schreiber A, 2002, HEREDITY, V89, P163, DOI 10.1038/sj.hdy.6800109; Sediva A, 2008, MOL ECOL, V17, P1277, DOI 10.1111/j.1365-294X.2007.03656.x; Sikhegyi F., 2002, EGU S MUELLER SPECIA, V3, P203; Slechtova V, 2005, FOLIA ZOOL, V54, P25; Sumegi P, 2008, DOC PRAEHIST, V35, P33, DOI 10.4312/dp.35.3; Takacs P, 2008, ACTA ZOOL ACAD SCI H, V54, P289; Takacs P, 2012, ANN LIMNOL-INT J LIM, V48, P53; Takacs Peter, 2011, Ecology of Lake Balaton, V1, P1; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Turan D, 2012, ZOOTAXA, P56, DOI 10.11646/zootaxa.3257.1.4; Vasil'eva ED, 2005, J ICHTHYOL+, V4, P730; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Vrijenhoek RC, 2009, DEEP-SEA RES PT II, V56, P1713, DOI 10.1016/j.dsr2.2009.05.016; Wachter GA, 2012, MOL ECOL, V21, P4983, DOI 10.1111/j.1365-294X.2012.05758.x; Watanabe K, 2000, ICHTHYOL RES, V47, P43, DOI 10.1007/BF02674312; Westram AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023879; Zickovich JM, 2007, FRESHWATER BIOL, V52, P1982, DOI 10.1111/j.1365-2427.2007.01822.x; Zieritz A, 2010, EVOL ECOL, V24, P923, DOI 10.1007/s10682-009-9350-0	79	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97278	10.1371/journal.pone.0097278	http://dx.doi.org/10.1371/journal.pone.0097278			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824751	Green Submitted, Green Published, gold			2022-12-27	WOS:000336369200085
J	Tavares, LDC; Zanon, G; Weber, AD; Neto, AT; Mostardeiro, CP; Da Cruz, IBM; Oliveira, RM; Ilha, V; Dalcol, II; Morel, AF				Tavares, Luciana de C.; Zanon, Graciane; Weber, Andreia D.; Neto, Alexandre T.; Mostardeiro, Clarice P.; Da Cruz, Ivana B. M.; Oliveira, Raul M.; Ilha, Vinicius; Dalcol, Ionara I.; Morel, Ademir F.			Structure-Activity Relationship of Benzophenanthridine Alkaloids from Zanthoxylum rhoifolium Having Antimicrobial Activity	PLOS ONE			English	Article							OXIDATIVE STRESS; CHELERYTHRINE; FUROQUINOLINE; SANGUINARINE; ANTIMALARIAL; CHELIDONINE; FAGARONINE; GENERATION	Zanthoxylum rhoifolium (Rutaceae) is a plant alkaloid that grows in South America and has been used in Brazilian traditional medicine for the treatment of different health problems. The present study was designed to evaluate the antimicrobial activity of the steam bark crude methanol extract, fractions, and pure alkaloids of Z. rhoifolium. Its stem bark extracts exhibited a broad spectrum of antimicrobial activity, ranging from 12.5 to 100 mu g/mL using bioautography method, and from 125 to 500 mu g/mL in the microdilution bioassay. From the dichloromethane basic fraction, three furoquinoline alkaloids (1-3), and nine benzophenanthridine alkaloids (4-12) were isolated and the antimicrobial activity of the benzophenanthridine alkaloids is discussed in terms of structure-activity relationships. The alkaloid with the widest spectrum of activity was chelerythrine (10), followed by avicine (12) and dihydrochelerythrine (4). The minimal inhibitory concentrations of chelerythrine, of 1.50 mu g/mL for all bacteria tested, and between 3.12 and 6.25 mu g/mL for the yeast tested, show this compound to be a more powerful antimicrobial agent when compared with the other active alkaloids isolated from Z. rhoifolium. To verify the potential importance of the methylenedioxy group (ring A) of these alkaloids, chelerythrine was selected to represent the remainder of the benzophenanthridine alkaloids isolated in this work and was subjected to a demethylation reaction giving derivative 14. Compared to chelerythrine, the derivative (14) was less active against the tested bacteria and fungi. Kinetic measurements of the bacteriolytic activities of chelerythrine against the bacteria Bacillus subtilis (Gram-positive) and Escherichia coli (Gram-negative) were determined by optical density based on real time assay, suggesting that its mechanism of action is not bacteriolytic. The present study did not detect hemolytic effects of chelerythrine on erythrocytes and found a protective effect considering the decrease in TBARS and AOPP (advanced oxidized protein products) levels when compared to the control group.	[Tavares, Luciana de C.; Zanon, Graciane; Weber, Andreia D.; Neto, Alexandre T.; Ilha, Vinicius; Dalcol, Ionara I.; Morel, Ademir F.] Univ Fed Santa Maria, Ctr Res Nat Prod NPPN, BR-97119900 Santa Maria, RS, Brazil; [Mostardeiro, Clarice P.; Da Cruz, Ivana B. M.; Oliveira, Raul M.; Dalcol, Ionara I.] Univ Fed Santa Maria, Hlth Sci Ctr, Grad Program Pharmacol, BR-97119900 Santa Maria, RS, Brazil; [Da Cruz, Ivana B. M.] Univ Fed Santa Maria, Grad Program Toxicol Biochem, BR-97119900 Santa Maria, RS, Brazil	Universidade Federal de Santa Maria (UFSM); Universidade Federal de Santa Maria (UFSM); Universidade Federal de Santa Maria (UFSM)	Morel, AF (corresponding author), Univ Fed Santa Maria, Ctr Res Nat Prod NPPN, BR-97119900 Santa Maria, RS, Brazil.	afmorel@base.ufsm.br	da Cruz, Ivana BM/G-4329-2012; Ilha, Vinicius/E-1690-2013; Dalcol, Ionara/AAN-4140-2020	da Cruz, Ivana BM/0000-0003-3008-6899; Ilha, Vinicius/0000-0003-2555-4731; 	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); FAPERGS (Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul)-PRONEX	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERGS (Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul)-PRONEX	The authors thank CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) and FAPERGS (Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul)-PRONEX for financial support for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSHAMMA A, 1979, PHYTOCHEMISTRY, V18, P1417, DOI 10.1016/0031-9422(79)83044-7; BARRET Y, 1992, PHYTOTHER RES, V6, P59, DOI 10.1002/ptr.2650060202; BASCO LK, 1994, ANTIMICROB AGENTS CH, V38, P1169, DOI 10.1128/AAC.38.5.1169; FANG SD, 1993, J ORG CHEM, V58, P5025, DOI 10.1021/jo00071a001; Fernandes CC, 2009, J BRAZIL CHEM SOC, V20, P379, DOI 10.1590/S0103-50532009000200025; Freitas FFBP, 2011, J ETHNOPHARMACOL, V137, P700, DOI 10.1016/j.jep.2011.06.026; Gehrke ITS, 2013, J ETHNOPHARMACOL, V148, P486, DOI 10.1016/j.jep.2013.04.043; Gonzaga WDA, 2003, PLANTA MED, V69, P371, DOI 10.1055/s-2003-38882; HAMBURGER MO, 1987, J NAT PROD, V50, P19, DOI 10.1021/np50049a003; Jentzsch AM, 1996, FREE RADICAL BIO MED, V20, P251, DOI 10.1016/0891-5849(95)02043-8; Jullian V, 2006, J ETHNOPHARMACOL, V106, P348, DOI 10.1016/j.jep.2006.01.011; Kemeny-Beke A, 2006, CANCER LETT, V237, P67, DOI 10.1016/j.canlet.2005.05.037; KHALID SA, 1982, J NAT PROD, V45, P343, DOI 10.1021/np50021a017; Kim J, 2005, J CELL BIOCHEM, V94, P39, DOI 10.1002/jcb.20276; Lehtinen J, 2006, J MICROBIOL METH, V66, P381, DOI 10.1016/j.mimet.2006.01.002; LENFELD J, 1981, PLANTA MED, V43, P161, DOI 10.1055/s-2007-971493; Mazzanti G, 2009, J ETHNOPHARMACOL, V126, P518, DOI 10.1016/j.jep.2009.09.004; MESSMER WM, 1972, J PHARM SCI-US, V61, P1858, DOI 10.1002/jps.2600611145; Miao F, 2011, NAT PROD RES, V25, P863, DOI 10.1080/14786419.2010.482055; Moura NF, 1998, FITOTERAPIA, V69, P271; Moura NF, 1997, PHYTOCHEMISTRY, V46, P443; Navarro V, 1999, J ETHNOPHARMACOL, V66, P223, DOI 10.1016/S0378-8741(98)00182-2; NCCLS: National Committee for Clinical Laboratory Standards, 2002, M27A2 NCCLS CLSI; NCCLS: National Committee for Clinical Laboratory Standards, 2002, M7A5 NCCLS CLSI; Nissanka APK, 2001, PHYTOCHEMISTRY, V56, P857, DOI 10.1016/S0031-9422(00)00402-7; Nyangulu JM, 2005, BIOORG MED CHEM LETT, V15, P2007, DOI 10.1016/j.bmcl.2005.02.074; ODEBIYI OO, 1979, PLANTA MED, V36, P204, DOI 10.1055/s-0028-1097271; de Oliveira S, 2008, CLIN HEMORHEOL MICRO, V39, P363, DOI 10.3233/CH-2008-1101; Panzer A, 2001, EUR J CELL BIOL, V80, P111, DOI 10.1078/0171-9335-00135; Parlakpinar H, 2006, CELL BIOCHEM FUNCT, V24, P41, DOI 10.1002/cbf.1182; Pereira SS, 2010, J ETHNOPHARMACOL, V129, P227, DOI 10.1016/j.jep.2010.03.009; RAHALISON L, 1991, PHYTOCHEM ANALYSIS, V2, P199, DOI 10.1002/pca.2800020503; Schiar VPP, 2009, CHEM-BIOL INTERACT, V177, P28, DOI 10.1016/j.cbi.2008.10.007; Selmeci L, 2005, CLIN CHEM LAB MED, V43, P294, DOI 10.1515/CCLM.2005.050; Taylor PW, 2013, INT J ANTIMICROB AG, V42, P195, DOI 10.1016/j.ijantimicag.2013.05.004; Tillequin Francois, 2007, Phytochemistry Reviews, V6, P65, DOI 10.1007/s11101-006-9010-8; TINWA M, 1974, J PHARM SCI-US, V63, P1476, DOI 10.1002/jps.2600630935; Wansi JD, 2010, PHYTOTHER RES, V24, P775, DOI 10.1002/ptr.2894; Weber AD, 2009, PLANTA MED, V75, P979; Yamamoto S, 2001, J MOL CELL CARDIOL, V33, P1829, DOI 10.1006/jmcc.2001.1446; Yang XJ, 2012, MOLECULES, V17, P13026, DOI 10.3390/molecules171113026	41	27	33	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97000	10.1371/journal.pone.0097000	http://dx.doi.org/10.1371/journal.pone.0097000			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824737	Green Submitted, Green Published, gold			2022-12-27	WOS:000336369200047
J	Venter, G; Oerlemans, FTJJ; Willemse, M; Wijers, M; Fransen, JAM; Wieringa, B				Venter, Gerda; Oerlemans, Frank T. J. J.; Willemse, Marieke; Wijers, Mietske; Fransen, Jack A. M.; Wieringa, Be			NAMPT-Mediated Salvage Synthesis of NAD(+) Controls Morphofunctional Changes of Macrophages	PLOS ONE			English	Article							ACTIN STRESS FIBERS; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PHARMACOLOGICAL INHIBITION; TYROSINE PHOSPHORYLATION; RESPIRATORY BURST; CREATINE-KINASE; CELL-ADHESION; RHO; ACTIVATION; LPS	Functional morphodynamic behavior of differentiated macrophages is strongly controlled by actin cytoskeleton rearrangements, a process in which also metabolic cofactors ATP and NAD(H) (i.e. NAD(+) and NADH) and NADP(H) (i.e. NADP(+) and NADPH) play an essential role. Whereas the link to intracellular ATP availability has been studied extensively, much less is known about the relationship between actin cytoskeleton dynamics and intracellular redox state and NAD(+)-supply. Here, we focus on the role of nicotinamide phosphoribosyltransferase (NAMPT), found in extracellular form as a cytokine and growth factor, and in intracellular form as one of the key enzymes for the production of NAD(+) in macrophages. Inhibition of NAD(+) salvage synthesis by the NAMPT-specific drug FK866 caused a decrease in cytosolic NAD(+) levels in RAW 264.7 and Maf-DKO macrophages and led to significant downregulation of the glycolytic flux without directly affecting cell viability, proliferation, ATP production capacity or mitochondrial respiratory activity. Concomitant with these differential metabolic changes, the capacity for phagocytic ingestion of particles and also substrate adhesion of macrophages were altered. Depletion of cytoplasmic NAD(+) induced cell-morphological changes and impaired early adhesion in phagocytosis of zymosan particles as well as spreading performance. Restoration of NAD(+) levels by NAD(+), NMN, or NADP(+) supplementation reversed the inhibitory effects of FK866. We conclude that direct coupling to local, actin-based, cytoskeletal dynamics is an important aspect of NAD(+)'s cytosolic role in the regulation of morphofunctional characteristics of macrophages.	[Venter, Gerda; Oerlemans, Frank T. J. J.; Willemse, Marieke; Wijers, Mietske; Fransen, Jack A. M.; Wieringa, Be] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Cell Biol, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Wieringa, B (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Cell Biol, NL-6525 ED Nijmegen, Netherlands.	b.wieringa@ncmls.ru.nl	Wieringa, Berend/A-5346-2011; Wijers-Rouw, Mietske/G-4456-2016; Fransen, Jack/E-8924-2010	Wieringa, Berend/0000-0001-9192-8020; Fransen, Jack/0000-0002-0571-7639; Venter, Gerda/0000-0002-8043-2203	Radboud University Medical Centre	Radboud University Medical Centre	Radboud University Medical Centre. The funders had no role in study design, data collection and analysis, decision topublish, or preparation of the manuscript.	ALBINA JE, 1993, AM J PHYSIOL, V264, pC1594, DOI 10.1152/ajpcell.1993.264.6.C1594; Atkinson SJ, 2004, J BIOL CHEM, V279, P5194, DOI 10.1074/jbc.M306973200; Aziz A, 2009, SCIENCE, V326, P867, DOI 10.1126/science.1176056; Beuchle D, 2007, MECH DEVELOP, V124, P390, DOI 10.1016/j.mod.2007.01.006; Beutler B, 2000, CURR OPIN IMMUNOL, V12, P20, DOI 10.1016/S0952-7915(99)00046-1; Braidy N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019194; Bruzzone S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007897; Busso N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002267; CALDER PC, 1995, P NUTR SOC, V54, P65, DOI 10.1079/PNS19950038; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Caron E, 2000, CURR BIOL, V10, P974, DOI 10.1016/S0960-9822(00)00641-2; Chang EJ, 2008, NAT MED, V14, P966, DOI 10.1038/nm.1860; Chiarugi P, 2003, J CELL BIOL, V161, P933, DOI 10.1083/jcb.200211118; CIFARELLI A, 1979, RES EXP MED, V174, P197, DOI 10.1007/BF01851332; Cougoule C, 2004, SEMIN CELL DEV BIOL, V15, P679, DOI 10.1016/j.semcdb.2004.09.001; Cougoule C, 2012, EUR J CELL BIOL, V91, P938, DOI 10.1016/j.ejcb.2012.07.002; Dalle-Donne I, 2001, FREE RADICAL BIO MED, V31, P1624, DOI 10.1016/S0891-5849(01)00749-3; Felici R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076938; Flannagan RS, 2010, J CELL BIOL, V191, P1205, DOI 10.1083/jcb.201007056; Forman HJ, 2002, AM J RESP CRIT CARE, V166, pS4, DOI 10.1164/rccm.2206007; Friebe D, 2011, DIABETOLOGIA, V54, P1200, DOI 10.1007/s00125-010-2042-z; Fukuzumi M, 1996, INFECT IMMUN, V64, P108, DOI 10.1128/IAI.64.1.108-112.1996; Giridharan SSP, 2012, J CELL SCI, V125, P614, DOI 10.1242/jcs.089367; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Guiet R, 2011, J IMMUNOL, V187, P3806, DOI 10.4049/jimmunol.1101245; Hahn EL, 2000, SHOCK, V13, P253, DOI 10.1097/00024382-200004000-00001; Hara N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022781; Hasmann M, 2003, CANCER RES, V63, P7436; Hazeki K, 2003, EUR J IMMUNOL, V33, P740, DOI 10.1002/eji.200323375; Heikal AA, 2010, BIOMARK MED, V4, P241, DOI 10.2217/BMM.10.1; Holen K, 2008, INVEST NEW DRUG, V26, P45, DOI 10.1007/s10637-007-9083-2; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Huang TY, 2008, DEV CELL, V15, P691, DOI 10.1016/j.devcel.2008.09.017; Hung R-J, 2011, AIDS RES HUM RETR S1; Hung RJ, 2010, NATURE, V463, P823, DOI 10.1038/nature08724; Hurd TR, 2012, TRENDS CELL BIOL, V22, P107, DOI 10.1016/j.tcb.2011.11.002; Ingerman E, 2013, J CELL BIOL, V200, P619, DOI 10.1083/jcb.201211069; Iqbal J, 2006, BIOCHEM BIOPH RES CO, V342, P1312, DOI 10.1016/j.bbrc.2006.02.109; JANMEY PA, 1994, ANNU REV PHYSIOL, V56, P169, DOI 10.1146/annurev.ph.56.030194.001125; Jia SH, 2004, J CLIN INVEST, V113, P1318, DOI [10.1172/JCI19930, 10.1172/JCI200419930]; Kim JG, 2012, J BIOL CHEM, V287, P5145, DOI 10.1074/jbc.M111.257634; Kim JS, 2009, MOL BIOL CELL, V20, P2650, DOI 10.1091/mbc.E09-02-0131; Kim YE, 2010, NAT METHODS, V7, P67, DOI [10.1038/nmeth.1405, 10.1038/NMETH.1405]; KLAIDMAN LK, 1995, ANAL BIOCHEM, V228, P312, DOI 10.1006/abio.1995.1356; Kleveta G, 2012, J CELL BIOCHEM, V113, P80, DOI 10.1002/jcb.23330; Kotas ME, 2013, ADIPOCYTE, V2, P113, DOI 10.4161/adip.23437; Kress H, 2007, P NATL ACAD SCI USA, V104, P11633, DOI 10.1073/pnas.0702449104; Kuiper JWP, 2008, PLOS BIOL, V6, P568, DOI 10.1371/journal.pbio.0060051; Kuiper JWP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005030; Lee BC, 2013, MOL CELL, V51, P397, DOI 10.1016/j.molcel.2013.06.019; Li YK, 2008, J BIOL CHEM, V283, P34833, DOI 10.1074/jbc.M805866200; Malam Z, 2011, J IMMUNOL, V186, P6474, DOI 10.4049/jimmunol.1003706; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Morinaka A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001127; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; NEWSHOLME P, 1986, BIOCHEM J, V239, P121, DOI 10.1042/bj2390121; Nikiforov A, 2011, J BIOL CHEM, V286, P21767, DOI 10.1074/jbc.M110.213298; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Olesen UH, 2010, MOL CANCER THER, V9, P1609, DOI 10.1158/1535-7163.MCT-09-1130; PARADISI F, 1979, Ricerca in Clinica e in Laboratorio, V9, P47; Patel PC, 2008, MOL BIOL CELL, V19, P4628, DOI 10.1091/mbc.E08-02-0223; Pittelli M, 2010, J BIOL CHEM, V285, P34106, DOI 10.1074/jbc.M110.136739; Pollak N, 2007, J BIOL CHEM, V282, P33562, DOI 10.1074/jbc.M704442200; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; POOLE RC, 1993, AM J PHYSIOL, V264, pC761, DOI 10.1152/ajpcell.1993.264.4.C761; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; RASCHKE WC, 1975, J NATL CANCER I, V54, P1249, DOI 10.1093/jnci/54.5.1249; REISS PD, 1984, ANAL BIOCHEM, V140, P162, DOI 10.1016/0003-2697(84)90148-9; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; SAHLIN S, 1983, J IMMUNOL METHODS, V60, P115, DOI 10.1016/0022-1759(83)90340-X; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Schilling E, 2011, INNATE IMMUN, V0, P1; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; Stock C, 2009, PFLUG ARCH EUR J PHY, V458, P981, DOI 10.1007/s00424-009-0677-8; Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272; Sumi T, 1999, J CELL BIOL, V147, P1519, DOI 10.1083/jcb.147.7.1519; Tan B, 2013, J BIOL CHEM, V288, P3500, DOI 10.1074/jbc.M112.394510; Tharmalingam S, 2011, J BIOL CHEM, V286, P40922, DOI 10.1074/jbc.M111.265454; Tu BP, 2007, P NATL ACAD SCI USA, V104, P16886, DOI 10.1073/pnas.0708365104; Van Gool F, 2009, NAT MED, V15, P206, DOI 10.1038/nm.1906; van Horssen R, 2013, CELL MOL LIFE SCI, P1; van Horssen R, 2009, J BIOL CHEM, V284, P1620, DOI 10.1074/jbc.M806974200; Vicente-Manzanares M, 2004, NAT REV IMMUNOL, V4, P110, DOI 10.1038/nri1268; Weintz G, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.29; Williams LM, 2000, J IMMUNOL, V164, P2028, DOI 10.4049/jimmunol.164.4.2028; Wosikowski K, 2002, CANCER RES, V62, P1057; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yin H, 2012, J CELL SCI, V125, P5770, DOI 10.1242/jcs.110262	96	26	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97378	10.1371/journal.pone.0097378	http://dx.doi.org/10.1371/journal.pone.0097378			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824795	Green Submitted, gold, Green Published			2022-12-27	WOS:000336369200105
J	Yamashita, H; Suzuki, G; Kai, S; Hayashibara, T; Koike, K				Yamashita, Hiroshi; Suzuki, Go; Kai, Sayaka; Hayashibara, Takeshi; Koike, Kazuhiko			Establishment of Coral-Algal Symbiosis Requires Attraction and Selection	PLOS ONE			English	Article							FREE-LIVING SYMBIODINIUM; GENUS SYMBIODINIUM; ACROPORA CORALS; REEF; ZOOXANTHELLAE; ACQUISITION; LARVAE; ONSET; IDENTIFICATION; FLEXIBILITY	Coral reef ecosystems are based on coral-zooxanthellae symbiosis. During the initiation of symbiosis, majority of corals acquire their own zooxanthellae (specifically from the dinoflagellate genus Symbiodinium) from surrounding environments. The mechanisms underlying the initial establishment of symbiosis have attracted much interest, and numerous field and laboratory experiments have been conducted to elucidate this establishment. However, it is still unclear whether the host corals selectively or randomly acquire their symbionts from surrounding environments. To address this issue, we initially compared genetic compositions of Symbiodinium within naturally settled about 2-week-old Acropora coral juveniles (recruits) and those in the adjacent seawater as the potential symbiont source. We then performed infection tests using several types of Symbiodinium culture strains and apo-symbiotic (does not have Symbiodinium cells yet) Acropora coral larvae. Our field observations indicated apparent preference toward specific Symbiodinium genotypes (A1 and D1-4) within the recruits, despite a rich abundance of other Symbiodinium in the environmental population pool. Laboratory experiments were in accordance with this field observation: Symbiodinium strains of type A1 and D1-4 showed higher infection rates for Acropora larvae than other genotype strains, even when supplied at lower cell densities. Subsequent attraction tests revealed that three Symbiodinium strains were attracted toward Acropora larvae, and within them, only A1 and D1-4 strains were acquired by the larvae. Another three strains did not intrinsically approach to the larvae. These findings suggest the initial establishment of corals-Symbiodinium symbiosis is not random, and the infection mechanism appeared to comprise two steps: initial attraction step and subsequent selective uptake by the coral.	[Yamashita, Hiroshi; Suzuki, Go; Kai, Sayaka; Hayashibara, Takeshi] Fisheries Res Agcy, Seikai Natl Fisheries Res Inst, Res Ctr Subtrop Fisheries, Ishigaki, Okinawa, Japan; [Koike, Kazuhiko] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima, Hiroshima 724, Japan	Japan Fisheries Research & Education Agency (FRA); Hiroshima University	Yamashita, H (corresponding author), Fisheries Res Agcy, Seikai Natl Fisheries Res Inst, Res Ctr Subtrop Fisheries, Ishigaki, Okinawa, Japan.	hyamashita@fra.affrc.go.jp	Koike, Kazuhiko/A-3392-2019	Kazuhiko, Koike/0000-0001-5380-5839	Ministry of Education, Culture, Sports, Science and Technology of Japan [21310011, 24570028]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research (B) (No. 21310011) and (C) (No. 24570028) from the Ministry of Education, Culture, Sports, Science and Technology of Japan to KK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrego D, 2009, MOL ECOL, V18, P3532, DOI 10.1111/j.1365-294X.2009.04276.x; Adams LM, 2009, MAR ECOL PROG SER, V377, P149, DOI 10.3354/meps07834; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Coffroth MA, 2005, PROTIST, V156, P19, DOI 10.1016/j.protis.2005.02.004; Coffroth MA, 2006, CURR BIOL, V16, pR985, DOI 10.1016/j.cub.2006.10.049; Cumbo VR, 2013, CORAL REEFS, V32, P111, DOI 10.1007/s00338-012-0951-7; FITT WK, 1985, J PHYCOL, V21, P62; Franklin EC, 2012, MOL ECOL RESOUR, V12, P369, DOI 10.1111/j.1755-0998.2011.03081.x; Gomez-Cabrera MD, 2008, CORAL REEFS, V27, P219, DOI 10.1007/s00338-007-0315-x; Harii S, 2009, MAR BIOL, V156, P1203, DOI 10.1007/s00227-009-1162-9; Hayashibara T, 2004, CORAL REEFS, V23, P406, DOI 10.1007/s00338-004-0406-x; Hirose M, 2008, CORAL REEFS, V27, P247, DOI 10.1007/s00338-007-0330-y; Hollingsworth L. L., 2006, P 10 INT COR REEF S, P99; Hollingsworth LL, 2005, CORAL REEFS, V24, P523, DOI 10.1007/s00338-005-0063-8; Jimbo M, 2013, J EXP MAR BIOL ECOL, V439, P129, DOI 10.1016/j.jembe.2012.10.022; Jimbo M, 2010, FISHERIES SCI, V76, P355, DOI 10.1007/s12562-009-0204-z; KINZIE RA, 1974, J EXP MAR BIOL ECOL, V15, P335, DOI 10.1016/0022-0981(74)90054-9; Koike K, 2004, BIOL BULL-US, V207, P80, DOI 10.2307/1543582; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P570, DOI 10.1093/molbev/msi042; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; LaJeunesse TC, 2010, J BIOGEOGR, V37, P785, DOI 10.1111/j.1365-2699.2010.02273.x; LaJeunesse TC, 2009, BIOL INVASIONS, V11, P995, DOI 10.1007/s10530-008-9311-5; Little AF, 2004, SCIENCE, V304, P1492, DOI 10.1126/science.1095733; Littman RA, 2008, J EXP MAR BIOL ECOL, V364, P48, DOI 10.1016/j.jembe.2008.06.034; Manning MM, 2008, LIMNOL OCEANOGR, V53, P1853, DOI 10.4319/lo.2008.53.5.1853; Mieog JC, 2007, CORAL REEFS, V26, P449, DOI 10.1007/s00338-007-0244-8; MONTGOMERY MK, 1995, MAR BIOL, V124, P147, DOI 10.1007/BF00349156; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; R Core Team, 2012, R LANG ENV STAT COMP; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; Sampayo EM, 2008, P NATL ACAD SCI USA, V105, P10444, DOI 10.1073/pnas.0708049105; Schwarz JA, 1999, BIOL BULL-US, V196, P70, DOI 10.2307/1543169; Suzuki G, 2012, CORAL REEFS, V31, P535, DOI 10.1007/s00338-011-0865-9; Suzuki G, 2008, MAR ECOL PROG SER, V355, P149, DOI 10.3354/meps07253; Takabayashi M, 2012, CORAL REEFS, V31, P157, DOI 10.1007/s00338-011-0832-5; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wood-Charlson EM, 2006, CELL MICROBIOL, V8, P1985, DOI 10.1111/j.1462-5822.2006.00765.x; Yamashita H, 2013, CORAL REEFS, V32, P355, DOI 10.1007/s00338-012-0980-2; Yamashita H, 2013, PHYCOL RES, V61, P68, DOI 10.1111/pre.12004; Yamashita H, 2011, MAR BIOL, V158, P87, DOI 10.1007/s00227-010-1544-z; Yamashita H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006303; Yuyama I, 2005, BIOCHEM BIOPH RES CO, V336, P793, DOI 10.1016/j.bbrc.2005.08.174; Yuyama I, 2012, MAR ENVIRON RES, V76, P41, DOI 10.1016/j.marenvres.2011.09.004	43	38	40	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97003	10.1371/journal.pone.0097003	http://dx.doi.org/10.1371/journal.pone.0097003			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824794	Green Submitted, Green Published, gold			2022-12-27	WOS:000336369200048
J	Yang, TT; Zhang, X; Wang, M; Zhang, J; Huang, F; Cai, J; Zhang, Q; Mao, F; Zhu, W; Qian, H; Xu, WR				Yang, Tingting; Zhang, Xu; Wang, Mei; Zhang, Jie; Huang, Feng; Cai, Jie; Zhang, Qiang; Mao, Fei; Zhu, Wei; Qian, Hui; Xu, Wenrong			Activation of Mesenchymal Stem Cells by Macrophages Prompts Human Gastric Cancer Growth through NF-kappa B Pathway	PLOS ONE			English	Article							FACTOR EXPRESSION; TRANSITION; INFLAMMATION; CYTOKINES; DRIVES	Accumulating evidence indicate that macrophages activate mesenchymal stem cells (MSCs) to acquire pro-inflammatory phenotype. However, the role of MSCs activated by macrophages in gastric cancer remains largely unknown. In this study, we found that MSCs were activated by macrophages to produce increased levels of inflammatory cytokines. Cell colony formation and transwell migration assays revealed that supernatants from the activated MSCs could promote both gastric epithelial cell and gastric cancer cell proliferation and migration. In addition, the expression of epithelial-mesenchymal transition (EMT), angiogenesis, and stemness-related genes was increased in activated MSCs. The phosphorylated forms of NF-kappa B, ERK and STAT3 in gastric cells were increased by active MSCs. Inhibition of NF-kappa B activation by PDTC blocked the effect of activated MSCs on gastric cancer cells. Co-injection of activated MSCs with gastric cancer cells could accelerate gastric cancer growth. Moreover, human peripheral blood monocytes derived macrophages also activated MSCs to prompt gastric cancer cell proliferation and migration. Taken together, our findings suggest that MSCs activated by macrophage acquire pro-inflammatory phenotype and prompt gastric cancer growth in an NF-kappa B-dependent manner, which provides new evidence for the modulation of MSCs by tumor microenvironment and further insight to the role of stromal cells in gastric carcinogenesis and cancer progression.	[Yang, Tingting; Zhang, Xu; Wang, Mei; Zhang, Jie; Huang, Feng; Cai, Jie; Zhang, Qiang; Mao, Fei; Zhu, Wei; Qian, Hui; Xu, Wenrong] Jiangsu Univ, Sch Med Sci, Zhenjiang, Jiangsu, Peoples R China; [Yang, Tingting; Zhang, Xu; Wang, Mei; Zhang, Jie; Huang, Feng; Cai, Jie; Zhang, Qiang; Mao, Fei; Zhu, Wei; Qian, Hui; Xu, Wenrong] Jiangsu Univ, Lab Med, Zhenjiang, Jiangsu, Peoples R China; [Xu, Wenrong] Jiangsu Univ, Affiliated Hosp, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University; Jiangsu University; Jiangsu University	Qian, H (corresponding author), Jiangsu Univ, Sch Med Sci, Zhenjiang, Jiangsu, Peoples R China.	lstmmmlst@163.com; icls@ujs.edu.cn	cai, jie/HHS-0606-2022	Qian, Hui/0000-0002-0098-3196	Major Research Plan of the National Natural Science Foundation of China [91129718]; National Natural Science Foundation of China [81302119, 81201660, 81071421]; Jiangsu Province for Outstanding Sci-tech Innovation Team in Colleges and Universities [SJK2013-10]; Jiangsu Province's Project of Scientific and Technological Innovation and Achievements Transformation [BL2012055]; Jiangsu Province's Outstanding Medical Academic Leader and Sci-tech Innovation Team Program [LJ201117]; Natural Science Foundation of the Jiangsu Province [BK2012709, BK20130540]; Doctoral Program Foundation of State Education Ministry [20113227110011]; Jiangsu Province for Natural Scicence Research in Colleges and Universities [13KJB320001]	Major Research Plan of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province for Outstanding Sci-tech Innovation Team in Colleges and Universities; Jiangsu Province's Project of Scientific and Technological Innovation and Achievements Transformation; Jiangsu Province's Outstanding Medical Academic Leader and Sci-tech Innovation Team Program; Natural Science Foundation of the Jiangsu Province(Natural Science Foundation of Jiangsu Province); Doctoral Program Foundation of State Education Ministry; Jiangsu Province for Natural Scicence Research in Colleges and Universities	This work was supported by the Major Research Plan of the National Natural Science Foundation of China (Grant No. 91129718), the National Natural Science Foundation of China (Grant no. 81302119, 81201660, 81071421), Jiangsu Province for Outstanding Sci-tech Innovation Team in Colleges and Universities (Grant no. SJK2013-10), Jiangsu Province's Project of Scientific and Technological Innovation and Achievements Transformation (Grant no.BL2012055), Jiangsu Province's Outstanding Medical Academic Leader and Sci-tech Innovation Team Program (Grant no.LJ201117), the Natural Science Foundation of the Jiangsu Province (Grant no.BK2012709, BK20130540), Doctoral Program Foundation of State Education Ministry (Grant no. 20113227110011), Jiangsu Province for Natural Scicence Research in Colleges and Universities (13KJB320001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035036; Atsumi T, 2014, CANCER RES, V74, P8, DOI 10.1158/0008-5472.CAN-13-2322; Bhowmick NA, 2005, CURR OPIN GENET DEV, V15, P97, DOI 10.1016/j.gde.2004.12.003; Cao HL, 2009, CANCER LETT, V274, P61, DOI 10.1016/j.canlet.2008.08.036; Catalano V, 2009, CRIT REV ONCOL HEMAT, V71, P127, DOI 10.1016/j.critrevonc.2009.01.004; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Fiaschi T, 2013, CELL CYCLE, V12, P1791, DOI 10.4161/cc.24902; Fiaschi T, 2012, CANCER RES, V72, P5130, DOI 10.1158/0008-5472.CAN-12-1949; Gingery A, 2008, EXP CELL RES, V314, P2725, DOI 10.1016/j.yexcr.2008.06.006; Gordon GM, 2009, J CELL PHYSIOL, V221, P402, DOI 10.1002/jcp.21869; Gu JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031698; He HJ, 2006, J BIOL CHEM, V281, P31369, DOI 10.1074/jbc.M603762200; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Li W, 2010, BIOL REPROD, V83, P481, DOI 10.1095/biolreprod.109.082578; Maeda K, 1999, CANCER, V86, P566, DOI 10.1002/(SICI)1097-0142(19990815)86:4<566::AID-CNCR4>3.0.CO;2-1; Maeda K, 1996, CANCER, V77, P858, DOI 10.1002/(SICI)1097-0142(19960301)77:5<858::AID-CNCR8>3.0.CO;2-A; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Mohamed MM, 2014, INT J BIOCHEM CELL B, V46, P138, DOI 10.1016/j.biocel.2013.11.015; Morales C, 2014, CANCER RES, V74, P446, DOI 10.1158/0008-5472.CAN-13-1677; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Nam SY, 2011, BRIT J CANCER, V104, P166, DOI 10.1038/sj.bjc.6606020; O'Connor PM, 2010, INFLAMM BOWEL DIS, V16, P1411, DOI 10.1002/ibd.21217; Qiao C, 2008, CELL BIOL INT, V32, P8, DOI 10.1016/j.cellbi.2007.08.002; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Ray A, 2010, MOL CANCER RES, V8, P1261, DOI 10.1158/1541-7786.MCR-10-0212; Ren GW, 2012, CELL STEM CELL, V11, P812, DOI 10.1016/j.stem.2012.08.013; Rokavec M, 2012, MOL CELL, V45, P777, DOI 10.1016/j.molcel.2012.01.015; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Shih CH, 2009, EUR J PHARMACOL, V618, P70, DOI 10.1016/j.ejphar.2009.07.007; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Takaishi S, 2008, J CLIN ONCOL, V26, P2876, DOI 10.1200/JCO.2007.15.2603; Tsuboi K, 2014, ONCOL REP, V31, P57, DOI 10.3892/or.2013.2842; Voon DCC, 2012, STEM CELLS, V30, P2088, DOI 10.1002/stem.1183; Yoon JH, 2013, J CELL BIOCHEM, V114, P1800, DOI 10.1002/jcb.24524; Zhu W, 2012, CANCER LETT, V315, P28, DOI 10.1016/j.canlet.2011.10.002	40	31	38	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97569	10.1371/journal.pone.0097569	http://dx.doi.org/10.1371/journal.pone.0097569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824968	Green Published, gold, Green Submitted			2022-12-27	WOS:000336369200130
J	Yang, Y; Lee, WS; Tang, X; Wadsworth, WG				Yang, Yong; Lee, Won Suk; Tang, Xia; Wadsworth, William G.			Extracellular Matrix Regulates UNC-6 (Netrin) Axon Guidance by Controlling the Direction of Intracellular UNC-40 (DCC) Outgrowth Activity	PLOS ONE			English	Article							MUSCLE-CELL ATTACHMENT; BODY-WALL MUSCLE; CAENORHABDITIS-ELEGANS; GROWTH CONE; CYTOPLASMIC DOMAINS; INVASIVE MEMBRANE; MIGRATIONS; RECEPTORS; PROTEIN; GENE	How extracellular molecules influence the direction of axon guidance is poorly understood. The HSN axon of Caenorhabditis elegans is guided towards a ventral source of secreted UNC-6 (netrin). The axon's outgrowth response to UNC-6 is mediated by the UNC-40 (DCC) receptor. We have proposed that in response to the UNC-6 molecule the direction of UNC-40-mediated axon outgrowth is stochastically determined. The direction of guidance is controlled by asymmetric cues, including the gradient of UNC-6, that regulate the probability that UNC-40-mediated axon outgrowth is directed on average, over time, in a specific direction. Here we provide genetic evidence that a specialized extracellular matrix, which lies ventral to the HSN cell body, regulates the probability that UNC-40-mediated axon outgrowth will be directed ventrally towards the matrix. We show that mutations that disrupt the function of proteins associated with this matrix, UNC-52 (perlecan), UNC-112 (kindlin), VAB-19 (Kank), and UNC-97 (PINCH), decrease the probability of UNC-40-mediated axon outgrowth in the ventral direction, while increasing the probability of outgrowth in the anterior and posterior directions. Other results suggest that INA-1 (alpha integrin) and MIG-15 (NIK kinase) signaling mediate the response in HSN. Although the AVM axon also migrates through this matrix, the mutations have little effect on the direction of AVM axon outgrowth, indicating that responses to the matrix are cell-specific. Together, these results suggest that an extracellular matrix can regulate the direction of UNC-6 guidance by increasing the probability that UNC-40-mediated axon outgrowth activity will be oriented in a specific direction.	[Yang, Yong; Lee, Won Suk; Tang, Xia; Wadsworth, William G.] Rutgers Robert Wood Johnson Med Sch, Dept Pathol, Piscataway, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Wadsworth, WG (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Pathol, Piscataway, NJ 08901 USA.	william.wadsworth@rwjms.rutgers.edu	Wadsworth, William G/N-7866-2014	Wadsworth, William G/0000-0003-3824-2948	National Institutes of Health [R01 NS033156, R01 NS061805]; New Jersey Commission on Spinal Cord; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033156, R01NS061805] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Commission on Spinal Cord; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Institutes of Health grants, R01 NS033156 and R01 NS061805, and grants from the New Jersey Commission on Spinal Cord. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Asakura T, 2007, DEV BIOL, V304, P800, DOI 10.1016/j.ydbio.2007.01.028; Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X; Baum PD, 1997, NEURON, V19, P51, DOI 10.1016/S0896-6273(00)80347-5; Baumeister R, 1996, GENE DEV, V10, P1395, DOI 10.1101/gad.10.11.1395; Colon-Ramos DA, 2007, SCIENCE, V318, P103, DOI 10.1126/science.1143762; Ding M, 2003, DEVELOPMENT, V130, P5791, DOI 10.1242/dev.00791; Emtage L, 2004, NEURON, V44, P795, DOI 10.1016/j.neuron.2004.11.010; FRANCIS R, 1991, J CELL BIOL, V114, P465, DOI 10.1083/jcb.114.3.465; GETTNER SN, 1995, J CELL BIOL, V129, P1127, DOI 10.1083/jcb.129.4.1127; Hagedorn EJ, 2013, J CELL BIOL, V201, P903, DOI 10.1083/jcb.201301091; Hagedorn EJ, 2009, DEV CELL, V17, P187, DOI 10.1016/j.devcel.2009.06.006; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hobert O, 1999, J CELL BIOL, V144, P45, DOI 10.1083/jcb.144.1.45; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; HRESKO MC, 1994, J CELL BIOL, V124, P491, DOI 10.1083/jcb.124.4.491; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; Kolodkin AL, 2011, COLD SPRING HARB PER, V3; Kulkarni G, 2013, BIOL OPEN, V2, P1300, DOI 10.1242/bio.20136346; Mehlen P, 2011, NAT REV CANCER, V11, P188, DOI 10.1038/nrc3005; Mehlen P, 2010, CURR OPIN ONCOL, V22, P46, DOI 10.1097/CCO.0b013e328333dcd1; Meighan CM, 2007, GENE DEV, V21, P1615, DOI 10.1101/gad.1534807; Merz DC, 2003, DEV BIOL, V256, P173, DOI 10.1016/S0012-1606(03)00014-9; Mullen GP, 1999, MOL BIOL CELL, V10, P3205, DOI 10.1091/mbc.10.10.3205; Nikolopoulos SN, 2005, CELL CYCLE, V4, P429, DOI 10.4161/cc.4.3.1547; Olsson-Carter K, 2011, DEV DYNAM, V240, P1815, DOI 10.1002/dvdy.22667; Olsson-Carter K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001054; Park J, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-28; Poinat P, 2002, CURR BIOL, V12, P622, DOI 10.1016/S0960-9822(02)00764-9; Poon VY, 2008, NATURE; Raper J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001933; ROGALSKI TM, 1995, GENETICS, V139, P159; Rogalski TM, 2000, J CELL BIOL, V150, P253, DOI 10.1083/jcb.150.1.253; ROGALSKI TM, 1993, GENE DEV, V7, P1471, DOI 10.1101/gad.7.8.1471; Shakir MA, 2006, GENETICS, V172, P893, DOI 10.1534/genetics.105.046359; Sun KLW, 2011, DEVELOPMENT, V138, P2153, DOI 10.1242/dev.044529; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Teuliere J, 2011, DEVELOPMENT, V138, P4475, DOI 10.1242/dev.061952; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WILLIAMS BD, 1994, J CELL BIOL, V124, P475, DOI 10.1083/jcb.124.4.475; Xu ZN, 2009, GENETICS, V183, P941, DOI 10.1534/genetics.109.108654; Yebra M, 2003, DEV CELL, V5, P695, DOI 10.1016/S1534-5807(03)00330-7; Yurchenco PD, 2004, CURR OPIN CELL BIOL, V16, P572, DOI 10.1016/j.ceb.2004.07.013; Ziel JW, 2009, NAT CELL BIOL, V11, P183, DOI 10.1038/ncb1825	46	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97258	10.1371/journal.pone.0097258	http://dx.doi.org/10.1371/journal.pone.0097258			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824544	Green Submitted, gold, Green Published			2022-12-27	WOS:000336369200082
J	Cheng, C; Wan, F; Liu, L; Zeng, FQ; Xing, SA; Wu, XF; Chen, XP; Zhu, ZH				Cheng, Chao; Wan, Feng; Liu, Lian; Zeng, Fuqing; Xing, Shi'an; Wu, Xiaofei; Chen, Xuepan; Zhu, Zhaohui			Overexpression of SATB1 Is Associated with Biologic Behavior in Human Renal Cell Carcinoma	PLOS ONE			English	Article							GLOBAL GENE REGULATOR; GASTRIC-CANCER; TUMOR PROGRESSION; PROGNOSTIC VALUE; BLADDER-CANCER; GROWTH-FACTOR; UP-REGULATION; EXPRESSION; CHROMATIN; METASTASIS	Special AT-rich sequence-binding protein-1 (SATB1) has been reported to be aberrantly expressed in various cancers and correlated with the malignant behavior of cancer cells. However, the function of SATB1 in RCC remains unclear. With the combination of immunohistochemistry, western blotting, immunofluorescence, qRT-PCR, and cell proliferation, migration and invasion assays, we found that levels of SATB1 mRNA and protein were dramatically increased in human ccRCC tissues (P<0.001 for both), and upregulation of SATB1 was significantly associated with depth of invasion (P<0.001), lymph node status (P = 0.001) and TNM stage (P = 0.009). SATB1 knockdown inhibited the proliferation, migration and invasion of 786-O cells, whereas SATB1 overexpression promoted the growth and aggressive phenotype of ACHN cells in vitro. Furthermore, SATB1 expression was positively correlated with ZEB2 expression (P = 0.013), and inversely linked to levels of SATB2 and E-cadherin (P = 0.005 and P<0.001, respectively) in ccRCC tissues. Our data provide a basis for the concept that overexpression of SATB1 may play a critical role in the acquisition of an aggressive phenotype for RCC cells through EMT, providing new insights into the significance of SATB1 in invasion and metastasis of ccRCC, which may contribute to fully elucidating the exact mechanism of development and progression of RCC.	[Cheng, Chao; Wan, Feng; Zeng, Fuqing; Wu, Xiaofei; Chen, Xuepan; Zhu, Zhaohui] Huazhong Univ Sci & Technol, Dept Urol, Union Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China; [Liu, Lian] Huazhong Univ Sci & Technol, Canc Ctr Union Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China; [Xing, Shi'an] Huazhong Univ Sci & Technol, Cent Lab, Tongji Med Coll, Union Hosp, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Zhu, ZH (corresponding author), Huazhong Univ Sci & Technol, Dept Urol, Union Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China.	zhuzhaohui316@sina.com						Basso M, 2010, UROL ONCOL-SEMIN ORI, V28, P121, DOI 10.1016/j.urolonc.2009.04.015; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Chen FF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056241; Chen HX, 2011, J DERMATOL SCI, V64, P39, DOI 10.1016/j.jdermsci.2011.06.007; Cheng C, 2010, APMIS, V118, P855, DOI 10.1111/j.1600-0463.2010.02673.x; Chu SH, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-149; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Fang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062558; Fang ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062823; Han B, 2013, TUMOR BIOL, V34, P2943, DOI 10.1007/s13277-013-0857-1; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Jiang Z, 2008, CLIN CANCER RES, V14, P5579, DOI 10.1158/1078-0432.CCR-08-0504; Kumar P, 2007, NAT CELL BIOL, V9, P45, DOI 10.1038/ncb1516; Lane BR, 2007, J UROLOGY, V178, P429, DOI 10.1016/j.juro.2007.03.106; Linehan WM, 2004, CANCER CELL, V6, P223, DOI 10.1016/j.ccr.2004.09.006; Lu XM, 2010, ONCOL REP, V24, P981, DOI 10.3892/or_00000945; Maloney EK, 2003, CANCER RES, V63, P5073; Meng WJ, 2012, INT J COLORECTAL DIS, V27, P143, DOI 10.1007/s00384-011-1302-9; Notani D, 2010, METHODS MOL BIOL, V647, P317, DOI 10.1007/978-1-60761-738-9_20; Patard JJ, 2005, J CLIN ONCOL, V23, P2763, DOI 10.1200/JCO.2005.07.055; Pavan KP, 2006, MOL CELL, V22, P231, DOI 10.1016/j.molcel.2006.03.010; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Sayan AE, 2009, P NATL ACAD SCI USA, V106, P14884, DOI 10.1073/pnas.0902042106; Seo J, 2005, J BIOL CHEM, V280, P24600, DOI 10.1074/jbc.M414076200; Shukla S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053527; Tang HW, 2008, CANCER INVEST, V26, P60, DOI 10.1080/07357900701519279; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tu W, 2012, LIVER INT, V32, P1064, DOI 10.1111/j.1478-3231.2012.02815.x; Xue YJ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-200; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084	31	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97406	10.1371/journal.pone.0097406	http://dx.doi.org/10.1371/journal.pone.0097406			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835085	Green Published, Green Submitted, gold			2022-12-27	WOS:000339614800044
J	Kwon, HM; Lee, KH; Han, BW; Han, MR; Kim, DH; Kim, DE				Kwon, Hyun-Mi; Lee, Kwang Hyun; Han, Byung Woo; Han, Mi Ra; Kim, Dong Ho; Kim, Dong-Eun			An RNA Aptamer That Specifically Binds to the Glycosylated Hemagglutinin of Avian Influenza Virus and Suppresses Viral Infection in Cells	PLOS ONE			English	Article							RECEPTOR-BINDING; MEMBRANE-FUSION; A VIRUS; SELECTION; PROTEIN; INHIBITION; MECHANISMS; EXPRESSION; LIGANDS; REGION	The influenza virus surface glycoprotein hemagglutinin (HA) is responsible for viral attachment to sialic acid-containing host cell receptors and it facilitates the initial stage of viral infection. In the present study, we isolated an RNA aptamer specific to the glycosylated receptor-binding domain of the HA protein (gHA1) after 12 cycles of the systematic evolution of ligands by exponential enrichment procedure (SELEX), and we then investigated if the selected aptamer suppresses viral infection in host cells. Nitrocellulose filter binding and enzyme-linked immunosorbent assay (ELISA) experiments revealed that 1 RNA aptamer, HA12-16, bound specifically to the gHA1 protein. Cell viability assay showed that the HA12-16 RNA aptamer suppressed viral infection in host cells by enhancing cell viability. Immunofluorescence microscopic analysis further demonstrated that the HA12-16 RNA aptamer suppresses viral attachment to host cells by neutralizing the receptor-binding site of influenza virus HA. These results indicate that the isolated RNA aptamer can be developed as an antiviral reagent against influenza through appropriate therapeutic formulation.	[Kwon, Hyun-Mi; Lee, Kwang Hyun; Kim, Dong-Eun] Konkuk Univ, Dept Biosci & Biotechnol, Seoul, South Korea; [Han, Byung Woo; Han, Mi Ra] Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul, South Korea; [Kim, Dong Ho] Korea Canc Ctr Hosp, Dept Pediat, Seoul, South Korea	Konkuk University; Seoul National University (SNU); National Cancer Center - Korea (NCC)	Kim, DE (corresponding author), Konkuk Univ, Dept Biosci & Biotechnol, Seoul, South Korea.	kimde@konkuk.ac.kr	Kim, Dong-Eun/D-8304-2011	Kim, Dong-Eun/0000-0001-6545-8387	National Research Foundation of Korea (NRF) grants - Korea Government (MEST) [2010-0019306]	National Research Foundation of Korea (NRF) grants - Korea Government (MEST)	This work was supported by the National Research Foundation of Korea (NRF) grants funded by the Korea Government (MEST) (2010-0019306). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Z, 2008, VIROLOGY, V380, P354, DOI 10.1016/j.virol.2008.08.010; Cheng CS, 2008, BIOCHEM BIOPH RES CO, V366, P670, DOI 10.1016/j.bbrc.2007.11.183; Chizmadzhev YA, 2004, BIOELECTROCHEMISTRY, V63, P129, DOI 10.1016/j.bioelechem.2003.10.016; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Fukuda K, 2000, EUR J BIOCHEM, V267, P3685, DOI 10.1046/j.1432-1327.2000.01400.x; Gopinath SCB, 2006, J BIOCHEM, V139, P837, DOI 10.1093/jb/mvj095; Jang KJ, 2008, BIOCHEM BIOPH RES CO, V366, P738, DOI 10.1016/j.bbrc.2007.12.020; Jeon SH, 2002, VIRAL IMMUNOL, V15, P165, DOI 10.1089/088282402317340314; KAWAOKA Y, 1990, VIROLOGY, V179, P759, DOI 10.1016/0042-6822(90)90143-F; KEIL W, 1985, EMBO J, V4, P2711, DOI 10.1002/j.1460-2075.1985.tb03991.x; Kuiken T, 2006, SCIENCE, V312, P394, DOI 10.1126/science.1122818; LEVI R, 1995, J VIROL METHODS, V52, P55, DOI 10.1016/0166-0934(94)00137-6; Misono TS, 2005, ANAL BIOCHEM, V342, P312, DOI 10.1016/j.ab.2005.04.013; Nimjee SM, 2005, ANNU REV MED, V56, P555, DOI 10.1146/annurev.med.56.062904.144915; Nwe N, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-16; Ohuchi R, 1997, J VIROL, V71, P3719, DOI 10.1128/JVI.71.5.3719-3725.1997; Park SY, 2011, NUCLEIC ACID THER, V21, P395, DOI 10.1089/nat.2011.0321; Perkins AC, 2007, Q J NUCL MED MOL IM, V51, P292; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716; Tombelli S, 2009, CURR OPIN MOL THER, V11, P179; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Wang ZM, 2001, J VIROL METHODS, V98, P53, DOI 10.1016/S0166-0934(01)00355-X; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Wongphatcharachai M, 2013, J CLIN MICROBIOL, V51, P46, DOI 10.1128/JCM.02118-12; ZUKER M, 1989, METHOD ENZYMOL, V180, P262	28	38	39	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97574	10.1371/journal.pone.0097574	http://dx.doi.org/10.1371/journal.pone.0097574			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835440	gold, Green Published, Green Submitted			2022-12-27	WOS:000339614800052
J	Dickson, RP; Erb-Downward, JR; Freeman, CM; Walker, N; Scales, BS; Beck, JM; Martinez, FJ; Curtis, JL; Lama, VN; Huffnagle, GB				Dickson, Robert P.; Erb-Downward, John R.; Freeman, Christine M.; Walker, Natalie; Scales, Brittan S.; Beck, James M.; Martinez, Fernando J.; Curtis, Jeffrey L.; Lama, Vibha N.; Huffnagle, Gary B.			Changes in the Lung Microbiome following Lung Transplantation Include the Emergence of Two Distinct Pseudomonas Species with Distinct Clinical Associations	PLOS ONE			English	Article							BRONCHIOLITIS-OBLITERANS-SYNDROME; RESPIRATORY MICROBIOME; FLUORESCENS; BACTERIAL; COLONIZATION; SEQUENCE; RISK; PCR; AERUGINOSA; EXPOSURE	Background: Multiple independent culture-based studies have identified the presence of Pseudomonas aeruginosa in respiratory samples as a positive risk factor for bronchiolitis obliterans syndrome (BOS). Yet, culture-independent microbiological techniques have identified a negative association between Pseudomonas species and BOS. Our objective was to investigate whether there may be a unifying explanation for these apparently dichotomous results. Methods: We performed bronchoscopies with bronchoalveolar lavage (BAL) on lung transplant recipients (46 procedures in 33 patients) and 26 non-transplant control subjects. We analyzed bacterial communities in the BAL fluid using qPCR and pyrosequencing of 16S rRNA gene amplicons and compared the culture-independent data with the clinical metadata and culture results from these subjects. Findings: Route of bronchoscopy (via nose or via mouth) was not associated with changes in BAL microbiota (p = 0.90). Among the subjects with positive Pseudomonas bacterial culture, P. aeruginosa was also identified by culture-independent methods. In contrast, a distinct Pseudomonas species, P. fluorescens, was often identified in asymptomatic transplant subjects by pyrosequencing but not detected via standard bacterial culture. The subject populations harboring these two distinct pseudomonads differed significantly with respect to associated symptoms, BAL neutrophilia, bacterial DNA burden and microbial diversity. Despite notable differences in culturability, a global database search of UM Hospital Clinical Microbiology Laboratory records indicated that P. fluorescens is commonly isolated from respiratory specimens. Interpretation: We have reported for the first time that two prominent and distinct Pseudomonas species (P. fluorescens and P. aeruginosa) exist within the post-transplant lung microbiome, each with unique genomic and microbiologic features and widely divergent clinical associations, including presence during acute infection.	[Dickson, Robert P.; Erb-Downward, John R.; Freeman, Christine M.; Walker, Natalie; Scales, Brittan S.; Martinez, Fernando J.; Curtis, Jeffrey L.; Lama, Vibha N.; Huffnagle, Gary B.] Univ Michigan, Sch Med, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA; [Freeman, Christine M.] Dept Vet Affairs Hlth Care Syst, Res Serv, Ann Arbor, MI USA; [Scales, Brittan S.; Huffnagle, Gary B.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Beck, James M.] Univ Colorado Denver, Dept Med, Aurora, CO USA; [Beck, James M.] Vet Affairs Eastern Colorado Hlth Care Syst, Med Serv, Denver, CO USA; [Curtis, Jeffrey L.] VA Ann Arbor Healthcare Syst, Med Serv, Pulm & Crit Care Med Sect, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Huffnagle, GB (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA.	ghuff@umich.edu	Dickson, Robert/AAU-2949-2020; Huffnagle, Gary B./ABF-1323-2020	Curtis, Jeffrey/0000-0001-5191-4847; Dickson, Robert/0000-0002-6875-4277; Walker, Natalie/0000-0002-7445-3534	National Institutes of Health [T32HL00774921, U01HL098961, R01HL094622, R01HL114447, T32AI007528]; Biomedical Laboratory and Clinical Science Research & Development Services, Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114447, R01HL094622, T32HL007287, T32HL007749, U01HL098961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090871, T32AI007528] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biomedical Laboratory and Clinical Science Research & Development Services, Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding provided by National Institutes of Health grants T32HL00774921 (RPD), U01HL098961 (JMB, JLC, GBH), R01HL094622 (VNL), R01HL114447 (GBH, FJM), T32AI007528 (BSS) and the Biomedical Laboratory and Clinical Science Research & Development Services, Department of Veterans Affairs (CMF, JMB, JLC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baader A, 1887, CORRES BLATT SCHWEIZ, V13, P385; Bahrani-Mougeot FK, 2007, J CLIN MICROBIOL, V45, P1588, DOI 10.1128/JCM.01963-06; BERNSTEIN DI, 1995, CHEST, V108, P636, DOI 10.1378/chest.108.3.636; Borewicz K, 2012, FEMS MICROBIOL LETT; Bossuyt X, 2006, CLIN CHEM, V52, P171, DOI 10.1373/clinchem.2005.058560; Botha P, 2008, TRANSPLANTATION, V85, P771, DOI 10.1097/TP.0b013e31816651de; Charlson ES, 2012, AM J RESP CRIT CARE, V186, P536, DOI 10.1164/rccm.201204-0693OC; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Christie JD, 2012, J HEART LUNG TRANSPL, V31, P1073, DOI 10.1016/j.healun.2012.08.004; Daigle Derek, 2011, Curr Protoc Mol Biol, VChapter 7, DOI 10.1002/0471142727.mb0705s96; Diaz PI, 2013, CLIN VACCINE IMMUNOL, V20, P920, DOI 10.1128/CVI.00734-12; Dickson RP, 2013, EXPERT REV RESP MED, V7, P245, DOI [10.1586/ers.13.24, 10.1586/ERS.13.24]; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Duncan Michael D, 2005, Proc Am Thorac Soc, V2, P449, DOI 10.1513/pats.200507-073JS; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Estenne M, 2002, J HEART LUNG TRANSPL, V21, P297, DOI 10.1016/S1053-2498(02)00398-4; Gershman MD, 2008, CLIN INFECT DIS, V47, P1372, DOI 10.1086/592968; Gottlieb J, 2009, RESP MED, V103, P743, DOI 10.1016/j.rmed.2008.11.015; Hill DA, 2010, MUCOSAL IMMUNOL, V3, P148, DOI 10.1038/mi.2009.132; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Husain Shahid, 2002, Semin Respir Infect, V17, P310, DOI 10.1053/srin.2002.36442; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; INGENITO EP, 1987, J APPL PHYSIOL, V63, P2075, DOI 10.1152/jappl.1987.63.5.2075; Jumpstart Consortium Human Microbiome Project Data Generation Working Group, 2010, HUM MICR CONS 16S 45; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Khalifah AP, 2004, AM J RESP CRIT CARE, V170, P181, DOI 10.1164/rccm.200310-1359OC; Kotloff RM, 2011, AM J RESP CRIT CARE, V184, P159, DOI 10.1164/rccm.201101-0134CI; Leung RK, 2012, CLIN MICROBIOL INFEC; Loper JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002784; Lozupone C, 2013, AM J RESP CRIT CARE; Mason KL, 2012, INFECT IMMUN, V80, P3371, DOI 10.1128/IAI.00449-12; Morris A, 2013, AM J RESP CRIT CARE, V187, P1067, DOI 10.1164/rccm.201210-1913OC; MORTENSEN JE, 1995, INFECT CONT HOSP EP, V16, P30; Mulet M, 2010, ENVIRON MICROBIOL, V12, P1513, DOI 10.1111/j.1462-2920.2010.02181.x; Patel SK, 2013, WORLD J GASTROENTERO, V19, P1056, DOI 10.3748/wjg.v19.i7.1056; Paulsen IT, 2005, NAT BIOTECHNOL, V23, P873, DOI 10.1038/nbt1110; Scarpellini M, 2004, FEMS MICROBIOL LETT, V236, P257, DOI 10.1016/j.femsle.2004.05.043; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Silby MW, 2011, FEMS MICROBIOL REV, V35, P652, DOI 10.1111/j.1574-6976.2011.00269.x; Spilker T, 2004, J CLIN MICROBIOL, V42, P2074, DOI 10.1128/JCM.42.5.2074-2079.2004; SUTHERLAND R, 1985, ANTIMICROB AGENTS CH, V27, P495, DOI 10.1128/AAC.27.4.495; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Twigg HL, 2013, LANCET RESP MED, V1, P354, DOI 10.1016/S2213-2600(13)70117-6; Vos R, 2008, EUR RESPIR J, V31, P1037, DOI 10.1183/09031936.00128607; Wei B, 2002, INFECT IMMUN, V70, P6567, DOI 10.1128/IAI.70.12.6567-6575.2002; Willner DL, 2013, AM J RESP CRIT CARE; WILMOTTE A, 1993, FEBS LETT, V317, P96, DOI 10.1016/0014-5793(93)81499-P; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhao JC, 2012, P NATL ACAD SCI USA, V109, P5809, DOI 10.1073/pnas.1120577109	49	124	128	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97214	10.1371/journal.pone.0097214	http://dx.doi.org/10.1371/journal.pone.0097214			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831685	gold, Green Published, Green Submitted			2022-12-27	WOS:000336789500040
J	Dolcino, M; Patuzzo, G; Barbieri, A; Tinazzi, E; Rizzi, M; Beri, R; Argentino, G; Ottria, A; Lunardi, C; Puccetti, A				Dolcino, Marzia; Patuzzo, Giuseppe; Barbieri, Alessandro; Tinazzi, Elisa; Rizzi, Monica; Beri, Ruggero; Argentino, Giuseppe; Ottria, Andrea; Lunardi, Claudio; Puccetti, Antonio			Gene Expression Profiling in Peripheral Blood Mononuclear Cells of Patients with Common Variable Immunodeficiency: Modulation of Adaptive Immune Response following Intravenous Immunoglobulin Therapy	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; T-CELLS; ACTIVATION; ANTIBODIES; APOPTOSIS; SUBSET; LEPTIN; CXCR4; CD38; CD4	Background: Regular intravenous immunoglobulin treatment is used to replace antibody deficiency in primary immunodeficiency diseases; however the therapeutic effect seems to be related not only to antibody replacement but also to an active role in the modulation of the immune response. Common variable immunodeficiency is the most frequent primary immunodeficiency seen in clinical practice. Methods: We have studied the effect of intravenous immunoglobulin replacement in patients with common variable immunodeficiency by evaluating the gene-expression profiles from Affimetrix HG-U133A. Some of the gene array results were validated by real time RT-PCR and by the measurement of circulating cytokines and chemokines by ELISA. Moreover we performed FACS analysis of blood mononuclear cells from the patients enrolled in the study. Results: A series of genes involved in innate and acquired immune responses were markedly up-or down-modulated before therapy. Such genes included CD14, CD36, LEPR, IRF-5, RGS-1, CD38, TNFRSF25, IL-4, CXCR4, CCR3, IL-8. Most of these modulated genes showed an expression similar to that of normal controls after immunoglobulin replacement. Real time RT-PCR of selected genes and serum levels of IL-4, CXCR4 before and after therapy changed accordingly to gene array results. Interestingly, serum levels of IL-8 remained unchanged, as the corresponding gene, before and after treatment. FACS analysis showed a marked decrease of CD8+T cells and an increase of CD4+T cells following treatment. Moreover we observed a marked increase of CD23(-)CD27(-)IgM(-)Ig(-) B cells (centrocytes). Conclusions: Our results are in accordance with previous reports and provide further support to the hypothesis that the benefits of intravenous immunoglobulin therapy are not only related to antibody replacement but also to its ability to modulate the immune response in common variable immunodeficiency.	[Dolcino, Marzia; Puccetti, Antonio] Inst Giannina Gaslini, Dept Immunol, Genoa, Italy; [Patuzzo, Giuseppe; Barbieri, Alessandro; Tinazzi, Elisa; Rizzi, Monica; Beri, Ruggero; Argentino, Giuseppe; Lunardi, Claudio] Univ Verona, Dept Med, I-37100 Verona, Italy; [Ottria, Andrea; Puccetti, Antonio] Univ Genoa, Dept Expt Med, Genoa, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Verona; University of Genoa	Puccetti, A (corresponding author), Inst Giannina Gaslini, Dept Immunol, Genoa, Italy.	antonio.puccetti@unige.it	Tinazzi, Elisa/AAB-9450-2020	Argentino, Giuseppe/0000-0002-4747-4655; Ottria, Andrea/0000-0001-8722-3968; PATUZZO, Giuseppe/0000-0001-8011-0004	Italian Ministry of education; Ministero della Sanita	Italian Ministry of education; Ministero della Sanita(Ministry of Health, Italy)	This work was supported by a grant from the Italian Ministry of education and from a grant from Ministero della Sanita (grant recipients: CL and AP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa RR, 2012, CLIN EXP IMMUNOL, V169, P263, DOI 10.1111/j.1365-2249.2012.04620.x; Bateman EAL, 2012, CLIN EXP IMMUNOL, V170, P202, DOI 10.1111/j.1365-2249.2012.04643.x; Bayry J, 2003, ARTHRITIS RHEUM-US, V48, P3497, DOI 10.1002/art.11346; Bayry J, 2004, BLOOD, V104, P2441, DOI 10.1182/blood-2004-04-1325; Bayry J, 2011, J AUTOIMMUN, V36, P9, DOI 10.1016/j.jaut.2010.09.006; Carvalho KI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012652; Dolcino M, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/198956; Dolcino M, 2013, IMMUNOL RES, V56, P465, DOI 10.1007/s12026-013-8420-0; FERRER JM, 1995, CLIN EXP IMMUNOL, V102, P286; Gelfand EW, 2013, NEW ENGL J MED, V368, P777, DOI 10.1056/NEJMc1215489; Goldberg AC, 2009, ANN NY ACAD SCI, V1153, P184, DOI 10.1111/j.1749-6632.2008.03971.x; Han JI, 2006, J LEUKOCYTE BIOL, V79, P1357, DOI 10.1189/jlb.1105693; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Janas ML, 2010, TRENDS IMMUNOL, V31, P370, DOI 10.1016/j.it.2010.07.002; Juarez J, 2004, HISTOL HISTOPATHOL, V19, P299, DOI 10.14670/HH-19.299; Kaveri SV, 2011, CLIN EXP IMMUNOL, V164, P2, DOI 10.1111/j.1365-2249.2011.04387.x; Kim SY, 2010, BIOCHEM BIOPH RES CO, V394, P562, DOI 10.1016/j.bbrc.2010.03.019; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lunardi C, 2006, PLOS MED, V3, P94, DOI 10.1371/journal.pmed.0030002; Lunardi C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000473; Maarschalk-Ellerbroek LJ, 2011, INT J ANTIMICROB AG, V37, P396, DOI 10.1016/j.ijantimicag.2010.11.027; Malvoisin E, 2011, ANAL BIOCHEM, V414, P202, DOI 10.1016/j.ab.2011.03.022; Notarangelo LD, 2010, J ALLERGY CLIN IMMUN, V125, pS182, DOI 10.1016/j.jaci.2009.07.053; Paquin-Proulx D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075199; Patuzzo G, 2013, ISRN IMMUNOLOGY; Resnick ES, 2012, CURR OPIN ALLERGY CL, V12, P595, DOI 10.1097/ACI.0b013e32835914b9; Rezaei N, 2008, J INVEST ALLERG CLIN, V18, P449; Rezaei N, 2010, IMMUNOBIOLOGY, V215, P81, DOI 10.1016/j.imbio.2009.01.011; Salzer U, 2012, ANN NY ACAD SCI, V1250, P41, DOI 10.1111/j.1749-6632.2011.06377.x; Schwab I, 2013, NAT REV IMMUNOL, V13, P176, DOI 10.1038/nri3401; Scott-Taylor TH, 2004, CLIN EXP IMMUNOL, V138, P484, DOI 10.1111/j.1365-2249.2004.02640.x; Shubinsky G, 1997, IMMUNITY, V7, P315, DOI 10.1016/S1074-7613(00)80353-2; Slebioda TJ, 2011, EUR J IMMUNOL, V41, P2606, DOI 10.1002/eji.201141477; Sokos DR, 2002, BIOL BLOOD MARROW TR, V8, P117, DOI 10.1053/bbmt.2002.v8.pm11939601; Tinazzi E, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3069; Trepanier P, 2012, BLOOD, V120, P2769, DOI 10.1182/blood-2012-07-445007; Vences-Catalan F, 2011, IUBMB LIFE, V63, P840, DOI 10.1002/iub.549; Walter U, 2005, CURR OPIN IMMUNOL, V17, P624, DOI 10.1016/j.coi.2005.09.014	38	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97571	10.1371/journal.pone.0097571	http://dx.doi.org/10.1371/journal.pone.0097571			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831519	Green Published, Green Submitted, gold			2022-12-27	WOS:000336789500079
J	Gerard, C; Baudson, N; Ory, T; Louahed, J				Gerard, Catherine; Baudson, Nathalie; Ory, Thierry; Louahed, Jamila			Tumor Mouse Model Confirms MAGE-A3 Cancer Immunotherapeutic As an Efficient Inducer of Long-Lasting Anti-Tumoral Responses	PLOS ONE			English	Article							T-CELL RESPONSES; INTERFERON-GAMMA; NECROSIS-FACTOR; PHASE-II; IN-VIVO; EXPRESSION; ADJUVANT; PROTEIN; MELANOMA; GROWTH	Purpose: MAGE-A3 is a potential target for immunotherapy due to its tumor-specific nature and expression in several tumor types. Clinical data on MAGE-A3 immunotherapy have raised many questions that can only be addressed by using animal models. In the present study, different aspects of the murine anti-tumor immune responses induced by a recombinant MAGE-A3 protein (recMAGE-A3) in combination with different immunostimulants (AS01, AS02, CpG7909 or AS15) were investigated. Experimental Design and Results: Based on cytokine profile analyses and protection against challenge with MAGE-A3-expressing tumor, the combination recMAGE-A3+AS15 was selected for further experimental work, in particular to study the mechanisms of anti-tumor responses. By using MHC class I-, MHC class II-, perforin-, B-cell- and IFN-gamma- knock-out mice and CD4(+) T cell-, CD8(+) T cell- and NK cell- depleted mice, we demonstrated that CD4(+) T cells and NK cells are the main antitumor effectors, and that IFN-gamma is a major effector molecule. This mouse tumor model also established the need to repeat recMAGE-A3+AS15 injections to sustain efficient anti-tumor responses. Furthermore, our results indicated that the efficacy of tumor rejection by the elicited anti-MAGE-A3 responses depends on the proportion of tumor cells expressing MAGE-A3. Conclusions: The recMAGE-A3+AS15 cancer immunotherapy efficiently induced an antigen-specific, functional and long-lasting immune response able to recognize and eliminate MAGE-A3-expressing tumor cells up to several months after the last immunization in mice. The data highlighted the importance of the immunostimulant to induce a Th1-type immune response, as well as the key role played by IFN-gamma, CD4(+) T cells and NK cells in the anti-tumoral effect.	[Gerard, Catherine; Baudson, Nathalie; Ory, Thierry; Louahed, Jamila] GlaxoSmithKline Vaccines, Rixensart, Belgium	GlaxoSmithKline	Gerard, C (corresponding author), GlaxoSmithKline Vaccines, Rixensart, Belgium.	catherine.gerard@gsk.com			GlaxoSmithKline Biologicals SA	GlaxoSmithKline Biologicals SA(GlaxoSmithKline)	The funders had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. GlaxoSmithKline Biologicals SA was the funding source and was involved in all stages of the study conduct and analysis. GlaxoSmithKline Biologicals SA also funded all costs associated with the development and publishing of the present manuscript. JL was involved in study supervision at all stages. All authors were involved in study design, review of study reports, data analysis and interpretation. NB and TO conducted the study and were involved in data generation. All authors were involved in drafting and approval of the manuscript.	Atanackovic D, 2004, J IMMUNOL, V172, P3289, DOI 10.4049/jimmunol.172.5.3289; Atanackovic D, 2008, P NATL ACAD SCI USA, V105, P1650, DOI 10.1073/pnas.0707140104; Bromberg JF, 1996, P NATL ACAD SCI USA, V93, P7673, DOI 10.1073/pnas.93.15.7673; Chin YE, 1997, MOL CELL BIOL, V17, P5328, DOI 10.1128/MCB.17.9.5328; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; Chu RS, 1997, J EXP MED, V186, P1623, DOI 10.1084/jem.186.10.1623; Corbiere V, 2011, CANCER RES, V71, P1253, DOI 10.1158/0008-5472.CAN-10-2693; Corthay A, 2005, IMMUNITY, V22, P371, DOI 10.1016/j.immuni.2005.02.003; Coughlin CM, 1998, IMMUNITY, V9, P25, DOI 10.1016/S1074-7613(00)80585-3; den Brok MHMGM, 2006, CANCER RES, V66, P7285, DOI 10.1158/0008-5472.CAN-06-0206; DEPLAEN E, 1994, IMMUNOGENETICS, V40, P360, DOI 10.1007/BF01246677; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; FRANSEN L, 1986, EUR J CANCER CLIN ON, V22, P419, DOI 10.1016/0277-5379(86)90107-0; Garcon N, 2007, EXPERT REV VACCINES, V6, P723, DOI 10.1586/14760584.6.5.723; Garcon Nathalie, 2003, Expert Rev Vaccines, V2, P231, DOI 10.1586/14760584.2.2.231; Garcon N, 2011, EXPERT REV VACCINES, V10, P471, DOI [10.1586/erv.11.29, 10.1586/ERV.11.29]; GAUGLER B, 1994, J EXP MED, V179, P921, DOI 10.1084/jem.179.3.921; GREENBERG PD, 1991, ADV IMMUNOL, V49, P281; HOCK H, 1991, J EXP MED, V174, P1291, DOI 10.1084/jem.174.6.1291; Hudolin T, 2009, ACTA DERMATOVENER CR, V17, P103; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Hung K, 1998, J EXP MED, V188, P2357, DOI 10.1084/jem.188.12.2357; Jungbluth AA, 2000, INT J CANCER, V85, P460, DOI 10.1002/(SICI)1097-0215(20000215)85:4<460::AID-IJC3>3.0.CO;2-N; Jungbluth Achim A, 2007, Cancer Immun, V7, P15; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Kruit WHJ, 2013, J CLIN ONCOL, V31, P2413, DOI 10.1200/JCO.2012.43.7111; Lally KM, 2001, INT J CANCER, V93, P841, DOI 10.1002/ijc.1420; LAURITZSEN GF, 1994, P NATL ACAD SCI USA, V91, P5700, DOI 10.1073/pnas.91.12.5700; Lin KY, 1996, CANCER RES, V56, P21; Marchand M, 2003, EUR J CANCER, V39, P70, DOI 10.1016/S0959-8049(02)00479-3; Marturano J, 2008, CANCER RES, V68, P1555, DOI 10.1158/0008-5472.CAN-07-5233; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Nierkens S, 2011, CANCER RES, V71, P6428, DOI 10.1158/0008-5472.CAN-11-2154; Perez-Diez A, 2007, BLOOD, V109, P5346, DOI 10.1182/blood-2006-10-051318; Qin ZH, 2000, IMMUNITY, V12, P677, DOI 10.1016/S1074-7613(00)80218-6; Rakhra K, 2010, CANCER CELL, V18, P485, DOI 10.1016/j.ccr.2010.10.002; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Seliger B, 2008, ADV CANCER RES, V101, P249, DOI 10.1016/S0065-230X(08)00407-7; Street SEA, 2001, BLOOD, V97, P192, DOI 10.1182/blood.V97.1.192; Street SEA, 2002, J EXP MED, V196, P129, DOI 10.1084/jem.20020063; Tatsumi T, 2002, J EXP MED, V196, P619, DOI 10.1084/jem.20012142; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; VANPEL A, 1995, IMMUNOL REV, V145, P229, DOI 10.1111/j.1600-065X.1995.tb00084.x; VANPEL A, 1982, P NATL ACAD SCI-BIOL, V79, P4718; Vansteenkiste J, 2013, J CLIN ONCOL, V31, P2396, DOI 10.1200/JCO.2012.43.7103; Vantomme V, 2004, J IMMUNOTHER, V27, P124, DOI 10.1097/00002371-200403000-00006; WILLIAMSON BD, 1983, P NATL ACAD SCI-BIOL, V80, P5397, DOI 10.1073/pnas.80.17.5397; Xu XL, 1998, CANCER RES, V58, P2832	49	22	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e94883	10.1371/journal.pone.0094883	http://dx.doi.org/10.1371/journal.pone.0094883			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830315	Green Submitted, gold, Green Published			2022-12-27	WOS:000336789500006
J	Hatzirodos, N; Hummitzsch, K; Irving-Rodgers, HF; Rodgers, RJ				Hatzirodos, Nicholas; Hummitzsch, Katja; Irving-Rodgers, Helen F.; Rodgers, Raymond J.			Transcriptome Profiling of the Theca Interna in Transition from Small to Large Antral Ovarian Follicles	PLOS ONE			English	Article							GROWTH-DIFFERENTIATION FACTOR-9; TUMOR-NECROSIS-FACTOR; GRANULOSA-CELLS; FOLLICULAR DEVELOPMENT; BINDING-PROTEINS; GENE-EXPRESSION; IN-VITRO; STIMULATING-HORMONE; LUTEINIZING-HORMONE; ANDROGEN PRODUCTION	The theca interna layer of the ovarian follicle forms during the antral stage of follicle development and lies adjacent to and directly outside the follicular basal lamina. It supplies androgens and communicates with the granulosa cells and the oocyte by extracellular signaling. To better understand developmental changes in the theca interna, we undertook transcriptome profiling of the theca interna from small (3-5 mm, n = 10) and large (9-12 mm, n = 5) healthy antral bovine follicles, representing a calculated >7-fold increase in the amount of thecal tissue. Principal Component Analysis and hierarchical classification of the signal intensity plots for the arrays showed no clustering of the theca interna samples into groups depending on follicle size or subcategories of small follicles. From the over 23,000 probe sets analysed, only 76 were differentially expressed between large and small healthy follicles. Some of the differentially expressed genes were associated with processes such as myoblast differentiation, protein ubiquitination, nitric oxide and transforming growth factor beta signaling. The most significant pathway affected from our analyses was found to be Wnt signaling, which was suppressed in large follicles via down-regulation of WNT2B and up-regulation of the inhibitor FRZB. These changes in the transcriptional profile could have been due to changes in cellular function or alternatively since the theca interna is composed of a number of different cell types it could have been due to any systematic change in the volume density of any particular cell type. However, our study suggests that the transcriptional profile of the theca interna is relatively stable during antral follicle development unlike that of granulosa cells observed previously. Thus both the cellular composition and cellular behavior of the theca interna and its contribution to follicular development appear to be relatively constant throughout the follicle growth phase examined.	[Hatzirodos, Nicholas; Hummitzsch, Katja; Irving-Rodgers, Helen F.; Rodgers, Raymond J.] Univ Adelaide, Res Ctr Reprod Hlth, Discipline Obstet & Gynaecol, Sch Paediat & Reprod Hlth,Robinson Res Inst, Adelaide, SA, Australia	Robinson Research Institute; University of Adelaide	Rodgers, RJ (corresponding author), Univ Adelaide, Res Ctr Reprod Hlth, Discipline Obstet & Gynaecol, Sch Paediat & Reprod Hlth,Robinson Res Inst, Adelaide, SA, Australia.	ray.rodgers@adelaide.edu.au	Hummitzsch, Katja/K-6940-2013; Irving-Rodgers, Helen/E-3660-2010; Rodgers, Raymond J/C-3476-2009	Hummitzsch, Katja/0000-0001-5023-2668; 	National Health and Medical Research Council of Australia; Australian Research Council; University of Adelaide	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); University of Adelaide	This work was supported by the National Health and Medical Research Council of Australia, the Australian Research Council and the University of Adelaide. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Salihi M, 2011, EPIGENETICS-US, V6, P1021, DOI 10.4161/epi.6.8.16064; [Anonymous], 2005, IPA NETW GEN ALG; BAIRD DT, 1981, BIOL REPROD, V24, P1013, DOI 10.1095/biolreprod24.5.1013; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Berisha B, 2000, J ENDOCRINOL, V167, P371, DOI 10.1677/joe.0.1670371; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BRUNSWIGSPICKENHEIER B, 1992, ENDOCRINOLOGY, V131, P1445, DOI 10.1210/en.131.3.1445; Castanon BI, 2012, J ANIM SCI, V90, P3789, DOI 10.2527/jas.2011-4696; Cheng Y, 2013, FASEB J, V27, P2175, DOI 10.1096/fj.12-223412; Christenson LK, 2013, MOL ENDOCRINOL, V27, P1153, DOI 10.1210/me.2013-1093; CONTI P, 1991, IMMUNOLOGY, V73, P450; Dassen H, 2007, CELL MOL LIFE SCI, V64, P1009, DOI 10.1007/s00018-007-6553-9; Elvin JA, 1999, MOL ENDOCRINOL, V13, P1018, DOI 10.1210/me.13.6.1018; Glister C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-72; Glister C, 2013, P NATL ACAD SCI USA, V110, pE1426, DOI 10.1073/pnas.1222216110; Gorlach A, 2001, CIRC RES, V89, P47, DOI 10.1161/hh1301.092678; Hanukoglu I, 2006, DRUG METAB REV, V38, P171, DOI 10.1080/03602530600570040; Hatzirodos N, 2014, PLOS ONE UNPUB; Hatzirodos N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-40; Hatzirodos N, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-24, 10.1186/1471-2164-15-40]; Hatzirodos N, 2012, MATRIX BIOL, V31, P45, DOI 10.1016/j.matbio.2011.10.002; Hellani A, 2000, ENDOCRINOLOGY, V141, P3012, DOI 10.1210/en.141.8.3012; Honda A, 2007, P NATL ACAD SCI USA, V104, P12389, DOI 10.1073/pnas.0703787104; Hsieh M, 2002, ENDOCRINOLOGY, V143, P898, DOI 10.1210/en.143.3.898; Huang CTF, 2001, BIOL REPROD, V64, P451, DOI 10.1095/biolreprod64.2.451; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irving-Rodgers HF, 2009, HUM REPROD, V24, P936, DOI 10.1093/humrep/den447; Irving-Rodgers HF, 2003, REPROD FERT DEVELOP, V15, P241, DOI 10.1071/RD03008; Irving-Rodgers HF, 2002, BIOL REPROD, V66, P934, DOI 10.1095/biolreprod66.4.934; Irving-Rodgers HF, 2000, J REPROD FERTIL, V118, P221, DOI 10.1530/reprod/118.2.221; Jing C, 2002, JNCI-J NATL CANCER I, V94, P482; Kaitu'u-Lino TJ, 2007, REPRODUCTION, V133, P1169, DOI 10.1530/REP-06-0385; Kazanskaya O, 2008, DEVELOPMENT, V135, P3655, DOI 10.1242/dev.027284; Kim KA, 2008, MOL BIOL CELL, V19, P2588, DOI 10.1091/mbc.E08-02-0187; Kratzer I, 2012, HISTOCHEM CELL BIOL, V138, P861, DOI 10.1007/s00418-012-1001-9; Lee YS, 2011, AM J PHYSIOL-ENDOC M, V301, pE196, DOI 10.1152/ajpendo.00686.2010; Logan KA, 2002, BIOL REPROD, V66, P906, DOI 10.1095/biolreprod66.4.906; Martelli A, 2009, REPRODUCTION, V137, P45, DOI 10.1530/REP-08-0117; Mazaud-Guittot S, 2011, METHODS MOL BIOL, V763, P223, DOI 10.1007/978-1-61779-191-8_15; Mehta V, 2011, DEV DYNAM, V240, P2548, DOI 10.1002/dvdy.22741; MONGET P, 1993, ENDOCRINOLOGY, V132, P1438, DOI 10.1210/en.132.4.1438; Newman JW, 2004, ENDOCRINOLOGY, V145, P5097, DOI 10.1210/en.2004-0710; Nguyen HPT, 2012, ENDOCRINOLOGY, V153, P2870, DOI 10.1210/en.2011-1839; Nicholas B, 2002, REPRODUCTION, V124, P439, DOI 10.1530/rep.0.1240439; Oldridge EE, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.6; OLESZAK E, 1988, EXP CELL RES, V179, P575, DOI 10.1016/0014-4827(88)90295-9; Orisaka M, 2006, BIOL REPROD, V75, P734, DOI 10.1095/biolreprod.105.050344; Palermo R, 2007, REPROD BIOMED ONLINE, V15, P326, DOI 10.1016/S1472-6483(10)60347-1; Parrott JA, 2000, MOL REPROD DEV, V55, P55, DOI 10.1002/(SICI)1098-2795(200001)55:1&lt;55::AID-MRD8&gt;3.0.CO;2-L; Prodoehl MJ, 2009, MOL CELL ENDOCRINOL, V307, P133, DOI 10.1016/j.mce.2009.03.002; Ricken A, 2002, ENDOCRINOLOGY, V143, P2741, DOI 10.1210/en.143.7.2741; Samuelov L, 2012, J INVEST DERMATOL, V132, P2332, DOI 10.1038/jid.2012.171; Schams D, 2002, DOMEST ANIM ENDOCRIN, V22, P51, DOI 10.1016/S0739-7240(01)00116-3; Schauser KH, 2001, BIOL REPROD, V65, P1672, DOI 10.1095/biolreprod65.6.1672; Solovyeva EV, 2000, BIOL REPROD, V63, P1214, DOI 10.1095/biolreprod63.4.1214; Stouffer RL, 2001, ARCH MED RES, V32, P567, DOI 10.1016/S0188-4409(01)00323-X; Tajima K, 2007, REPROD BIOMED ONLINE, V15, P591, DOI 10.1016/S1472-6483(10)60392-6; Tan KAL, 2005, ENDOCRINOLOGY, V146, P2674, DOI 10.1210/en.2004-1630; Wang HX, 2010, BIOL REPROD, V82, P865, DOI 10.1095/biolreprod.109.080903; Wu XM, 2004, MOL ENDOCRINOL, V18, P1509, DOI 10.1210/me.2003-0399; Young JM, 2012, J MOL ENDOCRINOL, V48, P49, DOI 10.1530/JME-11-0134; Young JM, 2010, REPRODUCTION, V140, P489, DOI 10.1530/REP-10-0094; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276	64	27	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97489	10.1371/journal.pone.0097489	http://dx.doi.org/10.1371/journal.pone.0097489			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830430	gold, Green Published			2022-12-27	WOS:000336789500068
J	Tseng, YJ; Chen, RS; Hsu, WY; Hsiao, FJ; Lin, YY				Tseng, Yi-Jhan; Chen, Rou-Shayn; Hsu, Wan-Yu; Hsiao, Fu-Jung; Lin, Yung-Yang			Reduced Motor Cortex Deactivation in Individuals Who Suffer from Writer's Cramp	PLOS ONE			English	Article							MOVEMENT-BETA-SYNCHRONIZATION; CORTICAL NETWORK; STIMULATION; OSCILLATIONS; DYSTONIA; RHYTHMS; FIELDS; INTEGRATION; RESPONSES	This study investigated the neuromagnetic activities of self-paced finger lifting task and electrical median nerve stimulation in ten writer's cramp patients and fourteen control subjects. The event-related de/synchronizations (ERD/ERS) of beta-band activity levels were evaluated and the somatosensory cortical activity levels were analyzed using equivalent-current dipole modeling. No significant difference between the patients and control subjects was found in the electrical stimulation-induced beta ERS and electrical evoked somatosensory cortical responses. Movement-related beta ERD did not differ between controls and patients. Notably, the amplitude of the beta ERS after termination of finger movement was significantly lower in the patients than in the control subjects. The reduced movement-related beta ERS might reflect an impairment of motor cortex deactivation. In conclusion, a motor dependent dysregulation of the sensorimotor network seems to be involved in the functional impairment of patients with writer's cramp.	[Tseng, Yi-Jhan; Lin, Yung-Yang] Natl Yang Ming Univ, Inst Physiol, Taipei 112, Taiwan; [Hsu, Wan-Yu; Hsiao, Fu-Jung; Lin, Yung-Yang] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Lin, Yung-Yang] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Tseng, Yi-Jhan; Hsu, Wan-Yu; Hsiao, Fu-Jung; Lin, Yung-Yang] Taipei Vet Gen Hosp, Neurophysiol Lab, Taipei, Taiwan; [Lin, Yung-Yang] Taipei Vet Gen Hosp, Integrated Brain Res Lab, Taipei, Taiwan; [Lin, Yung-Yang] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan; [Chen, Rou-Shayn] Chang Gung Mem Hosp, Dept Neurol, Taipei 10591, Taiwan; [Chen, Rou-Shayn] Chang Gung Univ, Coll Med, Taipei, Taiwan; [Hsiao, Fu-Jung] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Chang Gung Memorial Hospital; Chang Gung University; Taipei City Hospital	Lin, YY (corresponding author), Natl Yang Ming Univ, Inst Physiol, Taipei 112, Taiwan.	yylin@vghtpe.gov.tw			Taipei Veterans General Hospital [V96ER3-004, V97ER3-006, VGHUST97-P6-24, V98ER3-002, V98S4-018, V99ER3-006, V101C-023, V102C-101, V102E9-003, V103C-062, V103E9-003]; National Science Council [NSC-95-2314-B-010-030-MY3, NSC-96-2628-B-010-030-MY3, NSC-98-2321-B-010-007, NSC-99-2321-B-010-004, NSC-99-2628-B-010-011 -MY3, NSC-100-2321-B-010-004-MY3, NSC-101-2917-I-010-003, NSC-101-2314-B-010-068-MY3, NSC 102-2628-B-010-008-MY3]; Brain Research Center [102AC-B22, 102AC-B7]; National Yang-Ming University; Ministry of Education, Taipei, Taiwan	Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Science Council(Ministry of Science and Technology, Taiwan); Brain Research Center; National Yang-Ming University; Ministry of Education, Taipei, Taiwan	The authors thank all the grants supported by Taipei Veterans General Hospital (V96ER3-004, V97ER3-006, VGHUST97-P6-24, V98ER3-002, V98S4-018, V99ER3-006, V101C-023, V102C-101, V102E9-003, V103C-062, V103E9-003), National Science Council (NSC-95-2314-B-010-030-MY3, NSC-96-2628-B-010-030-MY3, NSC-98-2321-B-010-007, NSC-99-2321-B-010-004, NSC-99-2628-B-010-011 -MY3, NSC-100-2321-B-010-004-MY3, NSC-101-2917-I-010-003, NSC-101-2314-B-010-068-MY3, NSC 102-2628-B-010-008-MY3), and the Brain Research Center (102AC-B22, 102AC-B7), National Yang-Ming University and a grant from Ministry of Education (Aim for the Top University Plan), Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bara-Jimenez W, 2000, NEUROLOGY, V55, P1869, DOI 10.1212/WNL.55.12.1869; Bara-Jimenez W, 2000, ANN NEUROL, V47, P377, DOI 10.1002/1531-8249(200003)47:3<377::AID-ANA16>3.0.CO;2-2; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Cassim F, 2001, NEUROREPORT, V12, P3859, DOI 10.1097/00001756-200112040-00051; Chen R, 1998, ANN NEUROL, V44, P317, DOI 10.1002/ana.410440306; Cheyne DL, 2003, COGNITIVE BRAIN RES, V17, P599, DOI 10.1016/S0926-6410(03)00173-3; Contarino MF, 2007, CLIN NEUROPHYSIOL, V118, P2195, DOI 10.1016/j.clinph.2007.07.004; Delmaire C, 2009, ARCH NEUROL-CHICAGO, V66, P502, DOI 10.1001/archneurol.2009.8; FORSS N, 1994, ELECTROEN CLIN NEURO, V92, P510, DOI 10.1016/0168-5597(94)90135-X; Frasson E, 2001, MOVEMENT DISORD, V16, P674, DOI 10.1002/mds.1142; Gaetz W, 2006, NEUROIMAGE, V30, P899, DOI 10.1016/j.neuroimage.2005.10.009; Gaetz W, 2011, NEUROIMAGE, V55, P616, DOI 10.1016/j.neuroimage.2010.12.077; Hallett M, 2006, HUM MOVEMENT SCI, V25, P454, DOI 10.1016/j.humov.2006.05.004; Hallett M, 2011, NEUROBIOL DIS, V42, P177, DOI 10.1016/j.nbd.2010.08.025; Hamano T, 1999, CLIN NEUROPHYSIOL, V110, P508, DOI 10.1016/S1388-2457(98)00045-5; HARI R, 1993, EUR J NEUROSCI, V5, P724, DOI 10.1111/j.1460-9568.1993.tb00536.x; Jankowski J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078234; Jensen O, 2005, NEUROIMAGE, V26, P347, DOI 10.1016/j.neuroimage.2005.02.008; Jurkiewicz MT, 2006, NEUROIMAGE, V32, P1281, DOI 10.1016/j.neuroimage.2006.06.005; KAJI R, 1995, ANN NEUROL, V38, P155, DOI 10.1002/ana.410380206; Kakigi R, 2000, PROG NEUROBIOL, V61, P495, DOI 10.1016/S0301-0082(99)00063-5; Levy LM, 2002, ANN NEUROL, V51, P93, DOI 10.1002/ana.10073; Lin YY, 2005, NEUROIMAGE, V25, P1090, DOI 10.1016/j.neuroimage.2004.12.047; Lin YY, 2003, NEUROIMAGE, V20, P909, DOI 10.1016/S1053-8119(03)00387-2; Lin YY, 2000, NEUROIMAGE, V11, P334, DOI 10.1006/nimg.1999.0536; Mauguiere F, 1997, EVOKED POTENTIAL, V104, P281, DOI 10.1016/S0013-4694(97)00006-0; Murase N, 2000, BRAIN, V123, P1813, DOI 10.1093/brain/123.9.1813; Muthukumaraswamy SD, 2013, NEUROIMAGE, V66, P36, DOI 10.1016/j.neuroimage.2012.10.054; Naito E, 1999, J NEUROSCI, V19, P6134, DOI 10.1523/JNEUROSCI.19-14-06134.1999; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Pfurtscheller G, 2005, NEUROSCI LETT, V378, P156, DOI 10.1016/j.neulet.2004.12.034; Pfurtscheller G, 2001, J CLIN NEUROPHYSIOL, V18, P559, DOI 10.1097/00004691-200111000-00006; Pfurtscheller G, 1996, ELECTROEN CLIN NEURO, V98, P281, DOI 10.1016/0013-4694(95)00258-8; Reyns N, 2013, CLIN NEUROPHYSIOL, V124, P761, DOI 10.1016/j.clinph.2012.10.011; Rosenkranz K, 2005, BRAIN, V128, P918, DOI 10.1093/brain/awh402; Salenius S, 1997, NEUROIMAGE, V5, P221, DOI 10.1006/nimg.1997.0261; Salmelin R, 1995, NEUROIMAGE, V2, P237, DOI 10.1006/nimg.1995.1031; Tamas G, 2003, CLIN NEUROPHYSIOL, V114, P614, DOI 10.1016/S1388-2457(02)00424-8; Tamura Y, 2008, MOVEMENT DISORD, V23, P558, DOI 10.1002/mds.21870; Tecchio F, 2008, NEUROSCIENCE, V154, P563, DOI 10.1016/j.neuroscience.2008.03.045; Toro C, 2000, ANN NEUROL, V47, P456, DOI 10.1002/1531-8249(200004)47:4<456::AID-ANA8>3.3.CO;2-H; Tyvaert L, 2009, SLEEP MED, V10, P1090, DOI 10.1016/j.sleep.2008.11.008; Wikstrom H, 1996, EVOKED POTENTIAL, V100, P479	43	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97561	10.1371/journal.pone.0097561	http://dx.doi.org/10.1371/journal.pone.0097561			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831291	gold, Green Published, Green Submitted			2022-12-27	WOS:000336789500078
J	Saino, N; Romano, M; Rubolini, D; Ambrosini, R; Romano, A; Caprioli, M; Costanzo, A; Bazzi, G				Saino, Nicola; Romano, Maria; Rubolini, Diego; Ambrosini, Roberto; Romano, Andrea; Caprioli, Manuela; Costanzo, Alessandra; Bazzi, Gaia			A Trade-Off between Reproduction and Feather Growth in the Barn Swallow (Hirundo rustica)	PLOS ONE			English	Article							DAILY ENERGY-EXPENDITURE; MOLT STRATEGIES; NUTRITIONAL CONDITION; MIGRATORY BEHAVIOR; STURNUS-VULGARIS; ANNUAL ROUTINES; ANNUAL CYCLE; BROOD SIZE; PTILOCHRONOLOGY; BIRDS	Physiological trade-offs mediated by limiting energy, resources or time constrain the simultaneous expression of major functions and can lead to the evolution of temporal separation between demanding activities. In birds, plumage renewal is a demanding activity, which accomplishes fundamental functions, such as allowing thermal insulation, aerodynamics and socio-sexual signaling. Feather renewal is a very expensive and disabling process, and molt is often partitioned from breeding and migration. However, trade-offs between feather renewal and breeding have been only sparsely studied. In barn swallows (Hirundo rustica) breeding in Italy and undergoing molt during wintering in sub-Saharan Africa, we studied this trade-off by removing a tail feather from a large sample of individuals and analyzing growth bar width, reflecting feather growth rate, and length of the growing replacement feather in relation to the stage in the breeding cycle at removal and clutch size. Growth bar width of females and length of the growing replacement feather of both sexes were smaller when the original feather had been removed after clutch initiation. Importantly, in females both growth bar width and replacement feather length were negatively predicted by clutch size, and more strongly so for large clutches and when feather removal occurred immediately after clutch completion. Hence, we found strong, coherent evidence for a trade-off between reproduction, and laying effort in particular, and the ability to generate new feathers. These results support the hypothesis that the derived condition of molting during wintering in long-distance migrants is maintained by the costs of overlapping breeding and molt.	[Saino, Nicola; Romano, Maria; Rubolini, Diego; Romano, Andrea; Caprioli, Manuela; Costanzo, Alessandra; Bazzi, Gaia] Univ Milan, Dept Biosci, Milan, Italy; [Ambrosini, Roberto] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy	University of Milan; University of Milano-Bicocca	Saino, N (corresponding author), Univ Milan, Dept Biosci, Milan, Italy.	nicola.saino@unimi.it	Ambrosini, Roberto/F-3188-2012; Bazzi, Gaia/AAP-9154-2020; costanzo, alessandra/AAF-8987-2020; Romano, Andrea/B-3930-2012; Rubolini, Diego/F-2851-2011; Romano, Andrea/A-2780-2017	Ambrosini, Roberto/0000-0002-7148-1468; costanzo, alessandra/0000-0003-3781-0798; Rubolini, Diego/0000-0003-2703-5783; Romano, Andrea/0000-0002-0945-6018; BAZZI, GAIA/0000-0002-7220-6054; Saino, Nicola/0000-0002-0230-3967				[Anonymous], 2007, RMRSGTR189 USDA FOR; Barta Z, 2006, OIKOS, V112, P580, DOI 10.1111/j.0030-1299.2006.14240.x; Barta Z, 2008, PHILOS T R SOC B, V363, P211, DOI 10.1098/rstb.2007.2136; BENSCH S, 1985, ORNIS SCAND, V16, P151, DOI 10.2307/3676481; Berry WD, 2003, POULTRY SCI, V82, P971, DOI 10.1093/ps/82.6.971; Bonier F, 2007, ECOLOGY, V88, P2729, DOI 10.1890/07-0696.1; Clarkson CE, 2011, ECOL INDIC, V11, P1707, DOI 10.1016/j.ecolind.2011.04.019; Cramp S, 1998, COMPLETE BIRDS W PAL; Cyr NE, 2008, PHYSIOL BIOCHEM ZOOL, V81, P452, DOI 10.1086/589547; DAWSON A, 1994, IBIS, V136, P335, DOI 10.1111/j.1474-919X.1994.tb01104.x; DAWSON A, 1982, GEN COMP ENDOCR, V48, P213, DOI 10.1016/0016-6480(82)90019-3; Dawson A, 2008, PHILOS T R SOC B, V363, P1621, DOI 10.1098/rstb.2007.0004; Dawson A, 2006, GEN COMP ENDOCR, V147, P314, DOI 10.1016/j.ygcen.2006.02.001; de la Hera I, 2011, AUK, V128, P321, DOI 10.1525/auk.2011.10181; de la Hera I, 2009, J AVIAN BIOL, V40, P461, DOI 10.1111/j.1600-048X.2008.04689.x; de la Hera I, 2009, BIOL J LINN SOC, V97, P98, DOI 10.1111/j.1095-8312.2008.01189.x; DIETZ MW, 1992, PHYSIOL ZOOL, V65, P1217, DOI 10.1086/physzool.65.6.30158276; DRENT RH, 1980, ARDEA, V68, P225; Echeverry-Galvis MA, 2012, J EXP BIOL, V215, P1957, DOI 10.1242/jeb.065474; Echeverry-Galvis MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061106; FOSTER MS, 1975, CONDOR, V77, P304, DOI 10.2307/1366226; Ginn H. B., 1983, MOULT BIRDS BTO GUID; Grubb T. C., 2006, PTILOCHRONOLOGY FEAT; GRUBB TC, 1991, AUK, V108, P725, DOI 10.2307/4088120; GRUBB TC, 1989, AUK, V106, P314; Grubb TC, 1998, CONDOR, V100, P753, DOI 10.2307/1369761; Grubb Thomas C. Jr, 1995, Current Ornithology, V12, P89; Hall KSS, 2004, EVOL ECOL, V18, P85, DOI 10.1023/B:EVEC.0000017848.20735.8b; Hemborg C, 1998, BEHAV ECOL SOCIOBIOL, V43, P19, DOI 10.1007/s002650050462; Jenni L., 1994, BIOL MOULT BIRDS; Johnson EI, 2012, J AVIAN BIOL, V43, P141, DOI 10.1111/j.1600-048X.2011.05574.x; Jovani R, 2012, J AVIAN BIOL, V43, P97, DOI 10.1111/j.1600-048X.2012.05583.x; Jovani R, 2011, J AVIAN BIOL, V42, P1, DOI 10.1111/j.1600-048X.2010.05175.x; Kern MD, 2002, IBIS, V144, P23, DOI 10.1046/j.0019-1019.2001.00010.x; KLAASSEN M, 1995, OECOLOGIA, V104, P424, DOI 10.1007/BF00341339; LESSELLS CM, 1986, J ANIM ECOL, V55, P669, DOI 10.2307/4747; LINDSTROM A, 1993, PHYSIOL ZOOL, V66, P490, DOI 10.1086/physzool.66.4.30163805; MASMAN D, 1988, ARDEA, V76, P64; McNamara JM, 2008, PHILOS T R SOC B, V363, P301, DOI 10.1098/rstb.2007.2141; Moller AP., 1994, SEXUAL SELECTION BAR; Moreno J, 2001, OECOLOGIA, V129, P492, DOI 10.1007/s004420100767; Murphy Mary E., 1996, P158; MURPHY ME, 1991, AUK, V108, P695, DOI 10.2307/4088109; MURPHY ME, 1995, COMP BIOCHEM PHYS A, V111, P385, DOI 10.1016/0300-9629(95)00039-A; MURPHY ME, 1992, ORNIS SCAND, V23, P304, DOI 10.2307/3676654; MURPHY ME, 1992, AUK, V109, P676; Newton I, 2011, J ORNITHOL, V152, P169, DOI 10.1007/s10336-011-0689-y; Nilsson JA, 1996, P ROY SOC B-BIOL SCI, V263, P711, DOI 10.1098/rspb.1996.0106; Roff Derek A., 1992; Rohwer S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011586; Romero LM, 2006, GEN COMP ENDOCR, V149, P58, DOI 10.1016/j.ygcen.2006.05.004; Romero LM, 2005, COMP BIOCHEM PHYS A, V142, P65, DOI 10.1016/j.cbpa.2005.07.014; Roulin A, 2008, ANIM BEHAV, V75, P1351, DOI 10.1016/j.anbehav.2007.09.007; Rubolini D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048955; SAINO N, 1994, ANIM BEHAV, V48, P1325, DOI 10.1006/anbe.1994.1369; Saino N, 2013, J ORNITHOL, V154, P537, DOI 10.1007/s10336-012-0924-1; Saino N, 2012, J AVIAN BIOL, V43, P513, DOI 10.1111/j.1600-048X.2012.05622.x; Salewski V, 2004, J ORNITHOL, V145, P109, DOI 10.1007/s10336-004-0020-2; SIIKAMAKI P, 1994, FUNCT ECOL, V8, P587, DOI 10.2307/2389919; Sockman KW, 2006, BIOL REV, V81, P629, DOI 10.1017/S1464793106007147; Stearns S.C., 1992, pi; Strochlic DE, 2008, COMP BIOCHEM PHYS A, V149, P68, DOI 10.1016/j.cbpa.2007.10.011; Svensson E, 1999, BIOL J LINN SOC, V67, P263, DOI 10.1006/bijl.1998.0302; Turner A., 2006, BARN SWALLOW; Vangestel C, 2010, BIOL J LINN SOC, V101, P41, DOI 10.1111/j.1095-8312.2010.01493.x; Ward S, 1996, PHYSIOL ZOOL, V69, P930, DOI 10.1086/physzool.69.4.30164236; Williams T., 2012, PHYSL ADAPTATIONS BR; Williams TD, 2004, GEN COMP ENDOCR, V136, P346, DOI 10.1016/j.ygcen.2004.01.010; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006	69	16	17	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96428	10.1371/journal.pone.0096428	http://dx.doi.org/10.1371/journal.pone.0096428			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24826890	Green Published, Green Submitted, gold			2022-12-27	WOS:000336857400026
J	Gradwohl, G; Berdugo-Boura, N; Segev, Y; Tarasiuk, A				Gradwohl, Gideon; Berdugo-Boura, Nilly; Segev, Yael; Tarasiuk, Ariel			Chronic Upper Airway Obstruction Induces Abnormal Sleep/Wake Dynamics in Juvenile Rats	PLOS ONE			English	Article							GROWTH-HORMONE SECRETION; OREXIN KNOCKOUT MICE; SLOW-WAVE ACTIVITY; EEG POWER SPECTRA; APNEA SYNDROME; DAYTIME SLEEPINESS; RECEPTOR ANTAGONIST; BEHAVIORAL STATES; MOTOR-ACTIVITY; CHILDREN	Objectives: Conventional scoring of sleep provides little information about the process of transitioning between vigilance-states. We used the state space technique to explore whether rats with chronic upper airway obstruction (UAO) have abnormal sleep/wake states, faster movements between states, or abnormal transitions between states. Design: The tracheae of 22-day-old Sprague-Dawley rats were surgically narrowed to increase upper airway resistance with no evidence for frank obstructed apneas or hypopneas; 24-h electroencephalography of sleep/wake recordings of UAO and sham-control animals was analyzed using state space technique. This non-categorical approach allows quantitative and unbiased examination of vigilance-states and state transitions. Measurements were performed 2 weeks post-surgery at baseline and following administration of ritanserin (5-HT2 receptor antagonist) the next day to stimulate sleep. Measurements and Results: UAO rats spent less time in deep (delta-rich) slow wave sleep (SWS) and near transition zones between states. State transitions from light SWS to wake and vice versa and microarousals were more frequent and rapid in UAO rats, indicating that obstructed animals have more regions where vigilance-states are unstable. Ritanserin consolidated sleep in both groups by decreasing the number of microarousals and trajectories between wake and light SWS, and increasing deep SWS in UAO. Conclusions: State space technique enables visualization of vigilance-state transitions and velocities that were not evident by traditional scoring methods. This analysis provides new quantitative assessment of abnormal vigilance-state dynamics in UAO in the absence of frank obstructed apneas or hypopneas.	[Gradwohl, Gideon; Berdugo-Boura, Nilly; Tarasiuk, Ariel] Ben Gurion Univ Negev, Fac Hlth Sci, Soroka Univ Med Ctr, Sleep Wake Disorders Unit, IL-84105 Beer Sheva, Israel; [Gradwohl, Gideon; Berdugo-Boura, Nilly; Tarasiuk, Ariel] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol, IL-84105 Beer Sheva, Israel; [Berdugo-Boura, Nilly; Segev, Yael] Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol & Immunol, IL-84105 Beer Sheva, Israel; [Gradwohl, Gideon] Jerusalem Coll Technol, Dept Phys, Unit Biomed Engn, Jerusalem, Israel	Ben Gurion University; Soroka Medical Center; Ben Gurion University; Ben Gurion University	Tarasiuk, A (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Soroka Univ Med Ctr, Sleep Wake Disorders Unit, IL-84105 Beer Sheva, Israel.	tarasiuk@bgu.ac.il			Israel Science Foundation [160/10]	Israel Science Foundation(Israel Science Foundation)	This work was supported Israel Science Foundation Grant No. 160/10 to A. T. and Y.S. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann P, 1998, NEUROSCIENCE, V85, P1195, DOI 10.1016/S0306-4522(97)00692-1; American Academy of Sleep Medicine, 2007, AASM MAN SCOR SLEEP; Arens R, 2004, SLEEP, V27, P997, DOI 10.1093/sleep/27.5.997; Bandla HPR, 2000, PEDIATR PULM, V29, P359, DOI 10.1002/(SICI)1099-0496(200005)29:5<359::AID-PPUL4>3.3.CO;2-F; Bar A, 1999, J PEDIATR-US, V135, P76, DOI 10.1016/S0022-3476(99)70331-8; Behn CGD, 2010, SLEEP, V33, P297, DOI 10.1093/sleep/33.3.297; Ben-Israel N, 2011, EUR RESPIR J, V37, P1144, DOI 10.1183/09031936.00106710; Bhattacharjee R, 2010, AM J RESP CRIT CARE, V182, P676, DOI 10.1164/rccm.200912-1930OC; Blum RH, 2004, PAEDIATR ANAESTH, V14, P75, DOI 10.1046/j.1460-9592.2003.01193.x; Bonuck KA, 2009, ARCH DIS CHILD, V94, P83, DOI 10.1136/adc.2008.141192; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Chervin RD, 1998, SLEEP, V21, P799; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Dzirasa K, 2006, J NEUROSCI, V26, P10577, DOI 10.1523/JNEUROSCI.1767-06.2006; FINK BR, 1963, ANN NY ACAD SCI, V109, P892, DOI 10.1111/j.1749-6632.1963.tb13514.x; Friedman BC, 2003, SLEEP, V26, P999, DOI 10.1093/sleep/26.8.999; Gervasoni D, 2004, J NEUROSCI, V24, P11137, DOI 10.1523/JNEUROSCI.3524-04.2004; Goh DYT, AM J RESP CRIT CARE, V162, P682; Gottlieb DJ, 2000, AM J RESP CRIT CARE, V162, P1512, DOI 10.1164/ajrccm.162.4.9911073; GREENBERG HE, 1995, AM J RESP CRIT CARE, V152, P666, DOI 10.1164/ajrccm.152.2.7633724; Gronfier C, 1996, SLEEP, V19, P817, DOI 10.1093/sleep/19.10.817; GUILLEMINAULT C, 1988, CHEST, V94, P32, DOI 10.1378/chest.94.1.32; Heinzer R, 2001, CHEST, V119, P1807, DOI 10.1378/chest.119.6.1807; Kantor S, 2004, BRIT J PHARMACOL, V142, P1332, DOI 10.1038/sj.bjp.0705887; Kantor S, 2002, BRAIN RES, V943, P105, DOI 10.1016/S0006-8993(02)02698-7; Kirov R, 1998, INT J NEUROSCI, V93, P265, DOI 10.3109/00207459808986432; Li AH, 2010, J PHYSIOL-LONDON, V588, P2935, DOI 10.1113/jphysiol.2010.191288; Lin SC, 2007, METHODS NEURAL ENSEM; Marcus CL, 2013, NEW ENGL J MED, V368, P2366, DOI 10.1056/NEJMoa1215881; Marcus CL, 2012, PEDIATRICS, V130, pE714, DOI 10.1542/peds.2012-1672; MARCUS CL, 1994, J PEDIATR-US, V125, P556, DOI 10.1016/S0022-3476(94)70007-9; Murphy DJ, 1998, J PHARMACOL TOXICOL, V39, P137, DOI 10.1016/S1056-8719(98)00008-2; O'Malley EB, 2003, SLEEP, V26, P435, DOI 10.1093/sleep/26.4.435; OBAL F, 1991, BRAIN RES, V557, P149, DOI 10.1016/0006-8993(91)90128-I; Obal F, 2004, SLEEP MED REV, V8, P367, DOI 10.1016/j.smrv.2004.03.005; Pepin JL, 2012, RESPIRATION, V83, P559, DOI 10.1159/000335839; Pillar G, 2012, SLEEP, V35, P1195, DOI 10.5665/sleep.2064; PREZANT DJ, 1993, J APPL PHYSIOL, V74, P1212, DOI 10.1152/jappl.1993.74.3.1212; Reid WD, 1999, RESP PHYSIOL, V118, P203, DOI 10.1016/S0034-5687(99)00089-4; Richter DW, 2001, TRENDS NEUROSCI, V24, P464, DOI 10.1016/S0166-2236(00)01867-1; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; SALEJEE I, 1993, AM REV RESPIR DIS, V148, P1346, DOI 10.1164/ajrccm/148.5.1346; Segev Y, 2008, J APPL PHYSIOL, V105, P1602, DOI 10.1152/japplphysiol.90772.2008; STEPANSKI E, 1984, SLEEP, V7, P18, DOI 10.1093/sleep/7.1.18; STRADLING JR, 1990, LANCET, V335, P249, DOI 10.1016/0140-6736(90)90068-G; Tal A, 2003, CHEST, V124, P948, DOI 10.1378/chest.124.3.948; TARASIUK A, 1991, J APPL PHYSIOL, V70, P216, DOI 10.1152/jappl.1991.70.1.216; Tarasiuk A, 2011, EUR RESPIR J, V38, P870, DOI 10.1183/09031936.00197610; Tarasiuk A, SLEEP IN PRESS; Tarasiuk A, 2007, J APPL PHYSIOL, V102, P913, DOI 10.1152/japplphysiol.00838.2006; Timofeeva OA, 2001, BRAIN RES, V893, P165, DOI 10.1016/S0006-8993(00)03309-6; Tononi G, 2005, SLEEP MED, V6, pS8, DOI 10.1016/S1389-9457(05)80003-6; Viola AU, 2002, CLIN NEUROPHYSIOL, V113, P429, DOI 10.1016/S1388-2457(02)00014-7; Zhang JY, 1999, J NEUROSCI, V19, P2187	54	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97111	10.1371/journal.pone.0097111	http://dx.doi.org/10.1371/journal.pone.0097111			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824340	Green Published, gold			2022-12-27	WOS:000336369200060
J	Guery, B; Alberti, C; Servais, A; Harrami, E; Bererhi, L; Zins, B; Touam, M; Joly, D				Guery, Bruno; Alberti, Corinne; Servais, Aude; Harrami, Elarbi; Bererhi, Lynda; Zins, Brigitte; Touam, Malik; Joly, Dominique			Hemodialysis without Systemic Anticoagulation: A Prospective Randomized Trial to Evaluate 3 Strategies in Patients at Risk of Bleeding	PLOS ONE			English	Article							HEPARIN-FREE DIALYSIS; CITRATE ANTICOAGULATION; COAGULATION; MEMBRANE; PROSTACYCLIN; ACTIVATION; BINDING	Objective: In this clinical trial, we aimed to compare three means of performing chronic hemodialysis in patients with contra-indication to systemic heparinization. Methods: This open-label monocentric randomized << n-of-one >> trial, conducted in a single tertiary care center, recruited chronic hemodialysis patients with a contra-indication to systemic heparinization for at least 3 consecutive sessions. All patients underwent hemodialysis with an AN69ST dialyzer, and were administered three alternative dialysis procedures in a random sequence: intermittent saline flushes, constant saline infusion, or pre-dialysis heparin coating of the membrane. The primary outcome was the need to interrupt the dialysis session because of clotting events due to either (i) a complete coagulation of the circuit; (ii) a partial coagulation of the circuit; (iii) a>50% rise over baseline in the venous pressure. Results: At the end of the inclusion period (May, 2007 to December, 2008), the number of patients to include (n = 75) was not reached: only 46 patients were included and underwent randomization. The study was terminated, and statistical analysis took into account 224 hemodialysis sessions performed in 44 patients with analyzable data. Heparin adsorption was associated with a significant reduction of the need to interrupt the dialysis session because of clotting events: odds ratio 0.3 (CI 95% 0.2 to 0.6; p<0.001, versus intermittent saline flushes). Heparin adsorption was also associated with higher odds for performing>3 h dialysis sessions and for having complete blood restitution. There were no significant effects of the dialysis procedure on weight loss, online ionic dialysance, and adverse events. Conclusion: Heparin-coated AN69ST dialysis membrane is a safe and effective method to avoid or delay per-dialytic clotting events in patients with contra-indication to systemic anticoagulation. However, results are not generalizable safely to patients with active bleeding, since weak heparinemia, not assessed in this study, may occur.	[Guery, Bruno; Servais, Aude; Harrami, Elarbi; Bererhi, Lynda; Zins, Brigitte; Touam, Malik; Joly, Dominique] Univ Paris 05, Hop Necker Enfants Malad, AP HP, Serv Nephrol, Paris, France; [Alberti, Corinne] Univ Paris 07, Hop Robert Debre, AP HP, Unite Epidemiol Clin, Paris, France; [Alberti, Corinne] Inst Natl Sante & Rech Med CIE 5, Paris, France; [Joly, Dominique] Hop Necker Enfants Malad, INSERM, U845, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Joly, D (corresponding author), Univ Paris 05, Hop Necker Enfants Malad, AP HP, Serv Nephrol, Paris, France.	doume.joly@gmail.com		Servais, Aude/0000-0002-8165-8212	Departement a la Recherche Clinique et au Developpement, Assistance Publique-Hopitaux de Paris [CRC 05 032]; AURA (Association pour l'Utilisation du Rein Artificiel)	Departement a la Recherche Clinique et au Developpement, Assistance Publique-Hopitaux de Paris; AURA (Association pour l'Utilisation du Rein Artificiel)	This work was supported by a research grant from the Departement a la Recherche Clinique et au Developpement, Assistance Publique-Hopitaux de Paris, which was also the sponsor of the study (CRC 05 032), and AURA (Association pour l'Utilisation du Rein Artificiel). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apsner R, 2001, AM J KIDNEY DIS, V38, P979, DOI 10.1053/ajkd.2001.28584; Bartels PCM, 2000, SCAND J CLIN LAB INV, V60, P283, DOI 10.1080/003655100750046440; Camici M, 1997, INT J ARTIF ORGANS, V20, P163, DOI 10.1177/039139889702000307; CARUANA RJ, 1991, BLOOD PURIFICAT, V9, P296, DOI 10.1159/000170027; CARUANA RJ, 1987, KIDNEY INT, V31, P1351, DOI 10.1038/ki.1987.149; Chanard J, 2005, ASAIO J, V51, P342, DOI 10.1097/01.mat.0000169119.06419.ed; Evenepoel P, 2007, AM J KIDNEY DIS, V49, P642, DOI 10.1053/j.ajkd.2007.02.001; FLANIGAN MJ, 1987, AM J KIDNEY DIS, V9, P147, DOI 10.1016/S0272-6386(87)80092-6; Frank RD, 2006, NEPHROL DIAL TRANSPL, V21, P1013, DOI 10.1093/ndt/gfi293; JANSSEN MJFM, 1993, NEPHROL DIAL TRANSPL, V8, P1228; KELLEHER SP, 1987, AM J KIDNEY DIS, V9, P235, DOI 10.1016/S0272-6386(87)80061-6; Kodras K, 2008, BLOOD PURIFICAT, V26, P226, DOI 10.1159/000118846; Lavaud S, 2005, ASAIO J, V51, P348, DOI 10.1097/01.mat.0000169121.09075.53; Lavaud S, 2003, NEPHROL DIAL TRANSPL, V18, P2097, DOI 10.1093/ndt/gfg272; Lim W, 2004, J AM SOC NEPHROL, V15, P3192, DOI 10.1097/01.ASN.0000145014.80714.35; MARTINMALO A, 1993, KIDNEY INT, V43, pS213; Nurmohamed M T, 1991, ASAIO Trans, V37, pM459; PINNICK RV, 1983, NEW ENGL J MED, V308, P258, DOI 10.1056/NEJM198302033080506; PREUSCHOF L, 1988, INT J ARTIF ORGANS, V11, P255, DOI 10.1177/039139888801100408; Richtrova P, 2007, NEPHROL DIAL TRANSPL, V22, P2978, DOI 10.1093/ndt/gfm137; Romao JE, 1997, NEPHROL DIAL TRANSPL, V12, P106, DOI 10.1093/ndt/12.1.106; Sagedal S, 2006, NEPHROL DIAL TRANSPL, V21, P444, DOI 10.1093/ndt/gfi203; SCHWAB SJ, 1987, AM J MED, V83, P405, DOI 10.1016/0002-9343(87)90748-0; SWARTZ RD, 1988, J CLIN PHARMACOL, V28, P818, DOI 10.1002/j.1552-4604.1988.tb03222.x; SWARTZ RD, 1981, NEPHRON, V28, P65, DOI 10.1159/000182111; Weitz JI, 1997, NEW ENGL J MED, V337, P688, DOI 10.1056/NEJM199709043371007; Zucker DR, 2010, AM J KIDNEY DIS, V55, P635, DOI 10.1053/j.ajkd.2009.11.010	27	22	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97187	10.1371/journal.pone.0097187	http://dx.doi.org/10.1371/journal.pone.0097187			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24825343	gold, Green Submitted, Green Published			2022-12-27	WOS:000336369200071
J	Kocalevent, RD; Mierke, A; Danzer, G; Klapp, BF				Kocalevent, Rueya-Daniela; Mierke, Annett; Danzer, Gerhard; Klapp, Burghard F.			Adjustment Disorders as a Stress-Related Disorder: A Longitudinal Study of the Associations among Stress, Resources, and Mental Health	PLOS ONE			English	Article							GENERALIZED ANXIETY DISORDER; PRIMARY-CARE; DEPRESSIVE-DISORDERS; PREVALENCE; QUESTIONNAIRE; GENDER; VALIDATION; LIFE; VULNERABILITY; PSYCHOTHERAPY	Objective: Adjustment disorders are re-conceptualized in the DSM-5 as a stress-related disorder; however, besides the impact of an identifiable stressor, the specification of a stress concept, remains unclear. This study is the first to examine an existing stress-model from the general population, in patients diagnosed with adjustment disorders, using a longitudinal design. Methods: The study sample consisted of 108 patients consecutively admitted for adjustment disorders. Associations of stress perception, emotional distress, resources, and mental health were measured at three time points: the outpatients' presentation, admission for inpatient treatment, and discharge from the hospital. To evaluate a longitudinal stress model of ADs, we examined whether stress at admission predicted mental health at each of the three time points using multiple linear regressions and structural equation modeling. A series of repeated-measures one-way analyses of variance (rANOVAs) was performed to assess change over time. Results: Significant within-participant changes from baseline were observed between hospital admission and discharge with regard to mental health, stress perception, and emotional distress (p<0.001). Stress perception explained nearly half of the total variance (44%) of mental health at baseline; the adjusted R-2 increased (0.48), taking emotional distress (i.e., depressive symptoms) into account. The best predictor of mental health at discharge was the level of emotional distress (i.e., anxiety level) at baseline (beta = 20.23, R-corr(2) = 0.56, p<0.001). With a CFI of 0.86 and an NFI of 0.86, the fit indices did not allow for acceptance of the stress-model (C-min/df = 15.26; RMSEA = 0.21). Conclusions: Stress perception is an important predictor in adjustment disorders, and mental health-related treatment goals are dependent on and significantly impacted by stress perception and emotional distress.	[Kocalevent, Rueya-Daniela] Univ Med Ctr, Inst & Policlin Med Psychol, Hamburg, Germany; [Mierke, Annett; Danzer, Gerhard; Klapp, Burghard F.] Charite, Dept Psychosomat Med, D-13353 Berlin, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kocalevent, RD (corresponding author), Univ Med Ctr, Inst & Policlin Med Psychol, Hamburg, Germany.	r.kocalevent@uke.de						Ahern NR, 2006, COMPR CHILD ADOLES N, V29, P103, DOI 10.1080/01460860600677643; Altenhofer A, 2007, PSYCHOTHERAPEUT, V52, P24, DOI 10.1007/s00278-006-0520-z; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; ANDREASEN NC, 1982, AM J PSYCHIAT, V139, P584; [Anonymous], 1993, TESTING STRUCTURAL E; Appels A, 1997, ACTA PHYSIOL SCAND, V161, P153; Arbus C, 2013, EUR PSYCHIAT; Ayuso-Mateos JL, 2001, BRIT J PSYCHIAT, V179, P308, DOI 10.1192/bjp.179.4.308; Brewin CR, 1996, PSYCHOL REV, V103, P670, DOI 10.1037/0033-295X.103.4.670; Byrnes B., 2001, STRUCTURAL EQUATION; Casey P, 2013, COCHRANE DB SYST REV, V2013; Casey P, 2011, WORLD PSYCHIATRY, V10, P11; Catalina-Romero C, 2012, OCCUP MED-OXFORD, V62, P375, DOI 10.1093/occmed/kqs043; CREAMER M, 1992, J ABNORM PSYCHOL, V101, P452, DOI 10.1037/0021-843X.101.3.452; Day AL, 2003, CAN J BEHAV SCI, V35, P73, DOI 10.1037/h0087190; de Smet P, 2005, EUR J PUBLIC HEALTH, V15, P536, DOI 10.1093/eurpub/cki028; Dobricki M, 2010, SOC PSYCH PSYCH EPID, V45, P39, DOI 10.1007/s00127-009-0039-z; Eaton R.J., 2008, INT J STRESS MANAGE, V15, P94, DOI [10.1037/1072-5245.15.1.94, DOI 10.1037/1072-5245.15.1.94]; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Ellert U, 2005, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V48, P1330, DOI 10.1007/s00103-005-1168-5; Ellert U, 2013, BUNDESGESUNDHEITSBLA, V56, P643, DOI 10.1007/s00103-013-1700-y; Fernandez A, 2012, BRIT J PSYCHIAT, V201, P137, DOI 10.1192/bjp.bp.111.096305; Fliege H, 2005, PSYCHOSOM MED, V67, P78, DOI 10.1097/01.psy.0000151491.80178.78; Gorschenek N, 2008, PSYCHOTHER PSYCH MED, V58, P200, DOI 10.1055/s-2007-986180; Hapke U, 2013, BUNDESGESUNDHEITSBLA, V56, P749, DOI 10.1007/s00103-013-1690-9; Hecheltjen KG, 1973, GRUPPENDYNAMIK, V40, P110; Hoerhold M., 1993, Z MED PSYCH, V2, P27; Hogan JM, 2002, INT J STRESS MANAGE, V9, P289, DOI 10.1023/A:1019982316327; Hund B, 2013, PSYCHOTHER PSYCHOSOM; Jones R, 2002, J AFFECT DISORDERS, V71, P199, DOI 10.1016/S0165-0327(01)00390-1; Jones R, 1999, J AFFECT DISORDERS, V55, P55, DOI 10.1016/S0165-0327(98)00202-X; Karakus M, 2013, EDUC STUD-UK, V39, P68, DOI 10.1080/03055698.2012.671514; KESSLER RC, 1984, AM SOCIOL REV, V49, P620, DOI 10.2307/2095420; Kocalevent RD, 2007, J PSYCHOSOM RES, V63, P71, DOI 10.1016/j.jpsychores.2007.02.010; Kocalevent RD, 2013, PSYCHOTHER PSYCH MED, V63, P115, DOI 10.1055/s-0032-1327705; Kocalevent Ruya D, 2011, BMC Res Notes, V4, P238, DOI 10.1186/1756-0500-4-238; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Lazarus R.S., 1984, EMOTION ADAPTATION; Lazarus RS, 2000, AM PSYCHOL, V55, P665, DOI 10.1037//0003-066X.55.6.665; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Lowe B, 2004, J AFFECT DISORDERS, V81, P61, DOI 10.1016/S0165-0327(03)00198-8; Maercker A, 2008, COMPR PSYCHIAT, V49, P113, DOI 10.1016/j.comppsych.2007.07.002; Maercker A, 2007, PSYCHOPATHOLOGY, V40, P135, DOI 10.1159/000099290; Maercker A, 2012, SOC PSYCH PSYCH EPID, V47, P1745, DOI 10.1007/s00127-012-0493-x; Michael G, 2009, STRESS HEALTH, V25, P397, DOI 10.1002/smi.1248; Miller GE, 2007, PSYCHOL BULL, V133, P25, DOI 10.1037/0033-2909.133.1.25; Monteleone P, 2009, PSYCHOTHER PSYCHOSOM, V78, P381, DOI 10.1159/000235980; Nowils V, 1965, AFFECT COGNITION PER; Osorio LC, 2003, PERS INDIV DIFFER, V34, P831, DOI 10.1016/S0191-8869(02)00074-0; Phillips MR, 2009, LANCET, V373, P2041, DOI 10.1016/S0140-6736(09)60660-7; Sandanger I, 2004, SOC PSYCH PSYCH EPID, V39, P177, DOI 10.1007/s00127-004-0728-6; Scholler G, 1999, PSYCHOTHER PSYCH MED, V49, P275; Schwarzer R, 2011, REHABIL PSYCHOL, V56, P161, DOI 10.1037/a0024509; Sinclair VG, 2004, ASSESSMENT, V11, P94, DOI 10.1177/1073191103258144; Sliskovic A, 2011, ARH HIG RADA TOKSIKO, V62, P299, DOI 10.2478/10004-1254-62-2011-2135; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; STEWART AL, 1989, JAMA-J AM MED ASSOC, V262, P907, DOI 10.1001/jama.262.7.907; Stiles WB, 2008, J CONSULT CLIN PSYCH, V76, P298, DOI 10.1037/0022-006X.76.2.298; TURNER RJ, 1989, J NERV MENT DIS, V177, P443, DOI 10.1097/00005053-198908000-00001; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; World Health Organization, 2003, GEND DISP MENT HLTH; World Health Organization, 2013, ICD 11 BETA IN PRESS	64	6	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97303	10.1371/journal.pone.0097303	http://dx.doi.org/10.1371/journal.pone.0097303			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AH8EY	24825165	Green Published, gold, Green Submitted			2022-12-27	WOS:000336369200090
J	Li, S; Zhou, T; Li, C; Dai, ZY; Che, D; Yao, YC; Li, L; Ma, JX; Yang, X; Gao, GQ				Li, Shuai; Zhou, Ti; Li, Cen; Dai, Zhiyu; Che, Di; Yao, Yachao; Li, Lei; Ma, Jianxing; Yang, Xia; Gao, Guoquan			High Metastaticgastric and Breast Cancer Cells Consume Oleic Acid in an AMPK Dependent Manner	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; LIPID-METABOLISM; TUMOR-GROWTH; ENERGY; PROLIFERATION; OXIDATION; PHOSPHORYLATION; TRIACYLGLYCEROL; SURVIVAL; ANCIENT	Gastric cancer and breast cancer have a clear tendency toward metastasis and invasion to the microenvironment predominantly composed of adipocytes. Oleic acid is an abundant monounsaturated fatty acid that releases from adipocytes and impinges on different energy metabolism responses. The effect and underlying mechanisms of oleic acid on highly metastatic cancer cells are not completely understood. We reported that AMP-activated protein kinase (AMPK) was obviously activated in highly aggressive carcinoma cell lines treated by oleic acid, including gastric carcinoma HGC-27 and breast carcinoma MDA-MB-231 cell lines. AMPK enhanced the rates of fatty acid oxidation and ATP production and thus significantly promoted cancer growth and migration under serum deprivation. Inactivation of AMPK attenuated these activities of oleic acid. Oleic acid inhibited cancer cell growth and survival in low metastatic carcinoma cells, such as gastric carcinoma SGC7901 and breast carcinoma MCF-7 cell lines. Pharmacological activation of AMPK rescued the cell viability by maintained ATP levels by increasing fatty acid beta-oxidation. These results indicate that highly metastatic carcinoma cells could consume oleic acid to maintain malignancy in an AMPK-dependent manner. Our findings demonstrate the important contribution of fatty acid oxidation to cancer cell function.	[Li, Shuai; Zhou, Ti; Li, Cen; Dai, Zhiyu; Che, Di; Yao, Yachao; Li, Lei; Yang, Xia; Gao, Guoquan] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Biochem, Guangzhou, Guangdong, Peoples R China; [Ma, Jianxing] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK USA; [Yang, Xia] Sun Yat Sen Univ, Dept Educ Guangdong Prov, Key Lab Funct Mol Marine Microorganisms, Guangzhou, Guangdong, Peoples R China; [Gao, Guoquan] Sun Yat Sen Univ, China Key Lab Trop Dis Control, Minist Educ, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; University of Oklahoma System; University of Oklahoma Health Sciences Center; Sun Yat Sen University; Sun Yat Sen University	Yang, X (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Biochem, Guangzhou, Guangdong, Peoples R China.	yangxia@mail.sysu.edu.cn; gaogq@mail.sysu.edu.cn	Bardeesi, Adham Sameer A./V-1732-2019; Bardeesi, Adham Sameer A./Q-8466-2016; Dai, Zhiyu/H-3453-2019	Bardeesi, Adham Sameer A./0000-0002-5609-6385; Bardeesi, Adham Sameer A./0000-0002-5609-6385; Dai, Zhiyu/0000-0002-2945-7923	National Nature Science Foundation of China [30971208, 30973449, 81070746, 81001014, 81172163, 81272338, 81272515]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Nature Science Foundation of China (Grant Number: 30971208, 30973449, 81070746, 81001014, 81172163, 81272338, 81272515). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carracedo A, 2013, NAT REV CANCER, V13, P227, DOI 10.1038/nrc3483; Chen EI, 2007, CANCER RES, V67, P1472, DOI 10.1158/0008-5472.CAN-06-3137; Dandapani M, 2013, BIOCHEM SOC T, V41, P687, DOI 10.1042/BST20120351; Dirat B, 2011, CANCER RES, V71, P2455, DOI 10.1158/0008-5472.CAN-10-3323; Faubert B, 2013, CELL METAB, V17, P113, DOI 10.1016/j.cmet.2012.12.001; Fritz V, 2010, ONCOGENE, V29, P4369, DOI 10.1038/onc.2010.182; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2012, CHEM BIOL, V19, P1222, DOI 10.1016/j.chembiol.2012.08.019; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardy S, 2000, CANCER RES, V60, P6353; Hirsch HA, 2010, CANCER CELL, V17, P348, DOI 10.1016/j.ccr.2010.01.022; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Khandekar MJ, 2011, NAT REV CANCER, V11, P886, DOI 10.1038/nrc3174; Kim SY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.95; Kotronen A, 2010, OBESITY, V18, P937, DOI 10.1038/oby.2009.326; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Liu LD, 2012, NATURE, V483, P608, DOI 10.1038/nature10927; Liu Y, 2006, PROSTATE CANCER P D, V9, P230, DOI 10.1038/sj.pcan.4500879; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Muoio DM, 1999, BIOCHEM J, V338, P783, DOI 10.1042/0264-6021:3380783; Nieman KM, 2013, BBA-MOL CELL BIOL L, V1831, P1533, DOI 10.1016/j.bbalip.2013.02.010; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Nomoto-Kojima N, 2011, CELL TISSUE RES, V344, P287, DOI 10.1007/s00441-011-1144-3; Omar B, 2009, CELL SIGNAL, V21, P760, DOI 10.1016/j.cellsig.2009.01.015; Park HU, 2009, MOL CANCER THER, V8, P733, DOI 10.1158/1535-7163.MCT-08-0631; Pezeshkian M, 2009, METAB SYNDR RELAT D, V7, P125, DOI 10.1089/met.2008.0056; Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097; Przybytkowski E, 2007, BIOCHEM CELL BIOL, V85, P301, DOI 10.1139/O07-001; Rios M, 2013, CANCER RES, V73, P2628, DOI 10.1158/0008-5472.CAN-12-0861; Santos CR, 2012, FEBS J, V279, P2610, DOI 10.1111/j.1742-4658.2012.08644.x; Shaw RJ, 2006, CURR OPIN CELL BIOL, V18, P598, DOI 10.1016/j.ceb.2006.10.005; Smolkova K, 2011, INT J BIOCHEM CELL B, V43, P950, DOI 10.1016/j.biocel.2010.05.003; Swinnen JV, 2006, CURR OPIN CLIN NUTR, V9, P358, DOI 10.1097/01.mco.0000232894.28674.30; Tsikas D, 2011, BBA-MOL CELL BIOL L, V1811, P694, DOI 10.1016/j.bbalip.2011.06.015; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wu Y., 2012, PLOS ONE, V7; Zaugg K, 2011, GENE DEV, V25, P1041, DOI 10.1101/gad.1987211	37	45	46	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97330	10.1371/journal.pone.0097330	http://dx.doi.org/10.1371/journal.pone.0097330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24823908	Green Published, gold, Green Submitted			2022-12-27	WOS:000336369200096
J	Maman, S; Moodley, D; McNaughton-Reyes, HL; Groves, AK; Kagee, A; Moodley, P				Maman, Suzanne; Moodley, Dhayendre; McNaughton-Reyes, Heathe Luz; Groves, Allison K.; Kagee, Ashraf; Moodley, Prashini			Efficacy of Enhanced HIV Counseling for Risk Reduction during Pregnancy and in the Postpartum Period: A Randomized Controlled Trial	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; SOUTH-AFRICA; TRANSMISSION; PREVENTION; BEHAVIOR; HEALTH; STATES	Introduction: Pregnancy and the postpartum period present important intervention opportunities. Counseling can leverage the motivation women have during this time to change behaviors that may negatively affect their health and the heath of their infants. Methods: Pregnant women attending an antenatal clinic in South Africa were randomly allocated to treatment (n = 733) and control arms (n = 747). Treatment arm participants received enhanced HIV pre- and post-test counseling, legal support and access to support groups at baseline, which occurred at the first antenatal visit, and then six and ten weeks postpartum. Control arm participants received standard HIV testing and counseling (HTC) and two postpartum attention control sessions. Outcomes were incidence of sexually transmitted infection (STI) by 14 weeks postpartum and past 30-day inconsistent condom use at 14 weeks and 9 months postpartum. Results: There were no intervention effects on incident STIs for either HIV-negative (adjusted risk ratio (aRR) 1.01, 95% CI 0.71-1.44) or HIV-positive participants (aRR 0.86, 95% CI 0.61-1.23). The intervention was associated with a 28% decrease in risk of past 30-day inconsistent condom use at nine-months among HIV-negative women (aRR 0.72,95% CI 0.59-0.88), but did not affect inconsistent condom use among HIV-positive women (aRR1.08; 95% CI 0.67-1.75). Discussion: An enhanced counseling intervention during pregnancy and the postpartum period can lead to reductions in inconsistent condom use among HIV-negative women. Results underscore the importance of the counseling that accompanies HIV HTC. More work is needed to understand how to promote and sustain risk reduction among HIV-positive women.	[Maman, Suzanne; McNaughton-Reyes, Heathe Luz; Groves, Allison K.] Univ N Carolina, Chapel Hill, NC 27515 USA; [Moodley, Dhayendre; Moodley, Prashini] Univ KwaZulu Natal, Durban, South Africa; [Kagee, Ashraf] Univ Stellenbosch, Matieland, South Africa	University of North Carolina; University of North Carolina Chapel Hill; University of Kwazulu Natal; Stellenbosch University	Maman, S (corresponding author), Univ N Carolina, Chapel Hill, NC 27515 USA.	smaman@unc.edu	Kagee, Ashraf/H-4650-2019; Moodley, Dhayendre/U-6802-2019; Maman, Suzanne/A-3802-2016	McNaughton Reyes, Heathe Luz/0000-0002-8696-9140; Moodley, Pravi/0000-0002-9946-8783	U.S. National Institute of Mental Health [R01HD050134]; Open Society Institute and Elton John Foundation [20020472/20030878]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD050134] Funding Source: NIH RePORTER	U.S. National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Open Society Institute and Elton John Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was sponsored by the U.S. National Institute of Mental Health (R01HD050134). The authors also received funds from the Open Society Institute and Elton John Foundation (20020472/20030878). Views expressed are those of the authors, and not necessarily those of sponsoring agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison PD, 2001, MISSING DATE; [Anonymous], S AFR DEM HLTH SURV; Baek G, 2010, PUBLIC HEALTH REP, V125, P293, DOI 10.1177/003335491012500220; Barnighausen T, 2007, AIDS, V21, pS29, DOI 10.1097/01.aids.0000300533.59483.95; Berg S, 2004, S AFRICAN J EC, V72, P546, DOI DOI 10.1111/J.1813-6982.2004.TB00125.X; Blaau D P-KL, 2002, SOCIOECONOMIC INEQUA; Booysen F.L.R., 2002, J STUD EC EC, V26, P53; Brand JP, 1999, DEVELOPMENT; Carvalho FT, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007844.pub2; U.S. Public Health Service, 2001, MMWR Recomm Rep, V50, P1; Coovadia H, 2009, LANCET, V374, P817, DOI 10.1016/S0140-6736(09)60951-X; Denison JA, 2008, AIDS BEHAV, V12, P363, DOI 10.1007/s10461-007-9349-x; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Fowler MG, 2007, AM J OBSTET GYNECOL, V197, pS3, DOI 10.1016/j.ajog.2007.06.048; Gyekye Agyapong., 2003, E AFRICA SOCIAL SCI, V19, P89, DOI [10.1353/eas.2003.0005, DOI 10.1353/EAS.2003.0005]; Health SADo, 2007, GUID MAT CAR S AFR M; Health SANDo, 2001, S AFRICA; Johnson LF, 2005, SEX TRANSM INFECT, V81, P287, DOI 10.1136/sti.2004.013904; Kalichman SC, 2010, AM J PUBLIC HEALTH, V100, P714, DOI 10.2105/AJPH.2009.162602; Khan MR, 2012, AM J PUBLIC HEALTH, V102, P867, DOI 10.2105/AJPH.2011.300373; Mofenson LM, 2010, CLIN INFECT DIS, V50, pS130, DOI 10.1086/651484; Moodley D, 2009, AIDS, V23, P1255, DOI 10.1097/QAD.0b013e32832a5934; Mullick S, 2005, SEX TRANSM INFECT, V81, P294, DOI 10.1136/sti.2002.004077; Organization WH, 2012, S AFRICA; Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; Rubin DB, 2004, MULTIPLE IMPUTATION; Trust SAHS, 2002, INTERIM FINDINGS NAT; UNAIDS, 1997, COUNS HIV AIDS UNAID; Van Buuren S, 1999, 99054 TNOVGZPG; Verplanken B, 2006, J PUBLIC POLICY MARK, V25, P90, DOI 10.1509/jppm.25.1.90; WHO/UNAIDS, 2001, TECHN CONS VOL HIV C; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	33	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97092	10.1371/journal.pone.0097092	http://dx.doi.org/10.1371/journal.pone.0097092			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AH8EY	24824050	Green Published, gold, Green Submitted			2022-12-27	WOS:000336369200058
J	Wu, L; Zhi, Y; Sui, ZW; Liu, Y				Wu, Lun; Zhi, Ye; Sui, Zhengwei; Liu, Yu			Intra-Urban Human Mobility and Activity Transition: Evidence from Social Media Check-In Data	PLOS ONE			English	Article							MOVEMENT; PATTERNS; MODEL	Most existing human mobility literature focuses on exterior characteristics of movements but neglects activities, the driving force that underlies human movements. In this research, we combine activity-based analysis with a movement-based approach to model the intra-urban human mobility observed from about 15 million check-in records during a yearlong period in Shanghai, China. The proposed model is activity-based and includes two parts: the transition of travel demands during a specific time period and the movement between locations. For the first part, we find the transition probability between activities varies over time, and then we construct a temporal transition probability matrix to represent the transition probability of travel demands during a time interval. For the second part, we suggest that the travel demands can be divided into two classes, locationally mandatory activity (LMA) and locationally stochastic activity (LSA), according to whether the demand is associated with fixed location or not. By judging the combination of predecessor activity type and successor activity type we determine three trip patterns, each associated with a different decay parameter. To validate the model, we adopt the mechanism of an agent-based model and compare the simulated results with the observed pattern from the displacement distance distribution, the spatio-temporal distribution of activities, and the temporal distribution of travel demand transitions. The results show that the simulated patterns fit the observed data well, indicating that these findings open new directions for combining activity-based analysis with a movement-based approach using social media check-in data.	[Wu, Lun; Zhi, Ye; Liu, Yu] Peking Univ, Inst Remote Sensing & Geog Informat Syst, Beijing 100871, Peoples R China; [Sui, Zhengwei] China Ctr Resources Satellite Data & Applicat, Beijing, Peoples R China; [Liu, Yu] Harbin Inst Technol, Shenzhen Grad Sch, Shenzhen Key Lab Urban Planning & Decis Making, Shenzhen, Peoples R China	Peking University; Harbin Institute of Technology; University Town of Shenzhen	Liu, Y (corresponding author), Peking Univ, Inst Remote Sensing & Geog Informat Syst, Beijing 100871, Peoples R China.	liuyu@urban.pku.edu.cn	Liu, Yu/D-4022-2012	Liu, Yu/0000-0002-0016-2902	NSFC [41171296, 41271386]; Open Foundation of Shenzhen Key Laboratory of Urban Planning and Decision Making [UPDMHITSZ2014A01]	NSFC(National Natural Science Foundation of China (NSFC)); Open Foundation of Shenzhen Key Laboratory of Urban Planning and Decision Making	This research was supported by NSFC (http://www.nsfc.gov.cn, Grants 41171296 and 41271386) and the Open Foundation of Shenzhen Key Laboratory of Urban Planning and Decision Making (Grant UPDMHITSZ2014A01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TR, 1956, PAPERS REGIONAL SCI, V2, P175, DOI DOI 10.1111/J.1435-5597.1956.TB01563.X; Batty M., 2007, CITIES COMPLEXITY UN; Ben-Akiva M., 1998, TRANSPORTATION MODEL, P4; Bhat C, 2002, TRANSPORT RES B-METH, V36, P557, DOI 10.1016/S0191-2615(01)00019-4; Bhat C.R., 1999, HDB TRANSPORTATION S, P35; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Chen X, 2008, J OPER RES SOC, V59, P25, DOI 10.1057/palgrave.jors.2602321; Cheng Zhiyuan, 2011, ICWSM, P81; Cho Eunjoon, 2011, KDD, P1082, DOI [10.1145/2020408.2020579, DOI 10.1145/2020408.2020579]; Chowell G, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.066102; Crooks A, 2008, COMPUT ENVIRON URBAN, V32, P417, DOI 10.1016/j.compenvurbsys.2008.09.004; Gao H., 2012, P INT AAAI C WEB SOC; Goodman MK, 2011, GEOGR J, V177, P102, DOI 10.1111/j.1475-4959.2011.00401.x; Hammadou H., 2003, 43 C EUR REG SCI ASS; iuc-Pietro Daniel Preot, 2013, P 5 ANN ACM WEB SCI, P306; Kang C., 2010, 2010 35th International Conference on Infrared, Millimeter, and Terahertz Waves (IRMMW-THz 2010), DOI 10.1109/ICIMW.2010.5612960; Kang CG, 2012, PHYSICA A, V391, P1702, DOI 10.1016/j.physa.2011.11.005; KITAMURA R, 1988, TRANSPORTATION, V15, P9; Liang X, 2013, SCI REP-UK, V3, DOI 10.1038/srep02983; Liang X, 2012, PHYSICA A, V391, P2135, DOI 10.1016/j.physa.2011.11.035; Liu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086026; Liu Y, 2012, J GEOGR SYST, V14, P463, DOI 10.1007/s10109-012-0166-z; Liu Y, 2012, LANDSCAPE URBAN PLAN, V106, P73, DOI 10.1016/j.landurbplan.2012.02.012; Mascolo C., 2011, 5 INT AAAI C WEBL SO, V5, P329; Noulas A., 2011, P 5 INT AAAI C WEBL; Noulas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037027; Pelechrinis K, 2012, AAAI FALL S SOC NETW; Peng CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034487; Ratti C, 2006, ENVIRON PLANN B, V33, P727, DOI 10.1068/b32047; Rilett LR, 2001, TRANSPORT RES REC, P84; Sevtsuk A, 2010, J URBAN TECHNOL, V17, P41, DOI 10.1080/10630731003597322; Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856; Song CM, 2010, NAT PHYS, V6, P818, DOI 10.1038/NPHYS1760; Stouffer SA, 1940, AM SOCIOL REV, V5, P845, DOI 10.2307/2084520; van Knippenberg-den Brinker C., 1984, Traffic Engineering & Control, V25, P602; VEGELIUS J, 1986, QUAL QUANT, V20, P437; Zheng VW, 2012, ARTIF INTELL, V184, P17, DOI 10.1016/j.artint.2012.02.002; Zipf GK, 1946, AM SOCIOL REV, V11, P677, DOI 10.2307/2087063	42	143	146	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97010	10.1371/journal.pone.0097010	http://dx.doi.org/10.1371/journal.pone.0097010			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AH8EY	24824892	gold, Green Published, Green Submitted			2022-12-27	WOS:000336369200050
J	Zhu, PY; He, LY; Li, YQ; Huang, WP; Xi, F; Lin, L; Zhi, QH; Zhang, WW; Tang, YT; Geng, CY; Lu, ZY; Xu, X				Zhu, Pengyuan; He, Lingyu; Li, Yaqiao; Huang, Wenpan; Xi, Feng; Lin, Lin; Zhi, Qihuan; Zhang, Wenwei; Tang, Y. Tom; Geng, Chunyu; Lu, Zhiyuan; Xu, Xun			OTG-snpcaller: An Optimized Pipeline Based on TMAP and GATK for SNP Calling from Ion Torrent Data	PLOS ONE			English	Article							INTEGRATIVE GENOMICS VIEWER; DNA-SEQUENCING DATA; PERFORMANCE; FRAMEWORK	Because the new Proton platform from Life Technologies produced markedly different data from those of the Illumina platform, the conventional Illumina data analysis pipeline could not be used directly. We developed an optimized SNP calling method using TMAP and GATK (OTG-snpcaller). This method combined our own optimized processes, Remove Duplicates According to AS Tag (RDAST) and Alignment Optimize Structure (AOS), together with TMAP and GATK, to call SNPs from Proton data. We sequenced four sets of exomes captured by Agilent SureSelect and NimbleGen SeqCap EZ Kit, using Life Technology's Ion Proton sequencer. Then we applied OTG-snpcaller and compared our results with the results from Torrent Variants Caller. The results indicated that OTG-snpcaller can reduce both false positive and false negative rates. Moreover, we compared our results with Illumina results generated by GATK best practices, and we found that the results of these two platforms were comparable. The good performance in variant calling using GATK best practices can be primarily attributed to the high quality of the Illumina sequences.	[Zhu, Pengyuan; He, Lingyu; Li, Yaqiao; Huang, Wenpan; Xi, Feng; Lin, Lin; Zhi, Qihuan; Zhang, Wenwei; Geng, Chunyu; Lu, Zhiyuan; Xu, Xun] BGI Shenzhen, Shenzhen, Peoples R China; [Tang, Y. Tom] Complete Genom Inc, Mountain View, CA USA	Beijing Genomics Institute (BGI)	Lu, ZY (corresponding author), BGI Shenzhen, Shenzhen, Peoples R China.	luzhiyuan8@gmail.com; xuxun@genomics.cn	Xu, Xun/AAI-6763-2020	Xu, Xun/0000-0002-5338-5173	National High Technology Research and Development Program of China - 863 Program [2012AA02A201]; Shenzhen Key Laboratory of Transomics Biotechnologies [CXB201108250096A]	National High Technology Research and Development Program of China - 863 Program(National High Technology Research and Development Program of China); Shenzhen Key Laboratory of Transomics Biotechnologies	This project was supported by The National High Technology Research and Development Program of China - 863 Program (NO. 2012AA02A201); Shenzhen Key Laboratory of Transomics Biotechnologies (NO.CXB201108250096A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Balzer S, 2010, BIOINFORMATICS, V26, pi420, DOI 10.1093/bioinformatics/btq365; Clark MJ, 2011, NAT BIOTECHNOL, V29, P908, DOI 10.1038/nbt.1975; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Junemann S, 2013, NAT BIOTECHNOL, V31, P294, DOI 10.1038/nbt.2522; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Roberts ND, 2013, BIOINFORMATICS, V29, P2223, DOI 10.1093/bioinformatics/btt375; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yeo ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045798; Zeng F, 2013, BIOINFORMATICS	18	20	21	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97507	10.1371/journal.pone.0097507	http://dx.doi.org/10.1371/journal.pone.0097507			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824529	Green Submitted, Green Published, gold			2022-12-27	WOS:000336369200123
J	Chen, XF; Zhu, Q; Liu, YQ; Liu, P; Yin, YM; Guo, RH; Lu, KH; Gu, YH; Liu, LK; Wang, JH; Wang, ZX; Roe, OD; Shu, YQ; Zhu, LJ				Chen, Xiaofeng; Zhu, Quan; Liu, Yiqian; Liu, Ping; Yin, Yongmei; Guo, Renhua; Lu, Kaihua; Gu, Yanhong; Liu, Lianke; Wang, Jinghua; Wang, Zhaoxia; Roe, Oluf Dimitri; Shu, Yongqian; Zhu, Lingjun			Icotinib Is an Active Treatment of Non-Small-Cell Lung Cancer: A Retrospective Study	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; OPEN-LABEL; 1ST-LINE TREATMENT; CHINESE PATIENTS; MULTICENTER; CHEMOTHERAPY; GEFITINIB; ERLOTINIB; MUTATION; PLACEBO	Background: Icotinib hydrochloride is a novel epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) with preclinical and clinical activity in non-small cell lung cancer (NSCLC). This retrospective analysis was performed to assess the efficacy of icotinib on patients with non-small-cell lung cancer (NSCLC). Methods: 82 consecutive patients treated with icotinib as first (n = 24) or second/third line (n = 58) treatment at three hospitals in Nanjing were enrolled into our retrospective research. The Response Evaluation Criteria in Solid Tumors (RECIST) was used to evaluate the tumor responses and the progression-free survival (PFS) and overall survival (OS) was evaluated by the Kaplan-Meier method. Results: Median PFS was 4.0 months (95% CI 2.311-5.689). Median OS was 11.0 months (95% CI 8.537-13.463) in this cohort. Median PFS for first and second/third line were 7.0 months (95% CI 2.151-11.8) and 3.0 months (95% CI 1.042-4.958), respectively. Median OS for first and second/third line were 13.0 months (95% CI 10.305-15.695) and 10.0 months (95% CI 7.295-12.70), respectively. In patients with EGFR mutation (n = 19), icotinib significantly reduced the risk of progression (HR 0.36, 95% CI 0.18-0.70, p = 0.003) and death (HR 0.10, 95% CI 0.02-0.42, p = 0.002) compared with those EGFR status unknown (n = 63). The most common adverse events were acne-like rash (39.0%) and diarrhea (20.7%). Conclusions: Icotinib is active in the treatment of patients with NSCLC both in first or second/third line, especially in those patients harbouring EGFR mutations, with an acceptable adverse event profile.	[Chen, Xiaofeng; Liu, Yiqian; Liu, Ping; Yin, Yongmei; Guo, Renhua; Lu, Kaihua; Gu, Yanhong; Liu, Lianke; Shu, Yongqian; Zhu, Lingjun] Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China; [Zhu, Quan] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiothorac Surg, Nanjing, Jiangsu, Peoples R China; [Wang, Jinghua] Nanjing Univ, Sch Med, Jinling Hosp, Dept Oncol, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Zhaoxia] Nanjing Med Univ, Affiliated Hosp 2, Dept Oncol, Nanjing, Jiangsu, Peoples R China; [Roe, Oluf Dimitri] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Roe, Oluf Dimitri] Norwegian Univ Sci & Technol, N-7034 Trondheim, Norway; [Roe, Oluf Dimitri] Nord Trondelag Hlth Trust, Levanger Hosp, Canc Clin, Levanger, Norway	Nanjing Medical University; Nanjing Medical University; Nanjing University; Nanjing Medical University; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Shu, YQ (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China.	yongqianshu@126.com; zhulingjun@njmu.edu.cn	Shu, Yongqian/ABD-5698-2021	Roe, Oluf Dimitri/0000-0002-4870-5822	Program for Development of Innovative Research Teams; Jiangsu Province Clinical Science and Technology Projects (Clinical Research Center) [BL 2012008]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Provincial Initiative Program for Excellency Disciplines, Jiangsu Province, China	Program for Development of Innovative Research Teams; Jiangsu Province Clinical Science and Technology Projects (Clinical Research Center); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Provincial Initiative Program for Excellency Disciplines, Jiangsu Province, China	This work was partly supported by the Program for Development of Innovative Research Teams, by Jiangsu Province Clinical Science and Technology Projects (Clinical Research Center, BL 2012008), and by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) and by Provincial Initiative Program for Excellency Disciplines, Jiangsu Province, China. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cappuzzo F, 2010, LANCET ONCOL, V11, P521, DOI 10.1016/S1470-2045(10)70112-1; Chen XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059314; Ciuleanu T, 2012, LANCET ONCOL, V13, P300, DOI 10.1016/S1470-2045(11)70385-0; De Censi A, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.516; Han JY, 2012, J CLIN ONCOL, V30, P1122, DOI 10.1200/JCO.2011.36.8456; Han SW, 2005, J CLIN ONCOL, V23, P2493, DOI 10.1200/JCO.2005.01.388; Kim ES, 2008, LANCET, V372, P1809, DOI 10.1016/S0140-6736(08)61758-4; Kohrman M, 2012, J CLIN ONCOL, V30; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Ren GJ, 2011, CHINESE MED J-PEKING, V124, P19, DOI 10.3760/cma.j.issn.0366-6999.2011.01.005; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Shi Y, 2013, LANCET ONCOL; Tan FL, 2012, LUNG CANCER, V76, P177, DOI 10.1016/j.lungcan.2011.10.023; Thatcher N, 2005, LANCET, V366, P1527, DOI 10.1016/S0140-6736(05)67625-8; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Trotti A, 2003, SEMIN RADIAT ONCOL, V13, P176, DOI 10.1016/S1053-4296(03)00031-6; Wang HP, 2011, CHINESE MED J-PEKING, V124, P1933, DOI 10.3760/cma.j.issn.0366-6999.2011.13.003; Wu MN, 2010, LUNG CANCER, V67, P343, DOI 10.1016/j.lungcan.2009.04.011; Yang GD, 2012, ONCOL REP, V27, P2066, DOI 10.3892/or.2012.1741; Yarden Y, 2007, CELL, V131, DOI 10.1016/j.cell.2007.11.013; Zhang L, 2012, LANCET ONCOL, V13, P466, DOI 10.1016/S1470-2045(12)70117-1; Zhao QO, 2011, LUNG CANCER, V73, P195, DOI 10.1016/j.lungcan.2010.11.007; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	26	17	19	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e95897	10.1371/journal.pone.0095897	http://dx.doi.org/10.1371/journal.pone.0095897			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24836053	Green Published, Green Submitted, gold			2022-12-27	WOS:000339614800011
J	He, GH; Lin, JJ; Cai, WK; Xu, WM; Yu, ZP; Yin, SJ; Zhao, CH; Xu, GL				He, Gong-Hao; Lin, Jia-Ji; Cai, Wen-Ke; Xu, Wen-Mang; Yu, Zheng-Ping; Yin, Sun-Jun; Zhao, Can-Hu; Xu, Gui-Li			Associations of Polymorphisms in Histidine Decarboxylase, Histamine N-Methyltransferase and Histamine Receptor H-3 Genes with Breast Cancer	PLOS ONE			English	Article							RISK; H3	We previously found that genetic polymorphisms in gene coding for histamine H-4 receptors were related to the risk and malignant degree of breast cancer. The roles of polymorphisms in other histamine-related genes, such as histidine decarboxylase (HDC), histamine N-methyltransferase (HNMT) and histamine H-3 receptor (HRH3), remain unexplored. The aim of this study is to analyze the clinical associations of polymorphisms in HDC, HNMT and HRH3 with breast cancer. Two hundred and one unrelated Chinese Han breast cancer patients and 205 ethnicity-matched health controls were recruited for case-control investigation. Genomic DNA from the participants was extracted and 5 single nucleotide polymorphisms (SNPs) in HDC, HNMT and HRH3 were genotyped. We found that polymorphisms of HNMT and HRH3 were irrelevant with breast cancer in the present study. However, the T allele of rs7164386 in HDC significantly decreased the risk of breast cancer (adjusted odds ratios [ORs], 0.387; 95% confidence intervals [CIs], 0.208-0.720; P = 0.003). Furthermore, for HDC haplotypes, the CG haplotype of rs7164386-rs7182203 was more frequent among breast cancer patients (adjusted OR, 1.828; 95% CI, 1.218-2.744; P = 0.004) while the TG haplotype was more frequent among health controls (adjusted OR, 0.351; 95% CI, 0.182-0.678; P = 0.002). These findings indicated that polymorphisms of HDC gene were significantly associated with breast cancer in Chinese Han population and may be novel diagnostic or therapeutic targets for breast cancer. Further studies with larger participants worldwide are still needed for conclusion validation.	[He, Gong-Hao; Yin, Sun-Jun; Zhao, Can-Hu; Xu, Gui-Li] Kunming Gen Hosp Chengdu Mil Reg, Dept Pharm, Kunming, Yunnan, Peoples R China; [Lin, Jia-Ji] Fourth Mil Med Univ, Dept Neurol, Tangdu Hosp, Xian 710032, Peoples R China; [Cai, Wen-Ke] Kunming Gen Hosp Chengdu Mil Reg, Dept Cardiothorac Surg, Kunming, Yunnan, Peoples R China; [Xu, Wen-Mang] Kunming Gen Hosp Chengdu Mil Reg, Dept Pathol, Kunming, Yunnan, Peoples R China; [Yu, Zheng-Ping] Third Mil Med Univ, Dept Labour Hyg, Coll Mil Prevent Med, Chongqing, Peoples R China	Kunming General Hospital; Air Force Military Medical University; Kunming General Hospital; Kunming General Hospital; Army Medical University	Xu, GL (corresponding author), Kunming Gen Hosp Chengdu Mil Reg, Dept Pharm, Kunming, Yunnan, Peoples R China.	guilixu126@126.com		He, Gong-Hao/0000-0002-1274-3130	National Natural Science Foundation of China [81173643]; National Science Foundation for Post-doctoral Scientists of China [2013M532122]; Science Foundation of Kunming General Hospital of Chengdu Military Region [2012YG10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation for Post-doctoral Scientists of China(China Postdoctoral Science FoundationNational Natural Science Foundation of China (NSFC)); Science Foundation of Kunming General Hospital of Chengdu Military Region	This work was supported by the National Natural Science Foundation of China (NO. 81173643), the National Science Foundation for Post-doctoral Scientists of China (NO. 2013M532122) and the Science Foundation of Kunming General Hospital of Chengdu Military Region (NO. 2012YG10). The website of NSFC is http://www.most.gov.cn/index.htm. There is no website of Kunming General Hospital of Chengdu Military Region for military limitation. All these funds are received by corresponding author Gui-Li Xu, while the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaya Bruno, 2010, Inflammation & Allergy Drug Targets, V9, P146; Chen GL, 2003, CLIN CHIM ACTA, V334, P179, DOI 10.1016/S0009-8981(03)00239-0; Santos RPC, 2011, TUMOR BIOL, V32, P145, DOI 10.1007/s13277-010-0108-7; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Garcia-Martin E, 2009, PHARMACOGENOMICS, V10, P867, DOI 10.2217/PGS.09.26; Gervasini G, 2010, ALLERGY, V65, P1576, DOI 10.1111/j.1398-9995.2010.02425.x; Gonzalez-Neira A, 2012, PHARMACOGENOMICS, V13, P677, DOI [10.2217/pgs.12.44, 10.2217/PGS.12.44]; He GH, 2013, GENE, V519, P260, DOI 10.1016/j.gene.2013.02.020; Hegyesi H, 2007, J PHARMACOL SCI, V105, P66, DOI 10.1254/jphs.FP0070636; Horton JR, 2001, STRUCTURE, V9, P837, DOI 10.1016/S0969-2126(01)00643-8; Justenhoven C, 2012, PHARMACOGENOMICS, V13, P659, DOI [10.2217/PGS.11.144, 10.2217/pgs.11.144]; Lee HS, 2012, ALLERGY ASTHMA IMMUN, V4, P31, DOI 10.4168/aair.2012.4.1.31; Li SQ, 2012, CANCER EPIDEMIOL, V36, P283, DOI 10.1016/j.canep.2011.12.011; Maintz L, 2011, ALLERGY, V66, P893, DOI 10.1111/j.1398-9995.2011.02548.x; Marasovic-Susnjara I, 2011, NEUROSCI LETT, V489, P119, DOI 10.1016/j.neulet.2010.11.078; Medina V, 2008, CANCER BIOL THER, V7, P28, DOI 10.4161/cbt.7.1.5123; Medina V, 2006, CANCER BIOL THER, V5, P1462, DOI 10.4161/cbt.5.11.3273; Meng FY, 2011, HEPATOLOGY, V54, P1718, DOI 10.1002/hep.24573; Palada V, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.06.015; Sieja K, 2005, BREAST, V14, P236, DOI 10.1016/j.breast.2004.06.012; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Wei ZY, 2012, J PSYCHOPHARMACOL, V26, P813, DOI 10.1177/0269881111405358; Zhang F, 2006, BIOCHEM BIOPH RES CO, V348, P1378, DOI 10.1016/j.bbrc.2006.08.008	23	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97728	10.1371/journal.pone.0097728	http://dx.doi.org/10.1371/journal.pone.0097728			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835231	Green Submitted, Green Published, gold			2022-12-27	WOS:000339614800066
J	Hoefler, D; Nicklas, W; Mauter, P; Pawlita, M; Schmitt, M				Hoefler, Daniela; Nicklas, Werner; Mauter, Petra; Pawlita, Michael; Schmitt, Markus			A Bead-Based Multiplex Assay for the Detection of DNA Viruses Infecting Laboratory Rodents	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; ANTIBODY-PRODUCTION TEST; BIOLOGICAL-MATERIALS; MINUTE VIRUS; RAT COLONIES; IN-VIVO; MOUSE; MICE; PCR; CONTAMINATION	The Federation of European Laboratory Animal Science Association (FELASA) recommends screening of laboratory rodents and biological materials for a broad variety of bacterial agents, viruses, and parasites. Methods commonly used to date for pathogen detection are neither cost-effective nor time- and animal-efficient or uniform. However, an infection even if silent alters experimental results through changing the animals' physiology and increases inter-individual variability. As a consequence higher numbers of animals and experiments are needed for valid and significant results. We developed a novel high-throughput multiplex assay, called rodent DNA virus finder (rDVF) for the simultaneous identification of 24 DNA viruses infecting mice and rats. We detected all 24 DNA viruses with high specificity and reproducibility. Detection limits for the different DNA viruses varied between 10 and 1000 copies per PCR. The validation of rDVF was done with DNA isolated from homogenised organs amplified by pathogen specific primers in one multiplex PCR. The biotinylated amplicons were detected via hybridisation to specific oligonucleotide probes coupled to spectrally distinct sets of fluorescent Luminex beads. In conclusion, rDVF may have the potential to replace conventional testing and may simplify and improve routine detection of DNA viruses infecting rodents.	[Hoefler, Daniela; Pawlita, Michael; Schmitt, Markus] German Canc Res Ctr, Res Program Infect & Canc, Heidelberg, Baden Wurttembe, Germany; [Nicklas, Werner; Mauter, Petra] German Canc Res Ctr, Heidelberg, Baden Wurttembe, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Hoefler, D (corresponding author), German Canc Res Ctr, Res Program Infect & Canc, Heidelberg, Baden Wurttembe, Germany.	d.hoefler@dkfz.de	Waterboer, Tim/G-1252-2010; Schmitt, Markus/B-6410-2008	Schmitt, Markus/0000-0002-7827-6694; Pawlita, Michael/0000-0002-4720-8306				Baker D. G., 2003, NATURAL PATHOGENS LA; Bauer BA, 2004, BIOLOGICALS, V32, P177, DOI 10.1016/j.biologicals.2004.08.004; Berke Z, 2000, LEUKEMIA, V14, P419, DOI 10.1038/sj.leu.2401703; Besselsen DG, 2008, COMPARATIVE MED, V58, P140; BESSELSEN DG, 1995, J CLIN MICROBIOL, V33, P2859, DOI 10.1128/JCM.33.11.2859-2863.1995; BESSELSEN DG, 1995, J CLIN MICROBIOL, V33, P1699, DOI 10.1128/JCM.33.7.1699-1703.1995; Bootz F, 2003, LAB ANIM-UK, V37, P341, DOI 10.1258/002367703103051895; Bootz FO, 2007, ALTEX-ALTERN TIEREXP, V24, P19; Campe H, 2009, EMERG INFECT DIS, V15, P777, DOI 10.3201/eid1505.090159; Carty AJ, 2008, ILAR J, V49, P272, DOI 10.1093/ilar.49.3.272; Compton SR, 2001, COMPARATIVE MED, V51, P113; Connole MD, 2000, MED MYCOL, V38, P59, DOI 10.1080/mmy.38.s1.59.65; Henderson KS, 2013, J AM ASSOC LAB ANIM, V52, P763; Jumpertz T, 2011, ANAL BIOCHEM, V408, P64, DOI 10.1016/j.ab.2010.09.011; KILHAM L, 1970, P SOC EXP BIOL MED, V133, P1447; KRAFT V, 1994, LAB ANIM, V28, P1, DOI 10.1258/002367794781065933; Labelle P, 2009, COMPARATIVE MED, V59, P180; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lenaerts L, 2005, ANTIMICROB AGENTS CH, V49, P4689, DOI 10.1128/AAC.49.11.4689-4699.2005; LEWIS VJ, 1971, LAB ANIM SCI, V21, P203; Livingston RS, 2003, LAB ANIMAL, V32, P44, DOI 10.1038/laban0503-44; Mahabir E, 2004, J VIROL METHODS, V120, P239, DOI 10.1016/j.jviromet.2004.05.006; Neubauer H, 1997, LAB ANIM, V31, P201, DOI 10.1258/002367797780596275; Nicklas W, 2002, LAB ANIM-UK, V36, P20, DOI 10.1258/0023677021911740; Nicklas W, 1999, BERL MUNCH TIERARZTL, V112, P201; Nicklas W, 1999, LAB ANIM-UK, V33, P39, DOI 10.1258/002367799780639987; Nicklas W., 1993, SCANDANAVIAN J LAB A, V20, P53; PRINGAKERBLOM P, 1993, RES VIROLOGY, V144, P117, DOI 10.1016/S0923-2516(06)80020-8; Pritchett-Corning KR, 2009, LAB ANIM-UK, V43, P165, DOI 10.1258/la.2008.008009; Schmitt M, 2006, J CLIN MICROBIOL, V44, P504, DOI 10.1128/JCM.44.2.504-512.2006; Schmitt M, 2008, J CLIN MICROBIOL, V46, P1050, DOI 10.1128/JCM.02227-07; Schmitt M, 2011, CANCER EPIDEM BIOMAR, V20, P1558, DOI 10.1158/1055-9965.EPI-11-0424; Schmitt M, 2010, J MOL MICROB BIOTECH, V19, P204, DOI 10.1159/000321449; Schmitt M, 2010, J VIROL METHODS, V170, P67, DOI 10.1016/j.jviromet.2010.08.020; Shek WR, 2007, MOUSE BIOMEDICAL RES, P731; Szomolanyi-Tsuda E, 2006, J VIROL, V80, P4286, DOI 10.1128/JVI.80.9.4286-4291.2006; van de Ven EMES, 2006, LAB ANIM-UK, V40, P137, DOI 10.1258/002367706776319114; Wan CH, 2006, LAB ANIM-UK, V40, P63, DOI 10.1258/002367706775404408; Wan CH, 2002, J GEN VIROL, V83, P2075, DOI 10.1099/0022-1317-83-8-2075; YAGAMI K, 1995, LAB ANIM SCI, V45, P326; Zenner L, 2000, LAB ANIM-UK, V34, P76, DOI 10.1258/002367700780577957	41	7	8	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97525	10.1371/journal.pone.0097525	http://dx.doi.org/10.1371/journal.pone.0097525			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835244	Green Published, Green Submitted, gold			2022-12-27	WOS:000339614800048
J	Wurster, T; Tegtmeyer, R; Borst, O; Rath, D; Geisler, T; Gawaz, M; Bigalke, B				Wurster, Thomas; Tegtmeyer, Roland; Borst, Oliver; Rath, Dominik; Geisler, Tobias; Gawaz, Meinrad; Bigalke, Boris			Platelet Expression of Stromal Cell-Derived Factor-1 Is Associated with the Degree of Valvular Aortic Stenosis	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; VONWILLEBRAND-FACTOR; THROMBIN GENERATION; PRACTICE GUIDELINES; AMERICAN-COLLEGE; TASK-FORCE; MECHANISMS; AGGREGATION; ACTIVATION; BIOMARKERS	Background and Purpose: Platelet surface expression of stromal-cell-derived factor-1 (SDF-1) is increased during platelet activation and constitutes an important factor in hematopoetic progenitor cell trafficking at sites of vascular injury and ischemia. Enhanced platelet SDF-1 expression has been reported previously in patients suffering from acute coronary syndrome (ACS). We hypothesized that expression of platelet associated SDF-1 may also be influenced by calcified valvular aortic stenosis (AS). Methods: We consecutively evaluated 941 patients, who were admitted to the emergency department with dyspnea and chest pain. Platelet surface expression of SDF-1 was determined by flow cytometry, AS was assessed using echocardiography and hemodynamic assessment by heart catheterization. A 1:1 propensity score matching was implemented to match 218 cases with 109 pairs adjusting for age, sex, cardiovascular risk factors, and medication including ACE inhibitors, angiotensin receptor blockers, beta blockers, statins, aspirin, clopidogrel, GPIIb/IIIa antagonists, and vitamin K antagonists. Results: Patients with valvular AS showed enhanced platelet SDF-1 expression compared to patients without AS (non-valvular disease, NV) independent of ACS and stable coronary artery disease (SAP) [mean fluorescence intensity (MFI) for ACS (AS vs. NV): 75 +/- 40.4 vs. 39.5 +/- 23.3; P = 0.002; for SAP (AS vs. NV): 54.9 +/- 44.6 vs. 24.3 +/- 11.2; P = 0.008]. Moreover, the degree of AS significantly correlated with SDF-1 platelet surface expression (r = 0.462; P = 0.002). Conclusions: Valvular AS is associated with enhanced platelet-SDF-1 expression; moreover the degree of valvular AS correlates with SDF-1 platelet surface expression. These findings may have clinical implications in the future.	[Wurster, Thomas; Tegtmeyer, Roland; Borst, Oliver; Rath, Dominik; Geisler, Tobias; Gawaz, Meinrad; Bigalke, Boris] Eberhard Karls Univ Tubingen, Med Klin 3, Tubingen, Germany; [Bigalke, Boris] Kings Coll London, Div Imaging Sci & Biomed Engn, London WC2R 2LS, England	Eberhard Karls University of Tubingen; University of London; King's College London	Wurster, T (corresponding author), Eberhard Karls Univ Tubingen, Med Klin 3, Tubingen, Germany.	thomas.wurster@med.uni-tuebingen.de	Geisler, Tobias/AAO-4472-2020	Borst, Oliver/0000-0003-4002-4085	Deutsche Forschungsgemeinschaft [Klinische Forschergruppe KFO274]; German Cardiac Society (DGK)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Cardiac Society (DGK)	This study has been supported by the Deutsche Forschungsgemeinschaft -Klinische Forschergruppe KFO274 "Platelets - Molecular Mechanisms and Translational Implications" to M. G. and the German Cardiac Society (DGK) "molecular imaging of atherosclerotic plaques" to B. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JL, 2007, CIRCULATION, V116, pE148, DOI 10.1161/CIRCULATIONAHA.107.181940; Aronow WS, 1999, AM J CARDIOL, V83, P599, DOI 10.1016/S0002-9149(98)00922-9; Beckmann E, 2010, J HEART VALVE DIS, V19, P441; Biberthaler P, 1998, EUR J CARDIO-THORAC, V14, P503, DOI 10.1016/S1010-7940(98)00223-1; Blackshear JL, 2013, AM J CARDIOL, V111, P374, DOI 10.1016/j.amjcard.2012.10.015; Chatterjee M, 2013, J THROMB HAEMOST, V11, P1954, DOI 10.1111/jth.12404; Chatterjee M, 2011, BLOOD, V117, P3907, DOI 10.1182/blood-2010-12-327007; Chirkov YY, 2006, J HEART VALVE DIS, V15, P28; Chirkov YY, 2002, AM J CARDIOL, V90, P551, DOI 10.1016/S0002-9149(02)02536-5; DEMEYER E, 1995, EUR J PHARM-MOLEC PH, V291, P67; Dimitrow PP, 2008, HEART, V94, DOI 10.1136/hrt.2007.126896; Dimitrow Pawel Petkow, 2009, Atherosclerosis, V204, pe103, DOI 10.1016/j.atherosclerosis.2008.12.029; Gawaz M, 1996, THROMB RES, V83, P341, DOI 10.1016/0049-3848(96)00144-2; Gawaz M, 1999, CIRCULATION, V99, P2; Geisler T, 2012, EUR J RADIOL, V81, pE486, DOI 10.1016/j.ejrad.2011.06.019; Gibbons RJ, 2002, CIRCULATION, V106, P1883, DOI 10.1161/01.CIR.0000034670.06526.15; Goto S, 1998, J CLIN INVEST, V101, P479, DOI 10.1172/JCI973; Kucia M, 2005, STEM CELLS, V23, P879, DOI 10.1634/stemcells.2004-0342; Luszczak J, 2011, BLOOD COAGUL FIBRIN, V22, P473, DOI 10.1097/MBC.0b013e328346c2bb; Massberg S, 2006, J EXP MED, V203, P1221, DOI 10.1084/jem.20051772; MOAKE JL, 1986, J CLIN INVEST, V78, P1456, DOI 10.1172/JCI112736; Natorska J, 2011, HEART, V97, P2023, DOI 10.1136/hrt.2010.217273; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; OBRIEN JR, 1995, BRIT HEART J, V74, P641; PETERSON DM, 1987, BLOOD, V69, P625; Stellos K, 2012, J THROMB HAEMOST, V10, P49, DOI 10.1111/j.1538-7836.2011.04547.x; Stellos K, 2008, CIRCULATION, V117, P206, DOI 10.1161/CIRCULATIONAHA.107.714691; Stellos K, 2009, EUR HEART J, V30, P584, DOI 10.1093/eurheartj/ehn566; Stewart BF, 1997, J AM COLL CARDIOL, V29, P630, DOI 10.1016/S0735-1097(96)00563-3; Theroux P, 1998, CIRCULATION, V97, P1195, DOI 10.1161/01.CIR.97.12.1195; Warnes CA, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.10.001; Waxman DA, 2006, J AM COLL CARDIOL, V48, P1755, DOI 10.1016/j.jacc.2006.05.075; Wurster T, 2013, INT J CARDIOL, V164, P111, DOI 10.1016/j.ijcard.2011.06.082; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22	34	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97405	10.1371/journal.pone.0097405	http://dx.doi.org/10.1371/journal.pone.0097405			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24834915	gold, Green Published, Green Submitted			2022-12-27	WOS:000339614800043
J	Gomaraschi, M; Ossoli, A; Pozzi, S; Nilsson, P; Cefalu, AB; Averna, M; Kuivenhoven, JA; Hovingh, GK; Veglia, F; Franceschini, G; Calabresi, L				Gomaraschi, Monica; Ossoli, Alice; Pozzi, Silvia; Nilsson, Peter; Cefalu, Angelo B.; Averna, Maurizio; Kuivenhoven, Jan Albert; Hovingh, G. Kees; Veglia, Fabrizio; Franceschini, Guido; Calabresi, Laura			eNOS Activation by HDL Is Impaired in Genetic CETP Deficiency	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; ESTER TRANSFER PROTEIN; CELL-ADHESION MOLECULE-1; SCAVENGER RECEPTOR BI; NITRIC-OXIDE SYNTHASE; CHOLESTEROL EFFLUX; ENDOTHELIAL FUNCTION; ANTIINFLAMMATORY PROPERTIES; INHIBITION; TORCETRAPIB	Mutations in the CETP gene resulting in defective CETP activity have been shown to cause remarkable elevations of plasma HDL-C levels, with the accumulation in plasma of large, buoyant HDL particles enriched in apolipoprotein E. Genetic CETP deficiency thus represents a unique tool to evaluate how structural alterations of HDL impact on HDL atheroprotective functions. Aim of the present study was to assess the ability of HDL obtained from CETP-deficient subjects to protect endothelial cells from the development of endothelial dysfunction. HDL isolated from one homozygous and seven heterozygous carriers of CETP null mutations were evaluated for their ability to down-regulate cytokine-induced cell adhesion molecule expression and to promote NO production in cultured endothelial cells. When compared at the same protein concentration, HDL and HDL3 from carriers proved to be as effective as control HDL and HDL3 in down-regulating cytokine-induced VCAM-1, while carrier HDL2 were more effective than control HDL2 in inhibiting VCAM-1 expression. On the other hand, HDL and HDL fractions from carriers of CETP deficiency were significantly less effective than control HDL and HDL fractions in stimulating NO production, due to a reduced eNOS activating capacity, likely because of a reduced S1P content. In conclusion, the present findings support the notion that genetic CETP deficiency, by affecting HDL particle structure, impacts on HDL vasculoprotective functions. Understanding of these effects might be important for predicting the outcomes of pharmacological CETP inhibition.	[Gomaraschi, Monica; Ossoli, Alice; Pozzi, Silvia; Franceschini, Guido; Calabresi, Laura] Univ Milan, Ctr E Grossi Paoletti, Dipartimento Sci Farmacol & Biomol, Milan, Italy; [Nilsson, Peter] Univ Hosp, Dept Clin Sci, Malmo, Sweden; [Cefalu, Angelo B.; Averna, Maurizio] Univ Palermo, Dept Internal Med & Med Specialties, Policlin Paolo Giaccone, Palermo, Italy; [Kuivenhoven, Jan Albert] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Hovingh, G. Kees] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Veglia, Fabrizio] Ist Cardiol Monzino, Milan, Italy	University of Milan; Lund University; Skane University Hospital; University of Palermo; Policlinico Paolo Giaccone; University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam; IRCCS Centro Cardiologico Monzino	Calabresi, L (corresponding author), Univ Milan, Ctr E Grossi Paoletti, Dipartimento Sci Farmacol & Biomol, Milan, Italy.	laura.calabresi@unimi.it	Cefalu', Angelo B/K-9491-2016; Ossoli, Alice/K-5917-2016; Veglia, Fabrizio/K-1958-2016; Gomaraschi, Monica/A-3601-2014; Averna, Maurizio/U-9527-2017	Cefalu', Angelo B/0000-0003-1259-8284; Ossoli, Alice/0000-0002-9902-252X; Veglia, Fabrizio/0000-0002-9378-8874; Gomaraschi, Monica/0000-0003-3082-2120; Averna, Maurizio/0000-0003-3558-9209; Calabresi, Laura/0000-0001-5042-9532; FRANCESCHINI, GUIDO/0000-0003-2687-1771; Venkatasubramanian, Siddharth/0000-0002-5860-0768	Telethon-Italy [GGP08052]; Fondazione Cariplo [2009-2576]; European Community [BM0904]; Netherlands Organisation for Scientific Research [91612122]	Telethon-Italy(Fondazione Telethon); Fondazione Cariplo(Fondazione Cariplo); European Community(European Commission); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by grants from Telethon-Italy [GGP08052 to M. G.], Fondazione Cariplo [2009-2576 to M. G.], and the European Community [COST Action BM0904]. G. K. H. is a recipient of a Veni grant (91612122) from the Netherlands Organisation for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby DT, 1998, ARTERIOSCL THROM VAS, V18, P1450, DOI 10.1161/01.ATV.18.9.1450; Baker PW, 1999, J LIPID RES, V40, P345; Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Bellanger N, 2012, ATHEROSCLEROSIS, V221, P160, DOI 10.1016/j.atherosclerosis.2011.12.027; Besler C, 2011, J CLIN INVEST, V121, P2693, DOI 10.1172/JCI42946; Bisoendial RJ, 2003, CIRCULATION, V107, P2944, DOI 10.1161/01.CIR.0000070934.69310.1A; Bloomfield D, 2009, AM HEART J, V157, P352, DOI 10.1016/j.ahj.2008.09.022; Brousseau ME, 2004, NEW ENGL J MED, V350, P1505, DOI 10.1056/NEJMoa031766; Calabresi L, 2003, ARTERIOSCL THROM VAS, V23, P1724, DOI 10.1161/01.ATV.0000094961.74697.54; Calabresi L, 2009, ATHEROSCLEROSIS, V205, P506, DOI 10.1016/j.atherosclerosis.2009.01.006; Cefalu AB, 2009, ATHEROSCLEROSIS, V204, P202, DOI 10.1016/j.atherosclerosis.2008.08.031; Chantepie S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049336; Connelly MA, 2010, J CARDIOVASC PHARM, V55, P459, DOI 10.1097/FJC.0b013e3181cf03cb; de Beer MC, 2001, J BIOL CHEM, V276, P15832, DOI 10.1074/jbc.M100228200; Fulton D, 2001, J PHARMACOL EXP THER, V299, P818; Gomaraschi M, 2007, CIRCULATION, V116, P2165, DOI 10.1161/CIRCULATIONAHA.107.705657; Han S, 2013, BBA-MOL CELL BIOL L, V1831, P825, DOI 10.1016/j.bbalip.2012.12.008; Hermann F, 2009, THROMB RES, V123, P460, DOI 10.1016/j.thromres.2008.06.022; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Kuvin JT, 2002, AM HEART J, V144, P165, DOI 10.1067/mhj.2002.123145; Luscher TF, 2012, EUR HEART J, V33, P857, DOI 10.1093/eurheartj/ehs019; Matsuura F, 2006, J CLIN INVEST, V116, P1435, DOI 10.1172/JCI27602; Mineo C, 2006, CIRC RES, V98, P1352, DOI 10.1161/01.RES.0000225982.01988.93; Nagano Makoto, 2004, J Atheroscler Thromb, V11, P110; Nofer JR, 2004, J CLIN INVEST, V113, P569, DOI 10.1172/JCI200418004; Noto H, 2003, ATHEROSCLEROSIS, V171, P131, DOI 10.1016/j.atherosclerosis.2003.08.005; Patel S, 2009, ATHEROSCLEROSIS, V204, P424, DOI 10.1016/j.atherosclerosis.2008.07.047; Rader DJ, 2007, NEW ENGL J MED, V357, P2180, DOI 10.1056/NEJMe0707210; Rinninger F, 2003, ATHEROSCLEROSIS, V166, P31, DOI 10.1016/S0021-9150(02)00311-8; Rosenson RS, 2012, CIRCULATION, V125, P1905, DOI 10.1161/CIRCULATIONAHA.111.066589; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; Simic B, 2012, EUR HEART J, V33, P1615, DOI 10.1093/eurheartj/ehr348; Stein EA, 2009, AM J CARDIOL, V104, P82, DOI 10.1016/j.amjcard.2009.02.061; Terasaka N, 2008, J CLIN INVEST, V118, P3701, DOI 10.1172/JCI35470; van der Steeg WA, 2007, J LIPID RES, V48, P674, DOI 10.1194/jlr.M600405-JLR200; WARNICK GR, 1978, J LIPID RES, V19, P65; Whetzel AM, 2010, ARTERIOSCL THROM VAS, V30, P809, DOI 10.1161/ATVBAHA.109.199166; Yvan-Charvet L, 2007, ARTERIOSCL THROM VAS, V27, P1132, DOI 10.1161/ATVBAHA.106.138347; Yvan-Charvet L, 2010, ARTERIOSCL THROM VAS, V30, P1430, DOI 10.1161/ATVBAHA.110.207142	40	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e95925	10.1371/journal.pone.0095925	http://dx.doi.org/10.1371/journal.pone.0095925			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830642	Green Published, Green Submitted, gold			2022-12-27	WOS:000336789500010
J	Heesch, K; Raczkowski, F; Schumacher, V; Hunemoerder, S; Panzer, U; Mittrucker, HW				Heesch, Kira; Raczkowski, Friederike; Schumacher, Valea; Huenemoerder, Stefanie; Panzer, Ulf; Mittruecker, Hans-Willi			The Function of the Chemokine Receptor CXCR6 in the T Cell Response of Mice against Listeria monocytogenes	PLOS ONE			English	Article							EXPRESSION CLONING; IMMUNE-RESPONSES; DENDRITIC CELLS; CUTTING EDGE; LYMPHOCYTES; RECRUITMENT; INDUCTION; SUBSETS; MEMORY; LIGAND	The chemokine receptor CXCR6 is expressed on different T cell subsets and up-regulated following T cell activation. CXCR6 has been implicated in the localization of cells to the liver due to the constitutive expression of its ligand CXCL16 on liver sinusoidal endothelial cells. Here, we analyzed the role of CXCR6 in CD8(+) T cell responses to infection of mice with Listeria monocytogenes. CD8(+) T cells responding to listerial antigens acquired high expression levels of CXCR6. However, deficiency of mice in CXCR6 did not impair control of the L. monocytogenes infection. CXCR6-deficient mice were able to generate listeria-specific CD4(+) and CD8(+) T cell responses and showed accumulation of T cells in the infected liver. In transfer assays, we detected reduced accumulation of listeria-specific CXCR6-deficient CD8(+) T cells in the liver at early time points post infection. Though, CXCR6 was dispensable at later time points of the CD8(+) T cell response. When transferred CD8(+) T cells were followed for extended time periods, we observed a decline in CXCR6-deficient CD8(+) T cells. The manifestation of this cell loss depended on the tissue analyzed. In conclusion, our results demonstrate that CXCR6 is not required for the formation of a T cell response to L. monocytogenes and for the accumulation of T cells in the infected liver but CXCR6 appears to influence long-term survival and tissue distribution of activated cells.	[Heesch, Kira; Raczkowski, Friederike; Schumacher, Valea; Huenemoerder, Stefanie; Mittruecker, Hans-Willi] Univ Med Ctr Hamburg Eppendorf, Inst Immunol, Hamburg, Germany; [Panzer, Ulf] Univ Med Ctr Hamburg Eppendorf, Dept Med 3, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Heesch, K (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Immunol, Hamburg, Germany.	k.heesch@uke.de; h.mittruecker@uke.de			Deutsche Forschungsgemeinschaft [Klinische Forschergruppe 228, Sonderforschungsbereich 841]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Ulf Panzer: Klinische Forschergruppe 228 (Deutsche Forschungsgemeinschaft) http://kfo228.de/, http://www.dfg.de/. Hans-Willi Mittrucker: Sonderforschungsbereich 841 (Deutsche Forschungsgemeinschaft) http://www.sfb841.de/, http://www.dfg.de/, Klinische Forschergruppe 228 (Deutsche Forschungsgemeinschaft) http://kfo228.de/, http://www.dfg.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrunategui-Correa V, 2004, CELL IMMUNOL, V227, P109, DOI 10.1016/j.cellimm.2004.02.003; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Bjordahl RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042635; Boisvert J, 2003, J HEPATOL, V38, P67, DOI 10.1016/S0168-8278(02)00328-8; Bubnic SJ, 2005, HEMATOLOGY, V10, P289, DOI 10.1080/10245330500093468; Cose S, 2006, EUR J IMMUNOL, V36, P1423, DOI 10.1002/eji.200535539; Deng HK, 1997, NATURE, V388, P296, DOI 10.1038/40894; Deng L, 2010, BBA-REV CANCER, V1806, P42, DOI 10.1016/j.bbcan.2010.01.004; Emoto M, 2006, INFECT IMMUN, V74, P5903, DOI 10.1128/IAI.00311-06; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; GELLIN BG, 1989, JAMA-J AM MED ASSOC, V261, P1313, DOI 10.1001/jama.261.9.1313; Goubier A, 2013, J INVEST DERMATOL, V133, P980, DOI 10.1038/jid.2012.404; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Kim CH, 2001, J CLIN INVEST, V107, P595, DOI 10.1172/JCI11902; Kim CH, 2001, J CLIN INVEST, V108, P1331, DOI 10.1172/JCI13543; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Kurachi M, 2011, J EXP MED, V208, P1605, DOI 10.1084/jem.20102101; Kursar M, 2008, EUR J IMMUNOL, V38, P127, DOI 10.1002/eji.200737142; La Porta CAM, 2012, STEM CELL REV REP, V8, P1282, DOI 10.1007/s12015-012-9383-6; Liao F, 1997, J EXP MED, V185, P2015, DOI 10.1084/jem.185.11.2015; Loetscher M, 1997, CURR BIOL, V7, P652, DOI 10.1016/S0960-9822(06)00292-2; Matloubian M, 2000, NAT IMMUNOL, V1, P298, DOI 10.1038/79738; Matsumura S, 2008, J IMMUNOL, V181, P3099, DOI 10.4049/jimmunol.181.5.3099; Mattarollo SR, 2011, J IMMUNOL, V187, P1601, DOI 10.4049/jimmunol.1100756; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Riedel JH, 2012, J AM SOC NEPHROL, V23, P1987, DOI 10.1681/ASN.2012040394; Sato T, 2005, J IMMUNOL, V174, P277, DOI 10.4049/jimmunol.174.1.277; Sheikine Y, 2008, ATHEROSCLEROSIS, V197, P487, DOI 10.1016/j.atherosclerosis.2007.11.034; Shi C, 2010, J IMMUNOL, V184, P6266, DOI 10.4049/jimmunol.0904160; Shields PL, 1999, J IMMUNOL, V163, P6236; Shimaoka T, 2000, J BIOL CHEM, V275, P40663, DOI 10.1074/jbc.C000761200; Szalay G, 1999, J IMMUNOL, V162, P6955; Unutmaz D, 2000, J IMMUNOL, V165, P3284, DOI 10.4049/jimmunol.165.6.3284; van der Voort R, 2010, J LEUKOCYTE BIOL, V87, P1029, DOI 10.1189/jlb.0709482; Wilbanks A, 2001, J IMMUNOL, V166, P5145, DOI 10.4049/jimmunol.166.8.5145; Zhong MX, 2004, INFECT IMMUN, V72, P1057, DOI 10.1128/IAI.72.2.1057-1064.2004; Zhou YH, 1998, J IMMUNOL, V160, P4018	39	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97701	10.1371/journal.pone.0097701	http://dx.doi.org/10.1371/journal.pone.0097701			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24832098	Green Published, Green Submitted, gold			2022-12-27	WOS:000336789500104
J	Higaki, T; Higaki, S; Hirota, M; Hasezawa, S				Higaki, Takumi; Higaki, Shogo; Hirota, Masahiro; Hasezawa, Seiichiro			Radiocesium Distribution in Bamboo Shoots after the Fukushima Nuclear Accident	PLOS ONE			English	Article							RADIONUCLIDES; CHERNOBYL; PLANT; SOIL	The distribution of radiocesium was examined in bamboo shoots, Phyllostachys pubescens, collected from 10 sites located some 41 to 1140 km from the Fukushima Daiichi nuclear power plant, Japan, in the Spring of 2012, 1 year after the Fukushima nuclear accident. Maximum activity concentrations for radiocesium Cs-134 and Cs-137 in the edible bamboo shoot parts, 41 km away from the Fukushima Daiichi plant, were in excess of 15.3 and 21.8 kBq/kg (dry weight basis; 1.34 and 1.92 kBq/kg, fresh weight), respectively. In the radiocesium-contaminated samples, the radiocesium activities were higher in the inner tip parts, including the upper edible parts and the apical culm sheath, than in the hardened culm sheath and underground basal parts. The radiocesium/potassium ratios also tended to be higher in the inner tip parts. The radiocesium activities increased with bamboo shoot length in another bamboo species, Phyllostachys bambusoides, suggesting that radiocesium accumulated in the inner tip parts during growth of the shoots.	[Higaki, Takumi; Hasezawa, Seiichiro] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan; [Higaki, Shogo] Univ Tokyo, Radioisotope Ctr, Bunkyo Ku, Tokyo, Japan; [Hirota, Masahiro] Shinshu Univ, Res Ctr Human & Environm Sci, Matsumoto, Nagano 390, Japan; [Hasezawa, Seiichiro] Japan Sci & Technol Agcy JST, Chiyoda Ku, Tokyo, Japan	University of Tokyo; University of Tokyo; Shinshu University; Japan Science & Technology Agency (JST)	Higaki, T (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan.	takumi.higaki@gmail.com	Higaki, Shogo/G-5100-2013; Higaki, Shogo/N-8792-2019; Higaki, Takumi/N-1216-2015	Higaki, Shogo/0000-0002-5098-6475; Higaki, Shogo/0000-0002-5098-6475; 				Buesseler KO, 2012, P NATL ACAD SCI USA, V109, P5984, DOI 10.1073/pnas.1120794109; Hamada N, 2012, J ENVIRON RADIOACTIV, V111, P83, DOI 10.1016/j.jenvrad.2011.08.008; Higaki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034766; Japanese Ministry of Health Labour and Welfare (MHLW), 2012, SUM RAD TEST RES CAR; Japanese Ministry of Health Labour and Welfare (MHLW), 2013, SUM RAD TEST RES CAR; Kato H, 2012, J ENVIRON RADIOACTIV, V111, P59, DOI 10.1016/j.jenvrad.2011.10.003; Kinoshita N, 2011, P NATL ACAD SCI USA, V108, P19526, DOI 10.1073/pnas.1111724108; Kleinhenz V, 2001, ADV AGRON, V74, P99, DOI 10.1016/S0065-2113(01)74032-1; Madigan DJ, 2012, P NATL ACAD SCI USA, V109, P9483, DOI 10.1073/pnas.1204859109; Merz S, 2013, ENVIRON SCI TECHNOL, V47, P1248, DOI 10.1021/es3037498; MHLW, 2011, DAM SIT MEAS TAK GRE; Niimura N, 2015, J ENVIRON RADIOACTIV, V139, P234, DOI 10.1016/j.jenvrad.2013.12.020; Smolders Erik, 2011, Integrated Environmental Assessment and Management, V7, P379, DOI 10.1002/ieam.236; Steinhauser G, 2014, SCI TOTAL ENVIRON, V470, P800, DOI 10.1016/j.scitotenv.2013.10.029; Tagami K, 2012, J ENVIRON RADIOACTIV, V111, P65, DOI 10.1016/j.jenvrad.2011.09.017; TOPCUOGLU S, 1992, TOXICOL ENVIRON CHEM, V37, P95, DOI 10.1080/02772249209357858; Wu JS, 2009, J PLANT NUTR, V32, P489, DOI 10.1080/01904160802679958; Yasunari TJ, 2011, P NATL ACAD SCI USA, V108, P19530, DOI 10.1073/pnas.1112058108; Yoshihara T, 2013, J ENVIRON RADIOACTIV, V115, P60, DOI 10.1016/j.jenvrad.2012.07.002	19	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97659	10.1371/journal.pone.0097659	http://dx.doi.org/10.1371/journal.pone.0097659			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831096	Green Published, gold, Green Submitted			2022-12-27	WOS:000336789500097
J	Khailova, L; Petrie, B; Baird, CH; Rieg, JAD; Wischmeyer, PE				Khailova, Ludmila; Petrie, Benjamin; Baird, Christine H.; Rieg, Jessica A. Dominguez; Wischmeyer, Paul E.			Lactobacillus rhamnosus GG and Bifidobacterium longum Attenuate Lung Injury and Inflammatory Response in Experimental Sepsis	PLOS ONE			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; NITRIC-OXIDE SYNTHASE; TOLL-LIKE RECEPTOR-2; FACTOR-KAPPA-B; DOUBLE-BLIND; NECROTIZING ENTEROCOLITIS; BACTERIAL TRANSLOCATION; ACUTE-PANCREATITIS; GUT ORIGIN; PROBIOTICS	Introduction: Probiotic use to prevent nosocomial gastrointestinal and potentially respiratory tract infections in critical care has shown great promise in recent clinical trials of adult and pediatric patients. Despite well-documented benefits of probiotic use in intestinal disorders, the potential for probiotic treatment to reduce lung injury following infection and shock has not been well explored. Objective: Evaluate if Lactobacillus rhamnosus GG (LGG) or Bifidobacterium longum (BL) treatment in a weanling mouse model of cecal ligation and puncture (CLP) peritonitis will protect against lung injury. Methods: 3 week-old FVB/N mice were orally gavaged with 200 mu l of either LGG, BL or sterile water (vehicle) immediately prior to CLP. Mice were euthanized at 24 h. Lung injury was evaluated via histology and lung neutrophil infiltration was evaluated by myeloperoxidase (MPO) staining. mRNA levels of IL-6, TNF-alpha, MyD88, TLR-4, TLR-2, NFKB (p50/p105) and Cox-2 in the lung analyzed via real-time PCR. TNF-alpha and IL-6 in lung was analyzed via ELISA. Results: LGG and BL treatment significantly improved lung injury following experimental infection and sepsis and lung neutrophil infiltration was significantly lower than in untreated septic mice. Lung mRNA and protein levels of IL-6 and TNF-alpha and gene expression of Cox-2 were also significantly reduced in mice receiving LGG or BL treatment. Gene expression of TLR-2, MyD88 and NFKB (p50/p105) was significantly increased in septic mice compared to shams and decreased in the lung of mice receiving LGG or BL while TLR-4 levels remained unchanged. Conclusions: Treatment with LGG and BL can reduce lung injury following experimental infection and sepsis and is associated with reduced lung inflammatory cell infiltrate and decreased markers of lung inflammatory response. Probiotic therapy may be a promising intervention to improve clinical lung injury following systemic infection and sepsis.	[Khailova, Ludmila; Petrie, Benjamin; Baird, Christine H.; Rieg, Jessica A. Dominguez; Wischmeyer, Paul E.] Univ Colorado, Dept Anesthesiol, Sch Med, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Wischmeyer, PE (corresponding author), Univ Colorado, Dept Anesthesiol, Sch Med, Aurora, CO USA.	Paul.Wischmeyer@ucdenver.edu		Dominguez Rieg, Jessica/0000-0001-6190-7464	National Institutes of Health (NIH) [R01 GM078312]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078312] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by National Institutes of Health (NIH) R01 GM078312 to P. Wischmeyer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adams-Chapman I, 2006, CURR OPIN INFECT DIS, V19, P290, DOI 10.1097/01.qco.0000224825.57976.87; Aguero G, 2006, NUTRITION, V22, P810, DOI 10.1016/j.nut.2006.03.013; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alberda C, 2007, AM J CLIN NUTR, V85, P816, DOI 10.1093/ajcn/85.3.816; Anderson RC, 2010, FEMS MICROBIOL LETT, V309, P184, DOI 10.1111/j.1574-6968.2010.02038.x; Ang SF, 2011, J IMMUNOL, V187, P4778, DOI 10.4049/jimmunol.1101559; Annane D, 2005, CELL, V124, P783; APPLEBY SB, 1994, BIOCHEM J, V302, P723, DOI 10.1042/bj3020723; Armstrong L, 2004, CLIN EXP IMMUNOL, V136, P312, DOI 10.1111/j.1365-2249.2004.02433.x; Arribas B, 2009, BRIT J NUTR, V101, P51, DOI 10.1017/S0007114508986876; Arvola T, 1999, PEDIATRICS, V104, part. no., DOI 10.1542/peds.104.5.e64; Ashraf R, 2014, CRIT REV FOOD SCI, V54, P938, DOI 10.1080/10408398.2011.619671; BAKER CC, 1983, SURGERY, V94, P331; Bausserman M, 2005, J PEDIAT, V147, P197; Bin-Nun A, 2005, J PEDIATR-US, V147, P192, DOI 10.1016/j.jpeds.2005.03.054; Bitto A, 2012, CRIT CARE, V16, DOI 10.1186/1364-8535-16-R32; Cleveland J, 2001, INT J FOOD MICROBIOL, V71, P1, DOI 10.1016/S0168-1605(01)00560-8; Dahlem P, 2007, PAEDIATR RESPIR REV, V8, P348, DOI 10.1016/j.prrv.2007.03.001; Dani C, 2002, BIOL NEONATE, V82, P103, DOI 10.1159/000063096; Drouault-Holowacz S, 2008, GASTROEN CLIN BIOL, V32, P147, DOI 10.1016/j.gcb.2007.06.001; Edelman DA, 2006, J SURG RES, V134, P22, DOI 10.1016/j.jss.2006.03.007; Farley KS, 2006, AM J PHYSIOL-LUNG C, V290, pL1164, DOI 10.1152/ajplung.00248.2005; Flori HR, 2005, AM J RESP CRIT CARE, V171, P995, DOI 10.1164/rccm.200404-544OC; Giamarellos-Bourboulis EJ, 2009, J TRAUMA, V67, P815, DOI 10.1097/TA.0b013e31819d979e; Hajjar AM, 2005, AM J RESP CELL MOL, V33, P470, DOI 10.1165/rcmb.2005-0199OC; Hammerman C, 2004, CLIN PERINATOL, V31, P489, DOI 10.1016/j.clp.2004.04.015; Harb H, 2013, CLIN EXP ALLERGY, V43, P353, DOI 10.1111/cea.12047; Harter L, 2004, SHOCK, V22, P403, DOI 10.1097/01.shk.0000142256.23382.5d; Hojsak I, 2010, PEDIATRICS, V125, pE1171, DOI 10.1542/peds.2009-2568; Honeycutt TCB, 2007, PEDIATR CRIT CARE ME, V8, P452, DOI 10.1097/01.PCC.0000282176.41134.E6; Kermorvant-Duchemin E, 2008, PEDIATR CRIT CARE ME, V9, P186, DOI 10.1097/PCC.0b013e31816689a8; Khailova L, 2013, ANESTHESIOLOGY; Khailova L, 2010, AM J PHYSIOL-GASTR L, V299, pG1118, DOI 10.1152/ajpgi.00131.2010; Khailova L, 2009, AM J PHYSIOL-GASTR L, V297, pG940, DOI 10.1152/ajpgi.00141.2009; Kirkby NS, 2013, BIOCHEM BIOPH RES CO, V438, P249, DOI 10.1016/j.bbrc.2013.07.006; Kono Y, 2011, SURGERY; Kotzampassi K, 2006, WORLD J SURG, V30, P1848, DOI 10.1007/s00268-005-0653-1; Lee YK, 2000, APPL ENVIRON MICROB, V66, P3692, DOI 10.1128/AEM.66.9.3692-3697.2000; Li XH, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/354087; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lukacs SL, 2004, PEDIATR INFECT DIS J, V23, P599, DOI 10.1097/01.inf.0000131633.74921.90; Luyer MD, 2005, INFECT IMMUN, V73, P3686, DOI 10.1128/IAI.73.6.3686-3692.2005; MacFie J, 1999, GUT, V45, P223, DOI 10.1136/gut.45.2.223; Matsumoto T, 2008, J APPL MICROBIOL, V104, P672, DOI 10.1111/j.1365-2672.2007.03593.x; McNaught CE, 2005, CLIN NUTR, V24, P211, DOI 10.1016/j.clnu.2004.08.008; Morrow LE, 2010, AM J RESP CRIT CARE, V182, P1058, DOI 10.1164/rccm.200912-1853OC; Netea MG, 2003, TRENDS IMMUNOL, V24, P254, DOI 10.1016/S1471-4906(03)00079-6; Olah A, 2007, HEPATO-GASTROENTEROL, V54, P590; Pitsouni E, 2009, EUR J CLIN PHARMACOL, V65, P561, DOI 10.1007/s00228-009-0642-7; Racedo S, 2006, MICROBES INFECT, V8, P2359, DOI 10.1016/j.micinf.2006.04.022; Rajapakse N, 2008, IMMUNOLOGY, V123, P348, DOI 10.1111/j.1365-2567.2007.02683.x; Regel G, 1996, WORLD J SURG, V20, P422, DOI 10.1007/s002689900067; Robertson CM, 2008, J SURG RES, V150, P278, DOI 10.1016/j.jss.2008.02.009; Schultz MJ, 2010, CRIT CARE MED, V38, P1506, DOI 10.1097/CCM.0b013e3181d8c473; Shanahan F, 2002, BRIT J NUTR, V88, pS5, DOI 10.1079/BJN2002624; Siempos II, 2010, CRIT CARE MED, V38, P954, DOI 10.1097/CCM.0b013e3181c8fe4b; Singhi SC, 2008, INDIAN J PEDIATR, V75, P621, DOI 10.1007/s12098-008-0119-1; Singleton KD, 2007, AM J PHYSIOL-REG I, V292, pR1839, DOI 10.1152/ajpregu.00755.2006; Tao Y, 2006, AM J PHYSIOL-CELL PH, V290, pC1018, DOI 10.1152/ajpcell.00131.2005; Tok D, 2007, J TRAUMA, V62, P880, DOI 10.1097/01.ta.0000236019.00650.00; Tsujimoto H, 2005, SHOCK, V23, P39, DOI 10.1097/01.shk.0000145936.31967.d7; Tsujimoto H, 2004, J ENDOTOXIN RES, V10, P229, DOI 10.1179/096805104225005814; van Baarlen P, 2011, P NATL ACAD SCI USA, V108, P4562, DOI 10.1073/pnas.1000079107; Wang X, 1996, WORLD J SURG, V20, P307; Wang XD, 1996, WORLD J SURG, V20, P299, DOI 10.1007/s002689900048; Watson RS, 2003, AM J RESP CRIT CARE, V167, P695, DOI 10.1164/rccm.200207-682OC; Williams DL, 2003, CRIT CARE MED, V31, P1808, DOI 10.1097/01.CCM.0000069343.27691.F3; Williams DL, 1999, SURGERY, V126, P54, DOI 10.1067/msy.1999.99058; Wynn JL, 2007, SHOCK, V28, P675, DOI 10.1097/shk.0b013e3180556d09; Xu F, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-16; Yan F, 2002, J BIOL CHEM, V277, P50959, DOI 10.1074/jbc.M207050200; Yan F, 2007, GASTROENTEROLOGY, V132, P562, DOI 10.1053/j.gastro.2006.11.022; Yan F, 2012, GUT MICROBES, V3, P25, DOI 10.4161/gmic.19245; Yan F, 2011, J CLIN INVEST, V121, P2242, DOI 10.1172/JCI44031; Yu M, 2007, INT IMMUNOPHARMACOL, V7, P1076, DOI 10.1016/j.intimp.2007.04.003; Zareie M, 2006, GUT, V55, P1553, DOI 10.1136/gut.2005.080739; Zhang LN, 2011, EXP TOXICOL PATHOL, V63, P519, DOI 10.1016/j.etp.2010.04.002	77	45	47	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97861	10.1371/journal.pone.0097861	http://dx.doi.org/10.1371/journal.pone.0097861			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830455	Green Published, Green Submitted, gold			2022-12-27	WOS:000336789500129
J	Fujii, J; Kodama, M; Oike, A; Matsuo, Y; Min, MS; Hasebe, T; Ishizuya-Oka, A; Kawakami, K; Nakamura, M				Fujii, Jun; Kodama, Maho; Oike, Akira; Matsuo, Yasuki; Min, Mi-Sook; Hasebe, Takashi; Ishizuya-Oka, Atsuko; Kawakami, Koichi; Nakamura, Masahisa			Involvement of Androgen Receptor in Sex Determination in an Amphibian Species	PLOS ONE			English	Article							FROG RANA-RUGOSA; REVERSED GONADS; LINKED GENE; KEY-FACTOR; CHROMOSOMES; EXPRESSION; MICE; DIFFERENTIATION; DMRT1; MECHANISM	In mice and humans, the androgen receptor (AR) gene, located on the X chromosome, is not known to be involved in sex determination. In the Japanese frog Rana rugosa the AR is located on the sex chromosomes (X, Y, Z and W). Phylogenetic analysis shows that the AR on the X chromosome (X-AR) of the Korean R. rugosa is basal and segregates into two clusters: one containing W-AR of Japanese R. rugosa, the other containing Y-AR. AR expression is twice as high in ZZ (male) compared to ZW (female) embryos in which the W-AR is barely expressed. Higher AR-expression may be associated with male sex determination in this species. To examine whether the Z-AR is involved in sex determination in R. rugosa, we produced transgenic (Tg) frogs carrying an exogenous Z-AR. Analysis of ZW Tg frogs revealed development of masculinized gonads or 'ovotestes'. Expression of CYP17 and Dmrt1, genes known to be activated during normal male gonadal development, were up-regulated in the ZW ovotestis. Testosterone, supplied to the rearing water, completed the female-to-male sex-reversal in the AR-Tg ZW frogs. Here we report that Z-AR is involved in male sex-determination in an amphibian species.	[Fujii, Jun; Kodama, Maho; Oike, Akira; Matsuo, Yasuki; Nakamura, Masahisa] Waseda Univ, Dept Biol, Tokyo, Japan; [Min, Mi-Sook] Seoul Natl Univ, Lab Wildlife Conservat Genet, Seoul, South Korea; [Hasebe, Takashi; Ishizuya-Oka, Atsuko] Nippon Med Sch, Dept Biol, Kawasaki, Kanagawa, Japan; [Kawakami, Koichi] Natl Inst Genet, Div Mol & Dev Biol, Mishima, Shizuoka 411, Japan	Waseda University; Seoul National University (SNU); Nippon Medical School; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Nakamura, M (corresponding author), Waseda Univ, Dept Biol, Tokyo, Japan.	nakamra@waseda.jp	Kawakami, Koichi/AAF-1380-2019	Hasebe, Takashi/0000-0001-7200-8173	Ministry of Education, Science, and Culture of Japan [22370027]; Korean government from the National Research Foundation [NRF-2012R1A1A2040065]; Grants-in-Aid for Scientific Research [25440160] Funding Source: KAKEN	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Korean government from the National Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid to MN from the Ministry of Education, Science, and Culture of Japan to MN (No. 22370027) and by the Korean government to M-SM from the National Research Foundation (NRF-2012R1A1A2040065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama S, 2003, CYTOGENET GENOME RES, V101, P295, DOI 10.1159/000074352; Chang CS, 2004, P NATL ACAD SCI USA, V101, P6876, DOI 10.1073/pnas.0307306101; De Grandi A, 2000, MECH DEVELOP, V90, P323, DOI 10.1016/S0925-4773(99)00282-8; Iwade R, 2008, GEN COMP ENDOCR, V155, P79, DOI 10.1016/j.ygcen.2007.02.032; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Kerkhofs S, 2009, J MOL ENDOCRINOL, V42, P11, DOI 10.1677/JME-08-0122; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Miura I, 1998, MOL BIOL EVOL, V15, P1612, DOI 10.1093/oxfordjournals.molbev.a025889; Miura I, 2012, CHROMOSOME RES, V20, P47, DOI 10.1007/s10577-011-9258-8; Nakamura M, 2013, SEX DEV, V7, P104, DOI 10.1159/000339661; Nakamura M, 2010, J EXP ZOOL PART A, V313A, P381, DOI 10.1002/jez.616; Nishioka Midori, 1994, Scientific Report of the Laboratory for Amphibian Biology Hiroshima University, V13, P1; Ogata M, 2002, CYTOGENET GENOME RES, V99, P185, DOI 10.1159/000071592; Sakurai N, 2008, J STEROID BIOCHEM, V112, P5, DOI 10.1016/j.jsbmb.2008.07.002; Saotome K, 2010, J EXP ZOOL PART A, V313A, P452, DOI 10.1002/jez.617; Saotome K, 2010, J EXP ZOOL PART A, V313A, P369, DOI 10.1002/jez.607; Sato T, 2003, BIOCHEM BIOPH RES CO, V300, P167, DOI 10.1016/S0006-291X(02)02774-2; Schmid M., 1991, P393; Shibata K, 2002, GEN COMP ENDOCR, V127, P232, DOI 10.1016/S0016-6480(02)00039-4; Smith CA, 2009, NATURE, V461, P267, DOI 10.1038/nature08298; Steinemann S, 2005, BIOESSAYS, V27, P1076, DOI 10.1002/bies.20288; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Uno Y, 2008, CHROMOSOME RES, V16, P637, DOI 10.1007/s10577-008-1217-7; Wallace H, 1999, CELL MOL LIFE SCI, V55, P901, DOI 10.1007/s000180050343; Wang DS, 2010, ENDOCRINOLOGY, V151, P1331, DOI 10.1210/en.2009-0999; Yeh SY, 2002, P NATL ACAD SCI USA, V99, P13498, DOI 10.1073/pnas.212474399; Yokoyama S, 2009, J EXP ZOOL PART A, V311A, P1	27	24	25	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e93655	10.1371/journal.pone.0093655	http://dx.doi.org/10.1371/journal.pone.0093655			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24826887	Green Published, Green Submitted, gold			2022-12-27	WOS:000336857400006
J	Hohwu, L; Li, J; Olsen, J; Sorensen, TIA; Obel, C				Hohwu, Lena; Li, Jiong; Olsen, Jorn; Sorensen, Thorkild I. A.; Obel, Carsten			Severe Maternal Stress Exposure Due to Bereavement before, during and after Pregnancy and Risk of Overweight and Obesity in Young Adult Men: A Danish National Cohort Study	PLOS ONE			English	Article							PRENATAL STRESS; EARLY-LIFE; PERSPECTIVE; REGISTRY; DISEASE; PUBERTY; HEALTH; RATS; BMI	Background: Perinatal stress may programme overweight and obesity. We examined whether maternal pre- and post-natal bereavement was associated with overweight and obesity in young men. Methods: A cohort study was conducted including 119,908 men born from 1976 to 1993 and examined for military service between 2006 and 2011. Among them, 4,813 conscripts were born to mothers bereaved by death of a close relative from 12 months preconception to birth of the child (exposed group). Median body mass index (BMI) and prevalence of overweight and obesity were estimated. Odds ratio of overweight (BMI >= 25 kg/m(2)) and obesity (BMI >= 30 kg/m(2)) were estimated by logistic regression analysis adjusted for maternal educational level. Results: Median BMI was similar in the exposed and the unexposed group but the prevalence of overweight (33.3% versus 30.4%, p = 0.02) and obesity (9.8% versus 8.5%, p = 0.06) was higher in the exposed group. Conscripts exposed 6 to 0 months before conception and during pregnancy had a higher risk of overweight (odds ratio 1.15, 95% confidence interval (CI): 1.03; 1.27 and odds ratio 1.13, 95% CI: 1.03; 1.25, respectively). Conscripts born to mothers who experienced death of the child's biological father before child birth had a two-fold risk of obesity (odds ratio 2.00, 95% CI: 0.93; 4.31). There was no elevated risk in those who experienced maternal bereavement postnatally. Conclusion: Maternal bereavement during the prenatal period was associated with increased risk of overweight or obesity in a group of young male conscripts, and this may possibly be reflected to severe stress exposure early in life. However, not all associations were clear, and further studies are warranted.	[Hohwu, Lena; Obel, Carsten] Aarhus Univ, Dept Publ Hlth, Sect Gen Practice, Aarhus, Denmark; [Li, Jiong; Olsen, Jorn] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark; [Sorensen, Thorkild I. A.] Bispebjerg Hosp, Inst Prevent Med, DK-2400 Copenhagen, Denmark; [Sorensen, Thorkild I. A.] Frederiksbjerg Hosp, Copenhagen, Denmark; [Sorensen, Thorkild I. A.] Univ Copenhagen, Novo Nordisk Fdn, Ctr Basic Metab Res, Fac Hlth & Med Sci, Copenhagen, Denmark	Aarhus University; Aarhus University; University of Copenhagen; Bispebjerg Hospital; Novo Nordisk Foundation; University of Copenhagen	Hohwu, L (corresponding author), Aarhus Univ, Dept Publ Hlth, Sect Gen Practice, Aarhus, Denmark.	lena.hohwu@alm.au.dk	Olsen, Jørn/F-8801-2015; li, jiong/L-6534-2014; Obel, Carsten/H-9605-2016	Olsen, Jørn/0000-0001-7462-5140; li, jiong/0000-0002-1716-8067; Hohwu, Lena/0000-0002-9887-7745; li, jiong/0000-0003-1125-026X; Obel, Carsten/0000-0001-5004-1933	European Research Council [ERC-StG-2010-260242-PROGEURO]; Danish Medical Research Council [09-072986]; Aarhus University, Denmark	European Research Council(European Research Council (ERC)European Commission); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Aarhus University, Denmark	This work was supported by European Research Council (ERC-StG-2010-260242-PROGEURO to JL; the Danish Medical Research Council (project no. 09-072986)). Lena Hohwu is supported by a full PhD fellowship at Aarhus University, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajslev TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011136; Choi JH, 2013, CURR OPIN ENDOCRINOL, V20, P62, DOI 10.1097/MED.0b013e32835b7ec7; Forsvaret, 2013, MEN WOM QUAL UNF ARM; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; Ghoorah K, 2014, J STEROID BIOCH MOL; Gitau R, 1998, LANCET, V352, P707, DOI 10.1016/S0140-6736(05)60824-0; Gluckman PD, 2008, INT J OBESITY, V32, pS62, DOI 10.1038/ijo.2008.240; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gnanalingham MG, 2005, AM J PHYSIOL-REG I, V289, pR1407, DOI 10.1152/ajpregu.00375.2005; Goodkin K, 2001, ANONYMOUS HDB BEREAV, P671; Green A, 1996, DAN MED BULL, V43, P464; Heindel JJ, 2009, MOL CELL ENDOCRINOL, V304, P90, DOI 10.1016/j.mce.2009.02.025; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Ingstrup KG, 2012, J OBES, V2012, DOI 10.1155/2012/462845; Knudsen LB, 1998, DAN MED BULL, V45, P320; Kristensen P, 2012, PSYCHIATRY, V75, P76, DOI 10.1521/psyc.2012.75.1.76; Li J, 2012, OBESITY FACTS, V5, P881, DOI 10.1159/000345933; Li JO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011896; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Mairesse J, 2007, AM J PHYSIOL-ENDOC M, V292, pE1526, DOI 10.1152/ajpendo.00574.2006; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Monroe SM, 2005, PSYCHOL REV, V112, P417, DOI 10.1037/0033-295X.112.2.417; Mueller BR, 2006, PHYSIOL BEHAV, V88, P605, DOI 10.1016/j.physbeh.2006.05.019; O'Donnell KJ, 2012, PSYCHONEUROENDOCRINO, V37, P818, DOI 10.1016/j.psyneuen.2011.09.014; Paternain L, 2012, NEUROENDOCRINOLOGY, V96, P249, DOI 10.1159/000341684; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Ramasubramanian L, 2013, CHILD CARE HLTH DEV, V39, P134, DOI 10.1111/j.1365-2214.2011.01325.x; Reynolds RM, 2013, PSYCHONEUROENDOCRINO, V38, P1, DOI 10.1016/j.psyneuen.2012.08.012; Reynolds RM, 2010, J STEROID BIOCHEM, V122, P3, DOI 10.1016/j.jsbmb.2010.01.009; Roy JR, 2009, MED SCI MONITOR, V15, pRA137; Schoeters G, 2008, BASIC CLIN PHARMACOL, V102, P168, DOI 10.1111/j.1742-7843.2007.00180.x; Seckl JR, 2004, ANN NY ACAD SCI, V1032, P63, DOI 10.1196/annals.1314.006; Stenhammar C, 2010, ACTA PAEDIATR, V99, P1205, DOI 10.1111/j.1651-2227.2010.01776.x; Viner RM, 2006, INT J OBESITY, V30, P1368, DOI 10.1038/sj.ijo.0803183; Welberg LAM, 2005, J ENDOCRINOL, V186, pR7, DOI 10.1677/joe.1.06374; Welberg LAM, 2001, J NEUROENDOCRINOL, V13, P113, DOI 10.1046/j.1365-2826.2001.00601.x	37	35	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97490	10.1371/journal.pone.0097490	http://dx.doi.org/10.1371/journal.pone.0097490			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4TJ	24828434	Green Published, Green Submitted, gold			2022-12-27	WOS:000336857400101
J	Li, YH; Xu, JT; Gao, KS				Li, Yahe; Xu, Juntian; Gao, Kunshan			Light-Modulated Responses of Growth and Photosynthetic Performance to Ocean Acidification in the Model Diatom Phaeodactylum tricornutum	PLOS ONE			English	Article							CO2 CONCENTRATING MECHANISMS; PHOTOSYSTEM-II; SEAWATER ACIDIFICATION; INORGANIC CARBON; UV-RADIATION; MARINE; PHYTOPLANKTON; PHOTOINHIBITION; CALCIFICATION; EFFICIENCY	Ocean acidification (OA) due to atmospheric CO2 rise is expected to influence marine primary productivity. In order to investigate the interactive effects of OA and light changes on diatoms, we grew Phaeodactylum tricornutum, under ambient (390 ppmv; LC) and elevated CO2 (1000 ppmv; HC) conditions for 80 generations, and measured its physiological performance under different light levels (60 mu mol m(-2) s(-1), LL; 200 mu mol m(-2) s(-1), ML; 460 mu mol m(-2) s(-1), HL) for another 25 generations. The specific growth rate of the HC-grown cells was higher (about 12-18%) than that of the LC-grown ones, with the highest under the ML level. With increasing light levels, the effective photochemical yield of PSII (F-v'/F-m') decreased, but was enhanced by the elevated CO2, especially under the HL level. The cells acclimated to the HC condition showed a higher recovery rate of their photochemical yield of PSII compared to the LC-grown cells. For the HC-grown cells, dissolved inorganic carbon or CO2 levels for half saturation of photosynthesis (K-1/2 DIC or K-1/2 CO2) increased by 11, 55 and 32%, under the LL, ML and HL levels, reflecting a light dependent down-regulation of carbon concentrating mechanisms (CCMs). The linkage between higher level of the CCMs down-regulation and higher growth rate at ML under OA supports the theory that the saved energy from CCMs down-regulation adds on to enhance the growth of the diatom.	[Li, Yahe; Gao, Kunshan] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Fujian, Peoples R China; [Xu, Juntian] Huaihai Inst Technol, Sch Marine Sci & Technol, Lianyungang, Jiangsu, Peoples R China	Xiamen University; Jiangsu Ocean University	Gao, KS (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Fujian, Peoples R China.	ksgao@xmu.edu.cn	gao, kunshan/G-3374-2010; Xu, Juntian/AAW-4084-2021; Xu, juntian/ABB-8233-2021	Gao, Kunshan/0000-0001-7365-6332	National Basic Research Program of China [2011CB200902]; National Natural Science Foundation [41120164007]; Program for Changjiang Scholars and Innovative Research Team [IRT0941]; SOA [GASI-03-01-02-04]; China-Japan collaboration project from MOST [S2012GR0290]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); SOA; China-Japan collaboration project from MOST	This study was supported by National Basic Research Program of China (2011CB200902), National Natural Science Foundation (41120164007), Program for Changjiang Scholars and Innovative Research Team (IRT0941), SOA (GASI-03-01-02-04), and China-Japan collaboration project from MOST (S2012GR0290). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aro EM, 2005, J EXP BOT, V56, P347, DOI 10.1093/jxb/eri041; Bartual A, 2003, CAN J BOT, V81, P191, DOI [10.1139/B03-013, 10.1139/b03-013]; BEARDALL J, 1991, CAN J BOT, V69, P1146, DOI 10.1139/b91-147; Beardall J, 2002, FUNCT PLANT BIOL, V29, P335, DOI 10.1071/PP01195; Beardall J., 2013, ALGAE BIOFUELS ENERG, P153; Beaufort L, 2011, NATURE, V476, P80, DOI 10.1038/nature10295; Boelen P, 2011, J EXP MAR BIOL ECOL, V406, P38, DOI 10.1016/j.jembe.2011.06.012; Burkhardt S, 2001, LIMNOL OCEANOGR, V46, P1378, DOI 10.4319/lo.2001.46.6.1378; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Edelman M, 2008, PHOTOSYNTH RES, V98, P609, DOI 10.1007/s11120-008-9342-x; EILERS PHC, 1988, ECOL MODEL, V42, P199, DOI 10.1016/0304-3800(88)90057-9; Flynn KJ, 2012, NAT CLIM CHANGE, V2, P510, DOI 10.1038/NCLIMATE1489; GAO K, 1993, MAR BIOL, V117, P129, DOI 10.1007/BF00346434; Gao KS, 2014, FUNCT PLANT BIOL, V41, P449, DOI 10.1071/FP13247; Gao KS, 2012, MAR ECOL PROG SER, V470, P167, DOI 10.3354/meps10043; Gao KS, 2012, NAT CLIM CHANGE, V2, P519, DOI 10.1038/NCLIMATE1507; Gao KS, 2010, GLOBAL CHANGE BIOL, V16, P2388, DOI 10.1111/j.1365-2486.2009.02113.x; Gao KS, 2009, LIMNOL OCEANOGR, V54, P1855, DOI 10.4319/lo.2009.54.6.1855; Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052; Gordillo FJL, 2003, PLANTA, V218, P315, DOI 10.1007/s00425-003-1087-3; Hoppe CJM, 2014, NEW PHYTOL; HORTON P, 1994, PLANT PHYSIOL, V106, P415, DOI 10.1104/pp.106.2.415; Ihnken S, 2011, PHYCOLOGIA, V50, P182, DOI 10.2216/10-11.1; Janssen Meike, 2001, International Microbiology, V4, P27; Jin P, 2013, PLANT PHYSIOL, V162, P2084, DOI 10.1104/pp.113.219543; Kanazawa A, 2002, P NATL ACAD SCI USA, V99, P12789, DOI 10.1073/pnas.182427499; Kim JM, 2006, LIMNOL OCEANOGR, V51, P1629, DOI 10.4319/lo.2006.51.4.1629; King AL, 2011, ISME J, V5, P1388, DOI 10.1038/ismej.2010.211; Lavaud J, 2007, LIMNOL OCEANOGR, V52, P1188, DOI 10.4319/lo.2007.52.3.1188; Lewis ER, 1998, ESS-DIVE, DOI 10.15485/1464255; Li G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055562; Li Y, 2012, BIOGEOSCIENCES, V9, P3931, DOI 10.5194/bg-9-3931-2012; Low-Decarie E, 2011, GLOBAL CHANGE BIOL, V17, P2525, DOI 10.1111/j.1365-2486.2011.02402.x; McCarthy A, 2012, J PHYCOL, V48, P635, DOI 10.1111/j.1529-8817.2012.01171.x; MOREL FMM, 1979, J PHYCOL, V15, P135, DOI 10.1111/j.0022-3646.1979.00135.x; Murata N, 2007, BBA-BIOENERGETICS, V1767, P414, DOI 10.1016/j.bbabio.2006.11.019; Nishiyama Y, 2006, BBA-BIOENERGETICS, V1757, P742, DOI 10.1016/j.bbabio.2006.05.013; PERRY MJ, 1981, MAR BIOL, V62, P91, DOI 10.1007/BF00388170; Ralph PJ, 2005, AQUAT BOT, V82, P222, DOI 10.1016/j.aquabot.2005.02.006; Raven JA, 2011, PHOTOSYNTH RES, V109, P281, DOI 10.1007/s11120-011-9632-6; Riebesell U, 2007, NATURE, V450, P545, DOI 10.1038/nature06267; Riebesell U., 2011, OCEAN ACIDIFICATION, P99, DOI [10.1093/oso/9780199591091.003.0011, DOI 10.1093/OSO/9780199591091.003.0011]; Ritchie RJ, 2006, PHOTOSYNTH RES, V89, P27, DOI 10.1007/s11120-006-9065-9; ROY RN, 1993, MAR CHEM, V44, P249, DOI 10.1016/0304-4203(93)90207-5; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Schippers P, 2004, ECOL LETT, V7, P446, DOI 10.1111/j.1461-0248.2004.00597.x; SHIRAIWA Y, 1983, PLANT CELL PHYSIOL, V24, P919, DOI 10.1093/oxfordjournals.pcp.a076596; Six C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001341; Strickland J.D., 1972, J FISH RES BOARD CAN; Sugie K, 2013, J PHYCOL, V49, P475, DOI 10.1111/jpy.12054; Torstensson A, 2012, POLAR BIOL, V35, P205, DOI 10.1007/s00300-011-1056-4; Trimborn S, 2009, J EXP MAR BIOL ECOL, V376, P26, DOI 10.1016/j.jembe.2009.05.017; Venn AA, 2013, P NATL ACAD SCI USA, V110, P1634, DOI 10.1073/pnas.1216153110; Watson RT, 2001, CLIMATE CHANGE 2001, P398, DOI DOI 10.1256/004316502320517344; Wu Y, 2010, BIOGEOSCIENCES, V7, P2915, DOI 10.5194/bg-7-2915-2010; Yang GY, 2012, MAR ENVIRON RES, V79, P142, DOI 10.1016/j.marenvres.2012.06.002; Young EB, 2005, CAN J BOT, V83, P917, DOI 10.1139/B05-081	58	18	20	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96173	10.1371/journal.pone.0096173	http://dx.doi.org/10.1371/journal.pone.0096173			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828454	Green Published, gold, Green Submitted			2022-12-27	WOS:000336857400022
J	Mi, JX				Mi, Jian-Xun			A Novel Algorithm for Independent Component Analysis with Reference and Methods for Its Applications	PLOS ONE			English	Article							BLIND SEPARATION; CONSTRAINED ICA; UNKNOWN NUMBER; EXTRACTION; REJECTION	This paper presents a stable and fast algorithm for independent component analysis with reference (ICA-R). This is a technique for incorporating available reference signals into the ICA contrast function so as to form an augmented Lagrangian function under the framework of constrained ICA (cICA). The previous ICA-R algorithm was constructed by solving the optimization problem via a Newton-like learning style. Unfortunately, the slow convergence and potential misconvergence limit the capability of ICA-R. This paper first investigates and probes the flaws of the previous algorithm and then introduces a new stable algorithm with a faster convergence speed. There are two other highlights in this paper: first, new approaches, including the reference deflation technique and a direct way of obtaining references, are introduced to facilitate the application of ICA-R; second, a new method is proposed that the new ICA-R is used to recover the complete underlying sources with new advantages compared with other classical ICA methods. Finally, the experiments on both synthetic and real-world data verify the better performance of the new algorithm over both previous ICA-R and other well-known methods.	[Mi, Jian-Xun] Chongqing Univ Posts & Telecommun, Chongqing Key Lab Computat Intelligence, Chongqing, Peoples R China; [Mi, Jian-Xun] Chongqing Univ Posts & Telecommun, Coll Comp Sci & Technol, Chongqing, Peoples R China	Chongqing University of Posts & Telecommunications; Chongqing University of Posts & Telecommunications	Mi, JX (corresponding author), Chongqing Univ Posts & Telecommun, Chongqing Key Lab Computat Intelligence, Chongqing, Peoples R China.	mijianxun@gmail.com	Mi, Jianxun/U-3642-2019; Mi, Jianxun/J-9670-2014	Mi, Jianxun/0000-0002-7531-4341	National Nature Science Committee of China [61202276, 61203376]	National Nature Science Committee of China	The funding that has supported the work is from the National Nature Science Committee of China under Grant Nos. 61202276, 61203376. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Boyd S., 2004, CONVEX OPTIMIZATION; Cardoso JF, 1999, NEURAL COMPUT, V11, P157, DOI 10.1162/089976699300016863; Cichocki A, 1999, NEUROCOMPUTING, V24, P55, DOI 10.1016/S0925-2312(98)00091-5; Cruces-Alvarez SA, 2004, IEEE T NEURAL NETWOR, V15, P859, DOI 10.1109/TNN.2004.828764; de Moor D., DAISY DATABASE IDENT; DELFOSSE N, 1994, INT CONF ACOUST SPEE, P41; Du K L, 2014, NEURAL NETWORKS STAT, P419; Gibson O, 2002, P 2 EUR MED BIOL ENG, P424; Goldstein JS, 1999, INT CONF ACOUST SPEE, P1357, DOI 10.1109/ICASSP.1999.756232; Golub G. H., 2012, MATRIX COMPUTATIONS; Huang DS, 2007, IEEE T NEURAL NETWOR, V18, P1532, DOI 10.1109/TNN.2007.895910; Hyvarinen A, 1997, NEURAL COMPUT, V9, P1483, DOI 10.1162/neco.1997.9.7.1483; Hyvarinen A, 1998, ADV NEUR IN, V10, P273; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Hyvarinen A., 2004, INDEPENDENT COMPONEN; James CJ, 2005, PHYSIOL MEAS, V26, pR15, DOI 10.1088/0967-3334/26/1/R02; James CJ, 2003, IEEE T BIO-MED ENG, V50, P1108, DOI 10.1109/TBME.2003.816076; James CJ, 2002, IET C P, P4; JUTTEN C, 1991, SIGNAL PROCESS, V24, P1, DOI 10.1016/0165-1684(91)90079-X; Koldovsky Z, 2006, IEEE T NEURAL NETWOR, V17, P1265, DOI 10.1109/TNN.2006.875991; Leclercq Y, 2009, NEUROIMAGE, V44, P679, DOI 10.1016/j.neuroimage.2008.10.017; Lee TW, 1997, INDEPENDENT COMPONER; Lee WL, 2013, IEEE ENG MED BIO, P7064, DOI 10.1109/EMBC.2013.6611185; Lin QH, 2004, LECT NOTES COMPUT SC, V3173, P755; Lin QH, 2007, INFORM SCIENCES, V177, P1265, DOI 10.1016/j.ins.2006.09.011; Lu W, 2005, IEEE T NEURAL NETWOR, V16, P203, DOI 10.1109/TNN.2004.836795; Milanesi M, 2008, MED BIOL ENG COMPUT, V46, P251, DOI 10.1007/s11517-007-0293-8; NADAL JP, 1994, NETWORK-COMP NEURAL, V5, P565, DOI 10.1088/0954-898X/5/4/008; Oja E, 1997, NEUROCOMPUTING, V17, P25, DOI 10.1016/S0925-2312(97)00045-3; Peng C, 2007, NEURAL COMPUT APPL, V16, P581, DOI 10.1007/s00521-007-0100-3; Pham DT, 1997, IEEE T SIGNAL PROCES, V45, P1712, DOI 10.1109/78.599941; Sun TY, 2008, NEUROCOMPUTING, V71, P2271, DOI 10.1016/j.neucom.2007.07.036; Sun ZL, 2011, IEEE T INF FOREN SEC, V6, P360, DOI 10.1109/TIFS.2011.2118207; Sun ZL, 2010, NEUROCOMPUTING, V73, P1013, DOI 10.1016/j.neucom.2009.12.016; Wei L, 2006, NEUROCOMPUTING, V69, P2244, DOI 10.1016/j.neucom.2005.06.021; WIDROW B, 1975, P IEEE, V63, P1692, DOI 10.1109/PROC.1975.10036; Yu X, 2014, NATURAL GRADIENT FLE, P153; Zarzoso V, 2000, COMPUT CARDIOL, V27, P431, DOI 10.1109/CIC.2000.898549; Zhang J, 2013, IEEE IMTC P, P1459; Zhang ZL, 2008, NEUROCOMPUTING, V71, P1669, DOI 10.1016/j.neucom.2007.04.004	42	21	21	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e93984	10.1371/journal.pone.0093984	http://dx.doi.org/10.1371/journal.pone.0093984			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24826986	Green Submitted, Green Published, gold			2022-12-27	WOS:000336857400007
J	Zhang, GX; Liu, YF; Ni, Y; Meng, ZJ; Lu, T; Li, TL				Zhang, Guoxian; Liu, Yufeng; Ni, Yang; Meng, Zhaojuan; Lu, Tao; Li, Tianlai			Exogenous Calcium Alleviates Low Night Temperature Stress on the Photosynthetic Apparatus of Tomato Leaves	PLOS ONE			English	Article							CYCLIC ELECTRON FLOW; PHOTOSYSTEM-I; QUANTUM YIELD; CALMODULIN-BINDING; HYDROGEN-PEROXIDE; D1 PROTEIN; HIGH LIGHT; PHOTOINHIBITION; FLUORESCENCE; ARABIDOPSIS	The effect of exogenous CaCl2 on photosystem I and II (PSI and PSII) activities, cyclic electron flow (CEF), and proton motive force of tomato leaves under low night temperature (LNT) was investigated. LNT stress decreased the net photosynthetic rate (Pn), effective quantum yield of PSII [Y(II)], and photochemical quenching (qP), whereas CaCl2 pretreatment improved Pn, Y(II), and qP under LNT stress. LNT stress significantly increased the non-regulatory quantum yield of energy dissipation [Y(NO)], whereas CaCl2 alleviated this increase. Exogenous Ca2+ enhanced stimulation of CEF by LNT stress. Inhibition of oxidized PQ pools caused by LNT stress was alleviated by CaCl2 pretreatment. LNT stress reduced zeaxanthin formation and ATPase activity, but CaCl2 pretreatment reversed both of these effects. LNT stress caused excess formation of a proton gradient across the thylakoid membrane, whereas CaCl2 pretreatment decreased the said factor under LNT. Thus, our results showed that photoinhibition of LNT-stressed plants could be alleviated by CaCl2 pretreatment. Our findings further revealed that this alleviation was mediated in part by improvements in carbon fixation capacity, PQ pools, linear and cyclic electron transports, xanthophyll cycles, and ATPase activity.	[Zhang, Guoxian; Liu, Yufeng; Ni, Yang; Meng, Zhaojuan; Lu, Tao; Li, Tianlai] Shenyang Agr Univ, Dept Hort, Shenyang, Liaoning, Peoples R China; [Zhang, Guoxian; Liu, Yufeng; Ni, Yang; Meng, Zhaojuan; Lu, Tao; Li, Tianlai] Minist Educ, Key Lab Protected Hort, Shenyang, Liaoning, Peoples R China; [Zhang, Guoxian; Liu, Yufeng; Ni, Yang; Meng, Zhaojuan; Lu, Tao; Li, Tianlai] Key Lab Protected Hort Liaoning Prov, Shenyang, Liaoning, Peoples R China	Shenyang Agricultural University	Li, TL (corresponding author), Shenyang Agr Univ, Dept Hort, Shenyang, Liaoning, Peoples R China.	tianlaili@126.com	Zhang, Guoxian/AAK-3875-2021		National Natural Science Foundation of China [31301813]; China Agriculture Research System [CARS-25]; 12th Five-Year Support Project of China [2011BAD12B03]; Major Scientific Research Projects of Liaoning Province [2011215003]; Agriculture Science and Technology Development Program of Shenyang [F11092300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System; 12th Five-Year Support Project of China; Major Scientific Research Projects of Liaoning Province; Agriculture Science and Technology Development Program of Shenyang	This work was supported by the National Natural Science Foundation of China (Grant No. 31301813), the China Agriculture Research System (Grant No. CARS-25), the 12th Five-Year Support Project of China (Grant No. 2011BAD12B03), the Major Scientific Research Projects of Liaoning Province (Grant No. 2011215003), and the Agriculture Science and Technology Development Program of Shenyang (Grant No. F11092300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2005, PLANT SCI, V169, P559, DOI 10.1016/j.plantsci.2005.05.004; Ai XiZhen, 2006, Scientia Agricultura Sinica, V39, P2063; Avenson TJ, 2005, P NATL ACAD SCI USA, V102, P9709, DOI 10.1073/pnas.0503952102; Bayer RG, 2012, J EXP BOT, V63, P1713, DOI 10.1093/jxb/err377; Bellamine J, 1997, ACTA PHYSIOL PLANT, V19, P17, DOI 10.1007/s11738-997-0017-6; Busch F, 2009, FUNCT PLANT BIOL, V36, P1016, DOI 10.1071/FP08043; Chen HX, 2007, PHYSIOL PLANTARUM, V129, P386, DOI 10.1111/j.1399-3054.2006.00830.x; Chen LB, 2012, PHOTOSYNTH RES, V112, P141, DOI 10.1007/s11120-012-9750-9; Chigri F, 2006, P NATL ACAD SCI USA, V103, P16051, DOI 10.1073/pnas.0607150103; DELASRIVAS J, 1992, FEBS LETT, V301, P246, DOI 10.1016/0014-5793(92)80250-K; Dongsansuk A, 2013, PHOTOSYNTHETICA, V51, P13, DOI 10.1007/s11099-012-0070-2; Feng Z, 2010, AGR SCI CHINA, V9, P1777, DOI 10.1016/S1671-2927(09)60276-5; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Gerotto C, 2011, PLANT CELL ENVIRON, V34, P922, DOI 10.1111/j.1365-3040.2011.02294.x; Havaux M, 1999, P NATL ACAD SCI USA, V96, P8762, DOI 10.1073/pnas.96.15.8762; HAVAUX M, 1991, PLANTA, V186, P88, DOI 10.1007/BF00201502; Hideg E, 2001, PHYSIOL PLANTARUM, V112, P10, DOI 10.1034/j.1399-3054.2001.1120102.x; Huang Jun, 2012, Yingyong Shengtai Xuebao, V23, P2521; Huang W, 2011, PLANT CELL PHYSIOL, V52, P297, DOI 10.1093/pcp/pcq166; Huang W, 2010, PHOTOSYNTH RES, V103, P175, DOI 10.1007/s11120-010-9539-7; Ioannidis NE, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00071; Ioannidis NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029864; Ivanov AG, 2012, BBA-BIOENERGETICS, V1817, P1374, DOI 10.1016/j.bbabio.2012.03.010; Joliot P, 2013, PHOTOSYNTH RES, V115, P55, DOI 10.1007/s11120-013-9826-1; Kader MA, 2010, PLANT SIGNAL BEHAV, V5, P233, DOI 10.4161/psb.5.3.10740; Kanazawa A, 2002, P NATL ACAD SCI USA, V99, P12789, DOI 10.1073/pnas.182427499; KLUGHAMMER C, 1994, PLANTA, V192, P261, DOI 10.1007/BF01089043; Kramer DM, 2004, PHOTOSYNTH RES, V79, P209, DOI 10.1023/B:PRES.0000015391.99477.0d; Lazar D, 2006, FUNCT PLANT BIOL, V33, P9, DOI 10.1071/FP05095; Liu YF, 2012, PLANT SCI, V196, P8, DOI 10.1016/j.plantsci.2012.07.005; Liu YF, 2011, J HORTIC SCI BIOTECH, V86, P91, DOI 10.1080/14620316.2011.11512731; Liu YF, 2013, J INTEGR AGR, V12, P2172, DOI [10.1016/S2095-3119(13)60411-6, 10.1016/s2095-3119(13)60411-6]; Mi HL, 2000, PLANT CELL PHYSIOL, V41, P1129, DOI 10.1093/pcp/pcd038; Miyake C, 2004, PLANT CELL PHYSIOL, V45, P1426, DOI 10.1093/pcp/pch163; MIYAO M, 1995, BIOCHEMISTRY-US, V34, P10019, DOI 10.1021/bi00031a025; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Munekage Y, 2002, CELL, V110, P361, DOI 10.1016/S0092-8674(02)00867-X; Partelli FL, 2011, ENVIRON EXP BOT, V74, P194, DOI 10.1016/j.envexpbot.2011.06.001; Pospisil P, 2012, BBA-BIOENERGETICS, V1817, P218, DOI 10.1016/j.bbabio.2011.05.017; POWLES SB, 1984, ANNU REV PLANT PHYS, V35, P15, DOI 10.1146/annurev.pp.35.060184.000311; Qi MingFang, 2011, Scientia Agricultura Sinica, V44, P531; Rocha AG, 2012, PROTOPLASMA, V249, P957, DOI 10.1007/s00709-011-0373-3; Savitch LV, 2001, PLANTA, V214, P295, DOI 10.1007/s004250100622; Scheller HV, 2005, PLANTA, V221, P5, DOI 10.1007/s00425-005-1507-7; SCHREIBER U, 1988, Z NATURFORSCH C, V43, P686; SCHREIBER U, 1995, AUST J PLANT PHYSIOL, V22, P209, DOI 10.1071/PP9950209; SCHREIBER U, 1989, PHILOS T ROY SOC B, V323, P241, DOI 10.1098/rstb.1989.0007; Schreiber U., 2008, PAM APPL NOTES, V10, P1; Shikanai T, 2007, ANNU REV PLANT BIOL, V58, P199, DOI 10.1146/annurev.arplant.58.091406.110525; Shikanai T, 2014, CURR OPIN BIOTECH, V26, P25, DOI 10.1016/j.copbio.2013.08.012; SONOIKE K, 1994, PLANTA, V194, P287, DOI 10.1007/BF01101690; Stael S, 2011, FEBS LETT, V585, P517, DOI 10.1016/j.febslet.2011.01.001; Takahashi S, 2009, PLANT PHYSIOL, V149, P1560, DOI 10.1104/pp.108.134122; Tan W, 2011, J PLANT PHYSIOL, V168, P2063, DOI 10.1016/j.jplph.2011.06.009; Terashima M, 2012, P NATL ACAD SCI USA, V109, P17717, DOI 10.1073/pnas.1207118109; Turner WL, 2004, PLANT PHYSIOL, V135, P1243, DOI 10.1104/pp.104.040428; Xu CB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068214, 10.1371/journal.pone.0068837]; Yamori W, 2011, PLANT J, V68, P966, DOI 10.1111/j.1365-313X.2011.04747.x; Yi XP, 2005, J BIOL CHEM, V280, P16170, DOI 10.1074/jbc.M501550200; [由继红 You Jihong], 2002, [作物学报, Acta Agronomica Sinica], V28, P693; Zhang SP, 2004, PLANT CELL PHYSIOL, V45, P1595, DOI 10.1093/pcp/pch180	61	64	71	4	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97322	10.1371/journal.pone.0097322	http://dx.doi.org/10.1371/journal.pone.0097322			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828275	Green Submitted, Green Published, gold			2022-12-27	WOS:000336857400077
J	Sokunbi, MO; Gradin, VB; Waiter, GD; Cameron, GG; Ahearn, TS; Murray, AD; Steele, DJ; Staff, RT				Sokunbi, Moses O.; Gradin, Victoria B.; Waiter, Gordon D.; Cameron, George G.; Ahearn, Trevor S.; Murray, Alison D.; Steele, Douglas J.; Staff, Roger T.			Nonlinear Complexity Analysis of Brain fMRI Signals in Schizophrenia	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; FRACTAL ANALYSIS; EEG; CONNECTIVITY; PREDICTION; RESPONSES	We investigated the differences in brain fMRI signal complexity in patients with schizophrenia while performing the Cyberball social exclusion task, using measures of Sample entropy and Hurst exponent (H). 13 patients meeting diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM IV) criteria for schizophrenia and 16 healthy controls underwent fMRI scanning at 1.5 T. The fMRI data of both groups of participants were pre-processed, the entropy characterized and the Hurst exponent extracted. Whole brain entropy and H maps of the groups were generated and analysed. The results after adjusting for age and sex differences together show that patients with schizophrenia exhibited higher complexity than healthy controls, at mean whole brain and regional levels. Also, both Sample entropy and Hurst exponent agree that patients with schizophrenia have more complex fMRI signals than healthy controls. These results suggest that schizophrenia is associated with more complex signal patterns when compared to healthy controls, supporting the increase in complexity hypothesis, where system complexity increases with age or disease, and also consistent with the notion that schizophrenia is characterised by a dysregulation of the nonlinear dynamics of underlying neuronal systems.	[Sokunbi, Moses O.; Waiter, Gordon D.; Cameron, George G.; Ahearn, Trevor S.; Murray, Alison D.] Univ Aberdeen, Aberdeen Biomed Imaging Ctr, Aberdeen, Scotland; [Staff, Roger T.] Aberdeen Royal Infirm, Dept Nucl Med, Aberdeen, Scotland; [Gradin, Victoria B.; Steele, Douglas J.] Univ Dundee, Med Res Inst, Dundee, Scotland; [Gradin, Victoria B.] Univ Republica, Ctr Basic Res Psychol, Montevideo, Uruguay; [Sokunbi, Moses O.] Cardiff Univ, Brain Res Imaging Ctr, Cardiff CF10 3AX, S Glam, Wales; [Sokunbi, Moses O.] Cardiff Univ, Cardiff Sch Med, Inst Psychol Med & Clin Neurosci, MRC,Ctr Neuropsychiat Genet & Genom, Cardiff CF10 3AX, S Glam, Wales	University of Aberdeen; University of Aberdeen; University of Dundee; Universidad de la Republica, Uruguay; Cardiff University; Cardiff University	Sokunbi, MO (corresponding author), Univ Aberdeen, Aberdeen Biomed Imaging Ctr, Aberdeen, Scotland.	SokunbiMO@cardiff.ac.uk	Staff, Roger T/G-1826-2011; Waiter, Gordon/AAA-1141-2020; Murray, Alison/H-6250-2017; Steele, J Douglas/A-8972-2017; Sokunbi, Moses/AAY-6713-2020; Steele, Douglas/AAB-9889-2019	Staff, Roger T/0000-0003-0620-8673; Murray, Alison/0000-0003-4915-4847; Steele, J Douglas/0000-0002-9822-8753; Steele, Douglas/0000-0002-9822-8753; Sokunbi, Moses/0000-0002-8389-4577; Waiter, Gordon/0000-0002-5313-9845	Scottish Imaging Network - A Platform for Scientific Excellence (SINAPSE); ARUK, in Aberdeen, Scotland; SINAPSE; Miller Mckenzie Trust; Chief Scientist Office, Scotland	Scottish Imaging Network - A Platform for Scientific Excellence (SINAPSE); ARUK, in Aberdeen, Scotland; SINAPSE; Miller Mckenzie Trust; Chief Scientist Office, Scotland	MOS was supported by a studentship from Scottish Imaging Network - A Platform for Scientific Excellence (SINAPSE) and a small grant from the local ARUK, in Aberdeen, Scotland. VBG was supported by a studentship from SINAPSE. The Miller Mckenzie Trust and Chief Scientist Office, Scotland, funded the scanning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasolo D, 2006, PHYSIOL MEAS, V27, P241, DOI 10.1088/0967-3334/27/3/003; Bassett DS, 2012, NEUROIMAGE, V59, P2196, DOI 10.1016/j.neuroimage.2011.10.002; BASSINGTHWAIGHTE JB, 1995, ANN BIOMED ENG, V23, P491, DOI 10.1007/BF02584449; BASSINGTHWAIGHTE JB, 1989, CIRC RES, V65, P578, DOI 10.1161/01.RES.65.3.578; Beran J., 1994, STAT LONG MEMORY PRO; BERTOLACCINI M, 1978, IEEE T BIO-MED ENG, V25, P159, DOI 10.1109/TBME.1978.326242; Brunet-Gouet E, 2006, PSYCHIAT RES-NEUROIM, V148, P75, DOI 10.1016/j.pscychresns.2006.05.001; Corlett PR, 2007, BRAIN, V130, P2387, DOI 10.1093/brain/awm173; Couture SM, 2006, SCHIZOPHRENIA BULL, V32, pS44, DOI 10.1093/schbul/sbl029; ECKMANN JP, 1992, PHYSICA D, V56, P185, DOI 10.1016/0167-2789(92)90023-G; Eisenberger NI, 2007, EMOTION, V7, P745, DOI 10.1037/1528-3542.7.4.745; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Fadili MJ, 2002, NEUROIMAGE, V15, P217, DOI 10.1006/nimg.2001.0955; Fletcher P, 1999, NEUROIMAGE, V9, P337, DOI 10.1006/nimg.1998.0411; Friston KJ, 1998, MAGNET RESON MED, V39, P41, DOI 10.1002/mrm.1910390109; GLENNY RW, 1991, J APPL PHYSIOL, V70, P2351, DOI 10.1152/jappl.1991.70.6.2351; Gomez C, 2011, IEEE ENG MED BIO, P1765, DOI 10.1109/IEMBS.2011.6090504; Gomez C, 2009, ANN BIOMED ENG, V37, P586, DOI 10.1007/s10439-008-9633-6; Gradin VB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042608; GRANT PE, 1994, INVEST RADIOL, V29, P16, DOI 10.1097/00004424-199401000-00002; GRASSBERGER P, 1983, PHYS REV LETT, V50, P346, DOI 10.1103/PhysRevLett.50.346; HOFFMAN RE, 1993, SCHIZOPHRENIA BULL, V19, P119, DOI 10.1093/schbul/19.1.119; HURST HE, 1951, T AM SOC CIV ENG, V116, P770; Jeong J, 1998, ELECTROEN CLIN NEURO, V106, P220, DOI 10.1016/S0013-4694(97)00079-5; Jeong J, 2001, J CLIN NEUROPHYSIOL, V18, P58, DOI 10.1097/00004691-200101000-00010; Juckel G, 2006, NEUROIMAGE, V29, P409, DOI 10.1016/j.neuroimage.2005.07.051; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Keil A, 1998, SCHIZOPHR RES, V33, P169, DOI 10.1016/S0920-9964(98)00069-3; Kim WS, 2005, PHYSIOL MEAS, V26, P517, DOI 10.1088/0967-3334/26/4/016; Lake DE, 2002, AM J PHYSIOL-REG I, V283, P52; LIPSITZ LA, 1992, JAMA-J AM MED ASSOC, V267, P1806, DOI 10.1001/jama.267.13.1806; Lipsitz LA, 2004, PHYSL COMPLEXITY AGI, V2004; Lu S, 2008, IEEE T BIO-MED ENG, V55, P1966, DOI 10.1109/TBME.2008.919870; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; Picchioni MM, 2007, BMJ-BRIT MED J, V335, P91, DOI 10.1136/bmj.39227.616447.BE; Pilgram B, 1998, PHYSICA D, V114, P108, DOI 10.1016/S0167-2789(97)00188-7; PRITCHARD WS, 1994, ELECTROEN CLIN NEURO, V91, P118, DOI 10.1016/0013-4694(94)90033-7; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, P47; Robert PH, 1997, PSYCHOL MED, V27, P1287, DOI 10.1017/S0033291797005515; Roiser JP, 2009, PSYCHOL MED, V39, P199, DOI 10.1017/S0033291708003863; SCHEPERS HE, 1992, IEEE ENG MED BIOL, V11, P57, DOI 10.1109/51.139038; Sokunbi MO, 2013, PSYCHIAT RES-NEUROIM, V214, P341, DOI 10.1016/j.pscychresns.2013.10.001; Sokunbi MO, 2011, IEEE T BIO-MED ENG, V58, P3206, DOI 10.1109/TBME.2011.2164793; Somerville LH, 2006, NAT NEUROSCI, V9, P1007, DOI 10.1038/nn1728; STAM CJ, 1995, ELECTROEN CLIN NEURO, V95, P309, DOI 10.1016/0013-4694(95)00147-Q; Takahashi T, 2010, NEUROIMAGE, V51, P173, DOI 10.1016/j.neuroimage.2010.02.009; Vaillancourt DE, 2002, NEUROBIOL AGING, V23, P1, DOI 10.1016/S0197-4580(01)00247-0; Whitford TJ, 2007, AM J PSYCHIAT, V164, P1082, DOI 10.1176/appi.ajp.164.7.1082; Williams KD, 2000, J PERS SOC PSYCHOL, V79, P748, DOI 10.1037/0022-3514.79.5.748; WOLF A, 1985, PHYSICA D, V16, P285, DOI 10.1016/0167-2789(85)90011-9; YAMAMOTO Y, 1991, J APPL PHYSIOL, V71, P1143, DOI 10.1152/jappl.1991.71.3.1143; ZWEIG MH, 1993, CLIN CHEM, V39, P561	53	77	80	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e95146	10.1371/journal.pone.0095146	http://dx.doi.org/10.1371/journal.pone.0095146			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824731	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000336369200005
J	Kong, F; Zhen, ZL; Li, JG; Huang, LJ; Wang, X; Song, YY; Liu, J				Kong, Feng; Zhen, Zonglei; Li, Jingguang; Huang, Lijie; Wang, Xu; Song, Yiying; Liu, Jia			Sex-Related Neuroanatomical Basis of Emotion Regulation Ability	PLOS ONE			English	Article							HIPPOCAMPAL VOLUME; GENDER-DIFFERENCES; ANTERIOR CINGULATE; LIFE SATISFACTION; PREFRONTAL CORTEX; COGNITIVE CONTROL; NEURAL BASES; INTELLIGENCE; AMYGDALA; VALIDITY	Behavioral research has demonstrated that males have a higher capability of regulating their own and others' emotions than females; however, little is known about the sex-specific brain mechanisms involved in emotion regulation ability. In the present study, we used voxel-based morphometry to investigate the neural basis underlying emotion regulation ability in a large sample of young adults. Assessment of emotion regulation ability was performed using the Wong and Law Emotional Intelligence Scale. As expected, males significantly scored higher in emotion regulation ability than females did. More importantly, we found the sex differences in the neuroanatomical basis of emotion regulation ability. Males showed a stronger positive relation between emotion regulation ability and regional gray matter volume (rGMV) in the right dorsolateral prefrontal cortex. In contrast, females demonstrated a stronger positive relation between emotion regulation ability and rGMV in an anatomical cluster that extends from the left brainstem to the left hippocampus, the left amygdala and the insular cortex. The present study provides the first empirical evidence regarding the sex-linked neuroanatomical correlates of emotion regulation ability. These findings may help understand why there is a higher prevalence of affective disorders in females and maladaptive behaviors in males.	[Kong, Feng; Zhen, Zonglei; Li, Jingguang; Huang, Lijie; Wang, Xu; Song, Yiying] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Kong, Feng; Zhen, Zonglei; Li, Jingguang; Huang, Lijie; Wang, Xu; Song, Yiying] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing 100875, Peoples R China; [Liu, Jia] Beijing Normal Univ, Sch Psychol, Beijing 100875, Peoples R China; [Liu, Jia] Beijing Normal Univ, Ctr Collaborat & Innovat Brain & Learning Sci, Beijing 100875, Peoples R China	Beijing Normal University; Beijing Normal University; Beijing Normal University; Beijing Normal University	Liu, J (corresponding author), Beijing Normal Univ, Sch Psychol, Beijing 100875, Peoples R China.	liujia@bnu.edu.cn	Zhen, Zonglei/GPG-1239-2022; Kong, Feng/F-3051-2019	Kong, Feng/0000-0002-5571-3994; Liu, Jia/0000-0003-0383-0934; Li, Jingguang/0000-0003-2410-937X	National Natural Science Foundation of China [31230031, 91132703, 30800295, 31100808]; National Basic Research Program of China [2010CB833903]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This study was funded by the National Natural Science Foundation of China (31230031, 91132703, 30800295, 31100808) and the National Basic Research Program of China (2010CB833903). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amelang M, 2006, INTELLIGENCE, V34, P459, DOI 10.1016/j.intell.2006.03.003; [Anonymous], 1997, EMOTIONAL DEV EMOTIO; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Banks SJ, 2007, SOC COGN AFFECT NEUR, V2, P303, DOI 10.1093/scan/nsm029; Bar-On R, 2003, BRAIN, V126, P1790, DOI 10.1093/brain/awg177; Bar-On R, 2000, PERS INDIV DIFFER, V28, P1107, DOI 10.1016/S0191-8869(99)00160-9; Baron-Cohen S, 2002, TRENDS COGN SCI, V6, P248, DOI 10.1016/S1364-6613(02)01904-6; Bremner JD, 2000, AM J PSYCHIAT, V157, P115, DOI 10.1176/ajp.157.1.115; Carney MA, 2000, J CONSULT CLIN PSYCH, V68, P788, DOI 10.1037/0022-006X.68.5.788; Craig A, 2009, PERS INDIV DIFFER, V46, P111, DOI 10.1016/j.paid.2008.09.011; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Domes G, 2010, HUM BRAIN MAPP, V31, P758, DOI 10.1002/hbm.20903; EAGLY AH, 1986, PSYCHOL BULL, V100, P309, DOI 10.1037/0033-2909.100.3.309; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Extremera N, 2007, PERS INDIV DIFFER, V42, P1069, DOI 10.1016/j.paid.2006.09.014; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Gray, 2012, MEN ARE MARS WOMEN A; Harenski CL, 2006, NEUROIMAGE, V30, P313, DOI 10.1016/j.neuroimage.2005.09.034; Hartley CA, 2010, NEUROPSYCHOPHARMACOL, V35, P136, DOI 10.1038/npp.2009.121; Hastings RS, 2004, NEUROPSYCHOPHARMACOL, V29, P952, DOI 10.1038/sj.npp.1300371; Holland PC, 1999, TRENDS COGN SCI, V3, P65, DOI 10.1016/S1364-6613(98)01271-6; Iidaka T, 2003, HIPPOCAMPUS, V13, P429, DOI 10.1002/hipo.10059; Jha AP, 2006, BRAIN RES, V1097, P133, DOI 10.1016/j.brainres.2006.02.039; KESSLER RC, 1993, J AFFECT DISORDERS, V29, P85, DOI 10.1016/0165-0327(93)90026-G; Killgore WDS, 2012, NEUROREPORT, V23, P551, DOI 10.1097/WNR.0b013e32835446f7; Kim SH, 2007, J COGNITIVE NEUROSCI, V19, P776, DOI 10.1162/jocn.2007.19.5.776; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Kong F, 2013, PERS INDIV DIFFER, V54, P197, DOI 10.1016/j.paid.2012.08.028; Kong F, 2012, PERS INDIV DIFFER, V53, P1039, DOI 10.1016/j.paid.2012.07.032; Koven NS, 2011, SOC COGN AFFECT NEUR, V6, P582, DOI 10.1093/scan/nsq084; Krueger F, 2009, P NATL ACAD SCI USA, V106, P22486, DOI 10.1073/pnas.0912568106; Law KS, 2004, J APPL PSYCHOL, V89, P483, DOI 10.1037/0021-9010.89.3.483; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Mak AKY, 2009, NEUROPSYCHOLOGIA, V47, P2900, DOI 10.1016/j.neuropsychologia.2009.06.017; Matud MP, 2004, PERS INDIV DIFFER, V37, P1401, DOI 10.1016/j.paid.2004.01.010; Mcrae K, 2008, GROUP PROCESS INTERG, V11, P143, DOI 10.1177/1368430207088035; Mesulam M., 2000, PRINCIPLES BEHAV COG; Mikolajczak M, 2007, J PERS ASSESS, V88, P338, DOI 10.1080/00223890701333431; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Ochsner KN, 2012, ANN NY ACAD SCI, V1251, pE1, DOI 10.1111/j.1749-6632.2012.06751.x; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; OPPENHEIMER SM, 1992, NEUROLOGY, V42, P1727, DOI 10.1212/WNL.42.9.1727; Ortigue S, 2007, NEUROIMAGE, V37, P551, DOI 10.1016/j.neuroimage.2007.05.026; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Phelps EA, 2006, ANNU REV PSYCHOL, V57, P27, DOI 10.1146/annurev.psych.56.091103.070234; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; PTACEK JT, 1994, PERS SOC PSYCHOL B, V20, P421, DOI 10.1177/0146167294204009; Rosso IM, 2005, BIOL PSYCHIAT, V57, P21, DOI 10.1016/j.biopsych.2004.10.027; Saklofske DH, 2003, PERS INDIV DIFFER, V34, P707, DOI 10.1016/S0191-8869(02)00056-9; Sheline YI, 1999, J NEUROSCI, V19, P5034; Shi JQ, 2007, PERS INDIV DIFFER, V43, P377, DOI 10.1016/j.paid.2006.12.012; Steffens DC, 2000, BIOL PSYCHIAT, V48, P301, DOI 10.1016/S0006-3223(00)00829-5; Takeuchi H, 2011, HUM BRAIN MAPP, V32, P1497, DOI 10.1002/hbm.21122; Tang YQ, 2007, PSYCHIAT RES-NEUROIM, V156, P83, DOI 10.1016/j.pscychresns.2007.03.005; Thayer JF, 2000, J AFFECT DISORDERS, V61, P201, DOI 10.1016/S0165-0327(00)00338-4; Vakili K, 2000, BIOL PSYCHIAT, V47, P1087, DOI 10.1016/S0006-3223(99)00296-6; Van Rooy DL, 2005, PERS INDIV DIFFER, V38, P689, DOI 10.1016/j.paid.2004.05.023; Vrticka P, 2011, NEUROPSYCHOLOGIA, V49, P1067, DOI 10.1016/j.neuropsychologia.2011.02.020; Vythilingam M, 2002, AM J PSYCHIAT, V159, P2072, DOI 10.1176/appi.ajp.159.12.2072; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Ward B. D., 2000, SIMULTANEOUS INFEREN, DOI https://afni.nimh.nih.gov/pub/dist/doc/manuals/AlphaSim.pdf; Whalen PJ, 1998, CURR DIR PSYCHOL SCI, V7, P177, DOI 10.1111/1467-8721.ep10836912; Whittle S, 2011, BIOL PSYCHOL, V87, P319, DOI 10.1016/j.biopsycho.2011.05.003; Wong CS, 2002, LEADERSHIP QUART, V13, P243, DOI 10.1016/S1048-9843(02)00099-1; Yamasue H, 2008, CEREB CORTEX, V18, P2331, DOI 10.1093/cercor/bhm254	73	56	56	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97071	10.1371/journal.pone.0097071	http://dx.doi.org/10.1371/journal.pone.0097071			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM1NZ	24835267	gold, Green Submitted, Green Published			2022-12-27	WOS:000339614800026
J	Pearson-Fuhrhop, KM; Dunn, EC; Mortero, S; Devan, WJ; Falcone, GJ; Lee, P; Holmes, AJ; Hollinshead, MO; Roffman, JL; Smoller, JW; Rosand, J; Cramer, SC				Pearson-Fuhrhop, Kristin M.; Dunn, Erin C.; Mortero, Sarah; Devan, William J.; Falcone, Guido J.; Lee, Phil; Holmes, Avram J.; Hollinshead, Marisa O.; Roffman, Joshua L.; Smoller, Jordan W.; Rosand, Jonathan; Cramer, Steven C.			Dopamine Genetic Risk Score Predicts Depressive Symptoms in Healthy Adults and Adults with Depression	PLOS ONE			English	Article							VAL(108/158) MET GENOTYPE; RECEPTOR GENE; TARDIVE-DYSKINESIA; SER9GLY POLYMORPHISM; PARKINSONS-DISEASE; ASTERISK-D; ASSOCIATION; PROFILE; COMT; D2	Background: Depression is a common source of human disability for which etiologic insights remain limited. Although abnormalities of monoamine neurotransmission, including dopamine, are theorized to contribute to the pathophysiology of depression, evidence linking dopamine-related genes to depression has been mixed. The current study sought to address this knowledge-gap by examining whether the combined effect of dopamine polymorphisms was associated with depressive symptomatology in both healthy individuals and individuals with depression. Methods: Data were drawn from three independent samples: (1) a discovery sample of healthy adult participants (n = 273); (2) a replication sample of adults with depression (n = 1,267); and (3) a replication sample of healthy adult participants (n = 382). A genetic risk score was created by combining functional polymorphisms from five genes involved in synaptic dopamine availability (COMT and DAT) and dopamine receptor binding (DRD1, DRD2, DRD3). Results: In the discovery sample, the genetic risk score was associated with depressive symptomatology (beta = -0.80, p = 0.003), with lower dopamine genetic risk scores (indicating lower dopaminergic neurotransmission) predicting higher levels of depression. This result was replicated with a similar genetic risk score based on imputed genetic data from adults with depression (beta = -0.51, p = 0.04). Results were of similar magnitude and in the expected direction in a cohort of healthy adult participants (beta = -0.86, p = 0.15). Conclusions: Sequence variation in multiple genes regulating dopamine neurotransmission may influence depressive symptoms, in a manner that appears to be additive. Further studies are required to confirm the role of genetic variation in dopamine metabolism and depression.	[Pearson-Fuhrhop, Kristin M.; Mortero, Sarah; Cramer, Steven C.] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA; [Dunn, Erin C.; Devan, William J.; Falcone, Guido J.; Lee, Phil; Smoller, Jordan W.; Rosand, Jonathan] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Dunn, Erin C.; Lee, Phil; Holmes, Avram J.; Roffman, Joshua L.; Smoller, Jordan W.] Harvard Univ, Sch Med, Dept Psychiat, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Dunn, Erin C.; Lee, Phil; Smoller, Jordan W.] Broad Inst Harvard & MIT, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Holmes, Avram J.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [Hollinshead, Marisa O.] Harvard Univ, Dept Psychol, Ctr Brain Sci, Cambridge, MA 02138 USA; [Rosand, Jonathan] Harvard Univ, Sch Med, Dept Neurol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Rosand, Jonathan] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Cramer, Steven C.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA	University of California System; University of California Irvine; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Yale University; Harvard University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California Irvine	Cramer, SC (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA.	scramer@uci.edu	Fuhrhop, Kristin Pearson/AAD-5596-2021; Dunn, Erin C./AFM-9511-2022; Falcone, Guido/L-2287-2016; Roffman, Joshua/G-8228-2012	Dunn, Erin C./0000-0003-1413-3229; Falcone, Guido/0000-0002-6407-0302; Roffman, Joshua/0000-0003-4073-532X; Holmes, Avram/0000-0001-6583-803X	NIH [R01 NS058755, 5M011 RR-00827-29]; American Heart Association; Science of Health and Development Initiative at the Center on the Developing Child at Harvard University; NIMH [K24 MH094614, K01MH099232]; National Center for Research Resources; National Center for Advancing Translational Sciences, National Institutes of Health [UL1 TR000153]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K24HD074722] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000153] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH094614, K01MH099232, K99MH101367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058755] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Science of Health and Development Initiative at the Center on the Developing Child at Harvard University; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work has been supported by NIH grants R01 NS058755 (to SCC) and 5M011 RR-00827-29 (to UC Irvine), and a predoctoral fellowship from the American Heart Association (to KMPF). ECD was supported by the Science of Health and Development Initiative at the Center on the Developing Child at Harvard University and JWS was supported by NIMH grant K24 MH094614. The project described was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1 TR000153. AJH was supported by the NIMH grant K01MH099232. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker PR, 2006, SCHIZOPHR RES, V83, P185, DOI 10.1016/j.schres.2006.01.010; Berthele A, 2005, NEUROIMAGE, V28, P185, DOI 10.1016/j.neuroimage.2005.05.030; Bosker FJ, 2011, MOL PSYCHIATR, V16, P516, DOI 10.1038/mp.2010.38; Cabib S, 1996, PSYCHOPHARMACOLOGY, V128, P331, DOI 10.1007/s002130050142; Calhoon GG, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00168; CICHON S, 1994, HUM MOL GENET, V3, P209, DOI 10.1093/hmg/3.1.209; Comings DE, 1997, MOL PSYCHIATR, V2, P44, DOI 10.1038/sj.mp.4000207; Corrigan MH, 2000, DEPRESS ANXIETY, V11, P58, DOI 10.1002/(SICI)1520-6394(2000)11:2<58::AID-DA2>3.0.CO;2-H; D'Aquila PS, 2000, EUR J PHARMACOL, V405, P365, DOI 10.1016/S0014-2999(00)00566-5; Dmitrzak-Weglarz M, 2006, NEUROPSYCHOBIOLOGY, V53, P46, DOI 10.1159/000090703; Dunlop BW, 2007, ARCH GEN PSYCHIAT, V64, P327, DOI 10.1001/archpsyc.64.3.327; Dunn EC, 2011, J CHILD PSYCHOL PSYC, V52, P1223, DOI 10.1111/j.1469-7610.2011.02466.x; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Erro R, 2012, J NEUROL NEUROSURG P; Fava M, 2003, PSYCHIAT CLIN N AM, V26, P457, DOI 10.1016/S0193-953X(02)00107-7; Fuke S., 2001, Pharmacogenomics Journal, V1, P152; Garriock HA, 2010, BIOL PSYCHIAT, V67, P133, DOI 10.1016/j.biopsych.2009.08.029; Gershon AA, 2007, BIOL PSYCHIAT, V61, P145, DOI 10.1016/j.biopsych.2006.05.031; Gilbert DL, 2006, BRAIN, V129, P2038, DOI 10.1093/brain/awl147; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hauser RA, 2009, MOVEMENT DISORD, V24, P2328, DOI 10.1002/mds.22759; Heinz A, 2000, NEUROPSYCHOPHARMACOL, V22, P133, DOI 10.1016/S0893-133X(99)00099-8; Hek K, 2013, BIOL PSYCHIAT; Hirschfeld RMA, 2000, J CLIN PSYCHIAT, V61, P4; Holmes AJ, 2012, J NEUROSCI, V32, P18087, DOI 10.1523/JNEUROSCI.2531-12.2012; Hori H, 2012, SCI WORLD J, DOI 10.1100/2012/372474; Huang J, 2010, AM J PSYCHIAT, V167, P1254, DOI 10.1176/appi.ajp.2010.09091335; Huang W, 2008, HUM GENET, V123, P133, DOI 10.1007/s00439-007-0453-9; Inoue-Murayama M, 2002, NEUROSCI LETT, V334, P206, DOI 10.1016/S0304-3940(02)01125-4; Jeanneteau F, 2006, P NATL ACAD SCI USA, V103, P10753, DOI 10.1073/pnas.0508189103; Kang AM, 1999, BIOL PSYCHIAT, V46, P151, DOI 10.1016/S0006-3223(99)00101-8; KAPUR S, 1992, BIOL PSYCHIAT, V32, P1, DOI 10.1016/0006-3223(92)90137-O; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Lieberman A, 2006, ACTA NEUROL SCAND, V113, P1, DOI 10.1111/j.1600-0404.2006.00536.x; Limosin F, 2003, ALCOHOL CLIN EXP RES, V27, P1226, DOI 10.1097/01.ALC.0000081624.57507.87; Lopez-Leon S, 2008, MOL PSYCHIATR, V13, P772, DOI 10.1038/sj.mp.4002088; Lotrich FE, 2011, PSYCHIAT CLIN N AM, V34, P357, DOI 10.1016/j.psc.2011.02.003; Luft AR, 2009, INT J DEV NEUROSCI, V27, P415, DOI 10.1016/j.ijdevneu.2009.05.004; Maletic V, 2007, INT J CLIN PRACT, V61, P2030, DOI 10.1111/j.1742-1241.2007.01602.x; Mannisto PT, 1999, PHARMACOL REV, V51, P593; McNair D.M., 1971, MANUAL PROFILES MOOD; Mihara K, 2003, AM J MED GENET B, V117B, P57, DOI 10.1002/ajmg.b.10025; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Nikolova YS, 2011, NEUROPSYCHOPHARMACOL, V36, P1940, DOI 10.1038/npp.2011.82; NOBLE EP, 1994, MED HYPOTHESES, V42, P257, DOI 10.1016/0306-9877(94)90127-9; O'Tuathaigh CMP, 2012, CNS NEUROL DISORD-DR, V11, P282; Opmeer EM, 2010, PROG NEUROBIOL, V92, P112, DOI 10.1016/j.pneurobio.2010.06.003; Pearson-Fuhrhop KM, 2013, PLOS ONE IN PRESS; Pharoah PDP, 2008, NEW ENGL J MED, V358, P2796, DOI 10.1056/NEJMsa0708739; Pizzagalli DA, 2014, ANNU REV CLIN PSYCHO, V10, P393, DOI 10.1146/annurev-clinpsy-050212-185606; Pohjalainen T, 1998, MOL PSYCHIATR, V3, P256, DOI 10.1038/sj.mp.4000350; POLLOCK V, 1979, J NERV MENT DIS, V167, P612, DOI 10.1097/00005053-197910000-00004; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Roffman JL, 2013, SCHIZOPHRENIA BULL, V39, P330, DOI 10.1093/schbul/sbr150; Rush AJ, 2003, AM J PSYCHIAT, V160, P237, DOI 10.1176/appi.ajp.160.2.237; Salamone JD, 2012, NEURON, V76, P470, DOI 10.1016/j.neuron.2012.10.021; Savitz J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054108; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SHACHAM S, 1983, J PERS ASSESS, V47, P305, DOI 10.1207/s15327752jpa4703_14; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Shyn SI, 2011, MOL PSYCHIATR, V16, P202, DOI 10.1038/mp.2009.125; Stice E, 2012, J NEUROSCI, V32, P10093, DOI 10.1523/JNEUROSCI.1506-12.2012; STRANGE PG, 1991, TRENDS PHARMACOL SCI, V12, P48, DOI 10.1016/0165-6147(91)90494-D; Sullivan P, 2012, MOL PSYCHIATR, V17, P2, DOI 10.1038/mp.2011.94; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Tabachnick B. G., 2013, USING MULTIVARIATE S; Thompson J, 1997, PHARMACOGENETICS, V7, P479, DOI 10.1097/00008571-199712000-00006; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28; Tsai HT, 2010, AM J MED GENET B, V153B, P57, DOI 10.1002/ajmg.b.30946; Tye KM, 2013, NATURE, V493, P537, DOI 10.1038/nature11740; WADDINGTON JL, 1986, BIOCHEM PHARMACOL, V35, P3661, DOI 10.1016/0006-2952(86)90649-0; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Wise RA, 2009, TRENDS NEUROSCI, V32, P517, DOI 10.1016/j.tins.2009.06.004; Woo SI, 2002, PSYCHIAT CLIN NEUROS, V56, P469, DOI 10.1046/j.1440-1819.2002.01038.x; Wu K, 2012, BRAIN, V135, P2449, DOI 10.1093/brain/aws157; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819	78	48	49	6	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e93772	10.1371/journal.pone.0093772	http://dx.doi.org/10.1371/journal.pone.0093772			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24834916	Green Published, gold			2022-12-27	WOS:000339614800003
J	Tsuchiya, Y; Pham, U; Hu, WZ; Ohnuma, S; Gout, I				Tsuchiya, Yugo; Pham, Uyen; Hu, Wanzhou; Ohnuma, Shin-ichi; Gout, Ivan			Changes in Acetyl CoA Levels during the Early Embryonic Development of Xenopus laevis	PLOS ONE			English	Article							HISTONE ACETYLATION; TISSUE-EXTRACTS; MALONYL-COA; RAT-LIVER; COENZYME; METABOLISM; CELLS; TRANSCRIPTION; COMMITMENT; HEART	Coenzyme A (CoA) is a ubiquitous and fundamental intracellular cofactor. CoA acts as a carrier of metabolically important carboxylic acids in the form of CoA thioesters and is an obligatory component of a multitude of catabolic and anabolic reactions. Acetyl CoA is a CoA thioester derived from catabolism of all major carbon fuels. This metabolite is at a metabolic crossroads, either being further metabolised as an energy source or used as a building block for biosynthesis of lipids and cholesterol. In addition, acetyl CoA serves as the acetyl donor in protein acetylation reactions, linking metabolism to protein post-translational modifications. Recent studies in yeast and cultured mammalian cells have suggested that the intracellular level of acetyl CoA may play a role in the regulation of cell growth, proliferation and apoptosis, by affecting protein acetylation reactions. Yet, how the levels of this metabolite change in vivo during the development of a vertebrate is not known. We measured levels of acetyl CoA, free CoA and total short chain CoA esters during the early embryonic development of Xenopus laevis using HPLC. Acetyl CoA and total short chain CoA esters start to increase around midblastula transition (MBT) and continue to increase through stages of gastrulation, neurulation and early organogenesis. Pre-MBT embryos contain more free CoA relative to acetyl CoA but there is a shift in the ratio of acetyl CoA to CoA after MBT, suggesting a metabolic transition that results in net accumulation of acetyl CoA. At the whole-embryo level, there is an apparent correlation between the levels of acetyl CoA and levels of acetylation of a number of proteins including histones H3 and H2B. This suggests the level of acetyl CoA may be a factor, which determines the degree of acetylation of these proteins, hence may play a role in the regulation of embryogenesis.	[Tsuchiya, Yugo; Pham, Uyen; Gout, Ivan] UCL, Inst Struct & Mol Biol, London, England; [Hu, Wanzhou; Ohnuma, Shin-ichi] UCL, UCL Inst Ophthalmol, London, England	University of London; Birkbeck University London; University College London; University of London; University College London	Gout, I (corresponding author), UCL, Inst Struct & Mol Biol, London, England.	i.gout@ucl.ac.uk		Ohnuma, Shin-ichi/0000-0002-3305-5126	Association for International Cancer Research [09-0787]; Biotechnology and Biological Sciences Research Council [BB/L010410/1] Funding Source: researchfish; Worldwide Cancer Research [09-0787] Funding Source: researchfish; BBSRC [BB/L010410/1] Funding Source: UKRI	Association for International Cancer Research; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Worldwide Cancer Research; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study is funded by the Association for International Cancer Research (www.aicr.org.uk Grant No. 09-0787). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLRED JB, 1969, ANAL BIOCHEM, V29, P293, DOI 10.1016/0003-2697(69)90312-1; Bracha AL, 2010, NAT CHEM BIOL, V6, P202, DOI 10.1038/NCHEMBIO.301; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; CORKEY BE, 1981, ANAL BIOCHEM, V118, P30, DOI 10.1016/0003-2697(81)90152-4; De Robertis EM, 2009, MECH DEVELOP, V126, P925, DOI 10.1016/j.mod.2009.08.004; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Galdieri L, 2012, J BIOL CHEM, V287, P23865, DOI 10.1074/jbc.M112.380519; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; HORIE S, 1986, J BIOCHEM, V99, P1345, DOI 10.1093/oxfordjournals.jbchem.a135602; Hu WZ, 2013, EXP EYE RES, V116, P109, DOI 10.1016/j.exer.2013.07.021; Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; KUDO N, 1995, J BIOL CHEM, V270, P17513, DOI 10.1074/jbc.270.29.17513; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Legube G, 2003, EMBO REP, V4, P944, DOI 10.1038/sj.embor.embor941; Leonardi R, 2005, PROG LIPID RES, V44, P125, DOI 10.1016/j.plipres.2005.04.001; Marino G, 2014, MOL CELL, V53, P710, DOI 10.1016/j.molcel.2014.01.016; Mischerikow N, 2011, PROTEOMICS, V11, P571, DOI 10.1002/pmic.201000397; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Nicklay JJ, 2009, J BIOL CHEM, V284, P1075, DOI 10.1074/jbc.M807274200; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; O'Farrell PH, 2004, CURR BIOL, V14, pR35, DOI 10.1016/j.cub.2003.12.022; Peserico A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/371832; REIBEL DK, 1981, AM J PHYSIOL, V240, pH606, DOI 10.1152/ajpheart.1981.240.4.H606; Saggerson D, 2008, ANNU REV NUTR, V28, P253, DOI 10.1146/annurev.nutr.28.061807.155434; Schneider TD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022548; Shechter D, 2009, J BIOL CHEM, V284, P1064, DOI 10.1074/jbc.M807273200; Shi L, 2013, P NATL ACAD SCI USA, V110, P7318, DOI 10.1073/pnas.1302490110; Shimozono S, 2013, NATURE, V496, P363, DOI 10.1038/nature12037; Siudeja K, 2011, EMBO MOL MED, V3, P755, DOI 10.1002/emmm.201100180; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; SMITH CM, 1980, BIOCHEM J, V188, P175, DOI 10.1042/bj1880175; SMITH CM, 1978, J NUTR, V108, P854, DOI 10.1093/jn/108.5.854; SNAPE A, 1987, DEV BIOL, V119, P503, DOI 10.1016/0012-1606(87)90053-4; Solnica-Krezel L, 2012, ANNU REV CELL DEV BI, V28, P687, DOI 10.1146/annurev-cellbio-092910-154043; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; TUBBS PK, 1964, BIOCHEM J, V93, P550, DOI 10.1042/bj0930550; Vastag Livia, 2011, PLoS One, V6, pe16881, DOI 10.1371/journal.pone.0016881; Verdone Loredana, 2006, Briefings in Functional Genomics & Proteomics, V5, P209, DOI 10.1093/bfgp/ell028; Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; WYLIE CC, 1987, DEV BIOL, V119, P496, DOI 10.1016/0012-1606(87)90052-2; Xing SF, 2012, TRENDS PLANT SCI, V17, P423, DOI 10.1016/j.tplants.2012.03.008; Yi CH, 2011, CELL, V146, P607, DOI 10.1016/j.cell.2011.06.050; Zhao S, 2012, SCIENCE, V327, P1000	46	23	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97693	10.1371/journal.pone.0097693	http://dx.doi.org/10.1371/journal.pone.0097693			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831956	Green Published, Green Submitted, gold			2022-12-27	WOS:000336789500103
J	Alechine, E; Corach, D				Alechine, Evguenia; Corach, Daniel			High-Throughput Screening for Spermatogenesis Candidate Genes in the AZFc Region of the Y Chromosome by Multiplex Real Time PCR Followed by High Resolution Melting Analysis	PLOS ONE			English	Article							DELETION; MICRODELETIONS; RECOMBINATION; PALINDROMES; EXPRESSION; PROTEIN	Microdeletions in the AZF region of the Y chromosome are among the most frequent genetic causes of male infertility, although the specific role of the genes located in this region is not fully understood. AZFa and AZFb deletions impair spermatogenesis since no spermatozoa are found in the testis. Deletions of the AZFc region, despite being the most frequent in azoospermic patients, do not correlate with spermatogenic failure. Therefore, the aim of this work was to develop a screening method to ascertain the presence of the main spermatogenesis candidate genes located in the AZFc region in the light of the identification of those responsible for spermatogenic failure. DAZ, CDY, BPY2, PRY, GOLGA2LY and CSGP4LY genes were selected on the basis of their location in the AZFc region, testis-only expression, and confirmed or predicted protein codification. AMEL and SRY were used as amplification controls. The identification of Real Time PCR products was performed by High Resolution Melting analysis with SYTO 9 as intercalating dye. The herein described method allows a rapid, simple, low-cost, high-throughput screening for deletions of the main AZFc genes in patients with spermatogenic failure. This provides a strategy that would accelerate the identification of spermatogenesis candidate genes in larger populations of patients with non-obstructive idiopathic azoospermia.	[Alechine, Evguenia; Corach, Daniel] Univ Buenos Aires, Fac Farm & Bioquim, Serv Huellas Digitales Genet, RA-1113 Buenos Aires, DF, Argentina	University of Buenos Aires	Corach, D (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Serv Huellas Digitales Genet, RA-1113 Buenos Aires, DF, Argentina.	dcorach@yahoo.com		Alechine, Evguenia/0000-0001-6002-3093	National Research Council of Argentina (CONICET) (PIP) [1120110100914]; UBACyT [2011-2014 GC]	National Research Council of Argentina (CONICET) (PIP)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); UBACyT	This work was supported by the National Research Council of Argentina (CONICET) (PIP N o1120110100914) and UBACyT (2011-2014 GC) grants awarded to DC. DC in Principal Research fellow and EA is a Doctoral fellow of CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Eischeid Anne C, 2011, BMC Res Notes, V4, P263, DOI 10.1186/1756-0500-4-263; Ferlin A, 2007, J CLIN ENDOCR METAB, V92, P762, DOI 10.1210/jc.2006-1981; Ferlin A, 2006, REPROD TOXICOL, V22, P133, DOI 10.1016/j.reprotox.2006.04.016; Fernandes S, 2002, MOL HUM REPROD, V8, P286, DOI 10.1093/molehr/8.3.286; Foresta C, 2001, HUM REPROD, V16, P1543, DOI 10.1093/humrep/16.8.1543; Foresta C, 2000, HUM MOL GENET, V9, P1161, DOI 10.1093/hmg/9.8.1161; Huang WJ, 2008, HUM REPROD, V23, P1280, DOI 10.1093/humrep/den099; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757; Kozina V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023174; Krausz C, 2009, J MED GENET, V46, P21, DOI 10.1136/jmg.2008.059915; Kumari A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041488, 10.1371/journal.pone.0041230]; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; Lahn BT, 2002, P NATL ACAD SCI USA, V99, P8707, DOI 10.1073/pnas.082248899; Monis PT, 2005, ANAL BIOCHEM, V340, P24, DOI 10.1016/j.ab.2005.01.046; Moro E, 2000, J CLIN ENDOCR METAB, V85, P4069, DOI 10.1210/jc.85.11.4069; Noordam MJ, 2011, HUM MOL GENET, V20, P2457, DOI 10.1093/hmg/ddr119; Oklander LI, 2007, MOL ECOL NOTES, V7, P117, DOI 10.1111/j.1471-8286.2006.01529.x; Reijo RA, 2000, BIOL REPROD, V63, P1490, DOI 10.1095/biolreprod63.5.1490; Repping S, 2002, AM J HUM GENET, V71, P906, DOI 10.1086/342928; Rozen S, 2000, Methods Mol Biol, V132, P365; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; Simoni M, 2004, INT J ANDROL, V27, P240, DOI 10.1111/j.1365-2605.2004.00495.x; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Sun C, 2000, HUM MOL GENET, V9, P2291, DOI 10.1093/oxfordjournals.hmg.a018920; TIEPOLO L, 1976, HUM GENET, V34, P119, DOI 10.1007/BF00278879; Vogt PH, 1996, HUM MOL GENET, V5, P933, DOI 10.1093/hmg/5.7.933; Wong EYM, 2004, BIOL REPROD, V70, P775, DOI 10.1095/biolreprod.103.018531; Yang Y, 2010, INT J ANDROL, V33, P745, DOI 10.1111/j.1365-2605.2009.01015.x; Zuccarelli G, 2011, FORENSIC SCI INT-GEN, V5, P105, DOI 10.1016/j.fsigen.2010.08.018	29	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97227	10.1371/journal.pone.0097227	http://dx.doi.org/10.1371/journal.pone.0097227			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828879	gold, Green Published, Green Submitted			2022-12-27	WOS:000336857400065
J	Lo, CW; Chang, Y; Lee, JL; Tsai, WB; Chen, WS				Lo, Chia-Wen; Chang, Yung; Lee, Jyun-Lin; Tsai, Wei-Bor; Chen, Wen-Shiang			Tertiary-Amine Functionalized Polyplexes Enhanced Cellular Uptake and Prolonged Gene Expression	PLOS ONE			English	Article							IN-VIVO; TRANSFECTION EFFICIENCY; MOLECULAR-WEIGHT; PLASMID DNA; SKELETAL-MUSCLE; THERAPEUTIC ULTRASOUND; MICROBUBBLE ULTRASOUND; DELIVERY-SYSTEMS; PEI-DNA; POLYETHYLENIMINE	Ultrasound (US) has been found to facilitate the transport of DNA across cell membranes. However, the transfection efficiency is generally low, and the expression duration of the transfected gene is brief. In this study, a tertiary polycation, Poly(2-(dimethylamino) ethyl methacrylate) (PDMAEMA), was used as a carrier for US-mediated gene transfection. Its in-vitro and in-vivo effects on the transfection efficiency and the expression duration were evaluated. A mixture of pCI-neo-luc and PDMAEMA was transfected to cultured cells or mouse muscle by exposure to 1-MHz pulse US. A strong expression of luciferase was found 10 days after the transfection in vitro regardless of US exposure. However, effective transfection only occurred in the US groups in vivo. The transfection ability depended on the weight ratio of PDMAEMA to DNA, and was different for the in-vitro and in-vivo conditions. Lower weight ratios, e.g., 0.25, exhibited better in-vivo expression for at least 45 days.	[Lo, Chia-Wen; Lee, Jyun-Lin; Chen, Wen-Shiang] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Lo, Chia-Wen; Lee, Jyun-Lin; Chen, Wen-Shiang] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Chang, Yung] Chung Yuan Christian Univ, R&D Ctr Membrane Technol, Taoyuan, Taiwan; [Chang, Yung] Chung Yuan Christian Univ, Dept Chem Engn, Taoyuan, Taiwan; [Tsai, Wei-Bor] Natl Taiwan Univ, Dept Chem Engn, Coll Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; Chung Yuan Christian University; Chung Yuan Christian University; National Taiwan University	Chen, WS (corresponding author), Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan.	wenshiang@gmail.com	Wen-shiang, Chen/B-4794-2009; Chang, Yung/B-4788-2011	Wen-shiang, Chen/0000-0003-1488-5164; Tsai, Wei-Bor/0000-0002-2316-5751	National Science Council of the Republic of China [NSC 100-2923-B-002-004-MY3, 100-2923-B-002-003-MY3]	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by Grant NSC 100-2923-B-002-004-MY3 and 100-2923-B-002-003-MY3 (SonInCaRe ANR-NSC project) from the National Science Council of the Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker A, 1997, GENE THER, V4, P773, DOI 10.1038/sj.gt.3300471; Bekeredjian R, 2006, ULTRASCHALL MED, V27, P134, DOI 10.1055/s-2005-858993; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Cai JG, 2011, MACROMOLECULES, V44, P2050, DOI 10.1021/ma102498g; Diebold SS, 1999, J BIOL CHEM, V274, P19087, DOI 10.1074/jbc.274.27.19087; dos Santos T, 2011, SMALL, V7, P3341, DOI 10.1002/smll.201101076; Duvshani-Eshet M, 2007, CANCER GENE THER, V14, P306, DOI 10.1038/sj.cgt.7701015; Duvshani-Eshet M, 2007, MOL CANCER THER, V6, P2371, DOI 10.1158/1535-7163.MCT-07-0019; El-Aneed A, 2004, J CONTROL RELEASE, V94, P1, DOI 10.1016/j.jconrel.2003.09.013; Fischer D, 1999, PHARMACEUT RES, V16, P1273, DOI 10.1023/A:1014861900478; Godbey WT, 1999, J BIOMED MATER RES, V45, P268, DOI 10.1002/(SICI)1097-4636(19990605)45:3<268::AID-JBM15>3.0.CO;2-Q; Godbey WT, 1999, J CONTROL RELEASE, V60, P149, DOI 10.1016/S0168-3659(99)00090-5; Greenleaf WJ, 1998, ULTRASOUND MED BIOL, V24, P587, DOI 10.1016/S0301-5629(98)00003-9; Hayashi S, 2009, CANCER GENE THER, V16, P638, DOI 10.1038/cgt.2008.1; Huang YC, 2005, HUM GENE THER, V16, P609, DOI 10.1089/hum.2005.16.609; Kinoshita M, 2007, BIOCHEM BIOPH RES CO, V359, P860, DOI 10.1016/j.bbrc.2007.05.153; Lee JL, 2012, J CONTROL RELEASE, V160, P64, DOI 10.1016/j.jconrel.2012.03.007; Li YS, 2009, CANCER LETT, V273, P62, DOI 10.1016/j.canlet.2008.07.030; Liao ZK, 2012, CANCER GENE THER, V19, P171, DOI 10.1038/cgt.2011.73; Lo CH, 2010, J GENE MED, V12, P423, DOI 10.1002/jgm.1452; Lu QL, 2003, GENE THER, V10, P396, DOI 10.1038/sj.gt.3301913; Mannermaa E, 2005, CURR EYE RES, V30, P345, DOI 10.1080/02713680590934058; Marshall E, 1999, SCIENCE, V286, P2244, DOI 10.1126/science.286.5448.2244; Mehier-Humbert S, 2005, J CONTROL RELEASE, V104, P203, DOI 10.1016/j.jconrel.2005.01.011; MeunierDurmort C, 1997, GENE THER, V4, P808, DOI 10.1038/sj.gt.3300450; Moret I, 2001, J CONTROL RELEASE, V76, P169, DOI 10.1016/S0168-3659(01)00415-1; Morimoto K, 2003, MOL THER, V7, P254, DOI 10.1016/S1525-0016(02)00053-9; Newman CMH, 2007, GENE THER, V14, P465, DOI 10.1038/sj.gt.3302925; Niidome T, 2002, GENE THER, V9, P1647, DOI 10.1038/sj.gt.3301923; Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775; Park TG, 2006, ADV DRUG DELIVER REV, V58, P467, DOI 10.1016/j.addr.2006.03.007; Putnam D, 2006, NAT MATER, V5, P439, DOI 10.1038/nmat1645; Shohet RV, 2000, CIRCULATION, V101, P2554, DOI 10.1161/01.CIR.101.22.2554; Somia N, 2000, NAT REV GENET, V1, P91, DOI 10.1038/35038533; Synatschke CV, 2011, BIOMACROMOLECULES, V12, P4247, DOI 10.1021/bm201111d; Taniyama Y, 2002, GENE THER, V9, P372, DOI 10.1038/sj.gt.3301678; vandeWetering P, 1997, J CONTROL RELEASE, V49, P59, DOI 10.1016/S0168-3659(97)00059-X; Verbaan F, 2003, EUR J PHARM SCI, V20, P419, DOI 10.1016/j.ejps.2003.09.005; Wang XH, 2005, RADIOLOGY, V237, P224, DOI 10.1148/radiol.2371040805; Zhang XQ, 2008, J MICROENCAPSUL, V25, P1, DOI 10.1080/02652040701659347 	40	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97627	10.1371/journal.pone.0097627	http://dx.doi.org/10.1371/journal.pone.0097627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827929	Green Submitted, Green Published, gold			2022-12-27	WOS:000336857400113
J	Tissier, ML; Williams, TD; Criscuolo, F				Tissier, Mathilde L.; Williams, Tony D.; Criscuolo, Francois			Maternal Effects Underlie Ageing Costs of Growth in the Zebra Finch (Taeniopygia guttata)	PLOS ONE			English	Article							OXIDATIVE STRESS; TELOMERE LENGTH; QUANTITATIVE PCR; SEX-DIFFERENCES; CORTICOSTERONE; YOLK; ESTRADIOL; RATES; AGE; 17-BETA-ESTRADIOL	Maternal effects provide a mechanism to adapt offspring phenotype and optimize the mother's fitness to current environmental conditions. Transferring steroids to the yolk is one way mothers can translate environmental information into potential adaptive signals for offspring. However, maternally-derived hormones might also have adverse effects for offspring. For example, recent data in zebra finch chicks suggested that ageing related-processes (i.e. oxidative stress and telomere loss) were increased after egg-injection of corticosterone (CORT). Still, we have few experimental data describing the effect of maternal effects on the growth-ageing trade-off in offspring. Here, we chronically treated pre-laying zebra finch females (Taeniopygia guttata) with 17-beta-estradiol (E-2) or CORT, and followed offspring growth and cellular ageing rates (oxidative stress and telomere loss). CORT treatment decreased growth rate in male chicks and increased rate of telomere loss in mothers and female offspring. E-2 increased body mass gain in male offspring, while reducing oxidative stress in both sexes but without affecting telomere loss. Since shorter telomeres were previously found to be a proxy of individual lifespan in zebra finches, maternal effects may, through pleiotropic effects, be important determinants of offspring life-expectancy by modulating ageing rate during embryo and post-natal growth.	[Tissier, Mathilde L.; Criscuolo, Francois] Univ Strasbourg, CNRS, Inst Pluridisciplinaire Hubert Curien, Dept Ecol Physiol & Ethol, Strasbourg, France; [Williams, Tony D.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Simon Fraser University	Tissier, ML (corresponding author), Univ Strasbourg, CNRS, Inst Pluridisciplinaire Hubert Curien, Dept Ecol Physiol & Ethol, Strasbourg, France.	mathilde.tissier@iphc.cnrs.fr; francois.criscuolo@iphc.cnrs.fr			Natural Sciences and Engineering Research Council; Centre National de la Recherche Scientifique (CNRS)	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This work was supported by Natural Sciences and Engineering Research Council Discovery Grant funding to TDW. M. Tissier and the present experiment were both partly funded by the Centre National de la Recherche Scientifique (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Alvarez C, 2004, ECOL LETT, V7, P363, DOI 10.1111/j.1461-0248.2004.00594.x; Arendt JD, 1997, Q REV BIOL, V72, P149, DOI 10.1086/419764; Barrett ELB, 2011, AGING CELL, V10, P913, DOI 10.1111/j.1474-9726.2011.00741.x; Beaulieu M, 2010, P ROY SOC B-BIOL SCI, V277, P1087, DOI 10.1098/rspb.2009.1881; BEHL C, 1995, BIOCHEM BIOPH RES CO, V216, P473, DOI 10.1006/bbrc.1995.2647; Bize P, 2009, P R SOC B, V276, P1679, DOI 10.1098/rspb.2008.1817; Blackburn, 2006, TELOMERES; Breuner CW, 2000, HORM BEHAV, V37, P23, DOI 10.1006/hbeh.1999.1554; CALOW P, 1982, AM NAT, V120, P416, DOI 10.1086/284001; Casagrande S, 2012, BEHAV ECOL SOCIOBIOL, V66, P1319, DOI 10.1007/s00265-012-1387-3; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chaki SP, 2006, APOPTOSIS, V11, P1427, DOI 10.1007/s10495-006-8761-4; Choi J, 2008, BRAIN BEHAV IMMUN, V22, P600, DOI 10.1016/j.bbi.2007.12.004; Christians JK, 1999, J EXP BIOL, V202, P2679; Costantini D, 2006, J COMP PHYSIOL B, V176, P329, DOI 10.1007/s00360-005-0055-6; Criscuolo F, 2011, OECOLOGIA, V167, P315, DOI 10.1007/s00442-011-1986-0; Criscuolo F, 2009, J AVIAN BIOL, V40, P342, DOI 10.1111/j.1600-048X.2008.04623.x; Daniali L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2602; Eng ML, 2013, ENVIRON TOXICOL CHEM, V32, P345, DOI 10.1002/etc.2033; Gam AE, 2011, J AVIAN BIOL, V42, P253, DOI 10.1111/j.1600-048X.2010.05251.x; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Hall ME, 2004, P ROY SOC B-BIOL SCI, V271, P1571, DOI 10.1098/rspb.2004.2768; Harvey S, 2013, GEN COMP ENDOCR, V190, P3, DOI 10.1016/j.ygcen.2013.01.008; Haussmann MF, 2012, P ROY SOC B-BIOL SCI, V279, P1447, DOI 10.1098/rspb.2011.1913; Haussmann MF, 2010, CURR ZOOL, V56, P714, DOI 10.1093/czoolo/56.6.714; Hayward LS, 2006, GEN COMP ENDOCR, V146, P144, DOI 10.1016/j.ygcen.2005.10.016; Hayward LS, 2004, GEN COMP ENDOCR, V135, P365, DOI 10.1016/j.ygcen.2003.11.002; Heidinger BJ, 2012, P NATL ACAD SCI USA, V109, P1743, DOI 10.1073/pnas.1113306109; Henriksen R, 2013, GEN COMP ENDOCR, V191, P83, DOI 10.1016/j.ygcen.2013.05.028; HO KY, 1987, J CLIN ENDOCR METAB, V64, P51, DOI 10.1210/jcem-64-1-51; Hoogenboom MO, 2012, COMP BIOCHEM PHYS A, V163, P379, DOI 10.1016/j.cbpa.2012.07.002; Itagaki T, 2005, GUT, V54, P1782, DOI 10.1136/gut.2005.053278; Jennings BJ, 1999, FEBS LETT, V448, P4, DOI 10.1016/S0014-5793(99)00336-1; Kilgas P, 2010, COMP BIOCHEM PHYS B, V157, P288, DOI 10.1016/j.cbpb.2010.07.002; Kim SY, 2010, J EVOLUTION BIOL, V23, P769, DOI 10.1111/j.1420-9101.2010.01942.x; Kimura M, 2010, EXP HEMATOL, V38, P854, DOI 10.1016/j.exphem.2010.06.010; Kozlowski CP, 2010, GEN COMP ENDOCR, V168, P460, DOI 10.1016/j.ygcen.2010.06.006; Kyo S, 1999, CANCER RES, V59, P5917; Love OP, 2008, HORM BEHAV, V53, P104, DOI 10.1016/j.yhbeh.2007.09.007; Love OP, 2008, AM NAT, V172, pE135, DOI 10.1086/590959; Love OP, 2003, INTEGR COMP BIOL, V43, P838; Marasco V, 2012, J EXP BIOL, V215, P3955, DOI 10.1242/jeb.071423; Martins TLF, 2004, BEHAV ECOL, V15, P174, DOI 10.1093/beheco/arg094; Metcalfe NB, 2003, EXP GERONTOL, V38, P935, DOI 10.1016/S0531-5565(03)00159-1; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Monaghan P, 2006, TRENDS ECOL EVOL, V21, P47, DOI 10.1016/j.tree.2005.11.007; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Oddie KR, 2000, J ANIM ECOL, V69, P903, DOI 10.1046/j.1365-2656.2000.00438.x; Petraitis PS, 1996, FUNCT ECOL, V10, P421, DOI 10.2307/2389934; Reichert S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081496; Saino N, 2005, J EXP ZOOL PART A, V303A, P998, DOI 10.1002/jez.a.224; Salomons HM, 2009, P ROY SOC B-BIOL SCI, V276, P3157, DOI 10.1098/rspb.2009.0517; Salvante KG, 2003, GEN COMP ENDOCR, V130, P205, DOI 10.1016/S0016-6480(02)00637-8; Schultner J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2090; Sheriff MJ, 2013, ECOL LETT, V16, P271, DOI 10.1111/ele.12042; Shipley B, 2004, CAUSE CORRELATION BI; Spencer KA, 2008, GEN COMP ENDOCR, V159, P250, DOI 10.1016/j.ygcen.2008.09.007; Tarry-Adkins JL, 2009, FASEB J, V23, P1521, DOI 10.1096/fj.08-122796; Thierry AM, 2013, THESIS U STRASBOURG; von Engelhardt N, 2004, HORM BEHAV, V45, P306, DOI 10.1016/j.yhbeh.2003.12.009; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Williams TD, 2005, P ROY SOC B-BIOL SCI, V272, P173, DOI 10.1098/rspb.2004.2935; Williams TD, 2005, BIOSCIENCE, V55, P39, DOI 10.1641/0006-3568(2005)055[0039:MUTCOE]2.0.CO;2; You YY, 2009, PROG NAT SCI-MATER, V19, P427, DOI 10.1016/j.pnsc.2008.05.035	65	42	42	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97705	10.1371/journal.pone.0097705	http://dx.doi.org/10.1371/journal.pone.0097705			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828412	Green Published, gold, Green Submitted			2022-12-27	WOS:000336857400119
J	Wen, X; Kurtz, I; Paine, ML				Wen, Xin; Kurtz, Ira; Paine, Michael L.			Prevention of the Disrupted Enamel Phenotype in Slc4a4-Null Mice Using Explant Organ Culture Maintained in a Living Host Kidney Capsule	PLOS ONE			English	Article							RENAL TUBULAR-ACIDOSIS; COTRANSPORTER NBCE1; METABOLIC-ACIDOSIS; MISSENSE MUTATION; MINERALIZATION; DEFECTS; BONE; HYPOPHOSPHATASIA; AMELOBLASTS; MATURATION	Slc4a4-null mice are a model of proximal renal tubular acidosis ( pRTA). Slc4a4 encodes the electrogenic sodium base transporter NBCe1 that is involved in transcellular base transport and pH regulation during amelogenesis. Patients with mutations in the SLC4A4 gene and Slc4a4-null mice present with dysplastic enamel, amongst other pathologies. Loss of NBCe1 function leads to local abnormalities in enamel matrix pH regulation. Loss of NBCe1 function also results in systemic acidemic blood pH. Whether local changes in enamel pH and/or a decrease in systemic pH are the cause of the abnormal enamel phenotype is currently unknown. In the present study we addressed this question by explanting fetal wild-type and Slc4a4-null mandibles into healthy host kidney capsules to study enamel formation in the absence of systemic acidemia. Mandibular E11.5 explants from NBCe1(-/-) mice, maintained in host kidney capsules for 70 days, resulted in teeth with enamel and dentin with morphological and mineralization properties similar to cultured NBCe1(+/+) mandibles grown under identical conditions. Ameloblasts express a number of proteins involved in dynamic changes in H+/base transport during amelogenesis. Despite the capacity of ameloblasts to dynamically modulate the local pH of the enamel matrix, at least in the NBCe1(-/-) mice, the systemic pH also appears to contribute to the enamel phenotype. Extrapolating these data to humans, our findings suggest that in patients with NBCe1 mutations, correction of the systemic metabolic acidosis at a sufficiently early time point may lead to amelioration of enamel abnormalities.	[Wen, Xin; Paine, Michael L.] Univ So Calif, Ctr Craniofacial Mol Biol, Herman Ostrow Sch Dent, Los Angeles, CA 90033 USA; [Kurtz, Ira] Univ Calif Los Angeles, David Geffen Sch Med, Div Nephrol, Los Angeles, CA 90095 USA; [Kurtz, Ira] Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA	University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Paine, ML (corresponding author), Univ So Calif, Ctr Craniofacial Mol Biol, Herman Ostrow Sch Dent, 2250 Alcazar St, Los Angeles, CA 90033 USA.	paine@usc.edu			National Institutes of Health [DE019629, DK077162]; The Donald T. Sterling Charitable Foundation; Factor Family Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077162] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Donald T. Sterling Charitable Foundation; Factor Family Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants DE019629 (MLP) and DK077162 (IK) from the National Institutes of Health, and The Donald T. Sterling Charitable Foundation and the Factor Family Foundation (IK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuladze N, 2000, GENE, V251, P109, DOI 10.1016/S0378-1119(00)00204-3; CUNHA GR, 1989, BIOL REPROD, V40, P861, DOI 10.1095/biolreprod40.4.861; Demirci FYK, 2006, MOL VIS, V12, P324; Descroix V, 2010, J DENT RES, V89, P1427, DOI 10.1177/0022034510379603; Dinour D, 2004, J BIOL CHEM, V279, P52238, DOI 10.1074/jbc.M406591200; Fan YW, 2011, ACTA BIOMATER, V7, P2293, DOI 10.1016/j.actbio.2011.01.028; Fukui N, 2000, ORAL SURG ORAL MED O, V89, P208, DOI 10.1067/moe.2000.103884; Gauvin R, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-24; Gawenis LR, 2007, J BIOL CHEM, V282, P9042, DOI 10.1074/jbc.M607041200; Harada H, 2006, BIOCHEM BIOPH RES CO, V340, P611, DOI 10.1016/j.bbrc.2005.12.053; Hu JCC, 2000, EUR J ORAL SCI, V108, P189, DOI 10.1034/j.1600-0722.2000.108003189.x; Inatomi J, 2004, PFLUG ARCH EUR J PHY, V448, P438, DOI 10.1007/s00424-004-1278-1; KOPPANG HS, 1984, SCAND J DENT RES, V92, P489; Kraut JA, 2001, AM J KIDNEY DIS, V38, P703, DOI 10.1053/ajkd.2001.27688; Kraut JA, 2010, NAT REV NEPHROL, V6, P274, DOI 10.1038/nrneph.2010.33; Kurtz I, 2013, SELDIN GIEBISCHS KID, P1837, DOI DOI 10.1016/B978-0-12-381462-3.00053-7; Lacruz RS, 2013, J DENT RES, V92, P122, DOI 10.1177/0022034512470954; Lacruz RS, 2010, J BIOL CHEM, V285, P24432, DOI 10.1074/jbc.M110.115188; Lacruz RS, 2010, CALCIFIED TISSUE INT, V86, P91, DOI 10.1007/s00223-009-9326-7; Le Norcy E, 2011, J DENT RES, V90, P1091, DOI 10.1177/0022034511411301; Liu Y, 2011, GENOMICS, V98, P112, DOI 10.1016/j.ygeno.2011.04.010; Masuyama R, 2001, ENDOCRINOLOGY, V142, P494, DOI 10.1210/en.142.1.494; McAlear SD, 2006, J GEN PHYSIOL, V127, P639, DOI 10.1085/jgp.200609520; McCance RA, 1961, LANCET, V277, P293; Moradian-Oldak J, 2012, FRONT BIOSCI-LANDMRK, V17, P1996, DOI 10.2741/4034; Muller F, 1996, CLIN CHEM, V42, P1855; Nanci A., 2008, 10 CATES ORAL HISTOL; Paine ML, 2008, J DENT RES, V87, P391, DOI 10.1177/154405910808700415; Palmer LC, 2008, CHEM REV, V108, P4754, DOI 10.1021/cr8004422; Parker MD, 2013, PHYSIOL REV, V93, P803, DOI 10.1152/physrev.00023.2012; Sabbagh Y, 2005, P NATL ACAD SCI USA, V102, P9637, DOI 10.1073/pnas.0502249102; Simmer JP, 2010, J DENT RES, V89, P1024, DOI 10.1177/0022034510375829; Smith C E, 1996, Adv Dent Res, V10, P159; Smith CE, 2005, J BONE MINER RES, V20, P240, DOI 10.1359/JBMR.041002; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; SPACKMAN T, 1963, OBSTET GYNECOL, V22, P785; Wang LJ, 2008, J PHYS CHEM C, V112, P5892, DOI 10.1021/jp077105+; Yadav MC, 2012, J BONE MINER RES, V27, P1722, DOI 10.1002/jbmr.1619; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391; ZEICHNERDAVID M, 1995, INT J DEV BIOL, V39, P69; Zhang XM, 2009, ARCH ORAL BIOL, V54, P1105, DOI 10.1016/j.archoralbio.2009.09.004; Zhang XM, 2009, ARCH ORAL BIOL, V54, P299, DOI 10.1016/j.archoralbio.2009.01.002	42	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97318	10.1371/journal.pone.0097318	http://dx.doi.org/10.1371/journal.pone.0097318			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828138	Green Published, gold, Green Submitted			2022-12-27	WOS:000336857400076
J	Wolfe, KJ; Ren, HY; Trepte, P; Cyr, DM				Wolfe, Katie J.; Ren, Hong Yu; Trepte, Philipp; Cyr, Douglas M.			Polyglutamine-Rich Suppressors of Huntingtin Toxicity Act Upstream of Hsp70 and Sti1 in Spatial Quality Control of Amyloid-Like Proteins	PLOS ONE			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; UBIQUITIN-PROTEASOME SYSTEM; MUTANT HUNTINGTIN; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; EXPANDED POLYGLUTAMINE; EXPANSION PROTEINS; ALZHEIMERS-DISEASE; CASPASE CLEAVAGE; BODY FORMATION	Protein conformational maladies such as Huntington Disease are characterized by accumulation of intracellular and extracellular protein inclusions containing amyloid-like proteins. There is an inverse correlation between proteotoxicity and aggregation, so facilitated protein aggregation appears cytoprotective. To define mechanisms for protective protein aggregation, a screen for suppressors of nuclear huntingtin (Htt103Q) toxicity was conducted. Nuclear Htt103Q is highly toxic and less aggregation prone than its cytosolic form, so we identified suppressors of cytotoxicity caused by Htt103Q tagged with a nuclear localization signal (NLS). High copy suppressors of Htt103Q-NLS toxicity include the polyQ-domain containing proteins Nab3, Pop2, and Cbk1, and each suppresses Htt toxicity via a different mechanism. Htt103Q-NLS appears to inactivate the essential functions of Nab3 in RNA processing in the nucleus. Function of Pop2 and Cbk1 is not impaired by nuclear Htt103Q, as their respective polyQ-rich domains are sufficient to suppress Htt103Q toxicity. Pop2 is a subunit of an RNA processing complex and is localized throughout the cytoplasm. Expression of just the Pop2 polyQ domain and an adjacent proline-rich stretch is sufficient to suppress Htt103Q toxicity. The proline-rich domain in Pop2 resembles an aggresome targeting signal, so Pop2 may act in trans to positively impact spatial quality control of Htt103Q. Cbk1 accumulates in discrete perinuclear foci and overexpression of the Cbk1 polyQ domain concentrates diffuse Htt103Q into these foci, which correlates with suppression of Htt toxicity. Protective action of Pop2 and Cbk1 in spatial quality control is dependent upon the Hsp70 co-chaperone Sti1, which packages amyloid-like proteins into benign foci. Protein: protein interactions between Htt103Q and its intracellular neighbors lead to toxic and protective outcomes. A subset of polyQ-rich proteins buffer amyloid toxicity by funneling toxic aggregation intermediates to the Hsp70/Sti1 system for spatial organization into benign species.	[Wolfe, Katie J.; Ren, Hong Yu; Cyr, Douglas M.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27515 USA; [Trepte, Philipp] Max Delbruck Ctr Mol Med, Berlin, Germany	University of North Carolina; University of North Carolina Chapel Hill; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Cyr, DM (corresponding author), Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27515 USA.	dmcyr@med.unc.edu		Trepte, Philipp/0000-0002-8141-6272; Cyr, Douglas/0000-0002-4928-3414	NIH [R01GM56981, R01GM067785, F31NS074777]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056981, R01GM067785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS074777] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NIH: R01GM56981, R01GM067785, and F31NS074777. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Benn CL, 2005, HUM MOL GENET, V14, P3065, DOI 10.1093/hmg/ddi340; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Bhattacharyya A, 2006, J MOL BIOL, V355, P524, DOI 10.1016/j.jmb.2005.10.053; Bilen J, 2007, PLOS GENET, V3, P1950, DOI 10.1371/journal.pgen.003177; Busch A, 2003, J BIOL CHEM, V278, P41452, DOI 10.1074/jbc.M303354200; CARLSON M, 1982, CELL, V28, P145, DOI 10.1016/0092-8674(82)90384-1; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; CYR DM, 1994, TRENDS BIOCHEM SCI, V19, P176, DOI 10.1016/0968-0004(94)90281-X; Darnell GD, 2009, BIOPHYS J, V97, P2295, DOI 10.1016/j.bpj.2009.07.062; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Dehay B, 2006, J BIOL CHEM, V281, P35608, DOI 10.1074/jbc.M605558200; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Doi H, 2004, FEBS LETT, V571, P171, DOI 10.1016/j.febslet.2004.06.077; Douglas PM, 2008, P NATL ACAD SCI USA, V105, P7206, DOI 10.1073/pnas.0802593105; Douglas PM, 2009, MOL BIOL CELL; Doumanis J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007275; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11051, DOI 10.1073/pnas.0604548103; Duennwald ML, 2008, GENE DEV, V22, P3308, DOI 10.1101/gad.1673408; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Furukawa Y, 2009, J NEUROSCI, V29, P5153, DOI 10.1523/JNEUROSCI.0783-09.2009; Giorgini F, 2005, NAT GENET, V37, P526, DOI 10.1038/ng1542; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Gong YC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.26; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hobor F, 2011, J BIOL CHEM, V286, P3645, DOI 10.1074/jbc.M110.158774; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Karlin S, 2002, P NATL ACAD SCI USA, V99, P333, DOI 10.1073/pnas.012608599; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; Kuemmerle S, 1999, ANN NEUROL, V46, P842; Lakhani VV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000772; Leitman J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3753; Lessing D, 2008, PLOS BIOL, V6, P266, DOI 10.1371/journal.pbio.0060029; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Malinovska L, 2012, MOL BIOL CELL; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; Peters MF, 1999, MOL CELL NEUROSCI, V14, P121, DOI 10.1006/mcne.1999.0773; Robertson AL, 2011, NUCLEIC ACIDS RES, V39, pD272, DOI 10.1093/nar/gkq1100; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Slow EJ, 2005, P NATL ACAD SCI USA, V102, P11402, DOI 10.1073/pnas.0503634102; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Summers DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052099; Treusch S, 2012, J CELL BIOL, V197, P369, DOI 10.1083/jcb.201108146; Treusch S, 2009, CELL CYCLE, V8, P1668, DOI 10.4161/cc.8.11.8503; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Wang Y, 2009, FASEB J, V23, P451, DOI 10.1096/fj.08-117614; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Weiss EL, 2002, J CELL BIOL, V158, P885, DOI 10.1083/jcb.200203094; Wellington CL, 2002, J NEUROSCI, V22, P7862; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; WILSON SM, 1994, J CELL BIOL, V127, P1173, DOI 10.1083/jcb.127.5.1173; Wolfe KJ, 2013, MOL BIOL CELL	77	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e95914	10.1371/journal.pone.0095914	http://dx.doi.org/10.1371/journal.pone.0095914			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828240	Green Published, gold, Green Accepted			2022-12-27	WOS:000336857400017
J	Xie, L; Chen, JL; Zhang, WZ; Wang, SZ; Zhao, TL; Huang, C; Wang, J; Yang, JF; Yang, YF; Tan, ZP				Xie, Li; Chen, Jin-Lan; Zhang, Wei-Zhi; Wang, Shou-Zheng; Zhao, Tian-Li; Huang, Can; Wang, Jian; Yang, Jin-Fu; Yang, Yi-Feng; Tan, Zhi-Ping			Rare De Novo Copy Number Variants in Patients with Congenital Pulmonary Atresia	PLOS ONE			English	Article							HEART-DEFECTS; DIHYDROFOLATE-REDUCTASE; FOLATE PATHWAY; GENES; RISK; TETRALOGY; MUTATIONS; ANEURYSMS; GENETICS; DISEASE	Background: Ongoing studies using genomic microarrays and next-generation sequencing have demonstrated that the genetic contributions to cardiovascular diseases have been significantly ignored in the past. The aim of this study was to identify rare copy number variants in individuals with congenital pulmonary atresia (PA). Methods and Results: Based on the hypothesis that rare structural variants encompassing key genes play an important role in heart development in PA patients, we performed high-resolution genome-wide microarrays for copy number variations (CNVs) in 82 PA patient-parent trios and 189 controls with an Illumina SNP array platform. CNVs were identified in 17/82 patients (20.7%), and eight of these CNVs (9.8%) are considered potentially pathogenic. Five de novo CNVs occurred at two known congenital heart disease (CHD) loci (16p13.1 and 22q11.2). Two de novo CNVs that may affect folate and vitamin B-12 metabolism were identified for the first time. A de novo 1-Mb deletion at 17p13.2 may represent a rare genomic disorder that involves mild intellectual disability and associated facial features. Conclusions: Rare CNVs contribute to the pathogenesis of PA (9.8%), suggesting that the causes of PA are heterogeneous and pleiotropic. Together with previous data from animal models, our results might help identify a link between CHD and folate-mediated one-carbon metabolism (FOCM). With the accumulation of high-resolution SNP array data, these previously undescribed rare CNVs may help reveal critical gene(s) in CHD and may provide novel insights about CHD pathogenesis.	[Xie, Li; Chen, Jin-Lan; Zhang, Wei-Zhi; Wang, Shou-Zheng; Zhao, Tian-Li; Huang, Can; Wang, Jian; Yang, Jin-Fu; Yang, Yi-Feng; Tan, Zhi-Ping] Cent S Univ, Xiangya Hosp 2, Dept Cardiothorac Surg, Changsha, Hunan, Peoples R China; [Wang, Jian; Yang, Jin-Fu; Yang, Yi-Feng; Tan, Zhi-Ping] Cent S Univ, Xiangya Hosp 2, State Key Lab Med Genet, Clin Ctr Gene Diag & Therapy, Changsha, Hunan, Peoples R China	Central South University; Central South University	Yang, YF (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Cardiothorac Surg, Changsha, Hunan, Peoples R China.	yyf627@163.com; tanzhiping@gmail.com			National High Technology Research and Development Program of China (863 Program) [2011AA02A112]; National Key Technology R&D Program of China [2012BAI09B05]; National Natural Science Foundation of China [81101475, 81370204, 81300072, 81200087]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Key Technology R&D Program of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We appreciate supports from the National High Technology Research and Development Program of China (863 Program) (2011AA02A112 to YYF), the National Key Technology R&D Program of China (2012BAI09B05 to YYF), the National Natural Science Foundation of China (81101475 to TZP, 81370204 to YYF, 81300072 to CJL, and 81200087 to ZWZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amark KM, 2006, J AM COLL CARDIOL, V47, P1448, DOI 10.1016/j.jacc.2005.10.068; Andersen TA, 2014, CELL MOL LIFE SCI, V71, P1327, DOI 10.1007/s00018-013-1430-1; Arrington CB, 2012, CIRC-CARDIOVASC GENE, V5, P175, DOI 10.1161/CIRCGENETICS.111.961797; Bansal V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085375; Barc Julien, 2011, J Am Coll Cardiol, V57, P40, DOI 10.1016/j.jacc.2010.08.621; Bentham J, 2008, ANN NY ACAD SCI, V1123, P10, DOI 10.1196/annals.1420.003; Cario H, 2011, AM J HUM GENET, V88, P226, DOI 10.1016/j.ajhg.2011.01.007; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Digilio MC, 1996, AM J CARDIOL, V77, P1375, DOI 10.1016/S0002-9149(96)00212-3; Fahed AC, 2013, CIRC RES, V112, P707, DOI 10.1161/CIRCRESAHA.112.300853; Farrer RA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003703; Gelb BD, 2013, CURR OPIN P IN PRESS; Goldmuntz E, 2008, CIRC-CARDIOVASC GENE, V1, P126, DOI 10.1161/CIRCGENETICS.108.796342; Greenway SC, 2009, NAT GENET, V41, P931, DOI 10.1038/ng.415; Hitz MP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002903; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Kozyraki R, 2001, J MOL MED, V79, P161, DOI 10.1007/s001090100193; Krepischi-Santos ACV, 2009, CYTOGENET GENOME RES, V125, P1, DOI 10.1159/000218743; Lalani SR, 2013, EUR J HUM GENET, V21, P173, DOI 10.1038/ejhg.2012.155; Lee MS, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-12; Lei Y, 2010, NEW ENGL J MED, V362, P2232, DOI 10.1056/NEJMc0910820; Leonard H, 2000, HEART, V84, P499, DOI 10.1136/heart.84.5.499; Locke AE, 2010, GENET EPIDEMIOL, V34, P613, DOI 10.1002/gepi.20518; Luo C, 2012, AM J MED GENET A, V158A, P1918, DOI 10.1002/ajmg.a.35471; Pannu H, 2007, HUM MOL GENET, V16, P2453, DOI 10.1093/hmg/ddm201; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.1852; Prakash SK, 2010, AM J HUM GENET, V87, P743, DOI 10.1016/j.ajhg.2010.09.015; Refsum H, 2001, BRIT J NUTR, V85, pS109, DOI 10.1079/BJN2000302; Rodriguez RMG, 2013, INT J CARDIOL, V167, P768, DOI 10.1016/j.ijcard.2012.03.047; Roos L, 2009, J MED GENET, V46, P703, DOI 10.1136/jmg.2008.065094; Silversides CK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002843; Soemedi R, 2012, AM J HUM GENET, V91, P489, DOI 10.1016/j.ajhg.2012.08.003; Song K, 2006, CELL, V125, P453, DOI 10.1016/j.cell.2006.02.048; Stover PJ, 2011, ADV NUTR, V2, P325, DOI 10.3945/an.111.000596; Sun SN, 2011, ACTA BIOCH BIOPH SIN, V43, P957, DOI 10.1093/abbs/gmr098; Tang LS, 2004, BIRTH DEFECTS RES A, V70, P449, DOI 10.1002/bdra.20043; Thienpont B, 2007, EUR HEART J, V28, P2778, DOI 10.1093/eurheartj/ehl560; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; Tremblay N, 2011, EUR HEART J, V32, P568, DOI 10.1093/eurheartj/ehq447; Tsaroucha AK, 2008, CLIN EXP MED, V8, P165, DOI 10.1007/s10238-008-0174-y; van Beynum IM, 2006, EUR HEART J, V27, P981, DOI 10.1093/eurheartj/ehi815	41	17	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96471	10.1371/journal.pone.0096471	http://dx.doi.org/10.1371/journal.pone.0096471			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24826987	Green Published, Green Submitted, gold			2022-12-27	WOS:000336857400027
J	Yang, YS; Zhang, F; Tang, DJ; Yang, YH; Zhu, HL				Yang, Yu-Shun; Zhang, Fei; Tang, Dan-Jie; Yang, Yong-Hua; Zhu, Hai-Liang			Modification, Biological Evaluation and 3D QSAR Studies of Novel 2-(1,3-Diaryl-4,5-Dihydro-1H-Pyrazol-5-yl)Phenol Derivatives as Inhibitors of B-Raf Kinase	PLOS ONE			English	Article							SIGNALING PATHWAY; BRAF INHIBITORS; CANCER; ACTIVATION; MUTATIONS; MELANOMA; TUMORS; GENE	A series of novel 2-(1,3-diaryl- 4,5-dihydro-1H-pyrazol-5-yl)phenol derivatives (C1-C24) have been synthesized. The B-Raf inhibitory activity and anti-proliferation activity of these compounds have been tested. Compound C6 displayed the most potent biological activity against B-Raf(V600E) (IC50 = 0.15 mu M) and WM266.4 human melanoma cell line (GI(50) = 1.75 mu M), being comparable with the positive control (Vemurafenib and Erlotinib) and more potent than our previous best compounds. The docking simulation was performed to analyze the probable binding models and poses while the QSAR model was built to check the previous work as well as to introduce new directions. This work aimed at seeking more potent inhibitors as well as discussing some previous findings. As a result, the introduction of ortho-hydroxyl group on 4,5-dihydro-1H-pyrazole skeleton did reinforce the anti-tumor activity while enlarging the group on N-1 of pyrazoline was also helpful.	[Yang, Yu-Shun; Zhang, Fei; Tang, Dan-Jie; Yang, Yong-Hua; Zhu, Hai-Liang] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China; [Yang, Yu-Shun] Nanjing Univ, Inst Chem & Biomed Sci, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Yang, YH (corresponding author), Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China.	yangyh@nju.edu.cn; zhuhl@nju.edu.cn		Yang, Yu-Shun/0000-0001-5424-8202	National Natural Science Foundation of China [J1103512]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financed by National Natural Science Foundation of China (No. J1103512'). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azarifar D, 2003, MOLECULES, V8, P642, DOI 10.3390/80800642; Blackburn C, 2010, BIOORG MED CHEM LETT, V20, P4795, DOI 10.1016/j.bmcl.2010.06.110; Cohen J, 2003, J NATL CANCER I, V95, P625, DOI 10.1093/jnci/95.8.625; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; De DYD, 1998, J MED CHEM, V41, P4918, DOI 10.1021/jm980146x; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; El-Azab AS, 2010, EUR J MED CHEM, V45, P4188, DOI 10.1016/j.ejmech.2010.06.013; Gray-Schopfer VC, 2005, CANCER METAST REV, V24, P367, DOI 10.1007/s10555-005-1585-9; Hoshino R, 1999, ONCOGENE, V18, P813, DOI 10.1038/sj.onc.1202367; Kalinsky K, 2007, EXPERT REV ANTICANC, V7, P715, DOI 10.1586/14737140.7.5.715; Karasarides M, 2004, ONCOGENE, V23, P6292, DOI 10.1038/sj.onc.1207785; King AJ, 2006, CANCER RES, V66, P11100, DOI 10.1158/0008-5472.CAN-06-2554; Kirkpatrick P, 2004, NAT REV DRUG DISCOV, V3, P299, DOI 10.1038/nrd1364; Latif N, 1983, EGYPT J CHEM, V26, P521; Li CY, 2012, BIOORGAN MED CHEM, V20, P3746, DOI 10.1016/j.bmc.2012.04.047; Li NX, 2007, CURR OPIN INVEST DR, V8, P452; Liu JJ, 2012, BIOORGAN MED CHEM, V20, P6089, DOI 10.1016/j.bmc.2012.08.020; Mathieu S, 2012, J MED CHEM, V55, P2869, DOI 10.1021/jm300016v; Newhouse BJ, 2011, BIOORG MED CHEM LETT, V21, P3488, DOI 10.1016/j.bmcl.2010.12.038; Niculescu-Duvaz D, 2010, BIOORGAN MED CHEM, V18, P6934, DOI 10.1016/j.bmc.2010.06.031; Sommers JA, 2005, CANCER RES, V65, P1223, DOI 10.1158/0008-5472.CAN-03-0231; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Xu XL, 2003, CANCER RES, V63, P4561; Yang YS, 2012, BIOORGAN MED CHEM, V20, P6048, DOI 10.1016/j.bmc.2012.08.043	26	0	0	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e95702	10.1371/journal.pone.0095702	http://dx.doi.org/10.1371/journal.pone.0095702			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827980	Green Published, Green Submitted, gold			2022-12-27	WOS:000336857400014
J	Chen, XE; Lu, SM; Zhang, YL				Chen, Xi'en; Lu, Shumin; Zhang, Yalin			Characterization of Protein Phosphatase 5 from Three Lepidopteran Insects: Helicoverpa armigera, Mythimna separata and Plutella xylostella	PLOS ONE			English	Article							SERINE/THREONINE PHOSPHATASE; BIOCHEMICAL-CHARACTERIZATION; TETRATRICOPEPTIDE REPEAT; TPR DOMAIN; IDENTIFICATION; BINDING; ACTIVATION; HOMOLOG; CANCER; TYPE-5	Protein phosphatase 5 (PP5), a unique member of serine/threonine phosphatases, regulates a variety of biological processes. We obtained full-length PP5 cDNAs from three lepidopteran insects, Helicoverpa armigera, Mythimna separata and Plutella xylostella, encoding predicted proteins of 490 (55.98 kDa), 490 (55.82 kDa) and 491 (56.07 kDa) amino acids, respectively. These sequences shared a high identity with other insect PP5s and contained the TPR (tetratricopeptide repeat) domains at N-terminal regions and highly conserved C-terminal catalytic domains. Tissue-and stage-specific expression pattern analyses revealed these three PP5 genes were constitutively expressed in all stages and in tested tissues with predominant transcription occurring at the egg and adult stages. Activities of Escherichia coli-produced recombinant PP5 proteins could be enhanced by almost 2-fold by a known PP5 activator: arachidonic acid. Kinetic parameters of three recombinant proteins against substrate pNPP were similar both in the absence or presence of arachidonic acid. Protein phosphatases inhibitors, okadaic acid, cantharidin, and endothall strongly impeded the activities of the three recombinant PP5 proteins, as well as exerted an inhibitory effect on crude protein phosphatases extractions from these three insects. In summary, lepidopteran PP5s share similar characteristics and are all sensitive to the protein phosphatases inhibitors. Our results also imply protein phosphatase inhibitors might be used in the management of lepidopteran pests.	[Chen, Xi'en; Lu, Shumin; Zhang, Yalin] Northwest A&F Univ, Key Lab Plant Protect Resources & Pest Management, Minist Educ, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Zhang, YL (corresponding author), Northwest A&F Univ, Key Lab Plant Protect Resources & Pest Management, Minist Educ, Yangling, Shaanxi, Peoples R China.	yalinzh@nwsuaf.edu.cn			Special Fund for the Public Interest (Agriculture) [200903052]; Ministry of Science and Technology and The Ministry of Agriculture of China; 13115 Sci-Tech Innovation Project of Shaanxi Province [2007ZDKG-14]	Special Fund for the Public Interest (Agriculture); Ministry of Science and Technology and The Ministry of Agriculture of China; 13115 Sci-Tech Innovation Project of Shaanxi Province	This research is supported by the Special Fund for the Public Interest (Agriculture) (200903052) by The Ministry of Science and Technology and The Ministry of Agriculture of China and the '13115' Sci-Tech Innovation Project of Shaanxi Province (2007ZDKG-14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansai T, 1996, J BIOL CHEM, V271, P24401, DOI 10.1074/jbc.271.40.24401; Bajsa J, 2013, PHYSIOL PLANTARUM, V143, P188; Bajsa J, 2012, PESTIC BIOCHEM PHYS, V102, P38, DOI 10.1016/j.pestbp.2011.10.007; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown L, 2000, BBA-GENE STRUCT EXPR, V1492, P470, DOI 10.1016/S0167-4781(00)00105-6; Chaudhuri M, 2001, GENE, V266, P1, DOI 10.1016/S0378-1119(01)00367-5; Chen MX, 1997, FEBS LETT, V400, P136, DOI 10.1016/S0014-5793(96)01427-5; Chen XE, 2013, INT J MOL SCI, V14, P24501, DOI 10.3390/ijms141224501; Chen XE, 2014, MOL BIOSYST, V10, P240, DOI 10.1039/c3mb70410f; Cohen PTW, 2004, TOP CURR GENET, V5, P1; Davies TH, 2005, BIOCHEMISTRY-US, V44, P2030, DOI 10.1021/bi048503v; Golden T, 2008, CANCER METAST REV, V27, P169, DOI 10.1007/s10555-008-9125-z; Graves JD, 1999, PHARMACOL THERAPEUT, V82, P111, DOI 10.1016/S0163-7258(98)00056-4; Hinds TD, 2008, INT J BIOCHEM CELL B, V40, P2358, DOI 10.1016/j.biocel.2007.08.010; Honkanen RE, 2002, CURR MED CHEM, V9, P2055, DOI 10.2174/0929867023368836; Kang H, 2001, BIOCHEMISTRY-US, V40, P10485, DOI 10.1021/bi010999i; Kelker MS, 2009, J MOL BIOL, V385, P11, DOI 10.1016/j.jmb.2008.10.053; Lindenthal C, 2002, MOL BIOCHEM PARASIT, V120, P257, DOI 10.1016/S0166-6851(02)00007-5; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Skinner J, 1997, J BIOL CHEM, V272, P22464, DOI 10.1074/jbc.272.36.22464; Stebbing J, 2014, ONCOGENE, V33, P939, DOI 10.1038/onc.2013.80; Swingle MR, 2004, J BIOL CHEM, V279, P33992, DOI 10.1074/jbc.M402855200; TAKAI A, 1991, BIOCHEM J, V275, P233, DOI 10.1042/bj2750233; Yang J, 2005, EMBO J, V24, P1, DOI 10.1038/sj.emboj.7600496; ZHUO SQ, 1994, J BIOL CHEM, V269, P26234	25	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97437	10.1371/journal.pone.0097437	http://dx.doi.org/10.1371/journal.pone.0097437			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24823652	Green Submitted, Green Published, gold			2022-12-27	WOS:000336369200115
J	Li, PC; Pan, CH; Sheu, MJ; Wu, CC; Ma, WF; Wu, CH				Li, Pei-Chuan; Pan, Chun-Hsu; Sheu, Ming-Jyh; Wu, Chin-Ching; Ma, Wei-Fen; Wu, Chieh-Hsi			Deep Sea Water Prevents Balloon Angioplasty-Induced Hyperplasia through MMP-2: An In Vitro and In Vivo Study	PLOS ONE			English	Article							DIETARY MAGNESIUM INTAKE; MUSCLE-CELL PROLIFERATION; CARDIOVASCULAR-DISEASE; NEOINTIMAL FORMATION; HYPERTENSION; DRINKING; SUPPLEMENTATION; ASSOCIATIONS; THICKNESS; MIGRATION	Major facts about the development of restenosis include vascular smooth muscle cells (VSMCs) proliferation and migration. A previous study showed that in vitro treatment with magnesium chloride has the potential to affect the proliferation and migration of VSMCs. Magnesium is the major element in deep sea water (DSW) and is a biologically active mineral. It is unclear whether DSW intake can prevent abnormal proliferation and migration of VSMCs as well as balloon angioplasty-induced neointimal hyperplasia. Thus, we attempted to evaluate the anti-restenotic effects of DSW and its possible molecular mechanisms. Several concentrations of DSW, based on the dietary recommendations (RDA) for magnesium, were applied to a model of balloon angioplasty in SD rats. The results showed that DSW intake markedly increased magnesium content within the vascular wall and reduced the development of neointimal hyperplasia. The immunohistochemical analysis also showed that the expression of proteins associated with cell proliferation and migration were decreased in the balloon angioplasty groups with DSW supplement. Furthermore, in vitro treatment with DSW has a dose-dependent inhibitory effect on serum-stimulated proliferation and migration of VSMCs, whose effects might be mediated by modulation of mitogen-activated protein kinase (MAPK) signaling and of the activity of matrix metalloproteinase-2 (MMP-2). Our study suggested that DSW intake can help prevent neointimal hyperplasia (or restenosis), whose effects may be partially regulated by magnesium and other minerals.	[Li, Pei-Chuan; Sheu, Ming-Jyh; Wu, Chieh-Hsi] China Med Univ, Sch Pharm, Taichung, Taiwan; [Pan, Chun-Hsu; Wu, Chieh-Hsi] Taipei Med Univ, Coll Pharm, Taipei, Taiwan; [Wu, Chin-Ching] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Ma, Wei-Fen] China Med Univ, Sch Nursing, Taichung, Taiwan; [Wu, Chieh-Hsi] China Med Univ, Dept Biol Sci & Technol, Taichung, Taiwan	China Medical University Taiwan; Taipei Medical University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan	Sheu, MJ (corresponding author), China Med Univ, Sch Pharm, Taichung, Taiwan.	soybean13mtdtw@gmail.com; chhswu@mail.cmu.edu.tw	Wu, Chieh-Hsi/AAJ-1173-2020; Pan, Chun-Hsu/H-4358-2019	Pan, Chun-Hsu/0000-0001-8700-583X; Wu, Chieh-Hsi/0000-0002-2006-8243	China Medical University [CMU-10142624]	China Medical University(China Medical University)	This research was supported by a grant from China Medical University (CMU-10142624). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chakraborti S, 2002, MOL CELL BIOCHEM, V238, P163, DOI 10.1023/A:1019998702946; Chien YC, 2012, J NAT PROD, V75, P1524, DOI 10.1021/np3002145; Cunha AR, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/754250; Ferre S, 2007, MAGNESIUM RES, V20, P66; Ford ES, 2003, J NUTR, V133, P2879, DOI 10.1093/jn/133.9.2879; Fu ZY, 2012, J MED FOOD, V15, P535, DOI 10.1089/jmf.2011.2007; Gennaro G, 2004, CIRCULATION, V110, P3367, DOI 10.1161/01.CIR.0000147773.86866.CD; GRIENDLING KK, 1986, J BIOL CHEM, V261, P5901; Hataguchi Y, 2005, EUR J CLIN NUTR, V59, P1093, DOI 10.1038/sj.ejcn.1602218; Houston M, 2011, J CLIN HYPERTENS, V13, P843, DOI 10.1111/j.1751-7176.2011.00538.x; Ikari A, 2010, LIFE SCI, V86, P766, DOI 10.1016/j.lfs.2010.03.016; Indolfi C, 1999, Cardiol Rev, V7, P324, DOI 10.1097/00045415-199911000-00010; Katsuda S, 2008, BIOL PHARM BULL, V31, P38, DOI 10.1248/bpb.31.38; Kawano Y, 1998, J HYPERTENS, V16, P1693, DOI 10.1097/00004872-199816110-00017; Lai KH, 1996, J CLIN INVEST, V98, P1560, DOI 10.1172/JCI118949; Laurant P, 2000, BRIT J NUTR, V84, P757; MA J, 1995, J CLIN EPIDEMIOL, V48, P927, DOI 10.1016/0895-4356(94)00200-A; McIntyre M, 1999, HYPERTENSION, V34, P539, DOI 10.1161/01.HYP.34.4.539; Miyamura M, 2004, BIOL PHARM BULL, V27, P1784, DOI 10.1248/bpb.27.1784; Murphy KE, 2013, ANAL BIOANAL CHEM, V405, P4579, DOI 10.1007/s00216-013-6855-8; Muslin AJ, 2008, CLIN SCI, V115, P203, DOI 10.1042/CS20070430; Newby AC, 2006, CARDIOVASC RES, V69, P614, DOI 10.1016/j.cardiores.2005.08.002; RASMUSSEN HS, 1989, ARCH INTERN MED, V149, P1050, DOI 10.1001/archinte.149.5.1050; SAITO N, 1990, ANN NY ACAD SCI, V598, P527, DOI 10.1111/j.1749-6632.1990.tb42334.x; Shechter M, 2000, AM HEART J, V140, P212, DOI 10.1067/mhj.2000.107553; Shechter M, 2010, MAGNESIUM RES, V23, P60, DOI 10.1684/mrh.2010.0202; Sheu MJ, 2013, MAR DRUGS, V11, P2183, DOI 10.3390/md11062183; Sternberg K, 2012, J BIOMED MATER RES B, V100B, P41, DOI 10.1002/jbm.b.31918; Touyz R. M., 2003, Molecular Aspects of Medicine, V24, P107, DOI 10.1016/S0098-2997(02)00094-8; Turgut F, 2008, INT UROL NEPHROL, V40, P1075, DOI 10.1007/s11255-008-9410-3; Wang ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055471; Weintraub WS, 2007, AM J CARDIOL, V100, p3K, DOI 10.1016/j.amjcard.2007.06.002; Wolf FI, 2008, MAGNESIUM RES, V21, P58; Yoshioka S, 2003, BIOL PHARM BULL, V26, P1552, DOI 10.1248/bpb.26.1552; Zhang W, 2012, ATHEROSCLEROSIS, V221, P587, DOI 10.1016/j.atherosclerosis.2012.01.034	35	13	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96927	10.1371/journal.pone.0096927	http://dx.doi.org/10.1371/journal.pone.0096927			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824358	gold, Green Published, Green Submitted			2022-12-27	WOS:000336369200042
J	Moriwaki, S; Suzuki, K; Muramatsu, M; Nomura, A; Inoue, F; Into, T; Yoshiko, Y; Niida, S				Moriwaki, Sawako; Suzuki, Keiko; Muramatsu, Masashi; Nomura, Atsushi; Inoue, Fumihide; Into, Takeshi; Yoshiko, Yuji; Niida, Shumpei			Delphinidin, One of the Major Anthocyanidins, Prevents Bone Loss through the Inhibition of Excessive Osteoclastogenesis in Osteoporosis Model Mice	PLOS ONE			English	Article							INFLAMMATORY MEDIATORS; KAPPA-B; DIFFERENTIATION; FLAVONOIDS; RANKL; BIOAVAILABILITY; ABSORPTION; RAT; TRANSFORMATION; TRANSCRIPTION	Anthocyanins, one of the flavonoid subtypes, are a large family of water-soluble phytopigments and have a wide range of health-promoting benefits. Recently, an anthocyanin-rich compound from blueberries was reported to possess protective property against bone loss in ovariectomized (OVX) animal models. However, the active ingredients in the anthocyanin compound have not been identified. Here we show that delphinidin, one of the major anthocyanidins in berries, is a potent active ingredient in anti-osteoporotic bone resorption through the suppression of osteoclast formation. In vitro examinations revealed that delphinidin treatment markedly inhibited the differentiation of RAW264.7 cells into osteoclasts compared with other anthocyanidins, cyanidin and peonidin. Oral administration of delphinidin significantly prevented bone loss in both RANKL-induced osteoporosis model mice and OVX model mice. We further provide evidence that delphinidin suppressed the activity of NF-kappa B, c-fos, and Nfatc1, master transcriptional factors for osteoclastogenesis. These results strongly suggest that delphinidin is the most potent inhibitor of osteoclast differentiation and will be an effective agent for preventing bone loss in postmenopausal osteoporosis.	[Moriwaki, Sawako; Muramatsu, Masashi; Niida, Shumpei] NCGG, Lab Genom & Prote, Aichi, Japan; [Moriwaki, Sawako; Niida, Shumpei] NCGG, Biobank Omics Unit, Aichi, Japan; [Suzuki, Keiko] Showa Univ, Sch Dent, Dept Pharmacol, Tokyo 142, Japan; [Nomura, Atsushi; Inoue, Fumihide] Nihon Seiyaku Kogyo Co Ltd, Aichi, Japan; [Into, Takeshi] Asahi Univ, Sch Dent, Dept Oral Bacteriol, Div Oral Infect & Hlth Sci, Gifu, Japan; [Yoshiko, Yuji] Hiroshima Univ, Grad Sch Biomed Sci, Dept Oral Growth & Dev Biol, Hiroshima, Japan	Showa University; Asahi University; Hiroshima University	Niida, S (corresponding author), NCGG, Lab Genom & Prote, Aichi, Japan.	sniida@ncgg.go.jp			Japan Society for the Promotion of Science (KAKENHI) [20390469, 21791802]; Ministry of Health Labour and Welfare (Health Labour Sciences Research) [H24-Choju-007]; Grants-in-Aid for Scientific Research [23592747] Funding Source: KAKEN	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health Labour and Welfare (Health Labour Sciences Research)(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work has been supported by Japan Society for the Promotion of Science (KAKENHI Grant No. 20390469 to SN and No. 21791802 to SM) and by Ministry of Health Labour and Welfare (Health Labour Sciences Research Grant No. H24-Choju-007 to SN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bin Hafeez B, 2008, CELL CYCLE, V7, P3320, DOI 10.4161/cc.7.21.6969; Bu SY, 2008, CALCIFIED TISSUE INT, V82, P475, DOI 10.1007/s00223-008-9139-0; Chiba H, 2003, J NUTR, V133, P1892, DOI 10.1093/jn/133.6.1892; Devareddy L, 2008, J NUTR BIOCHEM, V19, P694, DOI 10.1016/j.jnutbio.2007.09.004; Diel P, 2004, MOL CELL ENDOCRINOL, V221, P21, DOI 10.1016/j.mce.2004.04.006; Einbond LS, 2004, FOOD CHEM, V84, P23, DOI 10.1016/S0308-8146(03)00162-6; Gehlbach SH, 2002, AM J PUBLIC HEALTH, V92, P271, DOI 10.2105/AJPH.92.2.271; GRYGLEWSKI RJ, 1987, BIOCHEM PHARMACOL, V36, P317, DOI 10.1016/0006-2952(87)90288-7; HAVSTEEN B, 1983, BIOCHEM PHARMACOL, V32, P1141, DOI 10.1016/0006-2952(83)90262-9; Hollman PCH, 2004, PHARM BIOL, V42, P74, DOI 10.3109/13880200490893492; Hou DX, 2004, CARCINOGENESIS, V25, P29, DOI 10.1093/carcin/bgg184; Inami K, 2008, ORTHOD WAVES, V67, P150, DOI 10.1016/j.odw.2008.04.003; Karlsen A, 2007, J NUTR, V137, P1951; Kawamori Y, 2010, BLOOD, V116, P5528, DOI 10.1182/blood-2010-04-279216; Kim TH, 2011, J NUTR BIOCHEM, V22, P8, DOI 10.1016/j.jnutbio.2009.11.002; Kwon JY, 2007, ANN NY ACAD SCI, V1095, P513, DOI 10.1196/annals.1397.055; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Manach C, 1997, FEBS LETT, V409, P12, DOI 10.1016/S0014-5793(97)00467-5; Matsumoto H, 2003, J AGR FOOD CHEM, V51, P3560, DOI 10.1021/jf034132y; McGhie TK, 2007, MOL NUTR FOOD RES, V51, P702, DOI 10.1002/mnfr.200700092; Meydani M, 2010, NUTRIENTS, V2, P737, DOI 10.3390/nu2070737; MIDDLETON E, 1992, BIOCHEM PHARMACOL, V43, P1167, DOI 10.1016/0006-2952(92)90489-6; Sen CK, 1996, FASEB J, V10, P709, DOI 10.1096/fasebj.10.7.8635688; Srinivasan S, 2010, ANN NY ACAD SCI, V1192, P245, DOI 10.1111/j.1749-6632.2009.05377.x; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Tomimori Y, 2009, J BONE MINER RES, V24, P1194, DOI [10.1359/JBMR.090217, 10.1359/jbmr.090217]; Tsuji M, 2009, J BONE MINER METAB, V27, P673, DOI 10.1007/s00774-009-0088-0; Ueda H, 2002, BIOL PHARM BULL, V25, P1197, DOI 10.1248/bpb.25.1197; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Wattel A, 2004, J CELL BIOCHEM, V92, P285, DOI 10.1002/jcb.20071; Welch A, 2012, J BONE MINER RES, V27, P1872, DOI 10.1002/jbmr.1649; Yoshiko Y, 2003, ENDOCRINOLOGY, V144, P4134, DOI 10.1210/en.2003-0130	35	69	71	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97177	10.1371/journal.pone.0097177	http://dx.doi.org/10.1371/journal.pone.0097177			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824988	Green Published, Green Submitted, gold			2022-12-27	WOS:000336369200069
J	Deas, M; Andrefouet, S; Leopold, M; Guillemot, N				Deas, Marilyn; Andrefouet, Serge; Leopold, Marc; Guillemot, Nicolas			Modulation of Habitat-Based Conservation Plans by Fishery Opportunity Costs: A New Caledonia Case Study Using Fine-Scale Catch Data	PLOS ONE			English	Article							MARINE PROTECTED AREAS; PACIFIC ISLAND COUNTRIES; CORAL-REEF FISHERIES; SOCIOECONOMIC DATA; LOCAL KNOWLEDGE; INFORMATION-SYSTEMS; MANAGEMENT; DESIGN; GIS; SUSTAINABILITY	Numerous threats impact coral reefs and conservation actions are urgently needed. Fast production of marine habitat maps promotes the use of habitat-only conservation plans, where a given percentage of the area of each habitat is set as conservation objectives. However, marine reserves can impact access to fishing grounds and generate opportunity costs for fishers that need to be minimized. In New Caledonia (Southwest Pacific), we used fine-scale fishery catch maps to define nineteen opportunity costs layers (expressed as biomass catch loss) considering i) total catches, ii) target fish families, iii) local marine tenure, and iv) gear type. The expected lower impacts on fishery catch when using the different cost constraints were ranked according to effectiveness in decreasing the costs generated by the habitat-only scenarios. The exercise was done for two habitat maps with different thematic richness. In most cases, habitat conservation objectives remained achievable, but effectiveness varied widely between scenarios and between habitat maps. The results provide practical guidelines for coral reef conservation and management. Habitat-only scenarios can be used to initiate conservation projects with stakeholders but the costs induced by such scenarios can be lowered by up to 50-60% when detailed exhaustive fishery data are used. When using partial data, the gain would be only in the 15-25% range. The best compromises are achieved when using local data.	[Deas, Marilyn; Andrefouet, Serge] CORAIL, Lab Excellence, Inst Rech Dev, UR CoReUs, Noumea, New Caledonia; [Leopold, Marc] CORAIL, Lab Excellence, Inst Rech Dev, UR CoReUs, Port Vila, Vanuatu, New Caledonia; [Leopold, Marc] Fisheries Dept Vanuatu, Port Vila, Vanuatu, New Caledonia	Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD)	Andrefouet, S (corresponding author), CORAIL, Lab Excellence, Inst Rech Dev, UR CoReUs, Noumea, New Caledonia.	serge.andrefouet@ird.fr			New Caledonia ZONECO Program; LITEAU French national Program (COGERON Project); Koniambo Nickel SAS mining company; NASA; IRD	New Caledonia ZONECO Program; LITEAU French national Program (COGERON Project); Koniambo Nickel SAS mining company; NASA(National Aeronautics & Space Administration (NASA)); IRD	Data acquisition funded by: New Caledonia ZONECO Program, the LITEAU French national Program (COGERON Project) and the Koniambo Nickel SAS mining company. The Millennium map is a product funded by NASA and the IRD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams VM, 2011, BIOL CONSERV, V144, P350, DOI 10.1016/j.biocon.2010.09.012; Andrefouet S, 2008, J SPAT SCI, V53, P113, DOI 10.1080/14498596.2008.9635140; Andrefouet S., 2006, P 10 INT COR REEF S, P1732; Andrefouet S., 2008, ATLAS RECIFS CORALLI; Andrefouet S., 2009, ATLAS W INDIAN OCEAN; Anuchiracheeva S, 2003, OCEAN COAST MANAGE, V46, P1049, DOI 10.1016/j.ocecoaman.2004.01.001; Aswani S, 2006, HUM ORGAN, V65, P81, DOI 10.17730/humo.65.1.4y2q0vhe4l30n0uj; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Ban NC, 2011, J EXP MAR BIOL ECOL, V408, P21, DOI 10.1016/j.jembe.2011.07.023; Ban NC, 2009, MAR POLICY, V33, P794, DOI 10.1016/j.marpol.2009.02.011; Bell, 2011, VULNERABILITY TROPIC; Bell JD, 2009, MAR POLICY, V33, P64, DOI 10.1016/j.marpol.2008.04.002; Carwardine J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002586; Dalleau M, 2010, CONSERV BIOL, V24, P541, DOI 10.1111/j.1523-1739.2009.01394.x; David G, 2010, MAR POLLUT BULL, V61, P323, DOI 10.1016/j.marpolbul.2010.06.020; De Freitas DM, 2009, J ENVIRON MANAGE, V90, P2071, DOI 10.1016/j.jenvman.2007.08.026; Guillemot N, 2009, ATLAS PECHE NONPROFE; Guillemot N., 2009, THESIS IRD AGROCAMPU; Guillemot N, 2009, FISH RES, V98, P51, DOI 10.1016/j.fishres.2009.03.013; Hall GB, 2007, FISH RES, V83, P11, DOI 10.1016/j.fishres.2006.08.015; Hamel MA, 2013, CONSERV LETT, V6, P46, DOI 10.1111/j.1755-263X.2012.00285.x; Hamel MA, 2010, MAR POLLUT BULL, V60, P1397, DOI 10.1016/j.marpolbul.2010.07.002; Klein CJ, 2008, CONSERV BIOL, V22, P691, DOI 10.1111/j.1523-1739.2008.00896.x; Klein CJ, 2013, CONSERV LETT, V6, P324, DOI 10.1111/conl.12005; Kronen M, 2012, OCEAN COAST MANAGE, V55, P63, DOI 10.1016/j.ocecoaman.2011.07.011; Leopold M., 2013, VERTIGO, V13, DOI [10.4000/vertigo.13297, DOI 10.4000/VERTIGO.13297]; Leopold M, 2014, ICES J MAR SCI, V71, P1781, DOI 10.1093/icesjms/fst204; NAIDOO R, 2006, TRENDS ECOL EVOL, V21, P7; Newton K, 2007, CURR BIOL, V17, P655, DOI 10.1016/j.cub.2007.02.054; Pinca S, 2012, FISH FISH, V13, P361, DOI 10.1111/j.1467-2979.2011.00425.x; Richardson EA, 2006, CONSERV BIOL, V20, P1191, DOI 10.1111/j.1523-1739.2006.00426.x; Stewart RR, 2005, ENVIRON MODEL ASSESS, V10, P203, DOI 10.1007/s10666-005-9001-y; van de Geer C, 2013, MAR POLICY, V39, P248, DOI 10.1016/j.marpol.2012.11.006; Walmsley SF, 2003, ENVIRON CONSERV, V30, P388, DOI 10.1017/S0376892903000407; Weeks R, 2013, CONSERV BIOL, V27, P1234, DOI 10.1111/cobi.12153; Weeks R, 2010, BIOL CONSERV, V143, P1236, DOI 10.1016/j.biocon.2010.02.031	36	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e97409	10.1371/journal.pone.0097409	http://dx.doi.org/10.1371/journal.pone.0097409			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835216	Green Published, gold, Green Submitted			2022-12-27	WOS:000339614800045
J	Feikin, DR; Bigogo, G; Audi, A; Pals, SL; Aol, G; Mbakaya, C; Williamson, J; Breiman, RF; Larson, CP				Feikin, Daniel R.; Bigogo, Godfrey; Audi, Allan; Pals, Sherri L.; Aol, George; Mbakaya, Charles; Williamson, John; Breiman, Robert F.; Larson, Charles P.			Village-Randomized Clinical Trial of Home Distribution of Zinc for Treatment of Childhood Diarrhea in Rural Western Kenya	PLOS ONE			English	Article							COMMUNITY CASE-MANAGEMENT; DEVELOPING-COUNTRIES; MORBIDITY SURVEILLANCE; POOLED ANALYSIS; CHILDREN; SUPPLEMENTATION; INFANTS; DISEASE; PNEUMONIA; MORTALITY	Background: Zinc treatment shortens diarrhea episodes and can prevent future episodes. In rural Africa, most children with diarrhea are not brought to health facilities. In a village-randomized trial in rural Kenya, we assessed if zinc treatment might have a community-level preventive effect on diarrhea incidence if available at home versus only at health facilities. Methods: We randomized 16 Kenyan villages (1,903 eligible children) to receive a 10-day course of zinc and two oral rehydration solution (ORS) sachets every two months at home and 17 villages (2,241 eligible children) to receive ORS at home, but zinc at the health-facility only. Children's caretakers were educated in zinc/ORS use by village workers, both unblinded to intervention arm. We evaluated whether incidence of diarrhea and acute lower respiratory illness (ALRI) reported at biweekly home visits and presenting to clinic were lower in zinc villages, using poisson regression adjusting for baseline disease rates, distance to clinic, and children's age. Results: There were no differences between village groups in diarrhea incidence either reported at the home or presenting to clinic. In zinc villages (1,440 children analyzed), 61.2% of diarrheal episodes were treated with zinc, compared to 5.4% in comparison villages (1,584 children analyzed, p<0.0001). There were no differences in ORS use between zinc (59.6%) and comparison villages (58.8%). Among children with fever or cough without diarrhea, zinc use was low (<0.5%). There was a lower incidence of reported ALRI in zinc villages (adjusted RR 0.68, 95% CI 0.46-0.99), but not presenting at clinic. Conclusions: In this study, home zinc use to treat diarrhea did not decrease disease rates in the community. However, with proper training, availability of zinc at home could lead to more episodes of pediatric diarrhea being treated with zinc in parts of rural Africa where healthcare utilization is low.	[Feikin, Daniel R.; Bigogo, Godfrey; Audi, Allan; Aol, George; Breiman, Robert F.] Ctr Dis Control & Prevent Kisumu, Int Emerging Infect Program, Kisumu, Kenya; [Pals, Sherri L.] US Ctr Dis Control & Prevent, Div Global HIV AIDS, Atlanta, GA USA; [Williamson, John] US Ctr Dis Control & Prevent, Ctr Global Hlth, Atlanta, GA USA; [Bigogo, Godfrey; Audi, Allan; Aol, George; Mbakaya, Charles] Kenya Govt Med Res Ctr, Nairobi, Kenya; [Larson, Charles P.] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; [Larson, Charles P.] Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Kenya Medical Research Institute; International Centre for Diarrhoeal Disease Research (ICDDR); University of British Columbia	Feikin, DR (corresponding author), Ctr Dis Control & Prevent Kisumu, Int Emerging Infect Program, Kisumu, Kenya.	dfeikin@jhsph.edu	Bigogo, Godfrey/W-3591-2019	Audi, Allan/0000-0003-1683-554X	The Bill and Melinda Gates Foundation; Centers for Disease Control and Prevention	The Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Support was provided by The Bill and Melinda Gates Foundation and Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baqui AH, 2002, BRIT MED J, V325, P1059, DOI 10.1136/bmj.325.7372.1059; Bhandari N, 2008, PEDIATRICS, V121, pE1279, DOI 10.1542/peds.2007-1939; Bhutta ZA, 1999, J PEDIATR-US, V135, P689, DOI 10.1016/S0022-3476(99)70086-7; Bhutta ZA, 2000, AM J CLIN NUTR, V72, P1516; Bigogo G, 2010, INT J INFECT DIS, V14, pE967, DOI 10.1016/j.ijid.2010.05.016; Brooks WA, 2005, AM J CLIN NUTR, V82, P605, DOI 10.1093/ajcn/82.3.605; Burton DC, 2011, J HEALTH POPUL NUTR, V29, P61, DOI 10.3329/jhpn.v29i1.7567; Deutscher M, 2012, J EPIDEMIOL IN PRESS; Feikin DR, 2013, PEDIATR INFECT DIS J, V32, pE14, DOI 10.1097/INF.0b013e31826fd39b; Feikin DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016085; Feikin DR, 2010, INT J EPIDEMIOL, V39, P450, DOI 10.1093/ije/dyp374; George A, 2012, AM J TROP MED HYG, V87, P85, DOI 10.4269/ajtmh.2012.11-0757; Gibson RS, 2008, BRIT J NUTR, V99, pS14, DOI 10.1017/S0007114508006818; Gill CJ, 2013, LANCET, V381, P1487, DOI 10.1016/S0140-6736(13)60314-1; Hamel MJ, 2011, AM J TROP MED HYG, V85, P597, DOI 10.4269/ajtmh.2011.10-0678; Hotz C., 2004, FOOD NUTR BULL, V25, pS91; Kenya national Bureau of statistics (KNBS) and ICF macro, 2010, KEN DEM HLTH SURV 20; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Larson CP, 2012, HEALTH POLICY PLANN, V27, P102, DOI 10.1093/heapol/czr015; Lazzerini M, 2012, COCHRANE DB SYST REV, V6; Marsh DR, 2012, AM J TROP MED HYG, V87, P2, DOI 10.4269/ajtmh.2012.12-0504; Phillips-Howard PA, 2003, AM J TROP MED HYG, V68, P38; Rochon J, 1998, STAT MED, V17, P1643, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1643::AID-SIM869>3.0.CO;2-3; Tougher S, 2012, LANCET, V380, P1916, DOI 10.1016/S0140-6736(12)61732-2; Walker CLF, 2007, AM J CLIN NUTR, V85, P887, DOI 10.1093/ajcn/85.3.887; Walker CLF, 2006, J PEDIATR GASTR NUTR, V43, P357, DOI 10.1097/01.mpg.0000232018.40907.00; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; WHO, 2010, GUID TREATM MAL, V2nd; WHO, 2008, INT MAN CHILDH ILLN; WHO/UNICEF, 2004, CLIN MAN AC DIARRH; WHO/UNICEF, 2013, INT GLOB ACT PLAN PR; Wilson SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033273; Winch PJ, 2008, J HEALTH POPUL NUTR, V26, P151; Winch PJ, 2006, AM J TROP MED HYG, V74, P880, DOI 10.4269/ajtmh.2006.74.880	34	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2014	9	5							e94436	10.1371/journal.pone.0094436	http://dx.doi.org/10.1371/journal.pone.0094436			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM1NZ	24835009	Green Submitted, Green Published, gold			2022-12-27	WOS:000339614800004
J	De Martin, S; Paliuri, G; Belloni, A; Orso, G; Zanarella, E; Stellin, G; Milanesi, O; Basso, G; Ruga, EM; Frasson, C; Gabbia, D; Perdoncin, G; Palatini, P; Bova, S				De Martin, Sara; Paliuri, Giovanna; Belloni, Annasandra; Orso, Genny; Zanarella, Erica; Stellin, Giovanni; Milanesi, Ornella; Basso, Giuseppe; Ruga, Ezia Maria; Frasson, Chiara; Gabbia, Daniela; Perdoncin, Giada; Palatini, Pietro; Bova, Sergio			Expression and Distribution of the Adrenomedullin System in Newborn Human Thymus	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; GENE-RELATED PEPTIDE; T-CELL DEVELOPMENT; EPITHELIAL-CELLS; RAT-HEART; CALCITONIN; ANGIOGENESIS; PROLIFERATION; ESTABLISHMENT; LOCALIZATION	Adrenomedullin (AM) is a multifunctional peptide endowed with various biological actions mediated by the interaction with the calcitonin receptor-like receptor (CLR), which couples to the receptor activity-modifying proteins 2 or 3 (RAMP2 or RAMP3) to form the functional plasma membrane receptors AM1 and AM2, respectively. In this study, we investigated for the first time the expression and localization of AM, CLR, RAMP2 and RAMP3 in human thymic tissue from newborns and in primary cultures of thymic epithelial cells (TECs) and thymocytes. Immunohistochemical analysis of thymic tissue showed that both AM and RAMP2 are abundantly expressed in the epithelial cells of medulla and cortex, blood vessels and mastocytes. In contrast, RAMP3 could not be detected. In cultured TECs, double immunofluorescence coupled to confocal microscopy revealed that AM is present in the cytoplasmic compartment, whereas RAMP2 could be detected in the cytoplasm and nucleus, but not in the cell membrane. At variance with RAMP2, CLR was not only present in the nucleus and cytoplasm of TECs, but could also be detected in the cell membrane. The nuclear and cytoplasmic localizations of RAMP2 and CLR and the absence of RAMP2 in the cell membrane were confirmed by western-blot analysis performed on cell fractions. AM, RAMP2 and CLR could also be detected in thymocytes by means of double immunofluorescence coupled to confocal microscopy, although these proteins were not present in the whole thymocyte population. In these cells, AM and RAMP2 were detected in the cytoplasm, whereas CLR could be observed in the cytoplasm and the plasma membrane. In conclusion, our results show that the AM system is widely expressed in human thymus from newborns and suggest that both AM1 receptor components CLR and RAMP2 are not associated with the plasma membrane of TECs and thymocytes but are located intracellularly, notably in the nucleus.	[De Martin, Sara; Paliuri, Giovanna; Gabbia, Daniela; Palatini, Pietro; Bova, Sergio] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy; [Belloni, Annasandra; Perdoncin, Giada] Univ Padua, Dept Mol Med, Padua, Italy; [Orso, Genny; Zanarella, Erica] Sci Inst IRCCS Eugenio Medea, Treviso, Italy; [Stellin, Giovanni] Univ Padua, Dept Cardiac Thorac & Vasc Surg, Pediat & Congenital Cardiac Surg Unit, Padua, Italy; [Milanesi, Ornella; Basso, Giuseppe; Ruga, Ezia Maria; Frasson, Chiara] Univ Padua, Dept Pediat, Padua, Italy	University of Padua; University of Padua; IRCCS Eugenio Medea; University of Padua; University of Padua	De Martin, S (corresponding author), Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy.	sara.demartin@unipd.it	De Martin, Sara/AAC-7396-2022; Gabbia, Daniela/J-9984-2019; Orso, Genny/C-6492-2016	De Martin, Sara/0000-0001-6398-8237; Gabbia, Daniela/0000-0003-2247-8227; Orso, Genny/0000-0002-2959-8806; STELLIN, GIOVANNI/0000-0002-1903-2542; BASSO, GIUSEPPE/0000-0002-2634-9302; Milanesi, Ornella/0000-0002-6875-9297	University of Padova	University of Padova	This work was supported by a grant from the University of Padova. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves NL, 2010, J IMMUNOL, V184, P5949, DOI 10.4049/jimmunol.1000601; Anderson G, 2006, IMMUNOL REV, V209, P10, DOI 10.1111/j.0105-2896.2006.00347.x; Anderson G, 2012, TRENDS IMMUNOL, V33, P256, DOI 10.1016/j.it.2012.03.005; Bai M, 2008, ANTICANCER RES, V28, P295; Belloni AS, 2006, INT J MOL MED, V17, P709; Belloni AS, 2005, INT J MOL MED, V15, P567; Belloni AS, 2004, INT J MOL MED, V13, P669; Belloni AS, 2003, PEPTIDES, V24, P295, DOI 10.1016/S0196-9781(03)00038-X; Belloni AS, 2001, HISTOL HISTOPATHOL, V16, P1263, DOI 10.14670/HH-16.1263; Bkaily G, 2009, CAN J PHYSIOL PHARM, V87, P108, DOI 10.1139/Y08-115; Boivin B, 2008, J RECEPT SIG TRANSD, V28, P15, DOI [10.1080/10799890801941889, 10.1080/10799890801941889 ]; Carraro G, 2002, INT J MOL MED, V10, P767; Cheung BMY, 2012, RECENT PATENTS ENDOC, V6, P4, DOI 10.2174/187221412799015263; Consonni A, 2011, MOL CELL NEUROSCI, V48, P151, DOI 10.1016/j.mcn.2011.07.006; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Dixit VD, 2007, J CLIN INVEST, V117, P2778, DOI 10.1172/JCI30248; FERNANDEZ E, 1994, BLOOD, V83, P3245; GALY AHM, 1992, J IMMUNOL, V149, P775; Grunewald TGP, 2007, BMC CANCER, V7, P1, DOI 10.1186/1471-2407-7-198; Gruver AL, 2008, J LEUKOCYTE BIOL, V84, P915, DOI 10.1189/jlb.0108025; Hay DL, 2003, BRIT J PHARMACOL, V140, P477, DOI 10.1038/sj.bjp.0705472; Hinson JP, 2000, ENDOCR REV, V21, P138, DOI 10.1210/er.21.2.138; Kitamura K, 2012, BIOCHEM BIOPH RES CO, V425, P548, DOI 10.1016/j.bbrc.2012.08.022; Kocemba KA, 2013, LEUKEMIA, V27, P1729, DOI 10.1038/leu.2013.76; Kuwasako K, 2000, J BIOL CHEM, V275, P29602, DOI 10.1074/jbc.M004534200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liverani E, 2012, INT IMMUNOPHARMACOL, V14, P75, DOI 10.1016/j.intimp.2012.06.011; Marie JC, 1999, J IMMUNOL, V162, P2103; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; PENIT C, 1989, P NATL ACAD SCI USA, V86, P5547, DOI 10.1073/pnas.86.14.5547; Pleguezuelos O, 2004, FEBS LETT, V577, P249, DOI 10.1016/j.febslet.2004.10.019; Ribatti D, 2005, PEPTIDES, V26, P1670, DOI 10.1016/j.peptides.2005.02.017; Ribatti D, 2008, PEPTIDES, V29, P1596, DOI 10.1016/j.peptides.2008.05.011; Schwarz N, 2006, J ENDOCRINOL, V190, P505, DOI 10.1677/joe.1.06806; Sexton PM, 2009, DRUG DISCOV TODAY, V14, P413, DOI 10.1016/j.drudis.2008.12.009; Takahama Y, 2006, NAT REV IMMUNOL, V6, P127, DOI 10.1038/nri1781; Welsch U, 2002, ACTA HISTOCHEM, V104, P65, DOI 10.1078/0065-1281-00623; Wong LYF, 2005, ENDOCRINOLOGY, V146, P1321, DOI 10.1210/en.2004-1080; Zhu T, 2006, CAN J PHYSIOL PHARM, V84, P377, DOI 10.1139/Y05-147	39	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97592	10.1371/journal.pone.0097592	http://dx.doi.org/10.1371/journal.pone.0097592			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831942	Green Submitted, Green Published, gold			2022-12-27	WOS:000336789500082
J	Ecsedi, S; Hernandez-Vargas, H; Lima, SC; Vizkeleti, L; Toth, R; Lazar, V; Koroknai, V; Kiss, T; Emri, G; Herceg, Z; Adany, R; Balazs, M				Ecsedi, Szilvia; Hernandez-Vargas, Hector; Lima, Sheila C.; Vizkeleti, Laura; Toth, Reka; Lazar, Viktoria; Koroknai, Viktoria; Kiss, Timea; Emri, Gabriella; Herceg, Zdenko; Adany, Roza; Balazs, Margit			DNA Methylation Characteristics of Primary Melanomas with Distinct Biological Behaviour	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENES; PROMOTER METHYLATION; MALIGNANT-MELANOMA; GENOME; CANCER; BRAF; 5-HYDROXYMETHYLCYTOSINE; IDENTIFICATION; EPIGENETICS; MUTATIONS	In melanoma, the presence of promoter related hypermethylation has previously been reported, however, no methylation-based distinction has been drawn among the diverse melanoma subtypes. Here, we investigated DNA methylation changes associated with melanoma progression and links between methylation patterns and other types of somatic alterations, including the most frequent mutations and DNA copy number changes. Our results revealed that the methylome, presenting in early stage samples and associated with the BRAF(V600E) mutation, gradually decreased in the medium and late stages of the disease. An inverse relationship among the other predefined groups and promoter methylation was also revealed except for histologic subtype, whereas the more aggressive, nodular subtype melanomas exhibited hypermethylation as well. The Breslow thickness, which is a continuous variable, allowed for the most precise insight into how promoter methylation decreases from stage to stage. Integrating our methylation results with a high-throughput copy number alteration dataset, local correlations were detected in the MYB and EYA4 genes. With regard to the effects of DNA hypermethylation on melanoma patients' survival, correcting for clinical cofounders, only the KIT gene was associated with a lower overall survival rate. In this study, we demonstrate the strong influence of promoter localized DNA methylation changes on melanoma initiation and show how hypermethylation decreases in melanomas associated with less favourable clinical outcomes. Furthermore, we establish the methylation pattern as part of an integrated apparatus of somatic DNA alterations.	[Ecsedi, Szilvia; Vizkeleti, Laura; Toth, Reka; Lazar, Viktoria; Koroknai, Viktoria; Kiss, Timea; Adany, Roza; Balazs, Margit] Univ Debrecen, Fac Publ Hlth, Dept Prevent Med, H-4012 Debrecen, Hungary; [Ecsedi, Szilvia; Vizkeleti, Laura; Adany, Roza; Balazs, Margit] Univ Debrecen, MTA DE Publ Hlth Res Grp, H-4012 Debrecen, Hungary; [Hernandez-Vargas, Hector; Lima, Sheila C.; Herceg, Zdenko] Int Agcy Res Canc, Sect Mech Carcinogenesis, Epigenet Grp, F-69372 Lyon, France; [Emri, Gabriella] Univ Debrecen, Fac Med, Dept Dermatol, H-4012 Debrecen, Hungary	University of Debrecen; Eotvos Lorand Research Network; Office for Supported Research Groups (ELKH); University of Debrecen; World Health Organization; International Agency for Research on Cancer (IARC); University of Debrecen	Balazs, M (corresponding author), Univ Debrecen, Fac Publ Hlth, Dept Prevent Med, H-4012 Debrecen, Hungary.	balazs.margit@sph.unideb.hu	Toth, Reka/AAB-1695-2020; Vizkeleti, Laura/T-4416-2017; Lima, Sheila C S/A-9059-2015; Lazar, Vladimir/AAQ-2086-2020	Toth, Reka/0000-0002-6096-1052; Vizkeleti, Laura/0000-0001-6870-3499; Lazar, Viktoria/0000-0002-9778-941X; Hernandez-Vargas, Hector/0000-0001-6045-2103	Hungarian National Research Fund [OTKA K75191]; TAMOP projects; European Union; European Social Fund; National Excellence Program - Elaborating and operating an inland student and researcher personal support system convergence program [TAMOP 4.2.4.A/2-11-1-2012-0001];  [TAMOP 4.2.1/B-09/1/KONV-2010-0007];  [TAMOP-4.2.2.A-11/1/KONV-2012-0031]	Hungarian National Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); TAMOP projects; European Union(European Commission); European Social Fund(European Social Fund (ESF)); National Excellence Program - Elaborating and operating an inland student and researcher personal support system convergence program; ; 	This research was supported by the Hungarian National Research Fund (OTKA K75191), the TAMOP 4.2.1/B-09/1/KONV-2010-0007 and the TAMOP-4.2.2.A-11/1/KONV-2012-0031 projects; the TAMOP projects are co-financed by the European Union and the European Social Fund. Furthermore, the research was realized in the frames of TAMOP 4.2.4.A/2-11-1-2012-0001 "National Excellence Program - Elaborating and operating an inland student and researcher personal support system convergence program." The project was subsidized by the European Union and co-financed by the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquaviva L, 2013, SCIENCE, V339, P215, DOI 10.1126/science.1225739; Adjemian JZ, 2009, INT J OCCUP ENV HEAL, V15, P331; Bae JM, 2013, HISTOL HISTOPATHOL; Balazs M, 2011, BREAKTHROUGHS MELANO, P237; Berger MF, 2009, HEMATOL ONCOL CLIN N, V23, P397, DOI 10.1016/j.hoc.2009.03.005; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI [10.2217/epi.09.14, 10.2217/EPI.09.14]; Christensen BC, 2010, CANCER RES, V70, P5686, DOI 10.1158/0008-5472.CAN-10-0190; Chu SH, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-156; Conway K, 2011, PIGM CELL MELANOMA R, V24, P352, DOI 10.1111/j.1755-148X.2011.00828.x; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Furuta J, 2004, CANCER SCI, V95, P962, DOI 10.1111/j.1349-7006.2004.tb03184.x; Gerami P, 2012, AM J SURG PATHOL, V36, P808, DOI 10.1097/PAS.0b013e31824b1efd; Gershenwald JE, 2010, ANN SURG ONCOL, V17, P1475, DOI 10.1245/s10434-010-0986-3; Greshock J, 2009, GENE CHROMOSOME CANC, V48, P419, DOI 10.1002/gcc.20651; Hernandez-Vargas H, 2011, EPIGENETICS-US, V6, P429, DOI 10.4161/epi.6.4.14515; Hernandez-Vargas H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009749; Heyn H, 2012, NAT REV GENET, V13, P679, DOI 10.1038/nrg3270; Hou P, 2012, CELL CYCLE, V11, P286, DOI 10.4161/cc.11.2.18707; Houseman EA, 2009, BIOINFORMATICS, V25, P1999, DOI 10.1093/bioinformatics/btp364; James SJ, 2003, J NUTR, V133, p3740S, DOI 10.1093/jn/133.11.3740S; Lahtz C, 2010, J INVEST DERMATOL, V130, P620, DOI 10.1038/jid.2009.226; Lazar V, 2012, MELANOMA RES, V22, P202, DOI 10.1097/CMR.0b013e328352dbc8; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Lima SCS, 2011, EPIGENETICS-US, V6, P1217, DOI 10.4161/epi.6.10.17199; Liu DX, 2012, BIOCHEM BIOPH RES CO, V425, P45, DOI 10.1016/j.bbrc.2012.07.046; Liu SH, 2008, PIGM CELL MELANOMA R, V21, P545, DOI 10.1111/j.1755-148X.2008.00484.x; Marini A, 2006, J INVEST DERMATOL, V126, P422, DOI 10.1038/sj.jid.5700073; Mori T, 2006, CANCER RES, V66, P6692, DOI 10.1158/0008-5472.CAN-06-0801; Rakosy Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054958; Rose AE, 2011, CANCER RES, V71, P2561, DOI 10.1158/0008-5472.CAN-10-2958; Scott M, 2006, INT J CANCER, V118, P1325, DOI 10.1002/ijc.21486; Senetta R, 2012, HISTOPATHOLOGY, V60, P706, DOI 10.1111/j.1365-2559.2011.03984.x; Sigalotti L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-185; Sigalotti L, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-56; Song CX, 2011, EPIGENOMICS-UK, V3, P521, DOI [10.2217/epi.11.74, 10.2217/EPI.11.74]; Tellez CS, 2009, MELANOMA RES, V19, P146, DOI 10.1097/CMR.0b013e32832b274e; Thomas NE, 2006, MELANOMA RES, V16, P97, DOI 10.1097/01.cmr.0000215035.38436.87; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; van den Hurk K, 2012, BBA-REV CANCER, V1826, P89, DOI 10.1016/j.bbcan.2012.03.011; van Roon EH, 2013, CLIN EPIGENETICS, V5, DOI 10.1186/1868-7083-5-2; Vizkeleti L, 2012, TUMOR BIOL, V33, P2189, DOI 10.1007/s13277-012-0480-6; Wild L, 2010, BBA-REV CANCER, V1806, P50, DOI 10.1016/j.bbcan.2010.03.003; Zhang HT, 2011, INT J MOL SCI, V12, P1505, DOI 10.3390/ijms12031505	44	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e96612	10.1371/journal.pone.0096612	http://dx.doi.org/10.1371/journal.pone.0096612			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24832207	Green Submitted, Green Published, gold			2022-12-27	WOS:000336789500024
J	Kupczik, K; Chattah, NLT				Kupczik, Kornelius; Chattah, Netta Lev-Tov			The Adaptive Significance of Enamel Loss in the Mandibular Incisors of Cercopithecine Primates (Mammalia: Cercopithecidae): A Finite Element Modelling Study	PLOS ONE			English	Article							ANTERIOR TOOTH USE; BEHAVIOR; DIET; INTERFEROMETRY; DENTITION; MOLARS; MICROSTRUCTURE; DEFORMATION; ANTHROPOIDS; ADAPTATION	In several primate groups enamel is reduced or absent from the lingual (tongue) side of the mandibular incisor crowns akin to other placental and marsupial mammalian groups such as rodents, lagomorphs and wombats. Here we investigate the presumed adaptation of crowns with unilateral enamel to the incision of tough foods in cercopithecines, an Old World monkey subfamily, using a simulation approach. We developed and validated a finite element model of the lower central incisor of the rhesus macaque (Macaca mulatta) with labial enamel only to compute three-dimensional displacements and maximum principal stresses on the crown subjected to compressive loads varying in orientation. Moreover, we developed a model of a macaque incisor with enamel present on both labial and lingual aspects, thus resembling the ancestral condition found in the sister taxon, the leaf-eating colobines. The results showed that, concomitant with experimental results, the cercopithecine crown with unilateral enamel bends predominantly towards the inside of the mouth, while displacements decreased when both labial and lingual enamel are present. Importantly, the cercopithecine incisor crown experienced lower maximum principal stress on the lingual side compared to the incisor with enamel on the lingual and labial aspects under non-axial loads directed either towards the inside or outside of the mouth. These findings suggest that cercopithecine mandibular incisors are adapted to a wide range of ingestive behaviours compared to colobines. We conclude that the evolutionary loss of lingual enamel in cercopithecines has conferred a safeguard against crown failure under a loading regime assumed for the ingestion (peeling, scraping) of tough-skinned fruits.	[Kupczik, Kornelius] Max Planck Inst Evolutionary Anthropol, Max Planck Weizmann Ctr Integrat Archaeol & Anthr, Leipzig, Germany; [Kupczik, Kornelius] Univ Jena, Inst Spezielle Zool & Evolut Biol, Jena, Germany; [Chattah, Netta Lev-Tov] Israel Natl Police, Dept Identificat & Forens Sci, Jerusalem, Israel	Max Planck Society; Friedrich Schiller University of Jena	Kupczik, K (corresponding author), Max Planck Inst Evolutionary Anthropol, Max Planck Weizmann Ctr Integrat Archaeol & Anthr, Leipzig, Germany.	kornelius_kupczik@eva.mpg.de	Kupczik, Kornelius/E-9788-2011	Kupczik, Kornelius/0000-0003-1502-581X	Max Planck Society; Minerva Stiftung	Max Planck Society(Max Planck SocietyFoundation CELLEX); Minerva Stiftung	Funding was provided by the Max Planck Society and the Minerva Stiftung (to NLTC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal K. R., 2008, TECHNIQUE APPL DENT, P349; Agrawal KR, 2003, P ROY SOC B-BIOL SCI, V270, P1277, DOI 10.1098/rspb.2003.2361; AIMI M, 1989, PRIMATES, V30, P261, DOI 10.1007/BF02381312; Anderson PSL, 2012, J R SOC INTERFACE, V9, P1846, DOI 10.1098/rsif.2012.0043; Barak MM, 2009, J STRUCT BIOL, V168, P511, DOI 10.1016/j.jsb.2009.07.019; Benazzi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069990; Benazzi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062263; Benazzi S, 2011, J ANAT, V219, P259, DOI 10.1111/j.1469-7580.2011.01396.x; BENEFIT BR, 1993, J HUM EVOL, V25, P83, DOI 10.1006/jhev.1993.1041; Benefit Brenda R., 2000, P133, DOI 10.1017/CBO9780511542589.007; Beynon AD, 1998, J HUM EVOL, V35, P163, DOI 10.1006/jhev.1998.0230; Chattah NLT, 2011, J ANAT, V218, P87, DOI 10.1111/j.1469-7580.2010.01234.x; Chattah NLT, 2009, ADV MATER, V21, P413, DOI 10.1002/adma.200801187; Constantino PJ, 2011, J HUM EVOL, V61, P89, DOI 10.1016/j.jhevol.2011.02.009; CRAIG RG, 1961, J DENT RES, V40, P936, DOI 10.1177/00220345610400051901; Deane A, 2012, AM J PHYS ANTHROPOL, V148, P249, DOI 10.1002/ajpa.21598; DELSON E, 1975, CONTRIB PRIMATOL, V5, P167; Fong H, 2000, MAT SCI ENG C-BIO S, V7, P119, DOI 10.1016/S0928-4931(99)00133-2; Giannini M, 2004, DENT MATER, V20, P322, DOI 10.1016/S0109-5641(03)00110-6; GILLINGS B, 1961, J DENT RES, V40, P105, DOI 10.1177/00220345610400010201; Hasegawa A, 2010, INT J BIOMATER, V2010, DOI 10.1155/2010/659802; Huo B, 2005, J BIOMECH, V38, P587, DOI 10.1016/j.jbiomech.2004.03.028; HYLANDER WL, 1975, SCIENCE, V189, P1095, DOI 10.1126/science.808855; Kupczik K, 2009, AM J PHYS ANTHROPOL, V139, P193, DOI 10.1002/ajpa.20972; Lawn BR, 2009, J MECH BEHAV BIOMED, V2, P33, DOI 10.1016/j.jmbbm.2008.05.007; Liu J, 2012, BIOMECH MODEL MECHAN, V11, P35, DOI 10.1007/s10237-011-0291-5; Lucas Peter W., 1994, P173; Luckett W. P., 1993, Journal of Mammalian Evolution, V1, P127, DOI 10.1007/BF01041591; Macho GA, 1999, AM J PHYS ANTHROPOL, V109, P211, DOI 10.1002/(SICI)1096-8644(199906)109:2<211::AID-AJPA6>3.3.CO;2-2; Magne P, 1999, J PROSTHET DENT, V81, P345, DOI 10.1016/S0022-3913(99)70279-9; Martin T, 2004, J VERTEBR PALEONTOL, V24, P411, DOI 10.1671/2513; Martin Thomas, 1999, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Zoologische Reihe, V75, P257; RASMUSSEN ST, 1976, J DENT RES, V55, P154, DOI 10.1177/00220345760550010901; Rees JS, 2001, J ORAL REHABIL, V28, P425, DOI 10.1046/j.1365-2842.2001.00686.x; ROSENBERGER AL, 1978, J MAMMAL, V59, P207, DOI 10.2307/1379899; SHELLIS R P, 1979, Scanning Electron Microscopy, P497; SHELLIS RP, 1986, AM J PHYS ANTHROPOL, V71, P103, DOI 10.1002/ajpa.1330710113; SIEBERT J R, 1984, Primates, V25, P507, DOI 10.1007/BF02381672; Spears IR, 1998, AM J PHYS ANTHROPOL, V106, P467, DOI 10.1002/(SICI)1096-8644(199808)106:4<467::AID-AJPA3>3.0.CO;2-G; Spears IR, 1997, J DENT RES, V76, P1690, DOI 10.1177/00220345970760101101; SPEARS IR, 1993, J DENT RES, V72, P1526, DOI 10.1177/00220345930720111101; STRASSER E, 1987, J HUM EVOL, V16, P81, DOI 10.1016/0047-2484(87)90061-3; Thenius E., 1989, ZAHNE GEBISS SAUGETI, P513; UNGAR PS, 1990, AM J PRIMATOL, V20, P43, DOI 10.1002/ajp.1350200107; Ungar PS, 1996, AM J PHYS ANTHROPOL, V100, P101; UNGAR PS, 1994, AM J PHYS ANTHROPOL, V95, P197, DOI 10.1002/ajpa.1330950207; Ungar PS, 1996, AM J PRIMATOL, V38, P145, DOI 10.1002/(SICI)1098-2345(1996)38:2<145::AID-AJP3>3.0.CO;2-Z; WALKER PL, 1976, AM J PHYS ANTHROPOL, V45, P299, DOI 10.1002/ajpa.1330450215; Wright BW, 2012, AM J PHYS ANTHROPOL, V148, P262, DOI 10.1002/ajpa.22081; Wright BW, 2005, J HUM EVOL, V48, P473, DOI 10.1016/j.jhevol.2005.01.006; Zaslansky P, 2006, ADV FUNCT MATER, V16, P1925, DOI 10.1002/adfm.200600120; Ziskind D, 2011, J STRUCT BIOL, V174, P23, DOI 10.1016/j.jsb.2010.09.010	52	11	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97677	10.1371/journal.pone.0097677	http://dx.doi.org/10.1371/journal.pone.0097677			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24831704	Green Published, gold			2022-12-27	WOS:000336789500101
J	Albino, S; Tabb, KM; Requena, D; Egoavil, M; Pineros-Leano, MF; Zunt, JR; Garcia, PJ				Albino, Sandra; Tabb, Karen M.; Requena, David; Egoavil, Miguel; Pineros-Leano, Maria F.; Zunt, Joseph R.; Garcia, Patricia J.			Perceptions and Acceptability of Short Message Services Technology to Improve Treatment Adherence amongst Tuberculosis Patients in Peru: A Focus Group Study	PLOS ONE			English	Article							MANAGEMENT; ATTITUDES; PHONES; SMS	Background: Tuberculosis (TB) is global health concern and a leading infectious cause of mortality. Reversing TB incidence and disease-related mortality is a major global health priority. Infectious disease mortality is directly linked to failure to adhere to treatments. Using technology to send reminders by short message services have been shown to improve treatment adherence. However, few studies have examined tuberculosis patient perceptions and attitudes towards using SMS technology to increase treatment adherence. In this study, we sought to investigate perceptions related to feasibility and acceptability of using text messaging to improve treatment adherence among adults who were receiving treatment for TB in Callao, Peru. Methods: We conducted focus group qualitative interviews with current TB positive and non-contagious participants to understand the attitudes, perceptions, and feasibility of using short message service (SMS) reminders to improve TB treatment adherence. Subjects receiving care through the National TB Program were recruited through public health centers in Ventanilla, Callao, Peru. In four focus groups, we interviewed 16 patients. All interviews were recorded and transcribed verbatim. Thematic network analysis and codebook techniques were used to analyze data. Results: Three major themes emerged from the data: limits on health literacy and information posed challenges to successful TB treatment adherence, treatment motivation at times facilitated adherence to TB treatment, and acceptability of SMS including positive perceptions of SMS to improve TB treatment adherence. The majority of patients shared considerations about how to effectively and confidentially administer an SMS intervention with TB positive participants. Conclusion: The overall perceptions of the use of SMS were positive and indicated that SMS technology may be an efficient way to transmit motivational texts on treatment, health education information, and simple reminders to increase treatment adherence for low-income TB patients living in Peru.	[Albino, Sandra; Requena, David; Egoavil, Miguel; Garcia, Patricia J.] Univ Peruana Cayetano Heredia, Epidemiol Unit, STD & HIV Sch Publ Hlth & Adm, Lima, Peru; [Tabb, Karen M.; Pineros-Leano, Maria F.] Univ Illinois, Sch Social Work, Urbana, IL USA; [Tabb, Karen M.] Univ Illinois, Ctr Latin Amer & Caribbean Studies, Urbana, IL USA; [Zunt, Joseph R.] Univ Washington, Sch Med, Dept Med Neurol, Seattle, WA USA; [Zunt, Joseph R.] Univ Washington, Sch Med, Dept Epidemiol, Seattle, WA USA; [Zunt, Joseph R.; Garcia, Patricia J.] Univ Washington, Sch Med, Dept Global Hlth, Seattle, WA USA; [Zunt, Joseph R.; Garcia, Patricia J.] Univ Washington, Sch Med, Dept Neurol, Seattle, WA USA	Universidad Peruana Cayetano Heredia; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Garcia, PJ (corresponding author), Univ Peruana Cayetano Heredia, Epidemiol Unit, STD & HIV Sch Publ Hlth & Adm, Lima, Peru.	patricia.garcia@upch.pe	Zunt, Joseph/ABD-2886-2021; Pineros-Leano, Maria/AAB-5459-2019; Requena, David/AAF-4255-2019; Pineros-Leano, Maria/X-7041-2019	Pineros-Leano, Maria/0000-0001-7057-8316; Egoavil, Miguel S./0000-0002-9065-2576; Requena, David/0000-0002-5968-1133; Albino, Sandra/0000-0002-9992-6158; Tabb Dina, Karen/0000-0002-4722-9502	Fogarty International Center, United States National Institutes of Health [5R25TW007490-02, D43TW008438-0109]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007543, R24HD042828] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R25TW007490, D43TW008438] Funding Source: NIH RePORTER	Fogarty International Center, United States National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This article was supported by the following grants: 5R25TW007490-02 and D43TW008438-0109 from the Fogarty International Center, United States National Institutes of Health. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Fogarty/NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailinger RL, 2007, J COMMUN HEALTH NURS, V24, P191, DOI 10.1080/07370010701429637; Alejandria M.M., 2009, ACTA MED PHILIPPINA, V43, P10; Bassett IV, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-390; Bonilla Asalde Cesar, 2008, Acta méd. peruana, V25, P163; Bourne C, 2011, SEX TRANSM INFECT, V87, P229, DOI 10.1136/sti.2010.048397; Culqui D, 2005, REV PANAMERICANA SAL, V18; Culqui DR, 2005, REV PANAM SALUD PUBL, V18, P14, DOI 10.1590/S1020-49892005000600003; Curioso WH, 2009, ITS TIME YOUR LIFE S; Deglise C, 2012, J TELEMED TELECARE, V18, P273, DOI 10.1258/jtt.2012.110810; Deglise C, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1823; DIRESA Callao, 2011, ESTR SAN REG PREV CO; Dye C, 2009, B WORLD HEALTH ORGAN, V87, P683, DOI 10.2471/BLT.08.058453; Ferrer-Roca O, 2004, J TELEMED TELECARE, V10, P282, DOI 10.1258/1357633042026341; Hoffman JA, 2010, AM J PREV MED, V39, P78, DOI 10.1016/j.amepre.2010.02.018; Hsieh CJ, 2008, J CLIN NURS, V17, P869, DOI 10.1111/j.1365-2702.2006.01924.x; Kaona FAD, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-68; Lester RT, 2006, AIDS, V20, P2242, DOI 10.1097/QAD.0b013e3280108508; Mittal Chhaya, 2011, Indian J Community Med, V36, P27, DOI 10.4103/0970-0218.80789; Mohammed S, 2012, J TELEMED TELECARE, V18, P404, DOI 10.1258/jtt.2012.120311; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Muture BN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-696; Nglazi MD, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-566; OSIPTEL, 2013, IND SERV MOB LIN SER; Person AK, 2011, TELEMED E-HEALTH, V17, P189, DOI 10.1089/tmj.2010.0164; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; Senbeto M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1222; Sidney K, 2012, AIDS CARE, V24, P612, DOI 10.1080/09540121.2011.630357; Strandbygaard U, 2010, RESP MED, V104, P1236, DOI 10.1016/j.rmed.2010.03.034; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	29	25	27	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e95770	10.1371/journal.pone.0095770	http://dx.doi.org/10.1371/journal.pone.0095770			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4TJ	24828031	gold, Green Published, Green Submitted			2022-12-27	WOS:000336857400015
J	Jain, R; Kazmierczak, BI				Jain, Ruchi; Kazmierczak, Barbara I.			A Conservative Amino Acid Mutation in the Master Regulator FleQ Renders Pseudomonas aeruginosa Aflagellate	PLOS ONE			English	Article							BURROWS-WHEELER TRANSFORM; CYSTIC-FIBROSIS PATIENTS; GRAM-NEGATIVE BACTERIA; GENE-EXPRESSION; III SECRETION; TRANSCRIPTIONAL ACTIVATOR; FLAGELLAR NUMBER; READ ALIGNMENT; DNA-SEQUENCES; MOTILITY	Flagellar-based motility plays a critical role in Pseudomonas aeruginosa pathogenesis, influencing both the establishment of bacterial infection and the host's response to the pathogen. Nonetheless, aflagellate clinical strains are often isolated from acutely and chronically infected patients and include the virulent laboratory strain PA103. We determined that PA103's aflagellate phenotype is the result of a single amino acid change (G240V) in the master flagellar regulator, FleQ. This mutation, which lies just outside the Walker B box of FleQ, abrogates the ability of FleQ to positively regulate flagellar gene expression. Reversal of this seemingly conservative amino acid substitution is sufficient to restore swimming motility to PA103, despite the presence of mutations in other flagellar genes of PA103. We also investigated the consequences of restoring flagellar assembly on PA103 virulence. Although a negative correlation between flagellar assembly and Type 3 secretion system (T3SS) expression has been reported previously, we did not observe downregulation of T3SS expression or function in Fla+ PA103. Restoration of flagellar assembly did, however, amplify IL-1 signals measured during murine pulmonary infection and was associated with increased bacterial clearance. These experiments suggest that loss of flagellar motility may primarily benefit PA103 by attenuating pathogen recognition and clearance during acute infection.	[Jain, Ruchi; Kazmierczak, Barbara I.] Yale Univ, Sch Med, Dept Internal Med Infect Dis, New Haven, CT 06520 USA; [Kazmierczak, Barbara I.] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT USA	Yale University; Yale University	Kazmierczak, BI (corresponding author), Yale Univ, Sch Med, Dept Internal Med Infect Dis, New Haven, CT 06520 USA.	barbara.kazmierczak@yale.edu		Kazmierczak, Barbara/0000-0002-8162-803X	Brown-Coxe Fellowship; National Institute of Allergy and Infectious Diseases [R01 AI075051, R01 AI081825]; Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Diseases Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075051, R01AI081825] Funding Source: NIH RePORTER	Brown-Coxe Fellowship; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Diseases Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Brown-Coxe Fellowship (R.J.), the National Institute of Allergy and Infectious Diseases (R01 AI075051, R01 AI081825 (B.I.K.)) and a Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Diseases Award (B.I.K.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel E, 2010, INFECT IMMUN, V78, P2937, DOI 10.1128/IAI.00144-10; Arora SK, 1997, J BACTERIOL, V179, P5574, DOI 10.1128/jb.179.17.5574-5581.1997; Arora SK, 2001, P NATL ACAD SCI USA, V98, P9342, DOI 10.1073/pnas.161249198; Baraquet C, 2013, P NATL ACAD SCI USA, V110, P18478, DOI 10.1073/pnas.1318972110; Baraquet C, 2012, NUCLEIC ACIDS RES, V40, P7207, DOI 10.1093/nar/gks384; Bardy SL, 2003, MICROBIOL-SGM, V149, P295, DOI 10.1099/mic.0.25948-0; Bush M, 2012, MICROBIOL MOL BIOL R, V76, P497, DOI 10.1128/MMBR.00006-12; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Dacheux D, 2001, INFECT IMMUN, V69, P538, DOI 10.1128/IAI.69.1.538-542.2001; Dasgupta N, 2003, MOL MICROBIOL, V50, P809, DOI 10.1046/j.1365-2958.2003.03740.x; Dasgupta N, 2000, J BACTERIOL, V182, P357, DOI 10.1128/JB.182.2.357-364.2000; Dasgupta N, 2001, J BACTERIOL, V183, P6636, DOI 10.1128/JB.183.22.6636-6644.2001; Feldman M, 1998, INFECT IMMUN, V66, P43, DOI 10.1128/IAI.66.1.43-51.1998; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Jyot J, 2007, MOL MICROBIOL, V63, P1026, DOI 10.1111/j.1365-2958.2006.05573.x; Kohler T, 2000, J BACTERIOL, V182, P5990, DOI 10.1128/JB.182.21.5990-5996.2000; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laskowski MA, 2004, MOL MICROBIOL, V54, P1090, DOI 10.1111/j.1365-2958.2004.04331.x; Ledizet M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049578; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Li, 2005, Ann Clin Microbiol Antimicrob, V4, P22, DOI 10.1186/1476-0711-4-22; Liu Y, 1996, J MED MICROBIOL, V45, P359, DOI 10.1099/00222615-45-5-359; LUZAR MA, 1985, INFECT IMMUN, V50, P577, DOI 10.1128/IAI.50.2.577-582.1985; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; MAHENTHIRALINGAM E, 1994, INFECT IMMUN, V62, P596, DOI 10.1128/IAI.62.2.596-605.1994; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Miao EA, 2008, P NATL ACAD SCI USA, V105, P2562, DOI 10.1073/pnas.0712183105; Mijares LA, 2011, J IMMUNOL, V186, P7080, DOI 10.4049/jimmunol.1003687; MONTIE TC, 1982, INFECT IMMUN, V38, P1296, DOI 10.1128/IAI.38.3.1296-1298.1982; MONTIE TC, 1982, INFECT IMMUN, V35, P281, DOI 10.1128/IAI.35.1.281-288.1982; Murray TS, 2006, J BACTERIOL, V188, P6995, DOI 10.1128/JB.00790-06; NICAS TI, 1985, CAN J MICROBIOL, V31, P387, DOI 10.1139/m85-074; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Palmer KL, 2005, J BACTERIOL, V187, P5267, DOI 10.1128/JB.187.15.5267-5277.2005; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Patankar YR, 2013, INFECT IMMUN, V81, P2043, DOI 10.1128/IAI.00054-13; Ramos HC, 2004, TRENDS MICROBIOL, V12, P509, DOI 10.1016/j.tim.2004.09.002; Schniederberend M, 2013, J BACTERIOL, V195, P1051, DOI 10.1128/JB.02013-12; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; SCHWEIZER HP, 1995, GENE, V158, P15, DOI 10.1016/0378-1119(95)00055-B; Shanks RMQ, 2006, APPL ENVIRON MICROB, V72, P5027, DOI 10.1128/AEM.00682-06; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Smith K, 2003, POETRY REV, V93, P5; Soscia C, 2007, J BACTERIOL, V189, P3124, DOI 10.1128/JB.01677-06; Spangenberg C, 1996, FEBS LETT, V396, P213, DOI 10.1016/0014-5793(96)01099-X; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Tart AH, 2005, J BACTERIOL, V187, P7955, DOI 10.1128/JB.187.23.7955-7962.2005; van Ditmarsch D, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-140; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Wangdi T, 2010, INFECT IMMUN, V78, P4744, DOI 10.1128/IAI.00744-10; Watson AA, 1996, GENE, V172, P163, DOI 10.1016/0378-1119(96)00026-1; Wolfgang MC, 2004, P NATL ACAD SCI USA, V101, P6664, DOI 10.1073/pnas.0307553101; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	57	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97439	10.1371/journal.pone.0097439	http://dx.doi.org/10.1371/journal.pone.0097439			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827992	Green Submitted, gold, Green Published			2022-12-27	WOS:000336857400094
J	Ji, Y; Abrams, N; Zhu, W; Salinas, E; Yu, ZY; Palmer, DC; Jailwala, P; Franco, Z; Roychoudhuri, R; Stahlberg, E; Gattinoni, L; Restifo, NP				Ji, Yun; Abrams, Natalie; Zhu, Wei; Salinas, Eddie; Yu, Zhiya; Palmer, Douglas C.; Jailwala, Parthav; Franco, Zulmarie; Roychoudhuri, Rahul; Stahlberg, Eric; Gattinoni, Luca; Restifo, Nicholas P.			Identification of the Genomic Insertion Site of Pmel-1 TCR alpha and beta Transgenes by Next-Generation Sequencing	PLOS ONE			English	Article							CD8(+) T-CELLS; SUPERIOR ANTITUMOR IMMUNITY; IN-VIVO; ADOPTIVE IMMUNOTHERAPY; TUMOR-REGRESSION; DENDRITIC CELLS; STEM-CELLS; MEMORY; EFFECTOR; ANTIGEN	The pmel-1 T cell receptor transgenic mouse has been extensively employed as an ideal model system to study the mechanisms of tumor immunology, CD8(+) T cell differentiation, autoimmunity and adoptive immunotherapy. The 'zygosity' of the transgene affects the transgene expression levels and may compromise optimal breeding scheme design. However, the integration sites for the pmel-1 mouse have remained uncharacterized. This is also true for many other commonly used transgenic mice created before the modern era of rapid and inexpensive next-generation sequencing. Here, we show that whole genome sequencing can be used to determine the exact pmel-1 genomic integration site, even with relatively "shallow" (8X) coverage. The results were used to develop a validated polymerase chain reaction-based genotyping assay. For the first time, we provide a quick and convenient polymerase chain reaction method to determine the dosage of pmel-1 transgene for this freely and publically available mouse resource. We also demonstrate that next-generation sequencing provides a feasible approach for mapping foreign DNA integration sites, even when information of the original vector sequences is only partially known.	[Ji, Yun; Zhu, Wei; Gattinoni, Luca] NCI, Expt Transplantat & Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Abrams, Natalie; Salinas, Eddie; Jailwala, Parthav; Stahlberg, Eric] Frederick Natl Lab Canc Res, Adv Biomed Comp Ctr, Frederick, MD USA; [Yu, Zhiya; Palmer, Douglas C.; Franco, Zulmarie; Roychoudhuri, Rahul; Restifo, Nicholas P.] NCI, Surg Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ji, Y (corresponding author), NCI, Expt Transplantat & Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	jiyun@mail.nih.gov; restifo@nih.gov	Abrams, Natalie/AAM-5468-2021; Palmer, Douglas/B-9454-2008; Waldmann, Thomas/AAT-5972-2021; Roychoudhuri, Rahul/A-7442-2010; Ji, Yun/B-7245-2009; Restifo, Nicholas Phillip/M-6549-2019; Abrams, Natalie/F-4845-2011; Restifo, Nicholas Phillip/Z-1614-2019; Gattinoni, Luca/A-2281-2008	Abrams, Natalie/0000-0001-9698-2819; Palmer, Douglas/0000-0001-5018-5734; Waldmann, Thomas/0000-0003-4500-6660; Roychoudhuri, Rahul/0000-0002-5392-1853; Ji, Yun/0000-0001-6340-7009; Abrams, Natalie/0000-0001-9698-2819; Gattinoni, Luca/0000-0003-2239-3282; Restifo, Nicholas P./0000-0003-4229-4580	National Cancer Institute, Center for Cancer Research of the US National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010763, ZICBC011532] Funding Source: NIH RePORTER	National Cancer Institute, Center for Cancer Research of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Cancer Institute, Center for Cancer Research of the US National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2003, GENESIS, V36, P134, DOI 10.1002/gene.10205; Amos SM, 2011, CANCER IMMUNOL IMMUN, V60, P671, DOI 10.1007/s00262-011-0984-8; Antony PA, 2005, J IMMUNOL, V174, P2591, DOI 10.4049/jimmunol.174.5.2591; Balatoni CE, 2009, AM J PATHOL, V175, P1653, DOI 10.2353/ajpath.2009.090091; Boni A, 2008, BLOOD, V112, P4746, DOI 10.1182/blood-2008-07-169797; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Byrne KT, 2014, J IMMUNOL; Chandler KJ, 2007, MAMM GENOME, V18, P693, DOI 10.1007/s00335-007-9056-y; Chapuis AG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004916; Church SE, 2014, EUR J IMMUNOL, V44, P69, DOI 10.1002/eji.201343718; COOLEY L, 1988, SCIENCE, V239, P1121, DOI 10.1126/science.2830671; Cui YZ, 2009, BLOOD, V114, P3831, DOI 10.1182/blood-2009-03-212134; DEVON RS, 1995, NUCLEIC ACIDS RES, V23, P1644, DOI 10.1093/nar/23.9.1644; Diaz-Montero CM, 2008, CANCER IMMUNOL IMMUN, V57, P563, DOI 10.1007/s00262-007-0394-0; DuBose AJ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1463; Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Gattinoni L, 2005, J EXP MED, V202, P907, DOI 10.1084/jem.20050732; Gattinoni L, 2006, BLOOD, V108, P3818, DOI 10.1182/blood-2006-07-034066; Gattinoni L, 2012, NAT REV CANCER, V12, P671, DOI 10.1038/nrc3322; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; He H, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-24; Hinrichs CS, 2008, BLOOD, V111, P5326, DOI 10.1182/blood-2007-09-113050; Hinrichs CS, 2009, P NATL ACAD SCI USA, V106, P17469, DOI 10.1073/pnas.0907448106; Hinrichs CS, 2009, BLOOD, V114, P596, DOI 10.1182/blood-2009-02-203935; Ji Y, 2011, NAT IMMUNOL, V12, P1230, DOI 10.1038/ni.2153; Johnson LDS, 2010, J IMMUNOL, V184, P5604, DOI 10.4049/jimmunol.1000109; Kaluza KM, 2012, HUM GENE THER, V23, P1054, DOI 10.1089/hum.2012.030; Kerkar SP, 2011, J CLIN INVEST, V121, P4746, DOI 10.1172/JCI58814; Kerkar SP, 2010, CANCER RES, V70, P6725, DOI 10.1158/0008-5472.CAN-10-0735; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Klebanoff CA, 2004, P NATL ACAD SCI USA, V101, P1969, DOI 10.1073/pnas.0307298101; Klebanoff CA, 2011, CLIN CANCER RES, V17, P5343, DOI 10.1158/1078-0432.CCR-11-0503; Klebanoff CA, 2009, BLOOD, V114, P1776, DOI 10.1182/blood-2008-12-192419; Kochenderfer JN, 2013, BLOOD, V122, P4129, DOI 10.1182/blood-2013-08-519413; Koya RC, 2012, CANCER RES, V72, P3928, DOI 10.1158/0008-5472.CAN-11-2837; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le Saux A, 2010, TRANSGENIC RES, V19, P923, DOI 10.1007/s11248-010-9368-7; Lee CH, 2006, MOL CANCER THER, V5, P2592, DOI 10.1158/1535-7163.MCT-06-0310; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu CW, 2013, CLIN CANCER RES, V19, P393, DOI 10.1158/1078-0432.CCR-12-1626; Lou YY, 2004, CANCER RES, V64, P6783, DOI 10.1158/0008-5472.CAN-04-1621; Lu Y, 2014, P NATL ACAD SCI US; Murakami T, 2003, J EXP MED, V198, P1337, DOI 10.1084/jem.20030593; Ohigashi I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014391; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Overwijk WW, 1998, J EXP MED, V188, P277, DOI 10.1084/jem.188.2.277; Palmer DC, 2004, J IMMUNOL, V173, P7209, DOI 10.4049/jimmunol.173.12.7209; Palmer DC, 2008, P NATL ACAD SCI USA, V105, P8061, DOI 10.1073/pnas.0710929105; Paulos CM, 2007, J CLIN INVEST, V117, P2197, DOI 10.1172/JCI32205; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Prins RM, 2008, CANCER IMMUNOL IMMUN, V57, P1279, DOI 10.1007/s00262-008-0461-1; Quatromoni JG, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-127; Radvanyi LG, 2012, CLIN CANCER RES, V18, P6758, DOI 10.1158/1078-0432.CCR-12-1177; Rashighi M, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007811; Rizzuto GA, 2009, J EXP MED, V206, P849, DOI 10.1084/jem.20081382; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rodriguez GM, 2013, J INVEST DERMATOL, V133, P2013, DOI 10.1038/jid.2013.86; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Rubinstein MP, 2012, J AM COLL SURGEONS, V214, P700, DOI 10.1016/j.jamcollsurg.2011.12.034; Salem ML, 2009, J IMMUNOL, V182, P2030, DOI 10.4049/jimmunol.0801829; Schneider MR, 2005, ANAL BIOCHEM, V344, P1, DOI 10.1016/j.ab.2005.03.035; Stephan MT, 2010, NAT MED, V16, P1035, DOI 10.1038/nm.2198; Sukumar M, 2013, J CLIN INVEST, V123, P4479, DOI 10.1172/JCI69589; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Uren AG, 2009, NAT PROTOC, V4, P789, DOI 10.1038/nprot.2009.64; Vo DD, 2009, CANCER RES, V69, P8693, DOI 10.1158/0008-5472.CAN-09-1456; Wang LX, 2005, CANCER RES, V65, P10569, DOI 10.1158/0008-5472.CAN-05-2117; Wrzesinski C, 2007, J CLIN INVEST, V117, P492, DOI 10.1172/JCI30414; Wrzesinski C, 2010, J IMMUNOTHER, V33, P1, DOI 10.1097/CJI.0b013e3181b88ffc; Zeitouni B, 2010, BIOINFORMATICS, V26, P1895, DOI 10.1093/bioinformatics/btq293; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057; Zhou P, 2014, NATURE	75	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96650	10.1371/journal.pone.0096650	http://dx.doi.org/10.1371/journal.pone.0096650			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827921	Green Submitted, Green Published, gold			2022-12-27	WOS:000336857400033
J	Li, XP; Treesukosol, Y; Moghadam, A; Smith, M; Ofeldt, E; Yang, DJ; Li, TX; Tamashiro, K; Choi, PQ; Moran, TH; Smith, WW				Li, Xueping; Treesukosol, Yada; Moghadam, Alexander; Smith, Megan; Ofeldt, Erica; Yang, Dejun; Li, Tianxia; Tamashiro, Kellie; Choi, Pique; Moran, Timothy H.; Smith, Wanli W.			Behavioral Characterization of the Hyperphagia Synphilin-1 Overexpressing Mice	PLOS ONE			English	Article							LACKING CCK-1 RECEPTORS; ALPHA-SYNUCLEIN; MEAL SIZE; OLETF RATS; PARKINSONS-DISEASE; NERVE TRANSECTION; LICKING RESPONSES; OBESITY MODEL; FEEDING RATS; LEWY BODIES	Synphilin-1 is a cytoplasmic protein that has been shown to be involved in the control of energy balance. Previously, we reported on the generation of a human synphilin-1 transgenic mouse model (SP1), in which overexpression of human synphilin-1 resulted in hyperphagia and obesity. Here, behavioral measures in SP1 mice were compared with those of their age-matched controls (NTg) at two time points: when there was not yet a group body weight difference ("pre-obese'') and when SP1 mice were heavier ("obese''). At both time points, meal pattern analyses revealed that SP1 mice displayed higher daily chow intake than non-transgenic control mice. Furthermore, there was an increase in meal size in SP1 mice compared with NTg control mice at the obese stage. In contrast, there was no meal number change between SP1 and NTg control mice. In a brief-access taste procedure, both "pre-obese'' and "obese" SP1 mice displayed concentration-dependent licking across a sucrose concentration range similar to their NTg controls. However, at the pre-obese stage, SP1 mice initiated significantly more trials to sucrose across the testing sessions and licked more vigorously at the highest concentration presented, than the NTg counterparts. These group differences in responsiveness to sucrose were no longer apparent in obese SP1 mice. These results suggest that at the pre-obese stage, the increased trials to sucrose in the SP1 mice reflects increased appetitive behavior to sucrose that may be indicative of the behavioral changes that may contribute to hyperphagia and development of obesity in SP1 mice. These studies provide new insight into synphilin-1 contributions to energy homeostasis.	[Li, Xueping; Yang, Dejun; Li, Tianxia; Smith, Wanli W.] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; [Treesukosol, Yada; Moghadam, Alexander; Smith, Megan; Ofeldt, Erica; Tamashiro, Kellie; Choi, Pique; Moran, Timothy H.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA	University System of Maryland; University of Maryland Baltimore; Johns Hopkins University	Moran, TH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA.	tmoran@jhmi.edu; wsmith@rx.umaryland.edu	Yang, Dejun/L-9865-2016; Aljarah, Ali/Q-7105-2016	Yang, Dejun/0000-0001-5118-0652; Tamashiro, Kellie/0000-0002-9398-8796; Aljarah, Ali/0000-0003-0535-090X	National Institutes of Health [DK083410]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637, R01DK083410] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK083410 to Wanli W. Smith. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aja S, 2006, AM J PHYSIOL-REG I, V291, pR148, DOI 10.1152/ajpregu.00041.2006; Azzara AV, 2002, PHYSIOL BEHAV, V77, P411, DOI 10.1016/S0031-9384(02)00883-1; Bi S, 2002, NEUROPEPTIDES, V36, P171, DOI 10.1054/npep.2002.0895; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Cottone P, 2013, INT J OBES IN PRESS; DAVIS JD, 1993, AM J PHYSIOL, V265, pR888, DOI 10.1152/ajpregu.1993.265.4.R888; DAVIS JD, 1990, AM J PHYSIOL, V259, pR1228, DOI 10.1152/ajpregu.1990.259.6.R1228; De Jonghe BC, 2005, AM J PHYSIOL-REG I, V288, pR292, DOI 10.1152/ajpregu.00481.2004; DREWNOWSKI A, 1978, PHARMACOL BIOCHEM BE, V9, P619, DOI 10.1016/0091-3057(78)90213-7; Eckel LA, 2004, PHYSIOL BEHAV, V82, P35, DOI 10.1016/j.physbeh.2004.04.023; Engelender S, 1999, NAT GENET, V22, P110, DOI 10.1038/8820; Glendinning JI, 2002, CHEM SENSES, V27, P461, DOI 10.1093/chemse/27.5.461; Hajnal A, 2005, AM J PHYSIOL-REG I, V289, pR1675, DOI 10.1152/ajpregu.00412.2005; Jiang ES, 2008, CHEM SENSES, V33, P709, DOI 10.1093/chemse/bjn039; Lee MD, 2002, PHARMACOL BIOCHEM BE, V71, P147, DOI 10.1016/S0091-3057(01)00630-X; Lee MD, 2002, PSYCHOPHARMACOLOGY, V164, P49, DOI 10.1007/s00213-002-1162-7; Li X, 2012, INT J OBESITY, V36, P1215, DOI 10.1038/ijo.2011.235; Li X, 2010, NEUROSCIENCE, V165, P455, DOI 10.1016/j.neuroscience.2009.10.042; Liani E, 2004, P NATL ACAD SCI USA, V101, P5500, DOI 10.1073/pnas.0401081101; Liu J, 2012, INT J OBESITY, V36, P1529, DOI 10.1038/ijo.2012.111; Moran TH, 1998, AM J PHYSIOL-REG I, V274, pR618, DOI 10.1152/ajpregu.1998.274.3.R618; Moran TH, 2006, PHILOS T R SOC B, V361, P1211, DOI 10.1098/rstb.2006.1857; Ribeiro CS, 2002, J BIOL CHEM, V277, P23927, DOI 10.1074/jbc.M201115200; Schwartz GJ, 1999, AM J PHYSIOL-REG I, V277, pR1144, DOI 10.1152/ajpregu.1999.277.4.R1144; Smith GP, 1996, NEUROSCI BIOBEHAV R, V20, P41, DOI 10.1016/0149-7634(95)00038-G; Smith JC, 2001, APPETITE, V36, P93, DOI 10.1006/appe.2000.0372; Smith WW, 2010, HUM MOL GENET, V19, P2087, DOI 10.1093/hmg/ddq086; Smith WW, 2005, J NEUROSCI, V25, P5544, DOI 10.1523/JNEUROSCI.0482-05.2005; Spector AC, 2000, NEUROSCI BIOBEHAV R, V24, P391, DOI 10.1016/S0149-7634(00)00013-0; Spector AC, 1996, BEHAV NEUROSCI, V110, P1096; Spector AC, 2009, CURR OPIN NEUROBIOL, V19, P370, DOI 10.1016/j.conb.2009.07.014; STROHMAYER AJ, 1987, APPETITE, V8, P111, DOI 10.1016/S0195-6663(87)80004-1; Travers JB, 1997, NEUROSCI BIOBEHAV R, V21, P631, DOI 10.1016/S0149-7634(96)00045-0; Treesukosol Y, 2013, PHYSIOL BEHAV, V110, P109, DOI 10.1016/j.physbeh.2013.01.003; Treesukosol Y, 2011, J NEUROSCI, V31, P13527, DOI 10.1523/JNEUROSCI.2179-11.2011; Treesukosol Y, 2009, AM J PHYSIOL-REG I, V296, pR855, DOI 10.1152/ajpregu.90869.2008; Wakabayashi K, 2000, ANN NEUROL, V47, P521, DOI 10.1002/1531-8249(200004)47:4<521::AID-ANA18>3.3.CO;2-2; Zhu GJ, 2012, PHYSIOL BEHAV, V105, P234, DOI 10.1016/j.physbeh.2011.08.007	38	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e91449	10.1371/journal.pone.0091449	http://dx.doi.org/10.1371/journal.pone.0091449			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24829096	Green Published, Green Submitted, gold			2022-12-27	WOS:000336857400004
J	Meliopoulos, VA; Kayali, G; Burnham, A; Oshansky, CM; Thomas, PG; Gray, GC; Beck, MA; Schultz-Cherry, S				Meliopoulos, Victoria A.; Kayali, Ghazi; Burnham, Andrew; Oshansky, Christine M.; Thomas, Paul G.; Gray, Gregory C.; Beck, Melinda A.; Schultz-Cherry, Stacey			Detection of Antibodies against Turkey Astrovirus in Humans	PLOS ONE			English	Article							INFECTION; POULTRY; RETROVIRUSES; MORTALITY; CHICKEN; VIRUS	Astroviruses are a leading cause of gastroenteritis in mammals and birds worldwide. Although historically thought to be species-specific, increasing evidence suggests that astroviruses may cross species barriers. In this report, we used enzyme-linked immunosorbent assays to screen sera from three distinct human cohorts involved in influenza studies in Memphis, TN or Chapel Hill, NC, and Midwestern poultry abattoir workers for antibodies to turkey astrovirus type 2 (TAstV-2). Surprisingly, 26% of one cohort's population was TAstV-2 positive as compared to 0 and 8.9% in the other cohorts. This cohort was composed of people with exposure to turkeys in the Midwestern United States including abattoir workers, turkey growers, and non-occupationally exposed participants. The odds of testing positive for antibodies against turkey astrovirus among abattoir workers were approximately 3 times higher than the other groups. These studies suggest that people with contact to turkeys can develop serological responses to turkey astrovirus. Further work is needed to determine if these exposures result in virus replication and/or clinical disease.	[Meliopoulos, Victoria A.; Kayali, Ghazi; Burnham, Andrew; Schultz-Cherry, Stacey] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Oshansky, Christine M.; Thomas, Paul G.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Gray, Gregory C.] Univ Florida, Coll Publ Hlth Profess, Dept Environm & Global Hlth, Gainesville, FL USA; [Beck, Melinda A.] Univ N Carolina, Dept Nutr, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; State University System of Florida; University of Florida; University of North Carolina; University of North Carolina Chapel Hill	Schultz-Cherry, S (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.	stacey.schultz-cherry@stjude.org	Schultz-Cherry, Stacey/N-2506-2018; Gray, Gregory C./ABF-1298-2020; Thomas, Paul G./H-1063-2018	Thomas, Paul G./0000-0001-7955-0256; Burnham, Andrew/0000-0002-2374-987X; Gray, Gregory/0000-0002-4628-5908	Hartwell Biomedical Foundation; National Institutes of Health (NIH)-National Institute of Allergies and Infectious Diseases (NIAID) [HHSN266200700005C]; ALSAC; U.S. Department of Defense Armed Forces Health Surveillance Center's Global Emerging Infections Surveillance and Response Program; NIAID [R01 AI068803]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078090] Funding Source: NIH RePORTER	Hartwell Biomedical Foundation; National Institutes of Health (NIH)-National Institute of Allergies and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)NIH National Institute of Neurological Disorders & Stroke (NINDS)); ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); U.S. Department of Defense Armed Forces Health Surveillance Center's Global Emerging Infections Surveillance and Response Program; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Hartwell Biomedical Foundation, National Institutes of Health (NIH)-National Institute of Allergies and Infectious Diseases (NIAID) contract number HHSN266200700005C, ALSAC, the U.S. Department of Defense Armed Forces Health Surveillance Center's Global Emerging Infections Surveillance and Response Program (GCG), and NIAID R01 AI068803 (GCG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOSCH A, 2013, ASTROVIRUS RES ESSEN, P1; Ulloa JC, 2010, CAN J MICROBIOL, V56, P569, DOI [10.1139/W10-042, 10.1139/w10-042]; Cattoli G, 2005, VET REC, V156, P220; Choudat D, 1996, OCCUP ENVIRON MED, V53, P403, DOI 10.1136/oem.53.6.403; Chu DKW, 2008, J VIROL, V82, P9107, DOI 10.1128/JVI.00857-08; Chu DKW, 2012, J VIROL, V86, P13772, DOI 10.1128/JVI.02105-12; Day JM, 2007, AVIAN DIS, V51, P681, DOI 10.1637/0005-2086(2007)51[681:AMRTFT]2.0.CO;2; De Benedictis P, 2011, INFECT GENET EVOL, V11, P1529, DOI 10.1016/j.meegid.2011.07.024; DuBois RM, 2013, J VIROL, V87, P7853, DOI 10.1128/JVI.03139-12; Fu Y, 2009, J GEN VIROL, V90, P1104, DOI 10.1099/vir.0.008599-0; Hertz T, 2013, P NATL ACAD SCI USA, V110, P13492, DOI 10.1073/pnas.1221555110; JOHNSON ES, 1994, CANCER DETECT PREV, V18, P9; Kayali G, 2011, VECTOR-BORNE ZOONOT, V11, P1453, DOI 10.1089/vbz.2011.0637; Moser LA, 2007, J VIROL, V81, P11937, DOI 10.1128/JVI.00942-07; Netto GF, 2003, OCCUP ENVIRON MED, V60, P784, DOI 10.1136/oem.60.10.784; Oshansky CM, 2013, AM J RESP CRITICAL C; Paich HA, 2013, OBESITY; Pantin-Jackwood MJ, 2008, AVIAN DIS, V52, P235, DOI 10.1637/8174-111507-Reg.1; Pantin-Jackwood MJ, 2006, VIRUS GENES, V32, P187, DOI 10.1007/s11262-005-6875-3; Rivera R, 2010, J GEN VIROL, V91, P166, DOI 10.1099/vir.0.015222-0; Schultz-Cherry S., 2013, ASTROVIRUS RES ESSEN; Sellers H, 2010, VACCINE, V28, P1253, DOI 10.1016/j.vaccine.2009.11.016; Sheridan PA, 2012, INT J OBESITY, V36, P1072, DOI 10.1038/ijo.2011.208; Tam VC, 2013, CELL, V154, P213, DOI 10.1016/j.cell.2013.05.052; Toffan A, 2009, VET MICROBIOL, V139, P147, DOI 10.1016/j.vetmic.2009.04.031	25	32	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96934	10.1371/journal.pone.0096934	http://dx.doi.org/10.1371/journal.pone.0096934			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24826893	Green Published, Green Submitted, gold			2022-12-27	WOS:000336857400046
J	Newie, I; Sokilde, R; Persson, H; Grabau, D; Rego, N; Kvist, A; von Stedingk, K; Axelson, H; Borg, A; Vallon-Christersson, J; Rovira, C				Newie, Inga; Sokilde, Rolf; Persson, Helena; Grabau, Dorthe; Rego, Natalia; Kvist, Anders; von Stedingk, Kristoffer; Axelson, Hakan; Borg, Ake; Vallon-Christersson, Johan; Rovira, Carlos			The HER2-Encoded miR-4728-3p Regulates ESR1 through a Non-Canonical Internal Seed Interaction	PLOS ONE			English	Article							BREAST-CANCER; ESTROGEN-RECEPTOR; CAENORHABDITIS-ELEGANS; TARGET RECOGNITION; MICRORNA TARGETS; BINDING; HER2; EXPRESSION; PREDICTION; IDENTIFICATION	Since the early 1980s remarkable progress has been made in understanding the role of the HER2 locus in carcinogenesis, but many details of its regulatory network are still elusive. We recently reported the finding of 367 new human microRNA (miRNA) genes of which one, mir-4728, is encoded in an intron of the HER2 gene. Here, we confirm that the HER2 oncogene is a bi-functional locus encoding the membrane receptor and a functional miRNA gene. We further show that miR-4728-3p has alternative functionalities depending on the region used for interaction with its target; the canonical seed between nucleotides 2-8 or a novel, more internal seed shifted to nucleotides 6-12. Analysis of public data shows that this internal seed region, although rare compared to the far more abundant canonical 2-8 seed interaction, can also direct targeted down-regulation by other miRNAs. Through the internal seed, miR-4728-3p regulates expression of estrogen receptor alpha, an interaction that would have remained undetected if classic rules for miRNA-target interaction had been applied. In summary, we present here an alternative mode of miRNA regulation and demonstrate this dual function of the HER2 locus, linking the two major biomarkers in breast cancer.	[Newie, Inga; Sokilde, Rolf; von Stedingk, Kristoffer; Axelson, Hakan; Borg, Ake; Rovira, Carlos] BioCare, Strateg Canc Res Program, Lund, Sweden; [Borg, Ake; Vallon-Christersson, Johan; Rovira, Carlos] CREATE Hlth, Strateg Ctr Translat Canc Res, Lund, Sweden; [Grabau, Dorthe] Skane Univ Hosp, Dept Pathol, Lund, Sweden; [von Stedingk, Kristoffer; Axelson, Hakan] Lund Univ Canc Ctr, Dept Lab Med, Lund, Sweden; [Newie, Inga; Sokilde, Rolf; Persson, Helena; Rego, Natalia; Kvist, Anders; Borg, Ake; Vallon-Christersson, Johan; Rovira, Carlos] Lund Univ Canc Ctr, Dept Pathol & Oncol, Lund, Sweden	Lund University; Skane University Hospital	Rovira, C (corresponding author), BioCare, Strateg Canc Res Program, Lund, Sweden.	Carlos.Rovira@med.lu.se	Søkilde, Rolf/F-5138-2015; Persson, Helena/ABE-5003-2020	Søkilde, Rolf/0000-0003-3010-3599; Vallon-Christersson, Johan/0000-0002-2195-0385; Newie, Inga/0000-0002-6047-6647; Persson, Helena/0000-0002-5187-6446; Kvist, Anders/0000-0002-1358-0695; Rego, Natalia/0000-0001-6944-2825	Swedish National Science Council; Swedish Cancer Society; Gunnar Nilsson Foundation; Berta Kamprads Foundation; BioCare, Lund	Swedish National Science Council; Swedish Cancer Society(Swedish Cancer Society); Gunnar Nilsson Foundation; Berta Kamprads Foundation; BioCare, Lund	Support was provided by the Swedish National Science Council, Swedish Cancer Society, Gunnar Nilsson Foundation, Berta Kamprads Foundation, and BioCare, Lund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baraniskin A, 2012, CARCINOGENESIS, V33, P732, DOI 10.1093/carcin/bgs020; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BORG A, 1994, CANCER LETT, V81, P137, DOI 10.1016/0304-3835(94)90194-5; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; Chi SW, 2012, NAT STRUCT MOL BIOL, V19, P321, DOI 10.1038/nsmb.2230; Chung YL, 2002, INT J CANCER, V97, P306, DOI 10.1002/ijc.1614; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Frogne T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2230; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo SQ, 2004, MOL CELL BIOL, V24, P8681, DOI 10.1128/MCB.24.19.8681-8690.2004; Ha I, 1996, GENE DEV, V10, P3041, DOI 10.1101/gad.10.23.3041; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Khorshid M, 2013, NAT METHODS, V10, P253, DOI [10.1038/NMETH.2341, 10.1038/nmeth.2341]; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lambert NJ, 2011, NUCLEIC ACIDS RES, V39, P4827, DOI 10.1093/nar/gkr077; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lipton A, 2002, J CLIN ONCOL, V20, P1467, DOI 10.1200/JCO.20.6.1467; Parra-Palau JL, 2010, CANCER RES, V70, P8537, DOI 10.1158/0008-5472.CAN-10-1701; Loeb GB, 2012, MOL CELL, V48, P760, DOI 10.1016/j.molcel.2012.10.002; Majoros WH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-152; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Moasser MM, 2007, ONCOGENE, V26, P6469, DOI 10.1038/sj.onc.1210477; Mortimer SA, 2013, NUCLEIC ACIDS RES, V41, P4230, DOI 10.1093/nar/gkt075; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Olayioye MA, 2001, BREAST CANCER RES, V3, P385, DOI 10.1186/bcr327; PADHY LC, 1982, CELL, V28, P865, DOI 10.1016/0092-8674(82)90065-4; Persson H, 2011, CANCER RES, V71, P78, DOI 10.1158/0008-5472.CAN-10-1869; Pinhel I, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3145; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; SCHECHTER AL, 1984, NATURE, V312, P513, DOI 10.1038/312513a0; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; van Dongen S, 2008, NAT METHODS, V5, P1023, DOI 10.1038/nmeth.1267; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; Zaczek A, 2005, HISTOL HISTOPATHOL, V20, P1005, DOI 10.14670/HH-20.1005	39	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97200	10.1371/journal.pone.0097200	http://dx.doi.org/10.1371/journal.pone.0097200			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828673	Green Published, Green Submitted, gold			2022-12-27	WOS:000336857400063
J	Stiburkova, B; Pavlikova, M; Sokolova, J; Kozich, V				Stiburkova, Blanka; Pavlikova, Marketa; Sokolova, Jitka; Kozich, Viktor			Metabolic Syndrome, Alcohol Consumption and Genetic Factors Are Associated with Serum Uric Acid Concentration	PLOS ONE			English	Article							TETRAHYDROFOLATE REDUCTASE GENE; METHYLENETETRAHYDROFOLATE REDUCTASE; RENAL HYPOURICEMIA; URATE TRANSPORTER; RISK-FACTORS; ABCG2 GENE; GOUT; SLC2A9; HYPERURICEMIA; POLYMORPHISM	Objective: Uric acid is the end product of purine metabolism in humans, and increased serum uric acid concentrations lead to gout. The objective of the current study was to identify factors that are independently associated with serum uric acid concentrations in a cohort of Czech control individuals. Methods: The cohort consisted of 589 healthy subjects aged 18-65 years. We studied the associations between the serum uric acid concentration and the following: (i) demographic, anthropometric and other variables previously reported to be associated with serum uric acid concentrations; (ii) the presence of metabolic syndrome and the levels of metabolic syndrome components; and (iii) selected genetic variants of the MTHFR (c.665C>T, c.1286A>C), SLC2A9 (c.844G>A, c.881G>A) and ABCG2 genes (c.421C>A). A backward model selection procedure was used to build two multiple linear regression models; in the second model, the number of metabolic syndrome criteria that were met replaced the metabolic syndrome-related variables. Results: The models had coefficients of determination of 0.59 and 0.53. The serum uric acid concentration strongly correlated with conventional determinants including male sex, and with metabolic syndrome-related variables. In the simplified second model, the serum uric acid concentration positively correlated with the number of metabolic syndrome criteria that were met, and this model retained the explanatory power of the first model. Moderate wine drinking did not increase serum uric acid concentrations, and the urate transporter ABCG2, unlike MTHFR, was a genetic determinant of serum uric acid concentrations. Conclusion: Metabolic syndrome, moderate wine drinking and the c.421C>A variant in the ABCG gene are independently associated with the serum uric acid concentration. Our model indicates that uric acid should be clinically monitored in persons with metabolic syndrome.	[Stiburkova, Blanka] Charles Univ Prague, Inst Inherited Metab Disorders, Fac Med 1, Prague, Czech Republic; Gen Univ Hosp Prague, Prague, Czech Republic	Charles University Prague; General University Hospital Prague	Stiburkova, B (corresponding author), Charles Univ Prague, Inst Inherited Metab Disorders, Fac Med 1, Prague, Czech Republic.	blanka.stiburkova@lf1.cuni.cz	Sokolová, Jitka/H-9924-2015; Kozich, Viktor/A-7672-2008; Pavlikova, Marketa/F-4563-2016; Stiburkova, Blanka/N-8824-2013	Sokolová, Jitka/0000-0002-0453-3336; Kozich, Viktor/0000-0001-5820-5277; Pavlikova, Marketa/0000-0003-4314-4357; Stiburkova, Blanka/0000-0003-2465-1476	Czech Republic Ministry of Health [IGA MZ NT/11322-4/2010, RVO VFN64165]	Czech Republic Ministry of Health(Ministry of Health, Czech Republic)	This study was supported by a grant from the Czech Republic Ministry of Health (IGA MZ NT/11322-4/2010 and RVO VFN64165) and by institutional support from a program at Charles University in Prague (PRVOUK-P24/LF1/3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Alderman M, 1999, Can J Cardiol, V15 Suppl F, p20F; BENGTSSON C, 1974, ACTA MED SCAND, V196, P93; Caulfield MJ, 2008, PLOS MED, V5, P1509, DOI 10.1371/journal.pmed.0050197; Choi HK, 2004, ARTHRIT RHEUM-ARTHR, V51, P1023, DOI 10.1002/art.20821; Davis JW, 1996, AM J EPIDEMIOL, V144, P480, DOI 10.1093/oxfordjournals.aje.a008954; De Vera M, 2008, ARTHRIT RHEUM-ARTHR, V59, P1549, DOI 10.1002/art.24193; Dehghan A, 2008, LANCET, V372, P1953, DOI 10.1016/S0140-6736(08)61343-4; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Enomoto A, 2002, NATURE, V417, P447, DOI 10.1038/nature742; FALLER J, 1982, NEW ENGL J MED, V307, P1598, DOI 10.1056/NEJM198212233072602; Golbahair J, 2007, NUTR METAB CARDIOVAS, V17, P462, DOI 10.1016/j.numecd.2006.02.002; Hayden Melvin R, 2004, Nutr Metab (Lond), V1, P10, DOI 10.1186/1743-7075-1-10; Heinig M, 2006, CLEV CLIN J MED, V73, P1059, DOI 10.3949/ccjm.73.12.1059; Hollis-Moffatt JE, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3356; Hong YS, 2004, J KOREAN MED SCI, V19, P209, DOI 10.3346/jkms.2004.19.2.209; Houlihan LM, 2010, HUM MOL GENET, V19, P2321, DOI 10.1093/hmg/ddq097; Ichida K, 2004, J AM SOC NEPHROL, V15, P164, DOI 10.1097/01.ASN.0000105320.04395.D0; Itou S, 2009, NUTR RES, V29, P710, DOI 10.1016/j.nutres.2009.10.006; Janosikova B, 2003, MOL GENET METAB, V79, P167, DOI 10.1016/S1096-7192(03)00079-9; Karns R, 2012, ANN HUM GENET, V76, P121, DOI 10.1111/j.1469-1809.2011.00698.x; Kawamoto R, 2001, J HUM GENET, V46, P506, DOI 10.1007/s100380170031; Lwin H, 2006, CIRC J, V70, P83, DOI 10.1253/circj.70.83; Matsuo H, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000237; Matsuo H, 2008, AM J HUM GENET, V83, P744, DOI 10.1016/j.ajhg.2008.11.001; Meisinger C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037180; Motti C, 1998, ATHEROSCLEROSIS, V139, P377, DOI 10.1016/S0021-9150(98)00079-3; Nakamura K, 2012, NUTR METAB CARDIOVAS, V22, P989, DOI 10.1016/j.numecd.2011.01.003; NAKASHIMA M, 1992, EUR J CLIN PHARMACOL, V42, P333; Nath SD, 2007, J AM SOC NEPHROL, V18, P3156, DOI 10.1681/ASN.2007040426; Onat A, 2006, AM J HYPERTENS, V19, P1055, DOI 10.1016/j.amjhyper.2006.02.014; Onat A, 2013, CLIN RHEUMATOL, V32, P1767, DOI 10.1007/s10067-013-2339-7; Phipps-Green AJ, 2010, HUM MOL GENET, V19, P4813, DOI 10.1093/hmg/ddq412; PUIG JG, 1984, J CLIN INVEST, V74, P936, DOI 10.1172/JCI111512; Rathmann W, 1998, ANN EPIDEMIOL, V8, P250, DOI 10.1016/S1047-2797(97)00204-4; Stiburkova B, 2013, EUR J HUM GENET, V21, P1067, DOI 10.1038/ejhg.2013.3; Stiburkova B, 2012, ADV CHRONIC KIDNEY D, V19, P372, DOI 10.1053/j.ackd.2012.07.010; Stiburkova B, 2012, PEDIATR NEPHROL, V27, P1411, DOI 10.1007/s00467-012-2174-0; Stiburkova B, 2011, MOL GENET METAB, V102, P430, DOI 10.1016/j.ymgme.2010.12.016; Tang WH, 2003, DIABETES, V52, P2840, DOI 10.2337/diabetes.52.11.2840; Tu HP, 2010, ANN RHEUM DIS, V69, P887, DOI 10.1136/ard.2009.113357; Urano W, 2010, ANN RHEUM DIS, V69, P932, DOI 10.1136/ard.2009.111096; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; Wilk JB, 2000, HUM GENET, V106, P355, DOI 10.1007/s004390051050; Wingrove CS, 1998, METABOLISM, V47, P435, DOI 10.1016/S0026-0495(98)90056-7; Woodward OM, 2009, P NATL ACAD SCI USA, V106, P10338, DOI 10.1073/pnas.0901249106; Yamagishi K, 2010, RHEUMATOLOGY, V49, P1461, DOI 10.1093/rheumatology/keq096; Yang Q, 2005, METABOLISM, V54, P1435, DOI 10.1016/j.metabol.2005.05.007; Yang T, 2012, ATHEROSCLEROSIS, V220, P525, DOI 10.1016/j.atherosclerosis.2011.11.014; Zuo M, 2000, J HUM GENET, V45, P257, DOI 10.1007/s100380070037	51	39	40	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97646	10.1371/journal.pone.0097646	http://dx.doi.org/10.1371/journal.pone.0097646			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24827988	gold, Green Published, Green Submitted			2022-12-27	WOS:000336857400114
J	Tin, MMY; Economo, EP; Mikheyev, AS				Tin, Mandy Man-Ying; Economo, Evan Philip; Mikheyev, Alexander Sergeyevich			Sequencing Degraded DNA from Non-Destructively Sampled Museum Specimens for RAD-Tagging and Low-Coverage Shotgun Phylogenetics	PLOS ONE			English	Article							DRAFT GENOME; EXTRACTION; DISCOVERY; ANCIENT; COLLECTIONS; DROSOPHILA; COST; AGE	Ancient and archival DNA samples are valuable resources for the study of diverse historical processes. In particular, museum specimens provide access to biotas distant in time and space, and can provide insights into ecological and evolutionary changes over time. However, archival specimens are difficult to handle; they are often fragile and irreplaceable, and typically contain only short segments of denatured DNA. Here we present a set of tools for processing such samples for state-of-the-art genetic analysis. First, we report a protocol for minimally destructive DNA extraction of insect museum specimens, which produced sequenceable DNA from all of the samples assayed. The 11 specimens analyzed had fragmented DNA, rarely exceeding 100 bp in length, and could not be amplified by conventional PCR targeting the mitochondrial cytochrome oxidase I gene. Our approach made these samples amenable to analysis with commonly used next-generation sequencing-based molecular analytic tools, including RAD-tagging and shotgun genome re-sequencing. First, we used museum ant specimens from three species, each with its own reference genome, for RAD-tag mapping. Were able to use the degraded DNA sequences, which were sequenced in full, to identify duplicate reads and filter them prior to base calling. Second, we re-sequenced six Hawaiian Drosophila species, with millions of years of divergence, but with only a single available reference genome. Despite a shallow coverage of 0.37 +/- 0.42 per base, we could recover a sufficient number of overlapping SNPs to fully resolve the species tree, which was consistent with earlier karyotypic studies, and previous molecular studies, at least in the regions of the tree that these studies could resolve. Although developed for use with degraded DNA, all of these techniques are readily applicable to more recent tissue, and are suitable for liquid handling automation.	[Tin, Mandy Man-Ying; Economo, Evan Philip; Mikheyev, Alexander Sergeyevich] Okinawa Inst Sci & Technol, Onna Son, Okinawa, Japan	Okinawa Institute of Science & Technology Graduate University	Mikheyev, AS (corresponding author), Okinawa Inst Sci & Technol, Onna Son, Okinawa, Japan.	sasha@homologo.us	Mikheyev, Alexander/E-7999-2013	Mikheyev, Alexander/0000-0003-4369-1019	Okinawa Institute of Science and Technology; Japan Society for the Promotion of Science [13058556]	Okinawa Institute of Science and Technology(Okinawa Institute of Science & Technology Graduate University); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was funded by the Okinawa Institute of Science and Technology, and a Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research # 13058556 to ASM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045549; Auwera G.A., 2013, CURRENT PROTOCOLS BI; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bonacum J, 2005, MOL PHYLOGENET EVOL, V37, P73, DOI 10.1016/j.ympev.2005.03.008; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; Buerkle CA, 2013, MOL ECOL, V22, P3028, DOI 10.1111/mec.12105; CARSON HL, 1976, ANNU REV ECOL SYST, V7, P311, DOI 10.1146/annurev.es.07.110176.001523; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Edwards KA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000487; Favret C, 2005, P ENTOMOL SOC WASH, V107, P469; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gansauge MT, 2013, NAT PROTOC, V8, P737, DOI 10.1038/nprot.2013.038; Gilbert MTP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000272; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hunter SJ, 2008, MOL ECOL RESOUR, V8, P56, DOI 10.1111/j.1471-8286.2007.01879.x; Jansen G, 2009, ZOOL SCR, V38, P527, DOI 10.1111/j.1463-6409.2009.00386.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li TW, 2006, ANAL BIOCHEM, V349, P242, DOI 10.1016/j.ab.2005.11.002; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; McCormack JE, 2013, MOL PHYLOGENET EVOL, V66, P526, DOI 10.1016/j.ympev.2011.12.007; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Mikheyev AS, 2009, MOL ECOL, V18, P2937, DOI 10.1111/j.1365-294X.2009.04213.x; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; O'Grady PM, 2011, MOL PHYLOGENET EVOL, V58, P244, DOI 10.1016/j.ympev.2010.11.022; O'Grady PM, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-6; Porco D, 2010, MOL ECOL RESOUR, V10, P942, DOI 10.1111/j.1755-0998.2010.2839.x; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reiss RA, 2006, QUATERNARY SCI REV, V25, P1877, DOI 10.1016/j.quascirev.2006.01.009; Rohland N, 2004, BIOTECHNIQUES, V36, P814, DOI 10.2144/04365ST05; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rowe KC, 2011, MOL ECOL RESOUR, V11, P1082, DOI 10.1111/j.1755-0998.2011.03052.x; Schmidt WM, 1996, NUCLEIC ACIDS RES, V24, P1789, DOI 10.1093/nar/24.9.1789; Shaffer HB, 1998, TRENDS ECOL EVOL, V13, P27, DOI 10.1016/S0169-5347(97)01177-4; Smit A., REPEATMASKER OPEN 3; Smith CR, 2011, P NATL ACAD SCI USA, V108, P5667, DOI 10.1073/pnas.1007901108; Smith CD, 2011, P NATL ACAD SCI USA, V108, P5673, DOI 10.1073/pnas.1008617108; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Suarez AV, 2004, BIOSCIENCE, V54, P66, DOI 10.1641/0006-3568(2004)054[0066:TVOMCF]2.0.CO;2; Thomsen PF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005048; Wagner CE, 2013, MOL ECOL, V22, P787, DOI 10.1111/mec.12023; Waugh J, 2007, BIOESSAYS, V29, P188, DOI 10.1002/bies.20529; Yue Dongxian, 2008, Curr Protoc Mol Biol, VChapter 3, DOI 10.1002/0471142727.mb0306s84; Zimmermann J, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-18	45	101	102	3	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e96793	10.1371/journal.pone.0096793	http://dx.doi.org/10.1371/journal.pone.0096793			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828244	Green Published, Green Submitted, gold			2022-12-27	WOS:000336857400037
J	Yun, Y; Ma, C; Ma, XC				Yun, Yan; Ma, Chi; Ma, XiaoChun			The SNP rs1883832 in CD40 Gene and Risk of Atherosclerosis in Chinese Population: A Meta-Analysis	PLOS ONE			English	Article							ACUTE CORONARY SYNDROMES; CD40-CD40 LIGAND INTERACTION; SIGNAL-TRANSDUCTION PATHWAY; PROTEIN-KINASE-C; ISCHEMIC-STROKE; POLYMORPHISM; ASSOCIATION; SYSTEM; DIACYLGLYCEROL; SUSCEPTIBILITY	Background:The complications of atherosclerosis such as coronary and cerebrovascular disease, are the most prevalent causes of mortality and morbidity worldwide. A single nucleotide polymorphism (SNP) rs1883832 (-1C/T) in CD40 gene has been recently suggested to contribute to the susceptibility to atherosclerosis in Chinese population; however, previous genetic association studies yielded inconsistent results. Methods: A meta-analysis of eligible studies reporting the association between rs1883832 and atherosclerosis in Chinese population was carried out. Results: Pooling 7 eligible case-control studies involving 2129 patients and 1895 controls demonstrated a significant association between rs1883832 and atherosclerosis under dominant model [odds ratio (OR) = 1.631, 95% confidence interval [CI] [1.176, 2.260] in Chinese population with evident heterogeneity. Meta-regression analysis indicated that the heterogeneity could be completely explained by disease category. In subgroup analysis, rs1883832 conferred ORs of 2.866 (C/C versus T/T, 95% CI [2.203, 3.729]) and 1.680 (C/T versus T/T, 95% CI [1.352, 2.086]) for coronary artery disease (CAD) under co-dominant model without heterogeneity. Similar results were obtained for acute coronary syndrome (ACS) (C/C versus T/ T, 3.674, 95% CI [2.638, 5.116]; C/T versus T/T, 1.981, 95% CI [1.483, 2.646]). The other genetic models including dominant, recessive and additive models, yielded consistent results without heterogeneity for CAD and ACS, respectively. However, a protective role was found for C allele in ischemic stroke (IS) under recessive model (0.582, 95% CI [0.393, 0.864]) and additive model (0.785, 95% CI [0.679, 0.909]) with reduced heterogeneity. Conclusions: This meta-analysis provided evidence of association of rs1883832 C allele with an overall increased risk of atherosclerosis but distinct effect of C allele on CAD (including ACS) and IS in Chinese population, respectively.	[Yun, Yan; Ma, Chi; Ma, XiaoChun] Shandong Univ, Sch Med, Jinan 250100, Shandong, Peoples R China	Shandong University	Ma, XC (corresponding author), Shandong Univ, Sch Med, Jinan 250100, Shandong, Peoples R China.	mxcmxc2008@163.com	Ma, XiaoChun/AAE-6798-2020					Aukrust P, 1999, CIRCULATION, V100, P614, DOI 10.1161/01.CIR.100.6.614; Burdon KP, 2006, AM HEART J, V151, P706, DOI 10.1016/j.ahj.2005.05.004; Chen KQ, 2006, CELL MOL IMMUNOL, V3, P163; del Rio-Espinola A, 2010, PHARMACOGENOMICS, V11, P763, DOI [10.2217/PGS.10.44, 10.2217/pgs.10.44]; Garcia-Bermudez M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049214; Jacobson EM, 2007, GENES IMMUN, V8, P205, DOI 10.1038/sj.gene.6364375; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Li Yan, 2007, Zhonghua Yi Xue Za Zhi, V87, P690; Liu X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066374; Ma Y, 2013, GENE, V529, P257, DOI 10.1016/j.gene.2013.07.086; Niu TH, 2004, GENET EPIDEMIOL, V27, P334, DOI 10.1002/gepi.20024; Niu TH, 2002, AM J HUM GENET, V70, P157, DOI 10.1086/338446; Phipps RP, 2000, P NATL ACAD SCI USA, V97, P6930, DOI 10.1073/pnas.97.13.6930; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Thakkinstian A, 2005, AM J EPIDEMIOL, V162, P201, DOI 10.1093/aje/kwi184; Thakkinstian A, 2005, STAT MED, V24, P1291, DOI 10.1002/sim.2010; Tian CX, 2010, BIOMED PHARMACOTHER, V64, P191, DOI 10.1016/j.biopha.2009.09.021; Urbich C, 2004, CAN J CARDIOL, V20, P681; Wang Cuiping, 2010, Clin Cardiol, V33, pE55, DOI 10.1002/clc.20667; Wang M, 2011, DNA CELL BIOL, V30, P173, DOI 10.1089/dna.2010.1129; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Wu Tian, 2012, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V37, P413, DOI 10.3969/j.issn.1672-7347.2012.04.017; Yan JC, 2004, CLIN CHIM ACTA, V343, P155, DOI 10.1016/j.cccn.2004.01.012; Yan JC, 2004, ACTA PHARMACOL SIN, V25, P251; Yan JC, 2003, CLIN CHIM ACTA, V337, P133, DOI 10.1016/j.cccn.2003.08.007; Yan JC, 2003, ACTA PHARMACOL SIN, V24, P687; Yan JC, 2002, CHINESE MED J-PEKING, V115, P491; Yan JC, 2010, CLIN EXP MED, V10, P253, DOI 10.1007/s10238-010-0092-7; Zhang BK, 2013, INT IMMUNOPHARMACOL, V16, P461, DOI 10.1016/j.intimp.2013.04.028; Zheng XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034625; Zhong H, 2010, GENET EPIDEMIOL, V34, P78, DOI 10.1002/gepi.20437	32	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97289	10.1371/journal.pone.0097289	http://dx.doi.org/10.1371/journal.pone.0097289			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24828072	Green Submitted, Green Published, gold			2022-12-27	WOS:000336857400075
J	Zhang, L; Dang, RJ; Li, H; Li, P; Yang, YM; Guo, XM; Wang, XY; Fang, NZ; Mao, N; Wen, N; Jiang, XX				Zhang, Lei; Dang, Rui-Jie; Li, Hong; Li, Ping; Yang, Yan-Mei; Guo, Xi-Min; Wang, Xiao-Yan; Fang, Nan-Zhu; Mao, Ning; Wen, Ning; Jiang, Xiao-Xia			SOCS1 Regulates the Immune Modulatory Properties of Mesenchymal Stem Cells by Inhibiting Nitric Oxide Production	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; DENDRITIC CELLS; MACROPHAGE ACTIVATION; MEDIATED IMMUNOSUPPRESSION; NEGATIVE REGULATOR; CYTOKINE; SUPPRESSOR; DIFFERENTIATION; RESPONSES; MARROW	Mesenchymal stem cells (MSCs) have been shown to be highly immunosuppressive and have been employed to treat various immune disorders. However, the mechanisms underlying the immunosuppressive capacity of MSCs are not fully understood. We found the suppressor of cytokine signaling 1 (SOCS1) was induced in MSCs treated with inflammatory cytokines. Knockdown of SOCS1 did not bring much difference on the proliferation and differentiation properties of MSCs. However, MSCs with SOCS1 knockdown exhibited enhanced immunosuppressive capacity, showing as inhibiting T cell proliferation at extremely low ratio (MSC to T) in vitro, significantly promoting tumor growth and inhibiting delayed-type hypersensitivity response in vivo. We further demonstrated that SOCS1 inhibited the immunosuppressive capacity of MSCs by reducing inducible nitric oxide synthase (iNOS) expression. Additionally, we found the significantly lower SOCS1 expression and higher nitric oxide (NO) production in MSCs isolated from synovial fluid of rheumatoid arthritis patients. Collectively, our data revealed a novel role of SOCS1 in regulating the immune modulatory activities of MSCs.	[Zhang, Lei; Li, Hong; Guo, Xi-Min; Wang, Xiao-Yan; Mao, Ning; Jiang, Xiao-Xia] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China; [Zhang, Lei; Fang, Nan-Zhu] Yanbian Univ, Yanji, Jilin Province, Peoples R China; [Dang, Rui-Jie; Li, Ping; Yang, Yan-Mei; Wen, Ning] Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Yanbian University; Chinese People's Liberation Army General Hospital	Wen, N (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China.	ning1972@sina.com; smilovxiaoxia@gmail.com	张, 西京/HIK-3273-2022		National Natural Science Foundation of China [81271936, 81070393, 81170523, 81170461, 31170926]; Chinese National Key Program on Basic Research [2010CB529904]; National High-Tech Research and Development Program [2011AA020114]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National Key Program on Basic Research; National High-Tech Research and Development Program(National High Technology Research and Development Program of China)	This study was supported by grants from the National Natural Science Foundation of China (81271936, 81070393, 81170523, 81170461, 31170926), the Chinese National Key Program on Basic Research(2010CB529904) and the National High-Tech Research and Development Program (2011AA020114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Asari S, 2009, EXP HEMATOL, V37, P604, DOI 10.1016/j.exphem.2009.01.005; Augello A, 2007, ARTHRITIS RHEUM-US, V56, P1175, DOI 10.1002/art.22511; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chatterjee D, 2012, IMMUNOLOGY, V137, P92; Chinen T, 2006, GASTROENTEROLOGY, V130, P373, DOI 10.1053/j.gastro.2005.10.051; Clancy RM, 1998, ARTHRITIS RHEUM-US, V41, P1141, DOI 10.1002/1529-0131(199807)41:7<1141::AID-ART2>3.0.CO;2-S; Djouad F, 2005, ARTHRITIS RHEUM-US, V52, P1595, DOI 10.1002/art.21012; Fenner JE, 2006, NAT IMMUNOL, V7, P33, DOI 10.1038/ni1287; Hanada T, 2005, J IMMUNOL, V174, P4325, DOI 10.4049/jimmunol.174.7.4325; Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Jorgensen C, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3105; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Li W, 2012, CELL DEATH DIFFER, V19, P1505, DOI 10.1038/cdd.2012.26; Ma S, 2014, CELL DEATH DIFFER, V21, P216, DOI 10.1038/cdd.2013.158; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Sahin G, 2006, RHEUMATOL INT, V26, P805, DOI 10.1007/s00296-005-0091-2; Sato K, 2007, BLOOD, V109, P228, DOI 10.1182/blood-2006-02-002246; Sayama K, 2004, J INVEST DERMATOL, V122, pA132; Shen L, 2004, NAT BIOTECHNOL, V22, P1546, DOI 10.1038/nbt1035; Shi YF, 2012, TRENDS IMMUNOL, V33, P136, DOI 10.1016/j.it.2011.11.004; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Su J, 2014, CELL DEATH DIFFER, V21, P388, DOI 10.1038/cdd.2013.149; Waiboci LW, 2007, J IMMUNOL, V178, P5058, DOI 10.4049/jimmunol.178.8.5058; Whyte CS, 2011, J LEUKOCYTE BIOL, V90, P845, DOI 10.1189/jlb.1110644; Wilson HM, 2010, J CELL MOL MED, V14, P2055, DOI 10.1111/j.1582-4934.2010.01121.x; Yahata Y, 2004, J INVEST DERMATOL, V122, pA2; Yang Yan-Mei, 2013, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V21, P1563, DOI 10.7534/j.issn.1009-2137.2013.06.037; Zhang Y, 2004, EXP HEMATOL, V32, P657, DOI 10.1016/j.exphem.2004.04.001	36	14	17	7	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2014	9	5							e97256	10.1371/journal.pone.0097256	http://dx.doi.org/10.1371/journal.pone.0097256			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TJ	24826993	gold, Green Published, Green Submitted			2022-12-27	WOS:000336857400067
J	Cheng, CM; Tzou, SC; Zhuang, YH; Huang, CC; Kao, CH; Liao, KW; Cheng, TC; Chuang, CH; Hsieh, YC; Tai, MH; Cheng, TL				Cheng, Chiu-Min; Tzou, Shey-Cherng; Zhuang, Ya-Han; Huang, Chien-Chiao; Kao, Chien-Han; Liao, Kuang-Wen; Cheng, Ta-Chun; Chuang, Chih-Hung; Hsieh, Yuan-Chin; Tai, Ming-Hong; Cheng, Tian-Lu			Functional Production of a Soluble and Secreted Single-Chain Antibody by a Bacterial Secretion System	PLOS ONE			English	Article							CIRCOVIRUS TYPE-2 PCV2; ESCHERICHIA-COLI; EXTRACELLULAR PRODUCTION; RECOMBINANT PROTEINS; EXPRESSION; FRAGMENT; FUSION; DISEASES; ANTIGEN; VIRUS	Single-chain variable fragments (scFvs) serve as an alternative to full-length monoclonal antibodies used in research and therapeutic and diagnostic applications. However, when recombinant scFvs are overexpressed in bacteria, they often form inclusion bodies and exhibit loss of function. To overcome this problem, we developed an scFv secretion system in which scFv was fused with osmotically inducible protein Y (osmY), a bacterial secretory carrier protein, for efficient protein secretion. Anti-EGFR scFv (alpha EGFR) was fused with osmY (N- and C-termini) and periplasmic leader sequence (pelB) to generate alpha EGFR-osmY, osmY-alpha EGFR, and pelB-alpha EGFR (control), respectively. In comparison with the control, both the osmY-fused alpha EGFR scFvs were soluble and secreted into the LB medium. Furthermore, the yield of soluble alpha EGFR-osmY was 20-fold higher, and the amount of secreted protein was 250-fold higher than that of osmY-alpha EGFR. In addition, the antigenbinding activity of both the osmY-fused alpha EGFRs was 2-fold higher than that of the refolded pelB-alpha EGFR from inclusion bodies. Similar results were observed with alpha TAG72-osmY and alpha Her2-osmY. These results suggest that the N-terminus of osmY fused with scFv produces a high yield of soluble, functional, and secreted scFv, and the osmY-based bacterial secretion system may be used for the large-scale industrial production of low-cost alpha EGFRprotein.	[Cheng, Chiu-Min] Natl Kaohsiung Marine Univ, Dept Aquaculture, Kaohsiung, Taiwan; [Tzou, Shey-Cherng; Liao, Kuang-Wen] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Zhuang, Ya-Han; Huang, Chien-Chiao; Chuang, Chih-Hung; Cheng, Tian-Lu] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan; [Kao, Chien-Han; Cheng, Ta-Chun; Hsieh, Yuan-Chin] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan; [Tai, Ming-Hong; Cheng, Tian-Lu] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 80424, Taiwan; [Cheng, Tian-Lu] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan	National Kaohsiung University of Science & Technology; National Yang Ming Chiao Tung University; Kaohsiung Medical University; Kaohsiung Medical University; National Sun Yat Sen University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Cheng, TL (corresponding author), Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan.	tlcheng@kmu.edu.tw		Hsieh, Yuan Chin/0000-0003-4005-5340; Cheng, Tian-Lu/0000-0002-7263-2766	National Research Program for Biopharmaceuticals, National Science Council, Taipei, Taiwan [NSC101-2325-B-037-001, NSC101-2321-B-037-001, NSC101-2313-B-022-001]; Department of Health, Executive Yuan, Taiwan [DOH100-TD-C-111-002]; Grant of Biosignature in Colorectal Cancers, Academia Sinica, Taiwan	National Research Program for Biopharmaceuticals, National Science Council, Taipei, Taiwan; Department of Health, Executive Yuan, Taiwan; Grant of Biosignature in Colorectal Cancers, Academia Sinica, Taiwan	This work was supported by grants from the National Research Program for Biopharmaceuticals, National Science Council, Taipei, Taiwan (NSC101-2325-B-037-001, NSC101-2321-B-037-001, NSC101-2313-B-022-001), the Department of Health, Executive Yuan, Taiwan (DOH100-TD-C-111-002) and the Grant of Biosignature in Colorectal Cancers, Academia Sinica, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad ZA, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/980250; Arbabi-Ghahroudi M, 2005, CANCER METAST REV, V24, P501, DOI 10.1007/s10555-005-6193-1; Cheng CM, 2008, CANCER GENE THER, V15, P393, DOI 10.1038/cgt.2008.10; Chi SC, 2003, DIS AQUAT ORGAN, V55, P221, DOI 10.3354/dao055221; Choi JH, 2004, APPL MICROBIOL BIOT, V64, P625, DOI 10.1007/s00253-004-1559-9; Darwich L, 2012, VIRUS RES, V164, P61, DOI 10.1016/j.virusres.2011.12.003; de Marco A, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-44; Francetic O, 2000, EMBO J, V19, P6697, DOI 10.1093/emboj/19.24.6697; Gamage LNA, 2012, CAN J VET RES, V76, P301; Hu XJ, 2007, PROTEIN EXPRES PURIF, V52, P194, DOI 10.1016/j.pep.2006.08.009; Huang L, 2013, INT J MOL SCI, V14, P19109, DOI 10.3390/ijms140919109; Ilk N, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-6; Intorasoot S, 2007, J VIROL METHODS, V143, P186, DOI 10.1016/j.jviromet.2007.03.008; Jurado P, 2006, J MOL BIOL, V357, P49, DOI 10.1016/j.jmb.2005.12.058; Kim H, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.83; Kipriyanov SM, 1996, PROTEIN ENG, V9, P203, DOI 10.1093/protein/9.2.203; Kotzsch A, 2011, PROTEIN SCI, V20, P597, DOI 10.1002/pro.593; Lorberboum-Galski H, 2011, EXPERT OPIN DRUG DEL, V8, P605, DOI 10.1517/17425247.2011.566269; Low KO, 2011, J IND MICROBIOL BIOT, V38, P1587, DOI 10.1007/s10295-011-0949-0; Makabe K, 2008, J BIOL CHEM, V283, P1156, DOI 10.1074/jbc.M706190200; Makrides SC, 1996, MICROBIOL REV, V60, P512, DOI 10.1128/MMBR.60.3.512-538.1996; Ni Y, 2009, BIOTECHNOL LETT, V31, P1661, DOI 10.1007/s10529-009-0077-3; Qian ZG, 2008, BIOTECHNOL BIOENG, V101, P587, DOI 10.1002/bit.21898; Ralph JP, 1999, APPL MICROBIOL BIOT, V52, P70, DOI 10.1007/s002530051489; Reinartz S, 2000, CANCER IMMUNOL IMMUN, V49, P186, DOI 10.1007/s002620000126; Shieh JR, 2005, DIS AQUAT ORGAN, V63, P53, DOI 10.3354/dao063053; Smallshaw JE, 1999, PROTEIN ENG, V12, P623, DOI 10.1093/protein/12.7.623; Yoon Sung Ho, 2010, Recent Pat Biotechnol, V4, P23, DOI 10.2174/187220810790069550; Zheng ZB, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-37	29	14	14	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97367	10.1371/journal.pone.0097367	http://dx.doi.org/10.1371/journal.pone.0097367			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824752	Green Published, Green Submitted, gold			2022-12-27	WOS:000336369200104
J	Fatemifar, G; Evans, DM; Tobias, JH				Fatemifar, Ghazaleh; Evans, David M.; Tobias, Jonathan H.			The Association between Primary Tooth Emergence and Anthropometric Measures in Young Adults: Findings from a Large Prospective Cohort Study	PLOS ONE			English	Article							CHILDHOOD OBESITY; ERUPTION; CONSEQUENCES; CHILDREN; HEIGHT; GROWTH; BIRTH	Cross sectional studies suggest a link may exist between tooth emergence and obesity. To explore this relationship, we aimed to evaluate the prospective associations between primary tooth emergence and anthropometric measures in young adults. Multivariable linear regression was used to analyse relationships between primary tooth emergence, and anthropometric measures measured at 17.8 years, in 2977 participants (1362 males and 1615 females) from the Avon Longitudinal Study of Parents and Children (ALSPAC). In minimally adjusted models, 'quintiles of number of paired teeth' (assessed by questionnaire at 15 months) was positively associated with height [change in height (cm) per quintile increase in 'number of paired teeth' (beta) = 0.35 ( 95%CI: 0.18, 0.52) P = 0.0001] and weight [ratio of geometric mean weight per quintile increase in ' number of paired teeth' (RGM) = 1.015 (95%CI: 1.010, 1.019) P<0.0001]. The relationship with weight was largely driven by fat mass, which showed an equivalent relationship with ' quintiles of number of paired teeth' to that seen for weight [RGM = 1.036 (95%CI: 1.022, 1.051) P<0.0001] (adjusted for height)]. Conversely, no association was seen between 'quintiles of number of paired teeth' and lean mass. An increase in 'quintiles of number of paired teeth' at age 15 months was associated with a higher Tanner stage at age 13 in girls but not boys, but further adjustment of associations between 'quintiles of number of paired teeth' and anthropometric traits for Tanner stage was without effect. Primary tooth emergence is associated with subsequent fat mass, suggesting these could share common constitutive factors, and that early primary tooth emergence may represent a hitherto unrecognised risk factor for the development of obesity in later life.	[Fatemifar, Ghazaleh; Evans, David M.] Univ Bristol, Sch Social & Community Med, Integrat Epidemiol Unit, Med Res Council, Bristol, Avon, England; [Evans, David M.] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld, Australia; [Tobias, Jonathan H.] Univ Bristol, Sch Clin Sci, Musculoskeletal Res Unit, Bristol, Avon, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Bristol; University of Queensland; University of Bristol	Tobias, JH (corresponding author), Univ Bristol, Sch Clin Sci, Musculoskeletal Res Unit, Bristol, Avon, England.	Jon.Tobias@bristol.ac.uk	Evans, David M/H-6325-2013; Tobias, Jon/E-2832-2014	Evans, David M/0000-0003-0663-4621; Tobias, Jon/0000-0002-7475-3932	UK Medical Research Council, the Wellcome Trust [092731]; University of Bristol provide core support for ALSPAC - Wellcome Trust 4-year PhD studentship in molecular, genetic, and life course epidemiology [WT083431MA]; Medical Research Council New Investigator Award [MRC G0800582]; UK Medical Research Council [G0600705]; University of Bristol; MRC [G0600705, G0800582] Funding Source: UKRI; Medical Research Council [MC_PC_15018, G0800582, G0600705, G9815508] Funding Source: researchfish	UK Medical Research Council, the Wellcome Trust(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Bristol provide core support for ALSPAC - Wellcome Trust 4-year PhD studentship in molecular, genetic, and life course epidemiology; Medical Research Council New Investigator Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Bristol; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the UK Medical Research Council, the Wellcome Trust (Grant ref 092731) and the University of Bristol provide core support for ALSPAC. G.F. is funded by a Wellcome Trust 4-year PhD studentship in molecular, genetic, and life course epidemiology (WT083431MA). This work and D.M.E. were supported by a Medical Research Council New Investigator Award (MRC G0800582). G.F. and D.M.E. work in a centre that receives funds from the UK Medical Research Council (G0600705) and the University of Bristol. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastos JL, 2007, ARCH ORAL BIOL, V52, P598, DOI 10.1016/j.archoralbio.2006.12.001; Bei M, 2009, CURR OPIN GENET DEV, V19, P504, DOI 10.1016/j.gde.2009.09.002; Bottcher Y, 2009, DIABETES, V58, P2119, DOI 10.2337/db08-1458; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Cassidy SB, 1997, J MED GENET, V34, P917, DOI 10.1136/jmg.34.11.917; DELGADO H, 1975, AM J CLIN NUTR, V28, P216, DOI 10.1093/ajcn/28.3.216; DEMIRJIAN A, 1985, AM J ORTHOD DENTOFAC, V88, P433, DOI 10.1016/0002-9416(85)90070-3; Dinsdale H, 2012, NATL CHILD MEASUREME; Eastwood P., 2013, STAT OBESITY PHYS AC; Fatemifar G, 2013, HUM MOL GENET, V22, P3807, DOI 10.1093/hmg/ddt231; Freedman DS, 2005, INT J OBESITY, V29, P1, DOI 10.1038/sj.ijo.0802735; Goulley J, 2007, CELL METAB, V5, P207, DOI 10.1016/j.cmet.2007.01.009; Hart PS, 1998, ANN NY ACAD SCI, V842, P125, DOI 10.1111/j.1749-6632.1998.tb09640.x; Hilgers KK, 2006, PEDIATR DENT, V28, P18; Jernvall J, 2012, DEVELOPMENT, V139, P3487, DOI 10.1242/dev.085084; Jussila M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008425; Must A, 1999, INT J OBESITY, V23, pS2, DOI 10.1038/sj.ijo.0800852; Must A, 2012, OBESITY, V20, P2070, DOI 10.1038/oby.2012.23; OUNSTED M, 1987, ARCH ORAL BIOL, V32, P787, DOI 10.1016/0003-9969(87)90004-5; Pillas D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000856; Prentice P, 2013, INT J OBESITY, V37, P1036, DOI 10.1038/ijo.2012.177; Reilly JJ, 2003, ARCH DIS CHILD, V88, P748, DOI 10.1136/adc.88.9.748; Sanchez-Perez L, 2010, ACTA ODONTOL SCAND, V68, P57, DOI 10.3109/00016350903449367; Son JW, 2011, ENDOCR J, V58, P39, DOI 10.1507/endocrj.K10E-248; Stein CJ, 2004, J CLIN ENDOCR METAB, V89, P2522, DOI 10.1210/jc.2004-0288; Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121; Wise GE, 2008, J DENT RES, V87, P414, DOI 10.1177/154405910808700509	27	6	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96355	10.1371/journal.pone.0096355	http://dx.doi.org/10.1371/journal.pone.0096355			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24823714	Green Published, gold, Green Submitted			2022-12-27	WOS:000336369200017
J	Huseth, AS; Groves, RL				Huseth, Anders S.; Groves, Russell L.			Environmental Fate of Soil Applied Neonicotinoid Insecticides in an Irrigated Potato Agroecosystem	PLOS ONE			English	Article							HONEY-BEES; LEACHING BEHAVIOR; RESIDUES; EXPOSURE; WATER; AGRICULTURE; GROUNDWATER; METABOLITES; POLLEN; RISKS	Since 1995, neonicotinoid insecticides have been a critical component of arthropod management in potato, Solanum tuberosum L. Recent detections of neonicotinoids in groundwater have generated questions about the sources of these contaminants and the relative contribution from commodities in U. S. agriculture. Delivery of neonicotinoids to crops typically occurs as a seed or in-furrow treatment to manage early season insect herbivores. Applied in this way, these insecticides become systemically mobile in the plant and provide control of key pest species. An outcome of this project links these soil insecticide application strategies in crop plants with neonicotinoid contamination of water leaching from the application zone. In 2011 and 2012, our objectives were to document the temporal patterns of neonicotinoid leachate below the planting furrow following common insecticide delivery methods in potato. Leaching loss of thiamethoxam from potato was measured using pan lysimeters from three at-plant treatments and one foliar application treatment. Insecticide concentration in leachate was assessed for six consecutive months using liquid chromatography-tandem mass spectrometry. Findings from this study suggest leaching of neonicotinoids from potato may be greater following crop harvest in comparison to other times during the growing season. Furthermore, this study documented recycling of neonicotinoid insecticides from contaminated groundwater back onto the crop via high capacity irrigation wells. These results document interactions between cultivated potato, different neonicotinoid delivery methods, and the potential for subsurface water contamination via leaching.	[Huseth, Anders S.] Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA; [Groves, Russell L.] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA	Cornell University; University of Wisconsin System; University of Wisconsin Madison	Groves, RL (corresponding author), Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA.	groves@entomology.wisc.edu		Huseth, Anders/0000-0002-5273-8555	Wisconsin Potato Industry Board; National Potato Council's State Cooperative Research Program [FY11-13]	Wisconsin Potato Industry Board; National Potato Council's State Cooperative Research Program	This research was supported by the Wisconsin Potato Industry Board and the National Potato Council's State Cooperative Research Program FY11-13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrian Inc, 2013, ADV PROD SEARCH; [Anonymous], 2013, ESTIMATION ANN AGR P; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Bussan A, 2012, PUBLICATION U WISC A; Casida JE, 2012, ENVIRON HEALTH PERSP, V120, P487, DOI 10.1289/ehp.1104405; Chauzat MP, 2006, J ECON ENTOMOL, V99, P253, DOI 10.1603/0022-0493-99.2.253; Chiovarou ED, 2008, SCI TOTAL ENVIRON, V389, P87, DOI 10.1016/j.scitotenv.2007.08.029; Cooley ET, 2009, SOIL SCI, V174, P321, DOI 10.1097/SS.0b013e3181a97514; Cresswell JE, 2012, ZOOLOGY, V115, P365, DOI 10.1016/j.zool.2012.05.003; Cresswell JE, 2012, PEST MANAG SCI, V68, P819, DOI 10.1002/ps.3290; Cullen EM, 2013, PUBLICATION U WISC A; Dively GP, 2012, J AGR FOOD CHEM, V60, P4449, DOI 10.1021/jf205393x; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; FREE J. B., 1955, INSECTES SOCIAUX, V2, P195, DOI 10.1007/BF02224381; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Girolami V, 2009, J ECON ENTOMOL, V102, P1808, DOI 10.1603/029.102.0511; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Gupta S, 2002, B ENVIRON CONTAM TOX, V68, P502, DOI 10.1007/s001280283; Gupta S, 2008, B ENVIRON CONTAM TOX, V80, P431, DOI 10.1007/s00128-008-9420-y; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Hladik M.L., 2012, US GEOLOGICAL SURVEY, P10; Hopwood J., 2012, ARE NEONICOTINOIDS K; Jeschke P, 2008, PEST MANAG SCI, V64, P1084, DOI 10.1002/ps.1631; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; Juraske R, 2009, J HAZARD MATER, V165, P683, DOI 10.1016/j.jhazmat.2008.10.043; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kraft GJ, 1999, GROUND WATER, V37, P572, DOI 10.1111/j.1745-6584.1999.tb01144.x; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Laurent FM, 2003, J AGR FOOD CHEM, V51, P8005, DOI 10.1021/jf034310n; Miranda GRB, 2011, HUM ECOL RISK ASSESS, V17, P981, DOI 10.1080/10807039.2011.588159; MOSSBARGER WA, 1989, J IRRIG DRAIN ENG, V115, P773, DOI 10.1061/(ASCE)0733-9437(1989)115:5(773); Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Papiernik SK, 2006, J AGR FOOD CHEM, V54, P8163, DOI 10.1021/jf061670c; Pinheiro J., 2007, LINEAR NONLINEAR MIX; Pinheiro J, 2001, MIXED EFFECTS MODELS; Postle JK, 2004, ENVIRON SCI TECHNOL, V38, P5339, DOI 10.1021/es040399h; Saad DA, 2008, J ENVIRON QUAL, V37, pS209, DOI 10.2134/jeq2007.0053; Sanchez-Bayo F., 2013, INSECTICIDES DEV SAF, V13, P365, DOI DOI 10.5772/52831; Seagraves MP, 2012, J PEST SCI, V85, P125, DOI 10.1007/s10340-011-0374-1; Seccia S, 2005, ANAL CHIM ACTA, V553, P21, DOI 10.1016/j.aca.2005.08.006; Starner K, 2012, B ENVIRON CONTAM TOX, V88, P316, DOI 10.1007/s00128-011-0515-5; Stone Wesley W, 2013, US GEOLOGICAL SURVEY, V752; Stoner KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039114; Szendrei Z, 2012, PEST MANAG SCI, V68, P941, DOI 10.1002/ps.3258; Tapparo A, 2012, ENVIRON SCI TECHNOL, V46, P2592, DOI 10.1021/es2035152; Team R Core, 2011, R LANG ENV STAT COMP; Tome HVV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038406; U.S. Environmental Protection Agency, 2003, FED REG, V68, P35303; United States Department of Agriculture - National Agricultural Imagery Program, 2010, WISC NAIP; United States Department of Agriculture - National Agricultural Statistics Service Cropland Data Layer, 2012, WISC CROPL DAT LAYER; United States Environmental Protection Agency, 2012, WHAT IS CONV RED RIS; US Department of Agriculture National Resources Conservation Service. (USDA-NRCS), 2013, WEB SOIL SURV; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Wickham H, 2007, J STAT SOFTW, V21, P1; Wisconsin Department of Agriculture Trade and Consumer Protection, 2010, 15 YEARS DATCP EXC W; Wisconsin Department of Agriculture Trade and Consumer Protection, 2011, AGR MAN BUR ANN REP; Wisconsin Department of Natural Resources, 2002, WISC DNR 2003 WAT; Wisconsin Department of Natural Resources, 2013, DNR DRINK WAT SYST H	58	74	80	2	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97081	10.1371/journal.pone.0097081	http://dx.doi.org/10.1371/journal.pone.0097081			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24823765	Green Published, gold			2022-12-27	WOS:000336369200056
J	Liu, S; Lv, Y; Wan, XR; Li, LM; Hu, B; Li, L				Liu, Shuai; Lv, Yan; Wan, Xiao-Rong; Li, Li-Mei; Hu, Bo; Li, Ling			Cloning and Expression Analysis of cDNAs Encoding ABA 8 '-Hydroxylase in Peanut Plants in Response to Osmotic Stress	PLOS ONE			English	Article							ABSCISIC-ACID BIOSYNTHESIS; 9-CIS-EPOXYCAROTENOID DIOXYGENASE GENE; MOLECULAR-CLONING; DROUGHT TOLERANCE; SWISS-MODEL; KEY ENZYME; ARABIDOPSIS; METABOLISM; PROTEIN; DEHYDRATION	Abscisic acid (ABA) catabolism is one of the determinants of endogenous ABA levels affecting numerous aspects of plant growth and abiotic-stress responses. The major ABA catabolic pathway is triggered by ABA 8 '-hydroxylation catalysed by ABA 8 '-hydroxylase, the cytochrome P450 CYP707A family. In this study, the full-length cDNAs of AhCYP707A1 and AhCYP707A2 were cloned and characterized from peanut. Expression analyses showed that AhCYP707A1 and AhCYP707A2 were expressed ubiquitously in peanut roots, stems, and leaves with different transcript accumulation levels, including the higher expression of AhCYP707A1 in roots. The expression of AhCYP707A2 was significantly up-regulated by 20% PEG6000 or 250 mmol/L NaCl in peanut roots, stems, and leaves, whereas the up-regulation of AhCYP707A1 transcript level by PEG6000 or NaCl was observed only in roots instead of leaves and stems. Due to the osmotic and ionic stresses of high concentration of NaCl to plants simultaneously, low concentration of LiCl (30 mmol/L, at which concentration osmotic status of cells is not seriously affected, the toxicity of Li+ being higher than that of Na+) was used to examine whether the effect of NaCl might be related to osmotic or ionic stress. The results revealed visually the susceptibility to osmotic stress and the resistance to salt ions in peanut seedlings. The significant up-regulation of AhCYP707A1, AhCYP707A2 and AhNCED1 transcripts and endogenous ABA levels by PEG6000 or NaCl instead of LiCl, showed that the osmotic stress instead of ionic stress affected the expression of those genes and the biosynthesis of ABA in peanut. The functional expression of AhCYP707A1 cDNA in yeast showed that the microsomal fractions prepared from yeast cell expressing recombinant AhCYP707A1 protein exhibited the catalytic activity of ABA 8 '-hydroxylase. These results demonstrate that the expressions of AhCYP707A1 and AhCYP707A2 play an important role in ABA catabolism in peanut, particularly in response to osmotic stress.	[Liu, Shuai; Lv, Yan; Li, Li-Mei; Hu, Bo; Li, Ling] S China Normal Univ, Coll Life Sci, Guangdong Prov Key Lab Biotechnol Plant Dev, Guangzhou, Guangdong, Peoples R China; [Wan, Xiao-Rong] Zhongkai Univ Agr & Engn, Coll Life Sci, Guangzhou, Guangdong, Peoples R China	South China Normal University; Zhongkai University of Agriculture & Engineering	Wan, XR (corresponding author), Zhongkai Univ Agr & Engn, Coll Life Sci, Guangzhou, Guangdong, Peoples R China.	bioxrwan@hotmail.com; liling502@126.com	Wan, Xiaorong/S-1681-2019		National Natural Science Foundation of China [30800077, 31171468]; Guangdong Natural Science Foundation [10251063101000010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This work was jointly supported by the grants from the National Natural Science Foundation of China (approved Nos. 30800077 and 31171468 granted to XRW and LL, respectively) and Guangdong Natural Science Foundation (approved No. 10251063101000010 granted to LL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allakhverdiev SI, 2000, PLANT PHYSIOL, V123, P1047, DOI 10.1104/pp.123.3.1047; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Bray EA, 1997, TRENDS PLANT SCI, V2, P48, DOI 10.1016/S1360-1385(97)82562-9; Chono M, 2006, J EXP BOT, V57, P2421, DOI 10.1093/jxb/erj215; Hong L, 2013, BIOL PLANTARUM, V57, P56, DOI 10.1007/s10535-012-0236-6; Hu B, 2013, ACTA PHYSIOL PLANT, V35, P1667, DOI 10.1007/s11738-012-1209-2; Iuchi S, 2001, PLANT J, V27, P325, DOI 10.1046/j.1365-313x.2001.01096.x; Kende H, 1997, PLANT CELL, V9, P1197, DOI 10.1105/tpc.9.7.1197; KIYOSUE T, 1994, PLANT MOL BIOL, V25, P791, DOI 10.1007/BF00028874; Krochko JE, 1998, PLANT PHYSIOL, V118, P849, DOI 10.1104/pp.118.3.849; Kushiro T, 2004, EMBO J, V23, P1647, DOI 10.1038/sj.emboj.7600121; Li XY, 2013, INT J MOL SCI, V14, P12827, DOI 10.3390/ijms140612827; Liang JH, 2009, BIOSCI BIOTECH BIOCH, V73, P2103, DOI 10.1271/bbb.90133; Liu CJ, 2003, PLANT J, V36, P471, DOI 10.1046/j.1365-313X.2003.01893.x; Liu X, 2011, BIOSCI BIOTECH BIOCH, V75, P443, DOI 10.1271/bbb.100614; Millar AA, 2006, PLANT J, V45, P942, DOI 10.1111/j.1365-313X.2006.02659.x; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; PIERCE M, 1981, PLANTA, V153, P156, DOI 10.1007/BF00384097; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; Qin XQ, 2002, PLANT PHYSIOL, V128, P544, DOI 10.1104/pp.010663; Qin XQ, 1999, P NATL ACAD SCI USA, V96, P15354, DOI 10.1073/pnas.96.26.15354; Saito S, 2004, PLANT PHYSIOL, V134, P1439, DOI 10.1104/pp.103.037614; Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Suttle JC, 2012, J EXP BOT, V63, P5717, DOI 10.1093/jxb/ers146; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tamura T, 2003, PLANT PHYSIOL, V131, P454, DOI 10.1104/pp.102.011007; Tan BC, 2003, PLANT J, V35, P44, DOI 10.1046/j.1365-313X.2003.01786.x; Tan BC, 1997, P NATL ACAD SCI USA, V94, P12235, DOI 10.1073/pnas.94.22.12235; Umezawa T, 2006, PLANT J, V46, P171, DOI 10.1111/j.1365-313X.2006.02683.X; Vallabhaneni R, 2010, ARCH BIOCHEM BIOPHYS, V504, P112, DOI 10.1016/j.abb.2010.07.005; Wan XR, 2006, BIOCHEM BIOPH RES CO, V347, P1030, DOI 10.1016/j.bbrc.2006.07.026; Wan XR, 2011, J BIOSCI BIOENG, V111, P478, DOI 10.1016/j.jbiosc.2010.11.021; Wan XR, 2005, DNA SEQUENCE, V16, P217, DOI 10.1080/10425170500129785; Yang SH, 2006, PLANT J, V47, P675, DOI 10.1111/j.1365-313X.2006.02815.x; Yang SH, 2006, BIOCHEM BIOPH RES CO, V350, P685, DOI 10.1016/j.bbrc.2006.09.098; ZEEVAART JAD, 1980, PLANT PHYSIOL, V66, P672, DOI 10.1104/pp.66.4.672; ZEEVAART JAD, 1988, ANNU REV PLANT PHYS, V39, P439, DOI 10.1146/annurev.pp.39.060188.002255; Zheng Y, 2012, ANN BOT-LONDON, V110, P743, DOI 10.1093/aob/mcs133; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	44	26	32	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97025	10.1371/journal.pone.0097025	http://dx.doi.org/10.1371/journal.pone.0097025			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24825163	Green Published, gold, Green Submitted			2022-12-27	WOS:000336369200052
J	Memish, ZA; Bamgboye, EA; Abuljadayel, N; Smadi, H; Abouzeid, MS; Al Hakeem, RF				Memish, Ziad Ahmed; Bamgboye, Elija Afolabi; Abuljadayel, Naila; Smadi, Hanan; Abouzeid, Mohamed Salamh; Al Hakeem, Rafat Faisal			Incidence of and Risk Factors Associated with Pulmonary and Extra-Pulmonary Tuberculosis in Saudi Arabia (2010-2011)	PLOS ONE			English	Article							EXTRAPULMONARY TUBERCULOSIS; EPIDEMIOLOGY	Setting: National Tuberculosis Program, Department of Public Health, Ministry of Health, Kingdom of Saudi Arabia (KSA). Objective: To summarize data on the incidence of tuberculosis and associated risk factors for cases reported during 2010-2011. Design: Retrospective analysis of routinely collected data through an established national disease notification system of the Ministry of Health in KSA. Results: The estimated incidence of all forms of tuberculosis fell from 15.8/100000 (95% CI: 15.3/100,000-16.3/100,000) in 2010 to 13.8/100,000 (95% CI: 13.4/100,000-14.2/100,000) in 2011. Saudis experienced a decrease from 11.8/100,000 (95% CI: 11.3/100,000 to 12.3/100,000) in 2010 to 9.9/100,000 (95% CI: 9.5/100,000-10.4/100,000) in 2011 while the incidence in non-Saudis declined from 24.7/100,000 (95% CI: 23.6/100,000 to 25.7/100,000) in 2010 to 22.5/100,000 (95% CI: 21.5/100,000 to 23.4/100,000) in 2011. The proportion of Extra Pulmonary TB (EPTB) which increased minimally from 30% in 2010 to 32% in 2011 was higher than global figures and strongly associated with age, sex, nationality and occupation. Conclusion: The current estimated incidence of about 14/100,000 in 2011 is less than half its estimated value of 44/100000 in 1990. Without prejudice to any under-reporting, the KSA appeared to be on the course for TB elimination by 2050 having reached the first milestone set by WHO. The proportion of EPTB remains higher than global figure and age, sex, nationality and occupation were significant independent predictors of EPTB.	[Memish, Ziad Ahmed; Bamgboye, Elija Afolabi; Abuljadayel, Naila; Smadi, Hanan; Abouzeid, Mohamed Salamh; Al Hakeem, Rafat Faisal] Minist Hlth, Publ Hlth Directorate, Riyadh, Saudi Arabia; [Memish, Ziad Ahmed] Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia; [Bamgboye, Elija Afolabi] Univ Ibadan, Dept Epidemiol & Med Stat, Ibadan, Nigeria	Ministry of Health - Saudi Arabia; Alfaisal University; University of Ibadan	Memish, ZA (corresponding author), Minist Hlth, Publ Hlth Directorate, Riyadh, Saudi Arabia.	zmemish@yahoo.com	Memish, Ziad Ahmed/AEJ-9424-2022	Memish, Ziad Ahmed/0000-0002-5099-0714				Abouzeid MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039478; Al-Kahtani NH, 2003, MANUAL NATL TB CONTR; Al-Otaibi F, 2010, INDIAN J PATHOL MICR, V53, P227, DOI 10.4103/0377-4929.64327; ALKASSIMI FA, 1993, TUBERCLE LUNG DIS, V74, P254, DOI 10.1016/0962-8479(93)90051-X; Alothman AF, 2011, BMC P S6, V5, P252, DOI 10,1186/1753-6561-5-S6-P252; [Anonymous], SAUD AR INC TUB; Cailhol J, 2005, J CLIN EPIDEMIOL, V58, P1066, DOI 10.1016/j.jclinepi.2005.02.023; DUBROW EL, 1976, J AM GERIATR SOC, V24, P481, DOI 10.1111/j.1532-5415.1976.tb03269.x; FAO, 2022, GLOB STRAT DIG HLTH; Fiske CT, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-16; Garcia-Rodriguez JF, 2011, ENFERM INFEC MICR CL, V29, P502, DOI 10.1016/j.eimc.2011.03.005; Gonzalez OY, 2003, INT J TUBERC LUNG D, V7, P1178; Gunal S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-154; IBM, 1968, STAT PACK SOC SCI SP; Jaryal A, 2011, LUNG INDIA, V28, P263, DOI 10.4103/0970-2113.85687; Lin JN, 2009, INT J TUBERC LUNG D, V13, P620; Ministry of Health, 1997, MIN HLTH ANN HLTH RE, P46; Oren E, 2011, AM J PUBLIC HEALTH, V101, P1256, DOI 10.2105/AJPH.2010.300030; Peto HM, 2009, CLIN INFECT DIS, V49, P1350, DOI 10.1086/605559; Saudi Arabia, 2011, HLTH STAT YB, P103; Waness A, 2011, RESPIROLOGY, V16, P755, DOI 10.1111/j.1440-1843.2011.01988.x; WHO, STOP TUB SAUS AR BEC; World Health Organization, 1994, TECHN CONS M TUB E M; World Health Organization, 2011, WHO REP SAUD AR TUB	24	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e95654	10.1371/journal.pone.0095654	http://dx.doi.org/10.1371/journal.pone.0095654			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824783	gold, Green Submitted, Green Published			2022-12-27	WOS:000336369200006
J	Zhu, LS; Xing, ZL; Gai, XC; Li, SJ; San, ZH; Wang, XP				Zhu, Lisai; Xing, Zeli; Gai, Xiaochun; Li, Sujing; San, Zhihao; Wang, Xinping			Identification of a Novel Enterovirus E Isolates HY12 from Cattle with Severe Respiratory and Enteric Diseases	PLOS ONE			English	Article							BOVINE ENTEROVIRUSES; CLASSIFICATION; DIVERSITY; ETIOLOGY; VIRUSES; REGION; CALF	In this study, a virus strain designated as HY12 was isolated from cattle with a disease of high morbidity and mortality in Jilin province. Biological and physiochemical properties showed that HY12 isolates is cytopathic with an extremely high infectivity. HY12 is resistant to treatment of organic solvent and acid, and unstable at 60 degrees C for 1 h. Electron microscopy observation revealed the virus is an approximately 22-28 nm in diameter. The complete genome sequence of HY12 consists of 7416 nucleotides, with a typical picornavirus genome organization including a 5'-untranslated region (UTR), a large single ORF encoding a polyprotein of 2176 amino acids, and a 3'-UTR. Phylogenetic analysis clustered HY12 isolates to a new serotype/genotype within the clade of enterovirus E (formerly BEV-A). Alignment analysis revealed a unique insertion of 2 amino acid residues (NF) at the C-terminal of VP1 protein between aa 825 and 826, and several rare mutations in VP1 and VP4 of HY12 isolates in relation to known bovine enterovirus (BEV) strains. This is the first report of an enterovirus E in China, which is potentially associated with an outbreak in cattle with severe respiratory and enteric diseases.	[Zhu, Lisai; Xing, Zeli; Gai, Xiaochun; Li, Sujing; San, Zhihao; Wang, Xinping] Jilin Univ, Coll Vet Med, Changchun 130023, Jilin, Peoples R China	Jilin University	Wang, XP (corresponding author), Jilin Univ, Coll Vet Med, Changchun 130023, Jilin, Peoples R China.	wangxp88@hotmail.com	Wang, Xin/AAN-8435-2021; Liu, Jian/P-4050-2014	Wang, Xin/0000-0002-4457-7376; Liu, Jian/0000-0003-4199-1296	Jilin Province Scientific and Technology Program [20140204064NY]; program fund of Jilin province for high-level creative and talented individuals	Jilin Province Scientific and Technology Program; program fund of Jilin province for high-level creative and talented individuals	This study is supported by the Key Science and Technology projects from Jilin Province Scientific and Technology Program (20140204064NY); program fund of Jilin province for high-level creative and talented individuals to Xinping Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blas-Machado U, 2007, VET PATHOL, V44, P110, DOI 10.1354/vp.44-1-110; Blas-Machado U, 2011, VET PATHOL, V48, P1075, DOI 10.1177/0300985810395728; Boros A, 2012, J GEN VIROL, V93, P1941, DOI 10.1099/vir.0.041335-0; BUCZEK J, 1970, ARCH GES VIRUSFORSCH, V30, P408, DOI 10.1007/BF01258371; BUERKI F, 1962, Pathol Microbiol (Basel), V25, P789; Cho YI, 2013, VET MICROBIOL, V166, P375, DOI 10.1016/j.vetmic.2013.07.001; Dubois E, 2004, INT J FOOD MICROBIOL, V92, P35, DOI 10.1016/j.ijfoodmicro.2003.06.001; DUNNE HW, 1974, J AM VET MED ASSOC, V164, P290; DUNNE HW, 1973, AM J VET RES, V34, P1121; Fong TT, 2005, APPL ENVIRON MICROB, V71, P2070, DOI 10.1128/AEM.71.4.2070-2078.2005; IDE PR, 1970, CANADIAN VET J, V11, P194; Jimenez-Clavero MA, 2005, APPL ENVIRON MICROB, V71, P3536, DOI 10.1128/AEM.71.7.3536-3543.2005; Kim H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068081; KNOWLES NJ, 1985, ARCH VIROL, V83, P141, DOI 10.1007/BF01309912; Knowles NJ, 2012, VIRUS TAXONOMY CLASS, P855, DOI DOI 10.1016/B978-0-12-384684-6.00074-4; Ley V, 2002, APPL ENVIRON MICROB, V68, P3455, DOI 10.1128/AEM.68.7.3455-3461.2002; Li YL, 2012, ARCH VIROL, V157, P2369, DOI 10.1007/s00705-012-1424-6; McCarthy FM, 1999, VET MICROBIOL, V68, P71, DOI 10.1016/S0378-1135(99)00062-0; McClenahan SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068777; McFERRAN J. B., 1958, Veterinary Record, V70, P999; McIntyre CL, 2010, J VIROL, V84, P10297, DOI 10.1128/JVI.00962-10; MOLL T, 1959, AM J VET RES, V20, P27; Nollens HH, 2009, VET MICROBIOL, V139, P170, DOI 10.1016/j.vetmic.2009.05.010; REED L. J., 1938, AMER JOUR HYG, V27, P493; ROVOZZO GC, 1965, CORNELL VET, V55, P121; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Smura T, 2007, J GEN VIROL, V88, P2520, DOI 10.1099/vir.0.82866-0; Straub O C, 1965, Berl Munch Tierarztl Wochenschr, V78, P386; STRAUB O. C., 1964, ARCH GESAMTE VIRUS FORSCH, V14, P272, DOI 10.1007/BF01555099; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANDERMAATEN MJ, 1967, AM J VET RES, V28, P677; Wang XP, 2001, ONCOGENE, V20, P523, DOI 10.1038/sj.onc.1204115; WELDON SL, 1979, J AM VET MED ASSOC, V174, P168; Yozwiak NL, 2010, J VIROL, V84, P9047, DOI 10.1128/JVI.00698-10; Zell R, 2006, J GEN VIROL, V87, P375, DOI 10.1099/vir.0.81298-0; Zell R, 1997, VIRUS RES, V51, P213, DOI 10.1016/S0168-1702(97)00096-8; Zell R, 1999, J GEN VIROL, V80, P2299, DOI 10.1099/0022-1317-80-9-2299; Zheng T, 2007, ARCH VIROL, V152, P191, DOI 10.1007/s00705-006-0838-4	38	358	389	20	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97730	10.1371/journal.pone.0097730	http://dx.doi.org/10.1371/journal.pone.0097730			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830424	Green Published, gold, Green Submitted			2022-12-27	WOS:000336789500108
J	Gai, XP; Wang, HY; Liu, J; Zhai, LM; Liu, S; Ren, TZ; Liu, HB				Gai, Xiapu; Wang, Hongyuan; Liu, Jian; Zhai, Limei; Liu, Shen; Ren, Tianzhi; Liu, Hongbin			Effects of Feedstock and Pyrolysis Temperature on Biochar Adsorption of Ammonium and Nitrate	PLOS ONE			English	Article							BLACK CARBON; NUTRIENT AVAILABILITY; SOIL; SORPTION; RESIDUE; MANURE; SULFAMETHOXAZOLE; PHOSPHATE; AMENDMENT; DYNAMICS	Biochar produced by pyrolysis of biomass can be used to counter nitrogen (N) pollution. The present study investigated the effects of feedstock and temperature on characteristics of biochars and their adsorption ability for ammonium N (NH4+-N) and nitrate N (NO3--N). Twelve biochars were produced from wheat-straw (W-BC), corn-straw (C-BC) and peanut-shell (P-BC) at pyrolysis temperatures of 400, 500, 600 and 700 degrees C. Biochar physical and chemical properties were determined and the biochars were used for N sorption experiments. The results showed that biochar yield and contents of N, hydrogen and oxygen decreased as pyrolysis temperature increased from 400 degrees C to 700 degrees C, whereas contents of ash, pH and carbon increased with greater pyrolysis temperature. All biochars could sorb substantial amounts of NH4+-N, and the sorption characteristics were well fitted to the Freundlich isotherm model. The ability of biochars to adsorb NH4+-N followed: C-BC. P-BC. W-BC, and the adsorption amount decreased with higher pyrolysis temperature. The ability of C-BC to sorb NH4+-N was the highest because it had the largest cation exchange capacity (CEC) among all biochars (e.g., C-BC400 with a CEC of 38.3 cmol kg(-1) adsorbed 2.3 mg NH4+-N g(-1) in solutions with 50 mg NH4+ L-1). Compared with NH4+-N, none of NO3 -N was adsorbed to biochars at different NO3 concentrations. Instead, some NO3- -N was even released from the biochar materials. We conclude that biochars can be used under conditions where NH4+-N (or NH3) pollution is a concern, but further research is needed in terms of applying biochars to reduce NO3--N pollution.	[Gai, Xiapu; Wang, Hongyuan; Liu, Jian; Zhai, Limei; Liu, Shen; Liu, Hongbin] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Minist Agr, Key Lab Nonpoint Source Pollut Control, Beijing 100193, Peoples R China; [Liu, Jian] ARS, USDA, Pasture Syst & Watershed Management Res Unit, University Pk, PA USA; [Ren, Tianzhi] Minist Agr, Inst Agroenvironm Protect, Tianjin, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs; United States Department of Agriculture (USDA); Chinese Academy of Agricultural Sciences; Agro-Environmental Protection Institute, CAAS; Ministry of Agriculture & Rural Affairs	Liu, HB (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Minist Agr, Key Lab Nonpoint Source Pollut Control, Beijing 100193, Peoples R China.	liuhongbin@caas.cn	Wang, Xin/AAN-8435-2021; Liu, Jian/P-4050-2014	Wang, Xin/0000-0002-4457-7376; Liu, Jian/0000-0003-4199-1296	National Natural Science Foundation of China [41301311, 41203072]; Special Fund for Agro-scientific Research in the Public Interest [201303095-10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest	Funding: This study was financially supported by the National Natural Science Foundation of China (41301311), the Special Fund for Agro-scientific Research in the Public Interest (201303095-10), and the National Natural Science Foundation of China (41203072). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afkhami A, 2007, J HAZARD MATER, V144, P427, DOI 10.1016/j.jhazmat.2006.10.062; Ahmad M, 2013, BIORESOURCE TECHNOL, V143, P615, DOI 10.1016/j.biortech.2013.06.033; Ahmad M, 2012, BIORESOURCE TECHNOL, V118, P536, DOI 10.1016/j.biortech.2012.05.042; Bruun EW, 2011, BIOMASS BIOENERG, V35, P1182, DOI 10.1016/j.biombioe.2010.12.008; Cantrell KB, 2012, BIORESOURCE TECHNOL, V107, P419, DOI 10.1016/j.biortech.2011.11.084; Cao XD, 2010, BIORESOURCE TECHNOL, V101, P5222, DOI 10.1016/j.biortech.2010.02.052; Cayuela ML, 2014, AGR ECOSYST ENVIRON, V191, P5, DOI 10.1016/j.agee.2013.10.009; Chen BL, 2008, ENVIRON SCI TECHNOL, V42, P5137, DOI 10.1021/es8002684; Chun Y, 2004, ENVIRON SCI TECHNOL, V38, P4649, DOI 10.1021/es035034w; Ding Y, 2010, WATER AIR SOIL POLL, V213, P47, DOI 10.1007/s11270-010-0366-4; Galvez A, 2012, AGR ECOSYST ENVIRON, V160, P3, DOI 10.1016/j.agee.2011.06.015; Gaskin JW, 2008, T ASABE, V51, P2061, DOI 10.13031/2013.25409; Gell K, 2011, J HAZARD MATER, V186, P2017, DOI 10.1016/j.jhazmat.2010.12.105; Hollister CC, 2013, J ENVIRON QUAL, V42, P137, DOI 10.2134/jeq2012.0033; Hossain MK, 2011, J ENVIRON MANAGE, V92, P223, DOI 10.1016/j.jenvman.2010.09.008; IFA/IFDC/IPI/PPI/FAO, 2009, FERT US CROP; Ji LL, 2011, ENVIRON SCI TECHNOL, V45, P5580, DOI 10.1021/es200483b; Kameyama K, 2012, J ENVIRON QUAL, V41, P1131, DOI 10.2134/jeq2010.0453; Keiluweit M, 2010, ENVIRON SCI TECHNOL, V44, P1247, DOI 10.1021/es9031419; Knowles OA, 2011, SCI TOTAL ENVIRON, V409, P3206, DOI 10.1016/j.scitotenv.2011.05.011; Laird D, 2010, GEODERMA, V158, P436, DOI 10.1016/j.geoderma.2010.05.012; Lehmann J, 2003, PLANT SOIL, V249, P343, DOI 10.1023/A:1022833116184; Lehmann J, 2009, EARTHSCAN, DOI [10.4324/9780203762264, DOI 10.4324/9780203762264]; Liang B, 2006, SOIL SCI SOC AM J, V70, P1719, DOI 10.2136/sssaj2005.0383; Mimmo T, 2014, BIOMASS BIOENERG, V62, P149, DOI 10.1016/j.biombioe.2014.01.004; Mizuta K, 2004, BIORESOURCE TECHNOL, V95, P255, DOI 10.1016/j.biortech.2004.02.015; Novak J. M., 2009, Annals of Environmental Science, V3, P195; Ohe K, 2003, J CHEM ENG JPN, V36, P511, DOI 10.1252/jcej.36.511; Ok YS, 2007, J HAZARD MATER, V147, P91, DOI 10.1016/j.jhazmat.2006.12.046; Quilliam RS, 2012, AGR ECOSYST ENVIRON, V158, P192, DOI 10.1016/j.agee.2012.06.011; Sohi SP, 2010, ADV AGRON, V105, P47, DOI 10.1016/S0065-2113(10)05002-9; Sun K, 2011, BIORESOURCE TECHNOL, V102, P5757, DOI 10.1016/j.biortech.2011.03.038; Sun L, 2013, BIORESOURCE TECHNOL, V140, P406, DOI 10.1016/j.biortech.2013.04.116; Wu WX, 2012, BIOMASS BIOENERG, V47, P268, DOI 10.1016/j.biombioe.2012.09.034; Yao Y, 2012, CHEMOSPHERE, V89, P1467, DOI 10.1016/j.chemosphere.2012.06.002; Yuan JH, 2011, BIORESOURCE TECHNOL, V102, P3488, DOI 10.1016/j.biortech.2010.11.018; Zhai LM, 2014, BIOL FERT SOILS; Zhang AF, 2013, AGR ECOSYST ENVIRON, V173, P37, DOI 10.1016/j.agee.2013.04.001; Zhao XC, 2013, BIORESOURCE TECHNOL, V147, P338, DOI 10.1016/j.biortech.2013.08.042; Zheng H, 2013, ENVIRON POLLUT, V181, P60, DOI 10.1016/j.envpol.2013.05.056; Zheng H, 2013, BIORESOURCE TECHNOL, V130, P463, DOI 10.1016/j.biortech.2012.12.044; Zhu AN, 2005, ENVIRON INT, V31, P904, DOI 10.1016/j.envint.2005.05.038	42	358	389	20	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113888	10.1371/journal.pone.0113888	http://dx.doi.org/10.1371/journal.pone.0113888			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	24830424	Green Published, Green Submitted, gold			2022-12-27	WOS:000349128700050
J	Zhou, JH; Wang, YF; Wang, Y; Yin, X; He, YF; Chen, LL; Wang, WW; Liu, T; Di, W				Zhou, Jinhua; Wang, Yunfei; Wang, You; Yin, Xia; He, Yifeng; Chen, Lilan; Wang, Wenwen; Liu, Ting; Di, Wen			FOXM1 Modulates Cisplatin Sensitivity by Regulating EXO1 in Ovarian Cancer	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; BREAST-CANCER; REPAIR; RESISTANCE; CELLS; CONTRIBUTES; EXPRESSION	Cisplatin is commonly used in ovarian cancer chemotherapy, however, chemoresistance to cisplatin remains a great clinical challenge. Oncogenic transcriptional factor FOXM1 has been reported to be overexpressed in ovarian cancer. In this study, we aimed to investigate the potential role of FOXM1 in ovarian cancers with chemoresistance to cisplatin. Our results indicate that FOXM1 is upregulated in chemoresistant ovarian cancer samples, and defends ovarian cancer cells against cytotoxicity of cisplatin. FOXM1 facilitates DNA repair through regulating direct transcriptional target EXO1 to protect ovarian cancer cells from cisplatin-mediated apoptosis. Attenuating FOXM1 and EXO1 expression by small interfering RNA, augments the chemotherapy efficacy against ovarian cancer. Our findings indicate that targeting FOXM1 and its target gene EXO1 could improve cisplatin effect in ovarian cancer, confirming their role in modulating cisplatin sensitivity.	[Zhou, Jinhua; Wang, Yunfei; Wang, You; Yin, Xia; He, Yifeng; Chen, Lilan; Wang, Wenwen; Liu, Ting; Di, Wen] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Obstet & Gynecol, Shanghai 200030, Peoples R China; [Zhou, Jinhua; Wang, Yunfei; Wang, You; Yin, Xia; He, Yifeng; Chen, Lilan; Wang, Wenwen; Liu, Ting; Di, Wen] Shanghai Key Lab Gynecol Oncol, Shanghai, Peoples R China; [Zhou, Jinhua; Wang, Yunfei; Di, Wen] Focus Construct Subject Shanghai Educ Dept, Shanghai, Peoples R China; [Zhou, Jinhua; Wang, Yunfei; Di, Wen] Shanghai Hlth Bur Key Disciplines & Specialties F, Shanghai, Peoples R China; [Zhou, Jinhua] Soochow Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Suzhou, Jiangsu, Peoples R China	Shanghai Jiao Tong University; Soochow University - China	Di, W (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Obstet & Gynecol, Shanghai 200030, Peoples R China.	diwen163@163.com	Xia, Kai/GYU-7618-2022; Singh, Brijesh Kumar/C-1093-2009	Yen, Paul/0000-0002-3790-8114; Singh, Brijesh Kumar/0000-0003-4615-3988; Wu, Yajun/0000-0001-9598-4433	National Natural Science Foundation of China [81272882, 81302275, 81072137]; Shanghai Committee of Science and Technology [12411950200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	In accomplish of this manuscript, the authors have received the support of the National Natural Science Foundation of China (Grant No. 81272882, 81302275, 81072137) and Shanghai Committee of Science and Technology (Grant No. 12411950200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Bolderson E, 2010, NUCLEIC ACIDS RES, V38, P1821, DOI 10.1093/nar/gkp1164; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Carozzi VA, 2010, CURR CANCER DRUG TAR, V10, P670; Carr JR, 2010, CANCER RES, V70, P5054, DOI 10.1158/0008-5472.CAN-10-0545; Chang IY, 2005, BIOCHEM BIOPH RES CO, V327, P225, DOI 10.1016/j.bbrc.2004.12.008; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Costa RH, 2005, NAT CELL BIOL, V7, P108, DOI 10.1038/ncb0205-108; Eccleston J, 2011, J IMMUNOL, V186, P2336, DOI 10.4049/jimmunol.1003104; Furuta T, 2002, CANCER RES, V62, P4899; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; dos Santos NAG, 2012, ARCH TOXICOL, V86, P1233, DOI 10.1007/s00204-012-0821-7; Halasi M, 2013, MOL CANCER THER, V12, P245, DOI 10.1158/1535-7163.MCT-12-0712; Halasi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031761; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kalin TV, 2011, CELL CYCLE, V10, P396, DOI 10.4161/cc.10.3.14709; Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138; Kim IM, 2006, CANCER RES, V66, P2153, DOI 10.1158/0008-5472.CAN-05-3003; Korver W, 1997, NUCLEIC ACIDS RES, V25, P1715, DOI 10.1093/nar/25.9.1715; Kwok JMM, 2010, MOL CANCER RES, V8, P24, DOI 10.1158/1541-7786.MCR-09-0432; Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006; Lok GTM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023790; Miller DS, 2009, J CLIN ONCOL, V27, P2686, DOI 10.1200/JCO.2008.19.2963; Myatt SS, 2008, NAT REV CANCER, V8, P244, DOI 10.1038/nrc2223-c2; Olive PL, 2011, RADIOTHER ONCOL, V101, P18, DOI 10.1016/j.radonc.2011.05.055; Park YY, 2012, CARCINOGENESIS, V33, P1843, DOI 10.1093/carcin/bgs167; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Ruggiero A, 2013, ANTI-CANCER DRUG, V24, P1007, DOI 10.1097/CAD.0b013e3283650bda; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Sperka T, 2012, NAT REV MOL CELL BIO, V13, P579, DOI 10.1038/nrm3420; Tan YJ, 2007, MOL CELL BIOL, V27, P1007, DOI 10.1128/MCB.01068-06; Tomimatsu N, 2012, DNA REPAIR, V11, P441, DOI 10.1016/j.dnarep.2012.01.006; Tran PT, 2004, DNA REPAIR, V3, P1549, DOI 10.1016/j.dnarep.2004.05.015; Yoshida Y, 2007, GASTROENTEROLOGY, V132, P1420, DOI 10.1053/j.gastro.2007.01.036; Zhang N, 2012, CLIN CANCER RES, V18, P5961, DOI 10.1158/1078-0432.CCR-12-0039; Zhao R, 2014, MOL CANCER RES, V12, P370, DOI 10.1158/1541-7786.MCR-13-0281; Zhu HW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031431; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Ziebarth AJ, 2013, CLIN CANCER RES, V19, P170, DOI 10.1158/1078-0432.CCR-12-1045	40	158	163	5	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96989	10.1371/journal.pone.0096989	http://dx.doi.org/10.1371/journal.pone.0096989			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824601	Green Submitted, Green Published, gold			2022-12-27	WOS:000336369200045
J	Zhou, J; Xiao, KF; Wei, BY; Wang, Z; Tian, Y; Tian, YX; Song, QS				Zhou, Ji; Xiao, Kaifu; Wei, Baoyang; Wang, Zhi; Tian, Yun; Tian, Yixing; Song, Qisheng			Bioaccumulation of Cry1Ab Protein from an Herbivore Reduces Anti-Oxidant Enzyme Activities in Two Spider Species	PLOS ONE			English	Article							BT RICE; SUPEROXIDE-DISMUTASE; BROWN PLANTHOPPER; FIELD-EVALUATION; TRANSGENIC RICE; GENES; RESISTANCE; DIVERSITY; LINES	Cry proteins are expressed in rice lines for lepidopteran pest control. These proteins can be transferred from transgenic rice plants to non-target arthropods, including planthoppers and then to a predatory spider. Movement of Cry proteins through food webs may reduce fitness of non-target arthropods, although recent publications indicated no serious changes in nontarget populations. Nonetheless, Cry protein intoxication influences gene expression in Cry-sensitive insects. We posed the hypothesis that Cry protein intoxication influences enzyme activities in spiders acting in tri-trophic food webs. Here we report on the outcomes of experiments designed to test our hypothesis with two spider species. We demonstrated that the movement of CryAb protein from Drosophila culture medium into fruit flies maintained on the CryAb containing medium and from the flies to the spiders Ummeliata insecticeps and Pardosa pseudoannulata. We also show that the activities of three key metabolic enzymes, acetylcholine esterase (AchE), glutathione peroxidase (GSH-Px), and superoxide dismutase (SOD) were significantly influenced in the spiders after feeding on Cry1Ab-containing fruit flies. We infer from these data that Cry proteins originating in transgenic crops impacts non-target arthropods at the physiological and biochemical levels, which may be one mechanism of Cry protein-related reductions in fitness of non-target beneficial predators.	[Zhou, Ji; Xiao, Kaifu; Wei, Baoyang; Wang, Zhi; Tian, Yun; Tian, Yixing; Song, Qisheng] Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha, Hunan, Peoples R China; [Song, Qisheng] Univ Missouri, Div Plant Sci, Columbia, MO USA	Hunan Agricultural University; University of Missouri System; University of Missouri Columbia	Wang, Z (corresponding author), Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha, Hunan, Peoples R China.	wangzhispider@hotmail.com; SongQ@missouri.edu	Xia, Kai/GYU-7618-2022; Singh, Brijesh Kumar/C-1093-2009	Yen, Paul/0000-0002-3790-8114; Singh, Brijesh Kumar/0000-0003-4615-3988; Wu, Yajun/0000-0001-9598-4433	Natural Science Foundation of P. R. China [31071943, 31272339]; Scientific Research Fund of Hunan Provincial Education Department [10A054]	Natural Science Foundation of P. R. China(National Natural Science Foundation of China (NSFC)); Scientific Research Fund of Hunan Provincial Education Department(Hunan Provincial Education Department)	This work was in part supported by the Natural Science Foundation of P. R. China (No. 31071943). The additional part of the funding of the study has come from Natural Science Foundation of P. R. China (No. 31272339) and Scientific Research Fund of Hunan Provincial Education Department(No. 10A054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bashir K, 2004, MOL BREEDING, V13, P301, DOI 10.1023/B:MOLB.0000034078.54872.25; Bernal CC, 2002, ENTOMOL EXP APPL, V102, P21, DOI 10.1023/A:1015278618586; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breitler JC, 2004, PLANT BIOTECHNOL J, V2, P417, DOI 10.1111/j.1467-7652.2004.00086.x; Chen H, 2008, J ECON ENTOMOL, V101, P182, DOI 10.1603/0022-0493(2008)101[182:EOTBTR]2.0.CO;2; Chen Mao, 2003, Acta Phytophylacica Sinica, V30, P365; Chen Mao, 2003, Journal of Zhejiang University (Agriculture and Life Sciences), V29, P29; Chen Mao, 2005, Acta Entomologica Sinica, V48, P208; Chen M, 2007, BIOL CONTROL, V42, P242, DOI 10.1016/j.biocontrol.2007.05.005; Chen M, 2011, ANNU REV ENTOMOL, V56, P81, DOI 10.1146/annurev-ento-120709-144810; GORUN V, 1978, ANAL BIOCHEM, V86, P324, DOI 10.1016/0003-2697(78)90350-0; Hoefler CD, 2006, J ECON ENTOMOL, V99, P432, DOI 10.1603/0022-0493-99.2.432; Jones AK, 2010, ADV EXP MED BIOL, V683, P25; Li FF, 2007, ENVIRON ENTOMOL, V36, P646, DOI 10.1603/0046-225X(2007)36[646:AAADIB]2.0.CO;2; Liu Li-Jun, 2010, Acta Arachnologica Sinica, V19, P47; Ministry of Agriculture of the People's Republic of China (MAPRC), 2009, 2 LIST APPR AGR GEN; Missirlis F, 2003, PROCEEDINGS OF THE MEETING OF THE SOCIETY FOR FREE RADICAL RESEARCH, EUROPEAN SECTION, P147; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Oppert B, 2012, PLOS ONE, V4; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Riaz N, 2006, S AFR J BOT, V72, P217, DOI 10.1016/j.sajb.2005.07.005; Rogina B, 2000, BIOGERONTOLOGY, V1, P163, DOI 10.1023/A:1010039813107; Sigsgaard L, 2007, B ENTOMOL RES, V97, P533, DOI 10.1017/S0007485307005196; Sogawa K, 2003, CHINESE J RICE SCI, V17, P47; Tian JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035164; Ye GY, 2001, J ECON ENTOMOL, V94, P271, DOI 10.1603/0022-0493-94.1.271; Ye RJ, 2009, PEST MANAG SCI, V65, P1015, DOI 10.1002/ps.1788; Zaidi MA, 2009, MOL BIOTECHNOL, V43, P232, DOI 10.1007/s12033-009-9201-9	28	158	163	5	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84724	10.1371/journal.pone.0084724	http://dx.doi.org/10.1371/journal.pone.0084724			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24824601	Green Published, gold, Green Submitted			2022-12-27	WOS:000329922500016
J	Wang, ZT; Akamatsu, T; Wang, KX; Wang, D				Wang, Zhitao; Akamatsu, Tomonari; Wang, Kexiong; Wang, Ding			The Diel Rhythms of Biosonar Behavior in the Yangtze Finless Porpoise (Neophocaena asiaeorientalis asiaeorientalis) in the Port of the Yangtze River: The Correlation between Prey Availability and Boat Traffic	PLOS ONE			English	Article							PANTROPICAL SPOTTED DOLPHINS; PHOCAENOIDES-ASIAEORIENTALIS; ECHOLOCATION BEHAVIOR; TEMPORAL PATTERNS; BEAKED-WHALES; FOOD-HABITS; CONSERVATION; SIGNALS; SONAR; MOVEMENTS	Information on the habitat use of the critically endangered Yangtze finless porpoise (Neophocaena asiaeorientalis asiaeorientalis) is critical for its conservation. The diel biosonar behavior of the porpoise in the port areas of the Yangtze River was examined along with simultaneous observations of fish density and boat traffic. Biosonar pulses from the porpoises were detected for 1233 min (5.77%) over a 21,380 min duration of effective observations. In total, 190 (5.63%) buzzes (an indication of prey capture attempts) were recorded among the 3372 identified click trains. Of the 168 echolocation encounters (bouts of click trains less than eight min apart), 150 (89.3%) involved single animals, indicating that solitary porpoises were frequently present and feeding in the port areas. Significant diel patterns were evident involving the biosonar behavior of the porpoises (including click trains and buzzes), fish density and boat traffic. The frequencies of the click trains and buzzes were significantly lower during the day than in the evening and at night, which suggests that porpoises in this region are primarily engaged in crepuscular and nocturnal foraging. The lack of a significant diel pattern in the echolocation encounters indicates the importance of the port in porpoise conservation. A forced feeding schedule may be associated with the lack of a significant correlation between porpoise acoustics and boat traffic. Overall, prey availability appears to be the primary factor that attracts porpoises. Additionally, porpoises tend to migrate or remain downstream in the morning and migrate or remain upstream in the evening, most likely to follow their prey. The findings of this study can be used to improve the conservation of the Yangtze finless porpoise.	[Wang, Zhitao; Wang, Kexiong; Wang, Ding] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China; [Wang, Zhitao] Univ Chinese Acad Sci, Beijing, Peoples R China; [Akamatsu, Tomonari] Natl Res Inst Fisheries Engn, Fisheries Res Agcy, Ibaraki, Japan	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Japan Fisheries Research & Education Agency (FRA)	Wang, KX (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China.	wangk@ihb.ac.cn; wangd@ihb.ac.cn	Wang, Zhi-Tao/F-1176-2015; zhang, lingling/HDM-2189-2022; meng, li/GVT-2063-2022	Wang, Zhi-Tao/0000-0002-5734-7385; Chen, Hou-Zao/0000-0001-6805-3182; Zhang, Tong/0000-0003-1148-4322	Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-Z-4]; National Natural Science Foundation of China [31170501, 31070347]; Special Fund for Agro-scientific Research in the Public Interest of the Ministry of Agriculture of China [201203086]; Ministry of Science and Technology of China [2011BAG07B05-3]; State Oceanic Administration of China [201105011-3]; CREST, Japan Science and Technology Agency; Ocean Park Conservation Foundation, Hong Kong; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC011074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R33DA026114] Funding Source: NIH RePORTER	Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest of the Ministry of Agriculture of China; Ministry of Science and Technology of China(Ministry of Science and Technology, China); State Oceanic Administration of China; CREST, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ocean Park Conservation Foundation, Hong Kong; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-Z-4), the National Natural Science Foundation of China (31170501 and 31070347), the Special Fund for Agro-scientific Research in the Public Interest of the Ministry of Agriculture of China (201203086), Ministry of Science and Technology of China (2011BAG07B05-3), State Oceanic Administration of China (201105011-3), CREST, Japan Science and Technology Agency and the Ocean Park Conservation Foundation, Hong Kong (There is no grant code). The funders had no roles in designing the study, collecting and analyzing data or preparing and deciding where to publish the manuscript.	Akamatsu T, 2008, J ACOUST SOC AM, V123, P4403, DOI 10.1121/1.2912449; Akamatsu T, 2000, J ACOUST SOC AM, V108, P1353, DOI 10.1121/1.1287841; Akamatsu T, 2005, MAR TECHNOL SOC J, V39, P3, DOI 10.4031/002533205787443980; Akamatsu T, 2005, J ACOUST SOC AM, V117, P3325, DOI 10.1121/1.1893325; Akamatsu T, 2010, J EXP BIOL, V213, P146, DOI 10.1242/jeb.037655; Akamatsu T, 2007, DEEP-SEA RES PT II, V54, P290, DOI 10.1016/j.dsr2.2006.11.006; Au W.W, 2008, PRINCIPLES MARINE BI; Au WWL, 2013, J ACOUST SOC AM, V133, P3119, DOI 10.1121/1.4798360; Baird RW, 2001, CAN J ZOOL, V79, P988, DOI 10.1139/cjz-79-6-988; Barros NB, 2002, RAFFLES B ZOOL, P115; Benoit-Bird KJ, 2004, MAR MAMMAL SCI, V20, P215, DOI 10.1111/j.1748-7692.2004.tb01152.x; Benoit-Bird KJ, 2003, BEHAV ECOL SOCIOBIOL, V53, P364, DOI 10.1007/s00265-003-0585-4; Carlstrom J, 2005, MAR MAMMAL SCI, V21, P1, DOI 10.1111/j.1748-7692.2005.tb01204.x; Dawson S, 2013, ENDANGER SPECIES RES, V21, P45, DOI 10.3354/esr00508; Dong Shou-Yue, 2012, Acta Hydrobiologica Sinica, V36, P246; Evans W.E., 1974, P385; Fabi G, 2002, ICES J MAR SCI, V59, pS309, DOI 10.1006/jmsc.2002.1194; FOOTE KG, 1987, J ACOUST SOC AM, V82, P981, DOI 10.1121/1.395298; Gannier Alexandre, 1999, Aquatic Mammals, V25, P123; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Henderson EE, 2012, MAR MAMMAL SCI, V28, P439, DOI 10.1111/j.1748-7692.2011.00498.x; Johnston DW, 2008, BIOL LETTERS, V4, P208, DOI 10.1098/rsbl.2007.0614; Kajimura H., 1981, FISH B-NOAA, V78, P951; Keenan SE, 2003, AM FISH S S, V36, P167; Kimura S, 2013, J ACOUST SOC AM, V133, P3128, DOI 10.1121/1.4796129; Kimura S, 2012, MAR MAMMAL SCI, V28, P308, DOI 10.1111/j.1748-7692.2011.00490.x; Kimura S, 2009, J ACOUST SOC AM, V125, P547, DOI 10.1121/1.3021302; Leeney RH, 2011, AQUAT MAMM, V37, P151, DOI 10.1578/AM.37.2.2011.151; Li S., 2008, BIOACOUSTICS, V17, P174, DOI [10.1080/09524622.2008.9753806, DOI 10.1080/09524622.2008.9753806]; Li SH, 2006, J ACOUST SOC AM, V120, P1803, DOI 10.1121/1.2335674; Li SH, 2010, WILDL PROT DESTR EXT, P343; Lin PC, 2013, J APPL ICHTHYOL, V29, P1402, DOI 10.1111/jai.12342; Linnenschmidt M, 2013, MAR MAMMAL SCI, V29, pE77, DOI 10.1111/j.1748-7692.2012.00592.x; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Madsen PT, 2005, J EXP BIOL, V208, P181, DOI 10.1242/jeb.01327; Miller PJO, 2004, P ROY SOC B-BIOL SCI, V271, P2239, DOI 10.1098/rspb.2004.2863; Payne NL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2363; Pilleri G., 1970, P27; Rasmussen MH, 2013, DEEP-SEA RES PT II, V88-89, P97, DOI 10.1016/j.dsr2.2012.07.011; Reubens JT, 2014, J SEA RES, V85, P214, DOI 10.1016/j.seares.2013.05.005; Richard S, 2010, SCIENCE, V329, P378; Robertson KM, 1997, FISH B-NOAA, V95, P334; Sasaki-Yamamoto Y, 2013, MAR MAMMAL SCI, V29, P589, DOI 10.1111/j.1748-7692.2012.00590.x; Scott MD, 2009, MAR MAMMAL SCI, V25, P137, DOI 10.1111/j.1748-7692.2008.00241.x; Shirakihara M, 2008, J MAMMAL, V89, P1248, DOI 10.1644/07-MAMM-A-264.1; Soldevilla MS, 2010, J ACOUST SOC AM, V127, P124, DOI 10.1121/1.3257586; Todd VLG, 2009, ICES J MAR SCI, V66, P734, DOI 10.1093/icesjms/fsp035; Turvey ST, 2007, BIOL LETTERS, V3, P537, DOI 10.1098/rsbl.2007.0292; Wang D., 2013, NEOPHOCAENA ASIAEORI, V2013, DOI DOI 10.2305/IUCN.UK.2013-1.RLTS.T43205774A45893487.EN; Wang D, 2009, CHINESE SCI BULL, V54, P3473, DOI 10.1007/s11434-009-0522-7; Wang KX, 2005, J ACOUST SOC AM, V118, P1180, DOI 10.1121/1.1945487; Wang ZT, 2014, INTEGRATIVE ZOOLOGY, V9; Watwood SL, 2006, J ANIM ECOL, V75, P814, DOI 10.1111/j.1365-2656.2006.01101.x; Wei Zhou, 2003, Acta Zoologica Sinica, V49, P163; Xiao JQ, 2005, ZOO BIOL, V24, P531, DOI 10.1002/zoo.20070; Yerushalmi S, 2009, ECOL LETT, V12, P970, DOI 10.1111/j.1461-0248.2009.01343.x; Zar J.H., 1999, ZAR KUHR 5 2019, V4th; Zhao XJ, 2008, BIOL CONSERV, V141, P3006, DOI 10.1016/j.biocon.2008.09.005; Zimmer WM., 2011, PASSIVE ACOUSTIC MON, DOI 10.1017/CBO9780511977107	59	444	463	25	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97907	10.1371/journal.pone.0097907	http://dx.doi.org/10.1371/journal.pone.0097907			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	25116432	Green Published, Green Submitted, gold			2022-12-27	WOS:000336369200137
J	Wang, ZL; Luo, XF; Li, MT; Xu, D; Zhou, S; Chen, HZ; Gao, N; Chen, Z; Zhang, LL; Zeng, XF				Wang, Zhuo-Long; Luo, Xiao-Fang; Li, Meng-Tao; Xu, Dong; Zhou, Shuang; Chen, Hou-Zao; Gao, Na; Chen, Zhen; Zhang, Ling-Ling; Zeng, Xiao-Feng			Resveratrol Possesses Protective Effects in a Pristane-Induced Lupus Mouse Model	PLOS ONE			English	Article							INDUCED APOPTOSIS; BALB/C MICE; AUTOANTIBODIES; MECHANISMS; DIFFERENTIATION; DISEASE; CELLS; SIRT1	Background: Systemic lupus erythematosus (SLE) is a multisystemic autoimmune disease characterized by the production of autoantibodies. To date, no therapy has been found to satisfactorily treat SLE. SIRT1 deficiency results in the development of an autoimmune syndrome in mice, including a high titer of anti-nuclear antibody in serum, immunoglobulin deposition in the kidney, and immune complex glomerulonephritis. Resveratrol is an activator of SIRT1 and possesses anti-inflammation and immune-regulatory properties. Objective: To evaluate the preventative effects of resveratrol on a pristane-induced lupus animal model and assess its putative immune modulation effects. Methods: BALB/c mice received a single intraperitoneal injection of 0.5 ml of pristane on day 1 and then various doses of resveratrol were given to the mice daily starting on day 2 and continuing for seven months. The autoantibodies in serum and supernatants were measured. Single cells isolated from spleen, isolated CD4+ T cells, and CD19+ B cells were cultured with or without resveratrol in vitro and assessed by flow cytometry. Results: Resveratrol attenuated proteinuria, immunoglobuin depositon in kidney, and glomerulonephritis as well as IgG1 and IgG2a in serum in pristane-induced lupus mice. Resveratrol also suppressed CD69 and CD71 expression on CD4+ T cells as well as CD4+ T cell proliferation, induced CD4+ T cell apoptosis, and decreased CD4 IFN gamma(+) Th1 cells and the ratio of Th1/Th2 cells in vitro. In vitro antibody production and proliferation of B cells were also inhibited. Conclusion: Resveratrol possesses protective effects in pristane-induced lupus mice and may represent a novel approach for the management of SLE.	[Wang, Zhuo-Long; Luo, Xiao-Fang; Li, Meng-Tao; Xu, Dong; Zhou, Shuang; Gao, Na; Chen, Zhen; Zhang, Ling-Ling; Zeng, Xiao-Feng] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100021, Peoples R China; [Wang, Zhuo-Long; Luo, Xiao-Fang; Li, Meng-Tao; Xu, Dong; Zhou, Shuang; Gao, Na; Chen, Zhen; Zhang, Ling-Ling; Zeng, Xiao-Feng] Chinese Acad Med Sci, Key Lab Rheumatol & Clin Immunol, Minist Educ, Beijing 100730, Peoples R China; [Chen, Hou-Zao] Peking Union Med Coll, Natl Lab Med Mol Biol, Inst Basic Med Sci, Beijing 100021, Peoples R China; [Chen, Hou-Zao] Chinese Acad Med Sci, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College	Zeng, XF (corresponding author), Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100021, Peoples R China.	zengxfpumc@gmail.com	Wang, Zhi-Tao/F-1176-2015; zhang, lingling/HDM-2189-2022; meng, li/GVT-2063-2022	Wang, Zhi-Tao/0000-0002-5734-7385; Chen, Hou-Zao/0000-0001-6805-3182; Zhang, Tong/0000-0003-1148-4322	Chinese National Key Technology R&D Program, Ministry of Science and Technology [2008BAI59B02]; Chinese National High Technology Research and Development Program, Ministry of Science and Technology [2012AA02A513]; Young Investigator Project, Peking Union Medical College Hospital [I457200]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC011074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R33DA026114] Funding Source: NIH RePORTER	Chinese National Key Technology R&D Program, Ministry of Science and Technology; Chinese National High Technology Research and Development Program, Ministry of Science and Technology(National High Technology Research and Development Program of China); Young Investigator Project, Peking Union Medical College Hospital; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the Chinese National Key Technology R&D Program, Ministry of Science and Technology (2008BAI59B02); the Chinese National High Technology Research and Development Program, Ministry of Science and Technology (2012AA02A513) and the Young Investigator Project, Peking Union Medical College Hospital (I457200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bereswill S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015099; Csiszar A, 2009, HYPERTENSION, V54, P668, DOI 10.1161/HYPERTENSIONAHA.109.133397; Cui XL, 2010, CANCER PREV RES, V3, P549, DOI 10.1158/1940-6207.CAPR-09-0117; Danila MI, 2009, RHEUMATOLOGY, V48, P542, DOI 10.1093/rheumatology/kep012; Dorrie J, 2001, CANCER RES, V61, P4731; Gao XZ, 2012, ANN RHEUM DIS, V71, P129, DOI 10.1136/ard.2011.149831; He MX, 2013, CELL DEATH DIFFER, V20, P188, DOI 10.1038/cdd.2012.148; Hoffman RW, 2004, CLIN IMMUNOL, V113, P4, DOI 10.1016/j.clim.2004.05.001; Imler TJ, 2009, INT IMMUNOPHARMACOL, V9, P134, DOI 10.1016/j.intimp.2008.10.015; Izawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048798; Ko YC, 2011, CANCER LETT, V309, P46, DOI 10.1016/j.canlet.2011.05.014; Kuo PL, 2002, LIFE SCI, V72, P23, DOI 10.1016/S0024-3205(02)02177-X; Kwon HS, 2008, CELL HOST MICROBE, V3, P158, DOI 10.1016/j.chom.2008.02.002; Lee PY, 2008, J EXP MED, V205, P2995, DOI 10.1084/jem.20080462; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Miyake K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/980286; Monneaux F, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2711; Nakata R, 2012, BIOL PHARM BULL, V35, P273, DOI 10.1248/bpb.35.273; Padayatty SJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011414, 10.1371/journal.pone.0015288]; Pervaiz S, 2003, FASEB J, V17, P1975, DOI 10.1096/fj.03-0168rev; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Richards HB, 1999, CLIN EXP IMMUNOL, V115, P547; Roman V, 2002, BRIT J HAEMATOL, V117, P842, DOI 10.1046/j.1365-2141.2002.03520.x; SATOH M, 1995, P NATL ACAD SCI USA, V92, P10934, DOI 10.1073/pnas.92.24.10934; SATOH M, 1994, J EXP MED, V180, P2341, DOI 10.1084/jem.180.6.2341; Savarese E, 2008, ARTHRITIS RHEUM, V58, P1107, DOI 10.1002/art.23407; Sequeira J, 2008, EXP CELL RES, V314, P3069, DOI 10.1016/j.yexcr.2008.07.011; Sestak AL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2176; Sharma S, 2007, CLIN EXP IMMUNOL, V147, P155, DOI 10.1111/j.1365-2249.2006.03257.x; Singh UP, 2010, J PHARMACOL EXP THER, V332, P829, DOI 10.1124/jpet.109.160838; Surh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X; Svajger U, 2010, IMMUNOLOGY, V129, P525, DOI 10.1111/j.1365-2567.2009.03205.x; Takahashi S, 1996, J CLIN INVEST, V97, P1597, DOI 10.1172/JCI118584; Wallace DJ, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-77; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902; Zhu X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017783, 10.1371/journal.pone.0027081]; Zou T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075139; Zunino SJ, 2009, J NUTR, V139, P1603, DOI 10.3945/jn.109.105064	39	444	463	25	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114792	10.1371/journal.pone.0114792	http://dx.doi.org/10.1371/journal.pone.0114792			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25116432	Green Submitted, gold, Green Published			2022-12-27	WOS:000347146700054
J	Wang, Z; Li, Y; Childress, AR; Detre, JA				Wang, Ze; Li, Yin; Childress, Anna Rose; Detre, John A.			Brain Entropy Mapping Using fMRI	PLOS ONE			English	Article							TIME-SERIES ANALYSIS; APPROXIMATE ENTROPY; COMPLEXITY ANALYSIS; SAMPLE ENTROPY; FUNCTIONAL MRI; DEFAULT MODE; NETWORKS; DISEASE; NOVELTY	Entropy is an important trait for life as well as the human brain. Characterizing brain entropy (BEN) may provide an informative tool to assess brain states and brain functions. Yet little is known about the distribution and regional organization of BEN in normal brain. The purpose of this study was to examine the whole brain entropy patterns using a large cohort of normal subjects. A series of experiments were first performed to validate an approximate entropy measure regarding its sensitivity, specificity, and reliability using synthetic data and fMRI data. Resting state fMRI data from a large cohort of normal subjects (n = 1049) from multi-sites were then used to derive a 3-dimensional BEN map, showing a sharp low-high entropy contrast between the neocortex and the rest of brain. The spatial heterogeneity of resting BEN was further studied using a data-driven clustering method, and the entire brain was found to be organized into 7 hierarchical regional BEN networks that are consistent with known structural and functional brain parcellations. These findings suggest BEN mapping as a physiologically and functionally meaningful measure for studying brain functions.	[Wang, Ze; Li, Yin; Childress, Anna Rose] Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA; [Wang, Ze; Detre, John A.] Univ Penn, Dept Radiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Detre, John A.] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Wang, Z (corresponding author), Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA.	zewang@mail.med.upenn.edu	Wang, Zhi-Tao/F-1176-2015; zhang, lingling/HDM-2189-2022; meng, li/GVT-2063-2022	Wang, Zhi-Tao/0000-0002-5734-7385; Chen, Hou-Zao/0000-0001-6805-3182; Zhang, Tong/0000-0003-1148-4322	National Institutes of Health [R21DC011074, 8P41-EB015893, 5R33DA026114-04]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC011074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R33DA026114] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants: R21DC011074, and 8P41-EB015893, and 5R33DA026114-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J, 2008, HUM BRAIN MAP POSTER, P496; Bassett DS, 2012, NEUROIMAGE, V59, P2196, DOI 10.1016/j.neuroimage.2011.10.002; Baumgartner R, 2000, MAGN RESON IMAGING, V18, P845, DOI 10.1016/S0730-725X(00)00171-5; BERGSTROM R M, 1969, Developmental Psychobiology, V2, P139, DOI 10.1002/dev.420020304; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bruna R, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036007; Buxton R., 2002, INTRO FUNCTIONAL MAG; Chen CH, 2012, SCIENCE, V335, P1634, DOI 10.1126/science.1215330; Chen X, 2005, P ANN INT IEEE EMBS, P4212; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; de Araujo DB, 2003, NEUROIMAGE, V20, P311, DOI 10.1016/S1053-8119(03)00306-9; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fernandez A, 2010, ALZ DIS ASSOC DIS, V24, P182, DOI 10.1097/WAD.0b013e3181c727f7; Frith CD, 1995, HUM BRAIN MAPP, V3, P153, DOI 10.1002/hbm.460030209; HITCHCOCK DR, 1967, ICARUS, V7, P149, DOI 10.1016/0019-1035(67)90059-0; Hu ZH, 2006, IEEE IMAGE PROC, P2861, DOI 10.1109/ICIP.2006.313026; Hyvarinen A, 1998, ADV NEUR IN, V10, P273; Kiebel SJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000209; Kolmogorov AN, 1998, THEOR COMPUT SCI, V207, P387, DOI 10.1016/S0304-3975(98)00075-9; Lake DE, 2002, AM J PHYSIOL-REG I, V283, pR789, DOI 10.1152/ajpregu.00069.2002; Li Z, 2012, JMRI; Li ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044556; Liu CY, 2013, J MAGN RESON IMAGING, V38, P36, DOI 10.1002/jmri.23961; Lovelock James, 1979, GAIA NEW LOOK LIFE E; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Palazzolo JA, 1998, AM J PHYSIOL-HEART C, V274, pH1099, DOI 10.1152/ajpheart.1998.274.4.H1099; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Pinker S., 1997, MIND WORKS; Poza J, 2008, ANN BIOMED ENG, V36, P141, DOI 10.1007/s10439-007-9402-y; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Rezek IA, 1998, IEEE T BIO-MED ENG, V45, P1186, DOI 10.1109/10.709563; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Rosso OA, 2001, J NEUROSCI METH, V105, P65, DOI 10.1016/S0165-0270(00)00356-3; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sandler S.I, 2006, CHEM ENG THERMODYNAM; Schrodinger E., 1944, WHAT IS LIFE PHYS AS; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Singer W, 2009, EUR REV, V17, P321, DOI 10.1017/S1062798709000751; Smith AM, 1999, NEUROIMAGE, V9, P526, DOI 10.1006/nimg.1999.0435; Sokunbi MO, 2011, IEEE T BIO-MED ENG, V58, P3206, DOI 10.1109/TBME.2011.2164793; Strange BA, 2005, NEURAL NETWORKS, V18, P225, DOI 10.1016/j.neunet.2004.12.004; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wang Z., 2012, 3 BIENN C REST STAT, P208; Wang Z, 2012, 2012 ANN M ORG HUM B; Wang Z, 2007, NEUROIMAGE, V36, P1139, DOI 10.1016/j.neuroimage.2007.03.072; Wang Z, 2009, NEUROIMAGE, V46, P608, DOI 10.1016/j.neuroimage.2009.03.016; Yang AC, 2013, NEUROBIOL AGING, V34, P428, DOI 10.1016/j.neurobiolaging.2012.05.004; Ze Wang A.M., 2013, 2013 ANN M INT SOC M, P4861; Ze Wang JS, 2013, 2013 ANN M SOC NEUR, P7491; Zhu HT, 2006, 9 INT C CONTR AUT RO, P1	57	444	463	25	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e89948	10.1371/journal.pone.0089948	http://dx.doi.org/10.1371/journal.pone.0089948			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	25116432	Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300008
